data_5mmu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5mmu _Structure_validation_residue.Date_analyzed 2017-02-10 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.482 ' CG2' ' CD2' ' A' ' 118' ' ' HIS . 7.7 p . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.907 0.384 . . . . 0.0 110.618 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -96.4 109.73 22.21 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.2 m -97.27 133.37 41.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.07 0.462 . . . . 0.0 110.62 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -132.26 132.14 42.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.739 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.423 ' C ' ' ND2' ' A' ' 7' ' ' ASN . 7.6 mt-10 -102.25 126.42 49.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.196 0.522 . . . . 0.0 110.613 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.473 ' N ' HD21 ' A' ' 7' ' ' ASN . 0.6 OUTLIER -131.26 161.17 32.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.771 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -155.27 153.12 30.12 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -142.92 141.15 31.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.28 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.73 147.32 22.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.742 0.306 . . . . 0.0 110.913 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -143.17 154.21 43.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 0.0 110.436 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -95.24 27.46 3.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.037 0.446 . . . . 0.0 110.4 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -118.19 125.23 28.04 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.648 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.67 151.2 3.55 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.672 1.581 . . . . 0.0 111.471 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -61.16 -24.24 78.78 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 C-N-CA 122.299 1.999 . . . . 0.0 112.483 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.446 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 68.8 m -70.64 -32.47 69.78 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.406 HH21 ' HB2' ' A' ' 16' ' ' SER . 11.2 mmt-85 -76.24 -59.74 2.63 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 mt -48.36 -48.87 36.24 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.646 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.5 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 16.4 t80 -44.75 -60.17 2.15 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.121 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.446 ' CG ' ' O ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -71.13 -26.32 62.96 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.142 -0.974 . . . . 0.0 110.917 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.07 -16.02 59.38 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.829 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.419 ' CE2' HD11 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -117.6 -6.27 11.14 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.5 ' CG2' ' O ' ' A' ' 19' ' ' PHE . 2.5 m -125.24 -35.99 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 118.5 0.591 . . . . 0.0 112.189 177.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 2.9 mp -92.28 -51.46 5.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.686 0.676 . . . . 0.0 111.412 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -106.93 -2.6 21.08 Favored 'General case' 0 C--O 1.206 -1.213 0 CA-C-O 119.22 -0.419 . . . . 0.0 111.496 -176.274 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.407 ' HB3' ' C ' ' A' ' 22' ' ' PHE . . . -45.08 -34.08 2.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.978 0.894 . . . . 0.0 111.473 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.442 ' HB3' ' HZ1' ' A' ' 54' ' ' LYS . 9.4 p-10 -84.69 12.77 6.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.327 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 25' ' ' ASP . 95.8 m-20 -140.5 -10.85 1.06 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 125.38 1.472 . . . . 0.0 108.269 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.53 ' O ' ' CG1' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -98.59 -48.42 4.99 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 125.499 1.52 . . . . 0.0 109.055 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.0 mt -56.24 -56.24 33.48 Favored Pre-proline 0 C--O 1.215 -0.726 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.24 -26.92 72.12 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 122.534 2.156 . . . . 0.0 114.342 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -68.76 -49.7 56.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.834 0.826 . . . . 0.0 111.725 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.53 ' CG1' ' O ' ' A' ' 29' ' ' LEU . 0.8 OUTLIER -95.08 -34.96 5.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.745 -177.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.448 ' N ' ' HG ' ' A' ' 145' ' ' LEU . . . -105.75 64.1 0.15 Allowed Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -176.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.402 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 86.9 Cg_endo -77.09 -26.66 7.51 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 121.625 1.55 . . . . 0.0 108.188 174.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -42.58 57.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.822 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.97 -77.19 0.12 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.584 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -104.46 145.45 13.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-O 121.377 0.608 . . . . 0.0 109.978 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -78.38 -53.87 6.8 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.998 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.544 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -173.17 166.06 4.9 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.19 0.519 . . . . 0.0 110.569 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.544 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -165.53 144.95 6.49 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.136 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -150.76 145.28 25.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.213 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.12 139.81 18.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.574 0.702 . . . . 0.0 111.143 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -90.75 -38.74 12.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.126 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.47 ' O ' ' CG2' ' A' ' 52' ' ' THR . 26.9 mt-10 -145.57 136.09 24.18 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.335 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.31 -156.05 22.56 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.566 ' ND2' ' H ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -136.06 -6.04 2.11 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 122.345 -0.503 . . . . 0.0 111.047 -179.047 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.494 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 130.7 11.33 2.4 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.8 -171.42 19.58 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.457 ' HD3' ' H ' ' A' ' 74' ' ' ILE . 8.7 Cg_endo -60.06 126.5 20.43 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 122.596 2.197 . . . . 0.0 113.117 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.39 3.28 55.48 Favored Glycine 0 CA--C 1.506 -0.495 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.47 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 45.7 m -94.02 140.74 29.34 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.14 -1.03 . . . . 0.0 111.008 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.97 129.07 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.442 ' HZ1' ' HB3' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -112.48 139.87 47.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.791 0.805 . . . . 0.0 111.11 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -117.89 121.15 39.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.489 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.2 mt -106.69 140.19 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.619 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.9 m -119.23 120.16 36.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.132 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -90.79 -173.41 3.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.38 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.06 143.29 29.92 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -60.64 -60.97 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.985 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.81 61.86 3.39 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.2 m -136.89 175.15 9.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.756 0.313 . . . . 0.0 110.563 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -62.19 -42.61 99.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.825 0.345 . . . . 0.0 110.559 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -91.53 136.12 33.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.547 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.59 -57.73 0.5 Allowed Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -145.8 155.2 42.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.973 0.416 . . . . 0.0 110.642 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 p -153.47 144.49 14.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.217 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -106.66 117.87 35.19 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.465 0.65 . . . . 0.0 112.211 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.478 ' CD2' ' C ' ' A' ' 69' ' ' HIS . 0.3 OUTLIER -109.34 118.87 37.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.74 178.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -102.28 130.78 49.08 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.051 0.453 . . . . 0.0 111.076 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.4 mt -88.81 145.47 7.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.563 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.597 ' C ' ' HG ' ' A' ' 73' ' ' SER . 25.6 t70 -104.1 -56.42 2.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.597 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 68.3 m -166.43 142.56 4.75 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.457 ' H ' ' HD3' ' A' ' 50' ' ' PRO . 10.7 mt -124.0 131.74 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.858 176.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -116.21 88.26 2.85 Favored 'General case' 0 C--O 1.209 -1.039 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.432 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -54.14 -30.69 50.05 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.36 -39.8 70.51 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.229 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.0 m -108.45 -10.31 15.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.953 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.2 m-85 62.74 46.8 5.02 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.629 -0.669 . . . . 0.0 109.818 -178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.3 p -105.73 148.26 27.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.207 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.626 ' CE2' ' CD2' ' A' ' 83' ' ' TYR . 41.8 t80 -140.31 120.33 13.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.694 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 p -127.45 130.33 49.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.812 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.626 ' CD2' ' CE2' ' A' ' 81' ' ' TYR . 11.4 p90 -144.73 170.62 15.75 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.1 m -146.06 136.38 23.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.387 0.613 . . . . 0.0 111.489 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.89 120.41 24.07 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.471 ' CG1' ' N ' ' A' ' 87' ' ' GLU . 2.5 pt -90.24 -45.03 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.489 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 2.9 tp10 -151.17 172.08 16.37 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.861 0.362 . . . . 0.0 110.413 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.595 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.87 177.68 17.87 Favored Glycine 0 CA--C 1.509 -0.334 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.79 2.63 0.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.595 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -68.04 -35.0 77.53 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.689 1.196 . . . . 0.0 110.986 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.64 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.51 13.11 22.75 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.285 0.634 . . . . 0.0 109.538 -178.091 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.505 ' CG2' ' CE1' ' A' ' 131' ' ' HIS . 28.3 p 46.94 -127.04 1.6 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.414 ' N ' ' OG1' ' A' ' 92' ' ' THR . 29.2 t70 -130.34 -11.21 4.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.25 0.548 . . . . 0.0 110.996 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.11 -5.92 20.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.371 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.41 HG23 ' CD1' ' A' ' 98' ' ' ILE . 66.2 mt -97.91 151.48 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -176.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.509 ' OE1' ' CE1' ' A' ' 120' ' ' HIS . 0.8 OUTLIER -88.85 -60.92 1.83 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.395 177.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.437 ' CG ' ' O ' ' A' ' 96' ' ' GLU . 36.9 mtmt -164.89 158.07 16.86 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.44 0.638 . . . . 0.0 111.192 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.41 ' CD1' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -132.75 123.5 49.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 1.161 ' HG ' ' CE1' ' A' ' 118' ' ' HIS . 0.9 OUTLIER -112.48 144.4 42.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.213 0.53 . . . . 0.0 111.398 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.401 ' CE2' ' OG ' ' A' ' 117' ' ' SER . 2.6 m-85 -137.18 130.67 31.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.558 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -129.28 134.3 47.88 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.14 131.68 28.74 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.972 -0.455 . . . . 0.0 110.186 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -124.17 134.48 53.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.66 131.06 45.14 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.004 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.29 136.89 57.64 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.904 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.92 134.22 44.68 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.261 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 19.6 t -121.13 169.99 9.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.882 0.372 . . . . 0.0 110.385 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.405 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.71 -30.22 42.99 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.7 p -90.33 -8.88 49.7 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 118.369 -2.842 . . . . 0.0 115.464 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 154.24 -93.25 0.14 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.443 1.973 . . . . 0.0 109.849 -171.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.1 m -159.16 129.21 5.7 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 126.691 1.996 . . . . 0.0 110.99 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.3 m -100.05 118.53 36.62 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.5 mt -92.17 131.2 39.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.56 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.85 116.62 32.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.6 t -111.89 118.19 34.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.421 0.629 . . . . 0.0 111.443 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.655 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -97.82 135.53 32.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 123.399 0.68 . . . . 0.0 109.565 -178.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.401 ' OG ' ' CE2' ' A' ' 100' ' ' TYR . 18.8 m -118.78 131.8 56.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.57 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 1.161 ' CE1' ' HG ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -136.41 115.11 12.04 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 122.702 1.239 . . . . 0.0 109.472 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -102.91 103.69 13.85 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 120.368 -1.457 . . . . 0.0 109.588 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.509 ' CE1' ' OE1' ' A' ' 96' ' ' GLU . 4.8 t-80 -89.68 104.68 17.22 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.506 0.669 . . . . 0.0 110.367 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.43 ' OG1' ' CG2' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -91.45 164.41 13.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.327 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -112.11 156.63 21.93 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 43.27 -124.45 4.52 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.443 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -95.39 -13.29 24.8 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.289 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.43 ' CG2' ' OG1' ' A' ' 121' ' ' THR . 1.1 tp -48.81 162.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.717 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -152.71 148.59 27.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.908 0.385 . . . . 0.0 111.108 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.4 mm -89.14 124.95 42.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 31.5 tttp -76.27 161.16 28.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.439 0.638 . . . . 0.0 111.469 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 1.2 pm0 -69.97 -45.34 67.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.518 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.09 -25.31 65.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.406 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.505 ' CE1' ' CG2' ' A' ' 92' ' ' THR . 2.7 t-80 -72.7 -51.88 17.53 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.387 0.613 . . . . 0.0 110.886 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.8 m -74.44 -24.22 18.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.45 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -67.22 -46.51 73.6 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 122.382 -0.199 . . . . 0.0 110.932 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 30.7 m -70.02 -43.96 78.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.735 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.57 -46.94 65.21 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -67.66 -45.51 75.06 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.683 -0.304 . . . . 0.0 110.853 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -53.81 -38.92 65.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.443 ' O ' ' CD2' ' A' ' 142' ' ' LEU . 15.9 tttt -68.74 -54.39 16.34 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.6 -43.25 46.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.746 0.784 . . . . 0.0 110.495 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -67.13 -36.51 82.04 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.33 -34.92 82.68 Favored Glycine 0 CA--C 1.519 0.313 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.443 ' CD2' ' O ' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -71.47 -48.36 49.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.589 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -59.47 -25.74 64.66 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -68.76 -40.51 79.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.935 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.483 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -64.45 -56.2 15.75 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.08 0.943 . . . . 0.0 108.746 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.515 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 59.6 mt -54.85 -48.41 74.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.601 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -46.08 -56.89 4.98 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.684 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.8 p -53.51 -42.35 67.25 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.525 0.679 . . . . 0.0 110.615 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.625 ' O ' ' N ' ' A' ' 153' ' ' HIS . 32.7 t80 -56.36 -48.73 76.22 Favored 'General case' 0 C--O 1.194 -1.839 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.515 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 1.9 mm? -65.65 -42.57 91.24 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 120.033 1.288 . . . . 0.0 112.02 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.24 -23.65 66.79 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.25 -13.6 15.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.625 ' N ' ' O ' ' A' ' 149' ' ' TYR . 23.3 m80 -156.32 67.49 4.52 Favored Pre-proline 0 C--N 1.309 -1.174 0 C-N-CA 125.062 1.345 . . . . 0.0 110.695 -178.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.497 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 56.0 Cg_endo -74.8 -3.28 13.66 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 122.495 2.13 . . . . 0.0 111.534 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.551 ' CA ' HD22 ' A' ' 158' ' ' ASN . 3.6 p30 -74.66 5.3 5.0 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.279 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.88 129.99 43.57 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.791 -1.193 . . . . 0.0 113.141 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 2.7 t80 54.51 6.06 0.1 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.551 HD22 ' CA ' ' A' ' 155' ' ' ASP . 1.5 p30 . . . . . 0 CA--C 1.514 -0.436 0 O-C-N 121.166 -0.959 . . . . 0.0 110.405 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 7.4 p . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.755 0.312 . . . . 0.0 111.348 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -97.6 110.03 22.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.52 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.744 ' HG1' ' CE1' ' A' ' 118' ' ' HIS . 62.7 m -95.78 133.37 39.98 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.657 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.526 ' CD2' ' ND2' ' A' ' 7' ' ' ASN . 51.5 t80 -137.75 132.38 32.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.046 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.476 ' C ' HD21 ' A' ' 7' ' ' ASN . 1.2 tt0 -102.48 137.4 40.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 111.296 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.526 ' ND2' ' CD2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -127.55 167.97 15.6 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -178.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -152.56 145.15 24.18 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -154.23 134.76 13.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.458 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.06 146.71 23.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.934 0.397 . . . . 0.0 111.451 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -136.32 154.14 50.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.247 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -98.49 21.84 10.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.173 0.511 . . . . 0.0 110.365 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -116.23 126.35 27.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.494 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -44.88 146.99 2.1 Favored 'Trans proline' 0 C--N 1.327 -0.603 0 C-N-CA 121.805 1.67 . . . . 0.0 111.776 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -57.19 -26.62 70.59 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 122.256 1.97 . . . . 0.0 113.149 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.9 m -70.7 -32.15 69.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -75.03 -57.71 3.73 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 mt -53.28 -35.84 60.53 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.801 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -54.46 -56.05 22.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.641 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.73 -43.2 69.39 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.295 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 26' ' ' ALA . . . -63.67 -3.2 2.1 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.386 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CE2' ' CE1' ' A' ' 143' ' ' PHE . 19.3 t80 -119.66 -8.54 9.92 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.1 m -129.7 -52.33 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.497 ' CD1' ' N ' ' A' ' 25' ' ' ASP . 1.7 pp -96.85 -31.52 12.56 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.497 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -114.25 -5.38 12.99 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 118.858 0.754 . . . . 0.0 111.364 -178.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 21' ' ' ALA . . . -67.7 -43.85 79.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.105 0.479 . . . . 0.0 111.861 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.573 ' CB ' ' HZ2' ' A' ' 54' ' ' LYS . 1.2 m-20 -83.01 12.21 5.27 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 122.101 0.953 . . . . 0.0 110.265 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -129.79 -9.42 4.46 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 26' ' ' ALA . 4.1 mt -93.94 -30.74 14.6 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.211 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.436 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.08 -53.42 58.77 Favored Pre-proline 0 C--O 1.215 -0.732 0 O-C-N 122.025 -0.422 . . . . 0.0 110.613 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 27.2 Cg_endo -63.89 -25.72 67.26 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 122.006 1.804 . . . . 0.0 112.538 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.84 -59.61 2.66 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.662 0.744 . . . . 0.0 112.194 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.49 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 1.3 pt -94.46 -36.14 6.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.909 -176.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.418 ' N ' ' HG ' ' A' ' 145' ' ' LEU . . . -105.87 65.23 0.16 Allowed Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.94 -26.91 9.0 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 C-N-CA 121.591 1.527 . . . . 0.0 108.367 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -74.1 -43.36 57.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.55 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.27 -71.94 0.26 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.896 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.18 144.85 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-O 121.254 0.549 . . . . 0.0 110.669 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -79.44 -50.34 10.95 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.079 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.639 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 52.8 tp60 -174.33 164.66 3.93 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.829 0.347 . . . . 0.0 110.758 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.639 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -166.13 144.74 5.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.076 0.465 . . . . 0.0 110.846 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -150.7 148.18 28.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.143 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.25 139.58 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.524 0.678 . . . . 0.0 110.729 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.1 -39.36 12.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.024 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.517 ' O ' ' CG2' ' A' ' 52' ' ' THR . 16.2 mt-10 -141.28 134.48 29.42 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.756 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.83 -156.6 31.55 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.6 HD22 ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -141.24 -5.15 1.11 Allowed 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.406 -0.467 . . . . 0.0 111.404 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.6 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 141.46 11.94 0.53 Allowed Glycine 0 C--O 1.218 -0.853 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.77 -171.71 19.66 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-N 117.233 0.516 . . . . 0.0 112.066 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -62.05 126.87 19.73 Favored 'Trans proline' 0 C--N 1.321 -0.892 0 C-N-CA 123.168 2.579 . . . . 0.0 113.343 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.72 6.12 57.36 Favored Glycine 0 N--CA 1.462 0.422 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.517 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 73.1 m -93.6 139.31 30.92 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.176 -1.012 . . . . 0.0 111.191 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.28 132.1 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.573 ' HZ2' ' CB ' ' A' ' 27' ' ' ASP . 1.9 mmtp -111.17 139.53 46.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.463 0.649 . . . . 0.0 111.258 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -118.2 113.42 21.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.147 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mt -106.28 138.27 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.662 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.7 m -119.21 118.11 30.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.267 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -93.0 -173.23 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.306 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.08 143.54 48.69 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -60.84 -48.39 82.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.806 0.336 . . . . 0.0 110.978 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.06 61.97 3.29 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.0 m -142.91 175.33 9.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.021 0.438 . . . . 0.0 110.626 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -61.84 -45.52 93.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.66 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.32 138.74 39.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.371 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.14 -52.92 0.59 Allowed Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -142.7 151.73 41.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 110.253 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.85 146.5 11.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.968 0.413 . . . . 0.0 110.672 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -105.58 109.51 21.51 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.35 0.595 . . . . 0.0 111.557 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.536 ' CE1' ' CD1' ' A' ' 83' ' ' TYR . 6.8 t60 -98.81 111.68 23.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.329 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.1 ttt-85 -101.56 131.19 47.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.233 0.54 . . . . 0.0 112.126 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.5 mt -82.31 136.68 22.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.461 -0.79 . . . . 0.0 108.96 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.63 ' C ' ' HG ' ' A' ' 73' ' ' SER . 50.7 t0 -96.97 -56.05 2.68 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.63 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 48.7 m -165.67 141.38 5.09 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.6 mt -124.96 129.62 73.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 79' ' ' TYR . 23.2 m-20 -115.45 88.33 2.86 Favored 'General case' 0 C--O 1.202 -1.401 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.582 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.0 OUTLIER -54.31 -36.17 63.45 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.51 -36.1 43.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 m -107.65 -10.87 15.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.828 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.596 ' N ' ' O ' ' A' ' 75' ' ' ASP . 48.2 m-85 56.68 42.53 26.8 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 121.522 -0.736 . . . . 0.0 110.818 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.26 149.2 28.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.909 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 82' ' ' SER . 3.6 t80 -134.8 126.38 28.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.92 0.391 . . . . 0.0 111.186 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.451 ' N ' ' CD1' ' A' ' 81' ' ' TYR . 85.8 p -126.88 136.49 52.39 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.462 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.536 ' CD1' ' CE1' ' A' ' 69' ' ' HIS . 34.3 p90 -144.88 165.63 27.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.561 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -147.08 134.14 20.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.082 0.468 . . . . 0.0 110.667 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mt -80.4 117.59 21.28 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.438 ' CG1' ' N ' ' A' ' 87' ' ' GLU . 5.1 pt -82.42 -44.69 19.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.718 0.294 . . . . 0.0 111.213 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 88' ' ' GLY . 0.6 OUTLIER -149.14 171.81 15.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.22 177.96 18.19 Favored Glycine 0 CA--C 1.509 -0.319 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.94 2.26 0.23 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.633 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -67.39 -35.08 78.6 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 124.314 1.046 . . . . 0.0 110.468 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.616 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -111.11 6.03 20.53 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 123.358 0.663 . . . . 0.0 110.273 -177.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.564 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 61.7 p 49.61 -126.15 2.14 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 18.8 p-10 -131.74 -10.3 3.51 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.827 -0.546 . . . . 0.0 110.911 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.73 -7.6 19.42 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 68.4 mt -99.71 152.81 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -176.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.443 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -87.43 -59.17 2.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.751 177.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.403 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 6.0 ptpt -171.95 154.25 3.45 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.199 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.65 124.88 73.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.87 144.84 32.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.137 0.494 . . . . 0.0 111.436 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 116' ' ' ILE . 0.4 OUTLIER -140.06 138.94 35.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 179.382 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -128.37 135.15 49.17 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 120.983 0.42 . . . . 0.0 110.737 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 p -133.86 131.24 38.94 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -120.32 135.39 55.03 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.4 mm? -96.46 124.66 40.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.255 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.61 136.62 43.58 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.192 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -73.16 139.57 46.44 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.85 -0.531 . . . . 0.0 110.142 177.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.424 ' N ' ' HA ' ' A' ' 111' ' ' SER . 13.6 t -121.36 170.97 9.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.714 0.292 . . . . 0.0 110.388 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.71 -34.6 50.73 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.5 p -94.76 -6.43 43.05 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 118.809 -2.583 . . . . 0.0 113.595 177.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 160.23 -78.62 0.17 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.082 1.801 . . . . 0.0 112.067 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.424 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 29.2 t -162.76 130.21 3.7 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.973 1.309 . . . . 0.0 111.599 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.7 m -99.97 134.9 42.2 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.105 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 mt -110.57 130.34 64.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.504 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.71 116.81 32.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.1 m -110.75 124.73 52.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.204 0.526 . . . . 0.0 110.865 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.608 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -106.29 135.76 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 C-N-CA 123.033 0.533 . . . . 0.0 109.825 -178.016 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.2 m -109.07 134.39 51.75 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.744 ' CE1' ' HG1' ' A' ' 4' ' ' THR . 41.9 m-70 -135.39 95.31 3.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.209 0.528 . . . . 0.0 111.049 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.426 ' N ' ' CD2' ' A' ' 119' ' ' TYR . 6.4 m-30 -84.56 101.39 12.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.874 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -92.87 98.64 11.51 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.7 p -101.3 174.35 6.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.91 0.862 . . . . 0.0 112.218 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.71 144.5 42.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.334 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.6 -110.0 1.1 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.552 HD21 ' N ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -115.9 1.55 13.37 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.449 -0.442 . . . . 0.0 111.607 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.552 ' N ' HD21 ' A' ' 124' ' ' ASN . 1.6 mp -45.48 161.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.177 0.513 . . . . 0.0 110.434 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.494 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 30.2 tt0 -155.42 148.66 24.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.48 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.3 mm -88.01 125.36 41.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -73.87 161.94 29.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.358 0.599 . . . . 0.0 111.541 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -69.01 -48.54 62.76 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.071 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -58.23 -26.11 62.47 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.985 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.421 ' NE2' ' CG2' ' A' ' 92' ' ' THR . 4.2 t60 -72.92 -49.56 28.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.476 0.655 . . . . 0.0 111.236 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.438 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.1 m -81.08 -27.17 10.76 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -66.62 -46.18 76.69 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.983 -0.448 . . . . 0.0 110.496 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.519 ' CG1' ' H ' ' A' ' 135' ' ' GLY . 7.7 p -69.01 -50.89 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 CA-C-O 121.443 0.64 . . . . 0.0 110.515 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.519 ' H ' ' CG1' ' A' ' 134' ' ' VAL . . . -62.81 -42.29 99.71 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.54 ' HZ3' ' CB ' ' A' ' 136' ' ' LYS . 5.9 ttpm? -67.04 -45.68 76.7 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 122.72 -0.283 . . . . 0.0 110.788 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -53.69 -43.34 68.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.516 ' HZ3' ' HB2' ' A' ' 138' ' ' LYS . 2.7 ttmp? -66.16 -53.6 35.6 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.32 -40.22 34.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.672 0.749 . . . . 0.0 110.726 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.91 -36.24 82.73 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.41 -43.79 98.33 Favored Glycine 0 C--O 1.227 -0.328 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.432 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -62.94 -43.01 99.95 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.505 ' CE1' ' CE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -59.44 -25.81 64.67 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -72.1 -42.7 65.82 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.272 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.49 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -62.44 -56.66 16.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.605 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.548 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 50.6 mt -59.62 -50.71 78.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.23 -177.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 8.9 tt0 -46.87 -56.74 5.8 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.136 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 62.0 m -51.08 -48.15 61.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.191 0.52 . . . . 0.0 111.551 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.549 ' O ' ' N ' ' A' ' 153' ' ' HIS . 0.2 OUTLIER -55.93 -49.43 73.51 Favored 'General case' 0 C--O 1.209 -1.033 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.548 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 1.9 mm? -62.53 -43.85 97.79 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 119.792 1.178 . . . . 0.0 111.77 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.432 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -59.14 -25.4 63.85 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.189 -0.945 . . . . 0.0 108.757 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.453 ' O ' ' ND1' ' A' ' 153' ' ' HIS . 49.2 t0 -99.27 -14.38 19.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.731 0.776 . . . . 0.0 109.91 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.549 ' N ' ' O ' ' A' ' 149' ' ' TYR . 68.3 m80 -154.11 68.16 5.94 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 124.261 1.024 . . . . 0.0 110.494 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.471 ' N ' ' O ' ' A' ' 150' ' ' LEU . 31.4 Cg_endo -68.34 -3.18 10.4 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.991 1.794 . . . . 0.0 110.637 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.596 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 14.4 m-20 -87.03 4.69 40.94 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.074 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.42 131.02 20.6 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.028 -1.67 . . . . 0.0 111.256 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 6.3 t80 55.83 7.19 0.25 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.352 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.677 0.275 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.45 109.36 22.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.704 177.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.2 m -97.92 140.65 31.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.877 0.37 . . . . 0.0 111.071 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -145.14 137.57 25.99 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.332 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.493 ' C ' HD21 ' A' ' 7' ' ' ASN . 15.6 mt-10 -102.29 139.24 38.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.197 0.523 . . . . 0.0 110.76 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.493 HD21 ' C ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -126.48 168.19 14.57 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -178.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.84 139.34 15.89 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -145.62 134.0 21.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.378 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.1 147.87 22.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.929 0.395 . . . . 0.0 111.254 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 p -144.39 154.26 42.8 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.51 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -94.37 27.61 2.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.889 0.376 . . . . 0.0 110.305 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.424 HD11 ' N ' ' A' ' 151' ' ' LYS . 1.3 mt -117.56 125.66 27.93 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.721 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.97 148.47 13.0 Favored 'Trans proline' 0 C--N 1.327 -0.581 0 C-N-CA 121.801 1.667 . . . . 0.0 111.409 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -59.04 -24.98 76.05 Favored 'Trans proline' 0 N--CA 1.482 0.836 0 C-N-CA 122.011 1.808 . . . . 0.0 112.116 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.442 ' C ' ' HZ1' ' A' ' 20' ' ' LYS . 66.3 m -65.72 -35.68 81.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.392 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -77.99 -57.68 3.67 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.1 mt -48.14 -48.25 34.31 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.909 -1.042 . . . . 0.0 108.599 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -48.85 -56.49 8.59 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.307 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.442 ' HZ1' ' C ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -70.21 -23.92 63.02 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.698 -179.775 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.48 -2.84 54.57 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.976 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.482 ' CE2' ' OH ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -119.08 -9.56 9.98 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.418 HG22 HD13 ' A' ' 24' ' ' LEU . 3.0 m -136.1 -36.57 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.584 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 3.2 mp -91.17 -53.05 4.52 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.152 0.887 . . . . 0.0 112.153 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -112.2 -4.68 14.32 Favored 'General case' 0 C--O 1.214 -0.771 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.039 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.16 -41.73 65.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.2 0.524 . . . . 0.0 111.715 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -83.39 17.49 2.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.629 0.728 . . . . 0.0 110.794 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -139.97 -8.89 1.19 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.501 HD22 ' CD1' ' A' ' 149' ' ' TYR . 0.6 OUTLIER -91.34 -33.51 15.27 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.438 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.426 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.74 -53.17 63.62 Favored Pre-proline 0 C--O 1.216 -0.678 0 O-C-N 122.083 -0.385 . . . . 0.0 111.127 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 20.0 Cg_endo -62.56 -24.67 75.28 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 121.876 1.718 . . . . 0.0 112.323 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -70.28 -59.83 2.64 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.73 0.776 . . . . 0.0 112.016 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.49 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 1.3 pt -95.29 -35.72 6.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.282 -176.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.424 ' CA ' ' HG ' ' A' ' 145' ' ' LEU . . . -105.54 64.53 0.14 Allowed Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.401 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 72.6 Cg_endo -76.88 -28.4 6.24 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 121.647 1.565 . . . . 0.0 108.175 174.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.408 ' CG ' ' N ' ' A' ' 37' ' ' ALA . 12.1 pt20 -74.14 -43.17 58.43 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.572 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.408 ' N ' ' CG ' ' A' ' 36' ' ' GLN . . . -72.81 -76.54 0.12 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.947 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.4 mm -99.51 145.08 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 121.092 0.472 . . . . 0.0 110.422 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -77.7 -49.86 13.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.673 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -176.98 166.61 2.46 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.111 0.482 . . . . 0.0 110.543 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.99 143.13 5.35 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.592 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -151.33 153.34 34.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.782 0.325 . . . . 0.0 110.595 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.06 138.52 18.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.597 0.713 . . . . 0.0 111.341 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.5 mp -88.9 -39.07 14.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.905 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.477 ' O ' ' CG2' ' A' ' 52' ' ' THR . 26.4 mt-10 -144.32 136.89 26.75 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.364 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.47 -156.21 22.55 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.709 HD21 ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -135.26 -11.34 2.18 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.09 0.472 . . . . 0.0 110.608 -179.357 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.709 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 136.65 11.08 1.15 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.29 -171.86 19.34 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -59.07 127.01 22.67 Favored 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 122.595 2.196 . . . . 0.0 113.213 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.67 2.14 52.87 Favored Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.477 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 51.8 m -94.42 140.49 29.75 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.146 -1.027 . . . . 0.0 111.753 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -121.51 129.74 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.428 ' HB3' ' HZ3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -114.73 140.44 48.87 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.021 0.438 . . . . 0.0 110.879 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -118.77 123.11 44.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.02 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.2 mt -104.9 140.64 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.86 0.362 . . . . 0.0 110.605 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.8 m -116.52 118.82 33.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.152 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -91.39 -176.44 4.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.316 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.33 142.68 32.11 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.468 ' CD ' ' N ' ' A' ' 61' ' ' GLY . 2.5 pp20? -61.15 -45.22 95.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.817 0.342 . . . . 0.0 111.23 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.468 ' N ' ' CD ' ' A' ' 60' ' ' GLU . . . -91.37 61.53 2.86 Favored Glycine 0 C--N 1.328 0.135 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.8 m -141.96 174.11 10.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.964 0.411 . . . . 0.0 110.816 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -68.16 -39.12 82.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.931 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.55 142.96 27.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.439 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.1 -62.06 0.53 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -146.07 145.29 30.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.952 0.406 . . . . 0.0 110.429 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.74 140.09 41.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.647 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -106.53 114.56 28.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.346 0.594 . . . . 0.0 112.413 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.553 ' CE1' ' CD2' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -92.89 123.89 36.48 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.29 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -100.89 112.4 24.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.012 0.434 . . . . 0.0 111.485 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.4 mt -74.17 135.42 27.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.538 ' C ' ' HG ' ' A' ' 73' ' ' SER . 29.0 m-20 -98.3 -55.67 2.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.538 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 69.5 m -165.97 142.38 5.14 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.6 mt -116.16 131.44 68.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.682 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 79' ' ' TYR . 9.4 t0 -113.97 87.45 2.62 Favored 'General case' 0 C--O 1.207 -1.148 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.513 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 7.2 pt-20 -54.87 -30.1 57.04 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.32 -40.0 70.64 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 m -108.63 -10.68 15.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.901 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.565 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.6 m-85 62.54 42.14 8.94 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.511 -0.743 . . . . 0.0 110.142 -178.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.2 t -116.87 139.8 50.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.233 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.482 ' OH ' ' CE2' ' A' ' 22' ' ' PHE . 41.1 p90 -132.26 132.78 43.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.088 0.47 . . . . 0.0 110.392 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 m -127.09 137.65 53.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.383 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -144.05 166.37 25.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.891 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.5 m -144.89 142.95 30.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.09 0.471 . . . . 0.0 110.828 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.553 ' CD2' ' CE1' ' A' ' 69' ' ' HIS . 7.9 mt -79.97 115.36 19.5 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.9 pt -77.49 -44.8 29.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.783 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -153.47 172.53 16.98 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.618 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.57 177.52 18.02 Favored Glycine 0 CA--C 1.51 -0.221 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -61.7 0.37 0.35 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 122.529 1.157 . . . . 0.0 108.395 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -62.17 -34.51 76.56 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 124.123 0.969 . . . . 0.0 110.236 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.62 ' C ' ' HG1' ' A' ' 92' ' ' THR . 0.0 OUTLIER -110.37 12.84 23.01 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 123.464 0.705 . . . . 0.0 109.935 -177.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.62 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 44.1 p 47.36 -126.31 1.68 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -130.72 -12.64 3.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.019 0.438 . . . . 0.0 111.452 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.23 -6.14 20.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 95.2 mt -98.08 152.17 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 122.159 0.981 . . . . 0.0 113.297 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.506 ' OE2' ' CE1' ' A' ' 120' ' ' HIS . 0.0 OUTLIER -93.44 -52.51 4.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.468 177.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.53 149.02 2.06 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-O 121.178 0.513 . . . . 0.0 111.32 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.406 ' CD1' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.87 126.68 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.488 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 0.1 OUTLIER -109.63 143.89 38.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.803 0.335 . . . . 0.0 111.621 -178.105 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -137.35 127.94 26.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.689 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -129.8 132.49 46.53 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.437 ' OG1' ' CE1' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -139.82 133.82 30.89 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.086 -0.384 . . . . 0.0 110.469 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -122.25 134.41 54.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.908 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.564 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -97.74 127.32 43.6 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.192 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -128.51 136.63 59.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.119 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.14 133.29 44.04 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.752 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -121.88 174.04 7.12 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.69 -34.18 55.95 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.871 -0.492 . . . . 0.0 111.871 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.1 m -76.78 -26.81 54.91 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.841 1.256 . . . . 0.0 114.182 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 159.67 -78.88 0.17 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.522 1.534 . . . . 0.0 111.876 -169.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 83.7 p -166.07 131.72 2.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.594 1.558 . . . . 0.0 111.079 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.8 m -99.29 118.74 36.63 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 54.4 mt -92.14 126.52 44.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.635 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 117.38 33.88 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.2 m -112.35 123.75 50.96 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.329 0.585 . . . . 0.0 111.313 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.638 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -103.53 137.16 33.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 123.591 0.756 . . . . 0.0 109.654 -178.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.95 132.09 55.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.715 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.488 ' ND1' ' O ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -138.38 112.32 8.45 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.405 ' CD1' ' N ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -101.83 108.38 19.84 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.223 -0.298 . . . . 0.0 110.803 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.506 ' CE1' ' OE2' ' A' ' 96' ' ' GLU . 13.8 t-160 -89.59 105.8 18.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.16 0.505 . . . . 0.0 109.679 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.9 p -100.22 178.01 4.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.841 0.829 . . . . 0.0 111.915 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 123' ' ' GLY . 3.8 mtpt -112.54 157.49 21.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.794 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . 35.16 -108.71 0.05 OUTLIER Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.467 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.2 OUTLIER -114.04 7.04 16.67 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.588 -0.36 . . . . 0.0 111.144 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.493 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.6 mp -45.42 160.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.221 0.534 . . . . 0.0 110.594 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.493 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 22.0 mt-10 -152.11 149.6 28.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.257 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 mm -88.21 125.01 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -73.85 161.96 29.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.202 0.525 . . . . 0.0 111.208 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -68.68 -44.41 74.08 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.112 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.57 -26.18 67.79 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.67 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -73.04 -49.32 29.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.106 0.479 . . . . 0.0 111.321 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.411 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.0 m -79.5 -29.72 13.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.176 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.4 tptt -66.92 -45.83 76.69 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.916 -0.49 . . . . 0.0 110.605 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.402 ' CG2' ' N ' ' A' ' 135' ' ' GLY . 24.2 m -70.45 -45.98 72.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.557 0.218 . . . . 0.0 110.567 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.402 ' N ' ' CG2' ' A' ' 134' ' ' VAL . . . -66.58 -46.66 74.67 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 29.3 ttpt -67.05 -46.15 75.26 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.676 -0.308 . . . . 0.0 110.653 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -54.49 -46.28 73.4 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -67.8 -52.29 38.76 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.54 -41.5 41.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.694 0.759 . . . . 0.0 110.616 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -36.33 83.41 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.42 -37.98 94.04 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.425 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -71.14 -42.43 69.19 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -59.54 -22.78 62.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.431 ' HB3' ' HZ3' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -77.3 -37.98 51.57 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.669 179.027 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.49 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.3 mm? -69.61 -56.73 6.47 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.146 0.498 . . . . 0.0 109.894 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.549 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 63.5 mt -54.53 -51.36 50.84 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.48 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -47.65 -55.5 9.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.03 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.402 ' O ' ' OD2' ' A' ' 152' ' ' ASP . 8.7 t -52.56 -43.77 65.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.322 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.621 ' O ' ' N ' ' A' ' 153' ' ' HIS . 20.4 t80 -58.15 -44.77 88.04 Favored 'General case' 0 C--O 1.189 -2.083 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.549 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 1.8 mm? -69.71 -42.84 73.51 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 120.552 -1.342 . . . . 0.0 111.88 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.424 ' N ' HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -61.97 -24.79 67.23 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 121.571 -0.705 . . . . 0.0 109.147 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 149' ' ' TYR . 5.1 p30 -107.32 -12.73 15.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.26 0.552 . . . . 0.0 110.379 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.621 ' N ' ' O ' ' A' ' 149' ' ' TYR . 1.2 t-160 -154.86 66.3 4.97 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 124.795 1.238 . . . . 0.0 110.108 -177.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.11 -3.54 13.47 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 122.761 2.307 . . . . 0.0 112.072 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.61 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 2.3 p30 -80.24 4.63 16.98 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.951 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.411 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -49.08 130.53 18.83 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 119.82 -1.8 . . . . 0.0 111.467 -178.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 6.2 t80 55.08 8.17 0.23 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.331 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.61 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.461 0 O-C-N 121.547 -0.721 . . . . 0.0 110.291 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 CA--C 1.519 -0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -98.51 110.5 23.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.24 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.912 ' HG1' ' CD2' ' A' ' 118' ' ' HIS . 98.3 m -96.41 140.12 31.54 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.828 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -146.96 134.16 20.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.918 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.493 ' C ' HD21 ' A' ' 7' ' ' ASN . 36.8 mt-10 -102.39 132.91 48.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.23 0.538 . . . . 0.0 111.273 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.493 HD21 ' C ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -127.04 166.86 16.79 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -155.95 142.1 18.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.46 139.62 37.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.276 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.515 HG22 ' HG ' ' A' ' 107' ' ' CYS . 0.7 OUTLIER -102.26 147.91 26.1 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.819 0.342 . . . . 0.0 111.532 -179.158 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 t -145.08 154.85 42.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.808 0.337 . . . . 0.0 110.51 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -93.8 24.99 3.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.948 0.404 . . . . 0.0 111.121 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.406 HD11 ' N ' ' A' ' 151' ' ' LYS . 2.1 mt -112.45 129.04 24.76 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.244 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.455 ' HB2' ' HE ' ' A' ' 17' ' ' ARG . 45.6 Cg_exo -46.03 144.63 5.96 Favored 'Trans proline' 0 C--N 1.327 -0.583 0 C-N-CA 121.192 1.261 . . . . 0.0 110.602 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -61.88 -24.55 77.25 Favored 'Trans proline' 0 C--N 1.321 -0.904 0 C-N-CA 122.316 2.011 . . . . 0.0 113.027 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.2 m -70.94 -28.6 64.61 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.455 ' HE ' ' HB2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -76.27 -57.6 3.77 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 mt -51.51 -43.53 62.29 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -47.45 -58.06 4.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.257 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.423 ' O ' HD11 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -69.89 -42.44 73.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 119.16 -1.016 . . . . 0.0 108.674 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.72 -5.12 3.67 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.627 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -120.25 -7.96 9.74 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.1 m -129.91 -49.64 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.495 ' CD1' ' N ' ' A' ' 25' ' ' ASP . 1.6 pp -96.51 -31.46 12.78 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.495 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 10.0 t70 -114.44 -5.79 12.87 Favored 'General case' 0 C--O 1.211 -0.944 0 O-C-N 121.798 -0.564 . . . . 0.0 111.544 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.79 -40.36 92.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.566 0.698 . . . . 0.0 111.978 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -83.58 16.68 2.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.6 0.714 . . . . 0.0 110.109 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -139.62 -9.34 1.23 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.51 HD21 ' CD1' ' A' ' 149' ' ' TYR . 0.3 OUTLIER -100.81 -39.82 7.62 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.001 -178.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.408 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 58.0 mt -53.89 -53.8 53.89 Favored Pre-proline 0 C--O 1.214 -0.79 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.191 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 29.3 Cg_endo -62.33 -25.29 76.38 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 121.876 1.717 . . . . 0.0 112.375 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 tmtp? -66.37 -55.33 16.41 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.984 0.897 . . . . 0.0 111.777 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.474 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 0.9 OUTLIER -95.4 -34.34 5.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.315 -176.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.425 ' N ' ' HG ' ' A' ' 145' ' ' LEU . . . -105.29 64.17 0.13 Allowed Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.407 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 71.7 Cg_endo -76.77 -24.41 10.14 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 N-CA-C 107.938 -1.601 . . . . 0.0 107.938 174.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -74.08 -43.83 56.29 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.273 -1.331 . . . . 0.0 109.494 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.503 ' O ' ' NZ ' ' A' ' 138' ' ' LYS . . . -70.54 -79.02 0.07 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.3 mt -98.93 146.64 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.019 0.437 . . . . 0.0 110.104 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -76.62 -44.36 34.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.81 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.622 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 49.2 tp60 -176.86 163.44 2.24 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.909 0.385 . . . . 0.0 110.773 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.622 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -167.0 143.78 4.56 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.926 0.393 . . . . 0.0 110.36 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.14 150.46 30.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.63 138.13 19.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.651 0.739 . . . . 0.0 110.952 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 8.3 mp -88.45 -39.32 14.33 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.766 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.503 ' O ' ' CG2' ' A' ' 52' ' ' THR . 47.9 mt-10 -142.02 134.22 27.69 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.952 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.62 -156.33 26.61 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.451 ' H ' HD21 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -139.69 -9.7 1.21 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.821 0.343 . . . . 0.0 110.962 -179.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.95 11.38 0.35 Allowed Glycine 0 C--O 1.223 -0.565 0 N-CA-C 111.914 -0.474 . . . . 0.0 111.914 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.43 -172.78 20.11 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 117.562 0.681 . . . . 0.0 111.976 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -60.02 126.59 20.72 Favored 'Trans proline' 0 N--CA 1.483 0.854 0 C-N-CA 122.774 2.316 . . . . 0.0 113.649 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.99 4.0 55.64 Favored Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.503 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 88.9 m -94.23 140.4 29.82 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.135 -1.033 . . . . 0.0 111.296 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -121.15 129.91 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.27 140.34 49.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.083 0.468 . . . . 0.0 110.688 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -118.75 121.74 40.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.011 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.1 mp -100.96 123.61 54.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.1 m -98.42 118.47 35.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.401 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -92.27 168.05 11.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.232 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.92 143.77 32.51 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.93 -48.05 83.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.724 0.297 . . . . 0.0 110.324 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.18 61.49 2.93 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.4 m -137.41 174.93 10.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.623 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -51.37 66.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.674 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -91.67 150.92 20.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.363 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.93 -59.71 0.58 Allowed Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -145.24 155.18 43.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.99 0.424 . . . . 0.0 110.941 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.5 p -154.69 138.35 8.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.821 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.3 mtmm -105.83 118.95 37.92 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.363 0.601 . . . . 0.0 112.228 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.566 ' CE1' ' CD2' ' A' ' 85' ' ' LEU . 1.9 m80 -97.25 114.43 26.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.3 ttp85 -101.2 112.56 25.08 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.123 0.487 . . . . 0.0 111.609 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.0 mt -73.73 134.11 30.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.292 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 73' ' ' SER . 2.2 p30 -98.01 -49.92 4.59 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.296 -0.562 . . . . 0.0 112.298 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.538 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -165.54 143.21 5.82 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.1 mt -126.68 126.46 68.81 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 CA-C-N 113.914 -1.494 . . . . 0.0 108.841 173.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 79' ' ' TYR . 23.4 m-20 -113.88 88.44 2.85 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.466 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 6.9 pt-20 -54.59 -30.62 55.01 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.32 -38.75 59.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.8 m -108.5 -11.02 15.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.777 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.513 ' N ' ' O ' ' A' ' 75' ' ' ASP . 12.3 m-85 62.53 43.29 7.88 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.273 0.559 . . . . 0.0 109.808 -178.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.3 p -105.95 141.06 37.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.802 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -132.59 118.65 19.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.62 0.248 . . . . 0.0 110.684 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.446 ' C ' ' OD2' ' A' ' 72' ' ' ASP . 42.0 t -128.43 143.62 51.02 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.696 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -148.93 173.11 13.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.165 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.93 135.53 23.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.091 0.472 . . . . 0.0 110.895 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.566 ' CD2' ' CE1' ' A' ' 69' ' ' HIS . 9.0 mt -80.24 113.27 18.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.31 -41.79 30.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.803 -178.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.481 ' OE1' ' N ' ' A' ' 88' ' ' GLY . 4.1 tm-20 -157.03 170.69 21.95 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.116 -0.365 . . . . 0.0 110.357 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.604 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 119.65 178.33 16.43 Favored Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -62.28 2.06 0.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 122.884 1.326 . . . . 0.0 108.412 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.604 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -66.0 -33.08 75.0 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 124.35 1.06 . . . . 0.0 110.399 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -109.77 16.2 22.22 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.195 0.598 . . . . 0.0 110.693 -176.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.501 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 65.2 p 43.35 -126.25 0.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.61 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -131.48 -13.29 3.4 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.126 -0.358 . . . . 0.0 111.054 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.1 p -104.68 -5.76 21.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.845 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.423 HG22 ' CD1' ' A' ' 98' ' ' ILE . 57.9 mt -99.53 152.91 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 121.962 0.887 . . . . 0.0 113.107 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -99.95 -49.1 4.44 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.17 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -170.79 147.41 2.76 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-O 121.832 0.825 . . . . 0.0 111.764 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.423 ' CD1' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.62 122.66 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.2 t -106.26 146.0 30.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.197 0.522 . . . . 0.0 111.324 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -139.14 133.53 31.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.286 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -128.75 133.29 48.06 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.21 131.82 37.15 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.002 -0.436 . . . . 0.0 110.254 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -120.22 133.7 55.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.54 129.78 45.73 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -178.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -131.76 137.18 55.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.987 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.24 134.89 44.44 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.728 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.515 ' HG ' HG22 ' A' ' 10' ' ' THR . 30.3 p -121.31 167.69 12.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.73 -27.17 34.76 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.8 m -86.97 -19.5 28.66 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 120.217 2.008 . . . . 0.0 113.743 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.24 -83.73 0.14 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.854 2.169 . . . . 0.0 111.104 -170.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.402 ' N ' ' SG ' ' A' ' 107' ' ' CYS . 27.7 t -164.22 130.96 3.13 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 125.657 1.583 . . . . 0.0 110.971 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 105' ' ' VAL . 39.0 m -99.72 117.82 34.88 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.7 mt -92.25 132.5 36.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.386 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -105.17 117.16 33.3 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.3 m -110.74 117.5 33.62 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.351 0.596 . . . . 0.0 110.783 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.648 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -99.9 135.8 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 123.561 0.744 . . . . 0.0 109.811 -177.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.8 p -104.3 133.98 48.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.912 ' CD2' ' HG1' ' A' ' 4' ' ' THR . 12.2 m80 -136.75 93.28 2.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.081 0.467 . . . . 0.0 109.927 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -87.37 101.77 13.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.835 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -91.51 100.05 12.87 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.1 p -100.7 179.95 4.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.528 0.68 . . . . 0.0 111.937 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.629 ' HZ1' ' CB ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -109.16 155.42 21.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.344 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 41.32 -109.8 0.18 Allowed Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.96 7.14 13.11 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.911 -0.17 . . . . 0.0 111.006 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -47.51 159.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.169 0.509 . . . . 0.0 110.295 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.449 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 38.2 mt-10 -150.57 147.11 27.05 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.056 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.2 mm -89.32 124.57 42.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.439 ' HG2' ' H ' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -75.36 162.49 28.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.473 0.654 . . . . 0.0 111.643 -178.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.19 -34.08 74.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.837 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.439 ' H ' ' HG2' ' A' ' 128' ' ' LYS . 62.9 mt-10 -64.93 -35.6 81.7 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.824 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -68.57 -53.86 20.27 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.173 0.511 . . . . 0.0 110.789 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.0 m -69.23 -20.27 24.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.469 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -66.22 -47.64 73.2 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 122.293 -0.254 . . . . 0.0 110.41 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.88 -48.71 55.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.669 0.271 . . . . 0.0 110.697 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.91 -47.08 89.39 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -67.49 -47.03 71.22 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 122.493 -0.416 . . . . 0.0 110.569 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -55.24 -46.83 76.03 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.503 ' NZ ' ' O ' ' A' ' 37' ' ' ALA . 25.1 tttp -63.28 -54.42 37.41 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.45 -41.76 41.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.771 0.796 . . . . 0.0 110.116 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -63.11 -36.72 84.56 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.229 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.09 -47.58 90.11 Favored Glycine 0 C--O 1.226 -0.36 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -64.71 -44.81 89.04 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -59.46 -23.63 62.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -76.67 -37.48 56.14 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.023 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.474 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -67.69 -56.19 10.27 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.354 1.073 . . . . 0.0 109.05 179.2 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.53 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 50.9 mt -53.95 -50.66 51.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.285 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -47.5 -56.89 6.11 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.587 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.1 p -52.98 -40.9 64.1 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.209 0.528 . . . . 0.0 111.468 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.638 ' O ' ' N ' ' A' ' 153' ' ' HIS . 22.1 t80 -61.47 -44.4 97.16 Favored 'General case' 0 C--O 1.193 -1.903 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 2.1 mm? -67.87 -42.71 80.86 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 119.995 1.27 . . . . 0.0 111.335 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.406 ' N ' HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -62.89 -23.81 67.52 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 121.505 -0.747 . . . . 0.0 109.13 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -105.72 -12.86 15.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.922 0.868 . . . . 0.0 110.342 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.638 ' N ' ' O ' ' A' ' 149' ' ' TYR . 0.2 OUTLIER -155.14 66.65 4.94 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 125.393 1.477 . . . . 0.0 110.041 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.42 ' N ' ' O ' ' A' ' 150' ' ' LEU . 39.8 Cg_endo -72.25 -3.44 13.34 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 C-N-CA 122.603 2.202 . . . . 0.0 111.68 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.633 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 4.2 m-20 -84.66 4.12 33.95 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.122 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.444 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -50.1 130.31 22.21 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 119.522 -1.986 . . . . 0.0 111.419 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.408 ' CD1' HD21 ' A' ' 24' ' ' LEU . 0.7 OUTLIER 55.15 6.47 0.15 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.633 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.499 0 O-C-N 121.832 -0.542 . . . . 0.0 110.253 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.234 0.256 0 CA-C-O 120.728 0.299 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -97.64 109.41 22.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.776 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.648 ' HG1' ' CD2' ' A' ' 118' ' ' HIS . 92.8 m -97.18 139.83 32.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 0.0 110.918 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -140.34 129.5 23.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.205 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.476 ' C ' HD21 ' A' ' 7' ' ' ASN . 1.4 tt0 -103.37 126.67 50.66 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.757 0.313 . . . . 0.0 110.894 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.476 HD21 ' C ' ' A' ' 6' ' ' GLU . 2.3 m120 -126.67 165.71 18.71 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.198 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -155.93 139.8 16.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 112.082 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -137.98 139.94 39.95 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.474 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.579 HG22 ' HG ' ' A' ' 107' ' ' CYS . 1.0 OUTLIER -97.27 145.04 26.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.82 0.343 . . . . 0.0 111.521 -179.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.485 ' HG ' ' CD ' ' A' ' 147' ' ' GLU . 3.0 t -145.38 155.06 42.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.534 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -93.23 29.32 1.93 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.894 0.378 . . . . 0.0 110.792 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -113.78 125.25 29.74 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.779 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -49.22 146.01 13.92 Favored 'Trans proline' 0 C--N 1.327 -0.559 0 C-N-CA 121.862 1.708 . . . . 0.0 111.615 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -57.56 -24.6 62.79 Favored 'Trans proline' 0 N--CA 1.483 0.853 0 C-N-CA 122.204 1.936 . . . . 0.0 112.412 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.9 m -67.64 -35.63 79.26 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -75.74 -57.26 3.99 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mt -49.19 -47.11 46.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.09 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -48.04 -56.66 7.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.488 ' CD ' ' O ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -69.99 -38.41 76.0 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 119.101 -1.039 . . . . 0.0 108.479 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.72 -3.71 7.26 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.541 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -119.94 -8.9 9.75 Favored 'General case' 0 CA--C 1.527 0.058 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.419 ' CG2' ' N ' ' A' ' 24' ' ' LEU . 22.3 m -129.31 -49.61 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.516 ' CD1' ' N ' ' A' ' 25' ' ' ASP . 2.7 pp -101.19 -30.53 11.49 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.516 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 50.2 m-20 -110.89 -4.07 15.38 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.813 -0.554 . . . . 0.0 111.398 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.453 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -66.82 -38.79 87.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.704 0.764 . . . . 0.0 112.099 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.492 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 17.3 m-20 -84.09 14.83 3.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.86 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 27' ' ' ASP . 8.2 m120 -138.84 -9.27 1.37 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.48 ' O ' ' CG1' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -92.03 -50.86 5.48 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.515 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.433 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 91.1 mt -55.33 -48.23 96.74 Favored Pre-proline 0 C--O 1.212 -0.884 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 29.7 Cg_endo -62.87 -26.16 74.52 Favored 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 121.773 1.649 . . . . 0.0 113.461 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -75.93 -48.61 20.56 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.662 0.744 . . . . 0.0 112.042 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.48 ' CG1' ' O ' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -94.45 -36.28 6.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.533 -177.262 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.407 ' N ' ' HG ' ' A' ' 145' ' ' LEU . . . -105.95 63.61 0.16 Allowed Pre-proline 0 C--N 1.324 -0.507 0 C-N-CA 122.817 0.447 . . . . 0.0 111.947 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.37 -25.73 9.5 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 N-CA-C 107.625 -1.721 . . . . 0.0 107.625 174.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -74.81 -43.9 52.19 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.609 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.73 -75.13 0.14 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.254 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.56 146.17 9.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.955 0.407 . . . . 0.0 110.221 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -77.66 -52.4 9.04 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.376 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.638 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 54.0 tp60 -175.68 164.0 2.94 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 110.546 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.638 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -166.96 144.0 4.67 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.134 0.492 . . . . 0.0 110.518 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.53 ' N ' ' NZ ' ' A' ' 54' ' ' LYS . 17.7 pt-20 -149.85 156.17 41.33 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.105 -0.372 . . . . 0.0 110.876 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.83 138.87 18.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.554 0.692 . . . . 0.0 111.008 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.97 -39.38 13.02 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.03 -0.987 . . . . 0.0 109.053 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.489 ' O ' ' CG2' ' A' ' 52' ' ' THR . 1.1 tt0 -142.41 138.22 30.95 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.22 -156.68 27.39 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.418 HD21 ' N ' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -135.08 -13.6 2.11 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.593 -0.357 . . . . 0.0 111.079 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.418 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 143.8 10.84 0.38 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.9 -172.99 19.84 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 117.525 0.662 . . . . 0.0 111.75 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.28 127.19 22.19 Favored 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 122.597 2.198 . . . . 0.0 113.207 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.95 1.94 55.01 Favored Glycine 0 CA--C 1.506 -0.512 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 95.8 m -93.59 136.16 34.15 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.313 -0.944 . . . . 0.0 110.761 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mp -109.56 119.22 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' NZ ' ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -109.25 136.4 48.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.781 0.8 . . . . 0.0 109.738 178.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -120.56 129.77 53.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.157 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.432 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 2.5 mp -95.41 136.38 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.4 m -107.97 118.43 36.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.491 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -98.29 166.85 11.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.638 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.7 144.52 30.31 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.81 -58.47 8.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.805 0.336 . . . . 0.0 110.694 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.35 61.6 3.22 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 m -137.41 176.05 9.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.945 0.403 . . . . 0.0 110.684 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -61.07 -52.66 63.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.658 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.26 155.97 18.16 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.05 -61.8 0.14 Allowed Glycine 0 N--CA 1.462 0.393 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.64 155.06 42.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 0.0 110.846 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 p -156.01 145.52 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.187 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.409 ' HZ1' ' CD1' ' A' ' 86' ' ' ILE . 0.4 OUTLIER -101.49 110.52 22.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.32 0.581 . . . . 0.0 111.802 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.487 ' HE2' ' CB ' ' A' ' 83' ' ' TYR . 0.3 OUTLIER -109.62 114.79 28.69 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.11 133.77 46.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.11 0.481 . . . . 0.0 111.693 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.5 mt -80.31 137.51 21.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.585 ' C ' ' HG ' ' A' ' 73' ' ' SER . 37.1 m-20 -95.54 -54.31 3.42 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -177.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.585 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 48.8 m -164.66 141.72 6.27 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.6 mt -128.21 130.0 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.712 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 79' ' ' TYR . 7.4 m-20 -115.61 88.78 2.95 Favored 'General case' 0 C--O 1.211 -0.928 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.414 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 7.4 mt-10 -54.26 -30.07 49.22 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.3 -38.08 70.77 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.426 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.07 -11.46 15.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.978 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 75' ' ' ASP . 7.5 m-85 61.16 41.47 13.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.795 -0.566 . . . . 0.0 110.498 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.9 t -115.41 132.66 56.55 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.736 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.509 ' CE2' ' OG1' ' A' ' 102' ' ' THR . 51.4 p90 -132.45 131.79 42.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.29 0.567 . . . . 0.0 110.92 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.3 t -126.81 145.15 50.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.226 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.487 ' CB ' ' HE2' ' A' ' 69' ' ' HIS . 50.2 p90 -151.26 163.63 38.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.1 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.7 m -146.4 142.5 28.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.233 0.54 . . . . 0.0 111.378 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.7 mt -81.19 120.56 25.03 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.477 ' CG1' ' N ' ' A' ' 87' ' ' GLU . 3.6 pt -80.75 -44.55 21.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.724 0.297 . . . . 0.0 111.665 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.477 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 4.6 tp10 -153.71 171.79 18.3 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.607 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.54 177.77 18.03 Favored Glycine 0 CA--C 1.508 -0.359 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -61.06 2.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.607 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -68.38 -35.06 77.15 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 124.168 0.987 . . . . 0.0 110.102 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.624 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.62 15.68 21.89 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 123.591 0.756 . . . . 0.0 109.799 -178.057 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.502 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 35.4 p 47.19 -126.8 1.65 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -130.74 -12.79 3.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.078 0.466 . . . . 0.0 111.195 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.6 p -105.53 -5.36 20.28 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 79.4 mt -97.55 152.17 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-O 122.16 0.981 . . . . 0.0 113.432 -176.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.424 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -89.41 -59.47 2.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 113.917 -1.492 . . . . 0.0 109.423 178.12 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.536 ' HB2' ' HZ2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -171.69 149.08 2.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.462 0.649 . . . . 0.0 111.285 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.412 ' CD1' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.92 123.24 69.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.4 t -111.14 146.43 36.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.353 0.597 . . . . 0.0 111.956 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -134.7 131.07 37.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.571 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -128.1 133.55 49.03 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.509 ' OG1' ' CE2' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -140.2 132.71 28.63 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.956 -0.465 . . . . 0.0 110.476 -178.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -121.76 133.93 54.92 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.529 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -100.12 126.35 46.36 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.19 137.17 58.6 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.159 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.81 133.92 44.69 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.379 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.579 ' HG ' HG22 ' A' ' 10' ' ' THR . 28.1 p -121.1 172.8 7.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.941 0.401 . . . . 0.0 110.258 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.12 -38.78 61.93 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.1 m -83.53 -15.57 48.82 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.63 1.172 . . . . 0.0 112.871 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 160.75 -85.48 0.11 Allowed Glycine 0 CA--C 1.54 1.596 0 C-N-CA 127.541 2.495 . . . . 0.0 112.794 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.58 130.32 7.46 Favored 'General case' 0 C--N 1.347 0.487 0 C-N-CA 127.995 2.518 . . . . 0.0 111.046 175.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.4 m -99.82 118.45 36.31 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.5 mt -91.83 128.73 43.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.54 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.626 ' CB ' ' HZ1' ' A' ' 114' ' ' LYS . 1.2 mtmp? -105.59 117.05 33.02 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.7 t -111.31 125.23 53.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.238 0.542 . . . . 0.0 110.845 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.646 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -107.17 135.76 44.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 123.22 0.608 . . . . 0.0 110.043 -177.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.2 t -107.1 137.94 44.22 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.885 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.648 ' CD2' ' HG1' ' A' ' 4' ' ' THR . 6.7 m80 -135.67 93.49 2.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.076 0.465 . . . . 0.0 110.589 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -86.56 101.6 13.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.173 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -99.3 107.88 20.28 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.138 0.494 . . . . 0.0 110.546 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.3 p -100.48 173.11 6.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.408 0.623 . . . . 0.0 111.167 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.445 ' HZ1' ' HB2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -108.97 155.17 21.18 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.187 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 40.3 -109.09 0.12 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 124' ' ' ASN . 0.1 OUTLIER -109.51 -1.4 18.3 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 122.779 -0.248 . . . . 0.0 111.213 179.039 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.453 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.4 mp -49.16 151.54 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.269 0.557 . . . . 0.0 109.877 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -147.7 148.29 30.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.642 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.7 mm -87.99 125.46 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -74.33 162.3 29.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.123 0.487 . . . . 0.0 111.798 -178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.4 -34.89 75.18 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.948 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.455 ' N ' ' CD ' ' A' ' 130' ' ' GLU . 0.6 OUTLIER -69.15 -28.62 66.59 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.108 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -72.49 -47.43 48.67 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.112 0.482 . . . . 0.0 111.108 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.4 m -79.29 -28.61 13.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.981 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -66.78 -45.64 77.85 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.169 -0.332 . . . . 0.0 110.855 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.35 -45.6 74.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.718 0.294 . . . . 0.0 110.529 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.9 -44.59 88.6 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 77.9 tttt -65.02 -46.04 83.01 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 122.696 -0.296 . . . . 0.0 110.673 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -54.42 -47.15 73.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.793 0.33 . . . . 0.0 110.135 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.1 ttpp -66.44 -52.99 40.55 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.69 -43.98 47.71 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.589 0.709 . . . . 0.0 110.546 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.37 -36.49 75.85 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -61.03 -42.4 99.78 Favored Glycine 0 C--O 1.22 -0.76 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.406 ' N ' HD21 ' A' ' 142' ' ' LEU . 0.2 OUTLIER -64.0 -46.84 82.74 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -60.74 -24.08 65.44 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -76.5 -38.56 55.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.808 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.477 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.0 OUTLIER -66.94 -57.01 7.76 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.365 0.602 . . . . 0.0 110.092 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.533 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 43.3 mt -55.3 -50.03 68.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.539 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.485 ' CD ' ' HG ' ' A' ' 11' ' ' SER . 15.1 tt0 -47.19 -53.23 13.64 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.667 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.3 m -55.39 -41.72 73.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.232 0.539 . . . . 0.0 110.908 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.657 ' O ' ' N ' ' A' ' 153' ' ' HIS . 22.0 t80 -60.8 -45.44 94.39 Favored 'General case' 0 C--O 1.194 -1.864 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.533 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 2.1 mm? -67.02 -42.95 84.06 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 120.653 1.57 . . . . 0.0 111.449 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -24.02 67.47 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.699 -0.625 . . . . 0.0 109.425 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -106.34 -13.17 15.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.842 0.83 . . . . 0.0 110.415 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.657 ' N ' ' O ' ' A' ' 149' ' ' TYR . 60.7 m80 -156.04 66.81 4.52 Favored Pre-proline 0 C--N 1.303 -1.436 0 C-N-CA 125.32 1.448 . . . . 0.0 110.173 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.86 -2.18 11.87 Favored 'Trans proline' 0 N--CA 1.48 0.708 0 C-N-CA 122.708 2.272 . . . . 0.0 111.154 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.644 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 9.1 m-20 -68.36 2.21 2.46 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.535 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -50.43 130.47 23.62 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 118.841 -2.412 . . . . 0.0 110.924 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 52.34 4.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.644 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 118.18 -0.915 . . . . 0.0 110.052 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.869 0.366 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -98.0 109.99 22.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.682 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.799 ' HG1' ' CE1' ' A' ' 118' ' ' HIS . 74.6 m -95.76 140.09 31.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 0.0 110.796 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -141.5 132.04 25.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.132 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -103.02 137.02 41.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.128 0.489 . . . . 0.0 111.47 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -136.16 165.39 25.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.971 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -155.62 149.63 25.52 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -149.65 140.73 22.99 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.512 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.432 HG22 ' HG ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -96.08 147.83 23.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.874 0.368 . . . . 0.0 111.659 -179.143 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.4 p -140.0 155.74 46.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.446 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -95.93 22.51 7.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.838 0.351 . . . . 0.0 111.044 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.425 ' CD1' ' O ' ' A' ' 147' ' ' GLU . 2.3 mt -119.31 128.07 26.13 Favored Pre-proline 0 C--O 1.217 -0.616 0 CA-C-O 118.946 -0.55 . . . . 0.0 110.375 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -45.7 144.8 5.04 Favored 'Trans proline' 0 C--N 1.325 -0.666 0 C-N-CA 121.68 1.587 . . . . 0.0 110.935 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.13 -23.63 77.64 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 122.172 1.915 . . . . 0.0 112.693 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.453 ' OG ' ' NH1' ' A' ' 17' ' ' ARG . 10.2 t -70.35 -30.18 67.07 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.511 ' N ' ' NE ' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -79.16 -52.3 8.35 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 22' ' ' PHE . 4.3 mt -53.45 -44.75 69.15 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.261 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.441 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 48.7 t80 -49.83 -57.44 7.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.94 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.45 ' CG ' ' O ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -68.63 -27.64 66.2 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.815 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.43 ' CB ' HD12 ' A' ' 150' ' ' LEU . . . -82.95 -1.63 52.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.655 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.59 ' CE1' ' CE2' ' A' ' 143' ' ' PHE . 13.1 t80 -120.31 -7.66 9.75 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' A' ' 19' ' ' PHE . 2.5 m -129.71 -35.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.587 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 4.3 mp -89.49 -54.46 4.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.777 0.717 . . . . 0.0 111.626 -176.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.527 ' CB ' ' CZ ' ' A' ' 157' ' ' TYR . 0.1 OUTLIER -115.8 0.83 13.29 Favored 'General case' 0 C--O 1.199 -1.596 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.341 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.53 -41.87 6.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 119.518 1.053 . . . . 0.0 111.879 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.477 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 4.8 p30 -84.81 17.4 2.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.507 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 27' ' ' ASP . 11.6 m120 -139.68 -10.97 1.18 Allowed 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 125.562 1.545 . . . . 0.0 108.722 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.568 HD22 ' CG ' ' A' ' 149' ' ' TYR . 0.2 OUTLIER -95.07 -43.02 8.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 125.19 1.396 . . . . 0.0 108.334 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.472 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 55.7 mt -54.5 -51.17 80.6 Favored Pre-proline 0 C--O 1.215 -0.73 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.072 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 26.2 Cg_endo -61.96 -22.79 74.97 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 122.148 1.899 . . . . 0.0 111.855 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -68.82 -55.45 11.14 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.505 0.669 . . . . 0.0 111.564 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -94.63 -40.97 11.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.732 -177.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.593 ' HB3' ' CD2' ' A' ' 145' ' ' LEU . . . -110.8 71.13 0.69 Allowed Pre-proline 0 CA--C 1.506 -0.737 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.016 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.21 -6.87 15.73 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 N-CA-C 108.115 -1.533 . . . . 0.0 108.115 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -71.98 -34.82 69.22 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.799 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.55 -82.0 0.11 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.263 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.81 143.66 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.882 0.372 . . . . 0.0 110.353 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -79.33 -43.74 22.95 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.986 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.564 ' NE2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -177.39 165.17 2.19 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.564 ' N ' ' NE2' ' A' ' 40' ' ' GLN . . . -165.47 145.63 6.83 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.751 0.31 . . . . 0.0 110.951 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -136.75 142.76 43.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.74 0.305 . . . . 0.0 110.213 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.57 140.11 17.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.523 0.678 . . . . 0.0 110.472 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.503 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 7.1 mp -88.84 -39.64 13.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.877 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.519 ' O ' ' CG2' ' A' ' 52' ' ' THR . 22.9 mt-10 -142.96 134.09 25.81 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.867 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.86 -156.05 35.89 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.553 HD21 ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -137.54 -0.53 2.16 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.554 -0.38 . . . . 0.0 111.363 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.553 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 134.87 16.24 1.0 Allowed Glycine 0 C--O 1.223 -0.56 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.406 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -110.48 -173.32 20.19 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 117.525 0.662 . . . . 0.0 111.458 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -60.39 125.92 18.68 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 122.181 1.921 . . . . 0.0 113.172 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.7 2.7 58.51 Favored Glycine 0 N--CA 1.462 0.412 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 90.7 m -94.05 140.16 30.07 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.359 -0.921 . . . . 0.0 111.267 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mp -120.68 130.94 74.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.452 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -119.83 140.0 51.49 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.302 0.572 . . . . 0.0 111.02 179.231 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.653 ' HE3' ' HZ3' ' A' ' 68' ' ' LYS . 35.5 ttmt -118.21 124.75 48.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.609 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.562 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 1.4 mp -102.84 129.58 54.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.4 m -112.46 119.88 39.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.248 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -92.63 -174.93 3.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.008 0.432 . . . . 0.0 110.849 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.36 146.63 50.47 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 3.5 mp0 -59.1 -48.96 79.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.869 0.366 . . . . 0.0 110.617 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.92 61.27 3.41 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -138.4 175.62 9.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.248 0.547 . . . . 0.0 110.412 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.591 ' NE2' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -67.1 -53.56 29.72 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.14 156.26 18.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.953 0.406 . . . . 0.0 110.18 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.31 -58.77 0.22 Allowed Glycine 0 CA--C 1.52 0.348 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -143.83 155.02 43.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.168 0.509 . . . . 0.0 110.58 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.52 ' CG1' ' HE2' ' A' ' 69' ' ' HIS . 5.1 p -154.23 146.54 13.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.361 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.653 ' HZ3' ' HE3' ' A' ' 55' ' ' LYS . 14.6 mmtt -107.46 112.43 25.21 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.285 0.564 . . . . 0.0 112.491 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.52 ' HE2' ' CG1' ' A' ' 67' ' ' VAL . 8.8 m-70 -104.83 114.83 29.28 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -101.91 120.76 40.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.653 0.263 . . . . 0.0 111.17 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.0 mp -70.48 145.15 13.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.617 ' C ' ' HG ' ' A' ' 73' ' ' SER . 10.5 t0 -102.02 -55.64 2.45 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.123 -0.36 . . . . 0.0 111.83 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.617 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 43.9 m -165.93 141.02 4.75 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.5 mt -124.53 130.99 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.922 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 79' ' ' TYR . 12.7 m-20 -115.16 87.67 2.71 Favored 'General case' 0 C--O 1.206 -1.213 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.486 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -54.72 -32.39 59.54 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.45 -38.55 66.48 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.43 ' OG ' ' NZ ' ' A' ' 103' ' ' LYS . 1.0 OUTLIER -108.06 -10.78 15.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.055 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.2 m-85 62.58 47.29 5.01 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.45 -0.781 . . . . 0.0 110.341 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.2 p -105.8 144.54 32.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.415 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.633 ' CE2' ' CD2' ' A' ' 83' ' ' TYR . 29.5 t80 -132.2 118.41 19.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.052 0.453 . . . . 0.0 110.712 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.6 p -127.12 130.44 49.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.748 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.633 ' CD2' ' CE2' ' A' ' 81' ' ' TYR . 12.9 p90 -144.8 164.63 30.47 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -140.1 137.01 34.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.329 0.585 . . . . 0.0 110.987 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.409 HD21 ' CE1' ' A' ' 69' ' ' HIS . 0.2 OUTLIER -79.75 118.65 21.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.479 ' CG1' ' N ' ' A' ' 87' ' ' GLU . 2.7 pt -87.27 -45.01 16.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.479 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 35.4 tt0 -152.65 171.76 17.68 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.85 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.611 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.87 177.46 17.87 Favored Glycine 0 CA--C 1.51 -0.245 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -62.16 2.05 0.27 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.611 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -66.01 -33.02 74.84 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 124.754 1.221 . . . . 0.0 110.608 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.604 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -109.75 16.14 22.27 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 123.439 0.695 . . . . 0.0 109.624 -178.08 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.509 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 53.4 p 45.85 -126.49 1.31 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -130.38 -12.99 3.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.96 0.41 . . . . 0.0 111.176 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.9 p -105.17 -6.74 19.56 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.425 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 59.0 mt -98.6 153.01 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 CA-C-O 122.004 0.907 . . . . 0.0 113.256 -176.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.441 ' CG ' ' N ' ' A' ' 97' ' ' LYS . 19.9 pt-20 -99.88 -46.11 5.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.377 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.441 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -172.62 146.83 1.73 Allowed 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 121.723 0.773 . . . . 0.0 112.415 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.14 123.47 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.402 ' HG ' ' CB ' ' A' ' 118' ' ' HIS . 0.1 OUTLIER -102.94 145.08 30.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.138 0.494 . . . . 0.0 111.369 -179.07 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.514 ' CD2' ' O ' ' A' ' 116' ' ' ILE . 0.4 OUTLIER -141.79 129.5 21.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.576 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -128.12 134.6 49.14 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.06 131.82 25.76 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.905 -0.497 . . . . 0.0 109.96 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.43 ' NZ ' ' OG ' ' A' ' 78' ' ' SER . 17.5 ttmm -125.62 134.15 51.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.123 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.615 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -99.9 125.97 45.96 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.116 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -126.2 137.26 58.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.795 -178.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.69 132.73 44.06 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.41 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 111' ' ' SER . 24.2 p -121.4 171.6 8.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.866 0.365 . . . . 0.0 110.293 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.94 -30.77 46.27 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.8 m -85.4 -16.81 38.55 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.379 -2.248 . . . . 0.0 114.352 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.74 -85.57 0.13 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.078 1.799 . . . . 0.0 109.858 -171.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.449 ' N ' ' SG ' ' A' ' 107' ' ' CYS . 0.3 OUTLIER -160.12 129.13 5.0 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.87 1.668 . . . . 0.0 110.921 -178.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 105' ' ' VAL . 33.1 m -99.43 117.8 34.64 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 55.5 mt -91.96 128.81 43.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.766 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -105.89 117.08 33.1 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.88 118.18 34.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.415 0.626 . . . . 0.0 111.556 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.642 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -99.31 135.03 36.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 123.773 0.829 . . . . 0.0 109.915 -178.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.9 136.86 46.91 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.799 ' CE1' ' HG1' ' A' ' 4' ' ' THR . 47.8 m-70 -136.09 97.81 3.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 120.999 0.428 . . . . 0.0 110.801 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.447 ' CD2' ' N ' ' A' ' 119' ' ' TYR . 3.6 m-30 -84.31 101.65 12.1 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.83 -0.434 . . . . 0.0 109.83 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -94.83 102.67 14.53 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.43 HG23 ' CA ' ' A' ' 126' ' ' GLU . 11.9 p -101.31 171.32 7.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.482 0.658 . . . . 0.0 111.421 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -112.35 143.0 44.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.508 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 50.38 -109.71 0.74 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -106.85 -6.51 17.62 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.649 -0.324 . . . . 0.0 111.478 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.421 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.4 mp -47.5 151.42 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.199 0.524 . . . . 0.0 109.751 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.43 ' CA ' HG23 ' A' ' 121' ' ' THR . 12.9 pt-20 -148.18 147.75 29.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.84 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.9 mm -88.19 127.67 41.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -73.76 159.88 32.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.614 0.721 . . . . 0.0 111.684 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.578 ' HB3' ' HZ1' ' A' ' 133' ' ' LYS . 70.0 mm-40 -70.15 -37.89 75.34 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.531 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.69 -26.58 68.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.877 0.37 . . . . 0.0 110.231 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -72.78 -49.23 32.03 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.161 0.505 . . . . 0.0 111.062 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 m -78.25 -28.99 15.08 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.121 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.578 ' HZ1' ' HB3' ' A' ' 129' ' ' GLU . 46.0 mttp -67.23 -46.2 74.5 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 122.004 -0.435 . . . . 0.0 110.746 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 25.8 m -70.42 -42.4 78.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.771 0.32 . . . . 0.0 110.679 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.86 -46.16 54.24 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -66.74 -48.43 69.18 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.568 -0.372 . . . . 0.0 110.911 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -56.03 -47.77 77.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.097 0.475 . . . . 0.0 110.126 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -64.7 -53.85 40.86 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.36 -46.8 37.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.352 0.596 . . . . 0.0 110.564 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -55.37 -37.44 67.55 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.99 -42.25 98.26 Favored Glycine 0 C--O 1.223 -0.532 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -66.49 -32.71 74.24 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 122.243 -0.563 . . . . 0.0 109.943 -179.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.59 ' CE2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -71.48 -20.03 62.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.224 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -72.6 -48.22 41.44 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.294 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.593 ' CD2' ' HB3' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -73.57 -44.33 57.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.165 -179.294 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.515 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 31.2 mt -52.57 -50.51 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.425 ' O ' ' CD1' ' A' ' 13' ' ' ILE . 27.1 tt0 -47.87 -49.43 29.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.1 t -51.74 -46.85 64.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.483 0.659 . . . . 0.0 110.959 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.607 ' O ' ' N ' ' A' ' 153' ' ' HIS . 12.2 t80 -58.55 -43.79 89.43 Favored 'General case' 0 C--O 1.199 -1.582 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.515 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 1.6 mm? -67.91 -43.23 79.7 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 119.675 1.125 . . . . 0.0 111.983 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.9 -24.58 64.42 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.253 -0.904 . . . . 0.0 108.953 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -105.73 -13.81 15.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.331 0.586 . . . . 0.0 110.575 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.607 ' N ' ' O ' ' A' ' 149' ' ' TYR . 0.3 OUTLIER -155.65 66.5 4.63 Favored Pre-proline 0 C--N 1.313 -0.982 0 C-N-CA 124.738 1.215 . . . . 0.0 110.47 -178.583 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.466 ' CD ' ' O ' ' A' ' 150' ' ' LEU . 9.7 Cg_endo -77.47 -8.58 17.26 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 C-N-CA 122.719 2.28 . . . . 0.0 111.743 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.546 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 14.0 t70 -89.94 6.54 41.6 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.388 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.473 ' C ' ' CG ' ' A' ' 157' ' ' TYR . . . -72.34 132.18 43.64 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 120.296 -1.503 . . . . 0.0 110.274 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.527 ' CZ ' ' CB ' ' A' ' 25' ' ' ASP . 1.7 m-85 64.95 9.12 5.15 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.794 176.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.546 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.747 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.669 0.271 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.28 109.78 22.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.694 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.791 ' HG1' ' CE1' ' A' ' 118' ' ' HIS . 61.3 m -96.88 140.01 32.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.802 0.334 . . . . 0.0 111.028 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.88 125.34 16.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.98 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.467 ' C ' ' ND2' ' A' ' 7' ' ' ASN . 0.9 OUTLIER -103.27 130.24 50.46 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.716 0.293 . . . . 0.0 111.429 -179.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.467 ' ND2' ' C ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -131.43 171.34 13.5 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -155.76 155.63 33.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -154.63 140.0 17.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.343 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 m -93.91 146.27 24.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.817 0.341 . . . . 0.0 111.583 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 p -135.15 154.32 51.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.398 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -97.41 26.92 4.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.084 0.468 . . . . 0.0 110.498 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.435 HD13 ' N ' ' A' ' 151' ' ' LYS . 2.2 mt -119.05 125.41 27.67 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.444 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -46.13 147.32 3.76 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 121.826 1.684 . . . . 0.0 111.522 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -59.56 -24.53 75.48 Favored 'Trans proline' 0 N--CA 1.482 0.812 0 C-N-CA 121.983 1.789 . . . . 0.0 112.212 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.47 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 67.1 m -68.13 -34.19 75.9 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -77.8 -56.09 4.79 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 121.395 -0.816 . . . . 0.0 109.272 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 mt -52.47 -43.05 64.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.226 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -54.87 -54.42 42.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 16' ' ' SER . 0.3 OUTLIER -70.89 -25.75 62.92 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.086 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.406 ' CB ' HD12 ' A' ' 150' ' ' LEU . . . -83.06 -2.04 54.31 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.524 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.542 ' CE2' ' CE2' ' A' ' 143' ' ' PHE . 2.8 m-85 -117.31 -7.87 11.15 Favored 'General case' 0 C--N 1.335 -0.035 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.7 m -134.89 -34.75 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.607 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 2.7 mp -88.88 -55.34 3.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.871 1.214 . . . . 0.0 111.443 -176.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.506 ' CG ' ' CE2' ' A' ' 157' ' ' TYR . 0.9 OUTLIER -114.76 -1.32 13.28 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.726 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.405 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . -45.77 -40.71 9.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.696 0.76 . . . . 0.0 111.57 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.493 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER -85.07 18.04 2.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.077 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 27' ' ' ASP . 9.8 m120 -139.53 -9.06 1.25 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 126.087 1.755 . . . . 0.0 108.683 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.491 HD23 ' CD1' ' A' ' 149' ' ' TYR . 0.1 OUTLIER -95.19 -40.99 9.3 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 124.737 1.215 . . . . 0.0 109.939 -179.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.514 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 80.6 mt -55.16 -42.17 94.51 Favored Pre-proline 0 C--O 1.21 -0.985 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.182 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 21.2 Cg_exo -63.79 -26.69 67.83 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 122.098 1.866 . . . . 0.0 112.039 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 tmtp? -71.01 -51.37 25.84 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 122.027 0.918 . . . . 0.0 111.858 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.477 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 0.5 OUTLIER -94.57 -35.23 6.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.008 -176.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.438 ' N ' ' HG ' ' A' ' 145' ' ' LEU . . . -105.48 65.04 0.14 Allowed Pre-proline 0 C--N 1.322 -0.606 0 C-N-CA 122.966 0.507 . . . . 0.0 111.89 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.401 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 73.2 Cg_endo -74.88 -23.05 14.44 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 N-CA-C 107.707 -1.69 . . . . 0.0 107.707 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -73.9 -43.51 58.2 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.315 -1.312 . . . . 0.0 109.231 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.525 ' C ' ' HZ3' ' A' ' 138' ' ' LYS . . . -73.78 -82.72 0.05 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.766 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.5 mt -100.5 145.84 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.083 0.468 . . . . 0.0 110.471 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -77.8 -54.99 5.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.787 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.402 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -174.21 166.4 4.13 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.099 0.476 . . . . 0.0 110.342 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.402 ' H ' ' HG2' ' A' ' 40' ' ' GLN . . . -166.25 144.25 5.47 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.475 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.417 ' N ' ' HE3' ' A' ' 54' ' ' LYS . 8.4 pt-20 -135.93 146.62 47.51 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.46 139.83 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.404 0.621 . . . . 0.0 110.695 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 8.1 mp -88.63 -39.93 13.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.142 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.504 ' O ' ' CG2' ' A' ' 52' ' ' THR . 47.1 mt-10 -142.33 133.98 26.78 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.942 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.39 -156.02 27.69 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.688 HD21 ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -142.45 -6.37 0.92 Allowed 'General case' 0 C--N 1.32 -0.684 0 O-C-N 122.355 -0.497 . . . . 0.0 111.177 -179.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.688 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 143.27 14.12 0.31 Allowed Glycine 0 C--O 1.221 -0.708 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.56 -172.61 19.99 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 117.493 0.647 . . . . 0.0 111.988 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -62.13 126.4 18.59 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 123.113 2.542 . . . . 0.0 113.432 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.44 5.8 57.78 Favored Glycine 0 CA--C 1.505 -0.549 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.504 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 84.3 m -93.37 137.45 32.67 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.339 -0.931 . . . . 0.0 111.128 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.21 129.37 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HE3' ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -116.21 139.06 50.74 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.206 0.526 . . . . 0.0 110.844 179.163 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -118.99 127.11 53.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.704 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.575 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 1.3 mp -98.98 131.98 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.9 m -105.88 118.84 37.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.349 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -98.65 175.46 5.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 110.782 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.61 145.06 49.68 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -59.31 -53.04 62.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.917 0.389 . . . . 0.0 110.736 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.11 61.73 3.29 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.3 m -140.56 175.03 9.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.36 . . . . 0.0 110.826 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -60.47 -56.12 25.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.976 0.417 . . . . 0.0 110.637 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -93.93 155.9 16.91 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.196 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -125.22 -59.78 0.17 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.38 154.17 45.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.091 0.472 . . . . 0.0 110.483 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.541 ' CG1' ' HE2' ' A' ' 69' ' ' HIS . 5.0 p -156.67 147.35 11.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.351 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -107.12 112.42 25.32 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.452 0.644 . . . . 0.0 112.389 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.541 ' HE2' ' CG1' ' A' ' 67' ' ' VAL . 8.0 m170 -101.9 120.58 40.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -102.92 115.79 31.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.629 0.252 . . . . 0.0 111.335 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.8 mt -70.0 135.97 27.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.705 ' CG ' ' HG1' ' A' ' 84' ' ' THR . 1.7 m-20 -96.94 -56.34 2.59 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.583 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 69.4 m -166.08 142.42 5.04 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.9 mt -122.63 131.87 72.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.288 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.586 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -115.35 87.7 2.72 Favored 'General case' 0 C--O 1.206 -1.196 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.109 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.503 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -54.67 -30.96 56.96 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.26 -39.06 72.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.2 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.9 m -107.97 -10.35 15.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.188 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.586 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.1 m-85 62.33 45.17 6.85 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.487 -0.758 . . . . 0.0 110.199 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.8 t -106.56 148.39 28.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.273 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -132.02 125.67 32.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.727 0.299 . . . . 0.0 110.848 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.8 t -133.47 138.41 46.15 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.607 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -144.14 160.83 40.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.698 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.705 ' HG1' ' CG ' ' A' ' 72' ' ' ASP . 10.1 m -140.03 129.88 24.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.327 0.584 . . . . 0.0 111.027 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.2 mt -78.94 119.46 22.13 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 pt -88.32 -43.89 15.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.496 ' CD ' ' N ' ' A' ' 88' ' ' GLY . 8.3 tm-20 -158.89 173.28 16.76 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.222 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.631 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.74 178.51 18.41 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.42 2.55 0.15 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.631 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -70.79 -37.1 73.28 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 123.517 0.727 . . . . 0.0 110.19 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.635 ' C ' ' HG1' ' A' ' 92' ' ' THR . 0.3 OUTLIER -111.39 17.17 20.4 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.635 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 56.7 p 51.93 -132.67 1.91 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -131.64 -0.34 3.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.946 0.403 . . . . 0.0 112.0 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.03 -7.43 19.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.502 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 12.0 mt -99.36 151.67 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.502 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -88.51 -51.53 5.66 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.355 176.026 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.03 148.36 2.23 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.128 0.489 . . . . 0.0 112.182 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.455 ' CD1' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.22 130.4 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 176.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.4 147.0 44.86 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 122.957 0.503 . . . . 0.0 111.436 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -137.39 140.74 41.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.67 0.271 . . . . 0.0 110.916 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -128.04 134.99 49.27 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 121.015 0.436 . . . . 0.0 110.647 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.0 131.0 42.15 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -120.91 133.84 55.29 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.461 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.3 mm? -96.67 124.06 40.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.63 136.91 43.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.065 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.95 140.04 47.14 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.79 177.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 34.9 t -121.47 169.95 10.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.8 0.333 . . . . 0.0 110.444 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.451 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.96 -38.09 59.54 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.819 -0.513 . . . . 0.0 111.819 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.0 m -87.97 -9.9 52.11 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.335 1.054 . . . . 0.0 112.883 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.15 -86.51 0.12 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 126.095 1.807 . . . . 0.0 112.539 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.442 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 0.7 OUTLIER -157.58 129.54 7.07 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 127.517 2.327 . . . . 0.0 111.152 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.6 m -99.37 134.44 42.22 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.1 mt -108.87 129.82 62.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.476 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -106.09 116.68 32.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.4 t -110.47 122.75 48.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.145 0.498 . . . . 0.0 110.437 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.602 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -105.73 135.05 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.027 -177.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.8 p -101.5 140.94 35.1 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.791 ' CE1' ' HG1' ' A' ' 4' ' ' THR . 0.1 OUTLIER -136.14 92.66 2.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.202 0.525 . . . . 0.0 109.909 -179.344 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -90.01 101.36 14.07 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.34 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.466 ' CD2' ' OE2' ' A' ' 96' ' ' GLU . 1.8 t-160 -91.44 103.81 16.4 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.33 160.29 16.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.544 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -112.8 142.84 44.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.229 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.0 -110.39 1.12 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.47 -2.95 11.92 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.769 -0.254 . . . . 0.0 110.675 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.6 tp -48.93 162.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 120.959 0.409 . . . . 0.0 110.862 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -148.41 149.97 32.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.132 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.3 mm -86.82 125.09 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -74.77 162.98 28.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.33 0.586 . . . . 0.0 111.104 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -68.95 -45.54 70.49 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.477 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -60.95 -24.8 66.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.641 0.257 . . . . 0.0 110.645 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.409 ' CD2' ' C ' ' A' ' 131' ' ' HIS . 9.6 t60 -73.04 -52.69 13.41 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.384 0.612 . . . . 0.0 110.989 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.412 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.0 m -76.7 -29.12 17.85 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.039 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.449 ' HB2' ' HZ3' ' A' ' 133' ' ' LYS . 3.7 ttmp? -67.27 -46.05 74.79 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.252 -0.28 . . . . 0.0 111.095 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 30.1 m -70.26 -42.65 78.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.746 0.308 . . . . 0.0 110.685 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.25 -43.75 62.16 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 29.5 ttmt -67.12 -46.49 73.97 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 122.739 -0.271 . . . . 0.0 110.864 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -54.9 -44.12 73.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.525 ' HZ3' ' C ' ' A' ' 37' ' ' ALA . 37.0 tttm -69.3 -56.18 8.3 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.875 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.94 -42.73 38.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.677 0.751 . . . . 0.0 110.746 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -64.13 -36.24 83.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.25 -37.12 92.51 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.416 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -68.05 -47.62 67.87 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.542 ' CE2' ' CE2' ' A' ' 22' ' ' PHE . 5.3 m-85 -59.32 -21.47 59.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -77.04 -38.34 52.95 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.316 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.477 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.9 -57.0 8.89 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.587 179.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.512 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 76.7 mt -53.9 -50.4 53.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.563 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -47.16 -55.02 9.25 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.019 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.7 t -52.94 -44.01 66.75 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.564 0.697 . . . . 0.0 111.392 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.621 ' O ' ' N ' ' A' ' 153' ' ' HIS . 15.4 t80 -58.83 -45.38 90.15 Favored 'General case' 0 C--O 1.195 -1.772 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.512 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 1.7 mm? -67.89 -41.77 82.23 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 119.944 1.247 . . . . 0.0 111.623 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.435 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -60.96 -24.3 65.98 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 121.17 -0.956 . . . . 0.0 108.665 179.45 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.506 ' OD1' ' CE1' ' A' ' 153' ' ' HIS . 33.4 t70 -106.15 -14.27 15.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.125 0.488 . . . . 0.0 110.916 178.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.621 ' N ' ' O ' ' A' ' 149' ' ' TYR . 39.8 m80 -156.19 66.83 4.45 Favored Pre-proline 0 C--N 1.31 -1.113 0 C-N-CA 125.214 1.406 . . . . 0.0 110.235 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.461 ' CD ' ' O ' ' A' ' 150' ' ' LEU . 59.6 Cg_endo -80.76 -4.77 12.97 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 122.7 2.267 . . . . 0.0 111.989 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.507 ' C ' ' ND2' ' A' ' 158' ' ' ASN . 5.3 m-20 -91.13 5.76 47.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.821 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.512 ' C ' HD22 ' A' ' 158' ' ' ASN . . . -72.91 131.36 42.11 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.356 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.506 ' CE2' ' CG ' ' A' ' 25' ' ' ASP . 1.5 m-85 64.38 8.93 4.55 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.778 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.512 HD22 ' C ' ' A' ' 156' ' ' ALA . 1.9 m-80 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.314 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.852 0.358 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -97.7 109.81 22.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.528 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.535 ' HG1' ' CE1' ' A' ' 118' ' ' HIS . 90.8 m -96.6 140.16 31.63 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.947 0.403 . . . . 0.0 110.942 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -143.9 132.08 21.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.005 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -102.2 136.99 41.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.967 0.413 . . . . 0.0 111.146 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.476 ' N ' HD21 ' A' ' 7' ' ' ASN . 0.8 OUTLIER -126.95 168.7 14.16 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.999 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.49 ' N ' ' CD ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -149.16 147.18 28.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.884 0.849 . . . . 0.0 111.73 -178.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.35 135.89 13.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.148 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -101.53 145.59 28.81 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 t -139.89 154.65 47.32 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.336 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -94.51 27.17 3.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.083 0.468 . . . . 0.0 110.908 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mt -113.03 125.76 29.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.558 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -46.68 143.35 9.0 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 121.622 1.548 . . . . 0.0 111.5 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -56.06 -26.17 58.13 Favored 'Trans proline' 0 N--CA 1.483 0.872 0 C-N-CA 122.221 1.947 . . . . 0.0 113.137 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.5 m -70.49 -31.05 68.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 154' ' ' PRO . 0.5 OUTLIER -76.16 -55.88 5.17 Favored 'General case' 0 CA--C 1.498 -1.044 0 O-C-N 121.413 -0.804 . . . . 0.0 108.879 -179.594 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 mt -53.71 -37.88 63.73 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.694 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -53.07 -59.21 4.83 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.48 -42.91 82.21 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 118.859 -1.136 . . . . 0.0 107.963 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 26' ' ' ALA . . . -63.69 -2.58 1.79 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.866 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -116.88 -9.83 11.11 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.7 m -133.49 -50.92 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.513 ' CD1' ' N ' ' A' ' 25' ' ' ASP . 1.9 pp -96.45 -31.5 12.79 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.513 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 6.6 t70 -114.66 -4.9 12.73 Favored 'General case' 0 C--O 1.211 -0.958 0 O-C-N 121.716 -0.615 . . . . 0.0 111.563 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 21' ' ' ALA . . . -66.48 -43.4 85.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.512 0.673 . . . . 0.0 111.809 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.444 ' HB2' ' HZ2' ' A' ' 54' ' ' LYS . 3.1 p30 -84.2 12.44 6.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.24 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -129.99 -9.35 4.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.428 HD23 ' CD2' ' A' ' 149' ' ' TYR . 0.4 OUTLIER -96.64 -34.27 11.46 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.877 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.2 mt -54.06 -56.0 30.54 Favored Pre-proline 0 C--O 1.217 -0.63 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.23 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.57 -24.84 78.6 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 121.979 1.786 . . . . 0.0 112.551 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -67.73 -57.48 6.28 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.856 0.836 . . . . 0.0 112.0 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.489 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 1.2 pt -95.2 -34.95 5.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.196 -176.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.41 ' CA ' ' HG ' ' A' ' 145' ' ' LEU . . . -105.23 64.45 0.13 Allowed Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.414 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 73.2 Cg_endo -76.33 -27.07 8.25 Favored 'Trans proline' 0 C--N 1.322 -0.858 0 C-N-CA 121.672 1.581 . . . . 0.0 108.18 175.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -73.61 -42.77 61.06 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.331 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.493 ' O ' ' NZ ' ' A' ' 138' ' ' LYS . . . -70.03 -79.89 0.06 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.217 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -99.33 147.47 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 121.785 -0.572 . . . . 0.0 110.351 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -77.12 -53.21 8.05 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.297 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.56 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -176.96 166.87 2.49 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 110.613 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.56 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -165.61 145.09 6.45 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.246 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.479 ' N ' ' HZ1' ' A' ' 54' ' ' LYS . 10.9 pt-20 -142.35 144.67 33.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.049 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.435 ' N ' ' HE2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -77.38 139.92 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.404 0.621 . . . . 0.0 110.673 -179.243 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.11 -39.59 13.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.987 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.478 ' O ' ' CG2' ' A' ' 52' ' ' THR . 62.8 mt-10 -148.2 134.91 19.91 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.465 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.98 -156.35 23.61 Favored Glycine 0 CA--C 1.525 0.676 0 O-C-N 123.271 0.357 . . . . 0.0 112.232 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.628 HD21 ' N ' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -137.82 3.28 2.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.896 0.379 . . . . 0.0 111.076 -179.355 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.628 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 122.34 16.28 3.91 Favored Glycine 0 C--O 1.222 -0.65 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -178.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.3 -171.47 19.95 Favored Glycine 0 C--O 1.222 -0.606 0 CA-C-O 121.448 0.471 . . . . 0.0 111.926 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -61.66 125.14 16.01 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 122.514 2.143 . . . . 0.0 113.065 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.22 5.64 59.26 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.478 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 87.0 m -93.39 140.26 29.76 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.457 -0.871 . . . . 0.0 110.851 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.76 132.57 67.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.479 ' HZ1' ' N ' ' A' ' 42' ' ' GLU . 3.9 mmtt -115.34 138.54 50.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.557 0.694 . . . . 0.0 110.957 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -119.52 122.04 40.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.972 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.1 mp -105.49 135.0 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.235 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.0 m -113.26 119.39 37.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.391 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -96.14 -176.88 3.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 110.725 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.43 144.8 47.4 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.573 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 5.5 mp0 -59.63 -54.07 50.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.003 0.43 . . . . 0.0 110.491 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.86 61.2 3.44 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 p -139.25 175.32 9.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.821 0.343 . . . . 0.0 110.751 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -62.08 -52.05 65.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 110.682 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -98.27 142.05 30.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.162 0.506 . . . . 0.0 110.399 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.72 -55.2 0.27 Allowed Glycine 0 N--CA 1.461 0.366 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -135.7 151.31 50.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.935 0.398 . . . . 0.0 110.344 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -156.22 147.5 11.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.595 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -106.05 108.07 19.4 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.042 0.448 . . . . 0.0 112.052 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.522 ' C ' ' ND1' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -109.84 112.96 25.32 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.047 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -107.64 133.01 52.69 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.1 mp -70.0 140.02 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.675 ' CG ' ' HG1' ' A' ' 84' ' ' THR . 1.0 OUTLIER -97.43 -55.07 2.94 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.19 -0.319 . . . . 0.0 111.638 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.579 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 49.7 m -165.05 141.14 5.57 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.5 mt -127.05 131.05 71.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.962 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 79' ' ' TYR . 46.1 m-20 -115.4 88.41 2.87 Favored 'General case' 0 C--O 1.203 -1.364 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -54.93 -30.32 58.41 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.44 -38.26 74.15 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.173 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.459 ' OG ' ' NZ ' ' A' ' 103' ' ' LYS . 0.9 OUTLIER -107.69 -10.4 15.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.944 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.597 ' N ' ' O ' ' A' ' 75' ' ' ASP . 20.3 m-85 59.8 47.46 10.22 Favored 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.49 -0.756 . . . . 0.0 110.372 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.5 t -106.33 145.78 31.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.997 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.608 ' CE1' ' CD2' ' A' ' 83' ' ' TYR . 31.0 t80 -131.71 122.84 26.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.121 0.486 . . . . 0.0 110.888 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 p -131.86 139.04 48.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.268 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.608 ' CD2' ' CE1' ' A' ' 81' ' ' TYR . 10.7 p90 -148.04 162.5 39.23 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.675 ' HG1' ' CG ' ' A' ' 72' ' ' ASP . 3.9 m -139.46 140.69 37.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.322 0.582 . . . . 0.0 111.252 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.416 ' CD1' ' CB ' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -82.77 113.87 20.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.371 178.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.89 -42.63 16.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 2.8 tp10 -153.61 172.96 16.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.964 0.411 . . . . 0.0 110.937 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.63 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.24 177.2 17.65 Favored Glycine 0 CA--C 1.509 -0.315 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.29 2.38 0.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.63 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -65.85 -34.24 77.7 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 124.837 1.255 . . . . 0.0 110.696 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.617 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -109.4 12.76 24.49 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 123.271 0.628 . . . . 0.0 109.905 -177.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.545 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 65.4 p 45.49 -126.27 1.22 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -130.86 -12.47 3.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.961 0.41 . . . . 0.0 111.198 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 p -105.42 -5.62 20.21 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 80.1 mt -97.78 152.34 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 122.239 1.019 . . . . 0.0 113.711 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.439 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -89.34 -60.38 1.96 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.89 178.536 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -168.29 149.22 4.93 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.272 0.558 . . . . 0.0 111.111 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.422 ' CD1' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -123.19 125.53 72.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.36 144.44 43.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.194 0.521 . . . . 0.0 111.311 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -136.34 133.58 36.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.458 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -129.17 135.58 49.03 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-O 120.869 0.366 . . . . 0.0 111.14 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.37 132.12 40.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.459 ' NZ ' ' OG ' ' A' ' 78' ' ' SER . 44.0 tttp -119.88 138.61 53.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.65 0.262 . . . . 0.0 110.486 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.5 mm? -96.98 125.53 41.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.292 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.626 HG11 ' HZ3' ' A' ' 114' ' ' LYS . 1.3 m -137.82 130.31 41.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.0 135.5 43.14 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.062 -0.399 . . . . 0.0 110.761 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.5 m -121.82 170.93 9.29 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 122.551 0.341 . . . . 0.0 110.095 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.97 -34.03 51.39 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.8 m -82.99 -12.38 57.33 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.312 1.445 . . . . 0.0 114.671 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.0 -89.47 0.14 Allowed Glycine 0 CA--C 1.537 1.418 0 C-N-CA 126.246 1.879 . . . . 0.0 111.246 -169.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.2 p -161.76 131.86 4.84 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.752 1.621 . . . . 0.0 110.87 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 46.1 m -98.98 133.18 43.61 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.556 0.693 . . . . 0.0 109.138 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mt -105.21 129.38 58.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.359 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.626 ' HZ3' HG11 ' A' ' 105' ' ' VAL . 6.5 mttp -105.48 117.51 34.21 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.6 m -110.14 117.69 34.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.51 0.671 . . . . 0.0 110.647 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.642 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -98.59 135.53 33.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 123.635 0.774 . . . . 0.0 110.293 -177.73 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.5 m -103.0 141.1 36.38 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.81 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.535 ' CE1' ' HG1' ' A' ' 4' ' ' THR . 2.2 t60 -136.3 93.88 2.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 0.0 110.905 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -92.8 100.31 12.81 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.997 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -92.55 101.06 13.49 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.6 p -97.1 168.67 10.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.754 0.788 . . . . 0.0 112.033 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -112.35 152.69 28.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.03 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . 34.13 -108.91 0.05 OUTLIER Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.47 HD21 ' N ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -105.76 -4.84 20.42 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.662 -0.317 . . . . 0.0 111.442 178.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.47 ' N ' HD21 ' A' ' 124' ' ' ASN . 1.4 mp -47.96 152.79 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -149.41 148.79 29.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.175 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.4 mm -87.62 124.77 41.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -75.31 159.53 31.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.301 0.572 . . . . 0.0 111.908 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -71.2 -35.41 71.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.938 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.448 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 8.0 pt-20 -67.87 -34.2 76.23 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.753 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -68.33 -49.04 63.09 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.154 0.502 . . . . 0.0 110.756 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.401 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 5.5 m -73.38 -22.34 19.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.805 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 57.4 mttt -66.92 -46.21 75.49 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 122.171 -0.33 . . . . 0.0 110.792 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.448 ' CG2' ' O ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -70.51 -44.94 76.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.667 0.27 . . . . 0.0 110.458 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.82 -47.01 69.38 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 0.1 OUTLIER -67.05 -47.01 72.65 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 122.485 -0.42 . . . . 0.0 110.316 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -54.04 -39.69 66.42 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.493 ' NZ ' ' O ' ' A' ' 37' ' ' ALA . 5.0 tttm -69.31 -53.83 17.65 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.12 -42.3 38.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.645 0.736 . . . . 0.0 110.251 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 51.4 t60 -64.09 -36.6 84.57 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.185 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.84 -41.73 99.31 Favored Glycine 0 C--O 1.222 -0.606 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -70.71 -40.3 72.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.511 ' CD2' ' O ' ' A' ' 143' ' ' PHE . 2.3 t80 -61.29 -28.17 69.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -69.32 -40.98 77.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.063 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.4 mm? -64.76 -56.74 11.75 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.722 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.525 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 85.1 mt -54.78 -51.07 55.65 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.991 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 8.8 tt0 -47.66 -57.33 5.63 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.212 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 58.2 m -52.49 -43.78 65.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.139 0.495 . . . . 0.0 111.065 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.616 ' O ' ' N ' ' A' ' 153' ' ' HIS . 56.7 t80 -55.31 -47.67 75.26 Favored 'General case' 0 C--O 1.2 -1.546 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 2.0 mm? -68.55 -43.02 77.52 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 119.836 1.198 . . . . 0.0 112.06 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 147' ' ' GLU . 0.4 OUTLIER -62.09 -24.05 66.88 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 121.375 -0.828 . . . . 0.0 109.267 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -107.17 -13.32 15.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.607 0.717 . . . . 0.0 110.585 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.616 ' N ' ' O ' ' A' ' 149' ' ' TYR . 1.1 t-80 -154.97 65.61 4.69 Favored Pre-proline 0 C--N 1.309 -1.159 0 C-N-CA 124.723 1.209 . . . . 0.0 109.883 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.524 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 53.0 Cg_endo -74.38 -3.47 13.89 Favored 'Trans proline' 0 C--O 1.204 -1.176 0 C-N-CA 122.698 2.266 . . . . 0.0 111.392 -177.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.606 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 1.0 OUTLIER -81.39 4.3 21.34 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 123.009 0.524 . . . . 0.0 112.032 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.46 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -50.07 130.17 21.9 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 119.877 -1.764 . . . . 0.0 111.381 -178.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 1.3 t80 54.48 6.32 0.11 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.476 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.606 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.414 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.237 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.907 0.384 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -99.28 111.52 23.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.617 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.4 m -96.32 139.99 31.64 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.632 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.539 ' CD1' ' ND2' ' A' ' 7' ' ' ASN . 57.0 t80 -136.84 134.14 36.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.612 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -103.33 128.83 50.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.0 0.429 . . . . 0.0 111.078 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.555 ' ND2' ' N ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -138.47 162.93 33.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.087 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.76 160.14 40.05 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.472 ' CE2' ' O ' ' A' ' 10' ' ' THR . 55.3 t80 -147.61 141.14 25.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.44 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.472 ' O ' ' CE2' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -93.14 148.63 21.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.726 0.298 . . . . 0.0 111.275 -179.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -143.91 154.35 43.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.775 0.321 . . . . 0.0 110.718 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -99.92 26.76 6.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.042 0.449 . . . . 0.0 110.634 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -113.74 131.6 22.99 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.317 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -48.89 141.24 22.0 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.148 1.232 . . . . 0.0 110.797 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.1 -23.57 73.93 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 122.365 2.043 . . . . 0.0 112.925 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.4 m -70.14 -30.56 67.76 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.3 mmt-85 -79.43 -54.38 5.98 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mt -48.57 -45.87 38.39 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -49.29 -57.79 6.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.22 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -67.37 -25.42 65.96 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.363 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.413 ' O ' ' CB ' ' A' ' 26' ' ' ALA . . . -84.02 -2.58 56.9 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.563 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.31 -10.94 10.66 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 117.917 0.326 . . . . 0.0 111.828 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.422 HG23 HD13 ' A' ' 24' ' ' LEU . 3.1 m -137.35 -34.61 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.579 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 2.4 mp -89.92 -53.47 4.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.824 0.738 . . . . 0.0 111.889 -176.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 29' ' ' LEU . 93.8 m-20 -112.91 -4.01 14.01 Favored 'General case' 0 C--O 1.216 -0.659 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 21' ' ' ALA . . . -53.67 -43.88 69.21 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.474 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 2.0 m-20 -83.34 18.7 1.7 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.212 0.529 . . . . 0.0 110.712 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 27' ' ' ASP . 4.5 m120 -139.37 -8.8 1.28 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.451 HD21 ' CD1' ' A' ' 149' ' ' TYR . 0.8 OUTLIER -92.38 -30.31 15.86 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.156 -178.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.409 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.52 -54.53 47.6 Favored Pre-proline 0 C--O 1.214 -0.787 0 O-C-N 122.2 -0.313 . . . . 0.0 111.419 -179.534 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 18.3 Cg_endo -62.82 -25.52 74.59 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.894 1.729 . . . . 0.0 112.721 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -68.22 -59.74 2.99 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.836 0.827 . . . . 0.0 111.814 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.487 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 1.3 pt -95.95 -35.53 5.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.38 -176.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.437 ' N ' ' HG ' ' A' ' 145' ' ' LEU . . . -105.36 65.24 0.14 Allowed Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.55 -27.17 7.83 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 121.699 1.599 . . . . 0.0 108.474 175.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -74.2 -43.65 56.36 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.633 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.87 -78.6 0.09 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.099 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.8 mm -99.43 144.85 11.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 121.328 0.585 . . . . 0.0 110.017 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -78.42 -53.52 7.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.725 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -178.18 167.6 1.95 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.238 0.542 . . . . 0.0 110.597 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.89 143.87 5.72 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.88 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -140.84 143.86 35.0 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.544 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.2 137.25 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 121.646 0.736 . . . . 0.0 111.823 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.4 mp -87.11 -38.77 16.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.188 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.479 ' O ' ' CG2' ' A' ' 52' ' ' THR . 54.9 mt-10 -148.24 136.83 21.56 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.09 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.09 -155.28 21.85 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.567 HD21 ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -141.13 -5.6 1.11 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 122.894 0.477 . . . . 0.0 110.941 -178.4 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.567 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 131.96 10.84 2.17 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.06 -172.84 19.15 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 117.114 0.457 . . . . 0.0 111.977 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -60.13 127.1 22.04 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 C-N-CA 122.732 2.288 . . . . 0.0 113.356 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.86 2.97 55.13 Favored Glycine 0 CA--C 1.507 -0.439 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 88.8 m -94.3 134.76 36.44 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.265 -0.967 . . . . 0.0 111.368 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -122.67 122.3 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -131.99 151.39 51.77 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 122.83 1.3 . . . . 0.0 110.684 178.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.57 137.57 52.5 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.318 -1.764 . . . . 0.0 112.966 -177.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.9 mm -90.19 140.76 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 64.3 m -110.5 117.33 33.28 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -108.89 166.17 11.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.918 0.39 . . . . 0.0 110.82 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.0 144.44 49.5 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.24 -47.21 86.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.805 0.336 . . . . 0.0 110.785 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.71 61.42 3.47 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.7 m -142.91 178.37 7.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.831 0.348 . . . . 0.0 110.677 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -64.11 -50.43 68.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.923 0.392 . . . . 0.0 110.723 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.83 156.38 17.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.375 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -119.57 -61.41 0.26 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -145.37 155.04 42.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.825 0.345 . . . . 0.0 110.573 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.4 p -156.02 153.75 7.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.77 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -104.87 110.97 23.55 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.53 0.681 . . . . 0.0 111.631 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -103.32 113.51 27.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.84 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -105.75 131.54 52.98 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.022 0.439 . . . . 0.0 111.735 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.5 mt -85.42 145.26 8.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.373 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.531 ' C ' ' HG ' ' A' ' 73' ' ' SER . 52.2 t0 -102.55 -54.89 2.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.531 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 66.7 m -165.88 142.21 5.17 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 45.6 mt -123.05 130.62 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.355 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.2 m-20 -115.25 87.95 2.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.505 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -54.82 -30.29 56.92 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.509 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.85 -38.84 70.62 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.175 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.1 p -108.36 -11.09 15.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.117 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.53 ' N ' ' O ' ' A' ' 75' ' ' ASP . 6.6 m-85 63.17 40.89 8.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.877 -0.515 . . . . 0.0 109.925 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.499 ' C ' ' CD2' ' A' ' 81' ' ' TYR . 6.0 p -109.22 138.65 45.25 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.857 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.901 ' HH ' ' CD1' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -132.13 133.57 44.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.723 0.297 . . . . 0.0 110.375 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 p -127.29 129.76 48.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.878 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -144.15 158.71 43.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.217 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.7 m -147.65 141.85 26.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.119 0.485 . . . . 0.0 111.2 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.7 mt -80.6 120.63 24.8 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.475 ' CG1' ' N ' ' A' ' 87' ' ' GLU . 3.8 pt -80.58 -44.98 21.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.808 0.337 . . . . 0.0 111.836 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.475 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 23.5 tt0 -156.74 172.26 18.92 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.615 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.95 178.12 17.83 Favored Glycine 0 CA--C 1.508 -0.357 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -61.37 1.13 0.22 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.615 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -67.55 -34.3 76.8 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 123.948 0.899 . . . . 0.0 109.963 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.615 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.52 16.38 21.56 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.692 0.797 . . . . 0.0 109.583 -177.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.437 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 37.8 p 49.48 -126.45 2.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -177.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -130.75 -12.9 3.75 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.091 -0.381 . . . . 0.0 111.217 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.0 -6.62 19.88 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.405 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 68.5 mt -99.13 152.36 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -176.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.463 ' CD ' ' CE1' ' A' ' 120' ' ' HIS . 0.0 OUTLIER -90.32 -56.78 3.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.249 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -171.91 150.48 2.6 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.099 0.476 . . . . 0.0 110.867 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.52 125.08 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.473 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 0.7 OUTLIER -105.67 144.5 32.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.006 0.432 . . . . 0.0 112.054 -178.084 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.505 ' CZ ' ' OG ' ' A' ' 117' ' ' SER . 4.8 m-85 -140.2 128.21 22.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.531 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -129.32 133.6 47.52 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.5 OUTLIER -135.55 131.49 36.03 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.9 -0.5 . . . . 0.0 110.45 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.458 ' HZ2' ' HB3' ' A' ' 103' ' ' LYS . 7.1 ttpm? -123.16 134.77 54.16 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.901 ' CD1' ' HH ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -98.53 126.53 44.13 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -125.59 137.14 58.64 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.572 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.62 133.88 44.88 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.873 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 7.1 t -121.22 175.2 6.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.128 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.66 -37.28 67.61 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.2 m -87.32 -6.15 58.62 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.793 1.296 . . . . 0.0 114.327 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 152.91 -88.48 0.13 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.671 1.129 . . . . 0.0 111.808 -174.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 85.5 p -161.98 131.91 4.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.547 1.939 . . . . 0.0 110.715 177.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.2 m -99.17 119.15 37.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.7 mt -91.13 128.95 42.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.36 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 102' ' ' THR . 4.1 mttm -105.45 117.17 33.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.6 m -110.84 121.21 44.78 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 121.459 0.647 . . . . 0.0 111.119 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.674 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -101.9 136.4 34.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 123.457 0.703 . . . . 0.0 109.571 -177.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.505 ' OG ' ' CZ ' ' A' ' 100' ' ' TYR . 23.7 t -118.29 132.36 56.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.651 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.473 ' ND1' ' O ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -137.28 113.71 10.14 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.505 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.676 ' CD2' ' N ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -102.41 102.53 12.87 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.448 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.463 ' CE1' ' CD ' ' A' ' 96' ' ' GLU . 11.6 t-160 -92.0 109.47 20.82 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.233 0.539 . . . . 0.0 110.246 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.6 p -99.65 172.52 7.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.611 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -112.2 143.53 43.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.871 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 54.94 -112.79 3.07 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.439 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.9 OUTLIER -112.9 -1.89 14.46 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.342 -0.504 . . . . 0.0 111.171 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -43.5 160.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.048 0.451 . . . . 0.0 110.614 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.481 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 92.8 mt-10 -148.21 144.28 27.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.038 0.447 . . . . 0.0 111.177 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.9 mm -89.1 125.29 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -74.68 161.18 29.9 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.669 0.747 . . . . 0.0 111.837 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -70.29 -32.14 69.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.418 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.429 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 43.3 mm-40 -70.12 -33.57 71.99 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.746 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -67.33 -51.26 54.6 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.33 0.586 . . . . 0.0 110.629 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.5 m -71.93 -21.53 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.79 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -66.45 -46.56 76.01 Favored 'General case' 0 C--O 1.223 -0.328 0 O-C-N 122.276 -0.265 . . . . 0.0 110.892 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -70.38 -51.15 40.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.726 0.298 . . . . 0.0 110.5 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.78 -47.05 93.14 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -67.96 -47.44 68.63 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 122.616 -0.343 . . . . 0.0 110.916 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -55.32 -47.06 76.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.78 0.324 . . . . 0.0 110.549 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -69.37 -50.2 48.34 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.31 -41.97 39.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.535 0.683 . . . . 0.0 110.528 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -36.4 84.22 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -61.64 -31.17 76.9 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.42 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.4 ' N ' HD21 ' A' ' 142' ' ' LEU . 0.2 OUTLIER -74.18 -47.18 37.34 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.27 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.491 ' CD2' ' N ' ' A' ' 143' ' ' PHE . 1.6 m-30 -59.89 -21.88 61.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -72.52 -41.82 65.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.85 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.487 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.44 -56.53 11.94 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.893 179.3 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.535 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 76.9 mt -53.24 -50.33 47.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.495 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -47.06 -57.02 5.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.751 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.5 t -50.35 -44.95 54.72 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.469 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.651 ' O ' ' N ' ' A' ' 153' ' ' HIS . 20.0 t80 -57.33 -48.77 78.13 Favored 'General case' 0 C--O 1.18 -2.581 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 1.7 mm? -65.1 -42.15 94.27 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 120.449 -1.407 . . . . 0.0 111.974 -177.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.435 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.5 OUTLIER -62.59 -25.25 67.98 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.407 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -107.26 -12.24 15.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.016 0.436 . . . . 0.0 110.687 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.651 ' N ' ' O ' ' A' ' 149' ' ' TYR . 49.5 m-70 -155.54 66.32 4.63 Favored Pre-proline 0 C--N 1.308 -1.215 0 C-N-CA 125.616 1.566 . . . . 0.0 110.411 -177.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.13 -3.27 12.97 Favored 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 122.662 2.241 . . . . 0.0 111.843 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.616 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 1.5 p30 -77.1 3.07 13.34 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.073 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.532 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . . . -50.51 128.79 20.97 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 119.328 -2.108 . . . . 0.0 111.352 -178.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 157' ' ' TYR . 16.5 t80 54.71 7.04 0.14 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.275 0.63 . . . . 0.0 112.137 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.616 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.278 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.074 0.464 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -97.77 110.29 22.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.721 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.7 m -96.97 140.45 31.49 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.577 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.95 134.7 26.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.368 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -102.4 129.69 48.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.582 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -126.71 168.67 14.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.172 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.13 146.98 22.04 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -145.64 140.71 27.52 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.302 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -107.49 147.93 29.85 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 111.804 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.5 t -145.87 162.73 37.07 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.548 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -98.77 24.92 7.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.406 . . . . 0.0 110.931 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mt -108.57 127.69 26.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.2 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.418 ' HB2' ' HE ' ' A' ' 17' ' ' ARG . 38.4 Cg_exo -46.98 144.69 8.06 Favored 'Trans proline' 0 C--N 1.327 -0.571 0 C-N-CA 121.16 1.24 . . . . 0.0 110.743 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -61.02 -24.51 79.72 Favored 'Trans proline' 0 C--N 1.322 -0.843 0 C-N-CA 122.337 2.025 . . . . 0.0 113.031 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.2 m -71.01 -30.3 66.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.418 ' HE ' ' HB2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -75.05 -56.41 4.77 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 22' ' ' PHE . 3.7 mt -51.18 -45.0 61.65 Favored 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.485 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -46.44 -58.96 3.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.427 ' CD ' ' O ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -68.28 -41.56 80.83 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 119.023 -1.071 . . . . 0.0 108.484 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.01 -2.47 2.72 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.236 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 18' ' ' LEU . 2.6 t80 -119.14 -8.71 10.12 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.8 m -131.88 -51.27 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.517 ' CD1' ' N ' ' A' ' 25' ' ' ASP . 1.7 pp -96.4 -31.28 12.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.517 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 45.5 m-20 -114.63 -5.09 12.74 Favored 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 118.439 0.563 . . . . 0.0 111.506 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . -68.56 -44.05 75.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.453 0.644 . . . . 0.0 112.289 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.46 18.15 2.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.882 0.849 . . . . 0.0 109.648 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 26' ' ' ALA . 64.9 m-20 -139.55 -8.31 1.27 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.578 -1.192 . . . . 0.0 107.843 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -96.21 -48.37 5.66 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.0 -178.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.525 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 85.2 mt -54.54 -43.22 97.8 Favored Pre-proline 0 C--O 1.212 -0.916 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.146 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 16.6 Cg_exo -64.46 -25.58 63.1 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.785 1.657 . . . . 0.0 110.97 177.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.02 -57.93 4.42 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.712 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.468 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 0.7 OUTLIER -96.54 -32.66 4.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.779 -176.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 30' ' ' ILE . . . -103.83 63.22 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.447 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 72.6 Cg_endo -75.57 -20.97 15.28 Favored 'Trans proline' 0 C--N 1.32 -0.924 0 N-CA-C 107.063 -1.937 . . . . 0.0 107.063 174.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -73.42 -44.02 59.23 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.76 177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.75 -75.02 0.16 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.266 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.9 mt -98.73 145.9 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 121.046 0.45 . . . . 0.0 110.204 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.83 -51.65 10.14 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.672 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.643 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 50.7 tp60 -177.3 164.62 2.18 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.958 0.409 . . . . 0.0 110.424 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.677 ' CB ' ' HZ1' ' A' ' 54' ' ' LYS . . . -166.02 145.21 6.06 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 120.89 0.376 . . . . 0.0 110.889 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -145.09 145.25 31.35 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.52 139.88 18.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.57 0.7 . . . . 0.0 110.995 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 mp -89.68 -39.27 13.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.963 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.467 ' O ' ' CG2' ' A' ' 52' ' ' THR . 30.2 mt-10 -147.19 136.66 22.75 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.542 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.39 -156.06 22.52 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.529 HD21 ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -142.5 1.48 1.37 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 122.456 -0.437 . . . . 0.0 111.343 -178.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.529 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 127.27 12.27 3.18 Favored Glycine 0 C--O 1.218 -0.864 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.45 -171.68 19.89 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 117.298 0.549 . . . . 0.0 111.905 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -61.86 125.94 17.74 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 C-N-CA 122.68 2.253 . . . . 0.0 113.028 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.76 5.07 56.76 Favored Glycine 0 N--CA 1.464 0.537 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.467 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 91.4 m -93.66 137.91 32.43 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.379 -0.911 . . . . 0.0 110.959 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.55 130.14 72.91 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.677 ' HZ1' ' CB ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -114.52 140.0 49.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.608 0.718 . . . . 0.0 110.761 179.144 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -118.37 123.15 44.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.7 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.524 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 1.8 mp -104.32 123.75 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.6 m -101.42 118.43 36.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.075 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -92.72 -176.74 4.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.72 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.429 ' O ' ' OG ' ' A' ' 62' ' ' SER . . . -71.64 144.45 37.02 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.99 -47.94 84.12 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.991 -0.711 . . . . 0.0 111.073 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.92 61.93 3.34 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 59' ' ' GLY . 0.3 OUTLIER -152.37 174.97 13.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.171 0.51 . . . . 0.0 110.383 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.621 ' NE2' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -65.09 -37.57 87.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.818 0.342 . . . . 0.0 110.603 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -98.76 140.38 33.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.378 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.415 ' O ' ' CD2' ' A' ' 66' ' ' TYR . . . -123.12 -56.2 0.19 Allowed Glycine 0 N--CA 1.461 0.363 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.415 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -145.82 151.35 37.77 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.772 0.32 . . . . 0.0 110.193 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 p -156.71 147.51 11.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.931 0.396 . . . . 0.0 110.945 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -104.81 108.06 19.35 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.298 0.57 . . . . 0.0 110.954 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.531 ' NE2' ' CD2' ' A' ' 83' ' ' TYR . 7.9 t60 -103.06 112.42 25.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.631 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -101.6 131.22 47.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 111.824 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.0 mt -83.08 137.23 21.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.572 ' C ' ' HG ' ' A' ' 73' ' ' SER . 33.9 t70 -96.71 -56.35 2.61 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.572 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 69.2 m -166.01 142.31 5.07 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.402 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 30.2 mt -123.93 131.15 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.885 176.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.587 ' O ' ' N ' ' A' ' 79' ' ' TYR . 27.1 m-20 -115.53 87.74 2.73 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.487 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 6.6 pt-20 -54.57 -30.12 53.33 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.08 73.52 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.6 m -108.2 -9.82 15.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.007 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.587 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.3 m-85 62.63 48.28 4.42 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 121.393 -0.817 . . . . 0.0 110.236 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -106.66 143.76 34.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.346 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.527 ' CE1' ' CD1' ' A' ' 83' ' ' TYR . 26.3 t80 -132.16 117.94 18.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.683 0.278 . . . . 0.0 110.253 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -127.5 137.65 52.71 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.112 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.531 ' CD2' ' NE2' ' A' ' 69' ' ' HIS . 12.5 p90 -146.11 163.86 33.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.069 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -146.57 135.68 22.59 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.05 0.452 . . . . 0.0 110.821 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mt -79.76 116.55 19.99 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.76 -41.78 17.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.829 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.468 ' CG ' ' H ' ' A' ' 88' ' ' GLY . 32.7 tt0 -153.8 171.52 18.79 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.09 -0.381 . . . . 0.0 110.586 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.637 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.19 177.54 18.71 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.78 2.1 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.637 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -66.09 -34.4 77.97 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.107 0.963 . . . . 0.0 110.239 177.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.609 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.26 14.7 22.68 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 123.543 0.737 . . . . 0.0 109.608 -177.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.582 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 68.8 p 46.96 -126.24 1.58 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -130.35 -11.14 4.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.106 0.479 . . . . 0.0 110.913 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.3 -7.55 18.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.441 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 90.7 mt -98.74 152.51 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 121.941 0.877 . . . . 0.0 113.259 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.441 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -90.86 -55.23 3.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.343 177.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.43 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 2.5 ptmm? -172.79 149.82 2.03 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.782 0.325 . . . . 0.0 110.84 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.29 125.42 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.34 144.49 43.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.925 0.393 . . . . 0.0 111.665 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -136.82 136.37 38.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.705 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -131.15 132.41 44.75 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.13 133.98 32.22 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.962 -0.461 . . . . 0.0 110.945 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -121.26 134.64 55.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -97.62 126.01 42.69 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.358 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.95 136.99 58.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.03 135.37 44.89 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.751 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.55 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 53.8 t -120.92 171.13 8.86 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.55 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -54.25 -35.7 55.77 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.3 p -89.69 -8.48 52.28 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.327 -1.69 . . . . 0.0 114.694 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 159.32 -85.44 0.12 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.069 1.318 . . . . 0.0 111.958 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 87.9 p -163.79 132.1 3.66 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.888 1.675 . . . . 0.0 110.961 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 78.8 m -99.28 118.24 35.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 61.9 mt -92.38 128.24 44.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.842 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -105.42 116.68 32.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.0 t -111.62 124.85 53.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.276 0.56 . . . . 0.0 111.101 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.67 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -106.04 136.43 40.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 123.25 0.62 . . . . 0.0 109.749 -177.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.1 m -113.18 133.09 55.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.982 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -137.08 105.35 5.72 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 120.83 0.348 . . . . 0.0 110.405 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER -101.69 103.39 14.17 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.081 -0.387 . . . . 0.0 110.045 179.201 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -90.91 107.88 19.49 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.226 0.536 . . . . 0.0 109.879 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.2 p -99.38 176.01 5.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.602 0.715 . . . . 0.0 111.442 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -112.31 146.12 38.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.432 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 54.21 -111.69 2.17 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.55 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -117.67 3.68 12.34 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.345 -0.503 . . . . 0.0 111.01 -179.575 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.463 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -45.85 160.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.941 0.4 . . . . 0.0 110.43 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.463 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 36.5 mt-10 -149.39 148.51 29.55 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.916 0.388 . . . . 0.0 111.267 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.5 mm -89.3 125.38 42.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.46 ' HG3' ' H ' ' A' ' 129' ' ' GLU . 18.6 tptt -74.45 160.33 31.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.157 0.503 . . . . 0.0 111.56 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.46 ' H ' ' HG3' ' A' ' 128' ' ' LYS . 49.8 mt-10 -70.09 -34.05 72.67 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.488 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.468 ' OE2' ' N ' ' A' ' 130' ' ' GLU . 1.8 mp0 -69.9 -27.79 65.09 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.461 ' NE2' ' CG2' ' A' ' 92' ' ' THR . 10.2 t-80 -72.89 -48.1 40.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.313 0.577 . . . . 0.0 110.87 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.8 m -79.76 -32.06 14.1 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.98 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -64.19 -46.18 85.1 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.216 -0.302 . . . . 0.0 110.721 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.424 ' CG2' ' N ' ' A' ' 135' ' ' GLY . 25.8 m -70.26 -47.71 65.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.62 0.248 . . . . 0.0 110.453 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.424 ' N ' ' CG2' ' A' ' 134' ' ' VAL . . . -62.73 -41.44 99.84 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -66.84 -46.25 75.68 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.751 -0.264 . . . . 0.0 110.684 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -54.28 -47.08 72.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 110.059 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 141' ' ' GLY . 22.8 tttp -64.58 -54.88 25.07 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.46 -40.78 27.47 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.698 0.761 . . . . 0.0 110.467 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.452 ' O ' ' ND1' ' A' ' 140' ' ' HIS . 0.6 OUTLIER -61.51 -36.49 80.67 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.958 0.885 . . . . 0.0 109.203 178.31 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' LYS . . . -62.68 -35.55 92.04 Favored Glycine 0 C--O 1.223 -0.54 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.455 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -66.9 -45.8 76.86 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.996 -0.708 . . . . 0.0 109.116 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -59.0 -30.1 67.73 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -64.83 -39.54 93.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.418 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.468 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.1 mm? -68.12 -56.99 6.81 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.174 0.511 . . . . 0.0 110.263 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.521 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 61.1 mt -57.91 -51.89 64.94 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.977 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -48.2 -56.84 6.91 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.814 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.7 t -51.75 -42.96 62.74 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.421 0.629 . . . . 0.0 110.141 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.641 ' O ' ' N ' ' A' ' 153' ' ' HIS . 8.6 t80 -55.69 -51.94 65.56 Favored 'General case' 0 C--O 1.178 -2.678 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 2.0 mm? -64.38 -43.02 95.8 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.239 -1.538 . . . . 0.0 111.883 -177.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.428 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -62.65 -24.33 67.56 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.531 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 149' ' ' TYR . 0.0 OUTLIER -106.98 -13.27 15.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.15 0.5 . . . . 0.0 110.657 178.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.641 ' N ' ' O ' ' A' ' 149' ' ' TYR . 42.7 m80 -155.39 66.31 4.7 Favored Pre-proline 0 C--N 1.305 -1.365 0 C-N-CA 125.944 1.697 . . . . 0.0 110.275 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.74 -3.35 13.59 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 122.7 2.267 . . . . 0.0 111.582 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.645 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 5.4 p30 -77.96 4.07 13.05 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.433 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -50.13 129.08 20.46 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 119.038 -2.289 . . . . 0.0 111.343 -178.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.507 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 36.9 t80 53.5 6.32 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.203 0.525 . . . . 0.0 112.219 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.645 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.091 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 120.745 0.307 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -98.33 110.23 22.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.321 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.798 ' HG1' ' CE1' ' A' ' 118' ' ' HIS . 68.8 m -96.13 134.3 39.37 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.794 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -133.55 131.05 39.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -102.97 126.7 50.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.881 0.372 . . . . 0.0 110.945 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -135.63 167.3 21.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.968 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -156.14 159.24 38.85 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -146.21 140.87 26.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.219 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.4 m -109.41 147.41 32.84 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.937 0.398 . . . . 0.0 111.831 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.659 ' HG ' ' CD ' ' A' ' 147' ' ' GLU . 8.4 t -145.68 154.76 42.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.432 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -87.86 25.44 1.53 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.124 0.488 . . . . 0.0 110.982 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -108.55 126.84 28.63 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.651 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -46.08 148.38 2.98 Favored 'Trans proline' 0 C--N 1.325 -0.675 0 C-N-CA 121.161 1.241 . . . . 0.0 110.857 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HA ' HD12 ' A' ' 18' ' ' LEU . 18.1 Cg_endo -64.86 -24.35 61.26 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 122.553 2.169 . . . . 0.0 112.915 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.3 m -70.51 -29.64 66.2 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -56.63 4.49 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 15' ' ' PRO . 3.2 mt -48.38 -48.84 36.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.494 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 40.2 t80 -44.66 -60.0 2.22 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.704 178.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -24.89 62.48 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.213 -0.93 . . . . 0.0 110.787 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.45 -14.37 58.96 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.808 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.45 -6.52 11.72 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 19' ' ' PHE . 3.0 m -129.99 -36.7 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 2.9 mp -92.55 -53.96 3.98 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.19 0.904 . . . . 0.0 112.206 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.82 16.42 20.45 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.516 ' O ' ' CD1' ' A' ' 30' ' ' ILE . . . -66.08 -43.2 88.05 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 121.062 0.458 . . . . 0.0 111.128 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.456 ' HB2' ' HZ2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -83.04 21.17 1.09 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.073 0.939 . . . . 0.0 110.501 -179.148 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -139.46 -8.85 1.27 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.434 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -94.43 -38.21 11.06 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.418 -1.719 . . . . 0.0 111.004 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.538 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.4 mm -55.38 -44.25 99.54 Favored Pre-proline 0 C--O 1.21 -0.986 0 CA-C-O 120.954 0.407 . . . . 0.0 111.928 -178.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 22.9 Cg_exo -63.1 -25.85 73.21 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.409 2.073 . . . . 0.0 113.304 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -83.28 -55.62 4.23 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.099 0.476 . . . . 0.0 112.27 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.459 ' O ' ' CD1' ' A' ' 145' ' ' LEU . 0.8 OUTLIER -95.09 -38.31 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.54 -177.06 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.516 ' CA ' ' HG ' ' A' ' 145' ' ' LEU . . . -108.38 61.36 0.24 Allowed Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -79.23 -28.94 3.41 Favored 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 121.812 1.675 . . . . 0.0 109.19 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -74.98 -42.58 57.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.258 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.07 -74.89 0.12 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.282 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.27 146.36 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.858 0.361 . . . . 0.0 110.071 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -78.12 -50.23 12.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.211 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.664 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 54.8 tp60 -176.36 165.74 2.75 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.918 0.389 . . . . 0.0 110.469 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.664 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -165.51 147.85 7.64 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.232 0.539 . . . . 0.0 110.583 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.75 ' N ' ' HZ1' ' A' ' 54' ' ' LYS . 23.2 pt-20 -148.09 140.88 24.68 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.099 -0.375 . . . . 0.0 110.764 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.72 140.29 17.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.391 0.615 . . . . 0.0 110.415 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.69 -40.01 13.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.173 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.53 ' O ' ' CG2' ' A' ' 52' ' ' THR . 21.0 mt-10 -140.98 133.84 29.0 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.749 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.21 -156.68 36.0 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.532 HD21 ' N ' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -136.38 -7.38 1.99 Allowed 'General case' 0 C--N 1.321 -0.642 0 O-C-N 122.535 -0.391 . . . . 0.0 111.108 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.532 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 142.71 14.89 0.33 Allowed Glycine 0 C--O 1.22 -0.747 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.68 -170.76 20.3 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 117.236 0.518 . . . . 0.0 111.929 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -61.57 125.8 17.6 Favored 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 122.787 2.325 . . . . 0.0 113.373 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.22 6.01 59.08 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 60.0 m -93.81 140.52 29.57 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.147 -1.027 . . . . 0.0 111.45 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -121.9 129.76 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.75 ' HZ1' ' N ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -114.48 138.3 50.77 Favored 'General case' 0 C--O 1.22 -0.449 0 O-C-N 123.288 0.368 . . . . 0.0 110.689 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -120.6 125.75 48.55 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.148 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -103.47 140.63 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.263 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.5 m -118.83 119.65 35.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.518 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -92.5 -178.59 4.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.902 0.382 . . . . 0.0 110.685 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.26 143.81 29.77 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.466 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 9.1 pt-20 -59.73 -46.57 88.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 0.0 110.864 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.466 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -100.65 61.67 0.62 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 t -138.04 177.06 8.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.025 0.44 . . . . 0.0 110.79 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -60.98 -54.19 48.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 110.842 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.55 151.9 20.54 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.73 -61.72 0.22 Allowed Glycine 0 CA--C 1.52 0.349 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.405 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 5.0 m-85 -145.6 151.33 37.93 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.811 0.338 . . . . 0.0 110.892 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 p -149.24 138.3 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.852 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.423 ' O ' HG13 ' A' ' 86' ' ' ILE . 10.1 mtpp -107.38 116.5 32.04 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 121.623 0.725 . . . . 0.0 112.187 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.646 ' N ' ' ND1' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -112.9 123.58 50.64 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.361 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -98.82 126.61 44.52 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.149 0.499 . . . . 0.0 111.532 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.457 HG12 ' HH ' ' A' ' 81' ' ' TYR . 33.9 mt -79.94 136.09 24.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.374 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.657 ' C ' ' HG ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -97.27 -55.78 2.74 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -177.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.657 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 3.3 m -165.29 141.77 5.57 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.405 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 12.6 mt -120.69 131.1 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.483 176.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 79' ' ' TYR . 54.7 m-20 -114.42 88.26 2.82 Favored 'General case' 0 C--O 1.206 -1.205 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 177.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.447 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 19.6 mt-10 -54.61 -30.54 55.08 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.89 -39.46 71.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.159 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.4 m -108.41 -10.07 15.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.109 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.579 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.5 m-85 62.13 46.96 5.94 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 121.502 -0.749 . . . . 0.0 110.083 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.7 p -105.76 149.23 26.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.076 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.563 ' CE1' ' CD1' ' A' ' 83' ' ' TYR . 39.5 t80 -142.38 118.65 10.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.39 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.4 p -128.89 128.44 43.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.594 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.563 ' CD1' ' CE1' ' A' ' 81' ' ' TYR . 19.7 p90 -145.32 162.35 37.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.872 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.68 143.19 37.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.004 0.431 . . . . 0.0 111.161 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mt -83.81 121.98 28.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.879 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 68' ' ' LYS . 2.5 pp -84.87 -41.4 15.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.309 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.496 ' CG ' ' H ' ' A' ' 88' ' ' GLY . 16.2 tt0 -156.6 172.31 18.79 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.176 -0.327 . . . . 0.0 110.569 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.581 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.82 177.45 17.29 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -61.52 1.98 0.2 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 122.415 1.102 . . . . 0.0 108.466 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.581 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -68.08 -34.61 76.74 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.174 0.989 . . . . 0.0 110.386 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.608 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.59 15.57 21.98 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.298 0.639 . . . . 0.0 110.263 -177.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.487 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 63.3 p 43.16 -126.47 0.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.507 -178.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -130.73 -13.07 3.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.966 0.412 . . . . 0.0 111.187 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 p -104.7 -5.8 20.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.924 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.424 HG22 ' CD1' ' A' ' 98' ' ' ILE . 69.3 mt -98.66 152.27 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-O 121.918 0.866 . . . . 0.0 113.038 -176.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.434 ' CG ' ' N ' ' A' ' 97' ' ' LYS . 17.3 pt-20 -99.97 -45.51 5.66 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.349 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HZ3' ' HB2' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -172.72 145.9 1.56 Allowed 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 121.655 0.74 . . . . 0.0 112.224 -179.562 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.424 ' CD1' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.94 124.35 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.701 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.479 ' HG ' ' CB ' ' A' ' 118' ' ' HIS . 0.1 OUTLIER -104.39 144.72 31.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.973 0.416 . . . . 0.0 111.774 -178.588 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -139.05 127.99 23.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -129.02 134.5 48.15 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.04 131.51 26.96 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.782 -0.574 . . . . 0.0 110.084 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -123.0 134.04 54.34 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.19 132.77 43.42 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -134.41 137.76 50.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.104 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.77 135.6 45.31 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.452 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.411 ' N ' ' HA ' ' A' ' 111' ' ' SER . 7.9 t -121.16 170.2 9.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.842 0.353 . . . . 0.0 110.176 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.75 -31.51 46.06 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 112.033 -0.427 . . . . 0.0 112.033 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.8 m -88.16 -11.74 45.99 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 119.559 -2.142 . . . . 0.0 115.827 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.02 -89.47 0.12 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.88 1.229 . . . . 0.0 110.478 -169.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.411 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 92.0 p -163.74 130.33 3.24 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.077 1.351 . . . . 0.0 110.928 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 105' ' ' VAL . 34.4 m -99.91 118.38 36.22 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 51.3 mt -92.21 132.08 37.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.167 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -105.78 116.64 32.29 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.1 t -111.07 118.32 35.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.282 0.563 . . . . 0.0 110.826 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.655 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -100.42 135.6 35.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 123.337 0.655 . . . . 0.0 109.818 -177.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.9 p -108.96 135.4 50.2 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.49 -0.777 . . . . 0.0 108.918 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.798 ' CE1' ' HG1' ' A' ' 4' ' ' THR . 31.6 m-70 -135.72 93.99 3.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 120.922 0.392 . . . . 0.0 110.627 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -83.24 101.8 11.49 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.174 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -96.59 104.32 16.3 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.9 p -101.56 176.19 5.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.403 0.62 . . . . 0.0 111.618 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.405 ' HZ3' ' HB2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -111.99 157.58 20.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.68 179.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 42.26 -109.98 0.22 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -116.29 5.66 13.65 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.819 -0.224 . . . . 0.0 110.968 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -49.01 159.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.117 0.484 . . . . 0.0 110.41 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.467 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 40.3 mt-10 -148.5 145.8 28.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.961 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.8 mm -88.88 124.53 41.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp -74.97 161.64 29.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.502 0.667 . . . . 0.0 111.77 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -70.48 -34.18 72.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.642 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.416 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 6.2 pt-20 -69.02 -30.83 69.29 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.647 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -67.99 -53.97 22.03 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.383 0.611 . . . . 0.0 110.363 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.91 -19.63 22.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.407 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 137' ' ' GLU . 52.4 tttm -66.85 -46.69 74.27 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 122.295 -0.253 . . . . 0.0 110.704 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -69.17 -46.52 77.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.762 0.315 . . . . 0.0 110.404 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.28 -47.41 71.76 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -67.95 -46.48 71.33 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.566 -0.373 . . . . 0.0 111.055 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 21.0 tp10 -54.36 -46.73 73.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.021 0.439 . . . . 0.0 110.363 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.468 ' O ' ' CD2' ' A' ' 142' ' ' LEU . 10.3 ttmt -69.21 -52.75 24.73 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.78 -46.81 41.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.395 0.617 . . . . 0.0 110.55 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -62.08 -36.98 83.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.96 -52.54 51.66 Favored Glycine 0 C--O 1.225 -0.435 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.468 ' CD2' ' O ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -60.01 -42.51 94.47 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 122.096 -0.65 . . . . 0.0 109.366 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -59.15 -30.02 67.85 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.494 ' C ' ' HZ3' ' A' ' 144' ' ' LYS . 0.3 OUTLIER -76.88 -34.61 57.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.12 178.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.516 ' HG ' ' CA ' ' A' ' 34' ' ' ALA . 1.7 mm? -70.43 -53.89 14.58 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.073 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.486 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 7.3 mt -54.58 -49.19 68.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.659 ' CD ' ' HG ' ' A' ' 11' ' ' SER . 19.3 tt0 -46.38 -53.77 10.34 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.4 t -52.29 -42.25 63.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.307 0.575 . . . . 0.0 110.992 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.604 ' O ' ' N ' ' A' ' 153' ' ' HIS . 0.3 OUTLIER -58.14 -44.67 87.94 Favored 'General case' 0 C--O 1.2 -1.542 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.486 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 2.1 mm? -66.87 -43.56 83.24 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 119.328 0.967 . . . . 0.0 112.073 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.72 -25.1 66.2 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.58 -13.19 15.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.148 0.499 . . . . 0.0 110.362 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.604 ' N ' ' O ' ' A' ' 149' ' ' TYR . 22.5 t60 -153.9 67.21 5.82 Favored Pre-proline 0 C--N 1.312 -1.05 0 C-N-CA 124.354 1.062 . . . . 0.0 110.688 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.99 -3.28 11.18 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 122.409 2.073 . . . . 0.0 111.521 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.619 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.1 OUTLIER -80.95 3.36 23.15 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.918 -178.6 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.431 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -49.55 129.95 19.83 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 119.453 -2.029 . . . . 0.0 111.237 -178.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.414 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 10.9 t80 54.3 7.1 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.205 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.619 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.366 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.234 0.284 0 CA-C-O 120.868 0.366 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -98.52 110.84 23.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.32 177.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 m -96.53 139.85 32.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.788 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -140.53 134.03 30.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.18 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.444 ' C ' HD21 ' A' ' 7' ' ' ASN . 8.2 mt-10 -102.79 128.81 49.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.071 0.462 . . . . 0.0 110.964 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -128.19 165.5 20.32 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -178.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -156.38 151.42 26.29 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -142.7 140.81 31.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.088 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -107.06 145.81 31.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.844 0.354 . . . . 0.0 111.687 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.544 ' HG ' ' CD ' ' A' ' 147' ' ' GLU . 4.6 t -146.14 154.53 41.89 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.822 0.344 . . . . 0.0 110.688 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -90.94 24.5 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.112 0.482 . . . . 0.0 110.691 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.408 HD13 ' N ' ' A' ' 151' ' ' LYS . 1.9 mt -107.59 128.02 26.7 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.359 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -46.1 143.78 7.05 Favored 'Trans proline' 0 C--N 1.326 -0.617 0 C-N-CA 121.308 1.339 . . . . 0.0 110.994 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -61.1 -23.58 77.59 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.45 2.1 . . . . 0.0 113.108 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.442 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . 66.0 m -70.43 -31.54 68.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -76.62 -56.41 4.64 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 mt -50.67 -43.06 57.33 Favored 'General case' 0 C--O 1.212 -0.905 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -47.67 -58.3 4.45 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.932 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.495 ' HA ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.85 -41.09 75.35 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.12 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.6 -2.55 1.71 Allowed 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.33 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.614 ' CE1' ' CE2' ' A' ' 143' ' ' PHE . 6.6 t80 -119.23 -9.24 9.99 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.4 m -134.67 -46.22 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.589 ' H ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -99.19 -32.01 11.44 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 120.607 1.548 . . . . 0.0 112.422 -178.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.14 -5.12 14.26 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 118.437 0.562 . . . . 0.0 111.645 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . -67.49 -42.53 82.74 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.28 0.562 . . . . 0.0 111.657 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -82.91 18.94 1.47 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.991 0.901 . . . . 0.0 109.906 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 26' ' ' ALA . 67.7 m-80 -139.27 -9.08 1.29 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.425 HD22 ' CD2' ' A' ' 149' ' ' TYR . 1.2 mt -94.12 -31.42 14.18 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.923 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.414 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.76 -53.97 54.66 Favored Pre-proline 0 C--O 1.214 -0.764 0 O-C-N 122.175 -0.328 . . . . 0.0 111.266 -179.321 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 22.8 Cg_endo -63.08 -24.92 73.28 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 121.908 1.739 . . . . 0.0 112.468 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -69.66 -60.41 2.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.73 0.776 . . . . 0.0 111.972 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.48 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 1.4 pt -95.91 -35.68 5.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.349 -176.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.428 ' CA ' ' HG ' ' A' ' 145' ' ' LEU . . . -105.37 65.03 0.14 Allowed Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.31 -28.07 7.43 Favored 'Trans proline' 0 C--N 1.32 -0.93 0 C-N-CA 121.638 1.559 . . . . 0.0 108.276 174.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -73.91 -43.59 57.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.317 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.52 -74.02 0.17 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.801 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -101.74 144.21 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 121.264 0.554 . . . . 0.0 109.818 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.9 ttpt -78.86 -62.16 1.78 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.603 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.713 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 57.2 tp60 -164.5 165.69 21.1 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.922 0.391 . . . . 0.0 110.012 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.713 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -165.93 149.44 7.73 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.06 0.457 . . . . 0.0 111.181 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -150.17 142.79 24.54 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.075 -179.351 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.469 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -76.96 141.34 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-O 122.015 0.912 . . . . 0.0 111.212 178.564 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.504 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 4.0 mp -88.36 -40.57 13.46 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.481 ' O ' ' CG2' ' A' ' 52' ' ' THR . 32.6 mt-10 -149.12 134.18 18.15 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.457 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.64 -156.38 23.14 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.416 ' ND2' ' N ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -134.19 -1.59 2.91 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.451 -0.44 . . . . 0.0 111.509 -178.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.86 18.36 2.65 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.48 -172.9 19.48 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -60.55 125.31 17.0 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 122.094 1.862 . . . . 0.0 112.96 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.5 -0.32 56.86 Favored Glycine 0 N--CA 1.462 0.428 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.481 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 99.1 m -93.91 136.95 33.66 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 114.377 -0.912 . . . . 0.0 111.229 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mp -113.95 132.35 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.508 ' HZ2' ' HB2' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -122.7 138.54 54.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.899 0.381 . . . . 0.0 110.522 179.082 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -119.9 130.2 54.73 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.098 -0.376 . . . . 0.0 110.906 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.485 HG12 ' HZ1' ' A' ' 54' ' ' LYS . 1.6 mm -95.93 140.8 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.795 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.7 m -108.71 117.75 35.01 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 59' ' ' GLY . 5.8 t80 -104.22 172.12 6.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 0.0 110.961 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.453 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -57.55 144.43 40.63 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -60.3 -67.45 0.39 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.899 0.38 . . . . 0.0 111.242 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.46 61.96 3.15 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 t -137.75 -172.47 3.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.882 0.373 . . . . 0.0 110.664 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -58.69 -55.28 37.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.638 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -99.67 155.66 17.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.599 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.22 -59.36 0.13 Allowed Glycine 0 CA--C 1.52 0.363 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -145.5 149.2 34.2 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.937 0.399 . . . . 0.0 110.674 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.579 ' CG1' ' HE2' ' A' ' 69' ' ' HIS . 4.3 p -156.9 143.72 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.721 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 36.2 mttp -106.63 112.51 25.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.338 0.59 . . . . 0.0 112.069 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.579 ' HE2' ' CG1' ' A' ' 67' ' ' VAL . 11.3 m-70 -101.3 123.47 45.46 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -106.57 119.32 38.99 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.027 -0.421 . . . . 0.0 111.5 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.0 mp -70.35 145.23 13.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -105.56 -54.88 2.41 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.7 144.4 6.11 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 45.3 mt -127.14 125.88 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.162 173.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 79' ' ' TYR . 13.4 m-20 -113.91 88.81 2.93 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.506 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 13.7 mt-10 -54.47 -30.36 52.83 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.68 70.04 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.006 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.93 -11.42 15.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.122 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.7 m-85 62.23 42.7 9.18 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.597 -0.689 . . . . 0.0 110.259 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.4 t -106.86 141.75 37.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.127 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -132.09 118.71 19.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.8 t -128.53 135.19 49.07 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.136 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -144.82 159.83 42.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.493 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -138.26 139.48 39.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.228 0.537 . . . . 0.0 110.821 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.445 ' CD2' ' CE1' ' A' ' 69' ' ' HIS . 8.7 mt -80.17 115.55 19.79 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 pt -80.79 -44.24 21.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.676 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -152.02 172.11 16.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.863 0.363 . . . . 0.0 110.745 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.19 177.12 18.72 Favored Glycine 0 C--O 1.238 0.377 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -61.52 -0.34 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 122.204 1.002 . . . . 0.0 108.442 178.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.612 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -62.46 -34.36 76.67 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.816 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.588 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.16 14.83 22.74 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 123.61 0.764 . . . . 0.0 110.198 -177.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.561 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 61.6 p 46.42 -126.5 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -130.66 -12.86 3.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.649 0.738 . . . . 0.0 111.068 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.455 ' HG1' ' CG1' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -104.76 -6.34 20.42 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.015 0.526 . . . . 0.0 112.108 -177.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 71.4 mt -98.77 152.6 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.712 0 CA-C-O 121.997 0.903 . . . . 0.0 113.347 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.408 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -91.4 -57.33 2.81 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.167 177.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.404 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 28.2 pttt -171.93 151.16 2.7 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.027 0.442 . . . . 0.0 110.584 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.56 124.15 71.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.481 ' HG ' ' HB2' ' A' ' 118' ' ' HIS . 0.1 OUTLIER -103.13 144.49 31.24 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 122.844 0.458 . . . . 0.0 111.896 -178.338 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.445 ' CZ ' ' OG ' ' A' ' 117' ' ' SER . 0.4 OUTLIER -139.13 127.93 23.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.5 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -133.57 132.86 41.38 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -133.43 136.32 45.12 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 122.208 -0.307 . . . . 0.0 110.425 -178.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -120.58 133.69 55.36 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -98.54 130.75 45.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.943 0.401 . . . . 0.0 110.003 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -132.62 137.24 54.55 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.063 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.01 135.71 44.96 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.649 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.402 ' N ' ' HA ' ' A' ' 111' ' ' SER . 13.2 t -121.25 168.82 11.2 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 122.593 0.357 . . . . 0.0 110.201 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.8 -29.81 42.71 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 112.233 -0.347 . . . . 0.0 112.233 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.6 p -92.06 -11.66 35.24 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 119.849 -1.971 . . . . 0.0 114.389 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.84 -86.14 0.12 Allowed Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.47 1.509 . . . . 0.0 112.066 -175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.402 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 88.4 p -164.54 130.97 2.97 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 125.86 1.664 . . . . 0.0 110.688 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.4 m -99.64 118.35 35.99 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.4 mt -91.83 131.23 39.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.118 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 102' ' ' THR . 8.9 mtpt -105.47 117.12 33.2 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.9 p -110.16 118.64 36.9 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.368 0.604 . . . . 0.0 111.047 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.684 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -99.89 136.91 29.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 123.536 0.734 . . . . 0.0 109.641 -177.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.445 ' OG ' ' CZ ' ' A' ' 100' ' ' TYR . 6.8 m -118.26 131.72 56.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.477 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.481 ' HB2' ' HG ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -138.2 112.26 8.51 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.657 ' CD2' ' N ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -102.83 103.77 13.98 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.211 -0.306 . . . . 0.0 110.441 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -90.58 107.24 19.04 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.207 0.527 . . . . 0.0 110.01 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.4 p -98.88 176.73 5.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.47 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -109.49 159.58 16.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.628 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 39.63 -109.77 0.13 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.464 -0.655 . . . . 0.0 111.464 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -116.04 3.66 13.62 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 122.702 -0.293 . . . . 0.0 111.069 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.483 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -45.58 160.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.316 0.579 . . . . 0.0 110.393 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.483 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 43.4 tt0 -149.49 145.66 26.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.212 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.0 mm -88.95 125.52 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -74.74 161.66 29.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.499 0.666 . . . . 0.0 111.53 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.599 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 1.0 OUTLIER -69.71 -47.55 62.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.192 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.457 ' N ' ' OE1' ' A' ' 130' ' ' GLU . 0.3 OUTLIER -59.81 -24.68 64.35 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.118 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -72.95 -51.34 18.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.259 0.552 . . . . 0.0 111.256 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 m -77.31 -27.1 15.76 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.934 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.4 tttm -67.28 -45.91 75.21 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.275 -0.266 . . . . 0.0 110.9 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 34.5 m -69.18 -45.38 79.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.886 0.375 . . . . 0.0 110.344 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.21 -41.76 96.69 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -67.14 -45.67 76.42 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 120.494 0.188 . . . . 0.0 110.691 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -53.96 -42.53 69.02 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.447 ' O ' ' CD2' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -69.48 -53.4 19.38 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.582 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.31 -41.73 39.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.583 0.706 . . . . 0.0 110.628 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -67.04 -36.34 81.86 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.93 -36.71 91.04 Favored Glycine 0 C--O 1.223 -0.576 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.447 ' CD2' ' O ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -73.31 -41.59 63.36 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.614 ' CE2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -59.87 -23.06 63.12 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.436 ' HZ2' ' C ' ' A' ' 144' ' ' LYS . 1.2 ttpp -76.01 -40.17 54.17 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.259 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.48 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.5 mm? -67.21 -55.85 12.34 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.31 0.576 . . . . 0.0 109.624 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.542 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 60.6 mt -53.48 -50.92 46.35 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.358 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.544 ' CD ' ' HG ' ' A' ' 11' ' ' SER . 15.4 tt0 -47.51 -54.27 12.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.983 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.8 t -53.45 -42.65 67.37 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.117 0.484 . . . . 0.0 111.494 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.634 ' O ' ' N ' ' A' ' 153' ' ' HIS . 19.2 t80 -60.27 -44.72 95.07 Favored 'General case' 0 C--O 1.199 -1.553 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.542 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 1.8 mm? -68.99 -42.55 76.34 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 119.993 1.27 . . . . 0.0 111.629 -178.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.408 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -62.79 -24.39 67.71 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 121.483 -0.761 . . . . 0.0 109.207 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -106.2 -13.15 15.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.566 0.698 . . . . 0.0 110.641 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 149' ' ' TYR . 16.9 t-80 -155.22 66.33 4.79 Favored Pre-proline 0 C--N 1.312 -1.063 0 C-N-CA 124.818 1.247 . . . . 0.0 110.181 -178.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.4 ' CD ' ' O ' ' A' ' 150' ' ' LEU . 43.1 Cg_endo -72.86 -4.01 14.61 Favored 'Trans proline' 0 N--CA 1.48 0.702 0 C-N-CA 122.472 2.115 . . . . 0.0 111.921 -178.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.621 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 3.8 p30 -82.51 3.48 28.24 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.07 0.948 . . . . 0.0 111.756 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.464 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -49.54 131.1 21.08 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 119.599 -1.938 . . . . 0.0 111.25 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.514 ' CG ' ' O ' ' A' ' 157' ' ' TYR . 80.9 t80 56.16 6.04 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.621 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.595 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.31 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.814 0.34 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -97.46 110.36 22.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.298 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.974 ' HG1' ' CD2' ' A' ' 118' ' ' HIS . 96.9 m -96.03 132.36 41.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.758 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.17 128.36 37.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.976 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -102.7 133.66 47.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.742 0.306 . . . . 0.0 110.705 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -126.37 170.87 11.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.472 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.96 149.37 27.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.309 0.576 . . . . 0.0 111.976 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -155.43 141.02 17.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.12 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.593 HG22 ' HG ' ' A' ' 107' ' ' CYS . 1.3 m -106.27 143.84 33.82 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.92 0.391 . . . . 0.0 111.941 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.0 t -133.75 154.49 50.93 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.262 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -93.42 18.86 9.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.896 0.379 . . . . 0.0 111.003 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mt -107.09 127.73 27.41 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -44.82 144.83 3.26 Favored 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 121.117 1.211 . . . . 0.0 110.797 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.81 -23.2 74.36 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 122.452 2.101 . . . . 0.0 112.542 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.482 ' C ' ' HZ2' ' A' ' 20' ' ' LYS . 70.1 m -69.3 -33.45 73.21 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.404 HH21 ' HB2' ' A' ' 16' ' ' SER . 11.5 mmt-85 -76.66 -56.83 4.26 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 118.882 0.764 . . . . 0.0 109.066 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mt -48.57 -48.64 38.71 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.728 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -48.41 -55.18 11.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.192 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.482 ' HZ2' ' C ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -70.23 -26.71 63.98 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.416 -0.913 . . . . 0.0 109.622 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.3 -2.9 50.83 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.994 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -118.78 -8.3 10.36 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -135.08 -35.46 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.619 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 2.4 mp -90.51 -54.69 3.89 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.652 1.114 . . . . 0.0 111.694 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -113.03 -3.93 13.94 Favored 'General case' 0 C--O 1.205 -1.243 0 O-C-N 122.261 -0.274 . . . . 0.0 111.129 -178.501 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.449 ' O ' ' CG2' ' A' ' 30' ' ' ILE . . . -46.07 -39.22 8.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 118.037 0.381 . . . . 0.0 111.526 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -85.41 12.98 7.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.629 0.728 . . . . 0.0 110.855 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -134.51 -10.32 2.46 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 124.969 1.308 . . . . 0.0 108.62 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.472 HD22 ' CD2' ' A' ' 149' ' ' TYR . 0.1 OUTLIER -95.84 -43.3 7.91 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 124.862 1.265 . . . . 0.0 109.188 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.449 ' CG2' ' O ' ' A' ' 26' ' ' ALA . 1.7 tt -55.62 -45.46 99.87 Favored Pre-proline 0 C--O 1.215 -0.757 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.486 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 36.4 Cg_endo -63.41 -24.67 71.02 Favored 'Trans proline' 0 N--CA 1.482 0.85 0 CA-C-N 121.231 1.475 . . . . 0.0 111.256 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -67.49 -54.45 20.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.663 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 0.9 OUTLIER -95.8 -35.75 6.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.248 -176.438 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.415 ' CA ' ' HG ' ' A' ' 145' ' ' LEU . . . -105.63 63.85 0.15 Allowed Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -77.1 -27.78 6.48 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 N-CA-C 107.917 -1.609 . . . . 0.0 107.917 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -75.23 -43.24 52.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.17 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.5 -75.27 0.12 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.861 -178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mm -99.98 147.78 7.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 CA-C-O 121.665 0.745 . . . . 0.0 111.021 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.66 ' H ' ' CD ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.08 -64.07 1.09 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.203 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -178.12 166.79 1.98 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.105 0.478 . . . . 0.0 110.345 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.96 143.76 5.6 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.987 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.81 145.95 35.32 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.82 139.08 18.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.683 0.754 . . . . 0.0 110.94 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.588 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 3.0 mp -89.49 -39.09 13.57 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' O ' ' CG2' ' A' ' 52' ' ' THR . 22.2 mt-10 -141.92 133.1 26.26 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.78 -156.41 28.8 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.582 ' ND2' ' H ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -134.19 -13.89 2.37 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 122.33 -0.512 . . . . 0.0 110.924 -179.562 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.567 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 143.39 18.03 0.24 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.88 -173.24 19.91 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -61.16 126.07 18.56 Favored 'Trans proline' 0 C--N 1.321 -0.904 0 C-N-CA 122.258 1.972 . . . . 0.0 113.319 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.81 1.89 56.24 Favored Glycine 0 N--CA 1.463 0.462 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 88.5 m -93.85 140.38 29.74 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.218 -0.991 . . . . 0.0 111.046 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.498 HG13 ' HE ' ' A' ' 70' ' ' ARG . 2.1 mp -117.65 133.13 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.17 141.02 52.41 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 121.037 0.446 . . . . 0.0 110.957 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -119.27 131.98 55.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.813 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.7 mm -94.04 142.01 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.678 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.3 m -108.86 117.58 34.56 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.474 ' HA ' ' HD3' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -90.53 162.24 15.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.779 0.323 . . . . 0.0 111.363 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.59 144.34 30.16 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 2.1 pm0 -56.73 -47.17 80.6 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 122.422 -0.458 . . . . 0.0 110.298 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.34 62.38 1.76 Allowed Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 62.7 p -136.54 174.54 10.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.058 0.456 . . . . 0.0 111.205 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.52 ' NE2' ' H ' ' A' ' 63' ' ' GLN . 4.0 mp0 -69.03 -50.01 52.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.25 156.24 17.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.053 0.454 . . . . 0.0 110.631 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.78 -61.49 0.51 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.27 154.82 42.14 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.071 0.462 . . . . 0.0 110.776 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.426 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 2.0 p -145.82 157.09 12.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.958 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.426 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 26.4 mtmt -105.78 113.12 26.48 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.446 0.641 . . . . 0.0 112.425 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -105.78 105.71 15.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.993 0.917 . . . . 0.0 109.579 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.498 ' HE ' HG13 ' A' ' 53' ' ' ILE . 25.3 ttm180 -101.63 131.19 47.98 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.953 -0.467 . . . . 0.0 111.433 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.4 mp -73.91 145.36 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -102.49 -56.01 2.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 119.227 -0.416 . . . . 0.0 112.073 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.8 m -165.35 141.38 5.38 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.5 mt -124.73 131.44 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.852 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.614 ' O ' ' N ' ' A' ' 79' ' ' TYR . 54.8 m-20 -114.84 87.92 2.75 Favored 'General case' 0 C--O 1.199 -1.575 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.454 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 9.5 pt-20 -54.41 -30.58 52.74 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.04 77.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.3 m -107.86 -9.98 15.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.736 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.614 ' N ' ' O ' ' A' ' 75' ' ' ASP . 20.7 m-85 58.54 48.63 11.68 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 121.415 -0.803 . . . . 0.0 110.538 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.2 p -106.58 147.22 29.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.985 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.635 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 35.9 t80 -132.1 125.86 32.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.968 0.413 . . . . 0.0 110.919 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 p -133.65 136.09 44.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.362 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.635 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 6.5 p90 -146.78 160.67 41.96 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.8 m -144.64 138.39 27.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.133 0.492 . . . . 0.0 111.229 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mp -80.36 119.99 23.81 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.5 -42.9 17.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.575 ' CD ' ' H ' ' A' ' 88' ' ' GLY . 1.2 tm-20 -157.64 173.55 16.68 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.326 -0.234 . . . . 0.0 110.493 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.635 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.74 177.44 17.34 Favored Glycine 0 CA--C 1.509 -0.316 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -61.54 1.76 0.21 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.635 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -64.88 -34.82 79.3 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.361 1.064 . . . . 0.0 110.071 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.601 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.0 16.31 21.98 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 123.702 0.801 . . . . 0.0 108.847 -178.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.555 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 82.8 p 44.89 -126.96 1.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -130.59 -9.62 4.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.133 0.492 . . . . 0.0 110.736 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.45 -7.25 18.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.171 -177.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.43 HG22 ' CD1' ' A' ' 98' ' ' ILE . 88.7 mt -100.04 152.5 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-O 122.085 0.945 . . . . 0.0 113.523 -177.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.43 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -90.42 -56.85 3.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.598 177.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -172.19 148.28 2.14 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.267 0.556 . . . . 0.0 111.454 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.43 ' CD1' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.31 130.1 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.26 145.07 46.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.917 0.389 . . . . 0.0 111.53 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -139.89 133.17 29.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.562 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -128.46 134.29 48.7 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 121.036 0.446 . . . . 0.0 110.963 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.14 133.01 52.99 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.714 -0.616 . . . . 0.0 109.634 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -120.11 133.0 55.63 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.4 mm? -97.81 125.42 42.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.132 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.65 136.86 45.85 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.16 139.45 46.36 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.173 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.593 ' HG ' HG22 ' A' ' 10' ' ' THR . 17.3 p -120.73 168.11 11.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.61 -26.85 32.89 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 121.398 -0.429 . . . . 0.0 112.125 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.2 m -91.27 -14.11 31.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 119.563 -2.139 . . . . 0.0 116.591 174.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.46 -89.91 0.12 Allowed Glycine 0 CA--C 1.537 1.424 0 O-C-N 120.454 -1.404 . . . . 0.0 110.981 -161.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.428 ' N ' ' SG ' ' A' ' 107' ' ' CYS . 17.2 t -164.84 133.78 3.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 119.035 1.417 . . . . 0.0 111.196 -178.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 52.1 m -100.06 126.05 46.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.1 mt -99.54 127.79 51.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.428 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -105.52 117.45 34.04 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.0 p -110.58 121.77 46.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.442 0.639 . . . . 0.0 110.542 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.636 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -104.73 135.26 43.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.296 0.569 . . . . 0.0 109.948 -177.358 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 71.1 m -107.73 138.33 44.16 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.8 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.974 ' CD2' ' HG1' ' A' ' 4' ' ' THR . 26.3 m80 -136.13 93.47 2.91 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.813 0.34 . . . . 0.0 110.454 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -88.12 102.16 14.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.213 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -90.28 102.87 15.59 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 p -92.47 160.57 15.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.905 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -112.39 142.5 44.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.029 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.24 -109.64 0.94 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.425 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.1 OUTLIER -116.46 -2.67 11.98 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.497 -0.413 . . . . 0.0 110.657 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.2 tp -49.3 160.65 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.88 0.371 . . . . 0.0 110.693 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -149.38 149.64 31.17 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.572 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 34.2 mm -87.05 125.16 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -75.2 162.35 28.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.485 0.66 . . . . 0.0 112.06 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -69.02 -42.19 76.73 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.855 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.424 ' N ' ' CD ' ' A' ' 130' ' ' GLU . 5.2 mp0 -61.57 -25.55 67.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.825 0.345 . . . . 0.0 110.174 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -72.59 -51.03 21.45 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.283 0.564 . . . . 0.0 111.038 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 m -77.03 -25.95 15.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.942 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -67.34 -46.31 73.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 122.332 -0.23 . . . . 0.0 110.787 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.2 -45.01 77.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.885 0.374 . . . . 0.0 110.593 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.16 -46.62 78.57 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -66.89 -46.89 73.51 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.636 -0.332 . . . . 0.0 110.714 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -55.2 -47.24 75.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.011 0.434 . . . . 0.0 110.031 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.436 ' HZ1' ' HB2' ' A' ' 138' ' ' LYS . 3.3 ttmp? -66.7 -52.87 39.76 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.885 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.22 -42.64 41.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.594 0.712 . . . . 0.0 110.567 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.475 ' O ' ' ND1' ' A' ' 140' ' ' HIS . 1.8 t-80 -61.16 -36.56 80.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.859 0.838 . . . . 0.0 109.052 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.9 -38.88 96.12 Favored Glycine 0 C--O 1.221 -0.665 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.411 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -66.1 -46.82 76.28 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -59.62 -24.48 63.86 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.68 -36.28 65.29 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.59 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.471 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.1 mm? -71.22 -57.67 4.27 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.426 0.631 . . . . 0.0 109.839 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.537 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 50.4 mt -54.54 -50.65 57.09 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.133 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -47.43 -56.76 6.32 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.864 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 20.5 p -50.68 -44.65 57.81 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.343 0.592 . . . . 0.0 111.285 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.637 ' O ' ' N ' ' A' ' 153' ' ' HIS . 28.2 t80 -59.88 -45.41 92.58 Favored 'General case' 0 C--O 1.193 -1.917 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.537 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 2.1 mm? -65.79 -42.74 90.37 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 120.443 1.474 . . . . 0.0 111.565 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.409 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.4 OUTLIER -62.53 -24.38 67.48 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.305 179.591 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -105.77 -13.08 15.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.321 0.581 . . . . 0.0 110.768 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.637 ' N ' ' O ' ' A' ' 149' ' ' TYR . 42.1 m80 -155.96 67.34 4.69 Favored Pre-proline 0 C--N 1.31 -1.131 0 C-N-CA 125.167 1.387 . . . . 0.0 110.202 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -72.35 -3.48 13.46 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 122.501 2.134 . . . . 0.0 111.704 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.649 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 13.0 m-20 -73.16 2.61 6.9 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.163 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -50.11 130.15 22.01 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 119.161 -2.212 . . . . 0.0 111.275 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.541 ' CG ' ' O ' ' A' ' 157' ' ' TYR . 92.8 t80 54.03 6.18 0.09 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.546 0.688 . . . . 0.0 112.124 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.649 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.503 0 O-C-N 120.994 -1.066 . . . . 0.0 110.055 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.725 0.298 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.73 110.27 22.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.659 177.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 1.027 ' HG1' ' CD2' ' A' ' 118' ' ' HIS . 90.4 m -95.93 140.06 31.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 0.0 111.013 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.482 ' CD2' ' ND2' ' A' ' 7' ' ' ASN . 7.2 t80 -143.28 128.09 18.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.172 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.637 ' C ' HD21 ' A' ' 7' ' ' ASN . 1.6 tt0 -102.89 131.19 49.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.874 0.368 . . . . 0.0 111.324 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.637 HD21 ' C ' ' A' ' 6' ' ' GLU . 1.8 m-80 -134.59 172.7 12.56 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 122.636 0.375 . . . . 0.0 110.387 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.42 153.49 30.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.202 0.525 . . . . 0.0 112.39 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -149.01 138.41 21.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.235 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.19 147.49 25.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 111.771 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.579 ' HG ' ' CD ' ' A' ' 147' ' ' GLU . 10.3 t -145.8 161.44 39.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.499 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -96.27 25.92 4.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.854 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -116.3 125.41 28.54 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.879 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -47.83 149.93 4.9 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.034 1.823 . . . . 0.0 111.784 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -60.93 -24.88 80.37 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.307 2.005 . . . . 0.0 112.59 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.6 m -68.68 -34.29 75.42 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -76.16 -55.77 5.27 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 mt -51.4 -41.85 61.01 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.733 178.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -50.97 -57.48 8.48 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' CD ' ' O ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -68.09 -40.08 82.74 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.254 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.62 -2.45 4.86 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.263 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -118.67 -9.64 10.18 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.408 ' CG2' ' N ' ' A' ' 24' ' ' LEU . 33.9 m -131.76 -50.91 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -178.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.53 ' CD1' ' N ' ' A' ' 25' ' ' ASP . 2.7 pp -99.65 -30.52 12.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -176.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.53 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 62.4 m-20 -112.84 -5.59 13.86 Favored 'General case' 0 C--O 1.214 -0.802 0 O-C-N 121.599 -0.688 . . . . 0.0 111.516 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -68.13 -40.99 82.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.259 0.552 . . . . 0.0 111.383 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.539 ' CB ' ' HZ3' ' A' ' 54' ' ' LYS . 13.9 m-20 -84.37 17.8 2.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.027 0.918 . . . . 0.0 110.889 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -139.07 -9.0 1.33 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.438 HD13 ' CG ' ' A' ' 149' ' ' TYR . 0.0 OUTLIER -89.23 -47.49 8.02 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.655 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.467 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -60.83 -43.03 90.35 Favored Pre-proline 0 C--O 1.208 -1.111 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 28.7 Cg_endo -62.2 -26.14 77.47 Favored 'Trans proline' 0 C--N 1.321 -0.905 0 CA-C-N 120.635 1.263 . . . . 0.0 112.252 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -76.94 -61.64 1.91 Allowed 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.351 0.596 . . . . 0.0 112.343 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.424 ' O ' ' CD ' ' A' ' 35' ' ' PRO . 2.1 pt -94.4 -34.55 5.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.617 -177.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.471 ' CB ' ' HG ' ' A' ' 145' ' ' LEU . . . -102.68 67.3 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 123.224 0.609 . . . . 0.0 112.513 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.424 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 65.2 Cg_endo -72.7 -20.18 23.28 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.219 1.28 . . . . 0.0 108.882 176.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -72.87 -38.63 66.95 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.517 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.09 -81.91 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.443 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 ' N ' ' CD1' ' A' ' 38' ' ' ILE . 2.0 mp -109.57 144.07 18.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.0 110.13 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.69 -42.43 28.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.139 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.618 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 48.2 tp60 -173.63 164.74 4.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.618 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -166.03 145.16 6.02 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.141 0.495 . . . . 0.0 110.893 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -148.32 142.99 26.59 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.106 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.75 140.53 17.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.409 0.623 . . . . 0.0 110.863 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.497 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 3.6 mp -89.55 -40.41 12.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.426 ' O ' HG21 ' A' ' 52' ' ' THR . 12.5 mm-40 -143.51 134.21 25.11 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.346 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.98 -155.12 22.27 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.896 -0.482 . . . . 0.0 111.896 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.492 ' ND2' ' N ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -133.95 -12.52 2.55 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 123.096 0.558 . . . . 0.0 111.232 -178.191 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.96 12.31 1.15 Allowed Glycine 0 C--O 1.221 -0.663 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.36 -170.87 22.99 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -60.76 126.28 19.35 Favored 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 122.803 2.336 . . . . 0.0 113.119 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.96 5.84 57.25 Favored Glycine 0 N--CA 1.465 0.612 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.426 HG21 ' O ' ' A' ' 45' ' ' GLU . 15.0 m -93.12 141.53 28.31 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.832 -0.684 . . . . 0.0 111.47 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mp -116.46 133.57 62.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.539 ' HZ3' ' CB ' ' A' ' 27' ' ' ASP . 4.7 tmtp? -119.67 140.32 50.83 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.542 0.686 . . . . 0.0 111.148 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.6 tttt -119.17 121.19 39.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.258 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.2 mp -105.52 127.12 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.5 m -102.57 118.88 37.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.245 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.53 177.37 6.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.585 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.41 144.45 40.78 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -60.03 -48.37 81.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.852 0.358 . . . . 0.0 110.752 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.7 61.62 3.45 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 m -149.54 174.66 12.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.936 0.398 . . . . 0.0 110.585 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.55 ' NE2' ' CE2' ' A' ' 64' ' ' TYR . 1.1 pt20 -66.79 -41.32 87.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.918 0.389 . . . . 0.0 110.664 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.55 ' CE2' ' NE2' ' A' ' 63' ' ' GLN . 73.9 m-85 -91.4 149.48 21.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.552 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.416 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . -127.85 -62.39 0.13 Allowed Glycine 0 N--CA 1.462 0.378 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -146.35 146.95 30.85 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.728 0.299 . . . . 0.0 110.211 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -157.02 147.66 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.93 0.395 . . . . 0.0 110.947 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -105.59 113.06 26.4 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.271 0.558 . . . . 0.0 111.243 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.86 110.15 21.02 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -101.96 129.69 48.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.918 0.389 . . . . 0.0 112.037 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 mp -70.86 137.26 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.618 ' C ' ' HG ' ' A' ' 73' ' ' SER . 24.5 t70 -96.25 -53.75 3.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.44 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.618 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 49.4 m -164.5 140.74 6.1 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 44.8 mt -129.16 130.65 68.06 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.15 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.625 ' O ' ' N ' ' A' ' 79' ' ' TYR . 38.4 m-20 -115.39 87.62 2.7 Favored 'General case' 0 C--O 1.194 -1.86 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.567 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.8 pm0 -55.32 -39.57 70.11 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.31 -37.08 45.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.131 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.21 -9.84 15.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.32 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.2 m-85 62.03 51.96 3.48 Favored 'General case' 0 N--CA 1.438 -1.068 0 O-C-N 121.055 -1.028 . . . . 0.0 110.101 -177.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 55.5 p -106.41 144.09 33.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.056 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -134.66 121.26 20.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.023 0.439 . . . . 0.0 110.933 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 m -136.42 147.38 47.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.226 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -162.65 169.76 19.57 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.779 0.323 . . . . 0.0 110.628 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -146.49 139.11 25.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.131 0.491 . . . . 0.0 110.771 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.1 mt -79.95 111.62 16.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.59 -40.75 41.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.4 -178.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' A' ' 88' ' ' GLY . 16.0 tt0 -155.24 171.98 18.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.81 0.338 . . . . 0.0 110.295 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.18 177.82 17.7 Favored Glycine 0 CA--C 1.509 -0.334 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -61.87 2.29 0.22 Allowed 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.627 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -66.61 -34.36 77.71 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.173 0.989 . . . . 0.0 110.35 177.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.602 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.31 14.96 22.56 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.175 0.59 . . . . 0.0 110.341 -177.095 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.528 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 63.4 p 45.16 -126.22 1.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.36 -178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -130.45 -13.01 3.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.967 0.413 . . . . 0.0 111.475 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.9 p -104.75 -5.73 21.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.42 HG22 ' CD1' ' A' ' 98' ' ' ILE . 72.1 mt -99.12 152.95 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 CA-C-O 122.059 0.933 . . . . 0.0 113.472 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.418 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -93.46 -54.01 3.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.919 178.279 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -171.66 147.64 2.33 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 121.623 0.725 . . . . 0.0 111.028 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.42 ' CD1' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.41 121.98 66.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.4 t -107.39 146.12 32.05 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.412 0.625 . . . . 0.0 111.438 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -136.68 131.5 33.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.286 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -127.96 133.66 49.23 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.88 133.0 29.63 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.894 -0.504 . . . . 0.0 109.899 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -119.77 133.22 55.69 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.43 128.28 49.09 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.94 137.27 55.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.239 -178.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.77 134.65 45.05 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.336 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 38.8 t -121.3 172.26 8.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.826 0.346 . . . . 0.0 110.152 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.482 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.73 -35.28 52.18 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.8 p -87.06 -16.79 34.56 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.696 -1.473 . . . . 0.0 113.87 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 162.24 -77.75 0.16 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.379 1.466 . . . . 0.0 111.779 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 83.1 p -164.62 130.98 2.94 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 126.07 1.748 . . . . 0.0 111.096 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.5 m -99.48 117.71 34.48 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mt -92.72 131.34 40.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.543 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -104.38 117.05 33.23 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 68.4 m -111.34 123.74 50.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.291 0.567 . . . . 0.0 111.066 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.624 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -107.69 135.67 45.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 123.35 0.66 . . . . 0.0 110.082 -178.045 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.1 m -104.8 135.15 46.72 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 1.027 ' CD2' ' HG1' ' A' ' 4' ' ' THR . 15.5 m80 -136.24 93.56 2.92 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.127 0.489 . . . . 0.0 110.378 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -86.82 101.92 13.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.229 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -95.73 101.37 13.05 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.288 0.566 . . . . 0.0 110.231 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.1 p -100.26 171.69 7.63 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.472 0.653 . . . . 0.0 111.335 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -108.07 157.52 18.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.837 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 42.26 -114.73 0.77 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.57 4.85 20.68 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.727 -0.278 . . . . 0.0 111.11 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -49.09 160.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.298 0.571 . . . . 0.0 110.227 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.467 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 19.8 pt-20 -150.25 146.06 26.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.08 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.8 mm -88.85 124.27 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -75.09 162.15 28.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.476 0.655 . . . . 0.0 111.839 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -69.53 -36.22 76.21 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.935 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -65.13 -30.41 71.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.792 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -72.41 -47.9 45.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.055 0.455 . . . . 0.0 111.027 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 m -77.47 -26.43 15.3 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.982 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -67.13 -46.28 74.59 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 122.138 -0.351 . . . . 0.0 110.699 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.4 -43.48 78.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.598 0.237 . . . . 0.0 110.818 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.16 -46.77 48.79 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -67.38 -48.97 65.83 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 122.503 -0.41 . . . . 0.0 110.84 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -55.72 -48.01 75.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 109.998 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -64.4 -53.9 41.27 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.427 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -47.76 -45.91 29.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.461 0.648 . . . . 0.0 110.55 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -55.73 -37.22 68.14 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.409 0.623 . . . . 0.0 109.545 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.83 -38.92 96.85 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -68.37 -38.5 81.45 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.518 ' O ' ' CD1' ' A' ' 143' ' ' PHE . 0.9 OUTLIER -58.85 -32.04 69.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.687 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -70.29 -33.76 71.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.769 177.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.471 ' HG ' ' CB ' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -67.79 -56.95 7.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.046 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.428 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 59.1 mt -65.94 -48.94 80.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.664 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.579 ' CD ' ' HG ' ' A' ' 11' ' ' SER . 29.3 tt0 -47.5 -45.1 26.08 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.403 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.0 t -58.81 -37.7 76.96 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.878 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.634 ' O ' ' N ' ' A' ' 153' ' ' HIS . 11.2 t80 -59.65 -45.83 90.84 Favored 'General case' 0 C--O 1.189 -2.128 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.528 ' H ' ' CD2' ' A' ' 150' ' ' LEU . 1.3 mm? -69.9 -42.79 72.92 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 119.445 1.021 . . . . 0.0 111.468 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -23.63 66.03 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.631 -0.668 . . . . 0.0 109.809 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.436 ' O ' ' ND1' ' A' ' 153' ' ' HIS . 4.7 m-20 -106.11 -14.22 15.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.353 0.597 . . . . 0.0 110.623 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 149' ' ' TYR . 44.0 m80 -155.38 66.94 4.91 Favored Pre-proline 0 C--N 1.304 -1.383 0 C-N-CA 125.572 1.549 . . . . 0.0 109.384 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.42 -3.13 10.37 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 C-N-CA 122.969 2.446 . . . . 0.0 111.562 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.599 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 5.1 p30 -72.59 3.18 5.23 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.82 -178.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.535 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -52.16 128.67 25.57 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 119.335 -2.103 . . . . 0.0 110.823 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 51.67 5.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.046 0.538 . . . . 0.0 112.423 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.599 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.636 0 CA-C-O 118.128 -0.939 . . . . 0.0 109.852 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.849 0.357 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -98.4 110.03 22.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.547 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.4 m -96.56 132.84 41.75 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.656 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.67 128.87 37.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.066 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.09 133.47 48.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.8 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -134.0 174.54 10.36 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.765 0.317 . . . . 0.0 110.205 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.65 145.4 21.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.825 0.821 . . . . 0.0 112.079 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.31 134.63 27.75 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.831 -0.543 . . . . 0.0 110.138 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.94 147.44 23.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.891 0.377 . . . . 0.0 111.257 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 p -145.15 154.75 42.77 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.456 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -93.68 29.84 1.93 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.91 0.386 . . . . 0.0 110.397 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -120.69 125.35 27.15 Favored Pre-proline 0 C--O 1.224 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.073 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -49.7 148.91 11.28 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 121.999 1.799 . . . . 0.0 111.708 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -57.78 -28.31 81.58 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.386 2.057 . . . . 0.0 112.746 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 m -65.14 -35.53 81.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.559 ' HE ' ' N ' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -74.95 -55.57 5.64 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -178.512 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mt -53.16 -40.27 64.18 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.012 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -50.25 -57.7 7.24 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.859 0.464 . . . . 0.0 112.09 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.77 -41.55 75.02 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.507 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.0 -4.4 3.39 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.603 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -119.79 -8.67 9.84 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.8 m -128.53 -50.53 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.487 ' CD1' ' N ' ' A' ' 25' ' ' ASP . 1.9 pp -98.0 -31.41 12.17 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -176.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.487 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 3.8 t70 -114.96 -5.59 12.54 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 118.842 0.746 . . . . 0.0 112.177 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . -62.4 -42.24 99.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.315 0.579 . . . . 0.0 111.702 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -83.76 19.7 1.62 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.865 0.84 . . . . 0.0 110.028 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 26' ' ' ALA . 3.0 m120 -139.85 -8.64 1.21 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -96.97 -50.15 4.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.224 -178.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.559 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 41.5 mt -55.04 -44.15 99.45 Favored Pre-proline 0 C--O 1.217 -0.632 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 20.7 Cg_exo -63.13 -22.64 73.17 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 122.353 2.036 . . . . 0.0 110.958 176.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -74.65 -55.08 6.28 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.537 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.447 ' CD1' ' O ' ' A' ' 145' ' ' LEU . 0.2 OUTLIER -95.54 -35.07 5.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.322 -177.159 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.437 ' N ' ' CD1' ' A' ' 145' ' ' LEU . . . -106.61 81.19 0.82 Allowed Pre-proline 0 CA--C 1.508 -0.639 0 CA-C-O 121.105 0.479 . . . . 0.0 111.93 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.75 -10.23 24.75 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 N-CA-C 107.33 -1.834 . . . . 0.0 107.33 174.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -74.61 -42.15 59.13 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.487 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.16 -80.03 0.12 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.188 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.6 mm -99.03 140.56 18.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.033 0.444 . . . . 0.0 110.99 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -81.57 -42.9 19.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.915 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.623 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 47.1 tp60 -178.44 165.51 1.77 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.623 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -165.08 144.08 6.63 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.201 0.524 . . . . 0.0 110.934 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.557 ' N ' ' NZ ' ' A' ' 54' ' ' LYS . 10.4 pt-20 -145.6 143.17 29.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.954 0.407 . . . . 0.0 111.249 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -78.57 142.09 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.485 0.66 . . . . 0.0 111.39 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.9 mt -86.36 -39.7 16.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.418 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.482 ' O ' ' CG2' ' A' ' 52' ' ' THR . 40.7 mt-10 -148.18 133.61 18.61 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.618 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.93 -156.26 22.87 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.696 HD21 ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -132.68 -10.54 3.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.95 0.405 . . . . 0.0 111.054 -179.203 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.696 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 134.36 21.0 0.78 Allowed Glycine 0 C--O 1.222 -0.619 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -178.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.3 -171.75 20.0 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -62.09 124.81 15.1 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 122.433 2.089 . . . . 0.0 113.036 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.8 3.78 59.23 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.482 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 66.5 m -93.69 140.57 29.49 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.555 -0.823 . . . . 0.0 111.064 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.58 125.21 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.557 ' NZ ' ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -115.52 138.18 51.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.254 0.55 . . . . 0.0 110.131 178.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -120.43 132.07 55.07 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.708 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.53 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 1.5 mp -103.28 140.8 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.0 m -113.48 118.64 35.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.83 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -101.47 -177.84 3.55 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.955 0.407 . . . . 0.0 110.942 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.25 145.77 35.17 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -59.61 -46.62 88.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.746 0.308 . . . . 0.0 110.794 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.72 61.56 3.45 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.3 t -142.96 175.04 10.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.916 0.389 . . . . 0.0 110.614 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -59.82 -51.49 69.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 110.665 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.461 ' OH ' ' NZ ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -107.11 143.47 35.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.165 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.06 -48.93 0.91 Allowed Glycine 0 CA--C 1.52 0.39 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -145.49 153.44 41.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.105 0.478 . . . . 0.0 110.624 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -154.02 146.34 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.554 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -105.57 106.11 16.45 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.436 0.636 . . . . 0.0 111.701 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -92.51 123.19 35.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.708 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -113.11 119.62 38.46 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.82 -0.55 . . . . 0.0 111.068 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.9 mp -70.22 137.16 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.569 ' C ' ' HG ' ' A' ' 73' ' ' SER . 26.2 t0 -99.61 -54.46 2.92 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.569 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 65.0 m -165.0 141.57 5.76 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.8 mt -129.98 131.03 66.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.619 177.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.598 ' O ' ' N ' ' A' ' 79' ' ' TYR . 7.2 m-20 -116.25 87.89 2.78 Favored 'General case' 0 C--O 1.206 -1.217 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.578 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.1 pm0 -54.83 -41.14 70.34 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.06 -35.97 27.29 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.492 0.663 . . . . 0.0 109.223 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.444 ' O ' ' NZ ' ' A' ' 103' ' ' LYS . 0.6 OUTLIER -107.95 -10.5 15.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.409 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.598 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.9 m-85 63.24 50.32 3.03 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 120.989 -1.07 . . . . 0.0 110.024 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 34.9 t -106.26 144.24 33.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.359 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -135.09 123.23 22.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.101 0.477 . . . . 0.0 110.588 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 p -132.57 134.64 45.2 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.133 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -144.62 159.08 43.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.145 0.498 . . . . 0.0 110.022 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.7 m -142.32 137.2 30.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.994 0.426 . . . . 0.0 110.586 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.2 mt -80.06 109.87 14.92 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.9 pt -79.56 -43.47 23.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.011 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.427 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 3.4 tp10 -149.99 172.1 15.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.739 0.304 . . . . 0.0 110.362 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.635 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.94 177.45 18.33 Favored Glycine 0 CA--C 1.509 -0.326 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -61.14 1.61 0.17 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.635 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -65.25 -35.36 80.81 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 124.105 0.962 . . . . 0.0 110.212 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.611 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.72 11.77 22.6 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 123.521 0.728 . . . . 0.0 109.623 -177.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.571 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 67.9 p 46.55 -126.65 1.49 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -131.04 -11.37 3.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.256 0.55 . . . . 0.0 110.816 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.432 ' HG1' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -105.19 -5.58 20.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.427 -177.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.436 HG22 ' CD1' ' A' ' 98' ' ' ILE . 94.4 mt -97.76 152.09 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.42 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -87.37 -61.27 1.76 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.337 177.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.417 ' O ' ' CB ' ' A' ' 120' ' ' HIS . 11.8 ptmt -172.26 149.59 2.28 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.489 0.661 . . . . 0.0 111.305 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.436 ' CD1' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.13 127.56 75.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.597 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.3 145.7 39.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.246 0.546 . . . . 0.0 111.635 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -138.45 136.66 36.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.265 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.13 134.2 49.07 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 120.916 0.389 . . . . 0.0 110.144 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.64 130.87 28.48 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.31 -0.869 . . . . 0.0 109.742 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' A' ' 78' ' ' SER . 25.9 tttp -127.22 134.3 50.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.605 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -102.99 125.27 49.68 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -178.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -130.32 137.89 55.19 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.624 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.916 -178.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.21 133.57 45.17 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.287 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 14.8 t -121.56 174.35 6.84 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 122.678 0.391 . . . . 0.0 110.426 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.41 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -54.97 -36.34 60.44 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 m -80.56 -15.28 57.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.411 1.484 . . . . 0.0 114.198 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.95 -90.13 0.13 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.426 1.965 . . . . 0.0 110.812 -168.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -157.22 129.09 7.11 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 127.728 2.411 . . . . 0.0 111.005 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.412 ' N ' ' O ' ' A' ' 105' ' ' VAL . 43.9 m -99.8 118.91 37.28 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.2 mt -92.66 131.65 39.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.535 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -105.25 116.64 32.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 53.4 p -111.56 128.45 56.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.383 0.611 . . . . 0.0 111.258 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.578 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -112.07 135.77 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 C-N-CA 123.327 0.651 . . . . 0.0 109.92 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 p -110.38 136.93 48.78 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.467 ' HE2' ' CG2' ' A' ' 116' ' ' ILE . 27.7 m-70 -135.7 95.54 3.26 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.026 0.441 . . . . 0.0 110.888 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -84.89 101.12 12.06 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.417 ' CB ' ' O ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -94.32 103.76 15.76 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.441 ' OG1' ' CG2' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -100.09 161.73 13.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.665 -178.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.442 ' H ' HG22 ' A' ' 125' ' ' ILE . 8.1 ptmt -112.22 157.15 21.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 41.01 -123.15 2.47 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.491 HD21 ' N ' ' A' ' 124' ' ' ASN . 0.1 OUTLIER -95.08 -12.09 27.14 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.694 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.442 HG22 ' H ' ' A' ' 122' ' ' LYS . 1.1 tp -49.32 162.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.632 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -159.62 150.09 19.08 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.229 -0.294 . . . . 0.0 110.9 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.3 mm -86.34 124.86 40.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -76.82 160.4 29.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.448 0.642 . . . . 0.0 111.718 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -70.24 -41.08 74.01 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.615 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.96 -26.14 68.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.674 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -72.97 -52.11 15.75 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.595 0.712 . . . . 0.0 111.162 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.413 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 3.6 m -77.02 -29.53 17.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.584 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.131 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -67.04 -45.85 76.19 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 122.259 -0.276 . . . . 0.0 111.105 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.68 -46.56 79.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.917 0.389 . . . . 0.0 110.542 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.28 91.44 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 85.1 tttt -67.12 -46.62 73.59 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 122.691 -0.299 . . . . 0.0 110.956 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -54.56 -47.8 72.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.952 0.406 . . . . 0.0 110.086 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.461 ' NZ ' ' OH ' ' A' ' 64' ' ' TYR . 32.9 ttmt -61.13 -52.22 65.77 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.456 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.39 -51.96 31.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.604 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -47.94 -38.56 16.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.79 -33.85 88.08 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.495 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -75.89 -32.85 59.85 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.561 0.696 . . . . 0.0 109.408 179.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -59.22 -30.12 68.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -68.35 -42.32 79.41 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.603 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 0.8 OUTLIER -50.93 -58.57 5.69 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 114.088 -1.414 . . . . 0.0 112.154 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.513 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 23.1 mt -73.73 -49.47 35.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.164 -176.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 13.2 tt0 -45.98 -56.25 5.76 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.556 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 20.7 t -50.8 -47.55 59.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.321 0.581 . . . . 0.0 110.48 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.644 ' O ' ' N ' ' A' ' 153' ' ' HIS . 8.3 t80 -52.03 -51.88 54.54 Favored 'General case' 0 C--O 1.192 -1.934 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.513 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 1.9 mm? -62.45 -42.15 99.27 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 119.576 1.08 . . . . 0.0 112.208 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -62.99 -24.34 67.87 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 121.454 -0.779 . . . . 0.0 109.203 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.96 -12.95 15.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.097 0.475 . . . . 0.0 110.671 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.644 ' N ' ' O ' ' A' ' 149' ' ' TYR . 75.1 m80 -155.45 66.31 4.67 Favored Pre-proline 0 C--N 1.311 -1.103 0 C-N-CA 125.452 1.501 . . . . 0.0 110.162 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.55 -3.58 12.82 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 122.598 2.198 . . . . 0.0 111.597 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.574 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.7 OUTLIER -85.75 4.17 38.03 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 123.312 0.645 . . . . 0.0 111.67 -178.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.427 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -49.53 130.01 19.82 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 120.062 -1.649 . . . . 0.0 111.264 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 2.8 t80 54.84 6.31 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.574 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 118.578 -0.725 . . . . 0.0 110.242 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.929 0.395 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.46 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 52.1 m-85 -99.36 111.66 23.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.735 177.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.7 m -96.48 140.17 31.51 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.958 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -138.73 134.49 33.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.21 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.45 129.4 50.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.82 0.343 . . . . 0.0 111.024 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -135.54 166.79 22.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.967 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.91 159.97 39.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.471 0.653 . . . . 0.0 112.593 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.474 ' CE1' ' O ' ' A' ' 10' ' ' THR . 81.6 t80 -151.01 140.85 21.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.365 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.474 ' O ' ' CE1' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -93.62 148.23 22.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.811 0.339 . . . . 0.0 111.363 -179.362 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 p -144.81 154.45 42.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.779 0.323 . . . . 0.0 110.698 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -96.72 25.06 5.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 110.555 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -113.14 125.93 28.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.48 144.96 12.78 Favored 'Trans proline' 0 C--N 1.326 -0.616 0 C-N-CA 121.913 1.742 . . . . 0.0 111.735 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -55.84 -24.64 48.21 Favored 'Trans proline' 0 N--CA 1.484 0.922 0 C-N-CA 122.457 2.105 . . . . 0.0 112.667 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 m -68.31 -36.19 78.94 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -76.36 -56.34 4.72 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.3 mt -48.48 -47.08 38.79 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.752 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -49.43 -57.22 7.37 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -24.46 63.43 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.364 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.1 -2.69 56.05 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.373 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -118.87 -8.23 10.32 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 m -134.07 -35.5 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.617 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 2.6 mp -90.71 -55.01 3.73 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.59 1.087 . . . . 0.0 111.922 -175.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 29' ' ' LEU . 17.4 t70 -113.59 -4.55 13.47 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.868 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.93 -42.25 17.41 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' CB ' ' HZ1' ' A' ' 54' ' ' LYS . 1.1 m-20 -84.95 18.3 2.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.67 0.748 . . . . 0.0 110.5 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -139.91 -9.79 1.17 Allowed 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 124.583 1.153 . . . . 0.0 108.555 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.467 HD23 ' CD2' ' A' ' 149' ' ' TYR . 0.5 OUTLIER -89.71 -45.78 9.08 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 124.513 1.125 . . . . 0.0 109.597 -178.693 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.447 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 26.3 mt -54.38 -53.99 53.29 Favored Pre-proline 0 C--O 1.214 -0.791 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 22.8 Cg_endo -60.78 -21.59 70.61 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 122.081 1.854 . . . . 0.0 111.542 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 tmtp? -69.12 -52.63 26.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.699 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.448 ' CD1' ' O ' ' A' ' 145' ' ' LEU . 0.1 OUTLIER -95.85 -36.5 6.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.077 -177.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.451 ' HB1' ' CD2' ' A' ' 145' ' ' LEU . . . -107.04 82.27 1.09 Allowed Pre-proline 0 CA--C 1.506 -0.717 0 C-N-CA 123.159 0.584 . . . . 0.0 111.573 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.36 -9.81 27.07 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 N-CA-C 107.476 -1.778 . . . . 0.0 107.476 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -73.95 -42.09 61.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.499 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.43 -82.34 0.07 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.751 -178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 89.1 mt -107.76 143.36 18.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.98 0.419 . . . . 0.0 110.655 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -79.83 -46.18 17.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.174 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.495 ' NE2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -179.5 166.59 1.43 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.467 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.495 ' N ' ' NE2' ' A' ' 40' ' ' GLN . . . -165.19 147.7 7.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.926 0.393 . . . . 0.0 111.044 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -137.79 145.41 42.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.31 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.16 139.94 17.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.509 0.671 . . . . 0.0 110.716 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 7.5 mp -89.02 -39.27 13.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.787 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.483 ' O ' ' CG2' ' A' ' 52' ' ' THR . 28.0 mt-10 -147.41 136.72 22.52 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.425 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.63 -155.92 22.91 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.07 0.02 1.9 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 122.819 0.448 . . . . 0.0 110.749 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.35 11.52 3.37 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.11 -172.2 19.53 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 117.349 0.574 . . . . 0.0 112.123 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -59.15 126.71 21.74 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 122.676 2.25 . . . . 0.0 113.275 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.5 2.73 56.51 Favored Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.483 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 60.8 m -94.4 139.8 30.64 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.104 -1.048 . . . . 0.0 111.651 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.08 126.26 75.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.405 ' HZ1' ' CB ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -114.28 139.02 49.76 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.362 0.601 . . . . 0.0 110.509 179.244 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -118.44 127.12 53.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.096 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.534 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 1.8 mp -105.5 135.7 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.6 m -111.25 120.5 42.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.08 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 59' ' ' GLY . 4.6 t80 -91.69 179.29 5.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.671 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.429 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -54.39 143.93 30.07 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -60.65 -59.45 5.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.884 0.373 . . . . 0.0 110.994 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.72 61.79 3.42 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.5 t -137.66 175.22 9.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.87 0.367 . . . . 0.0 110.692 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -61.49 -45.08 95.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.685 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -91.87 155.07 18.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.537 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.4 -61.37 0.13 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.17 154.7 42.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.084 0.469 . . . . 0.0 110.63 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 p -155.49 146.95 12.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.024 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -105.66 114.97 29.45 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.31 0.576 . . . . 0.0 112.267 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.588 ' CE1' ' CD2' ' A' ' 85' ' ' LEU . 1.8 m80 -100.56 116.84 33.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.729 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -102.0 119.59 39.05 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.969 -0.457 . . . . 0.0 111.29 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.2 mt -77.74 145.61 9.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.647 ' C ' ' HG ' ' A' ' 73' ' ' SER . 7.3 m-20 -106.53 -55.32 2.34 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.647 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 2.7 m -165.39 141.94 5.54 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.6 mt -123.16 131.18 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.287 176.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.2 m-20 -116.01 87.64 2.72 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.466 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 9.8 pt-20 -54.96 -30.25 58.62 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.71 -39.06 70.55 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.98 -10.11 15.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.094 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.543 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.9 m-85 63.28 41.6 7.67 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 121.676 -0.64 . . . . 0.0 110.21 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.1 t -107.55 149.11 28.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.051 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 27.3 p90 -151.56 124.04 8.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.216 0.531 . . . . 0.0 110.965 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.66 144.56 51.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.208 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -144.65 171.66 14.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.806 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 m -144.64 136.23 25.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.135 0.493 . . . . 0.0 110.554 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.588 ' CD2' ' CE1' ' A' ' 69' ' ' HIS . 9.1 mt -79.83 120.02 23.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.11 -43.31 16.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.612 -178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.479 ' OE2' ' N ' ' A' ' 88' ' ' GLY . 3.2 tm-20 -153.14 170.26 20.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.731 0.3 . . . . 0.0 110.265 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.619 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 118.17 178.48 17.16 Favored Glycine 0 CA--C 1.507 -0.465 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 178.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -61.83 2.03 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.293 1.044 . . . . 0.0 108.711 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -67.26 -34.31 77.17 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 124.215 1.006 . . . . 0.0 110.439 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.621 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.25 16.15 21.9 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 123.305 0.642 . . . . 0.0 110.136 -177.348 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.552 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 60.4 p 47.36 -126.19 1.67 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.199 -178.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -130.3 -13.05 3.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.769 0.318 . . . . 0.0 111.532 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.02 -7.04 19.48 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 63.7 mt -99.91 153.5 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 CA-C-O 121.8 0.809 . . . . 0.0 113.127 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.513 ' CG ' ' N ' ' A' ' 97' ' ' LYS . 5.9 pt-20 -99.41 -51.64 3.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.027 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.513 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 64.4 mttt -164.71 146.68 8.27 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 121.177 0.513 . . . . 0.0 111.915 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.3 122.5 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.33 144.91 30.74 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.481 ' CZ ' ' OG ' ' A' ' 117' ' ' SER . 0.6 OUTLIER -139.88 131.79 27.68 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.665 179.453 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.525 ' CD ' ' N ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -129.15 130.92 47.02 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.525 ' N ' ' CD ' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -140.93 132.88 27.68 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.523 -0.736 . . . . 0.0 111.227 179.532 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.494 ' HZ2' HG13 ' A' ' 105' ' ' VAL . 26.3 ttpp -122.87 134.69 54.38 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.128 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.572 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.37 125.74 43.63 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.221 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.494 HG13 ' HZ2' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -127.43 137.56 57.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.098 -178.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.3 133.71 45.15 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.368 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.441 ' SG ' ' N ' ' A' ' 111' ' ' SER . 27.1 p -121.66 174.25 6.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.945 0.402 . . . . 0.0 110.288 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.71 -34.51 56.39 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.6 m -79.31 -21.22 46.24 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.615 -1.521 . . . . 0.0 114.078 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.7 -88.45 0.12 Allowed Glycine 0 CA--C 1.524 0.626 0 C-N-CA 125.752 1.644 . . . . 0.0 109.5 -166.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.441 ' N ' ' SG ' ' A' ' 107' ' ' CYS . 0.8 OUTLIER -159.39 129.37 5.61 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 126.006 1.722 . . . . 0.0 111.336 -179.043 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 105' ' ' VAL . 26.8 m -99.6 118.53 36.34 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.9 mt -92.32 132.05 37.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.428 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -105.34 116.92 32.77 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.0 p -111.1 118.21 35.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.28 0.562 . . . . 0.0 111.36 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.658 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -102.59 135.76 38.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.481 ' OG ' ' CZ ' ' A' ' 100' ' ' TYR . 11.1 m -117.95 133.32 56.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.72 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -137.2 112.94 9.52 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.656 ' N ' ' CD1' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -102.28 103.31 13.77 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.989 -0.444 . . . . 0.0 110.122 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -91.04 107.98 19.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.119 0.485 . . . . 0.0 110.147 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -100.52 175.47 5.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.582 0.706 . . . . 0.0 111.127 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.484 ' HZ2' HG12 ' A' ' 125' ' ' ILE . 2.8 ptmm? -110.36 158.64 18.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.833 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 39.85 -111.13 0.2 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.613 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -112.75 0.4 15.27 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 122.502 -0.41 . . . . 0.0 111.515 179.339 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.484 HG12 ' HZ2' ' A' ' 122' ' ' LYS . 1.5 mp -44.39 160.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.155 0.502 . . . . 0.0 110.641 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.474 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 93.3 mt-10 -147.98 146.92 29.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.212 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 22.1 mm -89.16 122.07 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -75.59 162.43 28.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.439 0.638 . . . . 0.0 112.135 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -69.53 -55.02 11.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.667 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' A' ' 130' ' ' GLU . 1.5 pm0 -53.82 -24.25 14.91 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.931 -0.481 . . . . 0.0 110.992 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.513 ' CE1' ' OE2' ' A' ' 130' ' ' GLU . 9.8 m80 -73.55 -53.27 10.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.253 0.549 . . . . 0.0 110.067 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 3.9 m -77.81 -27.91 15.37 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.199 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -67.66 -46.1 73.36 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.979 -0.45 . . . . 0.0 110.928 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 28.2 m -70.0 -42.93 79.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.663 0.268 . . . . 0.0 110.548 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.74 -46.47 53.58 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 0.0 OUTLIER -67.36 -47.08 71.47 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 122.692 -0.299 . . . . 0.0 110.712 179.718 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -55.16 -48.2 74.07 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -62.4 -51.87 65.83 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -50.08 -53.73 25.19 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.722 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -47.4 -38.91 14.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.771 0.796 . . . . 0.0 109.358 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.55 -32.73 84.24 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 139' ' ' ALA . 0.6 OUTLIER -75.67 -36.3 60.14 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.698 0.761 . . . . 0.0 109.491 178.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -58.39 -25.47 62.13 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.57 -38.73 54.43 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.489 177.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.451 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -50.96 -58.64 5.53 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-O 122.442 1.115 . . . . 0.0 111.263 179.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.519 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 20.0 mt -72.81 -49.37 40.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.845 -177.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -46.07 -52.17 12.48 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.547 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 24.7 p -54.09 -44.98 71.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.153 0.502 . . . . 0.0 110.637 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.615 ' O ' ' N ' ' A' ' 153' ' ' HIS . 11.2 t80 -53.89 -45.95 71.23 Favored 'General case' 0 C--O 1.183 -2.417 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.519 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 1.6 mm? -69.5 -42.5 74.66 Favored 'General case' 0 C--O 1.218 -0.591 0 O-C-N 120.592 -1.317 . . . . 0.0 111.887 -177.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -25.48 68.22 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 121.569 -0.707 . . . . 0.0 109.594 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 149' ' ' TYR . 0.2 OUTLIER -106.98 -12.93 15.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.406 0.622 . . . . 0.0 110.307 178.304 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.615 ' N ' ' O ' ' A' ' 149' ' ' TYR . 13.5 t-80 -154.67 65.97 4.97 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 124.98 1.312 . . . . 0.0 110.23 -177.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.59 -3.12 11.26 Favored 'Trans proline' 0 N--CA 1.482 0.799 0 C-N-CA 122.576 2.184 . . . . 0.0 111.616 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.617 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 1.9 m-20 -74.52 2.66 9.13 Favored 'General case' 0 C--O 1.213 -0.859 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.913 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -50.33 129.48 21.7 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 119.354 -2.091 . . . . 0.0 110.996 -178.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 157' ' ' TYR . 86.2 t80 53.03 5.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.544 0 O-C-N 121.179 -0.95 . . . . 0.0 110.069 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.234 0.242 0 CA-C-O 121.028 0.442 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.61 109.82 22.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.451 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.767 ' HG1' ' CE1' ' A' ' 118' ' ' HIS . 74.2 m -96.25 139.89 31.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.799 0.333 . . . . 0.0 111.004 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.08 130.56 25.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.08 179.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.466 ' C ' HD21 ' A' ' 7' ' ' ASN . 0.8 OUTLIER -103.24 128.39 50.27 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.735 0.303 . . . . 0.0 110.766 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.466 HD21 ' C ' ' A' ' 6' ' ' GLU . 1.5 m120 -126.73 168.37 14.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.519 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -155.2 142.48 19.44 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -146.57 139.92 25.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.629 0.252 . . . . 0.0 110.766 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.45 148.23 23.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 111.227 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.4 p -144.77 154.44 42.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.564 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -92.1 18.76 7.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.906 0.384 . . . . 0.0 110.786 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mt -108.06 126.01 30.74 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.194 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.01 147.37 7.89 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 121.6 1.533 . . . . 0.0 111.392 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -63.99 -23.68 67.59 Favored 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 122.503 2.135 . . . . 0.0 112.754 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.8 m -66.19 -32.28 73.62 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.633 ' N ' ' CD ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -81.73 -55.14 4.82 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -178.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.4 mt -47.05 -44.13 20.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.413 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 54.7 t80 -51.79 -59.29 4.47 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.843 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -23.37 63.16 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.698 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 26' ' ' ALA . . . -82.25 -2.96 54.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.676 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CE2' ' OH ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -119.47 -9.22 9.89 Favored 'General case' 0 C--O 1.23 0.069 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.843 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 19' ' ' PHE . 2.8 m -136.14 -37.02 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.582 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 3.4 mp -91.18 -52.89 4.6 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.208 0.913 . . . . 0.0 112.131 -176.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -112.49 -4.18 14.26 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.43 ' O ' ' CG1' ' A' ' 30' ' ' ILE . . . -55.02 -40.39 70.13 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 121.493 -0.755 . . . . 0.0 112.235 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -83.89 16.41 2.83 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.59 0.71 . . . . 0.0 110.905 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.499 ' C ' ' ND2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -139.46 -10.2 1.24 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.555 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.461 HD23 ' CD1' ' A' ' 149' ' ' TYR . 0.4 OUTLIER -88.15 -40.96 13.32 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.722 -1.127 . . . . 0.0 110.119 -178.294 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.472 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.14 -50.65 83.31 Favored Pre-proline 0 C--O 1.207 -1.141 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 19.2 Cg_endo -62.18 -24.88 76.63 Favored 'Trans proline' 0 C--N 1.319 -1.014 0 C-N-CA 121.682 1.588 . . . . 0.0 112.185 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -67.98 -62.26 1.49 Allowed 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 121.74 0.781 . . . . 0.0 112.076 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.474 ' CD1' ' O ' ' A' ' 145' ' ' LEU . 1.9 pt -95.29 -32.98 4.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.075 -177.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.496 ' CB ' ' HG ' ' A' ' 145' ' ' LEU . . . -101.97 74.29 0.14 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 123.746 0.818 . . . . 0.0 112.679 -175.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.74 -20.06 26.83 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 121.201 1.267 . . . . 0.0 109.081 175.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.471 ' NE2' ' C ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -72.99 -40.98 64.79 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.84 178.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.419 ' N ' ' NE2' ' A' ' 36' ' ' GLN . . . -70.81 -82.13 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.94 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.405 ' N ' ' CD1' ' A' ' 38' ' ' ILE . 2.0 mp -112.54 145.09 19.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.145 0.498 . . . . 0.0 110.637 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -78.36 -47.1 18.4 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.329 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.563 ' NE2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -173.86 164.54 4.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.986 0.422 . . . . 0.0 110.003 179.298 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.563 ' N ' ' NE2' ' A' ' 40' ' ' GLN . . . -166.1 145.57 6.09 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.746 178.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -138.59 142.71 39.16 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.39 140.0 17.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.501 0.667 . . . . 0.0 110.513 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.516 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 6.6 mp -89.39 -40.5 12.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.66 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.549 ' O ' ' CG2' ' A' ' 52' ' ' THR . 27.8 mm-40 -137.52 133.6 34.74 Favored 'General case' 0 C--O 1.215 -0.753 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.67 -156.59 46.46 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.501 ' H ' HD21 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -135.79 -4.93 2.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.777 0.322 . . . . 0.0 111.32 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 142.09 18.94 0.28 Allowed Glycine 0 C--O 1.221 -0.718 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.403 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -109.86 -172.91 20.53 Favored Glycine 0 C--O 1.224 -0.51 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -62.08 125.06 15.58 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 122.443 2.095 . . . . 0.0 113.009 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.58 5.67 60.06 Favored Glycine 0 N--CA 1.464 0.509 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.549 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 87.2 m -93.53 140.69 29.32 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.414 -0.893 . . . . 0.0 111.005 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -122.5 128.84 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.45 139.36 50.53 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.272 0.558 . . . . 0.0 110.76 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -118.47 124.76 48.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.989 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.544 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 1.7 mp -103.26 130.89 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.6 m -109.26 118.49 36.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.828 0.347 . . . . 0.0 110.28 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -92.83 -175.58 3.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.558 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.97 144.04 32.26 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -59.72 -62.77 1.62 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.881 0.372 . . . . 0.0 110.809 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.94 61.9 3.34 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.1 m -137.28 175.38 9.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.746 0.308 . . . . 0.0 110.69 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -55.1 -53.52 54.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.841 0.353 . . . . 0.0 110.561 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -91.99 154.57 18.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.381 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.39 -61.57 0.14 Allowed Glycine 0 N--CA 1.461 0.321 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -145.62 148.01 32.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.942 0.401 . . . . 0.0 110.377 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.76 145.57 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.821 0.343 . . . . 0.0 110.846 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -105.87 109.6 21.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.401 0.62 . . . . 0.0 111.558 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.614 ' HE2' ' CB ' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -106.38 113.73 27.43 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.245 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -102.31 130.05 48.91 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.5 mp -70.63 141.14 17.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -99.37 -55.58 2.64 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -165.6 141.56 5.22 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.5 mt -130.01 129.87 65.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 120.968 0.413 . . . . 0.0 110.57 177.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 79' ' ' TYR . 39.2 m-20 -115.78 88.57 2.91 Favored 'General case' 0 C--O 1.212 -0.897 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -53.75 -30.08 42.71 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.89 -37.36 71.28 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.122 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -107.62 -11.21 15.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.806 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.547 ' N ' ' O ' ' A' ' 75' ' ' ASP . 32.0 m-85 60.2 45.0 12.05 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 121.797 -0.564 . . . . 0.0 110.339 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 p -112.92 148.98 33.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.498 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 6.2 p90 -147.62 127.64 13.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.251 0.548 . . . . 0.0 111.182 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 m -130.32 147.13 52.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.241 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.614 ' CB ' ' HE2' ' A' ' 69' ' ' HIS . 15.0 p90 -153.68 168.25 26.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.824 0.345 . . . . 0.0 110.184 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.7 m -145.6 139.45 26.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.054 0.454 . . . . 0.0 111.388 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.9 mt -80.52 111.91 17.37 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.01 -41.81 68.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.252 -177.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.469 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 17.4 tp10 -156.39 171.82 19.57 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.621 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.59 177.83 17.45 Favored Glycine 0 CA--C 1.508 -0.373 0 N-CA-C 110.214 -1.155 . . . . 0.0 110.214 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -61.21 2.15 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.621 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -67.61 -36.03 80.07 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.982 0.913 . . . . 0.0 110.094 177.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.643 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -111.8 13.26 21.01 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 123.694 0.797 . . . . 0.0 109.253 -178.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.626 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 47.1 p 48.07 -126.32 1.84 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -177.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -131.17 -9.23 3.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.092 0.472 . . . . 0.0 110.51 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.6 t -104.9 -6.66 19.97 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.433 HG22 ' CD1' ' A' ' 98' ' ' ILE . 57.6 mt -100.62 151.6 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.418 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -87.08 -58.83 2.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.514 177.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -170.55 148.77 3.13 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.191 0.52 . . . . 0.0 110.867 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.433 ' CD1' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.66 120.85 62.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.566 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.416 ' O ' ' CD1' ' A' ' 100' ' ' TYR . 9.5 t -109.65 145.5 36.38 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.375 0.607 . . . . 0.0 111.199 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 99' ' ' SER . 19.5 m-85 -135.69 129.41 32.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.221 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -127.8 133.72 49.45 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.32 136.37 36.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.859 0.361 . . . . 0.0 110.069 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -119.73 132.77 55.73 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -102.76 134.98 45.25 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.126 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.413 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.6 OUTLIER -137.05 136.77 47.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.994 -178.613 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.75 135.16 45.25 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.525 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.459 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 31.3 t -121.15 174.57 6.59 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.608 0.363 . . . . 0.0 110.161 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.459 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -55.8 -30.74 57.24 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 112.236 -0.346 . . . . 0.0 112.236 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.9 p -91.73 -12.47 33.87 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 119.552 -2.146 . . . . 0.0 115.634 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.16 -85.17 0.13 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.839 1.209 . . . . 0.0 111.407 -171.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.409 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 1.3 p -165.56 134.73 3.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.402 1.481 . . . . 0.0 110.858 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 105' ' ' VAL . 97.8 m -98.81 117.44 33.3 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.6 mt -92.81 127.54 44.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.69 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -104.25 116.23 31.8 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 34.2 t -112.13 124.84 53.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.144 0.497 . . . . 0.0 111.432 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.605 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -105.41 136.04 41.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 123.152 0.581 . . . . 0.0 109.486 -178.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.15 132.56 54.05 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.378 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.767 ' CE1' ' HG1' ' A' ' 4' ' ' THR . 26.1 m-70 -137.17 106.05 5.93 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 117.819 0.282 . . . . 0.0 110.91 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.423 ' CD2' ' N ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER -101.45 103.83 14.75 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -89.97 109.8 20.81 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.18 0.514 . . . . 0.0 109.965 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.483 ' CG2' ' O ' ' A' ' 125' ' ' ILE . 0.6 OUTLIER -95.05 164.45 12.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.356 -178.219 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.403 ' H ' ' CG2' ' A' ' 125' ' ' ILE . 11.4 mtmt -92.46 146.92 23.31 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 34.0 -115.97 0.16 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.606 HD21 ' N ' ' A' ' 125' ' ' ILE . 0.4 OUTLIER -95.11 -13.73 24.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.812 0.339 . . . . 0.0 110.177 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.606 ' N ' HD21 ' A' ' 124' ' ' ASN . 1.1 tp -48.82 163.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -149.35 150.5 32.57 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.683 -0.635 . . . . 0.0 112.049 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 26.7 mm -86.67 124.89 40.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -75.25 160.79 29.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.587 0.708 . . . . 0.0 112.055 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -70.22 -43.57 70.38 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.382 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -60.44 -24.87 65.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.348 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.424 ' HE2' HG22 ' A' ' 92' ' ' THR . 4.6 t60 -72.7 -52.46 15.13 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.371 0.605 . . . . 0.0 110.86 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.5 m -76.09 -26.31 17.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.909 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -67.62 -46.27 73.02 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.403 -0.186 . . . . 0.0 111.094 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 34.6 m -69.85 -43.99 79.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.13 -43.33 93.45 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -67.23 -46.98 72.17 Favored 'General case' 0 CA--C 1.518 -0.258 0 O-C-N 122.789 -0.242 . . . . 0.0 110.973 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -54.94 -47.63 74.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.879 0.371 . . . . 0.0 110.054 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.64 -55.13 22.18 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.403 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -47.67 -45.25 27.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.535 0.683 . . . . 0.0 110.776 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -56.83 -37.4 71.2 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.87 0.843 . . . . 0.0 109.3 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.16 -38.66 96.52 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -68.64 -36.53 78.72 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -59.04 -32.36 69.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.32 -34.44 77.36 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.868 177.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.496 ' HG ' ' CB ' ' A' ' 34' ' ' ALA . 1.2 mm? -68.27 -58.26 4.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.566 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.491 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 66.3 mt -60.79 -48.67 87.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.743 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -46.38 -52.96 11.89 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.14 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 21.5 p -50.17 -44.68 52.83 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.344 0.592 . . . . 0.0 111.349 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.68 ' O ' ' N ' ' A' ' 153' ' ' HIS . 32.9 t80 -58.5 -45.5 88.64 Favored 'General case' 0 C--O 1.182 -2.499 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.491 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 2.0 mm? -65.06 -42.02 94.58 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 119.917 1.235 . . . . 0.0 111.966 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.455 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.4 OUTLIER -64.76 -24.98 67.73 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -106.58 -12.54 15.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.276 0.56 . . . . 0.0 110.961 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.68 ' N ' ' O ' ' A' ' 149' ' ' TYR . 94.1 m-70 -156.54 66.53 4.18 Favored Pre-proline 0 C--N 1.303 -1.429 0 C-N-CA 125.689 1.596 . . . . 0.0 110.59 -177.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.48 -2.72 11.15 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 122.468 2.112 . . . . 0.0 111.474 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.615 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -77.36 3.7 12.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.914 -178.472 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -49.08 129.28 17.54 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 119.269 -2.145 . . . . 0.0 111.186 -178.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.505 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 23.6 t80 54.08 6.73 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.048 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.438 0 O-C-N 121.402 -0.811 . . . . 0.0 110.225 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.234 0.238 0 CA-C-O 120.889 0.376 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -97.89 109.73 22.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.526 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.2 m -97.05 136.03 38.19 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.67 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -135.47 129.29 32.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.328 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.404 ' C ' ' ND2' ' A' ' 7' ' ' ASN . 1.2 tt0 -103.14 134.16 47.03 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.643 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.404 ' ND2' ' C ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -127.14 168.78 14.19 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.627 -179.25 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -150.71 140.31 21.61 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -144.42 129.15 18.25 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.515 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 m -100.42 144.05 29.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.787 0.327 . . . . 0.0 111.653 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.583 ' HG ' ' CD ' ' A' ' 147' ' ' GLU . 7.0 t -145.43 164.34 31.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.485 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -94.66 25.75 3.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.746 0.308 . . . . 0.0 111.16 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -111.55 125.42 30.44 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.781 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -50.42 147.56 16.54 Favored 'Trans proline' 0 C--N 1.327 -0.594 0 C-N-CA 121.953 1.769 . . . . 0.0 111.652 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -58.3 -25.08 71.03 Favored 'Trans proline' 0 N--CA 1.483 0.863 0 C-N-CA 122.279 1.986 . . . . 0.0 112.623 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.41 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . 55.4 m -67.62 -35.27 78.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.311 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -75.42 -57.06 4.12 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 mt -50.17 -44.69 52.91 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.008 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -49.4 -58.68 4.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.005 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.41 ' NZ ' ' O ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -67.57 -40.35 84.87 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 118.83 -1.148 . . . . 0.0 108.415 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.59 -2.99 2.7 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.445 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -118.35 -9.26 10.42 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.22 -50.95 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.531 ' CD1' ' N ' ' A' ' 25' ' ' ASP . 1.9 pp -98.06 -31.32 12.2 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.531 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 26.9 m-20 -114.21 -3.96 13.13 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-N 118.648 0.658 . . . . 0.0 111.555 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -66.88 -39.54 87.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.989 0.899 . . . . 0.0 111.187 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.52 16.99 3.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.125 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -138.35 -9.5 1.47 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -90.47 -50.22 6.07 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.585 -1.643 . . . . 0.0 109.631 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.43 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 96.0 mt -55.65 -51.6 78.87 Favored Pre-proline 0 C--O 1.212 -0.883 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.054 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 29.1 Cg_endo -62.49 -26.05 76.13 Favored 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 121.747 1.632 . . . . 0.0 112.948 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.54 -60.79 2.08 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.633 0.73 . . . . 0.0 112.435 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.424 ' O ' ' CD ' ' A' ' 35' ' ' PRO . 1.9 pt -93.07 -33.03 5.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.583 -177.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.491 ' CB ' ' HG ' ' A' ' 145' ' ' LEU . . . -102.79 68.15 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 123.121 0.569 . . . . 0.0 112.311 -177.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.424 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 66.7 Cg_endo -72.89 -19.15 23.86 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 N-CA-C 108.726 -1.298 . . . . 0.0 108.726 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -73.4 -39.41 65.11 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.693 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.36 -82.15 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.69 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 73.3 mt -110.74 145.05 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.044 0.45 . . . . 0.0 110.588 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -77.8 -47.69 18.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.421 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.613 ' NE2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -174.02 164.82 4.19 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.754 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.613 ' N ' ' NE2' ' A' ' 40' ' ' GLN . . . -164.73 145.82 7.86 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.841 0.353 . . . . 0.0 110.993 178.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -137.63 145.5 42.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.716 0.293 . . . . 0.0 110.258 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.54 139.54 18.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.476 0.655 . . . . 0.0 110.654 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.502 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 6.9 mp -88.98 -39.48 13.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.795 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.514 ' O ' ' CG2' ' A' ' 52' ' ' THR . 42.9 mt-10 -141.89 133.57 27.0 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.843 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.24 -156.33 29.41 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.736 HD22 ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -139.76 -8.3 1.24 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.96 0.41 . . . . 0.0 111.131 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.736 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 143.46 16.22 0.26 Allowed Glycine 0 C--O 1.219 -0.814 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.41 -172.04 19.99 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 117.394 0.597 . . . . 0.0 111.907 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -62.74 126.05 17.37 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 C-N-CA 122.858 2.372 . . . . 0.0 113.307 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.19 5.97 59.14 Favored Glycine 0 CA--C 1.506 -0.523 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.514 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 92.7 m -93.18 138.65 31.39 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 114.239 -0.981 . . . . 0.0 110.949 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.89 128.46 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.79 139.79 50.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.726 0.774 . . . . 0.0 110.676 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -118.47 127.84 54.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.828 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 2.0 mp -104.47 136.61 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.9 m -117.15 120.0 36.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.368 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.04 169.06 10.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.365 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.11 143.99 28.82 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.553 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 0.8 OUTLIER -59.86 -50.38 74.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.849 0.357 . . . . 0.0 110.468 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.71 61.47 3.47 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.6 t -145.49 178.97 7.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 110.653 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -66.63 -45.68 78.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 0.0 110.626 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -91.46 154.74 18.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.397 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.44 -61.71 0.13 Allowed Glycine 0 CA--C 1.52 0.347 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.53 154.93 42.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.754 0.311 . . . . 0.0 110.28 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.83 149.95 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.723 0.297 . . . . 0.0 111.202 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.57 113.43 26.99 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.527 0.68 . . . . 0.0 112.044 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.607 ' CE1' ' CD1' ' A' ' 83' ' ' TYR . 6.7 t60 -109.63 112.08 23.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.721 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -102.4 131.44 49.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.144 0.497 . . . . 0.0 111.858 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.8 mt -86.17 143.08 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.584 ' C ' ' HG ' ' A' ' 73' ' ' SER . 35.3 t70 -106.66 -54.89 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.584 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 57.2 m -164.81 141.92 6.14 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 53.9 mt -124.81 131.26 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.872 176.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' A' ' 79' ' ' TYR . 5.8 m-20 -114.93 87.42 2.65 Favored 'General case' 0 C--O 1.21 -1.023 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.502 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 7.4 pt-20 -55.04 -30.63 59.97 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.57 -37.7 68.38 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.4 m -107.76 -10.46 15.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.922 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.56 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.2 m-85 62.84 44.57 6.19 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.625 -0.672 . . . . 0.0 109.865 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -105.96 145.66 31.03 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.469 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -132.13 120.82 22.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.191 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.473 ' CB ' ' OE1' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -127.11 133.25 50.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.321 -179.675 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.607 ' CD1' ' CE1' ' A' ' 69' ' ' HIS . 24.6 p90 -144.11 170.75 15.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.827 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.1 m -145.94 125.69 13.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.018 0.437 . . . . 0.0 110.876 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.08 118.25 20.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.75 -41.81 15.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -175.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.499 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 10.0 tp10 -162.59 174.75 12.2 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 118.948 0.795 . . . . 0.0 110.816 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.616 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 119.76 178.31 16.38 Favored Glycine 0 CA--C 1.505 -0.578 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.6 2.75 0.16 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.616 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -72.07 -37.38 69.64 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 123.917 0.887 . . . . 0.0 111.22 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.607 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -111.29 17.04 20.61 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 119.672 -0.204 . . . . 0.0 110.625 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.488 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 30.4 p 54.25 -133.4 1.74 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -177.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -131.81 -0.7 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.5 p -104.72 -7.71 19.35 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 6.9 mt -99.2 151.25 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.481 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -87.07 -50.5 6.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.351 176.165 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.436 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 12.1 ptmt -172.61 149.56 2.09 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.9 130.38 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.155 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.434 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -113.15 144.26 42.96 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.902 0.481 . . . . 0.0 111.015 -179.037 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.489 ' CE1' ' OG ' ' A' ' 117' ' ' SER . 0.3 OUTLIER -139.22 131.55 28.39 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.87 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.473 ' OE1' ' CB ' ' A' ' 82' ' ' SER . 8.9 tp10 -128.73 133.0 48.01 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.408 ' N ' ' CD ' ' A' ' 101' ' ' GLU . 0.5 OUTLIER -136.26 131.63 34.71 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 121.596 -0.69 . . . . 0.0 110.631 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -124.33 134.17 53.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.863 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.597 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -100.6 126.17 47.05 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -178.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -128.32 136.69 59.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.959 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.68 133.42 44.61 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.117 -0.364 . . . . 0.0 110.596 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 24.7 t -121.7 173.35 7.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.547 0.339 . . . . 0.0 110.158 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.443 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -54.4 -36.61 58.3 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.901 -0.479 . . . . 0.0 111.901 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.9 m -93.98 15.94 15.66 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.25 1.42 . . . . 0.0 113.363 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 130.0 -83.99 0.32 Allowed Glycine 0 CA--C 1.534 1.235 0 C-N-CA 126.4 1.952 . . . . 0.0 113.095 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 84.1 p -161.62 132.13 5.04 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 126.99 2.116 . . . . 0.0 111.057 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 45.0 m -99.83 118.12 35.61 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 60.5 mt -92.72 126.83 45.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.57 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.62 116.86 32.65 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 p -111.62 124.3 52.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.335 0.588 . . . . 0.0 110.877 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.654 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -106.8 136.18 42.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 123.148 0.579 . . . . 0.0 109.922 -177.699 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.489 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 7.2 t -116.52 133.04 56.48 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.788 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.434 ' ND1' ' O ' ' A' ' 99' ' ' SER . 0.2 OUTLIER -136.47 109.35 7.61 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 120.766 0.317 . . . . 0.0 110.522 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 119' ' ' TYR . 7.3 m-85 -102.14 104.02 14.61 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.228 -0.295 . . . . 0.0 110.512 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -90.86 110.16 21.37 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.064 0.459 . . . . 0.0 109.823 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.4 p -94.1 171.3 8.93 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 122.021 0.915 . . . . 0.0 111.929 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.569 ' HZ1' HG12 ' A' ' 125' ' ' ILE . 2.7 ptmm? -112.93 142.57 45.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.829 178.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 53.83 -109.68 1.19 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.573 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.1 OUTLIER -117.48 2.26 12.4 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 122.299 -0.53 . . . . 0.0 111.264 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.569 HG12 ' HZ1' ' A' ' 122' ' ' LYS . 1.4 mp -43.45 161.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.344 0.592 . . . . 0.0 110.812 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.484 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 9.9 pt-20 -148.31 150.28 33.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.238 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.6 mm -87.78 125.62 41.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -74.88 160.89 30.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.11 0.481 . . . . 0.0 111.002 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -70.1 -39.7 75.37 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.566 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -66.47 -25.15 66.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.587 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -72.42 -51.17 21.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.387 0.613 . . . . 0.0 110.81 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 m -78.42 -30.6 15.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.07 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -66.83 -46.0 76.5 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 122.156 -0.34 . . . . 0.0 111.077 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 25.4 m -70.5 -44.71 76.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.611 0.243 . . . . 0.0 110.771 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.06 -46.83 57.3 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -67.45 -50.49 58.99 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.504 -0.409 . . . . 0.0 110.866 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -55.27 -47.77 74.98 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -63.15 -53.64 50.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.429 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -48.49 -47.86 38.34 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.412 0.625 . . . . 0.0 110.837 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -54.26 -37.61 64.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.02 -32.4 84.05 Favored Glycine 0 C--O 1.228 -0.247 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.516 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -74.61 -41.06 61.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -59.33 -25.72 64.42 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -76.29 -33.76 59.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.85 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.491 ' HG ' ' CB ' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -66.26 -56.78 9.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.1 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.453 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 61.9 mt -65.02 -48.73 82.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.653 -178.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.583 ' CD ' ' HG ' ' A' ' 11' ' ' SER . 18.0 tt0 -47.0 -47.57 22.01 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.158 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.0 t -54.84 -42.95 72.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.469 0.652 . . . . 0.0 111.26 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.636 ' O ' ' N ' ' A' ' 153' ' ' HIS . 26.8 t80 -59.08 -44.67 91.92 Favored 'General case' 0 C--O 1.191 -1.997 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.485 ' H ' ' CD2' ' A' ' 150' ' ' LEU . 1.9 mm? -66.21 -42.48 88.7 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 119.491 1.041 . . . . 0.0 111.794 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -24.83 67.75 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 121.525 -0.734 . . . . 0.0 109.329 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.438 ' O ' ' ND1' ' A' ' 153' ' ' HIS . 28.6 t70 -106.22 -13.42 15.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.034 0.445 . . . . 0.0 110.774 178.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.636 ' N ' ' O ' ' A' ' 149' ' ' TYR . 54.4 m80 -155.82 66.8 4.63 Favored Pre-proline 0 C--N 1.309 -1.168 0 C-N-CA 125.425 1.49 . . . . 0.0 110.43 -178.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -74.18 -3.37 13.7 Favored 'Trans proline' 0 C--N 1.324 -0.739 0 C-N-CA 122.579 2.186 . . . . 0.0 111.522 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.612 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 4.0 p-10 -81.95 4.82 21.16 Favored 'General case' 0 C--O 1.21 -0.975 0 C-N-CA 123.953 0.901 . . . . 0.0 111.991 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.463 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -49.35 129.79 18.96 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 119.325 -2.11 . . . . 0.0 111.395 -178.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.419 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 13.6 t80 55.0 6.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.612 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.197 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.901 0.381 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.76 111.82 23.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.345 177.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.3 m -96.09 134.82 38.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.002 0.43 . . . . 0.0 110.2 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.688 ' CE2' ' ND2' ' A' ' 7' ' ' ASN . 0.2 OUTLIER -131.54 122.19 25.72 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.651 ' C ' HD21 ' A' ' 7' ' ' ASN . 1.5 tt0 -117.04 127.8 54.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.149 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.688 ' ND2' ' CE2' ' A' ' 5' ' ' PHE . 1.4 m-80 -138.26 175.74 9.31 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.591 0.234 . . . . 0.0 110.818 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -144.31 156.17 44.14 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -149.86 134.04 17.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.954 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -92.91 144.84 24.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.859 0.362 . . . . 0.0 111.803 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.45 154.02 50.0 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.114 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -96.38 28.18 3.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.044 0.45 . . . . 0.0 110.715 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -119.04 126.03 27.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.73 -178.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -46.99 145.64 6.94 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 121.823 1.682 . . . . 0.0 111.758 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -55.78 -29.73 73.14 Favored 'Trans proline' 0 N--CA 1.482 0.805 0 C-N-CA 122.263 1.975 . . . . 0.0 112.808 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.9 m -63.86 -35.46 80.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -74.96 -59.2 2.84 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 mt -50.88 -42.41 59.05 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.967 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -50.24 -57.44 7.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.675 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.516 ' HA ' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.89 -40.74 75.49 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 118.572 -1.251 . . . . 0.0 109.102 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.49 -2.74 1.7 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.648 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -118.96 -9.35 10.08 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.405 HG22 HD12 ' A' ' 24' ' ' LEU . 3.6 m -132.54 -49.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.657 ' H ' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -99.09 -31.56 11.71 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.033 1.288 . . . . 0.0 112.03 -178.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -107.68 -3.97 18.66 Favored 'General case' 0 C--O 1.211 -0.953 0 O-C-N 122.082 -0.386 . . . . 0.0 111.432 -178.511 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.457 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -67.05 -40.33 87.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.742 0.782 . . . . 0.0 111.728 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -84.02 13.89 4.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.837 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -134.85 -9.34 2.37 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.546 ' O ' ' CG1' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -96.71 -48.13 5.61 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.949 -179.693 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.8 mt -54.45 -56.1 30.38 Favored Pre-proline 0 C--O 1.217 -0.624 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.37 -26.32 71.11 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 C-N-CA 122.298 1.999 . . . . 0.0 113.886 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -71.69 -49.41 39.9 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.601 0.715 . . . . 0.0 111.896 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.546 ' CG1' ' O ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -94.76 -34.81 5.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.674 -177.472 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.443 ' N ' ' HG ' ' A' ' 145' ' ' LEU . . . -105.58 64.07 0.14 Allowed Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.413 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 73.0 Cg_endo -76.59 -24.46 10.37 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 N-CA-C 107.909 -1.612 . . . . 0.0 107.909 174.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -73.79 -44.2 56.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.411 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.11 -77.76 0.09 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.15 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 mt -100.32 146.22 9.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 121.085 0.469 . . . . 0.0 110.191 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -78.08 -53.18 7.68 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.22 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.589 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -173.14 165.86 4.92 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.157 0.503 . . . . 0.0 110.578 179.758 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.589 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -166.07 145.21 6.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.966 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -149.2 142.34 24.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.897 0.38 . . . . 0.0 110.412 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.418 ' N ' ' HZ2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -78.74 140.72 16.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.358 0.599 . . . . 0.0 111.201 -179.356 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.501 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 3.7 mp -90.47 -39.86 12.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.494 178.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.452 ' O ' HG22 ' A' ' 52' ' ' THR . 13.9 mm-40 -143.23 134.87 26.47 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.306 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.95 -155.02 22.23 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.991 -0.443 . . . . 0.0 111.991 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.68 HD21 ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -135.53 -11.72 2.1 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 123.416 0.686 . . . . 0.0 111.315 -177.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.68 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 135.2 12.23 1.28 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -178.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.63 -172.28 19.87 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -59.05 127.24 23.5 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 122.479 2.119 . . . . 0.0 113.283 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.84 4.8 55.54 Favored Glycine 0 N--CA 1.462 0.384 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 45' ' ' GLU . 19.3 m -94.18 142.06 27.84 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.626 -0.787 . . . . 0.0 111.883 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -118.17 132.86 66.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 176.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.418 ' HZ2' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -121.82 139.39 53.67 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.465 0.65 . . . . 0.0 111.148 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -119.23 118.73 32.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.293 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.23 137.69 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.634 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.1 m -118.97 117.77 29.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.165 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -94.91 -175.14 3.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.434 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.59 144.39 30.08 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.448 ' N ' ' CD ' ' A' ' 60' ' ' GLU . 7.3 mp0 -60.18 -59.48 5.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.924 0.392 . . . . 0.0 110.29 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.98 60.82 3.43 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.6 m -138.89 -178.13 5.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.129 0.49 . . . . 0.0 110.706 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.525 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 1.8 mp0 -68.4 -44.14 75.74 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.441 ' CD1' ' OD2' ' A' ' 89' ' ' ASP . 52.2 m-85 -91.58 145.12 24.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.97 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.3 -62.08 0.12 Allowed Glycine 0 CA--C 1.519 0.299 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -146.14 151.91 38.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.843 0.354 . . . . 0.0 110.494 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -157.21 150.29 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.946 0.403 . . . . 0.0 111.279 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -105.57 106.79 17.45 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.175 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.489 ' HE2' ' CB ' ' A' ' 83' ' ' TYR . 1.2 t-160 -105.24 111.02 23.61 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -105.2 128.83 53.6 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.816 0.341 . . . . 0.0 111.497 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.03 144.96 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.632 ' C ' ' HG ' ' A' ' 73' ' ' SER . 22.2 t0 -98.89 -55.51 2.69 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.792 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.632 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 62.9 m -165.94 141.22 4.8 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.5 mt -123.41 131.8 72.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 176.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 79' ' ' TYR . 2.8 m-20 -115.92 87.96 2.79 Favored 'General case' 0 C--O 1.208 -1.125 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -54.39 -29.89 50.26 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.73 75.66 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.023 177.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -107.11 -11.3 15.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.052 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.574 ' N ' ' O ' ' A' ' 75' ' ' ASP . 9.0 m-85 60.3 44.16 12.78 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.537 -0.727 . . . . 0.0 110.45 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 34.4 t -109.75 146.24 35.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.835 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -131.65 123.29 27.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.004 0.43 . . . . 0.0 111.111 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.35 134.65 48.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.056 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.489 ' CB ' ' HE2' ' A' ' 69' ' ' HIS . 22.4 p90 -143.93 166.03 26.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.903 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.0 m -145.9 135.3 23.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.17 0.509 . . . . 0.0 111.189 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.2 mt -80.75 117.09 21.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.468 ' CG1' ' N ' ' A' ' 87' ' ' GLU . 4.1 pt -81.68 -44.58 20.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.798 0.332 . . . . 0.0 111.487 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.468 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 19.9 tt0 -151.42 172.5 15.86 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.761 0.315 . . . . 0.0 110.451 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.573 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.74 177.23 18.44 Favored Glycine 0 CA--C 1.509 -0.287 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.441 ' OD2' ' CD1' ' A' ' 64' ' ' TYR . 6.4 p30 -61.27 1.12 0.21 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.573 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -62.92 -35.3 79.62 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.004 0.922 . . . . 0.0 109.931 177.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.601 ' C ' ' HG1' ' A' ' 92' ' ' THR . 0.0 OUTLIER -110.89 12.66 22.25 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 123.802 0.841 . . . . 0.0 109.575 -177.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.601 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 70.1 p 47.82 -126.3 1.78 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -130.44 -11.3 4.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.991 0.425 . . . . 0.0 111.07 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.4 -6.72 19.29 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 96.3 mt -98.16 152.01 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-O 122.251 1.024 . . . . 0.0 113.56 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.546 ' OE2' ' CE1' ' A' ' 120' ' ' HIS . 0.0 OUTLIER -91.08 -54.12 4.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.932 177.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.66 145.74 1.57 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.038 0.447 . . . . 0.0 111.943 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.428 ' CD1' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.41 132.64 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.222 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.472 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 0.3 OUTLIER -119.36 144.87 46.64 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.723 0.409 . . . . 0.0 111.51 -178.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.472 ' CD2' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -136.35 130.26 32.58 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.798 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -129.41 134.14 47.7 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.524 0.202 . . . . 0.0 110.511 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.7 OUTLIER -132.27 135.56 46.33 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.922 -0.486 . . . . 0.0 109.719 -179.037 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -119.53 133.82 55.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.58 126.07 40.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.466 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.426 ' C ' ' HG ' ' A' ' 111' ' ' SER . 1.1 m -137.27 135.25 47.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.422 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.33 138.72 45.56 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 121.936 -0.477 . . . . 0.0 110.304 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 52.4 t -121.34 170.39 9.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.889 0.376 . . . . 0.0 110.317 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.551 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.56 -34.75 50.13 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.9 m -85.41 -15.06 44.3 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.112 1.365 . . . . 0.0 114.321 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.18 -85.64 0.13 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.92 1.724 . . . . 0.0 111.396 -171.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.427 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 41.2 t -161.32 132.73 5.48 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.654 1.582 . . . . 0.0 111.221 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 55.0 m -99.92 128.76 45.98 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.299 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.2 mt -101.51 127.79 54.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.548 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 102' ' ' THR . 3.3 mtpt -105.37 116.89 32.71 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.68 123.08 49.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.954 0.407 . . . . 0.0 110.548 -178.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.61 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -109.65 136.39 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.358 -177.496 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.3 t -118.05 133.24 56.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.544 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.472 ' ND1' ' O ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -136.79 103.81 5.31 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 120.913 0.387 . . . . 0.0 110.176 -179.407 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.543 ' CD2' ' N ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER -97.33 108.41 21.13 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.029 -0.42 . . . . 0.0 110.524 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.546 ' CE1' ' OE2' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -88.98 104.74 17.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.793 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.3 p -88.52 170.42 10.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.996 0.903 . . . . 0.0 111.731 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.431 ' HZ3' ' HB2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -113.02 156.26 23.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.882 179.424 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . 35.07 -109.24 0.06 OUTLIER Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 124' ' ' ASN . 4.4 t30 -111.41 -2.79 15.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.939 0.399 . . . . 0.0 111.063 178.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.3 mp -43.21 160.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.274 0.559 . . . . 0.0 110.572 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.429 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 34.7 tt0 -152.54 148.7 27.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.284 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.2 mm -88.15 124.79 41.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -74.74 161.72 29.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.421 0.629 . . . . 0.0 111.698 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -69.72 -41.74 74.94 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.775 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -62.25 -27.09 68.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.713 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -73.03 -49.99 25.6 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.417 0.627 . . . . 0.0 111.342 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 m -77.61 -29.86 16.57 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.192 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -67.15 -45.73 76.18 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.22 -0.3 . . . . 0.0 110.96 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.99 -44.25 85.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.792 0.329 . . . . 0.0 110.287 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.37 -39.18 91.68 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -67.05 -47.22 71.99 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.711 -0.288 . . . . 0.0 110.661 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -55.2 -46.81 75.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.949 0.404 . . . . 0.0 110.201 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -64.71 -52.51 56.77 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.47 -42.66 43.86 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.55 0.691 . . . . 0.0 110.56 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . 0.414 ' O ' ' ND1' ' A' ' 140' ' ' HIS . 1.3 t60 -60.97 -36.09 78.51 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.891 0.853 . . . . 0.0 109.51 178.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -61.23 -44.79 97.66 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.415 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -65.57 -40.54 92.89 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -59.79 -28.69 67.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -77.49 -35.9 53.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.286 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.462 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -68.26 -57.69 5.58 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.514 0.674 . . . . 0.0 110.23 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.531 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 45.1 mt -58.21 -50.04 79.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.661 -177.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -46.87 -55.21 8.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.622 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 41.8 t -52.91 -44.49 66.99 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.508 0.671 . . . . 0.0 110.971 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.634 ' O ' ' N ' ' A' ' 153' ' ' HIS . 24.8 t80 -58.58 -45.58 88.74 Favored 'General case' 0 C--O 1.194 -1.832 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 2.2 mm? -66.22 -43.18 87.42 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 120.257 1.389 . . . . 0.0 111.565 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.417 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -61.5 -24.09 66.36 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 121.489 -0.757 . . . . 0.0 109.159 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.469 ' OD2' ' CE1' ' A' ' 153' ' ' HIS . 10.6 t70 -105.73 -13.26 15.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.46 0.648 . . . . 0.0 110.595 178.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 149' ' ' TYR . 56.0 m80 -155.51 67.14 4.89 Favored Pre-proline 0 C--N 1.312 -1.05 0 C-N-CA 125.199 1.4 . . . . 0.0 110.101 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.51 -3.62 14.02 Favored 'Trans proline' 0 N--CA 1.481 0.756 0 C-N-CA 122.566 2.177 . . . . 0.0 111.576 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.618 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.5 OUTLIER -83.9 5.16 26.37 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.953 -179.026 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -48.97 129.89 17.83 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 119.594 -1.941 . . . . 0.0 111.394 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.401 ' N ' ' OD2' ' A' ' 25' ' ' ASP . 0.3 OUTLIER 56.11 6.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.987 0.515 . . . . 0.0 112.059 178.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.618 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.202 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.829 0.347 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.76 109.7 22.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.601 177.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.7 m -96.53 137.27 35.86 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.313 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -135.52 129.18 32.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.471 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.439 ' C ' HD21 ' A' ' 7' ' ' ASN . 1.5 tt0 -103.36 129.39 50.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.94 0.4 . . . . 0.0 110.749 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.56 ' ND2' ' N ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -142.89 164.75 29.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -178.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -155.51 159.53 39.82 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -144.56 140.78 29.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.341 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.03 147.68 24.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 111.521 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.674 ' HG ' ' CD ' ' A' ' 147' ' ' GLU . 21.3 t -145.36 164.2 32.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.688 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -102.88 23.98 11.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.891 0.376 . . . . 0.0 110.843 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mt -112.57 126.61 28.05 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.627 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -47.35 144.21 10.05 Favored 'Trans proline' 0 C--N 1.326 -0.613 0 C-N-CA 122.019 1.813 . . . . 0.0 111.974 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -55.45 -24.55 44.26 Favored 'Trans proline' 0 N--CA 1.484 0.931 0 C-N-CA 122.361 2.04 . . . . 0.0 112.7 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.444 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 13.2 p -70.08 -37.04 75.36 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -75.22 -47.65 27.17 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.2 mt -57.42 -48.29 79.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.554 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -46.18 -57.51 4.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.081 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -69.72 -26.02 64.13 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.579 0.704 . . . . 0.0 109.953 -179.296 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.72 -2.57 56.53 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.293 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -117.55 -9.02 10.89 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.3 m -134.62 -36.76 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.611 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 2.5 mp -92.29 -53.06 4.38 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.185 0.902 . . . . 0.0 111.391 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.459 ' OD2' ' N ' ' A' ' 25' ' ' ASP . 1.4 m-20 -114.37 13.8 17.83 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 116.846 -0.161 . . . . 0.0 111.358 -176.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.436 ' O ' ' CG1' ' A' ' 30' ' ' ILE . . . -66.9 -42.17 85.93 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 121.244 0.545 . . . . 0.0 111.192 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -83.94 18.59 1.99 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.075 0.941 . . . . 0.0 110.259 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.418 ' H ' ' H ' ' A' ' 29' ' ' LEU . 13.6 m-80 -135.95 -9.11 2.07 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.418 ' H ' ' H ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -90.65 -51.31 5.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.493 -1.685 . . . . 0.0 110.706 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.474 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -58.5 -52.16 76.63 Favored Pre-proline 0 C--O 1.215 -0.723 0 CA-C-O 120.777 0.323 . . . . 0.0 110.742 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 22.8 Cg_endo -60.5 -21.79 69.6 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 C-N-CA 122.632 2.222 . . . . 0.0 112.763 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -75.22 -52.06 11.82 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.839 0.352 . . . . 0.0 111.07 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.5 ' CD1' ' O ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -95.2 -35.04 5.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.159 -177.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.448 ' N ' ' CD1' ' A' ' 145' ' ' LEU . . . -106.77 81.54 0.91 Allowed Pre-proline 0 CA--C 1.507 -0.679 0 C-N-CA 122.78 0.432 . . . . 0.0 111.728 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.15 -10.71 27.84 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 N-CA-C 107.227 -1.874 . . . . 0.0 107.227 174.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -42.29 58.24 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.402 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.79 -82.03 0.06 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.874 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.1 mm -107.63 142.82 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.965 0.412 . . . . 0.0 110.974 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -79.73 -45.12 19.48 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.67 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.581 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -178.6 166.28 1.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.814 179.024 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.581 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -166.13 145.06 5.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.241 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -141.43 146.05 36.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.208 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.67 139.6 18.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.471 0.653 . . . . 0.0 110.703 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.464 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 7.3 mp -88.52 -39.87 13.85 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.129 -0.942 . . . . 0.0 108.684 178.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.496 ' O ' ' CG2' ' A' ' 52' ' ' THR . 24.1 mt-10 -142.52 133.75 26.13 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.976 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.58 -156.15 24.57 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.446 ' H ' HD21 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -139.76 -10.62 1.18 Allowed 'General case' 0 C--N 1.32 -0.698 0 O-C-N 122.529 -0.394 . . . . 0.0 110.975 -179.613 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.6 13.09 0.32 Allowed Glycine 0 C--O 1.221 -0.718 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.26 -171.24 20.67 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 117.344 0.572 . . . . 0.0 112.089 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -62.53 126.15 17.73 Favored 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 123.024 2.483 . . . . 0.0 113.58 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.27 5.84 56.94 Favored Glycine 0 N--CA 1.463 0.479 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.496 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 88.3 m -93.37 140.5 29.5 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.271 -0.964 . . . . 0.0 111.145 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -119.18 129.98 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.16 140.93 49.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.074 0.464 . . . . 0.0 111.047 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -118.96 128.64 54.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.173 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.431 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 3.2 mp -105.21 125.36 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.715 -0.394 . . . . 0.0 109.956 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.1 m -102.54 118.61 37.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -92.62 -174.83 3.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.76 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.73 143.86 31.61 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.408 ' N ' ' CD ' ' A' ' 60' ' ' GLU . 8.9 mp0 -60.72 -63.57 1.25 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.909 0.385 . . . . 0.0 110.653 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.77 62.2 3.36 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.8 t -136.7 178.52 7.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.908 0.385 . . . . 0.0 110.754 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -60.81 -49.66 76.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.745 0.307 . . . . 0.0 111.018 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -91.92 137.83 32.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.496 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.4 -58.72 0.52 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.439 ' CD2' ' N ' ' A' ' 66' ' ' TYR . 7.3 p90 -145.71 152.42 39.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.001 0.429 . . . . 0.0 110.652 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.3 p -156.69 141.99 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.844 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.467 ' O ' ' CD1' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -108.2 118.6 37.18 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 122.705 1.24 . . . . 0.0 112.735 -178.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.602 ' CE1' ' CD2' ' A' ' 83' ' ' TYR . 1.7 t60 -100.43 119.23 38.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.977 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -102.39 126.65 49.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.046 0.451 . . . . 0.0 111.576 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.2 mt -84.69 137.2 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.565 ' C ' ' HG ' ' A' ' 73' ' ' SER . 9.5 m-20 -99.44 -55.98 2.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.565 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 49.8 m -165.26 141.87 5.63 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.7 mt -126.6 131.07 71.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.939 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 79' ' ' TYR . 43.1 m-20 -115.06 88.48 2.88 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.489 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 6.7 mt-10 -54.45 -30.37 52.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.92 -39.02 76.97 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.561 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -107.95 -10.42 15.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.213 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.5 m-85 63.17 47.15 4.25 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 121.537 -0.727 . . . . 0.0 109.886 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 p -105.86 142.72 35.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.749 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.406 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 17.3 t80 -132.67 120.73 22.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.814 0.34 . . . . 0.0 110.641 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 p -127.07 129.62 48.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.341 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.679 ' CE2' ' CD1' ' A' ' 100' ' ' TYR . 34.5 p90 -144.97 164.59 30.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.033 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.6 m -146.09 125.6 13.23 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.115 0.483 . . . . 0.0 111.069 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.17 121.67 25.86 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.599 HD13 ' H ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -83.72 -43.51 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -175.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.599 ' H ' HD13 ' A' ' 86' ' ' ILE . 6.0 tt0 -162.69 178.62 8.34 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.28 -0.888 . . . . 0.0 110.481 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.613 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.87 178.71 18.34 Favored Glycine 0 CA--C 1.504 -0.646 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.48 2.63 0.16 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.613 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -71.96 -38.03 69.82 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 123.572 0.749 . . . . 0.0 110.94 178.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.581 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -111.37 17.46 20.14 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 93' ' ' ASP . 6.9 p 57.11 -133.94 1.27 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.433 ' N ' ' OG1' ' A' ' 92' ' ' THR . 52.3 t0 -130.66 0.39 4.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.8 p -104.91 -8.41 18.66 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.382 -0.824 . . . . 0.0 113.124 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.47 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 4.6 mt -100.12 151.39 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.47 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -86.56 -50.75 6.61 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.285 176.107 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.416 ' HA ' ' CD1' ' A' ' 91' ' ' LEU . 13.0 ptpt -171.72 148.98 2.49 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.445 ' CG2' ' CD2' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -122.97 129.02 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.465 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.493 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 0.3 OUTLIER -119.69 145.3 46.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.847 -179.302 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.679 ' CD1' ' CE2' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -142.89 135.66 27.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.733 0.301 . . . . 0.0 110.497 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -130.62 132.46 45.49 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.2 OUTLIER -131.73 133.83 45.23 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.09 -0.381 . . . . 0.0 110.511 -178.828 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -119.9 133.17 55.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.98 132.33 43.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.36 137.18 52.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.105 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.94 134.68 44.84 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.411 178.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.541 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 43.1 t -121.32 171.16 8.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.79 0.329 . . . . 0.0 110.253 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.541 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.51 -34.68 49.74 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 112.08 -0.408 . . . . 0.0 112.08 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.5 p -89.83 -13.38 36.67 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 118.765 -2.609 . . . . 0.0 114.116 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.64 -80.76 0.12 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.411 1.481 . . . . 0.0 112.401 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 83.3 p -161.51 131.54 4.88 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 126.577 1.951 . . . . 0.0 111.178 176.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.1 m -99.9 118.74 36.97 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 36.5 mt -92.34 127.49 44.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.121 -178.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -105.26 116.33 31.77 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.551 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.2 p -111.93 123.97 51.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.199 0.523 . . . . 0.0 111.302 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.677 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -105.44 136.05 41.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -178.32 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.7 m -114.49 135.19 54.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.05 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.493 ' ND1' ' O ' ' A' ' 99' ' ' SER . 0.4 OUTLIER -137.24 109.17 7.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 110.433 -179.315 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.529 ' N ' ' CD1' ' A' ' 119' ' ' TYR . 5.4 m-85 -102.46 104.1 14.53 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -90.39 109.62 20.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.017 0.436 . . . . 0.0 109.852 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.2 p -93.93 169.9 9.95 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.952 0.882 . . . . 0.0 111.657 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -113.31 157.47 21.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.055 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 40.7 -109.73 0.16 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.531 HD21 ' N ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -116.19 7.51 14.13 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 122.703 -0.292 . . . . 0.0 111.396 179.38 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.531 ' N ' HD21 ' A' ' 124' ' ' ASN . 1.5 mp -48.35 161.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.311 0.577 . . . . 0.0 110.761 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.49 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 9.2 pt-20 -148.67 149.59 31.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.228 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.7 mm -87.69 124.5 40.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -75.92 160.09 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.561 0.696 . . . . 0.0 111.665 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -70.47 -47.34 61.09 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.446 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -59.96 -24.52 64.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.6 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.455 ' C ' ' ND1' ' A' ' 131' ' ' HIS . 2.1 t-80 -72.08 -53.91 11.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.365 0.602 . . . . 0.0 110.718 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 m -77.32 -28.11 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.167 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -67.03 -46.53 74.16 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.224 -0.298 . . . . 0.0 111.069 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 28.0 m -70.55 -44.18 77.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.678 0.275 . . . . 0.0 110.491 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.97 -41.49 87.53 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -67.13 -51.02 59.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.804 0.302 . . . . 0.0 111.02 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -56.63 -48.27 77.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 110.325 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -63.03 -51.38 66.97 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -49.71 -54.74 17.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.597 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -47.43 -38.67 13.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.342 0.591 . . . . 0.0 109.635 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.12 -31.5 80.93 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 139' ' ' ALA . 0.8 OUTLIER -74.99 -38.53 61.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.67 0.748 . . . . 0.0 109.993 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -58.07 -28.32 64.46 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -75.75 -34.46 60.29 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.733 -1.122 . . . . 0.0 109.972 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.5 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -57.39 -61.42 2.5 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 122.191 0.996 . . . . 0.0 112.043 -179.615 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.481 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 26.7 mt -69.11 -48.46 69.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.403 -177.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.674 ' CD ' ' HG ' ' A' ' 11' ' ' SER . 14.7 tt0 -47.16 -42.71 20.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.1 t -59.91 -43.14 95.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.218 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.654 ' O ' ' N ' ' A' ' 153' ' ' HIS . 19.5 t80 -58.39 -45.05 89.08 Favored 'General case' 0 C--O 1.185 -2.341 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.547 ' H ' ' CD2' ' A' ' 150' ' ' LEU . 1.4 mm? -68.06 -43.67 78.1 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 119.993 1.269 . . . . 0.0 111.653 -178.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -24.45 67.38 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.881 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.429 ' O ' ' CD2' ' A' ' 153' ' ' HIS . 51.6 t0 -106.92 -13.08 15.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.039 0.923 . . . . 0.0 110.948 178.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.654 ' N ' ' O ' ' A' ' 149' ' ' TYR . 30.4 m80 -155.8 66.68 4.61 Favored Pre-proline 0 C--N 1.302 -1.49 0 C-N-CA 125.403 1.481 . . . . 0.0 110.193 -177.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.528 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 36.3 Cg_endo -66.35 -2.8 7.73 Favored 'Trans proline' 0 N--CA 1.481 0.736 0 C-N-CA 122.571 2.181 . . . . 0.0 111.108 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.586 ' CA ' HD22 ' A' ' 158' ' ' ASN . 3.2 p30 -71.37 4.63 2.79 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.078 0.951 . . . . 0.0 113.077 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.94 129.71 43.16 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.584 -1.322 . . . . 0.0 113.042 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 157' ' ' TYR . 81.7 t80 53.23 4.51 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 177.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.586 HD22 ' CA ' ' A' ' 155' ' ' ASP . 2.5 p30 . . . . . 0 C--N 1.323 -0.559 0 O-C-N 120.506 -1.371 . . . . 0.0 110.381 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.912 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.482 ' CG2' ' CD2' ' A' ' 118' ' ' HIS . 7.7 p -134.81 149.04 29.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 O-C-N 122.314 -0.521 . . . . 0.0 110.618 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -96.4 109.73 22.21 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.2 m -97.27 133.37 41.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.07 0.462 . . . . 0.0 110.62 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -132.26 132.14 42.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.739 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.423 ' C ' ' ND2' ' A' ' 7' ' ' ASN . 7.6 mt-10 -102.25 126.42 49.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.196 0.522 . . . . 0.0 110.613 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.473 ' N ' HD21 ' A' ' 7' ' ' ASN . 0.6 OUTLIER -131.26 161.17 32.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.771 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -155.27 153.12 30.12 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -142.92 141.15 31.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.28 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.73 147.32 22.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.742 0.306 . . . . 0.0 110.913 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -143.17 154.21 43.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 0.0 110.436 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -95.24 27.46 3.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.037 0.446 . . . . 0.0 110.4 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -118.19 125.23 28.04 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.648 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.67 151.2 3.55 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.672 1.581 . . . . 0.0 111.471 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -61.16 -24.24 78.78 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 C-N-CA 122.299 1.999 . . . . 0.0 112.483 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.446 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 68.8 m -70.64 -32.47 69.78 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.406 HH21 ' HB2' ' A' ' 16' ' ' SER . 11.2 mmt-85 -76.24 -59.74 2.63 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 mt -48.36 -48.87 36.24 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.646 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.5 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 16.4 t80 -44.75 -60.17 2.15 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.121 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.446 ' CG ' ' O ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -71.13 -26.32 62.96 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.142 -0.974 . . . . 0.0 110.917 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.07 -16.02 59.38 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.829 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.419 ' CE2' HD11 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -117.6 -6.27 11.14 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.5 ' CG2' ' O ' ' A' ' 19' ' ' PHE . 2.5 m -125.24 -35.99 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 118.5 0.591 . . . . 0.0 112.189 177.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 2.9 mp -92.28 -51.46 5.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.686 0.676 . . . . 0.0 111.412 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -106.93 -2.6 21.08 Favored 'General case' 0 C--O 1.206 -1.213 0 CA-C-O 119.22 -0.419 . . . . 0.0 111.496 -176.274 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.407 ' HB3' ' C ' ' A' ' 22' ' ' PHE . . . -45.08 -34.08 2.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.978 0.894 . . . . 0.0 111.473 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.442 ' HB3' ' HZ1' ' A' ' 54' ' ' LYS . 9.4 p-10 -84.69 12.77 6.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.327 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 25' ' ' ASP . 95.8 m-20 -140.5 -10.85 1.06 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 125.38 1.472 . . . . 0.0 108.269 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.53 ' O ' ' CG1' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -98.59 -48.42 4.99 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 125.499 1.52 . . . . 0.0 109.055 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.0 mt -56.24 -56.24 33.48 Favored Pre-proline 0 C--O 1.215 -0.726 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.24 -26.92 72.12 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 122.534 2.156 . . . . 0.0 114.342 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -68.76 -49.7 56.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.834 0.826 . . . . 0.0 111.725 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.53 ' CG1' ' O ' ' A' ' 29' ' ' LEU . 0.8 OUTLIER -95.08 -34.96 5.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.745 -177.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.448 ' N ' ' HG ' ' A' ' 145' ' ' LEU . . . -105.75 64.1 0.15 Allowed Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -176.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.402 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 86.9 Cg_endo -77.09 -26.66 7.51 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 121.625 1.55 . . . . 0.0 108.188 174.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -42.58 57.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.822 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.97 -77.19 0.12 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.584 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -104.46 145.45 13.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-O 121.377 0.608 . . . . 0.0 109.978 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -78.38 -53.87 6.8 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.998 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.544 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -173.17 166.06 4.9 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.19 0.519 . . . . 0.0 110.569 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.544 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -165.53 144.95 6.49 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.136 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -150.76 145.28 25.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.213 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.12 139.81 18.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.574 0.702 . . . . 0.0 111.143 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -90.75 -38.74 12.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.126 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.47 ' O ' ' CG2' ' A' ' 52' ' ' THR . 26.9 mt-10 -145.57 136.09 24.18 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.335 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.31 -156.05 22.56 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.566 ' ND2' ' H ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -136.06 -6.04 2.11 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 122.345 -0.503 . . . . 0.0 111.047 -179.047 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.494 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 130.7 11.33 2.4 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.8 -171.42 19.58 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.457 ' HD3' ' H ' ' A' ' 74' ' ' ILE . 8.7 Cg_endo -60.06 126.5 20.43 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 122.596 2.197 . . . . 0.0 113.117 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.39 3.28 55.48 Favored Glycine 0 CA--C 1.506 -0.495 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.47 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 45.7 m -94.02 140.74 29.34 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.14 -1.03 . . . . 0.0 111.008 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.97 129.07 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.442 ' HZ1' ' HB3' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -112.48 139.87 47.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.791 0.805 . . . . 0.0 111.11 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -117.89 121.15 39.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.489 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.2 mt -106.69 140.19 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.619 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.9 m -119.23 120.16 36.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.132 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -90.79 -173.41 3.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.38 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.06 143.29 29.92 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -60.64 -60.97 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.985 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.81 61.86 3.39 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.2 m -136.89 175.15 9.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.756 0.313 . . . . 0.0 110.563 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -62.19 -42.61 99.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.825 0.345 . . . . 0.0 110.559 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -91.53 136.12 33.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.547 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.59 -57.73 0.5 Allowed Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -145.8 155.2 42.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.973 0.416 . . . . 0.0 110.642 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 p -153.47 144.49 14.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.217 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -106.66 117.87 35.19 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.465 0.65 . . . . 0.0 112.211 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.478 ' CD2' ' C ' ' A' ' 69' ' ' HIS . 0.3 OUTLIER -109.34 118.87 37.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.74 178.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -102.28 130.78 49.08 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.051 0.453 . . . . 0.0 111.076 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.4 mt -88.81 145.47 7.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.563 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.597 ' C ' ' HG ' ' A' ' 73' ' ' SER . 25.6 t70 -104.1 -56.42 2.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.597 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 68.3 m -166.43 142.56 4.75 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.457 ' H ' ' HD3' ' A' ' 50' ' ' PRO . 10.7 mt -124.0 131.74 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.858 176.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -116.21 88.26 2.85 Favored 'General case' 0 C--O 1.209 -1.039 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.432 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -54.14 -30.69 50.05 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.36 -39.8 70.51 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.229 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.0 m -108.45 -10.31 15.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.953 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.2 m-85 62.74 46.8 5.02 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.629 -0.669 . . . . 0.0 109.818 -178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.3 p -105.73 148.26 27.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.207 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.626 ' CE2' ' CD2' ' A' ' 83' ' ' TYR . 41.8 t80 -140.31 120.33 13.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.694 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 p -127.45 130.33 49.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.812 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.626 ' CD2' ' CE2' ' A' ' 81' ' ' TYR . 11.4 p90 -144.73 170.62 15.75 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.1 m -146.06 136.38 23.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.387 0.613 . . . . 0.0 111.489 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.89 120.41 24.07 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.471 ' CG1' ' N ' ' A' ' 87' ' ' GLU . 2.5 pt -90.24 -45.03 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.489 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 2.9 tp10 -151.17 172.08 16.37 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.861 0.362 . . . . 0.0 110.413 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.595 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.87 177.68 17.87 Favored Glycine 0 CA--C 1.509 -0.334 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.79 2.63 0.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.595 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -68.04 -35.0 77.53 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.689 1.196 . . . . 0.0 110.986 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.64 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.51 13.11 22.75 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.285 0.634 . . . . 0.0 109.538 -178.091 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.505 ' CG2' ' CE1' ' A' ' 131' ' ' HIS . 28.3 p 46.94 -127.04 1.6 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.414 ' N ' ' OG1' ' A' ' 92' ' ' THR . 29.2 t70 -130.34 -11.21 4.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.25 0.548 . . . . 0.0 110.996 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.11 -5.92 20.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.371 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.41 HG23 ' CD1' ' A' ' 98' ' ' ILE . 66.2 mt -97.91 151.48 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -176.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.509 ' OE1' ' CE1' ' A' ' 120' ' ' HIS . 0.8 OUTLIER -88.85 -60.92 1.83 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.395 177.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.437 ' CG ' ' O ' ' A' ' 96' ' ' GLU . 36.9 mtmt -164.89 158.07 16.86 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.44 0.638 . . . . 0.0 111.192 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.41 ' CD1' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -132.75 123.5 49.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 1.161 ' HG ' ' CE1' ' A' ' 118' ' ' HIS . 0.9 OUTLIER -112.48 144.4 42.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.213 0.53 . . . . 0.0 111.398 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.401 ' CE2' ' OG ' ' A' ' 117' ' ' SER . 2.6 m-85 -137.18 130.67 31.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.558 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -129.28 134.3 47.88 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.14 131.68 28.74 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.972 -0.455 . . . . 0.0 110.186 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -124.17 134.48 53.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.66 131.06 45.14 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.004 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.29 136.89 57.64 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.904 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.92 134.22 44.68 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.261 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 19.6 t -121.13 169.99 9.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.882 0.372 . . . . 0.0 110.385 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.405 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.71 -30.22 42.99 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.7 p -90.33 -8.88 49.7 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 118.369 -2.842 . . . . 0.0 115.464 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 154.24 -93.25 0.14 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.443 1.973 . . . . 0.0 109.849 -171.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.1 m -159.16 129.21 5.7 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 126.691 1.996 . . . . 0.0 110.99 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.3 m -100.05 118.53 36.62 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.5 mt -92.17 131.2 39.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.56 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.85 116.62 32.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.6 t -111.89 118.19 34.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.421 0.629 . . . . 0.0 111.443 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.655 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -97.82 135.53 32.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 123.399 0.68 . . . . 0.0 109.565 -178.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.401 ' OG ' ' CE2' ' A' ' 100' ' ' TYR . 18.8 m -118.78 131.8 56.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.57 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 1.161 ' CE1' ' HG ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -136.41 115.11 12.04 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 122.702 1.239 . . . . 0.0 109.472 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -102.91 103.69 13.85 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 120.368 -1.457 . . . . 0.0 109.588 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.509 ' CE1' ' OE1' ' A' ' 96' ' ' GLU . 4.8 t-80 -89.68 104.68 17.22 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.506 0.669 . . . . 0.0 110.367 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.43 ' OG1' ' CG2' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -91.45 164.41 13.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.327 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -112.11 156.63 21.93 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 43.27 -124.45 4.52 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.443 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -95.39 -13.29 24.8 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.289 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.43 ' CG2' ' OG1' ' A' ' 121' ' ' THR . 1.1 tp -48.81 162.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.717 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -152.71 148.59 27.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.908 0.385 . . . . 0.0 111.108 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.4 mm -89.14 124.95 42.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 31.5 tttp -76.27 161.16 28.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.439 0.638 . . . . 0.0 111.469 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 1.2 pm0 -69.97 -45.34 67.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.518 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.09 -25.31 65.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.406 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.505 ' CE1' ' CG2' ' A' ' 92' ' ' THR . 2.7 t-80 -72.7 -51.88 17.53 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.387 0.613 . . . . 0.0 110.886 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.8 m -74.44 -24.22 18.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.45 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -67.22 -46.51 73.6 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 122.382 -0.199 . . . . 0.0 110.932 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 30.7 m -70.02 -43.96 78.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.735 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.57 -46.94 65.21 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -67.66 -45.51 75.06 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.683 -0.304 . . . . 0.0 110.853 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -53.81 -38.92 65.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.443 ' O ' ' CD2' ' A' ' 142' ' ' LEU . 15.9 tttt -68.74 -54.39 16.34 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.6 -43.25 46.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.746 0.784 . . . . 0.0 110.495 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -67.13 -36.51 82.04 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.33 -34.92 82.68 Favored Glycine 0 CA--C 1.519 0.313 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.443 ' CD2' ' O ' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -71.47 -48.36 49.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.589 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -59.47 -25.74 64.66 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -68.76 -40.51 79.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.935 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.483 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -64.45 -56.2 15.75 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.08 0.943 . . . . 0.0 108.746 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.515 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 59.6 mt -54.85 -48.41 74.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.601 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -46.08 -56.89 4.98 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.684 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.8 p -53.51 -42.35 67.25 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.525 0.679 . . . . 0.0 110.615 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.625 ' O ' ' N ' ' A' ' 153' ' ' HIS . 32.7 t80 -56.36 -48.73 76.22 Favored 'General case' 0 C--O 1.194 -1.839 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.515 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 1.9 mm? -65.65 -42.57 91.24 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 120.033 1.288 . . . . 0.0 112.02 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.24 -23.65 66.79 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.25 -13.6 15.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.625 ' N ' ' O ' ' A' ' 149' ' ' TYR . 23.3 m80 -156.32 67.49 4.52 Favored Pre-proline 0 C--N 1.309 -1.174 0 C-N-CA 125.062 1.345 . . . . 0.0 110.695 -178.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.497 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 56.0 Cg_endo -74.8 -3.28 13.66 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 122.495 2.13 . . . . 0.0 111.534 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.551 ' CA ' HD22 ' A' ' 158' ' ' ASN . 3.6 p30 -74.66 5.3 5.0 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.279 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.88 129.99 43.57 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.791 -1.193 . . . . 0.0 113.141 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 2.7 t80 54.51 6.06 0.1 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.551 HD22 ' CA ' ' A' ' 155' ' ' ASP . 1.5 p30 . . . . . 0 CA--C 1.514 -0.436 0 O-C-N 121.166 -0.959 . . . . 0.0 110.405 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 7.4 p -134.79 149.36 29.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 0.0 111.348 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -97.6 110.03 22.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.52 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.744 ' HG1' ' CE1' ' A' ' 118' ' ' HIS . 62.7 m -95.78 133.37 39.98 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.657 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.526 ' CD2' ' ND2' ' A' ' 7' ' ' ASN . 51.5 t80 -137.75 132.38 32.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.046 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.476 ' C ' HD21 ' A' ' 7' ' ' ASN . 1.2 tt0 -102.48 137.4 40.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 111.296 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.526 ' ND2' ' CD2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -127.55 167.97 15.6 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -178.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -152.56 145.15 24.18 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -154.23 134.76 13.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.458 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.06 146.71 23.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.934 0.397 . . . . 0.0 111.451 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -136.32 154.14 50.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.247 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -98.49 21.84 10.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.173 0.511 . . . . 0.0 110.365 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -116.23 126.35 27.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.494 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -44.88 146.99 2.1 Favored 'Trans proline' 0 C--N 1.327 -0.603 0 C-N-CA 121.805 1.67 . . . . 0.0 111.776 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -57.19 -26.62 70.59 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 122.256 1.97 . . . . 0.0 113.149 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.9 m -70.7 -32.15 69.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -75.03 -57.71 3.73 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 mt -53.28 -35.84 60.53 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.801 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -54.46 -56.05 22.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.641 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.73 -43.2 69.39 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.295 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 26' ' ' ALA . . . -63.67 -3.2 2.1 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.386 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CE2' ' CE1' ' A' ' 143' ' ' PHE . 19.3 t80 -119.66 -8.54 9.92 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.1 m -129.7 -52.33 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.497 ' CD1' ' N ' ' A' ' 25' ' ' ASP . 1.7 pp -96.85 -31.52 12.56 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.497 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -114.25 -5.38 12.99 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 118.858 0.754 . . . . 0.0 111.364 -178.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 21' ' ' ALA . . . -67.7 -43.85 79.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.105 0.479 . . . . 0.0 111.861 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.573 ' CB ' ' HZ2' ' A' ' 54' ' ' LYS . 1.2 m-20 -83.01 12.21 5.27 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 122.101 0.953 . . . . 0.0 110.265 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -129.79 -9.42 4.46 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 26' ' ' ALA . 4.1 mt -93.94 -30.74 14.6 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.211 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.436 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.08 -53.42 58.77 Favored Pre-proline 0 C--O 1.215 -0.732 0 O-C-N 122.025 -0.422 . . . . 0.0 110.613 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 27.2 Cg_endo -63.89 -25.72 67.26 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 122.006 1.804 . . . . 0.0 112.538 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.84 -59.61 2.66 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.662 0.744 . . . . 0.0 112.194 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.49 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 1.3 pt -94.46 -36.14 6.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.909 -176.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.418 ' N ' ' HG ' ' A' ' 145' ' ' LEU . . . -105.87 65.23 0.16 Allowed Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.94 -26.91 9.0 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 C-N-CA 121.591 1.527 . . . . 0.0 108.367 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -74.1 -43.36 57.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.55 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.27 -71.94 0.26 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.896 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.18 144.85 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-O 121.254 0.549 . . . . 0.0 110.669 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -79.44 -50.34 10.95 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.079 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.639 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 52.8 tp60 -174.33 164.66 3.93 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.829 0.347 . . . . 0.0 110.758 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.639 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -166.13 144.74 5.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.076 0.465 . . . . 0.0 110.846 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -150.7 148.18 28.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.143 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.25 139.58 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.524 0.678 . . . . 0.0 110.729 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.1 -39.36 12.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.024 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.517 ' O ' ' CG2' ' A' ' 52' ' ' THR . 16.2 mt-10 -141.28 134.48 29.42 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.756 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.83 -156.6 31.55 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.6 HD22 ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -141.24 -5.15 1.11 Allowed 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.406 -0.467 . . . . 0.0 111.404 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.6 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 141.46 11.94 0.53 Allowed Glycine 0 C--O 1.218 -0.853 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.77 -171.71 19.66 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-N 117.233 0.516 . . . . 0.0 112.066 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -62.05 126.87 19.73 Favored 'Trans proline' 0 C--N 1.321 -0.892 0 C-N-CA 123.168 2.579 . . . . 0.0 113.343 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.72 6.12 57.36 Favored Glycine 0 N--CA 1.462 0.422 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.517 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 73.1 m -93.6 139.31 30.92 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.176 -1.012 . . . . 0.0 111.191 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.28 132.1 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.573 ' HZ2' ' CB ' ' A' ' 27' ' ' ASP . 1.9 mmtp -111.17 139.53 46.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.463 0.649 . . . . 0.0 111.258 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -118.2 113.42 21.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.147 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mt -106.28 138.27 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.662 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.7 m -119.21 118.11 30.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.267 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -93.0 -173.23 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.306 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.08 143.54 48.69 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -60.84 -48.39 82.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.806 0.336 . . . . 0.0 110.978 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.06 61.97 3.29 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.0 m -142.91 175.33 9.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.021 0.438 . . . . 0.0 110.626 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -61.84 -45.52 93.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.66 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.32 138.74 39.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.371 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.14 -52.92 0.59 Allowed Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -142.7 151.73 41.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 110.253 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.85 146.5 11.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.968 0.413 . . . . 0.0 110.672 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -105.58 109.51 21.51 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.35 0.595 . . . . 0.0 111.557 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.536 ' CE1' ' CD1' ' A' ' 83' ' ' TYR . 6.8 t60 -98.81 111.68 23.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.329 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.1 ttt-85 -101.56 131.19 47.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.233 0.54 . . . . 0.0 112.126 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.5 mt -82.31 136.68 22.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.461 -0.79 . . . . 0.0 108.96 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.63 ' C ' ' HG ' ' A' ' 73' ' ' SER . 50.7 t0 -96.97 -56.05 2.68 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.63 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 48.7 m -165.67 141.38 5.09 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.6 mt -124.96 129.62 73.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 79' ' ' TYR . 23.2 m-20 -115.45 88.33 2.86 Favored 'General case' 0 C--O 1.202 -1.401 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.582 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.0 OUTLIER -54.31 -36.17 63.45 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.51 -36.1 43.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 m -107.65 -10.87 15.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.828 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.596 ' N ' ' O ' ' A' ' 75' ' ' ASP . 48.2 m-85 56.68 42.53 26.8 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 121.522 -0.736 . . . . 0.0 110.818 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.26 149.2 28.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.909 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 82' ' ' SER . 3.6 t80 -134.8 126.38 28.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.92 0.391 . . . . 0.0 111.186 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.451 ' N ' ' CD1' ' A' ' 81' ' ' TYR . 85.8 p -126.88 136.49 52.39 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.462 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.536 ' CD1' ' CE1' ' A' ' 69' ' ' HIS . 34.3 p90 -144.88 165.63 27.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.561 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -147.08 134.14 20.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.082 0.468 . . . . 0.0 110.667 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mt -80.4 117.59 21.28 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.438 ' CG1' ' N ' ' A' ' 87' ' ' GLU . 5.1 pt -82.42 -44.69 19.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.718 0.294 . . . . 0.0 111.213 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 88' ' ' GLY . 0.6 OUTLIER -149.14 171.81 15.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.22 177.96 18.19 Favored Glycine 0 CA--C 1.509 -0.319 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.94 2.26 0.23 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.633 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -67.39 -35.08 78.6 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 124.314 1.046 . . . . 0.0 110.468 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.616 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -111.11 6.03 20.53 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 123.358 0.663 . . . . 0.0 110.273 -177.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.564 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 61.7 p 49.61 -126.15 2.14 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 18.8 p-10 -131.74 -10.3 3.51 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.827 -0.546 . . . . 0.0 110.911 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.73 -7.6 19.42 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 68.4 mt -99.71 152.81 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -176.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.443 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -87.43 -59.17 2.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.751 177.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.403 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 6.0 ptpt -171.95 154.25 3.45 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.199 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.65 124.88 73.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.87 144.84 32.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.137 0.494 . . . . 0.0 111.436 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 116' ' ' ILE . 0.4 OUTLIER -140.06 138.94 35.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 179.382 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -128.37 135.15 49.17 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 120.983 0.42 . . . . 0.0 110.737 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 p -133.86 131.24 38.94 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -120.32 135.39 55.03 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.4 mm? -96.46 124.66 40.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.255 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.61 136.62 43.58 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.192 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -73.16 139.57 46.44 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.85 -0.531 . . . . 0.0 110.142 177.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.424 ' N ' ' HA ' ' A' ' 111' ' ' SER . 13.6 t -121.36 170.97 9.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.714 0.292 . . . . 0.0 110.388 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.71 -34.6 50.73 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.5 p -94.76 -6.43 43.05 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 118.809 -2.583 . . . . 0.0 113.595 177.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 160.23 -78.62 0.17 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.082 1.801 . . . . 0.0 112.067 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.424 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 29.2 t -162.76 130.21 3.7 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.973 1.309 . . . . 0.0 111.599 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.7 m -99.97 134.9 42.2 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.105 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 mt -110.57 130.34 64.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.504 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.71 116.81 32.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.1 m -110.75 124.73 52.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.204 0.526 . . . . 0.0 110.865 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.608 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -106.29 135.76 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 C-N-CA 123.033 0.533 . . . . 0.0 109.825 -178.016 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.2 m -109.07 134.39 51.75 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.744 ' CE1' ' HG1' ' A' ' 4' ' ' THR . 41.9 m-70 -135.39 95.31 3.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.209 0.528 . . . . 0.0 111.049 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.426 ' N ' ' CD2' ' A' ' 119' ' ' TYR . 6.4 m-30 -84.56 101.39 12.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.874 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -92.87 98.64 11.51 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.7 p -101.3 174.35 6.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.91 0.862 . . . . 0.0 112.218 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.71 144.5 42.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.334 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.6 -110.0 1.1 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.552 HD21 ' N ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -115.9 1.55 13.37 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.449 -0.442 . . . . 0.0 111.607 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.552 ' N ' HD21 ' A' ' 124' ' ' ASN . 1.6 mp -45.48 161.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.177 0.513 . . . . 0.0 110.434 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.494 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 30.2 tt0 -155.42 148.66 24.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.48 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.3 mm -88.01 125.36 41.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -73.87 161.94 29.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.358 0.599 . . . . 0.0 111.541 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -69.01 -48.54 62.76 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.071 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -58.23 -26.11 62.47 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.985 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.421 ' NE2' ' CG2' ' A' ' 92' ' ' THR . 4.2 t60 -72.92 -49.56 28.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.476 0.655 . . . . 0.0 111.236 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.438 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.1 m -81.08 -27.17 10.76 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -66.62 -46.18 76.69 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.983 -0.448 . . . . 0.0 110.496 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.519 ' CG1' ' H ' ' A' ' 135' ' ' GLY . 7.7 p -69.01 -50.89 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 CA-C-O 121.443 0.64 . . . . 0.0 110.515 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.519 ' H ' ' CG1' ' A' ' 134' ' ' VAL . . . -62.81 -42.29 99.71 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.54 ' HZ3' ' CB ' ' A' ' 136' ' ' LYS . 5.9 ttpm? -67.04 -45.68 76.7 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 122.72 -0.283 . . . . 0.0 110.788 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -53.69 -43.34 68.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.516 ' HZ3' ' HB2' ' A' ' 138' ' ' LYS . 2.7 ttmp? -66.16 -53.6 35.6 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.32 -40.22 34.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.672 0.749 . . . . 0.0 110.726 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.91 -36.24 82.73 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.41 -43.79 98.33 Favored Glycine 0 C--O 1.227 -0.328 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.432 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -62.94 -43.01 99.95 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.505 ' CE1' ' CE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -59.44 -25.81 64.67 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -72.1 -42.7 65.82 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.272 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.49 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -62.44 -56.66 16.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.605 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.548 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 50.6 mt -59.62 -50.71 78.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.23 -177.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 8.9 tt0 -46.87 -56.74 5.8 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.136 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 62.0 m -51.08 -48.15 61.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.191 0.52 . . . . 0.0 111.551 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.549 ' O ' ' N ' ' A' ' 153' ' ' HIS . 0.2 OUTLIER -55.93 -49.43 73.51 Favored 'General case' 0 C--O 1.209 -1.033 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.548 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 1.9 mm? -62.53 -43.85 97.79 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 119.792 1.178 . . . . 0.0 111.77 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.432 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -59.14 -25.4 63.85 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.189 -0.945 . . . . 0.0 108.757 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.453 ' O ' ' ND1' ' A' ' 153' ' ' HIS . 49.2 t0 -99.27 -14.38 19.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.731 0.776 . . . . 0.0 109.91 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.549 ' N ' ' O ' ' A' ' 149' ' ' TYR . 68.3 m80 -154.11 68.16 5.94 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 124.261 1.024 . . . . 0.0 110.494 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.471 ' N ' ' O ' ' A' ' 150' ' ' LEU . 31.4 Cg_endo -68.34 -3.18 10.4 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.991 1.794 . . . . 0.0 110.637 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.596 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 14.4 m-20 -87.03 4.69 40.94 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.074 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.42 131.02 20.6 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.028 -1.67 . . . . 0.0 111.256 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 6.3 t80 55.83 7.19 0.25 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.352 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.8 148.47 29.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 O-C-N 122.517 -0.402 . . . . 0.0 110.972 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.45 109.36 22.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.704 177.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.2 m -97.92 140.65 31.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.877 0.37 . . . . 0.0 111.071 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -145.14 137.57 25.99 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.332 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.493 ' C ' HD21 ' A' ' 7' ' ' ASN . 15.6 mt-10 -102.29 139.24 38.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.197 0.523 . . . . 0.0 110.76 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.493 HD21 ' C ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -126.48 168.19 14.57 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -178.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.84 139.34 15.89 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -145.62 134.0 21.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.378 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.1 147.87 22.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.929 0.395 . . . . 0.0 111.254 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 p -144.39 154.26 42.8 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.51 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -94.37 27.61 2.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.889 0.376 . . . . 0.0 110.305 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.424 HD11 ' N ' ' A' ' 151' ' ' LYS . 1.3 mt -117.56 125.66 27.93 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.721 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.97 148.47 13.0 Favored 'Trans proline' 0 C--N 1.327 -0.581 0 C-N-CA 121.801 1.667 . . . . 0.0 111.409 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -59.04 -24.98 76.05 Favored 'Trans proline' 0 N--CA 1.482 0.836 0 C-N-CA 122.011 1.808 . . . . 0.0 112.116 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.442 ' C ' ' HZ1' ' A' ' 20' ' ' LYS . 66.3 m -65.72 -35.68 81.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.392 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -77.99 -57.68 3.67 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.1 mt -48.14 -48.25 34.31 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.909 -1.042 . . . . 0.0 108.599 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -48.85 -56.49 8.59 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.307 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.442 ' HZ1' ' C ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -70.21 -23.92 63.02 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.698 -179.775 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.48 -2.84 54.57 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.976 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.482 ' CE2' ' OH ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -119.08 -9.56 9.98 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.418 HG22 HD13 ' A' ' 24' ' ' LEU . 3.0 m -136.1 -36.57 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.584 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 3.2 mp -91.17 -53.05 4.52 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.152 0.887 . . . . 0.0 112.153 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -112.2 -4.68 14.32 Favored 'General case' 0 C--O 1.214 -0.771 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.039 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.16 -41.73 65.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.2 0.524 . . . . 0.0 111.715 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -83.39 17.49 2.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.629 0.728 . . . . 0.0 110.794 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -139.97 -8.89 1.19 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.501 HD22 ' CD1' ' A' ' 149' ' ' TYR . 0.6 OUTLIER -91.34 -33.51 15.27 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.438 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.426 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.74 -53.17 63.62 Favored Pre-proline 0 C--O 1.216 -0.678 0 O-C-N 122.083 -0.385 . . . . 0.0 111.127 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 20.0 Cg_endo -62.56 -24.67 75.28 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 121.876 1.718 . . . . 0.0 112.323 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -70.28 -59.83 2.64 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.73 0.776 . . . . 0.0 112.016 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.49 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 1.3 pt -95.29 -35.72 6.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.282 -176.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.424 ' CA ' ' HG ' ' A' ' 145' ' ' LEU . . . -105.54 64.53 0.14 Allowed Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.401 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 72.6 Cg_endo -76.88 -28.4 6.24 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 121.647 1.565 . . . . 0.0 108.175 174.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.408 ' CG ' ' N ' ' A' ' 37' ' ' ALA . 12.1 pt20 -74.14 -43.17 58.43 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.572 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.408 ' N ' ' CG ' ' A' ' 36' ' ' GLN . . . -72.81 -76.54 0.12 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.947 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.4 mm -99.51 145.08 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 121.092 0.472 . . . . 0.0 110.422 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -77.7 -49.86 13.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.673 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -176.98 166.61 2.46 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.111 0.482 . . . . 0.0 110.543 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.99 143.13 5.35 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.592 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -151.33 153.34 34.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.782 0.325 . . . . 0.0 110.595 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.06 138.52 18.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.597 0.713 . . . . 0.0 111.341 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.5 mp -88.9 -39.07 14.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.905 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.477 ' O ' ' CG2' ' A' ' 52' ' ' THR . 26.4 mt-10 -144.32 136.89 26.75 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.364 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.47 -156.21 22.55 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.709 HD21 ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -135.26 -11.34 2.18 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.09 0.472 . . . . 0.0 110.608 -179.357 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.709 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 136.65 11.08 1.15 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.29 -171.86 19.34 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -59.07 127.01 22.67 Favored 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 122.595 2.196 . . . . 0.0 113.213 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.67 2.14 52.87 Favored Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.477 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 51.8 m -94.42 140.49 29.75 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.146 -1.027 . . . . 0.0 111.753 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -121.51 129.74 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.428 ' HB3' ' HZ3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -114.73 140.44 48.87 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.021 0.438 . . . . 0.0 110.879 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -118.77 123.11 44.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.02 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.2 mt -104.9 140.64 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.86 0.362 . . . . 0.0 110.605 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.8 m -116.52 118.82 33.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.152 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -91.39 -176.44 4.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.316 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.33 142.68 32.11 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.468 ' CD ' ' N ' ' A' ' 61' ' ' GLY . 2.5 pp20? -61.15 -45.22 95.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.817 0.342 . . . . 0.0 111.23 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.468 ' N ' ' CD ' ' A' ' 60' ' ' GLU . . . -91.37 61.53 2.86 Favored Glycine 0 C--N 1.328 0.135 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.8 m -141.96 174.11 10.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.964 0.411 . . . . 0.0 110.816 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -68.16 -39.12 82.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.931 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.55 142.96 27.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.439 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.1 -62.06 0.53 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -146.07 145.29 30.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.952 0.406 . . . . 0.0 110.429 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.74 140.09 41.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.647 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -106.53 114.56 28.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.346 0.594 . . . . 0.0 112.413 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.553 ' CE1' ' CD2' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -92.89 123.89 36.48 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.29 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -100.89 112.4 24.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.012 0.434 . . . . 0.0 111.485 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.4 mt -74.17 135.42 27.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.538 ' C ' ' HG ' ' A' ' 73' ' ' SER . 29.0 m-20 -98.3 -55.67 2.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.538 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 69.5 m -165.97 142.38 5.14 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.6 mt -116.16 131.44 68.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.682 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 79' ' ' TYR . 9.4 t0 -113.97 87.45 2.62 Favored 'General case' 0 C--O 1.207 -1.148 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.513 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 7.2 pt-20 -54.87 -30.1 57.04 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.32 -40.0 70.64 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 m -108.63 -10.68 15.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.901 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.565 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.6 m-85 62.54 42.14 8.94 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.511 -0.743 . . . . 0.0 110.142 -178.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.2 t -116.87 139.8 50.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.233 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.482 ' OH ' ' CE2' ' A' ' 22' ' ' PHE . 41.1 p90 -132.26 132.78 43.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.088 0.47 . . . . 0.0 110.392 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 m -127.09 137.65 53.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.383 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -144.05 166.37 25.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.891 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.5 m -144.89 142.95 30.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.09 0.471 . . . . 0.0 110.828 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.553 ' CD2' ' CE1' ' A' ' 69' ' ' HIS . 7.9 mt -79.97 115.36 19.5 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.9 pt -77.49 -44.8 29.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.783 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -153.47 172.53 16.98 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.618 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.57 177.52 18.02 Favored Glycine 0 CA--C 1.51 -0.221 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -61.7 0.37 0.35 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 122.529 1.157 . . . . 0.0 108.395 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -62.17 -34.51 76.56 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 124.123 0.969 . . . . 0.0 110.236 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.62 ' C ' ' HG1' ' A' ' 92' ' ' THR . 0.0 OUTLIER -110.37 12.84 23.01 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 123.464 0.705 . . . . 0.0 109.935 -177.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.62 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 44.1 p 47.36 -126.31 1.68 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -177.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -130.72 -12.64 3.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.019 0.438 . . . . 0.0 111.452 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.23 -6.14 20.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 95.2 mt -98.08 152.17 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 122.159 0.981 . . . . 0.0 113.297 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.506 ' OE2' ' CE1' ' A' ' 120' ' ' HIS . 0.0 OUTLIER -93.44 -52.51 4.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.468 177.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.53 149.02 2.06 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-O 121.178 0.513 . . . . 0.0 111.32 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.406 ' CD1' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.87 126.68 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.488 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 0.1 OUTLIER -109.63 143.89 38.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.803 0.335 . . . . 0.0 111.621 -178.105 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -137.35 127.94 26.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.689 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -129.8 132.49 46.53 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.437 ' OG1' ' CE1' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -139.82 133.82 30.89 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.086 -0.384 . . . . 0.0 110.469 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -122.25 134.41 54.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.908 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.564 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -97.74 127.32 43.6 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.192 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -128.51 136.63 59.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.119 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.14 133.29 44.04 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.752 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -121.88 174.04 7.12 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.69 -34.18 55.95 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.871 -0.492 . . . . 0.0 111.871 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.1 m -76.78 -26.81 54.91 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.841 1.256 . . . . 0.0 114.182 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 159.67 -78.88 0.17 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.522 1.534 . . . . 0.0 111.876 -169.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 83.7 p -166.07 131.72 2.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.594 1.558 . . . . 0.0 111.079 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.8 m -99.29 118.74 36.63 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 54.4 mt -92.14 126.52 44.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.635 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 117.38 33.88 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.2 m -112.35 123.75 50.96 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.329 0.585 . . . . 0.0 111.313 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.638 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -103.53 137.16 33.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 123.591 0.756 . . . . 0.0 109.654 -178.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.95 132.09 55.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.715 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.488 ' ND1' ' O ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -138.38 112.32 8.45 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.405 ' CD1' ' N ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -101.83 108.38 19.84 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.223 -0.298 . . . . 0.0 110.803 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.506 ' CE1' ' OE2' ' A' ' 96' ' ' GLU . 13.8 t-160 -89.59 105.8 18.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.16 0.505 . . . . 0.0 109.679 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.9 p -100.22 178.01 4.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.841 0.829 . . . . 0.0 111.915 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 123' ' ' GLY . 3.8 mtpt -112.54 157.49 21.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.794 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . 35.16 -108.71 0.05 OUTLIER Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.467 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.2 OUTLIER -114.04 7.04 16.67 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.588 -0.36 . . . . 0.0 111.144 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.493 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.6 mp -45.42 160.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.221 0.534 . . . . 0.0 110.594 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.493 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 22.0 mt-10 -152.11 149.6 28.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.257 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 mm -88.21 125.01 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -73.85 161.96 29.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.202 0.525 . . . . 0.0 111.208 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -68.68 -44.41 74.08 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.112 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.57 -26.18 67.79 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.67 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -73.04 -49.32 29.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.106 0.479 . . . . 0.0 111.321 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.411 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.0 m -79.5 -29.72 13.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.176 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.4 tptt -66.92 -45.83 76.69 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.916 -0.49 . . . . 0.0 110.605 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.402 ' CG2' ' N ' ' A' ' 135' ' ' GLY . 24.2 m -70.45 -45.98 72.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.557 0.218 . . . . 0.0 110.567 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.402 ' N ' ' CG2' ' A' ' 134' ' ' VAL . . . -66.58 -46.66 74.67 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 29.3 ttpt -67.05 -46.15 75.26 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.676 -0.308 . . . . 0.0 110.653 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -54.49 -46.28 73.4 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -67.8 -52.29 38.76 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.54 -41.5 41.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.694 0.759 . . . . 0.0 110.616 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -36.33 83.41 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.42 -37.98 94.04 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.425 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -71.14 -42.43 69.19 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -59.54 -22.78 62.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.431 ' HB3' ' HZ3' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -77.3 -37.98 51.57 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.669 179.027 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.49 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.3 mm? -69.61 -56.73 6.47 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.146 0.498 . . . . 0.0 109.894 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.549 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 63.5 mt -54.53 -51.36 50.84 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.48 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -47.65 -55.5 9.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.03 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.402 ' O ' ' OD2' ' A' ' 152' ' ' ASP . 8.7 t -52.56 -43.77 65.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.322 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.621 ' O ' ' N ' ' A' ' 153' ' ' HIS . 20.4 t80 -58.15 -44.77 88.04 Favored 'General case' 0 C--O 1.189 -2.083 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.549 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 1.8 mm? -69.71 -42.84 73.51 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 120.552 -1.342 . . . . 0.0 111.88 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.424 ' N ' HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -61.97 -24.79 67.23 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 121.571 -0.705 . . . . 0.0 109.147 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 149' ' ' TYR . 5.1 p30 -107.32 -12.73 15.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.26 0.552 . . . . 0.0 110.379 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.621 ' N ' ' O ' ' A' ' 149' ' ' TYR . 1.2 t-160 -154.86 66.3 4.97 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 124.795 1.238 . . . . 0.0 110.108 -177.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.11 -3.54 13.47 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 122.761 2.307 . . . . 0.0 112.072 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.61 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 2.3 p30 -80.24 4.63 16.98 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.951 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.411 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -49.08 130.53 18.83 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 119.82 -1.8 . . . . 0.0 111.467 -178.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 6.2 t80 55.08 8.17 0.23 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.331 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.61 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.461 0 O-C-N 121.547 -0.721 . . . . 0.0 110.291 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 110.046 -1.221 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.1 p -134.92 148.3 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.052 0.453 . . . . 0.0 111.616 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -98.51 110.5 23.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.24 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.912 ' HG1' ' CD2' ' A' ' 118' ' ' HIS . 98.3 m -96.41 140.12 31.54 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.828 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -146.96 134.16 20.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.918 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.493 ' C ' HD21 ' A' ' 7' ' ' ASN . 36.8 mt-10 -102.39 132.91 48.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.23 0.538 . . . . 0.0 111.273 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.493 HD21 ' C ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -127.04 166.86 16.79 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -155.95 142.1 18.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.46 139.62 37.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.276 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.515 HG22 ' HG ' ' A' ' 107' ' ' CYS . 0.7 OUTLIER -102.26 147.91 26.1 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.819 0.342 . . . . 0.0 111.532 -179.158 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 t -145.08 154.85 42.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.808 0.337 . . . . 0.0 110.51 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -93.8 24.99 3.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.948 0.404 . . . . 0.0 111.121 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.406 HD11 ' N ' ' A' ' 151' ' ' LYS . 2.1 mt -112.45 129.04 24.76 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.244 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.455 ' HB2' ' HE ' ' A' ' 17' ' ' ARG . 45.6 Cg_exo -46.03 144.63 5.96 Favored 'Trans proline' 0 C--N 1.327 -0.583 0 C-N-CA 121.192 1.261 . . . . 0.0 110.602 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -61.88 -24.55 77.25 Favored 'Trans proline' 0 C--N 1.321 -0.904 0 C-N-CA 122.316 2.011 . . . . 0.0 113.027 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.2 m -70.94 -28.6 64.61 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.455 ' HE ' ' HB2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -76.27 -57.6 3.77 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 mt -51.51 -43.53 62.29 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -47.45 -58.06 4.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.257 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.423 ' O ' HD11 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -69.89 -42.44 73.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 119.16 -1.016 . . . . 0.0 108.674 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.72 -5.12 3.67 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.627 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -120.25 -7.96 9.74 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.1 m -129.91 -49.64 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.495 ' CD1' ' N ' ' A' ' 25' ' ' ASP . 1.6 pp -96.51 -31.46 12.78 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.495 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 10.0 t70 -114.44 -5.79 12.87 Favored 'General case' 0 C--O 1.211 -0.944 0 O-C-N 121.798 -0.564 . . . . 0.0 111.544 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.79 -40.36 92.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.566 0.698 . . . . 0.0 111.978 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -83.58 16.68 2.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.6 0.714 . . . . 0.0 110.109 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -139.62 -9.34 1.23 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.51 HD21 ' CD1' ' A' ' 149' ' ' TYR . 0.3 OUTLIER -100.81 -39.82 7.62 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.001 -178.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.408 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 58.0 mt -53.89 -53.8 53.89 Favored Pre-proline 0 C--O 1.214 -0.79 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.191 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 29.3 Cg_endo -62.33 -25.29 76.38 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 121.876 1.717 . . . . 0.0 112.375 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 tmtp? -66.37 -55.33 16.41 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.984 0.897 . . . . 0.0 111.777 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.474 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 0.9 OUTLIER -95.4 -34.34 5.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.315 -176.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.425 ' N ' ' HG ' ' A' ' 145' ' ' LEU . . . -105.29 64.17 0.13 Allowed Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.407 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 71.7 Cg_endo -76.77 -24.41 10.14 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 N-CA-C 107.938 -1.601 . . . . 0.0 107.938 174.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -74.08 -43.83 56.29 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.273 -1.331 . . . . 0.0 109.494 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.503 ' O ' ' NZ ' ' A' ' 138' ' ' LYS . . . -70.54 -79.02 0.07 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.3 mt -98.93 146.64 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.019 0.437 . . . . 0.0 110.104 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -76.62 -44.36 34.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.81 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.622 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 49.2 tp60 -176.86 163.44 2.24 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.909 0.385 . . . . 0.0 110.773 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.622 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -167.0 143.78 4.56 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.926 0.393 . . . . 0.0 110.36 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.14 150.46 30.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.63 138.13 19.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.651 0.739 . . . . 0.0 110.952 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 8.3 mp -88.45 -39.32 14.33 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.766 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.503 ' O ' ' CG2' ' A' ' 52' ' ' THR . 47.9 mt-10 -142.02 134.22 27.69 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.952 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.62 -156.33 26.61 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.451 ' H ' HD21 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -139.69 -9.7 1.21 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.821 0.343 . . . . 0.0 110.962 -179.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.95 11.38 0.35 Allowed Glycine 0 C--O 1.223 -0.565 0 N-CA-C 111.914 -0.474 . . . . 0.0 111.914 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.43 -172.78 20.11 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 117.562 0.681 . . . . 0.0 111.976 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -60.02 126.59 20.72 Favored 'Trans proline' 0 N--CA 1.483 0.854 0 C-N-CA 122.774 2.316 . . . . 0.0 113.649 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.99 4.0 55.64 Favored Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.503 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 88.9 m -94.23 140.4 29.82 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.135 -1.033 . . . . 0.0 111.296 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -121.15 129.91 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.27 140.34 49.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.083 0.468 . . . . 0.0 110.688 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -118.75 121.74 40.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.011 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.1 mp -100.96 123.61 54.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.1 m -98.42 118.47 35.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.401 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -92.27 168.05 11.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.232 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.92 143.77 32.51 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.93 -48.05 83.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.724 0.297 . . . . 0.0 110.324 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.18 61.49 2.93 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.4 m -137.41 174.93 10.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.623 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -51.37 66.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.674 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -91.67 150.92 20.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.363 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.93 -59.71 0.58 Allowed Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -145.24 155.18 43.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.99 0.424 . . . . 0.0 110.941 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.5 p -154.69 138.35 8.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.821 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.3 mtmm -105.83 118.95 37.92 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.363 0.601 . . . . 0.0 112.228 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.566 ' CE1' ' CD2' ' A' ' 85' ' ' LEU . 1.9 m80 -97.25 114.43 26.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.3 ttp85 -101.2 112.56 25.08 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.123 0.487 . . . . 0.0 111.609 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.0 mt -73.73 134.11 30.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.292 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 73' ' ' SER . 2.2 p30 -98.01 -49.92 4.59 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.296 -0.562 . . . . 0.0 112.298 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.538 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -165.54 143.21 5.82 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.1 mt -126.68 126.46 68.81 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 CA-C-N 113.914 -1.494 . . . . 0.0 108.841 173.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 79' ' ' TYR . 23.4 m-20 -113.88 88.44 2.85 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.466 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 6.9 pt-20 -54.59 -30.62 55.01 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.32 -38.75 59.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.8 m -108.5 -11.02 15.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.777 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.513 ' N ' ' O ' ' A' ' 75' ' ' ASP . 12.3 m-85 62.53 43.29 7.88 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.273 0.559 . . . . 0.0 109.808 -178.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.3 p -105.95 141.06 37.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.802 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -132.59 118.65 19.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.62 0.248 . . . . 0.0 110.684 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.446 ' C ' ' OD2' ' A' ' 72' ' ' ASP . 42.0 t -128.43 143.62 51.02 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.696 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -148.93 173.11 13.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.165 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.93 135.53 23.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.091 0.472 . . . . 0.0 110.895 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.566 ' CD2' ' CE1' ' A' ' 69' ' ' HIS . 9.0 mt -80.24 113.27 18.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.31 -41.79 30.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.803 -178.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.481 ' OE1' ' N ' ' A' ' 88' ' ' GLY . 4.1 tm-20 -157.03 170.69 21.95 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.116 -0.365 . . . . 0.0 110.357 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.604 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 119.65 178.33 16.43 Favored Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -62.28 2.06 0.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 122.884 1.326 . . . . 0.0 108.412 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.604 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -66.0 -33.08 75.0 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 124.35 1.06 . . . . 0.0 110.399 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -109.77 16.2 22.22 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.195 0.598 . . . . 0.0 110.693 -176.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.501 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 65.2 p 43.35 -126.25 0.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.61 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -131.48 -13.29 3.4 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.126 -0.358 . . . . 0.0 111.054 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.1 p -104.68 -5.76 21.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.845 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.423 HG22 ' CD1' ' A' ' 98' ' ' ILE . 57.9 mt -99.53 152.91 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 121.962 0.887 . . . . 0.0 113.107 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -99.95 -49.1 4.44 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.17 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -170.79 147.41 2.76 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-O 121.832 0.825 . . . . 0.0 111.764 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.423 ' CD1' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.62 122.66 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.2 t -106.26 146.0 30.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.197 0.522 . . . . 0.0 111.324 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -139.14 133.53 31.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.286 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -128.75 133.29 48.06 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.21 131.82 37.15 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.002 -0.436 . . . . 0.0 110.254 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -120.22 133.7 55.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.54 129.78 45.73 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -178.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -131.76 137.18 55.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.987 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.24 134.89 44.44 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.728 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.515 ' HG ' HG22 ' A' ' 10' ' ' THR . 30.3 p -121.31 167.69 12.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.73 -27.17 34.76 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.8 m -86.97 -19.5 28.66 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 120.217 2.008 . . . . 0.0 113.743 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.24 -83.73 0.14 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.854 2.169 . . . . 0.0 111.104 -170.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.402 ' N ' ' SG ' ' A' ' 107' ' ' CYS . 27.7 t -164.22 130.96 3.13 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 125.657 1.583 . . . . 0.0 110.971 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 105' ' ' VAL . 39.0 m -99.72 117.82 34.88 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.7 mt -92.25 132.5 36.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.386 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -105.17 117.16 33.3 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.3 m -110.74 117.5 33.62 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.351 0.596 . . . . 0.0 110.783 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.648 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -99.9 135.8 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 123.561 0.744 . . . . 0.0 109.811 -177.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.8 p -104.3 133.98 48.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.912 ' CD2' ' HG1' ' A' ' 4' ' ' THR . 12.2 m80 -136.75 93.28 2.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.081 0.467 . . . . 0.0 109.927 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -87.37 101.77 13.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.835 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -91.51 100.05 12.87 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.1 p -100.7 179.95 4.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.528 0.68 . . . . 0.0 111.937 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.629 ' HZ1' ' CB ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -109.16 155.42 21.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.344 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 41.32 -109.8 0.18 Allowed Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.96 7.14 13.11 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.911 -0.17 . . . . 0.0 111.006 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -47.51 159.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.169 0.509 . . . . 0.0 110.295 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.449 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 38.2 mt-10 -150.57 147.11 27.05 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.056 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.2 mm -89.32 124.57 42.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.439 ' HG2' ' H ' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -75.36 162.49 28.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.473 0.654 . . . . 0.0 111.643 -178.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.19 -34.08 74.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.837 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.439 ' H ' ' HG2' ' A' ' 128' ' ' LYS . 62.9 mt-10 -64.93 -35.6 81.7 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.824 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -68.57 -53.86 20.27 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.173 0.511 . . . . 0.0 110.789 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.0 m -69.23 -20.27 24.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.469 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -66.22 -47.64 73.2 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 122.293 -0.254 . . . . 0.0 110.41 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.88 -48.71 55.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.669 0.271 . . . . 0.0 110.697 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.91 -47.08 89.39 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -67.49 -47.03 71.22 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 122.493 -0.416 . . . . 0.0 110.569 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -55.24 -46.83 76.03 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.503 ' NZ ' ' O ' ' A' ' 37' ' ' ALA . 25.1 tttp -63.28 -54.42 37.41 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.45 -41.76 41.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.771 0.796 . . . . 0.0 110.116 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -63.11 -36.72 84.56 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.229 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.09 -47.58 90.11 Favored Glycine 0 C--O 1.226 -0.36 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -64.71 -44.81 89.04 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -59.46 -23.63 62.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -76.67 -37.48 56.14 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.023 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.474 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -67.69 -56.19 10.27 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.354 1.073 . . . . 0.0 109.05 179.2 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.53 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 50.9 mt -53.95 -50.66 51.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.285 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -47.5 -56.89 6.11 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.587 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.1 p -52.98 -40.9 64.1 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.209 0.528 . . . . 0.0 111.468 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.638 ' O ' ' N ' ' A' ' 153' ' ' HIS . 22.1 t80 -61.47 -44.4 97.16 Favored 'General case' 0 C--O 1.193 -1.903 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 2.1 mm? -67.87 -42.71 80.86 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 119.995 1.27 . . . . 0.0 111.335 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.406 ' N ' HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -62.89 -23.81 67.52 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 121.505 -0.747 . . . . 0.0 109.13 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -105.72 -12.86 15.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.922 0.868 . . . . 0.0 110.342 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.638 ' N ' ' O ' ' A' ' 149' ' ' TYR . 0.2 OUTLIER -155.14 66.65 4.94 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 125.393 1.477 . . . . 0.0 110.041 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.42 ' N ' ' O ' ' A' ' 150' ' ' LEU . 39.8 Cg_endo -72.25 -3.44 13.34 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 C-N-CA 122.603 2.202 . . . . 0.0 111.68 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.633 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 4.2 m-20 -84.66 4.12 33.95 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.122 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.444 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -50.1 130.31 22.21 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 119.522 -1.986 . . . . 0.0 111.419 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.408 ' CD1' HD21 ' A' ' 24' ' ' LEU . 0.7 OUTLIER 55.15 6.47 0.15 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.633 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.499 0 O-C-N 121.832 -0.542 . . . . 0.0 110.253 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.91 148.6 29.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 O-C-N 122.661 -0.317 . . . . 0.0 111.048 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -97.64 109.41 22.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.776 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.648 ' HG1' ' CD2' ' A' ' 118' ' ' HIS . 92.8 m -97.18 139.83 32.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 0.0 110.918 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -140.34 129.5 23.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.205 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.476 ' C ' HD21 ' A' ' 7' ' ' ASN . 1.4 tt0 -103.37 126.67 50.66 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.757 0.313 . . . . 0.0 110.894 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.476 HD21 ' C ' ' A' ' 6' ' ' GLU . 2.3 m120 -126.67 165.71 18.71 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.198 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -155.93 139.8 16.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 112.082 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -137.98 139.94 39.95 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.474 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.579 HG22 ' HG ' ' A' ' 107' ' ' CYS . 1.0 OUTLIER -97.27 145.04 26.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.82 0.343 . . . . 0.0 111.521 -179.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.485 ' HG ' ' CD ' ' A' ' 147' ' ' GLU . 3.0 t -145.38 155.06 42.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.534 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -93.23 29.32 1.93 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.894 0.378 . . . . 0.0 110.792 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -113.78 125.25 29.74 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.779 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -49.22 146.01 13.92 Favored 'Trans proline' 0 C--N 1.327 -0.559 0 C-N-CA 121.862 1.708 . . . . 0.0 111.615 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -57.56 -24.6 62.79 Favored 'Trans proline' 0 N--CA 1.483 0.853 0 C-N-CA 122.204 1.936 . . . . 0.0 112.412 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.9 m -67.64 -35.63 79.26 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -75.74 -57.26 3.99 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mt -49.19 -47.11 46.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.09 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -48.04 -56.66 7.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.488 ' CD ' ' O ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -69.99 -38.41 76.0 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 119.101 -1.039 . . . . 0.0 108.479 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.72 -3.71 7.26 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.541 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -119.94 -8.9 9.75 Favored 'General case' 0 CA--C 1.527 0.058 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.419 ' CG2' ' N ' ' A' ' 24' ' ' LEU . 22.3 m -129.31 -49.61 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.516 ' CD1' ' N ' ' A' ' 25' ' ' ASP . 2.7 pp -101.19 -30.53 11.49 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.516 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 50.2 m-20 -110.89 -4.07 15.38 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.813 -0.554 . . . . 0.0 111.398 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.453 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -66.82 -38.79 87.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.704 0.764 . . . . 0.0 112.099 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.492 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 17.3 m-20 -84.09 14.83 3.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.86 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 27' ' ' ASP . 8.2 m120 -138.84 -9.27 1.37 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.48 ' O ' ' CG1' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -92.03 -50.86 5.48 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.515 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.433 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 91.1 mt -55.33 -48.23 96.74 Favored Pre-proline 0 C--O 1.212 -0.884 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 29.7 Cg_endo -62.87 -26.16 74.52 Favored 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 121.773 1.649 . . . . 0.0 113.461 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -75.93 -48.61 20.56 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.662 0.744 . . . . 0.0 112.042 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.48 ' CG1' ' O ' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -94.45 -36.28 6.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.533 -177.262 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.407 ' N ' ' HG ' ' A' ' 145' ' ' LEU . . . -105.95 63.61 0.16 Allowed Pre-proline 0 C--N 1.324 -0.507 0 C-N-CA 122.817 0.447 . . . . 0.0 111.947 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.37 -25.73 9.5 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 N-CA-C 107.625 -1.721 . . . . 0.0 107.625 174.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -74.81 -43.9 52.19 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.609 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.73 -75.13 0.14 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.254 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.56 146.17 9.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.955 0.407 . . . . 0.0 110.221 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -77.66 -52.4 9.04 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.376 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.638 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 54.0 tp60 -175.68 164.0 2.94 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 110.546 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.638 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -166.96 144.0 4.67 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.134 0.492 . . . . 0.0 110.518 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.53 ' N ' ' NZ ' ' A' ' 54' ' ' LYS . 17.7 pt-20 -149.85 156.17 41.33 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.105 -0.372 . . . . 0.0 110.876 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.83 138.87 18.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.554 0.692 . . . . 0.0 111.008 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.97 -39.38 13.02 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.03 -0.987 . . . . 0.0 109.053 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.489 ' O ' ' CG2' ' A' ' 52' ' ' THR . 1.1 tt0 -142.41 138.22 30.95 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.22 -156.68 27.39 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.418 HD21 ' N ' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -135.08 -13.6 2.11 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.593 -0.357 . . . . 0.0 111.079 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.418 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 143.8 10.84 0.38 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.9 -172.99 19.84 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 117.525 0.662 . . . . 0.0 111.75 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.28 127.19 22.19 Favored 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 122.597 2.198 . . . . 0.0 113.207 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.95 1.94 55.01 Favored Glycine 0 CA--C 1.506 -0.512 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 95.8 m -93.59 136.16 34.15 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.313 -0.944 . . . . 0.0 110.761 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mp -109.56 119.22 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' NZ ' ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -109.25 136.4 48.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.781 0.8 . . . . 0.0 109.738 178.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -120.56 129.77 53.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.157 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.432 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 2.5 mp -95.41 136.38 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.4 m -107.97 118.43 36.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.491 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -98.29 166.85 11.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.638 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.7 144.52 30.31 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.81 -58.47 8.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.805 0.336 . . . . 0.0 110.694 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.35 61.6 3.22 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 m -137.41 176.05 9.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.945 0.403 . . . . 0.0 110.684 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -61.07 -52.66 63.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.658 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.26 155.97 18.16 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.05 -61.8 0.14 Allowed Glycine 0 N--CA 1.462 0.393 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.64 155.06 42.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 0.0 110.846 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 p -156.01 145.52 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.187 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.409 ' HZ1' ' CD1' ' A' ' 86' ' ' ILE . 0.4 OUTLIER -101.49 110.52 22.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.32 0.581 . . . . 0.0 111.802 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.487 ' HE2' ' CB ' ' A' ' 83' ' ' TYR . 0.3 OUTLIER -109.62 114.79 28.69 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.11 133.77 46.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.11 0.481 . . . . 0.0 111.693 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.5 mt -80.31 137.51 21.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.585 ' C ' ' HG ' ' A' ' 73' ' ' SER . 37.1 m-20 -95.54 -54.31 3.42 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -177.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.585 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 48.8 m -164.66 141.72 6.27 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.6 mt -128.21 130.0 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.712 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 79' ' ' TYR . 7.4 m-20 -115.61 88.78 2.95 Favored 'General case' 0 C--O 1.211 -0.928 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.414 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 7.4 mt-10 -54.26 -30.07 49.22 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.3 -38.08 70.77 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.426 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.07 -11.46 15.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.978 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 75' ' ' ASP . 7.5 m-85 61.16 41.47 13.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.795 -0.566 . . . . 0.0 110.498 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.9 t -115.41 132.66 56.55 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.736 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.509 ' CE2' ' OG1' ' A' ' 102' ' ' THR . 51.4 p90 -132.45 131.79 42.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.29 0.567 . . . . 0.0 110.92 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.3 t -126.81 145.15 50.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.226 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.487 ' CB ' ' HE2' ' A' ' 69' ' ' HIS . 50.2 p90 -151.26 163.63 38.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.1 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.7 m -146.4 142.5 28.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.233 0.54 . . . . 0.0 111.378 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.7 mt -81.19 120.56 25.03 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.477 ' CG1' ' N ' ' A' ' 87' ' ' GLU . 3.6 pt -80.75 -44.55 21.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.724 0.297 . . . . 0.0 111.665 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.477 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 4.6 tp10 -153.71 171.79 18.3 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.607 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.54 177.77 18.03 Favored Glycine 0 CA--C 1.508 -0.359 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -61.06 2.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.607 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -68.38 -35.06 77.15 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 124.168 0.987 . . . . 0.0 110.102 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.624 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.62 15.68 21.89 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 123.591 0.756 . . . . 0.0 109.799 -178.057 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.502 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 35.4 p 47.19 -126.8 1.65 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -130.74 -12.79 3.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.078 0.466 . . . . 0.0 111.195 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.6 p -105.53 -5.36 20.28 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 79.4 mt -97.55 152.17 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-O 122.16 0.981 . . . . 0.0 113.432 -176.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.424 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -89.41 -59.47 2.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 113.917 -1.492 . . . . 0.0 109.423 178.12 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.536 ' HB2' ' HZ2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -171.69 149.08 2.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.462 0.649 . . . . 0.0 111.285 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.412 ' CD1' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.92 123.24 69.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.4 t -111.14 146.43 36.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.353 0.597 . . . . 0.0 111.956 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -134.7 131.07 37.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.571 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -128.1 133.55 49.03 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.509 ' OG1' ' CE2' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -140.2 132.71 28.63 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.956 -0.465 . . . . 0.0 110.476 -178.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -121.76 133.93 54.92 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.529 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -100.12 126.35 46.36 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.19 137.17 58.6 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.159 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.81 133.92 44.69 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.379 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.579 ' HG ' HG22 ' A' ' 10' ' ' THR . 28.1 p -121.1 172.8 7.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.941 0.401 . . . . 0.0 110.258 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.12 -38.78 61.93 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.1 m -83.53 -15.57 48.82 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.63 1.172 . . . . 0.0 112.871 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 160.75 -85.48 0.11 Allowed Glycine 0 CA--C 1.54 1.596 0 C-N-CA 127.541 2.495 . . . . 0.0 112.794 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.58 130.32 7.46 Favored 'General case' 0 C--N 1.347 0.487 0 C-N-CA 127.995 2.518 . . . . 0.0 111.046 175.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.4 m -99.82 118.45 36.31 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.5 mt -91.83 128.73 43.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.54 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.626 ' CB ' ' HZ1' ' A' ' 114' ' ' LYS . 1.2 mtmp? -105.59 117.05 33.02 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.7 t -111.31 125.23 53.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.238 0.542 . . . . 0.0 110.845 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.646 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -107.17 135.76 44.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 123.22 0.608 . . . . 0.0 110.043 -177.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.2 t -107.1 137.94 44.22 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.885 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.648 ' CD2' ' HG1' ' A' ' 4' ' ' THR . 6.7 m80 -135.67 93.49 2.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.076 0.465 . . . . 0.0 110.589 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -86.56 101.6 13.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.173 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -99.3 107.88 20.28 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.138 0.494 . . . . 0.0 110.546 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.3 p -100.48 173.11 6.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.408 0.623 . . . . 0.0 111.167 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.445 ' HZ1' ' HB2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -108.97 155.17 21.18 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.187 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 40.3 -109.09 0.12 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 124' ' ' ASN . 0.1 OUTLIER -109.51 -1.4 18.3 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 122.779 -0.248 . . . . 0.0 111.213 179.039 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.453 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.4 mp -49.16 151.54 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.269 0.557 . . . . 0.0 109.877 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -147.7 148.29 30.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.642 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.7 mm -87.99 125.46 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -74.33 162.3 29.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.123 0.487 . . . . 0.0 111.798 -178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.4 -34.89 75.18 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.948 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.455 ' N ' ' CD ' ' A' ' 130' ' ' GLU . 0.6 OUTLIER -69.15 -28.62 66.59 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.108 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -72.49 -47.43 48.67 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.112 0.482 . . . . 0.0 111.108 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.4 m -79.29 -28.61 13.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.981 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -66.78 -45.64 77.85 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.169 -0.332 . . . . 0.0 110.855 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.35 -45.6 74.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.718 0.294 . . . . 0.0 110.529 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.9 -44.59 88.6 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 77.9 tttt -65.02 -46.04 83.01 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 122.696 -0.296 . . . . 0.0 110.673 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -54.42 -47.15 73.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.793 0.33 . . . . 0.0 110.135 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.1 ttpp -66.44 -52.99 40.55 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.69 -43.98 47.71 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.589 0.709 . . . . 0.0 110.546 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.37 -36.49 75.85 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -61.03 -42.4 99.78 Favored Glycine 0 C--O 1.22 -0.76 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.406 ' N ' HD21 ' A' ' 142' ' ' LEU . 0.2 OUTLIER -64.0 -46.84 82.74 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -60.74 -24.08 65.44 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -76.5 -38.56 55.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.808 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.477 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.0 OUTLIER -66.94 -57.01 7.76 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.365 0.602 . . . . 0.0 110.092 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.533 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 43.3 mt -55.3 -50.03 68.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.539 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.485 ' CD ' ' HG ' ' A' ' 11' ' ' SER . 15.1 tt0 -47.19 -53.23 13.64 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.667 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.3 m -55.39 -41.72 73.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.232 0.539 . . . . 0.0 110.908 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.657 ' O ' ' N ' ' A' ' 153' ' ' HIS . 22.0 t80 -60.8 -45.44 94.39 Favored 'General case' 0 C--O 1.194 -1.864 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.533 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 2.1 mm? -67.02 -42.95 84.06 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 120.653 1.57 . . . . 0.0 111.449 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -24.02 67.47 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.699 -0.625 . . . . 0.0 109.425 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -106.34 -13.17 15.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.842 0.83 . . . . 0.0 110.415 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.657 ' N ' ' O ' ' A' ' 149' ' ' TYR . 60.7 m80 -156.04 66.81 4.52 Favored Pre-proline 0 C--N 1.303 -1.436 0 C-N-CA 125.32 1.448 . . . . 0.0 110.173 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.86 -2.18 11.87 Favored 'Trans proline' 0 N--CA 1.48 0.708 0 C-N-CA 122.708 2.272 . . . . 0.0 111.154 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.644 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 9.1 m-20 -68.36 2.21 2.46 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.535 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -50.43 130.47 23.62 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 118.841 -2.412 . . . . 0.0 110.924 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 52.34 4.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.644 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 118.18 -0.915 . . . . 0.0 110.052 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -134.47 148.68 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.869 0.366 . . . . 0.0 111.329 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -98.0 109.99 22.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.682 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.799 ' HG1' ' CE1' ' A' ' 118' ' ' HIS . 74.6 m -95.76 140.09 31.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 0.0 110.796 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -141.5 132.04 25.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.132 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -103.02 137.02 41.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.128 0.489 . . . . 0.0 111.47 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -136.16 165.39 25.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.971 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -155.62 149.63 25.52 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -149.65 140.73 22.99 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.512 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.432 HG22 ' HG ' ' A' ' 107' ' ' CYS . 0.2 OUTLIER -96.08 147.83 23.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.874 0.368 . . . . 0.0 111.659 -179.143 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.4 p -140.0 155.74 46.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.446 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -95.93 22.51 7.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.838 0.351 . . . . 0.0 111.044 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.425 ' CD1' ' O ' ' A' ' 147' ' ' GLU . 2.3 mt -119.31 128.07 26.13 Favored Pre-proline 0 C--O 1.217 -0.616 0 CA-C-O 118.946 -0.55 . . . . 0.0 110.375 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -45.7 144.8 5.04 Favored 'Trans proline' 0 C--N 1.325 -0.666 0 C-N-CA 121.68 1.587 . . . . 0.0 110.935 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.13 -23.63 77.64 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 122.172 1.915 . . . . 0.0 112.693 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.453 ' OG ' ' NH1' ' A' ' 17' ' ' ARG . 10.2 t -70.35 -30.18 67.07 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.511 ' N ' ' NE ' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -79.16 -52.3 8.35 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 22' ' ' PHE . 4.3 mt -53.45 -44.75 69.15 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.261 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.441 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 48.7 t80 -49.83 -57.44 7.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.94 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.45 ' CG ' ' O ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -68.63 -27.64 66.2 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.815 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.43 ' CB ' HD12 ' A' ' 150' ' ' LEU . . . -82.95 -1.63 52.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.655 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.59 ' CE1' ' CE2' ' A' ' 143' ' ' PHE . 13.1 t80 -120.31 -7.66 9.75 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' A' ' 19' ' ' PHE . 2.5 m -129.71 -35.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.587 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 4.3 mp -89.49 -54.46 4.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.777 0.717 . . . . 0.0 111.626 -176.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.527 ' CB ' ' CZ ' ' A' ' 157' ' ' TYR . 0.1 OUTLIER -115.8 0.83 13.29 Favored 'General case' 0 C--O 1.199 -1.596 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.341 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.53 -41.87 6.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 119.518 1.053 . . . . 0.0 111.879 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.477 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 4.8 p30 -84.81 17.4 2.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.507 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 27' ' ' ASP . 11.6 m120 -139.68 -10.97 1.18 Allowed 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 125.562 1.545 . . . . 0.0 108.722 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.568 HD22 ' CG ' ' A' ' 149' ' ' TYR . 0.2 OUTLIER -95.07 -43.02 8.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 125.19 1.396 . . . . 0.0 108.334 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.472 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 55.7 mt -54.5 -51.17 80.6 Favored Pre-proline 0 C--O 1.215 -0.73 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.072 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 26.2 Cg_endo -61.96 -22.79 74.97 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 122.148 1.899 . . . . 0.0 111.855 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -68.82 -55.45 11.14 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.505 0.669 . . . . 0.0 111.564 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -94.63 -40.97 11.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.732 -177.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.593 ' HB3' ' CD2' ' A' ' 145' ' ' LEU . . . -110.8 71.13 0.69 Allowed Pre-proline 0 CA--C 1.506 -0.737 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.016 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.21 -6.87 15.73 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 N-CA-C 108.115 -1.533 . . . . 0.0 108.115 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -71.98 -34.82 69.22 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.799 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.55 -82.0 0.11 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.263 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.81 143.66 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.882 0.372 . . . . 0.0 110.353 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -79.33 -43.74 22.95 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.986 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.564 ' NE2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -177.39 165.17 2.19 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.564 ' N ' ' NE2' ' A' ' 40' ' ' GLN . . . -165.47 145.63 6.83 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.751 0.31 . . . . 0.0 110.951 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -136.75 142.76 43.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.74 0.305 . . . . 0.0 110.213 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.57 140.11 17.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.523 0.678 . . . . 0.0 110.472 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.503 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 7.1 mp -88.84 -39.64 13.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.877 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.519 ' O ' ' CG2' ' A' ' 52' ' ' THR . 22.9 mt-10 -142.96 134.09 25.81 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.867 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.86 -156.05 35.89 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.553 HD21 ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -137.54 -0.53 2.16 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.554 -0.38 . . . . 0.0 111.363 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.553 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 134.87 16.24 1.0 Allowed Glycine 0 C--O 1.223 -0.56 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.406 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -110.48 -173.32 20.19 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 117.525 0.662 . . . . 0.0 111.458 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -60.39 125.92 18.68 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 122.181 1.921 . . . . 0.0 113.172 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.7 2.7 58.51 Favored Glycine 0 N--CA 1.462 0.412 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 90.7 m -94.05 140.16 30.07 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.359 -0.921 . . . . 0.0 111.267 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mp -120.68 130.94 74.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.452 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -119.83 140.0 51.49 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.302 0.572 . . . . 0.0 111.02 179.231 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.653 ' HE3' ' HZ3' ' A' ' 68' ' ' LYS . 35.5 ttmt -118.21 124.75 48.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.609 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.562 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 1.4 mp -102.84 129.58 54.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.4 m -112.46 119.88 39.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.248 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -92.63 -174.93 3.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.008 0.432 . . . . 0.0 110.849 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.36 146.63 50.47 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 3.5 mp0 -59.1 -48.96 79.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.869 0.366 . . . . 0.0 110.617 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.92 61.27 3.41 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -138.4 175.62 9.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.248 0.547 . . . . 0.0 110.412 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.591 ' NE2' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -67.1 -53.56 29.72 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.14 156.26 18.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.953 0.406 . . . . 0.0 110.18 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.31 -58.77 0.22 Allowed Glycine 0 CA--C 1.52 0.348 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -143.83 155.02 43.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.168 0.509 . . . . 0.0 110.58 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.52 ' CG1' ' HE2' ' A' ' 69' ' ' HIS . 5.1 p -154.23 146.54 13.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.361 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.653 ' HZ3' ' HE3' ' A' ' 55' ' ' LYS . 14.6 mmtt -107.46 112.43 25.21 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.285 0.564 . . . . 0.0 112.491 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.52 ' HE2' ' CG1' ' A' ' 67' ' ' VAL . 8.8 m-70 -104.83 114.83 29.28 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -101.91 120.76 40.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.653 0.263 . . . . 0.0 111.17 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.0 mp -70.48 145.15 13.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.617 ' C ' ' HG ' ' A' ' 73' ' ' SER . 10.5 t0 -102.02 -55.64 2.45 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.123 -0.36 . . . . 0.0 111.83 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.617 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 43.9 m -165.93 141.02 4.75 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.5 mt -124.53 130.99 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.922 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 79' ' ' TYR . 12.7 m-20 -115.16 87.67 2.71 Favored 'General case' 0 C--O 1.206 -1.213 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.486 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -54.72 -32.39 59.54 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.45 -38.55 66.48 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.43 ' OG ' ' NZ ' ' A' ' 103' ' ' LYS . 1.0 OUTLIER -108.06 -10.78 15.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.055 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.2 m-85 62.58 47.29 5.01 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.45 -0.781 . . . . 0.0 110.341 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.2 p -105.8 144.54 32.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.415 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.633 ' CE2' ' CD2' ' A' ' 83' ' ' TYR . 29.5 t80 -132.2 118.41 19.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.052 0.453 . . . . 0.0 110.712 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.6 p -127.12 130.44 49.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.748 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.633 ' CD2' ' CE2' ' A' ' 81' ' ' TYR . 12.9 p90 -144.8 164.63 30.47 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -140.1 137.01 34.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.329 0.585 . . . . 0.0 110.987 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.409 HD21 ' CE1' ' A' ' 69' ' ' HIS . 0.2 OUTLIER -79.75 118.65 21.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.479 ' CG1' ' N ' ' A' ' 87' ' ' GLU . 2.7 pt -87.27 -45.01 16.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.479 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 35.4 tt0 -152.65 171.76 17.68 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.85 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.611 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.87 177.46 17.87 Favored Glycine 0 CA--C 1.51 -0.245 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -62.16 2.05 0.27 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.611 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -66.01 -33.02 74.84 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 124.754 1.221 . . . . 0.0 110.608 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.604 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -109.75 16.14 22.27 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 123.439 0.695 . . . . 0.0 109.624 -178.08 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.509 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 53.4 p 45.85 -126.49 1.31 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -130.38 -12.99 3.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.96 0.41 . . . . 0.0 111.176 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.9 p -105.17 -6.74 19.56 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.425 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 59.0 mt -98.6 153.01 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 CA-C-O 122.004 0.907 . . . . 0.0 113.256 -176.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.441 ' CG ' ' N ' ' A' ' 97' ' ' LYS . 19.9 pt-20 -99.88 -46.11 5.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.377 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.441 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -172.62 146.83 1.73 Allowed 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 121.723 0.773 . . . . 0.0 112.415 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.14 123.47 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.402 ' HG ' ' CB ' ' A' ' 118' ' ' HIS . 0.1 OUTLIER -102.94 145.08 30.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.138 0.494 . . . . 0.0 111.369 -179.07 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.514 ' CD2' ' O ' ' A' ' 116' ' ' ILE . 0.4 OUTLIER -141.79 129.5 21.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.576 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -128.12 134.6 49.14 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.06 131.82 25.76 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.905 -0.497 . . . . 0.0 109.96 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.43 ' NZ ' ' OG ' ' A' ' 78' ' ' SER . 17.5 ttmm -125.62 134.15 51.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.123 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.615 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -99.9 125.97 45.96 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.116 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -126.2 137.26 58.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.795 -178.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.69 132.73 44.06 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.41 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 111' ' ' SER . 24.2 p -121.4 171.6 8.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.866 0.365 . . . . 0.0 110.293 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.94 -30.77 46.27 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.8 m -85.4 -16.81 38.55 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.379 -2.248 . . . . 0.0 114.352 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.74 -85.57 0.13 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.078 1.799 . . . . 0.0 109.858 -171.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.449 ' N ' ' SG ' ' A' ' 107' ' ' CYS . 0.3 OUTLIER -160.12 129.13 5.0 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.87 1.668 . . . . 0.0 110.921 -178.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 105' ' ' VAL . 33.1 m -99.43 117.8 34.64 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 55.5 mt -91.96 128.81 43.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.766 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -105.89 117.08 33.1 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.88 118.18 34.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.415 0.626 . . . . 0.0 111.556 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.642 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -99.31 135.03 36.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 123.773 0.829 . . . . 0.0 109.915 -178.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.9 136.86 46.91 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.799 ' CE1' ' HG1' ' A' ' 4' ' ' THR . 47.8 m-70 -136.09 97.81 3.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 120.999 0.428 . . . . 0.0 110.801 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.447 ' CD2' ' N ' ' A' ' 119' ' ' TYR . 3.6 m-30 -84.31 101.65 12.1 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.83 -0.434 . . . . 0.0 109.83 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -94.83 102.67 14.53 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.43 HG23 ' CA ' ' A' ' 126' ' ' GLU . 11.9 p -101.31 171.32 7.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.482 0.658 . . . . 0.0 111.421 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -112.35 143.0 44.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.508 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 50.38 -109.71 0.74 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -106.85 -6.51 17.62 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.649 -0.324 . . . . 0.0 111.478 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.421 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.4 mp -47.5 151.42 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.199 0.524 . . . . 0.0 109.751 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.43 ' CA ' HG23 ' A' ' 121' ' ' THR . 12.9 pt-20 -148.18 147.75 29.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.84 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.9 mm -88.19 127.67 41.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -73.76 159.88 32.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.614 0.721 . . . . 0.0 111.684 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.578 ' HB3' ' HZ1' ' A' ' 133' ' ' LYS . 70.0 mm-40 -70.15 -37.89 75.34 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.531 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.69 -26.58 68.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.877 0.37 . . . . 0.0 110.231 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -72.78 -49.23 32.03 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.161 0.505 . . . . 0.0 111.062 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 m -78.25 -28.99 15.08 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.121 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.578 ' HZ1' ' HB3' ' A' ' 129' ' ' GLU . 46.0 mttp -67.23 -46.2 74.5 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 122.004 -0.435 . . . . 0.0 110.746 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 25.8 m -70.42 -42.4 78.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.771 0.32 . . . . 0.0 110.679 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.86 -46.16 54.24 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -66.74 -48.43 69.18 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.568 -0.372 . . . . 0.0 110.911 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -56.03 -47.77 77.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.097 0.475 . . . . 0.0 110.126 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -64.7 -53.85 40.86 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.36 -46.8 37.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.352 0.596 . . . . 0.0 110.564 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -55.37 -37.44 67.55 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.99 -42.25 98.26 Favored Glycine 0 C--O 1.223 -0.532 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -66.49 -32.71 74.24 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 122.243 -0.563 . . . . 0.0 109.943 -179.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.59 ' CE2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -71.48 -20.03 62.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.224 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -72.6 -48.22 41.44 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.294 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.593 ' CD2' ' HB3' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -73.57 -44.33 57.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.165 -179.294 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.515 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 31.2 mt -52.57 -50.51 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.425 ' O ' ' CD1' ' A' ' 13' ' ' ILE . 27.1 tt0 -47.87 -49.43 29.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.1 t -51.74 -46.85 64.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.483 0.659 . . . . 0.0 110.959 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.607 ' O ' ' N ' ' A' ' 153' ' ' HIS . 12.2 t80 -58.55 -43.79 89.43 Favored 'General case' 0 C--O 1.199 -1.582 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.515 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 1.6 mm? -67.91 -43.23 79.7 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 119.675 1.125 . . . . 0.0 111.983 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.9 -24.58 64.42 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.253 -0.904 . . . . 0.0 108.953 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -105.73 -13.81 15.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.331 0.586 . . . . 0.0 110.575 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.607 ' N ' ' O ' ' A' ' 149' ' ' TYR . 0.3 OUTLIER -155.65 66.5 4.63 Favored Pre-proline 0 C--N 1.313 -0.982 0 C-N-CA 124.738 1.215 . . . . 0.0 110.47 -178.583 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.466 ' CD ' ' O ' ' A' ' 150' ' ' LEU . 9.7 Cg_endo -77.47 -8.58 17.26 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 C-N-CA 122.719 2.28 . . . . 0.0 111.743 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.546 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 14.0 t70 -89.94 6.54 41.6 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.388 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.473 ' C ' ' CG ' ' A' ' 157' ' ' TYR . . . -72.34 132.18 43.64 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 120.296 -1.503 . . . . 0.0 110.274 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.527 ' CZ ' ' CB ' ' A' ' 25' ' ' ASP . 1.7 m-85 64.95 9.12 5.15 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.794 176.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.546 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.747 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.816 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.9 p -134.7 148.82 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 O-C-N 122.477 -0.426 . . . . 0.0 110.789 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.28 109.78 22.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.694 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.791 ' HG1' ' CE1' ' A' ' 118' ' ' HIS . 61.3 m -96.88 140.01 32.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.802 0.334 . . . . 0.0 111.028 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.88 125.34 16.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.98 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.467 ' C ' ' ND2' ' A' ' 7' ' ' ASN . 0.9 OUTLIER -103.27 130.24 50.46 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.716 0.293 . . . . 0.0 111.429 -179.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.467 ' ND2' ' C ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -131.43 171.34 13.5 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -155.76 155.63 33.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -154.63 140.0 17.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.343 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 m -93.91 146.27 24.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.817 0.341 . . . . 0.0 111.583 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 p -135.15 154.32 51.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.398 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -97.41 26.92 4.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.084 0.468 . . . . 0.0 110.498 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.435 HD13 ' N ' ' A' ' 151' ' ' LYS . 2.2 mt -119.05 125.41 27.67 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.444 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -46.13 147.32 3.76 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 121.826 1.684 . . . . 0.0 111.522 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -59.56 -24.53 75.48 Favored 'Trans proline' 0 N--CA 1.482 0.812 0 C-N-CA 121.983 1.789 . . . . 0.0 112.212 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.47 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 67.1 m -68.13 -34.19 75.9 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -77.8 -56.09 4.79 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 121.395 -0.816 . . . . 0.0 109.272 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 mt -52.47 -43.05 64.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.226 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -54.87 -54.42 42.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 16' ' ' SER . 0.3 OUTLIER -70.89 -25.75 62.92 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.086 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.406 ' CB ' HD12 ' A' ' 150' ' ' LEU . . . -83.06 -2.04 54.31 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.524 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.542 ' CE2' ' CE2' ' A' ' 143' ' ' PHE . 2.8 m-85 -117.31 -7.87 11.15 Favored 'General case' 0 C--N 1.335 -0.035 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.7 m -134.89 -34.75 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.607 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 2.7 mp -88.88 -55.34 3.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.871 1.214 . . . . 0.0 111.443 -176.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.506 ' CG ' ' CE2' ' A' ' 157' ' ' TYR . 0.9 OUTLIER -114.76 -1.32 13.28 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.726 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.405 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . -45.77 -40.71 9.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.696 0.76 . . . . 0.0 111.57 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.493 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER -85.07 18.04 2.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.077 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 27' ' ' ASP . 9.8 m120 -139.53 -9.06 1.25 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 126.087 1.755 . . . . 0.0 108.683 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.491 HD23 ' CD1' ' A' ' 149' ' ' TYR . 0.1 OUTLIER -95.19 -40.99 9.3 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 124.737 1.215 . . . . 0.0 109.939 -179.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.514 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 80.6 mt -55.16 -42.17 94.51 Favored Pre-proline 0 C--O 1.21 -0.985 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.182 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 21.2 Cg_exo -63.79 -26.69 67.83 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 122.098 1.866 . . . . 0.0 112.039 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 tmtp? -71.01 -51.37 25.84 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 122.027 0.918 . . . . 0.0 111.858 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.477 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 0.5 OUTLIER -94.57 -35.23 6.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.008 -176.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.438 ' N ' ' HG ' ' A' ' 145' ' ' LEU . . . -105.48 65.04 0.14 Allowed Pre-proline 0 C--N 1.322 -0.606 0 C-N-CA 122.966 0.507 . . . . 0.0 111.89 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.401 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 73.2 Cg_endo -74.88 -23.05 14.44 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 N-CA-C 107.707 -1.69 . . . . 0.0 107.707 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -73.9 -43.51 58.2 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.315 -1.312 . . . . 0.0 109.231 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.525 ' C ' ' HZ3' ' A' ' 138' ' ' LYS . . . -73.78 -82.72 0.05 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.766 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.5 mt -100.5 145.84 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.083 0.468 . . . . 0.0 110.471 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -77.8 -54.99 5.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.787 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.402 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -174.21 166.4 4.13 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.099 0.476 . . . . 0.0 110.342 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.402 ' H ' ' HG2' ' A' ' 40' ' ' GLN . . . -166.25 144.25 5.47 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.475 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.417 ' N ' ' HE3' ' A' ' 54' ' ' LYS . 8.4 pt-20 -135.93 146.62 47.51 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.46 139.83 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.404 0.621 . . . . 0.0 110.695 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 8.1 mp -88.63 -39.93 13.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.142 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.504 ' O ' ' CG2' ' A' ' 52' ' ' THR . 47.1 mt-10 -142.33 133.98 26.78 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.942 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.39 -156.02 27.69 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.688 HD21 ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -142.45 -6.37 0.92 Allowed 'General case' 0 C--N 1.32 -0.684 0 O-C-N 122.355 -0.497 . . . . 0.0 111.177 -179.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.688 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 143.27 14.12 0.31 Allowed Glycine 0 C--O 1.221 -0.708 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.56 -172.61 19.99 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 117.493 0.647 . . . . 0.0 111.988 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -62.13 126.4 18.59 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 123.113 2.542 . . . . 0.0 113.432 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.44 5.8 57.78 Favored Glycine 0 CA--C 1.505 -0.549 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.504 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 84.3 m -93.37 137.45 32.67 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.339 -0.931 . . . . 0.0 111.128 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.21 129.37 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HE3' ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -116.21 139.06 50.74 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.206 0.526 . . . . 0.0 110.844 179.163 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -118.99 127.11 53.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.704 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.575 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 1.3 mp -98.98 131.98 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.9 m -105.88 118.84 37.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.349 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -98.65 175.46 5.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 110.782 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.61 145.06 49.68 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -59.31 -53.04 62.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.917 0.389 . . . . 0.0 110.736 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.11 61.73 3.29 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.3 m -140.56 175.03 9.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.36 . . . . 0.0 110.826 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -60.47 -56.12 25.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.976 0.417 . . . . 0.0 110.637 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -93.93 155.9 16.91 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.196 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -125.22 -59.78 0.17 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.38 154.17 45.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.091 0.472 . . . . 0.0 110.483 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.541 ' CG1' ' HE2' ' A' ' 69' ' ' HIS . 5.0 p -156.67 147.35 11.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.351 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -107.12 112.42 25.32 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.452 0.644 . . . . 0.0 112.389 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.541 ' HE2' ' CG1' ' A' ' 67' ' ' VAL . 8.0 m170 -101.9 120.58 40.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -102.92 115.79 31.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.629 0.252 . . . . 0.0 111.335 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.8 mt -70.0 135.97 27.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.705 ' CG ' ' HG1' ' A' ' 84' ' ' THR . 1.7 m-20 -96.94 -56.34 2.59 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.583 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 69.4 m -166.08 142.42 5.04 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.9 mt -122.63 131.87 72.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.288 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.586 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -115.35 87.7 2.72 Favored 'General case' 0 C--O 1.206 -1.196 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.109 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.503 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -54.67 -30.96 56.96 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.26 -39.06 72.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.2 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.9 m -107.97 -10.35 15.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.188 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.586 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.1 m-85 62.33 45.17 6.85 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.487 -0.758 . . . . 0.0 110.199 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.8 t -106.56 148.39 28.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.273 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -132.02 125.67 32.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.727 0.299 . . . . 0.0 110.848 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.8 t -133.47 138.41 46.15 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.607 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -144.14 160.83 40.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.698 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.705 ' HG1' ' CG ' ' A' ' 72' ' ' ASP . 10.1 m -140.03 129.88 24.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.327 0.584 . . . . 0.0 111.027 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.2 mt -78.94 119.46 22.13 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 pt -88.32 -43.89 15.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.496 ' CD ' ' N ' ' A' ' 88' ' ' GLY . 8.3 tm-20 -158.89 173.28 16.76 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.222 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.631 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.74 178.51 18.41 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.42 2.55 0.15 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.631 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -70.79 -37.1 73.28 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 123.517 0.727 . . . . 0.0 110.19 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.635 ' C ' ' HG1' ' A' ' 92' ' ' THR . 0.3 OUTLIER -111.39 17.17 20.4 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.635 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 56.7 p 51.93 -132.67 1.91 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -131.64 -0.34 3.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.946 0.403 . . . . 0.0 112.0 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.03 -7.43 19.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.502 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 12.0 mt -99.36 151.67 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.502 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -88.51 -51.53 5.66 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.355 176.026 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.03 148.36 2.23 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.128 0.489 . . . . 0.0 112.182 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.455 ' CD1' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.22 130.4 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 176.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.4 147.0 44.86 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 122.957 0.503 . . . . 0.0 111.436 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -137.39 140.74 41.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.67 0.271 . . . . 0.0 110.916 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -128.04 134.99 49.27 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 121.015 0.436 . . . . 0.0 110.647 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.0 131.0 42.15 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -120.91 133.84 55.29 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.461 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.3 mm? -96.67 124.06 40.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.63 136.91 43.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.065 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.95 140.04 47.14 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.79 177.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 34.9 t -121.47 169.95 10.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.8 0.333 . . . . 0.0 110.444 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.451 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.96 -38.09 59.54 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.819 -0.513 . . . . 0.0 111.819 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.0 m -87.97 -9.9 52.11 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.335 1.054 . . . . 0.0 112.883 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.15 -86.51 0.12 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 126.095 1.807 . . . . 0.0 112.539 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.442 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 0.7 OUTLIER -157.58 129.54 7.07 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 127.517 2.327 . . . . 0.0 111.152 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.6 m -99.37 134.44 42.22 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.1 mt -108.87 129.82 62.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.476 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -106.09 116.68 32.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.4 t -110.47 122.75 48.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.145 0.498 . . . . 0.0 110.437 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.602 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -105.73 135.05 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.027 -177.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.8 p -101.5 140.94 35.1 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.791 ' CE1' ' HG1' ' A' ' 4' ' ' THR . 0.1 OUTLIER -136.14 92.66 2.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.202 0.525 . . . . 0.0 109.909 -179.344 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -90.01 101.36 14.07 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.34 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.466 ' CD2' ' OE2' ' A' ' 96' ' ' GLU . 1.8 t-160 -91.44 103.81 16.4 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.33 160.29 16.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.544 -178.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -112.8 142.84 44.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.229 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.0 -110.39 1.12 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.47 -2.95 11.92 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.769 -0.254 . . . . 0.0 110.675 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.6 tp -48.93 162.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 120.959 0.409 . . . . 0.0 110.862 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -148.41 149.97 32.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.132 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.3 mm -86.82 125.09 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -74.77 162.98 28.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.33 0.586 . . . . 0.0 111.104 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -68.95 -45.54 70.49 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.477 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -60.95 -24.8 66.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.641 0.257 . . . . 0.0 110.645 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.409 ' CD2' ' C ' ' A' ' 131' ' ' HIS . 9.6 t60 -73.04 -52.69 13.41 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.384 0.612 . . . . 0.0 110.989 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.412 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.0 m -76.7 -29.12 17.85 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.039 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.449 ' HB2' ' HZ3' ' A' ' 133' ' ' LYS . 3.7 ttmp? -67.27 -46.05 74.79 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.252 -0.28 . . . . 0.0 111.095 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 30.1 m -70.26 -42.65 78.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.746 0.308 . . . . 0.0 110.685 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.25 -43.75 62.16 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 29.5 ttmt -67.12 -46.49 73.97 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 122.739 -0.271 . . . . 0.0 110.864 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -54.9 -44.12 73.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.525 ' HZ3' ' C ' ' A' ' 37' ' ' ALA . 37.0 tttm -69.3 -56.18 8.3 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.875 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.94 -42.73 38.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.677 0.751 . . . . 0.0 110.746 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -64.13 -36.24 83.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.25 -37.12 92.51 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.416 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -68.05 -47.62 67.87 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.542 ' CE2' ' CE2' ' A' ' 22' ' ' PHE . 5.3 m-85 -59.32 -21.47 59.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -77.04 -38.34 52.95 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.316 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.477 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.9 -57.0 8.89 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.587 179.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.512 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 76.7 mt -53.9 -50.4 53.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.563 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -47.16 -55.02 9.25 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.019 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.7 t -52.94 -44.01 66.75 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.564 0.697 . . . . 0.0 111.392 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.621 ' O ' ' N ' ' A' ' 153' ' ' HIS . 15.4 t80 -58.83 -45.38 90.15 Favored 'General case' 0 C--O 1.195 -1.772 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.512 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 1.7 mm? -67.89 -41.77 82.23 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 119.944 1.247 . . . . 0.0 111.623 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.435 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -60.96 -24.3 65.98 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 121.17 -0.956 . . . . 0.0 108.665 179.45 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.506 ' OD1' ' CE1' ' A' ' 153' ' ' HIS . 33.4 t70 -106.15 -14.27 15.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.125 0.488 . . . . 0.0 110.916 178.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.621 ' N ' ' O ' ' A' ' 149' ' ' TYR . 39.8 m80 -156.19 66.83 4.45 Favored Pre-proline 0 C--N 1.31 -1.113 0 C-N-CA 125.214 1.406 . . . . 0.0 110.235 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.461 ' CD ' ' O ' ' A' ' 150' ' ' LEU . 59.6 Cg_endo -80.76 -4.77 12.97 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 122.7 2.267 . . . . 0.0 111.989 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.507 ' C ' ' ND2' ' A' ' 158' ' ' ASN . 5.3 m-20 -91.13 5.76 47.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.821 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.512 ' C ' HD22 ' A' ' 158' ' ' ASN . . . -72.91 131.36 42.11 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.356 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.506 ' CE2' ' CG ' ' A' ' 25' ' ' ASP . 1.5 m-85 64.38 8.93 4.55 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.778 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.512 HD22 ' C ' ' A' ' 156' ' ' ALA . 1.9 m-80 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.314 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.911 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.52 148.66 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 O-C-N 122.45 -0.441 . . . . 0.0 110.942 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -97.7 109.81 22.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.528 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.535 ' HG1' ' CE1' ' A' ' 118' ' ' HIS . 90.8 m -96.6 140.16 31.63 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.947 0.403 . . . . 0.0 110.942 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -143.9 132.08 21.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.005 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -102.2 136.99 41.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.967 0.413 . . . . 0.0 111.146 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.476 ' N ' HD21 ' A' ' 7' ' ' ASN . 0.8 OUTLIER -126.95 168.7 14.16 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.999 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.49 ' N ' ' CD ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -149.16 147.18 28.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.884 0.849 . . . . 0.0 111.73 -178.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.35 135.89 13.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.148 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -101.53 145.59 28.81 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 t -139.89 154.65 47.32 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.336 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -94.51 27.17 3.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.083 0.468 . . . . 0.0 110.908 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mt -113.03 125.76 29.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.558 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -46.68 143.35 9.0 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 121.622 1.548 . . . . 0.0 111.5 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -56.06 -26.17 58.13 Favored 'Trans proline' 0 N--CA 1.483 0.872 0 C-N-CA 122.221 1.947 . . . . 0.0 113.137 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.5 m -70.49 -31.05 68.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 154' ' ' PRO . 0.5 OUTLIER -76.16 -55.88 5.17 Favored 'General case' 0 CA--C 1.498 -1.044 0 O-C-N 121.413 -0.804 . . . . 0.0 108.879 -179.594 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 mt -53.71 -37.88 63.73 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.694 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -53.07 -59.21 4.83 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.48 -42.91 82.21 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 118.859 -1.136 . . . . 0.0 107.963 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 26' ' ' ALA . . . -63.69 -2.58 1.79 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.866 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -116.88 -9.83 11.11 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.7 m -133.49 -50.92 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.513 ' CD1' ' N ' ' A' ' 25' ' ' ASP . 1.9 pp -96.45 -31.5 12.79 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.513 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 6.6 t70 -114.66 -4.9 12.73 Favored 'General case' 0 C--O 1.211 -0.958 0 O-C-N 121.716 -0.615 . . . . 0.0 111.563 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 21' ' ' ALA . . . -66.48 -43.4 85.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.512 0.673 . . . . 0.0 111.809 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.444 ' HB2' ' HZ2' ' A' ' 54' ' ' LYS . 3.1 p30 -84.2 12.44 6.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.24 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -129.99 -9.35 4.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.428 HD23 ' CD2' ' A' ' 149' ' ' TYR . 0.4 OUTLIER -96.64 -34.27 11.46 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.877 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.2 mt -54.06 -56.0 30.54 Favored Pre-proline 0 C--O 1.217 -0.63 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.23 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.57 -24.84 78.6 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 121.979 1.786 . . . . 0.0 112.551 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -67.73 -57.48 6.28 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.856 0.836 . . . . 0.0 112.0 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.489 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 1.2 pt -95.2 -34.95 5.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.196 -176.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.41 ' CA ' ' HG ' ' A' ' 145' ' ' LEU . . . -105.23 64.45 0.13 Allowed Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.414 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 73.2 Cg_endo -76.33 -27.07 8.25 Favored 'Trans proline' 0 C--N 1.322 -0.858 0 C-N-CA 121.672 1.581 . . . . 0.0 108.18 175.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -73.61 -42.77 61.06 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.331 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.493 ' O ' ' NZ ' ' A' ' 138' ' ' LYS . . . -70.03 -79.89 0.06 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.217 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.2 mp -99.33 147.47 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 121.785 -0.572 . . . . 0.0 110.351 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -77.12 -53.21 8.05 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.297 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.56 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -176.96 166.87 2.49 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 110.613 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.56 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -165.61 145.09 6.45 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.246 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.479 ' N ' ' HZ1' ' A' ' 54' ' ' LYS . 10.9 pt-20 -142.35 144.67 33.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.049 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.435 ' N ' ' HE2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -77.38 139.92 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.404 0.621 . . . . 0.0 110.673 -179.243 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.11 -39.59 13.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.987 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.478 ' O ' ' CG2' ' A' ' 52' ' ' THR . 62.8 mt-10 -148.2 134.91 19.91 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.465 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.98 -156.35 23.61 Favored Glycine 0 CA--C 1.525 0.676 0 O-C-N 123.271 0.357 . . . . 0.0 112.232 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.628 HD21 ' N ' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -137.82 3.28 2.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.896 0.379 . . . . 0.0 111.076 -179.355 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.628 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 122.34 16.28 3.91 Favored Glycine 0 C--O 1.222 -0.65 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -178.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.3 -171.47 19.95 Favored Glycine 0 C--O 1.222 -0.606 0 CA-C-O 121.448 0.471 . . . . 0.0 111.926 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -61.66 125.14 16.01 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 122.514 2.143 . . . . 0.0 113.065 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.22 5.64 59.26 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.478 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 87.0 m -93.39 140.26 29.76 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.457 -0.871 . . . . 0.0 110.851 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.76 132.57 67.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.479 ' HZ1' ' N ' ' A' ' 42' ' ' GLU . 3.9 mmtt -115.34 138.54 50.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.557 0.694 . . . . 0.0 110.957 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -119.52 122.04 40.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.972 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.1 mp -105.49 135.0 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.235 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.0 m -113.26 119.39 37.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.391 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -96.14 -176.88 3.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 110.725 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.43 144.8 47.4 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.573 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 5.5 mp0 -59.63 -54.07 50.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.003 0.43 . . . . 0.0 110.491 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.86 61.2 3.44 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 p -139.25 175.32 9.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.821 0.343 . . . . 0.0 110.751 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -62.08 -52.05 65.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 110.682 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -98.27 142.05 30.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.162 0.506 . . . . 0.0 110.399 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.72 -55.2 0.27 Allowed Glycine 0 N--CA 1.461 0.366 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -135.7 151.31 50.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.935 0.398 . . . . 0.0 110.344 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -156.22 147.5 11.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.595 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -106.05 108.07 19.4 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.042 0.448 . . . . 0.0 112.052 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.522 ' C ' ' ND1' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -109.84 112.96 25.32 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.047 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -107.64 133.01 52.69 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.1 mp -70.0 140.02 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.675 ' CG ' ' HG1' ' A' ' 84' ' ' THR . 1.0 OUTLIER -97.43 -55.07 2.94 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.19 -0.319 . . . . 0.0 111.638 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.579 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 49.7 m -165.05 141.14 5.57 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.5 mt -127.05 131.05 71.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.962 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 79' ' ' TYR . 46.1 m-20 -115.4 88.41 2.87 Favored 'General case' 0 C--O 1.203 -1.364 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -54.93 -30.32 58.41 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.44 -38.26 74.15 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.173 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.459 ' OG ' ' NZ ' ' A' ' 103' ' ' LYS . 0.9 OUTLIER -107.69 -10.4 15.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.944 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.597 ' N ' ' O ' ' A' ' 75' ' ' ASP . 20.3 m-85 59.8 47.46 10.22 Favored 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.49 -0.756 . . . . 0.0 110.372 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.5 t -106.33 145.78 31.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.997 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.608 ' CE1' ' CD2' ' A' ' 83' ' ' TYR . 31.0 t80 -131.71 122.84 26.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.121 0.486 . . . . 0.0 110.888 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 p -131.86 139.04 48.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.268 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.608 ' CD2' ' CE1' ' A' ' 81' ' ' TYR . 10.7 p90 -148.04 162.5 39.23 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.675 ' HG1' ' CG ' ' A' ' 72' ' ' ASP . 3.9 m -139.46 140.69 37.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.322 0.582 . . . . 0.0 111.252 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.416 ' CD1' ' CB ' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -82.77 113.87 20.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.371 178.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.89 -42.63 16.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 2.8 tp10 -153.61 172.96 16.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.964 0.411 . . . . 0.0 110.937 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.63 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.24 177.2 17.65 Favored Glycine 0 CA--C 1.509 -0.315 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.29 2.38 0.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.63 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -65.85 -34.24 77.7 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 124.837 1.255 . . . . 0.0 110.696 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.617 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -109.4 12.76 24.49 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 123.271 0.628 . . . . 0.0 109.905 -177.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.545 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 65.4 p 45.49 -126.27 1.22 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -130.86 -12.47 3.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.961 0.41 . . . . 0.0 111.198 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 p -105.42 -5.62 20.21 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 80.1 mt -97.78 152.34 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 122.239 1.019 . . . . 0.0 113.711 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.439 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -89.34 -60.38 1.96 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.89 178.536 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -168.29 149.22 4.93 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.272 0.558 . . . . 0.0 111.111 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.422 ' CD1' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -123.19 125.53 72.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.36 144.44 43.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.194 0.521 . . . . 0.0 111.311 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -136.34 133.58 36.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.458 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -129.17 135.58 49.03 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-O 120.869 0.366 . . . . 0.0 111.14 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.37 132.12 40.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.459 ' NZ ' ' OG ' ' A' ' 78' ' ' SER . 44.0 tttp -119.88 138.61 53.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.65 0.262 . . . . 0.0 110.486 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.5 mm? -96.98 125.53 41.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.292 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.626 HG11 ' HZ3' ' A' ' 114' ' ' LYS . 1.3 m -137.82 130.31 41.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -74.0 135.5 43.14 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.062 -0.399 . . . . 0.0 110.761 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.5 m -121.82 170.93 9.29 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 122.551 0.341 . . . . 0.0 110.095 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.97 -34.03 51.39 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.8 m -82.99 -12.38 57.33 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.312 1.445 . . . . 0.0 114.671 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.0 -89.47 0.14 Allowed Glycine 0 CA--C 1.537 1.418 0 C-N-CA 126.246 1.879 . . . . 0.0 111.246 -169.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.2 p -161.76 131.86 4.84 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.752 1.621 . . . . 0.0 110.87 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 46.1 m -98.98 133.18 43.61 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.556 0.693 . . . . 0.0 109.138 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mt -105.21 129.38 58.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.359 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.626 ' HZ3' HG11 ' A' ' 105' ' ' VAL . 6.5 mttp -105.48 117.51 34.21 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.6 m -110.14 117.69 34.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.51 0.671 . . . . 0.0 110.647 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.642 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -98.59 135.53 33.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 123.635 0.774 . . . . 0.0 110.293 -177.73 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.5 m -103.0 141.1 36.38 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.81 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.535 ' CE1' ' HG1' ' A' ' 4' ' ' THR . 2.2 t60 -136.3 93.88 2.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 0.0 110.905 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -92.8 100.31 12.81 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.997 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -92.55 101.06 13.49 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.6 p -97.1 168.67 10.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.754 0.788 . . . . 0.0 112.033 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -112.35 152.69 28.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.03 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . 34.13 -108.91 0.05 OUTLIER Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.47 HD21 ' N ' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -105.76 -4.84 20.42 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.662 -0.317 . . . . 0.0 111.442 178.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.47 ' N ' HD21 ' A' ' 124' ' ' ASN . 1.4 mp -47.96 152.79 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -149.41 148.79 29.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.175 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.4 mm -87.62 124.77 41.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -75.31 159.53 31.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.301 0.572 . . . . 0.0 111.908 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -71.2 -35.41 71.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.938 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.448 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 8.0 pt-20 -67.87 -34.2 76.23 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.753 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -68.33 -49.04 63.09 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.154 0.502 . . . . 0.0 110.756 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.401 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 5.5 m -73.38 -22.34 19.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.805 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 57.4 mttt -66.92 -46.21 75.49 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 122.171 -0.33 . . . . 0.0 110.792 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.448 ' CG2' ' O ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -70.51 -44.94 76.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.667 0.27 . . . . 0.0 110.458 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.82 -47.01 69.38 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 0.1 OUTLIER -67.05 -47.01 72.65 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 122.485 -0.42 . . . . 0.0 110.316 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -54.04 -39.69 66.42 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.493 ' NZ ' ' O ' ' A' ' 37' ' ' ALA . 5.0 tttm -69.31 -53.83 17.65 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.12 -42.3 38.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.645 0.736 . . . . 0.0 110.251 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 51.4 t60 -64.09 -36.6 84.57 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.185 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.84 -41.73 99.31 Favored Glycine 0 C--O 1.222 -0.606 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.433 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -70.71 -40.3 72.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.511 ' CD2' ' O ' ' A' ' 143' ' ' PHE . 2.3 t80 -61.29 -28.17 69.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -69.32 -40.98 77.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.063 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.4 mm? -64.76 -56.74 11.75 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.722 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.525 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 85.1 mt -54.78 -51.07 55.65 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.991 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 8.8 tt0 -47.66 -57.33 5.63 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.212 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 58.2 m -52.49 -43.78 65.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.139 0.495 . . . . 0.0 111.065 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.616 ' O ' ' N ' ' A' ' 153' ' ' HIS . 56.7 t80 -55.31 -47.67 75.26 Favored 'General case' 0 C--O 1.2 -1.546 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 2.0 mm? -68.55 -43.02 77.52 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 119.836 1.198 . . . . 0.0 112.06 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 147' ' ' GLU . 0.4 OUTLIER -62.09 -24.05 66.88 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 121.375 -0.828 . . . . 0.0 109.267 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -107.17 -13.32 15.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.607 0.717 . . . . 0.0 110.585 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.616 ' N ' ' O ' ' A' ' 149' ' ' TYR . 1.1 t-80 -154.97 65.61 4.69 Favored Pre-proline 0 C--N 1.309 -1.159 0 C-N-CA 124.723 1.209 . . . . 0.0 109.883 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.524 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 53.0 Cg_endo -74.38 -3.47 13.89 Favored 'Trans proline' 0 C--O 1.204 -1.176 0 C-N-CA 122.698 2.266 . . . . 0.0 111.392 -177.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.606 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 1.0 OUTLIER -81.39 4.3 21.34 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 123.009 0.524 . . . . 0.0 112.032 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.46 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -50.07 130.17 21.9 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 119.877 -1.764 . . . . 0.0 111.381 -178.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 1.3 t80 54.48 6.32 0.11 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.476 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.606 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.414 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.237 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.862 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.02 147.93 29.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 O-C-N 122.37 -0.488 . . . . 0.0 111.105 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -99.28 111.52 23.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.617 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.4 m -96.32 139.99 31.64 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.632 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.539 ' CD1' ' ND2' ' A' ' 7' ' ' ASN . 57.0 t80 -136.84 134.14 36.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.612 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -103.33 128.83 50.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.0 0.429 . . . . 0.0 111.078 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.555 ' ND2' ' N ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -138.47 162.93 33.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.087 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.76 160.14 40.05 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.472 ' CE2' ' O ' ' A' ' 10' ' ' THR . 55.3 t80 -147.61 141.14 25.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.44 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.472 ' O ' ' CE2' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -93.14 148.63 21.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.726 0.298 . . . . 0.0 111.275 -179.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -143.91 154.35 43.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.775 0.321 . . . . 0.0 110.718 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -99.92 26.76 6.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.042 0.449 . . . . 0.0 110.634 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -113.74 131.6 22.99 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.317 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -48.89 141.24 22.0 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.148 1.232 . . . . 0.0 110.797 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.1 -23.57 73.93 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 122.365 2.043 . . . . 0.0 112.925 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.4 m -70.14 -30.56 67.76 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.3 mmt-85 -79.43 -54.38 5.98 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mt -48.57 -45.87 38.39 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -49.29 -57.79 6.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.22 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -67.37 -25.42 65.96 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.363 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.413 ' O ' ' CB ' ' A' ' 26' ' ' ALA . . . -84.02 -2.58 56.9 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.563 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.31 -10.94 10.66 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 117.917 0.326 . . . . 0.0 111.828 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.422 HG23 HD13 ' A' ' 24' ' ' LEU . 3.1 m -137.35 -34.61 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.579 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 2.4 mp -89.92 -53.47 4.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.824 0.738 . . . . 0.0 111.889 -176.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.412 ' O ' ' N ' ' A' ' 29' ' ' LEU . 93.8 m-20 -112.91 -4.01 14.01 Favored 'General case' 0 C--O 1.216 -0.659 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 21' ' ' ALA . . . -53.67 -43.88 69.21 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.474 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 2.0 m-20 -83.34 18.7 1.7 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.212 0.529 . . . . 0.0 110.712 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 27' ' ' ASP . 4.5 m120 -139.37 -8.8 1.28 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.451 HD21 ' CD1' ' A' ' 149' ' ' TYR . 0.8 OUTLIER -92.38 -30.31 15.86 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.156 -178.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.409 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.52 -54.53 47.6 Favored Pre-proline 0 C--O 1.214 -0.787 0 O-C-N 122.2 -0.313 . . . . 0.0 111.419 -179.534 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 18.3 Cg_endo -62.82 -25.52 74.59 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.894 1.729 . . . . 0.0 112.721 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -68.22 -59.74 2.99 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.836 0.827 . . . . 0.0 111.814 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.487 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 1.3 pt -95.95 -35.53 5.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.38 -176.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.437 ' N ' ' HG ' ' A' ' 145' ' ' LEU . . . -105.36 65.24 0.14 Allowed Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.55 -27.17 7.83 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 121.699 1.599 . . . . 0.0 108.474 175.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -74.2 -43.65 56.36 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.633 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.87 -78.6 0.09 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.099 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.8 mm -99.43 144.85 11.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 121.328 0.585 . . . . 0.0 110.017 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -78.42 -53.52 7.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.725 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -178.18 167.6 1.95 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.238 0.542 . . . . 0.0 110.597 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.89 143.87 5.72 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.88 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -140.84 143.86 35.0 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.544 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.2 137.25 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 121.646 0.736 . . . . 0.0 111.823 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.4 mp -87.11 -38.77 16.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.188 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.479 ' O ' ' CG2' ' A' ' 52' ' ' THR . 54.9 mt-10 -148.24 136.83 21.56 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.09 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.09 -155.28 21.85 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.567 HD21 ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -141.13 -5.6 1.11 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 122.894 0.477 . . . . 0.0 110.941 -178.4 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.567 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 131.96 10.84 2.17 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.06 -172.84 19.15 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 117.114 0.457 . . . . 0.0 111.977 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -60.13 127.1 22.04 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 C-N-CA 122.732 2.288 . . . . 0.0 113.356 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.86 2.97 55.13 Favored Glycine 0 CA--C 1.507 -0.439 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 88.8 m -94.3 134.76 36.44 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.265 -0.967 . . . . 0.0 111.368 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -122.67 122.3 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -131.99 151.39 51.77 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 122.83 1.3 . . . . 0.0 110.684 178.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.57 137.57 52.5 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.318 -1.764 . . . . 0.0 112.966 -177.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.9 mm -90.19 140.76 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 64.3 m -110.5 117.33 33.28 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -108.89 166.17 11.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.918 0.39 . . . . 0.0 110.82 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.0 144.44 49.5 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.24 -47.21 86.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.805 0.336 . . . . 0.0 110.785 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.71 61.42 3.47 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.7 m -142.91 178.37 7.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.831 0.348 . . . . 0.0 110.677 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -64.11 -50.43 68.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.923 0.392 . . . . 0.0 110.723 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.83 156.38 17.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.375 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -119.57 -61.41 0.26 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -145.37 155.04 42.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.825 0.345 . . . . 0.0 110.573 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.4 p -156.02 153.75 7.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.77 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -104.87 110.97 23.55 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.53 0.681 . . . . 0.0 111.631 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -103.32 113.51 27.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.84 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -105.75 131.54 52.98 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.022 0.439 . . . . 0.0 111.735 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.5 mt -85.42 145.26 8.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.373 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.531 ' C ' ' HG ' ' A' ' 73' ' ' SER . 52.2 t0 -102.55 -54.89 2.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.531 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 66.7 m -165.88 142.21 5.17 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 45.6 mt -123.05 130.62 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.355 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.2 m-20 -115.25 87.95 2.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.505 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -54.82 -30.29 56.92 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.509 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.85 -38.84 70.62 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.175 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.1 p -108.36 -11.09 15.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.117 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.53 ' N ' ' O ' ' A' ' 75' ' ' ASP . 6.6 m-85 63.17 40.89 8.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.877 -0.515 . . . . 0.0 109.925 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.499 ' C ' ' CD2' ' A' ' 81' ' ' TYR . 6.0 p -109.22 138.65 45.25 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.857 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.901 ' HH ' ' CD1' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -132.13 133.57 44.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.723 0.297 . . . . 0.0 110.375 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 p -127.29 129.76 48.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.878 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -144.15 158.71 43.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.217 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.7 m -147.65 141.85 26.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.119 0.485 . . . . 0.0 111.2 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.7 mt -80.6 120.63 24.8 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.475 ' CG1' ' N ' ' A' ' 87' ' ' GLU . 3.8 pt -80.58 -44.98 21.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.808 0.337 . . . . 0.0 111.836 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.475 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 23.5 tt0 -156.74 172.26 18.92 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.615 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.95 178.12 17.83 Favored Glycine 0 CA--C 1.508 -0.357 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -61.37 1.13 0.22 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.615 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -67.55 -34.3 76.8 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 123.948 0.899 . . . . 0.0 109.963 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.615 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.52 16.38 21.56 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.692 0.797 . . . . 0.0 109.583 -177.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.437 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 37.8 p 49.48 -126.45 2.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -177.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -130.75 -12.9 3.75 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.091 -0.381 . . . . 0.0 111.217 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.0 -6.62 19.88 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.405 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 68.5 mt -99.13 152.36 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -176.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.463 ' CD ' ' CE1' ' A' ' 120' ' ' HIS . 0.0 OUTLIER -90.32 -56.78 3.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.249 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -171.91 150.48 2.6 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.099 0.476 . . . . 0.0 110.867 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.52 125.08 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.473 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 0.7 OUTLIER -105.67 144.5 32.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.006 0.432 . . . . 0.0 112.054 -178.084 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.505 ' CZ ' ' OG ' ' A' ' 117' ' ' SER . 4.8 m-85 -140.2 128.21 22.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.531 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -129.32 133.6 47.52 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.5 OUTLIER -135.55 131.49 36.03 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.9 -0.5 . . . . 0.0 110.45 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.458 ' HZ2' ' HB3' ' A' ' 103' ' ' LYS . 7.1 ttpm? -123.16 134.77 54.16 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.901 ' CD1' ' HH ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -98.53 126.53 44.13 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -125.59 137.14 58.64 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.572 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.62 133.88 44.88 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.873 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 7.1 t -121.22 175.2 6.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.128 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.66 -37.28 67.61 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.2 m -87.32 -6.15 58.62 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.793 1.296 . . . . 0.0 114.327 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 152.91 -88.48 0.13 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.671 1.129 . . . . 0.0 111.808 -174.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 85.5 p -161.98 131.91 4.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.547 1.939 . . . . 0.0 110.715 177.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.2 m -99.17 119.15 37.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.7 mt -91.13 128.95 42.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.36 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 102' ' ' THR . 4.1 mttm -105.45 117.17 33.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.6 m -110.84 121.21 44.78 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 121.459 0.647 . . . . 0.0 111.119 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.674 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -101.9 136.4 34.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 123.457 0.703 . . . . 0.0 109.571 -177.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.505 ' OG ' ' CZ ' ' A' ' 100' ' ' TYR . 23.7 t -118.29 132.36 56.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.651 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.473 ' ND1' ' O ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -137.28 113.71 10.14 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.505 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.676 ' CD2' ' N ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -102.41 102.53 12.87 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.448 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.463 ' CE1' ' CD ' ' A' ' 96' ' ' GLU . 11.6 t-160 -92.0 109.47 20.82 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.233 0.539 . . . . 0.0 110.246 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.6 p -99.65 172.52 7.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.611 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -112.2 143.53 43.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.871 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 54.94 -112.79 3.07 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.439 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.9 OUTLIER -112.9 -1.89 14.46 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.342 -0.504 . . . . 0.0 111.171 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -43.5 160.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.048 0.451 . . . . 0.0 110.614 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.481 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 92.8 mt-10 -148.21 144.28 27.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.038 0.447 . . . . 0.0 111.177 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.9 mm -89.1 125.29 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -74.68 161.18 29.9 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.669 0.747 . . . . 0.0 111.837 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -70.29 -32.14 69.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.418 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.429 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 43.3 mm-40 -70.12 -33.57 71.99 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.746 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -67.33 -51.26 54.6 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.33 0.586 . . . . 0.0 110.629 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.5 m -71.93 -21.53 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.79 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -66.45 -46.56 76.01 Favored 'General case' 0 C--O 1.223 -0.328 0 O-C-N 122.276 -0.265 . . . . 0.0 110.892 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -70.38 -51.15 40.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.726 0.298 . . . . 0.0 110.5 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.78 -47.05 93.14 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -67.96 -47.44 68.63 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 122.616 -0.343 . . . . 0.0 110.916 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -55.32 -47.06 76.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.78 0.324 . . . . 0.0 110.549 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -69.37 -50.2 48.34 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.31 -41.97 39.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.535 0.683 . . . . 0.0 110.528 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -36.4 84.22 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -61.64 -31.17 76.9 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.42 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.4 ' N ' HD21 ' A' ' 142' ' ' LEU . 0.2 OUTLIER -74.18 -47.18 37.34 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.27 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.491 ' CD2' ' N ' ' A' ' 143' ' ' PHE . 1.6 m-30 -59.89 -21.88 61.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -72.52 -41.82 65.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.85 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.487 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.44 -56.53 11.94 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.893 179.3 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.535 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 76.9 mt -53.24 -50.33 47.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.495 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -47.06 -57.02 5.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.751 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.5 t -50.35 -44.95 54.72 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.469 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.651 ' O ' ' N ' ' A' ' 153' ' ' HIS . 20.0 t80 -57.33 -48.77 78.13 Favored 'General case' 0 C--O 1.18 -2.581 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 1.7 mm? -65.1 -42.15 94.27 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 120.449 -1.407 . . . . 0.0 111.974 -177.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.435 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.5 OUTLIER -62.59 -25.25 67.98 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.407 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -107.26 -12.24 15.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.016 0.436 . . . . 0.0 110.687 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.651 ' N ' ' O ' ' A' ' 149' ' ' TYR . 49.5 m-70 -155.54 66.32 4.63 Favored Pre-proline 0 C--N 1.308 -1.215 0 C-N-CA 125.616 1.566 . . . . 0.0 110.411 -177.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.13 -3.27 12.97 Favored 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 122.662 2.241 . . . . 0.0 111.843 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.616 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 1.5 p30 -77.1 3.07 13.34 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.073 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.532 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . . . -50.51 128.79 20.97 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 119.328 -2.108 . . . . 0.0 111.352 -178.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 157' ' ' TYR . 16.5 t80 54.71 7.04 0.14 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.275 0.63 . . . . 0.0 112.137 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.616 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.278 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.92 148.79 29.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 O-C-N 122.364 -0.492 . . . . 0.0 110.988 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -97.77 110.29 22.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.721 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.7 m -96.97 140.45 31.49 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.577 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.95 134.7 26.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.368 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -102.4 129.69 48.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.582 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -126.71 168.67 14.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.172 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.13 146.98 22.04 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -145.64 140.71 27.52 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.302 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -107.49 147.93 29.85 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 111.804 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.5 t -145.87 162.73 37.07 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.548 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -98.77 24.92 7.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.406 . . . . 0.0 110.931 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mt -108.57 127.69 26.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.2 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.418 ' HB2' ' HE ' ' A' ' 17' ' ' ARG . 38.4 Cg_exo -46.98 144.69 8.06 Favored 'Trans proline' 0 C--N 1.327 -0.571 0 C-N-CA 121.16 1.24 . . . . 0.0 110.743 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -61.02 -24.51 79.72 Favored 'Trans proline' 0 C--N 1.322 -0.843 0 C-N-CA 122.337 2.025 . . . . 0.0 113.031 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.2 m -71.01 -30.3 66.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.418 ' HE ' ' HB2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -75.05 -56.41 4.77 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 22' ' ' PHE . 3.7 mt -51.18 -45.0 61.65 Favored 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.485 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -46.44 -58.96 3.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.427 ' CD ' ' O ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -68.28 -41.56 80.83 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 119.023 -1.071 . . . . 0.0 108.484 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.01 -2.47 2.72 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.236 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 18' ' ' LEU . 2.6 t80 -119.14 -8.71 10.12 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.8 m -131.88 -51.27 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.517 ' CD1' ' N ' ' A' ' 25' ' ' ASP . 1.7 pp -96.4 -31.28 12.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.517 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 45.5 m-20 -114.63 -5.09 12.74 Favored 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 118.439 0.563 . . . . 0.0 111.506 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . -68.56 -44.05 75.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.453 0.644 . . . . 0.0 112.289 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.46 18.15 2.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.882 0.849 . . . . 0.0 109.648 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 26' ' ' ALA . 64.9 m-20 -139.55 -8.31 1.27 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.578 -1.192 . . . . 0.0 107.843 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -96.21 -48.37 5.66 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.0 -178.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.525 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 85.2 mt -54.54 -43.22 97.8 Favored Pre-proline 0 C--O 1.212 -0.916 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.146 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 16.6 Cg_exo -64.46 -25.58 63.1 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.785 1.657 . . . . 0.0 110.97 177.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.02 -57.93 4.42 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.712 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.468 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 0.7 OUTLIER -96.54 -32.66 4.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.779 -176.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 30' ' ' ILE . . . -103.83 63.22 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.447 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 72.6 Cg_endo -75.57 -20.97 15.28 Favored 'Trans proline' 0 C--N 1.32 -0.924 0 N-CA-C 107.063 -1.937 . . . . 0.0 107.063 174.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -73.42 -44.02 59.23 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.76 177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.75 -75.02 0.16 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.266 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.9 mt -98.73 145.9 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 121.046 0.45 . . . . 0.0 110.204 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.83 -51.65 10.14 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.672 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.643 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 50.7 tp60 -177.3 164.62 2.18 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.958 0.409 . . . . 0.0 110.424 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.677 ' CB ' ' HZ1' ' A' ' 54' ' ' LYS . . . -166.02 145.21 6.06 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 120.89 0.376 . . . . 0.0 110.889 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -145.09 145.25 31.35 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.52 139.88 18.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.57 0.7 . . . . 0.0 110.995 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 mp -89.68 -39.27 13.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.963 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.467 ' O ' ' CG2' ' A' ' 52' ' ' THR . 30.2 mt-10 -147.19 136.66 22.75 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.542 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.39 -156.06 22.52 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.529 HD21 ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -142.5 1.48 1.37 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 122.456 -0.437 . . . . 0.0 111.343 -178.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.529 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 127.27 12.27 3.18 Favored Glycine 0 C--O 1.218 -0.864 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.45 -171.68 19.89 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 117.298 0.549 . . . . 0.0 111.905 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -61.86 125.94 17.74 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 C-N-CA 122.68 2.253 . . . . 0.0 113.028 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.76 5.07 56.76 Favored Glycine 0 N--CA 1.464 0.537 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.467 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 91.4 m -93.66 137.91 32.43 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.379 -0.911 . . . . 0.0 110.959 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.55 130.14 72.91 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.677 ' HZ1' ' CB ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -114.52 140.0 49.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.608 0.718 . . . . 0.0 110.761 179.144 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -118.37 123.15 44.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.7 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.524 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 1.8 mp -104.32 123.75 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.6 m -101.42 118.43 36.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.075 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -92.72 -176.74 4.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.72 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.429 ' O ' ' OG ' ' A' ' 62' ' ' SER . . . -71.64 144.45 37.02 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.99 -47.94 84.12 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.991 -0.711 . . . . 0.0 111.073 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.92 61.93 3.34 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 59' ' ' GLY . 0.3 OUTLIER -152.37 174.97 13.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.171 0.51 . . . . 0.0 110.383 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.621 ' NE2' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -65.09 -37.57 87.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.818 0.342 . . . . 0.0 110.603 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -98.76 140.38 33.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.378 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.415 ' O ' ' CD2' ' A' ' 66' ' ' TYR . . . -123.12 -56.2 0.19 Allowed Glycine 0 N--CA 1.461 0.363 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.415 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -145.82 151.35 37.77 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.772 0.32 . . . . 0.0 110.193 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 p -156.71 147.51 11.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.931 0.396 . . . . 0.0 110.945 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -104.81 108.06 19.35 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.298 0.57 . . . . 0.0 110.954 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.531 ' NE2' ' CD2' ' A' ' 83' ' ' TYR . 7.9 t60 -103.06 112.42 25.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.631 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -101.6 131.22 47.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 111.824 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.0 mt -83.08 137.23 21.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.572 ' C ' ' HG ' ' A' ' 73' ' ' SER . 33.9 t70 -96.71 -56.35 2.61 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.572 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 69.2 m -166.01 142.31 5.07 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.402 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 30.2 mt -123.93 131.15 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.885 176.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.587 ' O ' ' N ' ' A' ' 79' ' ' TYR . 27.1 m-20 -115.53 87.74 2.73 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.487 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 6.6 pt-20 -54.57 -30.12 53.33 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.08 73.52 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.6 m -108.2 -9.82 15.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.007 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.587 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.3 m-85 62.63 48.28 4.42 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 121.393 -0.817 . . . . 0.0 110.236 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -106.66 143.76 34.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.346 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.527 ' CE1' ' CD1' ' A' ' 83' ' ' TYR . 26.3 t80 -132.16 117.94 18.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.683 0.278 . . . . 0.0 110.253 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -127.5 137.65 52.71 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.112 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.531 ' CD2' ' NE2' ' A' ' 69' ' ' HIS . 12.5 p90 -146.11 163.86 33.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.069 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -146.57 135.68 22.59 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.05 0.452 . . . . 0.0 110.821 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mt -79.76 116.55 19.99 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.76 -41.78 17.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.829 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.468 ' CG ' ' H ' ' A' ' 88' ' ' GLY . 32.7 tt0 -153.8 171.52 18.79 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.09 -0.381 . . . . 0.0 110.586 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.637 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.19 177.54 18.71 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.78 2.1 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.637 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -66.09 -34.4 77.97 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.107 0.963 . . . . 0.0 110.239 177.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.609 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.26 14.7 22.68 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 123.543 0.737 . . . . 0.0 109.608 -177.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.582 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 68.8 p 46.96 -126.24 1.58 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -130.35 -11.14 4.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.106 0.479 . . . . 0.0 110.913 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.3 -7.55 18.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.441 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 90.7 mt -98.74 152.51 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 121.941 0.877 . . . . 0.0 113.259 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.441 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -90.86 -55.23 3.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.343 177.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.43 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 2.5 ptmm? -172.79 149.82 2.03 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.782 0.325 . . . . 0.0 110.84 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.29 125.42 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.34 144.49 43.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.925 0.393 . . . . 0.0 111.665 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -136.82 136.37 38.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.705 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -131.15 132.41 44.75 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.13 133.98 32.22 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.962 -0.461 . . . . 0.0 110.945 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -121.26 134.64 55.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -97.62 126.01 42.69 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.358 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.95 136.99 58.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.03 135.37 44.89 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.751 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.55 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 53.8 t -120.92 171.13 8.86 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.55 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -54.25 -35.7 55.77 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.3 p -89.69 -8.48 52.28 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.327 -1.69 . . . . 0.0 114.694 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 159.32 -85.44 0.12 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.069 1.318 . . . . 0.0 111.958 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 87.9 p -163.79 132.1 3.66 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.888 1.675 . . . . 0.0 110.961 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 78.8 m -99.28 118.24 35.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 61.9 mt -92.38 128.24 44.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.842 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -105.42 116.68 32.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.0 t -111.62 124.85 53.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.276 0.56 . . . . 0.0 111.101 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.67 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -106.04 136.43 40.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 123.25 0.62 . . . . 0.0 109.749 -177.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.1 m -113.18 133.09 55.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.982 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -137.08 105.35 5.72 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 120.83 0.348 . . . . 0.0 110.405 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER -101.69 103.39 14.17 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.081 -0.387 . . . . 0.0 110.045 179.201 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -90.91 107.88 19.49 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.226 0.536 . . . . 0.0 109.879 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.2 p -99.38 176.01 5.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.602 0.715 . . . . 0.0 111.442 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -112.31 146.12 38.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.432 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 54.21 -111.69 2.17 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.55 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -117.67 3.68 12.34 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.345 -0.503 . . . . 0.0 111.01 -179.575 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.463 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -45.85 160.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.941 0.4 . . . . 0.0 110.43 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.463 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 36.5 mt-10 -149.39 148.51 29.55 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.916 0.388 . . . . 0.0 111.267 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.5 mm -89.3 125.38 42.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.46 ' HG3' ' H ' ' A' ' 129' ' ' GLU . 18.6 tptt -74.45 160.33 31.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.157 0.503 . . . . 0.0 111.56 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.46 ' H ' ' HG3' ' A' ' 128' ' ' LYS . 49.8 mt-10 -70.09 -34.05 72.67 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.488 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.468 ' OE2' ' N ' ' A' ' 130' ' ' GLU . 1.8 mp0 -69.9 -27.79 65.09 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.461 ' NE2' ' CG2' ' A' ' 92' ' ' THR . 10.2 t-80 -72.89 -48.1 40.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.313 0.577 . . . . 0.0 110.87 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.8 m -79.76 -32.06 14.1 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.98 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -64.19 -46.18 85.1 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.216 -0.302 . . . . 0.0 110.721 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.424 ' CG2' ' N ' ' A' ' 135' ' ' GLY . 25.8 m -70.26 -47.71 65.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.62 0.248 . . . . 0.0 110.453 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.424 ' N ' ' CG2' ' A' ' 134' ' ' VAL . . . -62.73 -41.44 99.84 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -66.84 -46.25 75.68 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.751 -0.264 . . . . 0.0 110.684 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -54.28 -47.08 72.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 110.059 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 141' ' ' GLY . 22.8 tttp -64.58 -54.88 25.07 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.46 -40.78 27.47 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.698 0.761 . . . . 0.0 110.467 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.452 ' O ' ' ND1' ' A' ' 140' ' ' HIS . 0.6 OUTLIER -61.51 -36.49 80.67 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.958 0.885 . . . . 0.0 109.203 178.31 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' LYS . . . -62.68 -35.55 92.04 Favored Glycine 0 C--O 1.223 -0.54 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.455 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -66.9 -45.8 76.86 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.996 -0.708 . . . . 0.0 109.116 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -59.0 -30.1 67.73 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -64.83 -39.54 93.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.418 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.468 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.1 mm? -68.12 -56.99 6.81 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.174 0.511 . . . . 0.0 110.263 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.521 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 61.1 mt -57.91 -51.89 64.94 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.977 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -48.2 -56.84 6.91 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.814 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.7 t -51.75 -42.96 62.74 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.421 0.629 . . . . 0.0 110.141 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.641 ' O ' ' N ' ' A' ' 153' ' ' HIS . 8.6 t80 -55.69 -51.94 65.56 Favored 'General case' 0 C--O 1.178 -2.678 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 2.0 mm? -64.38 -43.02 95.8 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.239 -1.538 . . . . 0.0 111.883 -177.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.428 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -62.65 -24.33 67.56 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.531 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 149' ' ' TYR . 0.0 OUTLIER -106.98 -13.27 15.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.15 0.5 . . . . 0.0 110.657 178.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.641 ' N ' ' O ' ' A' ' 149' ' ' TYR . 42.7 m80 -155.39 66.31 4.7 Favored Pre-proline 0 C--N 1.305 -1.365 0 C-N-CA 125.944 1.697 . . . . 0.0 110.275 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.74 -3.35 13.59 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 122.7 2.267 . . . . 0.0 111.582 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.645 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 5.4 p30 -77.96 4.07 13.05 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.433 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -50.13 129.08 20.46 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 119.038 -2.289 . . . . 0.0 111.343 -178.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.507 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 36.9 t80 53.5 6.32 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.203 0.525 . . . . 0.0 112.219 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.645 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.091 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.884 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.79 147.72 29.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 O-C-N 122.494 -0.415 . . . . 0.0 111.163 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -98.33 110.23 22.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.321 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.798 ' HG1' ' CE1' ' A' ' 118' ' ' HIS . 68.8 m -96.13 134.3 39.37 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.794 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -133.55 131.05 39.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -102.97 126.7 50.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.881 0.372 . . . . 0.0 110.945 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -135.63 167.3 21.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.968 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -156.14 159.24 38.85 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -146.21 140.87 26.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.219 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.4 m -109.41 147.41 32.84 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.937 0.398 . . . . 0.0 111.831 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.659 ' HG ' ' CD ' ' A' ' 147' ' ' GLU . 8.4 t -145.68 154.76 42.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.432 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -87.86 25.44 1.53 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.124 0.488 . . . . 0.0 110.982 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -108.55 126.84 28.63 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.651 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -46.08 148.38 2.98 Favored 'Trans proline' 0 C--N 1.325 -0.675 0 C-N-CA 121.161 1.241 . . . . 0.0 110.857 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HA ' HD12 ' A' ' 18' ' ' LEU . 18.1 Cg_endo -64.86 -24.35 61.26 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 122.553 2.169 . . . . 0.0 112.915 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.3 m -70.51 -29.64 66.2 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -56.63 4.49 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 15' ' ' PRO . 3.2 mt -48.38 -48.84 36.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.494 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 40.2 t80 -44.66 -60.0 2.22 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.704 178.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -24.89 62.48 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.213 -0.93 . . . . 0.0 110.787 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.45 -14.37 58.96 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.808 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.45 -6.52 11.72 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 19' ' ' PHE . 3.0 m -129.99 -36.7 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 2.9 mp -92.55 -53.96 3.98 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.19 0.904 . . . . 0.0 112.206 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.82 16.42 20.45 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.516 ' O ' ' CD1' ' A' ' 30' ' ' ILE . . . -66.08 -43.2 88.05 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 121.062 0.458 . . . . 0.0 111.128 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.456 ' HB2' ' HZ2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -83.04 21.17 1.09 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.073 0.939 . . . . 0.0 110.501 -179.148 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -139.46 -8.85 1.27 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.434 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -94.43 -38.21 11.06 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.418 -1.719 . . . . 0.0 111.004 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.538 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.4 mm -55.38 -44.25 99.54 Favored Pre-proline 0 C--O 1.21 -0.986 0 CA-C-O 120.954 0.407 . . . . 0.0 111.928 -178.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 22.9 Cg_exo -63.1 -25.85 73.21 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.409 2.073 . . . . 0.0 113.304 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -83.28 -55.62 4.23 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.099 0.476 . . . . 0.0 112.27 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.459 ' O ' ' CD1' ' A' ' 145' ' ' LEU . 0.8 OUTLIER -95.09 -38.31 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.54 -177.06 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.516 ' CA ' ' HG ' ' A' ' 145' ' ' LEU . . . -108.38 61.36 0.24 Allowed Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -79.23 -28.94 3.41 Favored 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 121.812 1.675 . . . . 0.0 109.19 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -74.98 -42.58 57.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.258 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.07 -74.89 0.12 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.282 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.27 146.36 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.858 0.361 . . . . 0.0 110.071 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -78.12 -50.23 12.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.211 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.664 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 54.8 tp60 -176.36 165.74 2.75 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.918 0.389 . . . . 0.0 110.469 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.664 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -165.51 147.85 7.64 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.232 0.539 . . . . 0.0 110.583 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.75 ' N ' ' HZ1' ' A' ' 54' ' ' LYS . 23.2 pt-20 -148.09 140.88 24.68 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.099 -0.375 . . . . 0.0 110.764 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.72 140.29 17.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.391 0.615 . . . . 0.0 110.415 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.69 -40.01 13.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.173 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.53 ' O ' ' CG2' ' A' ' 52' ' ' THR . 21.0 mt-10 -140.98 133.84 29.0 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.749 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.21 -156.68 36.0 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.532 HD21 ' N ' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -136.38 -7.38 1.99 Allowed 'General case' 0 C--N 1.321 -0.642 0 O-C-N 122.535 -0.391 . . . . 0.0 111.108 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.532 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 142.71 14.89 0.33 Allowed Glycine 0 C--O 1.22 -0.747 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.68 -170.76 20.3 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 117.236 0.518 . . . . 0.0 111.929 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -61.57 125.8 17.6 Favored 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 122.787 2.325 . . . . 0.0 113.373 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.22 6.01 59.08 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 60.0 m -93.81 140.52 29.57 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.147 -1.027 . . . . 0.0 111.45 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -121.9 129.76 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.75 ' HZ1' ' N ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -114.48 138.3 50.77 Favored 'General case' 0 C--O 1.22 -0.449 0 O-C-N 123.288 0.368 . . . . 0.0 110.689 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -120.6 125.75 48.55 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.148 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -103.47 140.63 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.263 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.5 m -118.83 119.65 35.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.518 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -92.5 -178.59 4.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.902 0.382 . . . . 0.0 110.685 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.26 143.81 29.77 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.466 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 9.1 pt-20 -59.73 -46.57 88.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 0.0 110.864 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.466 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -100.65 61.67 0.62 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 t -138.04 177.06 8.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.025 0.44 . . . . 0.0 110.79 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -60.98 -54.19 48.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 110.842 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.55 151.9 20.54 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.73 -61.72 0.22 Allowed Glycine 0 CA--C 1.52 0.349 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.405 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 5.0 m-85 -145.6 151.33 37.93 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.811 0.338 . . . . 0.0 110.892 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 p -149.24 138.3 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.852 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.423 ' O ' HG13 ' A' ' 86' ' ' ILE . 10.1 mtpp -107.38 116.5 32.04 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 121.623 0.725 . . . . 0.0 112.187 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.646 ' N ' ' ND1' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -112.9 123.58 50.64 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.361 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -98.82 126.61 44.52 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.149 0.499 . . . . 0.0 111.532 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.457 HG12 ' HH ' ' A' ' 81' ' ' TYR . 33.9 mt -79.94 136.09 24.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.374 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.657 ' C ' ' HG ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -97.27 -55.78 2.74 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -177.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.657 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 3.3 m -165.29 141.77 5.57 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.405 ' CD1' ' O ' ' A' ' 48' ' ' GLY . 12.6 mt -120.69 131.1 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.483 176.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 79' ' ' TYR . 54.7 m-20 -114.42 88.26 2.82 Favored 'General case' 0 C--O 1.206 -1.205 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 177.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.447 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 19.6 mt-10 -54.61 -30.54 55.08 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.89 -39.46 71.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.159 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.4 m -108.41 -10.07 15.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.109 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.579 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.5 m-85 62.13 46.96 5.94 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 121.502 -0.749 . . . . 0.0 110.083 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.7 p -105.76 149.23 26.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.076 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.563 ' CE1' ' CD1' ' A' ' 83' ' ' TYR . 39.5 t80 -142.38 118.65 10.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.39 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.4 p -128.89 128.44 43.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.594 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.563 ' CD1' ' CE1' ' A' ' 81' ' ' TYR . 19.7 p90 -145.32 162.35 37.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.872 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.68 143.19 37.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.004 0.431 . . . . 0.0 111.161 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.9 mt -83.81 121.98 28.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.879 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 68' ' ' LYS . 2.5 pp -84.87 -41.4 15.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.309 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.496 ' CG ' ' H ' ' A' ' 88' ' ' GLY . 16.2 tt0 -156.6 172.31 18.79 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.176 -0.327 . . . . 0.0 110.569 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.581 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.82 177.45 17.29 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -61.52 1.98 0.2 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 122.415 1.102 . . . . 0.0 108.466 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.581 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -68.08 -34.61 76.74 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.174 0.989 . . . . 0.0 110.386 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.608 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.59 15.57 21.98 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.298 0.639 . . . . 0.0 110.263 -177.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.487 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 63.3 p 43.16 -126.47 0.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.507 -178.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -130.73 -13.07 3.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.966 0.412 . . . . 0.0 111.187 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 p -104.7 -5.8 20.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.924 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.424 HG22 ' CD1' ' A' ' 98' ' ' ILE . 69.3 mt -98.66 152.27 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-O 121.918 0.866 . . . . 0.0 113.038 -176.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.434 ' CG ' ' N ' ' A' ' 97' ' ' LYS . 17.3 pt-20 -99.97 -45.51 5.66 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.349 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HZ3' ' HB2' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -172.72 145.9 1.56 Allowed 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 121.655 0.74 . . . . 0.0 112.224 -179.562 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.424 ' CD1' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.94 124.35 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.701 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.479 ' HG ' ' CB ' ' A' ' 118' ' ' HIS . 0.1 OUTLIER -104.39 144.72 31.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.973 0.416 . . . . 0.0 111.774 -178.588 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -139.05 127.99 23.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -129.02 134.5 48.15 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.04 131.51 26.96 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.782 -0.574 . . . . 0.0 110.084 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -123.0 134.04 54.34 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.19 132.77 43.42 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -134.41 137.76 50.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.104 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.77 135.6 45.31 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.452 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.411 ' N ' ' HA ' ' A' ' 111' ' ' SER . 7.9 t -121.16 170.2 9.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.842 0.353 . . . . 0.0 110.176 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.75 -31.51 46.06 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 112.033 -0.427 . . . . 0.0 112.033 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.8 m -88.16 -11.74 45.99 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 119.559 -2.142 . . . . 0.0 115.827 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.02 -89.47 0.12 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.88 1.229 . . . . 0.0 110.478 -169.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.411 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 92.0 p -163.74 130.33 3.24 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.077 1.351 . . . . 0.0 110.928 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 105' ' ' VAL . 34.4 m -99.91 118.38 36.22 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 51.3 mt -92.21 132.08 37.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.167 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -105.78 116.64 32.29 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.1 t -111.07 118.32 35.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.282 0.563 . . . . 0.0 110.826 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.655 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -100.42 135.6 35.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 123.337 0.655 . . . . 0.0 109.818 -177.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.9 p -108.96 135.4 50.2 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.49 -0.777 . . . . 0.0 108.918 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.798 ' CE1' ' HG1' ' A' ' 4' ' ' THR . 31.6 m-70 -135.72 93.99 3.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 120.922 0.392 . . . . 0.0 110.627 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -83.24 101.8 11.49 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.174 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -96.59 104.32 16.3 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.9 p -101.56 176.19 5.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.403 0.62 . . . . 0.0 111.618 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.405 ' HZ3' ' HB2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -111.99 157.58 20.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.68 179.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 42.26 -109.98 0.22 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -116.29 5.66 13.65 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.819 -0.224 . . . . 0.0 110.968 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -49.01 159.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.117 0.484 . . . . 0.0 110.41 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.467 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 40.3 mt-10 -148.5 145.8 28.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.961 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.8 mm -88.88 124.53 41.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp -74.97 161.64 29.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.502 0.667 . . . . 0.0 111.77 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -70.48 -34.18 72.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.642 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.416 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 6.2 pt-20 -69.02 -30.83 69.29 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.647 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -67.99 -53.97 22.03 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.383 0.611 . . . . 0.0 110.363 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.91 -19.63 22.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.407 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 137' ' ' GLU . 52.4 tttm -66.85 -46.69 74.27 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 122.295 -0.253 . . . . 0.0 110.704 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -69.17 -46.52 77.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.762 0.315 . . . . 0.0 110.404 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.28 -47.41 71.76 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -67.95 -46.48 71.33 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.566 -0.373 . . . . 0.0 111.055 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 21.0 tp10 -54.36 -46.73 73.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.021 0.439 . . . . 0.0 110.363 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.468 ' O ' ' CD2' ' A' ' 142' ' ' LEU . 10.3 ttmt -69.21 -52.75 24.73 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.78 -46.81 41.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.395 0.617 . . . . 0.0 110.55 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -62.08 -36.98 83.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.96 -52.54 51.66 Favored Glycine 0 C--O 1.225 -0.435 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.468 ' CD2' ' O ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -60.01 -42.51 94.47 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 122.096 -0.65 . . . . 0.0 109.366 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -59.15 -30.02 67.85 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.494 ' C ' ' HZ3' ' A' ' 144' ' ' LYS . 0.3 OUTLIER -76.88 -34.61 57.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.12 178.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.516 ' HG ' ' CA ' ' A' ' 34' ' ' ALA . 1.7 mm? -70.43 -53.89 14.58 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.073 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.486 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 7.3 mt -54.58 -49.19 68.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.659 ' CD ' ' HG ' ' A' ' 11' ' ' SER . 19.3 tt0 -46.38 -53.77 10.34 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.4 t -52.29 -42.25 63.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.307 0.575 . . . . 0.0 110.992 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.604 ' O ' ' N ' ' A' ' 153' ' ' HIS . 0.3 OUTLIER -58.14 -44.67 87.94 Favored 'General case' 0 C--O 1.2 -1.542 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.486 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 2.1 mm? -66.87 -43.56 83.24 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 119.328 0.967 . . . . 0.0 112.073 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.72 -25.1 66.2 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.58 -13.19 15.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.148 0.499 . . . . 0.0 110.362 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.604 ' N ' ' O ' ' A' ' 149' ' ' TYR . 22.5 t60 -153.9 67.21 5.82 Favored Pre-proline 0 C--N 1.312 -1.05 0 C-N-CA 124.354 1.062 . . . . 0.0 110.688 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.99 -3.28 11.18 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 122.409 2.073 . . . . 0.0 111.521 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.619 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.1 OUTLIER -80.95 3.36 23.15 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.918 -178.6 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.431 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -49.55 129.95 19.83 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 119.453 -2.029 . . . . 0.0 111.237 -178.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.414 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 10.9 t80 54.3 7.1 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.205 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.619 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.366 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.66 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.97 148.38 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.568 -0.372 . . . . 0.0 111.141 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -98.52 110.84 23.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.32 177.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 m -96.53 139.85 32.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.788 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -140.53 134.03 30.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.18 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.444 ' C ' HD21 ' A' ' 7' ' ' ASN . 8.2 mt-10 -102.79 128.81 49.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.071 0.462 . . . . 0.0 110.964 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -128.19 165.5 20.32 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -178.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -156.38 151.42 26.29 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -142.7 140.81 31.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.088 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -107.06 145.81 31.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.844 0.354 . . . . 0.0 111.687 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.544 ' HG ' ' CD ' ' A' ' 147' ' ' GLU . 4.6 t -146.14 154.53 41.89 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.822 0.344 . . . . 0.0 110.688 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -90.94 24.5 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.112 0.482 . . . . 0.0 110.691 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.408 HD13 ' N ' ' A' ' 151' ' ' LYS . 1.9 mt -107.59 128.02 26.7 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.359 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -46.1 143.78 7.05 Favored 'Trans proline' 0 C--N 1.326 -0.617 0 C-N-CA 121.308 1.339 . . . . 0.0 110.994 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -61.1 -23.58 77.59 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.45 2.1 . . . . 0.0 113.108 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.442 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . 66.0 m -70.43 -31.54 68.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -76.62 -56.41 4.64 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 mt -50.67 -43.06 57.33 Favored 'General case' 0 C--O 1.212 -0.905 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -47.67 -58.3 4.45 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.932 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.495 ' HA ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.85 -41.09 75.35 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.12 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.6 -2.55 1.71 Allowed 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.33 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.614 ' CE1' ' CE2' ' A' ' 143' ' ' PHE . 6.6 t80 -119.23 -9.24 9.99 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.4 m -134.67 -46.22 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.589 ' H ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -99.19 -32.01 11.44 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 120.607 1.548 . . . . 0.0 112.422 -178.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.14 -5.12 14.26 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 118.437 0.562 . . . . 0.0 111.645 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . -67.49 -42.53 82.74 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.28 0.562 . . . . 0.0 111.657 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -82.91 18.94 1.47 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.991 0.901 . . . . 0.0 109.906 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 26' ' ' ALA . 67.7 m-80 -139.27 -9.08 1.29 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.425 HD22 ' CD2' ' A' ' 149' ' ' TYR . 1.2 mt -94.12 -31.42 14.18 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.923 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.414 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.76 -53.97 54.66 Favored Pre-proline 0 C--O 1.214 -0.764 0 O-C-N 122.175 -0.328 . . . . 0.0 111.266 -179.321 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 22.8 Cg_endo -63.08 -24.92 73.28 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 121.908 1.739 . . . . 0.0 112.468 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -69.66 -60.41 2.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.73 0.776 . . . . 0.0 111.972 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.48 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 1.4 pt -95.91 -35.68 5.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.349 -176.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.428 ' CA ' ' HG ' ' A' ' 145' ' ' LEU . . . -105.37 65.03 0.14 Allowed Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.31 -28.07 7.43 Favored 'Trans proline' 0 C--N 1.32 -0.93 0 C-N-CA 121.638 1.559 . . . . 0.0 108.276 174.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -73.91 -43.59 57.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.317 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.52 -74.02 0.17 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.801 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mp -101.74 144.21 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 121.264 0.554 . . . . 0.0 109.818 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.9 ttpt -78.86 -62.16 1.78 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.603 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.713 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 57.2 tp60 -164.5 165.69 21.1 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.922 0.391 . . . . 0.0 110.012 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.713 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -165.93 149.44 7.73 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.06 0.457 . . . . 0.0 111.181 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -150.17 142.79 24.54 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.075 -179.351 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.469 ' N ' ' OE1' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -76.96 141.34 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-O 122.015 0.912 . . . . 0.0 111.212 178.564 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.504 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 4.0 mp -88.36 -40.57 13.46 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.481 ' O ' ' CG2' ' A' ' 52' ' ' THR . 32.6 mt-10 -149.12 134.18 18.15 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.457 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.64 -156.38 23.14 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.416 ' ND2' ' N ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -134.19 -1.59 2.91 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.451 -0.44 . . . . 0.0 111.509 -178.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.86 18.36 2.65 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.48 -172.9 19.48 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -60.55 125.31 17.0 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 122.094 1.862 . . . . 0.0 112.96 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.5 -0.32 56.86 Favored Glycine 0 N--CA 1.462 0.428 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.481 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 99.1 m -93.91 136.95 33.66 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 114.377 -0.912 . . . . 0.0 111.229 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mp -113.95 132.35 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.508 ' HZ2' ' HB2' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -122.7 138.54 54.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.899 0.381 . . . . 0.0 110.522 179.082 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -119.9 130.2 54.73 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.098 -0.376 . . . . 0.0 110.906 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.485 HG12 ' HZ1' ' A' ' 54' ' ' LYS . 1.6 mm -95.93 140.8 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.795 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.7 m -108.71 117.75 35.01 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 59' ' ' GLY . 5.8 t80 -104.22 172.12 6.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 0.0 110.961 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.453 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -57.55 144.43 40.63 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -60.3 -67.45 0.39 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.899 0.38 . . . . 0.0 111.242 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.46 61.96 3.15 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 t -137.75 -172.47 3.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.882 0.373 . . . . 0.0 110.664 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -58.69 -55.28 37.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.638 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -99.67 155.66 17.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.599 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.22 -59.36 0.13 Allowed Glycine 0 CA--C 1.52 0.363 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -145.5 149.2 34.2 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.937 0.399 . . . . 0.0 110.674 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.579 ' CG1' ' HE2' ' A' ' 69' ' ' HIS . 4.3 p -156.9 143.72 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.721 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 36.2 mttp -106.63 112.51 25.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.338 0.59 . . . . 0.0 112.069 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.579 ' HE2' ' CG1' ' A' ' 67' ' ' VAL . 11.3 m-70 -101.3 123.47 45.46 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -106.57 119.32 38.99 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.027 -0.421 . . . . 0.0 111.5 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.0 mp -70.35 145.23 13.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -105.56 -54.88 2.41 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.7 144.4 6.11 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 45.3 mt -127.14 125.88 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.162 173.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 79' ' ' TYR . 13.4 m-20 -113.91 88.81 2.93 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.506 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 13.7 mt-10 -54.47 -30.36 52.83 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.68 70.04 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.006 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.93 -11.42 15.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.122 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.7 m-85 62.23 42.7 9.18 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.597 -0.689 . . . . 0.0 110.259 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.4 t -106.86 141.75 37.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.127 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -132.09 118.71 19.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.8 t -128.53 135.19 49.07 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.136 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -144.82 159.83 42.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.493 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -138.26 139.48 39.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.228 0.537 . . . . 0.0 110.821 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.445 ' CD2' ' CE1' ' A' ' 69' ' ' HIS . 8.7 mt -80.17 115.55 19.79 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 pt -80.79 -44.24 21.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.676 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -152.02 172.11 16.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.863 0.363 . . . . 0.0 110.745 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.19 177.12 18.72 Favored Glycine 0 C--O 1.238 0.377 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -61.52 -0.34 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 122.204 1.002 . . . . 0.0 108.442 178.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.612 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -62.46 -34.36 76.67 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.816 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.588 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.16 14.83 22.74 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 123.61 0.764 . . . . 0.0 110.198 -177.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.561 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 61.6 p 46.42 -126.5 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -130.66 -12.86 3.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.649 0.738 . . . . 0.0 111.068 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.455 ' HG1' ' CG1' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -104.76 -6.34 20.42 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.015 0.526 . . . . 0.0 112.108 -177.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 71.4 mt -98.77 152.6 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.712 0 CA-C-O 121.997 0.903 . . . . 0.0 113.347 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.408 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -91.4 -57.33 2.81 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.167 177.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.404 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 28.2 pttt -171.93 151.16 2.7 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.027 0.442 . . . . 0.0 110.584 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.56 124.15 71.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.481 ' HG ' ' HB2' ' A' ' 118' ' ' HIS . 0.1 OUTLIER -103.13 144.49 31.24 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 122.844 0.458 . . . . 0.0 111.896 -178.338 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.445 ' CZ ' ' OG ' ' A' ' 117' ' ' SER . 0.4 OUTLIER -139.13 127.93 23.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.5 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -133.57 132.86 41.38 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -133.43 136.32 45.12 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 122.208 -0.307 . . . . 0.0 110.425 -178.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -120.58 133.69 55.36 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -98.54 130.75 45.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.943 0.401 . . . . 0.0 110.003 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -132.62 137.24 54.55 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.063 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.01 135.71 44.96 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.649 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.402 ' N ' ' HA ' ' A' ' 111' ' ' SER . 13.2 t -121.25 168.82 11.2 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 122.593 0.357 . . . . 0.0 110.201 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.8 -29.81 42.71 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 112.233 -0.347 . . . . 0.0 112.233 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.6 p -92.06 -11.66 35.24 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 119.849 -1.971 . . . . 0.0 114.389 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.84 -86.14 0.12 Allowed Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.47 1.509 . . . . 0.0 112.066 -175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.402 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 88.4 p -164.54 130.97 2.97 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 125.86 1.664 . . . . 0.0 110.688 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.4 m -99.64 118.35 35.99 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.4 mt -91.83 131.23 39.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.118 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 102' ' ' THR . 8.9 mtpt -105.47 117.12 33.2 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.9 p -110.16 118.64 36.9 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.368 0.604 . . . . 0.0 111.047 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.684 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -99.89 136.91 29.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 123.536 0.734 . . . . 0.0 109.641 -177.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.445 ' OG ' ' CZ ' ' A' ' 100' ' ' TYR . 6.8 m -118.26 131.72 56.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.477 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.481 ' HB2' ' HG ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -138.2 112.26 8.51 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.657 ' CD2' ' N ' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -102.83 103.77 13.98 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.211 -0.306 . . . . 0.0 110.441 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -90.58 107.24 19.04 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.207 0.527 . . . . 0.0 110.01 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.4 p -98.88 176.73 5.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.47 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -109.49 159.58 16.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.628 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 39.63 -109.77 0.13 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.464 -0.655 . . . . 0.0 111.464 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -116.04 3.66 13.62 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 122.702 -0.293 . . . . 0.0 111.069 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.483 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -45.58 160.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.316 0.579 . . . . 0.0 110.393 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.483 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 43.4 tt0 -149.49 145.66 26.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.212 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.0 mm -88.95 125.52 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -74.74 161.66 29.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.499 0.666 . . . . 0.0 111.53 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.599 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 1.0 OUTLIER -69.71 -47.55 62.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.192 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.457 ' N ' ' OE1' ' A' ' 130' ' ' GLU . 0.3 OUTLIER -59.81 -24.68 64.35 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.118 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -72.95 -51.34 18.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.259 0.552 . . . . 0.0 111.256 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 m -77.31 -27.1 15.76 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.934 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.4 tttm -67.28 -45.91 75.21 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.275 -0.266 . . . . 0.0 110.9 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 34.5 m -69.18 -45.38 79.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.886 0.375 . . . . 0.0 110.344 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.21 -41.76 96.69 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -67.14 -45.67 76.42 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 120.494 0.188 . . . . 0.0 110.691 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -53.96 -42.53 69.02 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.447 ' O ' ' CD2' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -69.48 -53.4 19.38 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.582 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.31 -41.73 39.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.583 0.706 . . . . 0.0 110.628 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -67.04 -36.34 81.86 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.93 -36.71 91.04 Favored Glycine 0 C--O 1.223 -0.576 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.447 ' CD2' ' O ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -73.31 -41.59 63.36 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.614 ' CE2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -59.87 -23.06 63.12 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.436 ' HZ2' ' C ' ' A' ' 144' ' ' LYS . 1.2 ttpp -76.01 -40.17 54.17 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.259 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.48 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.5 mm? -67.21 -55.85 12.34 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.31 0.576 . . . . 0.0 109.624 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.542 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 60.6 mt -53.48 -50.92 46.35 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.358 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.544 ' CD ' ' HG ' ' A' ' 11' ' ' SER . 15.4 tt0 -47.51 -54.27 12.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.983 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.8 t -53.45 -42.65 67.37 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.117 0.484 . . . . 0.0 111.494 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.634 ' O ' ' N ' ' A' ' 153' ' ' HIS . 19.2 t80 -60.27 -44.72 95.07 Favored 'General case' 0 C--O 1.199 -1.553 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.542 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 1.8 mm? -68.99 -42.55 76.34 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 119.993 1.27 . . . . 0.0 111.629 -178.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.408 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -62.79 -24.39 67.71 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 121.483 -0.761 . . . . 0.0 109.207 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -106.2 -13.15 15.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.566 0.698 . . . . 0.0 110.641 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 149' ' ' TYR . 16.9 t-80 -155.22 66.33 4.79 Favored Pre-proline 0 C--N 1.312 -1.063 0 C-N-CA 124.818 1.247 . . . . 0.0 110.181 -178.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.4 ' CD ' ' O ' ' A' ' 150' ' ' LEU . 43.1 Cg_endo -72.86 -4.01 14.61 Favored 'Trans proline' 0 N--CA 1.48 0.702 0 C-N-CA 122.472 2.115 . . . . 0.0 111.921 -178.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.621 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 3.8 p30 -82.51 3.48 28.24 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.07 0.948 . . . . 0.0 111.756 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.464 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -49.54 131.1 21.08 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 119.599 -1.938 . . . . 0.0 111.25 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.514 ' CG ' ' O ' ' A' ' 157' ' ' TYR . 80.9 t80 56.16 6.04 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.621 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.595 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.31 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.9 p -134.65 148.35 29.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 O-C-N 122.585 -0.362 . . . . 0.0 110.961 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -97.46 110.36 22.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.298 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.974 ' HG1' ' CD2' ' A' ' 118' ' ' HIS . 96.9 m -96.03 132.36 41.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.758 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.17 128.36 37.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.976 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -102.7 133.66 47.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.742 0.306 . . . . 0.0 110.705 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -126.37 170.87 11.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.472 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.96 149.37 27.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.309 0.576 . . . . 0.0 111.976 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -155.43 141.02 17.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.12 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.593 HG22 ' HG ' ' A' ' 107' ' ' CYS . 1.3 m -106.27 143.84 33.82 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.92 0.391 . . . . 0.0 111.941 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.0 t -133.75 154.49 50.93 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.262 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -93.42 18.86 9.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.896 0.379 . . . . 0.0 111.003 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mt -107.09 127.73 27.41 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -44.82 144.83 3.26 Favored 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 121.117 1.211 . . . . 0.0 110.797 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.81 -23.2 74.36 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 122.452 2.101 . . . . 0.0 112.542 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.482 ' C ' ' HZ2' ' A' ' 20' ' ' LYS . 70.1 m -69.3 -33.45 73.21 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.404 HH21 ' HB2' ' A' ' 16' ' ' SER . 11.5 mmt-85 -76.66 -56.83 4.26 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 118.882 0.764 . . . . 0.0 109.066 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mt -48.57 -48.64 38.71 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.728 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -48.41 -55.18 11.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.192 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.482 ' HZ2' ' C ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -70.23 -26.71 63.98 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.416 -0.913 . . . . 0.0 109.622 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.3 -2.9 50.83 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.994 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -118.78 -8.3 10.36 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -135.08 -35.46 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.619 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 2.4 mp -90.51 -54.69 3.89 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.652 1.114 . . . . 0.0 111.694 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -113.03 -3.93 13.94 Favored 'General case' 0 C--O 1.205 -1.243 0 O-C-N 122.261 -0.274 . . . . 0.0 111.129 -178.501 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.449 ' O ' ' CG2' ' A' ' 30' ' ' ILE . . . -46.07 -39.22 8.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 118.037 0.381 . . . . 0.0 111.526 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -85.41 12.98 7.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.629 0.728 . . . . 0.0 110.855 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -134.51 -10.32 2.46 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 124.969 1.308 . . . . 0.0 108.62 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.472 HD22 ' CD2' ' A' ' 149' ' ' TYR . 0.1 OUTLIER -95.84 -43.3 7.91 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 124.862 1.265 . . . . 0.0 109.188 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.449 ' CG2' ' O ' ' A' ' 26' ' ' ALA . 1.7 tt -55.62 -45.46 99.87 Favored Pre-proline 0 C--O 1.215 -0.757 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.486 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 36.4 Cg_endo -63.41 -24.67 71.02 Favored 'Trans proline' 0 N--CA 1.482 0.85 0 CA-C-N 121.231 1.475 . . . . 0.0 111.256 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -67.49 -54.45 20.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.663 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 0.9 OUTLIER -95.8 -35.75 6.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.248 -176.438 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.415 ' CA ' ' HG ' ' A' ' 145' ' ' LEU . . . -105.63 63.85 0.15 Allowed Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -77.1 -27.78 6.48 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 N-CA-C 107.917 -1.609 . . . . 0.0 107.917 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -75.23 -43.24 52.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.17 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.5 -75.27 0.12 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.861 -178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 mm -99.98 147.78 7.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 CA-C-O 121.665 0.745 . . . . 0.0 111.021 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.66 ' H ' ' CD ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.08 -64.07 1.09 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.203 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -178.12 166.79 1.98 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.105 0.478 . . . . 0.0 110.345 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.96 143.76 5.6 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.987 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.81 145.95 35.32 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.82 139.08 18.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.683 0.754 . . . . 0.0 110.94 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.588 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 3.0 mp -89.49 -39.09 13.57 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' O ' ' CG2' ' A' ' 52' ' ' THR . 22.2 mt-10 -141.92 133.1 26.26 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.78 -156.41 28.8 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.582 ' ND2' ' H ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -134.19 -13.89 2.37 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 122.33 -0.512 . . . . 0.0 110.924 -179.562 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.567 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 143.39 18.03 0.24 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.88 -173.24 19.91 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -61.16 126.07 18.56 Favored 'Trans proline' 0 C--N 1.321 -0.904 0 C-N-CA 122.258 1.972 . . . . 0.0 113.319 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.81 1.89 56.24 Favored Glycine 0 N--CA 1.463 0.462 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 88.5 m -93.85 140.38 29.74 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.218 -0.991 . . . . 0.0 111.046 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.498 HG13 ' HE ' ' A' ' 70' ' ' ARG . 2.1 mp -117.65 133.13 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.17 141.02 52.41 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 121.037 0.446 . . . . 0.0 110.957 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -119.27 131.98 55.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.813 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.7 mm -94.04 142.01 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.678 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.3 m -108.86 117.58 34.56 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.474 ' HA ' ' HD3' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -90.53 162.24 15.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.779 0.323 . . . . 0.0 111.363 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.59 144.34 30.16 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 2.1 pm0 -56.73 -47.17 80.6 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 122.422 -0.458 . . . . 0.0 110.298 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.34 62.38 1.76 Allowed Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 62.7 p -136.54 174.54 10.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.058 0.456 . . . . 0.0 111.205 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.52 ' NE2' ' H ' ' A' ' 63' ' ' GLN . 4.0 mp0 -69.03 -50.01 52.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.25 156.24 17.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.053 0.454 . . . . 0.0 110.631 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.78 -61.49 0.51 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.27 154.82 42.14 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.071 0.462 . . . . 0.0 110.776 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.426 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 2.0 p -145.82 157.09 12.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.958 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.426 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 26.4 mtmt -105.78 113.12 26.48 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.446 0.641 . . . . 0.0 112.425 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -105.78 105.71 15.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.993 0.917 . . . . 0.0 109.579 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.498 ' HE ' HG13 ' A' ' 53' ' ' ILE . 25.3 ttm180 -101.63 131.19 47.98 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.953 -0.467 . . . . 0.0 111.433 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.4 mp -73.91 145.36 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -102.49 -56.01 2.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 119.227 -0.416 . . . . 0.0 112.073 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.8 m -165.35 141.38 5.38 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.5 mt -124.73 131.44 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.852 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.614 ' O ' ' N ' ' A' ' 79' ' ' TYR . 54.8 m-20 -114.84 87.92 2.75 Favored 'General case' 0 C--O 1.199 -1.575 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.454 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 9.5 pt-20 -54.41 -30.58 52.74 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.04 77.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.3 m -107.86 -9.98 15.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.736 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.614 ' N ' ' O ' ' A' ' 75' ' ' ASP . 20.7 m-85 58.54 48.63 11.68 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 121.415 -0.803 . . . . 0.0 110.538 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.2 p -106.58 147.22 29.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.985 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.635 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 35.9 t80 -132.1 125.86 32.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.968 0.413 . . . . 0.0 110.919 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 p -133.65 136.09 44.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.362 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.635 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 6.5 p90 -146.78 160.67 41.96 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.8 m -144.64 138.39 27.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.133 0.492 . . . . 0.0 111.229 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mp -80.36 119.99 23.81 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.5 -42.9 17.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.575 ' CD ' ' H ' ' A' ' 88' ' ' GLY . 1.2 tm-20 -157.64 173.55 16.68 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.326 -0.234 . . . . 0.0 110.493 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.635 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.74 177.44 17.34 Favored Glycine 0 CA--C 1.509 -0.316 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -61.54 1.76 0.21 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.635 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -64.88 -34.82 79.3 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.361 1.064 . . . . 0.0 110.071 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.601 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.0 16.31 21.98 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 123.702 0.801 . . . . 0.0 108.847 -178.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.555 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 82.8 p 44.89 -126.96 1.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -130.59 -9.62 4.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.133 0.492 . . . . 0.0 110.736 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.45 -7.25 18.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.171 -177.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.43 HG22 ' CD1' ' A' ' 98' ' ' ILE . 88.7 mt -100.04 152.5 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-O 122.085 0.945 . . . . 0.0 113.523 -177.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.43 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -90.42 -56.85 3.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.598 177.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -172.19 148.28 2.14 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.267 0.556 . . . . 0.0 111.454 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.43 ' CD1' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.31 130.1 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.26 145.07 46.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.917 0.389 . . . . 0.0 111.53 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -139.89 133.17 29.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.562 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -128.46 134.29 48.7 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 121.036 0.446 . . . . 0.0 110.963 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.14 133.01 52.99 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.714 -0.616 . . . . 0.0 109.634 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -120.11 133.0 55.63 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.4 mm? -97.81 125.42 42.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.132 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.65 136.86 45.85 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.16 139.45 46.36 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.173 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.593 ' HG ' HG22 ' A' ' 10' ' ' THR . 17.3 p -120.73 168.11 11.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.61 -26.85 32.89 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 121.398 -0.429 . . . . 0.0 112.125 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.2 m -91.27 -14.11 31.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 119.563 -2.139 . . . . 0.0 116.591 174.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.46 -89.91 0.12 Allowed Glycine 0 CA--C 1.537 1.424 0 O-C-N 120.454 -1.404 . . . . 0.0 110.981 -161.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.428 ' N ' ' SG ' ' A' ' 107' ' ' CYS . 17.2 t -164.84 133.78 3.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 119.035 1.417 . . . . 0.0 111.196 -178.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 52.1 m -100.06 126.05 46.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.1 mt -99.54 127.79 51.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.428 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -105.52 117.45 34.04 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.0 p -110.58 121.77 46.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.442 0.639 . . . . 0.0 110.542 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.636 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -104.73 135.26 43.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.296 0.569 . . . . 0.0 109.948 -177.358 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 71.1 m -107.73 138.33 44.16 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.8 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.974 ' CD2' ' HG1' ' A' ' 4' ' ' THR . 26.3 m80 -136.13 93.47 2.91 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.813 0.34 . . . . 0.0 110.454 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -88.12 102.16 14.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.213 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -90.28 102.87 15.59 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 p -92.47 160.57 15.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.905 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -112.39 142.5 44.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.029 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.24 -109.64 0.94 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.425 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.1 OUTLIER -116.46 -2.67 11.98 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.497 -0.413 . . . . 0.0 110.657 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.2 tp -49.3 160.65 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.88 0.371 . . . . 0.0 110.693 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -149.38 149.64 31.17 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.572 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 34.2 mm -87.05 125.16 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -75.2 162.35 28.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.485 0.66 . . . . 0.0 112.06 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -69.02 -42.19 76.73 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.855 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.424 ' N ' ' CD ' ' A' ' 130' ' ' GLU . 5.2 mp0 -61.57 -25.55 67.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.825 0.345 . . . . 0.0 110.174 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -72.59 -51.03 21.45 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.283 0.564 . . . . 0.0 111.038 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 m -77.03 -25.95 15.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.942 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -67.34 -46.31 73.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 122.332 -0.23 . . . . 0.0 110.787 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.2 -45.01 77.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.885 0.374 . . . . 0.0 110.593 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.16 -46.62 78.57 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -66.89 -46.89 73.51 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.636 -0.332 . . . . 0.0 110.714 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -55.2 -47.24 75.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.011 0.434 . . . . 0.0 110.031 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.436 ' HZ1' ' HB2' ' A' ' 138' ' ' LYS . 3.3 ttmp? -66.7 -52.87 39.76 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.885 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.22 -42.64 41.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.594 0.712 . . . . 0.0 110.567 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.475 ' O ' ' ND1' ' A' ' 140' ' ' HIS . 1.8 t-80 -61.16 -36.56 80.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.859 0.838 . . . . 0.0 109.052 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.9 -38.88 96.12 Favored Glycine 0 C--O 1.221 -0.665 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.411 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -66.1 -46.82 76.28 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -59.62 -24.48 63.86 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.68 -36.28 65.29 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.59 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.471 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 1.1 mm? -71.22 -57.67 4.27 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.426 0.631 . . . . 0.0 109.839 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.537 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 50.4 mt -54.54 -50.65 57.09 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.133 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -47.43 -56.76 6.32 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.864 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 20.5 p -50.68 -44.65 57.81 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.343 0.592 . . . . 0.0 111.285 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.637 ' O ' ' N ' ' A' ' 153' ' ' HIS . 28.2 t80 -59.88 -45.41 92.58 Favored 'General case' 0 C--O 1.193 -1.917 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.537 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 2.1 mm? -65.79 -42.74 90.37 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 120.443 1.474 . . . . 0.0 111.565 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.409 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.4 OUTLIER -62.53 -24.38 67.48 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.305 179.591 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -105.77 -13.08 15.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.321 0.581 . . . . 0.0 110.768 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.637 ' N ' ' O ' ' A' ' 149' ' ' TYR . 42.1 m80 -155.96 67.34 4.69 Favored Pre-proline 0 C--N 1.31 -1.131 0 C-N-CA 125.167 1.387 . . . . 0.0 110.202 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -72.35 -3.48 13.46 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 122.501 2.134 . . . . 0.0 111.704 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.649 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 13.0 m-20 -73.16 2.61 6.9 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.163 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -50.11 130.15 22.01 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 119.161 -2.212 . . . . 0.0 111.275 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.541 ' CG ' ' O ' ' A' ' 157' ' ' TYR . 92.8 t80 54.03 6.18 0.09 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.546 0.688 . . . . 0.0 112.124 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.649 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.503 0 O-C-N 120.994 -1.066 . . . . 0.0 110.055 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.885 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -134.54 148.65 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 O-C-N 122.488 -0.419 . . . . 0.0 111.02 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.73 110.27 22.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.659 177.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 1.027 ' HG1' ' CD2' ' A' ' 118' ' ' HIS . 90.4 m -95.93 140.06 31.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 0.0 111.013 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.482 ' CD2' ' ND2' ' A' ' 7' ' ' ASN . 7.2 t80 -143.28 128.09 18.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.172 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.637 ' C ' HD21 ' A' ' 7' ' ' ASN . 1.6 tt0 -102.89 131.19 49.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.874 0.368 . . . . 0.0 111.324 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.637 HD21 ' C ' ' A' ' 6' ' ' GLU . 1.8 m-80 -134.59 172.7 12.56 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 122.636 0.375 . . . . 0.0 110.387 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.42 153.49 30.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.202 0.525 . . . . 0.0 112.39 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -149.01 138.41 21.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.235 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.19 147.49 25.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 111.771 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.579 ' HG ' ' CD ' ' A' ' 147' ' ' GLU . 10.3 t -145.8 161.44 39.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.499 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -96.27 25.92 4.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.854 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -116.3 125.41 28.54 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.879 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -47.83 149.93 4.9 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.034 1.823 . . . . 0.0 111.784 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -60.93 -24.88 80.37 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.307 2.005 . . . . 0.0 112.59 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.6 m -68.68 -34.29 75.42 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -76.16 -55.77 5.27 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 mt -51.4 -41.85 61.01 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.733 178.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -50.97 -57.48 8.48 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' CD ' ' O ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -68.09 -40.08 82.74 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.254 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.62 -2.45 4.86 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.263 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -118.67 -9.64 10.18 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.408 ' CG2' ' N ' ' A' ' 24' ' ' LEU . 33.9 m -131.76 -50.91 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -178.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.53 ' CD1' ' N ' ' A' ' 25' ' ' ASP . 2.7 pp -99.65 -30.52 12.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -176.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.53 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 62.4 m-20 -112.84 -5.59 13.86 Favored 'General case' 0 C--O 1.214 -0.802 0 O-C-N 121.599 -0.688 . . . . 0.0 111.516 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -68.13 -40.99 82.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.259 0.552 . . . . 0.0 111.383 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.539 ' CB ' ' HZ3' ' A' ' 54' ' ' LYS . 13.9 m-20 -84.37 17.8 2.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.027 0.918 . . . . 0.0 110.889 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -139.07 -9.0 1.33 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.438 HD13 ' CG ' ' A' ' 149' ' ' TYR . 0.0 OUTLIER -89.23 -47.49 8.02 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.655 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.467 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -60.83 -43.03 90.35 Favored Pre-proline 0 C--O 1.208 -1.111 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 28.7 Cg_endo -62.2 -26.14 77.47 Favored 'Trans proline' 0 C--N 1.321 -0.905 0 CA-C-N 120.635 1.263 . . . . 0.0 112.252 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -76.94 -61.64 1.91 Allowed 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.351 0.596 . . . . 0.0 112.343 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.424 ' O ' ' CD ' ' A' ' 35' ' ' PRO . 2.1 pt -94.4 -34.55 5.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.617 -177.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.471 ' CB ' ' HG ' ' A' ' 145' ' ' LEU . . . -102.68 67.3 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 123.224 0.609 . . . . 0.0 112.513 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.424 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 65.2 Cg_endo -72.7 -20.18 23.28 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.219 1.28 . . . . 0.0 108.882 176.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -72.87 -38.63 66.95 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.517 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.09 -81.91 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.443 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 ' N ' ' CD1' ' A' ' 38' ' ' ILE . 2.0 mp -109.57 144.07 18.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.0 110.13 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.69 -42.43 28.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.139 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.618 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 48.2 tp60 -173.63 164.74 4.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.618 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -166.03 145.16 6.02 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.141 0.495 . . . . 0.0 110.893 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -148.32 142.99 26.59 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.106 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.75 140.53 17.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.409 0.623 . . . . 0.0 110.863 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.497 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 3.6 mp -89.55 -40.41 12.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.426 ' O ' HG21 ' A' ' 52' ' ' THR . 12.5 mm-40 -143.51 134.21 25.11 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.346 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.98 -155.12 22.27 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.896 -0.482 . . . . 0.0 111.896 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.492 ' ND2' ' N ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -133.95 -12.52 2.55 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 123.096 0.558 . . . . 0.0 111.232 -178.191 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.96 12.31 1.15 Allowed Glycine 0 C--O 1.221 -0.663 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -106.36 -170.87 22.99 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -60.76 126.28 19.35 Favored 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 122.803 2.336 . . . . 0.0 113.119 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.96 5.84 57.25 Favored Glycine 0 N--CA 1.465 0.612 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.426 HG21 ' O ' ' A' ' 45' ' ' GLU . 15.0 m -93.12 141.53 28.31 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.832 -0.684 . . . . 0.0 111.47 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mp -116.46 133.57 62.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.539 ' HZ3' ' CB ' ' A' ' 27' ' ' ASP . 4.7 tmtp? -119.67 140.32 50.83 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.542 0.686 . . . . 0.0 111.148 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.6 tttt -119.17 121.19 39.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.258 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.2 mp -105.52 127.12 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.5 m -102.57 118.88 37.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.245 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.53 177.37 6.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.585 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.41 144.45 40.78 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -60.03 -48.37 81.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.852 0.358 . . . . 0.0 110.752 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.7 61.62 3.45 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 m -149.54 174.66 12.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.936 0.398 . . . . 0.0 110.585 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.55 ' NE2' ' CE2' ' A' ' 64' ' ' TYR . 1.1 pt20 -66.79 -41.32 87.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.918 0.389 . . . . 0.0 110.664 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.55 ' CE2' ' NE2' ' A' ' 63' ' ' GLN . 73.9 m-85 -91.4 149.48 21.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.552 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.416 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . -127.85 -62.39 0.13 Allowed Glycine 0 N--CA 1.462 0.378 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -146.35 146.95 30.85 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.728 0.299 . . . . 0.0 110.211 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -157.02 147.66 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.93 0.395 . . . . 0.0 110.947 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -105.59 113.06 26.4 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.271 0.558 . . . . 0.0 111.243 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.86 110.15 21.02 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -101.96 129.69 48.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.918 0.389 . . . . 0.0 112.037 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 mp -70.86 137.26 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.618 ' C ' ' HG ' ' A' ' 73' ' ' SER . 24.5 t70 -96.25 -53.75 3.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.44 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.618 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 49.4 m -164.5 140.74 6.1 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 44.8 mt -129.16 130.65 68.06 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.15 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.625 ' O ' ' N ' ' A' ' 79' ' ' TYR . 38.4 m-20 -115.39 87.62 2.7 Favored 'General case' 0 C--O 1.194 -1.86 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.567 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.8 pm0 -55.32 -39.57 70.11 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.31 -37.08 45.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.131 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.21 -9.84 15.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.32 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.2 m-85 62.03 51.96 3.48 Favored 'General case' 0 N--CA 1.438 -1.068 0 O-C-N 121.055 -1.028 . . . . 0.0 110.101 -177.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 55.5 p -106.41 144.09 33.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.056 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -134.66 121.26 20.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.023 0.439 . . . . 0.0 110.933 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 m -136.42 147.38 47.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.226 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -162.65 169.76 19.57 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.779 0.323 . . . . 0.0 110.628 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -146.49 139.11 25.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.131 0.491 . . . . 0.0 110.771 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.1 mt -79.95 111.62 16.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.59 -40.75 41.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.4 -178.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' A' ' 88' ' ' GLY . 16.0 tt0 -155.24 171.98 18.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.81 0.338 . . . . 0.0 110.295 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.18 177.82 17.7 Favored Glycine 0 CA--C 1.509 -0.334 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -61.87 2.29 0.22 Allowed 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.627 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -66.61 -34.36 77.71 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.173 0.989 . . . . 0.0 110.35 177.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.602 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.31 14.96 22.56 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.175 0.59 . . . . 0.0 110.341 -177.095 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.528 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 63.4 p 45.16 -126.22 1.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.36 -178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -130.45 -13.01 3.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.967 0.413 . . . . 0.0 111.475 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.9 p -104.75 -5.73 21.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.42 HG22 ' CD1' ' A' ' 98' ' ' ILE . 72.1 mt -99.12 152.95 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 CA-C-O 122.059 0.933 . . . . 0.0 113.472 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.418 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -93.46 -54.01 3.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.919 178.279 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -171.66 147.64 2.33 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 121.623 0.725 . . . . 0.0 111.028 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.42 ' CD1' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.41 121.98 66.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.4 t -107.39 146.12 32.05 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.412 0.625 . . . . 0.0 111.438 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -136.68 131.5 33.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.286 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -127.96 133.66 49.23 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.88 133.0 29.63 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.894 -0.504 . . . . 0.0 109.899 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -119.77 133.22 55.69 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.43 128.28 49.09 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.94 137.27 55.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.239 -178.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.77 134.65 45.05 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.336 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 38.8 t -121.3 172.26 8.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.826 0.346 . . . . 0.0 110.152 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.482 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.73 -35.28 52.18 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.8 p -87.06 -16.79 34.56 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.696 -1.473 . . . . 0.0 113.87 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 162.24 -77.75 0.16 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.379 1.466 . . . . 0.0 111.779 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 83.1 p -164.62 130.98 2.94 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 126.07 1.748 . . . . 0.0 111.096 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.5 m -99.48 117.71 34.48 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mt -92.72 131.34 40.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.543 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.7 mtpt -104.38 117.05 33.23 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 68.4 m -111.34 123.74 50.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.291 0.567 . . . . 0.0 111.066 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.624 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -107.69 135.67 45.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 123.35 0.66 . . . . 0.0 110.082 -178.045 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.1 m -104.8 135.15 46.72 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 1.027 ' CD2' ' HG1' ' A' ' 4' ' ' THR . 15.5 m80 -136.24 93.56 2.92 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.127 0.489 . . . . 0.0 110.378 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -86.82 101.92 13.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.229 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -95.73 101.37 13.05 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.288 0.566 . . . . 0.0 110.231 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.1 p -100.26 171.69 7.63 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.472 0.653 . . . . 0.0 111.335 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -108.07 157.52 18.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.837 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 42.26 -114.73 0.77 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.57 4.85 20.68 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.727 -0.278 . . . . 0.0 111.11 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -49.09 160.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.298 0.571 . . . . 0.0 110.227 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.467 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 19.8 pt-20 -150.25 146.06 26.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.08 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.8 mm -88.85 124.27 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -75.09 162.15 28.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.476 0.655 . . . . 0.0 111.839 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -69.53 -36.22 76.21 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.935 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -65.13 -30.41 71.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.792 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -72.41 -47.9 45.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.055 0.455 . . . . 0.0 111.027 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 m -77.47 -26.43 15.3 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.982 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -67.13 -46.28 74.59 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 122.138 -0.351 . . . . 0.0 110.699 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.4 -43.48 78.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.598 0.237 . . . . 0.0 110.818 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.16 -46.77 48.79 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -67.38 -48.97 65.83 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 122.503 -0.41 . . . . 0.0 110.84 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -55.72 -48.01 75.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 109.998 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -64.4 -53.9 41.27 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.427 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -47.76 -45.91 29.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.461 0.648 . . . . 0.0 110.55 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -55.73 -37.22 68.14 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.409 0.623 . . . . 0.0 109.545 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.83 -38.92 96.85 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -68.37 -38.5 81.45 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.518 ' O ' ' CD1' ' A' ' 143' ' ' PHE . 0.9 OUTLIER -58.85 -32.04 69.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.687 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -70.29 -33.76 71.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.769 177.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.471 ' HG ' ' CB ' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -67.79 -56.95 7.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.046 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.428 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 59.1 mt -65.94 -48.94 80.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.664 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.579 ' CD ' ' HG ' ' A' ' 11' ' ' SER . 29.3 tt0 -47.5 -45.1 26.08 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.403 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.0 t -58.81 -37.7 76.96 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.878 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.634 ' O ' ' N ' ' A' ' 153' ' ' HIS . 11.2 t80 -59.65 -45.83 90.84 Favored 'General case' 0 C--O 1.189 -2.128 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.528 ' H ' ' CD2' ' A' ' 150' ' ' LEU . 1.3 mm? -69.9 -42.79 72.92 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 119.445 1.021 . . . . 0.0 111.468 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -23.63 66.03 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.631 -0.668 . . . . 0.0 109.809 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.436 ' O ' ' ND1' ' A' ' 153' ' ' HIS . 4.7 m-20 -106.11 -14.22 15.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.353 0.597 . . . . 0.0 110.623 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 149' ' ' TYR . 44.0 m80 -155.38 66.94 4.91 Favored Pre-proline 0 C--N 1.304 -1.383 0 C-N-CA 125.572 1.549 . . . . 0.0 109.384 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.42 -3.13 10.37 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 C-N-CA 122.969 2.446 . . . . 0.0 111.562 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.599 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 5.1 p30 -72.59 3.18 5.23 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.82 -178.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.535 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -52.16 128.67 25.57 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 119.335 -2.103 . . . . 0.0 110.823 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 51.67 5.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.046 0.538 . . . . 0.0 112.423 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.599 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.636 0 CA-C-O 118.128 -0.939 . . . . 0.0 109.852 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.649 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.9 p -135.01 148.0 29.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.849 0.357 . . . . 0.0 111.229 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -98.4 110.03 22.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.547 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.4 m -96.56 132.84 41.75 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.656 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.67 128.87 37.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.066 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.09 133.47 48.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.8 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -134.0 174.54 10.36 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.765 0.317 . . . . 0.0 110.205 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.65 145.4 21.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.825 0.821 . . . . 0.0 112.079 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.31 134.63 27.75 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.831 -0.543 . . . . 0.0 110.138 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.94 147.44 23.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.891 0.377 . . . . 0.0 111.257 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 p -145.15 154.75 42.77 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.456 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -93.68 29.84 1.93 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.91 0.386 . . . . 0.0 110.397 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -120.69 125.35 27.15 Favored Pre-proline 0 C--O 1.224 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.073 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -49.7 148.91 11.28 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 121.999 1.799 . . . . 0.0 111.708 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -57.78 -28.31 81.58 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.386 2.057 . . . . 0.0 112.746 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 m -65.14 -35.53 81.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.559 ' HE ' ' N ' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -74.95 -55.57 5.64 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -178.512 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mt -53.16 -40.27 64.18 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.012 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -50.25 -57.7 7.24 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.859 0.464 . . . . 0.0 112.09 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.77 -41.55 75.02 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.507 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.0 -4.4 3.39 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.603 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -119.79 -8.67 9.84 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.8 m -128.53 -50.53 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.487 ' CD1' ' N ' ' A' ' 25' ' ' ASP . 1.9 pp -98.0 -31.41 12.17 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -176.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.487 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 3.8 t70 -114.96 -5.59 12.54 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 118.842 0.746 . . . . 0.0 112.177 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . -62.4 -42.24 99.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.315 0.579 . . . . 0.0 111.702 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -83.76 19.7 1.62 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.865 0.84 . . . . 0.0 110.028 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 26' ' ' ALA . 3.0 m120 -139.85 -8.64 1.21 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -96.97 -50.15 4.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.224 -178.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.559 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 41.5 mt -55.04 -44.15 99.45 Favored Pre-proline 0 C--O 1.217 -0.632 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 20.7 Cg_exo -63.13 -22.64 73.17 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 122.353 2.036 . . . . 0.0 110.958 176.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -74.65 -55.08 6.28 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.537 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.447 ' CD1' ' O ' ' A' ' 145' ' ' LEU . 0.2 OUTLIER -95.54 -35.07 5.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.322 -177.159 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.437 ' N ' ' CD1' ' A' ' 145' ' ' LEU . . . -106.61 81.19 0.82 Allowed Pre-proline 0 CA--C 1.508 -0.639 0 CA-C-O 121.105 0.479 . . . . 0.0 111.93 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.75 -10.23 24.75 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 N-CA-C 107.33 -1.834 . . . . 0.0 107.33 174.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -74.61 -42.15 59.13 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.487 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.16 -80.03 0.12 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.188 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.6 mm -99.03 140.56 18.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.033 0.444 . . . . 0.0 110.99 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -81.57 -42.9 19.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.915 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.623 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 47.1 tp60 -178.44 165.51 1.77 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.623 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -165.08 144.08 6.63 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.201 0.524 . . . . 0.0 110.934 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.557 ' N ' ' NZ ' ' A' ' 54' ' ' LYS . 10.4 pt-20 -145.6 143.17 29.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.954 0.407 . . . . 0.0 111.249 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -78.57 142.09 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.485 0.66 . . . . 0.0 111.39 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.9 mt -86.36 -39.7 16.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.418 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.482 ' O ' ' CG2' ' A' ' 52' ' ' THR . 40.7 mt-10 -148.18 133.61 18.61 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.618 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.93 -156.26 22.87 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.696 HD21 ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -132.68 -10.54 3.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.95 0.405 . . . . 0.0 111.054 -179.203 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.696 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 134.36 21.0 0.78 Allowed Glycine 0 C--O 1.222 -0.619 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -178.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.3 -171.75 20.0 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -62.09 124.81 15.1 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 122.433 2.089 . . . . 0.0 113.036 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.8 3.78 59.23 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.482 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 66.5 m -93.69 140.57 29.49 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.555 -0.823 . . . . 0.0 111.064 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.58 125.21 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.557 ' NZ ' ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -115.52 138.18 51.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.254 0.55 . . . . 0.0 110.131 178.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -120.43 132.07 55.07 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.708 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.53 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 1.5 mp -103.28 140.8 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.0 m -113.48 118.64 35.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.83 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -101.47 -177.84 3.55 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.955 0.407 . . . . 0.0 110.942 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.25 145.77 35.17 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -59.61 -46.62 88.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.746 0.308 . . . . 0.0 110.794 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.72 61.56 3.45 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.3 t -142.96 175.04 10.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.916 0.389 . . . . 0.0 110.614 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -59.82 -51.49 69.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 110.665 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.461 ' OH ' ' NZ ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -107.11 143.47 35.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.165 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.06 -48.93 0.91 Allowed Glycine 0 CA--C 1.52 0.39 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -145.49 153.44 41.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.105 0.478 . . . . 0.0 110.624 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -154.02 146.34 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.554 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -105.57 106.11 16.45 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.436 0.636 . . . . 0.0 111.701 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -92.51 123.19 35.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.708 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -113.11 119.62 38.46 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.82 -0.55 . . . . 0.0 111.068 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.9 mp -70.22 137.16 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.569 ' C ' ' HG ' ' A' ' 73' ' ' SER . 26.2 t0 -99.61 -54.46 2.92 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.569 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 65.0 m -165.0 141.57 5.76 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.8 mt -129.98 131.03 66.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.619 177.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.598 ' O ' ' N ' ' A' ' 79' ' ' TYR . 7.2 m-20 -116.25 87.89 2.78 Favored 'General case' 0 C--O 1.206 -1.217 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.578 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.1 pm0 -54.83 -41.14 70.34 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.06 -35.97 27.29 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.492 0.663 . . . . 0.0 109.223 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.444 ' O ' ' NZ ' ' A' ' 103' ' ' LYS . 0.6 OUTLIER -107.95 -10.5 15.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.409 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.598 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.9 m-85 63.24 50.32 3.03 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 120.989 -1.07 . . . . 0.0 110.024 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 34.9 t -106.26 144.24 33.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.359 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -135.09 123.23 22.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.101 0.477 . . . . 0.0 110.588 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 p -132.57 134.64 45.2 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.133 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -144.62 159.08 43.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.145 0.498 . . . . 0.0 110.022 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.7 m -142.32 137.2 30.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.994 0.426 . . . . 0.0 110.586 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.2 mt -80.06 109.87 14.92 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.9 pt -79.56 -43.47 23.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.011 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.427 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 3.4 tp10 -149.99 172.1 15.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.739 0.304 . . . . 0.0 110.362 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.635 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.94 177.45 18.33 Favored Glycine 0 CA--C 1.509 -0.326 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -61.14 1.61 0.17 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.635 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -65.25 -35.36 80.81 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 124.105 0.962 . . . . 0.0 110.212 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.611 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.72 11.77 22.6 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 123.521 0.728 . . . . 0.0 109.623 -177.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.571 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 67.9 p 46.55 -126.65 1.49 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -131.04 -11.37 3.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.256 0.55 . . . . 0.0 110.816 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.432 ' HG1' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -105.19 -5.58 20.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.427 -177.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.436 HG22 ' CD1' ' A' ' 98' ' ' ILE . 94.4 mt -97.76 152.09 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.42 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -87.37 -61.27 1.76 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.337 177.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' O ' ' CB ' ' A' ' 120' ' ' HIS . 11.8 ptmt -172.26 149.59 2.28 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.489 0.661 . . . . 0.0 111.305 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.436 ' CD1' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.13 127.56 75.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.597 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.3 145.7 39.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.246 0.546 . . . . 0.0 111.635 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -138.45 136.66 36.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.265 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.13 134.2 49.07 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 120.916 0.389 . . . . 0.0 110.144 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.64 130.87 28.48 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.31 -0.869 . . . . 0.0 109.742 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' A' ' 78' ' ' SER . 25.9 tttp -127.22 134.3 50.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.605 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -102.99 125.27 49.68 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -178.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -130.32 137.89 55.19 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.624 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.916 -178.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.21 133.57 45.17 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.287 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 14.8 t -121.56 174.35 6.84 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 122.678 0.391 . . . . 0.0 110.426 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.41 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -54.97 -36.34 60.44 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 m -80.56 -15.28 57.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.411 1.484 . . . . 0.0 114.198 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.95 -90.13 0.13 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.426 1.965 . . . . 0.0 110.812 -168.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -157.22 129.09 7.11 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 127.728 2.411 . . . . 0.0 111.005 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.412 ' N ' ' O ' ' A' ' 105' ' ' VAL . 43.9 m -99.8 118.91 37.28 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.2 mt -92.66 131.65 39.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.535 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -105.25 116.64 32.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 53.4 p -111.56 128.45 56.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.383 0.611 . . . . 0.0 111.258 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.578 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -112.07 135.77 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 C-N-CA 123.327 0.651 . . . . 0.0 109.92 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 p -110.38 136.93 48.78 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.467 ' HE2' ' CG2' ' A' ' 116' ' ' ILE . 27.7 m-70 -135.7 95.54 3.26 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.026 0.441 . . . . 0.0 110.888 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -84.89 101.12 12.06 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.417 ' CB ' ' O ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -94.32 103.76 15.76 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.441 ' OG1' ' CG2' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -100.09 161.73 13.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.665 -178.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.442 ' H ' HG22 ' A' ' 125' ' ' ILE . 8.1 ptmt -112.22 157.15 21.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 41.01 -123.15 2.47 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.491 HD21 ' N ' ' A' ' 124' ' ' ASN . 0.1 OUTLIER -95.08 -12.09 27.14 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.694 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.442 HG22 ' H ' ' A' ' 122' ' ' LYS . 1.1 tp -49.32 162.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.632 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -159.62 150.09 19.08 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.229 -0.294 . . . . 0.0 110.9 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.3 mm -86.34 124.86 40.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -76.82 160.4 29.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.448 0.642 . . . . 0.0 111.718 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -70.24 -41.08 74.01 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.615 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.96 -26.14 68.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.674 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -72.97 -52.11 15.75 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.595 0.712 . . . . 0.0 111.162 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.413 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 3.6 m -77.02 -29.53 17.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.584 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.131 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -67.04 -45.85 76.19 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 122.259 -0.276 . . . . 0.0 111.105 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.68 -46.56 79.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.917 0.389 . . . . 0.0 110.542 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.28 91.44 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 85.1 tttt -67.12 -46.62 73.59 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 122.691 -0.299 . . . . 0.0 110.956 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -54.56 -47.8 72.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.952 0.406 . . . . 0.0 110.086 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.461 ' NZ ' ' OH ' ' A' ' 64' ' ' TYR . 32.9 ttmt -61.13 -52.22 65.77 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.456 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.39 -51.96 31.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.604 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -47.94 -38.56 16.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.79 -33.85 88.08 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.495 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -75.89 -32.85 59.85 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.561 0.696 . . . . 0.0 109.408 179.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -59.22 -30.12 68.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -68.35 -42.32 79.41 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.603 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 0.8 OUTLIER -50.93 -58.57 5.69 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 114.088 -1.414 . . . . 0.0 112.154 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.513 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 23.1 mt -73.73 -49.47 35.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.164 -176.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 13.2 tt0 -45.98 -56.25 5.76 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.556 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 20.7 t -50.8 -47.55 59.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.321 0.581 . . . . 0.0 110.48 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.644 ' O ' ' N ' ' A' ' 153' ' ' HIS . 8.3 t80 -52.03 -51.88 54.54 Favored 'General case' 0 C--O 1.192 -1.934 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.513 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 1.9 mm? -62.45 -42.15 99.27 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 119.576 1.08 . . . . 0.0 112.208 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -62.99 -24.34 67.87 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 121.454 -0.779 . . . . 0.0 109.203 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.96 -12.95 15.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.097 0.475 . . . . 0.0 110.671 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.644 ' N ' ' O ' ' A' ' 149' ' ' TYR . 75.1 m80 -155.45 66.31 4.67 Favored Pre-proline 0 C--N 1.311 -1.103 0 C-N-CA 125.452 1.501 . . . . 0.0 110.162 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.55 -3.58 12.82 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 122.598 2.198 . . . . 0.0 111.597 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.574 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.7 OUTLIER -85.75 4.17 38.03 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 123.312 0.645 . . . . 0.0 111.67 -178.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.427 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -49.53 130.01 19.82 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 120.062 -1.649 . . . . 0.0 111.264 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 2.8 t80 54.84 6.31 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.574 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 118.578 -0.725 . . . . 0.0 110.242 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.92 148.45 29.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 O-C-N 122.518 -0.401 . . . . 0.0 111.177 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.46 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 52.1 m-85 -99.36 111.66 23.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.735 177.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.7 m -96.48 140.17 31.51 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.958 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -138.73 134.49 33.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.21 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.45 129.4 50.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.82 0.343 . . . . 0.0 111.024 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -135.54 166.79 22.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.967 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.91 159.97 39.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.471 0.653 . . . . 0.0 112.593 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.474 ' CE1' ' O ' ' A' ' 10' ' ' THR . 81.6 t80 -151.01 140.85 21.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.365 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.474 ' O ' ' CE1' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -93.62 148.23 22.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.811 0.339 . . . . 0.0 111.363 -179.362 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 p -144.81 154.45 42.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.779 0.323 . . . . 0.0 110.698 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -96.72 25.06 5.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 110.555 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -113.14 125.93 28.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.48 144.96 12.78 Favored 'Trans proline' 0 C--N 1.326 -0.616 0 C-N-CA 121.913 1.742 . . . . 0.0 111.735 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -55.84 -24.64 48.21 Favored 'Trans proline' 0 N--CA 1.484 0.922 0 C-N-CA 122.457 2.105 . . . . 0.0 112.667 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 m -68.31 -36.19 78.94 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -76.36 -56.34 4.72 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.3 mt -48.48 -47.08 38.79 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.752 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -49.43 -57.22 7.37 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -24.46 63.43 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.364 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.1 -2.69 56.05 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.373 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -118.87 -8.23 10.32 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 m -134.07 -35.5 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.617 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 2.6 mp -90.71 -55.01 3.73 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.59 1.087 . . . . 0.0 111.922 -175.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 29' ' ' LEU . 17.4 t70 -113.59 -4.55 13.47 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.868 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.93 -42.25 17.41 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.405 ' CB ' ' HZ1' ' A' ' 54' ' ' LYS . 1.1 m-20 -84.95 18.3 2.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.67 0.748 . . . . 0.0 110.5 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -139.91 -9.79 1.17 Allowed 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 124.583 1.153 . . . . 0.0 108.555 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.467 HD23 ' CD2' ' A' ' 149' ' ' TYR . 0.5 OUTLIER -89.71 -45.78 9.08 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 124.513 1.125 . . . . 0.0 109.597 -178.693 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.447 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 26.3 mt -54.38 -53.99 53.29 Favored Pre-proline 0 C--O 1.214 -0.791 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 22.8 Cg_endo -60.78 -21.59 70.61 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 122.081 1.854 . . . . 0.0 111.542 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 tmtp? -69.12 -52.63 26.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.699 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.448 ' CD1' ' O ' ' A' ' 145' ' ' LEU . 0.1 OUTLIER -95.85 -36.5 6.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.077 -177.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.451 ' HB1' ' CD2' ' A' ' 145' ' ' LEU . . . -107.04 82.27 1.09 Allowed Pre-proline 0 CA--C 1.506 -0.717 0 C-N-CA 123.159 0.584 . . . . 0.0 111.573 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.36 -9.81 27.07 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 N-CA-C 107.476 -1.778 . . . . 0.0 107.476 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -73.95 -42.09 61.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.499 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.43 -82.34 0.07 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.751 -178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 89.1 mt -107.76 143.36 18.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.98 0.419 . . . . 0.0 110.655 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -79.83 -46.18 17.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.174 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.495 ' NE2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -179.5 166.59 1.43 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.467 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.495 ' N ' ' NE2' ' A' ' 40' ' ' GLN . . . -165.19 147.7 7.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.926 0.393 . . . . 0.0 111.044 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -137.79 145.41 42.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.31 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.16 139.94 17.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.509 0.671 . . . . 0.0 110.716 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 7.5 mp -89.02 -39.27 13.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.787 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.483 ' O ' ' CG2' ' A' ' 52' ' ' THR . 28.0 mt-10 -147.41 136.72 22.52 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.425 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.63 -155.92 22.91 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.07 0.02 1.9 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 122.819 0.448 . . . . 0.0 110.749 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.35 11.52 3.37 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.11 -172.2 19.53 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 117.349 0.574 . . . . 0.0 112.123 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -59.15 126.71 21.74 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 122.676 2.25 . . . . 0.0 113.275 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.5 2.73 56.51 Favored Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.483 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 60.8 m -94.4 139.8 30.64 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.104 -1.048 . . . . 0.0 111.651 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -120.08 126.26 75.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.405 ' HZ1' ' CB ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -114.28 139.02 49.76 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.362 0.601 . . . . 0.0 110.509 179.244 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -118.44 127.12 53.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.096 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.534 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 1.8 mp -105.5 135.7 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.6 m -111.25 120.5 42.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.08 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 59' ' ' GLY . 4.6 t80 -91.69 179.29 5.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.671 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.429 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -54.39 143.93 30.07 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -60.65 -59.45 5.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.884 0.373 . . . . 0.0 110.994 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.72 61.79 3.42 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.5 t -137.66 175.22 9.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.87 0.367 . . . . 0.0 110.692 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -61.49 -45.08 95.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.685 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -91.87 155.07 18.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.537 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.4 -61.37 0.13 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.17 154.7 42.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.084 0.469 . . . . 0.0 110.63 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 p -155.49 146.95 12.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.024 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -105.66 114.97 29.45 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.31 0.576 . . . . 0.0 112.267 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.588 ' CE1' ' CD2' ' A' ' 85' ' ' LEU . 1.8 m80 -100.56 116.84 33.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.729 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -102.0 119.59 39.05 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.969 -0.457 . . . . 0.0 111.29 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.2 mt -77.74 145.61 9.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.647 ' C ' ' HG ' ' A' ' 73' ' ' SER . 7.3 m-20 -106.53 -55.32 2.34 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.647 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 2.7 m -165.39 141.94 5.54 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.6 mt -123.16 131.18 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.287 176.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.2 m-20 -116.01 87.64 2.72 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.466 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 9.8 pt-20 -54.96 -30.25 58.62 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.71 -39.06 70.55 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.98 -10.11 15.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.094 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.543 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.9 m-85 63.28 41.6 7.67 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 121.676 -0.64 . . . . 0.0 110.21 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.1 t -107.55 149.11 28.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.051 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 27.3 p90 -151.56 124.04 8.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.216 0.531 . . . . 0.0 110.965 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.66 144.56 51.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.208 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -144.65 171.66 14.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.806 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 m -144.64 136.23 25.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.135 0.493 . . . . 0.0 110.554 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.588 ' CD2' ' CE1' ' A' ' 69' ' ' HIS . 9.1 mt -79.83 120.02 23.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.11 -43.31 16.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.612 -178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.479 ' OE2' ' N ' ' A' ' 88' ' ' GLY . 3.2 tm-20 -153.14 170.26 20.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.731 0.3 . . . . 0.0 110.265 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.619 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 118.17 178.48 17.16 Favored Glycine 0 CA--C 1.507 -0.465 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 178.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -61.83 2.03 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.293 1.044 . . . . 0.0 108.711 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -67.26 -34.31 77.17 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 124.215 1.006 . . . . 0.0 110.439 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.621 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.25 16.15 21.9 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 123.305 0.642 . . . . 0.0 110.136 -177.348 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.552 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 60.4 p 47.36 -126.19 1.67 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.199 -178.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -130.3 -13.05 3.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.769 0.318 . . . . 0.0 111.532 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.02 -7.04 19.48 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 63.7 mt -99.91 153.5 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 CA-C-O 121.8 0.809 . . . . 0.0 113.127 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.513 ' CG ' ' N ' ' A' ' 97' ' ' LYS . 5.9 pt-20 -99.41 -51.64 3.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.027 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.513 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 64.4 mttt -164.71 146.68 8.27 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 121.177 0.513 . . . . 0.0 111.915 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.3 122.5 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.33 144.91 30.74 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.481 ' CZ ' ' OG ' ' A' ' 117' ' ' SER . 0.6 OUTLIER -139.88 131.79 27.68 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.665 179.453 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.525 ' CD ' ' N ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -129.15 130.92 47.02 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.525 ' N ' ' CD ' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -140.93 132.88 27.68 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.523 -0.736 . . . . 0.0 111.227 179.532 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.494 ' HZ2' HG13 ' A' ' 105' ' ' VAL . 26.3 ttpp -122.87 134.69 54.38 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.128 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.572 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.37 125.74 43.63 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.221 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.494 HG13 ' HZ2' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -127.43 137.56 57.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.098 -178.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.3 133.71 45.15 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.368 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.441 ' SG ' ' N ' ' A' ' 111' ' ' SER . 27.1 p -121.66 174.25 6.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.945 0.402 . . . . 0.0 110.288 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.71 -34.51 56.39 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.6 m -79.31 -21.22 46.24 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.615 -1.521 . . . . 0.0 114.078 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.7 -88.45 0.12 Allowed Glycine 0 CA--C 1.524 0.626 0 C-N-CA 125.752 1.644 . . . . 0.0 109.5 -166.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.441 ' N ' ' SG ' ' A' ' 107' ' ' CYS . 0.8 OUTLIER -159.39 129.37 5.61 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 126.006 1.722 . . . . 0.0 111.336 -179.043 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 105' ' ' VAL . 26.8 m -99.6 118.53 36.34 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.9 mt -92.32 132.05 37.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.428 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -105.34 116.92 32.77 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.0 p -111.1 118.21 35.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.28 0.562 . . . . 0.0 111.36 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.658 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -102.59 135.76 38.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.481 ' OG ' ' CZ ' ' A' ' 100' ' ' TYR . 11.1 m -117.95 133.32 56.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.72 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -137.2 112.94 9.52 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.656 ' N ' ' CD1' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -102.28 103.31 13.77 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.989 -0.444 . . . . 0.0 110.122 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -91.04 107.98 19.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.119 0.485 . . . . 0.0 110.147 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -100.52 175.47 5.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.582 0.706 . . . . 0.0 111.127 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.484 ' HZ2' HG12 ' A' ' 125' ' ' ILE . 2.8 ptmm? -110.36 158.64 18.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.833 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 39.85 -111.13 0.2 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.613 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -112.75 0.4 15.27 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 122.502 -0.41 . . . . 0.0 111.515 179.339 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.484 HG12 ' HZ2' ' A' ' 122' ' ' LYS . 1.5 mp -44.39 160.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.155 0.502 . . . . 0.0 110.641 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.474 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 93.3 mt-10 -147.98 146.92 29.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.212 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 22.1 mm -89.16 122.07 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -75.59 162.43 28.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.439 0.638 . . . . 0.0 112.135 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -69.53 -55.02 11.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.667 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' A' ' 130' ' ' GLU . 1.5 pm0 -53.82 -24.25 14.91 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.931 -0.481 . . . . 0.0 110.992 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.513 ' CE1' ' OE2' ' A' ' 130' ' ' GLU . 9.8 m80 -73.55 -53.27 10.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.253 0.549 . . . . 0.0 110.067 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 3.9 m -77.81 -27.91 15.37 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.199 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -67.66 -46.1 73.36 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.979 -0.45 . . . . 0.0 110.928 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 28.2 m -70.0 -42.93 79.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.663 0.268 . . . . 0.0 110.548 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.74 -46.47 53.58 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 0.0 OUTLIER -67.36 -47.08 71.47 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 122.692 -0.299 . . . . 0.0 110.712 179.718 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -55.16 -48.2 74.07 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -62.4 -51.87 65.83 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -50.08 -53.73 25.19 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.722 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -47.4 -38.91 14.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.771 0.796 . . . . 0.0 109.358 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.55 -32.73 84.24 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 139' ' ' ALA . 0.6 OUTLIER -75.67 -36.3 60.14 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.698 0.761 . . . . 0.0 109.491 178.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -58.39 -25.47 62.13 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.57 -38.73 54.43 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.489 177.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.451 ' CD2' ' HB1' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -50.96 -58.64 5.53 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-O 122.442 1.115 . . . . 0.0 111.263 179.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.519 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 20.0 mt -72.81 -49.37 40.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.845 -177.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -46.07 -52.17 12.48 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.547 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 24.7 p -54.09 -44.98 71.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.153 0.502 . . . . 0.0 110.637 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.615 ' O ' ' N ' ' A' ' 153' ' ' HIS . 11.2 t80 -53.89 -45.95 71.23 Favored 'General case' 0 C--O 1.183 -2.417 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.519 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 1.6 mm? -69.5 -42.5 74.66 Favored 'General case' 0 C--O 1.218 -0.591 0 O-C-N 120.592 -1.317 . . . . 0.0 111.887 -177.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -25.48 68.22 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 121.569 -0.707 . . . . 0.0 109.594 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 149' ' ' TYR . 0.2 OUTLIER -106.98 -12.93 15.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.406 0.622 . . . . 0.0 110.307 178.304 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.615 ' N ' ' O ' ' A' ' 149' ' ' TYR . 13.5 t-80 -154.67 65.97 4.97 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 124.98 1.312 . . . . 0.0 110.23 -177.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.59 -3.12 11.26 Favored 'Trans proline' 0 N--CA 1.482 0.799 0 C-N-CA 122.576 2.184 . . . . 0.0 111.616 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.617 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 1.9 m-20 -74.52 2.66 9.13 Favored 'General case' 0 C--O 1.213 -0.859 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.913 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -50.33 129.48 21.7 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 119.354 -2.091 . . . . 0.0 110.996 -178.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 157' ' ' TYR . 86.2 t80 53.03 5.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.544 0 O-C-N 121.179 -0.95 . . . . 0.0 110.069 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.889 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.68 149.62 29.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 O-C-N 122.313 -0.522 . . . . 0.0 110.703 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.61 109.82 22.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.451 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.767 ' HG1' ' CE1' ' A' ' 118' ' ' HIS . 74.2 m -96.25 139.89 31.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.799 0.333 . . . . 0.0 111.004 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.08 130.56 25.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.08 179.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.466 ' C ' HD21 ' A' ' 7' ' ' ASN . 0.8 OUTLIER -103.24 128.39 50.27 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.735 0.303 . . . . 0.0 110.766 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.466 HD21 ' C ' ' A' ' 6' ' ' GLU . 1.5 m120 -126.73 168.37 14.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.519 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -155.2 142.48 19.44 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -146.57 139.92 25.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.629 0.252 . . . . 0.0 110.766 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.45 148.23 23.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 111.227 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.4 p -144.77 154.44 42.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.564 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -92.1 18.76 7.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.906 0.384 . . . . 0.0 110.786 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mt -108.06 126.01 30.74 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.194 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.01 147.37 7.89 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 121.6 1.533 . . . . 0.0 111.392 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -63.99 -23.68 67.59 Favored 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 122.503 2.135 . . . . 0.0 112.754 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.8 m -66.19 -32.28 73.62 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.633 ' N ' ' CD ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -81.73 -55.14 4.82 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -178.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.4 mt -47.05 -44.13 20.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.413 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 54.7 t80 -51.79 -59.29 4.47 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.843 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -23.37 63.16 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.698 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 26' ' ' ALA . . . -82.25 -2.96 54.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.676 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CE2' ' OH ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -119.47 -9.22 9.89 Favored 'General case' 0 C--O 1.23 0.069 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.843 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 19' ' ' PHE . 2.8 m -136.14 -37.02 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.582 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 3.4 mp -91.18 -52.89 4.6 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.208 0.913 . . . . 0.0 112.131 -176.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -112.49 -4.18 14.26 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.43 ' O ' ' CG1' ' A' ' 30' ' ' ILE . . . -55.02 -40.39 70.13 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 121.493 -0.755 . . . . 0.0 112.235 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -83.89 16.41 2.83 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.59 0.71 . . . . 0.0 110.905 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.499 ' C ' ' ND2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -139.46 -10.2 1.24 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.555 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.461 HD23 ' CD1' ' A' ' 149' ' ' TYR . 0.4 OUTLIER -88.15 -40.96 13.32 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.722 -1.127 . . . . 0.0 110.119 -178.294 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.472 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.14 -50.65 83.31 Favored Pre-proline 0 C--O 1.207 -1.141 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 19.2 Cg_endo -62.18 -24.88 76.63 Favored 'Trans proline' 0 C--N 1.319 -1.014 0 C-N-CA 121.682 1.588 . . . . 0.0 112.185 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -67.98 -62.26 1.49 Allowed 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 121.74 0.781 . . . . 0.0 112.076 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.474 ' CD1' ' O ' ' A' ' 145' ' ' LEU . 1.9 pt -95.29 -32.98 4.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.075 -177.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.496 ' CB ' ' HG ' ' A' ' 145' ' ' LEU . . . -101.97 74.29 0.14 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 123.746 0.818 . . . . 0.0 112.679 -175.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.74 -20.06 26.83 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 121.201 1.267 . . . . 0.0 109.081 175.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.471 ' NE2' ' C ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -72.99 -40.98 64.79 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.84 178.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.419 ' N ' ' NE2' ' A' ' 36' ' ' GLN . . . -70.81 -82.13 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.94 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.405 ' N ' ' CD1' ' A' ' 38' ' ' ILE . 2.0 mp -112.54 145.09 19.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.145 0.498 . . . . 0.0 110.637 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -78.36 -47.1 18.4 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.329 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.563 ' NE2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -173.86 164.54 4.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.986 0.422 . . . . 0.0 110.003 179.298 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.563 ' N ' ' NE2' ' A' ' 40' ' ' GLN . . . -166.1 145.57 6.09 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.746 178.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -138.59 142.71 39.16 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.39 140.0 17.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.501 0.667 . . . . 0.0 110.513 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.516 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 6.6 mp -89.39 -40.5 12.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.66 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.549 ' O ' ' CG2' ' A' ' 52' ' ' THR . 27.8 mm-40 -137.52 133.6 34.74 Favored 'General case' 0 C--O 1.215 -0.753 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.67 -156.59 46.46 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.501 ' H ' HD21 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -135.79 -4.93 2.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.777 0.322 . . . . 0.0 111.32 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 142.09 18.94 0.28 Allowed Glycine 0 C--O 1.221 -0.718 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.403 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -109.86 -172.91 20.53 Favored Glycine 0 C--O 1.224 -0.51 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -62.08 125.06 15.58 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 122.443 2.095 . . . . 0.0 113.009 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.58 5.67 60.06 Favored Glycine 0 N--CA 1.464 0.509 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.549 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 87.2 m -93.53 140.69 29.32 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.414 -0.893 . . . . 0.0 111.005 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -122.5 128.84 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.45 139.36 50.53 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.272 0.558 . . . . 0.0 110.76 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -118.47 124.76 48.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.989 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.544 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 1.7 mp -103.26 130.89 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.6 m -109.26 118.49 36.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.828 0.347 . . . . 0.0 110.28 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -92.83 -175.58 3.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.558 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.97 144.04 32.26 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -59.72 -62.77 1.62 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.881 0.372 . . . . 0.0 110.809 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.94 61.9 3.34 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.1 m -137.28 175.38 9.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.746 0.308 . . . . 0.0 110.69 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -55.1 -53.52 54.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.841 0.353 . . . . 0.0 110.561 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -91.99 154.57 18.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.381 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.39 -61.57 0.14 Allowed Glycine 0 N--CA 1.461 0.321 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -145.62 148.01 32.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.942 0.401 . . . . 0.0 110.377 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.76 145.57 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.821 0.343 . . . . 0.0 110.846 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -105.87 109.6 21.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.401 0.62 . . . . 0.0 111.558 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.614 ' HE2' ' CB ' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -106.38 113.73 27.43 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.245 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -102.31 130.05 48.91 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.5 mp -70.63 141.14 17.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -99.37 -55.58 2.64 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -165.6 141.56 5.22 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.5 mt -130.01 129.87 65.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 120.968 0.413 . . . . 0.0 110.57 177.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 79' ' ' TYR . 39.2 m-20 -115.78 88.57 2.91 Favored 'General case' 0 C--O 1.212 -0.897 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -53.75 -30.08 42.71 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.89 -37.36 71.28 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.122 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -107.62 -11.21 15.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.806 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.547 ' N ' ' O ' ' A' ' 75' ' ' ASP . 32.0 m-85 60.2 45.0 12.05 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 121.797 -0.564 . . . . 0.0 110.339 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 p -112.92 148.98 33.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.498 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 6.2 p90 -147.62 127.64 13.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.251 0.548 . . . . 0.0 111.182 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 m -130.32 147.13 52.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.241 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.614 ' CB ' ' HE2' ' A' ' 69' ' ' HIS . 15.0 p90 -153.68 168.25 26.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.824 0.345 . . . . 0.0 110.184 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.7 m -145.6 139.45 26.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.054 0.454 . . . . 0.0 111.388 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.9 mt -80.52 111.91 17.37 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.01 -41.81 68.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.252 -177.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.469 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 17.4 tp10 -156.39 171.82 19.57 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.621 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.59 177.83 17.45 Favored Glycine 0 CA--C 1.508 -0.373 0 N-CA-C 110.214 -1.155 . . . . 0.0 110.214 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -61.21 2.15 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.621 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -67.61 -36.03 80.07 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.982 0.913 . . . . 0.0 110.094 177.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.643 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -111.8 13.26 21.01 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 123.694 0.797 . . . . 0.0 109.253 -178.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.626 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 47.1 p 48.07 -126.32 1.84 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -177.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -131.17 -9.23 3.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.092 0.472 . . . . 0.0 110.51 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.6 t -104.9 -6.66 19.97 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.433 HG22 ' CD1' ' A' ' 98' ' ' ILE . 57.6 mt -100.62 151.6 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.418 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -87.08 -58.83 2.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.514 177.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -170.55 148.77 3.13 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.191 0.52 . . . . 0.0 110.867 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.433 ' CD1' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.66 120.85 62.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.566 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.416 ' O ' ' CD1' ' A' ' 100' ' ' TYR . 9.5 t -109.65 145.5 36.38 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.375 0.607 . . . . 0.0 111.199 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 99' ' ' SER . 19.5 m-85 -135.69 129.41 32.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.221 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -127.8 133.72 49.45 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.32 136.37 36.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.859 0.361 . . . . 0.0 110.069 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -119.73 132.77 55.73 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -102.76 134.98 45.25 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.126 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.413 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.6 OUTLIER -137.05 136.77 47.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.994 -178.613 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.75 135.16 45.25 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.525 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.459 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 31.3 t -121.15 174.57 6.59 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.608 0.363 . . . . 0.0 110.161 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.459 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -55.8 -30.74 57.24 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 112.236 -0.346 . . . . 0.0 112.236 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.9 p -91.73 -12.47 33.87 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 119.552 -2.146 . . . . 0.0 115.634 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.16 -85.17 0.13 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.839 1.209 . . . . 0.0 111.407 -171.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.409 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 1.3 p -165.56 134.73 3.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.402 1.481 . . . . 0.0 110.858 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 105' ' ' VAL . 97.8 m -98.81 117.44 33.3 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.6 mt -92.81 127.54 44.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.69 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -104.25 116.23 31.8 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 34.2 t -112.13 124.84 53.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.144 0.497 . . . . 0.0 111.432 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.605 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -105.41 136.04 41.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 123.152 0.581 . . . . 0.0 109.486 -178.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.15 132.56 54.05 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.378 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.767 ' CE1' ' HG1' ' A' ' 4' ' ' THR . 26.1 m-70 -137.17 106.05 5.93 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 117.819 0.282 . . . . 0.0 110.91 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.423 ' CD2' ' N ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER -101.45 103.83 14.75 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -89.97 109.8 20.81 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.18 0.514 . . . . 0.0 109.965 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.483 ' CG2' ' O ' ' A' ' 125' ' ' ILE . 0.6 OUTLIER -95.05 164.45 12.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.356 -178.219 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.403 ' H ' ' CG2' ' A' ' 125' ' ' ILE . 11.4 mtmt -92.46 146.92 23.31 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 34.0 -115.97 0.16 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.606 HD21 ' N ' ' A' ' 125' ' ' ILE . 0.4 OUTLIER -95.11 -13.73 24.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.812 0.339 . . . . 0.0 110.177 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.606 ' N ' HD21 ' A' ' 124' ' ' ASN . 1.1 tp -48.82 163.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -149.35 150.5 32.57 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.683 -0.635 . . . . 0.0 112.049 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 26.7 mm -86.67 124.89 40.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -75.25 160.79 29.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.587 0.708 . . . . 0.0 112.055 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -70.22 -43.57 70.38 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.382 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -60.44 -24.87 65.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.348 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.424 ' HE2' HG22 ' A' ' 92' ' ' THR . 4.6 t60 -72.7 -52.46 15.13 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.371 0.605 . . . . 0.0 110.86 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.5 m -76.09 -26.31 17.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.909 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -67.62 -46.27 73.02 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.403 -0.186 . . . . 0.0 111.094 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 34.6 m -69.85 -43.99 79.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.13 -43.33 93.45 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -67.23 -46.98 72.17 Favored 'General case' 0 CA--C 1.518 -0.258 0 O-C-N 122.789 -0.242 . . . . 0.0 110.973 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -54.94 -47.63 74.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.879 0.371 . . . . 0.0 110.054 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.64 -55.13 22.18 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.403 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -47.67 -45.25 27.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.535 0.683 . . . . 0.0 110.776 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -56.83 -37.4 71.2 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.87 0.843 . . . . 0.0 109.3 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.16 -38.66 96.52 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -68.64 -36.53 78.72 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -59.04 -32.36 69.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.32 -34.44 77.36 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.868 177.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.496 ' HG ' ' CB ' ' A' ' 34' ' ' ALA . 1.2 mm? -68.27 -58.26 4.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.566 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.491 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 66.3 mt -60.79 -48.67 87.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.743 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -46.38 -52.96 11.89 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.14 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 21.5 p -50.17 -44.68 52.83 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.344 0.592 . . . . 0.0 111.349 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.68 ' O ' ' N ' ' A' ' 153' ' ' HIS . 32.9 t80 -58.5 -45.5 88.64 Favored 'General case' 0 C--O 1.182 -2.499 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.491 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 2.0 mm? -65.06 -42.02 94.58 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 119.917 1.235 . . . . 0.0 111.966 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.455 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.4 OUTLIER -64.76 -24.98 67.73 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -106.58 -12.54 15.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.276 0.56 . . . . 0.0 110.961 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.68 ' N ' ' O ' ' A' ' 149' ' ' TYR . 94.1 m-70 -156.54 66.53 4.18 Favored Pre-proline 0 C--N 1.303 -1.429 0 C-N-CA 125.689 1.596 . . . . 0.0 110.59 -177.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.48 -2.72 11.15 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 122.468 2.112 . . . . 0.0 111.474 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.615 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -77.36 3.7 12.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.914 -178.472 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -49.08 129.28 17.54 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 119.269 -2.145 . . . . 0.0 111.186 -178.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.505 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 23.6 t80 54.08 6.73 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.048 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.438 0 O-C-N 121.402 -0.811 . . . . 0.0 110.225 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.85 148.87 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 122.544 -0.386 . . . . 0.0 110.91 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -97.89 109.73 22.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.526 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.2 m -97.05 136.03 38.19 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.67 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -135.47 129.29 32.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.328 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.404 ' C ' ' ND2' ' A' ' 7' ' ' ASN . 1.2 tt0 -103.14 134.16 47.03 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.643 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.404 ' ND2' ' C ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -127.14 168.78 14.19 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.627 -179.25 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -150.71 140.31 21.61 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -144.42 129.15 18.25 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.515 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 m -100.42 144.05 29.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.787 0.327 . . . . 0.0 111.653 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.583 ' HG ' ' CD ' ' A' ' 147' ' ' GLU . 7.0 t -145.43 164.34 31.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.485 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -94.66 25.75 3.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.746 0.308 . . . . 0.0 111.16 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -111.55 125.42 30.44 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.781 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -50.42 147.56 16.54 Favored 'Trans proline' 0 C--N 1.327 -0.594 0 C-N-CA 121.953 1.769 . . . . 0.0 111.652 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -58.3 -25.08 71.03 Favored 'Trans proline' 0 N--CA 1.483 0.863 0 C-N-CA 122.279 1.986 . . . . 0.0 112.623 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.41 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . 55.4 m -67.62 -35.27 78.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.311 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -75.42 -57.06 4.12 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 mt -50.17 -44.69 52.91 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.008 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -49.4 -58.68 4.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.005 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.41 ' NZ ' ' O ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -67.57 -40.35 84.87 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 118.83 -1.148 . . . . 0.0 108.415 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.59 -2.99 2.7 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.445 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -118.35 -9.26 10.42 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.22 -50.95 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.531 ' CD1' ' N ' ' A' ' 25' ' ' ASP . 1.9 pp -98.06 -31.32 12.2 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.531 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 26.9 m-20 -114.21 -3.96 13.13 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-N 118.648 0.658 . . . . 0.0 111.555 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -66.88 -39.54 87.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.989 0.899 . . . . 0.0 111.187 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.52 16.99 3.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.125 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -138.35 -9.5 1.47 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -90.47 -50.22 6.07 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.585 -1.643 . . . . 0.0 109.631 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.43 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 96.0 mt -55.65 -51.6 78.87 Favored Pre-proline 0 C--O 1.212 -0.883 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.054 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 29.1 Cg_endo -62.49 -26.05 76.13 Favored 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 121.747 1.632 . . . . 0.0 112.948 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.54 -60.79 2.08 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.633 0.73 . . . . 0.0 112.435 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.424 ' O ' ' CD ' ' A' ' 35' ' ' PRO . 1.9 pt -93.07 -33.03 5.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.583 -177.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.491 ' CB ' ' HG ' ' A' ' 145' ' ' LEU . . . -102.79 68.15 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 123.121 0.569 . . . . 0.0 112.311 -177.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.424 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 66.7 Cg_endo -72.89 -19.15 23.86 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 N-CA-C 108.726 -1.298 . . . . 0.0 108.726 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -73.4 -39.41 65.11 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.693 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.36 -82.15 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.69 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 73.3 mt -110.74 145.05 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.044 0.45 . . . . 0.0 110.588 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -77.8 -47.69 18.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.421 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.613 ' NE2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -174.02 164.82 4.19 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.754 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.613 ' N ' ' NE2' ' A' ' 40' ' ' GLN . . . -164.73 145.82 7.86 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.841 0.353 . . . . 0.0 110.993 178.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -137.63 145.5 42.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.716 0.293 . . . . 0.0 110.258 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.54 139.54 18.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.476 0.655 . . . . 0.0 110.654 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.502 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 6.9 mp -88.98 -39.48 13.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.795 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.514 ' O ' ' CG2' ' A' ' 52' ' ' THR . 42.9 mt-10 -141.89 133.57 27.0 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.843 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.24 -156.33 29.41 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.736 HD22 ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -139.76 -8.3 1.24 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.96 0.41 . . . . 0.0 111.131 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.736 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 143.46 16.22 0.26 Allowed Glycine 0 C--O 1.219 -0.814 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.41 -172.04 19.99 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 117.394 0.597 . . . . 0.0 111.907 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -62.74 126.05 17.37 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 C-N-CA 122.858 2.372 . . . . 0.0 113.307 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.19 5.97 59.14 Favored Glycine 0 CA--C 1.506 -0.523 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.514 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 92.7 m -93.18 138.65 31.39 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 114.239 -0.981 . . . . 0.0 110.949 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.89 128.46 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.79 139.79 50.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.726 0.774 . . . . 0.0 110.676 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -118.47 127.84 54.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.828 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 2.0 mp -104.47 136.61 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.9 m -117.15 120.0 36.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.368 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.04 169.06 10.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.365 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.11 143.99 28.82 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.553 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 0.8 OUTLIER -59.86 -50.38 74.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.849 0.357 . . . . 0.0 110.468 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.71 61.47 3.47 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.6 t -145.49 178.97 7.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 110.653 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -66.63 -45.68 78.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 0.0 110.626 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -91.46 154.74 18.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.397 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.44 -61.71 0.13 Allowed Glycine 0 CA--C 1.52 0.347 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.53 154.93 42.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.754 0.311 . . . . 0.0 110.28 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.83 149.95 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.723 0.297 . . . . 0.0 111.202 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.57 113.43 26.99 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.527 0.68 . . . . 0.0 112.044 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.607 ' CE1' ' CD1' ' A' ' 83' ' ' TYR . 6.7 t60 -109.63 112.08 23.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.721 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -102.4 131.44 49.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.144 0.497 . . . . 0.0 111.858 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.8 mt -86.17 143.08 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.584 ' C ' ' HG ' ' A' ' 73' ' ' SER . 35.3 t70 -106.66 -54.89 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.584 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 57.2 m -164.81 141.92 6.14 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 53.9 mt -124.81 131.26 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.872 176.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' A' ' 79' ' ' TYR . 5.8 m-20 -114.93 87.42 2.65 Favored 'General case' 0 C--O 1.21 -1.023 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.502 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 7.4 pt-20 -55.04 -30.63 59.97 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.57 -37.7 68.38 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.4 m -107.76 -10.46 15.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.922 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.56 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.2 m-85 62.84 44.57 6.19 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.625 -0.672 . . . . 0.0 109.865 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -105.96 145.66 31.03 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.469 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -132.13 120.82 22.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.191 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.473 ' CB ' ' OE1' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -127.11 133.25 50.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.321 -179.675 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.607 ' CD1' ' CE1' ' A' ' 69' ' ' HIS . 24.6 p90 -144.11 170.75 15.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.827 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.1 m -145.94 125.69 13.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.018 0.437 . . . . 0.0 110.876 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.08 118.25 20.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.75 -41.81 15.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -175.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.499 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 10.0 tp10 -162.59 174.75 12.2 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 118.948 0.795 . . . . 0.0 110.816 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.616 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 119.76 178.31 16.38 Favored Glycine 0 CA--C 1.505 -0.578 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.6 2.75 0.16 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.616 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -72.07 -37.38 69.64 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 123.917 0.887 . . . . 0.0 111.22 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.607 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -111.29 17.04 20.61 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 119.672 -0.204 . . . . 0.0 110.625 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.488 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 30.4 p 54.25 -133.4 1.74 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -177.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -131.81 -0.7 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.5 p -104.72 -7.71 19.35 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 6.9 mt -99.2 151.25 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.481 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -87.07 -50.5 6.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.351 176.165 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.436 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 12.1 ptmt -172.61 149.56 2.09 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.9 130.38 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.155 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.434 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -113.15 144.26 42.96 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.902 0.481 . . . . 0.0 111.015 -179.037 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.489 ' CE1' ' OG ' ' A' ' 117' ' ' SER . 0.3 OUTLIER -139.22 131.55 28.39 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.87 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.473 ' OE1' ' CB ' ' A' ' 82' ' ' SER . 8.9 tp10 -128.73 133.0 48.01 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.408 ' N ' ' CD ' ' A' ' 101' ' ' GLU . 0.5 OUTLIER -136.26 131.63 34.71 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 121.596 -0.69 . . . . 0.0 110.631 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -124.33 134.17 53.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.863 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.597 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -100.6 126.17 47.05 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -178.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -128.32 136.69 59.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.959 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.68 133.42 44.61 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.117 -0.364 . . . . 0.0 110.596 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 24.7 t -121.7 173.35 7.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.547 0.339 . . . . 0.0 110.158 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.443 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -54.4 -36.61 58.3 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.901 -0.479 . . . . 0.0 111.901 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.9 m -93.98 15.94 15.66 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.25 1.42 . . . . 0.0 113.363 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 130.0 -83.99 0.32 Allowed Glycine 0 CA--C 1.534 1.235 0 C-N-CA 126.4 1.952 . . . . 0.0 113.095 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 84.1 p -161.62 132.13 5.04 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 126.99 2.116 . . . . 0.0 111.057 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 45.0 m -99.83 118.12 35.61 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 60.5 mt -92.72 126.83 45.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.57 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.62 116.86 32.65 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 p -111.62 124.3 52.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.335 0.588 . . . . 0.0 110.877 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.654 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -106.8 136.18 42.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 123.148 0.579 . . . . 0.0 109.922 -177.699 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.489 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 7.2 t -116.52 133.04 56.48 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.788 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.434 ' ND1' ' O ' ' A' ' 99' ' ' SER . 0.2 OUTLIER -136.47 109.35 7.61 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 120.766 0.317 . . . . 0.0 110.522 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 119' ' ' TYR . 7.3 m-85 -102.14 104.02 14.61 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.228 -0.295 . . . . 0.0 110.512 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -90.86 110.16 21.37 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.064 0.459 . . . . 0.0 109.823 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.4 p -94.1 171.3 8.93 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 122.021 0.915 . . . . 0.0 111.929 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.569 ' HZ1' HG12 ' A' ' 125' ' ' ILE . 2.7 ptmm? -112.93 142.57 45.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.829 178.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 53.83 -109.68 1.19 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.573 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.1 OUTLIER -117.48 2.26 12.4 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 122.299 -0.53 . . . . 0.0 111.264 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.569 HG12 ' HZ1' ' A' ' 122' ' ' LYS . 1.4 mp -43.45 161.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.344 0.592 . . . . 0.0 110.812 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.484 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 9.9 pt-20 -148.31 150.28 33.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.238 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.6 mm -87.78 125.62 41.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -74.88 160.89 30.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.11 0.481 . . . . 0.0 111.002 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -70.1 -39.7 75.37 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.566 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -66.47 -25.15 66.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.587 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -72.42 -51.17 21.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.387 0.613 . . . . 0.0 110.81 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 m -78.42 -30.6 15.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.07 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -66.83 -46.0 76.5 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 122.156 -0.34 . . . . 0.0 111.077 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 25.4 m -70.5 -44.71 76.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.611 0.243 . . . . 0.0 110.771 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.06 -46.83 57.3 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -67.45 -50.49 58.99 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.504 -0.409 . . . . 0.0 110.866 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -55.27 -47.77 74.98 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -63.15 -53.64 50.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.429 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -48.49 -47.86 38.34 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.412 0.625 . . . . 0.0 110.837 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -54.26 -37.61 64.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.02 -32.4 84.05 Favored Glycine 0 C--O 1.228 -0.247 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.516 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -74.61 -41.06 61.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -59.33 -25.72 64.42 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -76.29 -33.76 59.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.85 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.491 ' HG ' ' CB ' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -66.26 -56.78 9.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.1 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.453 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 61.9 mt -65.02 -48.73 82.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.653 -178.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.583 ' CD ' ' HG ' ' A' ' 11' ' ' SER . 18.0 tt0 -47.0 -47.57 22.01 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.158 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.0 t -54.84 -42.95 72.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.469 0.652 . . . . 0.0 111.26 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.636 ' O ' ' N ' ' A' ' 153' ' ' HIS . 26.8 t80 -59.08 -44.67 91.92 Favored 'General case' 0 C--O 1.191 -1.997 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.485 ' H ' ' CD2' ' A' ' 150' ' ' LEU . 1.9 mm? -66.21 -42.48 88.7 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 119.491 1.041 . . . . 0.0 111.794 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -24.83 67.75 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 121.525 -0.734 . . . . 0.0 109.329 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.438 ' O ' ' ND1' ' A' ' 153' ' ' HIS . 28.6 t70 -106.22 -13.42 15.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.034 0.445 . . . . 0.0 110.774 178.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.636 ' N ' ' O ' ' A' ' 149' ' ' TYR . 54.4 m80 -155.82 66.8 4.63 Favored Pre-proline 0 C--N 1.309 -1.168 0 C-N-CA 125.425 1.49 . . . . 0.0 110.43 -178.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -74.18 -3.37 13.7 Favored 'Trans proline' 0 C--N 1.324 -0.739 0 C-N-CA 122.579 2.186 . . . . 0.0 111.522 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.612 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 4.0 p-10 -81.95 4.82 21.16 Favored 'General case' 0 C--O 1.21 -0.975 0 C-N-CA 123.953 0.901 . . . . 0.0 111.991 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.463 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -49.35 129.79 18.96 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 119.325 -2.11 . . . . 0.0 111.395 -178.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.419 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 13.6 t80 55.0 6.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.612 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.197 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.653 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -134.66 148.96 29.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 122.547 -0.384 . . . . 0.0 111.032 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.76 111.82 23.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.345 177.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.3 m -96.09 134.82 38.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.002 0.43 . . . . 0.0 110.2 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.688 ' CE2' ' ND2' ' A' ' 7' ' ' ASN . 0.2 OUTLIER -131.54 122.19 25.72 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.651 ' C ' HD21 ' A' ' 7' ' ' ASN . 1.5 tt0 -117.04 127.8 54.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.149 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.688 ' ND2' ' CE2' ' A' ' 5' ' ' PHE . 1.4 m-80 -138.26 175.74 9.31 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.591 0.234 . . . . 0.0 110.818 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -144.31 156.17 44.14 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -149.86 134.04 17.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.954 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -92.91 144.84 24.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.859 0.362 . . . . 0.0 111.803 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.45 154.02 50.0 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.114 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -96.38 28.18 3.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.044 0.45 . . . . 0.0 110.715 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -119.04 126.03 27.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.73 -178.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -46.99 145.64 6.94 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 121.823 1.682 . . . . 0.0 111.758 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -55.78 -29.73 73.14 Favored 'Trans proline' 0 N--CA 1.482 0.805 0 C-N-CA 122.263 1.975 . . . . 0.0 112.808 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.9 m -63.86 -35.46 80.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -74.96 -59.2 2.84 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 mt -50.88 -42.41 59.05 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.967 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -50.24 -57.44 7.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.675 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' HA ' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.89 -40.74 75.49 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 118.572 -1.251 . . . . 0.0 109.102 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.49 -2.74 1.7 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.648 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -118.96 -9.35 10.08 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.405 HG22 HD12 ' A' ' 24' ' ' LEU . 3.6 m -132.54 -49.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.657 ' H ' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -99.09 -31.56 11.71 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.033 1.288 . . . . 0.0 112.03 -178.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -107.68 -3.97 18.66 Favored 'General case' 0 C--O 1.211 -0.953 0 O-C-N 122.082 -0.386 . . . . 0.0 111.432 -178.511 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.457 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -67.05 -40.33 87.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.742 0.782 . . . . 0.0 111.728 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -84.02 13.89 4.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.837 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -134.85 -9.34 2.37 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.546 ' O ' ' CG1' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -96.71 -48.13 5.61 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.949 -179.693 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.8 mt -54.45 -56.1 30.38 Favored Pre-proline 0 C--O 1.217 -0.624 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.37 -26.32 71.11 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 C-N-CA 122.298 1.999 . . . . 0.0 113.886 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -71.69 -49.41 39.9 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.601 0.715 . . . . 0.0 111.896 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.546 ' CG1' ' O ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -94.76 -34.81 5.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.674 -177.472 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.443 ' N ' ' HG ' ' A' ' 145' ' ' LEU . . . -105.58 64.07 0.14 Allowed Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.413 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 73.0 Cg_endo -76.59 -24.46 10.37 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 N-CA-C 107.909 -1.612 . . . . 0.0 107.909 174.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -73.79 -44.2 56.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.411 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.11 -77.76 0.09 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.15 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 mt -100.32 146.22 9.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 121.085 0.469 . . . . 0.0 110.191 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -78.08 -53.18 7.68 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.22 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.589 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -173.14 165.86 4.92 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.157 0.503 . . . . 0.0 110.578 179.758 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.589 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -166.07 145.21 6.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.966 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -149.2 142.34 24.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.897 0.38 . . . . 0.0 110.412 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.418 ' N ' ' HZ2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -78.74 140.72 16.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.358 0.599 . . . . 0.0 111.201 -179.356 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.501 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 3.7 mp -90.47 -39.86 12.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.494 178.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.452 ' O ' HG22 ' A' ' 52' ' ' THR . 13.9 mm-40 -143.23 134.87 26.47 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.306 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.95 -155.02 22.23 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.991 -0.443 . . . . 0.0 111.991 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.68 HD21 ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -135.53 -11.72 2.1 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 123.416 0.686 . . . . 0.0 111.315 -177.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.68 ' N ' HD21 ' A' ' 47' ' ' ASN . . . 135.2 12.23 1.28 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -178.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.63 -172.28 19.87 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -59.05 127.24 23.5 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 122.479 2.119 . . . . 0.0 113.283 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.84 4.8 55.54 Favored Glycine 0 N--CA 1.462 0.384 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 45' ' ' GLU . 19.3 m -94.18 142.06 27.84 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.626 -0.787 . . . . 0.0 111.883 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -118.17 132.86 66.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 176.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.418 ' HZ2' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -121.82 139.39 53.67 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.465 0.65 . . . . 0.0 111.148 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -119.23 118.73 32.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.293 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.23 137.69 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.634 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.1 m -118.97 117.77 29.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.165 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -94.91 -175.14 3.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.434 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.59 144.39 30.08 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.448 ' N ' ' CD ' ' A' ' 60' ' ' GLU . 7.3 mp0 -60.18 -59.48 5.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.924 0.392 . . . . 0.0 110.29 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.98 60.82 3.43 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.6 m -138.89 -178.13 5.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.129 0.49 . . . . 0.0 110.706 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.525 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 1.8 mp0 -68.4 -44.14 75.74 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.441 ' CD1' ' OD2' ' A' ' 89' ' ' ASP . 52.2 m-85 -91.58 145.12 24.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.97 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.3 -62.08 0.12 Allowed Glycine 0 CA--C 1.519 0.299 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -146.14 151.91 38.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.843 0.354 . . . . 0.0 110.494 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -157.21 150.29 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.946 0.403 . . . . 0.0 111.279 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -105.57 106.79 17.45 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.175 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.489 ' HE2' ' CB ' ' A' ' 83' ' ' TYR . 1.2 t-160 -105.24 111.02 23.61 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -105.2 128.83 53.6 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.816 0.341 . . . . 0.0 111.497 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.03 144.96 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.632 ' C ' ' HG ' ' A' ' 73' ' ' SER . 22.2 t0 -98.89 -55.51 2.69 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.792 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.632 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 62.9 m -165.94 141.22 4.8 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.5 mt -123.41 131.8 72.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 176.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 79' ' ' TYR . 2.8 m-20 -115.92 87.96 2.79 Favored 'General case' 0 C--O 1.208 -1.125 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -54.39 -29.89 50.26 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.73 75.66 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.023 177.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -107.11 -11.3 15.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.052 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.574 ' N ' ' O ' ' A' ' 75' ' ' ASP . 9.0 m-85 60.3 44.16 12.78 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.537 -0.727 . . . . 0.0 110.45 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 34.4 t -109.75 146.24 35.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.835 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -131.65 123.29 27.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.004 0.43 . . . . 0.0 111.111 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.35 134.65 48.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.056 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.489 ' CB ' ' HE2' ' A' ' 69' ' ' HIS . 22.4 p90 -143.93 166.03 26.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.903 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.0 m -145.9 135.3 23.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.17 0.509 . . . . 0.0 111.189 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.2 mt -80.75 117.09 21.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.468 ' CG1' ' N ' ' A' ' 87' ' ' GLU . 4.1 pt -81.68 -44.58 20.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.798 0.332 . . . . 0.0 111.487 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.468 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 19.9 tt0 -151.42 172.5 15.86 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.761 0.315 . . . . 0.0 110.451 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.573 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.74 177.23 18.44 Favored Glycine 0 CA--C 1.509 -0.287 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.441 ' OD2' ' CD1' ' A' ' 64' ' ' TYR . 6.4 p30 -61.27 1.12 0.21 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.573 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -62.92 -35.3 79.62 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.004 0.922 . . . . 0.0 109.931 177.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.601 ' C ' ' HG1' ' A' ' 92' ' ' THR . 0.0 OUTLIER -110.89 12.66 22.25 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 123.802 0.841 . . . . 0.0 109.575 -177.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.601 ' HG1' ' C ' ' A' ' 91' ' ' LEU . 70.1 p 47.82 -126.3 1.78 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -130.44 -11.3 4.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.991 0.425 . . . . 0.0 111.07 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.4 -6.72 19.29 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 96.3 mt -98.16 152.01 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-O 122.251 1.024 . . . . 0.0 113.56 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.546 ' OE2' ' CE1' ' A' ' 120' ' ' HIS . 0.0 OUTLIER -91.08 -54.12 4.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.932 177.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.66 145.74 1.57 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.038 0.447 . . . . 0.0 111.943 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.428 ' CD1' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.41 132.64 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.222 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.472 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 0.3 OUTLIER -119.36 144.87 46.64 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.723 0.409 . . . . 0.0 111.51 -178.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.472 ' CD2' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -136.35 130.26 32.58 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.798 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -129.41 134.14 47.7 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.524 0.202 . . . . 0.0 110.511 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.7 OUTLIER -132.27 135.56 46.33 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.922 -0.486 . . . . 0.0 109.719 -179.037 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -119.53 133.82 55.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.58 126.07 40.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.466 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.426 ' C ' ' HG ' ' A' ' 111' ' ' SER . 1.1 m -137.27 135.25 47.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.422 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.33 138.72 45.56 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 121.936 -0.477 . . . . 0.0 110.304 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 52.4 t -121.34 170.39 9.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.889 0.376 . . . . 0.0 110.317 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.551 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.56 -34.75 50.13 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.9 m -85.41 -15.06 44.3 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.112 1.365 . . . . 0.0 114.321 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.18 -85.64 0.13 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.92 1.724 . . . . 0.0 111.396 -171.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.427 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 41.2 t -161.32 132.73 5.48 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.654 1.582 . . . . 0.0 111.221 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 55.0 m -99.92 128.76 45.98 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.299 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.2 mt -101.51 127.79 54.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.548 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 102' ' ' THR . 3.3 mtpt -105.37 116.89 32.71 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.68 123.08 49.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.954 0.407 . . . . 0.0 110.548 -178.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.61 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -109.65 136.39 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.358 -177.496 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.3 t -118.05 133.24 56.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.544 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.472 ' ND1' ' O ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -136.79 103.81 5.31 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 120.913 0.387 . . . . 0.0 110.176 -179.407 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.543 ' CD2' ' N ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER -97.33 108.41 21.13 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.029 -0.42 . . . . 0.0 110.524 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.546 ' CE1' ' OE2' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -88.98 104.74 17.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.793 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.3 p -88.52 170.42 10.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.996 0.903 . . . . 0.0 111.731 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.431 ' HZ3' ' HB2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -113.02 156.26 23.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.882 179.424 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . 35.07 -109.24 0.06 OUTLIER Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 124' ' ' ASN . 4.4 t30 -111.41 -2.79 15.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.939 0.399 . . . . 0.0 111.063 178.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.3 mp -43.21 160.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.274 0.559 . . . . 0.0 110.572 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.429 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 34.7 tt0 -152.54 148.7 27.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.284 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.2 mm -88.15 124.79 41.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -74.74 161.72 29.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.421 0.629 . . . . 0.0 111.698 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -69.72 -41.74 74.94 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.775 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -62.25 -27.09 68.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.713 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -73.03 -49.99 25.6 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.417 0.627 . . . . 0.0 111.342 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 m -77.61 -29.86 16.57 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.192 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -67.15 -45.73 76.18 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.22 -0.3 . . . . 0.0 110.96 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.99 -44.25 85.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.792 0.329 . . . . 0.0 110.287 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.37 -39.18 91.68 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -67.05 -47.22 71.99 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.711 -0.288 . . . . 0.0 110.661 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -55.2 -46.81 75.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.949 0.404 . . . . 0.0 110.201 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -64.71 -52.51 56.77 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.47 -42.66 43.86 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.55 0.691 . . . . 0.0 110.56 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.414 ' O ' ' ND1' ' A' ' 140' ' ' HIS . 1.3 t60 -60.97 -36.09 78.51 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.891 0.853 . . . . 0.0 109.51 178.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -61.23 -44.79 97.66 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.415 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -65.57 -40.54 92.89 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -59.79 -28.69 67.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -77.49 -35.9 53.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.286 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.462 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -68.26 -57.69 5.58 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.514 0.674 . . . . 0.0 110.23 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.531 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 45.1 mt -58.21 -50.04 79.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.661 -177.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -46.87 -55.21 8.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.622 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 41.8 t -52.91 -44.49 66.99 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.508 0.671 . . . . 0.0 110.971 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.634 ' O ' ' N ' ' A' ' 153' ' ' HIS . 24.8 t80 -58.58 -45.58 88.74 Favored 'General case' 0 C--O 1.194 -1.832 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' A' ' 146' ' ' ILE . 2.2 mm? -66.22 -43.18 87.42 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 120.257 1.389 . . . . 0.0 111.565 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.417 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -61.5 -24.09 66.36 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 121.489 -0.757 . . . . 0.0 109.159 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.469 ' OD2' ' CE1' ' A' ' 153' ' ' HIS . 10.6 t70 -105.73 -13.26 15.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.46 0.648 . . . . 0.0 110.595 178.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 149' ' ' TYR . 56.0 m80 -155.51 67.14 4.89 Favored Pre-proline 0 C--N 1.312 -1.05 0 C-N-CA 125.199 1.4 . . . . 0.0 110.101 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.51 -3.62 14.02 Favored 'Trans proline' 0 N--CA 1.481 0.756 0 C-N-CA 122.566 2.177 . . . . 0.0 111.576 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.618 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.5 OUTLIER -83.9 5.16 26.37 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.953 -179.026 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -48.97 129.89 17.83 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 119.594 -1.941 . . . . 0.0 111.394 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.401 ' N ' ' OD2' ' A' ' 25' ' ' ASP . 0.3 OUTLIER 56.11 6.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.987 0.515 . . . . 0.0 112.059 178.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.618 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.202 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.46 148.49 29.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.829 0.347 . . . . 0.0 110.715 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.76 109.7 22.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.601 177.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.7 m -96.53 137.27 35.86 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.313 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -135.52 129.18 32.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.471 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.439 ' C ' HD21 ' A' ' 7' ' ' ASN . 1.5 tt0 -103.36 129.39 50.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.94 0.4 . . . . 0.0 110.749 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.56 ' ND2' ' N ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -142.89 164.75 29.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -178.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -155.51 159.53 39.82 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -144.56 140.78 29.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.341 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.03 147.68 24.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 111.521 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.674 ' HG ' ' CD ' ' A' ' 147' ' ' GLU . 21.3 t -145.36 164.2 32.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.688 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -102.88 23.98 11.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.891 0.376 . . . . 0.0 110.843 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mt -112.57 126.61 28.05 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.627 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -47.35 144.21 10.05 Favored 'Trans proline' 0 C--N 1.326 -0.613 0 C-N-CA 122.019 1.813 . . . . 0.0 111.974 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -55.45 -24.55 44.26 Favored 'Trans proline' 0 N--CA 1.484 0.931 0 C-N-CA 122.361 2.04 . . . . 0.0 112.7 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.444 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 13.2 p -70.08 -37.04 75.36 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -75.22 -47.65 27.17 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.2 mt -57.42 -48.29 79.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.554 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -46.18 -57.51 4.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.081 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -69.72 -26.02 64.13 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.579 0.704 . . . . 0.0 109.953 -179.296 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.72 -2.57 56.53 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.293 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -117.55 -9.02 10.89 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.3 m -134.62 -36.76 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.611 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 2.5 mp -92.29 -53.06 4.38 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.185 0.902 . . . . 0.0 111.391 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.459 ' OD2' ' N ' ' A' ' 25' ' ' ASP . 1.4 m-20 -114.37 13.8 17.83 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 116.846 -0.161 . . . . 0.0 111.358 -176.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.436 ' O ' ' CG1' ' A' ' 30' ' ' ILE . . . -66.9 -42.17 85.93 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 121.244 0.545 . . . . 0.0 111.192 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -83.94 18.59 1.99 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.075 0.941 . . . . 0.0 110.259 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.418 ' H ' ' H ' ' A' ' 29' ' ' LEU . 13.6 m-80 -135.95 -9.11 2.07 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.418 ' H ' ' H ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -90.65 -51.31 5.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.493 -1.685 . . . . 0.0 110.706 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.474 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -58.5 -52.16 76.63 Favored Pre-proline 0 C--O 1.215 -0.723 0 CA-C-O 120.777 0.323 . . . . 0.0 110.742 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 22.8 Cg_endo -60.5 -21.79 69.6 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 C-N-CA 122.632 2.222 . . . . 0.0 112.763 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -75.22 -52.06 11.82 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.839 0.352 . . . . 0.0 111.07 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.5 ' CD1' ' O ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -95.2 -35.04 5.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.159 -177.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.448 ' N ' ' CD1' ' A' ' 145' ' ' LEU . . . -106.77 81.54 0.91 Allowed Pre-proline 0 CA--C 1.507 -0.679 0 C-N-CA 122.78 0.432 . . . . 0.0 111.728 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.15 -10.71 27.84 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 N-CA-C 107.227 -1.874 . . . . 0.0 107.227 174.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -42.29 58.24 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.402 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.79 -82.03 0.06 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.874 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.1 mm -107.63 142.82 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.965 0.412 . . . . 0.0 110.974 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -79.73 -45.12 19.48 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.67 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.581 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -178.6 166.28 1.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.814 179.024 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.581 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -166.13 145.06 5.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.241 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -141.43 146.05 36.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.208 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.67 139.6 18.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.471 0.653 . . . . 0.0 110.703 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.464 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 7.3 mp -88.52 -39.87 13.85 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.129 -0.942 . . . . 0.0 108.684 178.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.496 ' O ' ' CG2' ' A' ' 52' ' ' THR . 24.1 mt-10 -142.52 133.75 26.13 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.976 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.58 -156.15 24.57 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.446 ' H ' HD21 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -139.76 -10.62 1.18 Allowed 'General case' 0 C--N 1.32 -0.698 0 O-C-N 122.529 -0.394 . . . . 0.0 110.975 -179.613 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.6 13.09 0.32 Allowed Glycine 0 C--O 1.221 -0.718 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.26 -171.24 20.67 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 117.344 0.572 . . . . 0.0 112.089 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -62.53 126.15 17.73 Favored 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 123.024 2.483 . . . . 0.0 113.58 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.27 5.84 56.94 Favored Glycine 0 N--CA 1.463 0.479 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.496 ' CG2' ' O ' ' A' ' 45' ' ' GLU . 88.3 m -93.37 140.5 29.5 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.271 -0.964 . . . . 0.0 111.145 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -119.18 129.98 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.16 140.93 49.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.074 0.464 . . . . 0.0 111.047 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -118.96 128.64 54.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.173 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.431 ' CD1' ' N ' ' A' ' 56' ' ' ILE . 3.2 mp -105.21 125.36 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.715 -0.394 . . . . 0.0 109.956 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.1 m -102.54 118.61 37.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -92.62 -174.83 3.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.76 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.73 143.86 31.61 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.408 ' N ' ' CD ' ' A' ' 60' ' ' GLU . 8.9 mp0 -60.72 -63.57 1.25 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.909 0.385 . . . . 0.0 110.653 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.77 62.2 3.36 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.8 t -136.7 178.52 7.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.908 0.385 . . . . 0.0 110.754 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -60.81 -49.66 76.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.745 0.307 . . . . 0.0 111.018 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -91.92 137.83 32.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.496 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.4 -58.72 0.52 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.439 ' CD2' ' N ' ' A' ' 66' ' ' TYR . 7.3 p90 -145.71 152.42 39.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.001 0.429 . . . . 0.0 110.652 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.3 p -156.69 141.99 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.844 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.467 ' O ' ' CD1' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -108.2 118.6 37.18 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 122.705 1.24 . . . . 0.0 112.735 -178.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.602 ' CE1' ' CD2' ' A' ' 83' ' ' TYR . 1.7 t60 -100.43 119.23 38.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.977 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -102.39 126.65 49.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.046 0.451 . . . . 0.0 111.576 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.2 mt -84.69 137.2 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.565 ' C ' ' HG ' ' A' ' 73' ' ' SER . 9.5 m-20 -99.44 -55.98 2.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.565 ' HG ' ' C ' ' A' ' 72' ' ' ASP . 49.8 m -165.26 141.87 5.63 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.7 mt -126.6 131.07 71.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.939 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 79' ' ' TYR . 43.1 m-20 -115.06 88.48 2.88 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.489 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 6.7 mt-10 -54.45 -30.37 52.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.92 -39.02 76.97 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.561 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -107.95 -10.42 15.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.213 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.5 m-85 63.17 47.15 4.25 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 121.537 -0.727 . . . . 0.0 109.886 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 p -105.86 142.72 35.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.749 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.406 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 17.3 t80 -132.67 120.73 22.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.814 0.34 . . . . 0.0 110.641 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 p -127.07 129.62 48.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.341 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.679 ' CE2' ' CD1' ' A' ' 100' ' ' TYR . 34.5 p90 -144.97 164.59 30.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.033 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.6 m -146.09 125.6 13.23 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.115 0.483 . . . . 0.0 111.069 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.17 121.67 25.86 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.599 HD13 ' H ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -83.72 -43.51 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -175.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.599 ' H ' HD13 ' A' ' 86' ' ' ILE . 6.0 tt0 -162.69 178.62 8.34 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.28 -0.888 . . . . 0.0 110.481 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.613 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.87 178.71 18.34 Favored Glycine 0 CA--C 1.504 -0.646 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.48 2.63 0.16 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.613 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -71.96 -38.03 69.82 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 123.572 0.749 . . . . 0.0 110.94 178.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.581 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -111.37 17.46 20.14 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 93' ' ' ASP . 6.9 p 57.11 -133.94 1.27 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.433 ' N ' ' OG1' ' A' ' 92' ' ' THR . 52.3 t0 -130.66 0.39 4.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.8 p -104.91 -8.41 18.66 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.382 -0.824 . . . . 0.0 113.124 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.47 ' CG2' ' N ' ' A' ' 96' ' ' GLU . 4.6 mt -100.12 151.39 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.47 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -86.56 -50.75 6.61 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.285 176.107 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.416 ' HA ' ' CD1' ' A' ' 91' ' ' LEU . 13.0 ptpt -171.72 148.98 2.49 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.445 ' CG2' ' CD2' ' A' ' 119' ' ' TYR . 0.0 OUTLIER -122.97 129.02 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.465 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.493 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 0.3 OUTLIER -119.69 145.3 46.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.847 -179.302 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.679 ' CD1' ' CE2' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -142.89 135.66 27.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.733 0.301 . . . . 0.0 110.497 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -130.62 132.46 45.49 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.2 OUTLIER -131.73 133.83 45.23 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.09 -0.381 . . . . 0.0 110.511 -178.828 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -119.9 133.17 55.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.98 132.33 43.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.36 137.18 52.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.105 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.94 134.68 44.84 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.411 178.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.541 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 43.1 t -121.32 171.16 8.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.79 0.329 . . . . 0.0 110.253 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.541 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.51 -34.68 49.74 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 112.08 -0.408 . . . . 0.0 112.08 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.5 p -89.83 -13.38 36.67 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 118.765 -2.609 . . . . 0.0 114.116 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.64 -80.76 0.12 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.411 1.481 . . . . 0.0 112.401 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 83.3 p -161.51 131.54 4.88 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 126.577 1.951 . . . . 0.0 111.178 176.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.1 m -99.9 118.74 36.97 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 36.5 mt -92.34 127.49 44.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.121 -178.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -105.26 116.33 31.77 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.551 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.2 p -111.93 123.97 51.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.199 0.523 . . . . 0.0 111.302 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.677 ' N ' ' CD1' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -105.44 136.05 41.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -178.32 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.7 m -114.49 135.19 54.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.05 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.493 ' ND1' ' O ' ' A' ' 99' ' ' SER . 0.4 OUTLIER -137.24 109.17 7.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 110.433 -179.315 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.529 ' N ' ' CD1' ' A' ' 119' ' ' TYR . 5.4 m-85 -102.46 104.1 14.53 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -90.39 109.62 20.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.017 0.436 . . . . 0.0 109.852 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.2 p -93.93 169.9 9.95 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.952 0.882 . . . . 0.0 111.657 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -113.31 157.47 21.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.055 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 40.7 -109.73 0.16 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.531 HD21 ' N ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -116.19 7.51 14.13 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 122.703 -0.292 . . . . 0.0 111.396 179.38 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.531 ' N ' HD21 ' A' ' 124' ' ' ASN . 1.5 mp -48.35 161.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.311 0.577 . . . . 0.0 110.761 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.49 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 9.2 pt-20 -148.67 149.59 31.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.228 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.7 mm -87.69 124.5 40.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -75.92 160.09 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.561 0.696 . . . . 0.0 111.665 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -70.47 -47.34 61.09 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.446 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -59.96 -24.52 64.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.6 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.455 ' C ' ' ND1' ' A' ' 131' ' ' HIS . 2.1 t-80 -72.08 -53.91 11.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.365 0.602 . . . . 0.0 110.718 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 m -77.32 -28.11 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.167 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -67.03 -46.53 74.16 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.224 -0.298 . . . . 0.0 111.069 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 28.0 m -70.55 -44.18 77.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.678 0.275 . . . . 0.0 110.491 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.97 -41.49 87.53 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -67.13 -51.02 59.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.804 0.302 . . . . 0.0 111.02 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -56.63 -48.27 77.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 110.325 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -63.03 -51.38 66.97 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 142' ' ' LEU . . . -49.71 -54.74 17.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.597 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -47.43 -38.67 13.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.342 0.591 . . . . 0.0 109.635 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.12 -31.5 80.93 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 139' ' ' ALA . 0.8 OUTLIER -74.99 -38.53 61.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.67 0.748 . . . . 0.0 109.993 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -58.07 -28.32 64.46 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -75.75 -34.46 60.29 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.733 -1.122 . . . . 0.0 109.972 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.5 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -57.39 -61.42 2.5 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 122.191 0.996 . . . . 0.0 112.043 -179.615 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.481 ' O ' ' CD2' ' A' ' 150' ' ' LEU . 26.7 mt -69.11 -48.46 69.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.403 -177.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.674 ' CD ' ' HG ' ' A' ' 11' ' ' SER . 14.7 tt0 -47.16 -42.71 20.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.1 t -59.91 -43.14 95.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.218 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.654 ' O ' ' N ' ' A' ' 153' ' ' HIS . 19.5 t80 -58.39 -45.05 89.08 Favored 'General case' 0 C--O 1.185 -2.341 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.547 ' H ' ' CD2' ' A' ' 150' ' ' LEU . 1.4 mm? -68.06 -43.67 78.1 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 119.993 1.269 . . . . 0.0 111.653 -178.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -24.45 67.38 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.881 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.429 ' O ' ' CD2' ' A' ' 153' ' ' HIS . 51.6 t0 -106.92 -13.08 15.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.039 0.923 . . . . 0.0 110.948 178.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.654 ' N ' ' O ' ' A' ' 149' ' ' TYR . 30.4 m80 -155.8 66.68 4.61 Favored Pre-proline 0 C--N 1.302 -1.49 0 C-N-CA 125.403 1.481 . . . . 0.0 110.193 -177.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.528 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 36.3 Cg_endo -66.35 -2.8 7.73 Favored 'Trans proline' 0 N--CA 1.481 0.736 0 C-N-CA 122.571 2.181 . . . . 0.0 111.108 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.586 ' CA ' HD22 ' A' ' 158' ' ' ASN . 3.2 p30 -71.37 4.63 2.79 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.078 0.951 . . . . 0.0 113.077 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.94 129.71 43.16 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.584 -1.322 . . . . 0.0 113.042 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 157' ' ' TYR . 81.7 t80 53.23 4.51 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 177.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.586 HD22 ' CA ' ' A' ' 155' ' ' ASP . 2.5 p30 . . . . . 0 C--N 1.323 -0.559 0 O-C-N 120.506 -1.371 . . . . 0.0 110.381 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.017 HG21 ' CD2' ' A' ' 118' ' ' HIS . 7.7 p . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.907 0.384 . . . . 0.0 110.618 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -96.4 109.73 22.21 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.2 m -97.27 133.37 41.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.07 0.462 . . . . 0.0 110.62 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -132.26 132.14 42.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.739 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -102.25 126.42 49.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.196 0.522 . . . . 0.0 110.613 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -131.26 161.17 32.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.771 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -155.27 153.12 30.12 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -142.92 141.15 31.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.28 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.73 147.32 22.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.742 0.306 . . . . 0.0 110.913 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -143.17 154.21 43.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 0.0 110.436 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -95.24 27.46 3.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.037 0.446 . . . . 0.0 110.4 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.53 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.5 mt -118.19 125.23 28.04 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.648 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.67 151.2 3.55 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.672 1.581 . . . . 0.0 111.471 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.582 ' CG ' ' HB2' ' A' ' 106' ' ' ALA . 21.8 Cg_exo -61.16 -24.24 78.78 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 C-N-CA 122.299 1.999 . . . . 0.0 112.483 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.446 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 68.8 m -70.64 -32.47 69.78 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.2 mmt-85 -76.24 -59.74 2.63 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.53 HD21 ' HB ' ' A' ' 13' ' ' ILE . 2.3 mt -48.36 -48.87 36.24 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.646 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.811 ' O ' HG22 ' A' ' 23' ' ' VAL . 16.4 t80 -44.75 -60.17 2.15 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.121 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.63 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -71.13 -26.32 62.96 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.142 -0.974 . . . . 0.0 110.917 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.945 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -77.07 -16.02 59.38 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.829 -177.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.505 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -117.6 -6.27 11.14 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.24 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.882 HG23 ' CD1' ' A' ' 24' ' ' LEU . 2.5 m -125.24 -35.99 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 118.5 0.591 . . . . 0.0 112.189 177.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.882 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.9 mp -92.28 -51.46 5.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.686 0.676 . . . . 0.0 111.412 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -106.93 -2.6 21.08 Favored 'General case' 0 C--O 1.206 -1.213 0 CA-C-O 119.22 -0.419 . . . . 0.0 111.496 -176.274 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.505 ' HB2' ' HA ' ' A' ' 22' ' ' PHE . . . -45.08 -34.08 2.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.978 0.894 . . . . 0.0 111.473 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -84.69 12.77 6.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.327 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 25' ' ' ASP . 95.8 m-20 -140.5 -10.85 1.06 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 125.38 1.472 . . . . 0.0 108.269 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.854 HD12 HG23 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -98.59 -48.42 4.99 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 125.499 1.52 . . . . 0.0 109.055 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.748 HG13 HD11 ' A' ' 146' ' ' ILE . 69.0 mt -56.24 -56.24 33.48 Favored Pre-proline 0 C--O 1.215 -0.726 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 32.4 Cg_endo -63.24 -26.92 72.12 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 122.534 2.156 . . . . 0.0 114.342 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -68.76 -49.7 56.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.834 0.826 . . . . 0.0 111.725 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.8 OUTLIER -95.08 -34.96 5.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.745 -177.232 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.815 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.75 64.1 0.15 Allowed Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -176.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.498 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 86.9 Cg_endo -77.09 -26.66 7.51 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 121.625 1.55 . . . . 0.0 108.188 174.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.469 ' OE1' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -74.97 -42.58 57.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.822 178.875 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.815 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -73.97 -77.19 0.12 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.584 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.559 HD13 ' CD2' ' A' ' 142' ' ' LEU . 1.1 mp -104.46 145.45 13.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-O 121.377 0.608 . . . . 0.0 109.978 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -78.38 -53.87 6.8 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.998 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -173.17 166.06 4.9 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.19 0.519 . . . . 0.0 110.569 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.53 144.95 6.49 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.136 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -150.76 145.28 25.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.213 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.602 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -77.12 139.81 18.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.574 0.702 . . . . 0.0 111.143 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -90.75 -38.74 12.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.126 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.844 ' O ' HG23 ' A' ' 52' ' ' THR . 26.9 mt-10 -145.57 136.09 24.18 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.335 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.31 -156.05 22.56 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -136.06 -6.04 2.11 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 122.345 -0.503 . . . . 0.0 111.047 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.46 ' O ' HD12 ' A' ' 74' ' ' ILE . . . 130.7 11.33 2.4 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.8 -171.42 19.58 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.577 ' HD3' ' H ' ' A' ' 74' ' ' ILE . 8.7 Cg_endo -60.06 126.5 20.43 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 122.596 2.197 . . . . 0.0 113.117 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.39 3.28 55.48 Favored Glycine 0 CA--C 1.506 -0.495 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.844 HG23 ' O ' ' A' ' 45' ' ' GLU . 45.7 m -94.02 140.74 29.34 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.14 -1.03 . . . . 0.0 111.008 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.584 HD12 ' C ' ' A' ' 52' ' ' THR . 1.8 mp -120.97 129.07 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.602 ' HG2' HG23 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -112.48 139.87 47.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.791 0.805 . . . . 0.0 111.11 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -117.89 121.15 39.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.489 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.2 mt -106.69 140.19 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.619 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.9 m -119.23 120.16 36.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.132 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -90.79 -173.41 3.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.38 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.06 143.29 29.92 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -60.64 -60.97 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.985 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.81 61.86 3.39 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.2 m -136.89 175.15 9.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.756 0.313 . . . . 0.0 110.563 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -62.19 -42.61 99.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.825 0.345 . . . . 0.0 110.559 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -91.53 136.12 33.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.547 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.59 -57.73 0.5 Allowed Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -145.8 155.2 42.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.973 0.416 . . . . 0.0 110.642 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 p -153.47 144.49 14.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.217 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.58 ' CB ' HD11 ' A' ' 86' ' ' ILE . 93.8 mttt -106.66 117.87 35.19 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.465 0.65 . . . . 0.0 112.211 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.478 ' CD2' ' C ' ' A' ' 69' ' ' HIS . 0.3 OUTLIER -109.34 118.87 37.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.74 178.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -102.28 130.78 49.08 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.051 0.453 . . . . 0.0 111.076 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.425 HD12 HG22 ' A' ' 52' ' ' THR . 36.4 mt -88.81 145.47 7.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.563 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -104.1 -56.42 2.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.3 m -166.43 142.56 4.75 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.577 ' H ' ' HD3' ' A' ' 50' ' ' PRO . 10.7 mt -124.0 131.74 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.858 176.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -116.21 88.26 2.85 Favored 'General case' 0 C--O 1.209 -1.039 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.432 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -54.14 -30.69 50.05 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.36 -39.8 70.51 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.229 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.0 m -108.45 -10.31 15.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.953 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.2 m-85 62.74 46.8 5.02 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.629 -0.669 . . . . 0.0 109.818 -178.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.3 p -105.73 148.26 27.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.207 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.626 ' CE2' ' CD2' ' A' ' 83' ' ' TYR . 41.8 t80 -140.31 120.33 13.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.694 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 p -127.45 130.33 49.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.812 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.626 ' CD2' ' CE2' ' A' ' 81' ' ' TYR . 11.4 p90 -144.73 170.62 15.75 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.1 m -146.06 136.38 23.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.387 0.613 . . . . 0.0 111.489 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.546 HD12 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -79.89 120.41 24.07 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.298 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.58 HD11 ' CB ' ' A' ' 68' ' ' LYS . 2.5 pt -90.24 -45.03 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.497 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 2.9 tp10 -151.17 172.08 16.37 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.861 0.362 . . . . 0.0 110.413 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.646 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.87 177.68 17.87 Favored Glycine 0 CA--C 1.509 -0.334 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.79 2.63 0.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.646 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -68.04 -35.0 77.53 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.689 1.196 . . . . 0.0 110.986 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.914 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.51 13.11 22.75 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.285 0.634 . . . . 0.0 109.538 -178.091 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.505 ' CG2' ' CE1' ' A' ' 131' ' ' HIS . 28.3 p 46.94 -127.04 1.6 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.414 ' N ' ' OG1' ' A' ' 92' ' ' THR . 29.2 t70 -130.34 -11.21 4.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.25 0.548 . . . . 0.0 110.996 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.11 -5.92 20.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.371 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.773 HG21 ' CD1' ' A' ' 98' ' ' ILE . 66.2 mt -97.91 151.48 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -176.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.509 ' OE1' ' CE1' ' A' ' 120' ' ' HIS . 0.8 OUTLIER -88.85 -60.92 1.83 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.395 177.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.437 ' CG ' ' O ' ' A' ' 96' ' ' GLU . 36.9 mtmt -164.89 158.07 16.86 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.44 0.638 . . . . 0.0 111.192 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.773 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -132.75 123.5 49.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.87 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.598 ' OG ' ' CE1' ' A' ' 118' ' ' HIS . 0.9 OUTLIER -112.48 144.4 42.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.213 0.53 . . . . 0.0 111.398 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -137.18 130.67 31.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.558 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.428 ' O ' HG12 ' A' ' 116' ' ' ILE . 20.5 mt-10 -129.28 134.3 47.88 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.14 131.68 28.74 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.972 -0.455 . . . . 0.0 110.186 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.58 ' C ' HD23 ' A' ' 104' ' ' LEU . 20.3 ttpp -124.17 134.48 53.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.76 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.66 131.06 45.14 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.004 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.29 136.89 57.64 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.904 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.582 ' HB2' ' CG ' ' A' ' 15' ' ' PRO . . . -72.92 134.22 44.68 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.261 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 19.6 t -121.13 169.99 9.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.882 0.372 . . . . 0.0 110.385 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.405 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.71 -30.22 42.99 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.7 p -90.33 -8.88 49.7 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 118.369 -2.842 . . . . 0.0 115.464 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 154.24 -93.25 0.14 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.443 1.973 . . . . 0.0 109.849 -171.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.1 m -159.16 129.21 5.7 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 126.691 1.996 . . . . 0.0 110.99 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.3 m -100.05 118.53 36.62 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.535 HD13 ' CE1' ' A' ' 143' ' ' PHE . 11.5 mt -92.17 131.2 39.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.56 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.85 116.62 32.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.703 ' C ' HD13 ' A' ' 116' ' ' ILE . 15.6 t -111.89 118.19 34.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.421 0.629 . . . . 0.0 111.443 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.96 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -97.82 135.53 32.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 123.399 0.68 . . . . 0.0 109.565 -178.518 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.8 m -118.78 131.8 56.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.57 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 1.017 ' CD2' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -136.41 115.11 12.04 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 122.702 1.239 . . . . 0.0 109.472 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.818 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.7 OUTLIER -102.91 103.69 13.85 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 120.368 -1.457 . . . . 0.0 109.588 179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.509 ' CE1' ' OE1' ' A' ' 96' ' ' GLU . 4.8 t-80 -89.68 104.68 17.22 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.506 0.669 . . . . 0.0 110.367 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.531 HG21 ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -91.45 164.41 13.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.327 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 125' ' ' ILE . 6.6 ptmm? -112.11 156.63 21.93 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 43.27 -124.45 4.52 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.39 -13.29 24.8 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.531 ' O ' HG21 ' A' ' 121' ' ' THR . 1.1 tp -48.81 162.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.717 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -152.71 148.59 27.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.908 0.385 . . . . 0.0 111.108 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.415 ' CD1' HG12 ' A' ' 95' ' ' ILE . 5.4 mm -89.14 124.95 42.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 31.5 tttp -76.27 161.16 28.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.439 0.638 . . . . 0.0 111.469 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.638 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 1.2 pm0 -69.97 -45.34 67.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.518 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.09 -25.31 65.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.406 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.505 ' CE1' ' CG2' ' A' ' 92' ' ' THR . 2.7 t-80 -72.7 -51.88 17.53 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.387 0.613 . . . . 0.0 110.886 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.8 m -74.44 -24.22 18.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.45 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -67.22 -46.51 73.6 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 122.382 -0.199 . . . . 0.0 110.932 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.438 HG23 ' N ' ' A' ' 135' ' ' GLY . 30.7 m -70.02 -43.96 78.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.735 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.438 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -67.57 -46.94 65.21 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -67.66 -45.51 75.06 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.683 -0.304 . . . . 0.0 110.853 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -53.81 -38.92 65.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.443 ' O ' ' CD2' ' A' ' 142' ' ' LEU . 15.9 tttt -68.74 -54.39 16.34 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.6 -43.25 46.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.746 0.784 . . . . 0.0 110.495 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -67.13 -36.51 82.04 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.33 -34.92 82.68 Favored Glycine 0 CA--C 1.519 0.313 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.559 ' CD2' HD13 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -71.47 -48.36 49.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.589 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.535 ' CE1' HD13 ' A' ' 113' ' ' ILE . 4.4 t80 -59.47 -25.74 64.66 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -68.76 -40.51 79.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.935 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.781 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -64.45 -56.2 15.75 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.08 0.943 . . . . 0.0 108.746 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.854 HG23 HD12 ' A' ' 29' ' ' LEU . 59.6 mt -54.85 -48.41 74.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.601 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 20.3 tt0 -46.08 -56.89 4.98 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.684 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.8 p -53.51 -42.35 67.25 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.525 0.679 . . . . 0.0 110.615 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.704 ' HB2' HD13 ' A' ' 33' ' ' ILE . 32.7 t80 -56.36 -48.73 76.22 Favored 'General case' 0 C--O 1.194 -1.839 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.945 HD11 ' HB2' ' A' ' 21' ' ' ALA . 1.9 mm? -65.65 -42.57 91.24 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 120.033 1.288 . . . . 0.0 112.02 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.451 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -62.24 -23.65 66.79 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.25 -13.6 15.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.625 ' N ' ' O ' ' A' ' 149' ' ' TYR . 23.3 m80 -156.32 67.49 4.52 Favored Pre-proline 0 C--N 1.309 -1.174 0 C-N-CA 125.062 1.345 . . . . 0.0 110.695 -178.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.497 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 56.0 Cg_endo -74.8 -3.28 13.66 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 122.495 2.13 . . . . 0.0 111.534 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.603 ' CA ' HD21 ' A' ' 158' ' ' ASN . 3.6 p30 -74.66 5.3 5.0 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.279 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.88 129.99 43.57 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.791 -1.193 . . . . 0.0 113.141 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.722 ' CD1' HD23 ' A' ' 24' ' ' LEU . 2.7 t80 54.51 6.06 0.1 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.603 HD21 ' CA ' ' A' ' 155' ' ' ASP . 1.5 p30 . . . . . 0 CA--C 1.514 -0.436 0 O-C-N 121.166 -0.959 . . . . 0.0 110.405 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.818 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.4 p . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.755 0.312 . . . . 0.0 111.348 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -97.6 110.03 22.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.52 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.56 ' HG1' ' CE1' ' A' ' 118' ' ' HIS . 62.7 m -95.78 133.37 39.98 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.657 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -137.75 132.38 32.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.046 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -102.48 137.4 40.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 111.296 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.55 167.97 15.6 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -152.56 145.15 24.18 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -154.23 134.76 13.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.458 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.06 146.71 23.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.934 0.397 . . . . 0.0 111.451 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -136.32 154.14 50.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.247 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -98.49 21.84 10.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.173 0.511 . . . . 0.0 110.365 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.693 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.3 mt -116.23 126.35 27.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.494 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -44.88 146.99 2.1 Favored 'Trans proline' 0 C--N 1.327 -0.603 0 C-N-CA 121.805 1.67 . . . . 0.0 111.776 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -57.19 -26.62 70.59 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 122.256 1.97 . . . . 0.0 113.149 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 67.9 m -70.7 -32.15 69.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -75.03 -57.71 3.73 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.693 HD21 ' HB ' ' A' ' 13' ' ' ILE . 1.5 mt -53.28 -35.84 60.53 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.801 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.867 ' O ' HG22 ' A' ' 23' ' ' VAL . 14.8 t80 -54.46 -56.05 22.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.641 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.76 ' HB2' HD11 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -70.73 -43.2 69.39 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.295 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.775 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -63.67 -3.2 2.1 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.386 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.512 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 19.3 t80 -119.66 -8.54 9.92 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 19' ' ' PHE . 15.1 m -129.7 -52.33 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.011 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.7 pp -96.85 -31.52 12.56 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 1.011 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -114.25 -5.38 12.99 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 118.858 0.754 . . . . 0.0 111.364 -178.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -67.7 -43.85 79.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.105 0.479 . . . . 0.0 111.861 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.502 ' HA ' HD11 ' A' ' 30' ' ' ILE . 1.2 m-20 -83.01 12.21 5.27 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 122.101 0.953 . . . . 0.0 110.265 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -129.79 -9.42 4.46 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.523 ' CD1' HG23 ' A' ' 146' ' ' ILE . 4.1 mt -93.94 -30.74 14.6 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.211 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.547 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.08 -53.42 58.77 Favored Pre-proline 0 C--O 1.215 -0.732 0 O-C-N 122.025 -0.422 . . . . 0.0 110.613 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 27.2 Cg_endo -63.89 -25.72 67.26 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 122.006 1.804 . . . . 0.0 112.538 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.84 -59.61 2.66 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.662 0.744 . . . . 0.0 112.194 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.8 HD12 ' HB3' ' A' ' 145' ' ' LEU . 1.3 pt -94.46 -36.14 6.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.909 -176.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.867 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.87 65.23 0.16 Allowed Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 71.8 Cg_endo -75.94 -26.91 9.0 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 C-N-CA 121.591 1.527 . . . . 0.0 108.367 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -74.1 -43.36 57.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.55 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.867 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -72.27 -71.94 0.26 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.896 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.526 HD13 HD22 ' A' ' 142' ' ' LEU . 1.4 mp -99.18 144.85 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-O 121.254 0.549 . . . . 0.0 110.669 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -79.44 -50.34 10.95 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.079 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.658 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 52.8 tp60 -174.33 164.66 3.93 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.829 0.347 . . . . 0.0 110.758 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.658 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -166.13 144.74 5.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.076 0.465 . . . . 0.0 110.846 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -150.7 148.18 28.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.143 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.578 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -83.25 139.58 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.524 0.678 . . . . 0.0 110.729 -179.183 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.1 -39.36 12.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.024 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.92 ' O ' HG23 ' A' ' 52' ' ' THR . 16.2 mt-10 -141.28 134.48 29.42 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.756 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.83 -156.6 31.55 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -141.24 -5.15 1.11 Allowed 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.406 -0.467 . . . . 0.0 111.404 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.435 ' O ' HD12 ' A' ' 74' ' ' ILE . . . 141.46 11.94 0.53 Allowed Glycine 0 C--O 1.218 -0.853 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.77 -171.71 19.66 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-N 117.233 0.516 . . . . 0.0 112.066 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -62.05 126.87 19.73 Favored 'Trans proline' 0 C--N 1.321 -0.892 0 C-N-CA 123.168 2.579 . . . . 0.0 113.343 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.72 6.12 57.36 Favored Glycine 0 N--CA 1.462 0.422 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.92 HG23 ' O ' ' A' ' 45' ' ' GLU . 73.1 m -93.6 139.31 30.92 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.176 -1.012 . . . . 0.0 111.191 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.28 132.1 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.578 ' HG2' HG23 ' A' ' 43' ' ' ILE . 1.9 mmtp -111.17 139.53 46.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.463 0.649 . . . . 0.0 111.258 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -118.2 113.42 21.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.147 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mt -106.28 138.27 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.662 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.7 m -119.21 118.11 30.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.267 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -93.0 -173.23 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.306 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.08 143.54 48.69 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -60.84 -48.39 82.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.806 0.336 . . . . 0.0 110.978 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.06 61.97 3.29 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.0 m -142.91 175.33 9.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.021 0.438 . . . . 0.0 110.626 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -61.84 -45.52 93.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.66 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.32 138.74 39.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.371 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.14 -52.92 0.59 Allowed Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -142.7 151.73 41.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 110.253 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.85 146.5 11.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.968 0.413 . . . . 0.0 110.672 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.602 ' HB3' HD11 ' A' ' 86' ' ' ILE . 25.0 mttp -105.58 109.51 21.51 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.35 0.595 . . . . 0.0 111.557 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.601 ' HE2' ' CB ' ' A' ' 83' ' ' TYR . 6.8 t60 -98.81 111.68 23.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.329 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.1 ttt-85 -101.56 131.19 47.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.233 0.54 . . . . 0.0 112.126 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.5 mt -82.31 136.68 22.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.461 -0.79 . . . . 0.0 108.96 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -96.97 -56.05 2.68 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.7 m -165.67 141.38 5.09 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.435 HD12 ' O ' ' A' ' 48' ' ' GLY . 40.6 mt -124.96 129.62 73.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 79' ' ' TYR . 23.2 m-20 -115.45 88.33 2.86 Favored 'General case' 0 C--O 1.202 -1.401 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.638 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.0 OUTLIER -54.31 -36.17 63.45 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.51 -36.1 43.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 m -107.65 -10.87 15.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.828 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.596 ' N ' ' O ' ' A' ' 75' ' ' ASP . 48.2 m-85 56.68 42.53 26.8 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 121.522 -0.736 . . . . 0.0 110.818 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.26 149.2 28.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.909 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 82' ' ' SER . 3.6 t80 -134.8 126.38 28.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.92 0.391 . . . . 0.0 111.186 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.451 ' N ' ' CD1' ' A' ' 81' ' ' TYR . 85.8 p -126.88 136.49 52.39 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.462 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.601 ' CB ' ' HE2' ' A' ' 69' ' ' HIS . 34.3 p90 -144.88 165.63 27.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.561 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -147.08 134.14 20.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.082 0.468 . . . . 0.0 110.667 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.604 HD13 ' HB1' ' A' ' 90' ' ' ALA . 5.6 mt -80.4 117.59 21.28 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' A' ' 68' ' ' LYS . 5.1 pt -82.42 -44.69 19.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.718 0.294 . . . . 0.0 111.213 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.625 ' CD ' ' H ' ' A' ' 88' ' ' GLY . 0.6 OUTLIER -149.14 171.81 15.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.625 ' H ' ' CD ' ' A' ' 87' ' ' GLU . . . 116.22 177.96 18.19 Favored Glycine 0 CA--C 1.509 -0.319 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.94 2.26 0.23 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.621 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -67.39 -35.08 78.6 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 124.314 1.046 . . . . 0.0 110.468 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.885 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -111.11 6.03 20.53 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 123.358 0.663 . . . . 0.0 110.273 -177.587 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.421 ' CG2' ' NE2' ' A' ' 131' ' ' HIS . 61.7 p 49.61 -126.15 2.14 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 18.8 p-10 -131.74 -10.3 3.51 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.827 -0.546 . . . . 0.0 110.911 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.73 -7.6 19.42 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.679 HG21 ' CD1' ' A' ' 98' ' ' ILE . 68.4 mt -99.71 152.81 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -176.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.506 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -87.43 -59.17 2.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.751 177.184 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HA ' HD12 ' A' ' 91' ' ' LEU . 6.0 ptpt -171.95 154.25 3.45 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.199 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.679 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.65 124.88 73.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.87 144.84 32.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.137 0.494 . . . . 0.0 111.436 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 116' ' ' ILE . 0.4 OUTLIER -140.06 138.94 35.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 179.382 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -128.37 135.15 49.17 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 120.983 0.42 . . . . 0.0 110.737 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 p -133.86 131.24 38.94 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -120.32 135.39 55.03 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.4 mm? -96.46 124.66 40.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.255 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.61 136.62 43.58 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.192 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -73.16 139.57 46.44 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.85 -0.531 . . . . 0.0 110.142 177.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.467 ' N ' ' HA ' ' A' ' 111' ' ' SER . 13.6 t -121.36 170.97 9.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.714 0.292 . . . . 0.0 110.388 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.71 -34.6 50.73 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.5 p -94.76 -6.43 43.05 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 118.809 -2.583 . . . . 0.0 113.595 177.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 160.23 -78.62 0.17 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.082 1.801 . . . . 0.0 112.067 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 29.2 t -162.76 130.21 3.7 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.973 1.309 . . . . 0.0 111.599 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.7 m -99.97 134.9 42.2 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.105 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 mt -110.57 130.34 64.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.504 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.71 116.81 32.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.814 ' C ' HD13 ' A' ' 116' ' ' ILE . 70.1 m -110.75 124.73 52.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.204 0.526 . . . . 0.0 110.865 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.874 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -106.29 135.76 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 C-N-CA 123.033 0.533 . . . . 0.0 109.825 -178.016 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.2 m -109.07 134.39 51.75 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.56 ' CE1' ' HG1' ' A' ' 4' ' ' THR . 41.9 m-70 -135.39 95.31 3.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.209 0.528 . . . . 0.0 111.049 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.818 ' C ' HG23 ' A' ' 2' ' ' VAL . 6.4 m-30 -84.56 101.39 12.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.874 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -92.87 98.64 11.51 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.7 p -101.3 174.35 6.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.91 0.862 . . . . 0.0 112.218 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.71 144.5 42.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.334 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.6 -110.0 1.1 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 36.8 p30 -115.9 1.55 13.37 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.449 -0.442 . . . . 0.0 111.607 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.6 mp -45.48 161.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.177 0.513 . . . . 0.0 110.434 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.494 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 30.2 tt0 -155.42 148.66 24.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.48 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.3 mm -88.01 125.36 41.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -73.87 161.94 29.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.358 0.599 . . . . 0.0 111.541 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -69.01 -48.54 62.76 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.071 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.599 ' O ' HG12 ' A' ' 134' ' ' VAL . 6.5 tt0 -58.23 -26.11 62.47 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.985 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.421 ' NE2' ' CG2' ' A' ' 92' ' ' THR . 4.2 t60 -72.92 -49.56 28.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.476 0.655 . . . . 0.0 111.236 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.438 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.1 m -81.08 -27.17 10.76 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -66.62 -46.18 76.69 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.983 -0.448 . . . . 0.0 110.496 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.676 HG13 ' N ' ' A' ' 135' ' ' GLY . 7.7 p -69.01 -50.89 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 CA-C-O 121.443 0.64 . . . . 0.0 110.515 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.676 ' N ' HG13 ' A' ' 134' ' ' VAL . . . -62.81 -42.29 99.71 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 5.9 ttpm? -67.04 -45.68 76.7 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 122.72 -0.283 . . . . 0.0 110.788 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -53.69 -43.34 68.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -66.16 -53.6 35.6 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.416 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.32 -40.22 34.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.672 0.749 . . . . 0.0 110.726 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.91 -36.24 82.73 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.41 -43.79 98.33 Favored Glycine 0 C--O 1.227 -0.328 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -62.94 -43.01 99.95 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.505 ' CE1' ' CE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -59.44 -25.81 64.67 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.05 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -72.1 -42.7 65.82 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.272 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.8 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -62.44 -56.66 16.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.605 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.689 ' O ' HD22 ' A' ' 150' ' ' LEU . 50.6 mt -59.62 -50.71 78.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.23 -177.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 8.9 tt0 -46.87 -56.74 5.8 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.136 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 62.0 m -51.08 -48.15 61.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.191 0.52 . . . . 0.0 111.551 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.549 ' O ' ' N ' ' A' ' 153' ' ' HIS . 0.2 OUTLIER -55.93 -49.43 73.51 Favored 'General case' 0 C--O 1.209 -1.033 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.843 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.9 mm? -62.53 -43.85 97.79 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 119.792 1.178 . . . . 0.0 111.77 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 147' ' ' GLU . 0.2 OUTLIER -59.14 -25.4 63.85 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.189 -0.945 . . . . 0.0 108.757 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.453 ' O ' ' ND1' ' A' ' 153' ' ' HIS . 49.2 t0 -99.27 -14.38 19.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.731 0.776 . . . . 0.0 109.91 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.549 ' N ' ' O ' ' A' ' 149' ' ' TYR . 68.3 m80 -154.11 68.16 5.94 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 124.261 1.024 . . . . 0.0 110.494 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.471 ' N ' ' O ' ' A' ' 150' ' ' LEU . 31.4 Cg_endo -68.34 -3.18 10.4 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.991 1.794 . . . . 0.0 110.637 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 14.4 m-20 -87.03 4.69 40.94 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.074 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.42 131.02 20.6 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.028 -1.67 . . . . 0.0 111.256 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.666 ' CG ' HD13 ' A' ' 24' ' ' LEU . 6.3 t80 55.83 7.19 0.25 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 3.9 p-10 . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.352 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.846 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.2 p . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.677 0.275 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.45 109.36 22.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.704 177.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.2 m -97.92 140.65 31.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.877 0.37 . . . . 0.0 111.071 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -145.14 137.57 25.99 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.332 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.55 ' HG2' HD12 ' A' ' 116' ' ' ILE . 15.6 mt-10 -102.29 139.24 38.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.197 0.523 . . . . 0.0 110.76 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.48 168.19 14.57 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.84 139.34 15.89 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -145.62 134.0 21.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.378 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.1 147.87 22.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.929 0.395 . . . . 0.0 111.254 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 p -144.39 154.26 42.8 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.51 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -94.37 27.61 2.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.889 0.376 . . . . 0.0 110.305 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.651 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.3 mt -117.56 125.66 27.93 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.721 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.97 148.47 13.0 Favored 'Trans proline' 0 C--N 1.327 -0.581 0 C-N-CA 121.801 1.667 . . . . 0.0 111.409 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.418 ' HA ' HD12 ' A' ' 18' ' ' LEU . 23.3 Cg_exo -59.04 -24.98 76.05 Favored 'Trans proline' 0 N--CA 1.482 0.836 0 C-N-CA 122.011 1.808 . . . . 0.0 112.116 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.434 ' C ' ' HZ2' ' A' ' 20' ' ' LYS . 66.3 m -65.72 -35.68 81.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.392 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.485 ' HA ' ' HZ2' ' A' ' 20' ' ' LYS . 8.0 mmt180 -77.99 -57.68 3.67 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.651 HD21 ' HB ' ' A' ' 13' ' ' ILE . 5.1 mt -48.14 -48.25 34.31 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.909 -1.042 . . . . 0.0 108.599 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.753 ' O ' HG22 ' A' ' 23' ' ' VAL . 70.1 t80 -48.85 -56.49 8.59 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.307 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.665 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -70.21 -23.92 63.02 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.698 -179.775 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.71 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -82.48 -2.84 54.57 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.976 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.473 ' CE2' ' OH ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -119.08 -9.56 9.98 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.853 HG23 HD13 ' A' ' 24' ' ' LEU . 3.0 m -136.1 -36.57 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.853 HD13 HG23 ' A' ' 23' ' ' VAL . 3.2 mp -91.17 -53.05 4.52 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.152 0.887 . . . . 0.0 112.153 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -112.2 -4.68 14.32 Favored 'General case' 0 C--O 1.214 -0.771 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.039 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.695 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -53.16 -41.73 65.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.2 0.524 . . . . 0.0 111.715 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -83.39 17.49 2.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.629 0.728 . . . . 0.0 110.794 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.413 ' H ' ' H ' ' A' ' 29' ' ' LEU . 15.8 m120 -139.97 -8.89 1.19 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.505 HD21 ' CD1' ' A' ' 149' ' ' TYR . 0.6 OUTLIER -91.34 -33.51 15.27 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.438 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.543 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.74 -53.17 63.62 Favored Pre-proline 0 C--O 1.216 -0.678 0 O-C-N 122.083 -0.385 . . . . 0.0 111.127 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 20.0 Cg_endo -62.56 -24.67 75.28 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 121.876 1.718 . . . . 0.0 112.323 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -70.28 -59.83 2.64 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.73 0.776 . . . . 0.0 112.016 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 145' ' ' LEU . 1.3 pt -95.29 -35.72 6.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.282 -176.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.902 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.54 64.53 0.14 Allowed Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.491 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 72.6 Cg_endo -76.88 -28.4 6.24 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 121.647 1.565 . . . . 0.0 108.175 174.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.408 ' CG ' ' N ' ' A' ' 37' ' ' ALA . 12.1 pt20 -74.14 -43.17 58.43 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.572 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.902 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -72.81 -76.54 0.12 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.947 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 38' ' ' ILE . 9.4 mm -99.51 145.08 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 121.092 0.472 . . . . 0.0 110.422 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -77.7 -49.86 13.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.673 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -176.98 166.61 2.46 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.111 0.482 . . . . 0.0 110.543 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.99 143.13 5.35 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.592 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -151.33 153.34 34.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.782 0.325 . . . . 0.0 110.595 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.06 138.52 18.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.597 0.713 . . . . 0.0 111.341 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.5 mp -88.9 -39.07 14.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.905 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.874 ' O ' HG23 ' A' ' 52' ' ' THR . 26.4 mt-10 -144.32 136.89 26.75 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.364 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.47 -156.21 22.55 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -135.26 -11.34 2.18 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.09 0.472 . . . . 0.0 110.608 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 136.65 11.08 1.15 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.29 -171.86 19.34 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -59.07 127.01 22.67 Favored 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 122.595 2.196 . . . . 0.0 113.213 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.67 2.14 52.87 Favored Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.874 HG23 ' O ' ' A' ' 45' ' ' GLU . 51.8 m -94.42 140.49 29.75 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.146 -1.027 . . . . 0.0 111.753 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -121.51 129.74 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.407 ' NZ ' ' HB3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -114.73 140.44 48.87 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.021 0.438 . . . . 0.0 110.879 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -118.77 123.11 44.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.02 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.2 mt -104.9 140.64 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.86 0.362 . . . . 0.0 110.605 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.8 m -116.52 118.82 33.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.152 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -91.39 -176.44 4.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.316 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.33 142.68 32.11 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.468 ' CD ' ' N ' ' A' ' 61' ' ' GLY . 2.5 pp20? -61.15 -45.22 95.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.817 0.342 . . . . 0.0 111.23 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.468 ' N ' ' CD ' ' A' ' 60' ' ' GLU . . . -91.37 61.53 2.86 Favored Glycine 0 C--N 1.328 0.135 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.8 m -141.96 174.11 10.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.964 0.411 . . . . 0.0 110.816 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -68.16 -39.12 82.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.931 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.55 142.96 27.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.439 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.1 -62.06 0.53 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -146.07 145.29 30.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.952 0.406 . . . . 0.0 110.429 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.74 140.09 41.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.647 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.493 ' HB2' HD11 ' A' ' 86' ' ' ILE . 61.3 mttm -106.53 114.56 28.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.346 0.594 . . . . 0.0 112.413 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.553 ' CE1' ' CD2' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -92.89 123.89 36.48 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.29 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -100.89 112.4 24.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.012 0.434 . . . . 0.0 111.485 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.4 mt -74.17 135.42 27.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -98.3 -55.67 2.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.5 m -165.97 142.38 5.14 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.6 mt -116.16 131.44 68.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.682 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 79' ' ' TYR . 9.4 t0 -113.97 87.45 2.62 Favored 'General case' 0 C--O 1.207 -1.148 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.513 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 7.2 pt-20 -54.87 -30.1 57.04 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.32 -40.0 70.64 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 m -108.63 -10.68 15.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.901 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.565 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.6 m-85 62.54 42.14 8.94 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.511 -0.743 . . . . 0.0 110.142 -178.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.2 t -116.87 139.8 50.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.233 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.473 ' OH ' ' CE2' ' A' ' 22' ' ' PHE . 41.1 p90 -132.26 132.78 43.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.088 0.47 . . . . 0.0 110.392 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 m -127.09 137.65 53.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.383 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -144.05 166.37 25.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.891 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.591 HG23 ' O ' ' A' ' 98' ' ' ILE . 5.5 m -144.89 142.95 30.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.09 0.471 . . . . 0.0 110.828 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.634 HD13 ' HB1' ' A' ' 90' ' ' ALA . 7.9 mt -79.97 115.36 19.5 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.493 HD11 ' HB2' ' A' ' 68' ' ' LYS . 2.9 pt -77.49 -44.8 29.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.783 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.434 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -153.47 172.53 16.98 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.603 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.57 177.52 18.02 Favored Glycine 0 CA--C 1.51 -0.221 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -61.7 0.37 0.35 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 122.529 1.157 . . . . 0.0 108.395 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.634 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -62.17 -34.51 76.56 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 124.123 0.969 . . . . 0.0 110.236 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.867 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.37 12.84 23.01 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 123.464 0.705 . . . . 0.0 109.935 -177.37 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.1 p 47.36 -126.31 1.68 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -130.72 -12.64 3.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.019 0.438 . . . . 0.0 111.452 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.23 -6.14 20.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.743 HG21 ' CD1' ' A' ' 98' ' ' ILE . 95.2 mt -98.08 152.17 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 122.159 0.981 . . . . 0.0 113.297 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.508 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -93.44 -52.51 4.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.468 177.649 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.53 149.02 2.06 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-O 121.178 0.513 . . . . 0.0 111.32 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.743 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.87 126.68 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.614 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.591 ' C ' ' HD1' ' A' ' 118' ' ' HIS . 0.1 OUTLIER -109.63 143.89 38.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.803 0.335 . . . . 0.0 111.621 -178.105 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -137.35 127.94 26.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.689 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -129.8 132.49 46.53 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -139.82 133.82 30.89 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.086 -0.384 . . . . 0.0 110.469 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.624 ' C ' HD23 ' A' ' 104' ' ' LEU . 55.0 tttt -122.25 134.41 54.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.908 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.789 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -97.74 127.32 43.6 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.192 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -128.51 136.63 59.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.119 -178.848 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -73.14 133.29 44.04 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.752 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -121.88 174.04 7.12 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.69 -34.18 55.95 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.871 -0.492 . . . . 0.0 111.871 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.1 m -76.78 -26.81 54.91 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.841 1.256 . . . . 0.0 114.182 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 159.67 -78.88 0.17 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.522 1.534 . . . . 0.0 111.876 -169.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 83.7 p -166.07 131.72 2.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.594 1.558 . . . . 0.0 111.079 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 105' ' ' VAL . 14.8 m -99.29 118.74 36.63 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 54.4 mt -92.14 126.52 44.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.635 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -105.68 117.38 33.88 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.763 ' C ' HD13 ' A' ' 116' ' ' ILE . 3.2 m -112.35 123.75 50.96 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.329 0.585 . . . . 0.0 111.313 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.937 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -103.53 137.16 33.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 123.591 0.756 . . . . 0.0 109.654 -178.031 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.95 132.09 55.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.715 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.591 ' HD1' ' C ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -138.38 112.32 8.45 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.846 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -101.83 108.38 19.84 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.223 -0.298 . . . . 0.0 110.803 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.506 ' CE1' ' OE2' ' A' ' 96' ' ' GLU . 13.8 t-160 -89.59 105.8 18.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.16 0.505 . . . . 0.0 109.679 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.9 p -100.22 178.01 4.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.841 0.829 . . . . 0.0 111.915 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 123' ' ' GLY . 3.8 mtpt -112.54 157.49 21.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.794 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . 35.16 -108.71 0.05 OUTLIER Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -114.04 7.04 16.67 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.588 -0.36 . . . . 0.0 111.144 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.493 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.6 mp -45.42 160.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.221 0.534 . . . . 0.0 110.594 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.493 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 22.0 mt-10 -152.11 149.6 28.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.257 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 mm -88.21 125.01 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.433 ' HG3' ' N ' ' A' ' 129' ' ' GLU . 15.8 tptm -73.85 161.96 29.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.202 0.525 . . . . 0.0 111.208 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' A' ' 128' ' ' LYS . 59.9 mt-10 -68.68 -44.41 74.08 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.112 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.523 ' O ' HG22 ' A' ' 134' ' ' VAL . 37.5 mt-10 -61.57 -26.18 67.79 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.67 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -73.04 -49.32 29.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.106 0.479 . . . . 0.0 111.321 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.411 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.0 m -79.5 -29.72 13.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.176 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.4 tptt -66.92 -45.83 76.69 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.916 -0.49 . . . . 0.0 110.605 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.552 HG23 ' N ' ' A' ' 135' ' ' GLY . 24.2 m -70.45 -45.98 72.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.557 0.218 . . . . 0.0 110.567 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.552 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -66.58 -46.66 74.67 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 29.3 ttpt -67.05 -46.15 75.26 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.676 -0.308 . . . . 0.0 110.653 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -54.49 -46.28 73.4 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -67.8 -52.29 38.76 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.437 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.54 -41.5 41.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.694 0.759 . . . . 0.0 110.616 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -36.33 83.41 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.42 -37.98 94.04 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -71.14 -42.43 69.19 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -59.54 -22.78 62.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -37.98 51.57 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.669 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.795 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.3 mm? -69.61 -56.73 6.47 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.146 0.498 . . . . 0.0 109.894 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.737 ' O ' HD22 ' A' ' 150' ' ' LEU . 63.5 mt -54.53 -51.36 50.84 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.48 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -47.65 -55.5 9.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.03 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.402 ' O ' ' OD2' ' A' ' 152' ' ' ASP . 8.7 t -52.56 -43.77 65.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.322 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.656 ' HB2' HD13 ' A' ' 33' ' ' ILE . 20.4 t80 -58.15 -44.77 88.04 Favored 'General case' 0 C--O 1.189 -2.083 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.765 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.8 mm? -69.71 -42.84 73.51 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 120.552 -1.342 . . . . 0.0 111.88 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.403 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -61.97 -24.79 67.23 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 121.571 -0.705 . . . . 0.0 109.147 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 149' ' ' TYR . 5.1 p30 -107.32 -12.73 15.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.26 0.552 . . . . 0.0 110.379 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.621 ' N ' ' O ' ' A' ' 149' ' ' TYR . 1.2 t-160 -154.86 66.3 4.97 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 124.795 1.238 . . . . 0.0 110.108 -177.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.11 -3.54 13.47 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 122.761 2.307 . . . . 0.0 112.072 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.555 ' OD1' ' CD2' ' A' ' 153' ' ' HIS . 2.3 p30 -80.24 4.63 16.98 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.951 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.08 130.53 18.83 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 119.82 -1.8 . . . . 0.0 111.467 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.749 ' CD1' HD23 ' A' ' 24' ' ' LEU . 6.2 t80 55.08 8.17 0.23 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.331 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 5.2 p-10 . . . . . 0 C--N 1.325 -0.461 0 O-C-N 121.547 -0.721 . . . . 0.0 110.291 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.847 HG23 ' C ' ' A' ' 119' ' ' TYR . 8.1 p . . . . . 0 CA--C 1.519 -0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 111.616 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -98.51 110.5 23.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.24 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.644 HG23 ' CE1' ' A' ' 118' ' ' HIS . 98.3 m -96.41 140.12 31.54 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.828 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -146.96 134.16 20.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.918 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -102.39 132.91 48.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.23 0.538 . . . . 0.0 111.273 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.04 166.86 16.79 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 1.6 pt-20 -155.95 142.1 18.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.46 139.62 37.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.276 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.26 147.91 26.1 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.819 0.342 . . . . 0.0 111.532 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 t -145.08 154.85 42.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.808 0.337 . . . . 0.0 110.51 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -93.8 24.99 3.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.948 0.404 . . . . 0.0 111.121 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.415 ' HB ' HD21 ' A' ' 18' ' ' LEU . 2.1 mt -112.45 129.04 24.76 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.244 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -46.03 144.63 5.96 Favored 'Trans proline' 0 C--N 1.327 -0.583 0 C-N-CA 121.192 1.261 . . . . 0.0 110.602 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.68 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 12.0 Cg_endo -61.88 -24.55 77.25 Favored 'Trans proline' 0 C--N 1.321 -0.904 0 C-N-CA 122.316 2.011 . . . . 0.0 113.027 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.2 m -70.94 -28.6 64.61 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.422 ' H ' ' HG2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -76.27 -57.6 3.77 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.519 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.482 ' H ' ' HG ' ' A' ' 18' ' ' LEU . 1.8 mt -51.51 -43.53 62.29 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.753 ' O ' HG22 ' A' ' 23' ' ' VAL . 49.7 t80 -47.45 -58.06 4.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.257 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.705 ' CB ' HD11 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -69.89 -42.44 73.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 119.16 -1.016 . . . . 0.0 108.674 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.816 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -63.72 -5.12 3.67 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.627 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.535 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 2.7 t80 -120.25 -7.96 9.74 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 19' ' ' PHE . 29.1 m -129.91 -49.64 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.008 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.6 pp -96.51 -31.46 12.78 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 1.008 ' N ' HD12 ' A' ' 24' ' ' LEU . 10.0 t70 -114.44 -5.79 12.87 Favored 'General case' 0 C--O 1.211 -0.944 0 O-C-N 121.798 -0.564 . . . . 0.0 111.544 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.535 ' HB2' ' HA ' ' A' ' 22' ' ' PHE . . . -60.79 -40.36 92.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.566 0.698 . . . . 0.0 111.978 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -83.58 16.68 2.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.6 0.714 . . . . 0.0 110.109 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -139.62 -9.34 1.23 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.659 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -100.81 -39.82 7.62 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.001 -178.856 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.511 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 58.0 mt -53.89 -53.8 53.89 Favored Pre-proline 0 C--O 1.214 -0.79 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.191 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 29.3 Cg_endo -62.33 -25.29 76.38 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 121.876 1.717 . . . . 0.0 112.375 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 tmtp? -66.37 -55.33 16.41 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.984 0.897 . . . . 0.0 111.777 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.753 HD12 ' C ' ' A' ' 145' ' ' LEU . 0.9 OUTLIER -95.4 -34.34 5.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.315 -176.647 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.781 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.29 64.17 0.13 Allowed Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.486 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 71.7 Cg_endo -76.77 -24.41 10.14 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 N-CA-C 107.938 -1.601 . . . . 0.0 107.938 174.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -74.08 -43.83 56.29 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.273 -1.331 . . . . 0.0 109.494 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.781 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -70.54 -79.02 0.07 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.3 mt -98.93 146.64 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.019 0.437 . . . . 0.0 110.104 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -76.62 -44.36 34.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.81 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.655 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 49.2 tp60 -176.86 163.44 2.24 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.909 0.385 . . . . 0.0 110.773 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.655 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -167.0 143.78 4.56 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.926 0.393 . . . . 0.0 110.36 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.14 150.46 30.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.462 ' H ' HG13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -83.63 138.13 19.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.651 0.739 . . . . 0.0 110.952 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.3 mp -88.45 -39.32 14.33 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.766 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.925 ' O ' HG23 ' A' ' 52' ' ' THR . 47.9 mt-10 -142.02 134.22 27.69 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.952 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.62 -156.33 26.61 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -139.69 -9.7 1.21 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.821 0.343 . . . . 0.0 110.962 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.95 11.38 0.35 Allowed Glycine 0 C--O 1.223 -0.565 0 N-CA-C 111.914 -0.474 . . . . 0.0 111.914 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.43 -172.78 20.11 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 117.562 0.681 . . . . 0.0 111.976 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD3' ' H ' ' A' ' 74' ' ' ILE . 10.2 Cg_endo -60.02 126.59 20.72 Favored 'Trans proline' 0 N--CA 1.483 0.854 0 C-N-CA 122.774 2.316 . . . . 0.0 113.649 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.99 4.0 55.64 Favored Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.925 HG23 ' O ' ' A' ' 45' ' ' GLU . 88.9 m -94.23 140.4 29.82 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.135 -1.033 . . . . 0.0 111.296 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.651 HD12 ' C ' ' A' ' 52' ' ' THR . 1.8 mp -121.15 129.91 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HB3' ' HZ3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -116.27 140.34 49.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.083 0.468 . . . . 0.0 110.688 179.545 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -118.75 121.74 40.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.011 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.1 mp -100.96 123.61 54.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.1 m -98.42 118.47 35.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.401 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -92.27 168.05 11.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.232 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.92 143.77 32.51 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.93 -48.05 83.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.724 0.297 . . . . 0.0 110.324 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.18 61.49 2.93 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.4 m -137.41 174.93 10.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.623 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -51.37 66.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.674 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -91.67 150.92 20.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.363 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.93 -59.71 0.58 Allowed Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -145.24 155.18 43.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.99 0.424 . . . . 0.0 110.941 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.5 p -154.69 138.35 8.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.821 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.3 mtmm -105.83 118.95 37.92 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.363 0.601 . . . . 0.0 112.228 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.566 ' CE1' ' CD2' ' A' ' 85' ' ' LEU . 1.9 m80 -97.25 114.43 26.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.3 ttp85 -101.2 112.56 25.08 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.123 0.487 . . . . 0.0 111.609 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.0 mt -73.73 134.11 30.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.292 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 73' ' ' SER . 2.2 p30 -98.01 -49.92 4.59 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.296 -0.562 . . . . 0.0 112.298 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.538 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -165.54 143.21 5.82 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.7 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.412 ' H ' ' HD3' ' A' ' 50' ' ' PRO . 32.1 mt -126.68 126.46 68.81 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 CA-C-N 113.914 -1.494 . . . . 0.0 108.841 173.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 79' ' ' TYR . 23.4 m-20 -113.88 88.44 2.85 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.466 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 6.9 pt-20 -54.59 -30.62 55.01 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.32 -38.75 59.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.8 m -108.5 -11.02 15.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.777 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.513 ' N ' ' O ' ' A' ' 75' ' ' ASP . 12.3 m-85 62.53 43.29 7.88 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.273 0.559 . . . . 0.0 109.808 -178.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.3 p -105.95 141.06 37.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.802 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -132.59 118.65 19.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.62 0.248 . . . . 0.0 110.684 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.446 ' C ' ' OD2' ' A' ' 72' ' ' ASP . 42.0 t -128.43 143.62 51.02 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.696 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -148.93 173.11 13.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.165 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.93 135.53 23.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.091 0.472 . . . . 0.0 110.895 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.663 HD13 ' HB1' ' A' ' 90' ' ' ALA . 9.0 mt -80.24 113.27 18.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.614 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -77.31 -41.79 30.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.803 -178.307 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.614 ' N ' HD13 ' A' ' 86' ' ' ILE . 4.1 tm-20 -157.03 170.69 21.95 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.116 -0.365 . . . . 0.0 110.357 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.609 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 119.65 178.33 16.43 Favored Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -62.28 2.06 0.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 122.884 1.326 . . . . 0.0 108.412 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.663 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -66.0 -33.08 75.0 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 124.35 1.06 . . . . 0.0 110.399 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.856 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -109.77 16.2 22.22 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.195 0.598 . . . . 0.0 110.693 -176.83 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 91' ' ' LEU . 65.2 p 43.35 -126.25 0.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.61 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -131.48 -13.29 3.4 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.126 -0.358 . . . . 0.0 111.054 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.1 p -104.68 -5.76 21.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.845 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.835 HG21 ' CD1' ' A' ' 98' ' ' ILE . 57.9 mt -99.53 152.91 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 121.962 0.887 . . . . 0.0 113.107 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.512 ' N ' HG22 ' A' ' 95' ' ' ILE . 5.7 pt-20 -99.95 -49.1 4.44 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.17 178.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -170.79 147.41 2.76 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-O 121.832 0.825 . . . . 0.0 111.764 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.835 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.62 122.66 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.2 t -106.26 146.0 30.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.197 0.522 . . . . 0.0 111.324 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -139.14 133.53 31.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.286 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -128.75 133.29 48.06 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -135.21 131.82 37.15 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.002 -0.436 . . . . 0.0 110.254 -178.693 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -120.22 133.7 55.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.522 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -99.54 129.78 45.73 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -178.71 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -131.76 137.18 55.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.987 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.68 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -73.24 134.89 44.44 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.728 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.404 ' N ' ' HA ' ' A' ' 111' ' ' SER . 30.3 p -121.31 167.69 12.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.73 -27.17 34.76 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.8 m -86.97 -19.5 28.66 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 120.217 2.008 . . . . 0.0 113.743 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.24 -83.73 0.14 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.854 2.169 . . . . 0.0 111.104 -170.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 27.7 t -164.22 130.96 3.13 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 125.657 1.583 . . . . 0.0 110.971 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 105' ' ' VAL . 39.0 m -99.72 117.82 34.88 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 45.7 mt -92.25 132.5 36.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.386 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 102' ' ' THR . 12.0 mttt -105.17 117.16 33.3 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.719 ' C ' HD13 ' A' ' 116' ' ' ILE . 10.3 m -110.74 117.5 33.62 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.351 0.596 . . . . 0.0 110.783 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.947 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -99.9 135.8 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 123.561 0.744 . . . . 0.0 109.811 -177.758 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.8 p -104.3 133.98 48.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.644 ' CE1' HG23 ' A' ' 4' ' ' THR . 12.2 m80 -136.75 93.28 2.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.081 0.467 . . . . 0.0 109.927 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.847 ' C ' HG23 ' A' ' 2' ' ' VAL . 22.6 m-85 -87.37 101.77 13.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.835 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.453 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 87.6 m-70 -91.51 100.05 12.87 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.1 p -100.7 179.95 4.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.528 0.68 . . . . 0.0 111.937 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.49 ' CB ' ' NZ ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -109.16 155.42 21.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.344 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 41.32 -109.8 0.18 Allowed Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -116.96 7.14 13.11 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.911 -0.17 . . . . 0.0 111.006 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -47.51 159.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.169 0.509 . . . . 0.0 110.295 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.449 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 38.2 mt-10 -150.57 147.11 27.05 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.056 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.413 HD12 ' CD1' ' A' ' 95' ' ' ILE . 10.2 mm -89.32 124.57 42.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.468 ' HG2' ' H ' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -75.36 162.49 28.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.473 0.654 . . . . 0.0 111.643 -178.758 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.19 -34.08 74.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.837 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.468 ' H ' ' HG2' ' A' ' 128' ' ' LYS . 62.9 mt-10 -64.93 -35.6 81.7 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.824 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -68.57 -53.86 20.27 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.173 0.511 . . . . 0.0 110.789 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.0 m -69.23 -20.27 24.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.469 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -66.22 -47.64 73.2 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 122.293 -0.254 . . . . 0.0 110.41 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.88 -48.71 55.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.669 0.271 . . . . 0.0 110.697 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.91 -47.08 89.39 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -67.49 -47.03 71.22 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 122.493 -0.416 . . . . 0.0 110.569 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -55.24 -46.83 76.03 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.503 ' NZ ' ' O ' ' A' ' 37' ' ' ALA . 25.1 tttp -63.28 -54.42 37.41 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.45 -41.76 41.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.771 0.796 . . . . 0.0 110.116 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -63.11 -36.72 84.56 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.229 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.09 -47.58 90.11 Favored Glycine 0 C--O 1.226 -0.36 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -64.71 -44.81 89.04 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -59.46 -23.63 62.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -76.67 -37.48 56.14 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.023 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.753 ' C ' HD12 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -67.69 -56.19 10.27 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.354 1.073 . . . . 0.0 109.05 179.2 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.708 ' O ' HD22 ' A' ' 150' ' ' LEU . 50.9 mt -53.95 -50.66 51.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.285 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -47.5 -56.89 6.11 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.587 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 145' ' ' LEU . 12.1 p -52.98 -40.9 64.1 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.209 0.528 . . . . 0.0 111.468 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.643 ' HB2' HD13 ' A' ' 33' ' ' ILE . 22.1 t80 -61.47 -44.4 97.16 Favored 'General case' 0 C--O 1.193 -1.903 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.816 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.1 mm? -67.87 -42.71 80.86 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 119.995 1.27 . . . . 0.0 111.335 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -62.89 -23.81 67.52 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 121.505 -0.747 . . . . 0.0 109.13 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -105.72 -12.86 15.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.922 0.868 . . . . 0.0 110.342 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.638 ' N ' ' O ' ' A' ' 149' ' ' TYR . 0.2 OUTLIER -155.14 66.65 4.94 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 125.393 1.477 . . . . 0.0 110.041 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.42 ' N ' ' O ' ' A' ' 150' ' ' LEU . 39.8 Cg_endo -72.25 -3.44 13.34 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 C-N-CA 122.603 2.202 . . . . 0.0 111.68 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.483 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 4.2 m-20 -84.66 4.12 33.95 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.122 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.405 ' O ' ' CD ' ' A' ' 20' ' ' LYS . . . -50.1 130.31 22.21 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 119.522 -1.986 . . . . 0.0 111.419 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.714 ' CG ' HD13 ' A' ' 24' ' ' LEU . 0.7 OUTLIER 55.15 6.47 0.15 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 4.4 p-10 . . . . . 0 C--N 1.325 -0.499 0 O-C-N 121.832 -0.542 . . . . 0.0 110.253 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.835 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.2 p . . . . . 0 C--O 1.234 0.256 0 CA-C-O 120.728 0.299 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -97.64 109.41 22.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.776 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.58 HG23 ' CE1' ' A' ' 118' ' ' HIS . 92.8 m -97.18 139.83 32.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 0.0 110.918 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -140.34 129.5 23.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.205 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.401 ' HG2' HD12 ' A' ' 116' ' ' ILE . 1.4 tt0 -103.37 126.67 50.66 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.757 0.313 . . . . 0.0 110.894 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -126.67 165.71 18.71 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.198 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -155.93 139.8 16.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 112.082 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -137.98 139.94 39.95 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.474 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.27 145.04 26.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.82 0.343 . . . . 0.0 111.521 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.0 t -145.38 155.06 42.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.534 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -93.23 29.32 1.93 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.894 0.378 . . . . 0.0 110.792 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.578 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.3 mt -113.78 125.25 29.74 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.779 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -49.22 146.01 13.92 Favored 'Trans proline' 0 C--N 1.327 -0.559 0 C-N-CA 121.862 1.708 . . . . 0.0 111.615 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.433 ' HA ' HD12 ' A' ' 18' ' ' LEU . 27.1 Cg_exo -57.56 -24.6 62.79 Favored 'Trans proline' 0 N--CA 1.483 0.853 0 C-N-CA 122.204 1.936 . . . . 0.0 112.412 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.522 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 52.9 m -67.64 -35.63 79.26 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -75.74 -57.26 3.99 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.578 HD11 ' O ' ' A' ' 13' ' ' ILE . 3.8 mt -49.19 -47.11 46.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.09 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.479 ' O ' HG22 ' A' ' 23' ' ' VAL . 40.2 t80 -48.04 -56.66 7.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.705 ' CB ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.99 -38.41 76.0 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 119.101 -1.039 . . . . 0.0 108.479 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.798 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -66.72 -3.71 7.26 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.541 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.499 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 7.9 m-85 -119.94 -8.9 9.75 Favored 'General case' 0 CA--C 1.527 0.058 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.578 HG23 ' N ' ' A' ' 24' ' ' LEU . 22.3 m -129.31 -49.61 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.033 HD12 ' N ' ' A' ' 25' ' ' ASP . 2.7 pp -101.19 -30.53 11.49 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 1.033 ' N ' HD12 ' A' ' 24' ' ' LEU . 50.2 m-20 -110.89 -4.07 15.38 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.813 -0.554 . . . . 0.0 111.398 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -66.82 -38.79 87.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.704 0.764 . . . . 0.0 112.099 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -84.09 14.83 3.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.86 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.436 ' H ' ' H ' ' A' ' 29' ' ' LEU . 95.7 m-20 -138.84 -9.27 1.37 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.965 HD12 HG23 ' A' ' 146' ' ' ILE . 0.1 OUTLIER -92.03 -50.86 5.48 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.515 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.598 HG13 HD11 ' A' ' 146' ' ' ILE . 91.1 mt -55.33 -48.23 96.74 Favored Pre-proline 0 C--O 1.212 -0.884 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 29.7 Cg_endo -62.87 -26.16 74.52 Favored 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 121.773 1.649 . . . . 0.0 113.461 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -75.93 -48.61 20.56 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.662 0.744 . . . . 0.0 112.042 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.777 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.6 OUTLIER -94.45 -36.28 6.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.533 -177.262 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.91 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.95 63.61 0.16 Allowed Pre-proline 0 C--N 1.324 -0.507 0 C-N-CA 122.817 0.447 . . . . 0.0 111.947 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.493 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 73.6 Cg_endo -76.37 -25.73 9.5 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 N-CA-C 107.625 -1.721 . . . . 0.0 107.625 174.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -74.81 -43.9 52.19 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.609 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.91 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -71.73 -75.13 0.14 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.254 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.56 146.17 9.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.955 0.407 . . . . 0.0 110.221 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -77.66 -52.4 9.04 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.376 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.697 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 54.0 tp60 -175.68 164.0 2.94 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 110.546 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.697 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -166.96 144.0 4.67 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.134 0.492 . . . . 0.0 110.518 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.53 ' N ' ' NZ ' ' A' ' 54' ' ' LYS . 17.7 pt-20 -149.85 156.17 41.33 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.105 -0.372 . . . . 0.0 110.876 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.442 HG13 ' H ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -83.83 138.87 18.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.554 0.692 . . . . 0.0 111.008 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.97 -39.38 13.02 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.03 -0.987 . . . . 0.0 109.053 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.904 ' O ' HG23 ' A' ' 52' ' ' THR . 1.1 tt0 -142.41 138.22 30.95 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.22 -156.68 27.39 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -135.08 -13.6 2.11 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.593 -0.357 . . . . 0.0 111.079 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.8 10.84 0.38 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.9 -172.99 19.84 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 117.525 0.662 . . . . 0.0 111.75 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.28 127.19 22.19 Favored 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 122.597 2.198 . . . . 0.0 113.207 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.95 1.94 55.01 Favored Glycine 0 CA--C 1.506 -0.512 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.904 HG23 ' O ' ' A' ' 45' ' ' GLU . 95.8 m -93.59 136.16 34.15 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.313 -0.944 . . . . 0.0 110.761 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mp -109.56 119.22 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' NZ ' ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -109.25 136.4 48.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.781 0.8 . . . . 0.0 109.738 178.595 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -120.56 129.77 53.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.157 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.672 ' N ' HD12 ' A' ' 56' ' ' ILE . 2.5 mp -95.41 136.38 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.4 m -107.97 118.43 36.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.491 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -98.29 166.85 11.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.638 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.7 144.52 30.31 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.81 -58.47 8.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.805 0.336 . . . . 0.0 110.694 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.35 61.6 3.22 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 m -137.41 176.05 9.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.945 0.403 . . . . 0.0 110.684 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -61.07 -52.66 63.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.658 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.26 155.97 18.16 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.05 -61.8 0.14 Allowed Glycine 0 N--CA 1.462 0.393 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.64 155.06 42.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 0.0 110.846 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 p -156.01 145.52 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.187 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.495 ' HZ2' ' HB3' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -101.49 110.52 22.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.32 0.581 . . . . 0.0 111.802 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.464 ' CD2' ' C ' ' A' ' 69' ' ' HIS . 0.3 OUTLIER -109.62 114.79 28.69 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.541 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.11 133.77 46.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.11 0.481 . . . . 0.0 111.693 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.5 mt -80.31 137.51 21.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -95.54 -54.31 3.42 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -177.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.8 m -164.66 141.72 6.27 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.441 HD13 HG11 ' A' ' 23' ' ' VAL . 22.6 mt -128.21 130.0 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.712 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 79' ' ' TYR . 7.4 m-20 -115.61 88.78 2.95 Favored 'General case' 0 C--O 1.211 -0.928 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.414 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 7.4 mt-10 -54.26 -30.07 49.22 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.3 -38.08 70.77 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.426 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.07 -11.46 15.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.978 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 75' ' ' ASP . 7.5 m-85 61.16 41.47 13.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.795 -0.566 . . . . 0.0 110.498 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.9 t -115.41 132.66 56.55 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.736 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.492 ' CE2' ' OG1' ' A' ' 102' ' ' THR . 51.4 p90 -132.45 131.79 42.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.29 0.567 . . . . 0.0 110.92 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.3 t -126.81 145.15 50.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.226 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -151.26 163.63 38.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.1 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 98' ' ' ILE . 5.7 m -146.4 142.5 28.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.233 0.54 . . . . 0.0 111.378 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.636 HD13 ' HB1' ' A' ' 90' ' ' ALA . 5.7 mt -81.19 120.56 25.03 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.477 ' CG1' ' N ' ' A' ' 87' ' ' GLU . 3.6 pt -80.75 -44.55 21.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.724 0.297 . . . . 0.0 111.665 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.517 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 4.6 tp10 -153.71 171.79 18.3 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.613 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.54 177.77 18.03 Favored Glycine 0 CA--C 1.508 -0.359 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -61.06 2.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.636 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -68.38 -35.06 77.15 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 124.168 0.987 . . . . 0.0 110.102 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.889 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.62 15.68 21.89 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 123.591 0.756 . . . . 0.0 109.799 -178.057 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.4 p 47.19 -126.8 1.65 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -130.74 -12.79 3.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.078 0.466 . . . . 0.0 111.195 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.514 ' O ' HG21 ' A' ' 125' ' ' ILE . 2.6 p -105.53 -5.36 20.28 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.714 HG21 ' CD1' ' A' ' 98' ' ' ILE . 79.4 mt -97.55 152.17 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-O 122.16 0.981 . . . . 0.0 113.432 -176.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.493 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -89.41 -59.47 2.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 113.917 -1.492 . . . . 0.0 109.423 178.12 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.442 ' CB ' ' NZ ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -171.69 149.08 2.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.462 0.649 . . . . 0.0 111.285 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.714 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.92 123.24 69.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.537 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.4 t -111.14 146.43 36.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.353 0.597 . . . . 0.0 111.956 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -134.7 131.07 37.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.571 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.427 ' O ' HG12 ' A' ' 116' ' ' ILE . 77.3 tt0 -128.1 133.55 49.03 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.492 ' OG1' ' CE2' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -140.2 132.71 28.63 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.956 -0.465 . . . . 0.0 110.476 -178.419 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.602 ' C ' HD23 ' A' ' 104' ' ' LEU . 54.3 tttm -121.76 133.93 54.92 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.73 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -100.12 126.35 46.36 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.39 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.19 137.17 58.6 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.159 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.81 133.92 44.69 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.379 178.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 28.1 p -121.1 172.8 7.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.941 0.401 . . . . 0.0 110.258 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.12 -38.78 61.93 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.1 m -83.53 -15.57 48.82 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.63 1.172 . . . . 0.0 112.871 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 160.75 -85.48 0.11 Allowed Glycine 0 CA--C 1.54 1.596 0 C-N-CA 127.541 2.495 . . . . 0.0 112.794 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.7 OUTLIER -157.58 130.32 7.46 Favored 'General case' 0 C--N 1.347 0.487 0 C-N-CA 127.995 2.518 . . . . 0.0 111.046 175.52 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.4 m -99.82 118.45 36.31 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.5 mt -91.83 128.73 43.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.54 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.431 ' CB ' ' NZ ' ' A' ' 114' ' ' LYS . 1.2 mtmp? -105.59 117.05 33.02 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.814 ' C ' HD13 ' A' ' 116' ' ' ILE . 43.7 t -111.31 125.23 53.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.238 0.542 . . . . 0.0 110.845 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.896 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -107.17 135.76 44.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 123.22 0.608 . . . . 0.0 110.043 -177.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.2 t -107.1 137.94 44.22 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.885 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.58 ' CE1' HG23 ' A' ' 4' ' ' THR . 6.7 m80 -135.67 93.49 2.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.076 0.465 . . . . 0.0 110.589 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.835 ' C ' HG23 ' A' ' 2' ' ' VAL . 88.8 m-85 -86.56 101.6 13.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.173 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -99.3 107.88 20.28 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.138 0.494 . . . . 0.0 110.546 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.779 HG21 ' HA ' ' A' ' 126' ' ' GLU . 9.3 p -100.48 173.11 6.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.408 0.623 . . . . 0.0 111.167 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.97 155.17 21.18 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.187 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 40.3 -109.09 0.12 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -109.51 -1.4 18.3 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 122.779 -0.248 . . . . 0.0 111.213 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.514 HG21 ' O ' ' A' ' 94' ' ' THR . 1.4 mp -49.16 151.54 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.269 0.557 . . . . 0.0 109.877 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.779 ' HA ' HG21 ' A' ' 121' ' ' THR . 35.2 tt0 -147.7 148.29 30.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.642 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.7 mm -87.99 125.46 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -74.33 162.3 29.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.123 0.487 . . . . 0.0 111.798 -178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.4 -34.89 75.18 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.948 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.472 ' O ' HG22 ' A' ' 134' ' ' VAL . 0.6 OUTLIER -69.15 -28.62 66.59 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.108 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -72.49 -47.43 48.67 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.112 0.482 . . . . 0.0 111.108 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.4 m -79.29 -28.61 13.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.981 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -66.78 -45.64 77.85 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.169 -0.332 . . . . 0.0 110.855 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.514 HG23 ' N ' ' A' ' 135' ' ' GLY . 32.6 m -70.35 -45.6 74.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.718 0.294 . . . . 0.0 110.529 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.514 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -66.9 -44.59 88.6 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 77.9 tttt -65.02 -46.04 83.01 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 122.696 -0.296 . . . . 0.0 110.673 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -54.42 -47.15 73.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.793 0.33 . . . . 0.0 110.135 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.1 ttpp -66.44 -52.99 40.55 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.69 -43.98 47.71 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.589 0.709 . . . . 0.0 110.546 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.37 -36.49 75.85 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.424 ' O ' HD22 ' A' ' 145' ' ' LEU . . . -61.03 -42.4 99.78 Favored Glycine 0 C--O 1.22 -0.76 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.559 ' CD2' ' HB1' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -64.0 -46.84 82.74 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -60.74 -24.08 65.44 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 141' ' ' GLY . 1.8 ttmm -76.5 -38.56 55.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.808 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.777 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -66.94 -57.01 7.76 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.365 0.602 . . . . 0.0 110.092 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.965 HG23 HD12 ' A' ' 29' ' ' LEU . 43.3 mt -55.3 -50.03 68.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.539 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -47.19 -53.23 13.64 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.667 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.3 m -55.39 -41.72 73.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.232 0.539 . . . . 0.0 110.908 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.719 ' HB2' HD13 ' A' ' 33' ' ' ILE . 22.0 t80 -60.8 -45.44 94.39 Favored 'General case' 0 C--O 1.194 -1.864 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.798 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.1 mm? -67.02 -42.95 84.06 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 120.653 1.57 . . . . 0.0 111.449 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -24.02 67.47 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.699 -0.625 . . . . 0.0 109.425 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -106.34 -13.17 15.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.842 0.83 . . . . 0.0 110.415 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.657 ' N ' ' O ' ' A' ' 149' ' ' TYR . 96.5 m-70 -156.04 66.81 4.52 Favored Pre-proline 0 C--N 1.303 -1.436 0 C-N-CA 125.32 1.448 . . . . 0.0 110.173 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.86 -2.18 11.87 Favored 'Trans proline' 0 N--CA 1.48 0.708 0 C-N-CA 122.708 2.272 . . . . 0.0 111.154 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 9.1 m-20 -68.36 2.21 2.46 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.535 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.602 ' O ' ' HD3' ' A' ' 20' ' ' LYS . . . -50.43 130.47 23.62 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 118.841 -2.412 . . . . 0.0 110.924 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.845 ' CD1' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER 52.34 4.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 179.243 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 3.2 p-10 . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 118.18 -0.915 . . . . 0.0 110.052 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.774 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.7 p . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.869 0.366 . . . . 0.0 111.329 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -98.0 109.99 22.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.682 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.502 ' OG1' ' CE1' ' A' ' 118' ' ' HIS . 74.6 m -95.76 140.09 31.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 0.0 110.796 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -141.5 132.04 25.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.132 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -103.02 137.02 41.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.128 0.489 . . . . 0.0 111.47 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -136.16 165.39 25.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.971 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -155.62 149.63 25.52 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -149.65 140.73 22.99 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.512 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.08 147.83 23.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.874 0.368 . . . . 0.0 111.659 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.4 p -140.0 155.74 46.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.446 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -95.93 22.51 7.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.838 0.351 . . . . 0.0 111.044 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.554 ' O ' HD11 ' A' ' 18' ' ' LEU . 2.3 mt -119.31 128.07 26.13 Favored Pre-proline 0 C--O 1.217 -0.616 0 CA-C-O 118.946 -0.55 . . . . 0.0 110.375 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -45.7 144.8 5.04 Favored 'Trans proline' 0 C--N 1.325 -0.666 0 C-N-CA 121.68 1.587 . . . . 0.0 110.935 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HA ' HD12 ' A' ' 18' ' ' LEU . 10.2 Cg_endo -61.13 -23.63 77.64 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 122.172 1.915 . . . . 0.0 112.693 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.506 ' C ' ' HE ' ' A' ' 17' ' ' ARG . 10.2 t -70.35 -30.18 67.07 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.696 ' HE ' ' N ' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -79.16 -52.3 8.35 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.554 HD11 ' O ' ' A' ' 13' ' ' ILE . 4.3 mt -53.45 -44.75 69.15 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.261 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.9 ' O ' HG22 ' A' ' 23' ' ' VAL . 48.7 t80 -49.83 -57.44 7.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.94 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.45 ' CG ' ' O ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -68.63 -27.64 66.2 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.815 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.024 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -82.95 -1.63 52.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.655 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.634 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 13.1 t80 -120.31 -7.66 9.75 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.9 HG22 ' O ' ' A' ' 19' ' ' PHE . 2.5 m -129.71 -35.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.845 ' CD1' HG23 ' A' ' 23' ' ' VAL . 4.3 mp -89.49 -54.46 4.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.777 0.717 . . . . 0.0 111.626 -176.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.527 ' CB ' ' CZ ' ' A' ' 157' ' ' TYR . 0.1 OUTLIER -115.8 0.83 13.29 Favored 'General case' 0 C--O 1.199 -1.596 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.341 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.634 ' HB2' ' HA ' ' A' ' 22' ' ' PHE . . . -44.53 -41.87 6.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 119.518 1.053 . . . . 0.0 111.879 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -84.81 17.4 2.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.507 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 25' ' ' ASP . 68.3 m-20 -139.68 -10.97 1.18 Allowed 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 125.562 1.545 . . . . 0.0 108.722 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.569 HD21 ' CD2' ' A' ' 149' ' ' TYR . 0.2 OUTLIER -95.07 -43.02 8.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 125.19 1.396 . . . . 0.0 108.334 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.73 HG13 HD11 ' A' ' 146' ' ' ILE . 55.7 mt -54.5 -51.17 80.6 Favored Pre-proline 0 C--O 1.215 -0.73 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.072 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 26.2 Cg_endo -61.96 -22.79 74.97 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 122.148 1.899 . . . . 0.0 111.855 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -68.82 -55.45 11.14 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.505 0.669 . . . . 0.0 111.564 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.722 HD12 ' HB2' ' A' ' 145' ' ' LEU . 0.5 OUTLIER -94.63 -40.97 11.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.732 -177.76 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.876 ' HB2' HD22 ' A' ' 145' ' ' LEU . . . -110.8 71.13 0.69 Allowed Pre-proline 0 CA--C 1.506 -0.737 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.016 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.21 -6.87 15.73 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 N-CA-C 108.115 -1.533 . . . . 0.0 108.115 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.429 ' H ' ' C ' ' A' ' 34' ' ' ALA . 24.7 pt20 -71.98 -34.82 69.22 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.799 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.586 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -79.55 -82.0 0.11 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.263 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 38' ' ' ILE . 1.8 mp -102.81 143.66 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.882 0.372 . . . . 0.0 110.353 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -79.33 -43.74 22.95 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.986 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.403 ' OE1' ' N ' ' A' ' 41' ' ' ALA . 1.4 pp0? -177.39 165.17 2.19 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.403 ' N ' ' OE1' ' A' ' 40' ' ' GLN . . . -165.47 145.63 6.83 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.751 0.31 . . . . 0.0 110.951 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -136.75 142.76 43.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.74 0.305 . . . . 0.0 110.213 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.618 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -79.57 140.11 17.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.523 0.678 . . . . 0.0 110.472 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.1 mp -88.84 -39.64 13.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.877 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.948 ' O ' HG23 ' A' ' 52' ' ' THR . 22.9 mt-10 -142.96 134.09 25.81 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.867 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.86 -156.05 35.89 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -137.54 -0.53 2.16 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.554 -0.38 . . . . 0.0 111.363 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.507 ' N ' HG21 ' A' ' 52' ' ' THR . . . 134.87 16.24 1.0 Allowed Glycine 0 C--O 1.223 -0.56 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.466 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -110.48 -173.32 20.19 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 117.525 0.662 . . . . 0.0 111.458 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -60.39 125.92 18.68 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 122.181 1.921 . . . . 0.0 113.172 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.7 2.7 58.51 Favored Glycine 0 N--CA 1.462 0.412 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.948 HG23 ' O ' ' A' ' 45' ' ' GLU . 90.7 m -94.05 140.16 30.07 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.359 -0.921 . . . . 0.0 111.267 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mp -120.68 130.94 74.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.618 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -119.83 140.0 51.49 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.302 0.572 . . . . 0.0 111.02 179.231 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.633 ' HE3' ' HZ3' ' A' ' 68' ' ' LYS . 35.5 ttmt -118.21 124.75 48.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.609 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.805 HD13 ' CD2' ' A' ' 69' ' ' HIS . 1.4 mp -102.84 129.58 54.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.4 m -112.46 119.88 39.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.248 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -92.63 -174.93 3.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.008 0.432 . . . . 0.0 110.849 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.36 146.63 50.47 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.631 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 3.5 mp0 -59.1 -48.96 79.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.869 0.366 . . . . 0.0 110.617 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.92 61.27 3.41 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -138.4 175.62 9.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.248 0.547 . . . . 0.0 110.412 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.58 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -67.1 -53.56 29.72 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.14 156.26 18.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.953 0.406 . . . . 0.0 110.18 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.31 -58.77 0.22 Allowed Glycine 0 CA--C 1.52 0.348 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -143.83 155.02 43.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.168 0.509 . . . . 0.0 110.58 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.466 ' CG2' HD11 ' A' ' 85' ' ' LEU . 5.1 p -154.23 146.54 13.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.361 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.633 ' HZ3' ' HE3' ' A' ' 55' ' ' LYS . 14.6 mmtt -107.46 112.43 25.21 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.285 0.564 . . . . 0.0 112.491 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.805 ' CD2' HD13 ' A' ' 56' ' ' ILE . 8.8 m-70 -104.83 114.83 29.28 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -101.91 120.76 40.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.653 0.263 . . . . 0.0 111.17 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.559 HD13 ' CG2' ' A' ' 52' ' ' THR . 5.0 mp -70.48 145.15 13.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -102.02 -55.64 2.45 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.123 -0.36 . . . . 0.0 111.83 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.9 m -165.93 141.02 4.75 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.5 mt -124.53 130.99 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.922 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 79' ' ' TYR . 12.7 m-20 -115.16 87.67 2.71 Favored 'General case' 0 C--O 1.206 -1.213 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.486 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -54.72 -32.39 59.54 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.45 -38.55 66.48 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.06 -10.78 15.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.055 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.2 m-85 62.58 47.29 5.01 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.45 -0.781 . . . . 0.0 110.341 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.496 ' HB3' ' HZ3' ' A' ' 103' ' ' LYS . 10.2 p -105.8 144.54 32.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.415 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.633 ' CE2' ' CD2' ' A' ' 83' ' ' TYR . 29.5 t80 -132.2 118.41 19.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.052 0.453 . . . . 0.0 110.712 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.6 p -127.12 130.44 49.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.748 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.633 ' CD2' ' CE2' ' A' ' 81' ' ' TYR . 12.9 p90 -144.8 164.63 30.47 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -140.1 137.01 34.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.329 0.585 . . . . 0.0 110.987 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.627 HD21 ' CE1' ' A' ' 69' ' ' HIS . 0.2 OUTLIER -79.75 118.65 21.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.696 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.569 HD11 ' CB ' ' A' ' 68' ' ' LYS . 2.7 pt -87.27 -45.01 16.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.479 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 35.4 tt0 -152.65 171.76 17.68 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.85 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.616 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.87 177.46 17.87 Favored Glycine 0 CA--C 1.51 -0.245 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -62.16 2.05 0.27 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.616 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -66.01 -33.02 74.84 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 124.754 1.221 . . . . 0.0 110.608 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.876 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -109.75 16.14 22.27 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 123.439 0.695 . . . . 0.0 109.624 -178.08 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 53.4 p 45.85 -126.49 1.31 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -130.38 -12.99 3.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.96 0.41 . . . . 0.0 111.176 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.9 p -105.17 -6.74 19.56 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.714 HG21 ' CD1' ' A' ' 98' ' ' ILE . 59.0 mt -98.6 153.01 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 CA-C-O 122.004 0.907 . . . . 0.0 113.256 -176.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.514 ' N ' HG22 ' A' ' 95' ' ' ILE . 19.9 pt-20 -99.88 -46.11 5.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.377 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.441 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -172.62 146.83 1.73 Allowed 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 121.723 0.773 . . . . 0.0 112.415 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.714 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.14 123.47 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.501 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.94 145.08 30.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.138 0.494 . . . . 0.0 111.369 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.514 ' CD2' ' O ' ' A' ' 116' ' ' ILE . 0.4 OUTLIER -141.79 129.5 21.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.576 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.419 ' O ' HG12 ' A' ' 116' ' ' ILE . 18.0 tt0 -128.12 134.6 49.14 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.06 131.82 25.76 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.905 -0.497 . . . . 0.0 109.96 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.697 ' C ' HD23 ' A' ' 104' ' ' LEU . 17.5 ttmm -125.62 134.15 51.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.123 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.873 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -99.9 125.97 45.96 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.116 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -126.2 137.26 58.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.795 -178.824 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.69 132.73 44.06 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.41 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 111' ' ' SER . 24.2 p -121.4 171.6 8.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.866 0.365 . . . . 0.0 110.293 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.94 -30.77 46.27 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.8 m -85.4 -16.81 38.55 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.379 -2.248 . . . . 0.0 114.352 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.74 -85.57 0.13 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.078 1.799 . . . . 0.0 109.858 -171.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.3 OUTLIER -160.12 129.13 5.0 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.87 1.668 . . . . 0.0 110.921 -178.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 105' ' ' VAL . 33.1 m -99.43 117.8 34.64 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 55.5 mt -91.96 128.81 43.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.766 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -105.89 117.08 33.1 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.719 ' C ' HD13 ' A' ' 116' ' ' ILE . 0.5 OUTLIER -111.88 118.18 34.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.415 0.626 . . . . 0.0 111.556 -178.291 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.95 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -99.31 135.03 36.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 123.773 0.829 . . . . 0.0 109.915 -178.727 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.9 136.86 46.91 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.502 ' CE1' ' OG1' ' A' ' 4' ' ' THR . 47.8 m-70 -136.09 97.81 3.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 120.999 0.428 . . . . 0.0 110.801 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.774 ' C ' HG23 ' A' ' 2' ' ' VAL . 3.6 m-30 -84.31 101.65 12.1 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.83 -0.434 . . . . 0.0 109.83 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.442 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -94.83 102.67 14.53 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.752 HG21 ' HA ' ' A' ' 126' ' ' GLU . 11.9 p -101.31 171.32 7.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.482 0.658 . . . . 0.0 111.421 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -112.35 143.0 44.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.508 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 50.38 -109.71 0.74 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -106.85 -6.51 17.62 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.649 -0.324 . . . . 0.0 111.478 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 125' ' ' ILE . 1.4 mp -47.5 151.42 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.199 0.524 . . . . 0.0 109.751 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.752 ' HA ' HG21 ' A' ' 121' ' ' THR . 12.9 pt-20 -148.18 147.75 29.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.84 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.9 mm -88.19 127.67 41.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.449 ' HG3' ' H ' ' A' ' 129' ' ' GLU . 10.7 tptp -73.76 159.88 32.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.614 0.721 . . . . 0.0 111.684 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.449 ' H ' ' HG3' ' A' ' 128' ' ' LYS . 70.0 mm-40 -70.15 -37.89 75.34 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.531 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.476 ' O ' HG13 ' A' ' 134' ' ' VAL . 43.8 mt-10 -64.69 -26.58 68.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.877 0.37 . . . . 0.0 110.231 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -72.78 -49.23 32.03 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.161 0.505 . . . . 0.0 111.062 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 m -78.25 -28.99 15.08 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.121 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -67.23 -46.2 74.5 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 122.004 -0.435 . . . . 0.0 110.746 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 135' ' ' GLY . 25.8 m -70.42 -42.4 78.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.771 0.32 . . . . 0.0 110.679 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.491 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -69.86 -46.16 54.24 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -66.74 -48.43 69.18 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.568 -0.372 . . . . 0.0 110.911 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -56.03 -47.77 77.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.097 0.475 . . . . 0.0 110.126 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -64.7 -53.85 40.86 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.449 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -48.36 -46.8 37.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.352 0.596 . . . . 0.0 110.564 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -55.37 -37.44 67.55 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.99 -42.25 98.26 Favored Glycine 0 C--O 1.223 -0.532 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.727 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -66.49 -32.71 74.24 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 122.243 -0.563 . . . . 0.0 109.943 -179.194 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.59 ' CE2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -71.48 -20.03 62.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.224 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -72.6 -48.22 41.44 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.294 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.876 HD22 ' HB2' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -73.57 -44.33 57.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.165 -179.294 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.73 HD11 HG13 ' A' ' 30' ' ' ILE . 31.2 mt -52.57 -50.51 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.425 ' O ' ' CD1' ' A' ' 13' ' ' ILE . 27.1 tt0 -47.87 -49.43 29.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.1 t -51.74 -46.85 64.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.483 0.659 . . . . 0.0 110.959 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.607 ' O ' ' N ' ' A' ' 153' ' ' HIS . 12.2 t80 -58.55 -43.79 89.43 Favored 'General case' 0 C--O 1.199 -1.582 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 1.024 HD11 ' HB2' ' A' ' 21' ' ' ALA . 1.6 mm? -67.91 -43.23 79.7 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 119.675 1.125 . . . . 0.0 111.983 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.501 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -59.9 -24.58 64.42 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.253 -0.904 . . . . 0.0 108.953 179.507 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -105.73 -13.81 15.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.331 0.586 . . . . 0.0 110.575 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.607 ' N ' ' O ' ' A' ' 149' ' ' TYR . 0.3 OUTLIER -155.65 66.5 4.63 Favored Pre-proline 0 C--N 1.313 -0.982 0 C-N-CA 124.738 1.215 . . . . 0.0 110.47 -178.583 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.466 ' CD ' ' O ' ' A' ' 150' ' ' LEU . 9.7 Cg_endo -77.47 -8.58 17.26 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 C-N-CA 122.719 2.28 . . . . 0.0 111.743 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.532 ' OD2' ' ND2' ' A' ' 158' ' ' ASN . 14.0 t70 -89.94 6.54 41.6 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.388 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.557 ' HB1' ' CE1' ' A' ' 157' ' ' TYR . . . -72.34 132.18 43.64 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 120.296 -1.503 . . . . 0.0 110.274 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.557 ' CE1' ' HB1' ' A' ' 156' ' ' ALA . 1.7 m-85 64.95 9.12 5.15 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.794 176.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.532 ' ND2' ' OD2' ' A' ' 155' ' ' ASP . 6.4 p-10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.747 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.812 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.9 p . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.669 0.271 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.28 109.78 22.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.694 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 61.3 m -96.88 140.01 32.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.802 0.334 . . . . 0.0 111.028 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.88 125.34 16.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.98 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.27 130.24 50.46 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.716 0.293 . . . . 0.0 111.429 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -131.43 171.34 13.5 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -155.76 155.63 33.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -154.63 140.0 17.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.343 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 m -93.91 146.27 24.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.817 0.341 . . . . 0.0 111.583 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 p -135.15 154.32 51.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.398 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -97.41 26.92 4.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.084 0.468 . . . . 0.0 110.498 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.585 ' HB ' HD21 ' A' ' 18' ' ' LEU . 2.2 mt -119.05 125.41 27.67 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.444 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -46.13 147.32 3.76 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 121.826 1.684 . . . . 0.0 111.522 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -59.56 -24.53 75.48 Favored 'Trans proline' 0 N--CA 1.482 0.812 0 C-N-CA 121.983 1.789 . . . . 0.0 112.212 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.47 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 67.1 m -68.13 -34.19 75.9 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -77.8 -56.09 4.79 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 121.395 -0.816 . . . . 0.0 109.272 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.585 HD21 ' HB ' ' A' ' 13' ' ' ILE . 2.8 mt -52.47 -43.05 64.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.226 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.796 ' O ' HG22 ' A' ' 23' ' ' VAL . 46.2 t80 -54.87 -54.42 42.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.497 ' CE ' ' ND2' ' A' ' 158' ' ' ASN . 0.3 OUTLIER -70.89 -25.75 62.92 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.086 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.854 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -83.06 -2.04 54.31 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.524 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.542 ' CE2' ' CE2' ' A' ' 143' ' ' PHE . 2.8 m-85 -117.31 -7.87 11.15 Favored 'General case' 0 C--N 1.335 -0.035 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.876 HG23 ' CD1' ' A' ' 24' ' ' LEU . 4.7 m -134.89 -34.75 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.876 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.7 mp -88.88 -55.34 3.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.871 1.214 . . . . 0.0 111.443 -176.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.506 ' CG ' ' CE2' ' A' ' 157' ' ' TYR . 0.9 OUTLIER -114.76 -1.32 13.28 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.726 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.485 ' HB2' ' CA ' ' A' ' 22' ' ' PHE . . . -45.77 -40.71 9.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.696 0.76 . . . . 0.0 111.57 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.404 ' HB2' ' HZ3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -85.07 18.04 2.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.077 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 25' ' ' ASP . 80.6 m-20 -139.53 -9.06 1.25 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 126.087 1.755 . . . . 0.0 108.683 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.483 HD21 ' CD1' ' A' ' 149' ' ' TYR . 0.1 OUTLIER -95.19 -40.99 9.3 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 124.737 1.215 . . . . 0.0 109.939 -179.061 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.514 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 80.6 mt -55.16 -42.17 94.51 Favored Pre-proline 0 C--O 1.21 -0.985 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.182 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 21.2 Cg_exo -63.79 -26.69 67.83 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 122.098 1.866 . . . . 0.0 112.039 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 tmtp? -71.01 -51.37 25.84 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 122.027 0.918 . . . . 0.0 111.858 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.778 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.5 OUTLIER -94.57 -35.23 6.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.008 -176.711 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.848 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.48 65.04 0.14 Allowed Pre-proline 0 C--N 1.322 -0.606 0 C-N-CA 122.966 0.507 . . . . 0.0 111.89 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.466 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 73.2 Cg_endo -74.88 -23.05 14.44 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 N-CA-C 107.707 -1.69 . . . . 0.0 107.707 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -73.9 -43.51 58.2 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.315 -1.312 . . . . 0.0 109.231 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.848 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -73.78 -82.72 0.05 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.766 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.5 mt -100.5 145.84 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.083 0.468 . . . . 0.0 110.471 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -77.8 -54.99 5.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.787 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.428 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -174.21 166.4 4.13 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.099 0.476 . . . . 0.0 110.342 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.428 ' H ' ' HG2' ' A' ' 40' ' ' GLN . . . -166.25 144.25 5.47 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.475 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.432 ' N ' ' HE3' ' A' ' 54' ' ' LYS . 8.4 pt-20 -135.93 146.62 47.51 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.516 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -78.46 139.83 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.404 0.621 . . . . 0.0 110.695 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 8.1 mp -88.63 -39.93 13.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.142 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.929 ' O ' HG23 ' A' ' 52' ' ' THR . 47.1 mt-10 -142.33 133.98 26.78 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.942 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.39 -156.02 27.69 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 36.8 p30 -142.45 -6.37 0.92 Allowed 'General case' 0 C--N 1.32 -0.684 0 O-C-N 122.355 -0.497 . . . . 0.0 111.177 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.27 14.12 0.31 Allowed Glycine 0 C--O 1.221 -0.708 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.56 -172.61 19.99 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 117.493 0.647 . . . . 0.0 111.988 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -62.13 126.4 18.59 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 123.113 2.542 . . . . 0.0 113.432 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.44 5.8 57.78 Favored Glycine 0 CA--C 1.505 -0.549 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.929 HG23 ' O ' ' A' ' 45' ' ' GLU . 84.3 m -93.37 137.45 32.67 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.339 -0.931 . . . . 0.0 111.128 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.21 129.37 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.516 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -116.21 139.06 50.74 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.206 0.526 . . . . 0.0 110.844 179.163 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.511 ' C ' HD12 ' A' ' 56' ' ' ILE . 66.5 tttt -118.99 127.11 53.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.704 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.827 HD13 ' CD2' ' A' ' 69' ' ' HIS . 1.3 mp -98.98 131.98 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.9 m -105.88 118.84 37.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.349 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -98.65 175.46 5.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 110.782 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.61 145.06 49.68 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -59.31 -53.04 62.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.917 0.389 . . . . 0.0 110.736 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.11 61.73 3.29 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.3 m -140.56 175.03 9.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.36 . . . . 0.0 110.826 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -60.47 -56.12 25.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.976 0.417 . . . . 0.0 110.637 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.93 155.9 16.91 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.196 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -125.22 -59.78 0.17 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.38 154.17 45.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.091 0.472 . . . . 0.0 110.483 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.0 p -156.67 147.35 11.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.351 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.455 ' HB3' HD11 ' A' ' 86' ' ' ILE . 1.5 tppt? -107.12 112.42 25.32 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.452 0.644 . . . . 0.0 112.389 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.827 ' CD2' HD13 ' A' ' 56' ' ' ILE . 8.0 m170 -101.9 120.58 40.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -102.92 115.79 31.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.629 0.252 . . . . 0.0 111.335 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.8 mt -70.0 135.97 27.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.417 ' O ' ' OG ' ' A' ' 73' ' ' SER . 1.7 m-20 -96.94 -56.34 2.59 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 69.4 m -166.08 142.42 5.04 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.9 mt -122.63 131.87 72.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.288 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -115.35 87.7 2.72 Favored 'General case' 0 C--O 1.206 -1.196 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.109 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.503 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -54.67 -30.96 56.96 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.594 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.26 -39.06 72.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.2 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.9 m -107.97 -10.35 15.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.188 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.1 m-85 62.33 45.17 6.85 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.487 -0.758 . . . . 0.0 110.199 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.8 t -106.56 148.39 28.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.273 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -132.02 125.67 32.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.727 0.299 . . . . 0.0 110.848 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.8 t -133.47 138.41 46.15 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.607 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -144.14 160.83 40.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.698 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 98' ' ' ILE . 10.1 m -140.03 129.88 24.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.327 0.584 . . . . 0.0 111.027 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.407 HD21 ' CE1' ' A' ' 69' ' ' HIS . 18.2 mt -78.94 119.46 22.13 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' A' ' 68' ' ' LYS . 5.2 pt -88.32 -43.89 15.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.496 ' CD ' ' N ' ' A' ' 88' ' ' GLY . 8.3 tm-20 -158.89 173.28 16.76 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.222 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.606 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.74 178.51 18.41 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.42 2.55 0.15 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.756 ' C ' HD23 ' A' ' 91' ' ' LEU . . . -70.79 -37.1 73.28 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 123.517 0.727 . . . . 0.0 110.19 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.867 HD23 ' N ' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -111.39 17.17 20.4 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 91' ' ' LEU . 56.7 p 51.93 -132.67 1.91 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -131.64 -0.34 3.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.946 0.403 . . . . 0.0 112.0 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.03 -7.43 19.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.807 HD11 HD12 ' A' ' 127' ' ' ILE . 12.0 mt -99.36 151.67 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.502 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -88.51 -51.53 5.66 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.355 176.026 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.03 148.36 2.23 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.128 0.489 . . . . 0.0 112.182 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.707 HD13 HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.22 130.4 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 176.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.4 147.0 44.86 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 122.957 0.503 . . . . 0.0 111.436 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -137.39 140.74 41.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.67 0.271 . . . . 0.0 110.916 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -128.04 134.99 49.27 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 121.015 0.436 . . . . 0.0 110.647 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.0 131.0 42.15 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -120.91 133.84 55.29 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.461 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.3 mm? -96.67 124.06 40.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.63 136.91 43.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.065 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.95 140.04 47.14 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.79 177.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.486 ' N ' ' HA ' ' A' ' 111' ' ' SER . 34.9 t -121.47 169.95 10.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.8 0.333 . . . . 0.0 110.444 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.451 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.96 -38.09 59.54 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.819 -0.513 . . . . 0.0 111.819 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.0 m -87.97 -9.9 52.11 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.335 1.054 . . . . 0.0 112.883 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.15 -86.51 0.12 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 126.095 1.807 . . . . 0.0 112.539 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.486 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 0.7 OUTLIER -157.58 129.54 7.07 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 127.517 2.327 . . . . 0.0 111.152 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.6 m -99.37 134.44 42.22 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.1 mt -108.87 129.82 62.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.476 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -106.09 116.68 32.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.802 ' C ' HD13 ' A' ' 116' ' ' ILE . 11.4 t -110.47 122.75 48.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.145 0.498 . . . . 0.0 110.437 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.859 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -105.73 135.05 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.027 -177.716 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.8 p -101.5 140.94 35.1 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.14 92.66 2.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.202 0.525 . . . . 0.0 109.909 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.812 ' C ' HG23 ' A' ' 2' ' ' VAL . 86.4 m-85 -90.01 101.36 14.07 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.34 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -91.44 103.81 16.4 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.434 HG21 ' HA ' ' A' ' 126' ' ' GLU . 1.0 OUTLIER -89.33 160.29 16.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.544 -178.212 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.451 ' H ' HG22 ' A' ' 125' ' ' ILE . 5.1 ptmt -112.8 142.84 44.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.229 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.0 -110.39 1.12 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -116.47 -2.95 11.92 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.769 -0.254 . . . . 0.0 110.675 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 122' ' ' LYS . 1.6 tp -48.93 162.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 120.959 0.409 . . . . 0.0 110.862 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.434 ' HA ' HG21 ' A' ' 121' ' ' THR . 11.6 pt-20 -148.41 149.97 32.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.132 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.807 HD12 HD11 ' A' ' 95' ' ' ILE . 3.3 mm -86.82 125.09 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -74.77 162.98 28.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.33 0.586 . . . . 0.0 111.104 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -68.95 -45.54 70.49 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.477 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.535 ' O ' HG22 ' A' ' 134' ' ' VAL . 16.3 mm-40 -60.95 -24.8 66.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.641 0.257 . . . . 0.0 110.645 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -73.04 -52.69 13.41 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.384 0.612 . . . . 0.0 110.989 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.412 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.0 m -76.7 -29.12 17.85 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.039 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -67.27 -46.05 74.79 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.252 -0.28 . . . . 0.0 111.095 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 130' ' ' GLU . 30.1 m -70.26 -42.65 78.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.746 0.308 . . . . 0.0 110.685 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.479 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -70.25 -43.75 62.16 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 29.5 ttmt -67.12 -46.49 73.97 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 122.739 -0.271 . . . . 0.0 110.864 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -54.9 -44.12 73.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.472 ' HZ1' ' C ' ' A' ' 37' ' ' ALA . 37.0 tttm -69.3 -56.18 8.3 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.875 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.424 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -48.94 -42.73 38.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.677 0.751 . . . . 0.0 110.746 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -64.13 -36.24 83.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.25 -37.12 92.51 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.569 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -68.05 -47.62 67.87 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.542 ' CE2' ' CE2' ' A' ' 22' ' ' PHE . 5.3 m-85 -59.32 -21.47 59.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -77.04 -38.34 52.95 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.316 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.778 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.9 -57.0 8.89 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.587 179.55 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.698 ' O ' HD22 ' A' ' 150' ' ' LEU . 76.7 mt -53.9 -50.4 53.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.563 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -47.16 -55.02 9.25 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.019 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.7 t -52.94 -44.01 66.75 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.564 0.697 . . . . 0.0 111.392 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.708 ' HB2' HD13 ' A' ' 33' ' ' ILE . 15.4 t80 -58.83 -45.38 90.15 Favored 'General case' 0 C--O 1.195 -1.772 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.854 HD11 ' HB2' ' A' ' 21' ' ' ALA . 1.7 mm? -67.89 -41.77 82.23 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 119.944 1.247 . . . . 0.0 111.623 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.42 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -60.96 -24.3 65.98 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 121.17 -0.956 . . . . 0.0 108.665 179.45 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -106.15 -14.27 15.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.125 0.488 . . . . 0.0 110.916 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.621 ' N ' ' O ' ' A' ' 149' ' ' TYR . 90.1 m-70 -156.19 66.83 4.45 Favored Pre-proline 0 C--N 1.31 -1.113 0 C-N-CA 125.214 1.406 . . . . 0.0 110.235 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.461 ' CD ' ' O ' ' A' ' 150' ' ' LEU . 59.6 Cg_endo -80.76 -4.77 12.97 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 122.7 2.267 . . . . 0.0 111.989 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -91.13 5.76 47.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.821 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.606 ' HB1' ' CE1' ' A' ' 157' ' ' TYR . . . -72.91 131.36 42.11 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.356 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.606 ' CE1' ' HB1' ' A' ' 156' ' ' ALA . 1.5 m-85 64.38 8.93 4.55 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.778 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.497 ' ND2' ' CE ' ' A' ' 20' ' ' LYS . 5.8 m120 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.314 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.818 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.6 p . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.852 0.358 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -97.7 109.81 22.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.528 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.8 m -96.6 140.16 31.63 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.947 0.403 . . . . 0.0 110.942 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -143.9 132.08 21.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.005 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.528 ' HG2' HD12 ' A' ' 116' ' ' ILE . 19.3 mt-10 -102.2 136.99 41.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.967 0.413 . . . . 0.0 111.146 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -126.95 168.7 14.16 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.999 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.49 ' N ' ' CD ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -149.16 147.18 28.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.884 0.849 . . . . 0.0 111.73 -178.425 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.35 135.89 13.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.148 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -101.53 145.59 28.81 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 t -139.89 154.65 47.32 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.336 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -94.51 27.17 3.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.083 0.468 . . . . 0.0 110.908 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.54 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.9 mt -113.03 125.76 29.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.558 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -46.68 143.35 9.0 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 121.622 1.548 . . . . 0.0 111.5 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.48 ' CG ' ' HB2' ' A' ' 106' ' ' ALA . 26.9 Cg_exo -56.06 -26.17 58.13 Favored 'Trans proline' 0 N--CA 1.483 0.872 0 C-N-CA 122.221 1.947 . . . . 0.0 113.137 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.5 m -70.49 -31.05 68.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' A' ' 154' ' ' PRO . 0.5 OUTLIER -76.16 -55.88 5.17 Favored 'General case' 0 CA--C 1.498 -1.044 0 O-C-N 121.413 -0.804 . . . . 0.0 108.879 -179.594 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.54 HD21 ' HB ' ' A' ' 13' ' ' ILE . 2.3 mt -53.71 -37.88 63.73 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.694 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.515 ' O ' HG22 ' A' ' 23' ' ' VAL . 38.3 t80 -53.07 -59.21 4.83 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.754 ' HB2' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -67.48 -42.91 82.21 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 118.859 -1.136 . . . . 0.0 107.963 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.895 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -63.69 -2.58 1.79 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.866 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 2.8 m-85 -116.88 -9.83 11.11 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 24' ' ' LEU . 32.7 m -133.49 -50.92 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.004 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.9 pp -96.45 -31.5 12.79 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 1.004 ' N ' HD12 ' A' ' 24' ' ' LEU . 6.6 t70 -114.66 -4.9 12.73 Favored 'General case' 0 C--O 1.211 -0.958 0 O-C-N 121.716 -0.615 . . . . 0.0 111.563 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -66.48 -43.4 85.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.512 0.673 . . . . 0.0 111.809 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.549 ' HB2' ' HZ2' ' A' ' 54' ' ' LYS . 3.1 p30 -84.2 12.44 6.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.24 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -129.99 -9.35 4.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.796 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -96.64 -34.27 11.46 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.877 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.487 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 25.2 mt -54.06 -56.0 30.54 Favored Pre-proline 0 C--O 1.217 -0.63 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.23 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 22.9 Cg_endo -61.57 -24.84 78.6 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 121.979 1.786 . . . . 0.0 112.551 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -67.73 -57.48 6.28 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.856 0.836 . . . . 0.0 112.0 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.791 HD12 ' HB3' ' A' ' 145' ' ' LEU . 1.2 pt -95.2 -34.95 5.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.196 -176.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.863 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.23 64.45 0.13 Allowed Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.486 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 73.2 Cg_endo -76.33 -27.07 8.25 Favored 'Trans proline' 0 C--N 1.322 -0.858 0 C-N-CA 121.672 1.581 . . . . 0.0 108.18 175.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -73.61 -42.77 61.06 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.331 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.863 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -70.03 -79.89 0.06 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.217 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.486 HD13 HD22 ' A' ' 142' ' ' LEU . 1.2 mp -99.33 147.47 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 121.785 -0.572 . . . . 0.0 110.351 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -77.12 -53.21 8.05 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.297 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -176.96 166.87 2.49 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 110.613 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.61 145.09 6.45 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.246 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.406 ' N ' ' HZ3' ' A' ' 54' ' ' LYS . 10.9 pt-20 -142.35 144.67 33.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.049 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.622 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -77.38 139.92 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.404 0.621 . . . . 0.0 110.673 -179.243 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.11 -39.59 13.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.987 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.883 ' O ' HG23 ' A' ' 52' ' ' THR . 62.8 mt-10 -148.2 134.91 19.91 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.465 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.98 -156.35 23.61 Favored Glycine 0 CA--C 1.525 0.676 0 O-C-N 123.271 0.357 . . . . 0.0 112.232 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.4 p30 -137.82 3.28 2.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.896 0.379 . . . . 0.0 111.076 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.424 ' H ' HG21 ' A' ' 52' ' ' THR . . . 122.34 16.28 3.91 Favored Glycine 0 C--O 1.222 -0.65 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -178.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -110.3 -171.47 19.95 Favored Glycine 0 C--O 1.222 -0.606 0 CA-C-O 121.448 0.471 . . . . 0.0 111.926 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -61.66 125.14 16.01 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 122.514 2.143 . . . . 0.0 113.065 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.22 5.64 59.26 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.883 HG23 ' O ' ' A' ' 45' ' ' GLU . 87.0 m -93.39 140.26 29.76 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.457 -0.871 . . . . 0.0 110.851 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.76 132.57 67.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.622 ' HG2' HG23 ' A' ' 43' ' ' ILE . 3.9 mmtt -115.34 138.54 50.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.557 0.694 . . . . 0.0 110.957 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -119.52 122.04 40.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.972 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.575 ' N ' HD12 ' A' ' 56' ' ' ILE . 4.1 mp -105.49 135.0 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.235 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.0 m -113.26 119.39 37.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.391 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -96.14 -176.88 3.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 110.725 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.43 144.8 47.4 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.615 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 5.5 mp0 -59.63 -54.07 50.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.003 0.43 . . . . 0.0 110.491 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.86 61.2 3.44 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 p -139.25 175.32 9.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.821 0.343 . . . . 0.0 110.751 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -62.08 -52.05 65.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 110.682 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.27 142.05 30.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.162 0.506 . . . . 0.0 110.399 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.72 -55.2 0.27 Allowed Glycine 0 N--CA 1.461 0.366 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -135.7 151.31 50.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.935 0.398 . . . . 0.0 110.344 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.416 ' CG2' HD11 ' A' ' 85' ' ' LEU . 2.5 p -156.22 147.5 11.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.595 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -106.05 108.07 19.4 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.042 0.448 . . . . 0.0 112.052 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.522 ' C ' ' ND1' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -109.84 112.96 25.32 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.047 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -107.64 133.01 52.69 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.573 ' H ' HD12 ' A' ' 71' ' ' ILE . 4.1 mp -70.0 140.02 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.43 -55.07 2.94 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.19 -0.319 . . . . 0.0 111.638 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.7 m -165.05 141.14 5.57 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.5 mt -127.05 131.05 71.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.962 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 79' ' ' TYR . 46.1 m-20 -115.4 88.41 2.87 Favored 'General case' 0 C--O 1.203 -1.364 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -54.93 -30.32 58.41 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.44 -38.26 74.15 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.173 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.459 ' OG ' ' NZ ' ' A' ' 103' ' ' LYS . 0.9 OUTLIER -107.69 -10.4 15.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.944 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.597 ' N ' ' O ' ' A' ' 75' ' ' ASP . 20.3 m-85 59.8 47.46 10.22 Favored 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.49 -0.756 . . . . 0.0 110.372 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.5 t -106.33 145.78 31.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.997 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.608 ' CE1' ' CD2' ' A' ' 83' ' ' TYR . 31.0 t80 -131.71 122.84 26.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.121 0.486 . . . . 0.0 110.888 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 p -131.86 139.04 48.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.268 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.608 ' CD2' ' CE1' ' A' ' 81' ' ' TYR . 10.7 p90 -148.04 162.5 39.23 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 m -139.46 140.69 37.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.322 0.582 . . . . 0.0 111.252 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.556 HD12 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -82.77 113.87 20.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.371 178.566 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -85.89 -42.63 16.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.583 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 2.8 tp10 -153.61 172.96 16.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.964 0.411 . . . . 0.0 110.937 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.648 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.24 177.2 17.65 Favored Glycine 0 CA--C 1.509 -0.315 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.29 2.38 0.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.648 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -65.85 -34.24 77.7 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 124.837 1.255 . . . . 0.0 110.696 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.884 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -109.4 12.76 24.49 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 123.271 0.628 . . . . 0.0 109.905 -177.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 65.4 p 45.49 -126.27 1.22 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -130.86 -12.47 3.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.961 0.41 . . . . 0.0 111.198 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 p -105.42 -5.62 20.21 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.727 HG21 ' CD1' ' A' ' 98' ' ' ILE . 80.1 mt -97.78 152.34 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 122.239 1.019 . . . . 0.0 113.711 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.499 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -89.34 -60.38 1.96 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.89 178.536 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -168.29 149.22 4.93 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.272 0.558 . . . . 0.0 111.111 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.727 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -123.19 125.53 72.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.36 144.44 43.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.194 0.521 . . . . 0.0 111.311 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -136.34 133.58 36.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.458 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -129.17 135.58 49.03 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-O 120.869 0.366 . . . . 0.0 111.14 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.37 132.12 40.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.459 ' NZ ' ' OG ' ' A' ' 78' ' ' SER . 44.0 tttp -119.88 138.61 53.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.65 0.262 . . . . 0.0 110.486 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.5 mm? -96.98 125.53 41.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.292 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.82 130.31 41.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.48 ' HB2' ' CG ' ' A' ' 15' ' ' PRO . . . -74.0 135.5 43.14 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.062 -0.399 . . . . 0.0 110.761 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.499 ' HG ' ' HG1' ' A' ' 112' ' ' THR . 5.5 m -121.82 170.93 9.29 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 122.551 0.341 . . . . 0.0 110.095 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.97 -34.03 51.39 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.8 m -82.99 -12.38 57.33 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.312 1.445 . . . . 0.0 114.671 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.0 -89.47 0.14 Allowed Glycine 0 CA--C 1.537 1.418 0 C-N-CA 126.246 1.879 . . . . 0.0 111.246 -169.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 28.2 p -161.76 131.86 4.84 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.752 1.621 . . . . 0.0 110.87 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.499 ' HG1' ' HG ' ' A' ' 107' ' ' CYS . 46.1 m -98.98 133.18 43.61 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.556 0.693 . . . . 0.0 109.138 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mt -105.21 129.38 58.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.359 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -105.48 117.51 34.21 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.726 ' C ' HD13 ' A' ' 116' ' ' ILE . 15.6 m -110.14 117.69 34.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.51 0.671 . . . . 0.0 110.647 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.902 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -98.59 135.53 33.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 123.635 0.774 . . . . 0.0 110.293 -177.73 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.5 m -103.0 141.1 36.38 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.81 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.516 ' CE1' HG11 ' A' ' 2' ' ' VAL . 0.4 OUTLIER -136.3 93.88 2.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 0.0 110.905 -178.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.818 ' C ' HG23 ' A' ' 2' ' ' VAL . 3.3 m-85 -92.8 100.31 12.81 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.997 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -92.55 101.06 13.49 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.577 HG21 ' HA ' ' A' ' 126' ' ' GLU . 18.6 p -97.1 168.67 10.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.754 0.788 . . . . 0.0 112.033 -177.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -112.35 152.69 28.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.03 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . 34.13 -108.91 0.05 OUTLIER Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -105.76 -4.84 20.42 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.662 -0.317 . . . . 0.0 111.442 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.4 mp -47.96 152.79 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.577 ' HA ' HG21 ' A' ' 121' ' ' THR . 35.2 mt-10 -149.41 148.79 29.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.175 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.4 mm -87.62 124.77 41.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.45 ' HG3' ' H ' ' A' ' 129' ' ' GLU . 3.8 tptm -75.31 159.53 31.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.301 0.572 . . . . 0.0 111.908 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.45 ' H ' ' HG3' ' A' ' 128' ' ' LYS . 18.4 mm-40 -71.2 -35.41 71.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.938 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.448 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 8.0 pt-20 -67.87 -34.2 76.23 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.753 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -68.33 -49.04 63.09 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.154 0.502 . . . . 0.0 110.756 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.401 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 5.5 m -73.38 -22.34 19.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.805 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 57.4 mttt -66.92 -46.21 75.49 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 122.171 -0.33 . . . . 0.0 110.792 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.448 ' CG2' ' O ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -70.51 -44.94 76.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.667 0.27 . . . . 0.0 110.458 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.82 -47.01 69.38 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 0.1 OUTLIER -67.05 -47.01 72.65 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 122.485 -0.42 . . . . 0.0 110.316 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -54.04 -39.69 66.42 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.493 ' NZ ' ' O ' ' A' ' 37' ' ' ALA . 5.0 tttm -69.31 -53.83 17.65 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.12 -42.3 38.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.645 0.736 . . . . 0.0 110.251 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 51.4 t60 -64.09 -36.6 84.57 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.185 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.84 -41.73 99.31 Favored Glycine 0 C--O 1.222 -0.606 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -70.71 -40.3 72.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.511 ' CD2' ' O ' ' A' ' 143' ' ' PHE . 2.3 t80 -61.29 -28.17 69.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -69.32 -40.98 77.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.063 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.791 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.4 mm? -64.76 -56.74 11.75 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.722 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.642 ' O ' HD22 ' A' ' 150' ' ' LEU . 85.1 mt -54.78 -51.07 55.65 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.991 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 8.8 tt0 -47.66 -57.33 5.63 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.212 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 58.2 m -52.49 -43.78 65.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.139 0.495 . . . . 0.0 111.065 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.664 ' HB2' HD13 ' A' ' 33' ' ' ILE . 56.7 t80 -55.31 -47.67 75.26 Favored 'General case' 0 C--O 1.2 -1.546 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.895 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.0 mm? -68.55 -43.02 77.52 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 119.836 1.198 . . . . 0.0 112.06 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 147' ' ' GLU . 0.4 OUTLIER -62.09 -24.05 66.88 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 121.375 -0.828 . . . . 0.0 109.267 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -107.17 -13.32 15.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.607 0.717 . . . . 0.0 110.585 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.616 ' N ' ' O ' ' A' ' 149' ' ' TYR . 4.1 t-160 -154.97 65.61 4.69 Favored Pre-proline 0 C--N 1.309 -1.159 0 C-N-CA 124.723 1.209 . . . . 0.0 109.883 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.527 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 53.0 Cg_endo -74.38 -3.47 13.89 Favored 'Trans proline' 0 C--O 1.204 -1.176 0 C-N-CA 122.698 2.266 . . . . 0.0 111.392 -177.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 1.0 OUTLIER -81.39 4.3 21.34 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 123.009 0.524 . . . . 0.0 112.032 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -50.07 130.17 21.9 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 119.877 -1.764 . . . . 0.0 111.381 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.603 ' CG ' HD13 ' A' ' 24' ' ' LEU . 1.3 t80 54.48 6.32 0.11 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.476 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 2.1 p-10 . . . . . 0 N--CA 1.451 -0.414 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.237 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.865 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.4 p . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.907 0.384 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.412 ' HB2' ' CD1' ' A' ' 119' ' ' TYR . 7.7 m-85 -99.28 111.52 23.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.617 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.4 m -96.32 139.99 31.64 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.632 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -136.84 134.14 36.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.612 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -103.33 128.83 50.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.0 0.429 . . . . 0.0 111.078 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 115' ' ' SER . 0.1 OUTLIER -138.47 162.93 33.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.087 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.76 160.14 40.05 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.472 ' CE2' ' O ' ' A' ' 10' ' ' THR . 55.3 t80 -147.61 141.14 25.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.44 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.472 ' O ' ' CE2' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -93.14 148.63 21.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.726 0.298 . . . . 0.0 111.275 -179.255 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -143.91 154.35 43.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.775 0.321 . . . . 0.0 110.718 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -99.92 26.76 6.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.042 0.449 . . . . 0.0 110.634 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.472 ' HB ' HD21 ' A' ' 18' ' ' LEU . 2.2 mt -113.74 131.6 22.99 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.317 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -48.89 141.24 22.0 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.148 1.232 . . . . 0.0 110.797 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.552 ' HA ' HD12 ' A' ' 18' ' ' LEU . 9.4 Cg_endo -60.1 -23.57 73.93 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 122.365 2.043 . . . . 0.0 112.925 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.456 ' HB2' HH21 ' A' ' 17' ' ' ARG . 69.4 m -70.14 -30.56 67.76 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.456 HH21 ' HB2' ' A' ' 16' ' ' SER . 25.3 mmt-85 -79.43 -54.38 5.98 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.552 HD12 ' HA ' ' A' ' 15' ' ' PRO . 6.4 mt -48.57 -45.87 38.39 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.584 ' HD2' ' HH ' ' A' ' 81' ' ' TYR . 11.8 t80 -49.29 -57.79 6.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.22 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -67.37 -25.42 65.96 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.363 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.763 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -84.02 -2.58 56.9 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.563 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.469 ' CA ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -117.31 -10.94 10.66 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 117.917 0.326 . . . . 0.0 111.828 -179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.845 HG23 HD13 ' A' ' 24' ' ' LEU . 3.1 m -137.35 -34.61 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.868 HD23 ' CD1' ' A' ' 157' ' ' TYR . 2.4 mp -89.92 -53.47 4.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.824 0.738 . . . . 0.0 111.889 -176.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 93.8 m-20 -112.91 -4.01 14.01 Favored 'General case' 0 C--O 1.216 -0.659 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -53.67 -43.88 69.21 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.34 18.7 1.7 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.212 0.529 . . . . 0.0 110.712 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -139.37 -8.8 1.28 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 149' ' ' TYR . 0.8 OUTLIER -92.38 -30.31 15.86 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.156 -178.725 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.506 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.52 -54.53 47.6 Favored Pre-proline 0 C--O 1.214 -0.787 0 O-C-N 122.2 -0.313 . . . . 0.0 111.419 -179.534 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 18.3 Cg_endo -62.82 -25.52 74.59 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.894 1.729 . . . . 0.0 112.721 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -68.22 -59.74 2.99 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.836 0.827 . . . . 0.0 111.814 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.765 HD12 ' HB3' ' A' ' 145' ' ' LEU . 1.3 pt -95.95 -35.53 5.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.38 -176.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.781 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.36 65.24 0.14 Allowed Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 72.9 Cg_endo -76.55 -27.17 7.83 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 121.699 1.599 . . . . 0.0 108.474 175.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -74.2 -43.65 56.36 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.633 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.781 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -73.87 -78.6 0.09 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.099 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.8 mm -99.43 144.85 11.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 121.328 0.585 . . . . 0.0 110.017 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -78.42 -53.52 7.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.725 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.407 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -178.18 167.6 1.95 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.238 0.542 . . . . 0.0 110.597 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.407 ' H ' ' HG2' ' A' ' 40' ' ' GLN . . . -165.89 143.87 5.72 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.88 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -140.84 143.86 35.0 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.862 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.2 137.25 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 121.646 0.736 . . . . 0.0 111.823 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.4 mp -87.11 -38.77 16.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.188 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.88 ' O ' HG23 ' A' ' 52' ' ' THR . 54.9 mt-10 -148.24 136.83 21.56 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.09 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.09 -155.28 21.85 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -141.13 -5.6 1.11 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 122.894 0.477 . . . . 0.0 110.941 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.96 10.84 2.17 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.06 -172.84 19.15 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 117.114 0.457 . . . . 0.0 111.977 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -60.13 127.1 22.04 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 C-N-CA 122.732 2.288 . . . . 0.0 113.356 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.86 2.97 55.13 Favored Glycine 0 CA--C 1.507 -0.439 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.88 HG23 ' O ' ' A' ' 45' ' ' GLU . 88.8 m -94.3 134.76 36.44 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.265 -0.967 . . . . 0.0 111.368 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -122.67 122.3 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.862 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -131.99 151.39 51.77 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 122.83 1.3 . . . . 0.0 110.684 178.441 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.525 ' N ' ' HD2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -117.57 137.57 52.5 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.318 -1.764 . . . . 0.0 112.966 -177.365 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.9 mm -90.19 140.76 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 64.3 m -110.5 117.33 33.28 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -108.89 166.17 11.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.918 0.39 . . . . 0.0 110.82 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.0 144.44 49.5 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.24 -47.21 86.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.805 0.336 . . . . 0.0 110.785 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.71 61.42 3.47 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.7 m -142.91 178.37 7.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.831 0.348 . . . . 0.0 110.677 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -64.11 -50.43 68.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.923 0.392 . . . . 0.0 110.723 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.83 156.38 17.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.375 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -119.57 -61.41 0.26 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -145.37 155.04 42.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.825 0.345 . . . . 0.0 110.573 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 87' ' ' GLU . 2.4 p -156.02 153.75 7.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.77 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.507 ' CB ' HD11 ' A' ' 86' ' ' ILE . 3.5 mptp? -104.87 110.97 23.55 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.53 0.681 . . . . 0.0 111.631 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -103.32 113.51 27.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.84 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -105.75 131.54 52.98 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.022 0.439 . . . . 0.0 111.735 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.5 mt -85.42 145.26 8.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.373 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -102.55 -54.89 2.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.7 m -165.88 142.21 5.17 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 45.6 mt -123.05 130.62 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.355 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.2 m-20 -115.25 87.95 2.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.505 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -54.82 -30.29 56.92 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.509 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.85 -38.84 70.62 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.175 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.1 p -108.36 -11.09 15.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.117 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.53 ' N ' ' O ' ' A' ' 75' ' ' ASP . 6.6 m-85 63.17 40.89 8.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.877 -0.515 . . . . 0.0 109.925 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.499 ' C ' ' CD2' ' A' ' 81' ' ' TYR . 6.0 p -109.22 138.65 45.25 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.857 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.584 ' HH ' ' HD2' ' A' ' 19' ' ' PHE . 0.1 OUTLIER -132.13 133.57 44.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.723 0.297 . . . . 0.0 110.375 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 p -127.29 129.76 48.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.878 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -144.15 158.71 43.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.217 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 98' ' ' ILE . 9.7 m -147.65 141.85 26.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.119 0.485 . . . . 0.0 111.2 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.659 HD13 ' HB1' ' A' ' 90' ' ' ALA . 9.7 mt -80.6 120.63 24.8 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.507 HD11 ' CB ' ' A' ' 68' ' ' LYS . 3.8 pt -80.58 -44.98 21.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.808 0.337 . . . . 0.0 111.836 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.475 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 23.5 tt0 -156.74 172.26 18.92 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.591 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.95 178.12 17.83 Favored Glycine 0 CA--C 1.508 -0.357 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -61.37 1.13 0.22 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.659 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -67.55 -34.3 76.8 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 123.948 0.899 . . . . 0.0 109.963 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.89 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.52 16.38 21.56 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.692 0.797 . . . . 0.0 109.583 -177.945 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.8 p 49.48 -126.45 2.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -130.75 -12.9 3.75 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.091 -0.381 . . . . 0.0 111.217 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.0 -6.62 19.88 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.718 HG21 ' CD1' ' A' ' 98' ' ' ILE . 68.5 mt -99.13 152.36 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -176.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.507 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -90.32 -56.78 3.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.249 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -171.91 150.48 2.6 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.099 0.476 . . . . 0.0 110.867 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.718 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.52 125.08 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.473 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 0.7 OUTLIER -105.67 144.5 32.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.006 0.432 . . . . 0.0 112.054 -178.084 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.504 ' CZ ' ' OG ' ' A' ' 117' ' ' SER . 4.8 m-85 -140.2 128.21 22.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.531 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -129.32 133.6 47.52 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.5 OUTLIER -135.55 131.49 36.03 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.9 -0.5 . . . . 0.0 110.45 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.608 ' C ' HD23 ' A' ' 104' ' ' LEU . 7.1 ttpm? -123.16 134.77 54.16 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.772 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.53 126.53 44.13 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.814 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -125.59 137.14 58.64 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.572 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.486 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -72.62 133.88 44.88 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.873 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.405 ' N ' ' HA ' ' A' ' 111' ' ' SER . 7.1 t -121.22 175.2 6.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.128 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.66 -37.28 67.61 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.2 m -87.32 -6.15 58.62 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.793 1.296 . . . . 0.0 114.327 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 152.91 -88.48 0.13 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.671 1.129 . . . . 0.0 111.808 -174.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 85.5 p -161.98 131.91 4.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.547 1.939 . . . . 0.0 110.715 177.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.2 m -99.17 119.15 37.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.7 mt -91.13 128.95 42.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.36 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 102' ' ' THR . 4.1 mttm -105.45 117.17 33.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.745 ' C ' HD13 ' A' ' 116' ' ' ILE . 69.6 m -110.84 121.21 44.78 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 121.459 0.647 . . . . 0.0 111.119 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.945 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -101.9 136.4 34.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 123.457 0.703 . . . . 0.0 109.571 -177.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.504 ' OG ' ' CZ ' ' A' ' 100' ' ' TYR . 23.7 t -118.29 132.36 56.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.651 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.473 ' ND1' ' O ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -137.28 113.71 10.14 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.505 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.865 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -102.41 102.53 12.87 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.448 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.463 ' CE1' ' CD ' ' A' ' 96' ' ' GLU . 11.6 t-160 -92.0 109.47 20.82 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.233 0.539 . . . . 0.0 110.246 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.432 HG22 HD11 ' A' ' 127' ' ' ILE . 12.6 p -99.65 172.52 7.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.611 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -112.2 143.53 43.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.871 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 54.94 -112.79 3.07 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -112.9 -1.89 14.46 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.342 -0.504 . . . . 0.0 111.171 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -43.5 160.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.048 0.451 . . . . 0.0 110.614 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.481 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 92.8 mt-10 -148.21 144.28 27.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.038 0.447 . . . . 0.0 111.177 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.432 HD11 HG22 ' A' ' 121' ' ' THR . 19.9 mm -89.1 125.29 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -74.68 161.18 29.9 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.669 0.747 . . . . 0.0 111.837 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -70.29 -32.14 69.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.418 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.429 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 43.3 mm-40 -70.12 -33.57 71.99 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.746 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -67.33 -51.26 54.6 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.33 0.586 . . . . 0.0 110.629 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.5 m -71.93 -21.53 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.79 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -66.45 -46.56 76.01 Favored 'General case' 0 C--O 1.223 -0.328 0 O-C-N 122.276 -0.265 . . . . 0.0 110.892 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -70.38 -51.15 40.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.726 0.298 . . . . 0.0 110.5 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.78 -47.05 93.14 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -67.96 -47.44 68.63 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 122.616 -0.343 . . . . 0.0 110.916 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -55.32 -47.06 76.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.78 0.324 . . . . 0.0 110.549 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -69.37 -50.2 48.34 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.401 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.31 -41.97 39.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.535 0.683 . . . . 0.0 110.528 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -36.4 84.22 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -61.64 -31.17 76.9 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.42 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -74.18 -47.18 37.34 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.27 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.491 ' CD2' ' N ' ' A' ' 143' ' ' PHE . 1.6 m-30 -59.89 -21.88 61.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -72.52 -41.82 65.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.85 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.765 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.44 -56.53 11.94 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.893 179.3 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.701 ' O ' HD22 ' A' ' 150' ' ' LEU . 76.9 mt -53.24 -50.33 47.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.495 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -47.06 -57.02 5.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.751 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.5 t -50.35 -44.95 54.72 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.469 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.685 ' HB2' HD13 ' A' ' 33' ' ' ILE . 20.0 t80 -57.33 -48.77 78.13 Favored 'General case' 0 C--O 1.18 -2.581 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.846 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.7 mm? -65.1 -42.15 94.27 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 120.449 -1.407 . . . . 0.0 111.974 -177.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.5 OUTLIER -62.59 -25.25 67.98 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.407 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -107.26 -12.24 15.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.016 0.436 . . . . 0.0 110.687 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.651 ' N ' ' O ' ' A' ' 149' ' ' TYR . 49.5 m-70 -155.54 66.32 4.63 Favored Pre-proline 0 C--N 1.308 -1.215 0 C-N-CA 125.616 1.566 . . . . 0.0 110.411 -177.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.413 ' HB2' ' HE ' ' A' ' 17' ' ' ARG . 44.7 Cg_endo -72.13 -3.27 12.97 Favored 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 122.662 2.241 . . . . 0.0 111.843 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 1.5 p30 -77.1 3.07 13.34 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.073 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.532 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . . . -50.51 128.79 20.97 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 119.328 -2.108 . . . . 0.0 111.352 -178.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.868 ' CD1' HD23 ' A' ' 24' ' ' LEU . 16.5 t80 54.71 7.04 0.14 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.275 0.63 . . . . 0.0 112.137 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 3.3 p-10 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.278 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.823 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.2 p . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.074 0.464 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -97.77 110.29 22.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.721 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.7 m -96.97 140.45 31.49 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.577 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.95 134.7 26.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.368 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.511 ' HG2' HD12 ' A' ' 116' ' ' ILE . 3.1 mt-10 -102.4 129.69 48.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.582 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -126.71 168.67 14.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.172 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.13 146.98 22.04 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -145.64 140.71 27.52 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.302 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -107.49 147.93 29.85 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 111.804 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.5 t -145.87 162.73 37.07 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.548 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -98.77 24.92 7.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.406 . . . . 0.0 110.931 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.51 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.9 mt -108.57 127.69 26.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.2 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -46.98 144.69 8.06 Favored 'Trans proline' 0 C--N 1.327 -0.571 0 C-N-CA 121.16 1.24 . . . . 0.0 110.743 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 10.9 Cg_endo -61.02 -24.51 79.72 Favored 'Trans proline' 0 C--N 1.322 -0.843 0 C-N-CA 122.337 2.025 . . . . 0.0 113.031 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.2 m -71.01 -30.3 66.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -75.05 -56.41 4.77 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.51 HD21 ' HB ' ' A' ' 13' ' ' ILE . 3.7 mt -51.18 -45.0 61.65 Favored 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.485 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.656 ' O ' HG22 ' A' ' 23' ' ' VAL . 47.0 t80 -46.44 -58.96 3.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.727 ' CB ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -68.28 -41.56 80.83 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 119.023 -1.071 . . . . 0.0 108.484 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.831 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -65.01 -2.47 2.72 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.236 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 2.6 t80 -119.14 -8.71 10.12 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 19' ' ' PHE . 30.8 m -131.88 -51.27 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.0 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.7 pp -96.4 -31.28 12.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 1.0 ' N ' HD12 ' A' ' 24' ' ' LEU . 45.5 m-20 -114.63 -5.09 12.74 Favored 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 118.439 0.563 . . . . 0.0 111.506 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.697 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -68.56 -44.05 75.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.453 0.644 . . . . 0.0 112.289 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.46 18.15 2.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.882 0.849 . . . . 0.0 109.648 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.41 ' H ' ' H ' ' A' ' 29' ' ' LEU . 64.9 m-20 -139.55 -8.31 1.27 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.578 -1.192 . . . . 0.0 107.843 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.823 HD21 ' CD2' ' A' ' 149' ' ' TYR . 0.8 OUTLIER -96.21 -48.37 5.66 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.0 -178.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.525 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 85.2 mt -54.54 -43.22 97.8 Favored Pre-proline 0 C--O 1.212 -0.916 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.146 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 16.6 Cg_exo -64.46 -25.58 63.1 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.785 1.657 . . . . 0.0 110.97 177.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.02 -57.93 4.42 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.712 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.692 ' HB ' HD12 ' A' ' 145' ' ' LEU . 0.7 OUTLIER -96.54 -32.66 4.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.779 -176.552 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.816 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -103.83 63.22 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.513 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 72.6 Cg_endo -75.57 -20.97 15.28 Favored 'Trans proline' 0 C--N 1.32 -0.924 0 N-CA-C 107.063 -1.937 . . . . 0.0 107.063 174.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -73.42 -44.02 59.23 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.76 177.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.816 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -73.75 -75.02 0.16 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.266 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.9 mt -98.73 145.9 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 121.046 0.45 . . . . 0.0 110.204 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.83 -51.65 10.14 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.672 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.526 ' CD ' ' H ' ' A' ' 41' ' ' ALA . 8.4 tp-100 -177.3 164.62 2.18 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.958 0.409 . . . . 0.0 110.424 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.552 ' C ' ' HZ3' ' A' ' 54' ' ' LYS . . . -166.02 145.21 6.06 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 120.89 0.376 . . . . 0.0 110.889 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -145.09 145.25 31.35 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.666 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -76.52 139.88 18.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.57 0.7 . . . . 0.0 110.995 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 mp -89.68 -39.27 13.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.963 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.886 ' O ' HG23 ' A' ' 52' ' ' THR . 30.2 mt-10 -147.19 136.66 22.75 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.542 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.39 -156.06 22.52 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -142.5 1.48 1.37 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 122.456 -0.437 . . . . 0.0 111.343 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.471 ' O ' HD12 ' A' ' 74' ' ' ILE . . . 127.27 12.27 3.18 Favored Glycine 0 C--O 1.218 -0.864 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.45 -171.68 19.89 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 117.298 0.549 . . . . 0.0 111.905 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -61.86 125.94 17.74 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 C-N-CA 122.68 2.253 . . . . 0.0 113.028 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.76 5.07 56.76 Favored Glycine 0 N--CA 1.464 0.537 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.886 HG23 ' O ' ' A' ' 45' ' ' GLU . 91.4 m -93.66 137.91 32.43 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.379 -0.911 . . . . 0.0 110.959 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.55 130.14 72.91 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.666 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -114.52 140.0 49.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.608 0.718 . . . . 0.0 110.761 179.144 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.474 ' C ' HD12 ' A' ' 56' ' ' ILE . 41.1 tttm -118.37 123.15 44.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.7 178.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.758 ' N ' HD12 ' A' ' 56' ' ' ILE . 1.8 mp -104.32 123.75 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.6 m -101.42 118.43 36.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.075 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -92.72 -176.74 4.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.72 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.429 ' O ' ' OG ' ' A' ' 62' ' ' SER . . . -71.64 144.45 37.02 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.99 -47.94 84.12 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.991 -0.711 . . . . 0.0 111.073 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.92 61.93 3.34 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 59' ' ' GLY . 0.3 OUTLIER -152.37 174.97 13.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.171 0.51 . . . . 0.0 110.383 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.573 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 4.7 mp0 -65.09 -37.57 87.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.818 0.342 . . . . 0.0 110.603 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -98.76 140.38 33.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.378 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.415 ' O ' ' CD2' ' A' ' 66' ' ' TYR . . . -123.12 -56.2 0.19 Allowed Glycine 0 N--CA 1.461 0.363 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.415 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -145.82 151.35 37.77 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.772 0.32 . . . . 0.0 110.193 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 p -156.71 147.51 11.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.931 0.396 . . . . 0.0 110.945 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -104.81 108.06 19.35 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.298 0.57 . . . . 0.0 110.954 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.531 ' NE2' ' CD2' ' A' ' 83' ' ' TYR . 7.9 t60 -103.06 112.42 25.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.631 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -101.6 131.22 47.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 111.824 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.0 mt -83.08 137.23 21.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -96.71 -56.35 2.61 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.2 m -166.01 142.31 5.07 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.471 HD12 ' O ' ' A' ' 48' ' ' GLY . 30.2 mt -123.93 131.15 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.885 176.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.587 ' O ' ' N ' ' A' ' 79' ' ' TYR . 27.1 m-20 -115.53 87.74 2.73 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.487 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 6.6 pt-20 -54.57 -30.12 53.33 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.08 73.52 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.6 m -108.2 -9.82 15.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.007 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.587 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.3 m-85 62.63 48.28 4.42 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 121.393 -0.817 . . . . 0.0 110.236 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -106.66 143.76 34.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.346 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.527 ' CE1' ' CD1' ' A' ' 83' ' ' TYR . 26.3 t80 -132.16 117.94 18.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.683 0.278 . . . . 0.0 110.253 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -127.5 137.65 52.71 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.112 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.531 ' CD2' ' NE2' ' A' ' 69' ' ' HIS . 12.5 p90 -146.11 163.86 33.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.069 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 98' ' ' ILE . 4.3 m -146.57 135.68 22.59 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.05 0.452 . . . . 0.0 110.821 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.626 HD13 ' HB1' ' A' ' 90' ' ' ALA . 7.0 mt -79.76 116.55 19.99 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.602 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -82.76 -41.78 17.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.829 -177.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.602 ' N ' HD13 ' A' ' 86' ' ' ILE . 32.7 tt0 -153.8 171.52 18.79 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.09 -0.381 . . . . 0.0 110.586 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.599 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.19 177.54 18.71 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.78 2.1 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.626 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -66.09 -34.4 77.97 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.107 0.963 . . . . 0.0 110.239 177.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.892 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.26 14.7 22.68 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 123.543 0.737 . . . . 0.0 109.608 -177.645 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.461 ' CG2' ' NE2' ' A' ' 131' ' ' HIS . 68.8 p 46.96 -126.24 1.58 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -130.35 -11.14 4.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.106 0.479 . . . . 0.0 110.913 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.3 -7.55 18.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.724 HG21 ' CD1' ' A' ' 98' ' ' ILE . 90.7 mt -98.74 152.51 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 121.941 0.877 . . . . 0.0 113.259 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.509 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -90.86 -55.23 3.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.343 177.787 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.43 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 2.5 ptmm? -172.79 149.82 2.03 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.782 0.325 . . . . 0.0 110.84 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.724 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.29 125.42 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.041 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.34 144.49 43.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.925 0.393 . . . . 0.0 111.665 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -136.82 136.37 38.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.705 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -131.15 132.41 44.75 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -139.13 133.98 32.22 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.962 -0.461 . . . . 0.0 110.945 -178.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.56 ' C ' HD23 ' A' ' 104' ' ' LEU . 25.9 ttpp -121.26 134.64 55.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.774 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -97.62 126.01 42.69 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.358 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.95 136.99 58.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.609 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -73.03 135.37 44.89 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.751 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.55 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 53.8 t -120.92 171.13 8.86 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.55 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -54.25 -35.7 55.77 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.3 p -89.69 -8.48 52.28 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.327 -1.69 . . . . 0.0 114.694 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 159.32 -85.44 0.12 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.069 1.318 . . . . 0.0 111.958 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 87.9 p -163.79 132.1 3.66 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.888 1.675 . . . . 0.0 110.961 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 78.8 m -99.28 118.24 35.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 61.9 mt -92.38 128.24 44.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.842 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 102' ' ' THR . 6.1 mtpt -105.42 116.68 32.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.799 ' C ' HD13 ' A' ' 116' ' ' ILE . 13.0 t -111.62 124.85 53.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.276 0.56 . . . . 0.0 111.101 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.914 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -106.04 136.43 40.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 123.25 0.62 . . . . 0.0 109.749 -177.652 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.1 m -113.18 133.09 55.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.982 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -137.08 105.35 5.72 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 120.83 0.348 . . . . 0.0 110.405 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.823 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -101.69 103.39 14.17 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.081 -0.387 . . . . 0.0 110.045 179.201 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -90.91 107.88 19.49 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.226 0.536 . . . . 0.0 109.879 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.2 p -99.38 176.01 5.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.602 0.715 . . . . 0.0 111.442 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -112.31 146.12 38.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.432 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 54.21 -111.69 2.17 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -117.67 3.68 12.34 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.345 -0.503 . . . . 0.0 111.01 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.463 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -45.85 160.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.941 0.4 . . . . 0.0 110.43 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.463 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 36.5 mt-10 -149.39 148.51 29.55 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.916 0.388 . . . . 0.0 111.267 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.408 HG13 ' CB ' ' A' ' 119' ' ' TYR . 3.5 mm -89.3 125.38 42.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.44 ' HG3' ' H ' ' A' ' 129' ' ' GLU . 18.6 tptt -74.45 160.33 31.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.157 0.503 . . . . 0.0 111.56 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.44 ' H ' ' HG3' ' A' ' 128' ' ' LYS . 49.8 mt-10 -70.09 -34.05 72.67 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.488 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 134' ' ' VAL . 1.8 mp0 -69.9 -27.79 65.09 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.461 ' NE2' ' CG2' ' A' ' 92' ' ' THR . 10.2 t-80 -72.89 -48.1 40.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.313 0.577 . . . . 0.0 110.87 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.8 m -79.76 -32.06 14.1 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.98 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -64.19 -46.18 85.1 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.216 -0.302 . . . . 0.0 110.721 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.564 HG23 ' N ' ' A' ' 135' ' ' GLY . 25.8 m -70.26 -47.71 65.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.62 0.248 . . . . 0.0 110.453 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.564 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -62.73 -41.44 99.84 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -66.84 -46.25 75.68 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.751 -0.264 . . . . 0.0 110.684 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -54.28 -47.08 72.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 110.059 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 141' ' ' GLY . 22.8 tttp -64.58 -54.88 25.07 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.432 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -48.46 -40.78 27.47 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.698 0.761 . . . . 0.0 110.467 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.437 ' O ' ' ND1' ' A' ' 140' ' ' HIS . 0.6 OUTLIER -61.51 -36.49 80.67 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.958 0.885 . . . . 0.0 109.203 178.31 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' LYS . . . -62.68 -35.55 92.04 Favored Glycine 0 C--O 1.223 -0.54 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -66.9 -45.8 76.86 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.996 -0.708 . . . . 0.0 109.116 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -59.0 -30.1 67.73 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -64.83 -39.54 93.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.418 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.692 HD12 ' HB ' ' A' ' 33' ' ' ILE . 1.1 mm? -68.12 -56.99 6.81 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.174 0.511 . . . . 0.0 110.263 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.752 HG23 HD13 ' A' ' 29' ' ' LEU . 61.1 mt -57.91 -51.89 64.94 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.977 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -48.2 -56.84 6.91 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.814 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.7 t -51.75 -42.96 62.74 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.421 0.629 . . . . 0.0 110.141 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.823 ' CD2' HD21 ' A' ' 29' ' ' LEU . 8.6 t80 -55.69 -51.94 65.56 Favored 'General case' 0 C--O 1.178 -2.678 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.841 ' H ' HD22 ' A' ' 150' ' ' LEU . 2.0 mm? -64.38 -43.02 95.8 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.239 -1.538 . . . . 0.0 111.883 -177.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -62.65 -24.33 67.56 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.531 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 149' ' ' TYR . 0.0 OUTLIER -106.98 -13.27 15.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.15 0.5 . . . . 0.0 110.657 178.3 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.641 ' N ' ' O ' ' A' ' 149' ' ' TYR . 42.7 m80 -155.39 66.31 4.7 Favored Pre-proline 0 C--N 1.305 -1.365 0 C-N-CA 125.944 1.697 . . . . 0.0 110.275 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.74 -3.35 13.59 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 122.7 2.267 . . . . 0.0 111.582 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.483 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 5.4 p30 -77.96 4.07 13.05 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.433 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.427 ' O ' ' CD ' ' A' ' 20' ' ' LYS . . . -50.13 129.08 20.46 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 119.038 -2.289 . . . . 0.0 111.343 -178.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.507 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 36.9 t80 53.5 6.32 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.203 0.525 . . . . 0.0 112.219 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 5.2 p-10 . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.091 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.833 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.2 p . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 120.745 0.307 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -98.33 110.23 22.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.321 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.514 HG23 ' NE2' ' A' ' 118' ' ' HIS . 68.8 m -96.13 134.3 39.37 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.794 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -133.55 131.05 39.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -102.97 126.7 50.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.881 0.372 . . . . 0.0 110.945 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -135.63 167.3 21.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.968 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -156.14 159.24 38.85 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -146.21 140.87 26.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.219 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.4 m -109.41 147.41 32.84 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.937 0.398 . . . . 0.0 111.831 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 t -145.68 154.76 42.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.432 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -87.86 25.44 1.53 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.124 0.488 . . . . 0.0 110.982 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.508 ' HB ' HD21 ' A' ' 18' ' ' LEU . 2.4 mt -108.55 126.84 28.63 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.651 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -46.08 148.38 2.98 Favored 'Trans proline' 0 C--N 1.325 -0.675 0 C-N-CA 121.161 1.241 . . . . 0.0 110.857 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.709 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 18.1 Cg_endo -64.86 -24.35 61.26 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 122.553 2.169 . . . . 0.0 112.915 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.565 ' CB ' HH11 ' A' ' 17' ' ' ARG . 66.3 m -70.51 -29.64 66.2 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.565 HH11 ' CB ' ' A' ' 16' ' ' SER . 0.4 OUTLIER -75.88 -56.63 4.49 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 15' ' ' PRO . 3.2 mt -48.38 -48.84 36.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.784 ' O ' HG22 ' A' ' 23' ' ' VAL . 40.2 t80 -44.66 -60.0 2.22 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.704 178.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.624 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -70.99 -24.89 62.48 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.213 -0.93 . . . . 0.0 110.787 -179.277 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.852 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -79.45 -14.37 58.96 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.808 -177.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.604 ' CE2' HD11 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -116.45 -6.52 11.72 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.595 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.858 HG23 ' CD1' ' A' ' 24' ' ' LEU . 3.0 m -129.99 -36.7 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.858 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.9 mp -92.55 -53.96 3.98 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.19 0.904 . . . . 0.0 112.206 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.82 16.42 20.45 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.547 ' HB2' ' HA ' ' A' ' 22' ' ' PHE . . . -66.08 -43.2 88.05 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 121.062 0.458 . . . . 0.0 111.128 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.04 21.17 1.09 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.073 0.939 . . . . 0.0 110.501 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.426 ' H ' ' H ' ' A' ' 29' ' ' LEU . 4.2 m120 -139.46 -8.85 1.27 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.633 HD13 ' CD1' ' A' ' 149' ' ' TYR . 0.0 OUTLIER -94.43 -38.21 11.06 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.418 -1.719 . . . . 0.0 111.004 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.538 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.4 mm -55.38 -44.25 99.54 Favored Pre-proline 0 C--O 1.21 -0.986 0 CA-C-O 120.954 0.407 . . . . 0.0 111.928 -178.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 22.9 Cg_exo -63.1 -25.85 73.21 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.409 2.073 . . . . 0.0 113.304 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -83.28 -55.62 4.23 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.099 0.476 . . . . 0.0 112.27 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.64 HD13 ' HB3' ' A' ' 145' ' ' LEU . 0.8 OUTLIER -95.09 -38.31 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.54 -177.06 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.594 ' CA ' ' HG ' ' A' ' 145' ' ' LEU . . . -108.38 61.36 0.24 Allowed Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.493 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 87.9 Cg_endo -79.23 -28.94 3.41 Favored 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 121.812 1.675 . . . . 0.0 109.19 175.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -74.98 -42.58 57.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.258 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.576 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -69.07 -74.89 0.12 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.282 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.27 146.36 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.858 0.361 . . . . 0.0 110.071 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -78.12 -50.23 12.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.211 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.712 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 54.8 tp60 -176.36 165.74 2.75 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.918 0.389 . . . . 0.0 110.469 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.737 ' HB1' ' HE2' ' A' ' 54' ' ' LYS . . . -165.51 147.85 7.64 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.232 0.539 . . . . 0.0 110.583 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.858 ' C ' ' HZ1' ' A' ' 54' ' ' LYS . 23.2 pt-20 -148.09 140.88 24.68 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.099 -0.375 . . . . 0.0 110.764 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.501 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -76.72 140.29 17.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.391 0.615 . . . . 0.0 110.415 -179.079 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.69 -40.01 13.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.173 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.934 ' O ' HG23 ' A' ' 52' ' ' THR . 21.0 mt-10 -140.98 133.84 29.0 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.749 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.21 -156.68 36.0 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.1 p30 -136.38 -7.38 1.99 Allowed 'General case' 0 C--N 1.321 -0.642 0 O-C-N 122.535 -0.391 . . . . 0.0 111.108 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.446 ' O ' HD12 ' A' ' 74' ' ' ILE . . . 142.71 14.89 0.33 Allowed Glycine 0 C--O 1.22 -0.747 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.68 -170.76 20.3 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 117.236 0.518 . . . . 0.0 111.929 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -61.57 125.8 17.6 Favored 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 122.787 2.325 . . . . 0.0 113.373 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.22 6.01 59.08 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.934 HG23 ' O ' ' A' ' 45' ' ' GLU . 60.0 m -93.81 140.52 29.57 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.147 -1.027 . . . . 0.0 111.45 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -121.9 129.76 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.858 ' HZ1' ' C ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -114.48 138.3 50.77 Favored 'General case' 0 C--O 1.22 -0.449 0 O-C-N 123.288 0.368 . . . . 0.0 110.689 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -120.6 125.75 48.55 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.148 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -103.47 140.63 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.263 178.626 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.435 HG23 ' CE2' ' A' ' 66' ' ' TYR . 38.5 m -118.83 119.65 35.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.518 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -92.5 -178.59 4.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.902 0.382 . . . . 0.0 110.685 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.26 143.81 29.77 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.466 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 9.1 pt-20 -59.73 -46.57 88.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 0.0 110.864 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.466 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -100.65 61.67 0.62 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.404 ' OG ' ' N ' ' A' ' 63' ' ' GLN . 22.8 t -138.04 177.06 8.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.025 0.44 . . . . 0.0 110.79 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.404 ' N ' ' OG ' ' A' ' 62' ' ' SER . 10.3 mm100 -60.98 -54.19 48.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 110.842 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.55 151.9 20.54 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.73 -61.72 0.22 Allowed Glycine 0 CA--C 1.52 0.349 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.435 ' CE2' HG23 ' A' ' 57' ' ' THR . 5.0 m-85 -145.6 151.33 37.93 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.811 0.338 . . . . 0.0 110.892 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 p -149.24 138.3 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.852 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.537 ' O ' HG13 ' A' ' 86' ' ' ILE . 10.1 mtpp -107.38 116.5 32.04 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 121.623 0.725 . . . . 0.0 112.187 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.646 ' N ' ' ND1' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -112.9 123.58 50.64 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.361 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -98.82 126.61 44.52 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.149 0.499 . . . . 0.0 111.532 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.455 HD12 HG22 ' A' ' 52' ' ' THR . 33.9 mt -79.94 136.09 24.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.374 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.4 ' O ' ' OG ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -97.27 -55.78 2.74 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -177.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 3.3 m -165.29 141.77 5.57 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 48' ' ' GLY . 12.6 mt -120.69 131.1 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.483 176.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 79' ' ' TYR . 54.7 m-20 -114.42 88.26 2.82 Favored 'General case' 0 C--O 1.206 -1.205 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 177.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.447 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 19.6 mt-10 -54.61 -30.54 55.08 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.89 -39.46 71.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.159 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.4 m -108.41 -10.07 15.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.109 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.579 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.5 m-85 62.13 46.96 5.94 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 121.502 -0.749 . . . . 0.0 110.083 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.7 p -105.76 149.23 26.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.076 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.563 ' CE1' ' CD1' ' A' ' 83' ' ' TYR . 39.5 t80 -142.38 118.65 10.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.39 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.4 p -128.89 128.44 43.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.594 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.563 ' CD1' ' CE1' ' A' ' 81' ' ' TYR . 19.7 p90 -145.32 162.35 37.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.872 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.68 143.19 37.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.004 0.431 . . . . 0.0 111.161 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.794 HD13 ' HB1' ' A' ' 90' ' ' ALA . 6.9 mt -83.81 121.98 28.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.879 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 68' ' ' LYS . 2.5 pp -84.87 -41.4 15.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.309 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.525 ' CB ' HD12 ' A' ' 86' ' ' ILE . 16.2 tt0 -156.6 172.31 18.79 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.176 -0.327 . . . . 0.0 110.569 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.614 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.82 177.45 17.29 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -61.52 1.98 0.2 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 122.415 1.102 . . . . 0.0 108.466 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.794 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -68.08 -34.61 76.74 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.174 0.989 . . . . 0.0 110.386 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.871 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.59 15.57 21.98 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.298 0.639 . . . . 0.0 110.263 -177.421 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.418 ' C ' ' O ' ' A' ' 91' ' ' LEU . 63.3 p 43.16 -126.47 0.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.507 -178.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -130.73 -13.07 3.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.966 0.412 . . . . 0.0 111.187 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 p -104.7 -5.8 20.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.924 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.83 HG21 ' CD1' ' A' ' 98' ' ' ILE . 69.3 mt -98.66 152.27 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-O 121.918 0.866 . . . . 0.0 113.038 -176.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.497 ' N ' HG22 ' A' ' 95' ' ' ILE . 17.3 pt-20 -99.97 -45.51 5.66 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.349 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.434 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 0.3 OUTLIER -172.72 145.9 1.56 Allowed 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 121.655 0.74 . . . . 0.0 112.224 -179.562 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.83 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.94 124.35 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.701 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.39 144.72 31.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.973 0.416 . . . . 0.0 111.774 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -139.05 127.99 23.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -129.02 134.5 48.15 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.2 OUTLIER -140.04 131.51 26.96 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.782 -0.574 . . . . 0.0 110.084 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.424 ' C ' HD23 ' A' ' 104' ' ' LEU . 14.4 ttmm -123.0 134.04 54.34 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.614 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.19 132.77 43.42 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -134.41 137.76 50.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.104 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.709 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -72.77 135.6 45.31 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.452 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.44 ' N ' ' HA ' ' A' ' 111' ' ' SER . 7.9 t -121.16 170.2 9.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.842 0.353 . . . . 0.0 110.176 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.75 -31.51 46.06 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 112.033 -0.427 . . . . 0.0 112.033 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.8 m -88.16 -11.74 45.99 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 119.559 -2.142 . . . . 0.0 115.827 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.02 -89.47 0.12 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.88 1.229 . . . . 0.0 110.478 -169.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 92.0 p -163.74 130.33 3.24 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.077 1.351 . . . . 0.0 110.928 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 105' ' ' VAL . 34.4 m -99.91 118.38 36.22 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 51.3 mt -92.21 132.08 37.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.167 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 102' ' ' THR . 2.9 mtpp -105.78 116.64 32.29 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.721 ' C ' HD13 ' A' ' 116' ' ' ILE . 11.1 t -111.07 118.32 35.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.282 0.563 . . . . 0.0 110.826 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.919 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -100.42 135.6 35.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 123.337 0.655 . . . . 0.0 109.818 -177.937 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.9 p -108.96 135.4 50.2 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.49 -0.777 . . . . 0.0 108.918 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.514 ' NE2' HG23 ' A' ' 4' ' ' THR . 31.6 m-70 -135.72 93.99 3.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 120.922 0.392 . . . . 0.0 110.627 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.833 ' C ' HG23 ' A' ' 2' ' ' VAL . 79.6 m-85 -83.24 101.8 11.49 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.174 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.457 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 1.5 t-80 -96.59 104.32 16.3 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.9 p -101.56 176.19 5.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.403 0.62 . . . . 0.0 111.618 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.99 157.58 20.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.68 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 42.26 -109.98 0.22 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -116.29 5.66 13.65 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.819 -0.224 . . . . 0.0 110.968 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -49.01 159.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.117 0.484 . . . . 0.0 110.41 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.467 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 40.3 mt-10 -148.5 145.8 28.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.961 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.8 mm -88.88 124.53 41.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp -74.97 161.64 29.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.502 0.667 . . . . 0.0 111.77 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -70.48 -34.18 72.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.642 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.416 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 6.2 pt-20 -69.02 -30.83 69.29 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.647 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -67.99 -53.97 22.03 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.383 0.611 . . . . 0.0 110.363 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.91 -19.63 22.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.407 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 137' ' ' GLU . 52.4 tttm -66.85 -46.69 74.27 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 122.295 -0.253 . . . . 0.0 110.704 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -69.17 -46.52 77.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.762 0.315 . . . . 0.0 110.404 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.28 -47.41 71.76 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -67.95 -46.48 71.33 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.566 -0.373 . . . . 0.0 111.055 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 21.0 tp10 -54.36 -46.73 73.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.021 0.439 . . . . 0.0 110.363 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.468 ' O ' ' CD2' ' A' ' 142' ' ' LEU . 10.3 ttmt -69.21 -52.75 24.73 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.78 -46.81 41.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.395 0.617 . . . . 0.0 110.55 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -62.08 -36.98 83.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.96 -52.54 51.66 Favored Glycine 0 C--O 1.225 -0.435 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.468 ' CD2' ' O ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -60.01 -42.51 94.47 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 122.096 -0.65 . . . . 0.0 109.366 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -59.15 -30.02 67.85 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.507 ' HB3' ' HZ2' ' A' ' 144' ' ' LYS . 0.3 OUTLIER -76.88 -34.61 57.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.12 178.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.64 ' HB3' HD13 ' A' ' 33' ' ' ILE . 1.7 mm? -70.43 -53.89 14.58 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.073 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.658 ' O ' HD22 ' A' ' 150' ' ' LEU . 7.3 mt -54.58 -49.19 68.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -46.38 -53.77 10.34 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.4 t -52.29 -42.25 63.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.307 0.575 . . . . 0.0 110.992 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.633 ' CD1' HD13 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -58.14 -44.67 87.94 Favored 'General case' 0 C--O 1.2 -1.542 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.786 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.852 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.1 mm? -66.87 -43.56 83.24 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 119.328 0.967 . . . . 0.0 112.073 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.532 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.4 OUTLIER -60.72 -25.1 66.2 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.58 -13.19 15.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.148 0.499 . . . . 0.0 110.362 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.604 ' N ' ' O ' ' A' ' 149' ' ' TYR . 22.5 t60 -153.9 67.21 5.82 Favored Pre-proline 0 C--N 1.312 -1.05 0 C-N-CA 124.354 1.062 . . . . 0.0 110.688 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.99 -3.28 11.18 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 122.409 2.073 . . . . 0.0 111.521 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.619 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.1 OUTLIER -80.95 3.36 23.15 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.918 -178.6 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.55 129.95 19.83 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 119.453 -2.029 . . . . 0.0 111.237 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.715 ' CD2' HD23 ' A' ' 24' ' ' LEU . 10.9 t80 54.3 7.1 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.205 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.619 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.366 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.883 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.1 p . . . . . 0 C--O 1.234 0.284 0 CA-C-O 120.868 0.366 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -98.52 110.84 23.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.32 177.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 m -96.53 139.85 32.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.788 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -140.53 134.03 30.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.18 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.423 ' HG2' HD12 ' A' ' 116' ' ' ILE . 8.2 mt-10 -102.79 128.81 49.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.071 0.462 . . . . 0.0 110.964 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 115' ' ' SER . 0.0 OUTLIER -128.19 165.5 20.32 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -178.843 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 1.3 pt-20 -156.38 151.42 26.29 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -142.7 140.81 31.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.088 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -107.06 145.81 31.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.844 0.354 . . . . 0.0 111.687 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 t -146.14 154.53 41.89 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.822 0.344 . . . . 0.0 110.688 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -90.94 24.5 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.112 0.482 . . . . 0.0 110.691 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.451 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.9 mt -107.59 128.02 26.7 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.359 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -46.1 143.78 7.05 Favored 'Trans proline' 0 C--N 1.326 -0.617 0 C-N-CA 121.308 1.339 . . . . 0.0 110.994 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HA ' HD12 ' A' ' 18' ' ' LEU . 11.0 Cg_endo -61.1 -23.58 77.59 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.45 2.1 . . . . 0.0 113.108 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.0 m -70.43 -31.54 68.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -76.62 -56.41 4.64 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 15' ' ' PRO . 2.8 mt -50.67 -43.06 57.33 Favored 'General case' 0 C--O 1.212 -0.905 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.721 ' O ' HG22 ' A' ' 23' ' ' VAL . 16.9 t80 -47.67 -58.3 4.45 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.932 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.86 ' CB ' HD21 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.85 -41.09 75.35 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.12 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.838 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -63.6 -2.55 1.71 Allowed 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.33 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.614 ' CE1' ' CE2' ' A' ' 143' ' ' PHE . 6.6 t80 -119.23 -9.24 9.99 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.913 HG23 HD13 ' A' ' 24' ' ' LEU . 5.4 m -134.67 -46.22 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.913 HD13 HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -99.19 -32.01 11.44 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 120.607 1.548 . . . . 0.0 112.422 -178.757 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.703 ' N ' HD22 ' A' ' 24' ' ' LEU . 0.5 OUTLIER -112.14 -5.12 14.26 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 118.437 0.562 . . . . 0.0 111.645 -178.782 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -67.49 -42.53 82.74 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.28 0.562 . . . . 0.0 111.657 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -82.91 18.94 1.47 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.991 0.901 . . . . 0.0 109.906 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.41 ' H ' ' C ' ' A' ' 26' ' ' ALA . 67.7 m-80 -139.27 -9.08 1.29 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.548 HD21 ' CD2' ' A' ' 149' ' ' TYR . 1.2 mt -94.12 -31.42 14.18 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.923 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.526 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.76 -53.97 54.66 Favored Pre-proline 0 C--O 1.214 -0.764 0 O-C-N 122.175 -0.328 . . . . 0.0 111.266 -179.321 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 22.8 Cg_endo -63.08 -24.92 73.28 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 121.908 1.739 . . . . 0.0 112.468 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -69.66 -60.41 2.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.73 0.776 . . . . 0.0 111.972 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.778 HD12 ' HB3' ' A' ' 145' ' ' LEU . 1.4 pt -95.91 -35.68 5.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.349 -176.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.94 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.37 65.03 0.14 Allowed Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.47 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 72.2 Cg_endo -76.31 -28.07 7.43 Favored 'Trans proline' 0 C--N 1.32 -0.93 0 C-N-CA 121.638 1.559 . . . . 0.0 108.276 174.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -73.91 -43.59 57.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.317 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.94 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -71.52 -74.02 0.17 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.801 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.556 HD13 HD22 ' A' ' 142' ' ' LEU . 1.1 mp -101.74 144.21 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 121.264 0.554 . . . . 0.0 109.818 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.9 ttpt -78.86 -62.16 1.78 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.603 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.753 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 57.2 tp60 -164.5 165.69 21.1 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.922 0.391 . . . . 0.0 110.012 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.753 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -165.93 149.44 7.73 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.06 0.457 . . . . 0.0 111.181 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -150.17 142.79 24.54 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.075 -179.351 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.471 ' H ' HG13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -76.96 141.34 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-O 122.015 0.912 . . . . 0.0 111.212 178.564 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.764 ' N ' HD12 ' A' ' 44' ' ' LEU . 4.0 mp -88.36 -40.57 13.46 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.9 ' O ' HG23 ' A' ' 52' ' ' THR . 32.6 mt-10 -149.12 134.18 18.15 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.457 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.64 -156.38 23.14 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -134.19 -1.59 2.91 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.451 -0.44 . . . . 0.0 111.509 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.498 ' N ' HG21 ' A' ' 52' ' ' THR . . . 124.86 18.36 2.65 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -111.48 -172.9 19.48 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HD3' ' H ' ' A' ' 74' ' ' ILE . 10.8 Cg_endo -60.55 125.31 17.0 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 122.094 1.862 . . . . 0.0 112.96 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.5 -0.32 56.86 Favored Glycine 0 N--CA 1.462 0.428 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.9 HG23 ' O ' ' A' ' 45' ' ' GLU . 99.1 m -93.91 136.95 33.66 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 114.377 -0.912 . . . . 0.0 111.229 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.625 HG22 HD13 ' A' ' 44' ' ' LEU . 2.5 mp -113.95 132.35 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.496 ' HB2' HD11 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -122.7 138.54 54.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.899 0.381 . . . . 0.0 110.522 179.082 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.68 ' HB3' HD11 ' A' ' 44' ' ' LEU . 29.4 ttpt -119.9 130.2 54.73 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.098 -0.376 . . . . 0.0 110.906 178.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.6 mm -95.93 140.8 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.795 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.7 m -108.71 117.75 35.01 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 59' ' ' GLY . 5.8 t80 -104.22 172.12 6.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 0.0 110.961 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.453 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -57.55 144.43 40.63 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -60.3 -67.45 0.39 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.899 0.38 . . . . 0.0 111.242 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.46 61.96 3.15 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 t -137.75 -172.47 3.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.882 0.373 . . . . 0.0 110.664 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -58.69 -55.28 37.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.638 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -99.67 155.66 17.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.599 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.22 -59.36 0.13 Allowed Glycine 0 CA--C 1.52 0.363 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -145.5 149.2 34.2 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.937 0.399 . . . . 0.0 110.674 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 p -156.9 143.72 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.721 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.694 ' HB3' HD11 ' A' ' 86' ' ' ILE . 36.2 mttp -106.63 112.51 25.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.338 0.59 . . . . 0.0 112.069 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.445 ' CE1' ' CD2' ' A' ' 85' ' ' LEU . 11.3 m-70 -101.3 123.47 45.46 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -106.57 119.32 38.99 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.027 -0.421 . . . . 0.0 111.5 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.663 HD13 HG22 ' A' ' 52' ' ' THR . 4.0 mp -70.35 145.23 13.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -105.56 -54.88 2.41 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.7 144.4 6.11 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.461 ' H ' ' HD3' ' A' ' 50' ' ' PRO . 45.3 mt -127.14 125.88 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.162 173.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 79' ' ' TYR . 13.4 m-20 -113.91 88.81 2.93 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.506 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 13.7 mt-10 -54.47 -30.36 52.83 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.68 70.04 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.006 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.93 -11.42 15.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.122 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.7 m-85 62.23 42.7 9.18 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.597 -0.689 . . . . 0.0 110.259 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.4 t -106.86 141.75 37.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.127 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -132.09 118.71 19.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.8 t -128.53 135.19 49.07 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.136 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -144.82 159.83 42.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.493 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -138.26 139.48 39.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.228 0.537 . . . . 0.0 110.821 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.577 HD13 ' HB1' ' A' ' 90' ' ' ALA . 8.7 mt -80.17 115.55 19.79 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.694 HD11 ' HB3' ' A' ' 68' ' ' LYS . 4.1 pt -80.79 -44.24 21.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.676 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -152.02 172.11 16.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.863 0.363 . . . . 0.0 110.745 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.579 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.19 177.12 18.72 Favored Glycine 0 C--O 1.238 0.377 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -61.52 -0.34 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 122.204 1.002 . . . . 0.0 108.442 178.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.579 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -62.46 -34.36 76.67 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.816 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.859 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.16 14.83 22.74 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 123.61 0.764 . . . . 0.0 110.198 -177.549 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.6 p 46.42 -126.5 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -130.66 -12.86 3.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.649 0.738 . . . . 0.0 111.068 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.76 -6.34 20.42 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.015 0.526 . . . . 0.0 112.108 -177.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.717 HG21 ' CD1' ' A' ' 98' ' ' ILE . 71.4 mt -98.77 152.6 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.712 0 CA-C-O 121.997 0.903 . . . . 0.0 113.347 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.509 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -91.4 -57.33 2.81 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.167 177.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.404 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 28.2 pttt -171.93 151.16 2.7 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.027 0.442 . . . . 0.0 110.584 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.717 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.56 124.15 71.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.558 ' C ' ' HD1' ' A' ' 118' ' ' HIS . 0.1 OUTLIER -103.13 144.49 31.24 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 122.844 0.458 . . . . 0.0 111.896 -178.338 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.421 ' CZ ' ' OG ' ' A' ' 117' ' ' SER . 0.4 OUTLIER -139.13 127.93 23.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.5 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -133.57 132.86 41.38 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -133.43 136.32 45.12 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 122.208 -0.307 . . . . 0.0 110.425 -178.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -120.58 133.69 55.36 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -98.54 130.75 45.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.943 0.401 . . . . 0.0 110.003 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -132.62 137.24 54.55 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.063 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -73.01 135.71 44.96 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.649 178.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.429 ' N ' ' HA ' ' A' ' 111' ' ' SER . 13.2 t -121.25 168.82 11.2 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 122.593 0.357 . . . . 0.0 110.201 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.8 -29.81 42.71 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 112.233 -0.347 . . . . 0.0 112.233 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.6 p -92.06 -11.66 35.24 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 119.849 -1.971 . . . . 0.0 114.389 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.84 -86.14 0.12 Allowed Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.47 1.509 . . . . 0.0 112.066 -175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 88.4 p -164.54 130.97 2.97 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 125.86 1.664 . . . . 0.0 110.688 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.4 m -99.64 118.35 35.99 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 42.4 mt -91.83 131.23 39.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.118 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 102' ' ' THR . 8.9 mtpt -105.47 117.12 33.2 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.706 ' C ' HD13 ' A' ' 116' ' ' ILE . 24.9 p -110.16 118.64 36.9 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.368 0.604 . . . . 0.0 111.047 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.94 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -99.89 136.91 29.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 123.536 0.734 . . . . 0.0 109.641 -177.809 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.421 ' OG ' ' CZ ' ' A' ' 100' ' ' TYR . 6.8 m -118.26 131.72 56.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.477 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.558 ' HD1' ' C ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -138.2 112.26 8.51 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.883 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -102.83 103.77 13.98 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.211 -0.306 . . . . 0.0 110.441 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -90.58 107.24 19.04 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.207 0.527 . . . . 0.0 110.01 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.4 p -98.88 176.73 5.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.47 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -109.49 159.58 16.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.628 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 39.63 -109.77 0.13 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.464 -0.655 . . . . 0.0 111.464 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -116.04 3.66 13.62 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 122.702 -0.293 . . . . 0.0 111.069 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.483 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -45.58 160.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.316 0.579 . . . . 0.0 110.393 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.483 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 43.4 tt0 -149.49 145.66 26.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.212 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.0 mm -88.95 125.52 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -74.74 161.66 29.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.499 0.666 . . . . 0.0 111.53 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 1.0 OUTLIER -69.71 -47.55 62.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.192 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.469 ' O ' HG22 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -59.81 -24.68 64.35 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.118 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -72.95 -51.34 18.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.259 0.552 . . . . 0.0 111.256 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 m -77.31 -27.1 15.76 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.934 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.4 tttm -67.28 -45.91 75.21 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.275 -0.266 . . . . 0.0 110.9 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 135' ' ' GLY . 34.5 m -69.18 -45.38 79.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.886 0.375 . . . . 0.0 110.344 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.487 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -65.21 -41.76 96.69 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -67.14 -45.67 76.42 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 120.494 0.188 . . . . 0.0 110.691 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -53.96 -42.53 69.02 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.447 ' O ' ' CD2' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -69.48 -53.4 19.38 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.582 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.415 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.31 -41.73 39.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.583 0.706 . . . . 0.0 110.628 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -67.04 -36.34 81.86 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.93 -36.71 91.04 Favored Glycine 0 C--O 1.223 -0.576 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.584 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -73.31 -41.59 63.36 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.614 ' CE2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -59.87 -23.06 63.12 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.506 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.484 ' HZ2' ' C ' ' A' ' 144' ' ' LYS . 1.2 ttpp -76.01 -40.17 54.17 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.259 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.778 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.5 mm? -67.21 -55.85 12.34 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.31 0.576 . . . . 0.0 109.624 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.729 ' O ' HD22 ' A' ' 150' ' ' LEU . 60.6 mt -53.48 -50.92 46.35 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.358 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -47.51 -54.27 12.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.983 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.8 t -53.45 -42.65 67.37 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.117 0.484 . . . . 0.0 111.494 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.678 ' HB2' HD13 ' A' ' 33' ' ' ILE . 19.2 t80 -60.27 -44.72 95.07 Favored 'General case' 0 C--O 1.199 -1.553 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.838 HD11 ' HB2' ' A' ' 21' ' ' ALA . 1.8 mm? -68.99 -42.55 76.34 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 119.993 1.27 . . . . 0.0 111.629 -178.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -24.39 67.71 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 121.483 -0.761 . . . . 0.0 109.207 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -106.2 -13.15 15.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.566 0.698 . . . . 0.0 110.641 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 149' ' ' TYR . 16.9 t-80 -155.22 66.33 4.79 Favored Pre-proline 0 C--N 1.312 -1.063 0 C-N-CA 124.818 1.247 . . . . 0.0 110.181 -178.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.4 ' CD ' ' O ' ' A' ' 150' ' ' LEU . 43.1 Cg_endo -72.86 -4.01 14.61 Favored 'Trans proline' 0 N--CA 1.48 0.702 0 C-N-CA 122.472 2.115 . . . . 0.0 111.921 -178.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.553 ' OD1' ' CG ' ' A' ' 153' ' ' HIS . 3.8 p30 -82.51 3.48 28.24 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.07 0.948 . . . . 0.0 111.756 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.54 131.1 21.08 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 119.599 -1.938 . . . . 0.0 111.25 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.514 ' CG ' ' O ' ' A' ' 157' ' ' TYR . 80.9 t80 56.16 6.04 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 4.3 p-10 . . . . . 0 C--N 1.322 -0.595 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.31 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.803 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.9 p . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.814 0.34 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -97.46 110.36 22.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.298 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.496 ' OG1' ' CD2' ' A' ' 118' ' ' HIS . 96.9 m -96.03 132.36 41.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.758 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.17 128.36 37.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.976 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -102.7 133.66 47.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.742 0.306 . . . . 0.0 110.705 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -126.37 170.87 11.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.472 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.96 149.37 27.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.309 0.576 . . . . 0.0 111.976 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -155.43 141.02 17.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.12 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 m -106.27 143.84 33.82 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.92 0.391 . . . . 0.0 111.941 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.0 t -133.75 154.49 50.93 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.262 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -93.42 18.86 9.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.896 0.379 . . . . 0.0 111.003 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.442 ' O ' HD11 ' A' ' 18' ' ' LEU . 2.1 mt -107.09 127.73 27.41 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -44.82 144.83 3.26 Favored 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 121.117 1.211 . . . . 0.0 110.797 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.667 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 19.4 Cg_endo -62.81 -23.2 74.36 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 122.452 2.101 . . . . 0.0 112.542 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.592 ' C ' ' HZ2' ' A' ' 20' ' ' LYS . 70.1 m -69.3 -33.45 73.21 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.415 HH21 ' HB2' ' A' ' 16' ' ' SER . 11.5 mmt-85 -76.66 -56.83 4.26 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 118.882 0.764 . . . . 0.0 109.066 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.464 ' H ' ' HG ' ' A' ' 18' ' ' LEU . 4.0 mt -48.57 -48.64 38.71 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.728 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.76 ' O ' HG22 ' A' ' 23' ' ' VAL . 27.9 t80 -48.41 -55.18 11.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.192 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.592 ' HZ2' ' C ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -70.23 -26.71 63.98 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.416 -0.913 . . . . 0.0 109.622 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.796 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -81.3 -2.9 50.83 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.994 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.503 ' CA ' ' HB2' ' A' ' 26' ' ' ALA . 1.6 t80 -118.78 -8.3 10.36 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.908 HG23 ' CD1' ' A' ' 24' ' ' LEU . 3.1 m -135.08 -35.46 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.908 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.4 mp -90.51 -54.69 3.89 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.652 1.114 . . . . 0.0 111.694 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -113.03 -3.93 13.94 Favored 'General case' 0 C--O 1.205 -1.243 0 O-C-N 122.261 -0.274 . . . . 0.0 111.129 -178.501 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.957 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -46.07 -39.22 8.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 118.037 0.381 . . . . 0.0 111.526 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -85.41 12.98 7.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.629 0.728 . . . . 0.0 110.855 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -134.51 -10.32 2.46 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 124.969 1.308 . . . . 0.0 108.62 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -95.84 -43.3 7.91 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 124.862 1.265 . . . . 0.0 109.188 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.957 HG22 ' O ' ' A' ' 26' ' ' ALA . 1.7 tt -55.62 -45.46 99.87 Favored Pre-proline 0 C--O 1.215 -0.757 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.486 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.846 ' HD3' HG23 ' A' ' 30' ' ' ILE . 36.4 Cg_endo -63.41 -24.67 71.02 Favored 'Trans proline' 0 N--CA 1.482 0.85 0 CA-C-N 121.231 1.475 . . . . 0.0 111.256 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -67.49 -54.45 20.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.663 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.767 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.9 OUTLIER -95.8 -35.75 6.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.248 -176.438 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.863 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.63 63.85 0.15 Allowed Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.489 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 80.3 Cg_endo -77.1 -27.78 6.48 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 N-CA-C 107.917 -1.609 . . . . 0.0 107.917 174.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -75.23 -43.24 52.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.17 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.863 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -70.5 -75.27 0.12 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.861 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.602 ' HB ' HD11 ' A' ' 30' ' ' ILE . 1.1 mm -99.98 147.78 7.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 CA-C-O 121.665 0.745 . . . . 0.0 111.021 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.772 ' HD2' ' H ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.08 -64.07 1.09 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.203 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.433 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -178.12 166.79 1.98 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.105 0.478 . . . . 0.0 110.345 179.452 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.433 ' H ' ' HG2' ' A' ' 40' ' ' GLN . . . -165.96 143.76 5.6 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.987 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.81 145.95 35.32 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.431 ' H ' HG13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -84.82 139.08 18.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.683 0.754 . . . . 0.0 110.94 -179.451 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.837 ' N ' HD12 ' A' ' 44' ' ' LEU . 3.0 mp -89.49 -39.09 13.57 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.933 ' O ' HG23 ' A' ' 52' ' ' THR . 22.2 mt-10 -141.92 133.1 26.26 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.78 -156.41 28.8 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -134.19 -13.89 2.37 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 122.33 -0.512 . . . . 0.0 110.924 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.39 18.03 0.24 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -110.88 -173.24 19.91 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -61.16 126.07 18.56 Favored 'Trans proline' 0 C--N 1.321 -0.904 0 C-N-CA 122.258 1.972 . . . . 0.0 113.319 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.81 1.89 56.24 Favored Glycine 0 N--CA 1.463 0.462 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.933 HG23 ' O ' ' A' ' 45' ' ' GLU . 88.5 m -93.85 140.38 29.74 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.218 -0.991 . . . . 0.0 111.046 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.517 HG13 ' HE ' ' A' ' 70' ' ' ARG . 2.1 mp -117.65 133.13 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.17 141.02 52.41 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 121.037 0.446 . . . . 0.0 110.957 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' HB3' HD11 ' A' ' 44' ' ' LEU . 33.7 ttpt -119.27 131.98 55.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.813 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.7 mm -94.04 142.01 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.678 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 18.3 m -108.86 117.58 34.56 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.579 ' HA ' ' HD3' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -90.53 162.24 15.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.779 0.323 . . . . 0.0 111.363 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.59 144.34 30.16 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.621 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 2.1 pm0 -56.73 -47.17 80.6 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 122.422 -0.458 . . . . 0.0 110.298 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.34 62.38 1.76 Allowed Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 62.7 p -136.54 174.54 10.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.058 0.456 . . . . 0.0 111.205 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.438 ' N ' ' CD ' ' A' ' 63' ' ' GLN . 13.0 mp0 -69.03 -50.01 52.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.25 156.24 17.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.053 0.454 . . . . 0.0 110.631 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.78 -61.49 0.51 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.27 154.82 42.14 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.071 0.462 . . . . 0.0 110.776 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.426 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 2.0 p -145.82 157.09 12.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.958 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.426 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 26.4 mtmt -105.78 113.12 26.48 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.446 0.641 . . . . 0.0 112.425 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -105.78 105.71 15.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.993 0.917 . . . . 0.0 109.579 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.517 ' HE ' HG13 ' A' ' 53' ' ' ILE . 25.3 ttm180 -101.63 131.19 47.98 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.953 -0.467 . . . . 0.0 111.433 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.564 HD13 ' CG2' ' A' ' 52' ' ' THR . 4.4 mp -73.91 145.36 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -102.49 -56.01 2.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 119.227 -0.416 . . . . 0.0 112.073 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.8 m -165.35 141.38 5.38 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.5 mt -124.73 131.44 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.852 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.614 ' O ' ' N ' ' A' ' 79' ' ' TYR . 54.8 m-20 -114.84 87.92 2.75 Favored 'General case' 0 C--O 1.199 -1.575 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.454 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 9.5 pt-20 -54.41 -30.58 52.74 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.04 77.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.3 m -107.86 -9.98 15.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.736 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.614 ' N ' ' O ' ' A' ' 75' ' ' ASP . 20.7 m-85 58.54 48.63 11.68 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 121.415 -0.803 . . . . 0.0 110.538 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.2 p -106.58 147.22 29.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.985 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.635 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 35.9 t80 -132.1 125.86 32.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.968 0.413 . . . . 0.0 110.919 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 p -133.65 136.09 44.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.362 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.635 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 6.5 p90 -146.78 160.67 41.96 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.8 m -144.64 138.39 27.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.133 0.492 . . . . 0.0 111.229 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.65 HD22 ' HB1' ' A' ' 90' ' ' ALA . 4.5 mp -80.36 119.99 23.81 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.485 ' H ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -84.5 -42.9 17.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -178.08 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' A' ' 88' ' ' GLY . 1.2 tm-20 -157.64 173.55 16.68 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.326 -0.234 . . . . 0.0 110.493 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.631 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.74 177.44 17.34 Favored Glycine 0 CA--C 1.509 -0.316 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -61.54 1.76 0.21 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.65 ' HB1' HD22 ' A' ' 85' ' ' LEU . . . -64.88 -34.82 79.3 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.361 1.064 . . . . 0.0 110.071 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.874 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.0 16.31 21.98 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 123.702 0.801 . . . . 0.0 108.847 -178.552 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.8 p 44.89 -126.96 1.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -130.59 -9.62 4.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.133 0.492 . . . . 0.0 110.736 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.45 -7.25 18.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.171 -177.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.745 HG21 ' CD1' ' A' ' 98' ' ' ILE . 88.7 mt -100.04 152.5 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-O 122.085 0.945 . . . . 0.0 113.523 -177.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.492 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -90.42 -56.85 3.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.598 177.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -172.19 148.28 2.14 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.267 0.556 . . . . 0.0 111.454 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.745 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.31 130.1 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.745 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.26 145.07 46.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.917 0.389 . . . . 0.0 111.53 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -139.89 133.17 29.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.562 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.427 ' O ' HG12 ' A' ' 116' ' ' ILE . 39.0 tt0 -128.46 134.29 48.7 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 121.036 0.446 . . . . 0.0 110.963 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.14 133.01 52.99 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.714 -0.616 . . . . 0.0 109.634 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -120.11 133.0 55.63 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.4 mm? -97.81 125.42 42.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.132 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.8 OUTLIER -137.65 136.86 45.85 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.667 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -73.16 139.45 46.36 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.173 178.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.454 ' N ' ' HA ' ' A' ' 111' ' ' SER . 17.3 p -120.73 168.11 11.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.61 -26.85 32.89 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 121.398 -0.429 . . . . 0.0 112.125 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.2 m -91.27 -14.11 31.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 119.563 -2.139 . . . . 0.0 116.591 174.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.46 -89.91 0.12 Allowed Glycine 0 CA--C 1.537 1.424 0 O-C-N 120.454 -1.404 . . . . 0.0 110.981 -161.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.454 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 17.2 t -164.84 133.78 3.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 119.035 1.417 . . . . 0.0 111.196 -178.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 105' ' ' VAL . 52.1 m -100.06 126.05 46.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.422 ' CG1' HD13 ' A' ' 104' ' ' LEU . 11.1 mt -99.54 127.79 51.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.428 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -105.52 117.45 34.04 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.792 ' C ' HD13 ' A' ' 116' ' ' ILE . 8.0 p -110.58 121.77 46.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.442 0.639 . . . . 0.0 110.542 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.924 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -104.73 135.26 43.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.296 0.569 . . . . 0.0 109.948 -177.358 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 71.1 m -107.73 138.33 44.16 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.8 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.496 ' CD2' ' OG1' ' A' ' 4' ' ' THR . 26.3 m80 -136.13 93.47 2.91 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.813 0.34 . . . . 0.0 110.454 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.803 ' C ' HG23 ' A' ' 2' ' ' VAL . 60.9 m-85 -88.12 102.16 14.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.213 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -90.28 102.87 15.59 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.519 HG21 ' HA ' ' A' ' 126' ' ' GLU . 1.2 p -92.47 160.57 15.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.905 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.406 ' H ' HG22 ' A' ' 125' ' ' ILE . 4.3 ptmt -112.39 142.5 44.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.029 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.24 -109.64 0.94 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -116.46 -2.67 11.98 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.497 -0.413 . . . . 0.0 110.657 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 125' ' ' ILE . 1.2 tp -49.3 160.65 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.88 0.371 . . . . 0.0 110.693 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.519 ' HA ' HG21 ' A' ' 121' ' ' THR . 2.7 pp20? -149.38 149.64 31.17 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.572 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 34.2 mm -87.05 125.16 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -75.2 162.35 28.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.485 0.66 . . . . 0.0 112.06 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -69.02 -42.19 76.73 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.855 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.459 ' O ' HG22 ' A' ' 134' ' ' VAL . 5.2 mp0 -61.57 -25.55 67.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.825 0.345 . . . . 0.0 110.174 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -72.59 -51.03 21.45 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.283 0.564 . . . . 0.0 111.038 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 m -77.03 -25.95 15.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.942 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -67.34 -46.31 73.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 122.332 -0.23 . . . . 0.0 110.787 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 135' ' ' GLY . 35.6 m -70.2 -45.01 77.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.885 0.374 . . . . 0.0 110.593 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.491 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -66.16 -46.62 78.57 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -66.89 -46.89 73.51 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.636 -0.332 . . . . 0.0 110.714 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -55.2 -47.24 75.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.011 0.434 . . . . 0.0 110.031 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -66.7 -52.87 39.76 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.885 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.422 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.22 -42.64 41.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.594 0.712 . . . . 0.0 110.567 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.509 ' HD1' ' C ' ' A' ' 140' ' ' HIS . 1.8 t-80 -61.16 -36.56 80.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.859 0.838 . . . . 0.0 109.052 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.9 -38.88 96.12 Favored Glycine 0 C--O 1.221 -0.665 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.571 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -66.1 -46.82 76.28 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -59.62 -24.48 63.86 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.68 -36.28 65.29 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.59 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.767 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.1 mm? -71.22 -57.67 4.27 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.426 0.631 . . . . 0.0 109.839 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.727 ' O ' HD22 ' A' ' 150' ' ' LEU . 50.4 mt -54.54 -50.65 57.09 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.133 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -47.43 -56.76 6.32 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.864 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 20.5 p -50.68 -44.65 57.81 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.343 0.592 . . . . 0.0 111.285 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.668 ' HB2' HD13 ' A' ' 33' ' ' ILE . 28.2 t80 -59.88 -45.41 92.58 Favored 'General case' 0 C--O 1.193 -1.917 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.796 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.1 mm? -65.79 -42.74 90.37 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 120.443 1.474 . . . . 0.0 111.565 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.53 -24.38 67.48 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.305 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -105.77 -13.08 15.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.321 0.581 . . . . 0.0 110.768 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.637 ' N ' ' O ' ' A' ' 149' ' ' TYR . 42.1 m80 -155.96 67.34 4.69 Favored Pre-proline 0 C--N 1.31 -1.131 0 C-N-CA 125.167 1.387 . . . . 0.0 110.202 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -72.35 -3.48 13.46 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 122.501 2.134 . . . . 0.0 111.704 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.5 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 13.0 m-20 -73.16 2.61 6.9 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.163 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -50.11 130.15 22.01 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 119.161 -2.212 . . . . 0.0 111.275 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.669 ' CG ' HD23 ' A' ' 24' ' ' LEU . 92.8 t80 54.03 6.18 0.09 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.546 0.688 . . . . 0.0 112.124 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.5 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 4.0 p-10 . . . . . 0 C--N 1.324 -0.503 0 O-C-N 120.994 -1.066 . . . . 0.0 110.055 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.823 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.5 p . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.725 0.298 . . . . 0.0 111.02 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.73 110.27 22.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.659 177.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.516 ' OG1' ' CD2' ' A' ' 118' ' ' HIS . 90.4 m -95.93 140.06 31.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 0.0 111.013 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -143.28 128.09 18.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.172 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.495 ' HG2' HD12 ' A' ' 116' ' ' ILE . 1.6 tt0 -102.89 131.19 49.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.874 0.368 . . . . 0.0 111.324 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -134.59 172.7 12.56 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 122.636 0.375 . . . . 0.0 110.387 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.42 153.49 30.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.202 0.525 . . . . 0.0 112.39 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -149.01 138.41 21.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.235 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.19 147.49 25.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 111.771 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.3 t -145.8 161.44 39.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.499 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -96.27 25.92 4.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.854 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.617 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.5 mt -116.3 125.41 28.54 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.879 -178.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -47.83 149.93 4.9 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.034 1.823 . . . . 0.0 111.784 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.423 ' CG ' ' HB2' ' A' ' 106' ' ' ALA . 22.8 Cg_exo -60.93 -24.88 80.37 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.307 2.005 . . . . 0.0 112.59 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.447 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 45.6 m -68.68 -34.29 75.42 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -76.16 -55.77 5.27 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.617 HD21 ' HB ' ' A' ' 13' ' ' ILE . 4.4 mt -51.4 -41.85 61.01 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.733 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.555 ' O ' HG22 ' A' ' 23' ' ' VAL . 61.2 t80 -50.97 -57.48 8.48 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.733 ' CB ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -68.09 -40.08 82.74 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.254 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.858 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -66.62 -2.45 4.86 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.263 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.443 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 2.6 m-85 -118.67 -9.64 10.18 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.6 HG23 ' N ' ' A' ' 24' ' ' LEU . 33.9 m -131.76 -50.91 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.059 HD12 ' N ' ' A' ' 25' ' ' ASP . 2.7 pp -99.65 -30.52 12.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -176.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 1.059 ' N ' HD12 ' A' ' 24' ' ' LEU . 62.4 m-20 -112.84 -5.59 13.86 Favored 'General case' 0 C--O 1.214 -0.802 0 O-C-N 121.599 -0.688 . . . . 0.0 111.516 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -68.13 -40.99 82.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.259 0.552 . . . . 0.0 111.383 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.585 ' CB ' ' HZ1' ' A' ' 54' ' ' LYS . 13.9 m-20 -84.37 17.8 2.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.027 0.918 . . . . 0.0 110.889 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.403 ' H ' ' H ' ' A' ' 29' ' ' LEU . 62.7 m-20 -139.07 -9.0 1.33 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.781 HD12 HG23 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -89.23 -47.49 8.02 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.655 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.593 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -60.83 -43.03 90.35 Favored Pre-proline 0 C--O 1.208 -1.111 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 28.7 Cg_endo -62.2 -26.14 77.47 Favored 'Trans proline' 0 C--N 1.321 -0.905 0 CA-C-N 120.635 1.263 . . . . 0.0 112.252 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -76.94 -61.64 1.91 Allowed 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.351 0.596 . . . . 0.0 112.343 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.452 HD13 ' HB2' ' A' ' 149' ' ' TYR . 2.1 pt -94.4 -34.55 5.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.617 -177.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.71 ' HB2' ' HG ' ' A' ' 145' ' ' LEU . . . -102.68 67.3 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 123.224 0.609 . . . . 0.0 112.513 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.424 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 65.2 Cg_endo -72.7 -20.18 23.28 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.219 1.28 . . . . 0.0 108.882 176.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -72.87 -38.63 66.95 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.517 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.766 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -70.09 -81.91 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.443 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.616 HD12 ' N ' ' A' ' 38' ' ' ILE . 2.0 mp -109.57 144.07 18.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.0 110.13 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.69 -42.43 28.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.139 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.526 ' CD ' ' H ' ' A' ' 41' ' ' ALA . 7.9 tp-100 -173.63 164.74 4.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.526 ' H ' ' CD ' ' A' ' 40' ' ' GLN . . . -166.03 145.16 6.02 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.141 0.495 . . . . 0.0 110.893 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -148.32 142.99 26.59 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.106 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.716 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -76.75 140.53 17.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.409 0.623 . . . . 0.0 110.863 -179.112 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.746 ' N ' HD12 ' A' ' 44' ' ' LEU . 3.6 mp -89.55 -40.41 12.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.652 ' O ' HG23 ' A' ' 52' ' ' THR . 12.5 mm-40 -143.51 134.21 25.11 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.346 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.98 -155.12 22.27 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.896 -0.482 . . . . 0.0 111.896 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -133.95 -12.52 2.55 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 123.096 0.558 . . . . 0.0 111.232 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.483 ' O ' HD12 ' A' ' 74' ' ' ILE . . . 135.96 12.31 1.15 Allowed Glycine 0 C--O 1.221 -0.663 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.436 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -106.36 -170.87 22.99 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -60.76 126.28 19.35 Favored 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 122.803 2.336 . . . . 0.0 113.119 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.96 5.84 57.25 Favored Glycine 0 N--CA 1.465 0.612 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 45' ' ' GLU . 15.0 m -93.12 141.53 28.31 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.832 -0.684 . . . . 0.0 111.47 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.674 HG22 HD13 ' A' ' 44' ' ' LEU . 2.2 mp -116.46 133.57 62.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.716 ' HG2' HG23 ' A' ' 43' ' ' ILE . 4.7 tmtp? -119.67 140.32 50.83 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.542 0.686 . . . . 0.0 111.148 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.742 ' CB ' HD11 ' A' ' 44' ' ' LEU . 54.6 tttt -119.17 121.19 39.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.258 178.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 56' ' ' ILE . 5.2 mp -105.52 127.12 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.5 m -102.57 118.88 37.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.245 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.53 177.37 6.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.585 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.41 144.45 40.78 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -60.03 -48.37 81.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.852 0.358 . . . . 0.0 110.752 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.7 61.62 3.45 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 m -149.54 174.66 12.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.936 0.398 . . . . 0.0 110.585 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -66.79 -41.32 87.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.918 0.389 . . . . 0.0 110.664 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -91.4 149.48 21.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.552 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.416 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . -127.85 -62.39 0.13 Allowed Glycine 0 N--CA 1.462 0.378 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -146.35 146.95 30.85 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.728 0.299 . . . . 0.0 110.211 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -157.02 147.66 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.93 0.395 . . . . 0.0 110.947 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -105.59 113.06 26.4 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.271 0.558 . . . . 0.0 111.243 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.86 110.15 21.02 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -101.96 129.69 48.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.918 0.389 . . . . 0.0 112.037 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 mp -70.86 137.26 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -96.25 -53.75 3.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.44 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.4 m -164.5 140.74 6.1 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.483 HD12 ' O ' ' A' ' 48' ' ' GLY . 44.8 mt -129.16 130.65 68.06 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.15 177.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.625 ' O ' ' N ' ' A' ' 79' ' ' TYR . 38.4 m-20 -115.39 87.62 2.7 Favored 'General case' 0 C--O 1.194 -1.86 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.638 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.8 pm0 -55.32 -39.57 70.11 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.31 -37.08 45.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.131 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.21 -9.84 15.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.32 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.2 m-85 62.03 51.96 3.48 Favored 'General case' 0 N--CA 1.438 -1.068 0 O-C-N 121.055 -1.028 . . . . 0.0 110.101 -177.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 55.5 p -106.41 144.09 33.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.056 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -134.66 121.26 20.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.023 0.439 . . . . 0.0 110.933 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 m -136.42 147.38 47.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.226 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -162.65 169.76 19.57 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.779 0.323 . . . . 0.0 110.628 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -146.49 139.11 25.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.131 0.491 . . . . 0.0 110.771 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.806 HD13 ' HB1' ' A' ' 90' ' ' ALA . 11.1 mt -79.95 111.62 16.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.61 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -75.59 -40.75 41.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.4 -178.386 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.61 ' N ' HD13 ' A' ' 86' ' ' ILE . 16.0 tt0 -155.24 171.98 18.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.81 0.338 . . . . 0.0 110.295 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.18 177.82 17.7 Favored Glycine 0 CA--C 1.509 -0.334 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -61.87 2.29 0.22 Allowed 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.806 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -66.61 -34.36 77.71 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.173 0.989 . . . . 0.0 110.35 177.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.876 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.31 14.96 22.56 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.175 0.59 . . . . 0.0 110.341 -177.095 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.4 p 45.16 -126.22 1.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.36 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -130.45 -13.01 3.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.967 0.413 . . . . 0.0 111.475 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.9 p -104.75 -5.73 21.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.79 HG21 ' CD1' ' A' ' 98' ' ' ILE . 72.1 mt -99.12 152.95 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 CA-C-O 122.059 0.933 . . . . 0.0 113.472 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -93.46 -54.01 3.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.919 178.279 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -171.66 147.64 2.33 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 121.623 0.725 . . . . 0.0 111.028 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.79 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.41 121.98 66.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.73 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 118' ' ' HIS . 11.4 t -107.39 146.12 32.05 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.412 0.625 . . . . 0.0 111.438 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -136.68 131.5 33.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.286 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.413 ' O ' HG12 ' A' ' 116' ' ' ILE . 29.4 tt0 -127.96 133.66 49.23 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.4 OUTLIER -139.88 133.0 29.63 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.894 -0.504 . . . . 0.0 109.899 -179.006 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.404 ' C ' HD23 ' A' ' 104' ' ' LEU . 87.1 tttt -119.77 133.22 55.69 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -102.43 128.28 49.09 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.8 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.94 137.27 55.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.239 -178.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.77 134.65 45.05 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.336 178.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 38.8 t -121.3 172.26 8.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.826 0.346 . . . . 0.0 110.152 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.482 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.73 -35.28 52.18 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.8 p -87.06 -16.79 34.56 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.696 -1.473 . . . . 0.0 113.87 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 162.24 -77.75 0.16 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.379 1.466 . . . . 0.0 111.779 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 83.1 p -164.62 130.98 2.94 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 126.07 1.748 . . . . 0.0 111.096 176.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.5 m -99.48 117.71 34.48 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mt -92.72 131.34 40.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.543 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 102' ' ' THR . 2.7 mtpt -104.38 117.05 33.23 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.828 ' C ' HD13 ' A' ' 116' ' ' ILE . 68.4 m -111.34 123.74 50.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.291 0.567 . . . . 0.0 111.066 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.915 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -107.69 135.67 45.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 123.35 0.66 . . . . 0.0 110.082 -178.045 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.1 m -104.8 135.15 46.72 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.516 ' CD2' ' OG1' ' A' ' 4' ' ' THR . 15.5 m80 -136.24 93.56 2.92 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.127 0.489 . . . . 0.0 110.378 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.823 ' C ' HG23 ' A' ' 2' ' ' VAL . 94.8 m-85 -86.82 101.92 13.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.229 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -95.73 101.37 13.05 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.288 0.566 . . . . 0.0 110.231 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.1 p -100.26 171.69 7.63 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.472 0.653 . . . . 0.0 111.335 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -108.07 157.52 18.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.837 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 42.26 -114.73 0.77 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -110.57 4.85 20.68 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.727 -0.278 . . . . 0.0 111.11 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -49.09 160.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.298 0.571 . . . . 0.0 110.227 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.467 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 19.8 pt-20 -150.25 146.06 26.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.08 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.8 mm -88.85 124.27 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -75.09 162.15 28.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.476 0.655 . . . . 0.0 111.839 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -69.53 -36.22 76.21 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.935 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.422 ' O ' HG22 ' A' ' 134' ' ' VAL . 49.2 mt-10 -65.13 -30.41 71.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.792 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -72.41 -47.9 45.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.055 0.455 . . . . 0.0 111.027 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 m -77.47 -26.43 15.3 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.982 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -67.13 -46.28 74.59 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 122.138 -0.351 . . . . 0.0 110.699 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.466 HG23 ' N ' ' A' ' 135' ' ' GLY . 35.4 m -70.4 -43.48 78.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.598 0.237 . . . . 0.0 110.818 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.466 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -70.16 -46.77 48.79 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -67.38 -48.97 65.83 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 122.503 -0.41 . . . . 0.0 110.84 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -55.72 -48.01 75.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 109.998 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -64.4 -53.9 41.27 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.526 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -47.76 -45.91 29.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.461 0.648 . . . . 0.0 110.55 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -55.73 -37.22 68.14 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.409 0.623 . . . . 0.0 109.545 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.83 -38.92 96.85 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.766 HD22 ' HB2' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -68.37 -38.5 81.45 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.518 ' O ' ' CD1' ' A' ' 143' ' ' PHE . 0.9 OUTLIER -58.85 -32.04 69.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.687 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -70.29 -33.76 71.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.769 177.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.71 ' HG ' ' HB2' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -67.79 -56.95 7.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.046 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.781 HG23 HD12 ' A' ' 29' ' ' LEU . 59.1 mt -65.94 -48.94 80.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.664 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -47.5 -45.1 26.08 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.403 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.0 t -58.81 -37.7 76.96 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.878 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.634 ' O ' ' N ' ' A' ' 153' ' ' HIS . 11.2 t80 -59.65 -45.83 90.84 Favored 'General case' 0 C--O 1.189 -2.128 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.888 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.3 mm? -69.9 -42.79 72.92 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 119.445 1.021 . . . . 0.0 111.468 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -23.63 66.03 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.631 -0.668 . . . . 0.0 109.809 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.436 ' O ' ' ND1' ' A' ' 153' ' ' HIS . 4.7 m-20 -106.11 -14.22 15.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.353 0.597 . . . . 0.0 110.623 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 149' ' ' TYR . 44.0 m80 -155.38 66.94 4.91 Favored Pre-proline 0 C--N 1.304 -1.383 0 C-N-CA 125.572 1.549 . . . . 0.0 109.384 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.42 -3.13 10.37 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 C-N-CA 122.969 2.446 . . . . 0.0 111.562 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 5.1 p30 -72.59 3.18 5.23 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.82 -178.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.578 ' O ' ' HD3' ' A' ' 20' ' ' LYS . . . -52.16 128.67 25.57 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 119.335 -2.103 . . . . 0.0 110.823 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.788 ' CD1' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER 51.67 5.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.046 0.538 . . . . 0.0 112.423 178.871 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.445 ' H ' ' C ' ' A' ' 156' ' ' ALA . 1.7 p-10 . . . . . 0 N--CA 1.446 -0.636 0 CA-C-O 118.128 -0.939 . . . . 0.0 109.852 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.809 HG23 ' C ' ' A' ' 119' ' ' TYR . 8.9 p . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.849 0.357 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -98.4 110.03 22.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.547 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.475 HG23 ' CE1' ' A' ' 118' ' ' HIS . 68.4 m -96.56 132.84 41.75 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.656 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.67 128.87 37.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.066 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.09 133.47 48.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.8 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -134.0 174.54 10.36 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.765 0.317 . . . . 0.0 110.205 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.65 145.4 21.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.825 0.821 . . . . 0.0 112.079 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.31 134.63 27.75 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.831 -0.543 . . . . 0.0 110.138 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.94 147.44 23.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.891 0.377 . . . . 0.0 111.257 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 p -145.15 154.75 42.77 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.456 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -93.68 29.84 1.93 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.91 0.386 . . . . 0.0 110.397 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.636 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.3 mt -120.69 125.35 27.15 Favored Pre-proline 0 C--O 1.224 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.073 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -49.7 148.91 11.28 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 121.999 1.799 . . . . 0.0 111.708 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.427 ' HA ' HD12 ' A' ' 18' ' ' LEU . 27.7 Cg_exo -57.78 -28.31 81.58 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.386 2.057 . . . . 0.0 112.746 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.476 ' C ' ' HE ' ' A' ' 17' ' ' ARG . 15.1 m -65.14 -35.53 81.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.713 ' HE ' ' N ' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -74.95 -55.57 5.64 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -178.512 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.636 HD11 ' O ' ' A' ' 13' ' ' ILE . 4.2 mt -53.16 -40.27 64.18 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.012 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.796 ' O ' HG22 ' A' ' 23' ' ' VAL . 62.4 t80 -50.25 -57.7 7.24 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.859 0.464 . . . . 0.0 112.09 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.73 ' HB2' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.77 -41.55 75.02 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.507 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.761 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -64.0 -4.4 3.39 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.603 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.504 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 5.0 m-85 -119.79 -8.67 9.84 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 19' ' ' PHE . 25.8 m -128.53 -50.53 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.007 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.9 pp -98.0 -31.41 12.17 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -176.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 1.007 ' N ' HD12 ' A' ' 24' ' ' LEU . 3.8 t70 -114.96 -5.59 12.54 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 118.842 0.746 . . . . 0.0 112.177 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -62.4 -42.24 99.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.315 0.579 . . . . 0.0 111.702 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -83.76 19.7 1.62 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.865 0.84 . . . . 0.0 110.028 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -139.85 -8.64 1.21 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.024 HD13 HG23 ' A' ' 146' ' ' ILE . 0.5 OUTLIER -96.97 -50.15 4.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.224 -178.633 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.559 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 41.5 mt -55.04 -44.15 99.45 Favored Pre-proline 0 C--O 1.217 -0.632 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 20.7 Cg_exo -63.13 -22.64 73.17 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 122.353 2.036 . . . . 0.0 110.958 176.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -74.65 -55.08 6.28 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.537 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.76 HD11 HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -95.54 -35.07 5.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.322 -177.159 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.845 ' HB2' ' CG ' ' A' ' 145' ' ' LEU . . . -106.61 81.19 0.82 Allowed Pre-proline 0 CA--C 1.508 -0.639 0 CA-C-O 121.105 0.479 . . . . 0.0 111.93 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.75 -10.23 24.75 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 N-CA-C 107.33 -1.834 . . . . 0.0 107.33 174.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -74.61 -42.15 59.13 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.487 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.499 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -78.16 -80.03 0.12 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.188 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.516 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 5.6 mm -99.03 140.56 18.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.033 0.444 . . . . 0.0 110.99 -177.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -81.57 -42.9 19.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.915 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.543 ' CD ' ' H ' ' A' ' 41' ' ' ALA . 7.6 tp-100 -178.44 165.51 1.77 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.802 ' HB1' ' NZ ' ' A' ' 54' ' ' LYS . . . -165.08 144.08 6.63 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.201 0.524 . . . . 0.0 110.934 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.557 ' N ' ' NZ ' ' A' ' 54' ' ' LYS . 10.4 pt-20 -145.6 143.17 29.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.954 0.407 . . . . 0.0 111.249 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.465 HG13 ' H ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -78.57 142.09 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.485 0.66 . . . . 0.0 111.39 -179.104 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.9 mt -86.36 -39.7 16.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.418 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.915 ' O ' HG23 ' A' ' 52' ' ' THR . 40.7 mt-10 -148.18 133.61 18.61 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.618 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.93 -156.26 22.87 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -132.68 -10.54 3.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.95 0.405 . . . . 0.0 111.054 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.409 ' O ' HD12 ' A' ' 74' ' ' ILE . . . 134.36 21.0 0.78 Allowed Glycine 0 C--O 1.222 -0.619 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -178.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -110.3 -171.75 20.0 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -62.09 124.81 15.1 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 122.433 2.089 . . . . 0.0 113.036 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.8 3.78 59.23 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.915 HG23 ' O ' ' A' ' 45' ' ' GLU . 66.5 m -93.69 140.57 29.49 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.555 -0.823 . . . . 0.0 111.064 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.58 125.21 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.802 ' NZ ' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -115.52 138.18 51.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.254 0.55 . . . . 0.0 110.131 178.44 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.404 ' C ' HD12 ' A' ' 56' ' ' ILE . 75.9 tttt -120.43 132.07 55.07 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.708 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.784 ' N ' HD12 ' A' ' 56' ' ' ILE . 1.5 mp -103.28 140.8 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.0 m -113.48 118.64 35.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.83 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.516 ' CZ ' HD13 ' A' ' 38' ' ' ILE . 7.4 m-85 -101.47 -177.84 3.55 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.955 0.407 . . . . 0.0 110.942 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.25 145.77 35.17 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -59.61 -46.62 88.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.746 0.308 . . . . 0.0 110.794 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.72 61.56 3.45 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.3 t -142.96 175.04 10.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.916 0.389 . . . . 0.0 110.614 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -59.82 -51.49 69.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 110.665 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.404 ' OH ' ' NZ ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -107.11 143.47 35.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.165 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.06 -48.93 0.91 Allowed Glycine 0 CA--C 1.52 0.39 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -145.49 153.44 41.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.105 0.478 . . . . 0.0 110.624 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -154.02 146.34 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.554 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.6 ' HB3' HD11 ' A' ' 86' ' ' ILE . 80.4 mttt -105.57 106.11 16.45 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.436 0.636 . . . . 0.0 111.701 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.49 ' CE1' HD21 ' A' ' 85' ' ' LEU . 1.1 m-70 -92.51 123.19 35.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.708 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -113.11 119.62 38.46 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.82 -0.55 . . . . 0.0 111.068 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.61 HD13 HG22 ' A' ' 52' ' ' THR . 4.9 mp -70.22 137.16 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -99.61 -54.46 2.92 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.0 m -165.0 141.57 5.76 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 48' ' ' GLY . 43.8 mt -129.98 131.03 66.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.619 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.598 ' O ' ' N ' ' A' ' 79' ' ' TYR . 7.2 m-20 -116.25 87.89 2.78 Favored 'General case' 0 C--O 1.206 -1.217 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.637 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.1 pm0 -54.83 -41.14 70.34 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.06 -35.97 27.29 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.492 0.663 . . . . 0.0 109.223 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.444 ' O ' ' NZ ' ' A' ' 103' ' ' LYS . 0.6 OUTLIER -107.95 -10.5 15.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.409 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.598 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.9 m-85 63.24 50.32 3.03 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 120.989 -1.07 . . . . 0.0 110.024 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 34.9 t -106.26 144.24 33.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.359 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -135.09 123.23 22.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.101 0.477 . . . . 0.0 110.588 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 p -132.57 134.64 45.2 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.133 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -144.62 159.08 43.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.145 0.498 . . . . 0.0 110.022 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.7 m -142.32 137.2 30.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.994 0.426 . . . . 0.0 110.586 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.594 HD13 ' HB1' ' A' ' 90' ' ' ALA . 6.2 mt -80.06 109.87 14.92 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' A' ' 68' ' ' LYS . 2.9 pt -79.56 -43.47 23.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.011 -178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 3.4 tp10 -149.99 172.1 15.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.739 0.304 . . . . 0.0 110.362 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.604 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.94 177.45 18.33 Favored Glycine 0 CA--C 1.509 -0.326 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -61.14 1.61 0.17 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.604 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -65.25 -35.36 80.81 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 124.105 0.962 . . . . 0.0 110.212 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.869 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.72 11.77 22.6 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 123.521 0.728 . . . . 0.0 109.623 -177.86 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.9 p 46.55 -126.65 1.49 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -131.04 -11.37 3.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.256 0.55 . . . . 0.0 110.816 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.19 -5.58 20.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.427 -177.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.711 HG21 ' CD1' ' A' ' 98' ' ' ILE . 94.4 mt -97.76 152.09 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.466 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -87.37 -61.27 1.76 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.337 177.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.417 ' O ' ' CB ' ' A' ' 120' ' ' HIS . 11.8 ptmt -172.26 149.59 2.28 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.489 0.661 . . . . 0.0 111.305 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.711 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.13 127.56 75.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.597 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.3 145.7 39.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.246 0.546 . . . . 0.0 111.635 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -138.45 136.66 36.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.265 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.13 134.2 49.07 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 120.916 0.389 . . . . 0.0 110.144 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.64 130.87 28.48 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.31 -0.869 . . . . 0.0 109.742 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.754 ' C ' HD23 ' A' ' 104' ' ' LEU . 25.9 tttp -127.22 134.3 50.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.867 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -102.99 125.27 49.68 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -178.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -130.32 137.89 55.19 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.624 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.916 -178.846 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.21 133.57 45.17 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.287 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 14.8 t -121.56 174.35 6.84 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 122.678 0.391 . . . . 0.0 110.426 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.422 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -54.97 -36.34 60.44 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 m -80.56 -15.28 57.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.411 1.484 . . . . 0.0 114.198 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.95 -90.13 0.13 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.426 1.965 . . . . 0.0 110.812 -168.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.8 OUTLIER -157.22 129.09 7.11 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 127.728 2.411 . . . . 0.0 111.005 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.412 ' N ' ' O ' ' A' ' 105' ' ' VAL . 43.9 m -99.8 118.91 37.28 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.2 mt -92.66 131.65 39.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.535 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -105.25 116.64 32.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.885 ' C ' HD13 ' A' ' 116' ' ' ILE . 53.4 p -111.56 128.45 56.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.383 0.611 . . . . 0.0 111.258 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.885 HD13 ' C ' ' A' ' 115' ' ' SER . 0.1 OUTLIER -112.07 135.77 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 C-N-CA 123.327 0.651 . . . . 0.0 109.92 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 p -110.38 136.93 48.78 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.475 ' CE1' HG23 ' A' ' 4' ' ' THR . 27.7 m-70 -135.7 95.54 3.26 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.026 0.441 . . . . 0.0 110.888 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.809 ' C ' HG23 ' A' ' 2' ' ' VAL . 5.6 m-85 -84.89 101.12 12.06 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.417 ' CB ' ' O ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -94.32 103.76 15.76 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.513 HG21 ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -100.09 161.73 13.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.665 -178.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.522 ' H ' HG22 ' A' ' 125' ' ' ILE . 8.1 ptmt -112.22 157.15 21.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 41.01 -123.15 2.47 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -95.08 -12.09 27.14 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.522 HG22 ' H ' ' A' ' 122' ' ' LYS . 1.1 tp -49.32 162.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.632 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -159.62 150.09 19.08 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.229 -0.294 . . . . 0.0 110.9 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.3 mm -86.34 124.86 40.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -76.82 160.4 29.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.448 0.642 . . . . 0.0 111.718 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -70.24 -41.08 74.01 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.615 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.558 ' O ' HG22 ' A' ' 134' ' ' VAL . 10.3 pt-20 -62.96 -26.14 68.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.674 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -72.97 -52.11 15.75 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.595 0.712 . . . . 0.0 111.162 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.413 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 3.6 m -77.02 -29.53 17.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.584 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.131 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -67.04 -45.85 76.19 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 122.259 -0.276 . . . . 0.0 111.105 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 130' ' ' GLU . 34.1 m -68.68 -46.56 79.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.917 0.389 . . . . 0.0 110.542 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.526 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -66.15 -44.28 91.44 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 85.1 tttt -67.12 -46.62 73.59 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 122.691 -0.299 . . . . 0.0 110.956 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -54.56 -47.8 72.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.952 0.406 . . . . 0.0 110.086 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.404 ' NZ ' ' OH ' ' A' ' 64' ' ' TYR . 32.9 ttmt -61.13 -52.22 65.77 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.623 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.39 -51.96 31.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.604 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -47.94 -38.56 16.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.79 -33.85 88.08 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.736 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -75.89 -32.85 59.85 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.561 0.696 . . . . 0.0 109.408 179.669 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -59.22 -30.12 68.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -68.35 -42.32 79.41 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.603 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.845 ' CG ' ' HB2' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -50.93 -58.57 5.69 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 114.088 -1.414 . . . . 0.0 112.154 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 1.024 HG23 HD13 ' A' ' 29' ' ' LEU . 23.1 mt -73.73 -49.47 35.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.164 -176.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 13.2 tt0 -45.98 -56.25 5.76 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.556 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 20.7 t -50.8 -47.55 59.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.321 0.581 . . . . 0.0 110.48 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.813 ' CG ' HD21 ' A' ' 29' ' ' LEU . 8.3 t80 -52.03 -51.88 54.54 Favored 'General case' 0 C--O 1.192 -1.934 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.837 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.9 mm? -62.45 -42.15 99.27 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 119.576 1.08 . . . . 0.0 112.208 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.47 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -62.99 -24.34 67.87 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 121.454 -0.779 . . . . 0.0 109.203 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.96 -12.95 15.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.097 0.475 . . . . 0.0 110.671 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.644 ' N ' ' O ' ' A' ' 149' ' ' TYR . 75.1 m80 -155.45 66.31 4.67 Favored Pre-proline 0 C--N 1.311 -1.103 0 C-N-CA 125.452 1.501 . . . . 0.0 110.162 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.55 -3.58 12.82 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 122.598 2.198 . . . . 0.0 111.597 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.57 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.7 OUTLIER -85.75 4.17 38.03 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 123.312 0.645 . . . . 0.0 111.67 -178.773 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.407 ' O ' ' HD3' ' A' ' 20' ' ' LYS . . . -49.53 130.01 19.82 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 120.062 -1.649 . . . . 0.0 111.264 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.642 ' CG ' HD13 ' A' ' 24' ' ' LEU . 2.8 t80 54.84 6.31 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.57 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 118.578 -0.725 . . . . 0.0 110.242 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.85 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.2 p . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.929 0.395 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.483 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 52.1 m-85 -99.36 111.66 23.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.735 177.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.7 m -96.48 140.17 31.51 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.958 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -138.73 134.49 33.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.21 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.44 ' HG2' HD12 ' A' ' 116' ' ' ILE . 0.8 OUTLIER -103.45 129.4 50.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.82 0.343 . . . . 0.0 111.024 -179.468 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -135.54 166.79 22.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.967 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.91 159.97 39.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.471 0.653 . . . . 0.0 112.593 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.474 ' CE1' ' O ' ' A' ' 10' ' ' THR . 81.6 t80 -151.01 140.85 21.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.365 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.474 ' O ' ' CE1' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -93.62 148.23 22.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.811 0.339 . . . . 0.0 111.363 -179.362 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 p -144.81 154.45 42.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.779 0.323 . . . . 0.0 110.698 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -96.72 25.06 5.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 110.555 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.684 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.3 mt -113.14 125.93 28.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.48 144.96 12.78 Favored 'Trans proline' 0 C--N 1.326 -0.616 0 C-N-CA 121.913 1.742 . . . . 0.0 111.735 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.638 ' CG ' ' HB2' ' A' ' 106' ' ' ALA . 31.2 Cg_exo -55.84 -24.64 48.21 Favored 'Trans proline' 0 N--CA 1.484 0.922 0 C-N-CA 122.457 2.105 . . . . 0.0 112.667 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.402 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 48.2 m -68.31 -36.19 78.94 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -178.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -76.36 -56.34 4.72 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.684 HD21 ' HB ' ' A' ' 13' ' ' ILE . 4.3 mt -48.48 -47.08 38.79 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.752 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.772 ' O ' HG22 ' A' ' 23' ' ' VAL . 39.0 t80 -49.43 -57.22 7.37 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.443 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.86 -24.46 63.43 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.364 -179.351 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.741 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -83.1 -2.69 56.05 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.373 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.433 ' CA ' ' HB2' ' A' ' 26' ' ' ALA . 2.1 m-85 -118.87 -8.23 10.32 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.896 HG23 ' CD1' ' A' ' 24' ' ' LEU . 2.8 m -134.07 -35.5 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.896 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.6 mp -90.71 -55.01 3.73 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.59 1.087 . . . . 0.0 111.922 -175.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 29' ' ' LEU . 17.4 t70 -113.59 -4.55 13.47 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.868 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -46.93 -42.25 17.41 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.511 ' HB3' ' HZ3' ' A' ' 54' ' ' LYS . 1.1 m-20 -84.95 18.3 2.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.67 0.748 . . . . 0.0 110.5 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -139.91 -9.79 1.17 Allowed 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 124.583 1.153 . . . . 0.0 108.555 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.996 HD13 HG23 ' A' ' 146' ' ' ILE . 0.5 OUTLIER -89.71 -45.78 9.08 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 124.513 1.125 . . . . 0.0 109.597 -178.693 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.616 HG13 HD11 ' A' ' 146' ' ' ILE . 26.3 mt -54.38 -53.99 53.29 Favored Pre-proline 0 C--O 1.214 -0.791 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 22.8 Cg_endo -60.78 -21.59 70.61 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 122.081 1.854 . . . . 0.0 111.542 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 tmtp? -69.12 -52.63 26.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.699 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.776 HG13 HD12 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -95.85 -36.5 6.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.077 -177.829 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.742 ' HB2' ' CG ' ' A' ' 145' ' ' LEU . . . -107.04 82.27 1.09 Allowed Pre-proline 0 CA--C 1.506 -0.717 0 C-N-CA 123.159 0.584 . . . . 0.0 111.573 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.36 -9.81 27.07 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 N-CA-C 107.476 -1.778 . . . . 0.0 107.476 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -73.95 -42.09 61.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.499 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.559 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -75.43 -82.34 0.07 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.751 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 89.1 mt -107.76 143.36 18.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.98 0.419 . . . . 0.0 110.655 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -79.83 -46.18 17.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.174 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -179.5 166.59 1.43 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.19 147.7 7.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.926 0.393 . . . . 0.0 111.044 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' N ' ' HE2' ' A' ' 54' ' ' LYS . 10.9 pt-20 -137.79 145.41 42.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.31 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.622 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -77.16 139.94 17.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.509 0.671 . . . . 0.0 110.716 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 7.5 mp -89.02 -39.27 13.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.787 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.876 ' O ' HG23 ' A' ' 52' ' ' THR . 28.0 mt-10 -147.41 136.72 22.52 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.425 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.63 -155.92 22.91 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.0 p-10 -139.07 0.02 1.9 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 122.819 0.448 . . . . 0.0 110.749 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.35 11.52 3.37 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.11 -172.2 19.53 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 117.349 0.574 . . . . 0.0 112.123 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -59.15 126.71 21.74 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 122.676 2.25 . . . . 0.0 113.275 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.5 2.73 56.51 Favored Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.876 HG23 ' O ' ' A' ' 45' ' ' GLU . 60.8 m -94.4 139.8 30.64 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.104 -1.048 . . . . 0.0 111.651 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.667 HD12 ' C ' ' A' ' 52' ' ' THR . 1.8 mp -120.08 126.26 75.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.622 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -114.28 139.02 49.76 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.362 0.601 . . . . 0.0 110.509 179.244 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.492 ' C ' HD12 ' A' ' 56' ' ' ILE . 34.5 ttpt -118.44 127.12 53.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.096 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.775 ' N ' HD12 ' A' ' 56' ' ' ILE . 1.8 mp -105.5 135.7 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.6 m -111.25 120.5 42.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.08 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 59' ' ' GLY . 4.6 t80 -91.69 179.29 5.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.671 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.429 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -54.39 143.93 30.07 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -60.65 -59.45 5.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.884 0.373 . . . . 0.0 110.994 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.72 61.79 3.42 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.5 t -137.66 175.22 9.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.87 0.367 . . . . 0.0 110.692 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -61.49 -45.08 95.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.685 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -91.87 155.07 18.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.537 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.4 -61.37 0.13 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.17 154.7 42.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.084 0.469 . . . . 0.0 110.63 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 p -155.49 146.95 12.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.024 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -105.66 114.97 29.45 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.31 0.576 . . . . 0.0 112.267 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.588 ' CE1' ' CD2' ' A' ' 85' ' ' LEU . 1.8 m80 -100.56 116.84 33.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.729 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -102.0 119.59 39.05 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.969 -0.457 . . . . 0.0 111.29 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.2 mt -77.74 145.61 9.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -106.53 -55.32 2.34 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.7 m -165.39 141.94 5.54 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.6 mt -123.16 131.18 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.287 176.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.2 m-20 -116.01 87.64 2.72 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.466 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 9.8 pt-20 -54.96 -30.25 58.62 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.71 -39.06 70.55 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.98 -10.11 15.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.094 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.543 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.9 m-85 63.28 41.6 7.67 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 121.676 -0.64 . . . . 0.0 110.21 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.1 t -107.55 149.11 28.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.051 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 27.3 p90 -151.56 124.04 8.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.216 0.531 . . . . 0.0 110.965 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.66 144.56 51.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.208 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -144.65 171.66 14.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.806 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 m -144.64 136.23 25.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.135 0.493 . . . . 0.0 110.554 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.635 HD13 ' HB1' ' A' ' 90' ' ' ALA . 9.1 mt -79.83 120.02 23.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.439 HG12 ' H ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -85.11 -43.31 16.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.612 -178.609 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.479 ' OE2' ' N ' ' A' ' 88' ' ' GLY . 3.2 tm-20 -153.14 170.26 20.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.731 0.3 . . . . 0.0 110.265 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.615 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 118.17 178.48 17.16 Favored Glycine 0 CA--C 1.507 -0.465 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 178.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -61.83 2.03 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.293 1.044 . . . . 0.0 108.711 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.635 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -67.26 -34.31 77.17 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 124.215 1.006 . . . . 0.0 110.439 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.897 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.25 16.15 21.9 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 123.305 0.642 . . . . 0.0 110.136 -177.348 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.4 p 47.36 -126.19 1.67 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.199 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -130.3 -13.05 3.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.769 0.318 . . . . 0.0 111.532 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.02 -7.04 19.48 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.778 HG21 ' CD1' ' A' ' 98' ' ' ILE . 63.7 mt -99.91 153.5 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 CA-C-O 121.8 0.809 . . . . 0.0 113.127 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.538 ' N ' HG22 ' A' ' 95' ' ' ILE . 5.9 pt-20 -99.41 -51.64 3.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.027 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.513 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 64.4 mttt -164.71 146.68 8.27 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 121.177 0.513 . . . . 0.0 111.915 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.778 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.3 122.5 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.33 144.91 30.74 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.478 ' CZ ' ' OG ' ' A' ' 117' ' ' SER . 0.6 OUTLIER -139.88 131.79 27.68 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.665 179.453 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.525 ' CD ' ' N ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -129.15 130.92 47.02 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.525 ' N ' ' CD ' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -140.93 132.88 27.68 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.523 -0.736 . . . . 0.0 111.227 179.532 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.647 ' C ' HD23 ' A' ' 104' ' ' LEU . 26.3 ttpp -122.87 134.69 54.38 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.128 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.843 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.37 125.74 43.63 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.221 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.462 HG12 ' NZ ' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -127.43 137.56 57.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.098 -178.904 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.638 ' HB2' ' CG ' ' A' ' 15' ' ' PRO . . . -72.3 133.71 45.15 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.368 178.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.441 ' SG ' ' N ' ' A' ' 111' ' ' SER . 27.1 p -121.66 174.25 6.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.945 0.402 . . . . 0.0 110.288 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.71 -34.51 56.39 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.6 m -79.31 -21.22 46.24 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.615 -1.521 . . . . 0.0 114.078 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.7 -88.45 0.12 Allowed Glycine 0 CA--C 1.524 0.626 0 C-N-CA 125.752 1.644 . . . . 0.0 109.5 -166.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.8 OUTLIER -159.39 129.37 5.61 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 126.006 1.722 . . . . 0.0 111.336 -179.043 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 105' ' ' VAL . 26.8 m -99.6 118.53 36.34 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.9 mt -92.32 132.05 37.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.428 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 102' ' ' THR . 7.2 mtpt -105.34 116.92 32.77 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.757 ' C ' HD13 ' A' ' 116' ' ' ILE . 40.0 p -111.1 118.21 35.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.28 0.562 . . . . 0.0 111.36 -178.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.936 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -102.59 135.76 38.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.726 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.478 ' OG ' ' CZ ' ' A' ' 100' ' ' TYR . 11.1 m -117.95 133.32 56.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.72 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -137.2 112.94 9.52 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.85 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -102.28 103.31 13.77 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.989 -0.444 . . . . 0.0 110.122 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -91.04 107.98 19.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.119 0.485 . . . . 0.0 110.147 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.438 HG22 HD11 ' A' ' 127' ' ' ILE . 11.3 p -100.52 175.47 5.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.582 0.706 . . . . 0.0 111.127 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.8 ptmm? -110.36 158.64 18.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.833 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 39.85 -111.13 0.2 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -112.75 0.4 15.27 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 122.502 -0.41 . . . . 0.0 111.515 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -44.39 160.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.155 0.502 . . . . 0.0 110.641 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.474 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 93.3 mt-10 -147.98 146.92 29.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.212 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 121' ' ' THR . 22.1 mm -89.16 122.07 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -75.59 162.43 28.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.439 0.638 . . . . 0.0 112.135 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -69.53 -55.02 11.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.667 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' A' ' 130' ' ' GLU . 1.5 pm0 -53.82 -24.25 14.91 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.931 -0.481 . . . . 0.0 110.992 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.513 ' CE1' ' OE2' ' A' ' 130' ' ' GLU . 9.8 m80 -73.55 -53.27 10.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.253 0.549 . . . . 0.0 110.067 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 3.9 m -77.81 -27.91 15.37 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.199 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -67.66 -46.1 73.36 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.979 -0.45 . . . . 0.0 110.928 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 130' ' ' GLU . 28.2 m -70.0 -42.93 79.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.663 0.268 . . . . 0.0 110.548 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.492 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -69.74 -46.47 53.58 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.462 ' HZ3' ' HB3' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -67.36 -47.08 71.47 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 122.692 -0.299 . . . . 0.0 110.712 179.718 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -55.16 -48.2 74.07 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -62.4 -51.87 65.83 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.62 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -50.08 -53.73 25.19 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.722 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -47.4 -38.91 14.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.771 0.796 . . . . 0.0 109.358 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.55 -32.73 84.24 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.674 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.6 OUTLIER -75.67 -36.3 60.14 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.698 0.761 . . . . 0.0 109.491 178.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -58.39 -25.47 62.13 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.57 -38.73 54.43 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.489 177.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.776 HD12 HG13 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -50.96 -58.64 5.53 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-O 122.442 1.115 . . . . 0.0 111.263 179.776 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.996 HG23 HD13 ' A' ' 29' ' ' LEU . 20.0 mt -72.81 -49.37 40.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.845 -177.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 38.2 tt0 -46.07 -52.17 12.48 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.547 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 24.7 p -54.09 -44.98 71.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.153 0.502 . . . . 0.0 110.637 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.732 ' CG ' HD21 ' A' ' 29' ' ' LEU . 11.2 t80 -53.89 -45.95 71.23 Favored 'General case' 0 C--O 1.183 -2.417 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.834 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.6 mm? -69.5 -42.5 74.66 Favored 'General case' 0 C--O 1.218 -0.591 0 O-C-N 120.592 -1.317 . . . . 0.0 111.887 -177.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.465 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.6 OUTLIER -63.72 -25.48 68.22 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 121.569 -0.707 . . . . 0.0 109.594 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 149' ' ' TYR . 0.2 OUTLIER -106.98 -12.93 15.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.406 0.622 . . . . 0.0 110.307 178.304 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.615 ' N ' ' O ' ' A' ' 149' ' ' TYR . 13.5 t-80 -154.67 65.97 4.97 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 124.98 1.312 . . . . 0.0 110.23 -177.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.59 -3.12 11.26 Favored 'Trans proline' 0 N--CA 1.482 0.799 0 C-N-CA 122.576 2.184 . . . . 0.0 111.616 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 1.9 m-20 -74.52 2.66 9.13 Favored 'General case' 0 C--O 1.213 -0.859 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.913 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.426 ' O ' ' HD2' ' A' ' 20' ' ' LYS . . . -50.33 129.48 21.7 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 119.354 -2.091 . . . . 0.0 110.996 -178.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.707 ' CG ' HD23 ' A' ' 24' ' ' LEU . 86.2 t80 53.03 5.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 2.1 p-10 . . . . . 0 C--N 1.323 -0.544 0 O-C-N 121.179 -0.95 . . . . 0.0 110.069 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.805 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.1 p . . . . . 0 C--O 1.234 0.242 0 CA-C-O 121.028 0.442 . . . . 0.0 110.703 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.61 109.82 22.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.451 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.643 HG23 ' NE2' ' A' ' 118' ' ' HIS . 74.2 m -96.25 139.89 31.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.799 0.333 . . . . 0.0 111.004 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.08 130.56 25.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.08 179.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.433 ' HG2' HD12 ' A' ' 116' ' ' ILE . 0.8 OUTLIER -103.24 128.39 50.27 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.735 0.303 . . . . 0.0 110.766 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -126.73 168.37 14.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.519 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -155.2 142.48 19.44 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -146.57 139.92 25.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.629 0.252 . . . . 0.0 110.766 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.45 148.23 23.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 111.227 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.4 p -144.77 154.44 42.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.564 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -92.1 18.76 7.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.906 0.384 . . . . 0.0 110.786 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.587 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.8 mt -108.06 126.01 30.74 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.194 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.01 147.37 7.89 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 121.6 1.533 . . . . 0.0 111.392 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.644 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 12.9 Cg_endo -63.99 -23.68 67.59 Favored 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 122.503 2.135 . . . . 0.0 112.754 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.8 m -66.19 -32.28 73.62 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.633 ' N ' ' CD ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -81.73 -55.14 4.82 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -178.818 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.599 HD12 ' HA ' ' A' ' 15' ' ' PRO . 7.4 mt -47.05 -44.13 20.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.777 ' O ' HG22 ' A' ' 23' ' ' VAL . 54.7 t80 -51.79 -59.29 4.47 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.843 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.645 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -69.97 -23.37 63.16 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.698 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.734 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -82.25 -2.96 54.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.676 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CE2' ' OH ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -119.47 -9.22 9.89 Favored 'General case' 0 C--O 1.23 0.069 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.843 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.871 HG23 HD13 ' A' ' 24' ' ' LEU . 2.8 m -136.14 -37.02 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.909 HD23 ' CD2' ' A' ' 157' ' ' TYR . 3.4 mp -91.18 -52.89 4.6 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.208 0.913 . . . . 0.0 112.131 -176.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 93.0 m-20 -112.49 -4.18 14.26 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -55.02 -40.39 70.13 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 121.493 -0.755 . . . . 0.0 112.235 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -83.89 16.41 2.83 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.59 0.71 . . . . 0.0 110.905 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.46 -10.2 1.24 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.813 HD13 HG23 ' A' ' 146' ' ' ILE . 0.4 OUTLIER -88.15 -40.96 13.32 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.722 -1.127 . . . . 0.0 110.119 -178.294 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.641 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -54.14 -50.65 83.31 Favored Pre-proline 0 C--O 1.207 -1.141 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 19.2 Cg_endo -62.18 -24.88 76.63 Favored 'Trans proline' 0 C--N 1.319 -1.014 0 C-N-CA 121.682 1.588 . . . . 0.0 112.185 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -67.98 -62.26 1.49 Allowed 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 121.74 0.781 . . . . 0.0 112.076 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.474 ' CD1' ' O ' ' A' ' 145' ' ' LEU . 1.9 pt -95.29 -32.98 4.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.075 -177.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.841 ' HB2' ' HG ' ' A' ' 145' ' ' LEU . . . -101.97 74.29 0.14 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 123.746 0.818 . . . . 0.0 112.679 -175.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.74 -20.06 26.83 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 121.201 1.267 . . . . 0.0 109.081 175.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -72.99 -40.98 64.79 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.84 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.701 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -70.81 -82.13 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.94 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.614 HD12 ' C ' ' A' ' 37' ' ' ALA . 2.0 mp -112.54 145.09 19.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.145 0.498 . . . . 0.0 110.637 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -78.36 -47.1 18.4 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.329 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.417 ' OE1' ' N ' ' A' ' 41' ' ' ALA . 1.3 pp0? -173.86 164.54 4.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.986 0.422 . . . . 0.0 110.003 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.417 ' N ' ' OE1' ' A' ' 40' ' ' GLN . . . -166.1 145.57 6.09 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.746 178.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -138.59 142.71 39.16 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.603 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -78.39 140.0 17.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.501 0.667 . . . . 0.0 110.513 -179.549 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 44' ' ' LEU . 6.6 mp -89.39 -40.5 12.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.66 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.989 ' O ' HG23 ' A' ' 52' ' ' THR . 27.8 mm-40 -137.52 133.6 34.74 Favored 'General case' 0 C--O 1.215 -0.753 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.67 -156.59 46.46 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -135.79 -4.93 2.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.777 0.322 . . . . 0.0 111.32 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.493 ' N ' HG21 ' A' ' 52' ' ' THR . . . 142.09 18.94 0.28 Allowed Glycine 0 C--O 1.221 -0.718 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -109.86 -172.91 20.53 Favored Glycine 0 C--O 1.224 -0.51 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -62.08 125.06 15.58 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 122.443 2.095 . . . . 0.0 113.009 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.58 5.67 60.06 Favored Glycine 0 N--CA 1.464 0.509 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.989 HG23 ' O ' ' A' ' 45' ' ' GLU . 87.2 m -93.53 140.69 29.32 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.414 -0.893 . . . . 0.0 111.005 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.686 HD12 ' C ' ' A' ' 52' ' ' THR . 1.9 mp -122.5 128.84 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.603 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -116.45 139.36 50.53 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.272 0.558 . . . . 0.0 110.76 178.92 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.46 ' C ' HD12 ' A' ' 56' ' ' ILE . 32.9 ttpt -118.47 124.76 48.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.989 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.783 ' N ' HD12 ' A' ' 56' ' ' ILE . 1.7 mp -103.26 130.89 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.6 m -109.26 118.49 36.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.828 0.347 . . . . 0.0 110.28 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -92.83 -175.58 3.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.558 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.97 144.04 32.26 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -59.72 -62.77 1.62 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.881 0.372 . . . . 0.0 110.809 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.94 61.9 3.34 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.1 m -137.28 175.38 9.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.746 0.308 . . . . 0.0 110.69 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -55.1 -53.52 54.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.841 0.353 . . . . 0.0 110.561 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -91.99 154.57 18.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.381 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.39 -61.57 0.14 Allowed Glycine 0 N--CA 1.461 0.321 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -145.62 148.01 32.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.942 0.401 . . . . 0.0 110.377 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.76 145.57 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.821 0.343 . . . . 0.0 110.846 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -105.87 109.6 21.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.401 0.62 . . . . 0.0 111.558 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.521 ' NE2' ' CG ' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -106.38 113.73 27.43 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.245 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -102.31 130.05 48.91 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.623 HD13 HG22 ' A' ' 52' ' ' THR . 4.5 mp -70.63 141.14 17.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -99.37 -55.58 2.64 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -165.6 141.56 5.22 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.406 HD11 ' CG1' ' A' ' 23' ' ' VAL . 69.5 mt -130.01 129.87 65.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 120.968 0.413 . . . . 0.0 110.57 177.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 79' ' ' TYR . 39.2 m-20 -115.78 88.57 2.91 Favored 'General case' 0 C--O 1.212 -0.897 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -53.75 -30.08 42.71 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.89 -37.36 71.28 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.122 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -107.62 -11.21 15.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.806 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.547 ' N ' ' O ' ' A' ' 75' ' ' ASP . 32.0 m-85 60.2 45.0 12.05 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 121.797 -0.564 . . . . 0.0 110.339 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 p -112.92 148.98 33.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.498 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 6.2 p90 -147.62 127.64 13.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.251 0.548 . . . . 0.0 111.182 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 m -130.32 147.13 52.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.241 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.521 ' CG ' ' NE2' ' A' ' 69' ' ' HIS . 15.0 p90 -153.68 168.25 26.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.824 0.345 . . . . 0.0 110.184 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 98' ' ' ILE . 3.7 m -145.6 139.45 26.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.054 0.454 . . . . 0.0 111.388 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.586 HD13 ' HB1' ' A' ' 90' ' ' ALA . 4.9 mt -80.52 111.91 17.37 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.691 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -72.01 -41.81 68.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.252 -177.713 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.691 ' N ' HD13 ' A' ' 86' ' ' ILE . 17.4 tp10 -156.39 171.82 19.57 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.617 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.59 177.83 17.45 Favored Glycine 0 CA--C 1.508 -0.373 0 N-CA-C 110.214 -1.155 . . . . 0.0 110.214 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -61.21 2.15 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.617 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -67.61 -36.03 80.07 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.982 0.913 . . . . 0.0 110.094 177.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.929 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -111.8 13.26 21.01 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 123.694 0.797 . . . . 0.0 109.253 -178.589 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 47.1 p 48.07 -126.32 1.84 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -131.17 -9.23 3.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.092 0.472 . . . . 0.0 110.51 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.6 t -104.9 -6.66 19.97 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.762 HG21 ' CD1' ' A' ' 98' ' ' ILE . 57.6 mt -100.62 151.6 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.485 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -87.08 -58.83 2.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.514 177.844 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -170.55 148.77 3.13 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.191 0.52 . . . . 0.0 110.867 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.762 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.66 120.85 62.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.566 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.416 ' O ' ' CD1' ' A' ' 100' ' ' TYR . 9.5 t -109.65 145.5 36.38 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.375 0.607 . . . . 0.0 111.199 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 99' ' ' SER . 19.5 m-85 -135.69 129.41 32.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.221 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.428 ' O ' HG12 ' A' ' 116' ' ' ILE . 18.6 tt0 -127.8 133.72 49.45 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.32 136.37 36.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.859 0.361 . . . . 0.0 110.069 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -119.73 132.77 55.73 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -102.76 134.98 45.25 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.126 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.413 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.6 OUTLIER -137.05 136.77 47.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.994 -178.613 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.644 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -72.75 135.16 45.25 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.525 178.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.459 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 31.3 t -121.15 174.57 6.59 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.608 0.363 . . . . 0.0 110.161 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.459 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -55.8 -30.74 57.24 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 112.236 -0.346 . . . . 0.0 112.236 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.9 p -91.73 -12.47 33.87 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 119.552 -2.146 . . . . 0.0 115.634 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.16 -85.17 0.13 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.839 1.209 . . . . 0.0 111.407 -171.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.3 p -165.56 134.73 3.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.402 1.481 . . . . 0.0 110.858 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 105' ' ' VAL . 97.8 m -98.81 117.44 33.3 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.6 mt -92.81 127.54 44.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.69 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -104.25 116.23 31.8 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.782 ' C ' HD13 ' A' ' 116' ' ' ILE . 34.2 t -112.13 124.84 53.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.144 0.497 . . . . 0.0 111.432 -178.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.924 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -105.41 136.04 41.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 123.152 0.581 . . . . 0.0 109.486 -178.773 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.15 132.56 54.05 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.378 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.643 ' NE2' HG23 ' A' ' 4' ' ' THR . 26.1 m-70 -137.17 106.05 5.93 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 117.819 0.282 . . . . 0.0 110.91 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.805 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -101.45 103.83 14.75 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -89.97 109.8 20.81 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.18 0.514 . . . . 0.0 109.965 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.61 HG21 ' O ' ' A' ' 125' ' ' ILE . 0.6 OUTLIER -95.05 164.45 12.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.356 -178.219 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.491 ' H ' HG22 ' A' ' 125' ' ' ILE . 11.4 mtmt -92.46 146.92 23.31 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 34.0 -115.97 0.16 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -95.11 -13.73 24.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.812 0.339 . . . . 0.0 110.177 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.61 ' O ' HG21 ' A' ' 121' ' ' THR . 1.1 tp -48.82 163.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -149.35 150.5 32.57 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.683 -0.635 . . . . 0.0 112.049 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.42 ' CD1' HG12 ' A' ' 95' ' ' ILE . 26.7 mm -86.67 124.89 40.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -75.25 160.79 29.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.587 0.708 . . . . 0.0 112.055 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -70.22 -43.57 70.38 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.382 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.441 ' O ' HG22 ' A' ' 134' ' ' VAL . 78.5 mt-10 -60.44 -24.87 65.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.348 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -72.7 -52.46 15.13 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.371 0.605 . . . . 0.0 110.86 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.5 m -76.09 -26.31 17.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.909 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -67.62 -46.27 73.02 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.403 -0.186 . . . . 0.0 111.094 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 135' ' ' GLY . 34.6 m -69.85 -43.99 79.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.478 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -66.13 -43.33 93.45 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -67.23 -46.98 72.17 Favored 'General case' 0 CA--C 1.518 -0.258 0 O-C-N 122.789 -0.242 . . . . 0.0 110.973 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -54.94 -47.63 74.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.879 0.371 . . . . 0.0 110.054 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.64 -55.13 22.18 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.494 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -47.67 -45.25 27.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.535 0.683 . . . . 0.0 110.776 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -56.83 -37.4 71.2 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.87 0.843 . . . . 0.0 109.3 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.16 -38.66 96.52 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.746 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -68.64 -36.53 78.72 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -59.04 -32.36 69.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.32 -34.44 77.36 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.868 177.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.841 ' HG ' ' HB2' ' A' ' 34' ' ' ALA . 1.2 mm? -68.27 -58.26 4.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.566 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.813 HG23 HD13 ' A' ' 29' ' ' LEU . 66.3 mt -60.79 -48.67 87.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.743 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -46.38 -52.96 11.89 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.14 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 21.5 p -50.17 -44.68 52.83 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.344 0.592 . . . . 0.0 111.349 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.683 ' CG ' HD21 ' A' ' 29' ' ' LEU . 32.9 t80 -58.5 -45.5 88.64 Favored 'General case' 0 C--O 1.182 -2.499 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.807 ' H ' HD22 ' A' ' 150' ' ' LEU . 2.0 mm? -65.06 -42.02 94.58 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 119.917 1.235 . . . . 0.0 111.966 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.463 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.4 OUTLIER -64.76 -24.98 67.73 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.66 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -106.58 -12.54 15.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.276 0.56 . . . . 0.0 110.961 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.68 ' N ' ' O ' ' A' ' 149' ' ' TYR . 68.9 m80 -156.54 66.53 4.18 Favored Pre-proline 0 C--N 1.303 -1.429 0 C-N-CA 125.689 1.596 . . . . 0.0 110.59 -177.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.48 -2.72 11.15 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 122.468 2.112 . . . . 0.0 111.474 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -77.36 3.7 12.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.914 -178.472 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.08 129.28 17.54 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 119.269 -2.145 . . . . 0.0 111.186 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.909 ' CD2' HD23 ' A' ' 24' ' ' LEU . 23.6 t80 54.08 6.73 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.048 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 1.3 p-10 . . . . . 0 N--CA 1.45 -0.438 0 O-C-N 121.402 -0.811 . . . . 0.0 110.225 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.829 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.1 p . . . . . 0 C--O 1.234 0.238 0 CA-C-O 120.889 0.376 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -97.89 109.73 22.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.526 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.2 m -97.05 136.03 38.19 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.67 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -135.47 129.29 32.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.328 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.4 ' HG2' HD12 ' A' ' 116' ' ' ILE . 1.2 tt0 -103.14 134.16 47.03 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.643 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -127.14 168.78 14.19 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.627 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -150.71 140.31 21.61 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -144.42 129.15 18.25 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.515 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 m -100.42 144.05 29.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.787 0.327 . . . . 0.0 111.653 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.0 t -145.43 164.34 31.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.485 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -94.66 25.75 3.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.746 0.308 . . . . 0.0 111.16 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.589 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.3 mt -111.55 125.42 30.44 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.781 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 45.9 Cg_exo -50.42 147.56 16.54 Favored 'Trans proline' 0 C--N 1.327 -0.594 0 C-N-CA 121.953 1.769 . . . . 0.0 111.652 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.439 ' HA ' HD12 ' A' ' 18' ' ' LEU . 26.8 Cg_exo -58.3 -25.08 71.03 Favored 'Trans proline' 0 N--CA 1.483 0.863 0 C-N-CA 122.279 1.986 . . . . 0.0 112.623 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.48 ' C ' ' HZ2' ' A' ' 20' ' ' LYS . 55.4 m -67.62 -35.27 78.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.311 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -75.42 -57.06 4.12 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.589 HD11 ' O ' ' A' ' 13' ' ' ILE . 4.6 mt -50.17 -44.69 52.91 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.008 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.529 ' O ' HG22 ' A' ' 23' ' ' VAL . 55.7 t80 -49.4 -58.68 4.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.005 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.771 ' CB ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -67.57 -40.35 84.87 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 118.83 -1.148 . . . . 0.0 108.415 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.871 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -64.59 -2.99 2.7 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.445 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.487 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 4.0 m-85 -118.35 -9.26 10.42 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 19' ' ' PHE . 30.7 m -130.22 -50.95 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.021 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.9 pp -98.06 -31.32 12.2 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 1.021 ' N ' HD12 ' A' ' 24' ' ' LEU . 26.9 m-20 -114.21 -3.96 13.13 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-N 118.648 0.658 . . . . 0.0 111.555 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -66.88 -39.54 87.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.989 0.899 . . . . 0.0 111.187 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.52 16.99 3.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.125 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -138.35 -9.5 1.47 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.946 HD12 HG23 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -90.47 -50.22 6.07 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.585 -1.643 . . . . 0.0 109.631 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.601 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 96.0 mt -55.65 -51.6 78.87 Favored Pre-proline 0 C--O 1.212 -0.883 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.054 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 29.1 Cg_endo -62.49 -26.05 76.13 Favored 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 121.747 1.632 . . . . 0.0 112.948 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.54 -60.79 2.08 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.633 0.73 . . . . 0.0 112.435 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.561 HD13 ' HB2' ' A' ' 149' ' ' TYR . 1.9 pt -93.07 -33.03 5.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.583 -177.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.861 ' HB2' ' HG ' ' A' ' 145' ' ' LEU . . . -102.79 68.15 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 123.121 0.569 . . . . 0.0 112.311 -177.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.424 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 66.7 Cg_endo -72.89 -19.15 23.86 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 N-CA-C 108.726 -1.298 . . . . 0.0 108.726 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -73.4 -39.41 65.11 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.693 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.677 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -70.36 -82.15 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.69 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 73.3 mt -110.74 145.05 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.044 0.45 . . . . 0.0 110.588 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -77.8 -47.69 18.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.421 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.461 ' OE1' ' N ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -174.02 164.82 4.19 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.754 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.461 ' N ' ' OE1' ' A' ' 40' ' ' GLN . . . -164.73 145.82 7.86 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.841 0.353 . . . . 0.0 110.993 178.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -137.63 145.5 42.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.716 0.293 . . . . 0.0 110.258 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.522 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -79.54 139.54 18.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.476 0.655 . . . . 0.0 110.654 -179.474 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 44' ' ' LEU . 6.9 mp -88.98 -39.48 13.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.795 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.944 ' O ' HG23 ' A' ' 52' ' ' THR . 42.9 mt-10 -141.89 133.57 27.0 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.843 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.24 -156.33 29.41 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.6 p30 -139.76 -8.3 1.24 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.96 0.41 . . . . 0.0 111.131 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' HD12 ' A' ' 74' ' ' ILE . . . 143.46 16.22 0.26 Allowed Glycine 0 C--O 1.219 -0.814 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.41 -172.04 19.99 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 117.394 0.597 . . . . 0.0 111.907 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -62.74 126.05 17.37 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 C-N-CA 122.858 2.372 . . . . 0.0 113.307 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.19 5.97 59.14 Favored Glycine 0 CA--C 1.506 -0.523 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.944 HG23 ' O ' ' A' ' 45' ' ' GLU . 92.7 m -93.18 138.65 31.39 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 114.239 -0.981 . . . . 0.0 110.949 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.89 128.46 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.522 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -116.79 139.79 50.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.726 0.774 . . . . 0.0 110.676 179.035 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.447 ' C ' HD12 ' A' ' 56' ' ' ILE . 46.7 tttm -118.47 127.84 54.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.828 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.757 ' N ' HD12 ' A' ' 56' ' ' ILE . 2.0 mp -104.47 136.61 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.9 m -117.15 120.0 36.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.368 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.04 169.06 10.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.365 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.11 143.99 28.82 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 0.8 OUTLIER -59.86 -50.38 74.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.849 0.357 . . . . 0.0 110.468 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.71 61.47 3.47 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.6 t -145.49 178.97 7.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 110.653 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -66.63 -45.68 78.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 0.0 110.626 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -91.46 154.74 18.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.397 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.44 -61.71 0.13 Allowed Glycine 0 CA--C 1.52 0.347 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.53 154.93 42.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.754 0.311 . . . . 0.0 110.28 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.83 149.95 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.723 0.297 . . . . 0.0 111.202 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.57 113.43 26.99 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.527 0.68 . . . . 0.0 112.044 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.607 ' CE1' ' CD1' ' A' ' 83' ' ' TYR . 6.7 t60 -109.63 112.08 23.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.721 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -102.4 131.44 49.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.144 0.497 . . . . 0.0 111.858 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.408 HD12 HG22 ' A' ' 52' ' ' THR . 13.8 mt -86.17 143.08 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -106.66 -54.89 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.2 m -164.81 141.92 6.14 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.459 HD12 ' O ' ' A' ' 48' ' ' GLY . 53.9 mt -124.81 131.26 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.872 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' A' ' 79' ' ' TYR . 5.8 m-20 -114.93 87.42 2.65 Favored 'General case' 0 C--O 1.21 -1.023 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.502 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 7.4 pt-20 -55.04 -30.63 59.97 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.57 -37.7 68.38 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.4 m -107.76 -10.46 15.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.922 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.56 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.2 m-85 62.84 44.57 6.19 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.625 -0.672 . . . . 0.0 109.865 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -105.96 145.66 31.03 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.469 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -132.13 120.82 22.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.191 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.473 ' CB ' ' OE1' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -127.11 133.25 50.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.321 -179.675 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.607 ' CD1' ' CE1' ' A' ' 69' ' ' HIS . 24.6 p90 -144.11 170.75 15.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.827 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.1 m -145.94 125.69 13.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.018 0.437 . . . . 0.0 110.876 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.529 HD12 HD21 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -79.08 118.25 20.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.722 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.673 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -85.75 -41.81 15.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -175.486 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.673 ' N ' HD13 ' A' ' 86' ' ' ILE . 10.0 tp10 -162.59 174.75 12.2 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 118.948 0.795 . . . . 0.0 110.816 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 119.76 178.31 16.38 Favored Glycine 0 CA--C 1.505 -0.578 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.6 2.75 0.16 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.758 ' C ' HD23 ' A' ' 91' ' ' LEU . . . -72.07 -37.38 69.64 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 123.917 0.887 . . . . 0.0 111.22 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.867 HD23 ' N ' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -111.29 17.04 20.61 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 119.672 -0.204 . . . . 0.0 110.625 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.4 p 54.25 -133.4 1.74 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -177.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -131.81 -0.7 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.5 p -104.72 -7.71 19.35 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.702 HG21 HD13 ' A' ' 98' ' ' ILE . 6.9 mt -99.2 151.25 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.481 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -87.07 -50.5 6.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.351 176.165 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.455 ' N ' ' HG2' ' A' ' 96' ' ' GLU . 12.1 ptmt -172.61 149.56 2.09 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.702 HD13 HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.9 130.38 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.155 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.434 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -113.15 144.26 42.96 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.902 0.481 . . . . 0.0 111.015 -179.037 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.489 ' CE1' ' OG ' ' A' ' 117' ' ' SER . 0.3 OUTLIER -139.22 131.55 28.39 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.87 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.473 ' OE1' ' CB ' ' A' ' 82' ' ' SER . 8.9 tp10 -128.73 133.0 48.01 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.408 ' N ' ' CD ' ' A' ' 101' ' ' GLU . 0.5 OUTLIER -136.26 131.63 34.71 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 121.596 -0.69 . . . . 0.0 110.631 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.734 ' C ' HD23 ' A' ' 104' ' ' LEU . 38.3 tttm -124.33 134.17 53.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.863 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.858 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -100.6 126.17 47.05 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -178.726 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -128.32 136.69 59.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.959 -178.843 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.68 133.42 44.61 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.117 -0.364 . . . . 0.0 110.596 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 24.7 t -121.7 173.35 7.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.547 0.339 . . . . 0.0 110.158 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.443 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -54.4 -36.61 58.3 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.901 -0.479 . . . . 0.0 111.901 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.9 m -93.98 15.94 15.66 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.25 1.42 . . . . 0.0 113.363 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 130.0 -83.99 0.32 Allowed Glycine 0 CA--C 1.534 1.235 0 C-N-CA 126.4 1.952 . . . . 0.0 113.095 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 84.1 p -161.62 132.13 5.04 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 126.99 2.116 . . . . 0.0 111.057 176.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 105' ' ' VAL . 45.0 m -99.83 118.12 35.61 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 60.5 mt -92.72 126.83 45.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.57 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.62 116.86 32.65 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.812 ' C ' HD13 ' A' ' 116' ' ' ILE . 1.9 p -111.62 124.3 52.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.335 0.588 . . . . 0.0 110.877 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.927 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -106.8 136.18 42.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 123.148 0.579 . . . . 0.0 109.922 -177.699 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.489 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 7.2 t -116.52 133.04 56.48 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.788 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.434 ' ND1' ' O ' ' A' ' 99' ' ' SER . 0.2 OUTLIER -136.47 109.35 7.61 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 120.766 0.317 . . . . 0.0 110.522 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.829 ' C ' HG23 ' A' ' 2' ' ' VAL . 7.3 m-85 -102.14 104.02 14.61 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.228 -0.295 . . . . 0.0 110.512 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -90.86 110.16 21.37 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.064 0.459 . . . . 0.0 109.823 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.4 p -94.1 171.3 8.93 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 122.021 0.915 . . . . 0.0 111.929 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.7 ptmm? -112.93 142.57 45.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.829 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 53.83 -109.68 1.19 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.48 2.26 12.4 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 122.299 -0.53 . . . . 0.0 111.264 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.484 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.4 mp -43.45 161.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.344 0.592 . . . . 0.0 110.812 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.484 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 9.9 pt-20 -148.31 150.28 33.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.238 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.551 HD12 HD11 ' A' ' 95' ' ' ILE . 1.6 mm -87.78 125.62 41.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -74.88 160.89 30.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.11 0.481 . . . . 0.0 111.002 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -70.1 -39.7 75.37 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.566 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.584 ' O ' HG22 ' A' ' 134' ' ' VAL . 8.8 mm-40 -66.47 -25.15 66.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.587 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -72.42 -51.17 21.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.387 0.613 . . . . 0.0 110.81 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 m -78.42 -30.6 15.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.07 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -66.83 -46.0 76.5 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 122.156 -0.34 . . . . 0.0 111.077 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 130' ' ' GLU . 25.4 m -70.5 -44.71 76.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.611 0.243 . . . . 0.0 110.771 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.522 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -69.06 -46.83 57.3 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -67.45 -50.49 58.99 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.504 -0.409 . . . . 0.0 110.866 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -55.27 -47.77 74.98 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -63.15 -53.64 50.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.539 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -48.49 -47.86 38.34 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.412 0.625 . . . . 0.0 110.837 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -54.26 -37.61 64.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.02 -32.4 84.05 Favored Glycine 0 C--O 1.228 -0.247 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.712 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -74.61 -41.06 61.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -59.33 -25.72 64.42 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -76.29 -33.76 59.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.85 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.861 ' HG ' ' HB2' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -66.26 -56.78 9.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.1 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.946 HG23 HD12 ' A' ' 29' ' ' LEU . 61.9 mt -65.02 -48.73 82.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.653 -178.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -47.0 -47.57 22.01 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.158 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.0 t -54.84 -42.95 72.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.469 0.652 . . . . 0.0 111.26 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.636 ' O ' ' N ' ' A' ' 153' ' ' HIS . 26.8 t80 -59.08 -44.67 91.92 Favored 'General case' 0 C--O 1.191 -1.997 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.871 HD11 ' HB2' ' A' ' 21' ' ' ALA . 1.9 mm? -66.21 -42.48 88.7 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 119.491 1.041 . . . . 0.0 111.794 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.458 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -62.57 -24.83 67.75 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 121.525 -0.734 . . . . 0.0 109.329 179.511 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.438 ' O ' ' ND1' ' A' ' 153' ' ' HIS . 28.6 t70 -106.22 -13.42 15.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.034 0.445 . . . . 0.0 110.774 178.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.636 ' N ' ' O ' ' A' ' 149' ' ' TYR . 54.4 m80 -155.82 66.8 4.63 Favored Pre-proline 0 C--N 1.309 -1.168 0 C-N-CA 125.425 1.49 . . . . 0.0 110.43 -178.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -74.18 -3.37 13.7 Favored 'Trans proline' 0 C--N 1.324 -0.739 0 C-N-CA 122.579 2.186 . . . . 0.0 111.522 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 4.0 p-10 -81.95 4.82 21.16 Favored 'General case' 0 C--O 1.21 -0.975 0 C-N-CA 123.953 0.901 . . . . 0.0 111.991 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.401 ' O ' ' CD ' ' A' ' 20' ' ' LYS . . . -49.35 129.79 18.96 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 119.325 -2.11 . . . . 0.0 111.395 -178.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.526 ' CD2' HD22 ' A' ' 24' ' ' LEU . 13.6 t80 55.0 6.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 5.7 p-10 . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.197 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.823 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.4 p . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.901 0.381 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.76 111.82 23.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.345 177.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.3 m -96.09 134.82 38.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.002 0.43 . . . . 0.0 110.2 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.537 ' CE2' ' OD1' ' A' ' 7' ' ' ASN . 0.2 OUTLIER -131.54 122.19 25.72 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.539 ' CG ' HD12 ' A' ' 116' ' ' ILE . 1.5 tt0 -117.04 127.8 54.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.149 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.537 ' OD1' ' CE2' ' A' ' 5' ' ' PHE . 2.8 m120 -138.26 175.74 9.31 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.591 0.234 . . . . 0.0 110.818 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -144.31 156.17 44.14 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -149.86 134.04 17.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.954 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -92.91 144.84 24.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.859 0.362 . . . . 0.0 111.803 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.45 154.02 50.0 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.114 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -96.38 28.18 3.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.044 0.45 . . . . 0.0 110.715 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.694 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.5 mt -119.04 126.03 27.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.73 -178.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -46.99 145.64 6.94 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 121.823 1.682 . . . . 0.0 111.758 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -55.78 -29.73 73.14 Favored 'Trans proline' 0 N--CA 1.482 0.805 0 C-N-CA 122.263 1.975 . . . . 0.0 112.808 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.9 m -63.86 -35.46 80.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -74.96 -59.2 2.84 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.694 HD21 ' HB ' ' A' ' 13' ' ' ILE . 2.3 mt -50.88 -42.41 59.05 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.967 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.732 ' O ' HG22 ' A' ' 23' ' ' VAL . 40.8 t80 -50.24 -57.44 7.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.675 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.836 ' CB ' HD21 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.89 -40.74 75.49 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 118.572 -1.251 . . . . 0.0 109.102 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.847 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -63.49 -2.74 1.7 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.648 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.488 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 5.4 t80 -118.96 -9.35 10.08 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.886 HG23 HD13 ' A' ' 24' ' ' LEU . 3.6 m -132.54 -49.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.98 ' H ' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -99.09 -31.56 11.71 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.033 1.288 . . . . 0.0 112.03 -178.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.813 ' N ' HD22 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -107.68 -3.97 18.66 Favored 'General case' 0 C--O 1.211 -0.953 0 O-C-N 122.082 -0.386 . . . . 0.0 111.432 -178.511 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -67.05 -40.33 87.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.742 0.782 . . . . 0.0 111.728 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -84.02 13.89 4.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.837 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.436 ' H ' ' H ' ' A' ' 29' ' ' LEU . 65.3 m-20 -134.85 -9.34 2.37 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.898 HD12 HG23 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -96.71 -48.13 5.61 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.949 -179.693 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.702 HG13 HD11 ' A' ' 146' ' ' ILE . 74.8 mt -54.45 -56.1 30.38 Favored Pre-proline 0 C--O 1.217 -0.624 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 34.9 Cg_endo -63.37 -26.32 71.11 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 C-N-CA 122.298 1.999 . . . . 0.0 113.886 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -71.69 -49.41 39.9 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.601 0.715 . . . . 0.0 111.896 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.755 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.7 OUTLIER -94.76 -34.81 5.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.674 -177.472 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.783 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.58 64.07 0.14 Allowed Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.5 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 73.0 Cg_endo -76.59 -24.46 10.37 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 N-CA-C 107.909 -1.612 . . . . 0.0 107.909 174.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -73.79 -44.2 56.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.411 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.783 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -71.11 -77.76 0.09 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.15 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 mt -100.32 146.22 9.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 121.085 0.469 . . . . 0.0 110.191 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -78.08 -53.18 7.68 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.22 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -173.14 165.86 4.92 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.157 0.503 . . . . 0.0 110.578 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.404 ' HB1' ' HE3' ' A' ' 54' ' ' LYS . . . -166.07 145.21 6.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.966 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -149.2 142.34 24.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.897 0.38 . . . . 0.0 110.412 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.625 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -78.74 140.72 16.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.358 0.599 . . . . 0.0 111.201 -179.356 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.761 ' N ' HD12 ' A' ' 44' ' ' LEU . 3.7 mp -90.47 -39.86 12.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.494 178.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 52' ' ' THR . 13.9 mm-40 -143.23 134.87 26.47 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.306 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.95 -155.02 22.23 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.991 -0.443 . . . . 0.0 111.991 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.407 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 13.0 p30 -135.53 -11.72 2.1 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 123.416 0.686 . . . . 0.0 111.315 -177.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.2 12.23 1.28 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -110.63 -172.28 19.87 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -59.05 127.24 23.5 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 122.479 2.119 . . . . 0.0 113.283 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.84 4.8 55.54 Favored Glycine 0 N--CA 1.462 0.384 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 45' ' ' GLU . 19.3 m -94.18 142.06 27.84 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.626 -0.787 . . . . 0.0 111.883 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.634 HD12 ' C ' ' A' ' 52' ' ' THR . 1.8 mp -118.17 132.86 66.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 176.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.625 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -121.82 139.39 53.67 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.465 0.65 . . . . 0.0 111.148 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.692 ' HB3' HD11 ' A' ' 44' ' ' LEU . 26.2 ttpt -119.23 118.73 32.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.293 178.043 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.23 137.69 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.634 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.1 m -118.97 117.77 29.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.165 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -94.91 -175.14 3.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.434 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.59 144.39 30.08 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 7.3 mp0 -60.18 -59.48 5.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.924 0.392 . . . . 0.0 110.29 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.98 60.82 3.43 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.6 m -138.89 -178.13 5.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.129 0.49 . . . . 0.0 110.706 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.585 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 1.8 mp0 -68.4 -44.14 75.74 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.441 ' CD1' ' OD2' ' A' ' 89' ' ' ASP . 52.2 m-85 -91.58 145.12 24.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.97 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.3 -62.08 0.12 Allowed Glycine 0 CA--C 1.519 0.299 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -146.14 151.91 38.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.843 0.354 . . . . 0.0 110.494 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -157.21 150.29 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.946 0.403 . . . . 0.0 111.279 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.58 ' HB3' HD11 ' A' ' 86' ' ' ILE . 28.2 mmtt -105.57 106.79 17.45 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.175 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.476 ' CD2' ' C ' ' A' ' 69' ' ' HIS . 1.2 t-160 -105.24 111.02 23.61 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -105.2 128.83 53.6 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.816 0.341 . . . . 0.0 111.497 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.485 HD13 ' CG2' ' A' ' 52' ' ' THR . 2.9 mp -74.03 144.96 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -98.89 -55.51 2.69 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.792 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.9 m -165.94 141.22 4.8 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.5 mt -123.41 131.8 72.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 176.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 79' ' ' TYR . 2.8 m-20 -115.92 87.96 2.79 Favored 'General case' 0 C--O 1.208 -1.125 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -54.39 -29.89 50.26 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.73 75.66 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.023 177.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -107.11 -11.3 15.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.052 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.574 ' N ' ' O ' ' A' ' 75' ' ' ASP . 9.0 m-85 60.3 44.16 12.78 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.537 -0.727 . . . . 0.0 110.45 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 34.4 t -109.75 146.24 35.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.835 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -131.65 123.29 27.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.004 0.43 . . . . 0.0 111.111 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.35 134.65 48.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.056 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -143.93 166.03 26.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.903 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.0 m -145.9 135.3 23.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.17 0.509 . . . . 0.0 111.189 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.589 HD13 ' HB1' ' A' ' 90' ' ' ALA . 10.2 mt -80.75 117.09 21.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.58 HD11 ' HB3' ' A' ' 68' ' ' LYS . 4.1 pt -81.68 -44.58 20.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.798 0.332 . . . . 0.0 111.487 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.468 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 19.9 tt0 -151.42 172.5 15.86 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.761 0.315 . . . . 0.0 110.451 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.74 177.23 18.44 Favored Glycine 0 CA--C 1.509 -0.287 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.441 ' OD2' ' CD1' ' A' ' 64' ' ' TYR . 6.4 p30 -61.27 1.12 0.21 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.589 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -62.92 -35.3 79.62 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.004 0.922 . . . . 0.0 109.931 177.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.878 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.89 12.66 22.25 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 123.802 0.841 . . . . 0.0 109.575 -177.842 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.1 p 47.82 -126.3 1.78 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -130.44 -11.3 4.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.991 0.425 . . . . 0.0 111.07 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.4 -6.72 19.29 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.747 HG21 ' CD1' ' A' ' 98' ' ' ILE . 96.3 mt -98.16 152.01 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-O 122.251 1.024 . . . . 0.0 113.56 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.546 ' OE2' ' CE1' ' A' ' 120' ' ' HIS . 0.0 OUTLIER -91.08 -54.12 4.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.932 177.949 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.66 145.74 1.57 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.038 0.447 . . . . 0.0 111.943 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.747 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.41 132.64 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.222 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.472 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 0.3 OUTLIER -119.36 144.87 46.64 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.723 0.409 . . . . 0.0 111.51 -178.501 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.472 ' CD2' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -136.35 130.26 32.58 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.798 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.506 ' O ' HG12 ' A' ' 116' ' ' ILE . 30.3 tt0 -129.41 134.14 47.7 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.524 0.202 . . . . 0.0 110.511 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.7 OUTLIER -132.27 135.56 46.33 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.922 -0.486 . . . . 0.0 109.719 -179.037 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -119.53 133.82 55.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.58 126.07 40.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.466 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.27 135.25 47.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.422 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -73.33 138.72 45.56 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 121.936 -0.477 . . . . 0.0 110.304 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 52.4 t -121.34 170.39 9.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.889 0.376 . . . . 0.0 110.317 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.551 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.56 -34.75 50.13 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.9 m -85.41 -15.06 44.3 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.112 1.365 . . . . 0.0 114.321 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.18 -85.64 0.13 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.92 1.724 . . . . 0.0 111.396 -171.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.468 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 41.2 t -161.32 132.73 5.48 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.654 1.582 . . . . 0.0 111.221 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 55.0 m -99.92 128.76 45.98 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.299 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.2 mt -101.51 127.79 54.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.548 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 102' ' ' THR . 3.3 mtpt -105.37 116.89 32.71 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.849 ' C ' HD13 ' A' ' 116' ' ' ILE . 0.9 OUTLIER -111.68 123.08 49.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.954 0.407 . . . . 0.0 110.548 -178.307 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.9 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -109.65 136.39 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.358 -177.496 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.3 t -118.05 133.24 56.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.544 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.472 ' ND1' ' O ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -136.79 103.81 5.31 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 120.913 0.387 . . . . 0.0 110.176 -179.407 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.823 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -97.33 108.41 21.13 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.029 -0.42 . . . . 0.0 110.524 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.546 ' CE1' ' OE2' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -88.98 104.74 17.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.793 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.3 p -88.52 170.42 10.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.996 0.903 . . . . 0.0 111.731 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -113.02 156.26 23.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.882 179.424 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . 35.07 -109.24 0.06 OUTLIER Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -111.41 -2.79 15.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.939 0.399 . . . . 0.0 111.063 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.3 mp -43.21 160.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.274 0.559 . . . . 0.0 110.572 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.429 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 34.7 tt0 -152.54 148.7 27.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.284 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.2 mm -88.15 124.79 41.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -74.74 161.72 29.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.421 0.629 . . . . 0.0 111.698 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -69.72 -41.74 74.94 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.775 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 134' ' ' VAL . 53.6 mt-10 -62.25 -27.09 68.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.713 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -73.03 -49.99 25.6 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.417 0.627 . . . . 0.0 111.342 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 m -77.61 -29.86 16.57 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.192 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -67.15 -45.73 76.18 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.22 -0.3 . . . . 0.0 110.96 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 130' ' ' GLU . 34.1 m -67.99 -44.25 85.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.792 0.329 . . . . 0.0 110.287 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -67.37 -39.18 91.68 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -67.05 -47.22 71.99 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.711 -0.288 . . . . 0.0 110.661 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -55.2 -46.81 75.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.949 0.404 . . . . 0.0 110.201 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -64.71 -52.51 56.77 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.454 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.47 -42.66 43.86 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.55 0.691 . . . . 0.0 110.56 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' HIS . . . . . 0.414 ' O ' ' ND1' ' A' ' 140' ' ' HIS . 1.3 t60 -60.97 -36.09 78.51 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.891 0.853 . . . . 0.0 109.51 178.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.411 ' O ' HD22 ' A' ' 145' ' ' LEU . . . -61.23 -44.79 97.66 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -65.57 -40.54 92.89 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -59.79 -28.69 67.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -77.49 -35.9 53.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.286 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.761 HD23 ' HB2' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -68.26 -57.69 5.58 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.514 0.674 . . . . 0.0 110.23 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.898 HG23 HD12 ' A' ' 29' ' ' LEU . 45.1 mt -58.21 -50.04 79.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.661 -177.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -46.87 -55.21 8.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.622 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 41.8 t -52.91 -44.49 66.99 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.508 0.671 . . . . 0.0 110.971 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.658 ' HB2' HD13 ' A' ' 33' ' ' ILE . 24.8 t80 -58.58 -45.58 88.74 Favored 'General case' 0 C--O 1.194 -1.832 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.847 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.2 mm? -66.22 -43.18 87.42 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 120.257 1.389 . . . . 0.0 111.565 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -61.5 -24.09 66.36 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 121.489 -0.757 . . . . 0.0 109.159 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.469 ' OD2' ' CE1' ' A' ' 153' ' ' HIS . 10.6 t70 -105.73 -13.26 15.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.46 0.648 . . . . 0.0 110.595 178.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 149' ' ' TYR . 56.0 m80 -155.51 67.14 4.89 Favored Pre-proline 0 C--N 1.312 -1.05 0 C-N-CA 125.199 1.4 . . . . 0.0 110.101 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.51 -3.62 14.02 Favored 'Trans proline' 0 N--CA 1.481 0.756 0 C-N-CA 122.566 2.177 . . . . 0.0 111.576 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 0.5 OUTLIER -83.9 5.16 26.37 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.953 -179.026 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -48.97 129.89 17.83 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 119.594 -1.941 . . . . 0.0 111.394 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.687 ' CG ' HD23 ' A' ' 24' ' ' LEU . 0.3 OUTLIER 56.11 6.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.987 0.515 . . . . 0.0 112.059 178.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 4.6 p-10 . . . . . 0 C--N 1.324 -0.511 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.202 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.828 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.3 p . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.829 0.347 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.76 109.7 22.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.601 177.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.7 m -96.53 137.27 35.86 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.313 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -135.52 129.18 32.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.471 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.471 ' C ' HD22 ' A' ' 7' ' ' ASN . 1.5 tt0 -103.36 129.39 50.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.94 0.4 . . . . 0.0 110.749 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.56 ' ND2' ' N ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -142.89 164.75 29.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -178.625 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -155.51 159.53 39.82 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -144.56 140.78 29.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.341 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.03 147.68 24.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 111.521 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.3 t -145.36 164.2 32.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.688 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -102.88 23.98 11.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.891 0.376 . . . . 0.0 110.843 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.686 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.7 mt -112.57 126.61 28.05 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.627 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -47.35 144.21 10.05 Favored 'Trans proline' 0 C--N 1.326 -0.613 0 C-N-CA 122.019 1.813 . . . . 0.0 111.974 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.505 ' HA ' HD12 ' A' ' 18' ' ' LEU . 39.6 Cg_exo -55.45 -24.55 44.26 Favored 'Trans proline' 0 N--CA 1.484 0.931 0 C-N-CA 122.361 2.04 . . . . 0.0 112.7 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.444 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 13.2 p -70.08 -37.04 75.36 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.425 HH21 ' HD2' ' A' ' 17' ' ' ARG . 4.5 mtt85 -75.22 -47.65 27.17 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.686 HD11 ' O ' ' A' ' 13' ' ' ILE . 5.2 mt -57.42 -48.29 79.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.554 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.741 ' O ' HG22 ' A' ' 23' ' ' VAL . 48.5 t80 -46.18 -57.51 4.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.081 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -69.72 -26.02 64.13 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.579 0.704 . . . . 0.0 109.953 -179.296 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.854 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -83.72 -2.57 56.53 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.293 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.484 ' CA ' ' HB2' ' A' ' 26' ' ' ALA . 1.6 t80 -117.55 -9.02 10.89 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.878 HG23 ' CD1' ' A' ' 24' ' ' LEU . 2.3 m -134.62 -36.76 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.878 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.5 mp -92.29 -53.06 4.38 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.185 0.902 . . . . 0.0 111.391 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.57 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.4 m-20 -114.37 13.8 17.83 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 116.846 -0.161 . . . . 0.0 111.358 -176.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -66.9 -42.17 85.93 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 121.244 0.545 . . . . 0.0 111.192 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -83.94 18.59 1.99 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.075 0.941 . . . . 0.0 110.259 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -135.95 -9.11 2.07 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.894 HD12 HG23 ' A' ' 146' ' ' ILE . 0.1 OUTLIER -90.65 -51.31 5.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.493 -1.685 . . . . 0.0 110.706 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.626 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -58.5 -52.16 76.63 Favored Pre-proline 0 C--O 1.215 -0.723 0 CA-C-O 120.777 0.323 . . . . 0.0 110.742 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 22.8 Cg_endo -60.5 -21.79 69.6 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 C-N-CA 122.632 2.222 . . . . 0.0 112.763 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -75.22 -52.06 11.82 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.839 0.352 . . . . 0.0 111.07 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -95.2 -35.04 5.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.159 -177.877 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.827 ' HB2' ' CG ' ' A' ' 145' ' ' LEU . . . -106.77 81.54 0.91 Allowed Pre-proline 0 CA--C 1.507 -0.679 0 C-N-CA 122.78 0.432 . . . . 0.0 111.728 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.15 -10.71 27.84 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 N-CA-C 107.227 -1.874 . . . . 0.0 107.227 174.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -42.29 58.24 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.402 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.512 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -73.79 -82.03 0.06 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.874 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.1 mm -107.63 142.82 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.965 0.412 . . . . 0.0 110.974 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -79.73 -45.12 19.48 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.67 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -178.6 166.28 1.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.814 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.13 145.06 5.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.241 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -141.43 146.05 36.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.208 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.417 HG13 ' H ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -79.67 139.6 18.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.471 0.653 . . . . 0.0 110.703 -179.4 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.3 mp -88.52 -39.87 13.85 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.129 -0.942 . . . . 0.0 108.684 178.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.911 ' O ' HG23 ' A' ' 52' ' ' THR . 24.1 mt-10 -142.52 133.75 26.13 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.976 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.58 -156.15 24.57 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -139.76 -10.62 1.18 Allowed 'General case' 0 C--N 1.32 -0.698 0 O-C-N 122.529 -0.394 . . . . 0.0 110.975 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.486 ' O ' HD12 ' A' ' 74' ' ' ILE . . . 143.6 13.09 0.32 Allowed Glycine 0 C--O 1.221 -0.718 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.26 -171.24 20.67 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 117.344 0.572 . . . . 0.0 112.089 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -62.53 126.15 17.73 Favored 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 123.024 2.483 . . . . 0.0 113.58 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.27 5.84 56.94 Favored Glycine 0 N--CA 1.463 0.479 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.911 HG23 ' O ' ' A' ' 45' ' ' GLU . 88.3 m -93.37 140.5 29.5 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.271 -0.964 . . . . 0.0 111.145 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -119.18 129.98 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.498 ' HB3' ' HZ3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -118.16 140.93 49.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.074 0.464 . . . . 0.0 111.047 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -118.96 128.64 54.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.173 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.681 ' N ' HD12 ' A' ' 56' ' ' ILE . 3.2 mp -105.21 125.36 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.715 -0.394 . . . . 0.0 109.956 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.1 m -102.54 118.61 37.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -92.62 -174.83 3.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.76 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.73 143.86 31.61 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 8.9 mp0 -60.72 -63.57 1.25 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.909 0.385 . . . . 0.0 110.653 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.77 62.2 3.36 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.8 t -136.7 178.52 7.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.908 0.385 . . . . 0.0 110.754 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -60.81 -49.66 76.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.745 0.307 . . . . 0.0 111.018 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -91.92 137.83 32.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.496 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.4 -58.72 0.52 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.439 ' CD2' ' N ' ' A' ' 66' ' ' TYR . 7.3 p90 -145.71 152.42 39.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.001 0.429 . . . . 0.0 110.652 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 87' ' ' GLU . 7.3 p -156.69 141.99 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.844 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.467 ' O ' ' CD1' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -108.2 118.6 37.18 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 122.705 1.24 . . . . 0.0 112.735 -178.724 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.546 ' HA ' HD22 ' A' ' 85' ' ' LEU . 1.8 t-80 -100.43 119.23 38.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.977 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -102.39 126.65 49.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.046 0.451 . . . . 0.0 111.576 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.2 mt -84.69 137.2 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -99.44 -55.98 2.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.8 m -165.26 141.87 5.63 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 48' ' ' GLY . 59.7 mt -126.6 131.07 71.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.939 176.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 79' ' ' TYR . 43.1 m-20 -115.06 88.48 2.88 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.489 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 6.7 mt-10 -54.45 -30.37 52.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.92 -39.02 76.97 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.561 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -107.95 -10.42 15.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.213 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.5 m-85 63.17 47.15 4.25 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 121.537 -0.727 . . . . 0.0 109.886 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 p -105.86 142.72 35.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.749 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.452 ' OH ' ' CE1' ' A' ' 69' ' ' HIS . 17.3 t80 -132.67 120.73 22.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.814 0.34 . . . . 0.0 110.641 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 p -127.07 129.62 48.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.341 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.679 ' CE2' ' CD1' ' A' ' 100' ' ' TYR . 34.5 p90 -144.97 164.59 30.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.033 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.6 m -146.09 125.6 13.23 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.115 0.483 . . . . 0.0 111.069 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.546 HD22 ' HA ' ' A' ' 69' ' ' HIS . 0.2 OUTLIER -80.17 121.67 25.86 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.582 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.738 HD13 ' H ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -83.72 -43.51 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -175.618 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.738 ' H ' HD13 ' A' ' 86' ' ' ILE . 6.0 tt0 -162.69 178.62 8.34 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.28 -0.888 . . . . 0.0 110.481 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.604 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.87 178.71 18.34 Favored Glycine 0 CA--C 1.504 -0.646 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.48 2.63 0.16 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.804 ' C ' HD23 ' A' ' 91' ' ' LEU . . . -71.96 -38.03 69.82 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 123.572 0.749 . . . . 0.0 110.94 178.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.858 HD23 ' N ' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -111.37 17.46 20.14 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 93' ' ' ASP . 6.9 p 57.11 -133.94 1.27 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.433 ' N ' ' OG1' ' A' ' 92' ' ' THR . 52.3 t0 -130.66 0.39 4.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.8 p -104.91 -8.41 18.66 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.382 -0.824 . . . . 0.0 113.124 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.688 HG21 HD13 ' A' ' 98' ' ' ILE . 4.6 mt -100.12 151.39 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.47 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -86.56 -50.75 6.61 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.285 176.107 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HA ' ' CD1' ' A' ' 91' ' ' LEU . 13.0 ptpt -171.72 148.98 2.49 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.688 HD13 HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.97 129.02 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.465 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.584 ' C ' ' HD1' ' A' ' 118' ' ' HIS . 0.3 OUTLIER -119.69 145.3 46.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.847 -179.302 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.679 ' CD1' ' CE2' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -142.89 135.66 27.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.733 0.301 . . . . 0.0 110.497 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -130.62 132.46 45.49 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.2 OUTLIER -131.73 133.83 45.23 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.09 -0.381 . . . . 0.0 110.511 -178.828 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -119.9 133.17 55.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -97.98 132.33 43.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -178.201 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.36 137.18 52.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.105 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.94 134.68 44.84 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.411 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.541 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 43.1 t -121.32 171.16 8.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.79 0.329 . . . . 0.0 110.253 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.541 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.51 -34.68 49.74 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 112.08 -0.408 . . . . 0.0 112.08 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.5 p -89.83 -13.38 36.67 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 118.765 -2.609 . . . . 0.0 114.116 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.64 -80.76 0.12 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.411 1.481 . . . . 0.0 112.401 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 83.3 p -161.51 131.54 4.88 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 126.577 1.951 . . . . 0.0 111.178 176.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.1 m -99.9 118.74 36.97 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 36.5 mt -92.34 127.49 44.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.121 -178.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -105.26 116.33 31.77 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.551 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.769 ' C ' HD13 ' A' ' 116' ' ' ILE . 69.2 p -111.93 123.97 51.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.199 0.523 . . . . 0.0 111.302 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.949 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -105.44 136.05 41.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -178.32 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.7 m -114.49 135.19 54.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.05 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.584 ' HD1' ' C ' ' A' ' 99' ' ' SER . 0.4 OUTLIER -137.24 109.17 7.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 110.433 -179.315 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.828 ' C ' HG23 ' A' ' 2' ' ' VAL . 5.4 m-85 -102.46 104.1 14.53 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -90.39 109.62 20.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.017 0.436 . . . . 0.0 109.852 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.2 p -93.93 169.9 9.95 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.952 0.882 . . . . 0.0 111.657 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -113.31 157.47 21.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.055 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 40.7 -109.73 0.16 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -116.19 7.51 14.13 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 122.703 -0.292 . . . . 0.0 111.396 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -48.35 161.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.311 0.577 . . . . 0.0 110.761 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.49 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 9.2 pt-20 -148.67 149.59 31.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.228 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.594 HD12 HD11 ' A' ' 95' ' ' ILE . 2.7 mm -87.69 124.5 40.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -75.92 160.09 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.561 0.696 . . . . 0.0 111.665 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -70.47 -47.34 61.09 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.446 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.542 ' O ' HG22 ' A' ' 134' ' ' VAL . 49.5 mt-10 -59.96 -24.52 64.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.6 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.59 ' C ' ' HD1' ' A' ' 131' ' ' HIS . 2.1 t-80 -72.08 -53.91 11.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.365 0.602 . . . . 0.0 110.718 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 m -77.32 -28.11 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.167 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -67.03 -46.53 74.16 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.224 -0.298 . . . . 0.0 111.069 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 130' ' ' GLU . 28.0 m -70.55 -44.18 77.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.678 0.275 . . . . 0.0 110.491 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.507 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -67.97 -41.49 87.53 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -67.13 -51.02 59.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.804 0.302 . . . . 0.0 111.02 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -56.63 -48.27 77.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 110.325 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -63.03 -51.38 66.97 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.61 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.71 -54.74 17.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.597 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -47.43 -38.67 13.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.342 0.591 . . . . 0.0 109.635 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.12 -31.5 80.93 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.667 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.8 OUTLIER -74.99 -38.53 61.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.67 0.748 . . . . 0.0 109.993 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -58.07 -28.32 64.46 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -75.75 -34.46 60.29 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.733 -1.122 . . . . 0.0 109.972 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.827 ' CG ' ' HB2' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -57.39 -61.42 2.5 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 122.191 0.996 . . . . 0.0 112.043 -179.615 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.894 HG23 HD12 ' A' ' 29' ' ' LEU . 26.7 mt -69.11 -48.46 69.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.403 -177.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -47.16 -42.71 20.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.1 t -59.91 -43.14 95.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.218 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.654 ' O ' ' N ' ' A' ' 153' ' ' HIS . 19.5 t80 -58.39 -45.05 89.08 Favored 'General case' 0 C--O 1.185 -2.341 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.923 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.4 mm? -68.06 -43.67 78.1 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 119.993 1.269 . . . . 0.0 111.653 -178.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.408 ' HG2' ' H ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -65.18 -24.45 67.38 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.881 179.509 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -106.92 -13.08 15.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.039 0.923 . . . . 0.0 110.948 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.654 ' N ' ' O ' ' A' ' 149' ' ' TYR . 68.3 m-70 -155.8 66.68 4.61 Favored Pre-proline 0 C--N 1.302 -1.49 0 C-N-CA 125.403 1.481 . . . . 0.0 110.193 -177.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.35 -2.8 7.73 Favored 'Trans proline' 0 N--CA 1.481 0.736 0 C-N-CA 122.571 2.181 . . . . 0.0 111.108 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.849 ' CA ' HD22 ' A' ' 158' ' ' ASN . 3.2 p30 -71.37 4.63 2.79 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.078 0.951 . . . . 0.0 113.077 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.94 129.71 43.16 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.584 -1.322 . . . . 0.0 113.042 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.685 ' CG ' HD23 ' A' ' 24' ' ' LEU . 81.7 t80 53.23 4.51 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 177.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.849 HD22 ' CA ' ' A' ' 155' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.559 0 O-C-N 120.506 -1.371 . . . . 0.0 110.381 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.912 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.017 HG21 ' CD2' ' A' ' 118' ' ' HIS . 7.7 p -134.81 149.04 29.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 O-C-N 122.314 -0.521 . . . . 0.0 110.618 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -96.4 109.73 22.21 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.2 m -97.27 133.37 41.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.07 0.462 . . . . 0.0 110.62 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -132.26 132.14 42.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.739 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -102.25 126.42 49.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.196 0.522 . . . . 0.0 110.613 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -131.26 161.17 32.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.771 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -155.27 153.12 30.12 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -142.92 141.15 31.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.28 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.73 147.32 22.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.742 0.306 . . . . 0.0 110.913 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -143.17 154.21 43.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 0.0 110.436 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -95.24 27.46 3.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.037 0.446 . . . . 0.0 110.4 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.53 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.5 mt -118.19 125.23 28.04 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.648 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.67 151.2 3.55 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.672 1.581 . . . . 0.0 111.471 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.582 ' CG ' ' HB2' ' A' ' 106' ' ' ALA . 21.8 Cg_exo -61.16 -24.24 78.78 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 C-N-CA 122.299 1.999 . . . . 0.0 112.483 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.446 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 68.8 m -70.64 -32.47 69.78 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.2 mmt-85 -76.24 -59.74 2.63 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.53 HD21 ' HB ' ' A' ' 13' ' ' ILE . 2.3 mt -48.36 -48.87 36.24 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.646 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.811 ' O ' HG22 ' A' ' 23' ' ' VAL . 16.4 t80 -44.75 -60.17 2.15 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.121 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.63 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -71.13 -26.32 62.96 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.142 -0.974 . . . . 0.0 110.917 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.945 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -77.07 -16.02 59.38 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.829 -177.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.505 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -117.6 -6.27 11.14 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.24 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.882 HG23 ' CD1' ' A' ' 24' ' ' LEU . 2.5 m -125.24 -35.99 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 118.5 0.591 . . . . 0.0 112.189 177.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.882 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.9 mp -92.28 -51.46 5.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.686 0.676 . . . . 0.0 111.412 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -106.93 -2.6 21.08 Favored 'General case' 0 C--O 1.206 -1.213 0 CA-C-O 119.22 -0.419 . . . . 0.0 111.496 -176.274 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.505 ' HB2' ' HA ' ' A' ' 22' ' ' PHE . . . -45.08 -34.08 2.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.978 0.894 . . . . 0.0 111.473 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -84.69 12.77 6.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.327 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 25' ' ' ASP . 95.8 m-20 -140.5 -10.85 1.06 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 125.38 1.472 . . . . 0.0 108.269 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.854 HD12 HG23 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -98.59 -48.42 4.99 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 125.499 1.52 . . . . 0.0 109.055 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.748 HG13 HD11 ' A' ' 146' ' ' ILE . 69.0 mt -56.24 -56.24 33.48 Favored Pre-proline 0 C--O 1.215 -0.726 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 32.4 Cg_endo -63.24 -26.92 72.12 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 122.534 2.156 . . . . 0.0 114.342 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -68.76 -49.7 56.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.834 0.826 . . . . 0.0 111.725 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.8 OUTLIER -95.08 -34.96 5.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.745 -177.232 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.815 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.75 64.1 0.15 Allowed Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -176.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.498 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 86.9 Cg_endo -77.09 -26.66 7.51 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 121.625 1.55 . . . . 0.0 108.188 174.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.469 ' OE1' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -74.97 -42.58 57.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.822 178.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.815 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -73.97 -77.19 0.12 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.584 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.559 HD13 ' CD2' ' A' ' 142' ' ' LEU . 1.1 mp -104.46 145.45 13.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-O 121.377 0.608 . . . . 0.0 109.978 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -78.38 -53.87 6.8 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.998 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -173.17 166.06 4.9 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.19 0.519 . . . . 0.0 110.569 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.53 144.95 6.49 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.136 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -150.76 145.28 25.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.213 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.602 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -77.12 139.81 18.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.574 0.702 . . . . 0.0 111.143 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -90.75 -38.74 12.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.126 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.844 ' O ' HG23 ' A' ' 52' ' ' THR . 26.9 mt-10 -145.57 136.09 24.18 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.335 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.31 -156.05 22.56 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -136.06 -6.04 2.11 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 122.345 -0.503 . . . . 0.0 111.047 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.46 ' O ' HD12 ' A' ' 74' ' ' ILE . . . 130.7 11.33 2.4 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.8 -171.42 19.58 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.577 ' HD3' ' H ' ' A' ' 74' ' ' ILE . 8.7 Cg_endo -60.06 126.5 20.43 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 122.596 2.197 . . . . 0.0 113.117 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.39 3.28 55.48 Favored Glycine 0 CA--C 1.506 -0.495 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.844 HG23 ' O ' ' A' ' 45' ' ' GLU . 45.7 m -94.02 140.74 29.34 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.14 -1.03 . . . . 0.0 111.008 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.584 HD12 ' C ' ' A' ' 52' ' ' THR . 1.8 mp -120.97 129.07 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.602 ' HG2' HG23 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -112.48 139.87 47.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.791 0.805 . . . . 0.0 111.11 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -117.89 121.15 39.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.489 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.2 mt -106.69 140.19 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.619 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.9 m -119.23 120.16 36.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.132 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -90.79 -173.41 3.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.38 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.06 143.29 29.92 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -60.64 -60.97 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.985 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.81 61.86 3.39 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.2 m -136.89 175.15 9.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.756 0.313 . . . . 0.0 110.563 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -62.19 -42.61 99.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.825 0.345 . . . . 0.0 110.559 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -91.53 136.12 33.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.547 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.59 -57.73 0.5 Allowed Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -145.8 155.2 42.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.973 0.416 . . . . 0.0 110.642 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 p -153.47 144.49 14.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.217 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.58 ' CB ' HD11 ' A' ' 86' ' ' ILE . 93.8 mttt -106.66 117.87 35.19 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.465 0.65 . . . . 0.0 112.211 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.478 ' CD2' ' C ' ' A' ' 69' ' ' HIS . 0.3 OUTLIER -109.34 118.87 37.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.74 178.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -102.28 130.78 49.08 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.051 0.453 . . . . 0.0 111.076 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.425 HD12 HG22 ' A' ' 52' ' ' THR . 36.4 mt -88.81 145.47 7.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.563 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -104.1 -56.42 2.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.3 m -166.43 142.56 4.75 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.577 ' H ' ' HD3' ' A' ' 50' ' ' PRO . 10.7 mt -124.0 131.74 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.858 176.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -116.21 88.26 2.85 Favored 'General case' 0 C--O 1.209 -1.039 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.432 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -54.14 -30.69 50.05 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.36 -39.8 70.51 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.229 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.0 m -108.45 -10.31 15.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.953 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.2 m-85 62.74 46.8 5.02 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.629 -0.669 . . . . 0.0 109.818 -178.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.3 p -105.73 148.26 27.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.207 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.626 ' CE2' ' CD2' ' A' ' 83' ' ' TYR . 41.8 t80 -140.31 120.33 13.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.694 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 p -127.45 130.33 49.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.812 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.626 ' CD2' ' CE2' ' A' ' 81' ' ' TYR . 11.4 p90 -144.73 170.62 15.75 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.1 m -146.06 136.38 23.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.387 0.613 . . . . 0.0 111.489 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.546 HD12 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -79.89 120.41 24.07 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.298 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.58 HD11 ' CB ' ' A' ' 68' ' ' LYS . 2.5 pt -90.24 -45.03 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.497 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 2.9 tp10 -151.17 172.08 16.37 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.861 0.362 . . . . 0.0 110.413 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.646 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.87 177.68 17.87 Favored Glycine 0 CA--C 1.509 -0.334 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.79 2.63 0.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.646 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -68.04 -35.0 77.53 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.689 1.196 . . . . 0.0 110.986 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.914 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.51 13.11 22.75 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.285 0.634 . . . . 0.0 109.538 -178.091 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.505 ' CG2' ' CE1' ' A' ' 131' ' ' HIS . 28.3 p 46.94 -127.04 1.6 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.414 ' N ' ' OG1' ' A' ' 92' ' ' THR . 29.2 t70 -130.34 -11.21 4.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.25 0.548 . . . . 0.0 110.996 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.11 -5.92 20.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.371 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.773 HG21 ' CD1' ' A' ' 98' ' ' ILE . 66.2 mt -97.91 151.48 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -176.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.509 ' OE1' ' CE1' ' A' ' 120' ' ' HIS . 0.8 OUTLIER -88.85 -60.92 1.83 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.395 177.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.437 ' CG ' ' O ' ' A' ' 96' ' ' GLU . 36.9 mtmt -164.89 158.07 16.86 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.44 0.638 . . . . 0.0 111.192 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.773 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -132.75 123.5 49.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.598 ' OG ' ' CE1' ' A' ' 118' ' ' HIS . 0.9 OUTLIER -112.48 144.4 42.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.213 0.53 . . . . 0.0 111.398 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -137.18 130.67 31.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.558 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.428 ' O ' HG12 ' A' ' 116' ' ' ILE . 20.5 mt-10 -129.28 134.3 47.88 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.14 131.68 28.74 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.972 -0.455 . . . . 0.0 110.186 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.58 ' C ' HD23 ' A' ' 104' ' ' LEU . 20.3 ttpp -124.17 134.48 53.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.76 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.66 131.06 45.14 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.004 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.29 136.89 57.64 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.904 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.582 ' HB2' ' CG ' ' A' ' 15' ' ' PRO . . . -72.92 134.22 44.68 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.261 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 19.6 t -121.13 169.99 9.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.882 0.372 . . . . 0.0 110.385 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.405 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.71 -30.22 42.99 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.7 p -90.33 -8.88 49.7 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 118.369 -2.842 . . . . 0.0 115.464 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 154.24 -93.25 0.14 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.443 1.973 . . . . 0.0 109.849 -171.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.1 m -159.16 129.21 5.7 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 126.691 1.996 . . . . 0.0 110.99 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.3 m -100.05 118.53 36.62 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.535 HD13 ' CE1' ' A' ' 143' ' ' PHE . 11.5 mt -92.17 131.2 39.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.56 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.85 116.62 32.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.703 ' C ' HD13 ' A' ' 116' ' ' ILE . 15.6 t -111.89 118.19 34.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.421 0.629 . . . . 0.0 111.443 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.96 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -97.82 135.53 32.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 123.399 0.68 . . . . 0.0 109.565 -178.518 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.8 m -118.78 131.8 56.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.57 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 1.017 ' CD2' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -136.41 115.11 12.04 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 122.702 1.239 . . . . 0.0 109.472 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.818 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.7 OUTLIER -102.91 103.69 13.85 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 120.368 -1.457 . . . . 0.0 109.588 179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.509 ' CE1' ' OE1' ' A' ' 96' ' ' GLU . 4.8 t-80 -89.68 104.68 17.22 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.506 0.669 . . . . 0.0 110.367 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.531 HG21 ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -91.45 164.41 13.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.327 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 125' ' ' ILE . 6.6 ptmm? -112.11 156.63 21.93 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 43.27 -124.45 4.52 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.39 -13.29 24.8 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.531 ' O ' HG21 ' A' ' 121' ' ' THR . 1.1 tp -48.81 162.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.717 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -152.71 148.59 27.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.908 0.385 . . . . 0.0 111.108 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.415 ' CD1' HG12 ' A' ' 95' ' ' ILE . 5.4 mm -89.14 124.95 42.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 31.5 tttp -76.27 161.16 28.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.439 0.638 . . . . 0.0 111.469 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.638 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 1.2 pm0 -69.97 -45.34 67.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.518 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.09 -25.31 65.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.406 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.505 ' CE1' ' CG2' ' A' ' 92' ' ' THR . 2.7 t-80 -72.7 -51.88 17.53 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.387 0.613 . . . . 0.0 110.886 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.8 m -74.44 -24.22 18.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.45 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -67.22 -46.51 73.6 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 122.382 -0.199 . . . . 0.0 110.932 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.438 HG23 ' N ' ' A' ' 135' ' ' GLY . 30.7 m -70.02 -43.96 78.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.735 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.438 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -67.57 -46.94 65.21 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -67.66 -45.51 75.06 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.683 -0.304 . . . . 0.0 110.853 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -53.81 -38.92 65.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.443 ' O ' ' CD2' ' A' ' 142' ' ' LEU . 15.9 tttt -68.74 -54.39 16.34 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.6 -43.25 46.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.746 0.784 . . . . 0.0 110.495 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -67.13 -36.51 82.04 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.33 -34.92 82.68 Favored Glycine 0 CA--C 1.519 0.313 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.559 ' CD2' HD13 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -71.47 -48.36 49.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.589 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.535 ' CE1' HD13 ' A' ' 113' ' ' ILE . 4.4 t80 -59.47 -25.74 64.66 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -68.76 -40.51 79.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.935 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.781 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -64.45 -56.2 15.75 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.08 0.943 . . . . 0.0 108.746 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.854 HG23 HD12 ' A' ' 29' ' ' LEU . 59.6 mt -54.85 -48.41 74.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.601 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 20.3 tt0 -46.08 -56.89 4.98 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.684 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.8 p -53.51 -42.35 67.25 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.525 0.679 . . . . 0.0 110.615 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.704 ' HB2' HD13 ' A' ' 33' ' ' ILE . 32.7 t80 -56.36 -48.73 76.22 Favored 'General case' 0 C--O 1.194 -1.839 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.945 HD11 ' HB2' ' A' ' 21' ' ' ALA . 1.9 mm? -65.65 -42.57 91.24 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 120.033 1.288 . . . . 0.0 112.02 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.451 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -62.24 -23.65 66.79 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.25 -13.6 15.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.625 ' N ' ' O ' ' A' ' 149' ' ' TYR . 23.3 m80 -156.32 67.49 4.52 Favored Pre-proline 0 C--N 1.309 -1.174 0 C-N-CA 125.062 1.345 . . . . 0.0 110.695 -178.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.497 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 56.0 Cg_endo -74.8 -3.28 13.66 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 122.495 2.13 . . . . 0.0 111.534 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.603 ' CA ' HD21 ' A' ' 158' ' ' ASN . 3.6 p30 -74.66 5.3 5.0 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.279 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.88 129.99 43.57 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.791 -1.193 . . . . 0.0 113.141 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.722 ' CD1' HD23 ' A' ' 24' ' ' LEU . 2.7 t80 54.51 6.06 0.1 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.603 HD21 ' CA ' ' A' ' 155' ' ' ASP . 1.5 p30 . . . . . 0 CA--C 1.514 -0.436 0 O-C-N 121.166 -0.959 . . . . 0.0 110.405 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.818 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.4 p -134.79 149.36 29.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 0.0 111.348 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -97.6 110.03 22.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.52 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.56 ' HG1' ' CE1' ' A' ' 118' ' ' HIS . 62.7 m -95.78 133.37 39.98 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.657 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -137.75 132.38 32.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.046 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -102.48 137.4 40.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 111.296 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.55 167.97 15.6 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -152.56 145.15 24.18 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -154.23 134.76 13.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.458 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.06 146.71 23.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.934 0.397 . . . . 0.0 111.451 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -136.32 154.14 50.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.247 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -98.49 21.84 10.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.173 0.511 . . . . 0.0 110.365 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.693 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.3 mt -116.23 126.35 27.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.494 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -44.88 146.99 2.1 Favored 'Trans proline' 0 C--N 1.327 -0.603 0 C-N-CA 121.805 1.67 . . . . 0.0 111.776 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -57.19 -26.62 70.59 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 122.256 1.97 . . . . 0.0 113.149 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 67.9 m -70.7 -32.15 69.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -75.03 -57.71 3.73 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.693 HD21 ' HB ' ' A' ' 13' ' ' ILE . 1.5 mt -53.28 -35.84 60.53 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.801 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.867 ' O ' HG22 ' A' ' 23' ' ' VAL . 14.8 t80 -54.46 -56.05 22.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.641 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.76 ' HB2' HD11 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -70.73 -43.2 69.39 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.295 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.775 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -63.67 -3.2 2.1 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.386 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.512 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 19.3 t80 -119.66 -8.54 9.92 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 19' ' ' PHE . 15.1 m -129.7 -52.33 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.011 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.7 pp -96.85 -31.52 12.56 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 1.011 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -114.25 -5.38 12.99 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 118.858 0.754 . . . . 0.0 111.364 -178.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -67.7 -43.85 79.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.105 0.479 . . . . 0.0 111.861 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.502 ' HA ' HD11 ' A' ' 30' ' ' ILE . 1.2 m-20 -83.01 12.21 5.27 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 122.101 0.953 . . . . 0.0 110.265 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -129.79 -9.42 4.46 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.523 ' CD1' HG23 ' A' ' 146' ' ' ILE . 4.1 mt -93.94 -30.74 14.6 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.211 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.547 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.08 -53.42 58.77 Favored Pre-proline 0 C--O 1.215 -0.732 0 O-C-N 122.025 -0.422 . . . . 0.0 110.613 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 27.2 Cg_endo -63.89 -25.72 67.26 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 122.006 1.804 . . . . 0.0 112.538 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.84 -59.61 2.66 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.662 0.744 . . . . 0.0 112.194 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.8 HD12 ' HB3' ' A' ' 145' ' ' LEU . 1.3 pt -94.46 -36.14 6.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.909 -176.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.867 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.87 65.23 0.16 Allowed Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 71.8 Cg_endo -75.94 -26.91 9.0 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 C-N-CA 121.591 1.527 . . . . 0.0 108.367 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -74.1 -43.36 57.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.55 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.867 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -72.27 -71.94 0.26 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.896 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.526 HD13 HD22 ' A' ' 142' ' ' LEU . 1.4 mp -99.18 144.85 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-O 121.254 0.549 . . . . 0.0 110.669 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -79.44 -50.34 10.95 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.079 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.658 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 52.8 tp60 -174.33 164.66 3.93 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.829 0.347 . . . . 0.0 110.758 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.658 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -166.13 144.74 5.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.076 0.465 . . . . 0.0 110.846 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -150.7 148.18 28.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.143 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.578 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -83.25 139.58 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.524 0.678 . . . . 0.0 110.729 -179.183 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.1 -39.36 12.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.024 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.92 ' O ' HG23 ' A' ' 52' ' ' THR . 16.2 mt-10 -141.28 134.48 29.42 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.756 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.83 -156.6 31.55 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -141.24 -5.15 1.11 Allowed 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.406 -0.467 . . . . 0.0 111.404 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.435 ' O ' HD12 ' A' ' 74' ' ' ILE . . . 141.46 11.94 0.53 Allowed Glycine 0 C--O 1.218 -0.853 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.77 -171.71 19.66 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-N 117.233 0.516 . . . . 0.0 112.066 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -62.05 126.87 19.73 Favored 'Trans proline' 0 C--N 1.321 -0.892 0 C-N-CA 123.168 2.579 . . . . 0.0 113.343 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.72 6.12 57.36 Favored Glycine 0 N--CA 1.462 0.422 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.92 HG23 ' O ' ' A' ' 45' ' ' GLU . 73.1 m -93.6 139.31 30.92 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.176 -1.012 . . . . 0.0 111.191 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.28 132.1 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.578 ' HG2' HG23 ' A' ' 43' ' ' ILE . 1.9 mmtp -111.17 139.53 46.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.463 0.649 . . . . 0.0 111.258 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -118.2 113.42 21.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.147 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mt -106.28 138.27 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.662 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.7 m -119.21 118.11 30.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.267 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -93.0 -173.23 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.306 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.08 143.54 48.69 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -60.84 -48.39 82.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.806 0.336 . . . . 0.0 110.978 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.06 61.97 3.29 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.0 m -142.91 175.33 9.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.021 0.438 . . . . 0.0 110.626 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -61.84 -45.52 93.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.66 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.32 138.74 39.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.371 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.14 -52.92 0.59 Allowed Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -142.7 151.73 41.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 110.253 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.85 146.5 11.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.968 0.413 . . . . 0.0 110.672 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.602 ' HB3' HD11 ' A' ' 86' ' ' ILE . 25.0 mttp -105.58 109.51 21.51 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.35 0.595 . . . . 0.0 111.557 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.601 ' HE2' ' CB ' ' A' ' 83' ' ' TYR . 6.8 t60 -98.81 111.68 23.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.329 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.1 ttt-85 -101.56 131.19 47.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.233 0.54 . . . . 0.0 112.126 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.5 mt -82.31 136.68 22.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.461 -0.79 . . . . 0.0 108.96 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -96.97 -56.05 2.68 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.7 m -165.67 141.38 5.09 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.435 HD12 ' O ' ' A' ' 48' ' ' GLY . 40.6 mt -124.96 129.62 73.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 79' ' ' TYR . 23.2 m-20 -115.45 88.33 2.86 Favored 'General case' 0 C--O 1.202 -1.401 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.638 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.0 OUTLIER -54.31 -36.17 63.45 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.51 -36.1 43.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 m -107.65 -10.87 15.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.828 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.596 ' N ' ' O ' ' A' ' 75' ' ' ASP . 48.2 m-85 56.68 42.53 26.8 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 121.522 -0.736 . . . . 0.0 110.818 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.26 149.2 28.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.909 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 82' ' ' SER . 3.6 t80 -134.8 126.38 28.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.92 0.391 . . . . 0.0 111.186 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.451 ' N ' ' CD1' ' A' ' 81' ' ' TYR . 85.8 p -126.88 136.49 52.39 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.462 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.601 ' CB ' ' HE2' ' A' ' 69' ' ' HIS . 34.3 p90 -144.88 165.63 27.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.561 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -147.08 134.14 20.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.082 0.468 . . . . 0.0 110.667 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.604 HD13 ' HB1' ' A' ' 90' ' ' ALA . 5.6 mt -80.4 117.59 21.28 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' A' ' 68' ' ' LYS . 5.1 pt -82.42 -44.69 19.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.718 0.294 . . . . 0.0 111.213 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.625 ' CD ' ' H ' ' A' ' 88' ' ' GLY . 0.6 OUTLIER -149.14 171.81 15.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.625 ' H ' ' CD ' ' A' ' 87' ' ' GLU . . . 116.22 177.96 18.19 Favored Glycine 0 CA--C 1.509 -0.319 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.94 2.26 0.23 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.621 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -67.39 -35.08 78.6 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 124.314 1.046 . . . . 0.0 110.468 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.885 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -111.11 6.03 20.53 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 123.358 0.663 . . . . 0.0 110.273 -177.587 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.421 ' CG2' ' NE2' ' A' ' 131' ' ' HIS . 61.7 p 49.61 -126.15 2.14 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 18.8 p-10 -131.74 -10.3 3.51 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.827 -0.546 . . . . 0.0 110.911 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.73 -7.6 19.42 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.679 HG21 ' CD1' ' A' ' 98' ' ' ILE . 68.4 mt -99.71 152.81 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -176.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.506 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -87.43 -59.17 2.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.751 177.184 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HA ' HD12 ' A' ' 91' ' ' LEU . 6.0 ptpt -171.95 154.25 3.45 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.199 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.679 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.65 124.88 73.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.87 144.84 32.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.137 0.494 . . . . 0.0 111.436 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 116' ' ' ILE . 0.4 OUTLIER -140.06 138.94 35.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 179.382 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -128.37 135.15 49.17 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 120.983 0.42 . . . . 0.0 110.737 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 p -133.86 131.24 38.94 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -120.32 135.39 55.03 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.4 mm? -96.46 124.66 40.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.255 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.61 136.62 43.58 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.192 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -73.16 139.57 46.44 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.85 -0.531 . . . . 0.0 110.142 177.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.467 ' N ' ' HA ' ' A' ' 111' ' ' SER . 13.6 t -121.36 170.97 9.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.714 0.292 . . . . 0.0 110.388 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.71 -34.6 50.73 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.5 p -94.76 -6.43 43.05 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 118.809 -2.583 . . . . 0.0 113.595 177.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 160.23 -78.62 0.17 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.082 1.801 . . . . 0.0 112.067 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 29.2 t -162.76 130.21 3.7 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.973 1.309 . . . . 0.0 111.599 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.7 m -99.97 134.9 42.2 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.105 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 mt -110.57 130.34 64.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.504 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.71 116.81 32.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.814 ' C ' HD13 ' A' ' 116' ' ' ILE . 70.1 m -110.75 124.73 52.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.204 0.526 . . . . 0.0 110.865 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.874 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -106.29 135.76 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 C-N-CA 123.033 0.533 . . . . 0.0 109.825 -178.016 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.2 m -109.07 134.39 51.75 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.56 ' CE1' ' HG1' ' A' ' 4' ' ' THR . 41.9 m-70 -135.39 95.31 3.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.209 0.528 . . . . 0.0 111.049 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.818 ' C ' HG23 ' A' ' 2' ' ' VAL . 6.4 m-30 -84.56 101.39 12.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.874 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -92.87 98.64 11.51 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.7 p -101.3 174.35 6.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.91 0.862 . . . . 0.0 112.218 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.71 144.5 42.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.334 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.6 -110.0 1.1 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 36.8 p30 -115.9 1.55 13.37 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.449 -0.442 . . . . 0.0 111.607 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.6 mp -45.48 161.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.177 0.513 . . . . 0.0 110.434 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.494 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 30.2 tt0 -155.42 148.66 24.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.48 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.3 mm -88.01 125.36 41.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -73.87 161.94 29.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.358 0.599 . . . . 0.0 111.541 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -69.01 -48.54 62.76 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.071 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.599 ' O ' HG12 ' A' ' 134' ' ' VAL . 6.5 tt0 -58.23 -26.11 62.47 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.985 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.421 ' NE2' ' CG2' ' A' ' 92' ' ' THR . 4.2 t60 -72.92 -49.56 28.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.476 0.655 . . . . 0.0 111.236 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.438 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.1 m -81.08 -27.17 10.76 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -66.62 -46.18 76.69 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.983 -0.448 . . . . 0.0 110.496 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.676 HG13 ' N ' ' A' ' 135' ' ' GLY . 7.7 p -69.01 -50.89 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 CA-C-O 121.443 0.64 . . . . 0.0 110.515 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.676 ' N ' HG13 ' A' ' 134' ' ' VAL . . . -62.81 -42.29 99.71 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 5.9 ttpm? -67.04 -45.68 76.7 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 122.72 -0.283 . . . . 0.0 110.788 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -53.69 -43.34 68.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -66.16 -53.6 35.6 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.416 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.32 -40.22 34.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.672 0.749 . . . . 0.0 110.726 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.91 -36.24 82.73 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.41 -43.79 98.33 Favored Glycine 0 C--O 1.227 -0.328 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -62.94 -43.01 99.95 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.505 ' CE1' ' CE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -59.44 -25.81 64.67 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.05 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -72.1 -42.7 65.82 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.272 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.8 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -62.44 -56.66 16.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.605 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.689 ' O ' HD22 ' A' ' 150' ' ' LEU . 50.6 mt -59.62 -50.71 78.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.23 -177.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 8.9 tt0 -46.87 -56.74 5.8 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.136 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 62.0 m -51.08 -48.15 61.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.191 0.52 . . . . 0.0 111.551 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.549 ' O ' ' N ' ' A' ' 153' ' ' HIS . 0.2 OUTLIER -55.93 -49.43 73.51 Favored 'General case' 0 C--O 1.209 -1.033 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.843 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.9 mm? -62.53 -43.85 97.79 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 119.792 1.178 . . . . 0.0 111.77 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 147' ' ' GLU . 0.2 OUTLIER -59.14 -25.4 63.85 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.189 -0.945 . . . . 0.0 108.757 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.453 ' O ' ' ND1' ' A' ' 153' ' ' HIS . 49.2 t0 -99.27 -14.38 19.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.731 0.776 . . . . 0.0 109.91 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.549 ' N ' ' O ' ' A' ' 149' ' ' TYR . 68.3 m80 -154.11 68.16 5.94 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 124.261 1.024 . . . . 0.0 110.494 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.471 ' N ' ' O ' ' A' ' 150' ' ' LEU . 31.4 Cg_endo -68.34 -3.18 10.4 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.991 1.794 . . . . 0.0 110.637 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 14.4 m-20 -87.03 4.69 40.94 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.074 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.42 131.02 20.6 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.028 -1.67 . . . . 0.0 111.256 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.666 ' CG ' HD13 ' A' ' 24' ' ' LEU . 6.3 t80 55.83 7.19 0.25 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 3.9 p-10 . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.352 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.846 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.2 p -134.8 148.47 29.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 O-C-N 122.517 -0.402 . . . . 0.0 110.972 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.45 109.36 22.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.704 177.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.2 m -97.92 140.65 31.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.877 0.37 . . . . 0.0 111.071 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -145.14 137.57 25.99 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.332 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.55 ' HG2' HD12 ' A' ' 116' ' ' ILE . 15.6 mt-10 -102.29 139.24 38.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.197 0.523 . . . . 0.0 110.76 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.48 168.19 14.57 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.84 139.34 15.89 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -145.62 134.0 21.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.378 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.1 147.87 22.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.929 0.395 . . . . 0.0 111.254 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 p -144.39 154.26 42.8 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.51 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -94.37 27.61 2.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.889 0.376 . . . . 0.0 110.305 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.651 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.3 mt -117.56 125.66 27.93 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.721 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.97 148.47 13.0 Favored 'Trans proline' 0 C--N 1.327 -0.581 0 C-N-CA 121.801 1.667 . . . . 0.0 111.409 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.418 ' HA ' HD12 ' A' ' 18' ' ' LEU . 23.3 Cg_exo -59.04 -24.98 76.05 Favored 'Trans proline' 0 N--CA 1.482 0.836 0 C-N-CA 122.011 1.808 . . . . 0.0 112.116 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.434 ' C ' ' HZ2' ' A' ' 20' ' ' LYS . 66.3 m -65.72 -35.68 81.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.392 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.485 ' HA ' ' HZ2' ' A' ' 20' ' ' LYS . 8.0 mmt180 -77.99 -57.68 3.67 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.651 HD21 ' HB ' ' A' ' 13' ' ' ILE . 5.1 mt -48.14 -48.25 34.31 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.909 -1.042 . . . . 0.0 108.599 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.753 ' O ' HG22 ' A' ' 23' ' ' VAL . 70.1 t80 -48.85 -56.49 8.59 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.307 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.665 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -70.21 -23.92 63.02 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.698 -179.775 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.71 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -82.48 -2.84 54.57 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.976 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.473 ' CE2' ' OH ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -119.08 -9.56 9.98 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.853 HG23 HD13 ' A' ' 24' ' ' LEU . 3.0 m -136.1 -36.57 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.853 HD13 HG23 ' A' ' 23' ' ' VAL . 3.2 mp -91.17 -53.05 4.52 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.152 0.887 . . . . 0.0 112.153 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -112.2 -4.68 14.32 Favored 'General case' 0 C--O 1.214 -0.771 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.039 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.695 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -53.16 -41.73 65.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.2 0.524 . . . . 0.0 111.715 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -83.39 17.49 2.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.629 0.728 . . . . 0.0 110.794 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.413 ' H ' ' H ' ' A' ' 29' ' ' LEU . 15.8 m120 -139.97 -8.89 1.19 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.505 HD21 ' CD1' ' A' ' 149' ' ' TYR . 0.6 OUTLIER -91.34 -33.51 15.27 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.438 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.543 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.74 -53.17 63.62 Favored Pre-proline 0 C--O 1.216 -0.678 0 O-C-N 122.083 -0.385 . . . . 0.0 111.127 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 20.0 Cg_endo -62.56 -24.67 75.28 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 121.876 1.718 . . . . 0.0 112.323 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -70.28 -59.83 2.64 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.73 0.776 . . . . 0.0 112.016 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 145' ' ' LEU . 1.3 pt -95.29 -35.72 6.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.282 -176.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.902 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.54 64.53 0.14 Allowed Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.491 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 72.6 Cg_endo -76.88 -28.4 6.24 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 121.647 1.565 . . . . 0.0 108.175 174.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.408 ' CG ' ' N ' ' A' ' 37' ' ' ALA . 12.1 pt20 -74.14 -43.17 58.43 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.572 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.902 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -72.81 -76.54 0.12 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.947 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 38' ' ' ILE . 9.4 mm -99.51 145.08 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 121.092 0.472 . . . . 0.0 110.422 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -77.7 -49.86 13.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.673 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -176.98 166.61 2.46 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.111 0.482 . . . . 0.0 110.543 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.99 143.13 5.35 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.592 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -151.33 153.34 34.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.782 0.325 . . . . 0.0 110.595 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.06 138.52 18.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.597 0.713 . . . . 0.0 111.341 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.5 mp -88.9 -39.07 14.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.905 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.874 ' O ' HG23 ' A' ' 52' ' ' THR . 26.4 mt-10 -144.32 136.89 26.75 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.364 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.47 -156.21 22.55 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -135.26 -11.34 2.18 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.09 0.472 . . . . 0.0 110.608 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 136.65 11.08 1.15 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.29 -171.86 19.34 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -59.07 127.01 22.67 Favored 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 122.595 2.196 . . . . 0.0 113.213 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.67 2.14 52.87 Favored Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.874 HG23 ' O ' ' A' ' 45' ' ' GLU . 51.8 m -94.42 140.49 29.75 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.146 -1.027 . . . . 0.0 111.753 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -121.51 129.74 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.407 ' NZ ' ' HB3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -114.73 140.44 48.87 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.021 0.438 . . . . 0.0 110.879 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -118.77 123.11 44.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.02 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.2 mt -104.9 140.64 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.86 0.362 . . . . 0.0 110.605 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.8 m -116.52 118.82 33.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.152 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -91.39 -176.44 4.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.316 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.33 142.68 32.11 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.468 ' CD ' ' N ' ' A' ' 61' ' ' GLY . 2.5 pp20? -61.15 -45.22 95.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.817 0.342 . . . . 0.0 111.23 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.468 ' N ' ' CD ' ' A' ' 60' ' ' GLU . . . -91.37 61.53 2.86 Favored Glycine 0 C--N 1.328 0.135 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.8 m -141.96 174.11 10.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.964 0.411 . . . . 0.0 110.816 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -68.16 -39.12 82.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.931 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.55 142.96 27.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.439 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.1 -62.06 0.53 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -146.07 145.29 30.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.952 0.406 . . . . 0.0 110.429 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.74 140.09 41.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.647 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.493 ' HB2' HD11 ' A' ' 86' ' ' ILE . 61.3 mttm -106.53 114.56 28.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.346 0.594 . . . . 0.0 112.413 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.553 ' CE1' ' CD2' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -92.89 123.89 36.48 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.29 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -100.89 112.4 24.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.012 0.434 . . . . 0.0 111.485 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.4 mt -74.17 135.42 27.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -98.3 -55.67 2.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.5 m -165.97 142.38 5.14 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.6 mt -116.16 131.44 68.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.682 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 79' ' ' TYR . 9.4 t0 -113.97 87.45 2.62 Favored 'General case' 0 C--O 1.207 -1.148 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.513 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 7.2 pt-20 -54.87 -30.1 57.04 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.32 -40.0 70.64 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 m -108.63 -10.68 15.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.901 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.565 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.6 m-85 62.54 42.14 8.94 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.511 -0.743 . . . . 0.0 110.142 -178.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.2 t -116.87 139.8 50.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.233 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.473 ' OH ' ' CE2' ' A' ' 22' ' ' PHE . 41.1 p90 -132.26 132.78 43.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.088 0.47 . . . . 0.0 110.392 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 m -127.09 137.65 53.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.383 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -144.05 166.37 25.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.891 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.591 HG23 ' O ' ' A' ' 98' ' ' ILE . 5.5 m -144.89 142.95 30.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.09 0.471 . . . . 0.0 110.828 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.634 HD13 ' HB1' ' A' ' 90' ' ' ALA . 7.9 mt -79.97 115.36 19.5 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.493 HD11 ' HB2' ' A' ' 68' ' ' LYS . 2.9 pt -77.49 -44.8 29.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.783 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.434 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -153.47 172.53 16.98 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.603 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.57 177.52 18.02 Favored Glycine 0 CA--C 1.51 -0.221 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -61.7 0.37 0.35 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 122.529 1.157 . . . . 0.0 108.395 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.634 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -62.17 -34.51 76.56 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 124.123 0.969 . . . . 0.0 110.236 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.867 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.37 12.84 23.01 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 123.464 0.705 . . . . 0.0 109.935 -177.37 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.1 p 47.36 -126.31 1.68 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -130.72 -12.64 3.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.019 0.438 . . . . 0.0 111.452 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.23 -6.14 20.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.743 HG21 ' CD1' ' A' ' 98' ' ' ILE . 95.2 mt -98.08 152.17 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 122.159 0.981 . . . . 0.0 113.297 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.508 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -93.44 -52.51 4.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.468 177.649 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.53 149.02 2.06 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-O 121.178 0.513 . . . . 0.0 111.32 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.743 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.87 126.68 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.614 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.591 ' C ' ' HD1' ' A' ' 118' ' ' HIS . 0.1 OUTLIER -109.63 143.89 38.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.803 0.335 . . . . 0.0 111.621 -178.105 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -137.35 127.94 26.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.689 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -129.8 132.49 46.53 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -139.82 133.82 30.89 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.086 -0.384 . . . . 0.0 110.469 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.624 ' C ' HD23 ' A' ' 104' ' ' LEU . 55.0 tttt -122.25 134.41 54.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.908 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.789 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -97.74 127.32 43.6 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.192 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -128.51 136.63 59.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.119 -178.848 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -73.14 133.29 44.04 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.752 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -121.88 174.04 7.12 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.69 -34.18 55.95 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.871 -0.492 . . . . 0.0 111.871 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.1 m -76.78 -26.81 54.91 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.841 1.256 . . . . 0.0 114.182 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 159.67 -78.88 0.17 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.522 1.534 . . . . 0.0 111.876 -169.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 83.7 p -166.07 131.72 2.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.594 1.558 . . . . 0.0 111.079 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 105' ' ' VAL . 14.8 m -99.29 118.74 36.63 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 54.4 mt -92.14 126.52 44.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.635 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -105.68 117.38 33.88 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.763 ' C ' HD13 ' A' ' 116' ' ' ILE . 3.2 m -112.35 123.75 50.96 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.329 0.585 . . . . 0.0 111.313 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.937 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -103.53 137.16 33.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 123.591 0.756 . . . . 0.0 109.654 -178.031 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.95 132.09 55.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.715 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.591 ' HD1' ' C ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -138.38 112.32 8.45 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.846 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -101.83 108.38 19.84 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.223 -0.298 . . . . 0.0 110.803 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.506 ' CE1' ' OE2' ' A' ' 96' ' ' GLU . 13.8 t-160 -89.59 105.8 18.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.16 0.505 . . . . 0.0 109.679 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.9 p -100.22 178.01 4.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.841 0.829 . . . . 0.0 111.915 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 123' ' ' GLY . 3.8 mtpt -112.54 157.49 21.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.794 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . 35.16 -108.71 0.05 OUTLIER Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -114.04 7.04 16.67 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.588 -0.36 . . . . 0.0 111.144 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.493 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.6 mp -45.42 160.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.221 0.534 . . . . 0.0 110.594 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.493 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 22.0 mt-10 -152.11 149.6 28.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.257 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 mm -88.21 125.01 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.433 ' HG3' ' N ' ' A' ' 129' ' ' GLU . 15.8 tptm -73.85 161.96 29.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.202 0.525 . . . . 0.0 111.208 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' A' ' 128' ' ' LYS . 59.9 mt-10 -68.68 -44.41 74.08 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.112 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.523 ' O ' HG22 ' A' ' 134' ' ' VAL . 37.5 mt-10 -61.57 -26.18 67.79 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.67 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -73.04 -49.32 29.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.106 0.479 . . . . 0.0 111.321 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.411 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.0 m -79.5 -29.72 13.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.176 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.4 tptt -66.92 -45.83 76.69 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.916 -0.49 . . . . 0.0 110.605 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.552 HG23 ' N ' ' A' ' 135' ' ' GLY . 24.2 m -70.45 -45.98 72.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.557 0.218 . . . . 0.0 110.567 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.552 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -66.58 -46.66 74.67 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 29.3 ttpt -67.05 -46.15 75.26 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.676 -0.308 . . . . 0.0 110.653 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -54.49 -46.28 73.4 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -67.8 -52.29 38.76 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.437 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.54 -41.5 41.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.694 0.759 . . . . 0.0 110.616 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -36.33 83.41 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.42 -37.98 94.04 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -71.14 -42.43 69.19 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -59.54 -22.78 62.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -37.98 51.57 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.669 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.795 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.3 mm? -69.61 -56.73 6.47 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.146 0.498 . . . . 0.0 109.894 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.737 ' O ' HD22 ' A' ' 150' ' ' LEU . 63.5 mt -54.53 -51.36 50.84 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.48 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -47.65 -55.5 9.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.03 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.402 ' O ' ' OD2' ' A' ' 152' ' ' ASP . 8.7 t -52.56 -43.77 65.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.322 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.656 ' HB2' HD13 ' A' ' 33' ' ' ILE . 20.4 t80 -58.15 -44.77 88.04 Favored 'General case' 0 C--O 1.189 -2.083 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.765 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.8 mm? -69.71 -42.84 73.51 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 120.552 -1.342 . . . . 0.0 111.88 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.403 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -61.97 -24.79 67.23 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 121.571 -0.705 . . . . 0.0 109.147 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 149' ' ' TYR . 5.1 p30 -107.32 -12.73 15.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.26 0.552 . . . . 0.0 110.379 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.621 ' N ' ' O ' ' A' ' 149' ' ' TYR . 1.2 t-160 -154.86 66.3 4.97 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 124.795 1.238 . . . . 0.0 110.108 -177.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.11 -3.54 13.47 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 122.761 2.307 . . . . 0.0 112.072 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.555 ' OD1' ' CD2' ' A' ' 153' ' ' HIS . 2.3 p30 -80.24 4.63 16.98 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.951 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.08 130.53 18.83 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 119.82 -1.8 . . . . 0.0 111.467 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.749 ' CD1' HD23 ' A' ' 24' ' ' LEU . 6.2 t80 55.08 8.17 0.23 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.331 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 5.2 p-10 . . . . . 0 C--N 1.325 -0.461 0 O-C-N 121.547 -0.721 . . . . 0.0 110.291 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 110.046 -1.221 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.847 HG23 ' C ' ' A' ' 119' ' ' TYR . 8.1 p -134.92 148.3 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.052 0.453 . . . . 0.0 111.616 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -98.51 110.5 23.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.24 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.644 HG23 ' CE1' ' A' ' 118' ' ' HIS . 98.3 m -96.41 140.12 31.54 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.828 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -146.96 134.16 20.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.918 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -102.39 132.91 48.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.23 0.538 . . . . 0.0 111.273 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.04 166.86 16.79 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 1.6 pt-20 -155.95 142.1 18.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.46 139.62 37.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.276 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.26 147.91 26.1 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.819 0.342 . . . . 0.0 111.532 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 t -145.08 154.85 42.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.808 0.337 . . . . 0.0 110.51 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -93.8 24.99 3.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.948 0.404 . . . . 0.0 111.121 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.415 ' HB ' HD21 ' A' ' 18' ' ' LEU . 2.1 mt -112.45 129.04 24.76 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.244 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -46.03 144.63 5.96 Favored 'Trans proline' 0 C--N 1.327 -0.583 0 C-N-CA 121.192 1.261 . . . . 0.0 110.602 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.68 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 12.0 Cg_endo -61.88 -24.55 77.25 Favored 'Trans proline' 0 C--N 1.321 -0.904 0 C-N-CA 122.316 2.011 . . . . 0.0 113.027 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.2 m -70.94 -28.6 64.61 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.422 ' H ' ' HG2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -76.27 -57.6 3.77 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.519 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.482 ' H ' ' HG ' ' A' ' 18' ' ' LEU . 1.8 mt -51.51 -43.53 62.29 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.753 ' O ' HG22 ' A' ' 23' ' ' VAL . 49.7 t80 -47.45 -58.06 4.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.257 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.705 ' CB ' HD11 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -69.89 -42.44 73.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 119.16 -1.016 . . . . 0.0 108.674 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.816 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -63.72 -5.12 3.67 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.627 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.535 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 2.7 t80 -120.25 -7.96 9.74 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 19' ' ' PHE . 29.1 m -129.91 -49.64 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.008 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.6 pp -96.51 -31.46 12.78 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 1.008 ' N ' HD12 ' A' ' 24' ' ' LEU . 10.0 t70 -114.44 -5.79 12.87 Favored 'General case' 0 C--O 1.211 -0.944 0 O-C-N 121.798 -0.564 . . . . 0.0 111.544 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.535 ' HB2' ' HA ' ' A' ' 22' ' ' PHE . . . -60.79 -40.36 92.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.566 0.698 . . . . 0.0 111.978 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -83.58 16.68 2.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.6 0.714 . . . . 0.0 110.109 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -139.62 -9.34 1.23 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.659 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -100.81 -39.82 7.62 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.001 -178.856 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.511 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 58.0 mt -53.89 -53.8 53.89 Favored Pre-proline 0 C--O 1.214 -0.79 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.191 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 29.3 Cg_endo -62.33 -25.29 76.38 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 121.876 1.717 . . . . 0.0 112.375 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 tmtp? -66.37 -55.33 16.41 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.984 0.897 . . . . 0.0 111.777 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.753 HD12 ' C ' ' A' ' 145' ' ' LEU . 0.9 OUTLIER -95.4 -34.34 5.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.315 -176.647 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.781 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.29 64.17 0.13 Allowed Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.486 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 71.7 Cg_endo -76.77 -24.41 10.14 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 N-CA-C 107.938 -1.601 . . . . 0.0 107.938 174.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -74.08 -43.83 56.29 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.273 -1.331 . . . . 0.0 109.494 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.781 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -70.54 -79.02 0.07 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.3 mt -98.93 146.64 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.019 0.437 . . . . 0.0 110.104 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -76.62 -44.36 34.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.81 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.655 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 49.2 tp60 -176.86 163.44 2.24 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.909 0.385 . . . . 0.0 110.773 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.655 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -167.0 143.78 4.56 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.926 0.393 . . . . 0.0 110.36 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.14 150.46 30.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.462 ' H ' HG13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -83.63 138.13 19.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.651 0.739 . . . . 0.0 110.952 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.3 mp -88.45 -39.32 14.33 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.766 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.925 ' O ' HG23 ' A' ' 52' ' ' THR . 47.9 mt-10 -142.02 134.22 27.69 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.952 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.62 -156.33 26.61 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -139.69 -9.7 1.21 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.821 0.343 . . . . 0.0 110.962 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.95 11.38 0.35 Allowed Glycine 0 C--O 1.223 -0.565 0 N-CA-C 111.914 -0.474 . . . . 0.0 111.914 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.43 -172.78 20.11 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 117.562 0.681 . . . . 0.0 111.976 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD3' ' H ' ' A' ' 74' ' ' ILE . 10.2 Cg_endo -60.02 126.59 20.72 Favored 'Trans proline' 0 N--CA 1.483 0.854 0 C-N-CA 122.774 2.316 . . . . 0.0 113.649 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.99 4.0 55.64 Favored Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.925 HG23 ' O ' ' A' ' 45' ' ' GLU . 88.9 m -94.23 140.4 29.82 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.135 -1.033 . . . . 0.0 111.296 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.651 HD12 ' C ' ' A' ' 52' ' ' THR . 1.8 mp -121.15 129.91 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HB3' ' HZ3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -116.27 140.34 49.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.083 0.468 . . . . 0.0 110.688 179.545 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -118.75 121.74 40.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.011 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.1 mp -100.96 123.61 54.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.1 m -98.42 118.47 35.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.401 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -92.27 168.05 11.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.232 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.92 143.77 32.51 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.93 -48.05 83.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.724 0.297 . . . . 0.0 110.324 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.18 61.49 2.93 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.4 m -137.41 174.93 10.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.623 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -51.37 66.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.674 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -91.67 150.92 20.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.363 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.93 -59.71 0.58 Allowed Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -145.24 155.18 43.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.99 0.424 . . . . 0.0 110.941 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.5 p -154.69 138.35 8.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.821 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.3 mtmm -105.83 118.95 37.92 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.363 0.601 . . . . 0.0 112.228 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.566 ' CE1' ' CD2' ' A' ' 85' ' ' LEU . 1.9 m80 -97.25 114.43 26.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.3 ttp85 -101.2 112.56 25.08 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.123 0.487 . . . . 0.0 111.609 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.0 mt -73.73 134.11 30.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.292 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 73' ' ' SER . 2.2 p30 -98.01 -49.92 4.59 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.296 -0.562 . . . . 0.0 112.298 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.538 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -165.54 143.21 5.82 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.412 ' H ' ' HD3' ' A' ' 50' ' ' PRO . 32.1 mt -126.68 126.46 68.81 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 CA-C-N 113.914 -1.494 . . . . 0.0 108.841 173.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 79' ' ' TYR . 23.4 m-20 -113.88 88.44 2.85 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.466 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 6.9 pt-20 -54.59 -30.62 55.01 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.32 -38.75 59.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.8 m -108.5 -11.02 15.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.777 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.513 ' N ' ' O ' ' A' ' 75' ' ' ASP . 12.3 m-85 62.53 43.29 7.88 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.273 0.559 . . . . 0.0 109.808 -178.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.3 p -105.95 141.06 37.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.802 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -132.59 118.65 19.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.62 0.248 . . . . 0.0 110.684 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.446 ' C ' ' OD2' ' A' ' 72' ' ' ASP . 42.0 t -128.43 143.62 51.02 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.696 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -148.93 173.11 13.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.165 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.93 135.53 23.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.091 0.472 . . . . 0.0 110.895 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.663 HD13 ' HB1' ' A' ' 90' ' ' ALA . 9.0 mt -80.24 113.27 18.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.614 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -77.31 -41.79 30.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.803 -178.307 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.614 ' N ' HD13 ' A' ' 86' ' ' ILE . 4.1 tm-20 -157.03 170.69 21.95 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.116 -0.365 . . . . 0.0 110.357 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.609 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 119.65 178.33 16.43 Favored Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -62.28 2.06 0.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 122.884 1.326 . . . . 0.0 108.412 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.663 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -66.0 -33.08 75.0 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 124.35 1.06 . . . . 0.0 110.399 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.856 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -109.77 16.2 22.22 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.195 0.598 . . . . 0.0 110.693 -176.83 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 91' ' ' LEU . 65.2 p 43.35 -126.25 0.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.61 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -131.48 -13.29 3.4 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.126 -0.358 . . . . 0.0 111.054 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.1 p -104.68 -5.76 21.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.845 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.835 HG21 ' CD1' ' A' ' 98' ' ' ILE . 57.9 mt -99.53 152.91 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 121.962 0.887 . . . . 0.0 113.107 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.512 ' N ' HG22 ' A' ' 95' ' ' ILE . 5.7 pt-20 -99.95 -49.1 4.44 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.17 178.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -170.79 147.41 2.76 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-O 121.832 0.825 . . . . 0.0 111.764 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.835 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.62 122.66 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.2 t -106.26 146.0 30.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.197 0.522 . . . . 0.0 111.324 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -139.14 133.53 31.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.286 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -128.75 133.29 48.06 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -135.21 131.82 37.15 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.002 -0.436 . . . . 0.0 110.254 -178.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -120.22 133.7 55.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.522 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -99.54 129.78 45.73 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -178.71 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -131.76 137.18 55.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.987 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.68 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -73.24 134.89 44.44 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.728 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.404 ' N ' ' HA ' ' A' ' 111' ' ' SER . 30.3 p -121.31 167.69 12.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.73 -27.17 34.76 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.8 m -86.97 -19.5 28.66 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 120.217 2.008 . . . . 0.0 113.743 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.24 -83.73 0.14 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.854 2.169 . . . . 0.0 111.104 -170.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 27.7 t -164.22 130.96 3.13 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 125.657 1.583 . . . . 0.0 110.971 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 105' ' ' VAL . 39.0 m -99.72 117.82 34.88 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 45.7 mt -92.25 132.5 36.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.386 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 102' ' ' THR . 12.0 mttt -105.17 117.16 33.3 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.719 ' C ' HD13 ' A' ' 116' ' ' ILE . 10.3 m -110.74 117.5 33.62 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.351 0.596 . . . . 0.0 110.783 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.947 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -99.9 135.8 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 123.561 0.744 . . . . 0.0 109.811 -177.758 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.8 p -104.3 133.98 48.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.644 ' CE1' HG23 ' A' ' 4' ' ' THR . 12.2 m80 -136.75 93.28 2.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.081 0.467 . . . . 0.0 109.927 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.847 ' C ' HG23 ' A' ' 2' ' ' VAL . 22.6 m-85 -87.37 101.77 13.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.835 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.453 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 87.6 m-70 -91.51 100.05 12.87 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.1 p -100.7 179.95 4.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.528 0.68 . . . . 0.0 111.937 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.49 ' CB ' ' NZ ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -109.16 155.42 21.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.344 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 41.32 -109.8 0.18 Allowed Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -116.96 7.14 13.11 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.911 -0.17 . . . . 0.0 111.006 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -47.51 159.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.169 0.509 . . . . 0.0 110.295 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.449 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 38.2 mt-10 -150.57 147.11 27.05 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.056 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.413 HD12 ' CD1' ' A' ' 95' ' ' ILE . 10.2 mm -89.32 124.57 42.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.468 ' HG2' ' H ' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -75.36 162.49 28.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.473 0.654 . . . . 0.0 111.643 -178.758 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.19 -34.08 74.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.837 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.468 ' H ' ' HG2' ' A' ' 128' ' ' LYS . 62.9 mt-10 -64.93 -35.6 81.7 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.824 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -68.57 -53.86 20.27 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.173 0.511 . . . . 0.0 110.789 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.0 m -69.23 -20.27 24.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.469 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -66.22 -47.64 73.2 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 122.293 -0.254 . . . . 0.0 110.41 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.88 -48.71 55.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.669 0.271 . . . . 0.0 110.697 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.91 -47.08 89.39 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -67.49 -47.03 71.22 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 122.493 -0.416 . . . . 0.0 110.569 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -55.24 -46.83 76.03 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.503 ' NZ ' ' O ' ' A' ' 37' ' ' ALA . 25.1 tttp -63.28 -54.42 37.41 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.45 -41.76 41.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.771 0.796 . . . . 0.0 110.116 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -63.11 -36.72 84.56 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.229 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.09 -47.58 90.11 Favored Glycine 0 C--O 1.226 -0.36 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -64.71 -44.81 89.04 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -59.46 -23.63 62.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -76.67 -37.48 56.14 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.023 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.753 ' C ' HD12 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -67.69 -56.19 10.27 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.354 1.073 . . . . 0.0 109.05 179.2 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.708 ' O ' HD22 ' A' ' 150' ' ' LEU . 50.9 mt -53.95 -50.66 51.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.285 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -47.5 -56.89 6.11 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.587 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 145' ' ' LEU . 12.1 p -52.98 -40.9 64.1 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.209 0.528 . . . . 0.0 111.468 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.643 ' HB2' HD13 ' A' ' 33' ' ' ILE . 22.1 t80 -61.47 -44.4 97.16 Favored 'General case' 0 C--O 1.193 -1.903 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.816 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.1 mm? -67.87 -42.71 80.86 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 119.995 1.27 . . . . 0.0 111.335 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -62.89 -23.81 67.52 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 121.505 -0.747 . . . . 0.0 109.13 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -105.72 -12.86 15.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.922 0.868 . . . . 0.0 110.342 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.638 ' N ' ' O ' ' A' ' 149' ' ' TYR . 0.2 OUTLIER -155.14 66.65 4.94 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 125.393 1.477 . . . . 0.0 110.041 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.42 ' N ' ' O ' ' A' ' 150' ' ' LEU . 39.8 Cg_endo -72.25 -3.44 13.34 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 C-N-CA 122.603 2.202 . . . . 0.0 111.68 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.483 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 4.2 m-20 -84.66 4.12 33.95 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.122 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.405 ' O ' ' CD ' ' A' ' 20' ' ' LYS . . . -50.1 130.31 22.21 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 119.522 -1.986 . . . . 0.0 111.419 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.714 ' CG ' HD13 ' A' ' 24' ' ' LEU . 0.7 OUTLIER 55.15 6.47 0.15 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 4.4 p-10 . . . . . 0 C--N 1.325 -0.499 0 O-C-N 121.832 -0.542 . . . . 0.0 110.253 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.835 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.2 p -134.91 148.6 29.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 O-C-N 122.661 -0.317 . . . . 0.0 111.048 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -97.64 109.41 22.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.776 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.58 HG23 ' CE1' ' A' ' 118' ' ' HIS . 92.8 m -97.18 139.83 32.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 0.0 110.918 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -140.34 129.5 23.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.205 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.401 ' HG2' HD12 ' A' ' 116' ' ' ILE . 1.4 tt0 -103.37 126.67 50.66 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.757 0.313 . . . . 0.0 110.894 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -126.67 165.71 18.71 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.198 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -155.93 139.8 16.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 112.082 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -137.98 139.94 39.95 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.474 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.27 145.04 26.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.82 0.343 . . . . 0.0 111.521 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.0 t -145.38 155.06 42.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.534 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -93.23 29.32 1.93 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.894 0.378 . . . . 0.0 110.792 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.578 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.3 mt -113.78 125.25 29.74 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.779 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -49.22 146.01 13.92 Favored 'Trans proline' 0 C--N 1.327 -0.559 0 C-N-CA 121.862 1.708 . . . . 0.0 111.615 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.433 ' HA ' HD12 ' A' ' 18' ' ' LEU . 27.1 Cg_exo -57.56 -24.6 62.79 Favored 'Trans proline' 0 N--CA 1.483 0.853 0 C-N-CA 122.204 1.936 . . . . 0.0 112.412 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.522 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 52.9 m -67.64 -35.63 79.26 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -75.74 -57.26 3.99 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.578 HD11 ' O ' ' A' ' 13' ' ' ILE . 3.8 mt -49.19 -47.11 46.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.09 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.479 ' O ' HG22 ' A' ' 23' ' ' VAL . 40.2 t80 -48.04 -56.66 7.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.705 ' CB ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.99 -38.41 76.0 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 119.101 -1.039 . . . . 0.0 108.479 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.798 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -66.72 -3.71 7.26 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.541 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.499 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 7.9 m-85 -119.94 -8.9 9.75 Favored 'General case' 0 CA--C 1.527 0.058 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.578 HG23 ' N ' ' A' ' 24' ' ' LEU . 22.3 m -129.31 -49.61 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.033 HD12 ' N ' ' A' ' 25' ' ' ASP . 2.7 pp -101.19 -30.53 11.49 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 1.033 ' N ' HD12 ' A' ' 24' ' ' LEU . 50.2 m-20 -110.89 -4.07 15.38 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.813 -0.554 . . . . 0.0 111.398 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -66.82 -38.79 87.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.704 0.764 . . . . 0.0 112.099 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -84.09 14.83 3.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.86 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.436 ' H ' ' H ' ' A' ' 29' ' ' LEU . 95.7 m-20 -138.84 -9.27 1.37 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.965 HD12 HG23 ' A' ' 146' ' ' ILE . 0.1 OUTLIER -92.03 -50.86 5.48 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.515 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.598 HG13 HD11 ' A' ' 146' ' ' ILE . 91.1 mt -55.33 -48.23 96.74 Favored Pre-proline 0 C--O 1.212 -0.884 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 29.7 Cg_endo -62.87 -26.16 74.52 Favored 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 121.773 1.649 . . . . 0.0 113.461 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -75.93 -48.61 20.56 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.662 0.744 . . . . 0.0 112.042 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.777 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.6 OUTLIER -94.45 -36.28 6.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.533 -177.262 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.91 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.95 63.61 0.16 Allowed Pre-proline 0 C--N 1.324 -0.507 0 C-N-CA 122.817 0.447 . . . . 0.0 111.947 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.493 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 73.6 Cg_endo -76.37 -25.73 9.5 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 N-CA-C 107.625 -1.721 . . . . 0.0 107.625 174.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -74.81 -43.9 52.19 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.609 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.91 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -71.73 -75.13 0.14 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.254 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.56 146.17 9.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.955 0.407 . . . . 0.0 110.221 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -77.66 -52.4 9.04 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.376 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.697 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 54.0 tp60 -175.68 164.0 2.94 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 110.546 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.697 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -166.96 144.0 4.67 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.134 0.492 . . . . 0.0 110.518 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.53 ' N ' ' NZ ' ' A' ' 54' ' ' LYS . 17.7 pt-20 -149.85 156.17 41.33 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.105 -0.372 . . . . 0.0 110.876 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.442 HG13 ' H ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -83.83 138.87 18.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.554 0.692 . . . . 0.0 111.008 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.97 -39.38 13.02 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.03 -0.987 . . . . 0.0 109.053 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.904 ' O ' HG23 ' A' ' 52' ' ' THR . 1.1 tt0 -142.41 138.22 30.95 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.22 -156.68 27.39 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -135.08 -13.6 2.11 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.593 -0.357 . . . . 0.0 111.079 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.8 10.84 0.38 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.9 -172.99 19.84 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 117.525 0.662 . . . . 0.0 111.75 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.28 127.19 22.19 Favored 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 122.597 2.198 . . . . 0.0 113.207 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.95 1.94 55.01 Favored Glycine 0 CA--C 1.506 -0.512 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.904 HG23 ' O ' ' A' ' 45' ' ' GLU . 95.8 m -93.59 136.16 34.15 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.313 -0.944 . . . . 0.0 110.761 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mp -109.56 119.22 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' NZ ' ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -109.25 136.4 48.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.781 0.8 . . . . 0.0 109.738 178.595 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -120.56 129.77 53.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.157 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.672 ' N ' HD12 ' A' ' 56' ' ' ILE . 2.5 mp -95.41 136.38 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.4 m -107.97 118.43 36.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.491 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -98.29 166.85 11.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.638 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.7 144.52 30.31 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.81 -58.47 8.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.805 0.336 . . . . 0.0 110.694 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.35 61.6 3.22 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 m -137.41 176.05 9.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.945 0.403 . . . . 0.0 110.684 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -61.07 -52.66 63.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.658 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.26 155.97 18.16 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.05 -61.8 0.14 Allowed Glycine 0 N--CA 1.462 0.393 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.64 155.06 42.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 0.0 110.846 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 p -156.01 145.52 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.187 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.495 ' HZ2' ' HB3' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -101.49 110.52 22.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.32 0.581 . . . . 0.0 111.802 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.464 ' CD2' ' C ' ' A' ' 69' ' ' HIS . 0.3 OUTLIER -109.62 114.79 28.69 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.541 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.11 133.77 46.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.11 0.481 . . . . 0.0 111.693 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.5 mt -80.31 137.51 21.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -95.54 -54.31 3.42 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -177.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.8 m -164.66 141.72 6.27 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.441 HD13 HG11 ' A' ' 23' ' ' VAL . 22.6 mt -128.21 130.0 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.712 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 79' ' ' TYR . 7.4 m-20 -115.61 88.78 2.95 Favored 'General case' 0 C--O 1.211 -0.928 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.414 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 7.4 mt-10 -54.26 -30.07 49.22 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.3 -38.08 70.77 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.426 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.07 -11.46 15.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.978 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 75' ' ' ASP . 7.5 m-85 61.16 41.47 13.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.795 -0.566 . . . . 0.0 110.498 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.9 t -115.41 132.66 56.55 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.736 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.492 ' CE2' ' OG1' ' A' ' 102' ' ' THR . 51.4 p90 -132.45 131.79 42.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.29 0.567 . . . . 0.0 110.92 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.3 t -126.81 145.15 50.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.226 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -151.26 163.63 38.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.1 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 98' ' ' ILE . 5.7 m -146.4 142.5 28.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.233 0.54 . . . . 0.0 111.378 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.636 HD13 ' HB1' ' A' ' 90' ' ' ALA . 5.7 mt -81.19 120.56 25.03 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.477 ' CG1' ' N ' ' A' ' 87' ' ' GLU . 3.6 pt -80.75 -44.55 21.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.724 0.297 . . . . 0.0 111.665 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.517 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 4.6 tp10 -153.71 171.79 18.3 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.613 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.54 177.77 18.03 Favored Glycine 0 CA--C 1.508 -0.359 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -61.06 2.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.636 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -68.38 -35.06 77.15 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 124.168 0.987 . . . . 0.0 110.102 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.889 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.62 15.68 21.89 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 123.591 0.756 . . . . 0.0 109.799 -178.057 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.4 p 47.19 -126.8 1.65 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -130.74 -12.79 3.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.078 0.466 . . . . 0.0 111.195 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.514 ' O ' HG21 ' A' ' 125' ' ' ILE . 2.6 p -105.53 -5.36 20.28 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.714 HG21 ' CD1' ' A' ' 98' ' ' ILE . 79.4 mt -97.55 152.17 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-O 122.16 0.981 . . . . 0.0 113.432 -176.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.493 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -89.41 -59.47 2.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 113.917 -1.492 . . . . 0.0 109.423 178.12 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.442 ' CB ' ' NZ ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -171.69 149.08 2.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.462 0.649 . . . . 0.0 111.285 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.714 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.92 123.24 69.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.537 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.4 t -111.14 146.43 36.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.353 0.597 . . . . 0.0 111.956 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -134.7 131.07 37.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.571 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.427 ' O ' HG12 ' A' ' 116' ' ' ILE . 77.3 tt0 -128.1 133.55 49.03 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.492 ' OG1' ' CE2' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -140.2 132.71 28.63 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.956 -0.465 . . . . 0.0 110.476 -178.419 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.602 ' C ' HD23 ' A' ' 104' ' ' LEU . 54.3 tttm -121.76 133.93 54.92 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.73 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -100.12 126.35 46.36 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.39 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.19 137.17 58.6 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.159 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.81 133.92 44.69 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.379 178.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 28.1 p -121.1 172.8 7.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.941 0.401 . . . . 0.0 110.258 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.12 -38.78 61.93 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.1 m -83.53 -15.57 48.82 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.63 1.172 . . . . 0.0 112.871 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 160.75 -85.48 0.11 Allowed Glycine 0 CA--C 1.54 1.596 0 C-N-CA 127.541 2.495 . . . . 0.0 112.794 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.7 OUTLIER -157.58 130.32 7.46 Favored 'General case' 0 C--N 1.347 0.487 0 C-N-CA 127.995 2.518 . . . . 0.0 111.046 175.52 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.4 m -99.82 118.45 36.31 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.5 mt -91.83 128.73 43.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.54 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.431 ' CB ' ' NZ ' ' A' ' 114' ' ' LYS . 1.2 mtmp? -105.59 117.05 33.02 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.814 ' C ' HD13 ' A' ' 116' ' ' ILE . 43.7 t -111.31 125.23 53.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.238 0.542 . . . . 0.0 110.845 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.896 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -107.17 135.76 44.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 123.22 0.608 . . . . 0.0 110.043 -177.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.2 t -107.1 137.94 44.22 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.885 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.58 ' CE1' HG23 ' A' ' 4' ' ' THR . 6.7 m80 -135.67 93.49 2.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.076 0.465 . . . . 0.0 110.589 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.835 ' C ' HG23 ' A' ' 2' ' ' VAL . 88.8 m-85 -86.56 101.6 13.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.173 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -99.3 107.88 20.28 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.138 0.494 . . . . 0.0 110.546 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.779 HG21 ' HA ' ' A' ' 126' ' ' GLU . 9.3 p -100.48 173.11 6.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.408 0.623 . . . . 0.0 111.167 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.97 155.17 21.18 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.187 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 40.3 -109.09 0.12 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -109.51 -1.4 18.3 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 122.779 -0.248 . . . . 0.0 111.213 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.514 HG21 ' O ' ' A' ' 94' ' ' THR . 1.4 mp -49.16 151.54 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.269 0.557 . . . . 0.0 109.877 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.779 ' HA ' HG21 ' A' ' 121' ' ' THR . 35.2 tt0 -147.7 148.29 30.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.642 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.7 mm -87.99 125.46 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -74.33 162.3 29.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.123 0.487 . . . . 0.0 111.798 -178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.4 -34.89 75.18 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.948 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.472 ' O ' HG22 ' A' ' 134' ' ' VAL . 0.6 OUTLIER -69.15 -28.62 66.59 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.108 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -72.49 -47.43 48.67 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.112 0.482 . . . . 0.0 111.108 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.4 m -79.29 -28.61 13.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.981 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -66.78 -45.64 77.85 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.169 -0.332 . . . . 0.0 110.855 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.514 HG23 ' N ' ' A' ' 135' ' ' GLY . 32.6 m -70.35 -45.6 74.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.718 0.294 . . . . 0.0 110.529 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.514 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -66.9 -44.59 88.6 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 77.9 tttt -65.02 -46.04 83.01 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 122.696 -0.296 . . . . 0.0 110.673 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -54.42 -47.15 73.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.793 0.33 . . . . 0.0 110.135 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.1 ttpp -66.44 -52.99 40.55 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.69 -43.98 47.71 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.589 0.709 . . . . 0.0 110.546 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.37 -36.49 75.85 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.424 ' O ' HD22 ' A' ' 145' ' ' LEU . . . -61.03 -42.4 99.78 Favored Glycine 0 C--O 1.22 -0.76 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.559 ' CD2' ' HB1' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -64.0 -46.84 82.74 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -60.74 -24.08 65.44 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 141' ' ' GLY . 1.8 ttmm -76.5 -38.56 55.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.808 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.777 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -66.94 -57.01 7.76 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.365 0.602 . . . . 0.0 110.092 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.965 HG23 HD12 ' A' ' 29' ' ' LEU . 43.3 mt -55.3 -50.03 68.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.539 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -47.19 -53.23 13.64 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.667 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.3 m -55.39 -41.72 73.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.232 0.539 . . . . 0.0 110.908 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.719 ' HB2' HD13 ' A' ' 33' ' ' ILE . 22.0 t80 -60.8 -45.44 94.39 Favored 'General case' 0 C--O 1.194 -1.864 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.798 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.1 mm? -67.02 -42.95 84.06 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 120.653 1.57 . . . . 0.0 111.449 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -24.02 67.47 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.699 -0.625 . . . . 0.0 109.425 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -106.34 -13.17 15.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.842 0.83 . . . . 0.0 110.415 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.657 ' N ' ' O ' ' A' ' 149' ' ' TYR . 96.5 m-70 -156.04 66.81 4.52 Favored Pre-proline 0 C--N 1.303 -1.436 0 C-N-CA 125.32 1.448 . . . . 0.0 110.173 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.86 -2.18 11.87 Favored 'Trans proline' 0 N--CA 1.48 0.708 0 C-N-CA 122.708 2.272 . . . . 0.0 111.154 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 9.1 m-20 -68.36 2.21 2.46 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.535 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.602 ' O ' ' HD3' ' A' ' 20' ' ' LYS . . . -50.43 130.47 23.62 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 118.841 -2.412 . . . . 0.0 110.924 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.845 ' CD1' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER 52.34 4.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 179.243 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 3.2 p-10 . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 118.18 -0.915 . . . . 0.0 110.052 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.774 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.7 p -134.47 148.68 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.869 0.366 . . . . 0.0 111.329 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -98.0 109.99 22.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.682 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.502 ' OG1' ' CE1' ' A' ' 118' ' ' HIS . 74.6 m -95.76 140.09 31.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 0.0 110.796 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -141.5 132.04 25.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.132 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -103.02 137.02 41.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.128 0.489 . . . . 0.0 111.47 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -136.16 165.39 25.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.971 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -155.62 149.63 25.52 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -149.65 140.73 22.99 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.512 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.08 147.83 23.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.874 0.368 . . . . 0.0 111.659 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.4 p -140.0 155.74 46.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.446 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -95.93 22.51 7.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.838 0.351 . . . . 0.0 111.044 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.554 ' O ' HD11 ' A' ' 18' ' ' LEU . 2.3 mt -119.31 128.07 26.13 Favored Pre-proline 0 C--O 1.217 -0.616 0 CA-C-O 118.946 -0.55 . . . . 0.0 110.375 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -45.7 144.8 5.04 Favored 'Trans proline' 0 C--N 1.325 -0.666 0 C-N-CA 121.68 1.587 . . . . 0.0 110.935 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HA ' HD12 ' A' ' 18' ' ' LEU . 10.2 Cg_endo -61.13 -23.63 77.64 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 122.172 1.915 . . . . 0.0 112.693 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.506 ' C ' ' HE ' ' A' ' 17' ' ' ARG . 10.2 t -70.35 -30.18 67.07 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.696 ' HE ' ' N ' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -79.16 -52.3 8.35 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.554 HD11 ' O ' ' A' ' 13' ' ' ILE . 4.3 mt -53.45 -44.75 69.15 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.261 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.9 ' O ' HG22 ' A' ' 23' ' ' VAL . 48.7 t80 -49.83 -57.44 7.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.94 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.45 ' CG ' ' O ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -68.63 -27.64 66.2 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.815 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.024 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -82.95 -1.63 52.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.655 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.634 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 13.1 t80 -120.31 -7.66 9.75 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.9 HG22 ' O ' ' A' ' 19' ' ' PHE . 2.5 m -129.71 -35.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.845 ' CD1' HG23 ' A' ' 23' ' ' VAL . 4.3 mp -89.49 -54.46 4.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.777 0.717 . . . . 0.0 111.626 -176.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.527 ' CB ' ' CZ ' ' A' ' 157' ' ' TYR . 0.1 OUTLIER -115.8 0.83 13.29 Favored 'General case' 0 C--O 1.199 -1.596 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.341 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.634 ' HB2' ' HA ' ' A' ' 22' ' ' PHE . . . -44.53 -41.87 6.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 119.518 1.053 . . . . 0.0 111.879 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -84.81 17.4 2.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.507 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 25' ' ' ASP . 68.3 m-20 -139.68 -10.97 1.18 Allowed 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 125.562 1.545 . . . . 0.0 108.722 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.569 HD21 ' CD2' ' A' ' 149' ' ' TYR . 0.2 OUTLIER -95.07 -43.02 8.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 125.19 1.396 . . . . 0.0 108.334 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.73 HG13 HD11 ' A' ' 146' ' ' ILE . 55.7 mt -54.5 -51.17 80.6 Favored Pre-proline 0 C--O 1.215 -0.73 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.072 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 26.2 Cg_endo -61.96 -22.79 74.97 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 122.148 1.899 . . . . 0.0 111.855 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -68.82 -55.45 11.14 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.505 0.669 . . . . 0.0 111.564 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.722 HD12 ' HB2' ' A' ' 145' ' ' LEU . 0.5 OUTLIER -94.63 -40.97 11.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.732 -177.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.876 ' HB2' HD22 ' A' ' 145' ' ' LEU . . . -110.8 71.13 0.69 Allowed Pre-proline 0 CA--C 1.506 -0.737 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.016 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.21 -6.87 15.73 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 N-CA-C 108.115 -1.533 . . . . 0.0 108.115 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.429 ' H ' ' C ' ' A' ' 34' ' ' ALA . 24.7 pt20 -71.98 -34.82 69.22 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.799 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.586 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -79.55 -82.0 0.11 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.263 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 38' ' ' ILE . 1.8 mp -102.81 143.66 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.882 0.372 . . . . 0.0 110.353 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -79.33 -43.74 22.95 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.986 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.403 ' OE1' ' N ' ' A' ' 41' ' ' ALA . 1.4 pp0? -177.39 165.17 2.19 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.403 ' N ' ' OE1' ' A' ' 40' ' ' GLN . . . -165.47 145.63 6.83 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.751 0.31 . . . . 0.0 110.951 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -136.75 142.76 43.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.74 0.305 . . . . 0.0 110.213 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.618 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -79.57 140.11 17.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.523 0.678 . . . . 0.0 110.472 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.1 mp -88.84 -39.64 13.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.877 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.948 ' O ' HG23 ' A' ' 52' ' ' THR . 22.9 mt-10 -142.96 134.09 25.81 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.867 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.86 -156.05 35.89 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -137.54 -0.53 2.16 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.554 -0.38 . . . . 0.0 111.363 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.507 ' N ' HG21 ' A' ' 52' ' ' THR . . . 134.87 16.24 1.0 Allowed Glycine 0 C--O 1.223 -0.56 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.466 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -110.48 -173.32 20.19 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 117.525 0.662 . . . . 0.0 111.458 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -60.39 125.92 18.68 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 122.181 1.921 . . . . 0.0 113.172 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.7 2.7 58.51 Favored Glycine 0 N--CA 1.462 0.412 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.948 HG23 ' O ' ' A' ' 45' ' ' GLU . 90.7 m -94.05 140.16 30.07 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.359 -0.921 . . . . 0.0 111.267 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mp -120.68 130.94 74.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.618 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -119.83 140.0 51.49 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.302 0.572 . . . . 0.0 111.02 179.231 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.633 ' HE3' ' HZ3' ' A' ' 68' ' ' LYS . 35.5 ttmt -118.21 124.75 48.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.609 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.805 HD13 ' CD2' ' A' ' 69' ' ' HIS . 1.4 mp -102.84 129.58 54.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.4 m -112.46 119.88 39.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.248 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -92.63 -174.93 3.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.008 0.432 . . . . 0.0 110.849 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.36 146.63 50.47 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.631 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 3.5 mp0 -59.1 -48.96 79.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.869 0.366 . . . . 0.0 110.617 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.92 61.27 3.41 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -138.4 175.62 9.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.248 0.547 . . . . 0.0 110.412 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.58 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -67.1 -53.56 29.72 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.14 156.26 18.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.953 0.406 . . . . 0.0 110.18 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.31 -58.77 0.22 Allowed Glycine 0 CA--C 1.52 0.348 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -143.83 155.02 43.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.168 0.509 . . . . 0.0 110.58 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.466 ' CG2' HD11 ' A' ' 85' ' ' LEU . 5.1 p -154.23 146.54 13.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.361 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.633 ' HZ3' ' HE3' ' A' ' 55' ' ' LYS . 14.6 mmtt -107.46 112.43 25.21 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.285 0.564 . . . . 0.0 112.491 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.805 ' CD2' HD13 ' A' ' 56' ' ' ILE . 8.8 m-70 -104.83 114.83 29.28 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -101.91 120.76 40.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.653 0.263 . . . . 0.0 111.17 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.559 HD13 ' CG2' ' A' ' 52' ' ' THR . 5.0 mp -70.48 145.15 13.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -102.02 -55.64 2.45 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.123 -0.36 . . . . 0.0 111.83 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.9 m -165.93 141.02 4.75 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.5 mt -124.53 130.99 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.922 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 79' ' ' TYR . 12.7 m-20 -115.16 87.67 2.71 Favored 'General case' 0 C--O 1.206 -1.213 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.486 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -54.72 -32.39 59.54 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.45 -38.55 66.48 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.06 -10.78 15.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.055 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.2 m-85 62.58 47.29 5.01 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.45 -0.781 . . . . 0.0 110.341 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.496 ' HB3' ' HZ3' ' A' ' 103' ' ' LYS . 10.2 p -105.8 144.54 32.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.415 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.633 ' CE2' ' CD2' ' A' ' 83' ' ' TYR . 29.5 t80 -132.2 118.41 19.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.052 0.453 . . . . 0.0 110.712 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.6 p -127.12 130.44 49.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.748 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.633 ' CD2' ' CE2' ' A' ' 81' ' ' TYR . 12.9 p90 -144.8 164.63 30.47 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -140.1 137.01 34.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.329 0.585 . . . . 0.0 110.987 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.627 HD21 ' CE1' ' A' ' 69' ' ' HIS . 0.2 OUTLIER -79.75 118.65 21.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.696 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.569 HD11 ' CB ' ' A' ' 68' ' ' LYS . 2.7 pt -87.27 -45.01 16.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.479 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 35.4 tt0 -152.65 171.76 17.68 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.85 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.616 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.87 177.46 17.87 Favored Glycine 0 CA--C 1.51 -0.245 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -62.16 2.05 0.27 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.616 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -66.01 -33.02 74.84 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 124.754 1.221 . . . . 0.0 110.608 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.876 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -109.75 16.14 22.27 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 123.439 0.695 . . . . 0.0 109.624 -178.08 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 53.4 p 45.85 -126.49 1.31 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -130.38 -12.99 3.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.96 0.41 . . . . 0.0 111.176 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.9 p -105.17 -6.74 19.56 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.714 HG21 ' CD1' ' A' ' 98' ' ' ILE . 59.0 mt -98.6 153.01 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 CA-C-O 122.004 0.907 . . . . 0.0 113.256 -176.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.514 ' N ' HG22 ' A' ' 95' ' ' ILE . 19.9 pt-20 -99.88 -46.11 5.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.377 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.441 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -172.62 146.83 1.73 Allowed 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 121.723 0.773 . . . . 0.0 112.415 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.714 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.14 123.47 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.501 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.94 145.08 30.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.138 0.494 . . . . 0.0 111.369 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.514 ' CD2' ' O ' ' A' ' 116' ' ' ILE . 0.4 OUTLIER -141.79 129.5 21.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.576 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.419 ' O ' HG12 ' A' ' 116' ' ' ILE . 18.0 tt0 -128.12 134.6 49.14 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.06 131.82 25.76 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.905 -0.497 . . . . 0.0 109.96 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.697 ' C ' HD23 ' A' ' 104' ' ' LEU . 17.5 ttmm -125.62 134.15 51.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.123 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.873 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -99.9 125.97 45.96 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.116 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -126.2 137.26 58.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.795 -178.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.69 132.73 44.06 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.41 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 111' ' ' SER . 24.2 p -121.4 171.6 8.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.866 0.365 . . . . 0.0 110.293 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.94 -30.77 46.27 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.8 m -85.4 -16.81 38.55 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.379 -2.248 . . . . 0.0 114.352 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.74 -85.57 0.13 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.078 1.799 . . . . 0.0 109.858 -171.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.3 OUTLIER -160.12 129.13 5.0 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.87 1.668 . . . . 0.0 110.921 -178.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 105' ' ' VAL . 33.1 m -99.43 117.8 34.64 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 55.5 mt -91.96 128.81 43.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.766 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -105.89 117.08 33.1 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.719 ' C ' HD13 ' A' ' 116' ' ' ILE . 0.5 OUTLIER -111.88 118.18 34.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.415 0.626 . . . . 0.0 111.556 -178.291 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.95 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -99.31 135.03 36.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 123.773 0.829 . . . . 0.0 109.915 -178.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.9 136.86 46.91 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.502 ' CE1' ' OG1' ' A' ' 4' ' ' THR . 47.8 m-70 -136.09 97.81 3.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 120.999 0.428 . . . . 0.0 110.801 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.774 ' C ' HG23 ' A' ' 2' ' ' VAL . 3.6 m-30 -84.31 101.65 12.1 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.83 -0.434 . . . . 0.0 109.83 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.442 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -94.83 102.67 14.53 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.752 HG21 ' HA ' ' A' ' 126' ' ' GLU . 11.9 p -101.31 171.32 7.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.482 0.658 . . . . 0.0 111.421 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -112.35 143.0 44.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.508 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 50.38 -109.71 0.74 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -106.85 -6.51 17.62 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.649 -0.324 . . . . 0.0 111.478 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 125' ' ' ILE . 1.4 mp -47.5 151.42 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.199 0.524 . . . . 0.0 109.751 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.752 ' HA ' HG21 ' A' ' 121' ' ' THR . 12.9 pt-20 -148.18 147.75 29.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.84 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.9 mm -88.19 127.67 41.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.449 ' HG3' ' H ' ' A' ' 129' ' ' GLU . 10.7 tptp -73.76 159.88 32.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.614 0.721 . . . . 0.0 111.684 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.449 ' H ' ' HG3' ' A' ' 128' ' ' LYS . 70.0 mm-40 -70.15 -37.89 75.34 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.531 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.476 ' O ' HG13 ' A' ' 134' ' ' VAL . 43.8 mt-10 -64.69 -26.58 68.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.877 0.37 . . . . 0.0 110.231 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -72.78 -49.23 32.03 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.161 0.505 . . . . 0.0 111.062 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 m -78.25 -28.99 15.08 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.121 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -67.23 -46.2 74.5 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 122.004 -0.435 . . . . 0.0 110.746 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 135' ' ' GLY . 25.8 m -70.42 -42.4 78.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.771 0.32 . . . . 0.0 110.679 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.491 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -69.86 -46.16 54.24 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -66.74 -48.43 69.18 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.568 -0.372 . . . . 0.0 110.911 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -56.03 -47.77 77.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.097 0.475 . . . . 0.0 110.126 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -64.7 -53.85 40.86 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.449 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -48.36 -46.8 37.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.352 0.596 . . . . 0.0 110.564 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -55.37 -37.44 67.55 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.99 -42.25 98.26 Favored Glycine 0 C--O 1.223 -0.532 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.727 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -66.49 -32.71 74.24 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 122.243 -0.563 . . . . 0.0 109.943 -179.194 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.59 ' CE2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -71.48 -20.03 62.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.224 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -72.6 -48.22 41.44 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.294 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.876 HD22 ' HB2' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -73.57 -44.33 57.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.165 -179.294 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.73 HD11 HG13 ' A' ' 30' ' ' ILE . 31.2 mt -52.57 -50.51 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.425 ' O ' ' CD1' ' A' ' 13' ' ' ILE . 27.1 tt0 -47.87 -49.43 29.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.1 t -51.74 -46.85 64.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.483 0.659 . . . . 0.0 110.959 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.607 ' O ' ' N ' ' A' ' 153' ' ' HIS . 12.2 t80 -58.55 -43.79 89.43 Favored 'General case' 0 C--O 1.199 -1.582 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 1.024 HD11 ' HB2' ' A' ' 21' ' ' ALA . 1.6 mm? -67.91 -43.23 79.7 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 119.675 1.125 . . . . 0.0 111.983 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.501 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -59.9 -24.58 64.42 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.253 -0.904 . . . . 0.0 108.953 179.507 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -105.73 -13.81 15.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.331 0.586 . . . . 0.0 110.575 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.607 ' N ' ' O ' ' A' ' 149' ' ' TYR . 0.3 OUTLIER -155.65 66.5 4.63 Favored Pre-proline 0 C--N 1.313 -0.982 0 C-N-CA 124.738 1.215 . . . . 0.0 110.47 -178.583 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.466 ' CD ' ' O ' ' A' ' 150' ' ' LEU . 9.7 Cg_endo -77.47 -8.58 17.26 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 C-N-CA 122.719 2.28 . . . . 0.0 111.743 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.532 ' OD2' ' ND2' ' A' ' 158' ' ' ASN . 14.0 t70 -89.94 6.54 41.6 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.388 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.557 ' HB1' ' CE1' ' A' ' 157' ' ' TYR . . . -72.34 132.18 43.64 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 120.296 -1.503 . . . . 0.0 110.274 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.557 ' CE1' ' HB1' ' A' ' 156' ' ' ALA . 1.7 m-85 64.95 9.12 5.15 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.794 176.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.532 ' ND2' ' OD2' ' A' ' 155' ' ' ASP . 6.4 p-10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.747 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.816 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.812 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.9 p -134.7 148.82 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 O-C-N 122.477 -0.426 . . . . 0.0 110.789 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.28 109.78 22.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.694 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 61.3 m -96.88 140.01 32.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.802 0.334 . . . . 0.0 111.028 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.88 125.34 16.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.98 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.27 130.24 50.46 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.716 0.293 . . . . 0.0 111.429 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -131.43 171.34 13.5 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -155.76 155.63 33.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -154.63 140.0 17.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.343 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 m -93.91 146.27 24.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.817 0.341 . . . . 0.0 111.583 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 p -135.15 154.32 51.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.398 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -97.41 26.92 4.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.084 0.468 . . . . 0.0 110.498 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.585 ' HB ' HD21 ' A' ' 18' ' ' LEU . 2.2 mt -119.05 125.41 27.67 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.444 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -46.13 147.32 3.76 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 121.826 1.684 . . . . 0.0 111.522 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -59.56 -24.53 75.48 Favored 'Trans proline' 0 N--CA 1.482 0.812 0 C-N-CA 121.983 1.789 . . . . 0.0 112.212 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.47 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 67.1 m -68.13 -34.19 75.9 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -77.8 -56.09 4.79 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 121.395 -0.816 . . . . 0.0 109.272 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.585 HD21 ' HB ' ' A' ' 13' ' ' ILE . 2.8 mt -52.47 -43.05 64.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.226 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.796 ' O ' HG22 ' A' ' 23' ' ' VAL . 46.2 t80 -54.87 -54.42 42.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.497 ' CE ' ' ND2' ' A' ' 158' ' ' ASN . 0.3 OUTLIER -70.89 -25.75 62.92 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.086 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.854 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -83.06 -2.04 54.31 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.524 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.542 ' CE2' ' CE2' ' A' ' 143' ' ' PHE . 2.8 m-85 -117.31 -7.87 11.15 Favored 'General case' 0 C--N 1.335 -0.035 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.876 HG23 ' CD1' ' A' ' 24' ' ' LEU . 4.7 m -134.89 -34.75 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.876 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.7 mp -88.88 -55.34 3.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.871 1.214 . . . . 0.0 111.443 -176.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.506 ' CG ' ' CE2' ' A' ' 157' ' ' TYR . 0.9 OUTLIER -114.76 -1.32 13.28 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.726 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.485 ' HB2' ' CA ' ' A' ' 22' ' ' PHE . . . -45.77 -40.71 9.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.696 0.76 . . . . 0.0 111.57 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.404 ' HB2' ' HZ3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -85.07 18.04 2.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.077 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 25' ' ' ASP . 80.6 m-20 -139.53 -9.06 1.25 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 126.087 1.755 . . . . 0.0 108.683 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.483 HD21 ' CD1' ' A' ' 149' ' ' TYR . 0.1 OUTLIER -95.19 -40.99 9.3 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 124.737 1.215 . . . . 0.0 109.939 -179.061 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.514 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 80.6 mt -55.16 -42.17 94.51 Favored Pre-proline 0 C--O 1.21 -0.985 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.182 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 21.2 Cg_exo -63.79 -26.69 67.83 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 122.098 1.866 . . . . 0.0 112.039 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 tmtp? -71.01 -51.37 25.84 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 122.027 0.918 . . . . 0.0 111.858 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.778 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.5 OUTLIER -94.57 -35.23 6.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.008 -176.711 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.848 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.48 65.04 0.14 Allowed Pre-proline 0 C--N 1.322 -0.606 0 C-N-CA 122.966 0.507 . . . . 0.0 111.89 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.466 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 73.2 Cg_endo -74.88 -23.05 14.44 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 N-CA-C 107.707 -1.69 . . . . 0.0 107.707 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -73.9 -43.51 58.2 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.315 -1.312 . . . . 0.0 109.231 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.848 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -73.78 -82.72 0.05 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.766 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.5 mt -100.5 145.84 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.083 0.468 . . . . 0.0 110.471 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -77.8 -54.99 5.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.787 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.428 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -174.21 166.4 4.13 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.099 0.476 . . . . 0.0 110.342 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.428 ' H ' ' HG2' ' A' ' 40' ' ' GLN . . . -166.25 144.25 5.47 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.475 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.432 ' N ' ' HE3' ' A' ' 54' ' ' LYS . 8.4 pt-20 -135.93 146.62 47.51 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.516 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -78.46 139.83 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.404 0.621 . . . . 0.0 110.695 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 8.1 mp -88.63 -39.93 13.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.142 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.929 ' O ' HG23 ' A' ' 52' ' ' THR . 47.1 mt-10 -142.33 133.98 26.78 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.942 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.39 -156.02 27.69 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 36.8 p30 -142.45 -6.37 0.92 Allowed 'General case' 0 C--N 1.32 -0.684 0 O-C-N 122.355 -0.497 . . . . 0.0 111.177 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.27 14.12 0.31 Allowed Glycine 0 C--O 1.221 -0.708 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.56 -172.61 19.99 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 117.493 0.647 . . . . 0.0 111.988 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -62.13 126.4 18.59 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 123.113 2.542 . . . . 0.0 113.432 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.44 5.8 57.78 Favored Glycine 0 CA--C 1.505 -0.549 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.929 HG23 ' O ' ' A' ' 45' ' ' GLU . 84.3 m -93.37 137.45 32.67 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.339 -0.931 . . . . 0.0 111.128 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.21 129.37 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.516 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -116.21 139.06 50.74 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.206 0.526 . . . . 0.0 110.844 179.163 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.511 ' C ' HD12 ' A' ' 56' ' ' ILE . 66.5 tttt -118.99 127.11 53.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.704 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.827 HD13 ' CD2' ' A' ' 69' ' ' HIS . 1.3 mp -98.98 131.98 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.9 m -105.88 118.84 37.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.349 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -98.65 175.46 5.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 110.782 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.61 145.06 49.68 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -59.31 -53.04 62.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.917 0.389 . . . . 0.0 110.736 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.11 61.73 3.29 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.3 m -140.56 175.03 9.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.36 . . . . 0.0 110.826 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -60.47 -56.12 25.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.976 0.417 . . . . 0.0 110.637 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.93 155.9 16.91 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.196 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -125.22 -59.78 0.17 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.38 154.17 45.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.091 0.472 . . . . 0.0 110.483 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.0 p -156.67 147.35 11.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.351 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.455 ' HB3' HD11 ' A' ' 86' ' ' ILE . 1.5 tppt? -107.12 112.42 25.32 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.452 0.644 . . . . 0.0 112.389 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.827 ' CD2' HD13 ' A' ' 56' ' ' ILE . 8.0 m170 -101.9 120.58 40.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -102.92 115.79 31.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.629 0.252 . . . . 0.0 111.335 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.8 mt -70.0 135.97 27.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.417 ' O ' ' OG ' ' A' ' 73' ' ' SER . 1.7 m-20 -96.94 -56.34 2.59 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 69.4 m -166.08 142.42 5.04 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.9 mt -122.63 131.87 72.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.288 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -115.35 87.7 2.72 Favored 'General case' 0 C--O 1.206 -1.196 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.109 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.503 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -54.67 -30.96 56.96 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.594 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.26 -39.06 72.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.2 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.9 m -107.97 -10.35 15.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.188 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.1 m-85 62.33 45.17 6.85 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.487 -0.758 . . . . 0.0 110.199 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.8 t -106.56 148.39 28.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.273 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -132.02 125.67 32.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.727 0.299 . . . . 0.0 110.848 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.8 t -133.47 138.41 46.15 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.607 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -144.14 160.83 40.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.698 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 98' ' ' ILE . 10.1 m -140.03 129.88 24.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.327 0.584 . . . . 0.0 111.027 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.407 HD21 ' CE1' ' A' ' 69' ' ' HIS . 18.2 mt -78.94 119.46 22.13 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' A' ' 68' ' ' LYS . 5.2 pt -88.32 -43.89 15.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.496 ' CD ' ' N ' ' A' ' 88' ' ' GLY . 8.3 tm-20 -158.89 173.28 16.76 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.222 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.606 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.74 178.51 18.41 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.42 2.55 0.15 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.756 ' C ' HD23 ' A' ' 91' ' ' LEU . . . -70.79 -37.1 73.28 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 123.517 0.727 . . . . 0.0 110.19 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.867 HD23 ' N ' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -111.39 17.17 20.4 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 91' ' ' LEU . 56.7 p 51.93 -132.67 1.91 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -131.64 -0.34 3.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.946 0.403 . . . . 0.0 112.0 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.03 -7.43 19.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.807 HD11 HD12 ' A' ' 127' ' ' ILE . 12.0 mt -99.36 151.67 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.502 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -88.51 -51.53 5.66 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.355 176.026 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.03 148.36 2.23 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.128 0.489 . . . . 0.0 112.182 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.707 HD13 HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.22 130.4 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 176.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.4 147.0 44.86 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 122.957 0.503 . . . . 0.0 111.436 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -137.39 140.74 41.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.67 0.271 . . . . 0.0 110.916 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -128.04 134.99 49.27 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 121.015 0.436 . . . . 0.0 110.647 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.0 131.0 42.15 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -120.91 133.84 55.29 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.461 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.3 mm? -96.67 124.06 40.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.63 136.91 43.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.065 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.95 140.04 47.14 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.79 177.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.486 ' N ' ' HA ' ' A' ' 111' ' ' SER . 34.9 t -121.47 169.95 10.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.8 0.333 . . . . 0.0 110.444 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.451 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.96 -38.09 59.54 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.819 -0.513 . . . . 0.0 111.819 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.0 m -87.97 -9.9 52.11 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.335 1.054 . . . . 0.0 112.883 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.15 -86.51 0.12 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 126.095 1.807 . . . . 0.0 112.539 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.486 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 0.7 OUTLIER -157.58 129.54 7.07 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 127.517 2.327 . . . . 0.0 111.152 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.6 m -99.37 134.44 42.22 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.1 mt -108.87 129.82 62.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.476 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -106.09 116.68 32.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.802 ' C ' HD13 ' A' ' 116' ' ' ILE . 11.4 t -110.47 122.75 48.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.145 0.498 . . . . 0.0 110.437 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.859 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -105.73 135.05 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.027 -177.716 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.8 p -101.5 140.94 35.1 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.14 92.66 2.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.202 0.525 . . . . 0.0 109.909 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.812 ' C ' HG23 ' A' ' 2' ' ' VAL . 86.4 m-85 -90.01 101.36 14.07 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.34 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -91.44 103.81 16.4 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.434 HG21 ' HA ' ' A' ' 126' ' ' GLU . 1.0 OUTLIER -89.33 160.29 16.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.544 -178.212 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.451 ' H ' HG22 ' A' ' 125' ' ' ILE . 5.1 ptmt -112.8 142.84 44.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.229 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.0 -110.39 1.12 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -116.47 -2.95 11.92 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.769 -0.254 . . . . 0.0 110.675 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 122' ' ' LYS . 1.6 tp -48.93 162.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 120.959 0.409 . . . . 0.0 110.862 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.434 ' HA ' HG21 ' A' ' 121' ' ' THR . 11.6 pt-20 -148.41 149.97 32.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.132 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.807 HD12 HD11 ' A' ' 95' ' ' ILE . 3.3 mm -86.82 125.09 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -74.77 162.98 28.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.33 0.586 . . . . 0.0 111.104 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -68.95 -45.54 70.49 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.477 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.535 ' O ' HG22 ' A' ' 134' ' ' VAL . 16.3 mm-40 -60.95 -24.8 66.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.641 0.257 . . . . 0.0 110.645 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -73.04 -52.69 13.41 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.384 0.612 . . . . 0.0 110.989 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.412 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.0 m -76.7 -29.12 17.85 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.039 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -67.27 -46.05 74.79 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.252 -0.28 . . . . 0.0 111.095 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 130' ' ' GLU . 30.1 m -70.26 -42.65 78.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.746 0.308 . . . . 0.0 110.685 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.479 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -70.25 -43.75 62.16 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 29.5 ttmt -67.12 -46.49 73.97 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 122.739 -0.271 . . . . 0.0 110.864 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -54.9 -44.12 73.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.472 ' HZ1' ' C ' ' A' ' 37' ' ' ALA . 37.0 tttm -69.3 -56.18 8.3 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.875 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.424 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -48.94 -42.73 38.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.677 0.751 . . . . 0.0 110.746 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -64.13 -36.24 83.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.25 -37.12 92.51 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.569 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -68.05 -47.62 67.87 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.542 ' CE2' ' CE2' ' A' ' 22' ' ' PHE . 5.3 m-85 -59.32 -21.47 59.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -77.04 -38.34 52.95 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.316 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.778 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.9 -57.0 8.89 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.587 179.55 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.698 ' O ' HD22 ' A' ' 150' ' ' LEU . 76.7 mt -53.9 -50.4 53.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.563 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -47.16 -55.02 9.25 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.019 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.7 t -52.94 -44.01 66.75 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.564 0.697 . . . . 0.0 111.392 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.708 ' HB2' HD13 ' A' ' 33' ' ' ILE . 15.4 t80 -58.83 -45.38 90.15 Favored 'General case' 0 C--O 1.195 -1.772 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.854 HD11 ' HB2' ' A' ' 21' ' ' ALA . 1.7 mm? -67.89 -41.77 82.23 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 119.944 1.247 . . . . 0.0 111.623 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.42 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -60.96 -24.3 65.98 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 121.17 -0.956 . . . . 0.0 108.665 179.45 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -106.15 -14.27 15.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.125 0.488 . . . . 0.0 110.916 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.621 ' N ' ' O ' ' A' ' 149' ' ' TYR . 90.1 m-70 -156.19 66.83 4.45 Favored Pre-proline 0 C--N 1.31 -1.113 0 C-N-CA 125.214 1.406 . . . . 0.0 110.235 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.461 ' CD ' ' O ' ' A' ' 150' ' ' LEU . 59.6 Cg_endo -80.76 -4.77 12.97 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 122.7 2.267 . . . . 0.0 111.989 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -91.13 5.76 47.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.821 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.606 ' HB1' ' CE1' ' A' ' 157' ' ' TYR . . . -72.91 131.36 42.11 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.356 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.606 ' CE1' ' HB1' ' A' ' 156' ' ' ALA . 1.5 m-85 64.38 8.93 4.55 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.778 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.497 ' ND2' ' CE ' ' A' ' 20' ' ' LYS . 5.8 m120 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.314 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.911 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.818 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.6 p -134.52 148.66 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 O-C-N 122.45 -0.441 . . . . 0.0 110.942 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -97.7 109.81 22.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.528 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.8 m -96.6 140.16 31.63 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.947 0.403 . . . . 0.0 110.942 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -143.9 132.08 21.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.005 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.528 ' HG2' HD12 ' A' ' 116' ' ' ILE . 19.3 mt-10 -102.2 136.99 41.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.967 0.413 . . . . 0.0 111.146 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -126.95 168.7 14.16 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.999 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.49 ' N ' ' CD ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -149.16 147.18 28.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.884 0.849 . . . . 0.0 111.73 -178.425 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.35 135.89 13.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.148 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -101.53 145.59 28.81 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 t -139.89 154.65 47.32 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.336 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -94.51 27.17 3.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.083 0.468 . . . . 0.0 110.908 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.54 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.9 mt -113.03 125.76 29.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.558 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -46.68 143.35 9.0 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 121.622 1.548 . . . . 0.0 111.5 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.48 ' CG ' ' HB2' ' A' ' 106' ' ' ALA . 26.9 Cg_exo -56.06 -26.17 58.13 Favored 'Trans proline' 0 N--CA 1.483 0.872 0 C-N-CA 122.221 1.947 . . . . 0.0 113.137 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.5 m -70.49 -31.05 68.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' A' ' 154' ' ' PRO . 0.5 OUTLIER -76.16 -55.88 5.17 Favored 'General case' 0 CA--C 1.498 -1.044 0 O-C-N 121.413 -0.804 . . . . 0.0 108.879 -179.594 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.54 HD21 ' HB ' ' A' ' 13' ' ' ILE . 2.3 mt -53.71 -37.88 63.73 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.694 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.515 ' O ' HG22 ' A' ' 23' ' ' VAL . 38.3 t80 -53.07 -59.21 4.83 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.754 ' HB2' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -67.48 -42.91 82.21 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 118.859 -1.136 . . . . 0.0 107.963 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.895 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -63.69 -2.58 1.79 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.866 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 2.8 m-85 -116.88 -9.83 11.11 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 24' ' ' LEU . 32.7 m -133.49 -50.92 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.004 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.9 pp -96.45 -31.5 12.79 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 1.004 ' N ' HD12 ' A' ' 24' ' ' LEU . 6.6 t70 -114.66 -4.9 12.73 Favored 'General case' 0 C--O 1.211 -0.958 0 O-C-N 121.716 -0.615 . . . . 0.0 111.563 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -66.48 -43.4 85.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.512 0.673 . . . . 0.0 111.809 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.549 ' HB2' ' HZ2' ' A' ' 54' ' ' LYS . 3.1 p30 -84.2 12.44 6.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.24 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -129.99 -9.35 4.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.796 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -96.64 -34.27 11.46 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.877 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.487 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 25.2 mt -54.06 -56.0 30.54 Favored Pre-proline 0 C--O 1.217 -0.63 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.23 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 22.9 Cg_endo -61.57 -24.84 78.6 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 121.979 1.786 . . . . 0.0 112.551 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -67.73 -57.48 6.28 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.856 0.836 . . . . 0.0 112.0 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.791 HD12 ' HB3' ' A' ' 145' ' ' LEU . 1.2 pt -95.2 -34.95 5.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.196 -176.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.863 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.23 64.45 0.13 Allowed Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.486 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 73.2 Cg_endo -76.33 -27.07 8.25 Favored 'Trans proline' 0 C--N 1.322 -0.858 0 C-N-CA 121.672 1.581 . . . . 0.0 108.18 175.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -73.61 -42.77 61.06 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.331 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.863 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -70.03 -79.89 0.06 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.217 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.486 HD13 HD22 ' A' ' 142' ' ' LEU . 1.2 mp -99.33 147.47 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 121.785 -0.572 . . . . 0.0 110.351 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -77.12 -53.21 8.05 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.297 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -176.96 166.87 2.49 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 110.613 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.61 145.09 6.45 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.246 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.406 ' N ' ' HZ3' ' A' ' 54' ' ' LYS . 10.9 pt-20 -142.35 144.67 33.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.049 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.622 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -77.38 139.92 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.404 0.621 . . . . 0.0 110.673 -179.243 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.11 -39.59 13.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.987 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.883 ' O ' HG23 ' A' ' 52' ' ' THR . 62.8 mt-10 -148.2 134.91 19.91 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.465 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.98 -156.35 23.61 Favored Glycine 0 CA--C 1.525 0.676 0 O-C-N 123.271 0.357 . . . . 0.0 112.232 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.4 p30 -137.82 3.28 2.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.896 0.379 . . . . 0.0 111.076 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.424 ' H ' HG21 ' A' ' 52' ' ' THR . . . 122.34 16.28 3.91 Favored Glycine 0 C--O 1.222 -0.65 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -178.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -110.3 -171.47 19.95 Favored Glycine 0 C--O 1.222 -0.606 0 CA-C-O 121.448 0.471 . . . . 0.0 111.926 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -61.66 125.14 16.01 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 122.514 2.143 . . . . 0.0 113.065 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.22 5.64 59.26 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.883 HG23 ' O ' ' A' ' 45' ' ' GLU . 87.0 m -93.39 140.26 29.76 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.457 -0.871 . . . . 0.0 110.851 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.76 132.57 67.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.622 ' HG2' HG23 ' A' ' 43' ' ' ILE . 3.9 mmtt -115.34 138.54 50.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.557 0.694 . . . . 0.0 110.957 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -119.52 122.04 40.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.972 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.575 ' N ' HD12 ' A' ' 56' ' ' ILE . 4.1 mp -105.49 135.0 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.235 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.0 m -113.26 119.39 37.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.391 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -96.14 -176.88 3.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 110.725 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.43 144.8 47.4 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.615 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 5.5 mp0 -59.63 -54.07 50.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.003 0.43 . . . . 0.0 110.491 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.86 61.2 3.44 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 p -139.25 175.32 9.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.821 0.343 . . . . 0.0 110.751 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -62.08 -52.05 65.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 110.682 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.27 142.05 30.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.162 0.506 . . . . 0.0 110.399 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.72 -55.2 0.27 Allowed Glycine 0 N--CA 1.461 0.366 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -135.7 151.31 50.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.935 0.398 . . . . 0.0 110.344 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.416 ' CG2' HD11 ' A' ' 85' ' ' LEU . 2.5 p -156.22 147.5 11.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.595 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -106.05 108.07 19.4 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.042 0.448 . . . . 0.0 112.052 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.522 ' C ' ' ND1' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -109.84 112.96 25.32 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.047 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -107.64 133.01 52.69 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.573 ' H ' HD12 ' A' ' 71' ' ' ILE . 4.1 mp -70.0 140.02 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.43 -55.07 2.94 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.19 -0.319 . . . . 0.0 111.638 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.7 m -165.05 141.14 5.57 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.5 mt -127.05 131.05 71.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.962 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 79' ' ' TYR . 46.1 m-20 -115.4 88.41 2.87 Favored 'General case' 0 C--O 1.203 -1.364 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -54.93 -30.32 58.41 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.44 -38.26 74.15 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.173 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.459 ' OG ' ' NZ ' ' A' ' 103' ' ' LYS . 0.9 OUTLIER -107.69 -10.4 15.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.944 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.597 ' N ' ' O ' ' A' ' 75' ' ' ASP . 20.3 m-85 59.8 47.46 10.22 Favored 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.49 -0.756 . . . . 0.0 110.372 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.5 t -106.33 145.78 31.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.997 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.608 ' CE1' ' CD2' ' A' ' 83' ' ' TYR . 31.0 t80 -131.71 122.84 26.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.121 0.486 . . . . 0.0 110.888 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 p -131.86 139.04 48.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.268 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.608 ' CD2' ' CE1' ' A' ' 81' ' ' TYR . 10.7 p90 -148.04 162.5 39.23 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 m -139.46 140.69 37.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.322 0.582 . . . . 0.0 111.252 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.556 HD12 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -82.77 113.87 20.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.371 178.566 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -85.89 -42.63 16.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.583 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 2.8 tp10 -153.61 172.96 16.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.964 0.411 . . . . 0.0 110.937 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.648 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.24 177.2 17.65 Favored Glycine 0 CA--C 1.509 -0.315 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.29 2.38 0.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.648 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -65.85 -34.24 77.7 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 124.837 1.255 . . . . 0.0 110.696 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.884 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -109.4 12.76 24.49 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 123.271 0.628 . . . . 0.0 109.905 -177.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 65.4 p 45.49 -126.27 1.22 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -130.86 -12.47 3.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.961 0.41 . . . . 0.0 111.198 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 p -105.42 -5.62 20.21 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.727 HG21 ' CD1' ' A' ' 98' ' ' ILE . 80.1 mt -97.78 152.34 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 122.239 1.019 . . . . 0.0 113.711 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.499 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -89.34 -60.38 1.96 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.89 178.536 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -168.29 149.22 4.93 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.272 0.558 . . . . 0.0 111.111 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.727 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -123.19 125.53 72.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.36 144.44 43.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.194 0.521 . . . . 0.0 111.311 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -136.34 133.58 36.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.458 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -129.17 135.58 49.03 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-O 120.869 0.366 . . . . 0.0 111.14 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.37 132.12 40.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.459 ' NZ ' ' OG ' ' A' ' 78' ' ' SER . 44.0 tttp -119.88 138.61 53.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.65 0.262 . . . . 0.0 110.486 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.5 mm? -96.98 125.53 41.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.292 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.82 130.31 41.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.48 ' HB2' ' CG ' ' A' ' 15' ' ' PRO . . . -74.0 135.5 43.14 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.062 -0.399 . . . . 0.0 110.761 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.499 ' HG ' ' HG1' ' A' ' 112' ' ' THR . 5.5 m -121.82 170.93 9.29 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 122.551 0.341 . . . . 0.0 110.095 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.97 -34.03 51.39 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.8 m -82.99 -12.38 57.33 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.312 1.445 . . . . 0.0 114.671 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.0 -89.47 0.14 Allowed Glycine 0 CA--C 1.537 1.418 0 C-N-CA 126.246 1.879 . . . . 0.0 111.246 -169.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 28.2 p -161.76 131.86 4.84 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.752 1.621 . . . . 0.0 110.87 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.499 ' HG1' ' HG ' ' A' ' 107' ' ' CYS . 46.1 m -98.98 133.18 43.61 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.556 0.693 . . . . 0.0 109.138 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mt -105.21 129.38 58.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.359 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -105.48 117.51 34.21 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.726 ' C ' HD13 ' A' ' 116' ' ' ILE . 15.6 m -110.14 117.69 34.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.51 0.671 . . . . 0.0 110.647 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.902 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -98.59 135.53 33.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 123.635 0.774 . . . . 0.0 110.293 -177.73 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.5 m -103.0 141.1 36.38 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.81 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.516 ' CE1' HG11 ' A' ' 2' ' ' VAL . 0.4 OUTLIER -136.3 93.88 2.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 0.0 110.905 -178.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.818 ' C ' HG23 ' A' ' 2' ' ' VAL . 3.3 m-85 -92.8 100.31 12.81 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.997 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -92.55 101.06 13.49 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.577 HG21 ' HA ' ' A' ' 126' ' ' GLU . 18.6 p -97.1 168.67 10.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.754 0.788 . . . . 0.0 112.033 -177.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -112.35 152.69 28.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.03 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . 34.13 -108.91 0.05 OUTLIER Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -105.76 -4.84 20.42 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.662 -0.317 . . . . 0.0 111.442 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.4 mp -47.96 152.79 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.577 ' HA ' HG21 ' A' ' 121' ' ' THR . 35.2 mt-10 -149.41 148.79 29.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.175 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.4 mm -87.62 124.77 41.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.45 ' HG3' ' H ' ' A' ' 129' ' ' GLU . 3.8 tptm -75.31 159.53 31.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.301 0.572 . . . . 0.0 111.908 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.45 ' H ' ' HG3' ' A' ' 128' ' ' LYS . 18.4 mm-40 -71.2 -35.41 71.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.938 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.448 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 8.0 pt-20 -67.87 -34.2 76.23 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.753 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -68.33 -49.04 63.09 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.154 0.502 . . . . 0.0 110.756 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.401 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 5.5 m -73.38 -22.34 19.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.805 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 57.4 mttt -66.92 -46.21 75.49 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 122.171 -0.33 . . . . 0.0 110.792 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.448 ' CG2' ' O ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -70.51 -44.94 76.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.667 0.27 . . . . 0.0 110.458 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.82 -47.01 69.38 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 0.1 OUTLIER -67.05 -47.01 72.65 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 122.485 -0.42 . . . . 0.0 110.316 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -54.04 -39.69 66.42 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.493 ' NZ ' ' O ' ' A' ' 37' ' ' ALA . 5.0 tttm -69.31 -53.83 17.65 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.12 -42.3 38.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.645 0.736 . . . . 0.0 110.251 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 51.4 t60 -64.09 -36.6 84.57 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.185 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.84 -41.73 99.31 Favored Glycine 0 C--O 1.222 -0.606 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -70.71 -40.3 72.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.511 ' CD2' ' O ' ' A' ' 143' ' ' PHE . 2.3 t80 -61.29 -28.17 69.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -69.32 -40.98 77.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.063 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.791 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.4 mm? -64.76 -56.74 11.75 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.722 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.642 ' O ' HD22 ' A' ' 150' ' ' LEU . 85.1 mt -54.78 -51.07 55.65 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.991 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 8.8 tt0 -47.66 -57.33 5.63 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.212 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 58.2 m -52.49 -43.78 65.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.139 0.495 . . . . 0.0 111.065 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.664 ' HB2' HD13 ' A' ' 33' ' ' ILE . 56.7 t80 -55.31 -47.67 75.26 Favored 'General case' 0 C--O 1.2 -1.546 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.895 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.0 mm? -68.55 -43.02 77.52 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 119.836 1.198 . . . . 0.0 112.06 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 147' ' ' GLU . 0.4 OUTLIER -62.09 -24.05 66.88 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 121.375 -0.828 . . . . 0.0 109.267 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -107.17 -13.32 15.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.607 0.717 . . . . 0.0 110.585 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.616 ' N ' ' O ' ' A' ' 149' ' ' TYR . 4.1 t-160 -154.97 65.61 4.69 Favored Pre-proline 0 C--N 1.309 -1.159 0 C-N-CA 124.723 1.209 . . . . 0.0 109.883 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.527 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 53.0 Cg_endo -74.38 -3.47 13.89 Favored 'Trans proline' 0 C--O 1.204 -1.176 0 C-N-CA 122.698 2.266 . . . . 0.0 111.392 -177.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 1.0 OUTLIER -81.39 4.3 21.34 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 123.009 0.524 . . . . 0.0 112.032 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -50.07 130.17 21.9 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 119.877 -1.764 . . . . 0.0 111.381 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.603 ' CG ' HD13 ' A' ' 24' ' ' LEU . 1.3 t80 54.48 6.32 0.11 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.476 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 2.1 p-10 . . . . . 0 N--CA 1.451 -0.414 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.237 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.862 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.865 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.4 p -135.02 147.93 29.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 O-C-N 122.37 -0.488 . . . . 0.0 111.105 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.412 ' HB2' ' CD1' ' A' ' 119' ' ' TYR . 7.7 m-85 -99.28 111.52 23.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.617 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.4 m -96.32 139.99 31.64 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.632 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -136.84 134.14 36.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.612 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -103.33 128.83 50.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.0 0.429 . . . . 0.0 111.078 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 115' ' ' SER . 0.1 OUTLIER -138.47 162.93 33.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.087 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.76 160.14 40.05 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.472 ' CE2' ' O ' ' A' ' 10' ' ' THR . 55.3 t80 -147.61 141.14 25.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.44 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.472 ' O ' ' CE2' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -93.14 148.63 21.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.726 0.298 . . . . 0.0 111.275 -179.255 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -143.91 154.35 43.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.775 0.321 . . . . 0.0 110.718 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -99.92 26.76 6.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.042 0.449 . . . . 0.0 110.634 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.472 ' HB ' HD21 ' A' ' 18' ' ' LEU . 2.2 mt -113.74 131.6 22.99 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.317 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -48.89 141.24 22.0 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.148 1.232 . . . . 0.0 110.797 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.552 ' HA ' HD12 ' A' ' 18' ' ' LEU . 9.4 Cg_endo -60.1 -23.57 73.93 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 122.365 2.043 . . . . 0.0 112.925 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.456 ' HB2' HH21 ' A' ' 17' ' ' ARG . 69.4 m -70.14 -30.56 67.76 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.456 HH21 ' HB2' ' A' ' 16' ' ' SER . 25.3 mmt-85 -79.43 -54.38 5.98 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.552 HD12 ' HA ' ' A' ' 15' ' ' PRO . 6.4 mt -48.57 -45.87 38.39 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.584 ' HD2' ' HH ' ' A' ' 81' ' ' TYR . 11.8 t80 -49.29 -57.79 6.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.22 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -67.37 -25.42 65.96 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.363 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.763 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -84.02 -2.58 56.9 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.563 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.469 ' CA ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -117.31 -10.94 10.66 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 117.917 0.326 . . . . 0.0 111.828 -179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.845 HG23 HD13 ' A' ' 24' ' ' LEU . 3.1 m -137.35 -34.61 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.868 HD23 ' CD1' ' A' ' 157' ' ' TYR . 2.4 mp -89.92 -53.47 4.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.824 0.738 . . . . 0.0 111.889 -176.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 93.8 m-20 -112.91 -4.01 14.01 Favored 'General case' 0 C--O 1.216 -0.659 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -53.67 -43.88 69.21 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.34 18.7 1.7 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.212 0.529 . . . . 0.0 110.712 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -139.37 -8.8 1.28 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 149' ' ' TYR . 0.8 OUTLIER -92.38 -30.31 15.86 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.156 -178.725 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.506 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.52 -54.53 47.6 Favored Pre-proline 0 C--O 1.214 -0.787 0 O-C-N 122.2 -0.313 . . . . 0.0 111.419 -179.534 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 18.3 Cg_endo -62.82 -25.52 74.59 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.894 1.729 . . . . 0.0 112.721 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -68.22 -59.74 2.99 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.836 0.827 . . . . 0.0 111.814 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.765 HD12 ' HB3' ' A' ' 145' ' ' LEU . 1.3 pt -95.95 -35.53 5.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.38 -176.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.781 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.36 65.24 0.14 Allowed Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 72.9 Cg_endo -76.55 -27.17 7.83 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 121.699 1.599 . . . . 0.0 108.474 175.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -74.2 -43.65 56.36 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.633 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.781 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -73.87 -78.6 0.09 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.099 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.8 mm -99.43 144.85 11.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 121.328 0.585 . . . . 0.0 110.017 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -78.42 -53.52 7.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.725 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.407 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -178.18 167.6 1.95 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.238 0.542 . . . . 0.0 110.597 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.407 ' H ' ' HG2' ' A' ' 40' ' ' GLN . . . -165.89 143.87 5.72 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.88 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -140.84 143.86 35.0 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.862 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.2 137.25 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 121.646 0.736 . . . . 0.0 111.823 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.4 mp -87.11 -38.77 16.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.188 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.88 ' O ' HG23 ' A' ' 52' ' ' THR . 54.9 mt-10 -148.24 136.83 21.56 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.09 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.09 -155.28 21.85 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -141.13 -5.6 1.11 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 122.894 0.477 . . . . 0.0 110.941 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.96 10.84 2.17 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.06 -172.84 19.15 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 117.114 0.457 . . . . 0.0 111.977 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -60.13 127.1 22.04 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 C-N-CA 122.732 2.288 . . . . 0.0 113.356 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.86 2.97 55.13 Favored Glycine 0 CA--C 1.507 -0.439 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.88 HG23 ' O ' ' A' ' 45' ' ' GLU . 88.8 m -94.3 134.76 36.44 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.265 -0.967 . . . . 0.0 111.368 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -122.67 122.3 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.862 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -131.99 151.39 51.77 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 122.83 1.3 . . . . 0.0 110.684 178.441 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.525 ' N ' ' HD2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -117.57 137.57 52.5 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.318 -1.764 . . . . 0.0 112.966 -177.365 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.9 mm -90.19 140.76 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 64.3 m -110.5 117.33 33.28 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -108.89 166.17 11.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.918 0.39 . . . . 0.0 110.82 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.0 144.44 49.5 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.24 -47.21 86.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.805 0.336 . . . . 0.0 110.785 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.71 61.42 3.47 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.7 m -142.91 178.37 7.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.831 0.348 . . . . 0.0 110.677 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -64.11 -50.43 68.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.923 0.392 . . . . 0.0 110.723 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.83 156.38 17.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.375 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -119.57 -61.41 0.26 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -145.37 155.04 42.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.825 0.345 . . . . 0.0 110.573 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 87' ' ' GLU . 2.4 p -156.02 153.75 7.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.77 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.507 ' CB ' HD11 ' A' ' 86' ' ' ILE . 3.5 mptp? -104.87 110.97 23.55 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.53 0.681 . . . . 0.0 111.631 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -103.32 113.51 27.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.84 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -105.75 131.54 52.98 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.022 0.439 . . . . 0.0 111.735 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.5 mt -85.42 145.26 8.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.373 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -102.55 -54.89 2.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.7 m -165.88 142.21 5.17 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 45.6 mt -123.05 130.62 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.355 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.2 m-20 -115.25 87.95 2.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.505 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -54.82 -30.29 56.92 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.509 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.85 -38.84 70.62 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.175 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.1 p -108.36 -11.09 15.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.117 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.53 ' N ' ' O ' ' A' ' 75' ' ' ASP . 6.6 m-85 63.17 40.89 8.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.877 -0.515 . . . . 0.0 109.925 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.499 ' C ' ' CD2' ' A' ' 81' ' ' TYR . 6.0 p -109.22 138.65 45.25 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.857 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.584 ' HH ' ' HD2' ' A' ' 19' ' ' PHE . 0.1 OUTLIER -132.13 133.57 44.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.723 0.297 . . . . 0.0 110.375 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 p -127.29 129.76 48.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.878 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -144.15 158.71 43.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.217 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 98' ' ' ILE . 9.7 m -147.65 141.85 26.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.119 0.485 . . . . 0.0 111.2 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.659 HD13 ' HB1' ' A' ' 90' ' ' ALA . 9.7 mt -80.6 120.63 24.8 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.507 HD11 ' CB ' ' A' ' 68' ' ' LYS . 3.8 pt -80.58 -44.98 21.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.808 0.337 . . . . 0.0 111.836 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.475 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 23.5 tt0 -156.74 172.26 18.92 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.591 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.95 178.12 17.83 Favored Glycine 0 CA--C 1.508 -0.357 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -61.37 1.13 0.22 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.659 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -67.55 -34.3 76.8 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 123.948 0.899 . . . . 0.0 109.963 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.89 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.52 16.38 21.56 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.692 0.797 . . . . 0.0 109.583 -177.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.8 p 49.48 -126.45 2.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -130.75 -12.9 3.75 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.091 -0.381 . . . . 0.0 111.217 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.0 -6.62 19.88 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.718 HG21 ' CD1' ' A' ' 98' ' ' ILE . 68.5 mt -99.13 152.36 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -176.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.507 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -90.32 -56.78 3.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.249 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -171.91 150.48 2.6 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.099 0.476 . . . . 0.0 110.867 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.718 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.52 125.08 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.473 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 0.7 OUTLIER -105.67 144.5 32.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.006 0.432 . . . . 0.0 112.054 -178.084 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.504 ' CZ ' ' OG ' ' A' ' 117' ' ' SER . 4.8 m-85 -140.2 128.21 22.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.531 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -129.32 133.6 47.52 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.5 OUTLIER -135.55 131.49 36.03 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.9 -0.5 . . . . 0.0 110.45 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.608 ' C ' HD23 ' A' ' 104' ' ' LEU . 7.1 ttpm? -123.16 134.77 54.16 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.772 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.53 126.53 44.13 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.814 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -125.59 137.14 58.64 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.572 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.486 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -72.62 133.88 44.88 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.873 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.405 ' N ' ' HA ' ' A' ' 111' ' ' SER . 7.1 t -121.22 175.2 6.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.128 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.66 -37.28 67.61 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.2 m -87.32 -6.15 58.62 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.793 1.296 . . . . 0.0 114.327 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 152.91 -88.48 0.13 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.671 1.129 . . . . 0.0 111.808 -174.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 85.5 p -161.98 131.91 4.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.547 1.939 . . . . 0.0 110.715 177.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.2 m -99.17 119.15 37.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.7 mt -91.13 128.95 42.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.36 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 102' ' ' THR . 4.1 mttm -105.45 117.17 33.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.745 ' C ' HD13 ' A' ' 116' ' ' ILE . 69.6 m -110.84 121.21 44.78 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 121.459 0.647 . . . . 0.0 111.119 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.945 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -101.9 136.4 34.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 123.457 0.703 . . . . 0.0 109.571 -177.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.504 ' OG ' ' CZ ' ' A' ' 100' ' ' TYR . 23.7 t -118.29 132.36 56.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.651 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.473 ' ND1' ' O ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -137.28 113.71 10.14 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.505 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.865 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -102.41 102.53 12.87 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.448 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.463 ' CE1' ' CD ' ' A' ' 96' ' ' GLU . 11.6 t-160 -92.0 109.47 20.82 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.233 0.539 . . . . 0.0 110.246 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.432 HG22 HD11 ' A' ' 127' ' ' ILE . 12.6 p -99.65 172.52 7.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.611 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -112.2 143.53 43.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.871 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 54.94 -112.79 3.07 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -112.9 -1.89 14.46 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.342 -0.504 . . . . 0.0 111.171 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -43.5 160.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.048 0.451 . . . . 0.0 110.614 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.481 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 92.8 mt-10 -148.21 144.28 27.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.038 0.447 . . . . 0.0 111.177 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.432 HD11 HG22 ' A' ' 121' ' ' THR . 19.9 mm -89.1 125.29 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -74.68 161.18 29.9 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.669 0.747 . . . . 0.0 111.837 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -70.29 -32.14 69.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.418 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.429 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 43.3 mm-40 -70.12 -33.57 71.99 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.746 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -67.33 -51.26 54.6 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.33 0.586 . . . . 0.0 110.629 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.5 m -71.93 -21.53 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.79 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -66.45 -46.56 76.01 Favored 'General case' 0 C--O 1.223 -0.328 0 O-C-N 122.276 -0.265 . . . . 0.0 110.892 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -70.38 -51.15 40.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.726 0.298 . . . . 0.0 110.5 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.78 -47.05 93.14 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -67.96 -47.44 68.63 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 122.616 -0.343 . . . . 0.0 110.916 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -55.32 -47.06 76.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.78 0.324 . . . . 0.0 110.549 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -69.37 -50.2 48.34 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.401 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.31 -41.97 39.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.535 0.683 . . . . 0.0 110.528 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -36.4 84.22 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -61.64 -31.17 76.9 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.42 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -74.18 -47.18 37.34 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.27 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.491 ' CD2' ' N ' ' A' ' 143' ' ' PHE . 1.6 m-30 -59.89 -21.88 61.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -72.52 -41.82 65.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.85 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.765 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.44 -56.53 11.94 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.893 179.3 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.701 ' O ' HD22 ' A' ' 150' ' ' LEU . 76.9 mt -53.24 -50.33 47.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.495 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -47.06 -57.02 5.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.751 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.5 t -50.35 -44.95 54.72 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.469 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.685 ' HB2' HD13 ' A' ' 33' ' ' ILE . 20.0 t80 -57.33 -48.77 78.13 Favored 'General case' 0 C--O 1.18 -2.581 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.846 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.7 mm? -65.1 -42.15 94.27 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 120.449 -1.407 . . . . 0.0 111.974 -177.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.5 OUTLIER -62.59 -25.25 67.98 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.407 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -107.26 -12.24 15.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.016 0.436 . . . . 0.0 110.687 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.651 ' N ' ' O ' ' A' ' 149' ' ' TYR . 49.5 m-70 -155.54 66.32 4.63 Favored Pre-proline 0 C--N 1.308 -1.215 0 C-N-CA 125.616 1.566 . . . . 0.0 110.411 -177.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.413 ' HB2' ' HE ' ' A' ' 17' ' ' ARG . 44.7 Cg_endo -72.13 -3.27 12.97 Favored 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 122.662 2.241 . . . . 0.0 111.843 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 1.5 p30 -77.1 3.07 13.34 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.073 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.532 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . . . -50.51 128.79 20.97 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 119.328 -2.108 . . . . 0.0 111.352 -178.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.868 ' CD1' HD23 ' A' ' 24' ' ' LEU . 16.5 t80 54.71 7.04 0.14 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.275 0.63 . . . . 0.0 112.137 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 3.3 p-10 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.278 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.823 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.2 p -134.92 148.79 29.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 O-C-N 122.364 -0.492 . . . . 0.0 110.988 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -97.77 110.29 22.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.721 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.7 m -96.97 140.45 31.49 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.577 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.95 134.7 26.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.368 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.511 ' HG2' HD12 ' A' ' 116' ' ' ILE . 3.1 mt-10 -102.4 129.69 48.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.582 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -126.71 168.67 14.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.172 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.13 146.98 22.04 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -145.64 140.71 27.52 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.302 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -107.49 147.93 29.85 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 111.804 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.5 t -145.87 162.73 37.07 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.548 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -98.77 24.92 7.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.406 . . . . 0.0 110.931 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.51 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.9 mt -108.57 127.69 26.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.2 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -46.98 144.69 8.06 Favored 'Trans proline' 0 C--N 1.327 -0.571 0 C-N-CA 121.16 1.24 . . . . 0.0 110.743 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 10.9 Cg_endo -61.02 -24.51 79.72 Favored 'Trans proline' 0 C--N 1.322 -0.843 0 C-N-CA 122.337 2.025 . . . . 0.0 113.031 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.2 m -71.01 -30.3 66.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -75.05 -56.41 4.77 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.51 HD21 ' HB ' ' A' ' 13' ' ' ILE . 3.7 mt -51.18 -45.0 61.65 Favored 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.485 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.656 ' O ' HG22 ' A' ' 23' ' ' VAL . 47.0 t80 -46.44 -58.96 3.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.727 ' CB ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -68.28 -41.56 80.83 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 119.023 -1.071 . . . . 0.0 108.484 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.831 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -65.01 -2.47 2.72 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.236 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 2.6 t80 -119.14 -8.71 10.12 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 19' ' ' PHE . 30.8 m -131.88 -51.27 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.0 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.7 pp -96.4 -31.28 12.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 1.0 ' N ' HD12 ' A' ' 24' ' ' LEU . 45.5 m-20 -114.63 -5.09 12.74 Favored 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 118.439 0.563 . . . . 0.0 111.506 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.697 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -68.56 -44.05 75.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.453 0.644 . . . . 0.0 112.289 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.46 18.15 2.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.882 0.849 . . . . 0.0 109.648 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.41 ' H ' ' H ' ' A' ' 29' ' ' LEU . 64.9 m-20 -139.55 -8.31 1.27 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.578 -1.192 . . . . 0.0 107.843 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.823 HD21 ' CD2' ' A' ' 149' ' ' TYR . 0.8 OUTLIER -96.21 -48.37 5.66 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.0 -178.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.525 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 85.2 mt -54.54 -43.22 97.8 Favored Pre-proline 0 C--O 1.212 -0.916 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.146 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 16.6 Cg_exo -64.46 -25.58 63.1 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.785 1.657 . . . . 0.0 110.97 177.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.02 -57.93 4.42 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.712 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.692 ' HB ' HD12 ' A' ' 145' ' ' LEU . 0.7 OUTLIER -96.54 -32.66 4.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.779 -176.552 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.816 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -103.83 63.22 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.513 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 72.6 Cg_endo -75.57 -20.97 15.28 Favored 'Trans proline' 0 C--N 1.32 -0.924 0 N-CA-C 107.063 -1.937 . . . . 0.0 107.063 174.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -73.42 -44.02 59.23 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.76 177.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.816 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -73.75 -75.02 0.16 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.266 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.9 mt -98.73 145.9 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 121.046 0.45 . . . . 0.0 110.204 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.83 -51.65 10.14 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.672 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.526 ' CD ' ' H ' ' A' ' 41' ' ' ALA . 8.4 tp-100 -177.3 164.62 2.18 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.958 0.409 . . . . 0.0 110.424 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.552 ' C ' ' HZ3' ' A' ' 54' ' ' LYS . . . -166.02 145.21 6.06 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 120.89 0.376 . . . . 0.0 110.889 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -145.09 145.25 31.35 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.666 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -76.52 139.88 18.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.57 0.7 . . . . 0.0 110.995 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 mp -89.68 -39.27 13.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.963 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.886 ' O ' HG23 ' A' ' 52' ' ' THR . 30.2 mt-10 -147.19 136.66 22.75 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.542 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.39 -156.06 22.52 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -142.5 1.48 1.37 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 122.456 -0.437 . . . . 0.0 111.343 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.471 ' O ' HD12 ' A' ' 74' ' ' ILE . . . 127.27 12.27 3.18 Favored Glycine 0 C--O 1.218 -0.864 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.45 -171.68 19.89 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 117.298 0.549 . . . . 0.0 111.905 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -61.86 125.94 17.74 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 C-N-CA 122.68 2.253 . . . . 0.0 113.028 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.76 5.07 56.76 Favored Glycine 0 N--CA 1.464 0.537 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.886 HG23 ' O ' ' A' ' 45' ' ' GLU . 91.4 m -93.66 137.91 32.43 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.379 -0.911 . . . . 0.0 110.959 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.55 130.14 72.91 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.666 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -114.52 140.0 49.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.608 0.718 . . . . 0.0 110.761 179.144 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.474 ' C ' HD12 ' A' ' 56' ' ' ILE . 41.1 tttm -118.37 123.15 44.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.7 178.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.758 ' N ' HD12 ' A' ' 56' ' ' ILE . 1.8 mp -104.32 123.75 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.6 m -101.42 118.43 36.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.075 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -92.72 -176.74 4.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.72 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.429 ' O ' ' OG ' ' A' ' 62' ' ' SER . . . -71.64 144.45 37.02 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.99 -47.94 84.12 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.991 -0.711 . . . . 0.0 111.073 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.92 61.93 3.34 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 59' ' ' GLY . 0.3 OUTLIER -152.37 174.97 13.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.171 0.51 . . . . 0.0 110.383 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.573 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 4.7 mp0 -65.09 -37.57 87.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.818 0.342 . . . . 0.0 110.603 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -98.76 140.38 33.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.378 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.415 ' O ' ' CD2' ' A' ' 66' ' ' TYR . . . -123.12 -56.2 0.19 Allowed Glycine 0 N--CA 1.461 0.363 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.415 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -145.82 151.35 37.77 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.772 0.32 . . . . 0.0 110.193 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 p -156.71 147.51 11.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.931 0.396 . . . . 0.0 110.945 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -104.81 108.06 19.35 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.298 0.57 . . . . 0.0 110.954 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.531 ' NE2' ' CD2' ' A' ' 83' ' ' TYR . 7.9 t60 -103.06 112.42 25.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.631 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -101.6 131.22 47.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 111.824 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.0 mt -83.08 137.23 21.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -96.71 -56.35 2.61 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.2 m -166.01 142.31 5.07 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.471 HD12 ' O ' ' A' ' 48' ' ' GLY . 30.2 mt -123.93 131.15 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.885 176.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.587 ' O ' ' N ' ' A' ' 79' ' ' TYR . 27.1 m-20 -115.53 87.74 2.73 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.487 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 6.6 pt-20 -54.57 -30.12 53.33 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.08 73.52 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.6 m -108.2 -9.82 15.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.007 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.587 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.3 m-85 62.63 48.28 4.42 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 121.393 -0.817 . . . . 0.0 110.236 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -106.66 143.76 34.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.346 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.527 ' CE1' ' CD1' ' A' ' 83' ' ' TYR . 26.3 t80 -132.16 117.94 18.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.683 0.278 . . . . 0.0 110.253 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -127.5 137.65 52.71 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.112 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.531 ' CD2' ' NE2' ' A' ' 69' ' ' HIS . 12.5 p90 -146.11 163.86 33.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.069 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 98' ' ' ILE . 4.3 m -146.57 135.68 22.59 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.05 0.452 . . . . 0.0 110.821 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.626 HD13 ' HB1' ' A' ' 90' ' ' ALA . 7.0 mt -79.76 116.55 19.99 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.602 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -82.76 -41.78 17.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.829 -177.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.602 ' N ' HD13 ' A' ' 86' ' ' ILE . 32.7 tt0 -153.8 171.52 18.79 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.09 -0.381 . . . . 0.0 110.586 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.599 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.19 177.54 18.71 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.78 2.1 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.626 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -66.09 -34.4 77.97 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.107 0.963 . . . . 0.0 110.239 177.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.892 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.26 14.7 22.68 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 123.543 0.737 . . . . 0.0 109.608 -177.645 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.461 ' CG2' ' NE2' ' A' ' 131' ' ' HIS . 68.8 p 46.96 -126.24 1.58 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -130.35 -11.14 4.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.106 0.479 . . . . 0.0 110.913 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.3 -7.55 18.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.724 HG21 ' CD1' ' A' ' 98' ' ' ILE . 90.7 mt -98.74 152.51 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 121.941 0.877 . . . . 0.0 113.259 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.509 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -90.86 -55.23 3.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.343 177.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.43 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 2.5 ptmm? -172.79 149.82 2.03 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.782 0.325 . . . . 0.0 110.84 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.724 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.29 125.42 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.041 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.34 144.49 43.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.925 0.393 . . . . 0.0 111.665 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -136.82 136.37 38.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.705 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -131.15 132.41 44.75 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -139.13 133.98 32.22 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.962 -0.461 . . . . 0.0 110.945 -178.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.56 ' C ' HD23 ' A' ' 104' ' ' LEU . 25.9 ttpp -121.26 134.64 55.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.774 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -97.62 126.01 42.69 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.358 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.95 136.99 58.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.609 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -73.03 135.37 44.89 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.751 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.55 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 53.8 t -120.92 171.13 8.86 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.55 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -54.25 -35.7 55.77 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.3 p -89.69 -8.48 52.28 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.327 -1.69 . . . . 0.0 114.694 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 159.32 -85.44 0.12 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.069 1.318 . . . . 0.0 111.958 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 87.9 p -163.79 132.1 3.66 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.888 1.675 . . . . 0.0 110.961 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 78.8 m -99.28 118.24 35.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 61.9 mt -92.38 128.24 44.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.842 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 102' ' ' THR . 6.1 mtpt -105.42 116.68 32.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.799 ' C ' HD13 ' A' ' 116' ' ' ILE . 13.0 t -111.62 124.85 53.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.276 0.56 . . . . 0.0 111.101 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.914 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -106.04 136.43 40.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 123.25 0.62 . . . . 0.0 109.749 -177.652 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.1 m -113.18 133.09 55.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.982 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -137.08 105.35 5.72 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 120.83 0.348 . . . . 0.0 110.405 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.823 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -101.69 103.39 14.17 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.081 -0.387 . . . . 0.0 110.045 179.201 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -90.91 107.88 19.49 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.226 0.536 . . . . 0.0 109.879 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.2 p -99.38 176.01 5.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.602 0.715 . . . . 0.0 111.442 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -112.31 146.12 38.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.432 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 54.21 -111.69 2.17 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -117.67 3.68 12.34 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.345 -0.503 . . . . 0.0 111.01 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.463 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -45.85 160.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.941 0.4 . . . . 0.0 110.43 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.463 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 36.5 mt-10 -149.39 148.51 29.55 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.916 0.388 . . . . 0.0 111.267 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.408 HG13 ' CB ' ' A' ' 119' ' ' TYR . 3.5 mm -89.3 125.38 42.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.44 ' HG3' ' H ' ' A' ' 129' ' ' GLU . 18.6 tptt -74.45 160.33 31.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.157 0.503 . . . . 0.0 111.56 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.44 ' H ' ' HG3' ' A' ' 128' ' ' LYS . 49.8 mt-10 -70.09 -34.05 72.67 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.488 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 134' ' ' VAL . 1.8 mp0 -69.9 -27.79 65.09 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.461 ' NE2' ' CG2' ' A' ' 92' ' ' THR . 10.2 t-80 -72.89 -48.1 40.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.313 0.577 . . . . 0.0 110.87 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.8 m -79.76 -32.06 14.1 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.98 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -64.19 -46.18 85.1 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.216 -0.302 . . . . 0.0 110.721 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.564 HG23 ' N ' ' A' ' 135' ' ' GLY . 25.8 m -70.26 -47.71 65.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.62 0.248 . . . . 0.0 110.453 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.564 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -62.73 -41.44 99.84 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -66.84 -46.25 75.68 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.751 -0.264 . . . . 0.0 110.684 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -54.28 -47.08 72.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 110.059 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 141' ' ' GLY . 22.8 tttp -64.58 -54.88 25.07 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.432 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -48.46 -40.78 27.47 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.698 0.761 . . . . 0.0 110.467 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.437 ' O ' ' ND1' ' A' ' 140' ' ' HIS . 0.6 OUTLIER -61.51 -36.49 80.67 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.958 0.885 . . . . 0.0 109.203 178.31 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' LYS . . . -62.68 -35.55 92.04 Favored Glycine 0 C--O 1.223 -0.54 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -66.9 -45.8 76.86 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.996 -0.708 . . . . 0.0 109.116 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -59.0 -30.1 67.73 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -64.83 -39.54 93.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.418 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.692 HD12 ' HB ' ' A' ' 33' ' ' ILE . 1.1 mm? -68.12 -56.99 6.81 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.174 0.511 . . . . 0.0 110.263 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.752 HG23 HD13 ' A' ' 29' ' ' LEU . 61.1 mt -57.91 -51.89 64.94 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.977 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -48.2 -56.84 6.91 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.814 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.7 t -51.75 -42.96 62.74 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.421 0.629 . . . . 0.0 110.141 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.823 ' CD2' HD21 ' A' ' 29' ' ' LEU . 8.6 t80 -55.69 -51.94 65.56 Favored 'General case' 0 C--O 1.178 -2.678 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.841 ' H ' HD22 ' A' ' 150' ' ' LEU . 2.0 mm? -64.38 -43.02 95.8 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.239 -1.538 . . . . 0.0 111.883 -177.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -62.65 -24.33 67.56 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.531 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 149' ' ' TYR . 0.0 OUTLIER -106.98 -13.27 15.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.15 0.5 . . . . 0.0 110.657 178.3 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.641 ' N ' ' O ' ' A' ' 149' ' ' TYR . 42.7 m80 -155.39 66.31 4.7 Favored Pre-proline 0 C--N 1.305 -1.365 0 C-N-CA 125.944 1.697 . . . . 0.0 110.275 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.74 -3.35 13.59 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 122.7 2.267 . . . . 0.0 111.582 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.483 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 5.4 p30 -77.96 4.07 13.05 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.433 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.427 ' O ' ' CD ' ' A' ' 20' ' ' LYS . . . -50.13 129.08 20.46 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 119.038 -2.289 . . . . 0.0 111.343 -178.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.507 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 36.9 t80 53.5 6.32 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.203 0.525 . . . . 0.0 112.219 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 5.2 p-10 . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.091 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.884 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.833 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.2 p -134.79 147.72 29.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 O-C-N 122.494 -0.415 . . . . 0.0 111.163 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -98.33 110.23 22.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.321 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.514 HG23 ' NE2' ' A' ' 118' ' ' HIS . 68.8 m -96.13 134.3 39.37 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.794 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -133.55 131.05 39.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -102.97 126.7 50.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.881 0.372 . . . . 0.0 110.945 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -135.63 167.3 21.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.968 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -156.14 159.24 38.85 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -146.21 140.87 26.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.219 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.4 m -109.41 147.41 32.84 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.937 0.398 . . . . 0.0 111.831 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 t -145.68 154.76 42.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.432 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -87.86 25.44 1.53 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.124 0.488 . . . . 0.0 110.982 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.508 ' HB ' HD21 ' A' ' 18' ' ' LEU . 2.4 mt -108.55 126.84 28.63 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.651 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -46.08 148.38 2.98 Favored 'Trans proline' 0 C--N 1.325 -0.675 0 C-N-CA 121.161 1.241 . . . . 0.0 110.857 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.709 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 18.1 Cg_endo -64.86 -24.35 61.26 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 122.553 2.169 . . . . 0.0 112.915 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.565 ' CB ' HH11 ' A' ' 17' ' ' ARG . 66.3 m -70.51 -29.64 66.2 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.565 HH11 ' CB ' ' A' ' 16' ' ' SER . 0.4 OUTLIER -75.88 -56.63 4.49 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 15' ' ' PRO . 3.2 mt -48.38 -48.84 36.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.784 ' O ' HG22 ' A' ' 23' ' ' VAL . 40.2 t80 -44.66 -60.0 2.22 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.704 178.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.624 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -70.99 -24.89 62.48 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.213 -0.93 . . . . 0.0 110.787 -179.277 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.852 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -79.45 -14.37 58.96 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.808 -177.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.604 ' CE2' HD11 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -116.45 -6.52 11.72 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.595 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.858 HG23 ' CD1' ' A' ' 24' ' ' LEU . 3.0 m -129.99 -36.7 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.858 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.9 mp -92.55 -53.96 3.98 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.19 0.904 . . . . 0.0 112.206 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.82 16.42 20.45 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.547 ' HB2' ' HA ' ' A' ' 22' ' ' PHE . . . -66.08 -43.2 88.05 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 121.062 0.458 . . . . 0.0 111.128 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.04 21.17 1.09 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.073 0.939 . . . . 0.0 110.501 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.426 ' H ' ' H ' ' A' ' 29' ' ' LEU . 4.2 m120 -139.46 -8.85 1.27 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.633 HD13 ' CD1' ' A' ' 149' ' ' TYR . 0.0 OUTLIER -94.43 -38.21 11.06 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.418 -1.719 . . . . 0.0 111.004 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.538 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.4 mm -55.38 -44.25 99.54 Favored Pre-proline 0 C--O 1.21 -0.986 0 CA-C-O 120.954 0.407 . . . . 0.0 111.928 -178.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 22.9 Cg_exo -63.1 -25.85 73.21 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.409 2.073 . . . . 0.0 113.304 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -83.28 -55.62 4.23 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.099 0.476 . . . . 0.0 112.27 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.64 HD13 ' HB3' ' A' ' 145' ' ' LEU . 0.8 OUTLIER -95.09 -38.31 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.54 -177.06 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.594 ' CA ' ' HG ' ' A' ' 145' ' ' LEU . . . -108.38 61.36 0.24 Allowed Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.493 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 87.9 Cg_endo -79.23 -28.94 3.41 Favored 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 121.812 1.675 . . . . 0.0 109.19 175.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -74.98 -42.58 57.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.258 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.576 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -69.07 -74.89 0.12 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.282 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.27 146.36 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.858 0.361 . . . . 0.0 110.071 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -78.12 -50.23 12.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.211 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.712 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 54.8 tp60 -176.36 165.74 2.75 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.918 0.389 . . . . 0.0 110.469 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.737 ' HB1' ' HE2' ' A' ' 54' ' ' LYS . . . -165.51 147.85 7.64 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.232 0.539 . . . . 0.0 110.583 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.858 ' C ' ' HZ1' ' A' ' 54' ' ' LYS . 23.2 pt-20 -148.09 140.88 24.68 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.099 -0.375 . . . . 0.0 110.764 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.501 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -76.72 140.29 17.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.391 0.615 . . . . 0.0 110.415 -179.079 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.69 -40.01 13.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.173 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.934 ' O ' HG23 ' A' ' 52' ' ' THR . 21.0 mt-10 -140.98 133.84 29.0 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.749 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.21 -156.68 36.0 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.1 p30 -136.38 -7.38 1.99 Allowed 'General case' 0 C--N 1.321 -0.642 0 O-C-N 122.535 -0.391 . . . . 0.0 111.108 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.446 ' O ' HD12 ' A' ' 74' ' ' ILE . . . 142.71 14.89 0.33 Allowed Glycine 0 C--O 1.22 -0.747 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.68 -170.76 20.3 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 117.236 0.518 . . . . 0.0 111.929 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -61.57 125.8 17.6 Favored 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 122.787 2.325 . . . . 0.0 113.373 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.22 6.01 59.08 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.934 HG23 ' O ' ' A' ' 45' ' ' GLU . 60.0 m -93.81 140.52 29.57 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.147 -1.027 . . . . 0.0 111.45 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -121.9 129.76 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.858 ' HZ1' ' C ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -114.48 138.3 50.77 Favored 'General case' 0 C--O 1.22 -0.449 0 O-C-N 123.288 0.368 . . . . 0.0 110.689 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -120.6 125.75 48.55 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.148 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -103.47 140.63 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.263 178.626 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.435 HG23 ' CE2' ' A' ' 66' ' ' TYR . 38.5 m -118.83 119.65 35.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.518 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -92.5 -178.59 4.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.902 0.382 . . . . 0.0 110.685 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.26 143.81 29.77 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.466 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 9.1 pt-20 -59.73 -46.57 88.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 0.0 110.864 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.466 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -100.65 61.67 0.62 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.404 ' OG ' ' N ' ' A' ' 63' ' ' GLN . 22.8 t -138.04 177.06 8.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.025 0.44 . . . . 0.0 110.79 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.404 ' N ' ' OG ' ' A' ' 62' ' ' SER . 10.3 mm100 -60.98 -54.19 48.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 110.842 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.55 151.9 20.54 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.73 -61.72 0.22 Allowed Glycine 0 CA--C 1.52 0.349 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.435 ' CE2' HG23 ' A' ' 57' ' ' THR . 5.0 m-85 -145.6 151.33 37.93 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.811 0.338 . . . . 0.0 110.892 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 p -149.24 138.3 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.852 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.537 ' O ' HG13 ' A' ' 86' ' ' ILE . 10.1 mtpp -107.38 116.5 32.04 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 121.623 0.725 . . . . 0.0 112.187 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.646 ' N ' ' ND1' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -112.9 123.58 50.64 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.361 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -98.82 126.61 44.52 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.149 0.499 . . . . 0.0 111.532 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.455 HD12 HG22 ' A' ' 52' ' ' THR . 33.9 mt -79.94 136.09 24.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.374 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.4 ' O ' ' OG ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -97.27 -55.78 2.74 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -177.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 3.3 m -165.29 141.77 5.57 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 48' ' ' GLY . 12.6 mt -120.69 131.1 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.483 176.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 79' ' ' TYR . 54.7 m-20 -114.42 88.26 2.82 Favored 'General case' 0 C--O 1.206 -1.205 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 177.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.447 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 19.6 mt-10 -54.61 -30.54 55.08 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.89 -39.46 71.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.159 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.4 m -108.41 -10.07 15.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.109 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.579 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.5 m-85 62.13 46.96 5.94 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 121.502 -0.749 . . . . 0.0 110.083 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.7 p -105.76 149.23 26.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.076 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.563 ' CE1' ' CD1' ' A' ' 83' ' ' TYR . 39.5 t80 -142.38 118.65 10.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.39 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.4 p -128.89 128.44 43.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.594 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.563 ' CD1' ' CE1' ' A' ' 81' ' ' TYR . 19.7 p90 -145.32 162.35 37.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.872 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.68 143.19 37.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.004 0.431 . . . . 0.0 111.161 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.794 HD13 ' HB1' ' A' ' 90' ' ' ALA . 6.9 mt -83.81 121.98 28.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.879 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 68' ' ' LYS . 2.5 pp -84.87 -41.4 15.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.309 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.525 ' CB ' HD12 ' A' ' 86' ' ' ILE . 16.2 tt0 -156.6 172.31 18.79 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.176 -0.327 . . . . 0.0 110.569 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.614 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.82 177.45 17.29 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -61.52 1.98 0.2 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 122.415 1.102 . . . . 0.0 108.466 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.794 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -68.08 -34.61 76.74 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.174 0.989 . . . . 0.0 110.386 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.871 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.59 15.57 21.98 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.298 0.639 . . . . 0.0 110.263 -177.421 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.418 ' C ' ' O ' ' A' ' 91' ' ' LEU . 63.3 p 43.16 -126.47 0.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.507 -178.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -130.73 -13.07 3.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.966 0.412 . . . . 0.0 111.187 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 p -104.7 -5.8 20.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.924 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.83 HG21 ' CD1' ' A' ' 98' ' ' ILE . 69.3 mt -98.66 152.27 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-O 121.918 0.866 . . . . 0.0 113.038 -176.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.497 ' N ' HG22 ' A' ' 95' ' ' ILE . 17.3 pt-20 -99.97 -45.51 5.66 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.349 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.434 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 0.3 OUTLIER -172.72 145.9 1.56 Allowed 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 121.655 0.74 . . . . 0.0 112.224 -179.562 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.83 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.94 124.35 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.701 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.39 144.72 31.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.973 0.416 . . . . 0.0 111.774 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -139.05 127.99 23.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -129.02 134.5 48.15 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.2 OUTLIER -140.04 131.51 26.96 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.782 -0.574 . . . . 0.0 110.084 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.424 ' C ' HD23 ' A' ' 104' ' ' LEU . 14.4 ttmm -123.0 134.04 54.34 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.614 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.19 132.77 43.42 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -134.41 137.76 50.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.104 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.709 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -72.77 135.6 45.31 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.452 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.44 ' N ' ' HA ' ' A' ' 111' ' ' SER . 7.9 t -121.16 170.2 9.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.842 0.353 . . . . 0.0 110.176 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.75 -31.51 46.06 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 112.033 -0.427 . . . . 0.0 112.033 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.8 m -88.16 -11.74 45.99 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 119.559 -2.142 . . . . 0.0 115.827 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.02 -89.47 0.12 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.88 1.229 . . . . 0.0 110.478 -169.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 92.0 p -163.74 130.33 3.24 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.077 1.351 . . . . 0.0 110.928 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 105' ' ' VAL . 34.4 m -99.91 118.38 36.22 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 51.3 mt -92.21 132.08 37.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.167 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 102' ' ' THR . 2.9 mtpp -105.78 116.64 32.29 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.721 ' C ' HD13 ' A' ' 116' ' ' ILE . 11.1 t -111.07 118.32 35.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.282 0.563 . . . . 0.0 110.826 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.919 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -100.42 135.6 35.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 123.337 0.655 . . . . 0.0 109.818 -177.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.9 p -108.96 135.4 50.2 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.49 -0.777 . . . . 0.0 108.918 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.514 ' NE2' HG23 ' A' ' 4' ' ' THR . 31.6 m-70 -135.72 93.99 3.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 120.922 0.392 . . . . 0.0 110.627 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.833 ' C ' HG23 ' A' ' 2' ' ' VAL . 79.6 m-85 -83.24 101.8 11.49 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.174 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.457 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 1.5 t-80 -96.59 104.32 16.3 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.9 p -101.56 176.19 5.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.403 0.62 . . . . 0.0 111.618 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.99 157.58 20.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.68 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 42.26 -109.98 0.22 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -116.29 5.66 13.65 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.819 -0.224 . . . . 0.0 110.968 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -49.01 159.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.117 0.484 . . . . 0.0 110.41 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.467 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 40.3 mt-10 -148.5 145.8 28.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.961 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.8 mm -88.88 124.53 41.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp -74.97 161.64 29.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.502 0.667 . . . . 0.0 111.77 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -70.48 -34.18 72.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.642 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.416 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 6.2 pt-20 -69.02 -30.83 69.29 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.647 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -67.99 -53.97 22.03 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.383 0.611 . . . . 0.0 110.363 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.91 -19.63 22.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.407 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 137' ' ' GLU . 52.4 tttm -66.85 -46.69 74.27 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 122.295 -0.253 . . . . 0.0 110.704 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -69.17 -46.52 77.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.762 0.315 . . . . 0.0 110.404 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.28 -47.41 71.76 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -67.95 -46.48 71.33 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.566 -0.373 . . . . 0.0 111.055 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 21.0 tp10 -54.36 -46.73 73.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.021 0.439 . . . . 0.0 110.363 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.468 ' O ' ' CD2' ' A' ' 142' ' ' LEU . 10.3 ttmt -69.21 -52.75 24.73 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.78 -46.81 41.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.395 0.617 . . . . 0.0 110.55 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -62.08 -36.98 83.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.96 -52.54 51.66 Favored Glycine 0 C--O 1.225 -0.435 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.468 ' CD2' ' O ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -60.01 -42.51 94.47 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 122.096 -0.65 . . . . 0.0 109.366 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -59.15 -30.02 67.85 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.507 ' HB3' ' HZ2' ' A' ' 144' ' ' LYS . 0.3 OUTLIER -76.88 -34.61 57.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.12 178.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.64 ' HB3' HD13 ' A' ' 33' ' ' ILE . 1.7 mm? -70.43 -53.89 14.58 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.073 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.658 ' O ' HD22 ' A' ' 150' ' ' LEU . 7.3 mt -54.58 -49.19 68.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -46.38 -53.77 10.34 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.4 t -52.29 -42.25 63.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.307 0.575 . . . . 0.0 110.992 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.633 ' CD1' HD13 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -58.14 -44.67 87.94 Favored 'General case' 0 C--O 1.2 -1.542 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.786 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.852 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.1 mm? -66.87 -43.56 83.24 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 119.328 0.967 . . . . 0.0 112.073 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.532 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.4 OUTLIER -60.72 -25.1 66.2 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.58 -13.19 15.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.148 0.499 . . . . 0.0 110.362 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.604 ' N ' ' O ' ' A' ' 149' ' ' TYR . 22.5 t60 -153.9 67.21 5.82 Favored Pre-proline 0 C--N 1.312 -1.05 0 C-N-CA 124.354 1.062 . . . . 0.0 110.688 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.99 -3.28 11.18 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 122.409 2.073 . . . . 0.0 111.521 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.619 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.1 OUTLIER -80.95 3.36 23.15 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.918 -178.6 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.55 129.95 19.83 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 119.453 -2.029 . . . . 0.0 111.237 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.715 ' CD2' HD23 ' A' ' 24' ' ' LEU . 10.9 t80 54.3 7.1 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.205 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.619 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.366 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.66 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.883 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.1 p -134.97 148.38 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.568 -0.372 . . . . 0.0 111.141 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -98.52 110.84 23.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.32 177.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 m -96.53 139.85 32.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.788 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -140.53 134.03 30.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.18 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.423 ' HG2' HD12 ' A' ' 116' ' ' ILE . 8.2 mt-10 -102.79 128.81 49.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.071 0.462 . . . . 0.0 110.964 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 115' ' ' SER . 0.0 OUTLIER -128.19 165.5 20.32 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -178.843 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 1.3 pt-20 -156.38 151.42 26.29 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -142.7 140.81 31.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.088 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -107.06 145.81 31.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.844 0.354 . . . . 0.0 111.687 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 t -146.14 154.53 41.89 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.822 0.344 . . . . 0.0 110.688 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -90.94 24.5 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.112 0.482 . . . . 0.0 110.691 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.451 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.9 mt -107.59 128.02 26.7 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.359 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -46.1 143.78 7.05 Favored 'Trans proline' 0 C--N 1.326 -0.617 0 C-N-CA 121.308 1.339 . . . . 0.0 110.994 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HA ' HD12 ' A' ' 18' ' ' LEU . 11.0 Cg_endo -61.1 -23.58 77.59 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.45 2.1 . . . . 0.0 113.108 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.0 m -70.43 -31.54 68.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -76.62 -56.41 4.64 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 15' ' ' PRO . 2.8 mt -50.67 -43.06 57.33 Favored 'General case' 0 C--O 1.212 -0.905 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.721 ' O ' HG22 ' A' ' 23' ' ' VAL . 16.9 t80 -47.67 -58.3 4.45 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.932 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.86 ' CB ' HD21 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.85 -41.09 75.35 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.12 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.838 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -63.6 -2.55 1.71 Allowed 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.33 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.614 ' CE1' ' CE2' ' A' ' 143' ' ' PHE . 6.6 t80 -119.23 -9.24 9.99 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.913 HG23 HD13 ' A' ' 24' ' ' LEU . 5.4 m -134.67 -46.22 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.913 HD13 HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -99.19 -32.01 11.44 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 120.607 1.548 . . . . 0.0 112.422 -178.757 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.703 ' N ' HD22 ' A' ' 24' ' ' LEU . 0.5 OUTLIER -112.14 -5.12 14.26 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 118.437 0.562 . . . . 0.0 111.645 -178.782 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -67.49 -42.53 82.74 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.28 0.562 . . . . 0.0 111.657 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -82.91 18.94 1.47 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.991 0.901 . . . . 0.0 109.906 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.41 ' H ' ' C ' ' A' ' 26' ' ' ALA . 67.7 m-80 -139.27 -9.08 1.29 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.548 HD21 ' CD2' ' A' ' 149' ' ' TYR . 1.2 mt -94.12 -31.42 14.18 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.923 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.526 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.76 -53.97 54.66 Favored Pre-proline 0 C--O 1.214 -0.764 0 O-C-N 122.175 -0.328 . . . . 0.0 111.266 -179.321 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 22.8 Cg_endo -63.08 -24.92 73.28 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 121.908 1.739 . . . . 0.0 112.468 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -69.66 -60.41 2.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.73 0.776 . . . . 0.0 111.972 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.778 HD12 ' HB3' ' A' ' 145' ' ' LEU . 1.4 pt -95.91 -35.68 5.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.349 -176.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.94 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.37 65.03 0.14 Allowed Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.47 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 72.2 Cg_endo -76.31 -28.07 7.43 Favored 'Trans proline' 0 C--N 1.32 -0.93 0 C-N-CA 121.638 1.559 . . . . 0.0 108.276 174.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -73.91 -43.59 57.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.317 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.94 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -71.52 -74.02 0.17 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.801 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.556 HD13 HD22 ' A' ' 142' ' ' LEU . 1.1 mp -101.74 144.21 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 121.264 0.554 . . . . 0.0 109.818 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.9 ttpt -78.86 -62.16 1.78 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.603 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.753 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 57.2 tp60 -164.5 165.69 21.1 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.922 0.391 . . . . 0.0 110.012 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.753 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -165.93 149.44 7.73 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.06 0.457 . . . . 0.0 111.181 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -150.17 142.79 24.54 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.075 -179.351 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.471 ' H ' HG13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -76.96 141.34 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-O 122.015 0.912 . . . . 0.0 111.212 178.564 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.764 ' N ' HD12 ' A' ' 44' ' ' LEU . 4.0 mp -88.36 -40.57 13.46 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.9 ' O ' HG23 ' A' ' 52' ' ' THR . 32.6 mt-10 -149.12 134.18 18.15 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.457 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.64 -156.38 23.14 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -134.19 -1.59 2.91 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.451 -0.44 . . . . 0.0 111.509 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.498 ' N ' HG21 ' A' ' 52' ' ' THR . . . 124.86 18.36 2.65 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -111.48 -172.9 19.48 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HD3' ' H ' ' A' ' 74' ' ' ILE . 10.8 Cg_endo -60.55 125.31 17.0 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 122.094 1.862 . . . . 0.0 112.96 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.5 -0.32 56.86 Favored Glycine 0 N--CA 1.462 0.428 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.9 HG23 ' O ' ' A' ' 45' ' ' GLU . 99.1 m -93.91 136.95 33.66 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 114.377 -0.912 . . . . 0.0 111.229 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.625 HG22 HD13 ' A' ' 44' ' ' LEU . 2.5 mp -113.95 132.35 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.496 ' HB2' HD11 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -122.7 138.54 54.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.899 0.381 . . . . 0.0 110.522 179.082 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.68 ' HB3' HD11 ' A' ' 44' ' ' LEU . 29.4 ttpt -119.9 130.2 54.73 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.098 -0.376 . . . . 0.0 110.906 178.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.6 mm -95.93 140.8 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.795 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.7 m -108.71 117.75 35.01 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 59' ' ' GLY . 5.8 t80 -104.22 172.12 6.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 0.0 110.961 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.453 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -57.55 144.43 40.63 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -60.3 -67.45 0.39 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.899 0.38 . . . . 0.0 111.242 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.46 61.96 3.15 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 t -137.75 -172.47 3.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.882 0.373 . . . . 0.0 110.664 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -58.69 -55.28 37.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.638 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -99.67 155.66 17.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.599 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.22 -59.36 0.13 Allowed Glycine 0 CA--C 1.52 0.363 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -145.5 149.2 34.2 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.937 0.399 . . . . 0.0 110.674 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 p -156.9 143.72 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.721 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.694 ' HB3' HD11 ' A' ' 86' ' ' ILE . 36.2 mttp -106.63 112.51 25.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.338 0.59 . . . . 0.0 112.069 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.445 ' CE1' ' CD2' ' A' ' 85' ' ' LEU . 11.3 m-70 -101.3 123.47 45.46 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -106.57 119.32 38.99 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.027 -0.421 . . . . 0.0 111.5 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.663 HD13 HG22 ' A' ' 52' ' ' THR . 4.0 mp -70.35 145.23 13.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -105.56 -54.88 2.41 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.7 144.4 6.11 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.461 ' H ' ' HD3' ' A' ' 50' ' ' PRO . 45.3 mt -127.14 125.88 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.162 173.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 79' ' ' TYR . 13.4 m-20 -113.91 88.81 2.93 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.506 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 13.7 mt-10 -54.47 -30.36 52.83 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.68 70.04 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.006 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.93 -11.42 15.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.122 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.7 m-85 62.23 42.7 9.18 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.597 -0.689 . . . . 0.0 110.259 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.4 t -106.86 141.75 37.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.127 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -132.09 118.71 19.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.8 t -128.53 135.19 49.07 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.136 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -144.82 159.83 42.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.493 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -138.26 139.48 39.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.228 0.537 . . . . 0.0 110.821 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.577 HD13 ' HB1' ' A' ' 90' ' ' ALA . 8.7 mt -80.17 115.55 19.79 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.694 HD11 ' HB3' ' A' ' 68' ' ' LYS . 4.1 pt -80.79 -44.24 21.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.676 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -152.02 172.11 16.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.863 0.363 . . . . 0.0 110.745 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.579 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.19 177.12 18.72 Favored Glycine 0 C--O 1.238 0.377 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -61.52 -0.34 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 122.204 1.002 . . . . 0.0 108.442 178.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.579 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -62.46 -34.36 76.67 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.816 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.859 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.16 14.83 22.74 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 123.61 0.764 . . . . 0.0 110.198 -177.549 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.6 p 46.42 -126.5 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -130.66 -12.86 3.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.649 0.738 . . . . 0.0 111.068 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.76 -6.34 20.42 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.015 0.526 . . . . 0.0 112.108 -177.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.717 HG21 ' CD1' ' A' ' 98' ' ' ILE . 71.4 mt -98.77 152.6 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.712 0 CA-C-O 121.997 0.903 . . . . 0.0 113.347 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.509 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -91.4 -57.33 2.81 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.167 177.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.404 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 28.2 pttt -171.93 151.16 2.7 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.027 0.442 . . . . 0.0 110.584 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.717 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.56 124.15 71.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.558 ' C ' ' HD1' ' A' ' 118' ' ' HIS . 0.1 OUTLIER -103.13 144.49 31.24 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 122.844 0.458 . . . . 0.0 111.896 -178.338 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.421 ' CZ ' ' OG ' ' A' ' 117' ' ' SER . 0.4 OUTLIER -139.13 127.93 23.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.5 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -133.57 132.86 41.38 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -133.43 136.32 45.12 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 122.208 -0.307 . . . . 0.0 110.425 -178.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -120.58 133.69 55.36 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -98.54 130.75 45.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.943 0.401 . . . . 0.0 110.003 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -132.62 137.24 54.55 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.063 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -73.01 135.71 44.96 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.649 178.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.429 ' N ' ' HA ' ' A' ' 111' ' ' SER . 13.2 t -121.25 168.82 11.2 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 122.593 0.357 . . . . 0.0 110.201 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.8 -29.81 42.71 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 112.233 -0.347 . . . . 0.0 112.233 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.6 p -92.06 -11.66 35.24 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 119.849 -1.971 . . . . 0.0 114.389 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.84 -86.14 0.12 Allowed Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.47 1.509 . . . . 0.0 112.066 -175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 88.4 p -164.54 130.97 2.97 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 125.86 1.664 . . . . 0.0 110.688 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.4 m -99.64 118.35 35.99 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 42.4 mt -91.83 131.23 39.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.118 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 102' ' ' THR . 8.9 mtpt -105.47 117.12 33.2 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.706 ' C ' HD13 ' A' ' 116' ' ' ILE . 24.9 p -110.16 118.64 36.9 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.368 0.604 . . . . 0.0 111.047 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.94 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -99.89 136.91 29.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 123.536 0.734 . . . . 0.0 109.641 -177.809 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.421 ' OG ' ' CZ ' ' A' ' 100' ' ' TYR . 6.8 m -118.26 131.72 56.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.477 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.558 ' HD1' ' C ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -138.2 112.26 8.51 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.883 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -102.83 103.77 13.98 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.211 -0.306 . . . . 0.0 110.441 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -90.58 107.24 19.04 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.207 0.527 . . . . 0.0 110.01 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.4 p -98.88 176.73 5.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.47 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -109.49 159.58 16.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.628 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 39.63 -109.77 0.13 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.464 -0.655 . . . . 0.0 111.464 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -116.04 3.66 13.62 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 122.702 -0.293 . . . . 0.0 111.069 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.483 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -45.58 160.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.316 0.579 . . . . 0.0 110.393 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.483 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 43.4 tt0 -149.49 145.66 26.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.212 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.0 mm -88.95 125.52 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -74.74 161.66 29.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.499 0.666 . . . . 0.0 111.53 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 1.0 OUTLIER -69.71 -47.55 62.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.192 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.469 ' O ' HG22 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -59.81 -24.68 64.35 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.118 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -72.95 -51.34 18.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.259 0.552 . . . . 0.0 111.256 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 m -77.31 -27.1 15.76 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.934 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.4 tttm -67.28 -45.91 75.21 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.275 -0.266 . . . . 0.0 110.9 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 135' ' ' GLY . 34.5 m -69.18 -45.38 79.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.886 0.375 . . . . 0.0 110.344 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.487 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -65.21 -41.76 96.69 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -67.14 -45.67 76.42 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 120.494 0.188 . . . . 0.0 110.691 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -53.96 -42.53 69.02 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.447 ' O ' ' CD2' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -69.48 -53.4 19.38 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.582 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.415 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.31 -41.73 39.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.583 0.706 . . . . 0.0 110.628 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -67.04 -36.34 81.86 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.93 -36.71 91.04 Favored Glycine 0 C--O 1.223 -0.576 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.584 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -73.31 -41.59 63.36 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.614 ' CE2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -59.87 -23.06 63.12 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.506 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.484 ' HZ2' ' C ' ' A' ' 144' ' ' LYS . 1.2 ttpp -76.01 -40.17 54.17 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.259 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.778 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.5 mm? -67.21 -55.85 12.34 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.31 0.576 . . . . 0.0 109.624 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.729 ' O ' HD22 ' A' ' 150' ' ' LEU . 60.6 mt -53.48 -50.92 46.35 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.358 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -47.51 -54.27 12.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.983 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.8 t -53.45 -42.65 67.37 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.117 0.484 . . . . 0.0 111.494 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.678 ' HB2' HD13 ' A' ' 33' ' ' ILE . 19.2 t80 -60.27 -44.72 95.07 Favored 'General case' 0 C--O 1.199 -1.553 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.838 HD11 ' HB2' ' A' ' 21' ' ' ALA . 1.8 mm? -68.99 -42.55 76.34 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 119.993 1.27 . . . . 0.0 111.629 -178.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -24.39 67.71 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 121.483 -0.761 . . . . 0.0 109.207 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -106.2 -13.15 15.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.566 0.698 . . . . 0.0 110.641 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 149' ' ' TYR . 16.9 t-80 -155.22 66.33 4.79 Favored Pre-proline 0 C--N 1.312 -1.063 0 C-N-CA 124.818 1.247 . . . . 0.0 110.181 -178.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.4 ' CD ' ' O ' ' A' ' 150' ' ' LEU . 43.1 Cg_endo -72.86 -4.01 14.61 Favored 'Trans proline' 0 N--CA 1.48 0.702 0 C-N-CA 122.472 2.115 . . . . 0.0 111.921 -178.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.553 ' OD1' ' CG ' ' A' ' 153' ' ' HIS . 3.8 p30 -82.51 3.48 28.24 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.07 0.948 . . . . 0.0 111.756 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.54 131.1 21.08 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 119.599 -1.938 . . . . 0.0 111.25 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.514 ' CG ' ' O ' ' A' ' 157' ' ' TYR . 80.9 t80 56.16 6.04 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 4.3 p-10 . . . . . 0 C--N 1.322 -0.595 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.31 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.803 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.9 p -134.65 148.35 29.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 O-C-N 122.585 -0.362 . . . . 0.0 110.961 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -97.46 110.36 22.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.298 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.496 ' OG1' ' CD2' ' A' ' 118' ' ' HIS . 96.9 m -96.03 132.36 41.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.758 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.17 128.36 37.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.976 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -102.7 133.66 47.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.742 0.306 . . . . 0.0 110.705 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -126.37 170.87 11.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.472 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.96 149.37 27.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.309 0.576 . . . . 0.0 111.976 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -155.43 141.02 17.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.12 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 m -106.27 143.84 33.82 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.92 0.391 . . . . 0.0 111.941 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.0 t -133.75 154.49 50.93 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.262 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -93.42 18.86 9.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.896 0.379 . . . . 0.0 111.003 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.442 ' O ' HD11 ' A' ' 18' ' ' LEU . 2.1 mt -107.09 127.73 27.41 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -44.82 144.83 3.26 Favored 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 121.117 1.211 . . . . 0.0 110.797 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.667 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 19.4 Cg_endo -62.81 -23.2 74.36 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 122.452 2.101 . . . . 0.0 112.542 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.592 ' C ' ' HZ2' ' A' ' 20' ' ' LYS . 70.1 m -69.3 -33.45 73.21 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.415 HH21 ' HB2' ' A' ' 16' ' ' SER . 11.5 mmt-85 -76.66 -56.83 4.26 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 118.882 0.764 . . . . 0.0 109.066 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.464 ' H ' ' HG ' ' A' ' 18' ' ' LEU . 4.0 mt -48.57 -48.64 38.71 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.728 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.76 ' O ' HG22 ' A' ' 23' ' ' VAL . 27.9 t80 -48.41 -55.18 11.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.192 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.592 ' HZ2' ' C ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -70.23 -26.71 63.98 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.416 -0.913 . . . . 0.0 109.622 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.796 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -81.3 -2.9 50.83 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.994 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.503 ' CA ' ' HB2' ' A' ' 26' ' ' ALA . 1.6 t80 -118.78 -8.3 10.36 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.908 HG23 ' CD1' ' A' ' 24' ' ' LEU . 3.1 m -135.08 -35.46 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.908 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.4 mp -90.51 -54.69 3.89 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.652 1.114 . . . . 0.0 111.694 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -113.03 -3.93 13.94 Favored 'General case' 0 C--O 1.205 -1.243 0 O-C-N 122.261 -0.274 . . . . 0.0 111.129 -178.501 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.957 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -46.07 -39.22 8.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 118.037 0.381 . . . . 0.0 111.526 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -85.41 12.98 7.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.629 0.728 . . . . 0.0 110.855 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -134.51 -10.32 2.46 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 124.969 1.308 . . . . 0.0 108.62 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -95.84 -43.3 7.91 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 124.862 1.265 . . . . 0.0 109.188 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.957 HG22 ' O ' ' A' ' 26' ' ' ALA . 1.7 tt -55.62 -45.46 99.87 Favored Pre-proline 0 C--O 1.215 -0.757 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.486 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.846 ' HD3' HG23 ' A' ' 30' ' ' ILE . 36.4 Cg_endo -63.41 -24.67 71.02 Favored 'Trans proline' 0 N--CA 1.482 0.85 0 CA-C-N 121.231 1.475 . . . . 0.0 111.256 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -67.49 -54.45 20.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.663 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.767 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.9 OUTLIER -95.8 -35.75 6.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.248 -176.438 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.863 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.63 63.85 0.15 Allowed Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.489 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 80.3 Cg_endo -77.1 -27.78 6.48 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 N-CA-C 107.917 -1.609 . . . . 0.0 107.917 174.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -75.23 -43.24 52.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.17 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.863 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -70.5 -75.27 0.12 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.861 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.602 ' HB ' HD11 ' A' ' 30' ' ' ILE . 1.1 mm -99.98 147.78 7.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 CA-C-O 121.665 0.745 . . . . 0.0 111.021 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.772 ' HD2' ' H ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.08 -64.07 1.09 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.203 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.433 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -178.12 166.79 1.98 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.105 0.478 . . . . 0.0 110.345 179.452 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.433 ' H ' ' HG2' ' A' ' 40' ' ' GLN . . . -165.96 143.76 5.6 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.987 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.81 145.95 35.32 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.431 ' H ' HG13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -84.82 139.08 18.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.683 0.754 . . . . 0.0 110.94 -179.451 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.837 ' N ' HD12 ' A' ' 44' ' ' LEU . 3.0 mp -89.49 -39.09 13.57 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.933 ' O ' HG23 ' A' ' 52' ' ' THR . 22.2 mt-10 -141.92 133.1 26.26 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.78 -156.41 28.8 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -134.19 -13.89 2.37 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 122.33 -0.512 . . . . 0.0 110.924 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.39 18.03 0.24 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -110.88 -173.24 19.91 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -61.16 126.07 18.56 Favored 'Trans proline' 0 C--N 1.321 -0.904 0 C-N-CA 122.258 1.972 . . . . 0.0 113.319 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.81 1.89 56.24 Favored Glycine 0 N--CA 1.463 0.462 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.933 HG23 ' O ' ' A' ' 45' ' ' GLU . 88.5 m -93.85 140.38 29.74 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.218 -0.991 . . . . 0.0 111.046 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.517 HG13 ' HE ' ' A' ' 70' ' ' ARG . 2.1 mp -117.65 133.13 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.17 141.02 52.41 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 121.037 0.446 . . . . 0.0 110.957 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' HB3' HD11 ' A' ' 44' ' ' LEU . 33.7 ttpt -119.27 131.98 55.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.813 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.7 mm -94.04 142.01 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.678 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 18.3 m -108.86 117.58 34.56 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.579 ' HA ' ' HD3' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -90.53 162.24 15.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.779 0.323 . . . . 0.0 111.363 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.59 144.34 30.16 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.621 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 2.1 pm0 -56.73 -47.17 80.6 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 122.422 -0.458 . . . . 0.0 110.298 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.34 62.38 1.76 Allowed Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 62.7 p -136.54 174.54 10.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.058 0.456 . . . . 0.0 111.205 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.438 ' N ' ' CD ' ' A' ' 63' ' ' GLN . 13.0 mp0 -69.03 -50.01 52.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.25 156.24 17.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.053 0.454 . . . . 0.0 110.631 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.78 -61.49 0.51 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.27 154.82 42.14 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.071 0.462 . . . . 0.0 110.776 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.426 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 2.0 p -145.82 157.09 12.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.958 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.426 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 26.4 mtmt -105.78 113.12 26.48 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.446 0.641 . . . . 0.0 112.425 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -105.78 105.71 15.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.993 0.917 . . . . 0.0 109.579 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.517 ' HE ' HG13 ' A' ' 53' ' ' ILE . 25.3 ttm180 -101.63 131.19 47.98 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.953 -0.467 . . . . 0.0 111.433 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.564 HD13 ' CG2' ' A' ' 52' ' ' THR . 4.4 mp -73.91 145.36 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -102.49 -56.01 2.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 119.227 -0.416 . . . . 0.0 112.073 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.8 m -165.35 141.38 5.38 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.5 mt -124.73 131.44 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.852 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.614 ' O ' ' N ' ' A' ' 79' ' ' TYR . 54.8 m-20 -114.84 87.92 2.75 Favored 'General case' 0 C--O 1.199 -1.575 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.454 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 9.5 pt-20 -54.41 -30.58 52.74 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.04 77.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.3 m -107.86 -9.98 15.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.736 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.614 ' N ' ' O ' ' A' ' 75' ' ' ASP . 20.7 m-85 58.54 48.63 11.68 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 121.415 -0.803 . . . . 0.0 110.538 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.2 p -106.58 147.22 29.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.985 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.635 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 35.9 t80 -132.1 125.86 32.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.968 0.413 . . . . 0.0 110.919 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 p -133.65 136.09 44.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.362 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.635 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 6.5 p90 -146.78 160.67 41.96 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.8 m -144.64 138.39 27.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.133 0.492 . . . . 0.0 111.229 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.65 HD22 ' HB1' ' A' ' 90' ' ' ALA . 4.5 mp -80.36 119.99 23.81 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.485 ' H ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -84.5 -42.9 17.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -178.08 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' A' ' 88' ' ' GLY . 1.2 tm-20 -157.64 173.55 16.68 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.326 -0.234 . . . . 0.0 110.493 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.631 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.74 177.44 17.34 Favored Glycine 0 CA--C 1.509 -0.316 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -61.54 1.76 0.21 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.65 ' HB1' HD22 ' A' ' 85' ' ' LEU . . . -64.88 -34.82 79.3 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.361 1.064 . . . . 0.0 110.071 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.874 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.0 16.31 21.98 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 123.702 0.801 . . . . 0.0 108.847 -178.552 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.8 p 44.89 -126.96 1.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -130.59 -9.62 4.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.133 0.492 . . . . 0.0 110.736 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.45 -7.25 18.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.171 -177.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.745 HG21 ' CD1' ' A' ' 98' ' ' ILE . 88.7 mt -100.04 152.5 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-O 122.085 0.945 . . . . 0.0 113.523 -177.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.492 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -90.42 -56.85 3.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.598 177.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -172.19 148.28 2.14 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.267 0.556 . . . . 0.0 111.454 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.745 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.31 130.1 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.745 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.26 145.07 46.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.917 0.389 . . . . 0.0 111.53 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -139.89 133.17 29.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.562 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.427 ' O ' HG12 ' A' ' 116' ' ' ILE . 39.0 tt0 -128.46 134.29 48.7 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 121.036 0.446 . . . . 0.0 110.963 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.14 133.01 52.99 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.714 -0.616 . . . . 0.0 109.634 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -120.11 133.0 55.63 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.4 mm? -97.81 125.42 42.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.132 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.8 OUTLIER -137.65 136.86 45.85 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.667 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -73.16 139.45 46.36 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.173 178.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.454 ' N ' ' HA ' ' A' ' 111' ' ' SER . 17.3 p -120.73 168.11 11.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.61 -26.85 32.89 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 121.398 -0.429 . . . . 0.0 112.125 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.2 m -91.27 -14.11 31.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 119.563 -2.139 . . . . 0.0 116.591 174.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.46 -89.91 0.12 Allowed Glycine 0 CA--C 1.537 1.424 0 O-C-N 120.454 -1.404 . . . . 0.0 110.981 -161.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.454 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 17.2 t -164.84 133.78 3.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 119.035 1.417 . . . . 0.0 111.196 -178.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 105' ' ' VAL . 52.1 m -100.06 126.05 46.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.422 ' CG1' HD13 ' A' ' 104' ' ' LEU . 11.1 mt -99.54 127.79 51.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.428 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -105.52 117.45 34.04 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.792 ' C ' HD13 ' A' ' 116' ' ' ILE . 8.0 p -110.58 121.77 46.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.442 0.639 . . . . 0.0 110.542 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.924 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -104.73 135.26 43.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.296 0.569 . . . . 0.0 109.948 -177.358 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 71.1 m -107.73 138.33 44.16 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.8 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.496 ' CD2' ' OG1' ' A' ' 4' ' ' THR . 26.3 m80 -136.13 93.47 2.91 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.813 0.34 . . . . 0.0 110.454 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.803 ' C ' HG23 ' A' ' 2' ' ' VAL . 60.9 m-85 -88.12 102.16 14.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.213 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -90.28 102.87 15.59 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.519 HG21 ' HA ' ' A' ' 126' ' ' GLU . 1.2 p -92.47 160.57 15.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.905 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.406 ' H ' HG22 ' A' ' 125' ' ' ILE . 4.3 ptmt -112.39 142.5 44.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.029 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.24 -109.64 0.94 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -116.46 -2.67 11.98 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.497 -0.413 . . . . 0.0 110.657 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 125' ' ' ILE . 1.2 tp -49.3 160.65 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.88 0.371 . . . . 0.0 110.693 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.519 ' HA ' HG21 ' A' ' 121' ' ' THR . 2.7 pp20? -149.38 149.64 31.17 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.572 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 34.2 mm -87.05 125.16 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -75.2 162.35 28.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.485 0.66 . . . . 0.0 112.06 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -69.02 -42.19 76.73 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.855 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.459 ' O ' HG22 ' A' ' 134' ' ' VAL . 5.2 mp0 -61.57 -25.55 67.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.825 0.345 . . . . 0.0 110.174 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -72.59 -51.03 21.45 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.283 0.564 . . . . 0.0 111.038 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 m -77.03 -25.95 15.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.942 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -67.34 -46.31 73.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 122.332 -0.23 . . . . 0.0 110.787 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 135' ' ' GLY . 35.6 m -70.2 -45.01 77.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.885 0.374 . . . . 0.0 110.593 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.491 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -66.16 -46.62 78.57 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -66.89 -46.89 73.51 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.636 -0.332 . . . . 0.0 110.714 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -55.2 -47.24 75.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.011 0.434 . . . . 0.0 110.031 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -66.7 -52.87 39.76 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.885 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.422 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.22 -42.64 41.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.594 0.712 . . . . 0.0 110.567 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.509 ' HD1' ' C ' ' A' ' 140' ' ' HIS . 1.8 t-80 -61.16 -36.56 80.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.859 0.838 . . . . 0.0 109.052 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.9 -38.88 96.12 Favored Glycine 0 C--O 1.221 -0.665 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.571 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -66.1 -46.82 76.28 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -59.62 -24.48 63.86 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.68 -36.28 65.29 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.59 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.767 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.1 mm? -71.22 -57.67 4.27 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.426 0.631 . . . . 0.0 109.839 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.727 ' O ' HD22 ' A' ' 150' ' ' LEU . 50.4 mt -54.54 -50.65 57.09 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.133 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -47.43 -56.76 6.32 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.864 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 20.5 p -50.68 -44.65 57.81 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.343 0.592 . . . . 0.0 111.285 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.668 ' HB2' HD13 ' A' ' 33' ' ' ILE . 28.2 t80 -59.88 -45.41 92.58 Favored 'General case' 0 C--O 1.193 -1.917 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.796 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.1 mm? -65.79 -42.74 90.37 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 120.443 1.474 . . . . 0.0 111.565 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.53 -24.38 67.48 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.305 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -105.77 -13.08 15.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.321 0.581 . . . . 0.0 110.768 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.637 ' N ' ' O ' ' A' ' 149' ' ' TYR . 42.1 m80 -155.96 67.34 4.69 Favored Pre-proline 0 C--N 1.31 -1.131 0 C-N-CA 125.167 1.387 . . . . 0.0 110.202 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -72.35 -3.48 13.46 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 122.501 2.134 . . . . 0.0 111.704 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.5 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 13.0 m-20 -73.16 2.61 6.9 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.163 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -50.11 130.15 22.01 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 119.161 -2.212 . . . . 0.0 111.275 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.669 ' CG ' HD23 ' A' ' 24' ' ' LEU . 92.8 t80 54.03 6.18 0.09 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.546 0.688 . . . . 0.0 112.124 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.5 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 4.0 p-10 . . . . . 0 C--N 1.324 -0.503 0 O-C-N 120.994 -1.066 . . . . 0.0 110.055 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.885 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.823 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.5 p -134.54 148.65 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 O-C-N 122.488 -0.419 . . . . 0.0 111.02 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.73 110.27 22.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.659 177.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.516 ' OG1' ' CD2' ' A' ' 118' ' ' HIS . 90.4 m -95.93 140.06 31.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 0.0 111.013 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -143.28 128.09 18.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.172 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.495 ' HG2' HD12 ' A' ' 116' ' ' ILE . 1.6 tt0 -102.89 131.19 49.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.874 0.368 . . . . 0.0 111.324 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -134.59 172.7 12.56 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 122.636 0.375 . . . . 0.0 110.387 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.42 153.49 30.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.202 0.525 . . . . 0.0 112.39 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -149.01 138.41 21.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.235 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.19 147.49 25.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 111.771 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.3 t -145.8 161.44 39.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.499 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -96.27 25.92 4.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.854 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.617 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.5 mt -116.3 125.41 28.54 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.879 -178.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -47.83 149.93 4.9 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.034 1.823 . . . . 0.0 111.784 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.423 ' CG ' ' HB2' ' A' ' 106' ' ' ALA . 22.8 Cg_exo -60.93 -24.88 80.37 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.307 2.005 . . . . 0.0 112.59 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.447 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 45.6 m -68.68 -34.29 75.42 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -76.16 -55.77 5.27 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.617 HD21 ' HB ' ' A' ' 13' ' ' ILE . 4.4 mt -51.4 -41.85 61.01 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.733 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.555 ' O ' HG22 ' A' ' 23' ' ' VAL . 61.2 t80 -50.97 -57.48 8.48 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.733 ' CB ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -68.09 -40.08 82.74 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.254 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.858 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -66.62 -2.45 4.86 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.263 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.443 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 2.6 m-85 -118.67 -9.64 10.18 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.6 HG23 ' N ' ' A' ' 24' ' ' LEU . 33.9 m -131.76 -50.91 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.059 HD12 ' N ' ' A' ' 25' ' ' ASP . 2.7 pp -99.65 -30.52 12.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -176.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 1.059 ' N ' HD12 ' A' ' 24' ' ' LEU . 62.4 m-20 -112.84 -5.59 13.86 Favored 'General case' 0 C--O 1.214 -0.802 0 O-C-N 121.599 -0.688 . . . . 0.0 111.516 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -68.13 -40.99 82.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.259 0.552 . . . . 0.0 111.383 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.585 ' CB ' ' HZ1' ' A' ' 54' ' ' LYS . 13.9 m-20 -84.37 17.8 2.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.027 0.918 . . . . 0.0 110.889 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.403 ' H ' ' H ' ' A' ' 29' ' ' LEU . 62.7 m-20 -139.07 -9.0 1.33 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.781 HD12 HG23 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -89.23 -47.49 8.02 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.655 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.593 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -60.83 -43.03 90.35 Favored Pre-proline 0 C--O 1.208 -1.111 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 28.7 Cg_endo -62.2 -26.14 77.47 Favored 'Trans proline' 0 C--N 1.321 -0.905 0 CA-C-N 120.635 1.263 . . . . 0.0 112.252 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -76.94 -61.64 1.91 Allowed 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.351 0.596 . . . . 0.0 112.343 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.452 HD13 ' HB2' ' A' ' 149' ' ' TYR . 2.1 pt -94.4 -34.55 5.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.617 -177.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.71 ' HB2' ' HG ' ' A' ' 145' ' ' LEU . . . -102.68 67.3 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 123.224 0.609 . . . . 0.0 112.513 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.424 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 65.2 Cg_endo -72.7 -20.18 23.28 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.219 1.28 . . . . 0.0 108.882 176.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -72.87 -38.63 66.95 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.517 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.766 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -70.09 -81.91 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.443 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.616 HD12 ' N ' ' A' ' 38' ' ' ILE . 2.0 mp -109.57 144.07 18.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.0 110.13 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.69 -42.43 28.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.139 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.526 ' CD ' ' H ' ' A' ' 41' ' ' ALA . 7.9 tp-100 -173.63 164.74 4.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.526 ' H ' ' CD ' ' A' ' 40' ' ' GLN . . . -166.03 145.16 6.02 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.141 0.495 . . . . 0.0 110.893 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -148.32 142.99 26.59 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.106 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.716 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -76.75 140.53 17.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.409 0.623 . . . . 0.0 110.863 -179.112 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.746 ' N ' HD12 ' A' ' 44' ' ' LEU . 3.6 mp -89.55 -40.41 12.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.652 ' O ' HG23 ' A' ' 52' ' ' THR . 12.5 mm-40 -143.51 134.21 25.11 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.346 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.98 -155.12 22.27 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.896 -0.482 . . . . 0.0 111.896 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -133.95 -12.52 2.55 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 123.096 0.558 . . . . 0.0 111.232 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.483 ' O ' HD12 ' A' ' 74' ' ' ILE . . . 135.96 12.31 1.15 Allowed Glycine 0 C--O 1.221 -0.663 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.436 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -106.36 -170.87 22.99 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -60.76 126.28 19.35 Favored 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 122.803 2.336 . . . . 0.0 113.119 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.96 5.84 57.25 Favored Glycine 0 N--CA 1.465 0.612 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 45' ' ' GLU . 15.0 m -93.12 141.53 28.31 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.832 -0.684 . . . . 0.0 111.47 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.674 HG22 HD13 ' A' ' 44' ' ' LEU . 2.2 mp -116.46 133.57 62.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.716 ' HG2' HG23 ' A' ' 43' ' ' ILE . 4.7 tmtp? -119.67 140.32 50.83 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.542 0.686 . . . . 0.0 111.148 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.742 ' CB ' HD11 ' A' ' 44' ' ' LEU . 54.6 tttt -119.17 121.19 39.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.258 178.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 56' ' ' ILE . 5.2 mp -105.52 127.12 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.5 m -102.57 118.88 37.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.245 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.53 177.37 6.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.585 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.41 144.45 40.78 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -60.03 -48.37 81.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.852 0.358 . . . . 0.0 110.752 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.7 61.62 3.45 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 m -149.54 174.66 12.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.936 0.398 . . . . 0.0 110.585 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -66.79 -41.32 87.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.918 0.389 . . . . 0.0 110.664 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -91.4 149.48 21.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.552 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.416 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . -127.85 -62.39 0.13 Allowed Glycine 0 N--CA 1.462 0.378 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -146.35 146.95 30.85 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.728 0.299 . . . . 0.0 110.211 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -157.02 147.66 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.93 0.395 . . . . 0.0 110.947 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -105.59 113.06 26.4 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.271 0.558 . . . . 0.0 111.243 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.86 110.15 21.02 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -101.96 129.69 48.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.918 0.389 . . . . 0.0 112.037 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 mp -70.86 137.26 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -96.25 -53.75 3.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.44 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.4 m -164.5 140.74 6.1 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.483 HD12 ' O ' ' A' ' 48' ' ' GLY . 44.8 mt -129.16 130.65 68.06 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.15 177.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.625 ' O ' ' N ' ' A' ' 79' ' ' TYR . 38.4 m-20 -115.39 87.62 2.7 Favored 'General case' 0 C--O 1.194 -1.86 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.638 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.8 pm0 -55.32 -39.57 70.11 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.31 -37.08 45.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.131 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.21 -9.84 15.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.32 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.2 m-85 62.03 51.96 3.48 Favored 'General case' 0 N--CA 1.438 -1.068 0 O-C-N 121.055 -1.028 . . . . 0.0 110.101 -177.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 55.5 p -106.41 144.09 33.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.056 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -134.66 121.26 20.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.023 0.439 . . . . 0.0 110.933 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 m -136.42 147.38 47.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.226 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -162.65 169.76 19.57 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.779 0.323 . . . . 0.0 110.628 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -146.49 139.11 25.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.131 0.491 . . . . 0.0 110.771 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.806 HD13 ' HB1' ' A' ' 90' ' ' ALA . 11.1 mt -79.95 111.62 16.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.61 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -75.59 -40.75 41.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.4 -178.386 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.61 ' N ' HD13 ' A' ' 86' ' ' ILE . 16.0 tt0 -155.24 171.98 18.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.81 0.338 . . . . 0.0 110.295 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.18 177.82 17.7 Favored Glycine 0 CA--C 1.509 -0.334 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -61.87 2.29 0.22 Allowed 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.806 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -66.61 -34.36 77.71 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.173 0.989 . . . . 0.0 110.35 177.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.876 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.31 14.96 22.56 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.175 0.59 . . . . 0.0 110.341 -177.095 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.4 p 45.16 -126.22 1.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.36 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -130.45 -13.01 3.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.967 0.413 . . . . 0.0 111.475 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.9 p -104.75 -5.73 21.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.79 HG21 ' CD1' ' A' ' 98' ' ' ILE . 72.1 mt -99.12 152.95 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 CA-C-O 122.059 0.933 . . . . 0.0 113.472 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -93.46 -54.01 3.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.919 178.279 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -171.66 147.64 2.33 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 121.623 0.725 . . . . 0.0 111.028 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.79 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.41 121.98 66.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.73 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 118' ' ' HIS . 11.4 t -107.39 146.12 32.05 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.412 0.625 . . . . 0.0 111.438 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -136.68 131.5 33.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.286 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.413 ' O ' HG12 ' A' ' 116' ' ' ILE . 29.4 tt0 -127.96 133.66 49.23 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.4 OUTLIER -139.88 133.0 29.63 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.894 -0.504 . . . . 0.0 109.899 -179.006 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.404 ' C ' HD23 ' A' ' 104' ' ' LEU . 87.1 tttt -119.77 133.22 55.69 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -102.43 128.28 49.09 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.8 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.94 137.27 55.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.239 -178.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.77 134.65 45.05 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.336 178.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 38.8 t -121.3 172.26 8.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.826 0.346 . . . . 0.0 110.152 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.482 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.73 -35.28 52.18 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.8 p -87.06 -16.79 34.56 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.696 -1.473 . . . . 0.0 113.87 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 162.24 -77.75 0.16 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.379 1.466 . . . . 0.0 111.779 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 83.1 p -164.62 130.98 2.94 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 126.07 1.748 . . . . 0.0 111.096 176.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.5 m -99.48 117.71 34.48 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mt -92.72 131.34 40.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.543 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 102' ' ' THR . 2.7 mtpt -104.38 117.05 33.23 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.828 ' C ' HD13 ' A' ' 116' ' ' ILE . 68.4 m -111.34 123.74 50.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.291 0.567 . . . . 0.0 111.066 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.915 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -107.69 135.67 45.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 123.35 0.66 . . . . 0.0 110.082 -178.045 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.1 m -104.8 135.15 46.72 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.516 ' CD2' ' OG1' ' A' ' 4' ' ' THR . 15.5 m80 -136.24 93.56 2.92 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.127 0.489 . . . . 0.0 110.378 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.823 ' C ' HG23 ' A' ' 2' ' ' VAL . 94.8 m-85 -86.82 101.92 13.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.229 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -95.73 101.37 13.05 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.288 0.566 . . . . 0.0 110.231 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.1 p -100.26 171.69 7.63 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.472 0.653 . . . . 0.0 111.335 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -108.07 157.52 18.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.837 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 42.26 -114.73 0.77 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -110.57 4.85 20.68 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.727 -0.278 . . . . 0.0 111.11 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -49.09 160.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.298 0.571 . . . . 0.0 110.227 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.467 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 19.8 pt-20 -150.25 146.06 26.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.08 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.8 mm -88.85 124.27 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -75.09 162.15 28.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.476 0.655 . . . . 0.0 111.839 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -69.53 -36.22 76.21 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.935 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.422 ' O ' HG22 ' A' ' 134' ' ' VAL . 49.2 mt-10 -65.13 -30.41 71.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.792 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -72.41 -47.9 45.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.055 0.455 . . . . 0.0 111.027 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 m -77.47 -26.43 15.3 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.982 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -67.13 -46.28 74.59 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 122.138 -0.351 . . . . 0.0 110.699 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.466 HG23 ' N ' ' A' ' 135' ' ' GLY . 35.4 m -70.4 -43.48 78.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.598 0.237 . . . . 0.0 110.818 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.466 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -70.16 -46.77 48.79 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -67.38 -48.97 65.83 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 122.503 -0.41 . . . . 0.0 110.84 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -55.72 -48.01 75.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 109.998 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -64.4 -53.9 41.27 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.526 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -47.76 -45.91 29.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.461 0.648 . . . . 0.0 110.55 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -55.73 -37.22 68.14 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.409 0.623 . . . . 0.0 109.545 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.83 -38.92 96.85 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.766 HD22 ' HB2' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -68.37 -38.5 81.45 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.518 ' O ' ' CD1' ' A' ' 143' ' ' PHE . 0.9 OUTLIER -58.85 -32.04 69.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.687 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -70.29 -33.76 71.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.769 177.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.71 ' HG ' ' HB2' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -67.79 -56.95 7.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.046 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.781 HG23 HD12 ' A' ' 29' ' ' LEU . 59.1 mt -65.94 -48.94 80.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.664 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -47.5 -45.1 26.08 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.403 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.0 t -58.81 -37.7 76.96 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.878 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.634 ' O ' ' N ' ' A' ' 153' ' ' HIS . 11.2 t80 -59.65 -45.83 90.84 Favored 'General case' 0 C--O 1.189 -2.128 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.888 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.3 mm? -69.9 -42.79 72.92 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 119.445 1.021 . . . . 0.0 111.468 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -23.63 66.03 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.631 -0.668 . . . . 0.0 109.809 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.436 ' O ' ' ND1' ' A' ' 153' ' ' HIS . 4.7 m-20 -106.11 -14.22 15.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.353 0.597 . . . . 0.0 110.623 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 149' ' ' TYR . 44.0 m80 -155.38 66.94 4.91 Favored Pre-proline 0 C--N 1.304 -1.383 0 C-N-CA 125.572 1.549 . . . . 0.0 109.384 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.42 -3.13 10.37 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 C-N-CA 122.969 2.446 . . . . 0.0 111.562 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 5.1 p30 -72.59 3.18 5.23 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.82 -178.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.578 ' O ' ' HD3' ' A' ' 20' ' ' LYS . . . -52.16 128.67 25.57 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 119.335 -2.103 . . . . 0.0 110.823 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.788 ' CD1' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER 51.67 5.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.046 0.538 . . . . 0.0 112.423 178.871 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.445 ' H ' ' C ' ' A' ' 156' ' ' ALA . 1.7 p-10 . . . . . 0 N--CA 1.446 -0.636 0 CA-C-O 118.128 -0.939 . . . . 0.0 109.852 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.649 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.809 HG23 ' C ' ' A' ' 119' ' ' TYR . 8.9 p -135.01 148.0 29.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.849 0.357 . . . . 0.0 111.229 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -98.4 110.03 22.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.547 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.475 HG23 ' CE1' ' A' ' 118' ' ' HIS . 68.4 m -96.56 132.84 41.75 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.656 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.67 128.87 37.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.066 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.09 133.47 48.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.8 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -134.0 174.54 10.36 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.765 0.317 . . . . 0.0 110.205 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.65 145.4 21.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.825 0.821 . . . . 0.0 112.079 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.31 134.63 27.75 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.831 -0.543 . . . . 0.0 110.138 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.94 147.44 23.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.891 0.377 . . . . 0.0 111.257 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 p -145.15 154.75 42.77 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.456 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -93.68 29.84 1.93 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.91 0.386 . . . . 0.0 110.397 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.636 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.3 mt -120.69 125.35 27.15 Favored Pre-proline 0 C--O 1.224 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.073 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -49.7 148.91 11.28 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 121.999 1.799 . . . . 0.0 111.708 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.427 ' HA ' HD12 ' A' ' 18' ' ' LEU . 27.7 Cg_exo -57.78 -28.31 81.58 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.386 2.057 . . . . 0.0 112.746 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.476 ' C ' ' HE ' ' A' ' 17' ' ' ARG . 15.1 m -65.14 -35.53 81.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.713 ' HE ' ' N ' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -74.95 -55.57 5.64 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -178.512 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.636 HD11 ' O ' ' A' ' 13' ' ' ILE . 4.2 mt -53.16 -40.27 64.18 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.012 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.796 ' O ' HG22 ' A' ' 23' ' ' VAL . 62.4 t80 -50.25 -57.7 7.24 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.859 0.464 . . . . 0.0 112.09 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.73 ' HB2' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.77 -41.55 75.02 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.507 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.761 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -64.0 -4.4 3.39 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.603 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.504 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 5.0 m-85 -119.79 -8.67 9.84 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 19' ' ' PHE . 25.8 m -128.53 -50.53 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.007 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.9 pp -98.0 -31.41 12.17 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -176.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 1.007 ' N ' HD12 ' A' ' 24' ' ' LEU . 3.8 t70 -114.96 -5.59 12.54 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 118.842 0.746 . . . . 0.0 112.177 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -62.4 -42.24 99.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.315 0.579 . . . . 0.0 111.702 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -83.76 19.7 1.62 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.865 0.84 . . . . 0.0 110.028 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -139.85 -8.64 1.21 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.024 HD13 HG23 ' A' ' 146' ' ' ILE . 0.5 OUTLIER -96.97 -50.15 4.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.224 -178.633 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.559 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 41.5 mt -55.04 -44.15 99.45 Favored Pre-proline 0 C--O 1.217 -0.632 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 20.7 Cg_exo -63.13 -22.64 73.17 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 122.353 2.036 . . . . 0.0 110.958 176.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -74.65 -55.08 6.28 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.537 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.76 HD11 HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -95.54 -35.07 5.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.322 -177.159 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.845 ' HB2' ' CG ' ' A' ' 145' ' ' LEU . . . -106.61 81.19 0.82 Allowed Pre-proline 0 CA--C 1.508 -0.639 0 CA-C-O 121.105 0.479 . . . . 0.0 111.93 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.75 -10.23 24.75 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 N-CA-C 107.33 -1.834 . . . . 0.0 107.33 174.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -74.61 -42.15 59.13 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.487 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.499 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -78.16 -80.03 0.12 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.188 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.516 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 5.6 mm -99.03 140.56 18.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.033 0.444 . . . . 0.0 110.99 -177.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -81.57 -42.9 19.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.915 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.543 ' CD ' ' H ' ' A' ' 41' ' ' ALA . 7.6 tp-100 -178.44 165.51 1.77 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.802 ' HB1' ' NZ ' ' A' ' 54' ' ' LYS . . . -165.08 144.08 6.63 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.201 0.524 . . . . 0.0 110.934 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.557 ' N ' ' NZ ' ' A' ' 54' ' ' LYS . 10.4 pt-20 -145.6 143.17 29.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.954 0.407 . . . . 0.0 111.249 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.465 HG13 ' H ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -78.57 142.09 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.485 0.66 . . . . 0.0 111.39 -179.104 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.9 mt -86.36 -39.7 16.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.418 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.915 ' O ' HG23 ' A' ' 52' ' ' THR . 40.7 mt-10 -148.18 133.61 18.61 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.618 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.93 -156.26 22.87 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -132.68 -10.54 3.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.95 0.405 . . . . 0.0 111.054 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.409 ' O ' HD12 ' A' ' 74' ' ' ILE . . . 134.36 21.0 0.78 Allowed Glycine 0 C--O 1.222 -0.619 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -178.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -110.3 -171.75 20.0 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -62.09 124.81 15.1 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 122.433 2.089 . . . . 0.0 113.036 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.8 3.78 59.23 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.915 HG23 ' O ' ' A' ' 45' ' ' GLU . 66.5 m -93.69 140.57 29.49 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.555 -0.823 . . . . 0.0 111.064 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.58 125.21 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.802 ' NZ ' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -115.52 138.18 51.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.254 0.55 . . . . 0.0 110.131 178.44 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.404 ' C ' HD12 ' A' ' 56' ' ' ILE . 75.9 tttt -120.43 132.07 55.07 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.708 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.784 ' N ' HD12 ' A' ' 56' ' ' ILE . 1.5 mp -103.28 140.8 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.0 m -113.48 118.64 35.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.83 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.516 ' CZ ' HD13 ' A' ' 38' ' ' ILE . 7.4 m-85 -101.47 -177.84 3.55 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.955 0.407 . . . . 0.0 110.942 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.25 145.77 35.17 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -59.61 -46.62 88.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.746 0.308 . . . . 0.0 110.794 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.72 61.56 3.45 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.3 t -142.96 175.04 10.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.916 0.389 . . . . 0.0 110.614 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -59.82 -51.49 69.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 110.665 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.404 ' OH ' ' NZ ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -107.11 143.47 35.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.165 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.06 -48.93 0.91 Allowed Glycine 0 CA--C 1.52 0.39 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -145.49 153.44 41.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.105 0.478 . . . . 0.0 110.624 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -154.02 146.34 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.554 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.6 ' HB3' HD11 ' A' ' 86' ' ' ILE . 80.4 mttt -105.57 106.11 16.45 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.436 0.636 . . . . 0.0 111.701 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.49 ' CE1' HD21 ' A' ' 85' ' ' LEU . 1.1 m-70 -92.51 123.19 35.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.708 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -113.11 119.62 38.46 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.82 -0.55 . . . . 0.0 111.068 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.61 HD13 HG22 ' A' ' 52' ' ' THR . 4.9 mp -70.22 137.16 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -99.61 -54.46 2.92 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.0 m -165.0 141.57 5.76 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 48' ' ' GLY . 43.8 mt -129.98 131.03 66.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.619 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.598 ' O ' ' N ' ' A' ' 79' ' ' TYR . 7.2 m-20 -116.25 87.89 2.78 Favored 'General case' 0 C--O 1.206 -1.217 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.637 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.1 pm0 -54.83 -41.14 70.34 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.06 -35.97 27.29 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.492 0.663 . . . . 0.0 109.223 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.444 ' O ' ' NZ ' ' A' ' 103' ' ' LYS . 0.6 OUTLIER -107.95 -10.5 15.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.409 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.598 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.9 m-85 63.24 50.32 3.03 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 120.989 -1.07 . . . . 0.0 110.024 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 34.9 t -106.26 144.24 33.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.359 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -135.09 123.23 22.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.101 0.477 . . . . 0.0 110.588 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 p -132.57 134.64 45.2 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.133 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -144.62 159.08 43.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.145 0.498 . . . . 0.0 110.022 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.7 m -142.32 137.2 30.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.994 0.426 . . . . 0.0 110.586 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.594 HD13 ' HB1' ' A' ' 90' ' ' ALA . 6.2 mt -80.06 109.87 14.92 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' A' ' 68' ' ' LYS . 2.9 pt -79.56 -43.47 23.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.011 -178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 3.4 tp10 -149.99 172.1 15.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.739 0.304 . . . . 0.0 110.362 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.604 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.94 177.45 18.33 Favored Glycine 0 CA--C 1.509 -0.326 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -61.14 1.61 0.17 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.604 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -65.25 -35.36 80.81 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 124.105 0.962 . . . . 0.0 110.212 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.869 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.72 11.77 22.6 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 123.521 0.728 . . . . 0.0 109.623 -177.86 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.9 p 46.55 -126.65 1.49 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -131.04 -11.37 3.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.256 0.55 . . . . 0.0 110.816 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.19 -5.58 20.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.427 -177.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.711 HG21 ' CD1' ' A' ' 98' ' ' ILE . 94.4 mt -97.76 152.09 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.466 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -87.37 -61.27 1.76 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.337 177.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' O ' ' CB ' ' A' ' 120' ' ' HIS . 11.8 ptmt -172.26 149.59 2.28 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.489 0.661 . . . . 0.0 111.305 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.711 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.13 127.56 75.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.597 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.3 145.7 39.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.246 0.546 . . . . 0.0 111.635 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -138.45 136.66 36.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.265 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.13 134.2 49.07 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 120.916 0.389 . . . . 0.0 110.144 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.64 130.87 28.48 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.31 -0.869 . . . . 0.0 109.742 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.754 ' C ' HD23 ' A' ' 104' ' ' LEU . 25.9 tttp -127.22 134.3 50.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.867 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -102.99 125.27 49.68 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -178.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -130.32 137.89 55.19 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.624 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.916 -178.846 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.21 133.57 45.17 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.287 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 14.8 t -121.56 174.35 6.84 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 122.678 0.391 . . . . 0.0 110.426 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.422 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -54.97 -36.34 60.44 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 m -80.56 -15.28 57.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.411 1.484 . . . . 0.0 114.198 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.95 -90.13 0.13 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.426 1.965 . . . . 0.0 110.812 -168.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.8 OUTLIER -157.22 129.09 7.11 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 127.728 2.411 . . . . 0.0 111.005 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.412 ' N ' ' O ' ' A' ' 105' ' ' VAL . 43.9 m -99.8 118.91 37.28 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.2 mt -92.66 131.65 39.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.535 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -105.25 116.64 32.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.885 ' C ' HD13 ' A' ' 116' ' ' ILE . 53.4 p -111.56 128.45 56.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.383 0.611 . . . . 0.0 111.258 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.885 HD13 ' C ' ' A' ' 115' ' ' SER . 0.1 OUTLIER -112.07 135.77 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 C-N-CA 123.327 0.651 . . . . 0.0 109.92 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 p -110.38 136.93 48.78 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.475 ' CE1' HG23 ' A' ' 4' ' ' THR . 27.7 m-70 -135.7 95.54 3.26 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.026 0.441 . . . . 0.0 110.888 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.809 ' C ' HG23 ' A' ' 2' ' ' VAL . 5.6 m-85 -84.89 101.12 12.06 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.417 ' CB ' ' O ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -94.32 103.76 15.76 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.513 HG21 ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -100.09 161.73 13.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.665 -178.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.522 ' H ' HG22 ' A' ' 125' ' ' ILE . 8.1 ptmt -112.22 157.15 21.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 41.01 -123.15 2.47 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -95.08 -12.09 27.14 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.522 HG22 ' H ' ' A' ' 122' ' ' LYS . 1.1 tp -49.32 162.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.632 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -159.62 150.09 19.08 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.229 -0.294 . . . . 0.0 110.9 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.3 mm -86.34 124.86 40.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -76.82 160.4 29.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.448 0.642 . . . . 0.0 111.718 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -70.24 -41.08 74.01 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.615 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.558 ' O ' HG22 ' A' ' 134' ' ' VAL . 10.3 pt-20 -62.96 -26.14 68.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.674 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -72.97 -52.11 15.75 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.595 0.712 . . . . 0.0 111.162 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.413 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 3.6 m -77.02 -29.53 17.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.584 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.131 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -67.04 -45.85 76.19 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 122.259 -0.276 . . . . 0.0 111.105 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 130' ' ' GLU . 34.1 m -68.68 -46.56 79.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.917 0.389 . . . . 0.0 110.542 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.526 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -66.15 -44.28 91.44 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 85.1 tttt -67.12 -46.62 73.59 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 122.691 -0.299 . . . . 0.0 110.956 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -54.56 -47.8 72.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.952 0.406 . . . . 0.0 110.086 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.404 ' NZ ' ' OH ' ' A' ' 64' ' ' TYR . 32.9 ttmt -61.13 -52.22 65.77 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.623 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.39 -51.96 31.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.604 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -47.94 -38.56 16.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.79 -33.85 88.08 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.736 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -75.89 -32.85 59.85 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.561 0.696 . . . . 0.0 109.408 179.669 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -59.22 -30.12 68.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -68.35 -42.32 79.41 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.603 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.845 ' CG ' ' HB2' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -50.93 -58.57 5.69 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 114.088 -1.414 . . . . 0.0 112.154 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 1.024 HG23 HD13 ' A' ' 29' ' ' LEU . 23.1 mt -73.73 -49.47 35.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.164 -176.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 13.2 tt0 -45.98 -56.25 5.76 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.556 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 20.7 t -50.8 -47.55 59.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.321 0.581 . . . . 0.0 110.48 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.813 ' CG ' HD21 ' A' ' 29' ' ' LEU . 8.3 t80 -52.03 -51.88 54.54 Favored 'General case' 0 C--O 1.192 -1.934 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.837 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.9 mm? -62.45 -42.15 99.27 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 119.576 1.08 . . . . 0.0 112.208 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.47 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -62.99 -24.34 67.87 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 121.454 -0.779 . . . . 0.0 109.203 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.96 -12.95 15.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.097 0.475 . . . . 0.0 110.671 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.644 ' N ' ' O ' ' A' ' 149' ' ' TYR . 75.1 m80 -155.45 66.31 4.67 Favored Pre-proline 0 C--N 1.311 -1.103 0 C-N-CA 125.452 1.501 . . . . 0.0 110.162 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.55 -3.58 12.82 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 122.598 2.198 . . . . 0.0 111.597 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.57 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.7 OUTLIER -85.75 4.17 38.03 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 123.312 0.645 . . . . 0.0 111.67 -178.773 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.407 ' O ' ' HD3' ' A' ' 20' ' ' LYS . . . -49.53 130.01 19.82 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 120.062 -1.649 . . . . 0.0 111.264 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.642 ' CG ' HD13 ' A' ' 24' ' ' LEU . 2.8 t80 54.84 6.31 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.57 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 118.578 -0.725 . . . . 0.0 110.242 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.85 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.2 p -134.92 148.45 29.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 O-C-N 122.518 -0.401 . . . . 0.0 111.177 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.483 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 52.1 m-85 -99.36 111.66 23.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.735 177.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.7 m -96.48 140.17 31.51 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.958 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -138.73 134.49 33.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.21 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.44 ' HG2' HD12 ' A' ' 116' ' ' ILE . 0.8 OUTLIER -103.45 129.4 50.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.82 0.343 . . . . 0.0 111.024 -179.468 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -135.54 166.79 22.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.967 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.91 159.97 39.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.471 0.653 . . . . 0.0 112.593 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.474 ' CE1' ' O ' ' A' ' 10' ' ' THR . 81.6 t80 -151.01 140.85 21.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.365 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.474 ' O ' ' CE1' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -93.62 148.23 22.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.811 0.339 . . . . 0.0 111.363 -179.362 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 p -144.81 154.45 42.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.779 0.323 . . . . 0.0 110.698 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -96.72 25.06 5.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 110.555 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.684 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.3 mt -113.14 125.93 28.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.48 144.96 12.78 Favored 'Trans proline' 0 C--N 1.326 -0.616 0 C-N-CA 121.913 1.742 . . . . 0.0 111.735 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.638 ' CG ' ' HB2' ' A' ' 106' ' ' ALA . 31.2 Cg_exo -55.84 -24.64 48.21 Favored 'Trans proline' 0 N--CA 1.484 0.922 0 C-N-CA 122.457 2.105 . . . . 0.0 112.667 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.402 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 48.2 m -68.31 -36.19 78.94 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -178.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -76.36 -56.34 4.72 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.684 HD21 ' HB ' ' A' ' 13' ' ' ILE . 4.3 mt -48.48 -47.08 38.79 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.752 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.772 ' O ' HG22 ' A' ' 23' ' ' VAL . 39.0 t80 -49.43 -57.22 7.37 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.443 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.86 -24.46 63.43 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.364 -179.351 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.741 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -83.1 -2.69 56.05 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.373 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.433 ' CA ' ' HB2' ' A' ' 26' ' ' ALA . 2.1 m-85 -118.87 -8.23 10.32 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.896 HG23 ' CD1' ' A' ' 24' ' ' LEU . 2.8 m -134.07 -35.5 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.896 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.6 mp -90.71 -55.01 3.73 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.59 1.087 . . . . 0.0 111.922 -175.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 29' ' ' LEU . 17.4 t70 -113.59 -4.55 13.47 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.868 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -46.93 -42.25 17.41 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.511 ' HB3' ' HZ3' ' A' ' 54' ' ' LYS . 1.1 m-20 -84.95 18.3 2.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.67 0.748 . . . . 0.0 110.5 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -139.91 -9.79 1.17 Allowed 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 124.583 1.153 . . . . 0.0 108.555 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.996 HD13 HG23 ' A' ' 146' ' ' ILE . 0.5 OUTLIER -89.71 -45.78 9.08 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 124.513 1.125 . . . . 0.0 109.597 -178.693 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.616 HG13 HD11 ' A' ' 146' ' ' ILE . 26.3 mt -54.38 -53.99 53.29 Favored Pre-proline 0 C--O 1.214 -0.791 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 22.8 Cg_endo -60.78 -21.59 70.61 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 122.081 1.854 . . . . 0.0 111.542 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 tmtp? -69.12 -52.63 26.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.699 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.776 HG13 HD12 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -95.85 -36.5 6.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.077 -177.829 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.742 ' HB2' ' CG ' ' A' ' 145' ' ' LEU . . . -107.04 82.27 1.09 Allowed Pre-proline 0 CA--C 1.506 -0.717 0 C-N-CA 123.159 0.584 . . . . 0.0 111.573 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.36 -9.81 27.07 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 N-CA-C 107.476 -1.778 . . . . 0.0 107.476 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -73.95 -42.09 61.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.499 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.559 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -75.43 -82.34 0.07 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.751 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 89.1 mt -107.76 143.36 18.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.98 0.419 . . . . 0.0 110.655 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -79.83 -46.18 17.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.174 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -179.5 166.59 1.43 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.19 147.7 7.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.926 0.393 . . . . 0.0 111.044 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' N ' ' HE2' ' A' ' 54' ' ' LYS . 10.9 pt-20 -137.79 145.41 42.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.31 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.622 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -77.16 139.94 17.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.509 0.671 . . . . 0.0 110.716 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 7.5 mp -89.02 -39.27 13.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.787 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.876 ' O ' HG23 ' A' ' 52' ' ' THR . 28.0 mt-10 -147.41 136.72 22.52 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.425 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.63 -155.92 22.91 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 47.0 p-10 -139.07 0.02 1.9 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 122.819 0.448 . . . . 0.0 110.749 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.35 11.52 3.37 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.11 -172.2 19.53 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 117.349 0.574 . . . . 0.0 112.123 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -59.15 126.71 21.74 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 122.676 2.25 . . . . 0.0 113.275 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.5 2.73 56.51 Favored Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.876 HG23 ' O ' ' A' ' 45' ' ' GLU . 60.8 m -94.4 139.8 30.64 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.104 -1.048 . . . . 0.0 111.651 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.667 HD12 ' C ' ' A' ' 52' ' ' THR . 1.8 mp -120.08 126.26 75.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.622 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -114.28 139.02 49.76 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.362 0.601 . . . . 0.0 110.509 179.244 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.492 ' C ' HD12 ' A' ' 56' ' ' ILE . 34.5 ttpt -118.44 127.12 53.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.096 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.775 ' N ' HD12 ' A' ' 56' ' ' ILE . 1.8 mp -105.5 135.7 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.6 m -111.25 120.5 42.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.08 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 59' ' ' GLY . 4.6 t80 -91.69 179.29 5.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.671 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.429 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -54.39 143.93 30.07 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -60.65 -59.45 5.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.884 0.373 . . . . 0.0 110.994 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.72 61.79 3.42 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.5 t -137.66 175.22 9.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.87 0.367 . . . . 0.0 110.692 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -61.49 -45.08 95.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.685 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -91.87 155.07 18.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.537 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.4 -61.37 0.13 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.17 154.7 42.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.084 0.469 . . . . 0.0 110.63 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 p -155.49 146.95 12.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.024 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -105.66 114.97 29.45 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.31 0.576 . . . . 0.0 112.267 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.588 ' CE1' ' CD2' ' A' ' 85' ' ' LEU . 1.8 m80 -100.56 116.84 33.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.729 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -102.0 119.59 39.05 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.969 -0.457 . . . . 0.0 111.29 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.2 mt -77.74 145.61 9.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -106.53 -55.32 2.34 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.7 m -165.39 141.94 5.54 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.6 mt -123.16 131.18 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.287 176.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.2 m-20 -116.01 87.64 2.72 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.466 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 9.8 pt-20 -54.96 -30.25 58.62 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.71 -39.06 70.55 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.98 -10.11 15.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.094 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.543 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.9 m-85 63.28 41.6 7.67 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 121.676 -0.64 . . . . 0.0 110.21 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.1 t -107.55 149.11 28.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.051 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 27.3 p90 -151.56 124.04 8.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.216 0.531 . . . . 0.0 110.965 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.66 144.56 51.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.208 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -144.65 171.66 14.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.806 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 m -144.64 136.23 25.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.135 0.493 . . . . 0.0 110.554 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.635 HD13 ' HB1' ' A' ' 90' ' ' ALA . 9.1 mt -79.83 120.02 23.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.439 HG12 ' H ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -85.11 -43.31 16.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.612 -178.609 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.479 ' OE2' ' N ' ' A' ' 88' ' ' GLY . 3.2 tm-20 -153.14 170.26 20.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.731 0.3 . . . . 0.0 110.265 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.615 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 118.17 178.48 17.16 Favored Glycine 0 CA--C 1.507 -0.465 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 178.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -61.83 2.03 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.293 1.044 . . . . 0.0 108.711 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.635 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -67.26 -34.31 77.17 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 124.215 1.006 . . . . 0.0 110.439 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.897 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.25 16.15 21.9 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 123.305 0.642 . . . . 0.0 110.136 -177.348 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.4 p 47.36 -126.19 1.67 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.199 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -130.3 -13.05 3.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.769 0.318 . . . . 0.0 111.532 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.02 -7.04 19.48 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.778 HG21 ' CD1' ' A' ' 98' ' ' ILE . 63.7 mt -99.91 153.5 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 CA-C-O 121.8 0.809 . . . . 0.0 113.127 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.538 ' N ' HG22 ' A' ' 95' ' ' ILE . 5.9 pt-20 -99.41 -51.64 3.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.027 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.513 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 64.4 mttt -164.71 146.68 8.27 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 121.177 0.513 . . . . 0.0 111.915 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.778 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.3 122.5 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.33 144.91 30.74 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.478 ' CZ ' ' OG ' ' A' ' 117' ' ' SER . 0.6 OUTLIER -139.88 131.79 27.68 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.665 179.453 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.525 ' CD ' ' N ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -129.15 130.92 47.02 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.525 ' N ' ' CD ' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -140.93 132.88 27.68 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.523 -0.736 . . . . 0.0 111.227 179.532 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.647 ' C ' HD23 ' A' ' 104' ' ' LEU . 26.3 ttpp -122.87 134.69 54.38 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.128 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.843 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.37 125.74 43.63 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.221 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.462 HG12 ' NZ ' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -127.43 137.56 57.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.098 -178.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.638 ' HB2' ' CG ' ' A' ' 15' ' ' PRO . . . -72.3 133.71 45.15 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.368 178.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.441 ' SG ' ' N ' ' A' ' 111' ' ' SER . 27.1 p -121.66 174.25 6.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.945 0.402 . . . . 0.0 110.288 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.71 -34.51 56.39 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.6 m -79.31 -21.22 46.24 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.615 -1.521 . . . . 0.0 114.078 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.7 -88.45 0.12 Allowed Glycine 0 CA--C 1.524 0.626 0 C-N-CA 125.752 1.644 . . . . 0.0 109.5 -166.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.8 OUTLIER -159.39 129.37 5.61 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 126.006 1.722 . . . . 0.0 111.336 -179.043 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 105' ' ' VAL . 26.8 m -99.6 118.53 36.34 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.9 mt -92.32 132.05 37.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.428 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 102' ' ' THR . 7.2 mtpt -105.34 116.92 32.77 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.757 ' C ' HD13 ' A' ' 116' ' ' ILE . 40.0 p -111.1 118.21 35.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.28 0.562 . . . . 0.0 111.36 -178.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.936 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -102.59 135.76 38.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.726 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.478 ' OG ' ' CZ ' ' A' ' 100' ' ' TYR . 11.1 m -117.95 133.32 56.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.72 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -137.2 112.94 9.52 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.85 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -102.28 103.31 13.77 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.989 -0.444 . . . . 0.0 110.122 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -91.04 107.98 19.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.119 0.485 . . . . 0.0 110.147 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.438 HG22 HD11 ' A' ' 127' ' ' ILE . 11.3 p -100.52 175.47 5.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.582 0.706 . . . . 0.0 111.127 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.8 ptmm? -110.36 158.64 18.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.833 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 39.85 -111.13 0.2 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -112.75 0.4 15.27 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 122.502 -0.41 . . . . 0.0 111.515 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -44.39 160.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.155 0.502 . . . . 0.0 110.641 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.474 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 93.3 mt-10 -147.98 146.92 29.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.212 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 121' ' ' THR . 22.1 mm -89.16 122.07 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -75.59 162.43 28.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.439 0.638 . . . . 0.0 112.135 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -69.53 -55.02 11.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.667 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' A' ' 130' ' ' GLU . 1.5 pm0 -53.82 -24.25 14.91 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.931 -0.481 . . . . 0.0 110.992 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.513 ' CE1' ' OE2' ' A' ' 130' ' ' GLU . 9.8 m80 -73.55 -53.27 10.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.253 0.549 . . . . 0.0 110.067 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 3.9 m -77.81 -27.91 15.37 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.199 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -67.66 -46.1 73.36 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.979 -0.45 . . . . 0.0 110.928 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 130' ' ' GLU . 28.2 m -70.0 -42.93 79.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.663 0.268 . . . . 0.0 110.548 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.492 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -69.74 -46.47 53.58 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.462 ' HZ3' ' HB3' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -67.36 -47.08 71.47 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 122.692 -0.299 . . . . 0.0 110.712 179.718 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -55.16 -48.2 74.07 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -62.4 -51.87 65.83 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.62 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -50.08 -53.73 25.19 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.722 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -47.4 -38.91 14.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.771 0.796 . . . . 0.0 109.358 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.55 -32.73 84.24 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.674 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.6 OUTLIER -75.67 -36.3 60.14 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.698 0.761 . . . . 0.0 109.491 178.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -58.39 -25.47 62.13 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.57 -38.73 54.43 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.489 177.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.776 HD12 HG13 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -50.96 -58.64 5.53 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-O 122.442 1.115 . . . . 0.0 111.263 179.776 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.996 HG23 HD13 ' A' ' 29' ' ' LEU . 20.0 mt -72.81 -49.37 40.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.845 -177.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 38.2 tt0 -46.07 -52.17 12.48 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.547 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 24.7 p -54.09 -44.98 71.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.153 0.502 . . . . 0.0 110.637 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.732 ' CG ' HD21 ' A' ' 29' ' ' LEU . 11.2 t80 -53.89 -45.95 71.23 Favored 'General case' 0 C--O 1.183 -2.417 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.834 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.6 mm? -69.5 -42.5 74.66 Favored 'General case' 0 C--O 1.218 -0.591 0 O-C-N 120.592 -1.317 . . . . 0.0 111.887 -177.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.465 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.6 OUTLIER -63.72 -25.48 68.22 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 121.569 -0.707 . . . . 0.0 109.594 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 149' ' ' TYR . 0.2 OUTLIER -106.98 -12.93 15.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.406 0.622 . . . . 0.0 110.307 178.304 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.615 ' N ' ' O ' ' A' ' 149' ' ' TYR . 13.5 t-80 -154.67 65.97 4.97 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 124.98 1.312 . . . . 0.0 110.23 -177.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.59 -3.12 11.26 Favored 'Trans proline' 0 N--CA 1.482 0.799 0 C-N-CA 122.576 2.184 . . . . 0.0 111.616 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 1.9 m-20 -74.52 2.66 9.13 Favored 'General case' 0 C--O 1.213 -0.859 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.913 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.426 ' O ' ' HD2' ' A' ' 20' ' ' LYS . . . -50.33 129.48 21.7 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 119.354 -2.091 . . . . 0.0 110.996 -178.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.707 ' CG ' HD23 ' A' ' 24' ' ' LEU . 86.2 t80 53.03 5.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 2.1 p-10 . . . . . 0 C--N 1.323 -0.544 0 O-C-N 121.179 -0.95 . . . . 0.0 110.069 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.889 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.805 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.1 p -134.68 149.62 29.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 O-C-N 122.313 -0.522 . . . . 0.0 110.703 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.61 109.82 22.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.451 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.643 HG23 ' NE2' ' A' ' 118' ' ' HIS . 74.2 m -96.25 139.89 31.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.799 0.333 . . . . 0.0 111.004 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.08 130.56 25.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.08 179.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.433 ' HG2' HD12 ' A' ' 116' ' ' ILE . 0.8 OUTLIER -103.24 128.39 50.27 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.735 0.303 . . . . 0.0 110.766 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -126.73 168.37 14.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.519 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -155.2 142.48 19.44 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -146.57 139.92 25.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.629 0.252 . . . . 0.0 110.766 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.45 148.23 23.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 111.227 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.4 p -144.77 154.44 42.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.564 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -92.1 18.76 7.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.906 0.384 . . . . 0.0 110.786 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.587 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.8 mt -108.06 126.01 30.74 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.194 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.01 147.37 7.89 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 121.6 1.533 . . . . 0.0 111.392 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.644 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 12.9 Cg_endo -63.99 -23.68 67.59 Favored 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 122.503 2.135 . . . . 0.0 112.754 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.8 m -66.19 -32.28 73.62 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.633 ' N ' ' CD ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -81.73 -55.14 4.82 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -178.818 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.599 HD12 ' HA ' ' A' ' 15' ' ' PRO . 7.4 mt -47.05 -44.13 20.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.777 ' O ' HG22 ' A' ' 23' ' ' VAL . 54.7 t80 -51.79 -59.29 4.47 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.843 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.645 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -69.97 -23.37 63.16 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.698 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.734 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -82.25 -2.96 54.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.676 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CE2' ' OH ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -119.47 -9.22 9.89 Favored 'General case' 0 C--O 1.23 0.069 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.843 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.871 HG23 HD13 ' A' ' 24' ' ' LEU . 2.8 m -136.14 -37.02 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.909 HD23 ' CD2' ' A' ' 157' ' ' TYR . 3.4 mp -91.18 -52.89 4.6 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.208 0.913 . . . . 0.0 112.131 -176.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 93.0 m-20 -112.49 -4.18 14.26 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -55.02 -40.39 70.13 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 121.493 -0.755 . . . . 0.0 112.235 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -83.89 16.41 2.83 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.59 0.71 . . . . 0.0 110.905 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.46 -10.2 1.24 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.813 HD13 HG23 ' A' ' 146' ' ' ILE . 0.4 OUTLIER -88.15 -40.96 13.32 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.722 -1.127 . . . . 0.0 110.119 -178.294 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.641 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -54.14 -50.65 83.31 Favored Pre-proline 0 C--O 1.207 -1.141 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 19.2 Cg_endo -62.18 -24.88 76.63 Favored 'Trans proline' 0 C--N 1.319 -1.014 0 C-N-CA 121.682 1.588 . . . . 0.0 112.185 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -67.98 -62.26 1.49 Allowed 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 121.74 0.781 . . . . 0.0 112.076 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.474 ' CD1' ' O ' ' A' ' 145' ' ' LEU . 1.9 pt -95.29 -32.98 4.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.075 -177.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.841 ' HB2' ' HG ' ' A' ' 145' ' ' LEU . . . -101.97 74.29 0.14 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 123.746 0.818 . . . . 0.0 112.679 -175.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.74 -20.06 26.83 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 121.201 1.267 . . . . 0.0 109.081 175.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -72.99 -40.98 64.79 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.84 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.701 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -70.81 -82.13 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.94 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.614 HD12 ' C ' ' A' ' 37' ' ' ALA . 2.0 mp -112.54 145.09 19.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.145 0.498 . . . . 0.0 110.637 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -78.36 -47.1 18.4 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.329 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.417 ' OE1' ' N ' ' A' ' 41' ' ' ALA . 1.3 pp0? -173.86 164.54 4.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.986 0.422 . . . . 0.0 110.003 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.417 ' N ' ' OE1' ' A' ' 40' ' ' GLN . . . -166.1 145.57 6.09 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.746 178.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -138.59 142.71 39.16 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.603 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -78.39 140.0 17.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.501 0.667 . . . . 0.0 110.513 -179.549 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 44' ' ' LEU . 6.6 mp -89.39 -40.5 12.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.66 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.989 ' O ' HG23 ' A' ' 52' ' ' THR . 27.8 mm-40 -137.52 133.6 34.74 Favored 'General case' 0 C--O 1.215 -0.753 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.67 -156.59 46.46 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 50.4 p-10 -135.79 -4.93 2.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.777 0.322 . . . . 0.0 111.32 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.493 ' N ' HG21 ' A' ' 52' ' ' THR . . . 142.09 18.94 0.28 Allowed Glycine 0 C--O 1.221 -0.718 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -109.86 -172.91 20.53 Favored Glycine 0 C--O 1.224 -0.51 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -62.08 125.06 15.58 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 122.443 2.095 . . . . 0.0 113.009 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.58 5.67 60.06 Favored Glycine 0 N--CA 1.464 0.509 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.989 HG23 ' O ' ' A' ' 45' ' ' GLU . 87.2 m -93.53 140.69 29.32 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.414 -0.893 . . . . 0.0 111.005 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.686 HD12 ' C ' ' A' ' 52' ' ' THR . 1.9 mp -122.5 128.84 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.603 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -116.45 139.36 50.53 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.272 0.558 . . . . 0.0 110.76 178.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.46 ' C ' HD12 ' A' ' 56' ' ' ILE . 32.9 ttpt -118.47 124.76 48.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.989 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.783 ' N ' HD12 ' A' ' 56' ' ' ILE . 1.7 mp -103.26 130.89 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.6 m -109.26 118.49 36.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.828 0.347 . . . . 0.0 110.28 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -92.83 -175.58 3.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.558 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.97 144.04 32.26 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -59.72 -62.77 1.62 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.881 0.372 . . . . 0.0 110.809 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.94 61.9 3.34 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.1 m -137.28 175.38 9.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.746 0.308 . . . . 0.0 110.69 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -55.1 -53.52 54.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.841 0.353 . . . . 0.0 110.561 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -91.99 154.57 18.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.381 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.39 -61.57 0.14 Allowed Glycine 0 N--CA 1.461 0.321 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -145.62 148.01 32.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.942 0.401 . . . . 0.0 110.377 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.76 145.57 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.821 0.343 . . . . 0.0 110.846 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -105.87 109.6 21.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.401 0.62 . . . . 0.0 111.558 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.521 ' NE2' ' CG ' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -106.38 113.73 27.43 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.245 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -102.31 130.05 48.91 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.623 HD13 HG22 ' A' ' 52' ' ' THR . 4.5 mp -70.63 141.14 17.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -99.37 -55.58 2.64 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -165.6 141.56 5.22 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.406 HD11 ' CG1' ' A' ' 23' ' ' VAL . 69.5 mt -130.01 129.87 65.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 120.968 0.413 . . . . 0.0 110.57 177.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 79' ' ' TYR . 39.2 m-20 -115.78 88.57 2.91 Favored 'General case' 0 C--O 1.212 -0.897 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -53.75 -30.08 42.71 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.89 -37.36 71.28 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.122 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -107.62 -11.21 15.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.806 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.547 ' N ' ' O ' ' A' ' 75' ' ' ASP . 32.0 m-85 60.2 45.0 12.05 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 121.797 -0.564 . . . . 0.0 110.339 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 p -112.92 148.98 33.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.498 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 6.2 p90 -147.62 127.64 13.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.251 0.548 . . . . 0.0 111.182 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 m -130.32 147.13 52.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.241 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.521 ' CG ' ' NE2' ' A' ' 69' ' ' HIS . 15.0 p90 -153.68 168.25 26.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.824 0.345 . . . . 0.0 110.184 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 98' ' ' ILE . 3.7 m -145.6 139.45 26.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.054 0.454 . . . . 0.0 111.388 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.586 HD13 ' HB1' ' A' ' 90' ' ' ALA . 4.9 mt -80.52 111.91 17.37 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.691 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -72.01 -41.81 68.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.252 -177.713 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.691 ' N ' HD13 ' A' ' 86' ' ' ILE . 17.4 tp10 -156.39 171.82 19.57 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.617 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.59 177.83 17.45 Favored Glycine 0 CA--C 1.508 -0.373 0 N-CA-C 110.214 -1.155 . . . . 0.0 110.214 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -61.21 2.15 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.617 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -67.61 -36.03 80.07 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.982 0.913 . . . . 0.0 110.094 177.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.929 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -111.8 13.26 21.01 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 123.694 0.797 . . . . 0.0 109.253 -178.589 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 47.1 p 48.07 -126.32 1.84 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -131.17 -9.23 3.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.092 0.472 . . . . 0.0 110.51 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.6 t -104.9 -6.66 19.97 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.762 HG21 ' CD1' ' A' ' 98' ' ' ILE . 57.6 mt -100.62 151.6 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.485 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -87.08 -58.83 2.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.514 177.844 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -170.55 148.77 3.13 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.191 0.52 . . . . 0.0 110.867 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.762 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.66 120.85 62.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.566 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.416 ' O ' ' CD1' ' A' ' 100' ' ' TYR . 9.5 t -109.65 145.5 36.38 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.375 0.607 . . . . 0.0 111.199 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 99' ' ' SER . 19.5 m-85 -135.69 129.41 32.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.221 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.428 ' O ' HG12 ' A' ' 116' ' ' ILE . 18.6 tt0 -127.8 133.72 49.45 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.32 136.37 36.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.859 0.361 . . . . 0.0 110.069 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -119.73 132.77 55.73 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -102.76 134.98 45.25 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.126 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.413 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.6 OUTLIER -137.05 136.77 47.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.994 -178.613 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.644 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -72.75 135.16 45.25 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.525 178.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.459 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 31.3 t -121.15 174.57 6.59 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.608 0.363 . . . . 0.0 110.161 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.459 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -55.8 -30.74 57.24 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 112.236 -0.346 . . . . 0.0 112.236 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.9 p -91.73 -12.47 33.87 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 119.552 -2.146 . . . . 0.0 115.634 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.16 -85.17 0.13 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.839 1.209 . . . . 0.0 111.407 -171.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.3 p -165.56 134.73 3.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.402 1.481 . . . . 0.0 110.858 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 105' ' ' VAL . 97.8 m -98.81 117.44 33.3 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.6 mt -92.81 127.54 44.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.69 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -104.25 116.23 31.8 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.782 ' C ' HD13 ' A' ' 116' ' ' ILE . 34.2 t -112.13 124.84 53.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.144 0.497 . . . . 0.0 111.432 -178.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.924 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -105.41 136.04 41.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 123.152 0.581 . . . . 0.0 109.486 -178.773 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.15 132.56 54.05 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.378 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.643 ' NE2' HG23 ' A' ' 4' ' ' THR . 26.1 m-70 -137.17 106.05 5.93 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 117.819 0.282 . . . . 0.0 110.91 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.805 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -101.45 103.83 14.75 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -89.97 109.8 20.81 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.18 0.514 . . . . 0.0 109.965 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.61 HG21 ' O ' ' A' ' 125' ' ' ILE . 0.6 OUTLIER -95.05 164.45 12.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.356 -178.219 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.491 ' H ' HG22 ' A' ' 125' ' ' ILE . 11.4 mtmt -92.46 146.92 23.31 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 34.0 -115.97 0.16 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -95.11 -13.73 24.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.812 0.339 . . . . 0.0 110.177 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.61 ' O ' HG21 ' A' ' 121' ' ' THR . 1.1 tp -48.82 163.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -149.35 150.5 32.57 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.683 -0.635 . . . . 0.0 112.049 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.42 ' CD1' HG12 ' A' ' 95' ' ' ILE . 26.7 mm -86.67 124.89 40.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -75.25 160.79 29.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.587 0.708 . . . . 0.0 112.055 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -70.22 -43.57 70.38 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.382 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.441 ' O ' HG22 ' A' ' 134' ' ' VAL . 78.5 mt-10 -60.44 -24.87 65.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.348 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -72.7 -52.46 15.13 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.371 0.605 . . . . 0.0 110.86 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.5 m -76.09 -26.31 17.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.909 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -67.62 -46.27 73.02 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.403 -0.186 . . . . 0.0 111.094 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 135' ' ' GLY . 34.6 m -69.85 -43.99 79.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.478 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -66.13 -43.33 93.45 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -67.23 -46.98 72.17 Favored 'General case' 0 CA--C 1.518 -0.258 0 O-C-N 122.789 -0.242 . . . . 0.0 110.973 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -54.94 -47.63 74.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.879 0.371 . . . . 0.0 110.054 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.64 -55.13 22.18 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.494 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -47.67 -45.25 27.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.535 0.683 . . . . 0.0 110.776 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -56.83 -37.4 71.2 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.87 0.843 . . . . 0.0 109.3 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.16 -38.66 96.52 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.746 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -68.64 -36.53 78.72 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -59.04 -32.36 69.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.32 -34.44 77.36 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.868 177.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.841 ' HG ' ' HB2' ' A' ' 34' ' ' ALA . 1.2 mm? -68.27 -58.26 4.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.566 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.813 HG23 HD13 ' A' ' 29' ' ' LEU . 66.3 mt -60.79 -48.67 87.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.743 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -46.38 -52.96 11.89 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.14 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 21.5 p -50.17 -44.68 52.83 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.344 0.592 . . . . 0.0 111.349 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.683 ' CG ' HD21 ' A' ' 29' ' ' LEU . 32.9 t80 -58.5 -45.5 88.64 Favored 'General case' 0 C--O 1.182 -2.499 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.807 ' H ' HD22 ' A' ' 150' ' ' LEU . 2.0 mm? -65.06 -42.02 94.58 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 119.917 1.235 . . . . 0.0 111.966 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.463 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.4 OUTLIER -64.76 -24.98 67.73 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.66 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -106.58 -12.54 15.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.276 0.56 . . . . 0.0 110.961 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.68 ' N ' ' O ' ' A' ' 149' ' ' TYR . 68.9 m80 -156.54 66.53 4.18 Favored Pre-proline 0 C--N 1.303 -1.429 0 C-N-CA 125.689 1.596 . . . . 0.0 110.59 -177.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.48 -2.72 11.15 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 122.468 2.112 . . . . 0.0 111.474 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -77.36 3.7 12.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.914 -178.472 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.08 129.28 17.54 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 119.269 -2.145 . . . . 0.0 111.186 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.909 ' CD2' HD23 ' A' ' 24' ' ' LEU . 23.6 t80 54.08 6.73 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.048 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 1.3 p-10 . . . . . 0 N--CA 1.45 -0.438 0 O-C-N 121.402 -0.811 . . . . 0.0 110.225 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.829 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.1 p -134.85 148.87 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 122.544 -0.386 . . . . 0.0 110.91 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -97.89 109.73 22.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.526 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.2 m -97.05 136.03 38.19 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.67 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -135.47 129.29 32.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.328 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.4 ' HG2' HD12 ' A' ' 116' ' ' ILE . 1.2 tt0 -103.14 134.16 47.03 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.643 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -127.14 168.78 14.19 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.627 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -150.71 140.31 21.61 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -144.42 129.15 18.25 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.515 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 m -100.42 144.05 29.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.787 0.327 . . . . 0.0 111.653 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.0 t -145.43 164.34 31.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.485 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -94.66 25.75 3.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.746 0.308 . . . . 0.0 111.16 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.589 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.3 mt -111.55 125.42 30.44 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.781 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 45.9 Cg_exo -50.42 147.56 16.54 Favored 'Trans proline' 0 C--N 1.327 -0.594 0 C-N-CA 121.953 1.769 . . . . 0.0 111.652 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.439 ' HA ' HD12 ' A' ' 18' ' ' LEU . 26.8 Cg_exo -58.3 -25.08 71.03 Favored 'Trans proline' 0 N--CA 1.483 0.863 0 C-N-CA 122.279 1.986 . . . . 0.0 112.623 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.48 ' C ' ' HZ2' ' A' ' 20' ' ' LYS . 55.4 m -67.62 -35.27 78.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.311 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -75.42 -57.06 4.12 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.589 HD11 ' O ' ' A' ' 13' ' ' ILE . 4.6 mt -50.17 -44.69 52.91 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.008 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.529 ' O ' HG22 ' A' ' 23' ' ' VAL . 55.7 t80 -49.4 -58.68 4.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.005 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.771 ' CB ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -67.57 -40.35 84.87 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 118.83 -1.148 . . . . 0.0 108.415 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.871 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -64.59 -2.99 2.7 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.445 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.487 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 4.0 m-85 -118.35 -9.26 10.42 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 19' ' ' PHE . 30.7 m -130.22 -50.95 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.021 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.9 pp -98.06 -31.32 12.2 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 1.021 ' N ' HD12 ' A' ' 24' ' ' LEU . 26.9 m-20 -114.21 -3.96 13.13 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-N 118.648 0.658 . . . . 0.0 111.555 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -66.88 -39.54 87.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.989 0.899 . . . . 0.0 111.187 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.52 16.99 3.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.125 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -138.35 -9.5 1.47 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.946 HD12 HG23 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -90.47 -50.22 6.07 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.585 -1.643 . . . . 0.0 109.631 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.601 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 96.0 mt -55.65 -51.6 78.87 Favored Pre-proline 0 C--O 1.212 -0.883 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.054 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 29.1 Cg_endo -62.49 -26.05 76.13 Favored 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 121.747 1.632 . . . . 0.0 112.948 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.54 -60.79 2.08 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.633 0.73 . . . . 0.0 112.435 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.561 HD13 ' HB2' ' A' ' 149' ' ' TYR . 1.9 pt -93.07 -33.03 5.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.583 -177.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.861 ' HB2' ' HG ' ' A' ' 145' ' ' LEU . . . -102.79 68.15 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 123.121 0.569 . . . . 0.0 112.311 -177.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.424 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 66.7 Cg_endo -72.89 -19.15 23.86 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 N-CA-C 108.726 -1.298 . . . . 0.0 108.726 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -73.4 -39.41 65.11 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.693 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.677 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -70.36 -82.15 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.69 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 73.3 mt -110.74 145.05 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.044 0.45 . . . . 0.0 110.588 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -77.8 -47.69 18.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.421 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.461 ' OE1' ' N ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -174.02 164.82 4.19 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.754 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.461 ' N ' ' OE1' ' A' ' 40' ' ' GLN . . . -164.73 145.82 7.86 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.841 0.353 . . . . 0.0 110.993 178.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -137.63 145.5 42.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.716 0.293 . . . . 0.0 110.258 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.522 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -79.54 139.54 18.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.476 0.655 . . . . 0.0 110.654 -179.474 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 44' ' ' LEU . 6.9 mp -88.98 -39.48 13.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.795 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.944 ' O ' HG23 ' A' ' 52' ' ' THR . 42.9 mt-10 -141.89 133.57 27.0 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.843 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.24 -156.33 29.41 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 38.6 p30 -139.76 -8.3 1.24 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.96 0.41 . . . . 0.0 111.131 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' HD12 ' A' ' 74' ' ' ILE . . . 143.46 16.22 0.26 Allowed Glycine 0 C--O 1.219 -0.814 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.41 -172.04 19.99 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 117.394 0.597 . . . . 0.0 111.907 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -62.74 126.05 17.37 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 C-N-CA 122.858 2.372 . . . . 0.0 113.307 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.19 5.97 59.14 Favored Glycine 0 CA--C 1.506 -0.523 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.944 HG23 ' O ' ' A' ' 45' ' ' GLU . 92.7 m -93.18 138.65 31.39 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 114.239 -0.981 . . . . 0.0 110.949 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.89 128.46 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.522 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -116.79 139.79 50.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.726 0.774 . . . . 0.0 110.676 179.035 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.447 ' C ' HD12 ' A' ' 56' ' ' ILE . 46.7 tttm -118.47 127.84 54.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.828 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.757 ' N ' HD12 ' A' ' 56' ' ' ILE . 2.0 mp -104.47 136.61 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.9 m -117.15 120.0 36.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.368 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.04 169.06 10.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.365 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.11 143.99 28.82 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 0.8 OUTLIER -59.86 -50.38 74.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.849 0.357 . . . . 0.0 110.468 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.71 61.47 3.47 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.6 t -145.49 178.97 7.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 110.653 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -66.63 -45.68 78.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 0.0 110.626 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -91.46 154.74 18.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.397 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.44 -61.71 0.13 Allowed Glycine 0 CA--C 1.52 0.347 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.53 154.93 42.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.754 0.311 . . . . 0.0 110.28 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.83 149.95 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.723 0.297 . . . . 0.0 111.202 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.57 113.43 26.99 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.527 0.68 . . . . 0.0 112.044 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.607 ' CE1' ' CD1' ' A' ' 83' ' ' TYR . 6.7 t60 -109.63 112.08 23.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.721 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -102.4 131.44 49.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.144 0.497 . . . . 0.0 111.858 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.408 HD12 HG22 ' A' ' 52' ' ' THR . 13.8 mt -86.17 143.08 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -106.66 -54.89 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.2 m -164.81 141.92 6.14 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.459 HD12 ' O ' ' A' ' 48' ' ' GLY . 53.9 mt -124.81 131.26 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.872 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' A' ' 79' ' ' TYR . 5.8 m-20 -114.93 87.42 2.65 Favored 'General case' 0 C--O 1.21 -1.023 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.502 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 7.4 pt-20 -55.04 -30.63 59.97 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.57 -37.7 68.38 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.4 m -107.76 -10.46 15.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.922 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.56 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.2 m-85 62.84 44.57 6.19 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.625 -0.672 . . . . 0.0 109.865 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -105.96 145.66 31.03 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.469 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -132.13 120.82 22.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.191 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.473 ' CB ' ' OE1' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -127.11 133.25 50.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.321 -179.675 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.607 ' CD1' ' CE1' ' A' ' 69' ' ' HIS . 24.6 p90 -144.11 170.75 15.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.827 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.1 m -145.94 125.69 13.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.018 0.437 . . . . 0.0 110.876 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.529 HD12 HD21 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -79.08 118.25 20.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.722 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.673 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -85.75 -41.81 15.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -175.486 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.673 ' N ' HD13 ' A' ' 86' ' ' ILE . 10.0 tp10 -162.59 174.75 12.2 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 118.948 0.795 . . . . 0.0 110.816 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 119.76 178.31 16.38 Favored Glycine 0 CA--C 1.505 -0.578 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.6 2.75 0.16 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.758 ' C ' HD23 ' A' ' 91' ' ' LEU . . . -72.07 -37.38 69.64 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 123.917 0.887 . . . . 0.0 111.22 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.867 HD23 ' N ' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -111.29 17.04 20.61 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 119.672 -0.204 . . . . 0.0 110.625 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.4 p 54.25 -133.4 1.74 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -177.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -131.81 -0.7 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.5 p -104.72 -7.71 19.35 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.702 HG21 HD13 ' A' ' 98' ' ' ILE . 6.9 mt -99.2 151.25 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.481 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -87.07 -50.5 6.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.351 176.165 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.455 ' N ' ' HG2' ' A' ' 96' ' ' GLU . 12.1 ptmt -172.61 149.56 2.09 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.702 HD13 HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.9 130.38 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.155 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.434 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -113.15 144.26 42.96 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.902 0.481 . . . . 0.0 111.015 -179.037 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.489 ' CE1' ' OG ' ' A' ' 117' ' ' SER . 0.3 OUTLIER -139.22 131.55 28.39 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.87 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.473 ' OE1' ' CB ' ' A' ' 82' ' ' SER . 8.9 tp10 -128.73 133.0 48.01 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.408 ' N ' ' CD ' ' A' ' 101' ' ' GLU . 0.5 OUTLIER -136.26 131.63 34.71 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 121.596 -0.69 . . . . 0.0 110.631 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.734 ' C ' HD23 ' A' ' 104' ' ' LEU . 38.3 tttm -124.33 134.17 53.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.863 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.858 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -100.6 126.17 47.05 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -178.726 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -128.32 136.69 59.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.959 -178.843 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.68 133.42 44.61 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.117 -0.364 . . . . 0.0 110.596 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 24.7 t -121.7 173.35 7.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.547 0.339 . . . . 0.0 110.158 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.443 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -54.4 -36.61 58.3 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.901 -0.479 . . . . 0.0 111.901 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.9 m -93.98 15.94 15.66 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.25 1.42 . . . . 0.0 113.363 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 130.0 -83.99 0.32 Allowed Glycine 0 CA--C 1.534 1.235 0 C-N-CA 126.4 1.952 . . . . 0.0 113.095 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 84.1 p -161.62 132.13 5.04 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 126.99 2.116 . . . . 0.0 111.057 176.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 105' ' ' VAL . 45.0 m -99.83 118.12 35.61 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 60.5 mt -92.72 126.83 45.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.57 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.62 116.86 32.65 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.812 ' C ' HD13 ' A' ' 116' ' ' ILE . 1.9 p -111.62 124.3 52.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.335 0.588 . . . . 0.0 110.877 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.927 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -106.8 136.18 42.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 123.148 0.579 . . . . 0.0 109.922 -177.699 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.489 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 7.2 t -116.52 133.04 56.48 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.788 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.434 ' ND1' ' O ' ' A' ' 99' ' ' SER . 0.2 OUTLIER -136.47 109.35 7.61 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 120.766 0.317 . . . . 0.0 110.522 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.829 ' C ' HG23 ' A' ' 2' ' ' VAL . 7.3 m-85 -102.14 104.02 14.61 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.228 -0.295 . . . . 0.0 110.512 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -90.86 110.16 21.37 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.064 0.459 . . . . 0.0 109.823 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.4 p -94.1 171.3 8.93 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 122.021 0.915 . . . . 0.0 111.929 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.7 ptmm? -112.93 142.57 45.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.829 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 53.83 -109.68 1.19 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.48 2.26 12.4 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 122.299 -0.53 . . . . 0.0 111.264 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.484 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.4 mp -43.45 161.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.344 0.592 . . . . 0.0 110.812 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.484 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 9.9 pt-20 -148.31 150.28 33.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.238 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.551 HD12 HD11 ' A' ' 95' ' ' ILE . 1.6 mm -87.78 125.62 41.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -74.88 160.89 30.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.11 0.481 . . . . 0.0 111.002 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -70.1 -39.7 75.37 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.566 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.584 ' O ' HG22 ' A' ' 134' ' ' VAL . 8.8 mm-40 -66.47 -25.15 66.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.587 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -72.42 -51.17 21.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.387 0.613 . . . . 0.0 110.81 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 m -78.42 -30.6 15.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.07 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -66.83 -46.0 76.5 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 122.156 -0.34 . . . . 0.0 111.077 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 130' ' ' GLU . 25.4 m -70.5 -44.71 76.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.611 0.243 . . . . 0.0 110.771 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.522 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -69.06 -46.83 57.3 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -67.45 -50.49 58.99 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.504 -0.409 . . . . 0.0 110.866 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -55.27 -47.77 74.98 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -63.15 -53.64 50.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.539 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -48.49 -47.86 38.34 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.412 0.625 . . . . 0.0 110.837 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -54.26 -37.61 64.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.02 -32.4 84.05 Favored Glycine 0 C--O 1.228 -0.247 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.712 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -74.61 -41.06 61.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -59.33 -25.72 64.42 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -76.29 -33.76 59.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.85 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.861 ' HG ' ' HB2' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -66.26 -56.78 9.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.1 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.946 HG23 HD12 ' A' ' 29' ' ' LEU . 61.9 mt -65.02 -48.73 82.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.653 -178.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -47.0 -47.57 22.01 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.158 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.0 t -54.84 -42.95 72.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.469 0.652 . . . . 0.0 111.26 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.636 ' O ' ' N ' ' A' ' 153' ' ' HIS . 26.8 t80 -59.08 -44.67 91.92 Favored 'General case' 0 C--O 1.191 -1.997 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.871 HD11 ' HB2' ' A' ' 21' ' ' ALA . 1.9 mm? -66.21 -42.48 88.7 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 119.491 1.041 . . . . 0.0 111.794 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.458 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -62.57 -24.83 67.75 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 121.525 -0.734 . . . . 0.0 109.329 179.511 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.438 ' O ' ' ND1' ' A' ' 153' ' ' HIS . 28.6 t70 -106.22 -13.42 15.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.034 0.445 . . . . 0.0 110.774 178.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.636 ' N ' ' O ' ' A' ' 149' ' ' TYR . 54.4 m80 -155.82 66.8 4.63 Favored Pre-proline 0 C--N 1.309 -1.168 0 C-N-CA 125.425 1.49 . . . . 0.0 110.43 -178.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -74.18 -3.37 13.7 Favored 'Trans proline' 0 C--N 1.324 -0.739 0 C-N-CA 122.579 2.186 . . . . 0.0 111.522 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 4.0 p-10 -81.95 4.82 21.16 Favored 'General case' 0 C--O 1.21 -0.975 0 C-N-CA 123.953 0.901 . . . . 0.0 111.991 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.401 ' O ' ' CD ' ' A' ' 20' ' ' LYS . . . -49.35 129.79 18.96 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 119.325 -2.11 . . . . 0.0 111.395 -178.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.526 ' CD2' HD22 ' A' ' 24' ' ' LEU . 13.6 t80 55.0 6.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 5.7 p-10 . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.197 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.653 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.823 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.4 p -134.66 148.96 29.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 122.547 -0.384 . . . . 0.0 111.032 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.76 111.82 23.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.345 177.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.3 m -96.09 134.82 38.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.002 0.43 . . . . 0.0 110.2 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.537 ' CE2' ' OD1' ' A' ' 7' ' ' ASN . 0.2 OUTLIER -131.54 122.19 25.72 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.539 ' CG ' HD12 ' A' ' 116' ' ' ILE . 1.5 tt0 -117.04 127.8 54.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.149 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.537 ' OD1' ' CE2' ' A' ' 5' ' ' PHE . 2.8 m120 -138.26 175.74 9.31 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.591 0.234 . . . . 0.0 110.818 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -144.31 156.17 44.14 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -149.86 134.04 17.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.954 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -92.91 144.84 24.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.859 0.362 . . . . 0.0 111.803 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.45 154.02 50.0 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.114 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -96.38 28.18 3.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.044 0.45 . . . . 0.0 110.715 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.694 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.5 mt -119.04 126.03 27.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.73 -178.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -46.99 145.64 6.94 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 121.823 1.682 . . . . 0.0 111.758 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -55.78 -29.73 73.14 Favored 'Trans proline' 0 N--CA 1.482 0.805 0 C-N-CA 122.263 1.975 . . . . 0.0 112.808 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.9 m -63.86 -35.46 80.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -74.96 -59.2 2.84 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.694 HD21 ' HB ' ' A' ' 13' ' ' ILE . 2.3 mt -50.88 -42.41 59.05 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.967 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.732 ' O ' HG22 ' A' ' 23' ' ' VAL . 40.8 t80 -50.24 -57.44 7.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.675 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.836 ' CB ' HD21 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.89 -40.74 75.49 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 118.572 -1.251 . . . . 0.0 109.102 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.847 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -63.49 -2.74 1.7 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.648 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.488 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 5.4 t80 -118.96 -9.35 10.08 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.886 HG23 HD13 ' A' ' 24' ' ' LEU . 3.6 m -132.54 -49.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.98 ' H ' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -99.09 -31.56 11.71 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.033 1.288 . . . . 0.0 112.03 -178.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.813 ' N ' HD22 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -107.68 -3.97 18.66 Favored 'General case' 0 C--O 1.211 -0.953 0 O-C-N 122.082 -0.386 . . . . 0.0 111.432 -178.511 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -67.05 -40.33 87.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.742 0.782 . . . . 0.0 111.728 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -84.02 13.89 4.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.837 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.436 ' H ' ' H ' ' A' ' 29' ' ' LEU . 65.3 m-20 -134.85 -9.34 2.37 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.898 HD12 HG23 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -96.71 -48.13 5.61 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.949 -179.693 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.702 HG13 HD11 ' A' ' 146' ' ' ILE . 74.8 mt -54.45 -56.1 30.38 Favored Pre-proline 0 C--O 1.217 -0.624 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 34.9 Cg_endo -63.37 -26.32 71.11 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 C-N-CA 122.298 1.999 . . . . 0.0 113.886 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -71.69 -49.41 39.9 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.601 0.715 . . . . 0.0 111.896 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.755 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.7 OUTLIER -94.76 -34.81 5.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.674 -177.472 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.783 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.58 64.07 0.14 Allowed Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.5 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 73.0 Cg_endo -76.59 -24.46 10.37 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 N-CA-C 107.909 -1.612 . . . . 0.0 107.909 174.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -73.79 -44.2 56.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.411 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.783 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -71.11 -77.76 0.09 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.15 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 mt -100.32 146.22 9.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 121.085 0.469 . . . . 0.0 110.191 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -78.08 -53.18 7.68 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.22 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -173.14 165.86 4.92 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.157 0.503 . . . . 0.0 110.578 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.404 ' HB1' ' HE3' ' A' ' 54' ' ' LYS . . . -166.07 145.21 6.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.966 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -149.2 142.34 24.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.897 0.38 . . . . 0.0 110.412 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.625 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -78.74 140.72 16.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.358 0.599 . . . . 0.0 111.201 -179.356 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.761 ' N ' HD12 ' A' ' 44' ' ' LEU . 3.7 mp -90.47 -39.86 12.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.494 178.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 52' ' ' THR . 13.9 mm-40 -143.23 134.87 26.47 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.306 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.95 -155.02 22.23 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.991 -0.443 . . . . 0.0 111.991 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.407 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 13.0 p30 -135.53 -11.72 2.1 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 123.416 0.686 . . . . 0.0 111.315 -177.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.2 12.23 1.28 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -110.63 -172.28 19.87 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -59.05 127.24 23.5 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 122.479 2.119 . . . . 0.0 113.283 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.84 4.8 55.54 Favored Glycine 0 N--CA 1.462 0.384 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 45' ' ' GLU . 19.3 m -94.18 142.06 27.84 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.626 -0.787 . . . . 0.0 111.883 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.634 HD12 ' C ' ' A' ' 52' ' ' THR . 1.8 mp -118.17 132.86 66.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 176.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.625 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -121.82 139.39 53.67 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.465 0.65 . . . . 0.0 111.148 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.692 ' HB3' HD11 ' A' ' 44' ' ' LEU . 26.2 ttpt -119.23 118.73 32.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.293 178.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.23 137.69 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.634 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.1 m -118.97 117.77 29.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.165 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -94.91 -175.14 3.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.434 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.59 144.39 30.08 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 7.3 mp0 -60.18 -59.48 5.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.924 0.392 . . . . 0.0 110.29 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.98 60.82 3.43 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.6 m -138.89 -178.13 5.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.129 0.49 . . . . 0.0 110.706 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.585 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 1.8 mp0 -68.4 -44.14 75.74 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.441 ' CD1' ' OD2' ' A' ' 89' ' ' ASP . 52.2 m-85 -91.58 145.12 24.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.97 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.3 -62.08 0.12 Allowed Glycine 0 CA--C 1.519 0.299 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -146.14 151.91 38.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.843 0.354 . . . . 0.0 110.494 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -157.21 150.29 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.946 0.403 . . . . 0.0 111.279 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.58 ' HB3' HD11 ' A' ' 86' ' ' ILE . 28.2 mmtt -105.57 106.79 17.45 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.175 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.476 ' CD2' ' C ' ' A' ' 69' ' ' HIS . 1.2 t-160 -105.24 111.02 23.61 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -105.2 128.83 53.6 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.816 0.341 . . . . 0.0 111.497 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.485 HD13 ' CG2' ' A' ' 52' ' ' THR . 2.9 mp -74.03 144.96 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -98.89 -55.51 2.69 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.792 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.9 m -165.94 141.22 4.8 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.5 mt -123.41 131.8 72.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 176.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 79' ' ' TYR . 2.8 m-20 -115.92 87.96 2.79 Favored 'General case' 0 C--O 1.208 -1.125 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -54.39 -29.89 50.26 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.73 75.66 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.023 177.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -107.11 -11.3 15.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.052 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.574 ' N ' ' O ' ' A' ' 75' ' ' ASP . 9.0 m-85 60.3 44.16 12.78 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.537 -0.727 . . . . 0.0 110.45 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 34.4 t -109.75 146.24 35.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.835 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -131.65 123.29 27.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.004 0.43 . . . . 0.0 111.111 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.35 134.65 48.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.056 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -143.93 166.03 26.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.903 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.0 m -145.9 135.3 23.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.17 0.509 . . . . 0.0 111.189 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.589 HD13 ' HB1' ' A' ' 90' ' ' ALA . 10.2 mt -80.75 117.09 21.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.58 HD11 ' HB3' ' A' ' 68' ' ' LYS . 4.1 pt -81.68 -44.58 20.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.798 0.332 . . . . 0.0 111.487 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.468 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 19.9 tt0 -151.42 172.5 15.86 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.761 0.315 . . . . 0.0 110.451 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.74 177.23 18.44 Favored Glycine 0 CA--C 1.509 -0.287 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.441 ' OD2' ' CD1' ' A' ' 64' ' ' TYR . 6.4 p30 -61.27 1.12 0.21 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.589 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -62.92 -35.3 79.62 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.004 0.922 . . . . 0.0 109.931 177.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.878 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.89 12.66 22.25 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 123.802 0.841 . . . . 0.0 109.575 -177.842 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.1 p 47.82 -126.3 1.78 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -130.44 -11.3 4.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.991 0.425 . . . . 0.0 111.07 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.4 -6.72 19.29 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.747 HG21 ' CD1' ' A' ' 98' ' ' ILE . 96.3 mt -98.16 152.01 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-O 122.251 1.024 . . . . 0.0 113.56 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.546 ' OE2' ' CE1' ' A' ' 120' ' ' HIS . 0.0 OUTLIER -91.08 -54.12 4.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.932 177.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.66 145.74 1.57 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.038 0.447 . . . . 0.0 111.943 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.747 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.41 132.64 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.222 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.472 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 0.3 OUTLIER -119.36 144.87 46.64 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.723 0.409 . . . . 0.0 111.51 -178.501 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.472 ' CD2' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -136.35 130.26 32.58 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.798 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.506 ' O ' HG12 ' A' ' 116' ' ' ILE . 30.3 tt0 -129.41 134.14 47.7 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.524 0.202 . . . . 0.0 110.511 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.7 OUTLIER -132.27 135.56 46.33 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.922 -0.486 . . . . 0.0 109.719 -179.037 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -119.53 133.82 55.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.58 126.07 40.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.466 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.27 135.25 47.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.422 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -73.33 138.72 45.56 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 121.936 -0.477 . . . . 0.0 110.304 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 52.4 t -121.34 170.39 9.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.889 0.376 . . . . 0.0 110.317 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.551 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.56 -34.75 50.13 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.9 m -85.41 -15.06 44.3 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.112 1.365 . . . . 0.0 114.321 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.18 -85.64 0.13 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.92 1.724 . . . . 0.0 111.396 -171.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.468 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 41.2 t -161.32 132.73 5.48 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.654 1.582 . . . . 0.0 111.221 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 55.0 m -99.92 128.76 45.98 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.299 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.2 mt -101.51 127.79 54.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.548 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 102' ' ' THR . 3.3 mtpt -105.37 116.89 32.71 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.849 ' C ' HD13 ' A' ' 116' ' ' ILE . 0.9 OUTLIER -111.68 123.08 49.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.954 0.407 . . . . 0.0 110.548 -178.307 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.9 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -109.65 136.39 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.358 -177.496 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.3 t -118.05 133.24 56.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.544 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.472 ' ND1' ' O ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -136.79 103.81 5.31 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 120.913 0.387 . . . . 0.0 110.176 -179.407 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.823 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -97.33 108.41 21.13 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.029 -0.42 . . . . 0.0 110.524 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.546 ' CE1' ' OE2' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -88.98 104.74 17.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.793 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.3 p -88.52 170.42 10.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.996 0.903 . . . . 0.0 111.731 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -113.02 156.26 23.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.882 179.424 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . 35.07 -109.24 0.06 OUTLIER Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -111.41 -2.79 15.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.939 0.399 . . . . 0.0 111.063 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.3 mp -43.21 160.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.274 0.559 . . . . 0.0 110.572 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.429 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 34.7 tt0 -152.54 148.7 27.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.284 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.2 mm -88.15 124.79 41.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -74.74 161.72 29.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.421 0.629 . . . . 0.0 111.698 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -69.72 -41.74 74.94 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.775 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 134' ' ' VAL . 53.6 mt-10 -62.25 -27.09 68.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.713 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -73.03 -49.99 25.6 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.417 0.627 . . . . 0.0 111.342 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 m -77.61 -29.86 16.57 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.192 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -67.15 -45.73 76.18 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.22 -0.3 . . . . 0.0 110.96 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 130' ' ' GLU . 34.1 m -67.99 -44.25 85.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.792 0.329 . . . . 0.0 110.287 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -67.37 -39.18 91.68 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -67.05 -47.22 71.99 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.711 -0.288 . . . . 0.0 110.661 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -55.2 -46.81 75.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.949 0.404 . . . . 0.0 110.201 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -64.71 -52.51 56.77 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.454 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.47 -42.66 43.86 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.55 0.691 . . . . 0.0 110.56 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.414 ' O ' ' ND1' ' A' ' 140' ' ' HIS . 1.3 t60 -60.97 -36.09 78.51 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.891 0.853 . . . . 0.0 109.51 178.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.411 ' O ' HD22 ' A' ' 145' ' ' LEU . . . -61.23 -44.79 97.66 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -65.57 -40.54 92.89 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -59.79 -28.69 67.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -77.49 -35.9 53.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.286 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.761 HD23 ' HB2' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -68.26 -57.69 5.58 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.514 0.674 . . . . 0.0 110.23 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.898 HG23 HD12 ' A' ' 29' ' ' LEU . 45.1 mt -58.21 -50.04 79.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.661 -177.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -46.87 -55.21 8.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.622 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 41.8 t -52.91 -44.49 66.99 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.508 0.671 . . . . 0.0 110.971 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.658 ' HB2' HD13 ' A' ' 33' ' ' ILE . 24.8 t80 -58.58 -45.58 88.74 Favored 'General case' 0 C--O 1.194 -1.832 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.847 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.2 mm? -66.22 -43.18 87.42 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 120.257 1.389 . . . . 0.0 111.565 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -61.5 -24.09 66.36 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 121.489 -0.757 . . . . 0.0 109.159 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.469 ' OD2' ' CE1' ' A' ' 153' ' ' HIS . 10.6 t70 -105.73 -13.26 15.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.46 0.648 . . . . 0.0 110.595 178.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 149' ' ' TYR . 56.0 m80 -155.51 67.14 4.89 Favored Pre-proline 0 C--N 1.312 -1.05 0 C-N-CA 125.199 1.4 . . . . 0.0 110.101 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.51 -3.62 14.02 Favored 'Trans proline' 0 N--CA 1.481 0.756 0 C-N-CA 122.566 2.177 . . . . 0.0 111.576 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 158' ' ' ASN . 0.5 OUTLIER -83.9 5.16 26.37 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.953 -179.026 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -48.97 129.89 17.83 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 119.594 -1.941 . . . . 0.0 111.394 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.687 ' CG ' HD23 ' A' ' 24' ' ' LEU . 0.3 OUTLIER 56.11 6.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.987 0.515 . . . . 0.0 112.059 178.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 155' ' ' ASP . 4.6 p-10 . . . . . 0 C--N 1.324 -0.511 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.202 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.828 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.3 p -134.46 148.49 29.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.829 0.347 . . . . 0.0 110.715 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.76 109.7 22.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.601 177.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.7 m -96.53 137.27 35.86 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.313 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -135.52 129.18 32.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.471 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.471 ' C ' HD22 ' A' ' 7' ' ' ASN . 1.5 tt0 -103.36 129.39 50.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.94 0.4 . . . . 0.0 110.749 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.56 ' ND2' ' N ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -142.89 164.75 29.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -178.625 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -155.51 159.53 39.82 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -144.56 140.78 29.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.341 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.03 147.68 24.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 111.521 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.3 t -145.36 164.2 32.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.688 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -102.88 23.98 11.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.891 0.376 . . . . 0.0 110.843 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.686 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.7 mt -112.57 126.61 28.05 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.627 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -47.35 144.21 10.05 Favored 'Trans proline' 0 C--N 1.326 -0.613 0 C-N-CA 122.019 1.813 . . . . 0.0 111.974 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.505 ' HA ' HD12 ' A' ' 18' ' ' LEU . 39.6 Cg_exo -55.45 -24.55 44.26 Favored 'Trans proline' 0 N--CA 1.484 0.931 0 C-N-CA 122.361 2.04 . . . . 0.0 112.7 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.444 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 13.2 p -70.08 -37.04 75.36 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.425 HH21 ' HD2' ' A' ' 17' ' ' ARG . 4.5 mtt85 -75.22 -47.65 27.17 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.686 HD11 ' O ' ' A' ' 13' ' ' ILE . 5.2 mt -57.42 -48.29 79.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.554 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.741 ' O ' HG22 ' A' ' 23' ' ' VAL . 48.5 t80 -46.18 -57.51 4.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.081 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -69.72 -26.02 64.13 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.579 0.704 . . . . 0.0 109.953 -179.296 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.854 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -83.72 -2.57 56.53 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.293 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.484 ' CA ' ' HB2' ' A' ' 26' ' ' ALA . 1.6 t80 -117.55 -9.02 10.89 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.878 HG23 ' CD1' ' A' ' 24' ' ' LEU . 2.3 m -134.62 -36.76 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.878 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.5 mp -92.29 -53.06 4.38 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.185 0.902 . . . . 0.0 111.391 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.57 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.4 m-20 -114.37 13.8 17.83 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 116.846 -0.161 . . . . 0.0 111.358 -176.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -66.9 -42.17 85.93 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 121.244 0.545 . . . . 0.0 111.192 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -83.94 18.59 1.99 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.075 0.941 . . . . 0.0 110.259 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -135.95 -9.11 2.07 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.894 HD12 HG23 ' A' ' 146' ' ' ILE . 0.1 OUTLIER -90.65 -51.31 5.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.493 -1.685 . . . . 0.0 110.706 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.626 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -58.5 -52.16 76.63 Favored Pre-proline 0 C--O 1.215 -0.723 0 CA-C-O 120.777 0.323 . . . . 0.0 110.742 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 22.8 Cg_endo -60.5 -21.79 69.6 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 C-N-CA 122.632 2.222 . . . . 0.0 112.763 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -75.22 -52.06 11.82 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.839 0.352 . . . . 0.0 111.07 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -95.2 -35.04 5.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.159 -177.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.827 ' HB2' ' CG ' ' A' ' 145' ' ' LEU . . . -106.77 81.54 0.91 Allowed Pre-proline 0 CA--C 1.507 -0.679 0 C-N-CA 122.78 0.432 . . . . 0.0 111.728 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.15 -10.71 27.84 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 N-CA-C 107.227 -1.874 . . . . 0.0 107.227 174.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -42.29 58.24 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.402 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.512 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -73.79 -82.03 0.06 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.874 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.1 mm -107.63 142.82 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.965 0.412 . . . . 0.0 110.974 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -79.73 -45.12 19.48 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.67 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -178.6 166.28 1.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.814 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.13 145.06 5.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.241 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -141.43 146.05 36.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.208 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.417 HG13 ' H ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -79.67 139.6 18.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.471 0.653 . . . . 0.0 110.703 -179.4 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.3 mp -88.52 -39.87 13.85 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.129 -0.942 . . . . 0.0 108.684 178.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.911 ' O ' HG23 ' A' ' 52' ' ' THR . 24.1 mt-10 -142.52 133.75 26.13 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.976 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.58 -156.15 24.57 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -139.76 -10.62 1.18 Allowed 'General case' 0 C--N 1.32 -0.698 0 O-C-N 122.529 -0.394 . . . . 0.0 110.975 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.486 ' O ' HD12 ' A' ' 74' ' ' ILE . . . 143.6 13.09 0.32 Allowed Glycine 0 C--O 1.221 -0.718 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.26 -171.24 20.67 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 117.344 0.572 . . . . 0.0 112.089 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -62.53 126.15 17.73 Favored 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 123.024 2.483 . . . . 0.0 113.58 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.27 5.84 56.94 Favored Glycine 0 N--CA 1.463 0.479 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.911 HG23 ' O ' ' A' ' 45' ' ' GLU . 88.3 m -93.37 140.5 29.5 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.271 -0.964 . . . . 0.0 111.145 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -119.18 129.98 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.498 ' HB3' ' HZ3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -118.16 140.93 49.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.074 0.464 . . . . 0.0 111.047 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -118.96 128.64 54.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.173 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.681 ' N ' HD12 ' A' ' 56' ' ' ILE . 3.2 mp -105.21 125.36 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.715 -0.394 . . . . 0.0 109.956 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.1 m -102.54 118.61 37.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -92.62 -174.83 3.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.76 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.73 143.86 31.61 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 8.9 mp0 -60.72 -63.57 1.25 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.909 0.385 . . . . 0.0 110.653 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.77 62.2 3.36 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.8 t -136.7 178.52 7.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.908 0.385 . . . . 0.0 110.754 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -60.81 -49.66 76.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.745 0.307 . . . . 0.0 111.018 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -91.92 137.83 32.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.496 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.4 -58.72 0.52 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.439 ' CD2' ' N ' ' A' ' 66' ' ' TYR . 7.3 p90 -145.71 152.42 39.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.001 0.429 . . . . 0.0 110.652 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 87' ' ' GLU . 7.3 p -156.69 141.99 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.844 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.467 ' O ' ' CD1' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -108.2 118.6 37.18 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 122.705 1.24 . . . . 0.0 112.735 -178.724 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.546 ' HA ' HD22 ' A' ' 85' ' ' LEU . 1.8 t-80 -100.43 119.23 38.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.977 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -102.39 126.65 49.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.046 0.451 . . . . 0.0 111.576 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.2 mt -84.69 137.2 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -99.44 -55.98 2.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.8 m -165.26 141.87 5.63 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 48' ' ' GLY . 59.7 mt -126.6 131.07 71.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.939 176.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 79' ' ' TYR . 43.1 m-20 -115.06 88.48 2.88 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.489 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 6.7 mt-10 -54.45 -30.37 52.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.92 -39.02 76.97 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.561 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -107.95 -10.42 15.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.213 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.5 m-85 63.17 47.15 4.25 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 121.537 -0.727 . . . . 0.0 109.886 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 p -105.86 142.72 35.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.749 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.452 ' OH ' ' CE1' ' A' ' 69' ' ' HIS . 17.3 t80 -132.67 120.73 22.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.814 0.34 . . . . 0.0 110.641 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 p -127.07 129.62 48.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.341 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.679 ' CE2' ' CD1' ' A' ' 100' ' ' TYR . 34.5 p90 -144.97 164.59 30.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.033 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.6 m -146.09 125.6 13.23 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.115 0.483 . . . . 0.0 111.069 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.546 HD22 ' HA ' ' A' ' 69' ' ' HIS . 0.2 OUTLIER -80.17 121.67 25.86 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.582 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.738 HD13 ' H ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -83.72 -43.51 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -175.618 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.738 ' H ' HD13 ' A' ' 86' ' ' ILE . 6.0 tt0 -162.69 178.62 8.34 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.28 -0.888 . . . . 0.0 110.481 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.604 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.87 178.71 18.34 Favored Glycine 0 CA--C 1.504 -0.646 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.48 2.63 0.16 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.804 ' C ' HD23 ' A' ' 91' ' ' LEU . . . -71.96 -38.03 69.82 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 123.572 0.749 . . . . 0.0 110.94 178.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.858 HD23 ' N ' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -111.37 17.46 20.14 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 93' ' ' ASP . 6.9 p 57.11 -133.94 1.27 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.433 ' N ' ' OG1' ' A' ' 92' ' ' THR . 52.3 t0 -130.66 0.39 4.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.8 p -104.91 -8.41 18.66 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.382 -0.824 . . . . 0.0 113.124 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.688 HG21 HD13 ' A' ' 98' ' ' ILE . 4.6 mt -100.12 151.39 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.47 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -86.56 -50.75 6.61 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.285 176.107 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HA ' ' CD1' ' A' ' 91' ' ' LEU . 13.0 ptpt -171.72 148.98 2.49 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.688 HD13 HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.97 129.02 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.465 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.584 ' C ' ' HD1' ' A' ' 118' ' ' HIS . 0.3 OUTLIER -119.69 145.3 46.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.847 -179.302 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.679 ' CD1' ' CE2' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -142.89 135.66 27.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.733 0.301 . . . . 0.0 110.497 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -130.62 132.46 45.49 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.2 OUTLIER -131.73 133.83 45.23 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.09 -0.381 . . . . 0.0 110.511 -178.828 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -119.9 133.17 55.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -97.98 132.33 43.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -178.201 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.36 137.18 52.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.105 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.94 134.68 44.84 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.411 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.541 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 43.1 t -121.32 171.16 8.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.79 0.329 . . . . 0.0 110.253 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.541 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.51 -34.68 49.74 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 112.08 -0.408 . . . . 0.0 112.08 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.5 p -89.83 -13.38 36.67 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 118.765 -2.609 . . . . 0.0 114.116 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.64 -80.76 0.12 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.411 1.481 . . . . 0.0 112.401 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 83.3 p -161.51 131.54 4.88 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 126.577 1.951 . . . . 0.0 111.178 176.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.1 m -99.9 118.74 36.97 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 36.5 mt -92.34 127.49 44.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.121 -178.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -105.26 116.33 31.77 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.551 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.769 ' C ' HD13 ' A' ' 116' ' ' ILE . 69.2 p -111.93 123.97 51.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.199 0.523 . . . . 0.0 111.302 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.949 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -105.44 136.05 41.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -178.32 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.7 m -114.49 135.19 54.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.05 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.584 ' HD1' ' C ' ' A' ' 99' ' ' SER . 0.4 OUTLIER -137.24 109.17 7.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 110.433 -179.315 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.828 ' C ' HG23 ' A' ' 2' ' ' VAL . 5.4 m-85 -102.46 104.1 14.53 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -90.39 109.62 20.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.017 0.436 . . . . 0.0 109.852 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.2 p -93.93 169.9 9.95 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.952 0.882 . . . . 0.0 111.657 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -113.31 157.47 21.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.055 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 40.7 -109.73 0.16 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.9 p30 -116.19 7.51 14.13 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 122.703 -0.292 . . . . 0.0 111.396 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -48.35 161.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.311 0.577 . . . . 0.0 110.761 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.49 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 9.2 pt-20 -148.67 149.59 31.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.228 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.594 HD12 HD11 ' A' ' 95' ' ' ILE . 2.7 mm -87.69 124.5 40.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -75.92 160.09 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.561 0.696 . . . . 0.0 111.665 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -70.47 -47.34 61.09 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.446 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.542 ' O ' HG22 ' A' ' 134' ' ' VAL . 49.5 mt-10 -59.96 -24.52 64.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.6 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.59 ' C ' ' HD1' ' A' ' 131' ' ' HIS . 2.1 t-80 -72.08 -53.91 11.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.365 0.602 . . . . 0.0 110.718 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 m -77.32 -28.11 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.167 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -67.03 -46.53 74.16 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.224 -0.298 . . . . 0.0 111.069 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 130' ' ' GLU . 28.0 m -70.55 -44.18 77.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.678 0.275 . . . . 0.0 110.491 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.507 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -67.97 -41.49 87.53 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -67.13 -51.02 59.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.804 0.302 . . . . 0.0 111.02 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -56.63 -48.27 77.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 110.325 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -63.03 -51.38 66.97 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.61 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.71 -54.74 17.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.597 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -47.43 -38.67 13.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.342 0.591 . . . . 0.0 109.635 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.12 -31.5 80.93 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.667 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.8 OUTLIER -74.99 -38.53 61.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.67 0.748 . . . . 0.0 109.993 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -58.07 -28.32 64.46 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -75.75 -34.46 60.29 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.733 -1.122 . . . . 0.0 109.972 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.827 ' CG ' ' HB2' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -57.39 -61.42 2.5 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 122.191 0.996 . . . . 0.0 112.043 -179.615 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.894 HG23 HD12 ' A' ' 29' ' ' LEU . 26.7 mt -69.11 -48.46 69.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.403 -177.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -47.16 -42.71 20.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.1 t -59.91 -43.14 95.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.218 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.654 ' O ' ' N ' ' A' ' 153' ' ' HIS . 19.5 t80 -58.39 -45.05 89.08 Favored 'General case' 0 C--O 1.185 -2.341 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.923 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.4 mm? -68.06 -43.67 78.1 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 119.993 1.269 . . . . 0.0 111.653 -178.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.408 ' HG2' ' H ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -65.18 -24.45 67.38 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.881 179.509 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -106.92 -13.08 15.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.039 0.923 . . . . 0.0 110.948 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.654 ' N ' ' O ' ' A' ' 149' ' ' TYR . 68.3 m-70 -155.8 66.68 4.61 Favored Pre-proline 0 C--N 1.302 -1.49 0 C-N-CA 125.403 1.481 . . . . 0.0 110.193 -177.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.35 -2.8 7.73 Favored 'Trans proline' 0 N--CA 1.481 0.736 0 C-N-CA 122.571 2.181 . . . . 0.0 111.108 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.849 ' CA ' HD22 ' A' ' 158' ' ' ASN . 3.2 p30 -71.37 4.63 2.79 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.078 0.951 . . . . 0.0 113.077 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.94 129.71 43.16 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.584 -1.322 . . . . 0.0 113.042 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.685 ' CG ' HD23 ' A' ' 24' ' ' LEU . 81.7 t80 53.23 4.51 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 177.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.849 HD22 ' CA ' ' A' ' 155' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.559 0 O-C-N 120.506 -1.371 . . . . 0.0 110.381 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.017 HG21 ' CD2' ' A' ' 118' ' ' HIS . 7.7 p . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.907 0.384 . . . . 0.0 110.618 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -96.4 109.73 22.21 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.2 m -97.27 133.37 41.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.07 0.462 . . . . 0.0 110.62 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -132.26 132.14 42.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.739 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.487 ' C ' HD22 ' A' ' 7' ' ' ASN . 7.6 mt-10 -102.25 126.42 49.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.196 0.522 . . . . 0.0 110.613 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.575 HD22 ' N ' ' A' ' 7' ' ' ASN . 0.6 OUTLIER -131.26 161.17 32.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.771 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -155.27 153.12 30.12 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -142.92 141.15 31.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.28 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.73 147.32 22.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.742 0.306 . . . . 0.0 110.913 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -143.17 154.21 43.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 0.0 110.436 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -95.24 27.46 3.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.037 0.446 . . . . 0.0 110.4 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.53 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.5 mt -118.19 125.23 28.04 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.648 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.67 151.2 3.55 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.672 1.581 . . . . 0.0 111.471 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.582 ' CG ' ' HB2' ' A' ' 106' ' ' ALA . 21.8 Cg_exo -61.16 -24.24 78.78 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 C-N-CA 122.299 1.999 . . . . 0.0 112.483 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.446 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 68.8 m -70.64 -32.47 69.78 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.2 mmt-85 -76.24 -59.74 2.63 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.53 HD21 ' HB ' ' A' ' 13' ' ' ILE . 2.3 mt -48.36 -48.87 36.24 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.646 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.811 ' O ' HG22 ' A' ' 23' ' ' VAL . 16.4 t80 -44.75 -60.17 2.15 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.121 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.63 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -71.13 -26.32 62.96 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.142 -0.974 . . . . 0.0 110.917 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.945 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -77.07 -16.02 59.38 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.829 -177.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.505 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -117.6 -6.27 11.14 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.882 HG23 ' CD1' ' A' ' 24' ' ' LEU . 2.5 m -125.24 -35.99 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 118.5 0.591 . . . . 0.0 112.189 177.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.882 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.9 mp -92.28 -51.46 5.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.686 0.676 . . . . 0.0 111.412 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -106.93 -2.6 21.08 Favored 'General case' 0 C--O 1.206 -1.213 0 CA-C-O 119.22 -0.419 . . . . 0.0 111.496 -176.274 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.505 ' HB2' ' HA ' ' A' ' 22' ' ' PHE . . . -45.08 -34.08 2.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.978 0.894 . . . . 0.0 111.473 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -84.69 12.77 6.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.327 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 25' ' ' ASP . 95.8 m-20 -140.5 -10.85 1.06 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 125.38 1.472 . . . . 0.0 108.269 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.854 HD12 HG23 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -98.59 -48.42 4.99 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 125.499 1.52 . . . . 0.0 109.055 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.748 HG13 HD11 ' A' ' 146' ' ' ILE . 69.0 mt -56.24 -56.24 33.48 Favored Pre-proline 0 C--O 1.215 -0.726 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 32.4 Cg_endo -63.24 -26.92 72.12 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 122.534 2.156 . . . . 0.0 114.342 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -68.76 -49.7 56.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.834 0.826 . . . . 0.0 111.725 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.8 OUTLIER -95.08 -34.96 5.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.745 -177.232 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.815 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.75 64.1 0.15 Allowed Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -176.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.498 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 86.9 Cg_endo -77.09 -26.66 7.51 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 121.625 1.55 . . . . 0.0 108.188 174.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.469 ' OE1' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -74.97 -42.58 57.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.822 178.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.815 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -73.97 -77.19 0.12 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.584 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.559 HD13 ' CD2' ' A' ' 142' ' ' LEU . 1.1 mp -104.46 145.45 13.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-O 121.377 0.608 . . . . 0.0 109.978 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -78.38 -53.87 6.8 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.998 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.728 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -173.17 166.06 4.9 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.19 0.519 . . . . 0.0 110.569 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.728 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -165.53 144.95 6.49 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.136 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -150.76 145.28 25.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.213 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.602 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -77.12 139.81 18.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.574 0.702 . . . . 0.0 111.143 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -90.75 -38.74 12.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.126 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.844 ' O ' HG23 ' A' ' 52' ' ' THR . 26.9 mt-10 -145.57 136.09 24.18 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.335 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.31 -156.05 22.56 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.679 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -136.06 -6.04 2.11 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 122.345 -0.503 . . . . 0.0 111.047 -179.047 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.542 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 130.7 11.33 2.4 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.8 -171.42 19.58 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.577 ' HD3' ' H ' ' A' ' 74' ' ' ILE . 8.7 Cg_endo -60.06 126.5 20.43 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 122.596 2.197 . . . . 0.0 113.117 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.39 3.28 55.48 Favored Glycine 0 CA--C 1.506 -0.495 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.844 HG23 ' O ' ' A' ' 45' ' ' GLU . 45.7 m -94.02 140.74 29.34 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.14 -1.03 . . . . 0.0 111.008 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.584 HD12 ' C ' ' A' ' 52' ' ' THR . 1.8 mp -120.97 129.07 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.602 ' HG2' HG23 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -112.48 139.87 47.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.791 0.805 . . . . 0.0 111.11 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -117.89 121.15 39.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.489 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.2 mt -106.69 140.19 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.619 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.9 m -119.23 120.16 36.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.132 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -90.79 -173.41 3.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.38 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.06 143.29 29.92 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -60.64 -60.97 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.985 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.81 61.86 3.39 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.2 m -136.89 175.15 9.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.756 0.313 . . . . 0.0 110.563 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -62.19 -42.61 99.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.825 0.345 . . . . 0.0 110.559 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -91.53 136.12 33.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.547 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.59 -57.73 0.5 Allowed Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -145.8 155.2 42.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.973 0.416 . . . . 0.0 110.642 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 p -153.47 144.49 14.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.217 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.58 ' CB ' HD11 ' A' ' 86' ' ' ILE . 93.8 mttt -106.66 117.87 35.19 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.465 0.65 . . . . 0.0 112.211 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.478 ' CD2' ' C ' ' A' ' 69' ' ' HIS . 0.3 OUTLIER -109.34 118.87 37.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.74 178.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -102.28 130.78 49.08 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.051 0.453 . . . . 0.0 111.076 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.425 HD12 HG22 ' A' ' 52' ' ' THR . 36.4 mt -88.81 145.47 7.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.563 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -104.1 -56.42 2.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.3 m -166.43 142.56 4.75 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.577 ' H ' ' HD3' ' A' ' 50' ' ' PRO . 10.7 mt -124.0 131.74 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.858 176.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -116.21 88.26 2.85 Favored 'General case' 0 C--O 1.209 -1.039 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.432 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -54.14 -30.69 50.05 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.36 -39.8 70.51 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.229 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.0 m -108.45 -10.31 15.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.953 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.2 m-85 62.74 46.8 5.02 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.629 -0.669 . . . . 0.0 109.818 -178.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.3 p -105.73 148.26 27.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.207 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.626 ' CE2' ' CD2' ' A' ' 83' ' ' TYR . 41.8 t80 -140.31 120.33 13.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.694 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 p -127.45 130.33 49.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.812 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.626 ' CD2' ' CE2' ' A' ' 81' ' ' TYR . 11.4 p90 -144.73 170.62 15.75 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.1 m -146.06 136.38 23.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.387 0.613 . . . . 0.0 111.489 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.546 HD12 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -79.89 120.41 24.07 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.298 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.58 HD11 ' CB ' ' A' ' 68' ' ' LYS . 2.5 pt -90.24 -45.03 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.497 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 2.9 tp10 -151.17 172.08 16.37 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.861 0.362 . . . . 0.0 110.413 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.646 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.87 177.68 17.87 Favored Glycine 0 CA--C 1.509 -0.334 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.79 2.63 0.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.646 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -68.04 -35.0 77.53 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.689 1.196 . . . . 0.0 110.986 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.914 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.51 13.11 22.75 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.285 0.634 . . . . 0.0 109.538 -178.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.505 ' CG2' ' CE1' ' A' ' 131' ' ' HIS . 28.3 p 46.94 -127.04 1.6 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.414 ' N ' ' OG1' ' A' ' 92' ' ' THR . 29.2 t70 -130.34 -11.21 4.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.25 0.548 . . . . 0.0 110.996 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.11 -5.92 20.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.371 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.773 HG21 ' CD1' ' A' ' 98' ' ' ILE . 66.2 mt -97.91 151.48 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -176.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.509 ' OE1' ' CE1' ' A' ' 120' ' ' HIS . 0.8 OUTLIER -88.85 -60.92 1.83 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.395 177.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.437 ' CG ' ' O ' ' A' ' 96' ' ' GLU . 36.9 mtmt -164.89 158.07 16.86 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.44 0.638 . . . . 0.0 111.192 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.773 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -132.75 123.5 49.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.598 ' OG ' ' CE1' ' A' ' 118' ' ' HIS . 0.9 OUTLIER -112.48 144.4 42.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.213 0.53 . . . . 0.0 111.398 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -137.18 130.67 31.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.558 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.428 ' O ' HG12 ' A' ' 116' ' ' ILE . 20.5 mt-10 -129.28 134.3 47.88 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.14 131.68 28.74 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.972 -0.455 . . . . 0.0 110.186 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.58 ' C ' HD23 ' A' ' 104' ' ' LEU . 20.3 ttpp -124.17 134.48 53.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.76 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.66 131.06 45.14 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.004 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.29 136.89 57.64 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.904 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.582 ' HB2' ' CG ' ' A' ' 15' ' ' PRO . . . -72.92 134.22 44.68 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.261 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 19.6 t -121.13 169.99 9.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.882 0.372 . . . . 0.0 110.385 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.405 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.71 -30.22 42.99 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.7 p -90.33 -8.88 49.7 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 118.369 -2.842 . . . . 0.0 115.464 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 154.24 -93.25 0.14 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.443 1.973 . . . . 0.0 109.849 -171.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.1 m -159.16 129.21 5.7 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 126.691 1.996 . . . . 0.0 110.99 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.3 m -100.05 118.53 36.62 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.535 HD13 ' CE1' ' A' ' 143' ' ' PHE . 11.5 mt -92.17 131.2 39.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.56 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.85 116.62 32.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.703 ' C ' HD13 ' A' ' 116' ' ' ILE . 15.6 t -111.89 118.19 34.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.421 0.629 . . . . 0.0 111.443 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.96 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -97.82 135.53 32.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 123.399 0.68 . . . . 0.0 109.565 -178.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.8 m -118.78 131.8 56.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.57 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 1.017 ' CD2' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -136.41 115.11 12.04 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 122.702 1.239 . . . . 0.0 109.472 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.818 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.7 OUTLIER -102.91 103.69 13.85 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 120.368 -1.457 . . . . 0.0 109.588 179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.509 ' CE1' ' OE1' ' A' ' 96' ' ' GLU . 4.8 t-80 -89.68 104.68 17.22 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.506 0.669 . . . . 0.0 110.367 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.531 HG21 ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -91.45 164.41 13.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.327 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 125' ' ' ILE . 6.6 ptmm? -112.11 156.63 21.93 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 43.27 -124.45 4.52 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.476 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -95.39 -13.29 24.8 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.289 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.531 ' O ' HG21 ' A' ' 121' ' ' THR . 1.1 tp -48.81 162.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.717 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -152.71 148.59 27.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.908 0.385 . . . . 0.0 111.108 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.415 ' CD1' HG12 ' A' ' 95' ' ' ILE . 5.4 mm -89.14 124.95 42.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 31.5 tttp -76.27 161.16 28.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.439 0.638 . . . . 0.0 111.469 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.638 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 1.2 pm0 -69.97 -45.34 67.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.518 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.09 -25.31 65.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.406 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.505 ' CE1' ' CG2' ' A' ' 92' ' ' THR . 2.7 t-80 -72.7 -51.88 17.53 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.387 0.613 . . . . 0.0 110.886 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.8 m -74.44 -24.22 18.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.45 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -67.22 -46.51 73.6 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 122.382 -0.199 . . . . 0.0 110.932 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.438 HG23 ' N ' ' A' ' 135' ' ' GLY . 30.7 m -70.02 -43.96 78.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.735 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.438 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -67.57 -46.94 65.21 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -67.66 -45.51 75.06 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.683 -0.304 . . . . 0.0 110.853 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -53.81 -38.92 65.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.443 ' O ' ' CD2' ' A' ' 142' ' ' LEU . 15.9 tttt -68.74 -54.39 16.34 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.6 -43.25 46.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.746 0.784 . . . . 0.0 110.495 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -67.13 -36.51 82.04 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.33 -34.92 82.68 Favored Glycine 0 CA--C 1.519 0.313 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.559 ' CD2' HD13 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -71.47 -48.36 49.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.589 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.535 ' CE1' HD13 ' A' ' 113' ' ' ILE . 4.4 t80 -59.47 -25.74 64.66 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -68.76 -40.51 79.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.935 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.781 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -64.45 -56.2 15.75 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.08 0.943 . . . . 0.0 108.746 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.854 HG23 HD12 ' A' ' 29' ' ' LEU . 59.6 mt -54.85 -48.41 74.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.601 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 20.3 tt0 -46.08 -56.89 4.98 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.684 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.8 p -53.51 -42.35 67.25 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.525 0.679 . . . . 0.0 110.615 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.704 ' HB2' HD13 ' A' ' 33' ' ' ILE . 32.7 t80 -56.36 -48.73 76.22 Favored 'General case' 0 C--O 1.194 -1.839 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.945 HD11 ' HB2' ' A' ' 21' ' ' ALA . 1.9 mm? -65.65 -42.57 91.24 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 120.033 1.288 . . . . 0.0 112.02 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.451 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -62.24 -23.65 66.79 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.25 -13.6 15.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.625 ' N ' ' O ' ' A' ' 149' ' ' TYR . 23.3 m80 -156.32 67.49 4.52 Favored Pre-proline 0 C--N 1.309 -1.174 0 C-N-CA 125.062 1.345 . . . . 0.0 110.695 -178.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.497 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 56.0 Cg_endo -74.8 -3.28 13.66 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 122.495 2.13 . . . . 0.0 111.534 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.603 ' CA ' HD21 ' A' ' 158' ' ' ASN . 3.6 p30 -74.66 5.3 5.0 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.279 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.88 129.99 43.57 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.791 -1.193 . . . . 0.0 113.141 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.722 ' CD1' HD23 ' A' ' 24' ' ' LEU . 2.7 t80 54.51 6.06 0.1 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.603 HD21 ' CA ' ' A' ' 155' ' ' ASP . 1.5 p30 . . . . . 0 CA--C 1.514 -0.436 0 O-C-N 121.166 -0.959 . . . . 0.0 110.405 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.818 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.4 p . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.755 0.312 . . . . 0.0 111.348 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -97.6 110.03 22.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.52 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.56 ' HG1' ' CE1' ' A' ' 118' ' ' HIS . 62.7 m -95.78 133.37 39.98 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.657 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.526 ' CD2' ' ND2' ' A' ' 7' ' ' ASN . 51.5 t80 -137.75 132.38 32.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.046 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.497 ' C ' HD22 ' A' ' 7' ' ' ASN . 1.2 tt0 -102.48 137.4 40.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 111.296 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.526 ' ND2' ' CD2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -127.55 167.97 15.6 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -178.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -152.56 145.15 24.18 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -154.23 134.76 13.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.458 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.06 146.71 23.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.934 0.397 . . . . 0.0 111.451 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -136.32 154.14 50.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.247 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -98.49 21.84 10.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.173 0.511 . . . . 0.0 110.365 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.693 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.3 mt -116.23 126.35 27.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.494 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -44.88 146.99 2.1 Favored 'Trans proline' 0 C--N 1.327 -0.603 0 C-N-CA 121.805 1.67 . . . . 0.0 111.776 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -57.19 -26.62 70.59 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 122.256 1.97 . . . . 0.0 113.149 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 67.9 m -70.7 -32.15 69.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -75.03 -57.71 3.73 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.693 HD21 ' HB ' ' A' ' 13' ' ' ILE . 1.5 mt -53.28 -35.84 60.53 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.801 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.867 ' O ' HG22 ' A' ' 23' ' ' VAL . 14.8 t80 -54.46 -56.05 22.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.641 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.76 ' HB2' HD11 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -70.73 -43.2 69.39 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.295 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.775 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -63.67 -3.2 2.1 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.386 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.512 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 19.3 t80 -119.66 -8.54 9.92 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 19' ' ' PHE . 15.1 m -129.7 -52.33 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.011 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.7 pp -96.85 -31.52 12.56 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 1.011 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -114.25 -5.38 12.99 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 118.858 0.754 . . . . 0.0 111.364 -178.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -67.7 -43.85 79.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.105 0.479 . . . . 0.0 111.861 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.502 ' HA ' HD11 ' A' ' 30' ' ' ILE . 1.2 m-20 -83.01 12.21 5.27 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 122.101 0.953 . . . . 0.0 110.265 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -129.79 -9.42 4.46 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.523 ' CD1' HG23 ' A' ' 146' ' ' ILE . 4.1 mt -93.94 -30.74 14.6 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.211 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.547 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.08 -53.42 58.77 Favored Pre-proline 0 C--O 1.215 -0.732 0 O-C-N 122.025 -0.422 . . . . 0.0 110.613 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 27.2 Cg_endo -63.89 -25.72 67.26 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 122.006 1.804 . . . . 0.0 112.538 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.84 -59.61 2.66 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.662 0.744 . . . . 0.0 112.194 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.8 HD12 ' HB3' ' A' ' 145' ' ' LEU . 1.3 pt -94.46 -36.14 6.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.909 -176.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.867 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.87 65.23 0.16 Allowed Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 71.8 Cg_endo -75.94 -26.91 9.0 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 C-N-CA 121.591 1.527 . . . . 0.0 108.367 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -74.1 -43.36 57.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.55 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.867 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -72.27 -71.94 0.26 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.896 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.526 HD13 HD22 ' A' ' 142' ' ' LEU . 1.4 mp -99.18 144.85 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-O 121.254 0.549 . . . . 0.0 110.669 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -79.44 -50.34 10.95 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.079 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.658 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 52.8 tp60 -174.33 164.66 3.93 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.829 0.347 . . . . 0.0 110.758 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.658 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -166.13 144.74 5.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.076 0.465 . . . . 0.0 110.846 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -150.7 148.18 28.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.143 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.578 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -83.25 139.58 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.524 0.678 . . . . 0.0 110.729 -179.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.1 -39.36 12.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.024 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.92 ' O ' HG23 ' A' ' 52' ' ' THR . 16.2 mt-10 -141.28 134.48 29.42 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.756 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.83 -156.6 31.55 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.724 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -141.24 -5.15 1.11 Allowed 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.406 -0.467 . . . . 0.0 111.404 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.469 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 141.46 11.94 0.53 Allowed Glycine 0 C--O 1.218 -0.853 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.77 -171.71 19.66 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-N 117.233 0.516 . . . . 0.0 112.066 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -62.05 126.87 19.73 Favored 'Trans proline' 0 C--N 1.321 -0.892 0 C-N-CA 123.168 2.579 . . . . 0.0 113.343 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.72 6.12 57.36 Favored Glycine 0 N--CA 1.462 0.422 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.92 HG23 ' O ' ' A' ' 45' ' ' GLU . 73.1 m -93.6 139.31 30.92 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.176 -1.012 . . . . 0.0 111.191 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.28 132.1 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.578 ' HG2' HG23 ' A' ' 43' ' ' ILE . 1.9 mmtp -111.17 139.53 46.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.463 0.649 . . . . 0.0 111.258 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -118.2 113.42 21.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.147 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mt -106.28 138.27 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.662 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.7 m -119.21 118.11 30.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.267 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -93.0 -173.23 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.306 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.08 143.54 48.69 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -60.84 -48.39 82.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.806 0.336 . . . . 0.0 110.978 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.06 61.97 3.29 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.0 m -142.91 175.33 9.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.021 0.438 . . . . 0.0 110.626 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -61.84 -45.52 93.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.66 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.32 138.74 39.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.371 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.14 -52.92 0.59 Allowed Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -142.7 151.73 41.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 110.253 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.85 146.5 11.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.968 0.413 . . . . 0.0 110.672 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.602 ' HB3' HD11 ' A' ' 86' ' ' ILE . 25.0 mttp -105.58 109.51 21.51 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.35 0.595 . . . . 0.0 111.557 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.601 ' HE2' ' CB ' ' A' ' 83' ' ' TYR . 6.8 t60 -98.81 111.68 23.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.329 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.1 ttt-85 -101.56 131.19 47.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.233 0.54 . . . . 0.0 112.126 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.5 mt -82.31 136.68 22.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.461 -0.79 . . . . 0.0 108.96 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -96.97 -56.05 2.68 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.7 m -165.67 141.38 5.09 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.435 HD12 ' O ' ' A' ' 48' ' ' GLY . 40.6 mt -124.96 129.62 73.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 79' ' ' TYR . 23.2 m-20 -115.45 88.33 2.86 Favored 'General case' 0 C--O 1.202 -1.401 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.638 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.0 OUTLIER -54.31 -36.17 63.45 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.51 -36.1 43.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 m -107.65 -10.87 15.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.828 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.596 ' N ' ' O ' ' A' ' 75' ' ' ASP . 48.2 m-85 56.68 42.53 26.8 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 121.522 -0.736 . . . . 0.0 110.818 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.26 149.2 28.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.909 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 82' ' ' SER . 3.6 t80 -134.8 126.38 28.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.92 0.391 . . . . 0.0 111.186 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.451 ' N ' ' CD1' ' A' ' 81' ' ' TYR . 85.8 p -126.88 136.49 52.39 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.462 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.601 ' CB ' ' HE2' ' A' ' 69' ' ' HIS . 34.3 p90 -144.88 165.63 27.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.561 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -147.08 134.14 20.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.082 0.468 . . . . 0.0 110.667 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.604 HD13 ' HB1' ' A' ' 90' ' ' ALA . 5.6 mt -80.4 117.59 21.28 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' A' ' 68' ' ' LYS . 5.1 pt -82.42 -44.69 19.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.718 0.294 . . . . 0.0 111.213 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.625 ' CD ' ' H ' ' A' ' 88' ' ' GLY . 0.6 OUTLIER -149.14 171.81 15.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.625 ' H ' ' CD ' ' A' ' 87' ' ' GLU . . . 116.22 177.96 18.19 Favored Glycine 0 CA--C 1.509 -0.319 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.94 2.26 0.23 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.621 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -67.39 -35.08 78.6 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 124.314 1.046 . . . . 0.0 110.468 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.885 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -111.11 6.03 20.53 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 123.358 0.663 . . . . 0.0 110.273 -177.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.421 ' CG2' ' NE2' ' A' ' 131' ' ' HIS . 61.7 p 49.61 -126.15 2.14 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 18.8 p-10 -131.74 -10.3 3.51 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.827 -0.546 . . . . 0.0 110.911 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.73 -7.6 19.42 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.679 HG21 ' CD1' ' A' ' 98' ' ' ILE . 68.4 mt -99.71 152.81 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -176.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.506 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -87.43 -59.17 2.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.751 177.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HA ' HD12 ' A' ' 91' ' ' LEU . 6.0 ptpt -171.95 154.25 3.45 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.199 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.679 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.65 124.88 73.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.87 144.84 32.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.137 0.494 . . . . 0.0 111.436 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 116' ' ' ILE . 0.4 OUTLIER -140.06 138.94 35.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 179.382 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -128.37 135.15 49.17 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 120.983 0.42 . . . . 0.0 110.737 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 p -133.86 131.24 38.94 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -120.32 135.39 55.03 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.4 mm? -96.46 124.66 40.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.255 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.61 136.62 43.58 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.192 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -73.16 139.57 46.44 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.85 -0.531 . . . . 0.0 110.142 177.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.467 ' N ' ' HA ' ' A' ' 111' ' ' SER . 13.6 t -121.36 170.97 9.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.714 0.292 . . . . 0.0 110.388 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.71 -34.6 50.73 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.5 p -94.76 -6.43 43.05 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 118.809 -2.583 . . . . 0.0 113.595 177.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 160.23 -78.62 0.17 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.082 1.801 . . . . 0.0 112.067 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 29.2 t -162.76 130.21 3.7 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.973 1.309 . . . . 0.0 111.599 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.7 m -99.97 134.9 42.2 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.105 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 mt -110.57 130.34 64.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.504 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.71 116.81 32.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.814 ' C ' HD13 ' A' ' 116' ' ' ILE . 70.1 m -110.75 124.73 52.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.204 0.526 . . . . 0.0 110.865 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.874 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -106.29 135.76 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 C-N-CA 123.033 0.533 . . . . 0.0 109.825 -178.016 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.2 m -109.07 134.39 51.75 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.56 ' CE1' ' HG1' ' A' ' 4' ' ' THR . 41.9 m-70 -135.39 95.31 3.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.209 0.528 . . . . 0.0 111.049 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.818 ' C ' HG23 ' A' ' 2' ' ' VAL . 6.4 m-30 -84.56 101.39 12.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.874 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -92.87 98.64 11.51 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.7 p -101.3 174.35 6.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.91 0.862 . . . . 0.0 112.218 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.71 144.5 42.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.334 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.6 -110.0 1.1 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.538 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.1 OUTLIER -115.9 1.55 13.37 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.449 -0.442 . . . . 0.0 111.607 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.524 ' N ' HD22 ' A' ' 124' ' ' ASN . 1.6 mp -45.48 161.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.177 0.513 . . . . 0.0 110.434 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.494 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 30.2 tt0 -155.42 148.66 24.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.48 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.3 mm -88.01 125.36 41.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -73.87 161.94 29.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.358 0.599 . . . . 0.0 111.541 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -69.01 -48.54 62.76 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.071 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.599 ' O ' HG12 ' A' ' 134' ' ' VAL . 6.5 tt0 -58.23 -26.11 62.47 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.985 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.421 ' NE2' ' CG2' ' A' ' 92' ' ' THR . 4.2 t60 -72.92 -49.56 28.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.476 0.655 . . . . 0.0 111.236 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.438 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.1 m -81.08 -27.17 10.76 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -66.62 -46.18 76.69 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.983 -0.448 . . . . 0.0 110.496 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.676 HG13 ' N ' ' A' ' 135' ' ' GLY . 7.7 p -69.01 -50.89 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 CA-C-O 121.443 0.64 . . . . 0.0 110.515 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.676 ' N ' HG13 ' A' ' 134' ' ' VAL . . . -62.81 -42.29 99.71 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 5.9 ttpm? -67.04 -45.68 76.7 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 122.72 -0.283 . . . . 0.0 110.788 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -53.69 -43.34 68.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -66.16 -53.6 35.6 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.416 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.32 -40.22 34.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.672 0.749 . . . . 0.0 110.726 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.91 -36.24 82.73 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.41 -43.79 98.33 Favored Glycine 0 C--O 1.227 -0.328 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -62.94 -43.01 99.95 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.505 ' CE1' ' CE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -59.44 -25.81 64.67 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -72.1 -42.7 65.82 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.272 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.8 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -62.44 -56.66 16.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.605 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.689 ' O ' HD22 ' A' ' 150' ' ' LEU . 50.6 mt -59.62 -50.71 78.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.23 -177.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 8.9 tt0 -46.87 -56.74 5.8 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.136 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 62.0 m -51.08 -48.15 61.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.191 0.52 . . . . 0.0 111.551 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.549 ' O ' ' N ' ' A' ' 153' ' ' HIS . 0.2 OUTLIER -55.93 -49.43 73.51 Favored 'General case' 0 C--O 1.209 -1.033 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.843 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.9 mm? -62.53 -43.85 97.79 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 119.792 1.178 . . . . 0.0 111.77 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 147' ' ' GLU . 0.2 OUTLIER -59.14 -25.4 63.85 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.189 -0.945 . . . . 0.0 108.757 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.453 ' O ' ' ND1' ' A' ' 153' ' ' HIS . 49.2 t0 -99.27 -14.38 19.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.731 0.776 . . . . 0.0 109.91 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.549 ' N ' ' O ' ' A' ' 149' ' ' TYR . 68.3 m80 -154.11 68.16 5.94 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 124.261 1.024 . . . . 0.0 110.494 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.471 ' N ' ' O ' ' A' ' 150' ' ' LEU . 31.4 Cg_endo -68.34 -3.18 10.4 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.991 1.794 . . . . 0.0 110.637 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.596 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 14.4 m-20 -87.03 4.69 40.94 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.074 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.42 131.02 20.6 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.028 -1.67 . . . . 0.0 111.256 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.666 ' CG ' HD13 ' A' ' 24' ' ' LEU . 6.3 t80 55.83 7.19 0.25 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.352 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.846 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.2 p . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.677 0.275 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.45 109.36 22.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.704 177.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.2 m -97.92 140.65 31.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.877 0.37 . . . . 0.0 111.071 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -145.14 137.57 25.99 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.332 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.55 ' HG2' HD12 ' A' ' 116' ' ' ILE . 15.6 mt-10 -102.29 139.24 38.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.197 0.523 . . . . 0.0 110.76 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.51 HD22 ' C ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -126.48 168.19 14.57 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -178.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.84 139.34 15.89 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -145.62 134.0 21.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.378 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.1 147.87 22.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.929 0.395 . . . . 0.0 111.254 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 p -144.39 154.26 42.8 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.51 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -94.37 27.61 2.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.889 0.376 . . . . 0.0 110.305 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.651 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.3 mt -117.56 125.66 27.93 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.721 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.97 148.47 13.0 Favored 'Trans proline' 0 C--N 1.327 -0.581 0 C-N-CA 121.801 1.667 . . . . 0.0 111.409 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.418 ' HA ' HD12 ' A' ' 18' ' ' LEU . 23.3 Cg_exo -59.04 -24.98 76.05 Favored 'Trans proline' 0 N--CA 1.482 0.836 0 C-N-CA 122.011 1.808 . . . . 0.0 112.116 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.434 ' C ' ' HZ2' ' A' ' 20' ' ' LYS . 66.3 m -65.72 -35.68 81.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.392 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.485 ' HA ' ' HZ2' ' A' ' 20' ' ' LYS . 8.0 mmt180 -77.99 -57.68 3.67 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.651 HD21 ' HB ' ' A' ' 13' ' ' ILE . 5.1 mt -48.14 -48.25 34.31 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.909 -1.042 . . . . 0.0 108.599 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.753 ' O ' HG22 ' A' ' 23' ' ' VAL . 70.1 t80 -48.85 -56.49 8.59 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.307 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.665 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -70.21 -23.92 63.02 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.698 -179.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.71 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -82.48 -2.84 54.57 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.976 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.473 ' CE2' ' OH ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -119.08 -9.56 9.98 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.853 HG23 HD13 ' A' ' 24' ' ' LEU . 3.0 m -136.1 -36.57 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.853 HD13 HG23 ' A' ' 23' ' ' VAL . 3.2 mp -91.17 -53.05 4.52 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.152 0.887 . . . . 0.0 112.153 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -112.2 -4.68 14.32 Favored 'General case' 0 C--O 1.214 -0.771 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.039 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.695 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -53.16 -41.73 65.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.2 0.524 . . . . 0.0 111.715 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -83.39 17.49 2.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.629 0.728 . . . . 0.0 110.794 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.413 ' H ' ' H ' ' A' ' 29' ' ' LEU . 15.8 m120 -139.97 -8.89 1.19 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.505 HD21 ' CD1' ' A' ' 149' ' ' TYR . 0.6 OUTLIER -91.34 -33.51 15.27 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.438 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.543 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.74 -53.17 63.62 Favored Pre-proline 0 C--O 1.216 -0.678 0 O-C-N 122.083 -0.385 . . . . 0.0 111.127 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 20.0 Cg_endo -62.56 -24.67 75.28 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 121.876 1.718 . . . . 0.0 112.323 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -70.28 -59.83 2.64 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.73 0.776 . . . . 0.0 112.016 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 145' ' ' LEU . 1.3 pt -95.29 -35.72 6.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.282 -176.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.902 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.54 64.53 0.14 Allowed Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.491 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 72.6 Cg_endo -76.88 -28.4 6.24 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 121.647 1.565 . . . . 0.0 108.175 174.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.408 ' CG ' ' N ' ' A' ' 37' ' ' ALA . 12.1 pt20 -74.14 -43.17 58.43 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.572 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.902 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -72.81 -76.54 0.12 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.947 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 38' ' ' ILE . 9.4 mm -99.51 145.08 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 121.092 0.472 . . . . 0.0 110.422 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -77.7 -49.86 13.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.673 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -176.98 166.61 2.46 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.111 0.482 . . . . 0.0 110.543 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.99 143.13 5.35 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.592 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -151.33 153.34 34.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.782 0.325 . . . . 0.0 110.595 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.06 138.52 18.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.597 0.713 . . . . 0.0 111.341 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.5 mp -88.9 -39.07 14.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.905 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.874 ' O ' HG23 ' A' ' 52' ' ' THR . 26.4 mt-10 -144.32 136.89 26.75 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.364 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.47 -156.21 22.55 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.699 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -135.26 -11.34 2.18 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.09 0.472 . . . . 0.0 110.608 -179.357 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.639 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 136.65 11.08 1.15 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.29 -171.86 19.34 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -59.07 127.01 22.67 Favored 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 122.595 2.196 . . . . 0.0 113.213 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.67 2.14 52.87 Favored Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.874 HG23 ' O ' ' A' ' 45' ' ' GLU . 51.8 m -94.42 140.49 29.75 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.146 -1.027 . . . . 0.0 111.753 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -121.51 129.74 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.407 ' NZ ' ' HB3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -114.73 140.44 48.87 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.021 0.438 . . . . 0.0 110.879 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -118.77 123.11 44.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.02 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.2 mt -104.9 140.64 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.86 0.362 . . . . 0.0 110.605 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.8 m -116.52 118.82 33.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.152 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -91.39 -176.44 4.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.316 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.33 142.68 32.11 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.468 ' CD ' ' N ' ' A' ' 61' ' ' GLY . 2.5 pp20? -61.15 -45.22 95.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.817 0.342 . . . . 0.0 111.23 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.468 ' N ' ' CD ' ' A' ' 60' ' ' GLU . . . -91.37 61.53 2.86 Favored Glycine 0 C--N 1.328 0.135 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.8 m -141.96 174.11 10.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.964 0.411 . . . . 0.0 110.816 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -68.16 -39.12 82.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.931 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.55 142.96 27.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.439 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.1 -62.06 0.53 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -146.07 145.29 30.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.952 0.406 . . . . 0.0 110.429 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.74 140.09 41.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.647 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.493 ' HB2' HD11 ' A' ' 86' ' ' ILE . 61.3 mttm -106.53 114.56 28.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.346 0.594 . . . . 0.0 112.413 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.553 ' CE1' ' CD2' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -92.89 123.89 36.48 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -100.89 112.4 24.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.012 0.434 . . . . 0.0 111.485 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.4 mt -74.17 135.42 27.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -98.3 -55.67 2.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.5 m -165.97 142.38 5.14 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.6 mt -116.16 131.44 68.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.682 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 79' ' ' TYR . 9.4 t0 -113.97 87.45 2.62 Favored 'General case' 0 C--O 1.207 -1.148 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.513 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 7.2 pt-20 -54.87 -30.1 57.04 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.32 -40.0 70.64 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 m -108.63 -10.68 15.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.901 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.565 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.6 m-85 62.54 42.14 8.94 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.511 -0.743 . . . . 0.0 110.142 -178.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.2 t -116.87 139.8 50.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.233 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.473 ' OH ' ' CE2' ' A' ' 22' ' ' PHE . 41.1 p90 -132.26 132.78 43.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.088 0.47 . . . . 0.0 110.392 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 m -127.09 137.65 53.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.383 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -144.05 166.37 25.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.891 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.591 HG23 ' O ' ' A' ' 98' ' ' ILE . 5.5 m -144.89 142.95 30.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.09 0.471 . . . . 0.0 110.828 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.634 HD13 ' HB1' ' A' ' 90' ' ' ALA . 7.9 mt -79.97 115.36 19.5 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.493 HD11 ' HB2' ' A' ' 68' ' ' LYS . 2.9 pt -77.49 -44.8 29.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.783 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.434 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -153.47 172.53 16.98 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.603 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.57 177.52 18.02 Favored Glycine 0 CA--C 1.51 -0.221 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -61.7 0.37 0.35 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 122.529 1.157 . . . . 0.0 108.395 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.634 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -62.17 -34.51 76.56 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 124.123 0.969 . . . . 0.0 110.236 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.867 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.37 12.84 23.01 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 123.464 0.705 . . . . 0.0 109.935 -177.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.1 p 47.36 -126.31 1.68 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -130.72 -12.64 3.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.019 0.438 . . . . 0.0 111.452 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.23 -6.14 20.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.743 HG21 ' CD1' ' A' ' 98' ' ' ILE . 95.2 mt -98.08 152.17 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 122.159 0.981 . . . . 0.0 113.297 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.508 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -93.44 -52.51 4.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.468 177.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.53 149.02 2.06 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-O 121.178 0.513 . . . . 0.0 111.32 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.743 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.87 126.68 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.591 ' C ' ' HD1' ' A' ' 118' ' ' HIS . 0.1 OUTLIER -109.63 143.89 38.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.803 0.335 . . . . 0.0 111.621 -178.105 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -137.35 127.94 26.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.689 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -129.8 132.49 46.53 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -139.82 133.82 30.89 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.086 -0.384 . . . . 0.0 110.469 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.624 ' C ' HD23 ' A' ' 104' ' ' LEU . 55.0 tttt -122.25 134.41 54.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.908 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.789 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -97.74 127.32 43.6 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -128.51 136.63 59.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.119 -178.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -73.14 133.29 44.04 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.752 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -121.88 174.04 7.12 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.69 -34.18 55.95 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.871 -0.492 . . . . 0.0 111.871 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.1 m -76.78 -26.81 54.91 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.841 1.256 . . . . 0.0 114.182 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 159.67 -78.88 0.17 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.522 1.534 . . . . 0.0 111.876 -169.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 83.7 p -166.07 131.72 2.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.594 1.558 . . . . 0.0 111.079 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 105' ' ' VAL . 14.8 m -99.29 118.74 36.63 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 54.4 mt -92.14 126.52 44.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.635 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -105.68 117.38 33.88 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.763 ' C ' HD13 ' A' ' 116' ' ' ILE . 3.2 m -112.35 123.75 50.96 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.329 0.585 . . . . 0.0 111.313 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.937 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -103.53 137.16 33.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 123.591 0.756 . . . . 0.0 109.654 -178.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.95 132.09 55.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.715 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.591 ' HD1' ' C ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -138.38 112.32 8.45 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.846 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -101.83 108.38 19.84 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.223 -0.298 . . . . 0.0 110.803 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.506 ' CE1' ' OE2' ' A' ' 96' ' ' GLU . 13.8 t-160 -89.59 105.8 18.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.16 0.505 . . . . 0.0 109.679 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.9 p -100.22 178.01 4.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.841 0.829 . . . . 0.0 111.915 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 123' ' ' GLY . 3.8 mtpt -112.54 157.49 21.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.794 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . 35.16 -108.71 0.05 OUTLIER Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.665 ' H ' HD22 ' A' ' 124' ' ' ASN . 0.2 OUTLIER -114.04 7.04 16.67 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.588 -0.36 . . . . 0.0 111.144 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.493 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.6 mp -45.42 160.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.221 0.534 . . . . 0.0 110.594 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.493 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 22.0 mt-10 -152.11 149.6 28.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.257 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 mm -88.21 125.01 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.433 ' HG3' ' N ' ' A' ' 129' ' ' GLU . 15.8 tptm -73.85 161.96 29.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.202 0.525 . . . . 0.0 111.208 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' A' ' 128' ' ' LYS . 59.9 mt-10 -68.68 -44.41 74.08 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.112 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.523 ' O ' HG22 ' A' ' 134' ' ' VAL . 37.5 mt-10 -61.57 -26.18 67.79 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.67 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -73.04 -49.32 29.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.106 0.479 . . . . 0.0 111.321 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.411 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.0 m -79.5 -29.72 13.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.176 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.4 tptt -66.92 -45.83 76.69 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.916 -0.49 . . . . 0.0 110.605 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.552 HG23 ' N ' ' A' ' 135' ' ' GLY . 24.2 m -70.45 -45.98 72.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.557 0.218 . . . . 0.0 110.567 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.552 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -66.58 -46.66 74.67 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 29.3 ttpt -67.05 -46.15 75.26 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.676 -0.308 . . . . 0.0 110.653 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -54.49 -46.28 73.4 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -67.8 -52.29 38.76 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.437 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.54 -41.5 41.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.694 0.759 . . . . 0.0 110.616 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -36.33 83.41 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.42 -37.98 94.04 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -71.14 -42.43 69.19 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -59.54 -22.78 62.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -37.98 51.57 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.669 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.795 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.3 mm? -69.61 -56.73 6.47 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.146 0.498 . . . . 0.0 109.894 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.737 ' O ' HD22 ' A' ' 150' ' ' LEU . 63.5 mt -54.53 -51.36 50.84 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.48 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -47.65 -55.5 9.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.03 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.402 ' O ' ' OD2' ' A' ' 152' ' ' ASP . 8.7 t -52.56 -43.77 65.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.322 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.656 ' HB2' HD13 ' A' ' 33' ' ' ILE . 20.4 t80 -58.15 -44.77 88.04 Favored 'General case' 0 C--O 1.189 -2.083 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.765 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.8 mm? -69.71 -42.84 73.51 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 120.552 -1.342 . . . . 0.0 111.88 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.403 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -61.97 -24.79 67.23 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 121.571 -0.705 . . . . 0.0 109.147 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 149' ' ' TYR . 5.1 p30 -107.32 -12.73 15.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.26 0.552 . . . . 0.0 110.379 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.621 ' N ' ' O ' ' A' ' 149' ' ' TYR . 1.2 t-160 -154.86 66.3 4.97 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 124.795 1.238 . . . . 0.0 110.108 -177.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.11 -3.54 13.47 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 122.761 2.307 . . . . 0.0 112.072 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.61 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 2.3 p30 -80.24 4.63 16.98 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.951 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.08 130.53 18.83 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 119.82 -1.8 . . . . 0.0 111.467 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.749 ' CD1' HD23 ' A' ' 24' ' ' LEU . 6.2 t80 55.08 8.17 0.23 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.331 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.61 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.461 0 O-C-N 121.547 -0.721 . . . . 0.0 110.291 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.847 HG23 ' C ' ' A' ' 119' ' ' TYR . 8.1 p . . . . . 0 CA--C 1.519 -0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 111.616 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -98.51 110.5 23.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.24 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.644 HG23 ' CE1' ' A' ' 118' ' ' HIS . 98.3 m -96.41 140.12 31.54 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.828 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -146.96 134.16 20.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.918 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.497 ' C ' HD22 ' A' ' 7' ' ' ASN . 36.8 mt-10 -102.39 132.91 48.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.23 0.538 . . . . 0.0 111.273 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.497 HD22 ' C ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -127.04 166.86 16.79 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 1.6 pt-20 -155.95 142.1 18.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.46 139.62 37.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.276 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.26 147.91 26.1 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.819 0.342 . . . . 0.0 111.532 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 t -145.08 154.85 42.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.808 0.337 . . . . 0.0 110.51 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -93.8 24.99 3.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.948 0.404 . . . . 0.0 111.121 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.415 ' HB ' HD21 ' A' ' 18' ' ' LEU . 2.1 mt -112.45 129.04 24.76 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.244 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -46.03 144.63 5.96 Favored 'Trans proline' 0 C--N 1.327 -0.583 0 C-N-CA 121.192 1.261 . . . . 0.0 110.602 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.68 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 12.0 Cg_endo -61.88 -24.55 77.25 Favored 'Trans proline' 0 C--N 1.321 -0.904 0 C-N-CA 122.316 2.011 . . . . 0.0 113.027 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.2 m -70.94 -28.6 64.61 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.422 ' H ' ' HG2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -76.27 -57.6 3.77 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.482 ' H ' ' HG ' ' A' ' 18' ' ' LEU . 1.8 mt -51.51 -43.53 62.29 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.753 ' O ' HG22 ' A' ' 23' ' ' VAL . 49.7 t80 -47.45 -58.06 4.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.257 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.705 ' CB ' HD11 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -69.89 -42.44 73.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 119.16 -1.016 . . . . 0.0 108.674 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.816 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -63.72 -5.12 3.67 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.627 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.535 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 2.7 t80 -120.25 -7.96 9.74 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 19' ' ' PHE . 29.1 m -129.91 -49.64 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.008 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.6 pp -96.51 -31.46 12.78 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 1.008 ' N ' HD12 ' A' ' 24' ' ' LEU . 10.0 t70 -114.44 -5.79 12.87 Favored 'General case' 0 C--O 1.211 -0.944 0 O-C-N 121.798 -0.564 . . . . 0.0 111.544 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.535 ' HB2' ' HA ' ' A' ' 22' ' ' PHE . . . -60.79 -40.36 92.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.566 0.698 . . . . 0.0 111.978 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -83.58 16.68 2.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.6 0.714 . . . . 0.0 110.109 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -139.62 -9.34 1.23 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.659 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -100.81 -39.82 7.62 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.001 -178.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.511 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 58.0 mt -53.89 -53.8 53.89 Favored Pre-proline 0 C--O 1.214 -0.79 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.191 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 29.3 Cg_endo -62.33 -25.29 76.38 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 121.876 1.717 . . . . 0.0 112.375 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 tmtp? -66.37 -55.33 16.41 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.984 0.897 . . . . 0.0 111.777 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.753 HD12 ' C ' ' A' ' 145' ' ' LEU . 0.9 OUTLIER -95.4 -34.34 5.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.315 -176.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.781 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.29 64.17 0.13 Allowed Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.486 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 71.7 Cg_endo -76.77 -24.41 10.14 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 N-CA-C 107.938 -1.601 . . . . 0.0 107.938 174.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -74.08 -43.83 56.29 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.273 -1.331 . . . . 0.0 109.494 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.781 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -70.54 -79.02 0.07 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.3 mt -98.93 146.64 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.019 0.437 . . . . 0.0 110.104 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -76.62 -44.36 34.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.81 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.655 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 49.2 tp60 -176.86 163.44 2.24 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.909 0.385 . . . . 0.0 110.773 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.655 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -167.0 143.78 4.56 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.926 0.393 . . . . 0.0 110.36 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.14 150.46 30.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.462 ' H ' HG13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -83.63 138.13 19.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.651 0.739 . . . . 0.0 110.952 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.3 mp -88.45 -39.32 14.33 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.766 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.925 ' O ' HG23 ' A' ' 52' ' ' THR . 47.9 mt-10 -142.02 134.22 27.69 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.952 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.62 -156.33 26.61 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.735 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -139.69 -9.7 1.21 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.821 0.343 . . . . 0.0 110.962 -179.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.51 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 143.95 11.38 0.35 Allowed Glycine 0 C--O 1.223 -0.565 0 N-CA-C 111.914 -0.474 . . . . 0.0 111.914 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.43 -172.78 20.11 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 117.562 0.681 . . . . 0.0 111.976 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD3' ' H ' ' A' ' 74' ' ' ILE . 10.2 Cg_endo -60.02 126.59 20.72 Favored 'Trans proline' 0 N--CA 1.483 0.854 0 C-N-CA 122.774 2.316 . . . . 0.0 113.649 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.99 4.0 55.64 Favored Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.925 HG23 ' O ' ' A' ' 45' ' ' GLU . 88.9 m -94.23 140.4 29.82 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.135 -1.033 . . . . 0.0 111.296 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.651 HD12 ' C ' ' A' ' 52' ' ' THR . 1.8 mp -121.15 129.91 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HB3' ' HZ3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -116.27 140.34 49.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.083 0.468 . . . . 0.0 110.688 179.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -118.75 121.74 40.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.011 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.1 mp -100.96 123.61 54.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.1 m -98.42 118.47 35.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.401 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -92.27 168.05 11.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.232 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.92 143.77 32.51 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.93 -48.05 83.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.724 0.297 . . . . 0.0 110.324 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.18 61.49 2.93 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.4 m -137.41 174.93 10.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.623 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -51.37 66.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.674 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -91.67 150.92 20.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.363 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.93 -59.71 0.58 Allowed Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -145.24 155.18 43.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.99 0.424 . . . . 0.0 110.941 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.5 p -154.69 138.35 8.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.821 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.3 mtmm -105.83 118.95 37.92 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.363 0.601 . . . . 0.0 112.228 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.566 ' CE1' ' CD2' ' A' ' 85' ' ' LEU . 1.9 m80 -97.25 114.43 26.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.3 ttp85 -101.2 112.56 25.08 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.123 0.487 . . . . 0.0 111.609 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.0 mt -73.73 134.11 30.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.292 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 73' ' ' SER . 2.2 p30 -98.01 -49.92 4.59 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.296 -0.562 . . . . 0.0 112.298 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.538 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -165.54 143.21 5.82 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.412 ' H ' ' HD3' ' A' ' 50' ' ' PRO . 32.1 mt -126.68 126.46 68.81 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 CA-C-N 113.914 -1.494 . . . . 0.0 108.841 173.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 79' ' ' TYR . 23.4 m-20 -113.88 88.44 2.85 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.466 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 6.9 pt-20 -54.59 -30.62 55.01 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.32 -38.75 59.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.8 m -108.5 -11.02 15.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.777 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.513 ' N ' ' O ' ' A' ' 75' ' ' ASP . 12.3 m-85 62.53 43.29 7.88 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.273 0.559 . . . . 0.0 109.808 -178.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.3 p -105.95 141.06 37.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.802 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -132.59 118.65 19.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.62 0.248 . . . . 0.0 110.684 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.446 ' C ' ' OD2' ' A' ' 72' ' ' ASP . 42.0 t -128.43 143.62 51.02 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.696 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -148.93 173.11 13.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.165 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.93 135.53 23.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.091 0.472 . . . . 0.0 110.895 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.663 HD13 ' HB1' ' A' ' 90' ' ' ALA . 9.0 mt -80.24 113.27 18.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.614 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -77.31 -41.79 30.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.803 -178.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.614 ' N ' HD13 ' A' ' 86' ' ' ILE . 4.1 tm-20 -157.03 170.69 21.95 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.116 -0.365 . . . . 0.0 110.357 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.609 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 119.65 178.33 16.43 Favored Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -62.28 2.06 0.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 122.884 1.326 . . . . 0.0 108.412 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.663 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -66.0 -33.08 75.0 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 124.35 1.06 . . . . 0.0 110.399 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.856 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -109.77 16.2 22.22 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.195 0.598 . . . . 0.0 110.693 -176.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 91' ' ' LEU . 65.2 p 43.35 -126.25 0.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.61 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -131.48 -13.29 3.4 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.126 -0.358 . . . . 0.0 111.054 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.1 p -104.68 -5.76 21.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.845 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.835 HG21 ' CD1' ' A' ' 98' ' ' ILE . 57.9 mt -99.53 152.91 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 121.962 0.887 . . . . 0.0 113.107 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.512 ' N ' HG22 ' A' ' 95' ' ' ILE . 5.7 pt-20 -99.95 -49.1 4.44 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.17 178.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -170.79 147.41 2.76 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-O 121.832 0.825 . . . . 0.0 111.764 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.835 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.62 122.66 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.2 t -106.26 146.0 30.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.197 0.522 . . . . 0.0 111.324 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -139.14 133.53 31.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.286 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -128.75 133.29 48.06 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -135.21 131.82 37.15 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.002 -0.436 . . . . 0.0 110.254 -178.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -120.22 133.7 55.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.522 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -99.54 129.78 45.73 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -178.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -131.76 137.18 55.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.987 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.68 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -73.24 134.89 44.44 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.728 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.404 ' N ' ' HA ' ' A' ' 111' ' ' SER . 30.3 p -121.31 167.69 12.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.73 -27.17 34.76 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.8 m -86.97 -19.5 28.66 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 120.217 2.008 . . . . 0.0 113.743 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.24 -83.73 0.14 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.854 2.169 . . . . 0.0 111.104 -170.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 27.7 t -164.22 130.96 3.13 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 125.657 1.583 . . . . 0.0 110.971 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 105' ' ' VAL . 39.0 m -99.72 117.82 34.88 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 45.7 mt -92.25 132.5 36.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.386 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 102' ' ' THR . 12.0 mttt -105.17 117.16 33.3 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.719 ' C ' HD13 ' A' ' 116' ' ' ILE . 10.3 m -110.74 117.5 33.62 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.351 0.596 . . . . 0.0 110.783 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.947 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -99.9 135.8 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 123.561 0.744 . . . . 0.0 109.811 -177.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.8 p -104.3 133.98 48.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.644 ' CE1' HG23 ' A' ' 4' ' ' THR . 12.2 m80 -136.75 93.28 2.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.081 0.467 . . . . 0.0 109.927 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.847 ' C ' HG23 ' A' ' 2' ' ' VAL . 22.6 m-85 -87.37 101.77 13.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.835 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.453 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 87.6 m-70 -91.51 100.05 12.87 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.1 p -100.7 179.95 4.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.528 0.68 . . . . 0.0 111.937 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.49 ' CB ' ' NZ ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -109.16 155.42 21.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.344 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 41.32 -109.8 0.18 Allowed Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.96 7.14 13.11 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.911 -0.17 . . . . 0.0 111.006 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -47.51 159.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.169 0.509 . . . . 0.0 110.295 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.449 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 38.2 mt-10 -150.57 147.11 27.05 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.056 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.413 HD12 ' CD1' ' A' ' 95' ' ' ILE . 10.2 mm -89.32 124.57 42.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.468 ' HG2' ' H ' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -75.36 162.49 28.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.473 0.654 . . . . 0.0 111.643 -178.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.19 -34.08 74.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.837 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.468 ' H ' ' HG2' ' A' ' 128' ' ' LYS . 62.9 mt-10 -64.93 -35.6 81.7 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.824 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -68.57 -53.86 20.27 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.173 0.511 . . . . 0.0 110.789 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.0 m -69.23 -20.27 24.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.469 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -66.22 -47.64 73.2 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 122.293 -0.254 . . . . 0.0 110.41 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.88 -48.71 55.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.669 0.271 . . . . 0.0 110.697 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.91 -47.08 89.39 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -67.49 -47.03 71.22 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 122.493 -0.416 . . . . 0.0 110.569 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -55.24 -46.83 76.03 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.503 ' NZ ' ' O ' ' A' ' 37' ' ' ALA . 25.1 tttp -63.28 -54.42 37.41 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.45 -41.76 41.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.771 0.796 . . . . 0.0 110.116 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -63.11 -36.72 84.56 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.229 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.09 -47.58 90.11 Favored Glycine 0 C--O 1.226 -0.36 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -64.71 -44.81 89.04 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -59.46 -23.63 62.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -76.67 -37.48 56.14 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.023 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.753 ' C ' HD12 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -67.69 -56.19 10.27 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.354 1.073 . . . . 0.0 109.05 179.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.708 ' O ' HD22 ' A' ' 150' ' ' LEU . 50.9 mt -53.95 -50.66 51.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.285 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -47.5 -56.89 6.11 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.587 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 145' ' ' LEU . 12.1 p -52.98 -40.9 64.1 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.209 0.528 . . . . 0.0 111.468 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.643 ' HB2' HD13 ' A' ' 33' ' ' ILE . 22.1 t80 -61.47 -44.4 97.16 Favored 'General case' 0 C--O 1.193 -1.903 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.816 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.1 mm? -67.87 -42.71 80.86 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 119.995 1.27 . . . . 0.0 111.335 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -62.89 -23.81 67.52 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 121.505 -0.747 . . . . 0.0 109.13 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -105.72 -12.86 15.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.922 0.868 . . . . 0.0 110.342 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.638 ' N ' ' O ' ' A' ' 149' ' ' TYR . 0.2 OUTLIER -155.14 66.65 4.94 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 125.393 1.477 . . . . 0.0 110.041 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.42 ' N ' ' O ' ' A' ' 150' ' ' LEU . 39.8 Cg_endo -72.25 -3.44 13.34 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 C-N-CA 122.603 2.202 . . . . 0.0 111.68 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.633 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 4.2 m-20 -84.66 4.12 33.95 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.122 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.405 ' O ' ' CD ' ' A' ' 20' ' ' LYS . . . -50.1 130.31 22.21 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 119.522 -1.986 . . . . 0.0 111.419 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.714 ' CG ' HD13 ' A' ' 24' ' ' LEU . 0.7 OUTLIER 55.15 6.47 0.15 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.633 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.499 0 O-C-N 121.832 -0.542 . . . . 0.0 110.253 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.835 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.2 p . . . . . 0 C--O 1.234 0.256 0 CA-C-O 120.728 0.299 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -97.64 109.41 22.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.776 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.58 HG23 ' CE1' ' A' ' 118' ' ' HIS . 92.8 m -97.18 139.83 32.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 0.0 110.918 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -140.34 129.5 23.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.205 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.527 ' C ' HD22 ' A' ' 7' ' ' ASN . 1.4 tt0 -103.37 126.67 50.66 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.757 0.313 . . . . 0.0 110.894 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.527 HD22 ' C ' ' A' ' 6' ' ' GLU . 2.3 m120 -126.67 165.71 18.71 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.198 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -155.93 139.8 16.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 112.082 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -137.98 139.94 39.95 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.474 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.27 145.04 26.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.82 0.343 . . . . 0.0 111.521 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.0 t -145.38 155.06 42.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.534 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -93.23 29.32 1.93 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.894 0.378 . . . . 0.0 110.792 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.578 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.3 mt -113.78 125.25 29.74 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.779 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -49.22 146.01 13.92 Favored 'Trans proline' 0 C--N 1.327 -0.559 0 C-N-CA 121.862 1.708 . . . . 0.0 111.615 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.433 ' HA ' HD12 ' A' ' 18' ' ' LEU . 27.1 Cg_exo -57.56 -24.6 62.79 Favored 'Trans proline' 0 N--CA 1.483 0.853 0 C-N-CA 122.204 1.936 . . . . 0.0 112.412 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.522 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 52.9 m -67.64 -35.63 79.26 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -75.74 -57.26 3.99 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.578 HD11 ' O ' ' A' ' 13' ' ' ILE . 3.8 mt -49.19 -47.11 46.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.09 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.479 ' O ' HG22 ' A' ' 23' ' ' VAL . 40.2 t80 -48.04 -56.66 7.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.705 ' CB ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.99 -38.41 76.0 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 119.101 -1.039 . . . . 0.0 108.479 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.798 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -66.72 -3.71 7.26 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.541 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.499 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 7.9 m-85 -119.94 -8.9 9.75 Favored 'General case' 0 CA--C 1.527 0.058 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.578 HG23 ' N ' ' A' ' 24' ' ' LEU . 22.3 m -129.31 -49.61 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.033 HD12 ' N ' ' A' ' 25' ' ' ASP . 2.7 pp -101.19 -30.53 11.49 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 1.033 ' N ' HD12 ' A' ' 24' ' ' LEU . 50.2 m-20 -110.89 -4.07 15.38 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.813 -0.554 . . . . 0.0 111.398 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -66.82 -38.79 87.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.704 0.764 . . . . 0.0 112.099 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.492 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 17.3 m-20 -84.09 14.83 3.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.86 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 27' ' ' ASP . 8.2 m120 -138.84 -9.27 1.37 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.965 HD12 HG23 ' A' ' 146' ' ' ILE . 0.1 OUTLIER -92.03 -50.86 5.48 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.515 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.598 HG13 HD11 ' A' ' 146' ' ' ILE . 91.1 mt -55.33 -48.23 96.74 Favored Pre-proline 0 C--O 1.212 -0.884 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 29.7 Cg_endo -62.87 -26.16 74.52 Favored 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 121.773 1.649 . . . . 0.0 113.461 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -75.93 -48.61 20.56 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.662 0.744 . . . . 0.0 112.042 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.777 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.6 OUTLIER -94.45 -36.28 6.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.533 -177.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.91 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.95 63.61 0.16 Allowed Pre-proline 0 C--N 1.324 -0.507 0 C-N-CA 122.817 0.447 . . . . 0.0 111.947 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.493 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 73.6 Cg_endo -76.37 -25.73 9.5 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 N-CA-C 107.625 -1.721 . . . . 0.0 107.625 174.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -74.81 -43.9 52.19 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.609 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.91 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -71.73 -75.13 0.14 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.254 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.56 146.17 9.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.955 0.407 . . . . 0.0 110.221 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -77.66 -52.4 9.04 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.376 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.697 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 54.0 tp60 -175.68 164.0 2.94 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 110.546 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.697 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -166.96 144.0 4.67 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.134 0.492 . . . . 0.0 110.518 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.53 ' N ' ' NZ ' ' A' ' 54' ' ' LYS . 17.7 pt-20 -149.85 156.17 41.33 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.105 -0.372 . . . . 0.0 110.876 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.442 HG13 ' H ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -83.83 138.87 18.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.554 0.692 . . . . 0.0 111.008 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.97 -39.38 13.02 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.03 -0.987 . . . . 0.0 109.053 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.904 ' O ' HG23 ' A' ' 52' ' ' THR . 1.1 tt0 -142.41 138.22 30.95 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.22 -156.68 27.39 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.685 HD22 ' N ' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -135.08 -13.6 2.11 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.593 -0.357 . . . . 0.0 111.079 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.685 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 143.8 10.84 0.38 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.9 -172.99 19.84 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 117.525 0.662 . . . . 0.0 111.75 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.28 127.19 22.19 Favored 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 122.597 2.198 . . . . 0.0 113.207 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.95 1.94 55.01 Favored Glycine 0 CA--C 1.506 -0.512 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.904 HG23 ' O ' ' A' ' 45' ' ' GLU . 95.8 m -93.59 136.16 34.15 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.313 -0.944 . . . . 0.0 110.761 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mp -109.56 119.22 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' NZ ' ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -109.25 136.4 48.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.781 0.8 . . . . 0.0 109.738 178.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -120.56 129.77 53.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.157 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.672 ' N ' HD12 ' A' ' 56' ' ' ILE . 2.5 mp -95.41 136.38 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.4 m -107.97 118.43 36.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.491 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -98.29 166.85 11.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.638 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.7 144.52 30.31 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.81 -58.47 8.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.805 0.336 . . . . 0.0 110.694 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.35 61.6 3.22 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 m -137.41 176.05 9.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.945 0.403 . . . . 0.0 110.684 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -61.07 -52.66 63.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.658 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.26 155.97 18.16 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.05 -61.8 0.14 Allowed Glycine 0 N--CA 1.462 0.393 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.64 155.06 42.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 0.0 110.846 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 p -156.01 145.52 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.187 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.495 ' HZ2' ' HB3' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -101.49 110.52 22.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.32 0.581 . . . . 0.0 111.802 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.464 ' CD2' ' C ' ' A' ' 69' ' ' HIS . 0.3 OUTLIER -109.62 114.79 28.69 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.11 133.77 46.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.11 0.481 . . . . 0.0 111.693 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.5 mt -80.31 137.51 21.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -95.54 -54.31 3.42 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -177.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.8 m -164.66 141.72 6.27 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.441 HD13 HG11 ' A' ' 23' ' ' VAL . 22.6 mt -128.21 130.0 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.712 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 79' ' ' TYR . 7.4 m-20 -115.61 88.78 2.95 Favored 'General case' 0 C--O 1.211 -0.928 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.414 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 7.4 mt-10 -54.26 -30.07 49.22 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.3 -38.08 70.77 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.426 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.07 -11.46 15.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.978 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 75' ' ' ASP . 7.5 m-85 61.16 41.47 13.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.795 -0.566 . . . . 0.0 110.498 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.9 t -115.41 132.66 56.55 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.736 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.492 ' CE2' ' OG1' ' A' ' 102' ' ' THR . 51.4 p90 -132.45 131.79 42.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.29 0.567 . . . . 0.0 110.92 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.3 t -126.81 145.15 50.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.226 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -151.26 163.63 38.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.1 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 98' ' ' ILE . 5.7 m -146.4 142.5 28.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.233 0.54 . . . . 0.0 111.378 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.636 HD13 ' HB1' ' A' ' 90' ' ' ALA . 5.7 mt -81.19 120.56 25.03 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.477 ' CG1' ' N ' ' A' ' 87' ' ' GLU . 3.6 pt -80.75 -44.55 21.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.724 0.297 . . . . 0.0 111.665 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.517 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 4.6 tp10 -153.71 171.79 18.3 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.613 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.54 177.77 18.03 Favored Glycine 0 CA--C 1.508 -0.359 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -61.06 2.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.636 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -68.38 -35.06 77.15 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 124.168 0.987 . . . . 0.0 110.102 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.889 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.62 15.68 21.89 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 123.591 0.756 . . . . 0.0 109.799 -178.057 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.4 p 47.19 -126.8 1.65 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -130.74 -12.79 3.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.078 0.466 . . . . 0.0 111.195 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.514 ' O ' HG21 ' A' ' 125' ' ' ILE . 2.6 p -105.53 -5.36 20.28 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.714 HG21 ' CD1' ' A' ' 98' ' ' ILE . 79.4 mt -97.55 152.17 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-O 122.16 0.981 . . . . 0.0 113.432 -176.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.493 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -89.41 -59.47 2.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 113.917 -1.492 . . . . 0.0 109.423 178.12 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.442 ' CB ' ' NZ ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -171.69 149.08 2.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.462 0.649 . . . . 0.0 111.285 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.714 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.92 123.24 69.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.4 t -111.14 146.43 36.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.353 0.597 . . . . 0.0 111.956 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -134.7 131.07 37.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.571 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.427 ' O ' HG12 ' A' ' 116' ' ' ILE . 77.3 tt0 -128.1 133.55 49.03 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.492 ' OG1' ' CE2' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -140.2 132.71 28.63 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.956 -0.465 . . . . 0.0 110.476 -178.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.602 ' C ' HD23 ' A' ' 104' ' ' LEU . 54.3 tttm -121.76 133.93 54.92 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.73 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -100.12 126.35 46.36 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.19 137.17 58.6 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.159 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.81 133.92 44.69 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.379 178.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 28.1 p -121.1 172.8 7.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.941 0.401 . . . . 0.0 110.258 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.12 -38.78 61.93 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.1 m -83.53 -15.57 48.82 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.63 1.172 . . . . 0.0 112.871 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 160.75 -85.48 0.11 Allowed Glycine 0 CA--C 1.54 1.596 0 C-N-CA 127.541 2.495 . . . . 0.0 112.794 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.7 OUTLIER -157.58 130.32 7.46 Favored 'General case' 0 C--N 1.347 0.487 0 C-N-CA 127.995 2.518 . . . . 0.0 111.046 175.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.4 m -99.82 118.45 36.31 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.5 mt -91.83 128.73 43.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.54 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.431 ' CB ' ' NZ ' ' A' ' 114' ' ' LYS . 1.2 mtmp? -105.59 117.05 33.02 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.814 ' C ' HD13 ' A' ' 116' ' ' ILE . 43.7 t -111.31 125.23 53.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.238 0.542 . . . . 0.0 110.845 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.896 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -107.17 135.76 44.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 123.22 0.608 . . . . 0.0 110.043 -177.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.2 t -107.1 137.94 44.22 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.885 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.58 ' CE1' HG23 ' A' ' 4' ' ' THR . 6.7 m80 -135.67 93.49 2.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.076 0.465 . . . . 0.0 110.589 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.835 ' C ' HG23 ' A' ' 2' ' ' VAL . 88.8 m-85 -86.56 101.6 13.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.173 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -99.3 107.88 20.28 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.138 0.494 . . . . 0.0 110.546 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.779 HG21 ' HA ' ' A' ' 126' ' ' GLU . 9.3 p -100.48 173.11 6.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.408 0.623 . . . . 0.0 111.167 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.97 155.17 21.18 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.187 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 40.3 -109.09 0.12 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.767 ' H ' HD22 ' A' ' 124' ' ' ASN . 0.1 OUTLIER -109.51 -1.4 18.3 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 122.779 -0.248 . . . . 0.0 111.213 179.039 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.514 HG21 ' O ' ' A' ' 94' ' ' THR . 1.4 mp -49.16 151.54 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.269 0.557 . . . . 0.0 109.877 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.779 ' HA ' HG21 ' A' ' 121' ' ' THR . 35.2 tt0 -147.7 148.29 30.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.642 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.7 mm -87.99 125.46 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -74.33 162.3 29.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.123 0.487 . . . . 0.0 111.798 -178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.4 -34.89 75.18 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.948 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.472 ' O ' HG22 ' A' ' 134' ' ' VAL . 0.6 OUTLIER -69.15 -28.62 66.59 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.108 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -72.49 -47.43 48.67 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.112 0.482 . . . . 0.0 111.108 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.4 m -79.29 -28.61 13.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.981 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -66.78 -45.64 77.85 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.169 -0.332 . . . . 0.0 110.855 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.514 HG23 ' N ' ' A' ' 135' ' ' GLY . 32.6 m -70.35 -45.6 74.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.718 0.294 . . . . 0.0 110.529 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.514 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -66.9 -44.59 88.6 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 77.9 tttt -65.02 -46.04 83.01 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 122.696 -0.296 . . . . 0.0 110.673 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -54.42 -47.15 73.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.793 0.33 . . . . 0.0 110.135 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.1 ttpp -66.44 -52.99 40.55 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.69 -43.98 47.71 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.589 0.709 . . . . 0.0 110.546 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.37 -36.49 75.85 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.424 ' O ' HD22 ' A' ' 145' ' ' LEU . . . -61.03 -42.4 99.78 Favored Glycine 0 C--O 1.22 -0.76 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.559 ' CD2' ' HB1' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -64.0 -46.84 82.74 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -60.74 -24.08 65.44 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 141' ' ' GLY . 1.8 ttmm -76.5 -38.56 55.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.808 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.777 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -66.94 -57.01 7.76 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.365 0.602 . . . . 0.0 110.092 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.965 HG23 HD12 ' A' ' 29' ' ' LEU . 43.3 mt -55.3 -50.03 68.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.539 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -47.19 -53.23 13.64 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.667 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.3 m -55.39 -41.72 73.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.232 0.539 . . . . 0.0 110.908 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.719 ' HB2' HD13 ' A' ' 33' ' ' ILE . 22.0 t80 -60.8 -45.44 94.39 Favored 'General case' 0 C--O 1.194 -1.864 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.798 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.1 mm? -67.02 -42.95 84.06 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 120.653 1.57 . . . . 0.0 111.449 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -24.02 67.47 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.699 -0.625 . . . . 0.0 109.425 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -106.34 -13.17 15.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.842 0.83 . . . . 0.0 110.415 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.657 ' N ' ' O ' ' A' ' 149' ' ' TYR . 60.7 m80 -156.04 66.81 4.52 Favored Pre-proline 0 C--N 1.303 -1.436 0 C-N-CA 125.32 1.448 . . . . 0.0 110.173 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.86 -2.18 11.87 Favored 'Trans proline' 0 N--CA 1.48 0.708 0 C-N-CA 122.708 2.272 . . . . 0.0 111.154 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.644 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 9.1 m-20 -68.36 2.21 2.46 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.535 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.602 ' O ' ' HD3' ' A' ' 20' ' ' LYS . . . -50.43 130.47 23.62 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 118.841 -2.412 . . . . 0.0 110.924 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.845 ' CD1' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER 52.34 4.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 179.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.644 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 118.18 -0.915 . . . . 0.0 110.052 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.774 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.7 p . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.869 0.366 . . . . 0.0 111.329 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -98.0 109.99 22.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.682 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.502 ' OG1' ' CE1' ' A' ' 118' ' ' HIS . 74.6 m -95.76 140.09 31.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 0.0 110.796 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -141.5 132.04 25.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.132 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -103.02 137.02 41.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.128 0.489 . . . . 0.0 111.47 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -136.16 165.39 25.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.971 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -155.62 149.63 25.52 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -149.65 140.73 22.99 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.512 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.08 147.83 23.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.874 0.368 . . . . 0.0 111.659 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.4 p -140.0 155.74 46.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.446 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -95.93 22.51 7.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.838 0.351 . . . . 0.0 111.044 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.554 ' O ' HD11 ' A' ' 18' ' ' LEU . 2.3 mt -119.31 128.07 26.13 Favored Pre-proline 0 C--O 1.217 -0.616 0 CA-C-O 118.946 -0.55 . . . . 0.0 110.375 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -45.7 144.8 5.04 Favored 'Trans proline' 0 C--N 1.325 -0.666 0 C-N-CA 121.68 1.587 . . . . 0.0 110.935 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HA ' HD12 ' A' ' 18' ' ' LEU . 10.2 Cg_endo -61.13 -23.63 77.64 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 122.172 1.915 . . . . 0.0 112.693 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.506 ' C ' ' HE ' ' A' ' 17' ' ' ARG . 10.2 t -70.35 -30.18 67.07 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.696 ' HE ' ' N ' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -79.16 -52.3 8.35 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.554 HD11 ' O ' ' A' ' 13' ' ' ILE . 4.3 mt -53.45 -44.75 69.15 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.261 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.9 ' O ' HG22 ' A' ' 23' ' ' VAL . 48.7 t80 -49.83 -57.44 7.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.94 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.45 ' CG ' ' O ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -68.63 -27.64 66.2 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.815 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.024 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -82.95 -1.63 52.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.655 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.634 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 13.1 t80 -120.31 -7.66 9.75 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.9 HG22 ' O ' ' A' ' 19' ' ' PHE . 2.5 m -129.71 -35.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.845 ' CD1' HG23 ' A' ' 23' ' ' VAL . 4.3 mp -89.49 -54.46 4.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.777 0.717 . . . . 0.0 111.626 -176.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.527 ' CB ' ' CZ ' ' A' ' 157' ' ' TYR . 0.1 OUTLIER -115.8 0.83 13.29 Favored 'General case' 0 C--O 1.199 -1.596 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.341 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.634 ' HB2' ' HA ' ' A' ' 22' ' ' PHE . . . -44.53 -41.87 6.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 119.518 1.053 . . . . 0.0 111.879 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.487 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 4.8 p30 -84.81 17.4 2.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.507 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 27' ' ' ASP . 11.6 m120 -139.68 -10.97 1.18 Allowed 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 125.562 1.545 . . . . 0.0 108.722 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.569 HD21 ' CD2' ' A' ' 149' ' ' TYR . 0.2 OUTLIER -95.07 -43.02 8.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 125.19 1.396 . . . . 0.0 108.334 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.73 HG13 HD11 ' A' ' 146' ' ' ILE . 55.7 mt -54.5 -51.17 80.6 Favored Pre-proline 0 C--O 1.215 -0.73 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.072 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 26.2 Cg_endo -61.96 -22.79 74.97 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 122.148 1.899 . . . . 0.0 111.855 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -68.82 -55.45 11.14 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.505 0.669 . . . . 0.0 111.564 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.722 HD12 ' HB2' ' A' ' 145' ' ' LEU . 0.5 OUTLIER -94.63 -40.97 11.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.732 -177.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.876 ' HB2' HD22 ' A' ' 145' ' ' LEU . . . -110.8 71.13 0.69 Allowed Pre-proline 0 CA--C 1.506 -0.737 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.016 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.21 -6.87 15.73 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 N-CA-C 108.115 -1.533 . . . . 0.0 108.115 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.429 ' H ' ' C ' ' A' ' 34' ' ' ALA . 24.7 pt20 -71.98 -34.82 69.22 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.799 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.586 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -79.55 -82.0 0.11 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.263 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 38' ' ' ILE . 1.8 mp -102.81 143.66 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.882 0.372 . . . . 0.0 110.353 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -79.33 -43.74 22.95 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.986 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.677 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -177.39 165.17 2.19 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.677 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -165.47 145.63 6.83 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.751 0.31 . . . . 0.0 110.951 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -136.75 142.76 43.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.74 0.305 . . . . 0.0 110.213 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.618 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -79.57 140.11 17.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.523 0.678 . . . . 0.0 110.472 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.1 mp -88.84 -39.64 13.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.877 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.948 ' O ' HG23 ' A' ' 52' ' ' THR . 22.9 mt-10 -142.96 134.09 25.81 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.867 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.86 -156.05 35.89 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.684 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -137.54 -0.53 2.16 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.554 -0.38 . . . . 0.0 111.363 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.507 ' N ' HG21 ' A' ' 52' ' ' THR . . . 134.87 16.24 1.0 Allowed Glycine 0 C--O 1.223 -0.56 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.466 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -110.48 -173.32 20.19 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 117.525 0.662 . . . . 0.0 111.458 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -60.39 125.92 18.68 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 122.181 1.921 . . . . 0.0 113.172 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.7 2.7 58.51 Favored Glycine 0 N--CA 1.462 0.412 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.948 HG23 ' O ' ' A' ' 45' ' ' GLU . 90.7 m -94.05 140.16 30.07 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.359 -0.921 . . . . 0.0 111.267 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mp -120.68 130.94 74.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.618 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -119.83 140.0 51.49 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.302 0.572 . . . . 0.0 111.02 179.231 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.633 ' HE3' ' HZ3' ' A' ' 68' ' ' LYS . 35.5 ttmt -118.21 124.75 48.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.609 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.805 HD13 ' CD2' ' A' ' 69' ' ' HIS . 1.4 mp -102.84 129.58 54.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.4 m -112.46 119.88 39.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.248 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -92.63 -174.93 3.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.008 0.432 . . . . 0.0 110.849 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.36 146.63 50.47 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.631 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 3.5 mp0 -59.1 -48.96 79.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.869 0.366 . . . . 0.0 110.617 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.92 61.27 3.41 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -138.4 175.62 9.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.248 0.547 . . . . 0.0 110.412 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.58 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -67.1 -53.56 29.72 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.14 156.26 18.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.953 0.406 . . . . 0.0 110.18 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.31 -58.77 0.22 Allowed Glycine 0 CA--C 1.52 0.348 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -143.83 155.02 43.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.168 0.509 . . . . 0.0 110.58 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.466 ' CG2' HD11 ' A' ' 85' ' ' LEU . 5.1 p -154.23 146.54 13.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.361 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.633 ' HZ3' ' HE3' ' A' ' 55' ' ' LYS . 14.6 mmtt -107.46 112.43 25.21 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.285 0.564 . . . . 0.0 112.491 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.805 ' CD2' HD13 ' A' ' 56' ' ' ILE . 8.8 m-70 -104.83 114.83 29.28 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -101.91 120.76 40.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.653 0.263 . . . . 0.0 111.17 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.559 HD13 ' CG2' ' A' ' 52' ' ' THR . 5.0 mp -70.48 145.15 13.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -102.02 -55.64 2.45 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.123 -0.36 . . . . 0.0 111.83 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.9 m -165.93 141.02 4.75 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.5 mt -124.53 130.99 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.922 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 79' ' ' TYR . 12.7 m-20 -115.16 87.67 2.71 Favored 'General case' 0 C--O 1.206 -1.213 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.486 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -54.72 -32.39 59.54 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.45 -38.55 66.48 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.06 -10.78 15.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.055 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.2 m-85 62.58 47.29 5.01 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.45 -0.781 . . . . 0.0 110.341 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.496 ' HB3' ' HZ3' ' A' ' 103' ' ' LYS . 10.2 p -105.8 144.54 32.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.415 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.633 ' CE2' ' CD2' ' A' ' 83' ' ' TYR . 29.5 t80 -132.2 118.41 19.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.052 0.453 . . . . 0.0 110.712 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.6 p -127.12 130.44 49.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.748 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.633 ' CD2' ' CE2' ' A' ' 81' ' ' TYR . 12.9 p90 -144.8 164.63 30.47 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -140.1 137.01 34.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.329 0.585 . . . . 0.0 110.987 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.627 HD21 ' CE1' ' A' ' 69' ' ' HIS . 0.2 OUTLIER -79.75 118.65 21.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.569 HD11 ' CB ' ' A' ' 68' ' ' LYS . 2.7 pt -87.27 -45.01 16.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.479 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 35.4 tt0 -152.65 171.76 17.68 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.85 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.616 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.87 177.46 17.87 Favored Glycine 0 CA--C 1.51 -0.245 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -62.16 2.05 0.27 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.616 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -66.01 -33.02 74.84 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 124.754 1.221 . . . . 0.0 110.608 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.876 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -109.75 16.14 22.27 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 123.439 0.695 . . . . 0.0 109.624 -178.08 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 53.4 p 45.85 -126.49 1.31 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -130.38 -12.99 3.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.96 0.41 . . . . 0.0 111.176 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.9 p -105.17 -6.74 19.56 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.714 HG21 ' CD1' ' A' ' 98' ' ' ILE . 59.0 mt -98.6 153.01 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 CA-C-O 122.004 0.907 . . . . 0.0 113.256 -176.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.514 ' N ' HG22 ' A' ' 95' ' ' ILE . 19.9 pt-20 -99.88 -46.11 5.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.377 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.441 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -172.62 146.83 1.73 Allowed 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 121.723 0.773 . . . . 0.0 112.415 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.714 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.14 123.47 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.94 145.08 30.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.138 0.494 . . . . 0.0 111.369 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.514 ' CD2' ' O ' ' A' ' 116' ' ' ILE . 0.4 OUTLIER -141.79 129.5 21.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.576 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.419 ' O ' HG12 ' A' ' 116' ' ' ILE . 18.0 tt0 -128.12 134.6 49.14 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.06 131.82 25.76 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.905 -0.497 . . . . 0.0 109.96 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.697 ' C ' HD23 ' A' ' 104' ' ' LEU . 17.5 ttmm -125.62 134.15 51.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.123 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.873 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -99.9 125.97 45.96 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.116 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -126.2 137.26 58.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.795 -178.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.69 132.73 44.06 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.41 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 111' ' ' SER . 24.2 p -121.4 171.6 8.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.866 0.365 . . . . 0.0 110.293 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.94 -30.77 46.27 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.8 m -85.4 -16.81 38.55 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.379 -2.248 . . . . 0.0 114.352 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.74 -85.57 0.13 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.078 1.799 . . . . 0.0 109.858 -171.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.3 OUTLIER -160.12 129.13 5.0 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.87 1.668 . . . . 0.0 110.921 -178.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 105' ' ' VAL . 33.1 m -99.43 117.8 34.64 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 55.5 mt -91.96 128.81 43.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.766 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -105.89 117.08 33.1 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.719 ' C ' HD13 ' A' ' 116' ' ' ILE . 0.5 OUTLIER -111.88 118.18 34.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.415 0.626 . . . . 0.0 111.556 -178.291 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.95 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -99.31 135.03 36.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 123.773 0.829 . . . . 0.0 109.915 -178.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.9 136.86 46.91 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.502 ' CE1' ' OG1' ' A' ' 4' ' ' THR . 47.8 m-70 -136.09 97.81 3.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 120.999 0.428 . . . . 0.0 110.801 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.774 ' C ' HG23 ' A' ' 2' ' ' VAL . 3.6 m-30 -84.31 101.65 12.1 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.83 -0.434 . . . . 0.0 109.83 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.442 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -94.83 102.67 14.53 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.752 HG21 ' HA ' ' A' ' 126' ' ' GLU . 11.9 p -101.31 171.32 7.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.482 0.658 . . . . 0.0 111.421 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -112.35 143.0 44.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.508 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 50.38 -109.71 0.74 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -106.85 -6.51 17.62 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.649 -0.324 . . . . 0.0 111.478 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 125' ' ' ILE . 1.4 mp -47.5 151.42 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.199 0.524 . . . . 0.0 109.751 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.752 ' HA ' HG21 ' A' ' 121' ' ' THR . 12.9 pt-20 -148.18 147.75 29.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.84 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.9 mm -88.19 127.67 41.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.449 ' HG3' ' H ' ' A' ' 129' ' ' GLU . 10.7 tptp -73.76 159.88 32.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.614 0.721 . . . . 0.0 111.684 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.449 ' H ' ' HG3' ' A' ' 128' ' ' LYS . 70.0 mm-40 -70.15 -37.89 75.34 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.531 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.476 ' O ' HG13 ' A' ' 134' ' ' VAL . 43.8 mt-10 -64.69 -26.58 68.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.877 0.37 . . . . 0.0 110.231 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -72.78 -49.23 32.03 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.161 0.505 . . . . 0.0 111.062 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 m -78.25 -28.99 15.08 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.121 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -67.23 -46.2 74.5 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 122.004 -0.435 . . . . 0.0 110.746 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 135' ' ' GLY . 25.8 m -70.42 -42.4 78.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.771 0.32 . . . . 0.0 110.679 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.491 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -69.86 -46.16 54.24 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -66.74 -48.43 69.18 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.568 -0.372 . . . . 0.0 110.911 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -56.03 -47.77 77.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.097 0.475 . . . . 0.0 110.126 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -64.7 -53.85 40.86 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.449 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -48.36 -46.8 37.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.352 0.596 . . . . 0.0 110.564 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -55.37 -37.44 67.55 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.99 -42.25 98.26 Favored Glycine 0 C--O 1.223 -0.532 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.727 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -66.49 -32.71 74.24 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 122.243 -0.563 . . . . 0.0 109.943 -179.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.59 ' CE2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -71.48 -20.03 62.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.224 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -72.6 -48.22 41.44 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.294 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.876 HD22 ' HB2' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -73.57 -44.33 57.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.165 -179.294 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.73 HD11 HG13 ' A' ' 30' ' ' ILE . 31.2 mt -52.57 -50.51 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.425 ' O ' ' CD1' ' A' ' 13' ' ' ILE . 27.1 tt0 -47.87 -49.43 29.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.1 t -51.74 -46.85 64.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.483 0.659 . . . . 0.0 110.959 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.607 ' O ' ' N ' ' A' ' 153' ' ' HIS . 12.2 t80 -58.55 -43.79 89.43 Favored 'General case' 0 C--O 1.199 -1.582 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 1.024 HD11 ' HB2' ' A' ' 21' ' ' ALA . 1.6 mm? -67.91 -43.23 79.7 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 119.675 1.125 . . . . 0.0 111.983 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.501 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -59.9 -24.58 64.42 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.253 -0.904 . . . . 0.0 108.953 179.507 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -105.73 -13.81 15.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.331 0.586 . . . . 0.0 110.575 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.607 ' N ' ' O ' ' A' ' 149' ' ' TYR . 0.3 OUTLIER -155.65 66.5 4.63 Favored Pre-proline 0 C--N 1.313 -0.982 0 C-N-CA 124.738 1.215 . . . . 0.0 110.47 -178.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.466 ' CD ' ' O ' ' A' ' 150' ' ' LEU . 9.7 Cg_endo -77.47 -8.58 17.26 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 C-N-CA 122.719 2.28 . . . . 0.0 111.743 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.546 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 14.0 t70 -89.94 6.54 41.6 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.388 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.557 ' HB1' ' CE1' ' A' ' 157' ' ' TYR . . . -72.34 132.18 43.64 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 120.296 -1.503 . . . . 0.0 110.274 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.557 ' CE1' ' HB1' ' A' ' 156' ' ' ALA . 1.7 m-85 64.95 9.12 5.15 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.794 176.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.546 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.747 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.812 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.9 p . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.669 0.271 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.28 109.78 22.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.694 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.544 ' OG1' ' CE1' ' A' ' 118' ' ' HIS . 61.3 m -96.88 140.01 32.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.802 0.334 . . . . 0.0 111.028 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.88 125.34 16.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.98 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.467 ' C ' ' ND2' ' A' ' 7' ' ' ASN . 0.9 OUTLIER -103.27 130.24 50.46 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.716 0.293 . . . . 0.0 111.429 -179.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.467 ' ND2' ' C ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -131.43 171.34 13.5 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -155.76 155.63 33.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -154.63 140.0 17.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.343 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 m -93.91 146.27 24.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.817 0.341 . . . . 0.0 111.583 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 p -135.15 154.32 51.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.398 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -97.41 26.92 4.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.084 0.468 . . . . 0.0 110.498 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.585 ' HB ' HD21 ' A' ' 18' ' ' LEU . 2.2 mt -119.05 125.41 27.67 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.444 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -46.13 147.32 3.76 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 121.826 1.684 . . . . 0.0 111.522 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -59.56 -24.53 75.48 Favored 'Trans proline' 0 N--CA 1.482 0.812 0 C-N-CA 121.983 1.789 . . . . 0.0 112.212 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.47 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 67.1 m -68.13 -34.19 75.9 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -77.8 -56.09 4.79 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 121.395 -0.816 . . . . 0.0 109.272 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.585 HD21 ' HB ' ' A' ' 13' ' ' ILE . 2.8 mt -52.47 -43.05 64.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.226 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.796 ' O ' HG22 ' A' ' 23' ' ' VAL . 46.2 t80 -54.87 -54.42 42.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 16' ' ' SER . 0.3 OUTLIER -70.89 -25.75 62.92 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.086 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.854 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -83.06 -2.04 54.31 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.524 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.542 ' CE2' ' CE2' ' A' ' 143' ' ' PHE . 2.8 m-85 -117.31 -7.87 11.15 Favored 'General case' 0 C--N 1.335 -0.035 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.876 HG23 ' CD1' ' A' ' 24' ' ' LEU . 4.7 m -134.89 -34.75 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.876 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.7 mp -88.88 -55.34 3.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.871 1.214 . . . . 0.0 111.443 -176.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.506 ' CG ' ' CE2' ' A' ' 157' ' ' TYR . 0.9 OUTLIER -114.76 -1.32 13.28 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.726 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.485 ' HB2' ' CA ' ' A' ' 22' ' ' PHE . . . -45.77 -40.71 9.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.696 0.76 . . . . 0.0 111.57 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.493 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER -85.07 18.04 2.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.077 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 27' ' ' ASP . 9.8 m120 -139.53 -9.06 1.25 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 126.087 1.755 . . . . 0.0 108.683 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.483 HD21 ' CD1' ' A' ' 149' ' ' TYR . 0.1 OUTLIER -95.19 -40.99 9.3 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 124.737 1.215 . . . . 0.0 109.939 -179.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.514 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 80.6 mt -55.16 -42.17 94.51 Favored Pre-proline 0 C--O 1.21 -0.985 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.182 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 21.2 Cg_exo -63.79 -26.69 67.83 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 122.098 1.866 . . . . 0.0 112.039 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 tmtp? -71.01 -51.37 25.84 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 122.027 0.918 . . . . 0.0 111.858 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.778 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.5 OUTLIER -94.57 -35.23 6.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.008 -176.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.848 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.48 65.04 0.14 Allowed Pre-proline 0 C--N 1.322 -0.606 0 C-N-CA 122.966 0.507 . . . . 0.0 111.89 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.466 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 73.2 Cg_endo -74.88 -23.05 14.44 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 N-CA-C 107.707 -1.69 . . . . 0.0 107.707 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -73.9 -43.51 58.2 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.315 -1.312 . . . . 0.0 109.231 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.848 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -73.78 -82.72 0.05 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.766 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.5 mt -100.5 145.84 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.083 0.468 . . . . 0.0 110.471 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -77.8 -54.99 5.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.787 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.428 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -174.21 166.4 4.13 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.099 0.476 . . . . 0.0 110.342 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.428 ' H ' ' HG2' ' A' ' 40' ' ' GLN . . . -166.25 144.25 5.47 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.475 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.432 ' N ' ' HE3' ' A' ' 54' ' ' LYS . 8.4 pt-20 -135.93 146.62 47.51 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.516 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -78.46 139.83 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.404 0.621 . . . . 0.0 110.695 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 8.1 mp -88.63 -39.93 13.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.142 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.929 ' O ' HG23 ' A' ' 52' ' ' THR . 47.1 mt-10 -142.33 133.98 26.78 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.942 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.39 -156.02 27.69 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.61 HD22 ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -142.45 -6.37 0.92 Allowed 'General case' 0 C--N 1.32 -0.684 0 O-C-N 122.355 -0.497 . . . . 0.0 111.177 -179.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.61 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 143.27 14.12 0.31 Allowed Glycine 0 C--O 1.221 -0.708 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.56 -172.61 19.99 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 117.493 0.647 . . . . 0.0 111.988 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -62.13 126.4 18.59 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 123.113 2.542 . . . . 0.0 113.432 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.44 5.8 57.78 Favored Glycine 0 CA--C 1.505 -0.549 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.929 HG23 ' O ' ' A' ' 45' ' ' GLU . 84.3 m -93.37 137.45 32.67 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.339 -0.931 . . . . 0.0 111.128 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.21 129.37 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.516 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -116.21 139.06 50.74 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.206 0.526 . . . . 0.0 110.844 179.163 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.511 ' C ' HD12 ' A' ' 56' ' ' ILE . 66.5 tttt -118.99 127.11 53.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.704 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.827 HD13 ' CD2' ' A' ' 69' ' ' HIS . 1.3 mp -98.98 131.98 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.9 m -105.88 118.84 37.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.349 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -98.65 175.46 5.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 110.782 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.61 145.06 49.68 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -59.31 -53.04 62.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.917 0.389 . . . . 0.0 110.736 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.11 61.73 3.29 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.3 m -140.56 175.03 9.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.36 . . . . 0.0 110.826 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -60.47 -56.12 25.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.976 0.417 . . . . 0.0 110.637 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.93 155.9 16.91 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.196 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -125.22 -59.78 0.17 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.38 154.17 45.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.091 0.472 . . . . 0.0 110.483 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.0 p -156.67 147.35 11.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.351 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.455 ' HB3' HD11 ' A' ' 86' ' ' ILE . 1.5 tppt? -107.12 112.42 25.32 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.452 0.644 . . . . 0.0 112.389 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.827 ' CD2' HD13 ' A' ' 56' ' ' ILE . 8.0 m170 -101.9 120.58 40.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -102.92 115.79 31.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.629 0.252 . . . . 0.0 111.335 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.8 mt -70.0 135.97 27.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.417 ' O ' ' OG ' ' A' ' 73' ' ' SER . 1.7 m-20 -96.94 -56.34 2.59 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 69.4 m -166.08 142.42 5.04 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.9 mt -122.63 131.87 72.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.288 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -115.35 87.7 2.72 Favored 'General case' 0 C--O 1.206 -1.196 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.109 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.503 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -54.67 -30.96 56.96 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.26 -39.06 72.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.2 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.9 m -107.97 -10.35 15.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.188 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.1 m-85 62.33 45.17 6.85 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.487 -0.758 . . . . 0.0 110.199 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.8 t -106.56 148.39 28.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.273 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -132.02 125.67 32.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.727 0.299 . . . . 0.0 110.848 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.8 t -133.47 138.41 46.15 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.607 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -144.14 160.83 40.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.698 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 98' ' ' ILE . 10.1 m -140.03 129.88 24.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.327 0.584 . . . . 0.0 111.027 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.407 HD21 ' CE1' ' A' ' 69' ' ' HIS . 18.2 mt -78.94 119.46 22.13 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' A' ' 68' ' ' LYS . 5.2 pt -88.32 -43.89 15.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.496 ' CD ' ' N ' ' A' ' 88' ' ' GLY . 8.3 tm-20 -158.89 173.28 16.76 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.222 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.606 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.74 178.51 18.41 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.42 2.55 0.15 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.756 ' C ' HD23 ' A' ' 91' ' ' LEU . . . -70.79 -37.1 73.28 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 123.517 0.727 . . . . 0.0 110.19 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.867 HD23 ' N ' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -111.39 17.17 20.4 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 91' ' ' LEU . 56.7 p 51.93 -132.67 1.91 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -131.64 -0.34 3.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.946 0.403 . . . . 0.0 112.0 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.03 -7.43 19.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.807 HD11 HD12 ' A' ' 127' ' ' ILE . 12.0 mt -99.36 151.67 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.502 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -88.51 -51.53 5.66 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.355 176.026 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.03 148.36 2.23 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.128 0.489 . . . . 0.0 112.182 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.707 HD13 HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.22 130.4 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 176.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.4 147.0 44.86 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 122.957 0.503 . . . . 0.0 111.436 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -137.39 140.74 41.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.67 0.271 . . . . 0.0 110.916 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -128.04 134.99 49.27 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 121.015 0.436 . . . . 0.0 110.647 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.0 131.0 42.15 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -120.91 133.84 55.29 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.461 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.3 mm? -96.67 124.06 40.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.63 136.91 43.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.065 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.95 140.04 47.14 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.79 177.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.486 ' N ' ' HA ' ' A' ' 111' ' ' SER . 34.9 t -121.47 169.95 10.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.8 0.333 . . . . 0.0 110.444 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.451 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.96 -38.09 59.54 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.819 -0.513 . . . . 0.0 111.819 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.0 m -87.97 -9.9 52.11 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.335 1.054 . . . . 0.0 112.883 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.15 -86.51 0.12 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 126.095 1.807 . . . . 0.0 112.539 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.486 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 0.7 OUTLIER -157.58 129.54 7.07 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 127.517 2.327 . . . . 0.0 111.152 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.6 m -99.37 134.44 42.22 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.1 mt -108.87 129.82 62.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.476 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -106.09 116.68 32.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.802 ' C ' HD13 ' A' ' 116' ' ' ILE . 11.4 t -110.47 122.75 48.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.145 0.498 . . . . 0.0 110.437 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.859 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -105.73 135.05 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.027 -177.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.8 p -101.5 140.94 35.1 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.544 ' CE1' ' OG1' ' A' ' 4' ' ' THR . 0.1 OUTLIER -136.14 92.66 2.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.202 0.525 . . . . 0.0 109.909 -179.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.812 ' C ' HG23 ' A' ' 2' ' ' VAL . 86.4 m-85 -90.01 101.36 14.07 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.34 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.466 ' CD2' ' OE2' ' A' ' 96' ' ' GLU . 1.8 t-160 -91.44 103.81 16.4 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.434 HG21 ' HA ' ' A' ' 126' ' ' GLU . 1.0 OUTLIER -89.33 160.29 16.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.544 -178.212 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.451 ' H ' HG22 ' A' ' 125' ' ' ILE . 5.1 ptmt -112.8 142.84 44.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.229 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.0 -110.39 1.12 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.498 ' C ' HD22 ' A' ' 124' ' ' ASN . 0.4 OUTLIER -116.47 -2.95 11.92 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.769 -0.254 . . . . 0.0 110.675 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 122' ' ' LYS . 1.6 tp -48.93 162.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 120.959 0.409 . . . . 0.0 110.862 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.434 ' HA ' HG21 ' A' ' 121' ' ' THR . 11.6 pt-20 -148.41 149.97 32.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.132 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.807 HD12 HD11 ' A' ' 95' ' ' ILE . 3.3 mm -86.82 125.09 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -74.77 162.98 28.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.33 0.586 . . . . 0.0 111.104 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -68.95 -45.54 70.49 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.477 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.535 ' O ' HG22 ' A' ' 134' ' ' VAL . 16.3 mm-40 -60.95 -24.8 66.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.641 0.257 . . . . 0.0 110.645 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.409 ' CD2' ' C ' ' A' ' 131' ' ' HIS . 9.6 t60 -73.04 -52.69 13.41 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.384 0.612 . . . . 0.0 110.989 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.412 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.0 m -76.7 -29.12 17.85 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.039 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -67.27 -46.05 74.79 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.252 -0.28 . . . . 0.0 111.095 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 130' ' ' GLU . 30.1 m -70.26 -42.65 78.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.746 0.308 . . . . 0.0 110.685 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.479 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -70.25 -43.75 62.16 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 29.5 ttmt -67.12 -46.49 73.97 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 122.739 -0.271 . . . . 0.0 110.864 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -54.9 -44.12 73.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.472 ' HZ1' ' C ' ' A' ' 37' ' ' ALA . 37.0 tttm -69.3 -56.18 8.3 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.875 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.424 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -48.94 -42.73 38.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.677 0.751 . . . . 0.0 110.746 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -64.13 -36.24 83.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.25 -37.12 92.51 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.569 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -68.05 -47.62 67.87 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.542 ' CE2' ' CE2' ' A' ' 22' ' ' PHE . 5.3 m-85 -59.32 -21.47 59.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -77.04 -38.34 52.95 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.316 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.778 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.9 -57.0 8.89 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.587 179.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.698 ' O ' HD22 ' A' ' 150' ' ' LEU . 76.7 mt -53.9 -50.4 53.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.563 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -47.16 -55.02 9.25 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.019 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.7 t -52.94 -44.01 66.75 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.564 0.697 . . . . 0.0 111.392 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.708 ' HB2' HD13 ' A' ' 33' ' ' ILE . 15.4 t80 -58.83 -45.38 90.15 Favored 'General case' 0 C--O 1.195 -1.772 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.854 HD11 ' HB2' ' A' ' 21' ' ' ALA . 1.7 mm? -67.89 -41.77 82.23 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 119.944 1.247 . . . . 0.0 111.623 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.42 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -60.96 -24.3 65.98 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 121.17 -0.956 . . . . 0.0 108.665 179.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.506 ' OD1' ' CE1' ' A' ' 153' ' ' HIS . 33.4 t70 -106.15 -14.27 15.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.125 0.488 . . . . 0.0 110.916 178.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.621 ' N ' ' O ' ' A' ' 149' ' ' TYR . 39.8 m80 -156.19 66.83 4.45 Favored Pre-proline 0 C--N 1.31 -1.113 0 C-N-CA 125.214 1.406 . . . . 0.0 110.235 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.461 ' CD ' ' O ' ' A' ' 150' ' ' LEU . 59.6 Cg_endo -80.76 -4.77 12.97 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 122.7 2.267 . . . . 0.0 111.989 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.507 ' C ' ' ND2' ' A' ' 158' ' ' ASN . 5.3 m-20 -91.13 5.76 47.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.821 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.606 ' HB1' ' CE1' ' A' ' 157' ' ' TYR . . . -72.91 131.36 42.11 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.356 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.606 ' CE1' ' HB1' ' A' ' 156' ' ' ALA . 1.5 m-85 64.38 8.93 4.55 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.778 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 156' ' ' ALA . 1.9 m-80 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.314 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.818 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.6 p . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.852 0.358 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -97.7 109.81 22.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.528 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.494 ' HG1' ' CE1' ' A' ' 118' ' ' HIS . 90.8 m -96.6 140.16 31.63 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.947 0.403 . . . . 0.0 110.942 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -143.9 132.08 21.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.005 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.528 ' HG2' HD12 ' A' ' 116' ' ' ILE . 19.3 mt-10 -102.2 136.99 41.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.967 0.413 . . . . 0.0 111.146 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.572 HD22 ' N ' ' A' ' 7' ' ' ASN . 0.8 OUTLIER -126.95 168.7 14.16 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.999 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.49 ' N ' ' CD ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -149.16 147.18 28.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.884 0.849 . . . . 0.0 111.73 -178.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.35 135.89 13.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.148 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -101.53 145.59 28.81 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 t -139.89 154.65 47.32 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.336 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -94.51 27.17 3.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.083 0.468 . . . . 0.0 110.908 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.54 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.9 mt -113.03 125.76 29.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.558 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -46.68 143.35 9.0 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 121.622 1.548 . . . . 0.0 111.5 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.48 ' CG ' ' HB2' ' A' ' 106' ' ' ALA . 26.9 Cg_exo -56.06 -26.17 58.13 Favored 'Trans proline' 0 N--CA 1.483 0.872 0 C-N-CA 122.221 1.947 . . . . 0.0 113.137 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.5 m -70.49 -31.05 68.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' A' ' 154' ' ' PRO . 0.5 OUTLIER -76.16 -55.88 5.17 Favored 'General case' 0 CA--C 1.498 -1.044 0 O-C-N 121.413 -0.804 . . . . 0.0 108.879 -179.594 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.54 HD21 ' HB ' ' A' ' 13' ' ' ILE . 2.3 mt -53.71 -37.88 63.73 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.694 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.515 ' O ' HG22 ' A' ' 23' ' ' VAL . 38.3 t80 -53.07 -59.21 4.83 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.754 ' HB2' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -67.48 -42.91 82.21 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 118.859 -1.136 . . . . 0.0 107.963 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.895 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -63.69 -2.58 1.79 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.866 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 2.8 m-85 -116.88 -9.83 11.11 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 24' ' ' LEU . 32.7 m -133.49 -50.92 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.004 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.9 pp -96.45 -31.5 12.79 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 1.004 ' N ' HD12 ' A' ' 24' ' ' LEU . 6.6 t70 -114.66 -4.9 12.73 Favored 'General case' 0 C--O 1.211 -0.958 0 O-C-N 121.716 -0.615 . . . . 0.0 111.563 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -66.48 -43.4 85.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.512 0.673 . . . . 0.0 111.809 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.549 ' HB2' ' HZ2' ' A' ' 54' ' ' LYS . 3.1 p30 -84.2 12.44 6.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.24 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -129.99 -9.35 4.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.796 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -96.64 -34.27 11.46 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.877 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.487 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 25.2 mt -54.06 -56.0 30.54 Favored Pre-proline 0 C--O 1.217 -0.63 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.23 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 22.9 Cg_endo -61.57 -24.84 78.6 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 121.979 1.786 . . . . 0.0 112.551 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -67.73 -57.48 6.28 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.856 0.836 . . . . 0.0 112.0 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.791 HD12 ' HB3' ' A' ' 145' ' ' LEU . 1.2 pt -95.2 -34.95 5.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.196 -176.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.863 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.23 64.45 0.13 Allowed Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.486 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 73.2 Cg_endo -76.33 -27.07 8.25 Favored 'Trans proline' 0 C--N 1.322 -0.858 0 C-N-CA 121.672 1.581 . . . . 0.0 108.18 175.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -73.61 -42.77 61.06 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.331 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.863 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -70.03 -79.89 0.06 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.217 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.486 HD13 HD22 ' A' ' 142' ' ' LEU . 1.2 mp -99.33 147.47 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 121.785 -0.572 . . . . 0.0 110.351 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -77.12 -53.21 8.05 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.297 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.716 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -176.96 166.87 2.49 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 110.613 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.716 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -165.61 145.09 6.45 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.246 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.406 ' N ' ' HZ3' ' A' ' 54' ' ' LYS . 10.9 pt-20 -142.35 144.67 33.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.049 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.622 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -77.38 139.92 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.404 0.621 . . . . 0.0 110.673 -179.243 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.11 -39.59 13.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.987 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.883 ' O ' HG23 ' A' ' 52' ' ' THR . 62.8 mt-10 -148.2 134.91 19.91 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.465 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.98 -156.35 23.61 Favored Glycine 0 CA--C 1.525 0.676 0 O-C-N 123.271 0.357 . . . . 0.0 112.232 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.578 HD22 ' N ' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -137.82 3.28 2.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.896 0.379 . . . . 0.0 111.076 -179.355 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.578 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 122.34 16.28 3.91 Favored Glycine 0 C--O 1.222 -0.65 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -178.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -110.3 -171.47 19.95 Favored Glycine 0 C--O 1.222 -0.606 0 CA-C-O 121.448 0.471 . . . . 0.0 111.926 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -61.66 125.14 16.01 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 122.514 2.143 . . . . 0.0 113.065 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.22 5.64 59.26 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.883 HG23 ' O ' ' A' ' 45' ' ' GLU . 87.0 m -93.39 140.26 29.76 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.457 -0.871 . . . . 0.0 110.851 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.76 132.57 67.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.622 ' HG2' HG23 ' A' ' 43' ' ' ILE . 3.9 mmtt -115.34 138.54 50.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.557 0.694 . . . . 0.0 110.957 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -119.52 122.04 40.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.972 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.575 ' N ' HD12 ' A' ' 56' ' ' ILE . 4.1 mp -105.49 135.0 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.235 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.0 m -113.26 119.39 37.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.391 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -96.14 -176.88 3.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 110.725 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.43 144.8 47.4 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.615 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 5.5 mp0 -59.63 -54.07 50.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.003 0.43 . . . . 0.0 110.491 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.86 61.2 3.44 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 p -139.25 175.32 9.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.821 0.343 . . . . 0.0 110.751 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -62.08 -52.05 65.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 110.682 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.27 142.05 30.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.162 0.506 . . . . 0.0 110.399 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.72 -55.2 0.27 Allowed Glycine 0 N--CA 1.461 0.366 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -135.7 151.31 50.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.935 0.398 . . . . 0.0 110.344 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.416 ' CG2' HD11 ' A' ' 85' ' ' LEU . 2.5 p -156.22 147.5 11.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.595 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -106.05 108.07 19.4 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.042 0.448 . . . . 0.0 112.052 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.522 ' C ' ' ND1' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -109.84 112.96 25.32 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.047 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -107.64 133.01 52.69 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.573 ' H ' HD12 ' A' ' 71' ' ' ILE . 4.1 mp -70.0 140.02 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.43 -55.07 2.94 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.19 -0.319 . . . . 0.0 111.638 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.7 m -165.05 141.14 5.57 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.5 mt -127.05 131.05 71.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.962 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 79' ' ' TYR . 46.1 m-20 -115.4 88.41 2.87 Favored 'General case' 0 C--O 1.203 -1.364 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -54.93 -30.32 58.41 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.44 -38.26 74.15 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.173 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.459 ' OG ' ' NZ ' ' A' ' 103' ' ' LYS . 0.9 OUTLIER -107.69 -10.4 15.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.944 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.597 ' N ' ' O ' ' A' ' 75' ' ' ASP . 20.3 m-85 59.8 47.46 10.22 Favored 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.49 -0.756 . . . . 0.0 110.372 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.5 t -106.33 145.78 31.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.997 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.608 ' CE1' ' CD2' ' A' ' 83' ' ' TYR . 31.0 t80 -131.71 122.84 26.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.121 0.486 . . . . 0.0 110.888 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 p -131.86 139.04 48.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.268 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.608 ' CD2' ' CE1' ' A' ' 81' ' ' TYR . 10.7 p90 -148.04 162.5 39.23 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 m -139.46 140.69 37.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.322 0.582 . . . . 0.0 111.252 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.556 HD12 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -82.77 113.87 20.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.371 178.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -85.89 -42.63 16.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 2.8 tp10 -153.61 172.96 16.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.964 0.411 . . . . 0.0 110.937 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.648 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.24 177.2 17.65 Favored Glycine 0 CA--C 1.509 -0.315 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.29 2.38 0.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.648 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -65.85 -34.24 77.7 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 124.837 1.255 . . . . 0.0 110.696 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.884 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -109.4 12.76 24.49 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 123.271 0.628 . . . . 0.0 109.905 -177.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 65.4 p 45.49 -126.27 1.22 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -130.86 -12.47 3.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.961 0.41 . . . . 0.0 111.198 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 p -105.42 -5.62 20.21 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.727 HG21 ' CD1' ' A' ' 98' ' ' ILE . 80.1 mt -97.78 152.34 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 122.239 1.019 . . . . 0.0 113.711 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.499 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -89.34 -60.38 1.96 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.89 178.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -168.29 149.22 4.93 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.272 0.558 . . . . 0.0 111.111 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.727 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -123.19 125.53 72.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.36 144.44 43.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.194 0.521 . . . . 0.0 111.311 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -136.34 133.58 36.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.458 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -129.17 135.58 49.03 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-O 120.869 0.366 . . . . 0.0 111.14 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.37 132.12 40.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.459 ' NZ ' ' OG ' ' A' ' 78' ' ' SER . 44.0 tttp -119.88 138.61 53.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.65 0.262 . . . . 0.0 110.486 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.5 mm? -96.98 125.53 41.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.292 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.82 130.31 41.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.48 ' HB2' ' CG ' ' A' ' 15' ' ' PRO . . . -74.0 135.5 43.14 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.062 -0.399 . . . . 0.0 110.761 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.499 ' HG ' ' HG1' ' A' ' 112' ' ' THR . 5.5 m -121.82 170.93 9.29 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 122.551 0.341 . . . . 0.0 110.095 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.97 -34.03 51.39 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.8 m -82.99 -12.38 57.33 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.312 1.445 . . . . 0.0 114.671 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.0 -89.47 0.14 Allowed Glycine 0 CA--C 1.537 1.418 0 C-N-CA 126.246 1.879 . . . . 0.0 111.246 -169.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 28.2 p -161.76 131.86 4.84 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.752 1.621 . . . . 0.0 110.87 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.499 ' HG1' ' HG ' ' A' ' 107' ' ' CYS . 46.1 m -98.98 133.18 43.61 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.556 0.693 . . . . 0.0 109.138 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mt -105.21 129.38 58.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.359 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -105.48 117.51 34.21 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.726 ' C ' HD13 ' A' ' 116' ' ' ILE . 15.6 m -110.14 117.69 34.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.51 0.671 . . . . 0.0 110.647 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.902 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -98.59 135.53 33.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 123.635 0.774 . . . . 0.0 110.293 -177.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.5 m -103.0 141.1 36.38 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.81 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.682 ' CD2' HG21 ' A' ' 2' ' ' VAL . 2.2 t60 -136.3 93.88 2.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 0.0 110.905 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.818 ' C ' HG23 ' A' ' 2' ' ' VAL . 3.3 m-85 -92.8 100.31 12.81 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.997 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -92.55 101.06 13.49 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.577 HG21 ' HA ' ' A' ' 126' ' ' GLU . 18.6 p -97.1 168.67 10.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.754 0.788 . . . . 0.0 112.033 -177.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -112.35 152.69 28.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.03 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . 34.13 -108.91 0.05 OUTLIER Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.599 ' H ' HD22 ' A' ' 124' ' ' ASN . 0.0 OUTLIER -105.76 -4.84 20.42 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.662 -0.317 . . . . 0.0 111.442 178.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.479 ' N ' HD22 ' A' ' 124' ' ' ASN . 1.4 mp -47.96 152.79 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.577 ' HA ' HG21 ' A' ' 121' ' ' THR . 35.2 mt-10 -149.41 148.79 29.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.175 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.4 mm -87.62 124.77 41.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.45 ' HG3' ' H ' ' A' ' 129' ' ' GLU . 3.8 tptm -75.31 159.53 31.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.301 0.572 . . . . 0.0 111.908 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.45 ' H ' ' HG3' ' A' ' 128' ' ' LYS . 18.4 mm-40 -71.2 -35.41 71.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.938 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.448 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 8.0 pt-20 -67.87 -34.2 76.23 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.753 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -68.33 -49.04 63.09 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.154 0.502 . . . . 0.0 110.756 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.401 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 5.5 m -73.38 -22.34 19.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.805 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 57.4 mttt -66.92 -46.21 75.49 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 122.171 -0.33 . . . . 0.0 110.792 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.448 ' CG2' ' O ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -70.51 -44.94 76.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.667 0.27 . . . . 0.0 110.458 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.82 -47.01 69.38 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 0.1 OUTLIER -67.05 -47.01 72.65 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 122.485 -0.42 . . . . 0.0 110.316 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -54.04 -39.69 66.42 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.493 ' NZ ' ' O ' ' A' ' 37' ' ' ALA . 5.0 tttm -69.31 -53.83 17.65 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.12 -42.3 38.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.645 0.736 . . . . 0.0 110.251 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 51.4 t60 -64.09 -36.6 84.57 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.185 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.84 -41.73 99.31 Favored Glycine 0 C--O 1.222 -0.606 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -70.71 -40.3 72.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.511 ' CD2' ' O ' ' A' ' 143' ' ' PHE . 2.3 t80 -61.29 -28.17 69.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -69.32 -40.98 77.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.063 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.791 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.4 mm? -64.76 -56.74 11.75 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.722 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.642 ' O ' HD22 ' A' ' 150' ' ' LEU . 85.1 mt -54.78 -51.07 55.65 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.991 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 8.8 tt0 -47.66 -57.33 5.63 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.212 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 58.2 m -52.49 -43.78 65.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.139 0.495 . . . . 0.0 111.065 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.664 ' HB2' HD13 ' A' ' 33' ' ' ILE . 56.7 t80 -55.31 -47.67 75.26 Favored 'General case' 0 C--O 1.2 -1.546 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.895 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.0 mm? -68.55 -43.02 77.52 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 119.836 1.198 . . . . 0.0 112.06 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 147' ' ' GLU . 0.4 OUTLIER -62.09 -24.05 66.88 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 121.375 -0.828 . . . . 0.0 109.267 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -107.17 -13.32 15.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.607 0.717 . . . . 0.0 110.585 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.616 ' N ' ' O ' ' A' ' 149' ' ' TYR . 1.1 t-80 -154.97 65.61 4.69 Favored Pre-proline 0 C--N 1.309 -1.159 0 C-N-CA 124.723 1.209 . . . . 0.0 109.883 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.527 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 53.0 Cg_endo -74.38 -3.47 13.89 Favored 'Trans proline' 0 C--O 1.204 -1.176 0 C-N-CA 122.698 2.266 . . . . 0.0 111.392 -177.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.606 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 1.0 OUTLIER -81.39 4.3 21.34 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 123.009 0.524 . . . . 0.0 112.032 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -50.07 130.17 21.9 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 119.877 -1.764 . . . . 0.0 111.381 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.603 ' CG ' HD13 ' A' ' 24' ' ' LEU . 1.3 t80 54.48 6.32 0.11 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.476 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.606 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.414 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.237 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.865 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.4 p . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.907 0.384 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.412 ' HB2' ' CD1' ' A' ' 119' ' ' TYR . 7.7 m-85 -99.28 111.52 23.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.617 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.4 m -96.32 139.99 31.64 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.632 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.539 ' CD1' ' ND2' ' A' ' 7' ' ' ASN . 57.0 t80 -136.84 134.14 36.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.612 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.48 ' C ' HD22 ' A' ' 7' ' ' ASN . 3.0 mt-10 -103.33 128.83 50.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.0 0.429 . . . . 0.0 111.078 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.555 ' ND2' ' N ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -138.47 162.93 33.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.087 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.76 160.14 40.05 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.472 ' CE2' ' O ' ' A' ' 10' ' ' THR . 55.3 t80 -147.61 141.14 25.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.44 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.472 ' O ' ' CE2' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -93.14 148.63 21.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.726 0.298 . . . . 0.0 111.275 -179.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -143.91 154.35 43.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.775 0.321 . . . . 0.0 110.718 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -99.92 26.76 6.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.042 0.449 . . . . 0.0 110.634 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.472 ' HB ' HD21 ' A' ' 18' ' ' LEU . 2.2 mt -113.74 131.6 22.99 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.317 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -48.89 141.24 22.0 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.148 1.232 . . . . 0.0 110.797 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.552 ' HA ' HD12 ' A' ' 18' ' ' LEU . 9.4 Cg_endo -60.1 -23.57 73.93 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 122.365 2.043 . . . . 0.0 112.925 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.456 ' HB2' HH21 ' A' ' 17' ' ' ARG . 69.4 m -70.14 -30.56 67.76 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.456 HH21 ' HB2' ' A' ' 16' ' ' SER . 25.3 mmt-85 -79.43 -54.38 5.98 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.552 HD12 ' HA ' ' A' ' 15' ' ' PRO . 6.4 mt -48.57 -45.87 38.39 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.584 ' HD2' ' HH ' ' A' ' 81' ' ' TYR . 11.8 t80 -49.29 -57.79 6.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.22 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -67.37 -25.42 65.96 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.363 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.763 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -84.02 -2.58 56.9 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.563 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.469 ' CA ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -117.31 -10.94 10.66 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 117.917 0.326 . . . . 0.0 111.828 -179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.845 HG23 HD13 ' A' ' 24' ' ' LEU . 3.1 m -137.35 -34.61 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.868 HD23 ' CD1' ' A' ' 157' ' ' TYR . 2.4 mp -89.92 -53.47 4.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.824 0.738 . . . . 0.0 111.889 -176.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 93.8 m-20 -112.91 -4.01 14.01 Favored 'General case' 0 C--O 1.216 -0.659 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -53.67 -43.88 69.21 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.474 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 2.0 m-20 -83.34 18.7 1.7 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.212 0.529 . . . . 0.0 110.712 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 27' ' ' ASP . 4.5 m120 -139.37 -8.8 1.28 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 149' ' ' TYR . 0.8 OUTLIER -92.38 -30.31 15.86 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.156 -178.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.506 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.52 -54.53 47.6 Favored Pre-proline 0 C--O 1.214 -0.787 0 O-C-N 122.2 -0.313 . . . . 0.0 111.419 -179.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 18.3 Cg_endo -62.82 -25.52 74.59 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.894 1.729 . . . . 0.0 112.721 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -68.22 -59.74 2.99 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.836 0.827 . . . . 0.0 111.814 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.765 HD12 ' HB3' ' A' ' 145' ' ' LEU . 1.3 pt -95.95 -35.53 5.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.38 -176.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.781 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.36 65.24 0.14 Allowed Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 72.9 Cg_endo -76.55 -27.17 7.83 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 121.699 1.599 . . . . 0.0 108.474 175.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -74.2 -43.65 56.36 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.633 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.781 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -73.87 -78.6 0.09 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.099 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.8 mm -99.43 144.85 11.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 121.328 0.585 . . . . 0.0 110.017 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -78.42 -53.52 7.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.725 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.407 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -178.18 167.6 1.95 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.238 0.542 . . . . 0.0 110.597 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.407 ' H ' ' HG2' ' A' ' 40' ' ' GLN . . . -165.89 143.87 5.72 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.88 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -140.84 143.86 35.0 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.862 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.2 137.25 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 121.646 0.736 . . . . 0.0 111.823 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.4 mp -87.11 -38.77 16.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.188 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.88 ' O ' HG23 ' A' ' 52' ' ' THR . 54.9 mt-10 -148.24 136.83 21.56 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.09 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.09 -155.28 21.85 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.649 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -141.13 -5.6 1.11 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 122.894 0.477 . . . . 0.0 110.941 -178.4 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.577 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 131.96 10.84 2.17 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.06 -172.84 19.15 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 117.114 0.457 . . . . 0.0 111.977 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -60.13 127.1 22.04 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 C-N-CA 122.732 2.288 . . . . 0.0 113.356 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.86 2.97 55.13 Favored Glycine 0 CA--C 1.507 -0.439 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.88 HG23 ' O ' ' A' ' 45' ' ' GLU . 88.8 m -94.3 134.76 36.44 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.265 -0.967 . . . . 0.0 111.368 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -122.67 122.3 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.862 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -131.99 151.39 51.77 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 122.83 1.3 . . . . 0.0 110.684 178.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.525 ' N ' ' HD2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -117.57 137.57 52.5 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.318 -1.764 . . . . 0.0 112.966 -177.365 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.9 mm -90.19 140.76 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 64.3 m -110.5 117.33 33.28 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -108.89 166.17 11.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.918 0.39 . . . . 0.0 110.82 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.0 144.44 49.5 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.24 -47.21 86.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.805 0.336 . . . . 0.0 110.785 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.71 61.42 3.47 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.7 m -142.91 178.37 7.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.831 0.348 . . . . 0.0 110.677 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -64.11 -50.43 68.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.923 0.392 . . . . 0.0 110.723 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.83 156.38 17.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.375 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -119.57 -61.41 0.26 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -145.37 155.04 42.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.825 0.345 . . . . 0.0 110.573 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 87' ' ' GLU . 2.4 p -156.02 153.75 7.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.77 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.507 ' CB ' HD11 ' A' ' 86' ' ' ILE . 3.5 mptp? -104.87 110.97 23.55 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.53 0.681 . . . . 0.0 111.631 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -103.32 113.51 27.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.84 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -105.75 131.54 52.98 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.022 0.439 . . . . 0.0 111.735 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.5 mt -85.42 145.26 8.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.373 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -102.55 -54.89 2.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.7 m -165.88 142.21 5.17 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 45.6 mt -123.05 130.62 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.355 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.2 m-20 -115.25 87.95 2.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.505 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -54.82 -30.29 56.92 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.509 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.85 -38.84 70.62 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.175 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.1 p -108.36 -11.09 15.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.117 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.53 ' N ' ' O ' ' A' ' 75' ' ' ASP . 6.6 m-85 63.17 40.89 8.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.877 -0.515 . . . . 0.0 109.925 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.499 ' C ' ' CD2' ' A' ' 81' ' ' TYR . 6.0 p -109.22 138.65 45.25 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.857 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.584 ' HH ' ' HD2' ' A' ' 19' ' ' PHE . 0.1 OUTLIER -132.13 133.57 44.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.723 0.297 . . . . 0.0 110.375 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 p -127.29 129.76 48.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.878 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -144.15 158.71 43.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.217 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 98' ' ' ILE . 9.7 m -147.65 141.85 26.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.119 0.485 . . . . 0.0 111.2 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.659 HD13 ' HB1' ' A' ' 90' ' ' ALA . 9.7 mt -80.6 120.63 24.8 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.507 HD11 ' CB ' ' A' ' 68' ' ' LYS . 3.8 pt -80.58 -44.98 21.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.808 0.337 . . . . 0.0 111.836 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.475 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 23.5 tt0 -156.74 172.26 18.92 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.591 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.95 178.12 17.83 Favored Glycine 0 CA--C 1.508 -0.357 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -61.37 1.13 0.22 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.659 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -67.55 -34.3 76.8 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 123.948 0.899 . . . . 0.0 109.963 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.89 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.52 16.38 21.56 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.692 0.797 . . . . 0.0 109.583 -177.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.8 p 49.48 -126.45 2.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -130.75 -12.9 3.75 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.091 -0.381 . . . . 0.0 111.217 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.0 -6.62 19.88 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.718 HG21 ' CD1' ' A' ' 98' ' ' ILE . 68.5 mt -99.13 152.36 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -176.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.507 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -90.32 -56.78 3.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.249 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -171.91 150.48 2.6 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.099 0.476 . . . . 0.0 110.867 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.718 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.52 125.08 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.473 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 0.7 OUTLIER -105.67 144.5 32.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.006 0.432 . . . . 0.0 112.054 -178.084 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.504 ' CZ ' ' OG ' ' A' ' 117' ' ' SER . 4.8 m-85 -140.2 128.21 22.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.531 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -129.32 133.6 47.52 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.5 OUTLIER -135.55 131.49 36.03 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.9 -0.5 . . . . 0.0 110.45 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.608 ' C ' HD23 ' A' ' 104' ' ' LEU . 7.1 ttpm? -123.16 134.77 54.16 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.772 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.53 126.53 44.13 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -125.59 137.14 58.64 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.572 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.486 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -72.62 133.88 44.88 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.873 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.405 ' N ' ' HA ' ' A' ' 111' ' ' SER . 7.1 t -121.22 175.2 6.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.128 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.66 -37.28 67.61 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.2 m -87.32 -6.15 58.62 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.793 1.296 . . . . 0.0 114.327 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 152.91 -88.48 0.13 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.671 1.129 . . . . 0.0 111.808 -174.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 85.5 p -161.98 131.91 4.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.547 1.939 . . . . 0.0 110.715 177.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.2 m -99.17 119.15 37.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.7 mt -91.13 128.95 42.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.36 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 102' ' ' THR . 4.1 mttm -105.45 117.17 33.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.745 ' C ' HD13 ' A' ' 116' ' ' ILE . 69.6 m -110.84 121.21 44.78 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 121.459 0.647 . . . . 0.0 111.119 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.945 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -101.9 136.4 34.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 123.457 0.703 . . . . 0.0 109.571 -177.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.504 ' OG ' ' CZ ' ' A' ' 100' ' ' TYR . 23.7 t -118.29 132.36 56.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.651 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.473 ' ND1' ' O ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -137.28 113.71 10.14 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.505 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.865 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -102.41 102.53 12.87 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.448 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.463 ' CE1' ' CD ' ' A' ' 96' ' ' GLU . 11.6 t-160 -92.0 109.47 20.82 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.233 0.539 . . . . 0.0 110.246 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.432 HG22 HD11 ' A' ' 127' ' ' ILE . 12.6 p -99.65 172.52 7.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.611 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -112.2 143.53 43.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.871 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 54.94 -112.79 3.07 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.492 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.9 OUTLIER -112.9 -1.89 14.46 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.342 -0.504 . . . . 0.0 111.171 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -43.5 160.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.048 0.451 . . . . 0.0 110.614 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.481 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 92.8 mt-10 -148.21 144.28 27.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.038 0.447 . . . . 0.0 111.177 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.432 HD11 HG22 ' A' ' 121' ' ' THR . 19.9 mm -89.1 125.29 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -74.68 161.18 29.9 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.669 0.747 . . . . 0.0 111.837 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -70.29 -32.14 69.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.418 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.429 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 43.3 mm-40 -70.12 -33.57 71.99 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.746 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -67.33 -51.26 54.6 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.33 0.586 . . . . 0.0 110.629 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.5 m -71.93 -21.53 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.79 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -66.45 -46.56 76.01 Favored 'General case' 0 C--O 1.223 -0.328 0 O-C-N 122.276 -0.265 . . . . 0.0 110.892 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -70.38 -51.15 40.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.726 0.298 . . . . 0.0 110.5 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.78 -47.05 93.14 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -67.96 -47.44 68.63 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 122.616 -0.343 . . . . 0.0 110.916 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -55.32 -47.06 76.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.78 0.324 . . . . 0.0 110.549 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -69.37 -50.2 48.34 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.401 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.31 -41.97 39.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.535 0.683 . . . . 0.0 110.528 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -36.4 84.22 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -61.64 -31.17 76.9 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.42 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -74.18 -47.18 37.34 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.27 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.491 ' CD2' ' N ' ' A' ' 143' ' ' PHE . 1.6 m-30 -59.89 -21.88 61.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -72.52 -41.82 65.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.85 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.765 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.44 -56.53 11.94 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.893 179.3 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.701 ' O ' HD22 ' A' ' 150' ' ' LEU . 76.9 mt -53.24 -50.33 47.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.495 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -47.06 -57.02 5.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.751 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.5 t -50.35 -44.95 54.72 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.469 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.685 ' HB2' HD13 ' A' ' 33' ' ' ILE . 20.0 t80 -57.33 -48.77 78.13 Favored 'General case' 0 C--O 1.18 -2.581 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.846 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.7 mm? -65.1 -42.15 94.27 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 120.449 -1.407 . . . . 0.0 111.974 -177.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.5 OUTLIER -62.59 -25.25 67.98 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.407 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -107.26 -12.24 15.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.016 0.436 . . . . 0.0 110.687 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.651 ' N ' ' O ' ' A' ' 149' ' ' TYR . 49.5 m-70 -155.54 66.32 4.63 Favored Pre-proline 0 C--N 1.308 -1.215 0 C-N-CA 125.616 1.566 . . . . 0.0 110.411 -177.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.413 ' HB2' ' HE ' ' A' ' 17' ' ' ARG . 44.7 Cg_endo -72.13 -3.27 12.97 Favored 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 122.662 2.241 . . . . 0.0 111.843 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.616 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 1.5 p30 -77.1 3.07 13.34 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.073 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.532 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . . . -50.51 128.79 20.97 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 119.328 -2.108 . . . . 0.0 111.352 -178.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.868 ' CD1' HD23 ' A' ' 24' ' ' LEU . 16.5 t80 54.71 7.04 0.14 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.275 0.63 . . . . 0.0 112.137 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.616 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.278 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.823 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.2 p . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.074 0.464 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -97.77 110.29 22.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.721 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.7 m -96.97 140.45 31.49 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.577 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.95 134.7 26.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.368 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.511 ' HG2' HD12 ' A' ' 116' ' ' ILE . 3.1 mt-10 -102.4 129.69 48.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.582 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -126.71 168.67 14.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.172 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.13 146.98 22.04 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -145.64 140.71 27.52 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.302 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -107.49 147.93 29.85 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 111.804 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.5 t -145.87 162.73 37.07 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.548 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -98.77 24.92 7.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.406 . . . . 0.0 110.931 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.51 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.9 mt -108.57 127.69 26.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.2 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -46.98 144.69 8.06 Favored 'Trans proline' 0 C--N 1.327 -0.571 0 C-N-CA 121.16 1.24 . . . . 0.0 110.743 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 10.9 Cg_endo -61.02 -24.51 79.72 Favored 'Trans proline' 0 C--N 1.322 -0.843 0 C-N-CA 122.337 2.025 . . . . 0.0 113.031 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.2 m -71.01 -30.3 66.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -75.05 -56.41 4.77 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.51 HD21 ' HB ' ' A' ' 13' ' ' ILE . 3.7 mt -51.18 -45.0 61.65 Favored 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.485 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.656 ' O ' HG22 ' A' ' 23' ' ' VAL . 47.0 t80 -46.44 -58.96 3.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.727 ' CB ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -68.28 -41.56 80.83 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 119.023 -1.071 . . . . 0.0 108.484 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.831 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -65.01 -2.47 2.72 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.236 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 2.6 t80 -119.14 -8.71 10.12 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 19' ' ' PHE . 30.8 m -131.88 -51.27 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.0 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.7 pp -96.4 -31.28 12.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 1.0 ' N ' HD12 ' A' ' 24' ' ' LEU . 45.5 m-20 -114.63 -5.09 12.74 Favored 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 118.439 0.563 . . . . 0.0 111.506 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.697 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -68.56 -44.05 75.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.453 0.644 . . . . 0.0 112.289 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.46 18.15 2.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.882 0.849 . . . . 0.0 109.648 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.41 ' H ' ' H ' ' A' ' 29' ' ' LEU . 64.9 m-20 -139.55 -8.31 1.27 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.578 -1.192 . . . . 0.0 107.843 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.823 HD21 ' CD2' ' A' ' 149' ' ' TYR . 0.8 OUTLIER -96.21 -48.37 5.66 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.0 -178.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.525 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 85.2 mt -54.54 -43.22 97.8 Favored Pre-proline 0 C--O 1.212 -0.916 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.146 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 16.6 Cg_exo -64.46 -25.58 63.1 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.785 1.657 . . . . 0.0 110.97 177.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.02 -57.93 4.42 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.712 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.692 ' HB ' HD12 ' A' ' 145' ' ' LEU . 0.7 OUTLIER -96.54 -32.66 4.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.779 -176.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.816 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -103.83 63.22 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.513 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 72.6 Cg_endo -75.57 -20.97 15.28 Favored 'Trans proline' 0 C--N 1.32 -0.924 0 N-CA-C 107.063 -1.937 . . . . 0.0 107.063 174.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -73.42 -44.02 59.23 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.76 177.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.816 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -73.75 -75.02 0.16 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.266 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.9 mt -98.73 145.9 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 121.046 0.45 . . . . 0.0 110.204 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.83 -51.65 10.14 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.672 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.675 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 50.7 tp60 -177.3 164.62 2.18 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.958 0.409 . . . . 0.0 110.424 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.675 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -166.02 145.21 6.06 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 120.89 0.376 . . . . 0.0 110.889 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -145.09 145.25 31.35 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.666 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -76.52 139.88 18.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.57 0.7 . . . . 0.0 110.995 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 mp -89.68 -39.27 13.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.963 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.886 ' O ' HG23 ' A' ' 52' ' ' THR . 30.2 mt-10 -147.19 136.66 22.75 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.542 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.39 -156.06 22.52 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.61 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -142.5 1.48 1.37 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 122.456 -0.437 . . . . 0.0 111.343 -178.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.479 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 127.27 12.27 3.18 Favored Glycine 0 C--O 1.218 -0.864 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.45 -171.68 19.89 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 117.298 0.549 . . . . 0.0 111.905 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -61.86 125.94 17.74 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 C-N-CA 122.68 2.253 . . . . 0.0 113.028 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.76 5.07 56.76 Favored Glycine 0 N--CA 1.464 0.537 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.886 HG23 ' O ' ' A' ' 45' ' ' GLU . 91.4 m -93.66 137.91 32.43 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.379 -0.911 . . . . 0.0 110.959 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.55 130.14 72.91 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.666 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -114.52 140.0 49.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.608 0.718 . . . . 0.0 110.761 179.144 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.474 ' C ' HD12 ' A' ' 56' ' ' ILE . 41.1 tttm -118.37 123.15 44.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.7 178.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.758 ' N ' HD12 ' A' ' 56' ' ' ILE . 1.8 mp -104.32 123.75 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.6 m -101.42 118.43 36.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.075 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -92.72 -176.74 4.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.72 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.429 ' O ' ' OG ' ' A' ' 62' ' ' SER . . . -71.64 144.45 37.02 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.99 -47.94 84.12 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.991 -0.711 . . . . 0.0 111.073 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.92 61.93 3.34 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 59' ' ' GLY . 0.3 OUTLIER -152.37 174.97 13.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.171 0.51 . . . . 0.0 110.383 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.706 ' NE2' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -65.09 -37.57 87.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.818 0.342 . . . . 0.0 110.603 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -98.76 140.38 33.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.378 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.415 ' O ' ' CD2' ' A' ' 66' ' ' TYR . . . -123.12 -56.2 0.19 Allowed Glycine 0 N--CA 1.461 0.363 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.415 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -145.82 151.35 37.77 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.772 0.32 . . . . 0.0 110.193 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 p -156.71 147.51 11.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.931 0.396 . . . . 0.0 110.945 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -104.81 108.06 19.35 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.298 0.57 . . . . 0.0 110.954 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.531 ' NE2' ' CD2' ' A' ' 83' ' ' TYR . 7.9 t60 -103.06 112.42 25.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.631 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -101.6 131.22 47.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 111.824 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.0 mt -83.08 137.23 21.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -96.71 -56.35 2.61 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.2 m -166.01 142.31 5.07 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.471 HD12 ' O ' ' A' ' 48' ' ' GLY . 30.2 mt -123.93 131.15 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.885 176.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.587 ' O ' ' N ' ' A' ' 79' ' ' TYR . 27.1 m-20 -115.53 87.74 2.73 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.487 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 6.6 pt-20 -54.57 -30.12 53.33 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.08 73.52 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.6 m -108.2 -9.82 15.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.007 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.587 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.3 m-85 62.63 48.28 4.42 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 121.393 -0.817 . . . . 0.0 110.236 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -106.66 143.76 34.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.346 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.527 ' CE1' ' CD1' ' A' ' 83' ' ' TYR . 26.3 t80 -132.16 117.94 18.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.683 0.278 . . . . 0.0 110.253 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -127.5 137.65 52.71 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.112 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.531 ' CD2' ' NE2' ' A' ' 69' ' ' HIS . 12.5 p90 -146.11 163.86 33.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.069 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 98' ' ' ILE . 4.3 m -146.57 135.68 22.59 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.05 0.452 . . . . 0.0 110.821 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.626 HD13 ' HB1' ' A' ' 90' ' ' ALA . 7.0 mt -79.76 116.55 19.99 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.602 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -82.76 -41.78 17.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.829 -177.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.602 ' N ' HD13 ' A' ' 86' ' ' ILE . 32.7 tt0 -153.8 171.52 18.79 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.09 -0.381 . . . . 0.0 110.586 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.599 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.19 177.54 18.71 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.78 2.1 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.626 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -66.09 -34.4 77.97 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.107 0.963 . . . . 0.0 110.239 177.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.892 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.26 14.7 22.68 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 123.543 0.737 . . . . 0.0 109.608 -177.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.461 ' CG2' ' NE2' ' A' ' 131' ' ' HIS . 68.8 p 46.96 -126.24 1.58 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -130.35 -11.14 4.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.106 0.479 . . . . 0.0 110.913 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.3 -7.55 18.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.724 HG21 ' CD1' ' A' ' 98' ' ' ILE . 90.7 mt -98.74 152.51 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 121.941 0.877 . . . . 0.0 113.259 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.509 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -90.86 -55.23 3.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.343 177.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.43 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 2.5 ptmm? -172.79 149.82 2.03 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.782 0.325 . . . . 0.0 110.84 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.724 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.29 125.42 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.041 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.34 144.49 43.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.925 0.393 . . . . 0.0 111.665 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -136.82 136.37 38.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.705 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -131.15 132.41 44.75 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -139.13 133.98 32.22 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.962 -0.461 . . . . 0.0 110.945 -178.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.56 ' C ' HD23 ' A' ' 104' ' ' LEU . 25.9 ttpp -121.26 134.64 55.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.774 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -97.62 126.01 42.69 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.358 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.95 136.99 58.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.609 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -73.03 135.37 44.89 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.751 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.55 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 53.8 t -120.92 171.13 8.86 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.55 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -54.25 -35.7 55.77 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.3 p -89.69 -8.48 52.28 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.327 -1.69 . . . . 0.0 114.694 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 159.32 -85.44 0.12 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.069 1.318 . . . . 0.0 111.958 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 87.9 p -163.79 132.1 3.66 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.888 1.675 . . . . 0.0 110.961 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 78.8 m -99.28 118.24 35.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 61.9 mt -92.38 128.24 44.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.842 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 102' ' ' THR . 6.1 mtpt -105.42 116.68 32.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.799 ' C ' HD13 ' A' ' 116' ' ' ILE . 13.0 t -111.62 124.85 53.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.276 0.56 . . . . 0.0 111.101 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.914 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -106.04 136.43 40.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 123.25 0.62 . . . . 0.0 109.749 -177.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.1 m -113.18 133.09 55.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.982 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -137.08 105.35 5.72 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 120.83 0.348 . . . . 0.0 110.405 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.823 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -101.69 103.39 14.17 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.081 -0.387 . . . . 0.0 110.045 179.201 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -90.91 107.88 19.49 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.226 0.536 . . . . 0.0 109.879 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.2 p -99.38 176.01 5.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.602 0.715 . . . . 0.0 111.442 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -112.31 146.12 38.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.432 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 54.21 -111.69 2.17 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.599 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -117.67 3.68 12.34 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.345 -0.503 . . . . 0.0 111.01 -179.575 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.463 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -45.85 160.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.941 0.4 . . . . 0.0 110.43 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.463 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 36.5 mt-10 -149.39 148.51 29.55 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.916 0.388 . . . . 0.0 111.267 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.408 HG13 ' CB ' ' A' ' 119' ' ' TYR . 3.5 mm -89.3 125.38 42.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.44 ' HG3' ' H ' ' A' ' 129' ' ' GLU . 18.6 tptt -74.45 160.33 31.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.157 0.503 . . . . 0.0 111.56 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.44 ' H ' ' HG3' ' A' ' 128' ' ' LYS . 49.8 mt-10 -70.09 -34.05 72.67 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.488 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 134' ' ' VAL . 1.8 mp0 -69.9 -27.79 65.09 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.461 ' NE2' ' CG2' ' A' ' 92' ' ' THR . 10.2 t-80 -72.89 -48.1 40.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.313 0.577 . . . . 0.0 110.87 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.8 m -79.76 -32.06 14.1 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.98 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -64.19 -46.18 85.1 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.216 -0.302 . . . . 0.0 110.721 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.564 HG23 ' N ' ' A' ' 135' ' ' GLY . 25.8 m -70.26 -47.71 65.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.62 0.248 . . . . 0.0 110.453 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.564 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -62.73 -41.44 99.84 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -66.84 -46.25 75.68 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.751 -0.264 . . . . 0.0 110.684 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -54.28 -47.08 72.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 110.059 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 141' ' ' GLY . 22.8 tttp -64.58 -54.88 25.07 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.432 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -48.46 -40.78 27.47 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.698 0.761 . . . . 0.0 110.467 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.437 ' O ' ' ND1' ' A' ' 140' ' ' HIS . 0.6 OUTLIER -61.51 -36.49 80.67 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.958 0.885 . . . . 0.0 109.203 178.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' LYS . . . -62.68 -35.55 92.04 Favored Glycine 0 C--O 1.223 -0.54 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -66.9 -45.8 76.86 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.996 -0.708 . . . . 0.0 109.116 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -59.0 -30.1 67.73 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -64.83 -39.54 93.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.418 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.692 HD12 ' HB ' ' A' ' 33' ' ' ILE . 1.1 mm? -68.12 -56.99 6.81 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.174 0.511 . . . . 0.0 110.263 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.752 HG23 HD13 ' A' ' 29' ' ' LEU . 61.1 mt -57.91 -51.89 64.94 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.977 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -48.2 -56.84 6.91 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.814 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.7 t -51.75 -42.96 62.74 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.421 0.629 . . . . 0.0 110.141 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.823 ' CD2' HD21 ' A' ' 29' ' ' LEU . 8.6 t80 -55.69 -51.94 65.56 Favored 'General case' 0 C--O 1.178 -2.678 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.841 ' H ' HD22 ' A' ' 150' ' ' LEU . 2.0 mm? -64.38 -43.02 95.8 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.239 -1.538 . . . . 0.0 111.883 -177.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -62.65 -24.33 67.56 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.531 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 149' ' ' TYR . 0.0 OUTLIER -106.98 -13.27 15.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.15 0.5 . . . . 0.0 110.657 178.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.641 ' N ' ' O ' ' A' ' 149' ' ' TYR . 42.7 m80 -155.39 66.31 4.7 Favored Pre-proline 0 C--N 1.305 -1.365 0 C-N-CA 125.944 1.697 . . . . 0.0 110.275 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.74 -3.35 13.59 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 122.7 2.267 . . . . 0.0 111.582 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.645 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 5.4 p30 -77.96 4.07 13.05 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.433 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.427 ' O ' ' CD ' ' A' ' 20' ' ' LYS . . . -50.13 129.08 20.46 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 119.038 -2.289 . . . . 0.0 111.343 -178.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.507 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 36.9 t80 53.5 6.32 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.203 0.525 . . . . 0.0 112.219 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.645 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.091 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.833 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.2 p . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 120.745 0.307 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -98.33 110.23 22.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.321 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.514 HG23 ' NE2' ' A' ' 118' ' ' HIS . 68.8 m -96.13 134.3 39.37 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.794 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -133.55 131.05 39.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.468 ' C ' HD22 ' A' ' 7' ' ' ASN . 1.7 tt0 -102.97 126.7 50.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.881 0.372 . . . . 0.0 110.945 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.468 HD22 ' C ' ' A' ' 6' ' ' GLU . 2.1 m-80 -135.63 167.3 21.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.968 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -156.14 159.24 38.85 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -146.21 140.87 26.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.219 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.4 m -109.41 147.41 32.84 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.937 0.398 . . . . 0.0 111.831 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 t -145.68 154.76 42.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.432 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -87.86 25.44 1.53 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.124 0.488 . . . . 0.0 110.982 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.508 ' HB ' HD21 ' A' ' 18' ' ' LEU . 2.4 mt -108.55 126.84 28.63 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.651 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -46.08 148.38 2.98 Favored 'Trans proline' 0 C--N 1.325 -0.675 0 C-N-CA 121.161 1.241 . . . . 0.0 110.857 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.709 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 18.1 Cg_endo -64.86 -24.35 61.26 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 122.553 2.169 . . . . 0.0 112.915 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.565 ' CB ' HH11 ' A' ' 17' ' ' ARG . 66.3 m -70.51 -29.64 66.2 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.565 HH11 ' CB ' ' A' ' 16' ' ' SER . 0.4 OUTLIER -75.88 -56.63 4.49 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 15' ' ' PRO . 3.2 mt -48.38 -48.84 36.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.784 ' O ' HG22 ' A' ' 23' ' ' VAL . 40.2 t80 -44.66 -60.0 2.22 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.704 178.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.624 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -70.99 -24.89 62.48 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.213 -0.93 . . . . 0.0 110.787 -179.277 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.852 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -79.45 -14.37 58.96 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.808 -177.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.604 ' CE2' HD11 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -116.45 -6.52 11.72 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.595 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.858 HG23 ' CD1' ' A' ' 24' ' ' LEU . 3.0 m -129.99 -36.7 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.858 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.9 mp -92.55 -53.96 3.98 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.19 0.904 . . . . 0.0 112.206 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.82 16.42 20.45 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.547 ' HB2' ' HA ' ' A' ' 22' ' ' PHE . . . -66.08 -43.2 88.05 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 121.062 0.458 . . . . 0.0 111.128 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.04 21.17 1.09 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.073 0.939 . . . . 0.0 110.501 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.426 ' H ' ' H ' ' A' ' 29' ' ' LEU . 4.2 m120 -139.46 -8.85 1.27 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.633 HD13 ' CD1' ' A' ' 149' ' ' TYR . 0.0 OUTLIER -94.43 -38.21 11.06 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.418 -1.719 . . . . 0.0 111.004 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.538 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.4 mm -55.38 -44.25 99.54 Favored Pre-proline 0 C--O 1.21 -0.986 0 CA-C-O 120.954 0.407 . . . . 0.0 111.928 -178.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 22.9 Cg_exo -63.1 -25.85 73.21 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.409 2.073 . . . . 0.0 113.304 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -83.28 -55.62 4.23 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.099 0.476 . . . . 0.0 112.27 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.64 HD13 ' HB3' ' A' ' 145' ' ' LEU . 0.8 OUTLIER -95.09 -38.31 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.54 -177.06 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.594 ' CA ' ' HG ' ' A' ' 145' ' ' LEU . . . -108.38 61.36 0.24 Allowed Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.493 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 87.9 Cg_endo -79.23 -28.94 3.41 Favored 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 121.812 1.675 . . . . 0.0 109.19 175.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -74.98 -42.58 57.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.258 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.576 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -69.07 -74.89 0.12 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.282 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.27 146.36 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.858 0.361 . . . . 0.0 110.071 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -78.12 -50.23 12.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.211 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.712 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 54.8 tp60 -176.36 165.74 2.75 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.918 0.389 . . . . 0.0 110.469 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.737 ' HB1' ' HE2' ' A' ' 54' ' ' LYS . . . -165.51 147.85 7.64 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.232 0.539 . . . . 0.0 110.583 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.858 ' C ' ' HZ1' ' A' ' 54' ' ' LYS . 23.2 pt-20 -148.09 140.88 24.68 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.099 -0.375 . . . . 0.0 110.764 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.501 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -76.72 140.29 17.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.391 0.615 . . . . 0.0 110.415 -179.079 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.69 -40.01 13.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.173 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.934 ' O ' HG23 ' A' ' 52' ' ' THR . 21.0 mt-10 -140.98 133.84 29.0 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.749 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.21 -156.68 36.0 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.649 HD22 ' N ' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -136.38 -7.38 1.99 Allowed 'General case' 0 C--N 1.321 -0.642 0 O-C-N 122.535 -0.391 . . . . 0.0 111.108 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.649 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 142.71 14.89 0.33 Allowed Glycine 0 C--O 1.22 -0.747 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.68 -170.76 20.3 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 117.236 0.518 . . . . 0.0 111.929 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -61.57 125.8 17.6 Favored 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 122.787 2.325 . . . . 0.0 113.373 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.22 6.01 59.08 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.934 HG23 ' O ' ' A' ' 45' ' ' GLU . 60.0 m -93.81 140.52 29.57 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.147 -1.027 . . . . 0.0 111.45 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -121.9 129.76 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.858 ' HZ1' ' C ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -114.48 138.3 50.77 Favored 'General case' 0 C--O 1.22 -0.449 0 O-C-N 123.288 0.368 . . . . 0.0 110.689 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -120.6 125.75 48.55 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.148 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -103.47 140.63 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.263 178.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.435 HG23 ' CE2' ' A' ' 66' ' ' TYR . 38.5 m -118.83 119.65 35.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.518 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -92.5 -178.59 4.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.902 0.382 . . . . 0.0 110.685 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.26 143.81 29.77 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.466 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 9.1 pt-20 -59.73 -46.57 88.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 0.0 110.864 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.466 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -100.65 61.67 0.62 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.404 ' OG ' ' N ' ' A' ' 63' ' ' GLN . 22.8 t -138.04 177.06 8.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.025 0.44 . . . . 0.0 110.79 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.404 ' N ' ' OG ' ' A' ' 62' ' ' SER . 6.6 mm-40 -60.98 -54.19 48.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 110.842 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.55 151.9 20.54 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.73 -61.72 0.22 Allowed Glycine 0 CA--C 1.52 0.349 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.435 ' CE2' HG23 ' A' ' 57' ' ' THR . 5.0 m-85 -145.6 151.33 37.93 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.811 0.338 . . . . 0.0 110.892 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 p -149.24 138.3 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.852 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.537 ' O ' HG13 ' A' ' 86' ' ' ILE . 10.1 mtpp -107.38 116.5 32.04 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 121.623 0.725 . . . . 0.0 112.187 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.646 ' N ' ' ND1' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -112.9 123.58 50.64 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -98.82 126.61 44.52 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.149 0.499 . . . . 0.0 111.532 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.455 HD12 HG22 ' A' ' 52' ' ' THR . 33.9 mt -79.94 136.09 24.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.374 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.4 ' O ' ' OG ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -97.27 -55.78 2.74 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -177.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 3.3 m -165.29 141.77 5.57 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 48' ' ' GLY . 12.6 mt -120.69 131.1 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.483 176.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 79' ' ' TYR . 54.7 m-20 -114.42 88.26 2.82 Favored 'General case' 0 C--O 1.206 -1.205 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 177.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.447 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 19.6 mt-10 -54.61 -30.54 55.08 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.89 -39.46 71.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.159 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.4 m -108.41 -10.07 15.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.109 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.579 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.5 m-85 62.13 46.96 5.94 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 121.502 -0.749 . . . . 0.0 110.083 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.7 p -105.76 149.23 26.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.076 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.563 ' CE1' ' CD1' ' A' ' 83' ' ' TYR . 39.5 t80 -142.38 118.65 10.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.39 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.4 p -128.89 128.44 43.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.594 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.563 ' CD1' ' CE1' ' A' ' 81' ' ' TYR . 19.7 p90 -145.32 162.35 37.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.872 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.68 143.19 37.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.004 0.431 . . . . 0.0 111.161 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.794 HD13 ' HB1' ' A' ' 90' ' ' ALA . 6.9 mt -83.81 121.98 28.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.879 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 68' ' ' LYS . 2.5 pp -84.87 -41.4 15.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.309 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.525 ' CB ' HD12 ' A' ' 86' ' ' ILE . 16.2 tt0 -156.6 172.31 18.79 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.176 -0.327 . . . . 0.0 110.569 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.614 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.82 177.45 17.29 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -61.52 1.98 0.2 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 122.415 1.102 . . . . 0.0 108.466 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.794 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -68.08 -34.61 76.74 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.174 0.989 . . . . 0.0 110.386 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.871 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.59 15.57 21.98 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.298 0.639 . . . . 0.0 110.263 -177.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.418 ' C ' ' O ' ' A' ' 91' ' ' LEU . 63.3 p 43.16 -126.47 0.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.507 -178.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -130.73 -13.07 3.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.966 0.412 . . . . 0.0 111.187 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 p -104.7 -5.8 20.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.924 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.83 HG21 ' CD1' ' A' ' 98' ' ' ILE . 69.3 mt -98.66 152.27 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-O 121.918 0.866 . . . . 0.0 113.038 -176.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.497 ' N ' HG22 ' A' ' 95' ' ' ILE . 17.3 pt-20 -99.97 -45.51 5.66 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.349 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.434 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 0.3 OUTLIER -172.72 145.9 1.56 Allowed 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 121.655 0.74 . . . . 0.0 112.224 -179.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.83 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.94 124.35 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.701 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.39 144.72 31.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.973 0.416 . . . . 0.0 111.774 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -139.05 127.99 23.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -129.02 134.5 48.15 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.2 OUTLIER -140.04 131.51 26.96 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.782 -0.574 . . . . 0.0 110.084 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.424 ' C ' HD23 ' A' ' 104' ' ' LEU . 14.4 ttmm -123.0 134.04 54.34 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.614 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.19 132.77 43.42 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -134.41 137.76 50.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.104 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.709 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -72.77 135.6 45.31 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.452 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.44 ' N ' ' HA ' ' A' ' 111' ' ' SER . 7.9 t -121.16 170.2 9.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.842 0.353 . . . . 0.0 110.176 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.75 -31.51 46.06 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 112.033 -0.427 . . . . 0.0 112.033 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.8 m -88.16 -11.74 45.99 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 119.559 -2.142 . . . . 0.0 115.827 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.02 -89.47 0.12 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.88 1.229 . . . . 0.0 110.478 -169.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 92.0 p -163.74 130.33 3.24 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.077 1.351 . . . . 0.0 110.928 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 105' ' ' VAL . 34.4 m -99.91 118.38 36.22 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 51.3 mt -92.21 132.08 37.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.167 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 102' ' ' THR . 2.9 mtpp -105.78 116.64 32.29 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.721 ' C ' HD13 ' A' ' 116' ' ' ILE . 11.1 t -111.07 118.32 35.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.282 0.563 . . . . 0.0 110.826 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.919 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -100.42 135.6 35.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 123.337 0.655 . . . . 0.0 109.818 -177.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.9 p -108.96 135.4 50.2 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.49 -0.777 . . . . 0.0 108.918 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.514 ' NE2' HG23 ' A' ' 4' ' ' THR . 31.6 m-70 -135.72 93.99 3.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 120.922 0.392 . . . . 0.0 110.627 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.833 ' C ' HG23 ' A' ' 2' ' ' VAL . 79.6 m-85 -83.24 101.8 11.49 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.174 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.457 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 1.5 t-80 -96.59 104.32 16.3 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.9 p -101.56 176.19 5.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.403 0.62 . . . . 0.0 111.618 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.99 157.58 20.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.68 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 42.26 -109.98 0.22 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -116.29 5.66 13.65 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.819 -0.224 . . . . 0.0 110.968 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -49.01 159.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.117 0.484 . . . . 0.0 110.41 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.467 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 40.3 mt-10 -148.5 145.8 28.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.961 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.8 mm -88.88 124.53 41.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp -74.97 161.64 29.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.502 0.667 . . . . 0.0 111.77 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -70.48 -34.18 72.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.642 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.416 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 6.2 pt-20 -69.02 -30.83 69.29 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.647 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -67.99 -53.97 22.03 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.383 0.611 . . . . 0.0 110.363 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.91 -19.63 22.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.407 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 137' ' ' GLU . 52.4 tttm -66.85 -46.69 74.27 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 122.295 -0.253 . . . . 0.0 110.704 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -69.17 -46.52 77.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.762 0.315 . . . . 0.0 110.404 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.28 -47.41 71.76 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -67.95 -46.48 71.33 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.566 -0.373 . . . . 0.0 111.055 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 21.0 tp10 -54.36 -46.73 73.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.021 0.439 . . . . 0.0 110.363 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.468 ' O ' ' CD2' ' A' ' 142' ' ' LEU . 10.3 ttmt -69.21 -52.75 24.73 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.78 -46.81 41.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.395 0.617 . . . . 0.0 110.55 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -62.08 -36.98 83.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.96 -52.54 51.66 Favored Glycine 0 C--O 1.225 -0.435 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.468 ' CD2' ' O ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -60.01 -42.51 94.47 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 122.096 -0.65 . . . . 0.0 109.366 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -59.15 -30.02 67.85 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.507 ' HB3' ' HZ2' ' A' ' 144' ' ' LYS . 0.3 OUTLIER -76.88 -34.61 57.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.12 178.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.64 ' HB3' HD13 ' A' ' 33' ' ' ILE . 1.7 mm? -70.43 -53.89 14.58 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.073 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.658 ' O ' HD22 ' A' ' 150' ' ' LEU . 7.3 mt -54.58 -49.19 68.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -46.38 -53.77 10.34 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.4 t -52.29 -42.25 63.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.307 0.575 . . . . 0.0 110.992 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.633 ' CD1' HD13 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -58.14 -44.67 87.94 Favored 'General case' 0 C--O 1.2 -1.542 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.852 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.1 mm? -66.87 -43.56 83.24 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 119.328 0.967 . . . . 0.0 112.073 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.532 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.4 OUTLIER -60.72 -25.1 66.2 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.58 -13.19 15.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.148 0.499 . . . . 0.0 110.362 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.604 ' N ' ' O ' ' A' ' 149' ' ' TYR . 22.5 t60 -153.9 67.21 5.82 Favored Pre-proline 0 C--N 1.312 -1.05 0 C-N-CA 124.354 1.062 . . . . 0.0 110.688 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.99 -3.28 11.18 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 122.409 2.073 . . . . 0.0 111.521 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.619 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.1 OUTLIER -80.95 3.36 23.15 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.918 -178.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.55 129.95 19.83 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 119.453 -2.029 . . . . 0.0 111.237 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.715 ' CD2' HD23 ' A' ' 24' ' ' LEU . 10.9 t80 54.3 7.1 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.205 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.619 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.366 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.883 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.1 p . . . . . 0 C--O 1.234 0.284 0 CA-C-O 120.868 0.366 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -98.52 110.84 23.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.32 177.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 m -96.53 139.85 32.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.788 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -140.53 134.03 30.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.18 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.508 ' C ' HD22 ' A' ' 7' ' ' ASN . 8.2 mt-10 -102.79 128.81 49.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.071 0.462 . . . . 0.0 110.964 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -128.19 165.5 20.32 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -178.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 1.3 pt-20 -156.38 151.42 26.29 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -142.7 140.81 31.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.088 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -107.06 145.81 31.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.844 0.354 . . . . 0.0 111.687 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 t -146.14 154.53 41.89 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.822 0.344 . . . . 0.0 110.688 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -90.94 24.5 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.112 0.482 . . . . 0.0 110.691 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.451 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.9 mt -107.59 128.02 26.7 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.359 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -46.1 143.78 7.05 Favored 'Trans proline' 0 C--N 1.326 -0.617 0 C-N-CA 121.308 1.339 . . . . 0.0 110.994 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HA ' HD12 ' A' ' 18' ' ' LEU . 11.0 Cg_endo -61.1 -23.58 77.59 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.45 2.1 . . . . 0.0 113.108 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.0 m -70.43 -31.54 68.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -76.62 -56.41 4.64 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 15' ' ' PRO . 2.8 mt -50.67 -43.06 57.33 Favored 'General case' 0 C--O 1.212 -0.905 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.721 ' O ' HG22 ' A' ' 23' ' ' VAL . 16.9 t80 -47.67 -58.3 4.45 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.932 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.86 ' CB ' HD21 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.85 -41.09 75.35 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.12 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.838 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -63.6 -2.55 1.71 Allowed 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.33 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.614 ' CE1' ' CE2' ' A' ' 143' ' ' PHE . 6.6 t80 -119.23 -9.24 9.99 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.913 HG23 HD13 ' A' ' 24' ' ' LEU . 5.4 m -134.67 -46.22 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.913 HD13 HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -99.19 -32.01 11.44 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 120.607 1.548 . . . . 0.0 112.422 -178.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.703 ' N ' HD22 ' A' ' 24' ' ' LEU . 0.5 OUTLIER -112.14 -5.12 14.26 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 118.437 0.562 . . . . 0.0 111.645 -178.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -67.49 -42.53 82.74 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.28 0.562 . . . . 0.0 111.657 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -82.91 18.94 1.47 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.991 0.901 . . . . 0.0 109.906 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.41 ' H ' ' C ' ' A' ' 26' ' ' ALA . 67.7 m-80 -139.27 -9.08 1.29 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.548 HD21 ' CD2' ' A' ' 149' ' ' TYR . 1.2 mt -94.12 -31.42 14.18 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.923 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.526 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.76 -53.97 54.66 Favored Pre-proline 0 C--O 1.214 -0.764 0 O-C-N 122.175 -0.328 . . . . 0.0 111.266 -179.321 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 22.8 Cg_endo -63.08 -24.92 73.28 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 121.908 1.739 . . . . 0.0 112.468 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -69.66 -60.41 2.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.73 0.776 . . . . 0.0 111.972 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.778 HD12 ' HB3' ' A' ' 145' ' ' LEU . 1.4 pt -95.91 -35.68 5.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.349 -176.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.94 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.37 65.03 0.14 Allowed Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.47 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 72.2 Cg_endo -76.31 -28.07 7.43 Favored 'Trans proline' 0 C--N 1.32 -0.93 0 C-N-CA 121.638 1.559 . . . . 0.0 108.276 174.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -73.91 -43.59 57.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.317 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.94 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -71.52 -74.02 0.17 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.801 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.556 HD13 HD22 ' A' ' 142' ' ' LEU . 1.1 mp -101.74 144.21 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 121.264 0.554 . . . . 0.0 109.818 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.9 ttpt -78.86 -62.16 1.78 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.603 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.753 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 57.2 tp60 -164.5 165.69 21.1 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.922 0.391 . . . . 0.0 110.012 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.753 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -165.93 149.44 7.73 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.06 0.457 . . . . 0.0 111.181 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -150.17 142.79 24.54 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.075 -179.351 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.471 ' H ' HG13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -76.96 141.34 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-O 122.015 0.912 . . . . 0.0 111.212 178.564 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.764 ' N ' HD12 ' A' ' 44' ' ' LEU . 4.0 mp -88.36 -40.57 13.46 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.9 ' O ' HG23 ' A' ' 52' ' ' THR . 32.6 mt-10 -149.12 134.18 18.15 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.457 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.64 -156.38 23.14 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.674 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -134.19 -1.59 2.91 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.451 -0.44 . . . . 0.0 111.509 -178.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.498 ' N ' HG21 ' A' ' 52' ' ' THR . . . 124.86 18.36 2.65 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -111.48 -172.9 19.48 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HD3' ' H ' ' A' ' 74' ' ' ILE . 10.8 Cg_endo -60.55 125.31 17.0 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 122.094 1.862 . . . . 0.0 112.96 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.5 -0.32 56.86 Favored Glycine 0 N--CA 1.462 0.428 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.9 HG23 ' O ' ' A' ' 45' ' ' GLU . 99.1 m -93.91 136.95 33.66 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 114.377 -0.912 . . . . 0.0 111.229 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.625 HG22 HD13 ' A' ' 44' ' ' LEU . 2.5 mp -113.95 132.35 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.496 ' HB2' HD11 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -122.7 138.54 54.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.899 0.381 . . . . 0.0 110.522 179.082 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.68 ' HB3' HD11 ' A' ' 44' ' ' LEU . 29.4 ttpt -119.9 130.2 54.73 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.098 -0.376 . . . . 0.0 110.906 178.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.6 mm -95.93 140.8 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.795 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.7 m -108.71 117.75 35.01 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 59' ' ' GLY . 5.8 t80 -104.22 172.12 6.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 0.0 110.961 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.453 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -57.55 144.43 40.63 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -60.3 -67.45 0.39 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.899 0.38 . . . . 0.0 111.242 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.46 61.96 3.15 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 t -137.75 -172.47 3.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.882 0.373 . . . . 0.0 110.664 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -58.69 -55.28 37.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.638 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -99.67 155.66 17.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.599 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.22 -59.36 0.13 Allowed Glycine 0 CA--C 1.52 0.363 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -145.5 149.2 34.2 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.937 0.399 . . . . 0.0 110.674 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 p -156.9 143.72 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.721 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.694 ' HB3' HD11 ' A' ' 86' ' ' ILE . 36.2 mttp -106.63 112.51 25.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.338 0.59 . . . . 0.0 112.069 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.445 ' CE1' ' CD2' ' A' ' 85' ' ' LEU . 11.3 m-70 -101.3 123.47 45.46 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -106.57 119.32 38.99 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.027 -0.421 . . . . 0.0 111.5 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.663 HD13 HG22 ' A' ' 52' ' ' THR . 4.0 mp -70.35 145.23 13.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -105.56 -54.88 2.41 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.7 144.4 6.11 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.461 ' H ' ' HD3' ' A' ' 50' ' ' PRO . 45.3 mt -127.14 125.88 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.162 173.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 79' ' ' TYR . 13.4 m-20 -113.91 88.81 2.93 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.506 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 13.7 mt-10 -54.47 -30.36 52.83 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.68 70.04 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.006 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.93 -11.42 15.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.122 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.7 m-85 62.23 42.7 9.18 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.597 -0.689 . . . . 0.0 110.259 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.4 t -106.86 141.75 37.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.127 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -132.09 118.71 19.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.8 t -128.53 135.19 49.07 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.136 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -144.82 159.83 42.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.493 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -138.26 139.48 39.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.228 0.537 . . . . 0.0 110.821 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.577 HD13 ' HB1' ' A' ' 90' ' ' ALA . 8.7 mt -80.17 115.55 19.79 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.694 HD11 ' HB3' ' A' ' 68' ' ' LYS . 4.1 pt -80.79 -44.24 21.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.676 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -152.02 172.11 16.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.863 0.363 . . . . 0.0 110.745 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.579 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.19 177.12 18.72 Favored Glycine 0 C--O 1.238 0.377 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -61.52 -0.34 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 122.204 1.002 . . . . 0.0 108.442 178.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.579 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -62.46 -34.36 76.67 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.816 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.859 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.16 14.83 22.74 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 123.61 0.764 . . . . 0.0 110.198 -177.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.6 p 46.42 -126.5 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -130.66 -12.86 3.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.649 0.738 . . . . 0.0 111.068 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.76 -6.34 20.42 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.015 0.526 . . . . 0.0 112.108 -177.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.717 HG21 ' CD1' ' A' ' 98' ' ' ILE . 71.4 mt -98.77 152.6 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.712 0 CA-C-O 121.997 0.903 . . . . 0.0 113.347 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.509 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -91.4 -57.33 2.81 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.167 177.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.404 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 28.2 pttt -171.93 151.16 2.7 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.027 0.442 . . . . 0.0 110.584 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.717 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.56 124.15 71.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.558 ' C ' ' HD1' ' A' ' 118' ' ' HIS . 0.1 OUTLIER -103.13 144.49 31.24 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 122.844 0.458 . . . . 0.0 111.896 -178.338 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.421 ' CZ ' ' OG ' ' A' ' 117' ' ' SER . 0.4 OUTLIER -139.13 127.93 23.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.5 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -133.57 132.86 41.38 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -133.43 136.32 45.12 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 122.208 -0.307 . . . . 0.0 110.425 -178.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -120.58 133.69 55.36 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -98.54 130.75 45.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.943 0.401 . . . . 0.0 110.003 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -132.62 137.24 54.55 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.063 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -73.01 135.71 44.96 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.649 178.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.429 ' N ' ' HA ' ' A' ' 111' ' ' SER . 13.2 t -121.25 168.82 11.2 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 122.593 0.357 . . . . 0.0 110.201 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.8 -29.81 42.71 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 112.233 -0.347 . . . . 0.0 112.233 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.6 p -92.06 -11.66 35.24 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 119.849 -1.971 . . . . 0.0 114.389 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.84 -86.14 0.12 Allowed Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.47 1.509 . . . . 0.0 112.066 -175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 88.4 p -164.54 130.97 2.97 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 125.86 1.664 . . . . 0.0 110.688 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.4 m -99.64 118.35 35.99 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 42.4 mt -91.83 131.23 39.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.118 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 102' ' ' THR . 8.9 mtpt -105.47 117.12 33.2 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.706 ' C ' HD13 ' A' ' 116' ' ' ILE . 24.9 p -110.16 118.64 36.9 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.368 0.604 . . . . 0.0 111.047 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.94 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -99.89 136.91 29.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 123.536 0.734 . . . . 0.0 109.641 -177.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.421 ' OG ' ' CZ ' ' A' ' 100' ' ' TYR . 6.8 m -118.26 131.72 56.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.477 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.558 ' HD1' ' C ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -138.2 112.26 8.51 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.883 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -102.83 103.77 13.98 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.211 -0.306 . . . . 0.0 110.441 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -90.58 107.24 19.04 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.207 0.527 . . . . 0.0 110.01 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.4 p -98.88 176.73 5.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.47 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -109.49 159.58 16.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.628 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 39.63 -109.77 0.13 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.464 -0.655 . . . . 0.0 111.464 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -116.04 3.66 13.62 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 122.702 -0.293 . . . . 0.0 111.069 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.483 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -45.58 160.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.316 0.579 . . . . 0.0 110.393 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.483 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 43.4 tt0 -149.49 145.66 26.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.212 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.0 mm -88.95 125.52 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -74.74 161.66 29.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.499 0.666 . . . . 0.0 111.53 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 1.0 OUTLIER -69.71 -47.55 62.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.192 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.469 ' O ' HG22 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -59.81 -24.68 64.35 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.118 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -72.95 -51.34 18.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.259 0.552 . . . . 0.0 111.256 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 m -77.31 -27.1 15.76 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.934 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.4 tttm -67.28 -45.91 75.21 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.275 -0.266 . . . . 0.0 110.9 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 135' ' ' GLY . 34.5 m -69.18 -45.38 79.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.886 0.375 . . . . 0.0 110.344 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.487 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -65.21 -41.76 96.69 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -67.14 -45.67 76.42 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 120.494 0.188 . . . . 0.0 110.691 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -53.96 -42.53 69.02 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.447 ' O ' ' CD2' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -69.48 -53.4 19.38 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.582 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.415 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.31 -41.73 39.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.583 0.706 . . . . 0.0 110.628 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -67.04 -36.34 81.86 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.93 -36.71 91.04 Favored Glycine 0 C--O 1.223 -0.576 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.584 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -73.31 -41.59 63.36 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.614 ' CE2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -59.87 -23.06 63.12 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.484 ' HZ2' ' C ' ' A' ' 144' ' ' LYS . 1.2 ttpp -76.01 -40.17 54.17 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.259 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.778 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.5 mm? -67.21 -55.85 12.34 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.31 0.576 . . . . 0.0 109.624 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.729 ' O ' HD22 ' A' ' 150' ' ' LEU . 60.6 mt -53.48 -50.92 46.35 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.358 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -47.51 -54.27 12.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.983 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.8 t -53.45 -42.65 67.37 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.117 0.484 . . . . 0.0 111.494 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.678 ' HB2' HD13 ' A' ' 33' ' ' ILE . 19.2 t80 -60.27 -44.72 95.07 Favored 'General case' 0 C--O 1.199 -1.553 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.838 HD11 ' HB2' ' A' ' 21' ' ' ALA . 1.8 mm? -68.99 -42.55 76.34 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 119.993 1.27 . . . . 0.0 111.629 -178.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -24.39 67.71 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 121.483 -0.761 . . . . 0.0 109.207 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -106.2 -13.15 15.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.566 0.698 . . . . 0.0 110.641 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 149' ' ' TYR . 16.9 t-80 -155.22 66.33 4.79 Favored Pre-proline 0 C--N 1.312 -1.063 0 C-N-CA 124.818 1.247 . . . . 0.0 110.181 -178.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.4 ' CD ' ' O ' ' A' ' 150' ' ' LEU . 43.1 Cg_endo -72.86 -4.01 14.61 Favored 'Trans proline' 0 N--CA 1.48 0.702 0 C-N-CA 122.472 2.115 . . . . 0.0 111.921 -178.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.621 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 3.8 p30 -82.51 3.48 28.24 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.07 0.948 . . . . 0.0 111.756 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.54 131.1 21.08 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 119.599 -1.938 . . . . 0.0 111.25 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.514 ' CG ' ' O ' ' A' ' 157' ' ' TYR . 80.9 t80 56.16 6.04 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.621 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.595 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.31 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.803 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.9 p . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.814 0.34 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -97.46 110.36 22.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.298 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.496 ' OG1' ' CD2' ' A' ' 118' ' ' HIS . 96.9 m -96.03 132.36 41.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.758 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.17 128.36 37.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.976 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -102.7 133.66 47.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.742 0.306 . . . . 0.0 110.705 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -126.37 170.87 11.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.472 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.96 149.37 27.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.309 0.576 . . . . 0.0 111.976 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -155.43 141.02 17.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.12 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 m -106.27 143.84 33.82 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.92 0.391 . . . . 0.0 111.941 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.0 t -133.75 154.49 50.93 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.262 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -93.42 18.86 9.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.896 0.379 . . . . 0.0 111.003 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.442 ' O ' HD11 ' A' ' 18' ' ' LEU . 2.1 mt -107.09 127.73 27.41 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -44.82 144.83 3.26 Favored 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 121.117 1.211 . . . . 0.0 110.797 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.667 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 19.4 Cg_endo -62.81 -23.2 74.36 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 122.452 2.101 . . . . 0.0 112.542 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.592 ' C ' ' HZ2' ' A' ' 20' ' ' LYS . 70.1 m -69.3 -33.45 73.21 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.415 HH21 ' HB2' ' A' ' 16' ' ' SER . 11.5 mmt-85 -76.66 -56.83 4.26 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 118.882 0.764 . . . . 0.0 109.066 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.464 ' H ' ' HG ' ' A' ' 18' ' ' LEU . 4.0 mt -48.57 -48.64 38.71 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.728 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.76 ' O ' HG22 ' A' ' 23' ' ' VAL . 27.9 t80 -48.41 -55.18 11.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.192 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.592 ' HZ2' ' C ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -70.23 -26.71 63.98 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.416 -0.913 . . . . 0.0 109.622 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.796 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -81.3 -2.9 50.83 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.994 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.503 ' CA ' ' HB2' ' A' ' 26' ' ' ALA . 1.6 t80 -118.78 -8.3 10.36 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.908 HG23 ' CD1' ' A' ' 24' ' ' LEU . 3.1 m -135.08 -35.46 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.908 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.4 mp -90.51 -54.69 3.89 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.652 1.114 . . . . 0.0 111.694 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -113.03 -3.93 13.94 Favored 'General case' 0 C--O 1.205 -1.243 0 O-C-N 122.261 -0.274 . . . . 0.0 111.129 -178.501 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.957 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -46.07 -39.22 8.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 118.037 0.381 . . . . 0.0 111.526 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -85.41 12.98 7.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.629 0.728 . . . . 0.0 110.855 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -134.51 -10.32 2.46 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 124.969 1.308 . . . . 0.0 108.62 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -95.84 -43.3 7.91 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 124.862 1.265 . . . . 0.0 109.188 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.957 HG22 ' O ' ' A' ' 26' ' ' ALA . 1.7 tt -55.62 -45.46 99.87 Favored Pre-proline 0 C--O 1.215 -0.757 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.486 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.846 ' HD3' HG23 ' A' ' 30' ' ' ILE . 36.4 Cg_endo -63.41 -24.67 71.02 Favored 'Trans proline' 0 N--CA 1.482 0.85 0 CA-C-N 121.231 1.475 . . . . 0.0 111.256 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -67.49 -54.45 20.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.663 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.767 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.9 OUTLIER -95.8 -35.75 6.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.248 -176.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.863 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.63 63.85 0.15 Allowed Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.489 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 80.3 Cg_endo -77.1 -27.78 6.48 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 N-CA-C 107.917 -1.609 . . . . 0.0 107.917 174.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -75.23 -43.24 52.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.17 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.863 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -70.5 -75.27 0.12 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.861 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.602 ' HB ' HD11 ' A' ' 30' ' ' ILE . 1.1 mm -99.98 147.78 7.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 CA-C-O 121.665 0.745 . . . . 0.0 111.021 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.772 ' HD2' ' H ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.08 -64.07 1.09 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.203 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.433 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -178.12 166.79 1.98 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.105 0.478 . . . . 0.0 110.345 179.452 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.433 ' H ' ' HG2' ' A' ' 40' ' ' GLN . . . -165.96 143.76 5.6 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.987 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.81 145.95 35.32 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.431 ' H ' HG13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -84.82 139.08 18.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.683 0.754 . . . . 0.0 110.94 -179.451 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.837 ' N ' HD12 ' A' ' 44' ' ' LEU . 3.0 mp -89.49 -39.09 13.57 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.933 ' O ' HG23 ' A' ' 52' ' ' THR . 22.2 mt-10 -141.92 133.1 26.26 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.78 -156.41 28.8 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.736 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -134.19 -13.89 2.37 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 122.33 -0.512 . . . . 0.0 110.924 -179.562 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.627 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 143.39 18.03 0.24 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -110.88 -173.24 19.91 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -61.16 126.07 18.56 Favored 'Trans proline' 0 C--N 1.321 -0.904 0 C-N-CA 122.258 1.972 . . . . 0.0 113.319 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.81 1.89 56.24 Favored Glycine 0 N--CA 1.463 0.462 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.933 HG23 ' O ' ' A' ' 45' ' ' GLU . 88.5 m -93.85 140.38 29.74 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.218 -0.991 . . . . 0.0 111.046 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.517 HG13 ' HE ' ' A' ' 70' ' ' ARG . 2.1 mp -117.65 133.13 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.17 141.02 52.41 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 121.037 0.446 . . . . 0.0 110.957 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' HB3' HD11 ' A' ' 44' ' ' LEU . 33.7 ttpt -119.27 131.98 55.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.813 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.7 mm -94.04 142.01 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.678 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 18.3 m -108.86 117.58 34.56 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.579 ' HA ' ' HD3' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -90.53 162.24 15.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.779 0.323 . . . . 0.0 111.363 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.59 144.34 30.16 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.621 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 2.1 pm0 -56.73 -47.17 80.6 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 122.422 -0.458 . . . . 0.0 110.298 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.34 62.38 1.76 Allowed Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 62.7 p -136.54 174.54 10.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.058 0.456 . . . . 0.0 111.205 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.484 ' NE2' ' H ' ' A' ' 63' ' ' GLN . 4.0 mp0 -69.03 -50.01 52.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.25 156.24 17.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.053 0.454 . . . . 0.0 110.631 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.78 -61.49 0.51 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.27 154.82 42.14 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.071 0.462 . . . . 0.0 110.776 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.426 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 2.0 p -145.82 157.09 12.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.958 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.426 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 26.4 mtmt -105.78 113.12 26.48 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.446 0.641 . . . . 0.0 112.425 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -105.78 105.71 15.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.993 0.917 . . . . 0.0 109.579 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.517 ' HE ' HG13 ' A' ' 53' ' ' ILE . 25.3 ttm180 -101.63 131.19 47.98 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.953 -0.467 . . . . 0.0 111.433 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.564 HD13 ' CG2' ' A' ' 52' ' ' THR . 4.4 mp -73.91 145.36 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -102.49 -56.01 2.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 119.227 -0.416 . . . . 0.0 112.073 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.8 m -165.35 141.38 5.38 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.5 mt -124.73 131.44 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.852 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.614 ' O ' ' N ' ' A' ' 79' ' ' TYR . 54.8 m-20 -114.84 87.92 2.75 Favored 'General case' 0 C--O 1.199 -1.575 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.454 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 9.5 pt-20 -54.41 -30.58 52.74 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.04 77.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.3 m -107.86 -9.98 15.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.736 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.614 ' N ' ' O ' ' A' ' 75' ' ' ASP . 20.7 m-85 58.54 48.63 11.68 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 121.415 -0.803 . . . . 0.0 110.538 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.2 p -106.58 147.22 29.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.985 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.635 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 35.9 t80 -132.1 125.86 32.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.968 0.413 . . . . 0.0 110.919 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 p -133.65 136.09 44.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.362 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.635 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 6.5 p90 -146.78 160.67 41.96 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.8 m -144.64 138.39 27.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.133 0.492 . . . . 0.0 111.229 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.65 HD22 ' HB1' ' A' ' 90' ' ' ALA . 4.5 mp -80.36 119.99 23.81 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.485 ' H ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -84.5 -42.9 17.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -178.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' A' ' 88' ' ' GLY . 1.2 tm-20 -157.64 173.55 16.68 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.326 -0.234 . . . . 0.0 110.493 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.631 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.74 177.44 17.34 Favored Glycine 0 CA--C 1.509 -0.316 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -61.54 1.76 0.21 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.65 ' HB1' HD22 ' A' ' 85' ' ' LEU . . . -64.88 -34.82 79.3 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.361 1.064 . . . . 0.0 110.071 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.874 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.0 16.31 21.98 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 123.702 0.801 . . . . 0.0 108.847 -178.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.8 p 44.89 -126.96 1.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -130.59 -9.62 4.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.133 0.492 . . . . 0.0 110.736 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.45 -7.25 18.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.171 -177.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.745 HG21 ' CD1' ' A' ' 98' ' ' ILE . 88.7 mt -100.04 152.5 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-O 122.085 0.945 . . . . 0.0 113.523 -177.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.492 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -90.42 -56.85 3.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.598 177.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -172.19 148.28 2.14 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.267 0.556 . . . . 0.0 111.454 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.745 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.31 130.1 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.26 145.07 46.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.917 0.389 . . . . 0.0 111.53 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -139.89 133.17 29.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.562 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.427 ' O ' HG12 ' A' ' 116' ' ' ILE . 39.0 tt0 -128.46 134.29 48.7 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 121.036 0.446 . . . . 0.0 110.963 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.14 133.01 52.99 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.714 -0.616 . . . . 0.0 109.634 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -120.11 133.0 55.63 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.4 mm? -97.81 125.42 42.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.132 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.8 OUTLIER -137.65 136.86 45.85 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.667 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -73.16 139.45 46.36 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.173 178.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.454 ' N ' ' HA ' ' A' ' 111' ' ' SER . 17.3 p -120.73 168.11 11.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.61 -26.85 32.89 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 121.398 -0.429 . . . . 0.0 112.125 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.2 m -91.27 -14.11 31.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 119.563 -2.139 . . . . 0.0 116.591 174.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.46 -89.91 0.12 Allowed Glycine 0 CA--C 1.537 1.424 0 O-C-N 120.454 -1.404 . . . . 0.0 110.981 -161.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.454 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 17.2 t -164.84 133.78 3.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 119.035 1.417 . . . . 0.0 111.196 -178.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 105' ' ' VAL . 52.1 m -100.06 126.05 46.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.422 ' CG1' HD13 ' A' ' 104' ' ' LEU . 11.1 mt -99.54 127.79 51.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.428 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -105.52 117.45 34.04 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.792 ' C ' HD13 ' A' ' 116' ' ' ILE . 8.0 p -110.58 121.77 46.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.442 0.639 . . . . 0.0 110.542 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.924 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -104.73 135.26 43.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.296 0.569 . . . . 0.0 109.948 -177.358 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 71.1 m -107.73 138.33 44.16 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.8 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.496 ' CD2' ' OG1' ' A' ' 4' ' ' THR . 26.3 m80 -136.13 93.47 2.91 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.813 0.34 . . . . 0.0 110.454 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.803 ' C ' HG23 ' A' ' 2' ' ' VAL . 60.9 m-85 -88.12 102.16 14.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.213 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -90.28 102.87 15.59 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.519 HG21 ' HA ' ' A' ' 126' ' ' GLU . 1.2 p -92.47 160.57 15.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.905 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.406 ' H ' HG22 ' A' ' 125' ' ' ILE . 4.3 ptmt -112.39 142.5 44.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.029 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.24 -109.64 0.94 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.747 ' H ' HD22 ' A' ' 124' ' ' ASN . 0.1 OUTLIER -116.46 -2.67 11.98 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.497 -0.413 . . . . 0.0 110.657 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 125' ' ' ILE . 1.2 tp -49.3 160.65 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.88 0.371 . . . . 0.0 110.693 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.519 ' HA ' HG21 ' A' ' 121' ' ' THR . 2.7 pp20? -149.38 149.64 31.17 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.572 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 34.2 mm -87.05 125.16 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -75.2 162.35 28.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.485 0.66 . . . . 0.0 112.06 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -69.02 -42.19 76.73 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.855 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.459 ' O ' HG22 ' A' ' 134' ' ' VAL . 5.2 mp0 -61.57 -25.55 67.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.825 0.345 . . . . 0.0 110.174 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -72.59 -51.03 21.45 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.283 0.564 . . . . 0.0 111.038 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 m -77.03 -25.95 15.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.942 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -67.34 -46.31 73.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 122.332 -0.23 . . . . 0.0 110.787 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 135' ' ' GLY . 35.6 m -70.2 -45.01 77.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.885 0.374 . . . . 0.0 110.593 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.491 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -66.16 -46.62 78.57 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -66.89 -46.89 73.51 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.636 -0.332 . . . . 0.0 110.714 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -55.2 -47.24 75.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.011 0.434 . . . . 0.0 110.031 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -66.7 -52.87 39.76 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.885 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.422 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.22 -42.64 41.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.594 0.712 . . . . 0.0 110.567 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.509 ' HD1' ' C ' ' A' ' 140' ' ' HIS . 1.8 t-80 -61.16 -36.56 80.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.859 0.838 . . . . 0.0 109.052 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.9 -38.88 96.12 Favored Glycine 0 C--O 1.221 -0.665 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.571 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -66.1 -46.82 76.28 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -59.62 -24.48 63.86 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.68 -36.28 65.29 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.59 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.767 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.1 mm? -71.22 -57.67 4.27 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.426 0.631 . . . . 0.0 109.839 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.727 ' O ' HD22 ' A' ' 150' ' ' LEU . 50.4 mt -54.54 -50.65 57.09 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.133 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -47.43 -56.76 6.32 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.864 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 20.5 p -50.68 -44.65 57.81 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.343 0.592 . . . . 0.0 111.285 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.668 ' HB2' HD13 ' A' ' 33' ' ' ILE . 28.2 t80 -59.88 -45.41 92.58 Favored 'General case' 0 C--O 1.193 -1.917 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.796 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.1 mm? -65.79 -42.74 90.37 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 120.443 1.474 . . . . 0.0 111.565 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.53 -24.38 67.48 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.305 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -105.77 -13.08 15.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.321 0.581 . . . . 0.0 110.768 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.637 ' N ' ' O ' ' A' ' 149' ' ' TYR . 42.1 m80 -155.96 67.34 4.69 Favored Pre-proline 0 C--N 1.31 -1.131 0 C-N-CA 125.167 1.387 . . . . 0.0 110.202 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -72.35 -3.48 13.46 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 122.501 2.134 . . . . 0.0 111.704 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.649 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 13.0 m-20 -73.16 2.61 6.9 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.163 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -50.11 130.15 22.01 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 119.161 -2.212 . . . . 0.0 111.275 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.669 ' CG ' HD23 ' A' ' 24' ' ' LEU . 92.8 t80 54.03 6.18 0.09 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.546 0.688 . . . . 0.0 112.124 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.649 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.503 0 O-C-N 120.994 -1.066 . . . . 0.0 110.055 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.823 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.5 p . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.725 0.298 . . . . 0.0 111.02 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.73 110.27 22.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.659 177.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.516 ' OG1' ' CD2' ' A' ' 118' ' ' HIS . 90.4 m -95.93 140.06 31.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 0.0 111.013 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.482 ' CD2' ' ND2' ' A' ' 7' ' ' ASN . 7.2 t80 -143.28 128.09 18.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.172 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.577 ' C ' HD22 ' A' ' 7' ' ' ASN . 1.6 tt0 -102.89 131.19 49.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.874 0.368 . . . . 0.0 111.324 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.577 HD22 ' C ' ' A' ' 6' ' ' GLU . 1.8 m-80 -134.59 172.7 12.56 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 122.636 0.375 . . . . 0.0 110.387 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.42 153.49 30.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.202 0.525 . . . . 0.0 112.39 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -149.01 138.41 21.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.235 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.19 147.49 25.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 111.771 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.3 t -145.8 161.44 39.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.499 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -96.27 25.92 4.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.854 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.617 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.5 mt -116.3 125.41 28.54 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.879 -178.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -47.83 149.93 4.9 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.034 1.823 . . . . 0.0 111.784 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.423 ' CG ' ' HB2' ' A' ' 106' ' ' ALA . 22.8 Cg_exo -60.93 -24.88 80.37 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.307 2.005 . . . . 0.0 112.59 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.447 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 45.6 m -68.68 -34.29 75.42 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -76.16 -55.77 5.27 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.617 HD21 ' HB ' ' A' ' 13' ' ' ILE . 4.4 mt -51.4 -41.85 61.01 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.733 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.555 ' O ' HG22 ' A' ' 23' ' ' VAL . 61.2 t80 -50.97 -57.48 8.48 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.733 ' CB ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -68.09 -40.08 82.74 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.254 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.858 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -66.62 -2.45 4.86 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.263 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.443 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 2.6 m-85 -118.67 -9.64 10.18 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.6 HG23 ' N ' ' A' ' 24' ' ' LEU . 33.9 m -131.76 -50.91 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.059 HD12 ' N ' ' A' ' 25' ' ' ASP . 2.7 pp -99.65 -30.52 12.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -176.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 1.059 ' N ' HD12 ' A' ' 24' ' ' LEU . 62.4 m-20 -112.84 -5.59 13.86 Favored 'General case' 0 C--O 1.214 -0.802 0 O-C-N 121.599 -0.688 . . . . 0.0 111.516 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -68.13 -40.99 82.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.259 0.552 . . . . 0.0 111.383 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.585 ' CB ' ' HZ1' ' A' ' 54' ' ' LYS . 13.9 m-20 -84.37 17.8 2.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.027 0.918 . . . . 0.0 110.889 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.403 ' H ' ' H ' ' A' ' 29' ' ' LEU . 62.7 m-20 -139.07 -9.0 1.33 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.781 HD12 HG23 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -89.23 -47.49 8.02 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.655 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.593 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -60.83 -43.03 90.35 Favored Pre-proline 0 C--O 1.208 -1.111 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 28.7 Cg_endo -62.2 -26.14 77.47 Favored 'Trans proline' 0 C--N 1.321 -0.905 0 CA-C-N 120.635 1.263 . . . . 0.0 112.252 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -76.94 -61.64 1.91 Allowed 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.351 0.596 . . . . 0.0 112.343 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.452 HD13 ' HB2' ' A' ' 149' ' ' TYR . 2.1 pt -94.4 -34.55 5.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.617 -177.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.71 ' HB2' ' HG ' ' A' ' 145' ' ' LEU . . . -102.68 67.3 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 123.224 0.609 . . . . 0.0 112.513 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.424 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 65.2 Cg_endo -72.7 -20.18 23.28 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.219 1.28 . . . . 0.0 108.882 176.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -72.87 -38.63 66.95 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.517 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.766 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -70.09 -81.91 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.443 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.616 HD12 ' N ' ' A' ' 38' ' ' ILE . 2.0 mp -109.57 144.07 18.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.0 110.13 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.69 -42.43 28.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.139 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.677 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 48.2 tp60 -173.63 164.74 4.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.677 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -166.03 145.16 6.02 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.141 0.495 . . . . 0.0 110.893 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -148.32 142.99 26.59 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.106 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.716 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -76.75 140.53 17.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.409 0.623 . . . . 0.0 110.863 -179.112 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.746 ' N ' HD12 ' A' ' 44' ' ' LEU . 3.6 mp -89.55 -40.41 12.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.652 ' O ' HG23 ' A' ' 52' ' ' THR . 12.5 mm-40 -143.51 134.21 25.11 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.346 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.98 -155.12 22.27 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.896 -0.482 . . . . 0.0 111.896 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.759 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -133.95 -12.52 2.55 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 123.096 0.558 . . . . 0.0 111.232 -178.191 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.63 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 135.96 12.31 1.15 Allowed Glycine 0 C--O 1.221 -0.663 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.436 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -106.36 -170.87 22.99 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -60.76 126.28 19.35 Favored 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 122.803 2.336 . . . . 0.0 113.119 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.96 5.84 57.25 Favored Glycine 0 N--CA 1.465 0.612 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 45' ' ' GLU . 15.0 m -93.12 141.53 28.31 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.832 -0.684 . . . . 0.0 111.47 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.674 HG22 HD13 ' A' ' 44' ' ' LEU . 2.2 mp -116.46 133.57 62.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.716 ' HG2' HG23 ' A' ' 43' ' ' ILE . 4.7 tmtp? -119.67 140.32 50.83 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.542 0.686 . . . . 0.0 111.148 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.742 ' CB ' HD11 ' A' ' 44' ' ' LEU . 54.6 tttt -119.17 121.19 39.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.258 178.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 56' ' ' ILE . 5.2 mp -105.52 127.12 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.5 m -102.57 118.88 37.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.245 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.53 177.37 6.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.585 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.41 144.45 40.78 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -60.03 -48.37 81.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.852 0.358 . . . . 0.0 110.752 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.7 61.62 3.45 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 m -149.54 174.66 12.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.936 0.398 . . . . 0.0 110.585 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.55 ' NE2' ' CE2' ' A' ' 64' ' ' TYR . 1.1 pt20 -66.79 -41.32 87.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.918 0.389 . . . . 0.0 110.664 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.55 ' CE2' ' NE2' ' A' ' 63' ' ' GLN . 73.9 m-85 -91.4 149.48 21.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.552 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.416 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . -127.85 -62.39 0.13 Allowed Glycine 0 N--CA 1.462 0.378 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -146.35 146.95 30.85 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.728 0.299 . . . . 0.0 110.211 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -157.02 147.66 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.93 0.395 . . . . 0.0 110.947 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -105.59 113.06 26.4 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.271 0.558 . . . . 0.0 111.243 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.86 110.15 21.02 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -101.96 129.69 48.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.918 0.389 . . . . 0.0 112.037 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 mp -70.86 137.26 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -96.25 -53.75 3.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.44 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.4 m -164.5 140.74 6.1 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.483 HD12 ' O ' ' A' ' 48' ' ' GLY . 44.8 mt -129.16 130.65 68.06 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.15 177.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.625 ' O ' ' N ' ' A' ' 79' ' ' TYR . 38.4 m-20 -115.39 87.62 2.7 Favored 'General case' 0 C--O 1.194 -1.86 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.638 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.8 pm0 -55.32 -39.57 70.11 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.31 -37.08 45.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.131 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.21 -9.84 15.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.32 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.2 m-85 62.03 51.96 3.48 Favored 'General case' 0 N--CA 1.438 -1.068 0 O-C-N 121.055 -1.028 . . . . 0.0 110.101 -177.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 55.5 p -106.41 144.09 33.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.056 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -134.66 121.26 20.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.023 0.439 . . . . 0.0 110.933 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 m -136.42 147.38 47.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.226 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -162.65 169.76 19.57 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.779 0.323 . . . . 0.0 110.628 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -146.49 139.11 25.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.131 0.491 . . . . 0.0 110.771 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.806 HD13 ' HB1' ' A' ' 90' ' ' ALA . 11.1 mt -79.95 111.62 16.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.61 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -75.59 -40.75 41.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.4 -178.386 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.61 ' N ' HD13 ' A' ' 86' ' ' ILE . 16.0 tt0 -155.24 171.98 18.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.81 0.338 . . . . 0.0 110.295 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.18 177.82 17.7 Favored Glycine 0 CA--C 1.509 -0.334 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -61.87 2.29 0.22 Allowed 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.806 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -66.61 -34.36 77.71 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.173 0.989 . . . . 0.0 110.35 177.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.876 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.31 14.96 22.56 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.175 0.59 . . . . 0.0 110.341 -177.095 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.4 p 45.16 -126.22 1.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.36 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -130.45 -13.01 3.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.967 0.413 . . . . 0.0 111.475 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.9 p -104.75 -5.73 21.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.79 HG21 ' CD1' ' A' ' 98' ' ' ILE . 72.1 mt -99.12 152.95 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 CA-C-O 122.059 0.933 . . . . 0.0 113.472 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -93.46 -54.01 3.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.919 178.279 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -171.66 147.64 2.33 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 121.623 0.725 . . . . 0.0 111.028 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.79 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.41 121.98 66.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 118' ' ' HIS . 11.4 t -107.39 146.12 32.05 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.412 0.625 . . . . 0.0 111.438 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -136.68 131.5 33.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.286 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.413 ' O ' HG12 ' A' ' 116' ' ' ILE . 29.4 tt0 -127.96 133.66 49.23 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.4 OUTLIER -139.88 133.0 29.63 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.894 -0.504 . . . . 0.0 109.899 -179.006 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.404 ' C ' HD23 ' A' ' 104' ' ' LEU . 87.1 tttt -119.77 133.22 55.69 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -102.43 128.28 49.09 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.94 137.27 55.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.239 -178.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.77 134.65 45.05 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.336 178.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 38.8 t -121.3 172.26 8.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.826 0.346 . . . . 0.0 110.152 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.482 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.73 -35.28 52.18 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.8 p -87.06 -16.79 34.56 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.696 -1.473 . . . . 0.0 113.87 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 162.24 -77.75 0.16 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.379 1.466 . . . . 0.0 111.779 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 83.1 p -164.62 130.98 2.94 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 126.07 1.748 . . . . 0.0 111.096 176.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.5 m -99.48 117.71 34.48 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mt -92.72 131.34 40.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.543 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 102' ' ' THR . 2.7 mtpt -104.38 117.05 33.23 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.828 ' C ' HD13 ' A' ' 116' ' ' ILE . 68.4 m -111.34 123.74 50.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.291 0.567 . . . . 0.0 111.066 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.915 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -107.69 135.67 45.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 123.35 0.66 . . . . 0.0 110.082 -178.045 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.1 m -104.8 135.15 46.72 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.516 ' CD2' ' OG1' ' A' ' 4' ' ' THR . 15.5 m80 -136.24 93.56 2.92 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.127 0.489 . . . . 0.0 110.378 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.823 ' C ' HG23 ' A' ' 2' ' ' VAL . 94.8 m-85 -86.82 101.92 13.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.229 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -95.73 101.37 13.05 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.288 0.566 . . . . 0.0 110.231 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.1 p -100.26 171.69 7.63 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.472 0.653 . . . . 0.0 111.335 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -108.07 157.52 18.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.837 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 42.26 -114.73 0.77 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.445 ' C ' HD22 ' A' ' 124' ' ' ASN . 0.4 OUTLIER -110.57 4.85 20.68 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.727 -0.278 . . . . 0.0 111.11 179.401 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -49.09 160.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.298 0.571 . . . . 0.0 110.227 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.467 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 19.8 pt-20 -150.25 146.06 26.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.08 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.8 mm -88.85 124.27 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -75.09 162.15 28.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.476 0.655 . . . . 0.0 111.839 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -69.53 -36.22 76.21 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.935 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.422 ' O ' HG22 ' A' ' 134' ' ' VAL . 49.2 mt-10 -65.13 -30.41 71.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.792 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -72.41 -47.9 45.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.055 0.455 . . . . 0.0 111.027 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 m -77.47 -26.43 15.3 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.982 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -67.13 -46.28 74.59 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 122.138 -0.351 . . . . 0.0 110.699 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.466 HG23 ' N ' ' A' ' 135' ' ' GLY . 35.4 m -70.4 -43.48 78.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.598 0.237 . . . . 0.0 110.818 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.466 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -70.16 -46.77 48.79 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -67.38 -48.97 65.83 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 122.503 -0.41 . . . . 0.0 110.84 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -55.72 -48.01 75.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 109.998 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -64.4 -53.9 41.27 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.526 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -47.76 -45.91 29.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.461 0.648 . . . . 0.0 110.55 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -55.73 -37.22 68.14 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.409 0.623 . . . . 0.0 109.545 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.83 -38.92 96.85 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.766 HD22 ' HB2' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -68.37 -38.5 81.45 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.518 ' O ' ' CD1' ' A' ' 143' ' ' PHE . 0.9 OUTLIER -58.85 -32.04 69.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.687 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -70.29 -33.76 71.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.769 177.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.71 ' HG ' ' HB2' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -67.79 -56.95 7.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.046 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.781 HG23 HD12 ' A' ' 29' ' ' LEU . 59.1 mt -65.94 -48.94 80.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.664 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -47.5 -45.1 26.08 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.403 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.0 t -58.81 -37.7 76.96 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.878 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.634 ' O ' ' N ' ' A' ' 153' ' ' HIS . 11.2 t80 -59.65 -45.83 90.84 Favored 'General case' 0 C--O 1.189 -2.128 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.888 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.3 mm? -69.9 -42.79 72.92 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 119.445 1.021 . . . . 0.0 111.468 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -23.63 66.03 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.631 -0.668 . . . . 0.0 109.809 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.436 ' O ' ' ND1' ' A' ' 153' ' ' HIS . 4.7 m-20 -106.11 -14.22 15.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.353 0.597 . . . . 0.0 110.623 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 149' ' ' TYR . 44.0 m80 -155.38 66.94 4.91 Favored Pre-proline 0 C--N 1.304 -1.383 0 C-N-CA 125.572 1.549 . . . . 0.0 109.384 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.42 -3.13 10.37 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 C-N-CA 122.969 2.446 . . . . 0.0 111.562 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.599 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 5.1 p30 -72.59 3.18 5.23 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.82 -178.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.578 ' O ' ' HD3' ' A' ' 20' ' ' LYS . . . -52.16 128.67 25.57 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 119.335 -2.103 . . . . 0.0 110.823 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.788 ' CD1' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER 51.67 5.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.046 0.538 . . . . 0.0 112.423 178.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.599 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.636 0 CA-C-O 118.128 -0.939 . . . . 0.0 109.852 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.809 HG23 ' C ' ' A' ' 119' ' ' TYR . 8.9 p . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.849 0.357 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -98.4 110.03 22.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.547 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.475 HG23 ' CE1' ' A' ' 118' ' ' HIS . 68.4 m -96.56 132.84 41.75 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.656 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.67 128.87 37.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.066 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.09 133.47 48.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.8 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.42 HD22 ' N ' ' A' ' 7' ' ' ASN . 1.4 m-80 -134.0 174.54 10.36 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.765 0.317 . . . . 0.0 110.205 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.65 145.4 21.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.825 0.821 . . . . 0.0 112.079 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.31 134.63 27.75 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.831 -0.543 . . . . 0.0 110.138 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.94 147.44 23.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.891 0.377 . . . . 0.0 111.257 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 p -145.15 154.75 42.77 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.456 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -93.68 29.84 1.93 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.91 0.386 . . . . 0.0 110.397 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.636 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.3 mt -120.69 125.35 27.15 Favored Pre-proline 0 C--O 1.224 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.073 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -49.7 148.91 11.28 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 121.999 1.799 . . . . 0.0 111.708 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.427 ' HA ' HD12 ' A' ' 18' ' ' LEU . 27.7 Cg_exo -57.78 -28.31 81.58 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.386 2.057 . . . . 0.0 112.746 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.476 ' C ' ' HE ' ' A' ' 17' ' ' ARG . 15.1 m -65.14 -35.53 81.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.713 ' HE ' ' N ' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -74.95 -55.57 5.64 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -178.512 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.636 HD11 ' O ' ' A' ' 13' ' ' ILE . 4.2 mt -53.16 -40.27 64.18 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.012 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.796 ' O ' HG22 ' A' ' 23' ' ' VAL . 62.4 t80 -50.25 -57.7 7.24 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.859 0.464 . . . . 0.0 112.09 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.73 ' HB2' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.77 -41.55 75.02 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.507 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.761 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -64.0 -4.4 3.39 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.603 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.504 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 5.0 m-85 -119.79 -8.67 9.84 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 19' ' ' PHE . 25.8 m -128.53 -50.53 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.007 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.9 pp -98.0 -31.41 12.17 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -176.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 1.007 ' N ' HD12 ' A' ' 24' ' ' LEU . 3.8 t70 -114.96 -5.59 12.54 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 118.842 0.746 . . . . 0.0 112.177 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -62.4 -42.24 99.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.315 0.579 . . . . 0.0 111.702 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -83.76 19.7 1.62 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.865 0.84 . . . . 0.0 110.028 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -139.85 -8.64 1.21 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.024 HD13 HG23 ' A' ' 146' ' ' ILE . 0.5 OUTLIER -96.97 -50.15 4.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.224 -178.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.559 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 41.5 mt -55.04 -44.15 99.45 Favored Pre-proline 0 C--O 1.217 -0.632 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 20.7 Cg_exo -63.13 -22.64 73.17 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 122.353 2.036 . . . . 0.0 110.958 176.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -74.65 -55.08 6.28 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.537 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.76 HD11 HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -95.54 -35.07 5.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.322 -177.159 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.845 ' HB2' ' CG ' ' A' ' 145' ' ' LEU . . . -106.61 81.19 0.82 Allowed Pre-proline 0 CA--C 1.508 -0.639 0 CA-C-O 121.105 0.479 . . . . 0.0 111.93 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.75 -10.23 24.75 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 N-CA-C 107.33 -1.834 . . . . 0.0 107.33 174.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -74.61 -42.15 59.13 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.487 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.499 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -78.16 -80.03 0.12 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.188 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.516 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 5.6 mm -99.03 140.56 18.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.033 0.444 . . . . 0.0 110.99 -177.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -81.57 -42.9 19.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.915 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.662 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 47.1 tp60 -178.44 165.51 1.77 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.802 ' HB1' ' NZ ' ' A' ' 54' ' ' LYS . . . -165.08 144.08 6.63 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.201 0.524 . . . . 0.0 110.934 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.557 ' N ' ' NZ ' ' A' ' 54' ' ' LYS . 10.4 pt-20 -145.6 143.17 29.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.954 0.407 . . . . 0.0 111.249 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.465 HG13 ' H ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -78.57 142.09 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.485 0.66 . . . . 0.0 111.39 -179.104 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.9 mt -86.36 -39.7 16.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.418 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.915 ' O ' HG23 ' A' ' 52' ' ' THR . 40.7 mt-10 -148.18 133.61 18.61 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.618 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.93 -156.26 22.87 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.678 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -132.68 -10.54 3.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.95 0.405 . . . . 0.0 111.054 -179.203 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.627 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 134.36 21.0 0.78 Allowed Glycine 0 C--O 1.222 -0.619 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -178.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -110.3 -171.75 20.0 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -62.09 124.81 15.1 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 122.433 2.089 . . . . 0.0 113.036 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.8 3.78 59.23 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.915 HG23 ' O ' ' A' ' 45' ' ' GLU . 66.5 m -93.69 140.57 29.49 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.555 -0.823 . . . . 0.0 111.064 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.58 125.21 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.802 ' NZ ' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -115.52 138.18 51.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.254 0.55 . . . . 0.0 110.131 178.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.404 ' C ' HD12 ' A' ' 56' ' ' ILE . 75.9 tttt -120.43 132.07 55.07 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.708 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.784 ' N ' HD12 ' A' ' 56' ' ' ILE . 1.5 mp -103.28 140.8 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.0 m -113.48 118.64 35.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.83 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.516 ' CZ ' HD13 ' A' ' 38' ' ' ILE . 7.4 m-85 -101.47 -177.84 3.55 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.955 0.407 . . . . 0.0 110.942 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.25 145.77 35.17 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -59.61 -46.62 88.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.746 0.308 . . . . 0.0 110.794 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.72 61.56 3.45 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.3 t -142.96 175.04 10.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.916 0.389 . . . . 0.0 110.614 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -59.82 -51.49 69.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 110.665 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.404 ' OH ' ' NZ ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -107.11 143.47 35.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.165 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.06 -48.93 0.91 Allowed Glycine 0 CA--C 1.52 0.39 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -145.49 153.44 41.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.105 0.478 . . . . 0.0 110.624 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -154.02 146.34 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.554 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.6 ' HB3' HD11 ' A' ' 86' ' ' ILE . 80.4 mttt -105.57 106.11 16.45 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.436 0.636 . . . . 0.0 111.701 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.49 ' CE1' HD21 ' A' ' 85' ' ' LEU . 1.1 m-70 -92.51 123.19 35.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.708 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -113.11 119.62 38.46 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.82 -0.55 . . . . 0.0 111.068 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.61 HD13 HG22 ' A' ' 52' ' ' THR . 4.9 mp -70.22 137.16 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -99.61 -54.46 2.92 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.0 m -165.0 141.57 5.76 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 48' ' ' GLY . 43.8 mt -129.98 131.03 66.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.619 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.598 ' O ' ' N ' ' A' ' 79' ' ' TYR . 7.2 m-20 -116.25 87.89 2.78 Favored 'General case' 0 C--O 1.206 -1.217 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.637 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.1 pm0 -54.83 -41.14 70.34 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.06 -35.97 27.29 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.492 0.663 . . . . 0.0 109.223 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.444 ' O ' ' NZ ' ' A' ' 103' ' ' LYS . 0.6 OUTLIER -107.95 -10.5 15.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.409 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.598 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.9 m-85 63.24 50.32 3.03 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 120.989 -1.07 . . . . 0.0 110.024 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 34.9 t -106.26 144.24 33.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.359 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -135.09 123.23 22.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.101 0.477 . . . . 0.0 110.588 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 p -132.57 134.64 45.2 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.133 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -144.62 159.08 43.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.145 0.498 . . . . 0.0 110.022 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.7 m -142.32 137.2 30.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.994 0.426 . . . . 0.0 110.586 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.594 HD13 ' HB1' ' A' ' 90' ' ' ALA . 6.2 mt -80.06 109.87 14.92 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' A' ' 68' ' ' LYS . 2.9 pt -79.56 -43.47 23.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.011 -178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 3.4 tp10 -149.99 172.1 15.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.739 0.304 . . . . 0.0 110.362 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.604 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.94 177.45 18.33 Favored Glycine 0 CA--C 1.509 -0.326 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -61.14 1.61 0.17 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.604 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -65.25 -35.36 80.81 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 124.105 0.962 . . . . 0.0 110.212 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.869 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.72 11.77 22.6 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 123.521 0.728 . . . . 0.0 109.623 -177.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.9 p 46.55 -126.65 1.49 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -131.04 -11.37 3.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.256 0.55 . . . . 0.0 110.816 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.19 -5.58 20.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.427 -177.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.711 HG21 ' CD1' ' A' ' 98' ' ' ILE . 94.4 mt -97.76 152.09 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.466 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -87.37 -61.27 1.76 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.337 177.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.417 ' O ' ' CB ' ' A' ' 120' ' ' HIS . 11.8 ptmt -172.26 149.59 2.28 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.489 0.661 . . . . 0.0 111.305 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.711 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.13 127.56 75.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.3 145.7 39.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.246 0.546 . . . . 0.0 111.635 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -138.45 136.66 36.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.265 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.13 134.2 49.07 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 120.916 0.389 . . . . 0.0 110.144 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.64 130.87 28.48 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.31 -0.869 . . . . 0.0 109.742 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.754 ' C ' HD23 ' A' ' 104' ' ' LEU . 25.9 tttp -127.22 134.3 50.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.867 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -102.99 125.27 49.68 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -178.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -130.32 137.89 55.19 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.624 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.916 -178.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.21 133.57 45.17 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.287 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 14.8 t -121.56 174.35 6.84 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 122.678 0.391 . . . . 0.0 110.426 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.422 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -54.97 -36.34 60.44 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 m -80.56 -15.28 57.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.411 1.484 . . . . 0.0 114.198 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.95 -90.13 0.13 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.426 1.965 . . . . 0.0 110.812 -168.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.8 OUTLIER -157.22 129.09 7.11 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 127.728 2.411 . . . . 0.0 111.005 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.412 ' N ' ' O ' ' A' ' 105' ' ' VAL . 43.9 m -99.8 118.91 37.28 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.2 mt -92.66 131.65 39.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.535 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -105.25 116.64 32.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.885 ' C ' HD13 ' A' ' 116' ' ' ILE . 53.4 p -111.56 128.45 56.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.383 0.611 . . . . 0.0 111.258 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.885 HD13 ' C ' ' A' ' 115' ' ' SER . 0.1 OUTLIER -112.07 135.77 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 C-N-CA 123.327 0.651 . . . . 0.0 109.92 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 p -110.38 136.93 48.78 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.475 ' CE1' HG23 ' A' ' 4' ' ' THR . 27.7 m-70 -135.7 95.54 3.26 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.026 0.441 . . . . 0.0 110.888 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.809 ' C ' HG23 ' A' ' 2' ' ' VAL . 5.6 m-85 -84.89 101.12 12.06 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.417 ' CB ' ' O ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -94.32 103.76 15.76 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.513 HG21 ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -100.09 161.73 13.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.665 -178.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.522 ' H ' HG22 ' A' ' 125' ' ' ILE . 8.1 ptmt -112.22 157.15 21.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 41.01 -123.15 2.47 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.769 ' H ' HD22 ' A' ' 124' ' ' ASN . 0.1 OUTLIER -95.08 -12.09 27.14 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.694 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.522 HG22 ' H ' ' A' ' 122' ' ' LYS . 1.1 tp -49.32 162.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.632 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -159.62 150.09 19.08 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.229 -0.294 . . . . 0.0 110.9 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.3 mm -86.34 124.86 40.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -76.82 160.4 29.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.448 0.642 . . . . 0.0 111.718 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -70.24 -41.08 74.01 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.615 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.558 ' O ' HG22 ' A' ' 134' ' ' VAL . 10.3 pt-20 -62.96 -26.14 68.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.674 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -72.97 -52.11 15.75 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.595 0.712 . . . . 0.0 111.162 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.413 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 3.6 m -77.02 -29.53 17.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.584 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.131 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -67.04 -45.85 76.19 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 122.259 -0.276 . . . . 0.0 111.105 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 130' ' ' GLU . 34.1 m -68.68 -46.56 79.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.917 0.389 . . . . 0.0 110.542 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.526 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -66.15 -44.28 91.44 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 85.1 tttt -67.12 -46.62 73.59 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 122.691 -0.299 . . . . 0.0 110.956 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -54.56 -47.8 72.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.952 0.406 . . . . 0.0 110.086 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.404 ' NZ ' ' OH ' ' A' ' 64' ' ' TYR . 32.9 ttmt -61.13 -52.22 65.77 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.623 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.39 -51.96 31.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.604 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -47.94 -38.56 16.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.79 -33.85 88.08 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.736 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -75.89 -32.85 59.85 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.561 0.696 . . . . 0.0 109.408 179.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -59.22 -30.12 68.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -68.35 -42.32 79.41 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.603 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.845 ' CG ' ' HB2' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -50.93 -58.57 5.69 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 114.088 -1.414 . . . . 0.0 112.154 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 1.024 HG23 HD13 ' A' ' 29' ' ' LEU . 23.1 mt -73.73 -49.47 35.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.164 -176.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 13.2 tt0 -45.98 -56.25 5.76 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.556 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 20.7 t -50.8 -47.55 59.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.321 0.581 . . . . 0.0 110.48 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.813 ' CG ' HD21 ' A' ' 29' ' ' LEU . 8.3 t80 -52.03 -51.88 54.54 Favored 'General case' 0 C--O 1.192 -1.934 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.837 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.9 mm? -62.45 -42.15 99.27 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 119.576 1.08 . . . . 0.0 112.208 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.47 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -62.99 -24.34 67.87 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 121.454 -0.779 . . . . 0.0 109.203 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.96 -12.95 15.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.097 0.475 . . . . 0.0 110.671 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.644 ' N ' ' O ' ' A' ' 149' ' ' TYR . 75.1 m80 -155.45 66.31 4.67 Favored Pre-proline 0 C--N 1.311 -1.103 0 C-N-CA 125.452 1.501 . . . . 0.0 110.162 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.55 -3.58 12.82 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 122.598 2.198 . . . . 0.0 111.597 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.57 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.7 OUTLIER -85.75 4.17 38.03 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 123.312 0.645 . . . . 0.0 111.67 -178.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.407 ' O ' ' HD3' ' A' ' 20' ' ' LYS . . . -49.53 130.01 19.82 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 120.062 -1.649 . . . . 0.0 111.264 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.642 ' CG ' HD13 ' A' ' 24' ' ' LEU . 2.8 t80 54.84 6.31 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.57 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 118.578 -0.725 . . . . 0.0 110.242 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.85 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.2 p . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.929 0.395 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.483 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 52.1 m-85 -99.36 111.66 23.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.735 177.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.7 m -96.48 140.17 31.51 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.958 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -138.73 134.49 33.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.21 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.44 ' HG2' HD12 ' A' ' 116' ' ' ILE . 0.8 OUTLIER -103.45 129.4 50.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.82 0.343 . . . . 0.0 111.024 -179.468 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -135.54 166.79 22.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.967 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.91 159.97 39.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.471 0.653 . . . . 0.0 112.593 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.474 ' CE1' ' O ' ' A' ' 10' ' ' THR . 81.6 t80 -151.01 140.85 21.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.365 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.474 ' O ' ' CE1' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -93.62 148.23 22.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.811 0.339 . . . . 0.0 111.363 -179.362 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 p -144.81 154.45 42.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.779 0.323 . . . . 0.0 110.698 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -96.72 25.06 5.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 110.555 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.684 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.3 mt -113.14 125.93 28.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.48 144.96 12.78 Favored 'Trans proline' 0 C--N 1.326 -0.616 0 C-N-CA 121.913 1.742 . . . . 0.0 111.735 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.638 ' CG ' ' HB2' ' A' ' 106' ' ' ALA . 31.2 Cg_exo -55.84 -24.64 48.21 Favored 'Trans proline' 0 N--CA 1.484 0.922 0 C-N-CA 122.457 2.105 . . . . 0.0 112.667 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.402 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 48.2 m -68.31 -36.19 78.94 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -178.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -76.36 -56.34 4.72 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.684 HD21 ' HB ' ' A' ' 13' ' ' ILE . 4.3 mt -48.48 -47.08 38.79 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.752 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.772 ' O ' HG22 ' A' ' 23' ' ' VAL . 39.0 t80 -49.43 -57.22 7.37 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.443 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.86 -24.46 63.43 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.364 -179.351 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.741 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -83.1 -2.69 56.05 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.373 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.433 ' CA ' ' HB2' ' A' ' 26' ' ' ALA . 2.1 m-85 -118.87 -8.23 10.32 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.896 HG23 ' CD1' ' A' ' 24' ' ' LEU . 2.8 m -134.07 -35.5 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.896 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.6 mp -90.71 -55.01 3.73 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.59 1.087 . . . . 0.0 111.922 -175.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 29' ' ' LEU . 17.4 t70 -113.59 -4.55 13.47 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.868 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -46.93 -42.25 17.41 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.511 ' HB3' ' HZ3' ' A' ' 54' ' ' LYS . 1.1 m-20 -84.95 18.3 2.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.67 0.748 . . . . 0.0 110.5 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -139.91 -9.79 1.17 Allowed 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 124.583 1.153 . . . . 0.0 108.555 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.996 HD13 HG23 ' A' ' 146' ' ' ILE . 0.5 OUTLIER -89.71 -45.78 9.08 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 124.513 1.125 . . . . 0.0 109.597 -178.693 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.616 HG13 HD11 ' A' ' 146' ' ' ILE . 26.3 mt -54.38 -53.99 53.29 Favored Pre-proline 0 C--O 1.214 -0.791 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 22.8 Cg_endo -60.78 -21.59 70.61 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 122.081 1.854 . . . . 0.0 111.542 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 tmtp? -69.12 -52.63 26.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.699 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.776 HG13 HD12 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -95.85 -36.5 6.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.077 -177.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.742 ' HB2' ' CG ' ' A' ' 145' ' ' LEU . . . -107.04 82.27 1.09 Allowed Pre-proline 0 CA--C 1.506 -0.717 0 C-N-CA 123.159 0.584 . . . . 0.0 111.573 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.36 -9.81 27.07 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 N-CA-C 107.476 -1.778 . . . . 0.0 107.476 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -73.95 -42.09 61.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.499 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.559 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -75.43 -82.34 0.07 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.751 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 89.1 mt -107.76 143.36 18.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.98 0.419 . . . . 0.0 110.655 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -79.83 -46.18 17.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.174 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.708 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -179.5 166.59 1.43 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.467 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.708 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -165.19 147.7 7.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.926 0.393 . . . . 0.0 111.044 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' N ' ' HE2' ' A' ' 54' ' ' LYS . 10.9 pt-20 -137.79 145.41 42.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.31 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.622 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -77.16 139.94 17.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.509 0.671 . . . . 0.0 110.716 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 7.5 mp -89.02 -39.27 13.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.787 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.876 ' O ' HG23 ' A' ' 52' ' ' THR . 28.0 mt-10 -147.41 136.72 22.52 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.425 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.63 -155.92 22.91 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.761 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -139.07 0.02 1.9 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 122.819 0.448 . . . . 0.0 110.749 -179.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.35 11.52 3.37 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.11 -172.2 19.53 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 117.349 0.574 . . . . 0.0 112.123 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -59.15 126.71 21.74 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 122.676 2.25 . . . . 0.0 113.275 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.5 2.73 56.51 Favored Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.876 HG23 ' O ' ' A' ' 45' ' ' GLU . 60.8 m -94.4 139.8 30.64 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.104 -1.048 . . . . 0.0 111.651 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.667 HD12 ' C ' ' A' ' 52' ' ' THR . 1.8 mp -120.08 126.26 75.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.622 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -114.28 139.02 49.76 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.362 0.601 . . . . 0.0 110.509 179.244 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.492 ' C ' HD12 ' A' ' 56' ' ' ILE . 34.5 ttpt -118.44 127.12 53.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.096 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.775 ' N ' HD12 ' A' ' 56' ' ' ILE . 1.8 mp -105.5 135.7 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.6 m -111.25 120.5 42.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.08 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 59' ' ' GLY . 4.6 t80 -91.69 179.29 5.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.671 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.429 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -54.39 143.93 30.07 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -60.65 -59.45 5.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.884 0.373 . . . . 0.0 110.994 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.72 61.79 3.42 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.5 t -137.66 175.22 9.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.87 0.367 . . . . 0.0 110.692 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -61.49 -45.08 95.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.685 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -91.87 155.07 18.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.537 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.4 -61.37 0.13 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.17 154.7 42.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.084 0.469 . . . . 0.0 110.63 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 p -155.49 146.95 12.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.024 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -105.66 114.97 29.45 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.31 0.576 . . . . 0.0 112.267 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.588 ' CE1' ' CD2' ' A' ' 85' ' ' LEU . 1.8 m80 -100.56 116.84 33.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.729 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -102.0 119.59 39.05 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.969 -0.457 . . . . 0.0 111.29 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.2 mt -77.74 145.61 9.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -106.53 -55.32 2.34 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.7 m -165.39 141.94 5.54 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.6 mt -123.16 131.18 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.287 176.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.2 m-20 -116.01 87.64 2.72 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.466 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 9.8 pt-20 -54.96 -30.25 58.62 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.71 -39.06 70.55 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.98 -10.11 15.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.094 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.543 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.9 m-85 63.28 41.6 7.67 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 121.676 -0.64 . . . . 0.0 110.21 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.1 t -107.55 149.11 28.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.051 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 27.3 p90 -151.56 124.04 8.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.216 0.531 . . . . 0.0 110.965 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.66 144.56 51.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.208 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -144.65 171.66 14.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.806 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 m -144.64 136.23 25.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.135 0.493 . . . . 0.0 110.554 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.635 HD13 ' HB1' ' A' ' 90' ' ' ALA . 9.1 mt -79.83 120.02 23.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.439 HG12 ' H ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -85.11 -43.31 16.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.612 -178.609 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.479 ' OE2' ' N ' ' A' ' 88' ' ' GLY . 3.2 tm-20 -153.14 170.26 20.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.731 0.3 . . . . 0.0 110.265 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.615 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 118.17 178.48 17.16 Favored Glycine 0 CA--C 1.507 -0.465 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 178.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -61.83 2.03 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.293 1.044 . . . . 0.0 108.711 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.635 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -67.26 -34.31 77.17 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 124.215 1.006 . . . . 0.0 110.439 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.897 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.25 16.15 21.9 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 123.305 0.642 . . . . 0.0 110.136 -177.348 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.4 p 47.36 -126.19 1.67 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.199 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -130.3 -13.05 3.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.769 0.318 . . . . 0.0 111.532 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.02 -7.04 19.48 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.778 HG21 ' CD1' ' A' ' 98' ' ' ILE . 63.7 mt -99.91 153.5 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 CA-C-O 121.8 0.809 . . . . 0.0 113.127 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.538 ' N ' HG22 ' A' ' 95' ' ' ILE . 5.9 pt-20 -99.41 -51.64 3.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.027 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.513 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 64.4 mttt -164.71 146.68 8.27 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 121.177 0.513 . . . . 0.0 111.915 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.778 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.3 122.5 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.33 144.91 30.74 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.478 ' CZ ' ' OG ' ' A' ' 117' ' ' SER . 0.6 OUTLIER -139.88 131.79 27.68 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.665 179.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.525 ' CD ' ' N ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -129.15 130.92 47.02 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.525 ' N ' ' CD ' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -140.93 132.88 27.68 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.523 -0.736 . . . . 0.0 111.227 179.532 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.647 ' C ' HD23 ' A' ' 104' ' ' LEU . 26.3 ttpp -122.87 134.69 54.38 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.128 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.843 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.37 125.74 43.63 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.221 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.462 HG12 ' NZ ' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -127.43 137.56 57.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.098 -178.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.638 ' HB2' ' CG ' ' A' ' 15' ' ' PRO . . . -72.3 133.71 45.15 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.368 178.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.441 ' SG ' ' N ' ' A' ' 111' ' ' SER . 27.1 p -121.66 174.25 6.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.945 0.402 . . . . 0.0 110.288 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.71 -34.51 56.39 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.6 m -79.31 -21.22 46.24 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.615 -1.521 . . . . 0.0 114.078 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.7 -88.45 0.12 Allowed Glycine 0 CA--C 1.524 0.626 0 C-N-CA 125.752 1.644 . . . . 0.0 109.5 -166.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.8 OUTLIER -159.39 129.37 5.61 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 126.006 1.722 . . . . 0.0 111.336 -179.043 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 105' ' ' VAL . 26.8 m -99.6 118.53 36.34 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.9 mt -92.32 132.05 37.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.428 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 102' ' ' THR . 7.2 mtpt -105.34 116.92 32.77 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.757 ' C ' HD13 ' A' ' 116' ' ' ILE . 40.0 p -111.1 118.21 35.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.28 0.562 . . . . 0.0 111.36 -178.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.936 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -102.59 135.76 38.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.478 ' OG ' ' CZ ' ' A' ' 100' ' ' TYR . 11.1 m -117.95 133.32 56.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.72 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -137.2 112.94 9.52 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.85 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -102.28 103.31 13.77 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.989 -0.444 . . . . 0.0 110.122 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -91.04 107.98 19.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.119 0.485 . . . . 0.0 110.147 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.438 HG22 HD11 ' A' ' 127' ' ' ILE . 11.3 p -100.52 175.47 5.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.582 0.706 . . . . 0.0 111.127 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.8 ptmm? -110.36 158.64 18.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.833 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 39.85 -111.13 0.2 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.802 ' H ' HD22 ' A' ' 124' ' ' ASN . 0.0 OUTLIER -112.75 0.4 15.27 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 122.502 -0.41 . . . . 0.0 111.515 179.339 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -44.39 160.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.155 0.502 . . . . 0.0 110.641 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.474 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 93.3 mt-10 -147.98 146.92 29.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.212 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 121' ' ' THR . 22.1 mm -89.16 122.07 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -75.59 162.43 28.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.439 0.638 . . . . 0.0 112.135 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -69.53 -55.02 11.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.667 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' A' ' 130' ' ' GLU . 1.5 pm0 -53.82 -24.25 14.91 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.931 -0.481 . . . . 0.0 110.992 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.513 ' CE1' ' OE2' ' A' ' 130' ' ' GLU . 9.8 m80 -73.55 -53.27 10.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.253 0.549 . . . . 0.0 110.067 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 3.9 m -77.81 -27.91 15.37 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.199 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -67.66 -46.1 73.36 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.979 -0.45 . . . . 0.0 110.928 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 130' ' ' GLU . 28.2 m -70.0 -42.93 79.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.663 0.268 . . . . 0.0 110.548 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.492 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -69.74 -46.47 53.58 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.462 ' HZ3' ' HB3' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -67.36 -47.08 71.47 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 122.692 -0.299 . . . . 0.0 110.712 179.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -55.16 -48.2 74.07 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -62.4 -51.87 65.83 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.62 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -50.08 -53.73 25.19 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.722 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -47.4 -38.91 14.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.771 0.796 . . . . 0.0 109.358 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.55 -32.73 84.24 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.674 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.6 OUTLIER -75.67 -36.3 60.14 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.698 0.761 . . . . 0.0 109.491 178.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -58.39 -25.47 62.13 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.57 -38.73 54.43 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.489 177.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.776 HD12 HG13 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -50.96 -58.64 5.53 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-O 122.442 1.115 . . . . 0.0 111.263 179.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.996 HG23 HD13 ' A' ' 29' ' ' LEU . 20.0 mt -72.81 -49.37 40.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.845 -177.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 38.2 tt0 -46.07 -52.17 12.48 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.547 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 24.7 p -54.09 -44.98 71.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.153 0.502 . . . . 0.0 110.637 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.732 ' CG ' HD21 ' A' ' 29' ' ' LEU . 11.2 t80 -53.89 -45.95 71.23 Favored 'General case' 0 C--O 1.183 -2.417 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.834 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.6 mm? -69.5 -42.5 74.66 Favored 'General case' 0 C--O 1.218 -0.591 0 O-C-N 120.592 -1.317 . . . . 0.0 111.887 -177.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.465 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.6 OUTLIER -63.72 -25.48 68.22 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 121.569 -0.707 . . . . 0.0 109.594 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 149' ' ' TYR . 0.2 OUTLIER -106.98 -12.93 15.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.406 0.622 . . . . 0.0 110.307 178.304 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.615 ' N ' ' O ' ' A' ' 149' ' ' TYR . 13.5 t-80 -154.67 65.97 4.97 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 124.98 1.312 . . . . 0.0 110.23 -177.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.59 -3.12 11.26 Favored 'Trans proline' 0 N--CA 1.482 0.799 0 C-N-CA 122.576 2.184 . . . . 0.0 111.616 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.617 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 1.9 m-20 -74.52 2.66 9.13 Favored 'General case' 0 C--O 1.213 -0.859 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.913 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.426 ' O ' ' HD2' ' A' ' 20' ' ' LYS . . . -50.33 129.48 21.7 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 119.354 -2.091 . . . . 0.0 110.996 -178.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.707 ' CG ' HD23 ' A' ' 24' ' ' LEU . 86.2 t80 53.03 5.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.544 0 O-C-N 121.179 -0.95 . . . . 0.0 110.069 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.805 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.1 p . . . . . 0 C--O 1.234 0.242 0 CA-C-O 121.028 0.442 . . . . 0.0 110.703 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.61 109.82 22.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.451 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.643 HG23 ' NE2' ' A' ' 118' ' ' HIS . 74.2 m -96.25 139.89 31.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.799 0.333 . . . . 0.0 111.004 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.08 130.56 25.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.08 179.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.492 ' C ' HD22 ' A' ' 7' ' ' ASN . 0.8 OUTLIER -103.24 128.39 50.27 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.735 0.303 . . . . 0.0 110.766 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.492 HD22 ' C ' ' A' ' 6' ' ' GLU . 1.5 m120 -126.73 168.37 14.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.519 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -155.2 142.48 19.44 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -146.57 139.92 25.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.629 0.252 . . . . 0.0 110.766 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.45 148.23 23.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 111.227 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.4 p -144.77 154.44 42.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.564 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -92.1 18.76 7.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.906 0.384 . . . . 0.0 110.786 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.587 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.8 mt -108.06 126.01 30.74 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.194 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.01 147.37 7.89 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 121.6 1.533 . . . . 0.0 111.392 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.644 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 12.9 Cg_endo -63.99 -23.68 67.59 Favored 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 122.503 2.135 . . . . 0.0 112.754 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.8 m -66.19 -32.28 73.62 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.633 ' N ' ' CD ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -81.73 -55.14 4.82 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -178.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.599 HD12 ' HA ' ' A' ' 15' ' ' PRO . 7.4 mt -47.05 -44.13 20.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.777 ' O ' HG22 ' A' ' 23' ' ' VAL . 54.7 t80 -51.79 -59.29 4.47 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.843 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.645 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -69.97 -23.37 63.16 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.698 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.734 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -82.25 -2.96 54.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.676 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CE2' ' OH ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -119.47 -9.22 9.89 Favored 'General case' 0 C--O 1.23 0.069 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.871 HG23 HD13 ' A' ' 24' ' ' LEU . 2.8 m -136.14 -37.02 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.909 HD23 ' CD2' ' A' ' 157' ' ' TYR . 3.4 mp -91.18 -52.89 4.6 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.208 0.913 . . . . 0.0 112.131 -176.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 93.0 m-20 -112.49 -4.18 14.26 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -55.02 -40.39 70.13 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 121.493 -0.755 . . . . 0.0 112.235 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -83.89 16.41 2.83 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.59 0.71 . . . . 0.0 110.905 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.499 ' C ' ' ND2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -139.46 -10.2 1.24 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.555 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.813 HD13 HG23 ' A' ' 146' ' ' ILE . 0.4 OUTLIER -88.15 -40.96 13.32 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.722 -1.127 . . . . 0.0 110.119 -178.294 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.641 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -54.14 -50.65 83.31 Favored Pre-proline 0 C--O 1.207 -1.141 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 19.2 Cg_endo -62.18 -24.88 76.63 Favored 'Trans proline' 0 C--N 1.319 -1.014 0 C-N-CA 121.682 1.588 . . . . 0.0 112.185 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -67.98 -62.26 1.49 Allowed 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 121.74 0.781 . . . . 0.0 112.076 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.474 ' CD1' ' O ' ' A' ' 145' ' ' LEU . 1.9 pt -95.29 -32.98 4.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.075 -177.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.841 ' HB2' ' HG ' ' A' ' 145' ' ' LEU . . . -101.97 74.29 0.14 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 123.746 0.818 . . . . 0.0 112.679 -175.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.74 -20.06 26.83 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 121.201 1.267 . . . . 0.0 109.081 175.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.646 HE21 ' N ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -72.99 -40.98 64.79 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.84 178.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.701 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -70.81 -82.13 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.94 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.614 HD12 ' C ' ' A' ' 37' ' ' ALA . 2.0 mp -112.54 145.09 19.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.145 0.498 . . . . 0.0 110.637 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -78.36 -47.1 18.4 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.329 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.686 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -173.86 164.54 4.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.986 0.422 . . . . 0.0 110.003 179.298 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.686 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -166.1 145.57 6.09 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.746 178.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -138.59 142.71 39.16 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.603 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -78.39 140.0 17.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.501 0.667 . . . . 0.0 110.513 -179.549 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 44' ' ' LEU . 6.6 mp -89.39 -40.5 12.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.66 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.989 ' O ' HG23 ' A' ' 52' ' ' THR . 27.8 mm-40 -137.52 133.6 34.74 Favored 'General case' 0 C--O 1.215 -0.753 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.67 -156.59 46.46 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.632 HD22 ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -135.79 -4.93 2.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.777 0.322 . . . . 0.0 111.32 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.632 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 142.09 18.94 0.28 Allowed Glycine 0 C--O 1.221 -0.718 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -109.86 -172.91 20.53 Favored Glycine 0 C--O 1.224 -0.51 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -62.08 125.06 15.58 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 122.443 2.095 . . . . 0.0 113.009 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.58 5.67 60.06 Favored Glycine 0 N--CA 1.464 0.509 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.989 HG23 ' O ' ' A' ' 45' ' ' GLU . 87.2 m -93.53 140.69 29.32 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.414 -0.893 . . . . 0.0 111.005 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.686 HD12 ' C ' ' A' ' 52' ' ' THR . 1.9 mp -122.5 128.84 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.603 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -116.45 139.36 50.53 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.272 0.558 . . . . 0.0 110.76 178.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.46 ' C ' HD12 ' A' ' 56' ' ' ILE . 32.9 ttpt -118.47 124.76 48.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.989 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.783 ' N ' HD12 ' A' ' 56' ' ' ILE . 1.7 mp -103.26 130.89 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.6 m -109.26 118.49 36.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.828 0.347 . . . . 0.0 110.28 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -92.83 -175.58 3.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.558 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.97 144.04 32.26 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -59.72 -62.77 1.62 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.881 0.372 . . . . 0.0 110.809 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.94 61.9 3.34 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.1 m -137.28 175.38 9.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.746 0.308 . . . . 0.0 110.69 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -55.1 -53.52 54.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.841 0.353 . . . . 0.0 110.561 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -91.99 154.57 18.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.381 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.39 -61.57 0.14 Allowed Glycine 0 N--CA 1.461 0.321 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -145.62 148.01 32.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.942 0.401 . . . . 0.0 110.377 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.76 145.57 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.821 0.343 . . . . 0.0 110.846 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -105.87 109.6 21.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.401 0.62 . . . . 0.0 111.558 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.521 ' NE2' ' CG ' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -106.38 113.73 27.43 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.245 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -102.31 130.05 48.91 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.623 HD13 HG22 ' A' ' 52' ' ' THR . 4.5 mp -70.63 141.14 17.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -99.37 -55.58 2.64 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -165.6 141.56 5.22 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.406 HD11 ' CG1' ' A' ' 23' ' ' VAL . 69.5 mt -130.01 129.87 65.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 120.968 0.413 . . . . 0.0 110.57 177.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 79' ' ' TYR . 39.2 m-20 -115.78 88.57 2.91 Favored 'General case' 0 C--O 1.212 -0.897 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -53.75 -30.08 42.71 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.89 -37.36 71.28 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.122 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -107.62 -11.21 15.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.806 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.547 ' N ' ' O ' ' A' ' 75' ' ' ASP . 32.0 m-85 60.2 45.0 12.05 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 121.797 -0.564 . . . . 0.0 110.339 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 p -112.92 148.98 33.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.498 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 6.2 p90 -147.62 127.64 13.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.251 0.548 . . . . 0.0 111.182 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 m -130.32 147.13 52.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.241 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.521 ' CG ' ' NE2' ' A' ' 69' ' ' HIS . 15.0 p90 -153.68 168.25 26.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.824 0.345 . . . . 0.0 110.184 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 98' ' ' ILE . 3.7 m -145.6 139.45 26.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.054 0.454 . . . . 0.0 111.388 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.586 HD13 ' HB1' ' A' ' 90' ' ' ALA . 4.9 mt -80.52 111.91 17.37 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.691 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -72.01 -41.81 68.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.252 -177.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.691 ' N ' HD13 ' A' ' 86' ' ' ILE . 17.4 tp10 -156.39 171.82 19.57 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.617 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.59 177.83 17.45 Favored Glycine 0 CA--C 1.508 -0.373 0 N-CA-C 110.214 -1.155 . . . . 0.0 110.214 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -61.21 2.15 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.617 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -67.61 -36.03 80.07 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.982 0.913 . . . . 0.0 110.094 177.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.929 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -111.8 13.26 21.01 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 123.694 0.797 . . . . 0.0 109.253 -178.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 47.1 p 48.07 -126.32 1.84 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -131.17 -9.23 3.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.092 0.472 . . . . 0.0 110.51 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.6 t -104.9 -6.66 19.97 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.762 HG21 ' CD1' ' A' ' 98' ' ' ILE . 57.6 mt -100.62 151.6 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.485 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -87.08 -58.83 2.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.514 177.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -170.55 148.77 3.13 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.191 0.52 . . . . 0.0 110.867 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.762 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.66 120.85 62.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.566 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.416 ' O ' ' CD1' ' A' ' 100' ' ' TYR . 9.5 t -109.65 145.5 36.38 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.375 0.607 . . . . 0.0 111.199 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 99' ' ' SER . 19.5 m-85 -135.69 129.41 32.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.221 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.428 ' O ' HG12 ' A' ' 116' ' ' ILE . 18.6 tt0 -127.8 133.72 49.45 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.32 136.37 36.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.859 0.361 . . . . 0.0 110.069 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -119.73 132.77 55.73 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -102.76 134.98 45.25 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.126 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.413 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.6 OUTLIER -137.05 136.77 47.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.994 -178.613 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.644 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -72.75 135.16 45.25 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.525 178.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.459 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 31.3 t -121.15 174.57 6.59 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.608 0.363 . . . . 0.0 110.161 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.459 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -55.8 -30.74 57.24 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 112.236 -0.346 . . . . 0.0 112.236 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.9 p -91.73 -12.47 33.87 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 119.552 -2.146 . . . . 0.0 115.634 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.16 -85.17 0.13 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.839 1.209 . . . . 0.0 111.407 -171.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.3 p -165.56 134.73 3.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.402 1.481 . . . . 0.0 110.858 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 105' ' ' VAL . 97.8 m -98.81 117.44 33.3 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.6 mt -92.81 127.54 44.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.69 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -104.25 116.23 31.8 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.782 ' C ' HD13 ' A' ' 116' ' ' ILE . 34.2 t -112.13 124.84 53.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.144 0.497 . . . . 0.0 111.432 -178.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.924 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -105.41 136.04 41.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 123.152 0.581 . . . . 0.0 109.486 -178.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.15 132.56 54.05 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.378 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.643 ' NE2' HG23 ' A' ' 4' ' ' THR . 26.1 m-70 -137.17 106.05 5.93 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 117.819 0.282 . . . . 0.0 110.91 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.805 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -101.45 103.83 14.75 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -89.97 109.8 20.81 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.18 0.514 . . . . 0.0 109.965 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.61 HG21 ' O ' ' A' ' 125' ' ' ILE . 0.6 OUTLIER -95.05 164.45 12.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.356 -178.219 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.491 ' H ' HG22 ' A' ' 125' ' ' ILE . 11.4 mtmt -92.46 146.92 23.31 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 34.0 -115.97 0.16 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.684 HD22 ' N ' ' A' ' 125' ' ' ILE . 0.4 OUTLIER -95.11 -13.73 24.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.812 0.339 . . . . 0.0 110.177 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.684 ' N ' HD22 ' A' ' 124' ' ' ASN . 1.1 tp -48.82 163.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -149.35 150.5 32.57 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.683 -0.635 . . . . 0.0 112.049 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.42 ' CD1' HG12 ' A' ' 95' ' ' ILE . 26.7 mm -86.67 124.89 40.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -75.25 160.79 29.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.587 0.708 . . . . 0.0 112.055 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -70.22 -43.57 70.38 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.382 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.441 ' O ' HG22 ' A' ' 134' ' ' VAL . 78.5 mt-10 -60.44 -24.87 65.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.348 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -72.7 -52.46 15.13 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.371 0.605 . . . . 0.0 110.86 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.5 m -76.09 -26.31 17.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.909 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -67.62 -46.27 73.02 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.403 -0.186 . . . . 0.0 111.094 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 135' ' ' GLY . 34.6 m -69.85 -43.99 79.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.478 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -66.13 -43.33 93.45 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -67.23 -46.98 72.17 Favored 'General case' 0 CA--C 1.518 -0.258 0 O-C-N 122.789 -0.242 . . . . 0.0 110.973 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -54.94 -47.63 74.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.879 0.371 . . . . 0.0 110.054 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.64 -55.13 22.18 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.494 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -47.67 -45.25 27.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.535 0.683 . . . . 0.0 110.776 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -56.83 -37.4 71.2 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.87 0.843 . . . . 0.0 109.3 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.16 -38.66 96.52 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.746 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -68.64 -36.53 78.72 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -59.04 -32.36 69.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.32 -34.44 77.36 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.868 177.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.841 ' HG ' ' HB2' ' A' ' 34' ' ' ALA . 1.2 mm? -68.27 -58.26 4.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.566 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.813 HG23 HD13 ' A' ' 29' ' ' LEU . 66.3 mt -60.79 -48.67 87.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.743 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -46.38 -52.96 11.89 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.14 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 21.5 p -50.17 -44.68 52.83 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.344 0.592 . . . . 0.0 111.349 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.683 ' CG ' HD21 ' A' ' 29' ' ' LEU . 32.9 t80 -58.5 -45.5 88.64 Favored 'General case' 0 C--O 1.182 -2.499 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.807 ' H ' HD22 ' A' ' 150' ' ' LEU . 2.0 mm? -65.06 -42.02 94.58 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 119.917 1.235 . . . . 0.0 111.966 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.463 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.4 OUTLIER -64.76 -24.98 67.73 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -106.58 -12.54 15.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.276 0.56 . . . . 0.0 110.961 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.68 ' N ' ' O ' ' A' ' 149' ' ' TYR . 94.1 m-70 -156.54 66.53 4.18 Favored Pre-proline 0 C--N 1.303 -1.429 0 C-N-CA 125.689 1.596 . . . . 0.0 110.59 -177.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.48 -2.72 11.15 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 122.468 2.112 . . . . 0.0 111.474 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.615 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -77.36 3.7 12.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.914 -178.472 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.08 129.28 17.54 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 119.269 -2.145 . . . . 0.0 111.186 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.909 ' CD2' HD23 ' A' ' 24' ' ' LEU . 23.6 t80 54.08 6.73 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.048 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.438 0 O-C-N 121.402 -0.811 . . . . 0.0 110.225 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.829 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.1 p . . . . . 0 C--O 1.234 0.238 0 CA-C-O 120.889 0.376 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -97.89 109.73 22.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.526 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.2 m -97.05 136.03 38.19 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.67 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -135.47 129.29 32.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.328 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.404 ' C ' ' ND2' ' A' ' 7' ' ' ASN . 1.2 tt0 -103.14 134.16 47.03 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.643 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.404 ' ND2' ' C ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -127.14 168.78 14.19 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.627 -179.25 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -150.71 140.31 21.61 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -144.42 129.15 18.25 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.515 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 m -100.42 144.05 29.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.787 0.327 . . . . 0.0 111.653 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.0 t -145.43 164.34 31.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.485 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -94.66 25.75 3.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.746 0.308 . . . . 0.0 111.16 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.589 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.3 mt -111.55 125.42 30.44 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.781 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 45.9 Cg_exo -50.42 147.56 16.54 Favored 'Trans proline' 0 C--N 1.327 -0.594 0 C-N-CA 121.953 1.769 . . . . 0.0 111.652 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.439 ' HA ' HD12 ' A' ' 18' ' ' LEU . 26.8 Cg_exo -58.3 -25.08 71.03 Favored 'Trans proline' 0 N--CA 1.483 0.863 0 C-N-CA 122.279 1.986 . . . . 0.0 112.623 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.48 ' C ' ' HZ2' ' A' ' 20' ' ' LYS . 55.4 m -67.62 -35.27 78.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.311 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -75.42 -57.06 4.12 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.589 HD11 ' O ' ' A' ' 13' ' ' ILE . 4.6 mt -50.17 -44.69 52.91 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.008 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.529 ' O ' HG22 ' A' ' 23' ' ' VAL . 55.7 t80 -49.4 -58.68 4.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.005 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.771 ' CB ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -67.57 -40.35 84.87 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 118.83 -1.148 . . . . 0.0 108.415 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.871 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -64.59 -2.99 2.7 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.445 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.487 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 4.0 m-85 -118.35 -9.26 10.42 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 19' ' ' PHE . 30.7 m -130.22 -50.95 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.021 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.9 pp -98.06 -31.32 12.2 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 1.021 ' N ' HD12 ' A' ' 24' ' ' LEU . 26.9 m-20 -114.21 -3.96 13.13 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-N 118.648 0.658 . . . . 0.0 111.555 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -66.88 -39.54 87.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.989 0.899 . . . . 0.0 111.187 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.52 16.99 3.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.125 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -138.35 -9.5 1.47 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.946 HD12 HG23 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -90.47 -50.22 6.07 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.585 -1.643 . . . . 0.0 109.631 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.601 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 96.0 mt -55.65 -51.6 78.87 Favored Pre-proline 0 C--O 1.212 -0.883 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.054 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 29.1 Cg_endo -62.49 -26.05 76.13 Favored 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 121.747 1.632 . . . . 0.0 112.948 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.54 -60.79 2.08 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.633 0.73 . . . . 0.0 112.435 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.561 HD13 ' HB2' ' A' ' 149' ' ' TYR . 1.9 pt -93.07 -33.03 5.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.583 -177.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.861 ' HB2' ' HG ' ' A' ' 145' ' ' LEU . . . -102.79 68.15 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 123.121 0.569 . . . . 0.0 112.311 -177.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.424 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 66.7 Cg_endo -72.89 -19.15 23.86 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 N-CA-C 108.726 -1.298 . . . . 0.0 108.726 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -73.4 -39.41 65.11 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.693 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.677 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -70.36 -82.15 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.69 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 73.3 mt -110.74 145.05 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.044 0.45 . . . . 0.0 110.588 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -77.8 -47.69 18.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.421 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.618 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -174.02 164.82 4.19 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.754 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.618 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -164.73 145.82 7.86 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.841 0.353 . . . . 0.0 110.993 178.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -137.63 145.5 42.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.716 0.293 . . . . 0.0 110.258 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.522 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -79.54 139.54 18.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.476 0.655 . . . . 0.0 110.654 -179.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 44' ' ' LEU . 6.9 mp -88.98 -39.48 13.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.795 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.944 ' O ' HG23 ' A' ' 52' ' ' THR . 42.9 mt-10 -141.89 133.57 27.0 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.843 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.24 -156.33 29.41 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.639 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -139.76 -8.3 1.24 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.96 0.41 . . . . 0.0 111.131 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.625 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 143.46 16.22 0.26 Allowed Glycine 0 C--O 1.219 -0.814 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.41 -172.04 19.99 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 117.394 0.597 . . . . 0.0 111.907 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -62.74 126.05 17.37 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 C-N-CA 122.858 2.372 . . . . 0.0 113.307 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.19 5.97 59.14 Favored Glycine 0 CA--C 1.506 -0.523 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.944 HG23 ' O ' ' A' ' 45' ' ' GLU . 92.7 m -93.18 138.65 31.39 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 114.239 -0.981 . . . . 0.0 110.949 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.89 128.46 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.522 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -116.79 139.79 50.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.726 0.774 . . . . 0.0 110.676 179.035 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.447 ' C ' HD12 ' A' ' 56' ' ' ILE . 46.7 tttm -118.47 127.84 54.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.828 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.757 ' N ' HD12 ' A' ' 56' ' ' ILE . 2.0 mp -104.47 136.61 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.9 m -117.15 120.0 36.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.368 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.04 169.06 10.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.365 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.11 143.99 28.82 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 0.8 OUTLIER -59.86 -50.38 74.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.849 0.357 . . . . 0.0 110.468 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.71 61.47 3.47 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.6 t -145.49 178.97 7.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 110.653 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -66.63 -45.68 78.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 0.0 110.626 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -91.46 154.74 18.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.397 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.44 -61.71 0.13 Allowed Glycine 0 CA--C 1.52 0.347 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.53 154.93 42.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.754 0.311 . . . . 0.0 110.28 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.83 149.95 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.723 0.297 . . . . 0.0 111.202 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.57 113.43 26.99 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.527 0.68 . . . . 0.0 112.044 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.607 ' CE1' ' CD1' ' A' ' 83' ' ' TYR . 6.7 t60 -109.63 112.08 23.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.721 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -102.4 131.44 49.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.144 0.497 . . . . 0.0 111.858 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.408 HD12 HG22 ' A' ' 52' ' ' THR . 13.8 mt -86.17 143.08 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -106.66 -54.89 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.2 m -164.81 141.92 6.14 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.459 HD12 ' O ' ' A' ' 48' ' ' GLY . 53.9 mt -124.81 131.26 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.872 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' A' ' 79' ' ' TYR . 5.8 m-20 -114.93 87.42 2.65 Favored 'General case' 0 C--O 1.21 -1.023 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.502 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 7.4 pt-20 -55.04 -30.63 59.97 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.57 -37.7 68.38 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.4 m -107.76 -10.46 15.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.922 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.56 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.2 m-85 62.84 44.57 6.19 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.625 -0.672 . . . . 0.0 109.865 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -105.96 145.66 31.03 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.469 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -132.13 120.82 22.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.191 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.473 ' CB ' ' OE1' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -127.11 133.25 50.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.321 -179.675 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.607 ' CD1' ' CE1' ' A' ' 69' ' ' HIS . 24.6 p90 -144.11 170.75 15.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.827 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.1 m -145.94 125.69 13.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.018 0.437 . . . . 0.0 110.876 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.529 HD12 HD21 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -79.08 118.25 20.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.673 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -85.75 -41.81 15.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -175.486 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.673 ' N ' HD13 ' A' ' 86' ' ' ILE . 10.0 tp10 -162.59 174.75 12.2 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 118.948 0.795 . . . . 0.0 110.816 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 119.76 178.31 16.38 Favored Glycine 0 CA--C 1.505 -0.578 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.6 2.75 0.16 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.758 ' C ' HD23 ' A' ' 91' ' ' LEU . . . -72.07 -37.38 69.64 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 123.917 0.887 . . . . 0.0 111.22 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.867 HD23 ' N ' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -111.29 17.04 20.61 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 119.672 -0.204 . . . . 0.0 110.625 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.4 p 54.25 -133.4 1.74 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -177.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -131.81 -0.7 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.5 p -104.72 -7.71 19.35 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.702 HG21 HD13 ' A' ' 98' ' ' ILE . 6.9 mt -99.2 151.25 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.481 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -87.07 -50.5 6.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.351 176.165 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.455 ' N ' ' HG2' ' A' ' 96' ' ' GLU . 12.1 ptmt -172.61 149.56 2.09 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.702 HD13 HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.9 130.38 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.155 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.434 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -113.15 144.26 42.96 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.902 0.481 . . . . 0.0 111.015 -179.037 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.489 ' CE1' ' OG ' ' A' ' 117' ' ' SER . 0.3 OUTLIER -139.22 131.55 28.39 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.87 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.473 ' OE1' ' CB ' ' A' ' 82' ' ' SER . 8.9 tp10 -128.73 133.0 48.01 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.408 ' N ' ' CD ' ' A' ' 101' ' ' GLU . 0.5 OUTLIER -136.26 131.63 34.71 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 121.596 -0.69 . . . . 0.0 110.631 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.734 ' C ' HD23 ' A' ' 104' ' ' LEU . 38.3 tttm -124.33 134.17 53.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.863 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.858 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -100.6 126.17 47.05 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -178.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -128.32 136.69 59.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.959 -178.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.68 133.42 44.61 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.117 -0.364 . . . . 0.0 110.596 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 24.7 t -121.7 173.35 7.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.547 0.339 . . . . 0.0 110.158 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.443 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -54.4 -36.61 58.3 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.901 -0.479 . . . . 0.0 111.901 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.9 m -93.98 15.94 15.66 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.25 1.42 . . . . 0.0 113.363 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 130.0 -83.99 0.32 Allowed Glycine 0 CA--C 1.534 1.235 0 C-N-CA 126.4 1.952 . . . . 0.0 113.095 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 84.1 p -161.62 132.13 5.04 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 126.99 2.116 . . . . 0.0 111.057 176.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 105' ' ' VAL . 45.0 m -99.83 118.12 35.61 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 60.5 mt -92.72 126.83 45.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.57 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.62 116.86 32.65 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.812 ' C ' HD13 ' A' ' 116' ' ' ILE . 1.9 p -111.62 124.3 52.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.335 0.588 . . . . 0.0 110.877 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.927 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -106.8 136.18 42.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 123.148 0.579 . . . . 0.0 109.922 -177.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.489 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 7.2 t -116.52 133.04 56.48 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.788 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.434 ' ND1' ' O ' ' A' ' 99' ' ' SER . 0.2 OUTLIER -136.47 109.35 7.61 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 120.766 0.317 . . . . 0.0 110.522 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.829 ' C ' HG23 ' A' ' 2' ' ' VAL . 7.3 m-85 -102.14 104.02 14.61 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.228 -0.295 . . . . 0.0 110.512 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -90.86 110.16 21.37 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.064 0.459 . . . . 0.0 109.823 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.4 p -94.1 171.3 8.93 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 122.021 0.915 . . . . 0.0 111.929 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.7 ptmm? -112.93 142.57 45.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.829 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 53.83 -109.68 1.19 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.615 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.1 OUTLIER -117.48 2.26 12.4 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 122.299 -0.53 . . . . 0.0 111.264 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.484 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.4 mp -43.45 161.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.344 0.592 . . . . 0.0 110.812 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.484 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 9.9 pt-20 -148.31 150.28 33.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.238 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.551 HD12 HD11 ' A' ' 95' ' ' ILE . 1.6 mm -87.78 125.62 41.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -74.88 160.89 30.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.11 0.481 . . . . 0.0 111.002 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -70.1 -39.7 75.37 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.566 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.584 ' O ' HG22 ' A' ' 134' ' ' VAL . 8.8 mm-40 -66.47 -25.15 66.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.587 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -72.42 -51.17 21.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.387 0.613 . . . . 0.0 110.81 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 m -78.42 -30.6 15.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.07 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -66.83 -46.0 76.5 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 122.156 -0.34 . . . . 0.0 111.077 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 130' ' ' GLU . 25.4 m -70.5 -44.71 76.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.611 0.243 . . . . 0.0 110.771 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.522 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -69.06 -46.83 57.3 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -67.45 -50.49 58.99 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.504 -0.409 . . . . 0.0 110.866 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -55.27 -47.77 74.98 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -63.15 -53.64 50.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.539 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -48.49 -47.86 38.34 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.412 0.625 . . . . 0.0 110.837 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -54.26 -37.61 64.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.02 -32.4 84.05 Favored Glycine 0 C--O 1.228 -0.247 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.712 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -74.61 -41.06 61.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -59.33 -25.72 64.42 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -76.29 -33.76 59.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.85 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.861 ' HG ' ' HB2' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -66.26 -56.78 9.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.1 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.946 HG23 HD12 ' A' ' 29' ' ' LEU . 61.9 mt -65.02 -48.73 82.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.653 -178.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -47.0 -47.57 22.01 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.158 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.0 t -54.84 -42.95 72.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.469 0.652 . . . . 0.0 111.26 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.636 ' O ' ' N ' ' A' ' 153' ' ' HIS . 26.8 t80 -59.08 -44.67 91.92 Favored 'General case' 0 C--O 1.191 -1.997 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.871 HD11 ' HB2' ' A' ' 21' ' ' ALA . 1.9 mm? -66.21 -42.48 88.7 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 119.491 1.041 . . . . 0.0 111.794 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.458 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -62.57 -24.83 67.75 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 121.525 -0.734 . . . . 0.0 109.329 179.511 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.438 ' O ' ' ND1' ' A' ' 153' ' ' HIS . 28.6 t70 -106.22 -13.42 15.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.034 0.445 . . . . 0.0 110.774 178.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.636 ' N ' ' O ' ' A' ' 149' ' ' TYR . 54.4 m80 -155.82 66.8 4.63 Favored Pre-proline 0 C--N 1.309 -1.168 0 C-N-CA 125.425 1.49 . . . . 0.0 110.43 -178.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -74.18 -3.37 13.7 Favored 'Trans proline' 0 C--N 1.324 -0.739 0 C-N-CA 122.579 2.186 . . . . 0.0 111.522 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.612 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 4.0 p-10 -81.95 4.82 21.16 Favored 'General case' 0 C--O 1.21 -0.975 0 C-N-CA 123.953 0.901 . . . . 0.0 111.991 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.401 ' O ' ' CD ' ' A' ' 20' ' ' LYS . . . -49.35 129.79 18.96 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 119.325 -2.11 . . . . 0.0 111.395 -178.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.526 ' CD2' HD22 ' A' ' 24' ' ' LEU . 13.6 t80 55.0 6.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.612 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.197 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.823 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.4 p . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.901 0.381 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.76 111.82 23.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.345 177.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.3 m -96.09 134.82 38.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.002 0.43 . . . . 0.0 110.2 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.688 ' CE2' ' ND2' ' A' ' 7' ' ' ASN . 0.2 OUTLIER -131.54 122.19 25.72 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.688 ' C ' HD22 ' A' ' 7' ' ' ASN . 1.5 tt0 -117.04 127.8 54.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.149 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.688 HD22 ' C ' ' A' ' 6' ' ' GLU . 1.4 m-80 -138.26 175.74 9.31 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.591 0.234 . . . . 0.0 110.818 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -144.31 156.17 44.14 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -149.86 134.04 17.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.954 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -92.91 144.84 24.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.859 0.362 . . . . 0.0 111.803 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.45 154.02 50.0 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.114 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -96.38 28.18 3.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.044 0.45 . . . . 0.0 110.715 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.694 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.5 mt -119.04 126.03 27.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.73 -178.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -46.99 145.64 6.94 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 121.823 1.682 . . . . 0.0 111.758 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -55.78 -29.73 73.14 Favored 'Trans proline' 0 N--CA 1.482 0.805 0 C-N-CA 122.263 1.975 . . . . 0.0 112.808 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.9 m -63.86 -35.46 80.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -74.96 -59.2 2.84 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.694 HD21 ' HB ' ' A' ' 13' ' ' ILE . 2.3 mt -50.88 -42.41 59.05 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.967 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.732 ' O ' HG22 ' A' ' 23' ' ' VAL . 40.8 t80 -50.24 -57.44 7.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.675 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.836 ' CB ' HD21 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.89 -40.74 75.49 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 118.572 -1.251 . . . . 0.0 109.102 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.847 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -63.49 -2.74 1.7 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.648 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.488 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 5.4 t80 -118.96 -9.35 10.08 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.886 HG23 HD13 ' A' ' 24' ' ' LEU . 3.6 m -132.54 -49.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.98 ' H ' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -99.09 -31.56 11.71 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.033 1.288 . . . . 0.0 112.03 -178.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.813 ' N ' HD22 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -107.68 -3.97 18.66 Favored 'General case' 0 C--O 1.211 -0.953 0 O-C-N 122.082 -0.386 . . . . 0.0 111.432 -178.511 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -67.05 -40.33 87.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.742 0.782 . . . . 0.0 111.728 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -84.02 13.89 4.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.837 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.436 ' H ' ' H ' ' A' ' 29' ' ' LEU . 65.3 m-20 -134.85 -9.34 2.37 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.898 HD12 HG23 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -96.71 -48.13 5.61 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.949 -179.693 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.702 HG13 HD11 ' A' ' 146' ' ' ILE . 74.8 mt -54.45 -56.1 30.38 Favored Pre-proline 0 C--O 1.217 -0.624 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 34.9 Cg_endo -63.37 -26.32 71.11 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 C-N-CA 122.298 1.999 . . . . 0.0 113.886 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -71.69 -49.41 39.9 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.601 0.715 . . . . 0.0 111.896 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.755 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.7 OUTLIER -94.76 -34.81 5.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.674 -177.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.783 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.58 64.07 0.14 Allowed Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.5 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 73.0 Cg_endo -76.59 -24.46 10.37 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 N-CA-C 107.909 -1.612 . . . . 0.0 107.909 174.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -73.79 -44.2 56.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.411 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.783 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -71.11 -77.76 0.09 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.15 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 mt -100.32 146.22 9.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 121.085 0.469 . . . . 0.0 110.191 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -78.08 -53.18 7.68 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.22 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.715 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -173.14 165.86 4.92 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.157 0.503 . . . . 0.0 110.578 179.758 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.715 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -166.07 145.21 6.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.966 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -149.2 142.34 24.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.897 0.38 . . . . 0.0 110.412 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.625 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -78.74 140.72 16.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.358 0.599 . . . . 0.0 111.201 -179.356 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.761 ' N ' HD12 ' A' ' 44' ' ' LEU . 3.7 mp -90.47 -39.86 12.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.494 178.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 52' ' ' THR . 13.9 mm-40 -143.23 134.87 26.47 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.306 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.95 -155.02 22.23 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.991 -0.443 . . . . 0.0 111.991 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.751 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -135.53 -11.72 2.1 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 123.416 0.686 . . . . 0.0 111.315 -177.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.604 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 135.2 12.23 1.28 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -178.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -110.63 -172.28 19.87 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -59.05 127.24 23.5 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 122.479 2.119 . . . . 0.0 113.283 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.84 4.8 55.54 Favored Glycine 0 N--CA 1.462 0.384 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 45' ' ' GLU . 19.3 m -94.18 142.06 27.84 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.626 -0.787 . . . . 0.0 111.883 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.634 HD12 ' C ' ' A' ' 52' ' ' THR . 1.8 mp -118.17 132.86 66.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 176.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.625 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -121.82 139.39 53.67 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.465 0.65 . . . . 0.0 111.148 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.692 ' HB3' HD11 ' A' ' 44' ' ' LEU . 26.2 ttpt -119.23 118.73 32.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.293 178.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.23 137.69 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.634 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.1 m -118.97 117.77 29.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.165 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -94.91 -175.14 3.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.434 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.59 144.39 30.08 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 7.3 mp0 -60.18 -59.48 5.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.924 0.392 . . . . 0.0 110.29 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.98 60.82 3.43 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.6 m -138.89 -178.13 5.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.129 0.49 . . . . 0.0 110.706 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.585 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 1.8 mp0 -68.4 -44.14 75.74 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.441 ' CD1' ' OD2' ' A' ' 89' ' ' ASP . 52.2 m-85 -91.58 145.12 24.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.97 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.3 -62.08 0.12 Allowed Glycine 0 CA--C 1.519 0.299 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -146.14 151.91 38.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.843 0.354 . . . . 0.0 110.494 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -157.21 150.29 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.946 0.403 . . . . 0.0 111.279 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.58 ' HB3' HD11 ' A' ' 86' ' ' ILE . 28.2 mmtt -105.57 106.79 17.45 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.175 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.476 ' CD2' ' C ' ' A' ' 69' ' ' HIS . 1.2 t-160 -105.24 111.02 23.61 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -105.2 128.83 53.6 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.816 0.341 . . . . 0.0 111.497 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.485 HD13 ' CG2' ' A' ' 52' ' ' THR . 2.9 mp -74.03 144.96 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -98.89 -55.51 2.69 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.792 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.9 m -165.94 141.22 4.8 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.5 mt -123.41 131.8 72.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 176.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 79' ' ' TYR . 2.8 m-20 -115.92 87.96 2.79 Favored 'General case' 0 C--O 1.208 -1.125 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -54.39 -29.89 50.26 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.73 75.66 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.023 177.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -107.11 -11.3 15.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.052 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.574 ' N ' ' O ' ' A' ' 75' ' ' ASP . 9.0 m-85 60.3 44.16 12.78 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.537 -0.727 . . . . 0.0 110.45 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 34.4 t -109.75 146.24 35.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.835 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -131.65 123.29 27.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.004 0.43 . . . . 0.0 111.111 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.35 134.65 48.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.056 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -143.93 166.03 26.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.903 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.0 m -145.9 135.3 23.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.17 0.509 . . . . 0.0 111.189 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.589 HD13 ' HB1' ' A' ' 90' ' ' ALA . 10.2 mt -80.75 117.09 21.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.58 HD11 ' HB3' ' A' ' 68' ' ' LYS . 4.1 pt -81.68 -44.58 20.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.798 0.332 . . . . 0.0 111.487 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.468 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 19.9 tt0 -151.42 172.5 15.86 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.761 0.315 . . . . 0.0 110.451 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.74 177.23 18.44 Favored Glycine 0 CA--C 1.509 -0.287 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.441 ' OD2' ' CD1' ' A' ' 64' ' ' TYR . 6.4 p30 -61.27 1.12 0.21 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.589 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -62.92 -35.3 79.62 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.004 0.922 . . . . 0.0 109.931 177.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.878 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.89 12.66 22.25 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 123.802 0.841 . . . . 0.0 109.575 -177.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.1 p 47.82 -126.3 1.78 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -130.44 -11.3 4.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.991 0.425 . . . . 0.0 111.07 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.4 -6.72 19.29 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.747 HG21 ' CD1' ' A' ' 98' ' ' ILE . 96.3 mt -98.16 152.01 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-O 122.251 1.024 . . . . 0.0 113.56 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.546 ' OE2' ' CE1' ' A' ' 120' ' ' HIS . 0.0 OUTLIER -91.08 -54.12 4.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.932 177.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.66 145.74 1.57 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.038 0.447 . . . . 0.0 111.943 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.747 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.41 132.64 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.222 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.472 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 0.3 OUTLIER -119.36 144.87 46.64 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.723 0.409 . . . . 0.0 111.51 -178.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.472 ' CD2' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -136.35 130.26 32.58 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.798 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.506 ' O ' HG12 ' A' ' 116' ' ' ILE . 30.3 tt0 -129.41 134.14 47.7 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.524 0.202 . . . . 0.0 110.511 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.7 OUTLIER -132.27 135.56 46.33 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.922 -0.486 . . . . 0.0 109.719 -179.037 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -119.53 133.82 55.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.58 126.07 40.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.466 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.27 135.25 47.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.422 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -73.33 138.72 45.56 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 121.936 -0.477 . . . . 0.0 110.304 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 52.4 t -121.34 170.39 9.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.889 0.376 . . . . 0.0 110.317 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.551 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.56 -34.75 50.13 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.9 m -85.41 -15.06 44.3 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.112 1.365 . . . . 0.0 114.321 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.18 -85.64 0.13 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.92 1.724 . . . . 0.0 111.396 -171.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.468 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 41.2 t -161.32 132.73 5.48 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.654 1.582 . . . . 0.0 111.221 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 55.0 m -99.92 128.76 45.98 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.299 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.2 mt -101.51 127.79 54.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.548 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 102' ' ' THR . 3.3 mtpt -105.37 116.89 32.71 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.849 ' C ' HD13 ' A' ' 116' ' ' ILE . 0.9 OUTLIER -111.68 123.08 49.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.954 0.407 . . . . 0.0 110.548 -178.307 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.9 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -109.65 136.39 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.358 -177.496 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.3 t -118.05 133.24 56.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.544 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.472 ' ND1' ' O ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -136.79 103.81 5.31 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 120.913 0.387 . . . . 0.0 110.176 -179.407 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.823 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -97.33 108.41 21.13 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.029 -0.42 . . . . 0.0 110.524 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.546 ' CE1' ' OE2' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -88.98 104.74 17.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.793 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.3 p -88.52 170.42 10.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.996 0.903 . . . . 0.0 111.731 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -113.02 156.26 23.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.882 179.424 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . 35.07 -109.24 0.06 OUTLIER Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 124' ' ' ASN . 4.4 t30 -111.41 -2.79 15.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.939 0.399 . . . . 0.0 111.063 178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.3 mp -43.21 160.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.274 0.559 . . . . 0.0 110.572 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.429 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 34.7 tt0 -152.54 148.7 27.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.284 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.2 mm -88.15 124.79 41.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -74.74 161.72 29.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.421 0.629 . . . . 0.0 111.698 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -69.72 -41.74 74.94 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.775 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 134' ' ' VAL . 53.6 mt-10 -62.25 -27.09 68.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.713 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -73.03 -49.99 25.6 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.417 0.627 . . . . 0.0 111.342 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 m -77.61 -29.86 16.57 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.192 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -67.15 -45.73 76.18 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.22 -0.3 . . . . 0.0 110.96 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 130' ' ' GLU . 34.1 m -67.99 -44.25 85.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.792 0.329 . . . . 0.0 110.287 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -67.37 -39.18 91.68 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -67.05 -47.22 71.99 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.711 -0.288 . . . . 0.0 110.661 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -55.2 -46.81 75.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.949 0.404 . . . . 0.0 110.201 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -64.71 -52.51 56.77 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.454 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.47 -42.66 43.86 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.55 0.691 . . . . 0.0 110.56 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . 0.414 ' O ' ' ND1' ' A' ' 140' ' ' HIS . 1.3 t60 -60.97 -36.09 78.51 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.891 0.853 . . . . 0.0 109.51 178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.411 ' O ' HD22 ' A' ' 145' ' ' LEU . . . -61.23 -44.79 97.66 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -65.57 -40.54 92.89 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -59.79 -28.69 67.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -77.49 -35.9 53.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.286 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.761 HD23 ' HB2' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -68.26 -57.69 5.58 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.514 0.674 . . . . 0.0 110.23 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.898 HG23 HD12 ' A' ' 29' ' ' LEU . 45.1 mt -58.21 -50.04 79.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.661 -177.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -46.87 -55.21 8.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.622 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 41.8 t -52.91 -44.49 66.99 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.508 0.671 . . . . 0.0 110.971 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.658 ' HB2' HD13 ' A' ' 33' ' ' ILE . 24.8 t80 -58.58 -45.58 88.74 Favored 'General case' 0 C--O 1.194 -1.832 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.847 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.2 mm? -66.22 -43.18 87.42 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 120.257 1.389 . . . . 0.0 111.565 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -61.5 -24.09 66.36 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 121.489 -0.757 . . . . 0.0 109.159 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.469 ' OD2' ' CE1' ' A' ' 153' ' ' HIS . 10.6 t70 -105.73 -13.26 15.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.46 0.648 . . . . 0.0 110.595 178.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 149' ' ' TYR . 56.0 m80 -155.51 67.14 4.89 Favored Pre-proline 0 C--N 1.312 -1.05 0 C-N-CA 125.199 1.4 . . . . 0.0 110.101 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.51 -3.62 14.02 Favored 'Trans proline' 0 N--CA 1.481 0.756 0 C-N-CA 122.566 2.177 . . . . 0.0 111.576 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.618 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.5 OUTLIER -83.9 5.16 26.37 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.953 -179.026 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -48.97 129.89 17.83 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 119.594 -1.941 . . . . 0.0 111.394 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.687 ' CG ' HD23 ' A' ' 24' ' ' LEU . 0.3 OUTLIER 56.11 6.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.987 0.515 . . . . 0.0 112.059 178.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.618 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.202 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.828 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.3 p . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.829 0.347 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.76 109.7 22.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.601 177.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.7 m -96.53 137.27 35.86 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.313 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -135.52 129.18 32.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.471 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.471 ' C ' HD22 ' A' ' 7' ' ' ASN . 1.5 tt0 -103.36 129.39 50.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.94 0.4 . . . . 0.0 110.749 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.56 ' ND2' ' N ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -142.89 164.75 29.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -178.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -155.51 159.53 39.82 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -144.56 140.78 29.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.341 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.03 147.68 24.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 111.521 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.3 t -145.36 164.2 32.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.688 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -102.88 23.98 11.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.891 0.376 . . . . 0.0 110.843 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.686 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.7 mt -112.57 126.61 28.05 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.627 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -47.35 144.21 10.05 Favored 'Trans proline' 0 C--N 1.326 -0.613 0 C-N-CA 122.019 1.813 . . . . 0.0 111.974 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.505 ' HA ' HD12 ' A' ' 18' ' ' LEU . 39.6 Cg_exo -55.45 -24.55 44.26 Favored 'Trans proline' 0 N--CA 1.484 0.931 0 C-N-CA 122.361 2.04 . . . . 0.0 112.7 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.444 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 13.2 p -70.08 -37.04 75.36 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.425 HH21 ' HD2' ' A' ' 17' ' ' ARG . 4.5 mtt85 -75.22 -47.65 27.17 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.686 HD11 ' O ' ' A' ' 13' ' ' ILE . 5.2 mt -57.42 -48.29 79.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.554 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.741 ' O ' HG22 ' A' ' 23' ' ' VAL . 48.5 t80 -46.18 -57.51 4.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.081 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -69.72 -26.02 64.13 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.579 0.704 . . . . 0.0 109.953 -179.296 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.854 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -83.72 -2.57 56.53 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.293 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.484 ' CA ' ' HB2' ' A' ' 26' ' ' ALA . 1.6 t80 -117.55 -9.02 10.89 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.878 HG23 ' CD1' ' A' ' 24' ' ' LEU . 2.3 m -134.62 -36.76 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.878 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.5 mp -92.29 -53.06 4.38 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.185 0.902 . . . . 0.0 111.391 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.57 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.4 m-20 -114.37 13.8 17.83 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 116.846 -0.161 . . . . 0.0 111.358 -176.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -66.9 -42.17 85.93 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 121.244 0.545 . . . . 0.0 111.192 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -83.94 18.59 1.99 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.075 0.941 . . . . 0.0 110.259 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -135.95 -9.11 2.07 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.894 HD12 HG23 ' A' ' 146' ' ' ILE . 0.1 OUTLIER -90.65 -51.31 5.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.493 -1.685 . . . . 0.0 110.706 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.626 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -58.5 -52.16 76.63 Favored Pre-proline 0 C--O 1.215 -0.723 0 CA-C-O 120.777 0.323 . . . . 0.0 110.742 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 22.8 Cg_endo -60.5 -21.79 69.6 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 C-N-CA 122.632 2.222 . . . . 0.0 112.763 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -75.22 -52.06 11.82 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.839 0.352 . . . . 0.0 111.07 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -95.2 -35.04 5.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.159 -177.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.827 ' HB2' ' CG ' ' A' ' 145' ' ' LEU . . . -106.77 81.54 0.91 Allowed Pre-proline 0 CA--C 1.507 -0.679 0 C-N-CA 122.78 0.432 . . . . 0.0 111.728 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.15 -10.71 27.84 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 N-CA-C 107.227 -1.874 . . . . 0.0 107.227 174.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -42.29 58.24 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.402 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.512 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -73.79 -82.03 0.06 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.874 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.1 mm -107.63 142.82 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.965 0.412 . . . . 0.0 110.974 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -79.73 -45.12 19.48 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.67 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.687 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -178.6 166.28 1.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.814 179.024 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.687 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -166.13 145.06 5.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.241 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -141.43 146.05 36.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.208 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.417 HG13 ' H ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -79.67 139.6 18.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.471 0.653 . . . . 0.0 110.703 -179.4 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.3 mp -88.52 -39.87 13.85 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.129 -0.942 . . . . 0.0 108.684 178.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.911 ' O ' HG23 ' A' ' 52' ' ' THR . 24.1 mt-10 -142.52 133.75 26.13 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.976 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.58 -156.15 24.57 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.734 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -139.76 -10.62 1.18 Allowed 'General case' 0 C--N 1.32 -0.698 0 O-C-N 122.529 -0.394 . . . . 0.0 110.975 -179.613 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.499 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 143.6 13.09 0.32 Allowed Glycine 0 C--O 1.221 -0.718 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.26 -171.24 20.67 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 117.344 0.572 . . . . 0.0 112.089 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -62.53 126.15 17.73 Favored 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 123.024 2.483 . . . . 0.0 113.58 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.27 5.84 56.94 Favored Glycine 0 N--CA 1.463 0.479 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.911 HG23 ' O ' ' A' ' 45' ' ' GLU . 88.3 m -93.37 140.5 29.5 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.271 -0.964 . . . . 0.0 111.145 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -119.18 129.98 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.498 ' HB3' ' HZ3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -118.16 140.93 49.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.074 0.464 . . . . 0.0 111.047 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -118.96 128.64 54.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.173 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.681 ' N ' HD12 ' A' ' 56' ' ' ILE . 3.2 mp -105.21 125.36 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.715 -0.394 . . . . 0.0 109.956 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.1 m -102.54 118.61 37.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -92.62 -174.83 3.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.76 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.73 143.86 31.61 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 8.9 mp0 -60.72 -63.57 1.25 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.909 0.385 . . . . 0.0 110.653 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.77 62.2 3.36 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.8 t -136.7 178.52 7.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.908 0.385 . . . . 0.0 110.754 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -60.81 -49.66 76.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.745 0.307 . . . . 0.0 111.018 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -91.92 137.83 32.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.496 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.4 -58.72 0.52 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.439 ' CD2' ' N ' ' A' ' 66' ' ' TYR . 7.3 p90 -145.71 152.42 39.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.001 0.429 . . . . 0.0 110.652 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 87' ' ' GLU . 7.3 p -156.69 141.99 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.844 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.467 ' O ' ' CD1' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -108.2 118.6 37.18 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 122.705 1.24 . . . . 0.0 112.735 -178.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.602 ' CE1' ' CD2' ' A' ' 83' ' ' TYR . 1.7 t60 -100.43 119.23 38.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.977 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -102.39 126.65 49.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.046 0.451 . . . . 0.0 111.576 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.2 mt -84.69 137.2 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -99.44 -55.98 2.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.8 m -165.26 141.87 5.63 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 48' ' ' GLY . 59.7 mt -126.6 131.07 71.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.939 176.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 79' ' ' TYR . 43.1 m-20 -115.06 88.48 2.88 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.489 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 6.7 mt-10 -54.45 -30.37 52.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.92 -39.02 76.97 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.561 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -107.95 -10.42 15.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.213 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.5 m-85 63.17 47.15 4.25 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 121.537 -0.727 . . . . 0.0 109.886 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 p -105.86 142.72 35.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.749 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.406 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 17.3 t80 -132.67 120.73 22.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.814 0.34 . . . . 0.0 110.641 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 p -127.07 129.62 48.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.341 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.679 ' CE2' ' CD1' ' A' ' 100' ' ' TYR . 34.5 p90 -144.97 164.59 30.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.033 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.6 m -146.09 125.6 13.23 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.115 0.483 . . . . 0.0 111.069 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.546 HD22 ' HA ' ' A' ' 69' ' ' HIS . 0.2 OUTLIER -80.17 121.67 25.86 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.582 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.738 HD13 ' H ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -83.72 -43.51 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -175.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.738 ' H ' HD13 ' A' ' 86' ' ' ILE . 6.0 tt0 -162.69 178.62 8.34 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.28 -0.888 . . . . 0.0 110.481 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.604 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.87 178.71 18.34 Favored Glycine 0 CA--C 1.504 -0.646 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.48 2.63 0.16 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.804 ' C ' HD23 ' A' ' 91' ' ' LEU . . . -71.96 -38.03 69.82 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 123.572 0.749 . . . . 0.0 110.94 178.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.858 HD23 ' N ' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -111.37 17.46 20.14 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 93' ' ' ASP . 6.9 p 57.11 -133.94 1.27 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.433 ' N ' ' OG1' ' A' ' 92' ' ' THR . 52.3 t0 -130.66 0.39 4.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.8 p -104.91 -8.41 18.66 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.382 -0.824 . . . . 0.0 113.124 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.688 HG21 HD13 ' A' ' 98' ' ' ILE . 4.6 mt -100.12 151.39 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.47 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -86.56 -50.75 6.61 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.285 176.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HA ' ' CD1' ' A' ' 91' ' ' LEU . 13.0 ptpt -171.72 148.98 2.49 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.688 HD13 HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.97 129.02 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.465 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.584 ' C ' ' HD1' ' A' ' 118' ' ' HIS . 0.3 OUTLIER -119.69 145.3 46.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.847 -179.302 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.679 ' CD1' ' CE2' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -142.89 135.66 27.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.733 0.301 . . . . 0.0 110.497 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -130.62 132.46 45.49 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.2 OUTLIER -131.73 133.83 45.23 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.09 -0.381 . . . . 0.0 110.511 -178.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -119.9 133.17 55.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -97.98 132.33 43.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -178.201 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.36 137.18 52.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.105 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.94 134.68 44.84 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.411 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.541 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 43.1 t -121.32 171.16 8.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.79 0.329 . . . . 0.0 110.253 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.541 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.51 -34.68 49.74 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 112.08 -0.408 . . . . 0.0 112.08 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.5 p -89.83 -13.38 36.67 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 118.765 -2.609 . . . . 0.0 114.116 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.64 -80.76 0.12 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.411 1.481 . . . . 0.0 112.401 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 83.3 p -161.51 131.54 4.88 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 126.577 1.951 . . . . 0.0 111.178 176.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.1 m -99.9 118.74 36.97 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 36.5 mt -92.34 127.49 44.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.121 -178.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -105.26 116.33 31.77 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.551 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.769 ' C ' HD13 ' A' ' 116' ' ' ILE . 69.2 p -111.93 123.97 51.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.199 0.523 . . . . 0.0 111.302 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.949 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -105.44 136.05 41.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -178.32 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.7 m -114.49 135.19 54.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.05 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.584 ' HD1' ' C ' ' A' ' 99' ' ' SER . 0.4 OUTLIER -137.24 109.17 7.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 110.433 -179.315 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.828 ' C ' HG23 ' A' ' 2' ' ' VAL . 5.4 m-85 -102.46 104.1 14.53 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -90.39 109.62 20.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.017 0.436 . . . . 0.0 109.852 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.2 p -93.93 169.9 9.95 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.952 0.882 . . . . 0.0 111.657 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -113.31 157.47 21.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.055 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 40.7 -109.73 0.16 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.546 HD22 ' N ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -116.19 7.51 14.13 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 122.703 -0.292 . . . . 0.0 111.396 179.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.546 ' N ' HD22 ' A' ' 124' ' ' ASN . 1.5 mp -48.35 161.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.311 0.577 . . . . 0.0 110.761 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.49 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 9.2 pt-20 -148.67 149.59 31.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.228 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.594 HD12 HD11 ' A' ' 95' ' ' ILE . 2.7 mm -87.69 124.5 40.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -75.92 160.09 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.561 0.696 . . . . 0.0 111.665 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -70.47 -47.34 61.09 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.446 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.542 ' O ' HG22 ' A' ' 134' ' ' VAL . 49.5 mt-10 -59.96 -24.52 64.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.6 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.59 ' C ' ' HD1' ' A' ' 131' ' ' HIS . 2.1 t-80 -72.08 -53.91 11.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.365 0.602 . . . . 0.0 110.718 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 m -77.32 -28.11 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.167 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -67.03 -46.53 74.16 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.224 -0.298 . . . . 0.0 111.069 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 130' ' ' GLU . 28.0 m -70.55 -44.18 77.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.678 0.275 . . . . 0.0 110.491 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.507 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -67.97 -41.49 87.53 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -67.13 -51.02 59.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.804 0.302 . . . . 0.0 111.02 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -56.63 -48.27 77.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 110.325 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -63.03 -51.38 66.97 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.61 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.71 -54.74 17.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.597 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -47.43 -38.67 13.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.342 0.591 . . . . 0.0 109.635 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.12 -31.5 80.93 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.667 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.8 OUTLIER -74.99 -38.53 61.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.67 0.748 . . . . 0.0 109.993 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -58.07 -28.32 64.46 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -75.75 -34.46 60.29 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.733 -1.122 . . . . 0.0 109.972 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.827 ' CG ' ' HB2' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -57.39 -61.42 2.5 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 122.191 0.996 . . . . 0.0 112.043 -179.615 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.894 HG23 HD12 ' A' ' 29' ' ' LEU . 26.7 mt -69.11 -48.46 69.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.403 -177.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -47.16 -42.71 20.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.1 t -59.91 -43.14 95.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.218 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.654 ' O ' ' N ' ' A' ' 153' ' ' HIS . 19.5 t80 -58.39 -45.05 89.08 Favored 'General case' 0 C--O 1.185 -2.341 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.923 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.4 mm? -68.06 -43.67 78.1 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 119.993 1.269 . . . . 0.0 111.653 -178.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.408 ' HG2' ' H ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -65.18 -24.45 67.38 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.881 179.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.429 ' O ' ' CD2' ' A' ' 153' ' ' HIS . 51.6 t0 -106.92 -13.08 15.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.039 0.923 . . . . 0.0 110.948 178.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.654 ' N ' ' O ' ' A' ' 149' ' ' TYR . 30.4 m80 -155.8 66.68 4.61 Favored Pre-proline 0 C--N 1.302 -1.49 0 C-N-CA 125.403 1.481 . . . . 0.0 110.193 -177.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.53 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 36.3 Cg_endo -66.35 -2.8 7.73 Favored 'Trans proline' 0 N--CA 1.481 0.736 0 C-N-CA 122.571 2.181 . . . . 0.0 111.108 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.61 ' CA ' HD21 ' A' ' 158' ' ' ASN . 3.2 p30 -71.37 4.63 2.79 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.078 0.951 . . . . 0.0 113.077 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.94 129.71 43.16 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.584 -1.322 . . . . 0.0 113.042 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.685 ' CG ' HD23 ' A' ' 24' ' ' LEU . 81.7 t80 53.23 4.51 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 177.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.61 HD21 ' CA ' ' A' ' 155' ' ' ASP . 2.5 p30 . . . . . 0 C--N 1.323 -0.559 0 O-C-N 120.506 -1.371 . . . . 0.0 110.381 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.912 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.017 HG21 ' CD2' ' A' ' 118' ' ' HIS . 7.7 p -134.81 149.04 29.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 O-C-N 122.314 -0.521 . . . . 0.0 110.618 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -96.4 109.73 22.21 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.2 m -97.27 133.37 41.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.07 0.462 . . . . 0.0 110.62 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -132.26 132.14 42.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.739 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.487 ' C ' HD22 ' A' ' 7' ' ' ASN . 7.6 mt-10 -102.25 126.42 49.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.196 0.522 . . . . 0.0 110.613 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.575 HD22 ' N ' ' A' ' 7' ' ' ASN . 0.6 OUTLIER -131.26 161.17 32.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.771 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -155.27 153.12 30.12 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -142.92 141.15 31.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.28 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.73 147.32 22.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.742 0.306 . . . . 0.0 110.913 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -143.17 154.21 43.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 0.0 110.436 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -95.24 27.46 3.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.037 0.446 . . . . 0.0 110.4 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.53 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.5 mt -118.19 125.23 28.04 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.648 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.67 151.2 3.55 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.672 1.581 . . . . 0.0 111.471 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.582 ' CG ' ' HB2' ' A' ' 106' ' ' ALA . 21.8 Cg_exo -61.16 -24.24 78.78 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 C-N-CA 122.299 1.999 . . . . 0.0 112.483 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.446 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 68.8 m -70.64 -32.47 69.78 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.2 mmt-85 -76.24 -59.74 2.63 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.53 HD21 ' HB ' ' A' ' 13' ' ' ILE . 2.3 mt -48.36 -48.87 36.24 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.646 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.811 ' O ' HG22 ' A' ' 23' ' ' VAL . 16.4 t80 -44.75 -60.17 2.15 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.121 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.63 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -71.13 -26.32 62.96 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.142 -0.974 . . . . 0.0 110.917 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.945 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -77.07 -16.02 59.38 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.829 -177.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.505 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -117.6 -6.27 11.14 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.882 HG23 ' CD1' ' A' ' 24' ' ' LEU . 2.5 m -125.24 -35.99 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 118.5 0.591 . . . . 0.0 112.189 177.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.882 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.9 mp -92.28 -51.46 5.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.686 0.676 . . . . 0.0 111.412 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -106.93 -2.6 21.08 Favored 'General case' 0 C--O 1.206 -1.213 0 CA-C-O 119.22 -0.419 . . . . 0.0 111.496 -176.274 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.505 ' HB2' ' HA ' ' A' ' 22' ' ' PHE . . . -45.08 -34.08 2.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.978 0.894 . . . . 0.0 111.473 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -84.69 12.77 6.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.327 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 25' ' ' ASP . 95.8 m-20 -140.5 -10.85 1.06 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 125.38 1.472 . . . . 0.0 108.269 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.854 HD12 HG23 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -98.59 -48.42 4.99 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 125.499 1.52 . . . . 0.0 109.055 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.748 HG13 HD11 ' A' ' 146' ' ' ILE . 69.0 mt -56.24 -56.24 33.48 Favored Pre-proline 0 C--O 1.215 -0.726 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 32.4 Cg_endo -63.24 -26.92 72.12 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 122.534 2.156 . . . . 0.0 114.342 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -68.76 -49.7 56.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.834 0.826 . . . . 0.0 111.725 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.8 OUTLIER -95.08 -34.96 5.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.745 -177.232 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.815 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.75 64.1 0.15 Allowed Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -176.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.498 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 86.9 Cg_endo -77.09 -26.66 7.51 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 121.625 1.55 . . . . 0.0 108.188 174.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.469 ' OE1' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -74.97 -42.58 57.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.822 178.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.815 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -73.97 -77.19 0.12 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.584 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.559 HD13 ' CD2' ' A' ' 142' ' ' LEU . 1.1 mp -104.46 145.45 13.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-O 121.377 0.608 . . . . 0.0 109.978 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -78.38 -53.87 6.8 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.998 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.728 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -173.17 166.06 4.9 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.19 0.519 . . . . 0.0 110.569 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.728 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -165.53 144.95 6.49 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.136 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -150.76 145.28 25.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.213 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.602 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -77.12 139.81 18.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.574 0.702 . . . . 0.0 111.143 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -90.75 -38.74 12.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.126 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.844 ' O ' HG23 ' A' ' 52' ' ' THR . 26.9 mt-10 -145.57 136.09 24.18 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.335 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.31 -156.05 22.56 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.679 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -136.06 -6.04 2.11 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 122.345 -0.503 . . . . 0.0 111.047 -179.047 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.542 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 130.7 11.33 2.4 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.8 -171.42 19.58 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.577 ' HD3' ' H ' ' A' ' 74' ' ' ILE . 8.7 Cg_endo -60.06 126.5 20.43 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 122.596 2.197 . . . . 0.0 113.117 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.39 3.28 55.48 Favored Glycine 0 CA--C 1.506 -0.495 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.844 HG23 ' O ' ' A' ' 45' ' ' GLU . 45.7 m -94.02 140.74 29.34 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 114.14 -1.03 . . . . 0.0 111.008 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.584 HD12 ' C ' ' A' ' 52' ' ' THR . 1.8 mp -120.97 129.07 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.602 ' HG2' HG23 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -112.48 139.87 47.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.791 0.805 . . . . 0.0 111.11 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -117.89 121.15 39.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.489 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.2 mt -106.69 140.19 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.619 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.9 m -119.23 120.16 36.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.132 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -90.79 -173.41 3.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.38 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.06 143.29 29.92 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -60.64 -60.97 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.985 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.81 61.86 3.39 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.2 m -136.89 175.15 9.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.756 0.313 . . . . 0.0 110.563 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -62.19 -42.61 99.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.825 0.345 . . . . 0.0 110.559 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -91.53 136.12 33.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.547 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.59 -57.73 0.5 Allowed Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -145.8 155.2 42.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.973 0.416 . . . . 0.0 110.642 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 p -153.47 144.49 14.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.217 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.58 ' CB ' HD11 ' A' ' 86' ' ' ILE . 93.8 mttt -106.66 117.87 35.19 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.465 0.65 . . . . 0.0 112.211 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.478 ' CD2' ' C ' ' A' ' 69' ' ' HIS . 0.3 OUTLIER -109.34 118.87 37.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.74 178.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -102.28 130.78 49.08 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.051 0.453 . . . . 0.0 111.076 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.425 HD12 HG22 ' A' ' 52' ' ' THR . 36.4 mt -88.81 145.47 7.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.563 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -104.1 -56.42 2.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.3 m -166.43 142.56 4.75 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.577 ' H ' ' HD3' ' A' ' 50' ' ' PRO . 10.7 mt -124.0 131.74 72.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.858 176.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -116.21 88.26 2.85 Favored 'General case' 0 C--O 1.209 -1.039 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.432 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -54.14 -30.69 50.05 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.36 -39.8 70.51 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.229 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.0 m -108.45 -10.31 15.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.953 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.2 m-85 62.74 46.8 5.02 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 121.629 -0.669 . . . . 0.0 109.818 -178.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 79.3 p -105.73 148.26 27.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.207 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.626 ' CE2' ' CD2' ' A' ' 83' ' ' TYR . 41.8 t80 -140.31 120.33 13.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.694 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 p -127.45 130.33 49.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.812 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.626 ' CD2' ' CE2' ' A' ' 81' ' ' TYR . 11.4 p90 -144.73 170.62 15.75 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.1 m -146.06 136.38 23.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.387 0.613 . . . . 0.0 111.489 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.546 HD12 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -79.89 120.41 24.07 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.298 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.58 HD11 ' CB ' ' A' ' 68' ' ' LYS . 2.5 pt -90.24 -45.03 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.497 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 2.9 tp10 -151.17 172.08 16.37 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.861 0.362 . . . . 0.0 110.413 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.646 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.87 177.68 17.87 Favored Glycine 0 CA--C 1.509 -0.334 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.79 2.63 0.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.646 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -68.04 -35.0 77.53 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.689 1.196 . . . . 0.0 110.986 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.914 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.51 13.11 22.75 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.285 0.634 . . . . 0.0 109.538 -178.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.505 ' CG2' ' CE1' ' A' ' 131' ' ' HIS . 28.3 p 46.94 -127.04 1.6 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.414 ' N ' ' OG1' ' A' ' 92' ' ' THR . 29.2 t70 -130.34 -11.21 4.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.25 0.548 . . . . 0.0 110.996 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.11 -5.92 20.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.371 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.773 HG21 ' CD1' ' A' ' 98' ' ' ILE . 66.2 mt -97.91 151.48 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -176.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.509 ' OE1' ' CE1' ' A' ' 120' ' ' HIS . 0.8 OUTLIER -88.85 -60.92 1.83 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.395 177.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.437 ' CG ' ' O ' ' A' ' 96' ' ' GLU . 36.9 mtmt -164.89 158.07 16.86 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.44 0.638 . . . . 0.0 111.192 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.773 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -132.75 123.5 49.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.598 ' OG ' ' CE1' ' A' ' 118' ' ' HIS . 0.9 OUTLIER -112.48 144.4 42.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.213 0.53 . . . . 0.0 111.398 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -137.18 130.67 31.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.558 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.428 ' O ' HG12 ' A' ' 116' ' ' ILE . 20.5 mt-10 -129.28 134.3 47.88 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.14 131.68 28.74 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.972 -0.455 . . . . 0.0 110.186 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.58 ' C ' HD23 ' A' ' 104' ' ' LEU . 20.3 ttpp -124.17 134.48 53.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.76 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.66 131.06 45.14 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.004 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -130.29 136.89 57.64 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.904 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.582 ' HB2' ' CG ' ' A' ' 15' ' ' PRO . . . -72.92 134.22 44.68 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.261 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 19.6 t -121.13 169.99 9.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.882 0.372 . . . . 0.0 110.385 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.405 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.71 -30.22 42.99 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.7 p -90.33 -8.88 49.7 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 118.369 -2.842 . . . . 0.0 115.464 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 154.24 -93.25 0.14 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.443 1.973 . . . . 0.0 109.849 -171.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.1 m -159.16 129.21 5.7 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 126.691 1.996 . . . . 0.0 110.99 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.3 m -100.05 118.53 36.62 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.535 HD13 ' CE1' ' A' ' 143' ' ' PHE . 11.5 mt -92.17 131.2 39.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.56 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.85 116.62 32.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.703 ' C ' HD13 ' A' ' 116' ' ' ILE . 15.6 t -111.89 118.19 34.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.421 0.629 . . . . 0.0 111.443 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.96 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -97.82 135.53 32.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 123.399 0.68 . . . . 0.0 109.565 -178.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 18.8 m -118.78 131.8 56.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.57 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 1.017 ' CD2' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -136.41 115.11 12.04 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 122.702 1.239 . . . . 0.0 109.472 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.818 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.7 OUTLIER -102.91 103.69 13.85 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 120.368 -1.457 . . . . 0.0 109.588 179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.509 ' CE1' ' OE1' ' A' ' 96' ' ' GLU . 4.8 t-80 -89.68 104.68 17.22 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.506 0.669 . . . . 0.0 110.367 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.531 HG21 ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -91.45 164.41 13.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.327 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 125' ' ' ILE . 6.6 ptmm? -112.11 156.63 21.93 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 43.27 -124.45 4.52 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.476 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -95.39 -13.29 24.8 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.289 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.531 ' O ' HG21 ' A' ' 121' ' ' THR . 1.1 tp -48.81 162.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.717 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -152.71 148.59 27.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.908 0.385 . . . . 0.0 111.108 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.415 ' CD1' HG12 ' A' ' 95' ' ' ILE . 5.4 mm -89.14 124.95 42.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 31.5 tttp -76.27 161.16 28.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.439 0.638 . . . . 0.0 111.469 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.638 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 1.2 pm0 -69.97 -45.34 67.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.518 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.09 -25.31 65.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.406 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.505 ' CE1' ' CG2' ' A' ' 92' ' ' THR . 2.7 t-80 -72.7 -51.88 17.53 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.387 0.613 . . . . 0.0 110.886 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.8 m -74.44 -24.22 18.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.45 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -67.22 -46.51 73.6 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 122.382 -0.199 . . . . 0.0 110.932 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.438 HG23 ' N ' ' A' ' 135' ' ' GLY . 30.7 m -70.02 -43.96 78.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.735 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.438 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -67.57 -46.94 65.21 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -67.66 -45.51 75.06 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.683 -0.304 . . . . 0.0 110.853 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -53.81 -38.92 65.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.443 ' O ' ' CD2' ' A' ' 142' ' ' LEU . 15.9 tttt -68.74 -54.39 16.34 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.6 -43.25 46.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.746 0.784 . . . . 0.0 110.495 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -67.13 -36.51 82.04 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.33 -34.92 82.68 Favored Glycine 0 CA--C 1.519 0.313 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.559 ' CD2' HD13 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -71.47 -48.36 49.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.589 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.535 ' CE1' HD13 ' A' ' 113' ' ' ILE . 4.4 t80 -59.47 -25.74 64.66 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -68.76 -40.51 79.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.935 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.781 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -64.45 -56.2 15.75 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.08 0.943 . . . . 0.0 108.746 178.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.854 HG23 HD12 ' A' ' 29' ' ' LEU . 59.6 mt -54.85 -48.41 74.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.601 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 20.3 tt0 -46.08 -56.89 4.98 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.684 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.8 p -53.51 -42.35 67.25 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.525 0.679 . . . . 0.0 110.615 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.704 ' HB2' HD13 ' A' ' 33' ' ' ILE . 32.7 t80 -56.36 -48.73 76.22 Favored 'General case' 0 C--O 1.194 -1.839 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.945 HD11 ' HB2' ' A' ' 21' ' ' ALA . 1.9 mm? -65.65 -42.57 91.24 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 120.033 1.288 . . . . 0.0 112.02 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.451 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -62.24 -23.65 66.79 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.25 -13.6 15.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.625 ' N ' ' O ' ' A' ' 149' ' ' TYR . 23.3 m80 -156.32 67.49 4.52 Favored Pre-proline 0 C--N 1.309 -1.174 0 C-N-CA 125.062 1.345 . . . . 0.0 110.695 -178.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.497 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 56.0 Cg_endo -74.8 -3.28 13.66 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 122.495 2.13 . . . . 0.0 111.534 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.603 ' CA ' HD21 ' A' ' 158' ' ' ASN . 3.6 p30 -74.66 5.3 5.0 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.279 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.88 129.99 43.57 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.791 -1.193 . . . . 0.0 113.141 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.722 ' CD1' HD23 ' A' ' 24' ' ' LEU . 2.7 t80 54.51 6.06 0.1 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.603 HD21 ' CA ' ' A' ' 155' ' ' ASP . 1.5 p30 . . . . . 0 CA--C 1.514 -0.436 0 O-C-N 121.166 -0.959 . . . . 0.0 110.405 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.818 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.4 p -134.79 149.36 29.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 0.0 111.348 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -97.6 110.03 22.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.52 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.56 ' HG1' ' CE1' ' A' ' 118' ' ' HIS . 62.7 m -95.78 133.37 39.98 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.657 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.526 ' CD2' ' ND2' ' A' ' 7' ' ' ASN . 51.5 t80 -137.75 132.38 32.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.046 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.497 ' C ' HD22 ' A' ' 7' ' ' ASN . 1.2 tt0 -102.48 137.4 40.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.009 0.433 . . . . 0.0 111.296 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.526 ' ND2' ' CD2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -127.55 167.97 15.6 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -178.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -152.56 145.15 24.18 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -154.23 134.76 13.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.458 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.06 146.71 23.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.934 0.397 . . . . 0.0 111.451 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -136.32 154.14 50.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.247 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -98.49 21.84 10.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.173 0.511 . . . . 0.0 110.365 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.693 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.3 mt -116.23 126.35 27.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.494 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -44.88 146.99 2.1 Favored 'Trans proline' 0 C--N 1.327 -0.603 0 C-N-CA 121.805 1.67 . . . . 0.0 111.776 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -57.19 -26.62 70.59 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 122.256 1.97 . . . . 0.0 113.149 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 67.9 m -70.7 -32.15 69.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -75.03 -57.71 3.73 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.693 HD21 ' HB ' ' A' ' 13' ' ' ILE . 1.5 mt -53.28 -35.84 60.53 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.801 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.867 ' O ' HG22 ' A' ' 23' ' ' VAL . 14.8 t80 -54.46 -56.05 22.7 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.641 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.76 ' HB2' HD11 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -70.73 -43.2 69.39 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.295 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.775 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -63.67 -3.2 2.1 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.386 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.512 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 19.3 t80 -119.66 -8.54 9.92 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 19' ' ' PHE . 15.1 m -129.7 -52.33 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.011 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.7 pp -96.85 -31.52 12.56 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 1.011 ' N ' HD12 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -114.25 -5.38 12.99 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 118.858 0.754 . . . . 0.0 111.364 -178.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -67.7 -43.85 79.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.105 0.479 . . . . 0.0 111.861 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.502 ' HA ' HD11 ' A' ' 30' ' ' ILE . 1.2 m-20 -83.01 12.21 5.27 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 122.101 0.953 . . . . 0.0 110.265 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -129.79 -9.42 4.46 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.523 ' CD1' HG23 ' A' ' 146' ' ' ILE . 4.1 mt -93.94 -30.74 14.6 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.211 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.547 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.08 -53.42 58.77 Favored Pre-proline 0 C--O 1.215 -0.732 0 O-C-N 122.025 -0.422 . . . . 0.0 110.613 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 27.2 Cg_endo -63.89 -25.72 67.26 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 122.006 1.804 . . . . 0.0 112.538 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.84 -59.61 2.66 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.662 0.744 . . . . 0.0 112.194 -178.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.8 HD12 ' HB3' ' A' ' 145' ' ' LEU . 1.3 pt -94.46 -36.14 6.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.909 -176.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.867 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.87 65.23 0.16 Allowed Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 71.8 Cg_endo -75.94 -26.91 9.0 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 C-N-CA 121.591 1.527 . . . . 0.0 108.367 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -74.1 -43.36 57.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.55 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.867 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -72.27 -71.94 0.26 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.896 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.526 HD13 HD22 ' A' ' 142' ' ' LEU . 1.4 mp -99.18 144.85 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-O 121.254 0.549 . . . . 0.0 110.669 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -79.44 -50.34 10.95 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.079 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.658 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 52.8 tp60 -174.33 164.66 3.93 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.829 0.347 . . . . 0.0 110.758 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.658 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -166.13 144.74 5.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.076 0.465 . . . . 0.0 110.846 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -150.7 148.18 28.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.143 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.578 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -83.25 139.58 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.524 0.678 . . . . 0.0 110.729 -179.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.1 -39.36 12.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.024 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.92 ' O ' HG23 ' A' ' 52' ' ' THR . 16.2 mt-10 -141.28 134.48 29.42 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.756 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.83 -156.6 31.55 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.724 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -141.24 -5.15 1.11 Allowed 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.406 -0.467 . . . . 0.0 111.404 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.469 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 141.46 11.94 0.53 Allowed Glycine 0 C--O 1.218 -0.853 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.77 -171.71 19.66 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-N 117.233 0.516 . . . . 0.0 112.066 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -62.05 126.87 19.73 Favored 'Trans proline' 0 C--N 1.321 -0.892 0 C-N-CA 123.168 2.579 . . . . 0.0 113.343 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.72 6.12 57.36 Favored Glycine 0 N--CA 1.462 0.422 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.92 HG23 ' O ' ' A' ' 45' ' ' GLU . 73.1 m -93.6 139.31 30.92 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.176 -1.012 . . . . 0.0 111.191 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.28 132.1 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.578 ' HG2' HG23 ' A' ' 43' ' ' ILE . 1.9 mmtp -111.17 139.53 46.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.463 0.649 . . . . 0.0 111.258 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -118.2 113.42 21.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.147 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mt -106.28 138.27 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.662 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.7 m -119.21 118.11 30.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.267 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -93.0 -173.23 3.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.306 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.08 143.54 48.69 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -60.84 -48.39 82.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.806 0.336 . . . . 0.0 110.978 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.06 61.97 3.29 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.0 m -142.91 175.33 9.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.021 0.438 . . . . 0.0 110.626 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -61.84 -45.52 93.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.66 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.32 138.74 39.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.371 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.14 -52.92 0.59 Allowed Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -142.7 151.73 41.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 110.253 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.85 146.5 11.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.968 0.413 . . . . 0.0 110.672 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.602 ' HB3' HD11 ' A' ' 86' ' ' ILE . 25.0 mttp -105.58 109.51 21.51 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.35 0.595 . . . . 0.0 111.557 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.601 ' HE2' ' CB ' ' A' ' 83' ' ' TYR . 6.8 t60 -98.81 111.68 23.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.329 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.1 ttt-85 -101.56 131.19 47.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.233 0.54 . . . . 0.0 112.126 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.5 mt -82.31 136.68 22.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.461 -0.79 . . . . 0.0 108.96 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -96.97 -56.05 2.68 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.7 m -165.67 141.38 5.09 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.435 HD12 ' O ' ' A' ' 48' ' ' GLY . 40.6 mt -124.96 129.62 73.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 79' ' ' TYR . 23.2 m-20 -115.45 88.33 2.86 Favored 'General case' 0 C--O 1.202 -1.401 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.638 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.0 OUTLIER -54.31 -36.17 63.45 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.51 -36.1 43.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 m -107.65 -10.87 15.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.828 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.596 ' N ' ' O ' ' A' ' 75' ' ' ASP . 48.2 m-85 56.68 42.53 26.8 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 121.522 -0.736 . . . . 0.0 110.818 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.26 149.2 28.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.909 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 82' ' ' SER . 3.6 t80 -134.8 126.38 28.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.92 0.391 . . . . 0.0 111.186 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.451 ' N ' ' CD1' ' A' ' 81' ' ' TYR . 85.8 p -126.88 136.49 52.39 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.462 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.601 ' CB ' ' HE2' ' A' ' 69' ' ' HIS . 34.3 p90 -144.88 165.63 27.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.561 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -147.08 134.14 20.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.082 0.468 . . . . 0.0 110.667 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.604 HD13 ' HB1' ' A' ' 90' ' ' ALA . 5.6 mt -80.4 117.59 21.28 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' A' ' 68' ' ' LYS . 5.1 pt -82.42 -44.69 19.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.718 0.294 . . . . 0.0 111.213 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.625 ' CD ' ' H ' ' A' ' 88' ' ' GLY . 0.6 OUTLIER -149.14 171.81 15.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.625 ' H ' ' CD ' ' A' ' 87' ' ' GLU . . . 116.22 177.96 18.19 Favored Glycine 0 CA--C 1.509 -0.319 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.94 2.26 0.23 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.621 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -67.39 -35.08 78.6 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 124.314 1.046 . . . . 0.0 110.468 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.885 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -111.11 6.03 20.53 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 123.358 0.663 . . . . 0.0 110.273 -177.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.421 ' CG2' ' NE2' ' A' ' 131' ' ' HIS . 61.7 p 49.61 -126.15 2.14 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 18.8 p-10 -131.74 -10.3 3.51 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.827 -0.546 . . . . 0.0 110.911 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.73 -7.6 19.42 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.679 HG21 ' CD1' ' A' ' 98' ' ' ILE . 68.4 mt -99.71 152.81 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -176.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.506 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -87.43 -59.17 2.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.751 177.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HA ' HD12 ' A' ' 91' ' ' LEU . 6.0 ptpt -171.95 154.25 3.45 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.199 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.679 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.65 124.88 73.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.87 144.84 32.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.137 0.494 . . . . 0.0 111.436 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 116' ' ' ILE . 0.4 OUTLIER -140.06 138.94 35.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 179.382 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -128.37 135.15 49.17 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 120.983 0.42 . . . . 0.0 110.737 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 p -133.86 131.24 38.94 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -120.32 135.39 55.03 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.4 mm? -96.46 124.66 40.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.255 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.61 136.62 43.58 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.192 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -73.16 139.57 46.44 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.85 -0.531 . . . . 0.0 110.142 177.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.467 ' N ' ' HA ' ' A' ' 111' ' ' SER . 13.6 t -121.36 170.97 9.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.714 0.292 . . . . 0.0 110.388 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.71 -34.6 50.73 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.5 p -94.76 -6.43 43.05 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 118.809 -2.583 . . . . 0.0 113.595 177.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 160.23 -78.62 0.17 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.082 1.801 . . . . 0.0 112.067 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 29.2 t -162.76 130.21 3.7 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.973 1.309 . . . . 0.0 111.599 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.7 m -99.97 134.9 42.2 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.105 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 mt -110.57 130.34 64.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.504 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.71 116.81 32.57 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.814 ' C ' HD13 ' A' ' 116' ' ' ILE . 70.1 m -110.75 124.73 52.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.204 0.526 . . . . 0.0 110.865 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.874 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -106.29 135.76 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 C-N-CA 123.033 0.533 . . . . 0.0 109.825 -178.016 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.2 m -109.07 134.39 51.75 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.56 ' CE1' ' HG1' ' A' ' 4' ' ' THR . 41.9 m-70 -135.39 95.31 3.25 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.209 0.528 . . . . 0.0 111.049 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.818 ' C ' HG23 ' A' ' 2' ' ' VAL . 6.4 m-30 -84.56 101.39 12.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.874 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -92.87 98.64 11.51 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.7 p -101.3 174.35 6.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.91 0.862 . . . . 0.0 112.218 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.71 144.5 42.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.334 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.6 -110.0 1.1 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.538 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.1 OUTLIER -115.9 1.55 13.37 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.449 -0.442 . . . . 0.0 111.607 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.524 ' N ' HD22 ' A' ' 124' ' ' ASN . 1.6 mp -45.48 161.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.177 0.513 . . . . 0.0 110.434 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.494 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 30.2 tt0 -155.42 148.66 24.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.48 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.3 mm -88.01 125.36 41.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -73.87 161.94 29.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.358 0.599 . . . . 0.0 111.541 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -69.01 -48.54 62.76 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.071 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.599 ' O ' HG12 ' A' ' 134' ' ' VAL . 6.5 tt0 -58.23 -26.11 62.47 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.985 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.421 ' NE2' ' CG2' ' A' ' 92' ' ' THR . 4.2 t60 -72.92 -49.56 28.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.476 0.655 . . . . 0.0 111.236 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.438 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.1 m -81.08 -27.17 10.76 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -66.62 -46.18 76.69 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 121.983 -0.448 . . . . 0.0 110.496 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.676 HG13 ' N ' ' A' ' 135' ' ' GLY . 7.7 p -69.01 -50.89 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.707 0 CA-C-O 121.443 0.64 . . . . 0.0 110.515 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.676 ' N ' HG13 ' A' ' 134' ' ' VAL . . . -62.81 -42.29 99.71 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 5.9 ttpm? -67.04 -45.68 76.7 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 122.72 -0.283 . . . . 0.0 110.788 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -53.69 -43.34 68.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -66.16 -53.6 35.6 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.416 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.32 -40.22 34.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.672 0.749 . . . . 0.0 110.726 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.91 -36.24 82.73 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.41 -43.79 98.33 Favored Glycine 0 C--O 1.227 -0.328 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -62.94 -43.01 99.95 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.505 ' CE1' ' CE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -59.44 -25.81 64.67 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -72.1 -42.7 65.82 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.272 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.8 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -62.44 -56.66 16.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.605 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.689 ' O ' HD22 ' A' ' 150' ' ' LEU . 50.6 mt -59.62 -50.71 78.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.23 -177.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 8.9 tt0 -46.87 -56.74 5.8 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.136 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 62.0 m -51.08 -48.15 61.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.191 0.52 . . . . 0.0 111.551 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.549 ' O ' ' N ' ' A' ' 153' ' ' HIS . 0.2 OUTLIER -55.93 -49.43 73.51 Favored 'General case' 0 C--O 1.209 -1.033 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.843 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.9 mm? -62.53 -43.85 97.79 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 119.792 1.178 . . . . 0.0 111.77 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 147' ' ' GLU . 0.2 OUTLIER -59.14 -25.4 63.85 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.189 -0.945 . . . . 0.0 108.757 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.453 ' O ' ' ND1' ' A' ' 153' ' ' HIS . 49.2 t0 -99.27 -14.38 19.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.731 0.776 . . . . 0.0 109.91 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.549 ' N ' ' O ' ' A' ' 149' ' ' TYR . 68.3 m80 -154.11 68.16 5.94 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 124.261 1.024 . . . . 0.0 110.494 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.471 ' N ' ' O ' ' A' ' 150' ' ' LEU . 31.4 Cg_endo -68.34 -3.18 10.4 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.991 1.794 . . . . 0.0 110.637 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.596 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 14.4 m-20 -87.03 4.69 40.94 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.074 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.42 131.02 20.6 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.028 -1.67 . . . . 0.0 111.256 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.666 ' CG ' HD13 ' A' ' 24' ' ' LEU . 6.3 t80 55.83 7.19 0.25 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.352 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.846 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.2 p -134.8 148.47 29.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 O-C-N 122.517 -0.402 . . . . 0.0 110.972 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.45 109.36 22.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.704 177.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.2 m -97.92 140.65 31.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.877 0.37 . . . . 0.0 111.071 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -145.14 137.57 25.99 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.332 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.55 ' HG2' HD12 ' A' ' 116' ' ' ILE . 15.6 mt-10 -102.29 139.24 38.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.197 0.523 . . . . 0.0 110.76 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.51 HD22 ' C ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -126.48 168.19 14.57 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -178.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.84 139.34 15.89 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -145.62 134.0 21.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.378 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.1 147.87 22.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.929 0.395 . . . . 0.0 111.254 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 p -144.39 154.26 42.8 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.51 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -94.37 27.61 2.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.889 0.376 . . . . 0.0 110.305 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.651 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.3 mt -117.56 125.66 27.93 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.721 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.97 148.47 13.0 Favored 'Trans proline' 0 C--N 1.327 -0.581 0 C-N-CA 121.801 1.667 . . . . 0.0 111.409 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.418 ' HA ' HD12 ' A' ' 18' ' ' LEU . 23.3 Cg_exo -59.04 -24.98 76.05 Favored 'Trans proline' 0 N--CA 1.482 0.836 0 C-N-CA 122.011 1.808 . . . . 0.0 112.116 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.434 ' C ' ' HZ2' ' A' ' 20' ' ' LYS . 66.3 m -65.72 -35.68 81.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.392 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.485 ' HA ' ' HZ2' ' A' ' 20' ' ' LYS . 8.0 mmt180 -77.99 -57.68 3.67 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.651 HD21 ' HB ' ' A' ' 13' ' ' ILE . 5.1 mt -48.14 -48.25 34.31 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.909 -1.042 . . . . 0.0 108.599 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.753 ' O ' HG22 ' A' ' 23' ' ' VAL . 70.1 t80 -48.85 -56.49 8.59 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.307 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.665 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -70.21 -23.92 63.02 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.698 -179.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.71 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -82.48 -2.84 54.57 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.976 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.473 ' CE2' ' OH ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -119.08 -9.56 9.98 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.853 HG23 HD13 ' A' ' 24' ' ' LEU . 3.0 m -136.1 -36.57 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.853 HD13 HG23 ' A' ' 23' ' ' VAL . 3.2 mp -91.17 -53.05 4.52 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.152 0.887 . . . . 0.0 112.153 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -112.2 -4.68 14.32 Favored 'General case' 0 C--O 1.214 -0.771 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.039 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.695 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -53.16 -41.73 65.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.2 0.524 . . . . 0.0 111.715 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -83.39 17.49 2.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.629 0.728 . . . . 0.0 110.794 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.413 ' H ' ' H ' ' A' ' 29' ' ' LEU . 15.8 m120 -139.97 -8.89 1.19 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.505 HD21 ' CD1' ' A' ' 149' ' ' TYR . 0.6 OUTLIER -91.34 -33.51 15.27 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.438 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.543 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.74 -53.17 63.62 Favored Pre-proline 0 C--O 1.216 -0.678 0 O-C-N 122.083 -0.385 . . . . 0.0 111.127 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 20.0 Cg_endo -62.56 -24.67 75.28 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 121.876 1.718 . . . . 0.0 112.323 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -70.28 -59.83 2.64 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.73 0.776 . . . . 0.0 112.016 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 145' ' ' LEU . 1.3 pt -95.29 -35.72 6.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.282 -176.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.902 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.54 64.53 0.14 Allowed Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.491 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 72.6 Cg_endo -76.88 -28.4 6.24 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 121.647 1.565 . . . . 0.0 108.175 174.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.408 ' CG ' ' N ' ' A' ' 37' ' ' ALA . 12.1 pt20 -74.14 -43.17 58.43 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.572 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.902 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -72.81 -76.54 0.12 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.947 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 38' ' ' ILE . 9.4 mm -99.51 145.08 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-O 121.092 0.472 . . . . 0.0 110.422 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -77.7 -49.86 13.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.673 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -176.98 166.61 2.46 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.111 0.482 . . . . 0.0 110.543 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.99 143.13 5.35 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.592 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -151.33 153.34 34.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.782 0.325 . . . . 0.0 110.595 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.06 138.52 18.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.597 0.713 . . . . 0.0 111.341 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.5 mp -88.9 -39.07 14.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.905 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.874 ' O ' HG23 ' A' ' 52' ' ' THR . 26.4 mt-10 -144.32 136.89 26.75 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.364 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.47 -156.21 22.55 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.699 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -135.26 -11.34 2.18 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.09 0.472 . . . . 0.0 110.608 -179.357 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.639 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 136.65 11.08 1.15 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.29 -171.86 19.34 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -59.07 127.01 22.67 Favored 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 122.595 2.196 . . . . 0.0 113.213 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.67 2.14 52.87 Favored Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.874 HG23 ' O ' ' A' ' 45' ' ' GLU . 51.8 m -94.42 140.49 29.75 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.146 -1.027 . . . . 0.0 111.753 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -121.51 129.74 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.407 ' NZ ' ' HB3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -114.73 140.44 48.87 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.021 0.438 . . . . 0.0 110.879 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -118.77 123.11 44.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.02 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.2 mt -104.9 140.64 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.86 0.362 . . . . 0.0 110.605 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.8 m -116.52 118.82 33.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.152 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -91.39 -176.44 4.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.316 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.33 142.68 32.11 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.468 ' CD ' ' N ' ' A' ' 61' ' ' GLY . 2.5 pp20? -61.15 -45.22 95.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.817 0.342 . . . . 0.0 111.23 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.468 ' N ' ' CD ' ' A' ' 60' ' ' GLU . . . -91.37 61.53 2.86 Favored Glycine 0 C--N 1.328 0.135 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.8 m -141.96 174.11 10.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.964 0.411 . . . . 0.0 110.816 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -68.16 -39.12 82.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.931 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.55 142.96 27.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.439 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.1 -62.06 0.53 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -146.07 145.29 30.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.952 0.406 . . . . 0.0 110.429 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.74 140.09 41.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.647 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.493 ' HB2' HD11 ' A' ' 86' ' ' ILE . 61.3 mttm -106.53 114.56 28.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.346 0.594 . . . . 0.0 112.413 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.553 ' CE1' ' CD2' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -92.89 123.89 36.48 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -100.89 112.4 24.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.012 0.434 . . . . 0.0 111.485 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.4 mt -74.17 135.42 27.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -98.3 -55.67 2.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.5 m -165.97 142.38 5.14 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.6 mt -116.16 131.44 68.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.552 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.682 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 79' ' ' TYR . 9.4 t0 -113.97 87.45 2.62 Favored 'General case' 0 C--O 1.207 -1.148 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.513 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 7.2 pt-20 -54.87 -30.1 57.04 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.32 -40.0 70.64 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 m -108.63 -10.68 15.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.901 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.565 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.6 m-85 62.54 42.14 8.94 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.511 -0.743 . . . . 0.0 110.142 -178.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.2 t -116.87 139.8 50.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.233 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.473 ' OH ' ' CE2' ' A' ' 22' ' ' PHE . 41.1 p90 -132.26 132.78 43.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.088 0.47 . . . . 0.0 110.392 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 m -127.09 137.65 53.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.383 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -144.05 166.37 25.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.891 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.591 HG23 ' O ' ' A' ' 98' ' ' ILE . 5.5 m -144.89 142.95 30.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.09 0.471 . . . . 0.0 110.828 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.634 HD13 ' HB1' ' A' ' 90' ' ' ALA . 7.9 mt -79.97 115.36 19.5 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.493 HD11 ' HB2' ' A' ' 68' ' ' LYS . 2.9 pt -77.49 -44.8 29.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.783 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.434 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 0.1 OUTLIER -153.47 172.53 16.98 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.603 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.57 177.52 18.02 Favored Glycine 0 CA--C 1.51 -0.221 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -61.7 0.37 0.35 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 122.529 1.157 . . . . 0.0 108.395 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.634 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -62.17 -34.51 76.56 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 124.123 0.969 . . . . 0.0 110.236 177.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.867 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.37 12.84 23.01 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 123.464 0.705 . . . . 0.0 109.935 -177.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.1 p 47.36 -126.31 1.68 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -130.72 -12.64 3.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.019 0.438 . . . . 0.0 111.452 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.23 -6.14 20.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.743 HG21 ' CD1' ' A' ' 98' ' ' ILE . 95.2 mt -98.08 152.17 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 122.159 0.981 . . . . 0.0 113.297 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.508 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -93.44 -52.51 4.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.468 177.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.53 149.02 2.06 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-O 121.178 0.513 . . . . 0.0 111.32 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.743 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.87 126.68 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.591 ' C ' ' HD1' ' A' ' 118' ' ' HIS . 0.1 OUTLIER -109.63 143.89 38.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.803 0.335 . . . . 0.0 111.621 -178.105 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -137.35 127.94 26.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.689 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -129.8 132.49 46.53 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -139.82 133.82 30.89 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.086 -0.384 . . . . 0.0 110.469 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.624 ' C ' HD23 ' A' ' 104' ' ' LEU . 55.0 tttt -122.25 134.41 54.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.908 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.789 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -97.74 127.32 43.6 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -128.51 136.63 59.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.119 -178.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -73.14 133.29 44.04 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.752 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -121.88 174.04 7.12 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.69 -34.18 55.95 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.871 -0.492 . . . . 0.0 111.871 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.1 m -76.78 -26.81 54.91 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.841 1.256 . . . . 0.0 114.182 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 159.67 -78.88 0.17 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.522 1.534 . . . . 0.0 111.876 -169.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 83.7 p -166.07 131.72 2.43 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.594 1.558 . . . . 0.0 111.079 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 105' ' ' VAL . 14.8 m -99.29 118.74 36.63 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 54.4 mt -92.14 126.52 44.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.635 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -105.68 117.38 33.88 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.763 ' C ' HD13 ' A' ' 116' ' ' ILE . 3.2 m -112.35 123.75 50.96 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 121.329 0.585 . . . . 0.0 111.313 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.937 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -103.53 137.16 33.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 123.591 0.756 . . . . 0.0 109.654 -178.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.95 132.09 55.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.715 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.591 ' HD1' ' C ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -138.38 112.32 8.45 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.846 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -101.83 108.38 19.84 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.223 -0.298 . . . . 0.0 110.803 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.506 ' CE1' ' OE2' ' A' ' 96' ' ' GLU . 13.8 t-160 -89.59 105.8 18.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.16 0.505 . . . . 0.0 109.679 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.9 p -100.22 178.01 4.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.841 0.829 . . . . 0.0 111.915 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 123' ' ' GLY . 3.8 mtpt -112.54 157.49 21.09 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.794 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . 35.16 -108.71 0.05 OUTLIER Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.665 ' H ' HD22 ' A' ' 124' ' ' ASN . 0.2 OUTLIER -114.04 7.04 16.67 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.588 -0.36 . . . . 0.0 111.144 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.493 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.6 mp -45.42 160.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.221 0.534 . . . . 0.0 110.594 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.493 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 22.0 mt-10 -152.11 149.6 28.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.257 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 mm -88.21 125.01 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.433 ' HG3' ' N ' ' A' ' 129' ' ' GLU . 15.8 tptm -73.85 161.96 29.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.202 0.525 . . . . 0.0 111.208 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' A' ' 128' ' ' LYS . 59.9 mt-10 -68.68 -44.41 74.08 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.112 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.523 ' O ' HG22 ' A' ' 134' ' ' VAL . 37.5 mt-10 -61.57 -26.18 67.79 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.67 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -73.04 -49.32 29.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.106 0.479 . . . . 0.0 111.321 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.411 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.0 m -79.5 -29.72 13.47 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.176 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.4 tptt -66.92 -45.83 76.69 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.916 -0.49 . . . . 0.0 110.605 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.552 HG23 ' N ' ' A' ' 135' ' ' GLY . 24.2 m -70.45 -45.98 72.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.557 0.218 . . . . 0.0 110.567 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.552 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -66.58 -46.66 74.67 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 29.3 ttpt -67.05 -46.15 75.26 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.676 -0.308 . . . . 0.0 110.653 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -54.49 -46.28 73.4 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -67.8 -52.29 38.76 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.437 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.54 -41.5 41.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.694 0.759 . . . . 0.0 110.616 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -36.33 83.41 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.42 -37.98 94.04 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -71.14 -42.43 69.19 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -59.54 -22.78 62.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -37.98 51.57 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.669 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.795 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.3 mm? -69.61 -56.73 6.47 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.146 0.498 . . . . 0.0 109.894 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.737 ' O ' HD22 ' A' ' 150' ' ' LEU . 63.5 mt -54.53 -51.36 50.84 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.48 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -47.65 -55.5 9.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.03 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.402 ' O ' ' OD2' ' A' ' 152' ' ' ASP . 8.7 t -52.56 -43.77 65.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.322 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.656 ' HB2' HD13 ' A' ' 33' ' ' ILE . 20.4 t80 -58.15 -44.77 88.04 Favored 'General case' 0 C--O 1.189 -2.083 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.765 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.8 mm? -69.71 -42.84 73.51 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 120.552 -1.342 . . . . 0.0 111.88 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.403 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -61.97 -24.79 67.23 Favored 'General case' 0 C--N 1.319 -0.742 0 O-C-N 121.571 -0.705 . . . . 0.0 109.147 -179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 149' ' ' TYR . 5.1 p30 -107.32 -12.73 15.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.26 0.552 . . . . 0.0 110.379 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.621 ' N ' ' O ' ' A' ' 149' ' ' TYR . 1.2 t-160 -154.86 66.3 4.97 Favored Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 124.795 1.238 . . . . 0.0 110.108 -177.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.11 -3.54 13.47 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 122.761 2.307 . . . . 0.0 112.072 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.61 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 2.3 p30 -80.24 4.63 16.98 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.951 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.08 130.53 18.83 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 119.82 -1.8 . . . . 0.0 111.467 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.749 ' CD1' HD23 ' A' ' 24' ' ' LEU . 6.2 t80 55.08 8.17 0.23 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.331 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.61 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.461 0 O-C-N 121.547 -0.721 . . . . 0.0 110.291 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 110.046 -1.221 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.847 HG23 ' C ' ' A' ' 119' ' ' TYR . 8.1 p -134.92 148.3 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.052 0.453 . . . . 0.0 111.616 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -98.51 110.5 23.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.24 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.644 HG23 ' CE1' ' A' ' 118' ' ' HIS . 98.3 m -96.41 140.12 31.54 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.828 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -146.96 134.16 20.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.918 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.497 ' C ' HD22 ' A' ' 7' ' ' ASN . 36.8 mt-10 -102.39 132.91 48.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.23 0.538 . . . . 0.0 111.273 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.497 HD22 ' C ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -127.04 166.86 16.79 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 1.6 pt-20 -155.95 142.1 18.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.46 139.62 37.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.276 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.26 147.91 26.1 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.819 0.342 . . . . 0.0 111.532 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 t -145.08 154.85 42.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.808 0.337 . . . . 0.0 110.51 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -93.8 24.99 3.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.948 0.404 . . . . 0.0 111.121 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.415 ' HB ' HD21 ' A' ' 18' ' ' LEU . 2.1 mt -112.45 129.04 24.76 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.244 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -46.03 144.63 5.96 Favored 'Trans proline' 0 C--N 1.327 -0.583 0 C-N-CA 121.192 1.261 . . . . 0.0 110.602 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.68 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 12.0 Cg_endo -61.88 -24.55 77.25 Favored 'Trans proline' 0 C--N 1.321 -0.904 0 C-N-CA 122.316 2.011 . . . . 0.0 113.027 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 62.2 m -70.94 -28.6 64.61 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.422 ' H ' ' HG2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -76.27 -57.6 3.77 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.482 ' H ' ' HG ' ' A' ' 18' ' ' LEU . 1.8 mt -51.51 -43.53 62.29 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.753 ' O ' HG22 ' A' ' 23' ' ' VAL . 49.7 t80 -47.45 -58.06 4.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.257 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.705 ' CB ' HD11 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -69.89 -42.44 73.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 119.16 -1.016 . . . . 0.0 108.674 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.816 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -63.72 -5.12 3.67 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.627 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.535 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 2.7 t80 -120.25 -7.96 9.74 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 19' ' ' PHE . 29.1 m -129.91 -49.64 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.008 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.6 pp -96.51 -31.46 12.78 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 1.008 ' N ' HD12 ' A' ' 24' ' ' LEU . 10.0 t70 -114.44 -5.79 12.87 Favored 'General case' 0 C--O 1.211 -0.944 0 O-C-N 121.798 -0.564 . . . . 0.0 111.544 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.535 ' HB2' ' HA ' ' A' ' 22' ' ' PHE . . . -60.79 -40.36 92.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.566 0.698 . . . . 0.0 111.978 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -83.58 16.68 2.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.6 0.714 . . . . 0.0 110.109 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -139.62 -9.34 1.23 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.659 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -100.81 -39.82 7.62 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.001 -178.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.511 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 58.0 mt -53.89 -53.8 53.89 Favored Pre-proline 0 C--O 1.214 -0.79 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.191 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 29.3 Cg_endo -62.33 -25.29 76.38 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 121.876 1.717 . . . . 0.0 112.375 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 tmtp? -66.37 -55.33 16.41 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.984 0.897 . . . . 0.0 111.777 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.753 HD12 ' C ' ' A' ' 145' ' ' LEU . 0.9 OUTLIER -95.4 -34.34 5.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.315 -176.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.781 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.29 64.17 0.13 Allowed Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.486 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 71.7 Cg_endo -76.77 -24.41 10.14 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 N-CA-C 107.938 -1.601 . . . . 0.0 107.938 174.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -74.08 -43.83 56.29 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.273 -1.331 . . . . 0.0 109.494 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.781 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -70.54 -79.02 0.07 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.3 mt -98.93 146.64 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.019 0.437 . . . . 0.0 110.104 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -76.62 -44.36 34.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.81 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.655 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 49.2 tp60 -176.86 163.44 2.24 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.909 0.385 . . . . 0.0 110.773 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.655 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -167.0 143.78 4.56 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 120.926 0.393 . . . . 0.0 110.36 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.14 150.46 30.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.462 ' H ' HG13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -83.63 138.13 19.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.651 0.739 . . . . 0.0 110.952 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.3 mp -88.45 -39.32 14.33 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.766 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.925 ' O ' HG23 ' A' ' 52' ' ' THR . 47.9 mt-10 -142.02 134.22 27.69 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.952 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.62 -156.33 26.61 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.735 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -139.69 -9.7 1.21 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.821 0.343 . . . . 0.0 110.962 -179.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.51 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 143.95 11.38 0.35 Allowed Glycine 0 C--O 1.223 -0.565 0 N-CA-C 111.914 -0.474 . . . . 0.0 111.914 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.43 -172.78 20.11 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 117.562 0.681 . . . . 0.0 111.976 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD3' ' H ' ' A' ' 74' ' ' ILE . 10.2 Cg_endo -60.02 126.59 20.72 Favored 'Trans proline' 0 N--CA 1.483 0.854 0 C-N-CA 122.774 2.316 . . . . 0.0 113.649 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.99 4.0 55.64 Favored Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.925 HG23 ' O ' ' A' ' 45' ' ' GLU . 88.9 m -94.23 140.4 29.82 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.135 -1.033 . . . . 0.0 111.296 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.651 HD12 ' C ' ' A' ' 52' ' ' THR . 1.8 mp -121.15 129.91 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HB3' ' HZ3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -116.27 140.34 49.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.083 0.468 . . . . 0.0 110.688 179.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -118.75 121.74 40.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.011 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.1 mp -100.96 123.61 54.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.1 m -98.42 118.47 35.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.401 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -92.27 168.05 11.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.232 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.92 143.77 32.51 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.93 -48.05 83.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.724 0.297 . . . . 0.0 110.324 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -91.18 61.49 2.93 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.4 m -137.41 174.93 10.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.623 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -51.37 66.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.674 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -91.67 150.92 20.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.363 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.93 -59.71 0.58 Allowed Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -145.24 155.18 43.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.99 0.424 . . . . 0.0 110.941 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.5 p -154.69 138.35 8.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.821 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.3 mtmm -105.83 118.95 37.92 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.363 0.601 . . . . 0.0 112.228 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.566 ' CE1' ' CD2' ' A' ' 85' ' ' LEU . 1.9 m80 -97.25 114.43 26.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.3 ttp85 -101.2 112.56 25.08 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.123 0.487 . . . . 0.0 111.609 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.0 mt -73.73 134.11 30.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.292 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 73' ' ' SER . 2.2 p30 -98.01 -49.92 4.59 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.296 -0.562 . . . . 0.0 112.298 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.538 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -165.54 143.21 5.82 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -177.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.412 ' H ' ' HD3' ' A' ' 50' ' ' PRO . 32.1 mt -126.68 126.46 68.81 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 CA-C-N 113.914 -1.494 . . . . 0.0 108.841 173.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 79' ' ' TYR . 23.4 m-20 -113.88 88.44 2.85 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.466 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 6.9 pt-20 -54.59 -30.62 55.01 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.32 -38.75 59.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.8 m -108.5 -11.02 15.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.777 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.513 ' N ' ' O ' ' A' ' 75' ' ' ASP . 12.3 m-85 62.53 43.29 7.88 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.273 0.559 . . . . 0.0 109.808 -178.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.3 p -105.95 141.06 37.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.802 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -132.59 118.65 19.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.62 0.248 . . . . 0.0 110.684 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.446 ' C ' ' OD2' ' A' ' 72' ' ' ASP . 42.0 t -128.43 143.62 51.02 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.696 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -148.93 173.11 13.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.165 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.93 135.53 23.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.091 0.472 . . . . 0.0 110.895 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.663 HD13 ' HB1' ' A' ' 90' ' ' ALA . 9.0 mt -80.24 113.27 18.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.614 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -77.31 -41.79 30.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.803 -178.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.614 ' N ' HD13 ' A' ' 86' ' ' ILE . 4.1 tm-20 -157.03 170.69 21.95 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.116 -0.365 . . . . 0.0 110.357 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.609 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 119.65 178.33 16.43 Favored Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -62.28 2.06 0.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 122.884 1.326 . . . . 0.0 108.412 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.663 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -66.0 -33.08 75.0 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 124.35 1.06 . . . . 0.0 110.399 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.856 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -109.77 16.2 22.22 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 123.195 0.598 . . . . 0.0 110.693 -176.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 91' ' ' LEU . 65.2 p 43.35 -126.25 0.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.61 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -131.48 -13.29 3.4 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.126 -0.358 . . . . 0.0 111.054 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.1 p -104.68 -5.76 21.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.845 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.835 HG21 ' CD1' ' A' ' 98' ' ' ILE . 57.9 mt -99.53 152.91 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 121.962 0.887 . . . . 0.0 113.107 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.512 ' N ' HG22 ' A' ' 95' ' ' ILE . 5.7 pt-20 -99.95 -49.1 4.44 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.17 178.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -170.79 147.41 2.76 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-O 121.832 0.825 . . . . 0.0 111.764 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.835 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.62 122.66 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.2 t -106.26 146.0 30.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.197 0.522 . . . . 0.0 111.324 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -139.14 133.53 31.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.286 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -128.75 133.29 48.06 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -135.21 131.82 37.15 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.002 -0.436 . . . . 0.0 110.254 -178.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -120.22 133.7 55.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.522 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -99.54 129.78 45.73 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -178.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -131.76 137.18 55.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.987 -179.375 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.68 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -73.24 134.89 44.44 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.728 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.404 ' N ' ' HA ' ' A' ' 111' ' ' SER . 30.3 p -121.31 167.69 12.46 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.73 -27.17 34.76 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.8 m -86.97 -19.5 28.66 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 120.217 2.008 . . . . 0.0 113.743 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.24 -83.73 0.14 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.854 2.169 . . . . 0.0 111.104 -170.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 27.7 t -164.22 130.96 3.13 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 125.657 1.583 . . . . 0.0 110.971 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 105' ' ' VAL . 39.0 m -99.72 117.82 34.88 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 45.7 mt -92.25 132.5 36.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.386 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 102' ' ' THR . 12.0 mttt -105.17 117.16 33.3 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.719 ' C ' HD13 ' A' ' 116' ' ' ILE . 10.3 m -110.74 117.5 33.62 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.351 0.596 . . . . 0.0 110.783 -178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.947 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -99.9 135.8 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 123.561 0.744 . . . . 0.0 109.811 -177.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.8 p -104.3 133.98 48.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.644 ' CE1' HG23 ' A' ' 4' ' ' THR . 12.2 m80 -136.75 93.28 2.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.081 0.467 . . . . 0.0 109.927 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.847 ' C ' HG23 ' A' ' 2' ' ' VAL . 22.6 m-85 -87.37 101.77 13.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.835 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.453 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 87.6 m-70 -91.51 100.05 12.87 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.1 p -100.7 179.95 4.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.528 0.68 . . . . 0.0 111.937 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.49 ' CB ' ' NZ ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -109.16 155.42 21.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.344 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 41.32 -109.8 0.18 Allowed Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.96 7.14 13.11 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.911 -0.17 . . . . 0.0 111.006 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -47.51 159.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.169 0.509 . . . . 0.0 110.295 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.449 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 38.2 mt-10 -150.57 147.11 27.05 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.056 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.413 HD12 ' CD1' ' A' ' 95' ' ' ILE . 10.2 mm -89.32 124.57 42.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.468 ' HG2' ' H ' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -75.36 162.49 28.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.473 0.654 . . . . 0.0 111.643 -178.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -69.19 -34.08 74.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.837 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.468 ' H ' ' HG2' ' A' ' 128' ' ' LYS . 62.9 mt-10 -64.93 -35.6 81.7 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.824 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -68.57 -53.86 20.27 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.173 0.511 . . . . 0.0 110.789 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.0 m -69.23 -20.27 24.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.469 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -66.22 -47.64 73.2 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 122.293 -0.254 . . . . 0.0 110.41 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.88 -48.71 55.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.669 0.271 . . . . 0.0 110.697 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.91 -47.08 89.39 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -67.49 -47.03 71.22 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 122.493 -0.416 . . . . 0.0 110.569 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -55.24 -46.83 76.03 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.503 ' NZ ' ' O ' ' A' ' 37' ' ' ALA . 25.1 tttp -63.28 -54.42 37.41 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.45 -41.76 41.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.771 0.796 . . . . 0.0 110.116 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -63.11 -36.72 84.56 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.229 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.09 -47.58 90.11 Favored Glycine 0 C--O 1.226 -0.36 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -64.71 -44.81 89.04 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -59.46 -23.63 62.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -76.67 -37.48 56.14 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.023 178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.753 ' C ' HD12 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -67.69 -56.19 10.27 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.354 1.073 . . . . 0.0 109.05 179.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.708 ' O ' HD22 ' A' ' 150' ' ' LEU . 50.9 mt -53.95 -50.66 51.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.285 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -47.5 -56.89 6.11 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.587 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 145' ' ' LEU . 12.1 p -52.98 -40.9 64.1 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.209 0.528 . . . . 0.0 111.468 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.643 ' HB2' HD13 ' A' ' 33' ' ' ILE . 22.1 t80 -61.47 -44.4 97.16 Favored 'General case' 0 C--O 1.193 -1.903 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.816 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.1 mm? -67.87 -42.71 80.86 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 119.995 1.27 . . . . 0.0 111.335 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -62.89 -23.81 67.52 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 121.505 -0.747 . . . . 0.0 109.13 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -105.72 -12.86 15.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.922 0.868 . . . . 0.0 110.342 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.638 ' N ' ' O ' ' A' ' 149' ' ' TYR . 0.2 OUTLIER -155.14 66.65 4.94 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 125.393 1.477 . . . . 0.0 110.041 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.42 ' N ' ' O ' ' A' ' 150' ' ' LEU . 39.8 Cg_endo -72.25 -3.44 13.34 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 C-N-CA 122.603 2.202 . . . . 0.0 111.68 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.633 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 4.2 m-20 -84.66 4.12 33.95 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.122 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.405 ' O ' ' CD ' ' A' ' 20' ' ' LYS . . . -50.1 130.31 22.21 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 119.522 -1.986 . . . . 0.0 111.419 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.714 ' CG ' HD13 ' A' ' 24' ' ' LEU . 0.7 OUTLIER 55.15 6.47 0.15 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.633 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.499 0 O-C-N 121.832 -0.542 . . . . 0.0 110.253 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.835 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.2 p -134.91 148.6 29.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 O-C-N 122.661 -0.317 . . . . 0.0 111.048 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -97.64 109.41 22.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.776 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.58 HG23 ' CE1' ' A' ' 118' ' ' HIS . 92.8 m -97.18 139.83 32.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 0.0 110.918 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -140.34 129.5 23.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.205 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.527 ' C ' HD22 ' A' ' 7' ' ' ASN . 1.4 tt0 -103.37 126.67 50.66 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.757 0.313 . . . . 0.0 110.894 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.527 HD22 ' C ' ' A' ' 6' ' ' GLU . 2.3 m120 -126.67 165.71 18.71 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.198 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -155.93 139.8 16.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 112.082 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -137.98 139.94 39.95 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.474 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.27 145.04 26.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.82 0.343 . . . . 0.0 111.521 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.0 t -145.38 155.06 42.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.534 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -93.23 29.32 1.93 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.894 0.378 . . . . 0.0 110.792 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.578 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.3 mt -113.78 125.25 29.74 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.779 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -49.22 146.01 13.92 Favored 'Trans proline' 0 C--N 1.327 -0.559 0 C-N-CA 121.862 1.708 . . . . 0.0 111.615 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.433 ' HA ' HD12 ' A' ' 18' ' ' LEU . 27.1 Cg_exo -57.56 -24.6 62.79 Favored 'Trans proline' 0 N--CA 1.483 0.853 0 C-N-CA 122.204 1.936 . . . . 0.0 112.412 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.522 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 52.9 m -67.64 -35.63 79.26 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -75.74 -57.26 3.99 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.578 HD11 ' O ' ' A' ' 13' ' ' ILE . 3.8 mt -49.19 -47.11 46.32 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.09 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.479 ' O ' HG22 ' A' ' 23' ' ' VAL . 40.2 t80 -48.04 -56.66 7.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.705 ' CB ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.99 -38.41 76.0 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 119.101 -1.039 . . . . 0.0 108.479 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.798 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -66.72 -3.71 7.26 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.541 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.499 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 7.9 m-85 -119.94 -8.9 9.75 Favored 'General case' 0 CA--C 1.527 0.058 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.578 HG23 ' N ' ' A' ' 24' ' ' LEU . 22.3 m -129.31 -49.61 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.033 HD12 ' N ' ' A' ' 25' ' ' ASP . 2.7 pp -101.19 -30.53 11.49 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 1.033 ' N ' HD12 ' A' ' 24' ' ' LEU . 50.2 m-20 -110.89 -4.07 15.38 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.813 -0.554 . . . . 0.0 111.398 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -66.82 -38.79 87.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.704 0.764 . . . . 0.0 112.099 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.492 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 17.3 m-20 -84.09 14.83 3.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.86 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 27' ' ' ASP . 8.2 m120 -138.84 -9.27 1.37 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.965 HD12 HG23 ' A' ' 146' ' ' ILE . 0.1 OUTLIER -92.03 -50.86 5.48 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.515 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.598 HG13 HD11 ' A' ' 146' ' ' ILE . 91.1 mt -55.33 -48.23 96.74 Favored Pre-proline 0 C--O 1.212 -0.884 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 29.7 Cg_endo -62.87 -26.16 74.52 Favored 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 121.773 1.649 . . . . 0.0 113.461 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -75.93 -48.61 20.56 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.662 0.744 . . . . 0.0 112.042 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.777 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.6 OUTLIER -94.45 -36.28 6.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.533 -177.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.91 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.95 63.61 0.16 Allowed Pre-proline 0 C--N 1.324 -0.507 0 C-N-CA 122.817 0.447 . . . . 0.0 111.947 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.493 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 73.6 Cg_endo -76.37 -25.73 9.5 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 N-CA-C 107.625 -1.721 . . . . 0.0 107.625 174.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -74.81 -43.9 52.19 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.609 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.91 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -71.73 -75.13 0.14 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.254 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.56 146.17 9.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.955 0.407 . . . . 0.0 110.221 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -77.66 -52.4 9.04 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.376 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.697 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 54.0 tp60 -175.68 164.0 2.94 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.861 0.362 . . . . 0.0 110.546 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.697 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -166.96 144.0 4.67 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.134 0.492 . . . . 0.0 110.518 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.53 ' N ' ' NZ ' ' A' ' 54' ' ' LYS . 17.7 pt-20 -149.85 156.17 41.33 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.105 -0.372 . . . . 0.0 110.876 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.442 HG13 ' H ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -83.83 138.87 18.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.554 0.692 . . . . 0.0 111.008 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.97 -39.38 13.02 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.03 -0.987 . . . . 0.0 109.053 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.904 ' O ' HG23 ' A' ' 52' ' ' THR . 1.1 tt0 -142.41 138.22 30.95 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.22 -156.68 27.39 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.685 HD22 ' N ' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -135.08 -13.6 2.11 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.593 -0.357 . . . . 0.0 111.079 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.685 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 143.8 10.84 0.38 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.9 -172.99 19.84 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 117.525 0.662 . . . . 0.0 111.75 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -60.28 127.19 22.19 Favored 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 122.597 2.198 . . . . 0.0 113.207 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.95 1.94 55.01 Favored Glycine 0 CA--C 1.506 -0.512 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.904 HG23 ' O ' ' A' ' 45' ' ' GLU . 95.8 m -93.59 136.16 34.15 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.313 -0.944 . . . . 0.0 110.761 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mp -109.56 119.22 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' NZ ' ' N ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -109.25 136.4 48.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.781 0.8 . . . . 0.0 109.738 178.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -120.56 129.77 53.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.157 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.672 ' N ' HD12 ' A' ' 56' ' ' ILE . 2.5 mp -95.41 136.38 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.4 m -107.97 118.43 36.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.491 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -98.29 166.85 11.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.638 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.7 144.52 30.31 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.81 -58.47 8.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.805 0.336 . . . . 0.0 110.694 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.35 61.6 3.22 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.4 m -137.41 176.05 9.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.945 0.403 . . . . 0.0 110.684 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -61.07 -52.66 63.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.658 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.26 155.97 18.16 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.05 -61.8 0.14 Allowed Glycine 0 N--CA 1.462 0.393 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.64 155.06 42.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 0.0 110.846 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 p -156.01 145.52 12.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.187 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.495 ' HZ2' ' HB3' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -101.49 110.52 22.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.32 0.581 . . . . 0.0 111.802 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.464 ' CD2' ' C ' ' A' ' 69' ' ' HIS . 0.3 OUTLIER -109.62 114.79 28.69 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.11 133.77 46.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.11 0.481 . . . . 0.0 111.693 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.5 mt -80.31 137.51 21.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -95.54 -54.31 3.42 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -177.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.8 m -164.66 141.72 6.27 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.441 HD13 HG11 ' A' ' 23' ' ' VAL . 22.6 mt -128.21 130.0 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.712 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 79' ' ' TYR . 7.4 m-20 -115.61 88.78 2.95 Favored 'General case' 0 C--O 1.211 -0.928 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.414 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 7.4 mt-10 -54.26 -30.07 49.22 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.3 -38.08 70.77 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.426 177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.07 -11.46 15.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.978 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 75' ' ' ASP . 7.5 m-85 61.16 41.47 13.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.795 -0.566 . . . . 0.0 110.498 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.9 t -115.41 132.66 56.55 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.736 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.492 ' CE2' ' OG1' ' A' ' 102' ' ' THR . 51.4 p90 -132.45 131.79 42.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.29 0.567 . . . . 0.0 110.92 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.3 t -126.81 145.15 50.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.226 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -151.26 163.63 38.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.1 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 98' ' ' ILE . 5.7 m -146.4 142.5 28.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.233 0.54 . . . . 0.0 111.378 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.636 HD13 ' HB1' ' A' ' 90' ' ' ALA . 5.7 mt -81.19 120.56 25.03 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.477 ' CG1' ' N ' ' A' ' 87' ' ' GLU . 3.6 pt -80.75 -44.55 21.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.724 0.297 . . . . 0.0 111.665 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.517 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 4.6 tp10 -153.71 171.79 18.3 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.613 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.54 177.77 18.03 Favored Glycine 0 CA--C 1.508 -0.359 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -61.06 2.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.636 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -68.38 -35.06 77.15 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 124.168 0.987 . . . . 0.0 110.102 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.889 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.62 15.68 21.89 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 123.591 0.756 . . . . 0.0 109.799 -178.057 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.4 p 47.19 -126.8 1.65 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -130.74 -12.79 3.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.078 0.466 . . . . 0.0 111.195 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.514 ' O ' HG21 ' A' ' 125' ' ' ILE . 2.6 p -105.53 -5.36 20.28 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.714 HG21 ' CD1' ' A' ' 98' ' ' ILE . 79.4 mt -97.55 152.17 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-O 122.16 0.981 . . . . 0.0 113.432 -176.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.493 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -89.41 -59.47 2.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 113.917 -1.492 . . . . 0.0 109.423 178.12 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.442 ' CB ' ' NZ ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -171.69 149.08 2.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.462 0.649 . . . . 0.0 111.285 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.714 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.92 123.24 69.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.4 t -111.14 146.43 36.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.353 0.597 . . . . 0.0 111.956 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -134.7 131.07 37.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.571 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.427 ' O ' HG12 ' A' ' 116' ' ' ILE . 77.3 tt0 -128.1 133.55 49.03 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.492 ' OG1' ' CE2' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -140.2 132.71 28.63 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 121.956 -0.465 . . . . 0.0 110.476 -178.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.602 ' C ' HD23 ' A' ' 104' ' ' LEU . 54.3 tttm -121.76 133.93 54.92 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.73 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -100.12 126.35 46.36 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.19 137.17 58.6 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.159 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.81 133.92 44.69 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.379 178.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 28.1 p -121.1 172.8 7.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.941 0.401 . . . . 0.0 110.258 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.12 -38.78 61.93 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.1 m -83.53 -15.57 48.82 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.63 1.172 . . . . 0.0 112.871 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 160.75 -85.48 0.11 Allowed Glycine 0 CA--C 1.54 1.596 0 C-N-CA 127.541 2.495 . . . . 0.0 112.794 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.7 OUTLIER -157.58 130.32 7.46 Favored 'General case' 0 C--N 1.347 0.487 0 C-N-CA 127.995 2.518 . . . . 0.0 111.046 175.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.4 m -99.82 118.45 36.31 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.5 mt -91.83 128.73 43.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.54 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.431 ' CB ' ' NZ ' ' A' ' 114' ' ' LYS . 1.2 mtmp? -105.59 117.05 33.02 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.814 ' C ' HD13 ' A' ' 116' ' ' ILE . 43.7 t -111.31 125.23 53.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.238 0.542 . . . . 0.0 110.845 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.896 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -107.17 135.76 44.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 123.22 0.608 . . . . 0.0 110.043 -177.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.2 t -107.1 137.94 44.22 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.885 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.58 ' CE1' HG23 ' A' ' 4' ' ' THR . 6.7 m80 -135.67 93.49 2.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.076 0.465 . . . . 0.0 110.589 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.835 ' C ' HG23 ' A' ' 2' ' ' VAL . 88.8 m-85 -86.56 101.6 13.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.173 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -99.3 107.88 20.28 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.138 0.494 . . . . 0.0 110.546 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.779 HG21 ' HA ' ' A' ' 126' ' ' GLU . 9.3 p -100.48 173.11 6.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.408 0.623 . . . . 0.0 111.167 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.97 155.17 21.18 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.187 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 40.3 -109.09 0.12 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.767 ' H ' HD22 ' A' ' 124' ' ' ASN . 0.1 OUTLIER -109.51 -1.4 18.3 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 122.779 -0.248 . . . . 0.0 111.213 179.039 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.514 HG21 ' O ' ' A' ' 94' ' ' THR . 1.4 mp -49.16 151.54 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.269 0.557 . . . . 0.0 109.877 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.779 ' HA ' HG21 ' A' ' 121' ' ' THR . 35.2 tt0 -147.7 148.29 30.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.642 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.7 mm -87.99 125.46 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -74.33 162.3 29.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.123 0.487 . . . . 0.0 111.798 -178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.4 -34.89 75.18 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.948 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.472 ' O ' HG22 ' A' ' 134' ' ' VAL . 0.6 OUTLIER -69.15 -28.62 66.59 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.108 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -72.49 -47.43 48.67 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.112 0.482 . . . . 0.0 111.108 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.4 m -79.29 -28.61 13.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.981 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -66.78 -45.64 77.85 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.169 -0.332 . . . . 0.0 110.855 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.514 HG23 ' N ' ' A' ' 135' ' ' GLY . 32.6 m -70.35 -45.6 74.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.718 0.294 . . . . 0.0 110.529 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.514 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -66.9 -44.59 88.6 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 77.9 tttt -65.02 -46.04 83.01 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 122.696 -0.296 . . . . 0.0 110.673 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -54.42 -47.15 73.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.793 0.33 . . . . 0.0 110.135 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.1 ttpp -66.44 -52.99 40.55 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.69 -43.98 47.71 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.589 0.709 . . . . 0.0 110.546 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.37 -36.49 75.85 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.424 ' O ' HD22 ' A' ' 145' ' ' LEU . . . -61.03 -42.4 99.78 Favored Glycine 0 C--O 1.22 -0.76 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.559 ' CD2' ' HB1' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -64.0 -46.84 82.74 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -60.74 -24.08 65.44 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 141' ' ' GLY . 1.8 ttmm -76.5 -38.56 55.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.808 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.777 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -66.94 -57.01 7.76 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.365 0.602 . . . . 0.0 110.092 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.965 HG23 HD12 ' A' ' 29' ' ' LEU . 43.3 mt -55.3 -50.03 68.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.539 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -47.19 -53.23 13.64 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.667 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.3 m -55.39 -41.72 73.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.232 0.539 . . . . 0.0 110.908 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.719 ' HB2' HD13 ' A' ' 33' ' ' ILE . 22.0 t80 -60.8 -45.44 94.39 Favored 'General case' 0 C--O 1.194 -1.864 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.798 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.1 mm? -67.02 -42.95 84.06 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 120.653 1.57 . . . . 0.0 111.449 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -24.02 67.47 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.699 -0.625 . . . . 0.0 109.425 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -106.34 -13.17 15.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.842 0.83 . . . . 0.0 110.415 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.657 ' N ' ' O ' ' A' ' 149' ' ' TYR . 60.7 m80 -156.04 66.81 4.52 Favored Pre-proline 0 C--N 1.303 -1.436 0 C-N-CA 125.32 1.448 . . . . 0.0 110.173 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.86 -2.18 11.87 Favored 'Trans proline' 0 N--CA 1.48 0.708 0 C-N-CA 122.708 2.272 . . . . 0.0 111.154 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.644 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 9.1 m-20 -68.36 2.21 2.46 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.535 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.602 ' O ' ' HD3' ' A' ' 20' ' ' LYS . . . -50.43 130.47 23.62 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 118.841 -2.412 . . . . 0.0 110.924 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.845 ' CD1' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER 52.34 4.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 179.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.644 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 118.18 -0.915 . . . . 0.0 110.052 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.774 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.7 p -134.47 148.68 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.869 0.366 . . . . 0.0 111.329 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -98.0 109.99 22.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.682 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.502 ' OG1' ' CE1' ' A' ' 118' ' ' HIS . 74.6 m -95.76 140.09 31.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 0.0 110.796 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -141.5 132.04 25.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.132 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -103.02 137.02 41.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.128 0.489 . . . . 0.0 111.47 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -136.16 165.39 25.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.971 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -155.62 149.63 25.52 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -149.65 140.73 22.99 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.512 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.08 147.83 23.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.874 0.368 . . . . 0.0 111.659 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.4 p -140.0 155.74 46.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.446 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -95.93 22.51 7.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.838 0.351 . . . . 0.0 111.044 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.554 ' O ' HD11 ' A' ' 18' ' ' LEU . 2.3 mt -119.31 128.07 26.13 Favored Pre-proline 0 C--O 1.217 -0.616 0 CA-C-O 118.946 -0.55 . . . . 0.0 110.375 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -45.7 144.8 5.04 Favored 'Trans proline' 0 C--N 1.325 -0.666 0 C-N-CA 121.68 1.587 . . . . 0.0 110.935 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HA ' HD12 ' A' ' 18' ' ' LEU . 10.2 Cg_endo -61.13 -23.63 77.64 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 122.172 1.915 . . . . 0.0 112.693 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.506 ' C ' ' HE ' ' A' ' 17' ' ' ARG . 10.2 t -70.35 -30.18 67.07 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.696 ' HE ' ' N ' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -79.16 -52.3 8.35 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.554 HD11 ' O ' ' A' ' 13' ' ' ILE . 4.3 mt -53.45 -44.75 69.15 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.261 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.9 ' O ' HG22 ' A' ' 23' ' ' VAL . 48.7 t80 -49.83 -57.44 7.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.94 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.45 ' CG ' ' O ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -68.63 -27.64 66.2 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.815 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.024 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -82.95 -1.63 52.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.655 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.634 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 13.1 t80 -120.31 -7.66 9.75 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.9 HG22 ' O ' ' A' ' 19' ' ' PHE . 2.5 m -129.71 -35.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.845 ' CD1' HG23 ' A' ' 23' ' ' VAL . 4.3 mp -89.49 -54.46 4.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.777 0.717 . . . . 0.0 111.626 -176.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.527 ' CB ' ' CZ ' ' A' ' 157' ' ' TYR . 0.1 OUTLIER -115.8 0.83 13.29 Favored 'General case' 0 C--O 1.199 -1.596 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.341 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.634 ' HB2' ' HA ' ' A' ' 22' ' ' PHE . . . -44.53 -41.87 6.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 119.518 1.053 . . . . 0.0 111.879 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.487 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 4.8 p30 -84.81 17.4 2.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.507 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 27' ' ' ASP . 11.6 m120 -139.68 -10.97 1.18 Allowed 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 125.562 1.545 . . . . 0.0 108.722 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.569 HD21 ' CD2' ' A' ' 149' ' ' TYR . 0.2 OUTLIER -95.07 -43.02 8.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 125.19 1.396 . . . . 0.0 108.334 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.73 HG13 HD11 ' A' ' 146' ' ' ILE . 55.7 mt -54.5 -51.17 80.6 Favored Pre-proline 0 C--O 1.215 -0.73 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.072 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 26.2 Cg_endo -61.96 -22.79 74.97 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 122.148 1.899 . . . . 0.0 111.855 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -68.82 -55.45 11.14 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.505 0.669 . . . . 0.0 111.564 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.722 HD12 ' HB2' ' A' ' 145' ' ' LEU . 0.5 OUTLIER -94.63 -40.97 11.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.732 -177.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.876 ' HB2' HD22 ' A' ' 145' ' ' LEU . . . -110.8 71.13 0.69 Allowed Pre-proline 0 CA--C 1.506 -0.737 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.016 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.21 -6.87 15.73 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 N-CA-C 108.115 -1.533 . . . . 0.0 108.115 176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.429 ' H ' ' C ' ' A' ' 34' ' ' ALA . 24.7 pt20 -71.98 -34.82 69.22 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.799 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.586 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -79.55 -82.0 0.11 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.263 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 38' ' ' ILE . 1.8 mp -102.81 143.66 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.882 0.372 . . . . 0.0 110.353 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -79.33 -43.74 22.95 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.986 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.677 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -177.39 165.17 2.19 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.677 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -165.47 145.63 6.83 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.751 0.31 . . . . 0.0 110.951 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -136.75 142.76 43.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.74 0.305 . . . . 0.0 110.213 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.618 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -79.57 140.11 17.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.523 0.678 . . . . 0.0 110.472 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.1 mp -88.84 -39.64 13.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.877 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.948 ' O ' HG23 ' A' ' 52' ' ' THR . 22.9 mt-10 -142.96 134.09 25.81 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.867 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.86 -156.05 35.89 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.684 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -137.54 -0.53 2.16 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.554 -0.38 . . . . 0.0 111.363 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.507 ' N ' HG21 ' A' ' 52' ' ' THR . . . 134.87 16.24 1.0 Allowed Glycine 0 C--O 1.223 -0.56 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.466 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -110.48 -173.32 20.19 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 117.525 0.662 . . . . 0.0 111.458 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -60.39 125.92 18.68 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 122.181 1.921 . . . . 0.0 113.172 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.7 2.7 58.51 Favored Glycine 0 N--CA 1.462 0.412 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.948 HG23 ' O ' ' A' ' 45' ' ' GLU . 90.7 m -94.05 140.16 30.07 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.359 -0.921 . . . . 0.0 111.267 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 mp -120.68 130.94 74.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.618 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -119.83 140.0 51.49 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.302 0.572 . . . . 0.0 111.02 179.231 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.633 ' HE3' ' HZ3' ' A' ' 68' ' ' LYS . 35.5 ttmt -118.21 124.75 48.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.609 178.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.805 HD13 ' CD2' ' A' ' 69' ' ' HIS . 1.4 mp -102.84 129.58 54.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.4 m -112.46 119.88 39.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.248 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -92.63 -174.93 3.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.008 0.432 . . . . 0.0 110.849 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.36 146.63 50.47 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.631 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 3.5 mp0 -59.1 -48.96 79.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.869 0.366 . . . . 0.0 110.617 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.92 61.27 3.41 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -138.4 175.62 9.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.248 0.547 . . . . 0.0 110.412 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.58 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -67.1 -53.56 29.72 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.14 156.26 18.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.953 0.406 . . . . 0.0 110.18 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.31 -58.77 0.22 Allowed Glycine 0 CA--C 1.52 0.348 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -143.83 155.02 43.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.168 0.509 . . . . 0.0 110.58 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.466 ' CG2' HD11 ' A' ' 85' ' ' LEU . 5.1 p -154.23 146.54 13.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.361 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.633 ' HZ3' ' HE3' ' A' ' 55' ' ' LYS . 14.6 mmtt -107.46 112.43 25.21 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.285 0.564 . . . . 0.0 112.491 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.805 ' CD2' HD13 ' A' ' 56' ' ' ILE . 8.8 m-70 -104.83 114.83 29.28 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -101.91 120.76 40.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.653 0.263 . . . . 0.0 111.17 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.559 HD13 ' CG2' ' A' ' 52' ' ' THR . 5.0 mp -70.48 145.15 13.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -102.02 -55.64 2.45 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.123 -0.36 . . . . 0.0 111.83 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.9 m -165.93 141.02 4.75 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.5 mt -124.53 130.99 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.922 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 79' ' ' TYR . 12.7 m-20 -115.16 87.67 2.71 Favored 'General case' 0 C--O 1.206 -1.213 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.486 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -54.72 -32.39 59.54 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.45 -38.55 66.48 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -108.06 -10.78 15.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.055 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.591 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.2 m-85 62.58 47.29 5.01 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.45 -0.781 . . . . 0.0 110.341 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.496 ' HB3' ' HZ3' ' A' ' 103' ' ' LYS . 10.2 p -105.8 144.54 32.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.415 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.633 ' CE2' ' CD2' ' A' ' 83' ' ' TYR . 29.5 t80 -132.2 118.41 19.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.052 0.453 . . . . 0.0 110.712 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.6 p -127.12 130.44 49.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.748 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.633 ' CD2' ' CE2' ' A' ' 81' ' ' TYR . 12.9 p90 -144.8 164.63 30.47 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -140.1 137.01 34.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.329 0.585 . . . . 0.0 110.987 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.627 HD21 ' CE1' ' A' ' 69' ' ' HIS . 0.2 OUTLIER -79.75 118.65 21.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.569 HD11 ' CB ' ' A' ' 68' ' ' LYS . 2.7 pt -87.27 -45.01 16.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.479 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 35.4 tt0 -152.65 171.76 17.68 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.85 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.616 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.87 177.46 17.87 Favored Glycine 0 CA--C 1.51 -0.245 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -62.16 2.05 0.27 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.616 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -66.01 -33.02 74.84 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 124.754 1.221 . . . . 0.0 110.608 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.876 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -109.75 16.14 22.27 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 123.439 0.695 . . . . 0.0 109.624 -178.08 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 53.4 p 45.85 -126.49 1.31 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -130.38 -12.99 3.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.96 0.41 . . . . 0.0 111.176 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.9 p -105.17 -6.74 19.56 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.714 HG21 ' CD1' ' A' ' 98' ' ' ILE . 59.0 mt -98.6 153.01 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 CA-C-O 122.004 0.907 . . . . 0.0 113.256 -176.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.514 ' N ' HG22 ' A' ' 95' ' ' ILE . 19.9 pt-20 -99.88 -46.11 5.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.377 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.441 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -172.62 146.83 1.73 Allowed 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 121.723 0.773 . . . . 0.0 112.415 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.714 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.14 123.47 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.94 145.08 30.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.138 0.494 . . . . 0.0 111.369 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.514 ' CD2' ' O ' ' A' ' 116' ' ' ILE . 0.4 OUTLIER -141.79 129.5 21.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.576 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.419 ' O ' HG12 ' A' ' 116' ' ' ILE . 18.0 tt0 -128.12 134.6 49.14 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.06 131.82 25.76 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.905 -0.497 . . . . 0.0 109.96 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.697 ' C ' HD23 ' A' ' 104' ' ' LEU . 17.5 ttmm -125.62 134.15 51.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.123 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.873 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -99.9 125.97 45.96 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.116 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -126.2 137.26 58.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.795 -178.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.69 132.73 44.06 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.41 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.449 ' SG ' ' N ' ' A' ' 111' ' ' SER . 24.2 p -121.4 171.6 8.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.866 0.365 . . . . 0.0 110.293 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.94 -30.77 46.27 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.8 m -85.4 -16.81 38.55 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 119.379 -2.248 . . . . 0.0 114.352 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.74 -85.57 0.13 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.078 1.799 . . . . 0.0 109.858 -171.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.3 OUTLIER -160.12 129.13 5.0 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.87 1.668 . . . . 0.0 110.921 -178.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 105' ' ' VAL . 33.1 m -99.43 117.8 34.64 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 55.5 mt -91.96 128.81 43.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.766 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -105.89 117.08 33.1 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.719 ' C ' HD13 ' A' ' 116' ' ' ILE . 0.5 OUTLIER -111.88 118.18 34.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.415 0.626 . . . . 0.0 111.556 -178.291 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.95 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -99.31 135.03 36.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 123.773 0.829 . . . . 0.0 109.915 -178.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.9 136.86 46.91 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.502 ' CE1' ' OG1' ' A' ' 4' ' ' THR . 47.8 m-70 -136.09 97.81 3.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 120.999 0.428 . . . . 0.0 110.801 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.774 ' C ' HG23 ' A' ' 2' ' ' VAL . 3.6 m-30 -84.31 101.65 12.1 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.83 -0.434 . . . . 0.0 109.83 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.442 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -94.83 102.67 14.53 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.752 HG21 ' HA ' ' A' ' 126' ' ' GLU . 11.9 p -101.31 171.32 7.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.482 0.658 . . . . 0.0 111.421 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -112.35 143.0 44.18 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.508 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 50.38 -109.71 0.74 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -106.85 -6.51 17.62 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.649 -0.324 . . . . 0.0 111.478 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 125' ' ' ILE . 1.4 mp -47.5 151.42 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.199 0.524 . . . . 0.0 109.751 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.752 ' HA ' HG21 ' A' ' 121' ' ' THR . 12.9 pt-20 -148.18 147.75 29.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.84 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.9 mm -88.19 127.67 41.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.449 ' HG3' ' H ' ' A' ' 129' ' ' GLU . 10.7 tptp -73.76 159.88 32.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.614 0.721 . . . . 0.0 111.684 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.449 ' H ' ' HG3' ' A' ' 128' ' ' LYS . 70.0 mm-40 -70.15 -37.89 75.34 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.531 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.476 ' O ' HG13 ' A' ' 134' ' ' VAL . 43.8 mt-10 -64.69 -26.58 68.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.877 0.37 . . . . 0.0 110.231 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -72.78 -49.23 32.03 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.161 0.505 . . . . 0.0 111.062 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 m -78.25 -28.99 15.08 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.121 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -67.23 -46.2 74.5 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 122.004 -0.435 . . . . 0.0 110.746 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 135' ' ' GLY . 25.8 m -70.42 -42.4 78.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.771 0.32 . . . . 0.0 110.679 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.491 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -69.86 -46.16 54.24 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -66.74 -48.43 69.18 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.568 -0.372 . . . . 0.0 110.911 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -56.03 -47.77 77.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.097 0.475 . . . . 0.0 110.126 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -64.7 -53.85 40.86 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.449 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -48.36 -46.8 37.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.352 0.596 . . . . 0.0 110.564 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -55.37 -37.44 67.55 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.99 -42.25 98.26 Favored Glycine 0 C--O 1.223 -0.532 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.727 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -66.49 -32.71 74.24 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 122.243 -0.563 . . . . 0.0 109.943 -179.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.59 ' CE2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -71.48 -20.03 62.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.224 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -72.6 -48.22 41.44 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.294 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.876 HD22 ' HB2' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -73.57 -44.33 57.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.165 -179.294 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.73 HD11 HG13 ' A' ' 30' ' ' ILE . 31.2 mt -52.57 -50.51 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.425 ' O ' ' CD1' ' A' ' 13' ' ' ILE . 27.1 tt0 -47.87 -49.43 29.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.1 t -51.74 -46.85 64.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.483 0.659 . . . . 0.0 110.959 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.607 ' O ' ' N ' ' A' ' 153' ' ' HIS . 12.2 t80 -58.55 -43.79 89.43 Favored 'General case' 0 C--O 1.199 -1.582 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 1.024 HD11 ' HB2' ' A' ' 21' ' ' ALA . 1.6 mm? -67.91 -43.23 79.7 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 119.675 1.125 . . . . 0.0 111.983 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.501 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -59.9 -24.58 64.42 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.253 -0.904 . . . . 0.0 108.953 179.507 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -105.73 -13.81 15.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.331 0.586 . . . . 0.0 110.575 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.607 ' N ' ' O ' ' A' ' 149' ' ' TYR . 0.3 OUTLIER -155.65 66.5 4.63 Favored Pre-proline 0 C--N 1.313 -0.982 0 C-N-CA 124.738 1.215 . . . . 0.0 110.47 -178.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.466 ' CD ' ' O ' ' A' ' 150' ' ' LEU . 9.7 Cg_endo -77.47 -8.58 17.26 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 C-N-CA 122.719 2.28 . . . . 0.0 111.743 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.546 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 14.0 t70 -89.94 6.54 41.6 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.388 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.557 ' HB1' ' CE1' ' A' ' 157' ' ' TYR . . . -72.34 132.18 43.64 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 120.296 -1.503 . . . . 0.0 110.274 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.557 ' CE1' ' HB1' ' A' ' 156' ' ' ALA . 1.7 m-85 64.95 9.12 5.15 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.794 176.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.546 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.747 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.816 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.812 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.9 p -134.7 148.82 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 O-C-N 122.477 -0.426 . . . . 0.0 110.789 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.28 109.78 22.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.694 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.544 ' OG1' ' CE1' ' A' ' 118' ' ' HIS . 61.3 m -96.88 140.01 32.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.802 0.334 . . . . 0.0 111.028 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.88 125.34 16.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.98 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.467 ' C ' ' ND2' ' A' ' 7' ' ' ASN . 0.9 OUTLIER -103.27 130.24 50.46 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.716 0.293 . . . . 0.0 111.429 -179.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.467 ' ND2' ' C ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -131.43 171.34 13.5 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -155.76 155.63 33.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -154.63 140.0 17.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.343 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 m -93.91 146.27 24.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.817 0.341 . . . . 0.0 111.583 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 p -135.15 154.32 51.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.398 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -97.41 26.92 4.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.084 0.468 . . . . 0.0 110.498 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.585 ' HB ' HD21 ' A' ' 18' ' ' LEU . 2.2 mt -119.05 125.41 27.67 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.444 -178.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -46.13 147.32 3.76 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 121.826 1.684 . . . . 0.0 111.522 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -59.56 -24.53 75.48 Favored 'Trans proline' 0 N--CA 1.482 0.812 0 C-N-CA 121.983 1.789 . . . . 0.0 112.212 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.47 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 67.1 m -68.13 -34.19 75.9 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -77.8 -56.09 4.79 Favored 'General case' 0 CA--C 1.503 -0.832 0 O-C-N 121.395 -0.816 . . . . 0.0 109.272 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.585 HD21 ' HB ' ' A' ' 13' ' ' ILE . 2.8 mt -52.47 -43.05 64.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.226 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.796 ' O ' HG22 ' A' ' 23' ' ' VAL . 46.2 t80 -54.87 -54.42 42.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 16' ' ' SER . 0.3 OUTLIER -70.89 -25.75 62.92 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.086 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.854 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -83.06 -2.04 54.31 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.524 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.542 ' CE2' ' CE2' ' A' ' 143' ' ' PHE . 2.8 m-85 -117.31 -7.87 11.15 Favored 'General case' 0 C--N 1.335 -0.035 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.876 HG23 ' CD1' ' A' ' 24' ' ' LEU . 4.7 m -134.89 -34.75 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.876 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.7 mp -88.88 -55.34 3.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.871 1.214 . . . . 0.0 111.443 -176.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.506 ' CG ' ' CE2' ' A' ' 157' ' ' TYR . 0.9 OUTLIER -114.76 -1.32 13.28 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.726 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.485 ' HB2' ' CA ' ' A' ' 22' ' ' PHE . . . -45.77 -40.71 9.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.696 0.76 . . . . 0.0 111.57 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.493 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER -85.07 18.04 2.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.077 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 27' ' ' ASP . 9.8 m120 -139.53 -9.06 1.25 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 126.087 1.755 . . . . 0.0 108.683 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.483 HD21 ' CD1' ' A' ' 149' ' ' TYR . 0.1 OUTLIER -95.19 -40.99 9.3 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 124.737 1.215 . . . . 0.0 109.939 -179.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.514 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 80.6 mt -55.16 -42.17 94.51 Favored Pre-proline 0 C--O 1.21 -0.985 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.182 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 21.2 Cg_exo -63.79 -26.69 67.83 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 122.098 1.866 . . . . 0.0 112.039 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.6 tmtp? -71.01 -51.37 25.84 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 122.027 0.918 . . . . 0.0 111.858 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.778 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.5 OUTLIER -94.57 -35.23 6.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.008 -176.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.848 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.48 65.04 0.14 Allowed Pre-proline 0 C--N 1.322 -0.606 0 C-N-CA 122.966 0.507 . . . . 0.0 111.89 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.466 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 73.2 Cg_endo -74.88 -23.05 14.44 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 N-CA-C 107.707 -1.69 . . . . 0.0 107.707 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -73.9 -43.51 58.2 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.315 -1.312 . . . . 0.0 109.231 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.848 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -73.78 -82.72 0.05 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.766 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.5 mt -100.5 145.84 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.083 0.468 . . . . 0.0 110.471 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -77.8 -54.99 5.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.787 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.428 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -174.21 166.4 4.13 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.099 0.476 . . . . 0.0 110.342 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.428 ' H ' ' HG2' ' A' ' 40' ' ' GLN . . . -166.25 144.25 5.47 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.475 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.432 ' N ' ' HE3' ' A' ' 54' ' ' LYS . 8.4 pt-20 -135.93 146.62 47.51 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.516 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -78.46 139.83 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.404 0.621 . . . . 0.0 110.695 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 8.1 mp -88.63 -39.93 13.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.142 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.929 ' O ' HG23 ' A' ' 52' ' ' THR . 47.1 mt-10 -142.33 133.98 26.78 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.942 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.39 -156.02 27.69 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.61 HD22 ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -142.45 -6.37 0.92 Allowed 'General case' 0 C--N 1.32 -0.684 0 O-C-N 122.355 -0.497 . . . . 0.0 111.177 -179.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.61 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 143.27 14.12 0.31 Allowed Glycine 0 C--O 1.221 -0.708 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.56 -172.61 19.99 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 117.493 0.647 . . . . 0.0 111.988 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -62.13 126.4 18.59 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 123.113 2.542 . . . . 0.0 113.432 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.44 5.8 57.78 Favored Glycine 0 CA--C 1.505 -0.549 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.929 HG23 ' O ' ' A' ' 45' ' ' GLU . 84.3 m -93.37 137.45 32.67 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 114.339 -0.931 . . . . 0.0 111.128 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.21 129.37 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.516 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -116.21 139.06 50.74 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.206 0.526 . . . . 0.0 110.844 179.163 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.511 ' C ' HD12 ' A' ' 56' ' ' ILE . 66.5 tttt -118.99 127.11 53.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.704 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.827 HD13 ' CD2' ' A' ' 69' ' ' HIS . 1.3 mp -98.98 131.98 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.9 m -105.88 118.84 37.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.349 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -98.65 175.46 5.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 110.782 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.61 145.06 49.68 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -59.31 -53.04 62.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.917 0.389 . . . . 0.0 110.736 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.11 61.73 3.29 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.3 m -140.56 175.03 9.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.855 0.36 . . . . 0.0 110.826 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -60.47 -56.12 25.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.976 0.417 . . . . 0.0 110.637 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.93 155.9 16.91 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.196 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -125.22 -59.78 0.17 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.38 154.17 45.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.091 0.472 . . . . 0.0 110.483 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.0 p -156.67 147.35 11.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.351 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.455 ' HB3' HD11 ' A' ' 86' ' ' ILE . 1.5 tppt? -107.12 112.42 25.32 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.452 0.644 . . . . 0.0 112.389 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.827 ' CD2' HD13 ' A' ' 56' ' ' ILE . 8.0 m170 -101.9 120.58 40.61 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -102.92 115.79 31.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.629 0.252 . . . . 0.0 111.335 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.8 mt -70.0 135.97 27.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.417 ' O ' ' OG ' ' A' ' 73' ' ' SER . 1.7 m-20 -96.94 -56.34 2.59 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -177.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 69.4 m -166.08 142.42 5.04 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.9 mt -122.63 131.87 72.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.288 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -115.35 87.7 2.72 Favored 'General case' 0 C--O 1.206 -1.196 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.109 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.503 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -54.67 -30.96 56.96 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.26 -39.06 72.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.2 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.9 m -107.97 -10.35 15.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.188 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.1 m-85 62.33 45.17 6.85 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.487 -0.758 . . . . 0.0 110.199 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.8 t -106.56 148.39 28.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.273 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -132.02 125.67 32.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.727 0.299 . . . . 0.0 110.848 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.8 t -133.47 138.41 46.15 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.607 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -144.14 160.83 40.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.698 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 98' ' ' ILE . 10.1 m -140.03 129.88 24.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.327 0.584 . . . . 0.0 111.027 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.407 HD21 ' CE1' ' A' ' 69' ' ' HIS . 18.2 mt -78.94 119.46 22.13 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' A' ' 68' ' ' LYS . 5.2 pt -88.32 -43.89 15.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.496 ' CD ' ' N ' ' A' ' 88' ' ' GLY . 8.3 tm-20 -158.89 173.28 16.76 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.222 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.606 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.74 178.51 18.41 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.42 2.55 0.15 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.756 ' C ' HD23 ' A' ' 91' ' ' LEU . . . -70.79 -37.1 73.28 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 123.517 0.727 . . . . 0.0 110.19 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.867 HD23 ' N ' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -111.39 17.17 20.4 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 91' ' ' LEU . 56.7 p 51.93 -132.67 1.91 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -131.64 -0.34 3.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.946 0.403 . . . . 0.0 112.0 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.03 -7.43 19.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.807 HD11 HD12 ' A' ' 127' ' ' ILE . 12.0 mt -99.36 151.67 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.502 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -88.51 -51.53 5.66 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.355 176.026 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.03 148.36 2.23 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.128 0.489 . . . . 0.0 112.182 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.707 HD13 HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.22 130.4 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 176.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.4 147.0 44.86 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 122.957 0.503 . . . . 0.0 111.436 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -137.39 140.74 41.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.67 0.271 . . . . 0.0 110.916 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -128.04 134.99 49.27 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 121.015 0.436 . . . . 0.0 110.647 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.0 131.0 42.15 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -120.91 133.84 55.29 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.461 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.3 mm? -96.67 124.06 40.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.63 136.91 43.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.065 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.95 140.04 47.14 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.79 177.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.486 ' N ' ' HA ' ' A' ' 111' ' ' SER . 34.9 t -121.47 169.95 10.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.8 0.333 . . . . 0.0 110.444 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.451 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.96 -38.09 59.54 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.819 -0.513 . . . . 0.0 111.819 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.0 m -87.97 -9.9 52.11 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.335 1.054 . . . . 0.0 112.883 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.15 -86.51 0.12 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 126.095 1.807 . . . . 0.0 112.539 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.486 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 0.7 OUTLIER -157.58 129.54 7.07 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 127.517 2.327 . . . . 0.0 111.152 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 21.6 m -99.37 134.44 42.22 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.1 mt -108.87 129.82 62.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.476 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -106.09 116.68 32.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.802 ' C ' HD13 ' A' ' 116' ' ' ILE . 11.4 t -110.47 122.75 48.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.145 0.498 . . . . 0.0 110.437 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.859 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -105.73 135.05 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.027 -177.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.8 p -101.5 140.94 35.1 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.544 ' CE1' ' OG1' ' A' ' 4' ' ' THR . 0.1 OUTLIER -136.14 92.66 2.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.202 0.525 . . . . 0.0 109.909 -179.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.812 ' C ' HG23 ' A' ' 2' ' ' VAL . 86.4 m-85 -90.01 101.36 14.07 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.34 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.466 ' CD2' ' OE2' ' A' ' 96' ' ' GLU . 1.8 t-160 -91.44 103.81 16.4 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.434 HG21 ' HA ' ' A' ' 126' ' ' GLU . 1.0 OUTLIER -89.33 160.29 16.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.544 -178.212 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.451 ' H ' HG22 ' A' ' 125' ' ' ILE . 5.1 ptmt -112.8 142.84 44.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.229 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.0 -110.39 1.12 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.498 ' C ' HD22 ' A' ' 124' ' ' ASN . 0.4 OUTLIER -116.47 -2.95 11.92 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.769 -0.254 . . . . 0.0 110.675 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 122' ' ' LYS . 1.6 tp -48.93 162.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 120.959 0.409 . . . . 0.0 110.862 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.434 ' HA ' HG21 ' A' ' 121' ' ' THR . 11.6 pt-20 -148.41 149.97 32.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.132 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.807 HD12 HD11 ' A' ' 95' ' ' ILE . 3.3 mm -86.82 125.09 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -74.77 162.98 28.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.33 0.586 . . . . 0.0 111.104 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -68.95 -45.54 70.49 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.477 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.535 ' O ' HG22 ' A' ' 134' ' ' VAL . 16.3 mm-40 -60.95 -24.8 66.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.641 0.257 . . . . 0.0 110.645 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.409 ' CD2' ' C ' ' A' ' 131' ' ' HIS . 9.6 t60 -73.04 -52.69 13.41 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.384 0.612 . . . . 0.0 110.989 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.412 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 4.0 m -76.7 -29.12 17.85 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.039 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -67.27 -46.05 74.79 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.252 -0.28 . . . . 0.0 111.095 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 130' ' ' GLU . 30.1 m -70.26 -42.65 78.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.746 0.308 . . . . 0.0 110.685 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.479 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -70.25 -43.75 62.16 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 29.5 ttmt -67.12 -46.49 73.97 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 122.739 -0.271 . . . . 0.0 110.864 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -54.9 -44.12 73.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.472 ' HZ1' ' C ' ' A' ' 37' ' ' ALA . 37.0 tttm -69.3 -56.18 8.3 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.875 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.424 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -48.94 -42.73 38.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.677 0.751 . . . . 0.0 110.746 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -64.13 -36.24 83.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.25 -37.12 92.51 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.569 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -68.05 -47.62 67.87 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.542 ' CE2' ' CE2' ' A' ' 22' ' ' PHE . 5.3 m-85 -59.32 -21.47 59.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -77.04 -38.34 52.95 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.316 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.778 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.9 -57.0 8.89 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.587 179.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.698 ' O ' HD22 ' A' ' 150' ' ' LEU . 76.7 mt -53.9 -50.4 53.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.563 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -47.16 -55.02 9.25 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.019 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.7 t -52.94 -44.01 66.75 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.564 0.697 . . . . 0.0 111.392 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.708 ' HB2' HD13 ' A' ' 33' ' ' ILE . 15.4 t80 -58.83 -45.38 90.15 Favored 'General case' 0 C--O 1.195 -1.772 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.854 HD11 ' HB2' ' A' ' 21' ' ' ALA . 1.7 mm? -67.89 -41.77 82.23 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 119.944 1.247 . . . . 0.0 111.623 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.42 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -60.96 -24.3 65.98 Favored 'General case' 0 C--N 1.317 -0.847 0 O-C-N 121.17 -0.956 . . . . 0.0 108.665 179.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.506 ' OD1' ' CE1' ' A' ' 153' ' ' HIS . 33.4 t70 -106.15 -14.27 15.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.125 0.488 . . . . 0.0 110.916 178.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.621 ' N ' ' O ' ' A' ' 149' ' ' TYR . 39.8 m80 -156.19 66.83 4.45 Favored Pre-proline 0 C--N 1.31 -1.113 0 C-N-CA 125.214 1.406 . . . . 0.0 110.235 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.461 ' CD ' ' O ' ' A' ' 150' ' ' LEU . 59.6 Cg_endo -80.76 -4.77 12.97 Favored 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 122.7 2.267 . . . . 0.0 111.989 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.507 ' C ' ' ND2' ' A' ' 158' ' ' ASN . 5.3 m-20 -91.13 5.76 47.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.821 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.606 ' HB1' ' CE1' ' A' ' 157' ' ' TYR . . . -72.91 131.36 42.11 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.356 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.606 ' CE1' ' HB1' ' A' ' 156' ' ' ALA . 1.5 m-85 64.38 8.93 4.55 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.778 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 156' ' ' ALA . 1.9 m-80 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.314 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.911 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.818 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.6 p -134.52 148.66 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 O-C-N 122.45 -0.441 . . . . 0.0 110.942 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -97.7 109.81 22.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.528 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.494 ' HG1' ' CE1' ' A' ' 118' ' ' HIS . 90.8 m -96.6 140.16 31.63 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.947 0.403 . . . . 0.0 110.942 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -143.9 132.08 21.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.005 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.528 ' HG2' HD12 ' A' ' 116' ' ' ILE . 19.3 mt-10 -102.2 136.99 41.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.967 0.413 . . . . 0.0 111.146 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.572 HD22 ' N ' ' A' ' 7' ' ' ASN . 0.8 OUTLIER -126.95 168.7 14.16 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.999 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.49 ' N ' ' CD ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -149.16 147.18 28.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.884 0.849 . . . . 0.0 111.73 -178.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.35 135.89 13.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.148 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -101.53 145.59 28.81 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 t -139.89 154.65 47.32 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.336 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -94.51 27.17 3.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.083 0.468 . . . . 0.0 110.908 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.54 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.9 mt -113.03 125.76 29.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.558 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -46.68 143.35 9.0 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 121.622 1.548 . . . . 0.0 111.5 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.48 ' CG ' ' HB2' ' A' ' 106' ' ' ALA . 26.9 Cg_exo -56.06 -26.17 58.13 Favored 'Trans proline' 0 N--CA 1.483 0.872 0 C-N-CA 122.221 1.947 . . . . 0.0 113.137 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.5 m -70.49 -31.05 68.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' A' ' 154' ' ' PRO . 0.5 OUTLIER -76.16 -55.88 5.17 Favored 'General case' 0 CA--C 1.498 -1.044 0 O-C-N 121.413 -0.804 . . . . 0.0 108.879 -179.594 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.54 HD21 ' HB ' ' A' ' 13' ' ' ILE . 2.3 mt -53.71 -37.88 63.73 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.694 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.515 ' O ' HG22 ' A' ' 23' ' ' VAL . 38.3 t80 -53.07 -59.21 4.83 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.754 ' HB2' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -67.48 -42.91 82.21 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 118.859 -1.136 . . . . 0.0 107.963 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.895 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -63.69 -2.58 1.79 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.866 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 2.8 m-85 -116.88 -9.83 11.11 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 24' ' ' LEU . 32.7 m -133.49 -50.92 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.004 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.9 pp -96.45 -31.5 12.79 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 1.004 ' N ' HD12 ' A' ' 24' ' ' LEU . 6.6 t70 -114.66 -4.9 12.73 Favored 'General case' 0 C--O 1.211 -0.958 0 O-C-N 121.716 -0.615 . . . . 0.0 111.563 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -66.48 -43.4 85.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.512 0.673 . . . . 0.0 111.809 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.549 ' HB2' ' HZ2' ' A' ' 54' ' ' LYS . 3.1 p30 -84.2 12.44 6.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.24 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -129.99 -9.35 4.36 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.796 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -96.64 -34.27 11.46 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.877 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.487 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 25.2 mt -54.06 -56.0 30.54 Favored Pre-proline 0 C--O 1.217 -0.63 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.23 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 22.9 Cg_endo -61.57 -24.84 78.6 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 121.979 1.786 . . . . 0.0 112.551 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -67.73 -57.48 6.28 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.856 0.836 . . . . 0.0 112.0 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.791 HD12 ' HB3' ' A' ' 145' ' ' LEU . 1.2 pt -95.2 -34.95 5.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.196 -176.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.863 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.23 64.45 0.13 Allowed Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.486 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 73.2 Cg_endo -76.33 -27.07 8.25 Favored 'Trans proline' 0 C--N 1.322 -0.858 0 C-N-CA 121.672 1.581 . . . . 0.0 108.18 175.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -73.61 -42.77 61.06 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.331 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.863 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -70.03 -79.89 0.06 Allowed 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.217 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.486 HD13 HD22 ' A' ' 142' ' ' LEU . 1.2 mp -99.33 147.47 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 121.785 -0.572 . . . . 0.0 110.351 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -77.12 -53.21 8.05 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.297 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.716 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -176.96 166.87 2.49 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 110.613 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.716 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -165.61 145.09 6.45 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.246 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.406 ' N ' ' HZ3' ' A' ' 54' ' ' LYS . 10.9 pt-20 -142.35 144.67 33.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.049 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.622 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -77.38 139.92 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.404 0.621 . . . . 0.0 110.673 -179.243 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.11 -39.59 13.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.987 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.883 ' O ' HG23 ' A' ' 52' ' ' THR . 62.8 mt-10 -148.2 134.91 19.91 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.465 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.98 -156.35 23.61 Favored Glycine 0 CA--C 1.525 0.676 0 O-C-N 123.271 0.357 . . . . 0.0 112.232 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.578 HD22 ' N ' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -137.82 3.28 2.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.896 0.379 . . . . 0.0 111.076 -179.355 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.578 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 122.34 16.28 3.91 Favored Glycine 0 C--O 1.222 -0.65 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -178.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -110.3 -171.47 19.95 Favored Glycine 0 C--O 1.222 -0.606 0 CA-C-O 121.448 0.471 . . . . 0.0 111.926 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -61.66 125.14 16.01 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 122.514 2.143 . . . . 0.0 113.065 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.22 5.64 59.26 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.883 HG23 ' O ' ' A' ' 45' ' ' GLU . 87.0 m -93.39 140.26 29.76 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 114.457 -0.871 . . . . 0.0 110.851 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -117.76 132.57 67.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.526 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.622 ' HG2' HG23 ' A' ' 43' ' ' ILE . 3.9 mmtt -115.34 138.54 50.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.557 0.694 . . . . 0.0 110.957 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -119.52 122.04 40.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.972 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.575 ' N ' HD12 ' A' ' 56' ' ' ILE . 4.1 mp -105.49 135.0 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.235 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.0 m -113.26 119.39 37.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.391 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -96.14 -176.88 3.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 110.725 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.43 144.8 47.4 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.615 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 5.5 mp0 -59.63 -54.07 50.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.003 0.43 . . . . 0.0 110.491 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.86 61.2 3.44 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 p -139.25 175.32 9.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.821 0.343 . . . . 0.0 110.751 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -62.08 -52.05 65.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 110.682 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.27 142.05 30.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.162 0.506 . . . . 0.0 110.399 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.72 -55.2 0.27 Allowed Glycine 0 N--CA 1.461 0.366 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -135.7 151.31 50.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.935 0.398 . . . . 0.0 110.344 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.416 ' CG2' HD11 ' A' ' 85' ' ' LEU . 2.5 p -156.22 147.5 11.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.595 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.7 mttm -106.05 108.07 19.4 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.042 0.448 . . . . 0.0 112.052 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.522 ' C ' ' ND1' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -109.84 112.96 25.32 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.047 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -107.64 133.01 52.69 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.573 ' H ' HD12 ' A' ' 71' ' ' ILE . 4.1 mp -70.0 140.02 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.43 -55.07 2.94 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.19 -0.319 . . . . 0.0 111.638 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.7 m -165.05 141.14 5.57 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.5 mt -127.05 131.05 71.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.962 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.597 ' O ' ' N ' ' A' ' 79' ' ' TYR . 46.1 m-20 -115.4 88.41 2.87 Favored 'General case' 0 C--O 1.203 -1.364 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -54.93 -30.32 58.41 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.44 -38.26 74.15 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.173 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.459 ' OG ' ' NZ ' ' A' ' 103' ' ' LYS . 0.9 OUTLIER -107.69 -10.4 15.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.944 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.597 ' N ' ' O ' ' A' ' 75' ' ' ASP . 20.3 m-85 59.8 47.46 10.22 Favored 'General case' 0 N--CA 1.44 -0.942 0 O-C-N 121.49 -0.756 . . . . 0.0 110.372 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.5 t -106.33 145.78 31.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.997 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.608 ' CE1' ' CD2' ' A' ' 83' ' ' TYR . 31.0 t80 -131.71 122.84 26.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.121 0.486 . . . . 0.0 110.888 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 p -131.86 139.04 48.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.268 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.608 ' CD2' ' CE1' ' A' ' 81' ' ' TYR . 10.7 p90 -148.04 162.5 39.23 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 m -139.46 140.69 37.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.322 0.582 . . . . 0.0 111.252 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.556 HD12 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -82.77 113.87 20.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.371 178.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -85.89 -42.63 16.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 2.8 tp10 -153.61 172.96 16.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.964 0.411 . . . . 0.0 110.937 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.648 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.24 177.2 17.65 Favored Glycine 0 CA--C 1.509 -0.315 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.29 2.38 0.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.648 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -65.85 -34.24 77.7 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 124.837 1.255 . . . . 0.0 110.696 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.884 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -109.4 12.76 24.49 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 123.271 0.628 . . . . 0.0 109.905 -177.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 65.4 p 45.49 -126.27 1.22 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -130.86 -12.47 3.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.961 0.41 . . . . 0.0 111.198 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 p -105.42 -5.62 20.21 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.727 HG21 ' CD1' ' A' ' 98' ' ' ILE . 80.1 mt -97.78 152.34 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 122.239 1.019 . . . . 0.0 113.711 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.499 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -89.34 -60.38 1.96 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.89 178.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -168.29 149.22 4.93 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.272 0.558 . . . . 0.0 111.111 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.727 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -123.19 125.53 72.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.36 144.44 43.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.194 0.521 . . . . 0.0 111.311 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -136.34 133.58 36.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.458 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -129.17 135.58 49.03 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-O 120.869 0.366 . . . . 0.0 111.14 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.37 132.12 40.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.459 ' NZ ' ' OG ' ' A' ' 78' ' ' SER . 44.0 tttp -119.88 138.61 53.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.65 0.262 . . . . 0.0 110.486 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.5 mm? -96.98 125.53 41.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.292 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.82 130.31 41.0 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.48 ' HB2' ' CG ' ' A' ' 15' ' ' PRO . . . -74.0 135.5 43.14 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.062 -0.399 . . . . 0.0 110.761 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.499 ' HG ' ' HG1' ' A' ' 112' ' ' THR . 5.5 m -121.82 170.93 9.29 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 122.551 0.341 . . . . 0.0 110.095 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.97 -34.03 51.39 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.8 m -82.99 -12.38 57.33 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.312 1.445 . . . . 0.0 114.671 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.0 -89.47 0.14 Allowed Glycine 0 CA--C 1.537 1.418 0 C-N-CA 126.246 1.879 . . . . 0.0 111.246 -169.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 28.2 p -161.76 131.86 4.84 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.752 1.621 . . . . 0.0 110.87 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.499 ' HG1' ' HG ' ' A' ' 107' ' ' CYS . 46.1 m -98.98 133.18 43.61 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.556 0.693 . . . . 0.0 109.138 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mt -105.21 129.38 58.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.359 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -105.48 117.51 34.21 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.726 ' C ' HD13 ' A' ' 116' ' ' ILE . 15.6 m -110.14 117.69 34.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.51 0.671 . . . . 0.0 110.647 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.902 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -98.59 135.53 33.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 123.635 0.774 . . . . 0.0 110.293 -177.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.5 m -103.0 141.1 36.38 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.81 177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.682 ' CD2' HG21 ' A' ' 2' ' ' VAL . 2.2 t60 -136.3 93.88 2.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 0.0 110.905 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.818 ' C ' HG23 ' A' ' 2' ' ' VAL . 3.3 m-85 -92.8 100.31 12.81 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.997 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -92.55 101.06 13.49 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.577 HG21 ' HA ' ' A' ' 126' ' ' GLU . 18.6 p -97.1 168.67 10.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.754 0.788 . . . . 0.0 112.033 -177.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -112.35 152.69 28.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.03 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . 34.13 -108.91 0.05 OUTLIER Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.599 ' H ' HD22 ' A' ' 124' ' ' ASN . 0.0 OUTLIER -105.76 -4.84 20.42 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.662 -0.317 . . . . 0.0 111.442 178.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.479 ' N ' HD22 ' A' ' 124' ' ' ASN . 1.4 mp -47.96 152.79 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.577 ' HA ' HG21 ' A' ' 121' ' ' THR . 35.2 mt-10 -149.41 148.79 29.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.175 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.4 mm -87.62 124.77 41.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.45 ' HG3' ' H ' ' A' ' 129' ' ' GLU . 3.8 tptm -75.31 159.53 31.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.301 0.572 . . . . 0.0 111.908 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.45 ' H ' ' HG3' ' A' ' 128' ' ' LYS . 18.4 mm-40 -71.2 -35.41 71.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.938 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.448 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 8.0 pt-20 -67.87 -34.2 76.23 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.753 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -68.33 -49.04 63.09 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.154 0.502 . . . . 0.0 110.756 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.401 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 5.5 m -73.38 -22.34 19.14 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.805 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 57.4 mttt -66.92 -46.21 75.49 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 122.171 -0.33 . . . . 0.0 110.792 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.448 ' CG2' ' O ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -70.51 -44.94 76.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.667 0.27 . . . . 0.0 110.458 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.82 -47.01 69.38 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 0.1 OUTLIER -67.05 -47.01 72.65 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 122.485 -0.42 . . . . 0.0 110.316 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -54.04 -39.69 66.42 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.493 ' NZ ' ' O ' ' A' ' 37' ' ' ALA . 5.0 tttm -69.31 -53.83 17.65 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.12 -42.3 38.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.645 0.736 . . . . 0.0 110.251 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 51.4 t60 -64.09 -36.6 84.57 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.185 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.84 -41.73 99.31 Favored Glycine 0 C--O 1.222 -0.606 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -70.71 -40.3 72.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.511 ' CD2' ' O ' ' A' ' 143' ' ' PHE . 2.3 t80 -61.29 -28.17 69.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -69.32 -40.98 77.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.063 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.791 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.4 mm? -64.76 -56.74 11.75 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.722 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.642 ' O ' HD22 ' A' ' 150' ' ' LEU . 85.1 mt -54.78 -51.07 55.65 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.991 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 8.8 tt0 -47.66 -57.33 5.63 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.212 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 58.2 m -52.49 -43.78 65.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.139 0.495 . . . . 0.0 111.065 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.664 ' HB2' HD13 ' A' ' 33' ' ' ILE . 56.7 t80 -55.31 -47.67 75.26 Favored 'General case' 0 C--O 1.2 -1.546 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.895 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.0 mm? -68.55 -43.02 77.52 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 119.836 1.198 . . . . 0.0 112.06 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 147' ' ' GLU . 0.4 OUTLIER -62.09 -24.05 66.88 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 121.375 -0.828 . . . . 0.0 109.267 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -107.17 -13.32 15.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.607 0.717 . . . . 0.0 110.585 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.616 ' N ' ' O ' ' A' ' 149' ' ' TYR . 1.1 t-80 -154.97 65.61 4.69 Favored Pre-proline 0 C--N 1.309 -1.159 0 C-N-CA 124.723 1.209 . . . . 0.0 109.883 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.527 ' O ' ' NH1' ' A' ' 17' ' ' ARG . 53.0 Cg_endo -74.38 -3.47 13.89 Favored 'Trans proline' 0 C--O 1.204 -1.176 0 C-N-CA 122.698 2.266 . . . . 0.0 111.392 -177.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.606 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 1.0 OUTLIER -81.39 4.3 21.34 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 123.009 0.524 . . . . 0.0 112.032 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -50.07 130.17 21.9 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 119.877 -1.764 . . . . 0.0 111.381 -178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.603 ' CG ' HD13 ' A' ' 24' ' ' LEU . 1.3 t80 54.48 6.32 0.11 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.476 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.606 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.414 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.237 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.862 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.865 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.4 p -135.02 147.93 29.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 O-C-N 122.37 -0.488 . . . . 0.0 111.105 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.412 ' HB2' ' CD1' ' A' ' 119' ' ' TYR . 7.7 m-85 -99.28 111.52 23.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.617 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.4 m -96.32 139.99 31.64 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.632 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.539 ' CD1' ' ND2' ' A' ' 7' ' ' ASN . 57.0 t80 -136.84 134.14 36.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.612 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.48 ' C ' HD22 ' A' ' 7' ' ' ASN . 3.0 mt-10 -103.33 128.83 50.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.0 0.429 . . . . 0.0 111.078 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.555 ' ND2' ' N ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -138.47 162.93 33.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.087 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.76 160.14 40.05 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.472 ' CE2' ' O ' ' A' ' 10' ' ' THR . 55.3 t80 -147.61 141.14 25.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.44 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.472 ' O ' ' CE2' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -93.14 148.63 21.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.726 0.298 . . . . 0.0 111.275 -179.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -143.91 154.35 43.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.775 0.321 . . . . 0.0 110.718 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -99.92 26.76 6.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.042 0.449 . . . . 0.0 110.634 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.472 ' HB ' HD21 ' A' ' 18' ' ' LEU . 2.2 mt -113.74 131.6 22.99 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.317 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -48.89 141.24 22.0 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.148 1.232 . . . . 0.0 110.797 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.552 ' HA ' HD12 ' A' ' 18' ' ' LEU . 9.4 Cg_endo -60.1 -23.57 73.93 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 122.365 2.043 . . . . 0.0 112.925 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.456 ' HB2' HH21 ' A' ' 17' ' ' ARG . 69.4 m -70.14 -30.56 67.76 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.456 HH21 ' HB2' ' A' ' 16' ' ' SER . 25.3 mmt-85 -79.43 -54.38 5.98 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.552 HD12 ' HA ' ' A' ' 15' ' ' PRO . 6.4 mt -48.57 -45.87 38.39 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.584 ' HD2' ' HH ' ' A' ' 81' ' ' TYR . 11.8 t80 -49.29 -57.79 6.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.22 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -67.37 -25.42 65.96 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.363 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.763 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -84.02 -2.58 56.9 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.563 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.469 ' CA ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -117.31 -10.94 10.66 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 117.917 0.326 . . . . 0.0 111.828 -179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.845 HG23 HD13 ' A' ' 24' ' ' LEU . 3.1 m -137.35 -34.61 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.868 HD23 ' CD1' ' A' ' 157' ' ' TYR . 2.4 mp -89.92 -53.47 4.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.824 0.738 . . . . 0.0 111.889 -176.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 93.8 m-20 -112.91 -4.01 14.01 Favored 'General case' 0 C--O 1.216 -0.659 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -53.67 -43.88 69.21 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.474 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 2.0 m-20 -83.34 18.7 1.7 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.212 0.529 . . . . 0.0 110.712 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 27' ' ' ASP . 4.5 m120 -139.37 -8.8 1.28 Allowed 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 177.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 149' ' ' TYR . 0.8 OUTLIER -92.38 -30.31 15.86 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.156 -178.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.506 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.52 -54.53 47.6 Favored Pre-proline 0 C--O 1.214 -0.787 0 O-C-N 122.2 -0.313 . . . . 0.0 111.419 -179.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 18.3 Cg_endo -62.82 -25.52 74.59 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.894 1.729 . . . . 0.0 112.721 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -68.22 -59.74 2.99 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.836 0.827 . . . . 0.0 111.814 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.765 HD12 ' HB3' ' A' ' 145' ' ' LEU . 1.3 pt -95.95 -35.53 5.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.38 -176.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.781 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.36 65.24 0.14 Allowed Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 72.9 Cg_endo -76.55 -27.17 7.83 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 121.699 1.599 . . . . 0.0 108.474 175.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -74.2 -43.65 56.36 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.633 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.781 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -73.87 -78.6 0.09 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.099 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.8 mm -99.43 144.85 11.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 121.328 0.585 . . . . 0.0 110.017 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -78.42 -53.52 7.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.725 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.407 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -178.18 167.6 1.95 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.238 0.542 . . . . 0.0 110.597 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.407 ' H ' ' HG2' ' A' ' 40' ' ' GLN . . . -165.89 143.87 5.72 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.88 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -140.84 143.86 35.0 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.862 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.2 137.25 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 121.646 0.736 . . . . 0.0 111.823 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.4 mp -87.11 -38.77 16.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.188 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.88 ' O ' HG23 ' A' ' 52' ' ' THR . 54.9 mt-10 -148.24 136.83 21.56 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.09 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.09 -155.28 21.85 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.649 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -141.13 -5.6 1.11 Allowed 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 122.894 0.477 . . . . 0.0 110.941 -178.4 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.577 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 131.96 10.84 2.17 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.06 -172.84 19.15 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 117.114 0.457 . . . . 0.0 111.977 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -60.13 127.1 22.04 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 C-N-CA 122.732 2.288 . . . . 0.0 113.356 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.86 2.97 55.13 Favored Glycine 0 CA--C 1.507 -0.439 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.88 HG23 ' O ' ' A' ' 45' ' ' GLU . 88.8 m -94.3 134.76 36.44 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.265 -0.967 . . . . 0.0 111.368 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -122.67 122.3 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.862 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -131.99 151.39 51.77 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 122.83 1.3 . . . . 0.0 110.684 178.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.525 ' N ' ' HD2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -117.57 137.57 52.5 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.318 -1.764 . . . . 0.0 112.966 -177.365 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.9 mm -90.19 140.76 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 64.3 m -110.5 117.33 33.28 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -108.89 166.17 11.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.918 0.39 . . . . 0.0 110.82 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.0 144.44 49.5 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.24 -47.21 86.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.805 0.336 . . . . 0.0 110.785 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.71 61.42 3.47 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.7 m -142.91 178.37 7.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.831 0.348 . . . . 0.0 110.677 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -64.11 -50.43 68.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.923 0.392 . . . . 0.0 110.723 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.83 156.38 17.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.375 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -119.57 -61.41 0.26 Allowed Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -145.37 155.04 42.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.825 0.345 . . . . 0.0 110.573 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 87' ' ' GLU . 2.4 p -156.02 153.75 7.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.77 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.507 ' CB ' HD11 ' A' ' 86' ' ' ILE . 3.5 mptp? -104.87 110.97 23.55 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.53 0.681 . . . . 0.0 111.631 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -103.32 113.51 27.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.84 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -105.75 131.54 52.98 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.022 0.439 . . . . 0.0 111.735 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.5 mt -85.42 145.26 8.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.373 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -102.55 -54.89 2.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.7 m -165.88 142.21 5.17 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 45.6 mt -123.05 130.62 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.355 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.2 m-20 -115.25 87.95 2.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.505 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -54.82 -30.29 56.92 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.509 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.85 -38.84 70.62 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.175 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.1 p -108.36 -11.09 15.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.117 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.53 ' N ' ' O ' ' A' ' 75' ' ' ASP . 6.6 m-85 63.17 40.89 8.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 121.877 -0.515 . . . . 0.0 109.925 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.499 ' C ' ' CD2' ' A' ' 81' ' ' TYR . 6.0 p -109.22 138.65 45.25 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.857 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.584 ' HH ' ' HD2' ' A' ' 19' ' ' PHE . 0.1 OUTLIER -132.13 133.57 44.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.723 0.297 . . . . 0.0 110.375 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 p -127.29 129.76 48.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.878 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -144.15 158.71 43.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.217 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 98' ' ' ILE . 9.7 m -147.65 141.85 26.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.119 0.485 . . . . 0.0 111.2 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.659 HD13 ' HB1' ' A' ' 90' ' ' ALA . 9.7 mt -80.6 120.63 24.8 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.507 HD11 ' CB ' ' A' ' 68' ' ' LYS . 3.8 pt -80.58 -44.98 21.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.808 0.337 . . . . 0.0 111.836 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.475 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 23.5 tt0 -156.74 172.26 18.92 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.591 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 116.95 178.12 17.83 Favored Glycine 0 CA--C 1.508 -0.357 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -61.37 1.13 0.22 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.659 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -67.55 -34.3 76.8 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 123.948 0.899 . . . . 0.0 109.963 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.89 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.52 16.38 21.56 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.692 0.797 . . . . 0.0 109.583 -177.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.8 p 49.48 -126.45 2.13 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -130.75 -12.9 3.75 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.091 -0.381 . . . . 0.0 111.217 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.0 -6.62 19.88 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.718 HG21 ' CD1' ' A' ' 98' ' ' ILE . 68.5 mt -99.13 152.36 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -176.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.507 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -90.32 -56.78 3.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.249 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -171.91 150.48 2.6 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.099 0.476 . . . . 0.0 110.867 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.718 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.52 125.08 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.473 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 0.7 OUTLIER -105.67 144.5 32.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.006 0.432 . . . . 0.0 112.054 -178.084 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.504 ' CZ ' ' OG ' ' A' ' 117' ' ' SER . 4.8 m-85 -140.2 128.21 22.15 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.531 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -129.32 133.6 47.52 Favored 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.5 OUTLIER -135.55 131.49 36.03 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.9 -0.5 . . . . 0.0 110.45 -178.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.608 ' C ' HD23 ' A' ' 104' ' ' LEU . 7.1 ttpm? -123.16 134.77 54.16 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.772 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.53 126.53 44.13 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -125.59 137.14 58.64 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.572 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.486 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -72.62 133.88 44.88 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.873 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.405 ' N ' ' HA ' ' A' ' 111' ' ' SER . 7.1 t -121.22 175.2 6.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.128 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -55.66 -37.28 67.61 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.2 m -87.32 -6.15 58.62 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.793 1.296 . . . . 0.0 114.327 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 152.91 -88.48 0.13 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.671 1.129 . . . . 0.0 111.808 -174.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 85.5 p -161.98 131.91 4.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.547 1.939 . . . . 0.0 110.715 177.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.2 m -99.17 119.15 37.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.7 mt -91.13 128.95 42.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.36 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 102' ' ' THR . 4.1 mttm -105.45 117.17 33.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.745 ' C ' HD13 ' A' ' 116' ' ' ILE . 69.6 m -110.84 121.21 44.78 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-O 121.459 0.647 . . . . 0.0 111.119 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.945 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -101.9 136.4 34.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 123.457 0.703 . . . . 0.0 109.571 -177.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.504 ' OG ' ' CZ ' ' A' ' 100' ' ' TYR . 23.7 t -118.29 132.36 56.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.651 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.473 ' ND1' ' O ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -137.28 113.71 10.14 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.505 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.865 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -102.41 102.53 12.87 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.448 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.463 ' CE1' ' CD ' ' A' ' 96' ' ' GLU . 11.6 t-160 -92.0 109.47 20.82 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.233 0.539 . . . . 0.0 110.246 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.432 HG22 HD11 ' A' ' 127' ' ' ILE . 12.6 p -99.65 172.52 7.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.611 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -112.2 143.53 43.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.871 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 54.94 -112.79 3.07 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.492 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.9 OUTLIER -112.9 -1.89 14.46 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.342 -0.504 . . . . 0.0 111.171 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -43.5 160.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.048 0.451 . . . . 0.0 110.614 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.481 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 92.8 mt-10 -148.21 144.28 27.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.038 0.447 . . . . 0.0 111.177 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.432 HD11 HG22 ' A' ' 121' ' ' THR . 19.9 mm -89.1 125.29 42.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -74.68 161.18 29.9 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.669 0.747 . . . . 0.0 111.837 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -70.29 -32.14 69.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.418 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.429 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 43.3 mm-40 -70.12 -33.57 71.99 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.746 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -67.33 -51.26 54.6 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.33 0.586 . . . . 0.0 110.629 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.5 m -71.93 -21.53 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.79 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -66.45 -46.56 76.01 Favored 'General case' 0 C--O 1.223 -0.328 0 O-C-N 122.276 -0.265 . . . . 0.0 110.892 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -70.38 -51.15 40.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.726 0.298 . . . . 0.0 110.5 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.78 -47.05 93.14 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -67.96 -47.44 68.63 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 122.616 -0.343 . . . . 0.0 110.916 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -55.32 -47.06 76.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.78 0.324 . . . . 0.0 110.549 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -69.37 -50.2 48.34 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.401 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.31 -41.97 39.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.535 0.683 . . . . 0.0 110.528 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -36.4 84.22 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -61.64 -31.17 76.9 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.42 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -74.18 -47.18 37.34 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.27 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.491 ' CD2' ' N ' ' A' ' 143' ' ' PHE . 1.6 m-30 -59.89 -21.88 61.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -72.52 -41.82 65.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.85 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.765 ' HB3' HD12 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -65.44 -56.53 11.94 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.893 179.3 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.701 ' O ' HD22 ' A' ' 150' ' ' LEU . 76.9 mt -53.24 -50.33 47.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.495 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -47.06 -57.02 5.48 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.751 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.5 t -50.35 -44.95 54.72 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.469 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.685 ' HB2' HD13 ' A' ' 33' ' ' ILE . 20.0 t80 -57.33 -48.77 78.13 Favored 'General case' 0 C--O 1.18 -2.581 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -178.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.846 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.7 mm? -65.1 -42.15 94.27 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 120.449 -1.407 . . . . 0.0 111.974 -177.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.5 OUTLIER -62.59 -25.25 67.98 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.407 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -107.26 -12.24 15.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.016 0.436 . . . . 0.0 110.687 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.651 ' N ' ' O ' ' A' ' 149' ' ' TYR . 49.5 m-70 -155.54 66.32 4.63 Favored Pre-proline 0 C--N 1.308 -1.215 0 C-N-CA 125.616 1.566 . . . . 0.0 110.411 -177.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.413 ' HB2' ' HE ' ' A' ' 17' ' ' ARG . 44.7 Cg_endo -72.13 -3.27 12.97 Favored 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 122.662 2.241 . . . . 0.0 111.843 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.616 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 1.5 p30 -77.1 3.07 13.34 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.073 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.532 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . . . -50.51 128.79 20.97 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 119.328 -2.108 . . . . 0.0 111.352 -178.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.868 ' CD1' HD23 ' A' ' 24' ' ' LEU . 16.5 t80 54.71 7.04 0.14 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.275 0.63 . . . . 0.0 112.137 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.616 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.278 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.823 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.2 p -134.92 148.79 29.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 O-C-N 122.364 -0.492 . . . . 0.0 110.988 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -97.77 110.29 22.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.721 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.7 m -96.97 140.45 31.49 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.577 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.95 134.7 26.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.368 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.511 ' HG2' HD12 ' A' ' 116' ' ' ILE . 3.1 mt-10 -102.4 129.69 48.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.582 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -126.71 168.67 14.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.172 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.13 146.98 22.04 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -145.64 140.71 27.52 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.302 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -107.49 147.93 29.85 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 111.804 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.5 t -145.87 162.73 37.07 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.548 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -98.77 24.92 7.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.954 0.406 . . . . 0.0 110.931 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.51 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.9 mt -108.57 127.69 26.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.2 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -46.98 144.69 8.06 Favored 'Trans proline' 0 C--N 1.327 -0.571 0 C-N-CA 121.16 1.24 . . . . 0.0 110.743 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 10.9 Cg_endo -61.02 -24.51 79.72 Favored 'Trans proline' 0 C--N 1.322 -0.843 0 C-N-CA 122.337 2.025 . . . . 0.0 113.031 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.2 m -71.01 -30.3 66.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -75.05 -56.41 4.77 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.51 HD21 ' HB ' ' A' ' 13' ' ' ILE . 3.7 mt -51.18 -45.0 61.65 Favored 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.485 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.656 ' O ' HG22 ' A' ' 23' ' ' VAL . 47.0 t80 -46.44 -58.96 3.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.727 ' CB ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -68.28 -41.56 80.83 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 119.023 -1.071 . . . . 0.0 108.484 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.831 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -65.01 -2.47 2.72 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.236 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 2.6 t80 -119.14 -8.71 10.12 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 19' ' ' PHE . 30.8 m -131.88 -51.27 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.0 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.7 pp -96.4 -31.28 12.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 1.0 ' N ' HD12 ' A' ' 24' ' ' LEU . 45.5 m-20 -114.63 -5.09 12.74 Favored 'General case' 0 C--O 1.211 -0.934 0 CA-C-N 118.439 0.563 . . . . 0.0 111.506 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.697 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -68.56 -44.05 75.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.453 0.644 . . . . 0.0 112.289 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.46 18.15 2.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.882 0.849 . . . . 0.0 109.648 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.41 ' H ' ' H ' ' A' ' 29' ' ' LEU . 64.9 m-20 -139.55 -8.31 1.27 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.578 -1.192 . . . . 0.0 107.843 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.823 HD21 ' CD2' ' A' ' 149' ' ' TYR . 0.8 OUTLIER -96.21 -48.37 5.66 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.0 -178.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.525 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 85.2 mt -54.54 -43.22 97.8 Favored Pre-proline 0 C--O 1.212 -0.916 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.146 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 16.6 Cg_exo -64.46 -25.58 63.1 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.785 1.657 . . . . 0.0 110.97 177.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.02 -57.93 4.42 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.712 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.692 ' HB ' HD12 ' A' ' 145' ' ' LEU . 0.7 OUTLIER -96.54 -32.66 4.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.779 -176.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.816 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -103.83 63.22 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.513 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 72.6 Cg_endo -75.57 -20.97 15.28 Favored 'Trans proline' 0 C--N 1.32 -0.924 0 N-CA-C 107.063 -1.937 . . . . 0.0 107.063 174.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -73.42 -44.02 59.23 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.76 177.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.816 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -73.75 -75.02 0.16 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.266 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.9 mt -98.73 145.9 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-O 121.046 0.45 . . . . 0.0 110.204 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.83 -51.65 10.14 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.672 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.675 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 50.7 tp60 -177.3 164.62 2.18 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.958 0.409 . . . . 0.0 110.424 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.675 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -166.02 145.21 6.06 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 120.89 0.376 . . . . 0.0 110.889 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -145.09 145.25 31.35 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.666 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -76.52 139.88 18.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.57 0.7 . . . . 0.0 110.995 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 mp -89.68 -39.27 13.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.963 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.886 ' O ' HG23 ' A' ' 52' ' ' THR . 30.2 mt-10 -147.19 136.66 22.75 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.542 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.39 -156.06 22.52 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.679 -0.569 . . . . 0.0 111.679 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.61 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -142.5 1.48 1.37 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 122.456 -0.437 . . . . 0.0 111.343 -178.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.479 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 127.27 12.27 3.18 Favored Glycine 0 C--O 1.218 -0.864 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.45 -171.68 19.89 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 117.298 0.549 . . . . 0.0 111.905 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -61.86 125.94 17.74 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 C-N-CA 122.68 2.253 . . . . 0.0 113.028 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.76 5.07 56.76 Favored Glycine 0 N--CA 1.464 0.537 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.886 HG23 ' O ' ' A' ' 45' ' ' GLU . 91.4 m -93.66 137.91 32.43 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.379 -0.911 . . . . 0.0 110.959 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.55 130.14 72.91 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.666 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -114.52 140.0 49.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.608 0.718 . . . . 0.0 110.761 179.144 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.474 ' C ' HD12 ' A' ' 56' ' ' ILE . 41.1 tttm -118.37 123.15 44.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.7 178.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.758 ' N ' HD12 ' A' ' 56' ' ' ILE . 1.8 mp -104.32 123.75 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.6 m -101.42 118.43 36.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.075 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -92.72 -176.74 4.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.72 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.429 ' O ' ' OG ' ' A' ' 62' ' ' SER . . . -71.64 144.45 37.02 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.99 -47.94 84.12 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.991 -0.711 . . . . 0.0 111.073 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.92 61.93 3.34 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 59' ' ' GLY . 0.3 OUTLIER -152.37 174.97 13.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.171 0.51 . . . . 0.0 110.383 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.706 ' NE2' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -65.09 -37.57 87.92 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.818 0.342 . . . . 0.0 110.603 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -98.76 140.38 33.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.378 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.415 ' O ' ' CD2' ' A' ' 66' ' ' TYR . . . -123.12 -56.2 0.19 Allowed Glycine 0 N--CA 1.461 0.363 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.415 ' CD2' ' O ' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -145.82 151.35 37.77 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.772 0.32 . . . . 0.0 110.193 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 p -156.71 147.51 11.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.931 0.396 . . . . 0.0 110.945 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -104.81 108.06 19.35 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.298 0.57 . . . . 0.0 110.954 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.531 ' NE2' ' CD2' ' A' ' 83' ' ' TYR . 7.9 t60 -103.06 112.42 25.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.631 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -101.6 131.22 47.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 111.824 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.0 mt -83.08 137.23 21.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -96.71 -56.35 2.61 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.2 m -166.01 142.31 5.07 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.471 HD12 ' O ' ' A' ' 48' ' ' GLY . 30.2 mt -123.93 131.15 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.885 176.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.587 ' O ' ' N ' ' A' ' 79' ' ' TYR . 27.1 m-20 -115.53 87.74 2.73 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.487 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 6.6 pt-20 -54.57 -30.12 53.33 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.08 73.52 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.6 m -108.2 -9.82 15.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.007 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.587 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.3 m-85 62.63 48.28 4.42 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 121.393 -0.817 . . . . 0.0 110.236 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.2 t -106.66 143.76 34.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.346 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.527 ' CE1' ' CD1' ' A' ' 83' ' ' TYR . 26.3 t80 -132.16 117.94 18.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.683 0.278 . . . . 0.0 110.253 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.7 t -127.5 137.65 52.71 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.112 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.531 ' CD2' ' NE2' ' A' ' 69' ' ' HIS . 12.5 p90 -146.11 163.86 33.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.069 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 98' ' ' ILE . 4.3 m -146.57 135.68 22.59 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.05 0.452 . . . . 0.0 110.821 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.626 HD13 ' HB1' ' A' ' 90' ' ' ALA . 7.0 mt -79.76 116.55 19.99 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.602 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -82.76 -41.78 17.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.829 -177.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.602 ' N ' HD13 ' A' ' 86' ' ' ILE . 32.7 tt0 -153.8 171.52 18.79 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.09 -0.381 . . . . 0.0 110.586 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.599 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.19 177.54 18.71 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.78 2.1 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.626 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -66.09 -34.4 77.97 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.107 0.963 . . . . 0.0 110.239 177.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.892 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.26 14.7 22.68 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 123.543 0.737 . . . . 0.0 109.608 -177.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.461 ' CG2' ' NE2' ' A' ' 131' ' ' HIS . 68.8 p 46.96 -126.24 1.58 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -130.35 -11.14 4.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.106 0.479 . . . . 0.0 110.913 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.3 -7.55 18.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.724 HG21 ' CD1' ' A' ' 98' ' ' ILE . 90.7 mt -98.74 152.51 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 CA-C-O 121.941 0.877 . . . . 0.0 113.259 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.509 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -90.86 -55.23 3.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.343 177.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.43 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 2.5 ptmm? -172.79 149.82 2.03 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.782 0.325 . . . . 0.0 110.84 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.724 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.29 125.42 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.041 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.34 144.49 43.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.925 0.393 . . . . 0.0 111.665 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -136.82 136.37 38.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.705 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -131.15 132.41 44.75 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -139.13 133.98 32.22 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.962 -0.461 . . . . 0.0 110.945 -178.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.56 ' C ' HD23 ' A' ' 104' ' ' LEU . 25.9 ttpp -121.26 134.64 55.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.774 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -97.62 126.01 42.69 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.358 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.95 136.99 58.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.609 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -73.03 135.37 44.89 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.751 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.55 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 53.8 t -120.92 171.13 8.86 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.55 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -54.25 -35.7 55.77 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.3 p -89.69 -8.48 52.28 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.327 -1.69 . . . . 0.0 114.694 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 159.32 -85.44 0.12 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.069 1.318 . . . . 0.0 111.958 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 87.9 p -163.79 132.1 3.66 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.888 1.675 . . . . 0.0 110.961 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 78.8 m -99.28 118.24 35.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 61.9 mt -92.38 128.24 44.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.842 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 102' ' ' THR . 6.1 mtpt -105.42 116.68 32.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.799 ' C ' HD13 ' A' ' 116' ' ' ILE . 13.0 t -111.62 124.85 53.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.276 0.56 . . . . 0.0 111.101 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.914 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -106.04 136.43 40.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 123.25 0.62 . . . . 0.0 109.749 -177.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.1 m -113.18 133.09 55.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.982 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -137.08 105.35 5.72 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 120.83 0.348 . . . . 0.0 110.405 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.823 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -101.69 103.39 14.17 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.081 -0.387 . . . . 0.0 110.045 179.201 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -90.91 107.88 19.49 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.226 0.536 . . . . 0.0 109.879 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.2 p -99.38 176.01 5.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.602 0.715 . . . . 0.0 111.442 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -112.31 146.12 38.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.432 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 54.21 -111.69 2.17 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.599 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -117.67 3.68 12.34 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.345 -0.503 . . . . 0.0 111.01 -179.575 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.463 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -45.85 160.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.941 0.4 . . . . 0.0 110.43 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.463 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 36.5 mt-10 -149.39 148.51 29.55 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.916 0.388 . . . . 0.0 111.267 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.408 HG13 ' CB ' ' A' ' 119' ' ' TYR . 3.5 mm -89.3 125.38 42.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.44 ' HG3' ' H ' ' A' ' 129' ' ' GLU . 18.6 tptt -74.45 160.33 31.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.157 0.503 . . . . 0.0 111.56 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.44 ' H ' ' HG3' ' A' ' 128' ' ' LYS . 49.8 mt-10 -70.09 -34.05 72.67 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.488 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 134' ' ' VAL . 1.8 mp0 -69.9 -27.79 65.09 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.461 ' NE2' ' CG2' ' A' ' 92' ' ' THR . 10.2 t-80 -72.89 -48.1 40.2 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.313 0.577 . . . . 0.0 110.87 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.8 m -79.76 -32.06 14.1 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.98 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -64.19 -46.18 85.1 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.216 -0.302 . . . . 0.0 110.721 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.564 HG23 ' N ' ' A' ' 135' ' ' GLY . 25.8 m -70.26 -47.71 65.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.62 0.248 . . . . 0.0 110.453 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.564 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -62.73 -41.44 99.84 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -66.84 -46.25 75.68 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.751 -0.264 . . . . 0.0 110.684 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -54.28 -47.08 72.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.961 0.41 . . . . 0.0 110.059 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 141' ' ' GLY . 22.8 tttp -64.58 -54.88 25.07 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.432 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -48.46 -40.78 27.47 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.698 0.761 . . . . 0.0 110.467 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.437 ' O ' ' ND1' ' A' ' 140' ' ' HIS . 0.6 OUTLIER -61.51 -36.49 80.67 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.958 0.885 . . . . 0.0 109.203 178.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' LYS . . . -62.68 -35.55 92.04 Favored Glycine 0 C--O 1.223 -0.54 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -66.9 -45.8 76.86 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.996 -0.708 . . . . 0.0 109.116 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -59.0 -30.1 67.73 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -64.83 -39.54 93.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.418 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.692 HD12 ' HB ' ' A' ' 33' ' ' ILE . 1.1 mm? -68.12 -56.99 6.81 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.174 0.511 . . . . 0.0 110.263 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.752 HG23 HD13 ' A' ' 29' ' ' LEU . 61.1 mt -57.91 -51.89 64.94 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.977 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -48.2 -56.84 6.91 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.814 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.7 t -51.75 -42.96 62.74 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.421 0.629 . . . . 0.0 110.141 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.823 ' CD2' HD21 ' A' ' 29' ' ' LEU . 8.6 t80 -55.69 -51.94 65.56 Favored 'General case' 0 C--O 1.178 -2.678 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.841 ' H ' HD22 ' A' ' 150' ' ' LEU . 2.0 mm? -64.38 -43.02 95.8 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.239 -1.538 . . . . 0.0 111.883 -177.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -62.65 -24.33 67.56 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.531 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 149' ' ' TYR . 0.0 OUTLIER -106.98 -13.27 15.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.15 0.5 . . . . 0.0 110.657 178.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.641 ' N ' ' O ' ' A' ' 149' ' ' TYR . 42.7 m80 -155.39 66.31 4.7 Favored Pre-proline 0 C--N 1.305 -1.365 0 C-N-CA 125.944 1.697 . . . . 0.0 110.275 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.74 -3.35 13.59 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 122.7 2.267 . . . . 0.0 111.582 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.645 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 5.4 p30 -77.96 4.07 13.05 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.433 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.427 ' O ' ' CD ' ' A' ' 20' ' ' LYS . . . -50.13 129.08 20.46 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 119.038 -2.289 . . . . 0.0 111.343 -178.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.507 ' O ' ' CD2' ' A' ' 157' ' ' TYR . 36.9 t80 53.5 6.32 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.203 0.525 . . . . 0.0 112.219 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.645 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.091 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.884 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.833 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.2 p -134.79 147.72 29.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 O-C-N 122.494 -0.415 . . . . 0.0 111.163 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -98.33 110.23 22.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.321 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.514 HG23 ' NE2' ' A' ' 118' ' ' HIS . 68.8 m -96.13 134.3 39.37 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.794 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -133.55 131.05 39.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.468 ' C ' HD22 ' A' ' 7' ' ' ASN . 1.7 tt0 -102.97 126.7 50.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.881 0.372 . . . . 0.0 110.945 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.468 HD22 ' C ' ' A' ' 6' ' ' GLU . 2.1 m-80 -135.63 167.3 21.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.968 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -156.14 159.24 38.85 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -146.21 140.87 26.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.219 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.4 m -109.41 147.41 32.84 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.937 0.398 . . . . 0.0 111.831 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 t -145.68 154.76 42.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.432 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -87.86 25.44 1.53 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.124 0.488 . . . . 0.0 110.982 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.508 ' HB ' HD21 ' A' ' 18' ' ' LEU . 2.4 mt -108.55 126.84 28.63 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.651 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -46.08 148.38 2.98 Favored 'Trans proline' 0 C--N 1.325 -0.675 0 C-N-CA 121.161 1.241 . . . . 0.0 110.857 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.709 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 18.1 Cg_endo -64.86 -24.35 61.26 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 122.553 2.169 . . . . 0.0 112.915 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.565 ' CB ' HH11 ' A' ' 17' ' ' ARG . 66.3 m -70.51 -29.64 66.2 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.565 HH11 ' CB ' ' A' ' 16' ' ' SER . 0.4 OUTLIER -75.88 -56.63 4.49 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 15' ' ' PRO . 3.2 mt -48.38 -48.84 36.47 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.784 ' O ' HG22 ' A' ' 23' ' ' VAL . 40.2 t80 -44.66 -60.0 2.22 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.704 178.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.624 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -70.99 -24.89 62.48 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.213 -0.93 . . . . 0.0 110.787 -179.277 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.852 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -79.45 -14.37 58.96 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.808 -177.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.604 ' CE2' HD11 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -116.45 -6.52 11.72 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.595 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.858 HG23 ' CD1' ' A' ' 24' ' ' LEU . 3.0 m -129.99 -36.7 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.858 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.9 mp -92.55 -53.96 3.98 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.19 0.904 . . . . 0.0 112.206 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.82 16.42 20.45 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.547 ' HB2' ' HA ' ' A' ' 22' ' ' PHE . . . -66.08 -43.2 88.05 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 121.062 0.458 . . . . 0.0 111.128 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.04 21.17 1.09 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.073 0.939 . . . . 0.0 110.501 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.426 ' H ' ' H ' ' A' ' 29' ' ' LEU . 4.2 m120 -139.46 -8.85 1.27 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.633 HD13 ' CD1' ' A' ' 149' ' ' TYR . 0.0 OUTLIER -94.43 -38.21 11.06 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.418 -1.719 . . . . 0.0 111.004 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.538 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.4 mm -55.38 -44.25 99.54 Favored Pre-proline 0 C--O 1.21 -0.986 0 CA-C-O 120.954 0.407 . . . . 0.0 111.928 -178.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 22.9 Cg_exo -63.1 -25.85 73.21 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.409 2.073 . . . . 0.0 113.304 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -83.28 -55.62 4.23 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.099 0.476 . . . . 0.0 112.27 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.64 HD13 ' HB3' ' A' ' 145' ' ' LEU . 0.8 OUTLIER -95.09 -38.31 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.54 -177.06 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.594 ' CA ' ' HG ' ' A' ' 145' ' ' LEU . . . -108.38 61.36 0.24 Allowed Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.493 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 87.9 Cg_endo -79.23 -28.94 3.41 Favored 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 121.812 1.675 . . . . 0.0 109.19 175.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -74.98 -42.58 57.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.258 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.576 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -69.07 -74.89 0.12 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.282 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.27 146.36 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.858 0.361 . . . . 0.0 110.071 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -78.12 -50.23 12.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.211 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.712 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 54.8 tp60 -176.36 165.74 2.75 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.918 0.389 . . . . 0.0 110.469 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.737 ' HB1' ' HE2' ' A' ' 54' ' ' LYS . . . -165.51 147.85 7.64 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.232 0.539 . . . . 0.0 110.583 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.858 ' C ' ' HZ1' ' A' ' 54' ' ' LYS . 23.2 pt-20 -148.09 140.88 24.68 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.099 -0.375 . . . . 0.0 110.764 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.501 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -76.72 140.29 17.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.391 0.615 . . . . 0.0 110.415 -179.079 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.69 -40.01 13.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.173 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.934 ' O ' HG23 ' A' ' 52' ' ' THR . 21.0 mt-10 -140.98 133.84 29.0 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.749 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.21 -156.68 36.0 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.649 HD22 ' N ' ' A' ' 48' ' ' GLY . 0.1 OUTLIER -136.38 -7.38 1.99 Allowed 'General case' 0 C--N 1.321 -0.642 0 O-C-N 122.535 -0.391 . . . . 0.0 111.108 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.649 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 142.71 14.89 0.33 Allowed Glycine 0 C--O 1.22 -0.747 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.68 -170.76 20.3 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 117.236 0.518 . . . . 0.0 111.929 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -61.57 125.8 17.6 Favored 'Trans proline' 0 C--N 1.319 -0.988 0 C-N-CA 122.787 2.325 . . . . 0.0 113.373 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.22 6.01 59.08 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.934 HG23 ' O ' ' A' ' 45' ' ' GLU . 60.0 m -93.81 140.52 29.57 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.147 -1.027 . . . . 0.0 111.45 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -121.9 129.76 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.858 ' HZ1' ' C ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -114.48 138.3 50.77 Favored 'General case' 0 C--O 1.22 -0.449 0 O-C-N 123.288 0.368 . . . . 0.0 110.689 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -120.6 125.75 48.55 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.148 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -103.47 140.63 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.263 178.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.435 HG23 ' CE2' ' A' ' 66' ' ' TYR . 38.5 m -118.83 119.65 35.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.518 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -92.5 -178.59 4.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.902 0.382 . . . . 0.0 110.685 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.26 143.81 29.77 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.466 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 9.1 pt-20 -59.73 -46.57 88.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 0.0 110.864 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.466 ' N ' ' CG ' ' A' ' 60' ' ' GLU . . . -100.65 61.67 0.62 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.404 ' OG ' ' N ' ' A' ' 63' ' ' GLN . 22.8 t -138.04 177.06 8.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.025 0.44 . . . . 0.0 110.79 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.404 ' N ' ' OG ' ' A' ' 62' ' ' SER . 6.6 mm-40 -60.98 -54.19 48.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 110.842 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.55 151.9 20.54 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -121.73 -61.72 0.22 Allowed Glycine 0 CA--C 1.52 0.349 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.435 ' CE2' HG23 ' A' ' 57' ' ' THR . 5.0 m-85 -145.6 151.33 37.93 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.811 0.338 . . . . 0.0 110.892 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 p -149.24 138.3 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.852 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.537 ' O ' HG13 ' A' ' 86' ' ' ILE . 10.1 mtpp -107.38 116.5 32.04 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-O 121.623 0.725 . . . . 0.0 112.187 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.646 ' N ' ' ND1' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -112.9 123.58 50.64 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -98.82 126.61 44.52 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.149 0.499 . . . . 0.0 111.532 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.455 HD12 HG22 ' A' ' 52' ' ' THR . 33.9 mt -79.94 136.09 24.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.374 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.4 ' O ' ' OG ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -97.27 -55.78 2.74 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -177.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 72' ' ' ASP . 3.3 m -165.29 141.77 5.57 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 48' ' ' GLY . 12.6 mt -120.69 131.1 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.483 176.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 79' ' ' TYR . 54.7 m-20 -114.42 88.26 2.82 Favored 'General case' 0 C--O 1.206 -1.205 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 177.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.447 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 19.6 mt-10 -54.61 -30.54 55.08 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.89 -39.46 71.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.159 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.4 m -108.41 -10.07 15.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.109 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.579 ' N ' ' O ' ' A' ' 75' ' ' ASP . 5.5 m-85 62.13 46.96 5.94 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 121.502 -0.749 . . . . 0.0 110.083 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.7 p -105.76 149.23 26.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.076 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.563 ' CE1' ' CD1' ' A' ' 83' ' ' TYR . 39.5 t80 -142.38 118.65 10.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.39 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.4 p -128.89 128.44 43.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.594 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.563 ' CD1' ' CE1' ' A' ' 81' ' ' TYR . 19.7 p90 -145.32 162.35 37.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.872 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.68 143.19 37.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.004 0.431 . . . . 0.0 111.161 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.794 HD13 ' HB1' ' A' ' 90' ' ' ALA . 6.9 mt -83.81 121.98 28.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.879 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 68' ' ' LYS . 2.5 pp -84.87 -41.4 15.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.309 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.525 ' CB ' HD12 ' A' ' 86' ' ' ILE . 16.2 tt0 -156.6 172.31 18.79 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.176 -0.327 . . . . 0.0 110.569 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.614 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.82 177.45 17.29 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -61.52 1.98 0.2 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 122.415 1.102 . . . . 0.0 108.466 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.794 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -68.08 -34.61 76.74 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.174 0.989 . . . . 0.0 110.386 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.871 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.59 15.57 21.98 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.298 0.639 . . . . 0.0 110.263 -177.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.418 ' C ' ' O ' ' A' ' 91' ' ' LEU . 63.3 p 43.16 -126.47 0.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.507 -178.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -130.73 -13.07 3.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.966 0.412 . . . . 0.0 111.187 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 p -104.7 -5.8 20.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.924 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.83 HG21 ' CD1' ' A' ' 98' ' ' ILE . 69.3 mt -98.66 152.27 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-O 121.918 0.866 . . . . 0.0 113.038 -176.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.497 ' N ' HG22 ' A' ' 95' ' ' ILE . 17.3 pt-20 -99.97 -45.51 5.66 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.349 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.434 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 0.3 OUTLIER -172.72 145.9 1.56 Allowed 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 121.655 0.74 . . . . 0.0 112.224 -179.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.83 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.94 124.35 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.701 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.39 144.72 31.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.973 0.416 . . . . 0.0 111.774 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -139.05 127.99 23.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -129.02 134.5 48.15 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.2 OUTLIER -140.04 131.51 26.96 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.782 -0.574 . . . . 0.0 110.084 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.424 ' C ' HD23 ' A' ' 104' ' ' LEU . 14.4 ttmm -123.0 134.04 54.34 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.614 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.19 132.77 43.42 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -134.41 137.76 50.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.104 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.709 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -72.77 135.6 45.31 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.452 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.44 ' N ' ' HA ' ' A' ' 111' ' ' SER . 7.9 t -121.16 170.2 9.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.842 0.353 . . . . 0.0 110.176 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.75 -31.51 46.06 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 112.033 -0.427 . . . . 0.0 112.033 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.8 m -88.16 -11.74 45.99 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 119.559 -2.142 . . . . 0.0 115.827 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.02 -89.47 0.12 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.88 1.229 . . . . 0.0 110.478 -169.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 92.0 p -163.74 130.33 3.24 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.077 1.351 . . . . 0.0 110.928 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 105' ' ' VAL . 34.4 m -99.91 118.38 36.22 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 51.3 mt -92.21 132.08 37.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.167 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 102' ' ' THR . 2.9 mtpp -105.78 116.64 32.29 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.721 ' C ' HD13 ' A' ' 116' ' ' ILE . 11.1 t -111.07 118.32 35.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.282 0.563 . . . . 0.0 110.826 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.919 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -100.42 135.6 35.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 123.337 0.655 . . . . 0.0 109.818 -177.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.9 p -108.96 135.4 50.2 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.49 -0.777 . . . . 0.0 108.918 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.514 ' NE2' HG23 ' A' ' 4' ' ' THR . 31.6 m-70 -135.72 93.99 3.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 120.922 0.392 . . . . 0.0 110.627 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.833 ' C ' HG23 ' A' ' 2' ' ' VAL . 79.6 m-85 -83.24 101.8 11.49 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.174 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.457 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 1.5 t-80 -96.59 104.32 16.3 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.9 p -101.56 176.19 5.31 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.403 0.62 . . . . 0.0 111.618 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.99 157.58 20.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.68 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 42.26 -109.98 0.22 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -116.29 5.66 13.65 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.819 -0.224 . . . . 0.0 110.968 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -49.01 159.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.117 0.484 . . . . 0.0 110.41 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.467 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 40.3 mt-10 -148.5 145.8 28.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.961 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.8 mm -88.88 124.53 41.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp -74.97 161.64 29.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.502 0.667 . . . . 0.0 111.77 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -70.48 -34.18 72.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.642 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.416 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 6.2 pt-20 -69.02 -30.83 69.29 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.647 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -67.99 -53.97 22.03 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.383 0.611 . . . . 0.0 110.363 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.91 -19.63 22.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.407 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 137' ' ' GLU . 52.4 tttm -66.85 -46.69 74.27 Favored 'General case' 0 C--O 1.219 -0.525 0 O-C-N 122.295 -0.253 . . . . 0.0 110.704 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -69.17 -46.52 77.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.762 0.315 . . . . 0.0 110.404 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.28 -47.41 71.76 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -67.95 -46.48 71.33 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.566 -0.373 . . . . 0.0 111.055 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 21.0 tp10 -54.36 -46.73 73.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.021 0.439 . . . . 0.0 110.363 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.468 ' O ' ' CD2' ' A' ' 142' ' ' LEU . 10.3 ttmt -69.21 -52.75 24.73 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.78 -46.81 41.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.395 0.617 . . . . 0.0 110.55 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -62.08 -36.98 83.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.96 -52.54 51.66 Favored Glycine 0 C--O 1.225 -0.435 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.468 ' CD2' ' O ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -60.01 -42.51 94.47 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 122.096 -0.65 . . . . 0.0 109.366 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -59.15 -30.02 67.85 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.507 ' HB3' ' HZ2' ' A' ' 144' ' ' LYS . 0.3 OUTLIER -76.88 -34.61 57.75 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.12 178.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.64 ' HB3' HD13 ' A' ' 33' ' ' ILE . 1.7 mm? -70.43 -53.89 14.58 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.073 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.658 ' O ' HD22 ' A' ' 150' ' ' LEU . 7.3 mt -54.58 -49.19 68.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -46.38 -53.77 10.34 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.4 t -52.29 -42.25 63.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.307 0.575 . . . . 0.0 110.992 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.633 ' CD1' HD13 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -58.14 -44.67 87.94 Favored 'General case' 0 C--O 1.2 -1.542 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.852 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.1 mm? -66.87 -43.56 83.24 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 119.328 0.967 . . . . 0.0 112.073 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.532 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.4 OUTLIER -60.72 -25.1 66.2 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.58 -13.19 15.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.148 0.499 . . . . 0.0 110.362 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.604 ' N ' ' O ' ' A' ' 149' ' ' TYR . 22.5 t60 -153.9 67.21 5.82 Favored Pre-proline 0 C--N 1.312 -1.05 0 C-N-CA 124.354 1.062 . . . . 0.0 110.688 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.99 -3.28 11.18 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 122.409 2.073 . . . . 0.0 111.521 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.619 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.1 OUTLIER -80.95 3.36 23.15 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.918 -178.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.55 129.95 19.83 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 119.453 -2.029 . . . . 0.0 111.237 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.715 ' CD2' HD23 ' A' ' 24' ' ' LEU . 10.9 t80 54.3 7.1 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.205 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.619 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.366 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.66 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.883 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.1 p -134.97 148.38 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.568 -0.372 . . . . 0.0 111.141 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -98.52 110.84 23.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.32 177.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 m -96.53 139.85 32.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.788 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -140.53 134.03 30.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.18 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.508 ' C ' HD22 ' A' ' 7' ' ' ASN . 8.2 mt-10 -102.79 128.81 49.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.071 0.462 . . . . 0.0 110.964 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -128.19 165.5 20.32 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -178.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 1.3 pt-20 -156.38 151.42 26.29 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -142.7 140.81 31.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.088 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -107.06 145.81 31.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.844 0.354 . . . . 0.0 111.687 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.6 t -146.14 154.53 41.89 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.822 0.344 . . . . 0.0 110.688 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -90.94 24.5 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.112 0.482 . . . . 0.0 110.691 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.451 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.9 mt -107.59 128.02 26.7 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.359 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -46.1 143.78 7.05 Favored 'Trans proline' 0 C--N 1.326 -0.617 0 C-N-CA 121.308 1.339 . . . . 0.0 110.994 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HA ' HD12 ' A' ' 18' ' ' LEU . 11.0 Cg_endo -61.1 -23.58 77.59 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.45 2.1 . . . . 0.0 113.108 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.0 m -70.43 -31.54 68.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -76.62 -56.41 4.64 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 15' ' ' PRO . 2.8 mt -50.67 -43.06 57.33 Favored 'General case' 0 C--O 1.212 -0.905 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.721 ' O ' HG22 ' A' ' 23' ' ' VAL . 16.9 t80 -47.67 -58.3 4.45 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.932 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.86 ' CB ' HD21 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.85 -41.09 75.35 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.12 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.838 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -63.6 -2.55 1.71 Allowed 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.33 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.614 ' CE1' ' CE2' ' A' ' 143' ' ' PHE . 6.6 t80 -119.23 -9.24 9.99 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.913 HG23 HD13 ' A' ' 24' ' ' LEU . 5.4 m -134.67 -46.22 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.913 HD13 HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -99.19 -32.01 11.44 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 120.607 1.548 . . . . 0.0 112.422 -178.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.703 ' N ' HD22 ' A' ' 24' ' ' LEU . 0.5 OUTLIER -112.14 -5.12 14.26 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 118.437 0.562 . . . . 0.0 111.645 -178.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -67.49 -42.53 82.74 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.28 0.562 . . . . 0.0 111.657 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -82.91 18.94 1.47 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.991 0.901 . . . . 0.0 109.906 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.41 ' H ' ' C ' ' A' ' 26' ' ' ALA . 67.7 m-80 -139.27 -9.08 1.29 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.548 HD21 ' CD2' ' A' ' 149' ' ' TYR . 1.2 mt -94.12 -31.42 14.18 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.923 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.526 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -54.76 -53.97 54.66 Favored Pre-proline 0 C--O 1.214 -0.764 0 O-C-N 122.175 -0.328 . . . . 0.0 111.266 -179.321 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 22.8 Cg_endo -63.08 -24.92 73.28 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 121.908 1.739 . . . . 0.0 112.468 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -69.66 -60.41 2.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.73 0.776 . . . . 0.0 111.972 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.778 HD12 ' HB3' ' A' ' 145' ' ' LEU . 1.4 pt -95.91 -35.68 5.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.349 -176.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.94 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.37 65.03 0.14 Allowed Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.47 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 72.2 Cg_endo -76.31 -28.07 7.43 Favored 'Trans proline' 0 C--N 1.32 -0.93 0 C-N-CA 121.638 1.559 . . . . 0.0 108.276 174.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -73.91 -43.59 57.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.317 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.94 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -71.52 -74.02 0.17 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.801 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.556 HD13 HD22 ' A' ' 142' ' ' LEU . 1.1 mp -101.74 144.21 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 121.264 0.554 . . . . 0.0 109.818 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.9 ttpt -78.86 -62.16 1.78 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.603 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.753 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 57.2 tp60 -164.5 165.69 21.1 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.922 0.391 . . . . 0.0 110.012 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.753 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -165.93 149.44 7.73 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.06 0.457 . . . . 0.0 111.181 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -150.17 142.79 24.54 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.075 -179.351 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.471 ' H ' HG13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -76.96 141.34 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-O 122.015 0.912 . . . . 0.0 111.212 178.564 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.764 ' N ' HD12 ' A' ' 44' ' ' LEU . 4.0 mp -88.36 -40.57 13.46 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.9 ' O ' HG23 ' A' ' 52' ' ' THR . 32.6 mt-10 -149.12 134.18 18.15 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.457 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.64 -156.38 23.14 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.674 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -134.19 -1.59 2.91 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.451 -0.44 . . . . 0.0 111.509 -178.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.498 ' N ' HG21 ' A' ' 52' ' ' THR . . . 124.86 18.36 2.65 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -111.48 -172.9 19.48 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HD3' ' H ' ' A' ' 74' ' ' ILE . 10.8 Cg_endo -60.55 125.31 17.0 Favored 'Trans proline' 0 C--N 1.321 -0.876 0 C-N-CA 122.094 1.862 . . . . 0.0 112.96 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.5 -0.32 56.86 Favored Glycine 0 N--CA 1.462 0.428 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.9 HG23 ' O ' ' A' ' 45' ' ' GLU . 99.1 m -93.91 136.95 33.66 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 114.377 -0.912 . . . . 0.0 111.229 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.625 HG22 HD13 ' A' ' 44' ' ' LEU . 2.5 mp -113.95 132.35 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.496 ' HB2' HD11 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -122.7 138.54 54.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.899 0.381 . . . . 0.0 110.522 179.082 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.68 ' HB3' HD11 ' A' ' 44' ' ' LEU . 29.4 ttpt -119.9 130.2 54.73 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.098 -0.376 . . . . 0.0 110.906 178.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.6 mm -95.93 140.8 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.795 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.7 m -108.71 117.75 35.01 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 59' ' ' GLY . 5.8 t80 -104.22 172.12 6.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 0.0 110.961 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.453 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -57.55 144.43 40.63 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -60.3 -67.45 0.39 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.899 0.38 . . . . 0.0 111.242 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.46 61.96 3.15 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 t -137.75 -172.47 3.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.882 0.373 . . . . 0.0 110.664 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -58.69 -55.28 37.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.638 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -99.67 155.66 17.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.599 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.22 -59.36 0.13 Allowed Glycine 0 CA--C 1.52 0.363 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -145.5 149.2 34.2 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.937 0.399 . . . . 0.0 110.674 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 p -156.9 143.72 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.721 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.694 ' HB3' HD11 ' A' ' 86' ' ' ILE . 36.2 mttp -106.63 112.51 25.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.338 0.59 . . . . 0.0 112.069 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.445 ' CE1' ' CD2' ' A' ' 85' ' ' LEU . 11.3 m-70 -101.3 123.47 45.46 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -106.57 119.32 38.99 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.027 -0.421 . . . . 0.0 111.5 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.663 HD13 HG22 ' A' ' 52' ' ' THR . 4.0 mp -70.35 145.23 13.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -105.56 -54.88 2.41 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.7 144.4 6.11 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.461 ' H ' ' HD3' ' A' ' 50' ' ' PRO . 45.3 mt -127.14 125.88 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.162 173.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 79' ' ' TYR . 13.4 m-20 -113.91 88.81 2.93 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.506 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 13.7 mt-10 -54.47 -30.36 52.83 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.68 70.04 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.006 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.93 -11.42 15.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.122 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.7 m-85 62.23 42.7 9.18 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.597 -0.689 . . . . 0.0 110.259 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.4 t -106.86 141.75 37.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.127 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -132.09 118.71 19.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.8 t -128.53 135.19 49.07 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.136 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -144.82 159.83 42.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.493 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -138.26 139.48 39.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.228 0.537 . . . . 0.0 110.821 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.577 HD13 ' HB1' ' A' ' 90' ' ' ALA . 8.7 mt -80.17 115.55 19.79 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.694 HD11 ' HB3' ' A' ' 68' ' ' LYS . 4.1 pt -80.79 -44.24 21.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.676 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -152.02 172.11 16.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.863 0.363 . . . . 0.0 110.745 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.579 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.19 177.12 18.72 Favored Glycine 0 C--O 1.238 0.377 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -61.52 -0.34 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 122.204 1.002 . . . . 0.0 108.442 178.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.579 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -62.46 -34.36 76.67 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.816 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.859 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.16 14.83 22.74 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 123.61 0.764 . . . . 0.0 110.198 -177.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.6 p 46.42 -126.5 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -130.66 -12.86 3.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.649 0.738 . . . . 0.0 111.068 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.76 -6.34 20.42 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.015 0.526 . . . . 0.0 112.108 -177.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.717 HG21 ' CD1' ' A' ' 98' ' ' ILE . 71.4 mt -98.77 152.6 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.712 0 CA-C-O 121.997 0.903 . . . . 0.0 113.347 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.509 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -91.4 -57.33 2.81 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.167 177.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.404 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 28.2 pttt -171.93 151.16 2.7 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.027 0.442 . . . . 0.0 110.584 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.717 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.56 124.15 71.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.558 ' C ' ' HD1' ' A' ' 118' ' ' HIS . 0.1 OUTLIER -103.13 144.49 31.24 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 122.844 0.458 . . . . 0.0 111.896 -178.338 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.421 ' CZ ' ' OG ' ' A' ' 117' ' ' SER . 0.4 OUTLIER -139.13 127.93 23.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.5 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -133.57 132.86 41.38 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -133.43 136.32 45.12 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 122.208 -0.307 . . . . 0.0 110.425 -178.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -120.58 133.69 55.36 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -98.54 130.75 45.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.943 0.401 . . . . 0.0 110.003 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -132.62 137.24 54.55 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.063 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -73.01 135.71 44.96 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.649 178.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.429 ' N ' ' HA ' ' A' ' 111' ' ' SER . 13.2 t -121.25 168.82 11.2 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 122.593 0.357 . . . . 0.0 110.201 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.8 -29.81 42.71 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 112.233 -0.347 . . . . 0.0 112.233 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.6 p -92.06 -11.66 35.24 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 119.849 -1.971 . . . . 0.0 114.389 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.84 -86.14 0.12 Allowed Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.47 1.509 . . . . 0.0 112.066 -175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 88.4 p -164.54 130.97 2.97 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 125.86 1.664 . . . . 0.0 110.688 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.4 m -99.64 118.35 35.99 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 42.4 mt -91.83 131.23 39.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.118 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 102' ' ' THR . 8.9 mtpt -105.47 117.12 33.2 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.706 ' C ' HD13 ' A' ' 116' ' ' ILE . 24.9 p -110.16 118.64 36.9 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.368 0.604 . . . . 0.0 111.047 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.94 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -99.89 136.91 29.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 123.536 0.734 . . . . 0.0 109.641 -177.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.421 ' OG ' ' CZ ' ' A' ' 100' ' ' TYR . 6.8 m -118.26 131.72 56.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.477 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.558 ' HD1' ' C ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -138.2 112.26 8.51 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.883 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -102.83 103.77 13.98 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.211 -0.306 . . . . 0.0 110.441 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -90.58 107.24 19.04 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.207 0.527 . . . . 0.0 110.01 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.4 p -98.88 176.73 5.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.47 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -109.49 159.58 16.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.628 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 39.63 -109.77 0.13 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.464 -0.655 . . . . 0.0 111.464 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -116.04 3.66 13.62 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 122.702 -0.293 . . . . 0.0 111.069 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.483 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -45.58 160.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.316 0.579 . . . . 0.0 110.393 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.483 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 43.4 tt0 -149.49 145.66 26.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.212 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.0 mm -88.95 125.52 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -74.74 161.66 29.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.499 0.666 . . . . 0.0 111.53 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 129' ' ' GLU . 1.0 OUTLIER -69.71 -47.55 62.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.192 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.469 ' O ' HG22 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -59.81 -24.68 64.35 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.118 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -72.95 -51.34 18.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.259 0.552 . . . . 0.0 111.256 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 m -77.31 -27.1 15.76 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.934 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.4 tttm -67.28 -45.91 75.21 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.275 -0.266 . . . . 0.0 110.9 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 135' ' ' GLY . 34.5 m -69.18 -45.38 79.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.886 0.375 . . . . 0.0 110.344 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.487 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -65.21 -41.76 96.69 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -67.14 -45.67 76.42 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 120.494 0.188 . . . . 0.0 110.691 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -53.96 -42.53 69.02 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.447 ' O ' ' CD2' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -69.48 -53.4 19.38 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.582 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.415 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.31 -41.73 39.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.583 0.706 . . . . 0.0 110.628 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -67.04 -36.34 81.86 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.93 -36.71 91.04 Favored Glycine 0 C--O 1.223 -0.576 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.584 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.1 OUTLIER -73.31 -41.59 63.36 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.614 ' CE2' ' CE1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -59.87 -23.06 63.12 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.484 ' HZ2' ' C ' ' A' ' 144' ' ' LYS . 1.2 ttpp -76.01 -40.17 54.17 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.259 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.778 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.5 mm? -67.21 -55.85 12.34 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.31 0.576 . . . . 0.0 109.624 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.729 ' O ' HD22 ' A' ' 150' ' ' LEU . 60.6 mt -53.48 -50.92 46.35 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.358 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -47.51 -54.27 12.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.983 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.8 t -53.45 -42.65 67.37 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.117 0.484 . . . . 0.0 111.494 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.678 ' HB2' HD13 ' A' ' 33' ' ' ILE . 19.2 t80 -60.27 -44.72 95.07 Favored 'General case' 0 C--O 1.199 -1.553 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.838 HD11 ' HB2' ' A' ' 21' ' ' ALA . 1.8 mm? -68.99 -42.55 76.34 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 119.993 1.27 . . . . 0.0 111.629 -178.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -24.39 67.71 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 121.483 -0.761 . . . . 0.0 109.207 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -106.2 -13.15 15.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.566 0.698 . . . . 0.0 110.641 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 149' ' ' TYR . 16.9 t-80 -155.22 66.33 4.79 Favored Pre-proline 0 C--N 1.312 -1.063 0 C-N-CA 124.818 1.247 . . . . 0.0 110.181 -178.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.4 ' CD ' ' O ' ' A' ' 150' ' ' LEU . 43.1 Cg_endo -72.86 -4.01 14.61 Favored 'Trans proline' 0 N--CA 1.48 0.702 0 C-N-CA 122.472 2.115 . . . . 0.0 111.921 -178.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.621 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 3.8 p30 -82.51 3.48 28.24 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.07 0.948 . . . . 0.0 111.756 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.54 131.1 21.08 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 119.599 -1.938 . . . . 0.0 111.25 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.514 ' CG ' ' O ' ' A' ' 157' ' ' TYR . 80.9 t80 56.16 6.04 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.621 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.595 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.31 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.803 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.9 p -134.65 148.35 29.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 O-C-N 122.585 -0.362 . . . . 0.0 110.961 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -97.46 110.36 22.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.298 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.496 ' OG1' ' CD2' ' A' ' 118' ' ' HIS . 96.9 m -96.03 132.36 41.46 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.758 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.17 128.36 37.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.976 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -102.7 133.66 47.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.742 0.306 . . . . 0.0 110.705 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -126.37 170.87 11.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.472 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.96 149.37 27.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.309 0.576 . . . . 0.0 111.976 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -155.43 141.02 17.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.12 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 m -106.27 143.84 33.82 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.92 0.391 . . . . 0.0 111.941 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.0 t -133.75 154.49 50.93 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.262 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -93.42 18.86 9.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.896 0.379 . . . . 0.0 111.003 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.442 ' O ' HD11 ' A' ' 18' ' ' LEU . 2.1 mt -107.09 127.73 27.41 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -44.82 144.83 3.26 Favored 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 121.117 1.211 . . . . 0.0 110.797 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.667 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 19.4 Cg_endo -62.81 -23.2 74.36 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 122.452 2.101 . . . . 0.0 112.542 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.592 ' C ' ' HZ2' ' A' ' 20' ' ' LYS . 70.1 m -69.3 -33.45 73.21 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.415 HH21 ' HB2' ' A' ' 16' ' ' SER . 11.5 mmt-85 -76.66 -56.83 4.26 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 118.882 0.764 . . . . 0.0 109.066 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.464 ' H ' ' HG ' ' A' ' 18' ' ' LEU . 4.0 mt -48.57 -48.64 38.71 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.728 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.76 ' O ' HG22 ' A' ' 23' ' ' VAL . 27.9 t80 -48.41 -55.18 11.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.192 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.592 ' HZ2' ' C ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -70.23 -26.71 63.98 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 119.416 -0.913 . . . . 0.0 109.622 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.796 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -81.3 -2.9 50.83 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.994 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.503 ' CA ' ' HB2' ' A' ' 26' ' ' ALA . 1.6 t80 -118.78 -8.3 10.36 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.908 HG23 ' CD1' ' A' ' 24' ' ' LEU . 3.1 m -135.08 -35.46 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.908 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.4 mp -90.51 -54.69 3.89 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.652 1.114 . . . . 0.0 111.694 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -113.03 -3.93 13.94 Favored 'General case' 0 C--O 1.205 -1.243 0 O-C-N 122.261 -0.274 . . . . 0.0 111.129 -178.501 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.957 ' O ' HG22 ' A' ' 30' ' ' ILE . . . -46.07 -39.22 8.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 118.037 0.381 . . . . 0.0 111.526 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -85.41 12.98 7.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.629 0.728 . . . . 0.0 110.855 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -134.51 -10.32 2.46 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 124.969 1.308 . . . . 0.0 108.62 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -95.84 -43.3 7.91 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 124.862 1.265 . . . . 0.0 109.188 -179.462 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.957 HG22 ' O ' ' A' ' 26' ' ' ALA . 1.7 tt -55.62 -45.46 99.87 Favored Pre-proline 0 C--O 1.215 -0.757 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.486 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.846 ' HD3' HG23 ' A' ' 30' ' ' ILE . 36.4 Cg_endo -63.41 -24.67 71.02 Favored 'Trans proline' 0 N--CA 1.482 0.85 0 CA-C-N 121.231 1.475 . . . . 0.0 111.256 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -67.49 -54.45 20.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.663 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.767 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.9 OUTLIER -95.8 -35.75 6.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.248 -176.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.863 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.63 63.85 0.15 Allowed Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.489 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 80.3 Cg_endo -77.1 -27.78 6.48 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 N-CA-C 107.917 -1.609 . . . . 0.0 107.917 174.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -75.23 -43.24 52.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.17 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.863 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -70.5 -75.27 0.12 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.861 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.602 ' HB ' HD11 ' A' ' 30' ' ' ILE . 1.1 mm -99.98 147.78 7.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 CA-C-O 121.665 0.745 . . . . 0.0 111.021 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.772 ' HD2' ' H ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.08 -64.07 1.09 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.203 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.433 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -178.12 166.79 1.98 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.105 0.478 . . . . 0.0 110.345 179.452 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.433 ' H ' ' HG2' ' A' ' 40' ' ' GLN . . . -165.96 143.76 5.6 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.987 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.81 145.95 35.32 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.431 ' H ' HG13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -84.82 139.08 18.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.683 0.754 . . . . 0.0 110.94 -179.451 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.837 ' N ' HD12 ' A' ' 44' ' ' LEU . 3.0 mp -89.49 -39.09 13.57 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.933 ' O ' HG23 ' A' ' 52' ' ' THR . 22.2 mt-10 -141.92 133.1 26.26 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.78 -156.41 28.8 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.736 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -134.19 -13.89 2.37 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 122.33 -0.512 . . . . 0.0 110.924 -179.562 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.627 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 143.39 18.03 0.24 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -110.88 -173.24 19.91 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -61.16 126.07 18.56 Favored 'Trans proline' 0 C--N 1.321 -0.904 0 C-N-CA 122.258 1.972 . . . . 0.0 113.319 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.81 1.89 56.24 Favored Glycine 0 N--CA 1.463 0.462 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.933 HG23 ' O ' ' A' ' 45' ' ' GLU . 88.5 m -93.85 140.38 29.74 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.218 -0.991 . . . . 0.0 111.046 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.517 HG13 ' HE ' ' A' ' 70' ' ' ARG . 2.1 mp -117.65 133.13 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 177.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.17 141.02 52.41 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 121.037 0.446 . . . . 0.0 110.957 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' HB3' HD11 ' A' ' 44' ' ' LEU . 33.7 ttpt -119.27 131.98 55.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.813 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.7 mm -94.04 142.01 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.678 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 18.3 m -108.86 117.58 34.56 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.579 ' HA ' ' HD3' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -90.53 162.24 15.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.779 0.323 . . . . 0.0 111.363 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.59 144.34 30.16 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.621 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 2.1 pm0 -56.73 -47.17 80.6 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 122.422 -0.458 . . . . 0.0 110.298 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.34 62.38 1.76 Allowed Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 62.7 p -136.54 174.54 10.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.058 0.456 . . . . 0.0 111.205 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.484 ' NE2' ' H ' ' A' ' 63' ' ' GLN . 4.0 mp0 -69.03 -50.01 52.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.25 156.24 17.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.053 0.454 . . . . 0.0 110.631 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.78 -61.49 0.51 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.27 154.82 42.14 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.071 0.462 . . . . 0.0 110.776 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.426 ' CG2' ' N ' ' A' ' 68' ' ' LYS . 2.0 p -145.82 157.09 12.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.958 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.426 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 26.4 mtmt -105.78 113.12 26.48 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.446 0.641 . . . . 0.0 112.425 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -105.78 105.71 15.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.993 0.917 . . . . 0.0 109.579 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.517 ' HE ' HG13 ' A' ' 53' ' ' ILE . 25.3 ttm180 -101.63 131.19 47.98 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.953 -0.467 . . . . 0.0 111.433 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.564 HD13 ' CG2' ' A' ' 52' ' ' THR . 4.4 mp -73.91 145.36 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -102.49 -56.01 2.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 119.227 -0.416 . . . . 0.0 112.073 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.8 m -165.35 141.38 5.38 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.5 mt -124.73 131.44 72.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.852 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.614 ' O ' ' N ' ' A' ' 79' ' ' TYR . 54.8 m-20 -114.84 87.92 2.75 Favored 'General case' 0 C--O 1.199 -1.575 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.454 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 9.5 pt-20 -54.41 -30.58 52.74 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.04 77.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.3 m -107.86 -9.98 15.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.736 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.614 ' N ' ' O ' ' A' ' 75' ' ' ASP . 20.7 m-85 58.54 48.63 11.68 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 121.415 -0.803 . . . . 0.0 110.538 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.2 p -106.58 147.22 29.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.985 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.635 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 35.9 t80 -132.1 125.86 32.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.968 0.413 . . . . 0.0 110.919 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 p -133.65 136.09 44.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.362 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.635 ' CD1' ' CE2' ' A' ' 81' ' ' TYR . 6.5 p90 -146.78 160.67 41.96 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.8 m -144.64 138.39 27.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.133 0.492 . . . . 0.0 111.229 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.65 HD22 ' HB1' ' A' ' 90' ' ' ALA . 4.5 mp -80.36 119.99 23.81 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.485 ' H ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -84.5 -42.9 17.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 -178.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.549 ' CD ' ' H ' ' A' ' 88' ' ' GLY . 1.2 tm-20 -157.64 173.55 16.68 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.326 -0.234 . . . . 0.0 110.493 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.631 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.74 177.44 17.34 Favored Glycine 0 CA--C 1.509 -0.316 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -61.54 1.76 0.21 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.65 ' HB1' HD22 ' A' ' 85' ' ' LEU . . . -64.88 -34.82 79.3 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.361 1.064 . . . . 0.0 110.071 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.874 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.0 16.31 21.98 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 123.702 0.801 . . . . 0.0 108.847 -178.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.8 p 44.89 -126.96 1.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -130.59 -9.62 4.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.133 0.492 . . . . 0.0 110.736 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.45 -7.25 18.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.171 -177.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.745 HG21 ' CD1' ' A' ' 98' ' ' ILE . 88.7 mt -100.04 152.5 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 CA-C-O 122.085 0.945 . . . . 0.0 113.523 -177.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.492 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -90.42 -56.85 3.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.598 177.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -172.19 148.28 2.14 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.267 0.556 . . . . 0.0 111.454 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.745 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.31 130.1 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.26 145.07 46.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.917 0.389 . . . . 0.0 111.53 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -139.89 133.17 29.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.562 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.427 ' O ' HG12 ' A' ' 116' ' ' ILE . 39.0 tt0 -128.46 134.29 48.7 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 121.036 0.446 . . . . 0.0 110.963 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.14 133.01 52.99 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.714 -0.616 . . . . 0.0 109.634 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -120.11 133.0 55.63 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 1.4 mm? -97.81 125.42 42.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.132 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.8 OUTLIER -137.65 136.86 45.85 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.667 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -73.16 139.45 46.36 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.173 178.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.454 ' N ' ' HA ' ' A' ' 111' ' ' SER . 17.3 p -120.73 168.11 11.76 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -53.61 -26.85 32.89 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 121.398 -0.429 . . . . 0.0 112.125 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.2 m -91.27 -14.11 31.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 119.563 -2.139 . . . . 0.0 116.591 174.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.46 -89.91 0.12 Allowed Glycine 0 CA--C 1.537 1.424 0 O-C-N 120.454 -1.404 . . . . 0.0 110.981 -161.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.454 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 17.2 t -164.84 133.78 3.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 119.035 1.417 . . . . 0.0 111.196 -178.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 105' ' ' VAL . 52.1 m -100.06 126.05 46.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.422 ' CG1' HD13 ' A' ' 104' ' ' LEU . 11.1 mt -99.54 127.79 51.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.428 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -105.52 117.45 34.04 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.792 ' C ' HD13 ' A' ' 116' ' ' ILE . 8.0 p -110.58 121.77 46.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.442 0.639 . . . . 0.0 110.542 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.924 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -104.73 135.26 43.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.296 0.569 . . . . 0.0 109.948 -177.358 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 71.1 m -107.73 138.33 44.16 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.8 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.496 ' CD2' ' OG1' ' A' ' 4' ' ' THR . 26.3 m80 -136.13 93.47 2.91 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.813 0.34 . . . . 0.0 110.454 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.803 ' C ' HG23 ' A' ' 2' ' ' VAL . 60.9 m-85 -88.12 102.16 14.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.213 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -90.28 102.87 15.59 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.519 HG21 ' HA ' ' A' ' 126' ' ' GLU . 1.2 p -92.47 160.57 15.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.905 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.406 ' H ' HG22 ' A' ' 125' ' ' ILE . 4.3 ptmt -112.39 142.5 44.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.029 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.24 -109.64 0.94 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.747 ' H ' HD22 ' A' ' 124' ' ' ASN . 0.1 OUTLIER -116.46 -2.67 11.98 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 122.497 -0.413 . . . . 0.0 110.657 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 125' ' ' ILE . 1.2 tp -49.3 160.65 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.88 0.371 . . . . 0.0 110.693 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.519 ' HA ' HG21 ' A' ' 121' ' ' THR . 2.7 pp20? -149.38 149.64 31.17 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.572 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 34.2 mm -87.05 125.16 40.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -75.2 162.35 28.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.485 0.66 . . . . 0.0 112.06 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -69.02 -42.19 76.73 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.855 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.459 ' O ' HG22 ' A' ' 134' ' ' VAL . 5.2 mp0 -61.57 -25.55 67.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.825 0.345 . . . . 0.0 110.174 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -72.59 -51.03 21.45 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.283 0.564 . . . . 0.0 111.038 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 m -77.03 -25.95 15.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.942 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -67.34 -46.31 73.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 122.332 -0.23 . . . . 0.0 110.787 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 135' ' ' GLY . 35.6 m -70.2 -45.01 77.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.885 0.374 . . . . 0.0 110.593 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.491 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -66.16 -46.62 78.57 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -66.89 -46.89 73.51 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.636 -0.332 . . . . 0.0 110.714 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -55.2 -47.24 75.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.011 0.434 . . . . 0.0 110.031 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -66.7 -52.87 39.76 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.885 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.422 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.22 -42.64 41.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.594 0.712 . . . . 0.0 110.567 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.509 ' HD1' ' C ' ' A' ' 140' ' ' HIS . 1.8 t-80 -61.16 -36.56 80.15 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.859 0.838 . . . . 0.0 109.052 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.9 -38.88 96.12 Favored Glycine 0 C--O 1.221 -0.665 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.571 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -66.1 -46.82 76.28 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -59.62 -24.48 63.86 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.68 -36.28 65.29 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.59 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.767 ' HB3' HD12 ' A' ' 33' ' ' ILE . 1.1 mm? -71.22 -57.67 4.27 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.426 0.631 . . . . 0.0 109.839 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.727 ' O ' HD22 ' A' ' 150' ' ' LEU . 50.4 mt -54.54 -50.65 57.09 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.133 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -47.43 -56.76 6.32 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.864 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 20.5 p -50.68 -44.65 57.81 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.343 0.592 . . . . 0.0 111.285 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.668 ' HB2' HD13 ' A' ' 33' ' ' ILE . 28.2 t80 -59.88 -45.41 92.58 Favored 'General case' 0 C--O 1.193 -1.917 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.796 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.1 mm? -65.79 -42.74 90.37 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 120.443 1.474 . . . . 0.0 111.565 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.53 -24.38 67.48 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.305 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -105.77 -13.08 15.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.321 0.581 . . . . 0.0 110.768 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.637 ' N ' ' O ' ' A' ' 149' ' ' TYR . 42.1 m80 -155.96 67.34 4.69 Favored Pre-proline 0 C--N 1.31 -1.131 0 C-N-CA 125.167 1.387 . . . . 0.0 110.202 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -72.35 -3.48 13.46 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 122.501 2.134 . . . . 0.0 111.704 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.649 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 13.0 m-20 -73.16 2.61 6.9 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.163 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 158' ' ' ASN . . . -50.11 130.15 22.01 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 119.161 -2.212 . . . . 0.0 111.275 -178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.669 ' CG ' HD23 ' A' ' 24' ' ' LEU . 92.8 t80 54.03 6.18 0.09 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.546 0.688 . . . . 0.0 112.124 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.649 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.503 0 O-C-N 120.994 -1.066 . . . . 0.0 110.055 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.885 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.823 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.5 p -134.54 148.65 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 O-C-N 122.488 -0.419 . . . . 0.0 111.02 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.73 110.27 22.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.659 177.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.516 ' OG1' ' CD2' ' A' ' 118' ' ' HIS . 90.4 m -95.93 140.06 31.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.82 0.343 . . . . 0.0 111.013 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.482 ' CD2' ' ND2' ' A' ' 7' ' ' ASN . 7.2 t80 -143.28 128.09 18.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.172 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.577 ' C ' HD22 ' A' ' 7' ' ' ASN . 1.6 tt0 -102.89 131.19 49.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.874 0.368 . . . . 0.0 111.324 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.577 HD22 ' C ' ' A' ' 6' ' ' GLU . 1.8 m-80 -134.59 172.7 12.56 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 122.636 0.375 . . . . 0.0 110.387 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.42 153.49 30.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.202 0.525 . . . . 0.0 112.39 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -149.01 138.41 21.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.235 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.19 147.49 25.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 111.771 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.3 t -145.8 161.44 39.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.499 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -96.27 25.92 4.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.854 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.617 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.5 mt -116.3 125.41 28.54 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.879 -178.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -47.83 149.93 4.9 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.034 1.823 . . . . 0.0 111.784 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.423 ' CG ' ' HB2' ' A' ' 106' ' ' ALA . 22.8 Cg_exo -60.93 -24.88 80.37 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.307 2.005 . . . . 0.0 112.59 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.447 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 45.6 m -68.68 -34.29 75.42 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -76.16 -55.77 5.27 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.617 HD21 ' HB ' ' A' ' 13' ' ' ILE . 4.4 mt -51.4 -41.85 61.01 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.733 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.555 ' O ' HG22 ' A' ' 23' ' ' VAL . 61.2 t80 -50.97 -57.48 8.48 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.733 ' CB ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -68.09 -40.08 82.74 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.254 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.858 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -66.62 -2.45 4.86 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.263 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.443 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 2.6 m-85 -118.67 -9.64 10.18 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.6 HG23 ' N ' ' A' ' 24' ' ' LEU . 33.9 m -131.76 -50.91 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.059 HD12 ' N ' ' A' ' 25' ' ' ASP . 2.7 pp -99.65 -30.52 12.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -176.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 1.059 ' N ' HD12 ' A' ' 24' ' ' LEU . 62.4 m-20 -112.84 -5.59 13.86 Favored 'General case' 0 C--O 1.214 -0.802 0 O-C-N 121.599 -0.688 . . . . 0.0 111.516 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -68.13 -40.99 82.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.259 0.552 . . . . 0.0 111.383 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.585 ' CB ' ' HZ1' ' A' ' 54' ' ' LYS . 13.9 m-20 -84.37 17.8 2.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.027 0.918 . . . . 0.0 110.889 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.403 ' H ' ' H ' ' A' ' 29' ' ' LEU . 62.7 m-20 -139.07 -9.0 1.33 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.781 HD12 HG23 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -89.23 -47.49 8.02 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.655 -179.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.593 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -60.83 -43.03 90.35 Favored Pre-proline 0 C--O 1.208 -1.111 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 28.7 Cg_endo -62.2 -26.14 77.47 Favored 'Trans proline' 0 C--N 1.321 -0.905 0 CA-C-N 120.635 1.263 . . . . 0.0 112.252 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -76.94 -61.64 1.91 Allowed 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.351 0.596 . . . . 0.0 112.343 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.452 HD13 ' HB2' ' A' ' 149' ' ' TYR . 2.1 pt -94.4 -34.55 5.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.617 -177.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.71 ' HB2' ' HG ' ' A' ' 145' ' ' LEU . . . -102.68 67.3 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 123.224 0.609 . . . . 0.0 112.513 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.424 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 65.2 Cg_endo -72.7 -20.18 23.28 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.219 1.28 . . . . 0.0 108.882 176.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -72.87 -38.63 66.95 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.517 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.766 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -70.09 -81.91 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.443 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.616 HD12 ' N ' ' A' ' 38' ' ' ILE . 2.0 mp -109.57 144.07 18.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.0 110.13 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.69 -42.43 28.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.139 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.677 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 48.2 tp60 -173.63 164.74 4.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.677 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -166.03 145.16 6.02 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.141 0.495 . . . . 0.0 110.893 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -148.32 142.99 26.59 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.106 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.716 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -76.75 140.53 17.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.409 0.623 . . . . 0.0 110.863 -179.112 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.746 ' N ' HD12 ' A' ' 44' ' ' LEU . 3.6 mp -89.55 -40.41 12.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.652 ' O ' HG23 ' A' ' 52' ' ' THR . 12.5 mm-40 -143.51 134.21 25.11 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.346 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.98 -155.12 22.27 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.896 -0.482 . . . . 0.0 111.896 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.759 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -133.95 -12.52 2.55 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 123.096 0.558 . . . . 0.0 111.232 -178.191 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.63 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 135.96 12.31 1.15 Allowed Glycine 0 C--O 1.221 -0.663 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.436 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -106.36 -170.87 22.99 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -60.76 126.28 19.35 Favored 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 122.803 2.336 . . . . 0.0 113.119 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.96 5.84 57.25 Favored Glycine 0 N--CA 1.465 0.612 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 45' ' ' GLU . 15.0 m -93.12 141.53 28.31 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.832 -0.684 . . . . 0.0 111.47 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.674 HG22 HD13 ' A' ' 44' ' ' LEU . 2.2 mp -116.46 133.57 62.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.716 ' HG2' HG23 ' A' ' 43' ' ' ILE . 4.7 tmtp? -119.67 140.32 50.83 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.542 0.686 . . . . 0.0 111.148 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.742 ' CB ' HD11 ' A' ' 44' ' ' LEU . 54.6 tttt -119.17 121.19 39.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.258 178.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 56' ' ' ILE . 5.2 mp -105.52 127.12 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.5 m -102.57 118.88 37.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.245 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.53 177.37 6.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.585 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.41 144.45 40.78 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -60.03 -48.37 81.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.852 0.358 . . . . 0.0 110.752 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.7 61.62 3.45 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 m -149.54 174.66 12.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.936 0.398 . . . . 0.0 110.585 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.55 ' NE2' ' CE2' ' A' ' 64' ' ' TYR . 1.1 pt20 -66.79 -41.32 87.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.918 0.389 . . . . 0.0 110.664 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.55 ' CE2' ' NE2' ' A' ' 63' ' ' GLN . 73.9 m-85 -91.4 149.48 21.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.552 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.416 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . -127.85 -62.39 0.13 Allowed Glycine 0 N--CA 1.462 0.378 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -146.35 146.95 30.85 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.728 0.299 . . . . 0.0 110.211 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -157.02 147.66 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.93 0.395 . . . . 0.0 110.947 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -105.59 113.06 26.4 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.271 0.558 . . . . 0.0 111.243 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.86 110.15 21.02 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -101.96 129.69 48.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.918 0.389 . . . . 0.0 112.037 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 mp -70.86 137.26 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -96.25 -53.75 3.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.44 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.4 m -164.5 140.74 6.1 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.483 HD12 ' O ' ' A' ' 48' ' ' GLY . 44.8 mt -129.16 130.65 68.06 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.15 177.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.625 ' O ' ' N ' ' A' ' 79' ' ' TYR . 38.4 m-20 -115.39 87.62 2.7 Favored 'General case' 0 C--O 1.194 -1.86 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.638 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.8 pm0 -55.32 -39.57 70.11 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.31 -37.08 45.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.131 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.21 -9.84 15.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.32 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.2 m-85 62.03 51.96 3.48 Favored 'General case' 0 N--CA 1.438 -1.068 0 O-C-N 121.055 -1.028 . . . . 0.0 110.101 -177.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 55.5 p -106.41 144.09 33.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.056 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -134.66 121.26 20.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.023 0.439 . . . . 0.0 110.933 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 m -136.42 147.38 47.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.226 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -162.65 169.76 19.57 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.779 0.323 . . . . 0.0 110.628 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -146.49 139.11 25.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.131 0.491 . . . . 0.0 110.771 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.806 HD13 ' HB1' ' A' ' 90' ' ' ALA . 11.1 mt -79.95 111.62 16.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.61 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -75.59 -40.75 41.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.4 -178.386 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.61 ' N ' HD13 ' A' ' 86' ' ' ILE . 16.0 tt0 -155.24 171.98 18.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.81 0.338 . . . . 0.0 110.295 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.18 177.82 17.7 Favored Glycine 0 CA--C 1.509 -0.334 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -61.87 2.29 0.22 Allowed 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.806 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -66.61 -34.36 77.71 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.173 0.989 . . . . 0.0 110.35 177.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.876 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.31 14.96 22.56 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.175 0.59 . . . . 0.0 110.341 -177.095 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.4 p 45.16 -126.22 1.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.36 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -130.45 -13.01 3.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.967 0.413 . . . . 0.0 111.475 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.9 p -104.75 -5.73 21.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.79 HG21 ' CD1' ' A' ' 98' ' ' ILE . 72.1 mt -99.12 152.95 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 CA-C-O 122.059 0.933 . . . . 0.0 113.472 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -93.46 -54.01 3.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.919 178.279 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -171.66 147.64 2.33 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 121.623 0.725 . . . . 0.0 111.028 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.79 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.41 121.98 66.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 118' ' ' HIS . 11.4 t -107.39 146.12 32.05 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.412 0.625 . . . . 0.0 111.438 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -136.68 131.5 33.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.286 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.413 ' O ' HG12 ' A' ' 116' ' ' ILE . 29.4 tt0 -127.96 133.66 49.23 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.4 OUTLIER -139.88 133.0 29.63 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.894 -0.504 . . . . 0.0 109.899 -179.006 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.404 ' C ' HD23 ' A' ' 104' ' ' LEU . 87.1 tttt -119.77 133.22 55.69 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -102.43 128.28 49.09 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.94 137.27 55.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.239 -178.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.77 134.65 45.05 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.336 178.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 38.8 t -121.3 172.26 8.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.826 0.346 . . . . 0.0 110.152 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.482 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.73 -35.28 52.18 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.8 p -87.06 -16.79 34.56 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.696 -1.473 . . . . 0.0 113.87 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 162.24 -77.75 0.16 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.379 1.466 . . . . 0.0 111.779 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 83.1 p -164.62 130.98 2.94 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 126.07 1.748 . . . . 0.0 111.096 176.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.5 m -99.48 117.71 34.48 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mt -92.72 131.34 40.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.543 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 102' ' ' THR . 2.7 mtpt -104.38 117.05 33.23 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.828 ' C ' HD13 ' A' ' 116' ' ' ILE . 68.4 m -111.34 123.74 50.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.291 0.567 . . . . 0.0 111.066 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.915 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -107.69 135.67 45.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 123.35 0.66 . . . . 0.0 110.082 -178.045 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.1 m -104.8 135.15 46.72 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.516 ' CD2' ' OG1' ' A' ' 4' ' ' THR . 15.5 m80 -136.24 93.56 2.92 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.127 0.489 . . . . 0.0 110.378 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.823 ' C ' HG23 ' A' ' 2' ' ' VAL . 94.8 m-85 -86.82 101.92 13.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.229 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -95.73 101.37 13.05 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.288 0.566 . . . . 0.0 110.231 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.1 p -100.26 171.69 7.63 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.472 0.653 . . . . 0.0 111.335 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -108.07 157.52 18.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.837 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 42.26 -114.73 0.77 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.445 ' C ' HD22 ' A' ' 124' ' ' ASN . 0.4 OUTLIER -110.57 4.85 20.68 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 122.727 -0.278 . . . . 0.0 111.11 179.401 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -49.09 160.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.298 0.571 . . . . 0.0 110.227 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.467 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 19.8 pt-20 -150.25 146.06 26.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.08 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.8 mm -88.85 124.27 41.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -75.09 162.15 28.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.476 0.655 . . . . 0.0 111.839 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -69.53 -36.22 76.21 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.935 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.422 ' O ' HG22 ' A' ' 134' ' ' VAL . 49.2 mt-10 -65.13 -30.41 71.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.792 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -72.41 -47.9 45.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.055 0.455 . . . . 0.0 111.027 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.3 m -77.47 -26.43 15.3 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.982 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -67.13 -46.28 74.59 Favored 'General case' 0 C--O 1.222 -0.386 0 O-C-N 122.138 -0.351 . . . . 0.0 110.699 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.466 HG23 ' N ' ' A' ' 135' ' ' GLY . 35.4 m -70.4 -43.48 78.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.598 0.237 . . . . 0.0 110.818 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.466 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -70.16 -46.77 48.79 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -67.38 -48.97 65.83 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 122.503 -0.41 . . . . 0.0 110.84 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -55.72 -48.01 75.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 109.998 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -64.4 -53.9 41.27 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.526 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -47.76 -45.91 29.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.461 0.648 . . . . 0.0 110.55 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -55.73 -37.22 68.14 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.409 0.623 . . . . 0.0 109.545 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.83 -38.92 96.85 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.766 HD22 ' HB2' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -68.37 -38.5 81.45 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.518 ' O ' ' CD1' ' A' ' 143' ' ' PHE . 0.9 OUTLIER -58.85 -32.04 69.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.687 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -70.29 -33.76 71.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.769 177.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.71 ' HG ' ' HB2' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -67.79 -56.95 7.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.046 -179.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.781 HG23 HD12 ' A' ' 29' ' ' LEU . 59.1 mt -65.94 -48.94 80.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.664 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -47.5 -45.1 26.08 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.403 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.0 t -58.81 -37.7 76.96 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.878 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.634 ' O ' ' N ' ' A' ' 153' ' ' HIS . 11.2 t80 -59.65 -45.83 90.84 Favored 'General case' 0 C--O 1.189 -2.128 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.888 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.3 mm? -69.9 -42.79 72.92 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 119.445 1.021 . . . . 0.0 111.468 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -23.63 66.03 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.631 -0.668 . . . . 0.0 109.809 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.436 ' O ' ' ND1' ' A' ' 153' ' ' HIS . 4.7 m-20 -106.11 -14.22 15.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.353 0.597 . . . . 0.0 110.623 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 149' ' ' TYR . 44.0 m80 -155.38 66.94 4.91 Favored Pre-proline 0 C--N 1.304 -1.383 0 C-N-CA 125.572 1.549 . . . . 0.0 109.384 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.42 -3.13 10.37 Favored 'Trans proline' 0 C--N 1.321 -0.913 0 C-N-CA 122.969 2.446 . . . . 0.0 111.562 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.599 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 5.1 p30 -72.59 3.18 5.23 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.82 -178.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.578 ' O ' ' HD3' ' A' ' 20' ' ' LYS . . . -52.16 128.67 25.57 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 119.335 -2.103 . . . . 0.0 110.823 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.788 ' CD1' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER 51.67 5.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.046 0.538 . . . . 0.0 112.423 178.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.599 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.636 0 CA-C-O 118.128 -0.939 . . . . 0.0 109.852 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.649 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.809 HG23 ' C ' ' A' ' 119' ' ' TYR . 8.9 p -135.01 148.0 29.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.849 0.357 . . . . 0.0 111.229 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -98.4 110.03 22.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.547 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.475 HG23 ' CE1' ' A' ' 118' ' ' HIS . 68.4 m -96.56 132.84 41.75 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.656 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.67 128.87 37.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.066 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.09 133.47 48.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.8 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.42 HD22 ' N ' ' A' ' 7' ' ' ASN . 1.4 m-80 -134.0 174.54 10.36 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.765 0.317 . . . . 0.0 110.205 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.65 145.4 21.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.825 0.821 . . . . 0.0 112.079 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.31 134.63 27.75 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.831 -0.543 . . . . 0.0 110.138 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.94 147.44 23.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.891 0.377 . . . . 0.0 111.257 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 p -145.15 154.75 42.77 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.456 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -93.68 29.84 1.93 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.91 0.386 . . . . 0.0 110.397 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.636 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.3 mt -120.69 125.35 27.15 Favored Pre-proline 0 C--O 1.224 -0.265 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.073 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -49.7 148.91 11.28 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 121.999 1.799 . . . . 0.0 111.708 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.427 ' HA ' HD12 ' A' ' 18' ' ' LEU . 27.7 Cg_exo -57.78 -28.31 81.58 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.386 2.057 . . . . 0.0 112.746 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.476 ' C ' ' HE ' ' A' ' 17' ' ' ARG . 15.1 m -65.14 -35.53 81.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.713 ' HE ' ' N ' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -74.95 -55.57 5.64 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -178.512 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.636 HD11 ' O ' ' A' ' 13' ' ' ILE . 4.2 mt -53.16 -40.27 64.18 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.012 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.796 ' O ' HG22 ' A' ' 23' ' ' VAL . 62.4 t80 -50.25 -57.7 7.24 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.859 0.464 . . . . 0.0 112.09 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.73 ' HB2' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.77 -41.55 75.02 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.507 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.761 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -64.0 -4.4 3.39 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.603 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.504 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 5.0 m-85 -119.79 -8.67 9.84 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 19' ' ' PHE . 25.8 m -128.53 -50.53 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.007 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.9 pp -98.0 -31.41 12.17 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -176.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 1.007 ' N ' HD12 ' A' ' 24' ' ' LEU . 3.8 t70 -114.96 -5.59 12.54 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 118.842 0.746 . . . . 0.0 112.177 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -62.4 -42.24 99.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.315 0.579 . . . . 0.0 111.702 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -83.76 19.7 1.62 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.865 0.84 . . . . 0.0 110.028 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -139.85 -8.64 1.21 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.024 HD13 HG23 ' A' ' 146' ' ' ILE . 0.5 OUTLIER -96.97 -50.15 4.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.224 -178.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.559 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 41.5 mt -55.04 -44.15 99.45 Favored Pre-proline 0 C--O 1.217 -0.632 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 20.7 Cg_exo -63.13 -22.64 73.17 Favored 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 122.353 2.036 . . . . 0.0 110.958 176.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -74.65 -55.08 6.28 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.537 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.76 HD11 HD22 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -95.54 -35.07 5.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.322 -177.159 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.845 ' HB2' ' CG ' ' A' ' 145' ' ' LEU . . . -106.61 81.19 0.82 Allowed Pre-proline 0 CA--C 1.508 -0.639 0 CA-C-O 121.105 0.479 . . . . 0.0 111.93 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.75 -10.23 24.75 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 N-CA-C 107.33 -1.834 . . . . 0.0 107.33 174.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -74.61 -42.15 59.13 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.487 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.499 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -78.16 -80.03 0.12 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.188 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.516 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 5.6 mm -99.03 140.56 18.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.033 0.444 . . . . 0.0 110.99 -177.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -81.57 -42.9 19.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.915 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.662 ' NE2' ' H ' ' A' ' 41' ' ' ALA . 47.1 tp60 -178.44 165.51 1.77 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.802 ' HB1' ' NZ ' ' A' ' 54' ' ' LYS . . . -165.08 144.08 6.63 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.201 0.524 . . . . 0.0 110.934 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.557 ' N ' ' NZ ' ' A' ' 54' ' ' LYS . 10.4 pt-20 -145.6 143.17 29.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.954 0.407 . . . . 0.0 111.249 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.465 HG13 ' H ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -78.57 142.09 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.485 0.66 . . . . 0.0 111.39 -179.104 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.9 mt -86.36 -39.7 16.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.418 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.915 ' O ' HG23 ' A' ' 52' ' ' THR . 40.7 mt-10 -148.18 133.61 18.61 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.618 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.93 -156.26 22.87 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.678 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -132.68 -10.54 3.12 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.95 0.405 . . . . 0.0 111.054 -179.203 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.627 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 134.36 21.0 0.78 Allowed Glycine 0 C--O 1.222 -0.619 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -178.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -110.3 -171.75 20.0 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -62.09 124.81 15.1 Favored 'Trans proline' 0 C--N 1.32 -0.966 0 C-N-CA 122.433 2.089 . . . . 0.0 113.036 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.8 3.78 59.23 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.915 HG23 ' O ' ' A' ' 45' ' ' GLU . 66.5 m -93.69 140.57 29.49 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.555 -0.823 . . . . 0.0 111.064 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.58 125.21 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.802 ' NZ ' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -115.52 138.18 51.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.254 0.55 . . . . 0.0 110.131 178.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.404 ' C ' HD12 ' A' ' 56' ' ' ILE . 75.9 tttt -120.43 132.07 55.07 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.708 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.784 ' N ' HD12 ' A' ' 56' ' ' ILE . 1.5 mp -103.28 140.8 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.0 m -113.48 118.64 35.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.83 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.516 ' CZ ' HD13 ' A' ' 38' ' ' ILE . 7.4 m-85 -101.47 -177.84 3.55 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.955 0.407 . . . . 0.0 110.942 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.25 145.77 35.17 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -59.61 -46.62 88.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.746 0.308 . . . . 0.0 110.794 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.72 61.56 3.45 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.3 t -142.96 175.04 10.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.916 0.389 . . . . 0.0 110.614 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -59.82 -51.49 69.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 110.665 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.404 ' OH ' ' NZ ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -107.11 143.47 35.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.165 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.06 -48.93 0.91 Allowed Glycine 0 CA--C 1.52 0.39 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -145.49 153.44 41.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.105 0.478 . . . . 0.0 110.624 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -154.02 146.34 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.554 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.6 ' HB3' HD11 ' A' ' 86' ' ' ILE . 80.4 mttt -105.57 106.11 16.45 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.436 0.636 . . . . 0.0 111.701 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.49 ' CE1' HD21 ' A' ' 85' ' ' LEU . 1.1 m-70 -92.51 123.19 35.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.708 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -113.11 119.62 38.46 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.82 -0.55 . . . . 0.0 111.068 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.61 HD13 HG22 ' A' ' 52' ' ' THR . 4.9 mp -70.22 137.16 24.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -99.61 -54.46 2.92 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.0 m -165.0 141.57 5.76 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 48' ' ' GLY . 43.8 mt -129.98 131.03 66.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.619 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.598 ' O ' ' N ' ' A' ' 79' ' ' TYR . 7.2 m-20 -116.25 87.89 2.78 Favored 'General case' 0 C--O 1.206 -1.217 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.637 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.1 pm0 -54.83 -41.14 70.34 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.06 -35.97 27.29 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.492 0.663 . . . . 0.0 109.223 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.444 ' O ' ' NZ ' ' A' ' 103' ' ' LYS . 0.6 OUTLIER -107.95 -10.5 15.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.409 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.598 ' N ' ' O ' ' A' ' 75' ' ' ASP . 1.9 m-85 63.24 50.32 3.03 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 120.989 -1.07 . . . . 0.0 110.024 -177.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 34.9 t -106.26 144.24 33.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.359 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -135.09 123.23 22.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.101 0.477 . . . . 0.0 110.588 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 p -132.57 134.64 45.2 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.133 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -144.62 159.08 43.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.145 0.498 . . . . 0.0 110.022 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.7 m -142.32 137.2 30.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.994 0.426 . . . . 0.0 110.586 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.594 HD13 ' HB1' ' A' ' 90' ' ' ALA . 6.2 mt -80.06 109.87 14.92 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' A' ' 68' ' ' LYS . 2.9 pt -79.56 -43.47 23.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.011 -178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' A' ' 88' ' ' GLY . 3.4 tp10 -149.99 172.1 15.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.739 0.304 . . . . 0.0 110.362 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.604 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.94 177.45 18.33 Favored Glycine 0 CA--C 1.509 -0.326 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -61.14 1.61 0.17 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.604 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -65.25 -35.36 80.81 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 124.105 0.962 . . . . 0.0 110.212 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.869 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.72 11.77 22.6 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 123.521 0.728 . . . . 0.0 109.623 -177.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.9 p 46.55 -126.65 1.49 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -131.04 -11.37 3.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.256 0.55 . . . . 0.0 110.816 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.19 -5.58 20.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.427 -177.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.711 HG21 ' CD1' ' A' ' 98' ' ' ILE . 94.4 mt -97.76 152.09 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.466 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -87.37 -61.27 1.76 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.337 177.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' O ' ' CB ' ' A' ' 120' ' ' HIS . 11.8 ptmt -172.26 149.59 2.28 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.489 0.661 . . . . 0.0 111.305 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.711 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.13 127.56 75.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.3 145.7 39.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.246 0.546 . . . . 0.0 111.635 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -138.45 136.66 36.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.265 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.13 134.2 49.07 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 120.916 0.389 . . . . 0.0 110.144 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.64 130.87 28.48 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.31 -0.869 . . . . 0.0 109.742 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.754 ' C ' HD23 ' A' ' 104' ' ' LEU . 25.9 tttp -127.22 134.3 50.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.867 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -102.99 125.27 49.68 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -178.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -130.32 137.89 55.19 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.624 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.916 -178.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.21 133.57 45.17 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.287 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 14.8 t -121.56 174.35 6.84 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 122.678 0.391 . . . . 0.0 110.426 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.422 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -54.97 -36.34 60.44 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 m -80.56 -15.28 57.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.411 1.484 . . . . 0.0 114.198 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.95 -90.13 0.13 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.426 1.965 . . . . 0.0 110.812 -168.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.8 OUTLIER -157.22 129.09 7.11 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 127.728 2.411 . . . . 0.0 111.005 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.412 ' N ' ' O ' ' A' ' 105' ' ' VAL . 43.9 m -99.8 118.91 37.28 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.2 mt -92.66 131.65 39.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.535 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -105.25 116.64 32.3 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.885 ' C ' HD13 ' A' ' 116' ' ' ILE . 53.4 p -111.56 128.45 56.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.383 0.611 . . . . 0.0 111.258 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.885 HD13 ' C ' ' A' ' 115' ' ' SER . 0.1 OUTLIER -112.07 135.77 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 C-N-CA 123.327 0.651 . . . . 0.0 109.92 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 p -110.38 136.93 48.78 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.475 ' CE1' HG23 ' A' ' 4' ' ' THR . 27.7 m-70 -135.7 95.54 3.26 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.026 0.441 . . . . 0.0 110.888 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.809 ' C ' HG23 ' A' ' 2' ' ' VAL . 5.6 m-85 -84.89 101.12 12.06 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.417 ' CB ' ' O ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -94.32 103.76 15.76 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.513 HG21 ' O ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER -100.09 161.73 13.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.665 -178.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.522 ' H ' HG22 ' A' ' 125' ' ' ILE . 8.1 ptmt -112.22 157.15 21.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 41.01 -123.15 2.47 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.769 ' H ' HD22 ' A' ' 124' ' ' ASN . 0.1 OUTLIER -95.08 -12.09 27.14 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.694 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.522 HG22 ' H ' ' A' ' 122' ' ' LYS . 1.1 tp -49.32 162.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.632 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -159.62 150.09 19.08 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.229 -0.294 . . . . 0.0 110.9 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.3 mm -86.34 124.86 40.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -76.82 160.4 29.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.448 0.642 . . . . 0.0 111.718 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -70.24 -41.08 74.01 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.615 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.558 ' O ' HG22 ' A' ' 134' ' ' VAL . 10.3 pt-20 -62.96 -26.14 68.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.674 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -72.97 -52.11 15.75 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.595 0.712 . . . . 0.0 111.162 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.413 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 3.6 m -77.02 -29.53 17.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.584 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.131 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -67.04 -45.85 76.19 Favored 'General case' 0 C--O 1.221 -0.4 0 O-C-N 122.259 -0.276 . . . . 0.0 111.105 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 130' ' ' GLU . 34.1 m -68.68 -46.56 79.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.917 0.389 . . . . 0.0 110.542 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.526 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -66.15 -44.28 91.44 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 132' ' ' VAL . 85.1 tttt -67.12 -46.62 73.59 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 122.691 -0.299 . . . . 0.0 110.956 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -54.56 -47.8 72.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.952 0.406 . . . . 0.0 110.086 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.404 ' NZ ' ' OH ' ' A' ' 64' ' ' TYR . 32.9 ttmt -61.13 -52.22 65.77 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.623 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.39 -51.96 31.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.604 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -47.94 -38.56 16.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.79 -33.85 88.08 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.736 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -75.89 -32.85 59.85 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.561 0.696 . . . . 0.0 109.408 179.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -59.22 -30.12 68.0 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -68.35 -42.32 79.41 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.603 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.845 ' CG ' ' HB2' ' A' ' 34' ' ' ALA . 0.8 OUTLIER -50.93 -58.57 5.69 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 114.088 -1.414 . . . . 0.0 112.154 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 1.024 HG23 HD13 ' A' ' 29' ' ' LEU . 23.1 mt -73.73 -49.47 35.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.164 -176.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 13.2 tt0 -45.98 -56.25 5.76 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.556 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 20.7 t -50.8 -47.55 59.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.321 0.581 . . . . 0.0 110.48 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.813 ' CG ' HD21 ' A' ' 29' ' ' LEU . 8.3 t80 -52.03 -51.88 54.54 Favored 'General case' 0 C--O 1.192 -1.934 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.837 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.9 mm? -62.45 -42.15 99.27 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-N 119.576 1.08 . . . . 0.0 112.208 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.47 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -62.99 -24.34 67.87 Favored 'General case' 0 C--N 1.319 -0.733 0 O-C-N 121.454 -0.779 . . . . 0.0 109.203 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.96 -12.95 15.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.097 0.475 . . . . 0.0 110.671 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.644 ' N ' ' O ' ' A' ' 149' ' ' TYR . 75.1 m80 -155.45 66.31 4.67 Favored Pre-proline 0 C--N 1.311 -1.103 0 C-N-CA 125.452 1.501 . . . . 0.0 110.162 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.55 -3.58 12.82 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 122.598 2.198 . . . . 0.0 111.597 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.57 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.7 OUTLIER -85.75 4.17 38.03 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 123.312 0.645 . . . . 0.0 111.67 -178.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.407 ' O ' ' HD3' ' A' ' 20' ' ' LYS . . . -49.53 130.01 19.82 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 120.062 -1.649 . . . . 0.0 111.264 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.642 ' CG ' HD13 ' A' ' 24' ' ' LEU . 2.8 t80 54.84 6.31 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.57 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 118.578 -0.725 . . . . 0.0 110.242 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.85 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.2 p -134.92 148.45 29.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 O-C-N 122.518 -0.401 . . . . 0.0 111.177 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.483 ' HB2' ' CD2' ' A' ' 119' ' ' TYR . 52.1 m-85 -99.36 111.66 23.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.735 177.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.7 m -96.48 140.17 31.51 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.958 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -138.73 134.49 33.62 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.21 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.44 ' HG2' HD12 ' A' ' 116' ' ' ILE . 0.8 OUTLIER -103.45 129.4 50.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.82 0.343 . . . . 0.0 111.024 -179.468 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -135.54 166.79 22.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.967 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.91 159.97 39.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.471 0.653 . . . . 0.0 112.593 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.474 ' CE1' ' O ' ' A' ' 10' ' ' THR . 81.6 t80 -151.01 140.85 21.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.365 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.474 ' O ' ' CE1' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -93.62 148.23 22.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.811 0.339 . . . . 0.0 111.363 -179.362 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 p -144.81 154.45 42.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.779 0.323 . . . . 0.0 110.698 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -96.72 25.06 5.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 110.555 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.684 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.3 mt -113.14 125.93 28.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -48.48 144.96 12.78 Favored 'Trans proline' 0 C--N 1.326 -0.616 0 C-N-CA 121.913 1.742 . . . . 0.0 111.735 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.638 ' CG ' ' HB2' ' A' ' 106' ' ' ALA . 31.2 Cg_exo -55.84 -24.64 48.21 Favored 'Trans proline' 0 N--CA 1.484 0.922 0 C-N-CA 122.457 2.105 . . . . 0.0 112.667 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.402 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 48.2 m -68.31 -36.19 78.94 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -178.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -76.36 -56.34 4.72 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.684 HD21 ' HB ' ' A' ' 13' ' ' ILE . 4.3 mt -48.48 -47.08 38.79 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.752 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.772 ' O ' HG22 ' A' ' 23' ' ' VAL . 39.0 t80 -49.43 -57.22 7.37 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.443 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.86 -24.46 63.43 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.364 -179.351 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.741 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -83.1 -2.69 56.05 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.373 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.433 ' CA ' ' HB2' ' A' ' 26' ' ' ALA . 2.1 m-85 -118.87 -8.23 10.32 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.896 HG23 ' CD1' ' A' ' 24' ' ' LEU . 2.8 m -134.07 -35.5 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.896 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.6 mp -90.71 -55.01 3.73 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.59 1.087 . . . . 0.0 111.922 -175.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 29' ' ' LEU . 17.4 t70 -113.59 -4.55 13.47 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.868 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -46.93 -42.25 17.41 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.511 ' HB3' ' HZ3' ' A' ' 54' ' ' LYS . 1.1 m-20 -84.95 18.3 2.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.67 0.748 . . . . 0.0 110.5 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -139.91 -9.79 1.17 Allowed 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 124.583 1.153 . . . . 0.0 108.555 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.996 HD13 HG23 ' A' ' 146' ' ' ILE . 0.5 OUTLIER -89.71 -45.78 9.08 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 124.513 1.125 . . . . 0.0 109.597 -178.693 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.616 HG13 HD11 ' A' ' 146' ' ' ILE . 26.3 mt -54.38 -53.99 53.29 Favored Pre-proline 0 C--O 1.214 -0.791 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 22.8 Cg_endo -60.78 -21.59 70.61 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 122.081 1.854 . . . . 0.0 111.542 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.5 tmtp? -69.12 -52.63 26.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.699 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.776 HG13 HD12 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -95.85 -36.5 6.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.077 -177.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.742 ' HB2' ' CG ' ' A' ' 145' ' ' LEU . . . -107.04 82.27 1.09 Allowed Pre-proline 0 CA--C 1.506 -0.717 0 C-N-CA 123.159 0.584 . . . . 0.0 111.573 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.36 -9.81 27.07 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 N-CA-C 107.476 -1.778 . . . . 0.0 107.476 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -73.95 -42.09 61.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.499 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.559 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -75.43 -82.34 0.07 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.751 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 89.1 mt -107.76 143.36 18.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.98 0.419 . . . . 0.0 110.655 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -79.83 -46.18 17.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.174 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.708 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -179.5 166.59 1.43 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.467 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.708 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -165.19 147.7 7.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.926 0.393 . . . . 0.0 111.044 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' N ' ' HE2' ' A' ' 54' ' ' LYS . 10.9 pt-20 -137.79 145.41 42.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.31 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.622 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -77.16 139.94 17.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.509 0.671 . . . . 0.0 110.716 -179.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 7.5 mp -89.02 -39.27 13.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.787 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.876 ' O ' HG23 ' A' ' 52' ' ' THR . 28.0 mt-10 -147.41 136.72 22.52 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.425 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.63 -155.92 22.91 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.761 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -139.07 0.02 1.9 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 122.819 0.448 . . . . 0.0 110.749 -179.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.35 11.52 3.37 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -111.11 -172.2 19.53 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 117.349 0.574 . . . . 0.0 112.123 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -59.15 126.71 21.74 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 122.676 2.25 . . . . 0.0 113.275 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.5 2.73 56.51 Favored Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.876 HG23 ' O ' ' A' ' 45' ' ' GLU . 60.8 m -94.4 139.8 30.64 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.104 -1.048 . . . . 0.0 111.651 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.667 HD12 ' C ' ' A' ' 52' ' ' THR . 1.8 mp -120.08 126.26 75.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.622 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -114.28 139.02 49.76 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.362 0.601 . . . . 0.0 110.509 179.244 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.492 ' C ' HD12 ' A' ' 56' ' ' ILE . 34.5 ttpt -118.44 127.12 53.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.096 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.775 ' N ' HD12 ' A' ' 56' ' ' ILE . 1.8 mp -105.5 135.7 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.6 m -111.25 120.5 42.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.08 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 59' ' ' GLY . 4.6 t80 -91.69 179.29 5.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.671 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.429 ' N ' ' CD1' ' A' ' 58' ' ' PHE . . . -54.39 143.93 30.07 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -60.65 -59.45 5.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.884 0.373 . . . . 0.0 110.994 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.72 61.79 3.42 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.5 t -137.66 175.22 9.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.87 0.367 . . . . 0.0 110.692 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -61.49 -45.08 95.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.685 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -91.87 155.07 18.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.537 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.4 -61.37 0.13 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.17 154.7 42.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.084 0.469 . . . . 0.0 110.63 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 p -155.49 146.95 12.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.024 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -105.66 114.97 29.45 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.31 0.576 . . . . 0.0 112.267 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.588 ' CE1' ' CD2' ' A' ' 85' ' ' LEU . 1.8 m80 -100.56 116.84 33.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.729 177.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -102.0 119.59 39.05 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.969 -0.457 . . . . 0.0 111.29 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.2 mt -77.74 145.61 9.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -106.53 -55.32 2.34 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.7 m -165.39 141.94 5.54 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.6 mt -123.16 131.18 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.287 176.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 79' ' ' TYR . 1.2 m-20 -116.01 87.64 2.72 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.466 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 9.8 pt-20 -54.96 -30.25 58.62 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.71 -39.06 70.55 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.98 -10.11 15.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.094 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.543 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.9 m-85 63.28 41.6 7.67 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 121.676 -0.64 . . . . 0.0 110.21 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.1 t -107.55 149.11 28.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.051 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 27.3 p90 -151.56 124.04 8.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.216 0.531 . . . . 0.0 110.965 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.66 144.56 51.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.208 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -144.65 171.66 14.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.806 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 m -144.64 136.23 25.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.135 0.493 . . . . 0.0 110.554 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.635 HD13 ' HB1' ' A' ' 90' ' ' ALA . 9.1 mt -79.83 120.02 23.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.439 HG12 ' H ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -85.11 -43.31 16.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.612 -178.609 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.479 ' OE2' ' N ' ' A' ' 88' ' ' GLY . 3.2 tm-20 -153.14 170.26 20.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.731 0.3 . . . . 0.0 110.265 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.615 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 118.17 178.48 17.16 Favored Glycine 0 CA--C 1.507 -0.465 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 178.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -61.83 2.03 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.293 1.044 . . . . 0.0 108.711 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.635 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -67.26 -34.31 77.17 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 124.215 1.006 . . . . 0.0 110.439 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.897 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.1 OUTLIER -110.25 16.15 21.9 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 123.305 0.642 . . . . 0.0 110.136 -177.348 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.4 p 47.36 -126.19 1.67 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.199 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -130.3 -13.05 3.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.769 0.318 . . . . 0.0 111.532 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.02 -7.04 19.48 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.778 HG21 ' CD1' ' A' ' 98' ' ' ILE . 63.7 mt -99.91 153.5 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 CA-C-O 121.8 0.809 . . . . 0.0 113.127 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.538 ' N ' HG22 ' A' ' 95' ' ' ILE . 5.9 pt-20 -99.41 -51.64 3.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.027 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.513 ' N ' ' CG ' ' A' ' 96' ' ' GLU . 64.4 mttt -164.71 146.68 8.27 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 121.177 0.513 . . . . 0.0 111.915 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.778 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.3 122.5 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.33 144.91 30.74 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.478 ' CZ ' ' OG ' ' A' ' 117' ' ' SER . 0.6 OUTLIER -139.88 131.79 27.68 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.665 179.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.525 ' CD ' ' N ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -129.15 130.92 47.02 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.525 ' N ' ' CD ' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -140.93 132.88 27.68 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.523 -0.736 . . . . 0.0 111.227 179.532 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.647 ' C ' HD23 ' A' ' 104' ' ' LEU . 26.3 ttpp -122.87 134.69 54.38 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.128 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.843 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.37 125.74 43.63 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.221 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.462 HG12 ' NZ ' ' A' ' 103' ' ' LYS . 0.7 OUTLIER -127.43 137.56 57.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.098 -178.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.638 ' HB2' ' CG ' ' A' ' 15' ' ' PRO . . . -72.3 133.71 45.15 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.368 178.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.441 ' SG ' ' N ' ' A' ' 111' ' ' SER . 27.1 p -121.66 174.25 6.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.945 0.402 . . . . 0.0 110.288 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.71 -34.51 56.39 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.6 m -79.31 -21.22 46.24 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 120.615 -1.521 . . . . 0.0 114.078 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.7 -88.45 0.12 Allowed Glycine 0 CA--C 1.524 0.626 0 C-N-CA 125.752 1.644 . . . . 0.0 109.5 -166.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 0.8 OUTLIER -159.39 129.37 5.61 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 126.006 1.722 . . . . 0.0 111.336 -179.043 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 105' ' ' VAL . 26.8 m -99.6 118.53 36.34 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.9 mt -92.32 132.05 37.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.428 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 102' ' ' THR . 7.2 mtpt -105.34 116.92 32.77 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.757 ' C ' HD13 ' A' ' 116' ' ' ILE . 40.0 p -111.1 118.21 35.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.28 0.562 . . . . 0.0 111.36 -178.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.936 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -102.59 135.76 38.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.478 ' OG ' ' CZ ' ' A' ' 100' ' ' TYR . 11.1 m -117.95 133.32 56.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.72 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -137.2 112.94 9.52 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.85 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -102.28 103.31 13.77 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.989 -0.444 . . . . 0.0 110.122 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -91.04 107.98 19.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.119 0.485 . . . . 0.0 110.147 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.438 HG22 HD11 ' A' ' 127' ' ' ILE . 11.3 p -100.52 175.47 5.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.582 0.706 . . . . 0.0 111.127 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.8 ptmm? -110.36 158.64 18.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.833 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 39.85 -111.13 0.2 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.802 ' H ' HD22 ' A' ' 124' ' ' ASN . 0.0 OUTLIER -112.75 0.4 15.27 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 122.502 -0.41 . . . . 0.0 111.515 179.339 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.5 mp -44.39 160.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.155 0.502 . . . . 0.0 110.641 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.474 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 93.3 mt-10 -147.98 146.92 29.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.212 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 121' ' ' THR . 22.1 mm -89.16 122.07 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -75.59 162.43 28.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.439 0.638 . . . . 0.0 112.135 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -69.53 -55.02 11.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.667 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' A' ' 130' ' ' GLU . 1.5 pm0 -53.82 -24.25 14.91 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.931 -0.481 . . . . 0.0 110.992 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.513 ' CE1' ' OE2' ' A' ' 130' ' ' GLU . 9.8 m80 -73.55 -53.27 10.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.253 0.549 . . . . 0.0 110.067 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 136' ' ' LYS . 3.9 m -77.81 -27.91 15.37 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.199 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -67.66 -46.1 73.36 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.979 -0.45 . . . . 0.0 110.928 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 130' ' ' GLU . 28.2 m -70.0 -42.93 79.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.663 0.268 . . . . 0.0 110.548 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.492 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -69.74 -46.47 53.58 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.462 ' HZ3' ' HB3' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -67.36 -47.08 71.47 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 122.692 -0.299 . . . . 0.0 110.712 179.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -55.16 -48.2 74.07 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -62.4 -51.87 65.83 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.62 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -50.08 -53.73 25.19 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.722 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -47.4 -38.91 14.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.771 0.796 . . . . 0.0 109.358 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.55 -32.73 84.24 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.674 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.6 OUTLIER -75.67 -36.3 60.14 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.698 0.761 . . . . 0.0 109.491 178.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -58.39 -25.47 62.13 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.57 -38.73 54.43 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.489 177.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.776 HD12 HG13 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -50.96 -58.64 5.53 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-O 122.442 1.115 . . . . 0.0 111.263 179.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.996 HG23 HD13 ' A' ' 29' ' ' LEU . 20.0 mt -72.81 -49.37 40.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.845 -177.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 38.2 tt0 -46.07 -52.17 12.48 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.547 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 24.7 p -54.09 -44.98 71.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.153 0.502 . . . . 0.0 110.637 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.732 ' CG ' HD21 ' A' ' 29' ' ' LEU . 11.2 t80 -53.89 -45.95 71.23 Favored 'General case' 0 C--O 1.183 -2.417 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.834 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.6 mm? -69.5 -42.5 74.66 Favored 'General case' 0 C--O 1.218 -0.591 0 O-C-N 120.592 -1.317 . . . . 0.0 111.887 -177.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.465 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.6 OUTLIER -63.72 -25.48 68.22 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 121.569 -0.707 . . . . 0.0 109.594 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 149' ' ' TYR . 0.2 OUTLIER -106.98 -12.93 15.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.406 0.622 . . . . 0.0 110.307 178.304 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.615 ' N ' ' O ' ' A' ' 149' ' ' TYR . 13.5 t-80 -154.67 65.97 4.97 Favored Pre-proline 0 C--N 1.306 -1.325 0 C-N-CA 124.98 1.312 . . . . 0.0 110.23 -177.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.59 -3.12 11.26 Favored 'Trans proline' 0 N--CA 1.482 0.799 0 C-N-CA 122.576 2.184 . . . . 0.0 111.616 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.617 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 1.9 m-20 -74.52 2.66 9.13 Favored 'General case' 0 C--O 1.213 -0.859 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.913 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.426 ' O ' ' HD2' ' A' ' 20' ' ' LYS . . . -50.33 129.48 21.7 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 119.354 -2.091 . . . . 0.0 110.996 -178.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.707 ' CG ' HD23 ' A' ' 24' ' ' LEU . 86.2 t80 53.03 5.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.544 0 O-C-N 121.179 -0.95 . . . . 0.0 110.069 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.889 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.805 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.1 p -134.68 149.62 29.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 O-C-N 122.313 -0.522 . . . . 0.0 110.703 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.61 109.82 22.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.451 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.643 HG23 ' NE2' ' A' ' 118' ' ' HIS . 74.2 m -96.25 139.89 31.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.799 0.333 . . . . 0.0 111.004 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.08 130.56 25.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.08 179.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.492 ' C ' HD22 ' A' ' 7' ' ' ASN . 0.8 OUTLIER -103.24 128.39 50.27 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.735 0.303 . . . . 0.0 110.766 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.492 HD22 ' C ' ' A' ' 6' ' ' GLU . 1.5 m120 -126.73 168.37 14.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.519 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -155.2 142.48 19.44 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -146.57 139.92 25.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.629 0.252 . . . . 0.0 110.766 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.45 148.23 23.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 111.227 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.4 p -144.77 154.44 42.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.564 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -92.1 18.76 7.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.906 0.384 . . . . 0.0 110.786 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.587 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.8 mt -108.06 126.01 30.74 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.194 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.01 147.37 7.89 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 121.6 1.533 . . . . 0.0 111.392 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.644 ' HG3' ' HB2' ' A' ' 106' ' ' ALA . 12.9 Cg_endo -63.99 -23.68 67.59 Favored 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 122.503 2.135 . . . . 0.0 112.754 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.8 m -66.19 -32.28 73.62 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.633 ' N ' ' CD ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -81.73 -55.14 4.82 Favored 'General case' 0 CA--C 1.496 -1.096 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -178.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.599 HD12 ' HA ' ' A' ' 15' ' ' PRO . 7.4 mt -47.05 -44.13 20.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.777 ' O ' HG22 ' A' ' 23' ' ' VAL . 54.7 t80 -51.79 -59.29 4.47 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.843 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.645 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -69.97 -23.37 63.16 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.698 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.734 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -82.25 -2.96 54.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.676 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CE2' ' OH ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -119.47 -9.22 9.89 Favored 'General case' 0 C--O 1.23 0.069 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.871 HG23 HD13 ' A' ' 24' ' ' LEU . 2.8 m -136.14 -37.02 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.909 HD23 ' CD2' ' A' ' 157' ' ' TYR . 3.4 mp -91.18 -52.89 4.6 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.208 0.913 . . . . 0.0 112.131 -176.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 93.0 m-20 -112.49 -4.18 14.26 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -55.02 -40.39 70.13 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 121.493 -0.755 . . . . 0.0 112.235 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -83.89 16.41 2.83 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.59 0.71 . . . . 0.0 110.905 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.499 ' C ' ' ND2' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -139.46 -10.2 1.24 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.555 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.813 HD13 HG23 ' A' ' 146' ' ' ILE . 0.4 OUTLIER -88.15 -40.96 13.32 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.722 -1.127 . . . . 0.0 110.119 -178.294 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.641 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -54.14 -50.65 83.31 Favored Pre-proline 0 C--O 1.207 -1.141 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 19.2 Cg_endo -62.18 -24.88 76.63 Favored 'Trans proline' 0 C--N 1.319 -1.014 0 C-N-CA 121.682 1.588 . . . . 0.0 112.185 178.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -67.98 -62.26 1.49 Allowed 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 121.74 0.781 . . . . 0.0 112.076 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.474 ' CD1' ' O ' ' A' ' 145' ' ' LEU . 1.9 pt -95.29 -32.98 4.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.075 -177.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.841 ' HB2' ' HG ' ' A' ' 145' ' ' LEU . . . -101.97 74.29 0.14 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 123.746 0.818 . . . . 0.0 112.679 -175.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.74 -20.06 26.83 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 121.201 1.267 . . . . 0.0 109.081 175.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.646 HE21 ' N ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -72.99 -40.98 64.79 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.84 178.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.701 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -70.81 -82.13 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.94 -177.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.614 HD12 ' C ' ' A' ' 37' ' ' ALA . 2.0 mp -112.54 145.09 19.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.145 0.498 . . . . 0.0 110.637 -177.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -78.36 -47.1 18.4 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.329 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.686 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -173.86 164.54 4.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.986 0.422 . . . . 0.0 110.003 179.298 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.686 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -166.1 145.57 6.09 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.746 178.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -138.59 142.71 39.16 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.603 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -78.39 140.0 17.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.501 0.667 . . . . 0.0 110.513 -179.549 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 44' ' ' LEU . 6.6 mp -89.39 -40.5 12.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.66 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.989 ' O ' HG23 ' A' ' 52' ' ' THR . 27.8 mm-40 -137.52 133.6 34.74 Favored 'General case' 0 C--O 1.215 -0.753 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.67 -156.59 46.46 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.632 HD22 ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -135.79 -4.93 2.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.777 0.322 . . . . 0.0 111.32 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.632 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 142.09 18.94 0.28 Allowed Glycine 0 C--O 1.221 -0.718 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -109.86 -172.91 20.53 Favored Glycine 0 C--O 1.224 -0.51 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -62.08 125.06 15.58 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 122.443 2.095 . . . . 0.0 113.009 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.58 5.67 60.06 Favored Glycine 0 N--CA 1.464 0.509 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.989 HG23 ' O ' ' A' ' 45' ' ' GLU . 87.2 m -93.53 140.69 29.32 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.414 -0.893 . . . . 0.0 111.005 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.686 HD12 ' C ' ' A' ' 52' ' ' THR . 1.9 mp -122.5 128.84 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.603 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -116.45 139.36 50.53 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.272 0.558 . . . . 0.0 110.76 178.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.46 ' C ' HD12 ' A' ' 56' ' ' ILE . 32.9 ttpt -118.47 124.76 48.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.989 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.783 ' N ' HD12 ' A' ' 56' ' ' ILE . 1.7 mp -103.26 130.89 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.6 m -109.26 118.49 36.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.828 0.347 . . . . 0.0 110.28 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -92.83 -175.58 3.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.558 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.97 144.04 32.26 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -59.72 -62.77 1.62 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.881 0.372 . . . . 0.0 110.809 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.94 61.9 3.34 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.1 m -137.28 175.38 9.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.746 0.308 . . . . 0.0 110.69 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -55.1 -53.52 54.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.841 0.353 . . . . 0.0 110.561 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -91.99 154.57 18.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.381 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.39 -61.57 0.14 Allowed Glycine 0 N--CA 1.461 0.321 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -145.62 148.01 32.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.942 0.401 . . . . 0.0 110.377 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.76 145.57 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.821 0.343 . . . . 0.0 110.846 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -105.87 109.6 21.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.401 0.62 . . . . 0.0 111.558 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.521 ' NE2' ' CG ' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -106.38 113.73 27.43 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.245 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -102.31 130.05 48.91 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.623 HD13 HG22 ' A' ' 52' ' ' THR . 4.5 mp -70.63 141.14 17.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -99.37 -55.58 2.64 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -165.6 141.56 5.22 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.406 HD11 ' CG1' ' A' ' 23' ' ' VAL . 69.5 mt -130.01 129.87 65.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 120.968 0.413 . . . . 0.0 110.57 177.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 79' ' ' TYR . 39.2 m-20 -115.78 88.57 2.91 Favored 'General case' 0 C--O 1.212 -0.897 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -53.75 -30.08 42.71 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.89 -37.36 71.28 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.122 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -107.62 -11.21 15.49 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.806 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.547 ' N ' ' O ' ' A' ' 75' ' ' ASP . 32.0 m-85 60.2 45.0 12.05 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 121.797 -0.564 . . . . 0.0 110.339 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 p -112.92 148.98 33.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.498 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 6.2 p90 -147.62 127.64 13.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.251 0.548 . . . . 0.0 111.182 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 m -130.32 147.13 52.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.241 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.521 ' CG ' ' NE2' ' A' ' 69' ' ' HIS . 15.0 p90 -153.68 168.25 26.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.824 0.345 . . . . 0.0 110.184 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 98' ' ' ILE . 3.7 m -145.6 139.45 26.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.054 0.454 . . . . 0.0 111.388 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.586 HD13 ' HB1' ' A' ' 90' ' ' ALA . 4.9 mt -80.52 111.91 17.37 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.691 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -72.01 -41.81 68.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.252 -177.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.691 ' N ' HD13 ' A' ' 86' ' ' ILE . 17.4 tp10 -156.39 171.82 19.57 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.617 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 117.59 177.83 17.45 Favored Glycine 0 CA--C 1.508 -0.373 0 N-CA-C 110.214 -1.155 . . . . 0.0 110.214 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -61.21 2.15 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.617 ' H ' ' C ' ' A' ' 88' ' ' GLY . . . -67.61 -36.03 80.07 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.982 0.913 . . . . 0.0 110.094 177.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.929 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -111.8 13.26 21.01 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 123.694 0.797 . . . . 0.0 109.253 -178.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 47.1 p 48.07 -126.32 1.84 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -131.17 -9.23 3.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.092 0.472 . . . . 0.0 110.51 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.6 t -104.9 -6.66 19.97 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.762 HG21 ' CD1' ' A' ' 98' ' ' ILE . 57.6 mt -100.62 151.6 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.485 ' N ' HG22 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -87.08 -58.83 2.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.514 177.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -170.55 148.77 3.13 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.191 0.52 . . . . 0.0 110.867 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.762 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.66 120.85 62.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.566 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.416 ' O ' ' CD1' ' A' ' 100' ' ' TYR . 9.5 t -109.65 145.5 36.38 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.375 0.607 . . . . 0.0 111.199 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 99' ' ' SER . 19.5 m-85 -135.69 129.41 32.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.221 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.428 ' O ' HG12 ' A' ' 116' ' ' ILE . 18.6 tt0 -127.8 133.72 49.45 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.32 136.37 36.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.859 0.361 . . . . 0.0 110.069 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -119.73 132.77 55.73 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -102.76 134.98 45.25 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.126 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.413 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.6 OUTLIER -137.05 136.77 47.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.994 -178.613 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.644 ' HB2' ' HG3' ' A' ' 15' ' ' PRO . . . -72.75 135.16 45.25 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.525 178.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.459 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 31.3 t -121.15 174.57 6.59 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.608 0.363 . . . . 0.0 110.161 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.459 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -55.8 -30.74 57.24 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 112.236 -0.346 . . . . 0.0 112.236 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.9 p -91.73 -12.47 33.87 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 119.552 -2.146 . . . . 0.0 115.634 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 158.16 -85.17 0.13 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.839 1.209 . . . . 0.0 111.407 -171.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.3 p -165.56 134.73 3.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.402 1.481 . . . . 0.0 110.858 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 105' ' ' VAL . 97.8 m -98.81 117.44 33.3 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 46.6 mt -92.81 127.54 44.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.69 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -104.25 116.23 31.8 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.782 ' C ' HD13 ' A' ' 116' ' ' ILE . 34.2 t -112.13 124.84 53.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.144 0.497 . . . . 0.0 111.432 -178.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.924 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -105.41 136.04 41.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 123.152 0.581 . . . . 0.0 109.486 -178.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.15 132.56 54.05 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.378 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.643 ' NE2' HG23 ' A' ' 4' ' ' THR . 26.1 m-70 -137.17 106.05 5.93 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 117.819 0.282 . . . . 0.0 110.91 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.805 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -101.45 103.83 14.75 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -89.97 109.8 20.81 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.18 0.514 . . . . 0.0 109.965 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.61 HG21 ' O ' ' A' ' 125' ' ' ILE . 0.6 OUTLIER -95.05 164.45 12.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.356 -178.219 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.491 ' H ' HG22 ' A' ' 125' ' ' ILE . 11.4 mtmt -92.46 146.92 23.31 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 34.0 -115.97 0.16 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.684 HD22 ' N ' ' A' ' 125' ' ' ILE . 0.4 OUTLIER -95.11 -13.73 24.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.812 0.339 . . . . 0.0 110.177 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.684 ' N ' HD22 ' A' ' 124' ' ' ASN . 1.1 tp -48.82 163.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -149.35 150.5 32.57 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.683 -0.635 . . . . 0.0 112.049 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.42 ' CD1' HG12 ' A' ' 95' ' ' ILE . 26.7 mm -86.67 124.89 40.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -75.25 160.79 29.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.587 0.708 . . . . 0.0 112.055 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -70.22 -43.57 70.38 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.382 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.441 ' O ' HG22 ' A' ' 134' ' ' VAL . 78.5 mt-10 -60.44 -24.87 65.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.348 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -72.7 -52.46 15.13 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.371 0.605 . . . . 0.0 110.86 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.5 m -76.09 -26.31 17.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.909 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -67.62 -46.27 73.02 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.403 -0.186 . . . . 0.0 111.094 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 135' ' ' GLY . 34.6 m -69.85 -43.99 79.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.478 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -66.13 -43.33 93.45 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -67.23 -46.98 72.17 Favored 'General case' 0 CA--C 1.518 -0.258 0 O-C-N 122.789 -0.242 . . . . 0.0 110.973 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -54.94 -47.63 74.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.879 0.371 . . . . 0.0 110.054 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.64 -55.13 22.18 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.494 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -47.67 -45.25 27.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.535 0.683 . . . . 0.0 110.776 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -56.83 -37.4 71.2 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.87 0.843 . . . . 0.0 109.3 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.16 -38.66 96.52 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.746 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -68.64 -36.53 78.72 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -59.04 -32.36 69.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.32 -34.44 77.36 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.868 177.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.841 ' HG ' ' HB2' ' A' ' 34' ' ' ALA . 1.2 mm? -68.27 -58.26 4.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.566 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.813 HG23 HD13 ' A' ' 29' ' ' LEU . 66.3 mt -60.79 -48.67 87.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.743 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -46.38 -52.96 11.89 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.14 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 21.5 p -50.17 -44.68 52.83 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.344 0.592 . . . . 0.0 111.349 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.683 ' CG ' HD21 ' A' ' 29' ' ' LEU . 32.9 t80 -58.5 -45.5 88.64 Favored 'General case' 0 C--O 1.182 -2.499 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.807 ' H ' HD22 ' A' ' 150' ' ' LEU . 2.0 mm? -65.06 -42.02 94.58 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 119.917 1.235 . . . . 0.0 111.966 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.463 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.4 OUTLIER -64.76 -24.98 67.73 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -106.58 -12.54 15.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.276 0.56 . . . . 0.0 110.961 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.68 ' N ' ' O ' ' A' ' 149' ' ' TYR . 94.1 m-70 -156.54 66.53 4.18 Favored Pre-proline 0 C--N 1.303 -1.429 0 C-N-CA 125.689 1.596 . . . . 0.0 110.59 -177.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.48 -2.72 11.15 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 122.468 2.112 . . . . 0.0 111.474 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.615 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.0 OUTLIER -77.36 3.7 12.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.914 -178.472 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.08 129.28 17.54 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 119.269 -2.145 . . . . 0.0 111.186 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.909 ' CD2' HD23 ' A' ' 24' ' ' LEU . 23.6 t80 54.08 6.73 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.048 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.438 0 O-C-N 121.402 -0.811 . . . . 0.0 110.225 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.829 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.1 p -134.85 148.87 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 122.544 -0.386 . . . . 0.0 110.91 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -97.89 109.73 22.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.526 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.2 m -97.05 136.03 38.19 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.67 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -135.47 129.29 32.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.328 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.404 ' C ' ' ND2' ' A' ' 7' ' ' ASN . 1.2 tt0 -103.14 134.16 47.03 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.643 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.404 ' ND2' ' C ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -127.14 168.78 14.19 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.627 -179.25 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -150.71 140.31 21.61 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -144.42 129.15 18.25 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.515 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 m -100.42 144.05 29.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.787 0.327 . . . . 0.0 111.653 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.0 t -145.43 164.34 31.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.485 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -94.66 25.75 3.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.746 0.308 . . . . 0.0 111.16 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.589 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.3 mt -111.55 125.42 30.44 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.781 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 45.9 Cg_exo -50.42 147.56 16.54 Favored 'Trans proline' 0 C--N 1.327 -0.594 0 C-N-CA 121.953 1.769 . . . . 0.0 111.652 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.439 ' HA ' HD12 ' A' ' 18' ' ' LEU . 26.8 Cg_exo -58.3 -25.08 71.03 Favored 'Trans proline' 0 N--CA 1.483 0.863 0 C-N-CA 122.279 1.986 . . . . 0.0 112.623 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.48 ' C ' ' HZ2' ' A' ' 20' ' ' LYS . 55.4 m -67.62 -35.27 78.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.311 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -75.42 -57.06 4.12 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.589 HD11 ' O ' ' A' ' 13' ' ' ILE . 4.6 mt -50.17 -44.69 52.91 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.008 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.529 ' O ' HG22 ' A' ' 23' ' ' VAL . 55.7 t80 -49.4 -58.68 4.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.005 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.771 ' CB ' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -67.57 -40.35 84.87 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 118.83 -1.148 . . . . 0.0 108.415 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.871 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -64.59 -2.99 2.7 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.445 179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.487 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 4.0 m-85 -118.35 -9.26 10.42 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 19' ' ' PHE . 30.7 m -130.22 -50.95 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.021 HD12 ' N ' ' A' ' 25' ' ' ASP . 1.9 pp -98.06 -31.32 12.2 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 1.021 ' N ' HD12 ' A' ' 24' ' ' LEU . 26.9 m-20 -114.21 -3.96 13.13 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-N 118.648 0.658 . . . . 0.0 111.555 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -66.88 -39.54 87.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.989 0.899 . . . . 0.0 111.187 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.52 16.99 3.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.125 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -138.35 -9.5 1.47 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.946 HD12 HG23 ' A' ' 146' ' ' ILE . 0.0 OUTLIER -90.47 -50.22 6.07 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.585 -1.643 . . . . 0.0 109.631 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.601 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 96.0 mt -55.65 -51.6 78.87 Favored Pre-proline 0 C--O 1.212 -0.883 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.054 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 29.1 Cg_endo -62.49 -26.05 76.13 Favored 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 121.747 1.632 . . . . 0.0 112.948 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.54 -60.79 2.08 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.633 0.73 . . . . 0.0 112.435 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.561 HD13 ' HB2' ' A' ' 149' ' ' TYR . 1.9 pt -93.07 -33.03 5.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.583 -177.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.861 ' HB2' ' HG ' ' A' ' 145' ' ' LEU . . . -102.79 68.15 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 123.121 0.569 . . . . 0.0 112.311 -177.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.424 ' CD ' ' O ' ' A' ' 33' ' ' ILE . 66.7 Cg_endo -72.89 -19.15 23.86 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 N-CA-C 108.726 -1.298 . . . . 0.0 108.726 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -73.4 -39.41 65.11 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.693 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.677 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -70.36 -82.15 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.69 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 73.3 mt -110.74 145.05 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.044 0.45 . . . . 0.0 110.588 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -77.8 -47.69 18.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.421 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.618 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -174.02 164.82 4.19 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.754 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.618 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -164.73 145.82 7.86 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 120.841 0.353 . . . . 0.0 110.993 178.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -137.63 145.5 42.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.716 0.293 . . . . 0.0 110.258 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.522 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -79.54 139.54 18.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.476 0.655 . . . . 0.0 110.654 -179.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 44' ' ' LEU . 6.9 mp -88.98 -39.48 13.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.795 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.944 ' O ' HG23 ' A' ' 52' ' ' THR . 42.9 mt-10 -141.89 133.57 27.0 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.843 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.24 -156.33 29.41 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.639 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -139.76 -8.3 1.24 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.96 0.41 . . . . 0.0 111.131 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.625 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 143.46 16.22 0.26 Allowed Glycine 0 C--O 1.219 -0.814 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.41 -172.04 19.99 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 117.394 0.597 . . . . 0.0 111.907 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -62.74 126.05 17.37 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 C-N-CA 122.858 2.372 . . . . 0.0 113.307 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.19 5.97 59.14 Favored Glycine 0 CA--C 1.506 -0.523 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.944 HG23 ' O ' ' A' ' 45' ' ' GLU . 92.7 m -93.18 138.65 31.39 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 114.239 -0.981 . . . . 0.0 110.949 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.89 128.46 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.522 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -116.79 139.79 50.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.726 0.774 . . . . 0.0 110.676 179.035 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.447 ' C ' HD12 ' A' ' 56' ' ' ILE . 46.7 tttm -118.47 127.84 54.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.828 178.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.757 ' N ' HD12 ' A' ' 56' ' ' ILE . 2.0 mp -104.47 136.61 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.9 m -117.15 120.0 36.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.368 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.04 169.06 10.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.365 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.11 143.99 28.82 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 0.8 OUTLIER -59.86 -50.38 74.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.849 0.357 . . . . 0.0 110.468 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.71 61.47 3.47 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.6 t -145.49 178.97 7.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 110.653 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -66.63 -45.68 78.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 0.0 110.626 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -91.46 154.74 18.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.397 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.44 -61.71 0.13 Allowed Glycine 0 CA--C 1.52 0.347 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.53 154.93 42.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.754 0.311 . . . . 0.0 110.28 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.83 149.95 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.723 0.297 . . . . 0.0 111.202 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.57 113.43 26.99 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.527 0.68 . . . . 0.0 112.044 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.607 ' CE1' ' CD1' ' A' ' 83' ' ' TYR . 6.7 t60 -109.63 112.08 23.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.721 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -102.4 131.44 49.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.144 0.497 . . . . 0.0 111.858 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.408 HD12 HG22 ' A' ' 52' ' ' THR . 13.8 mt -86.17 143.08 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -106.66 -54.89 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.2 m -164.81 141.92 6.14 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.459 HD12 ' O ' ' A' ' 48' ' ' GLY . 53.9 mt -124.81 131.26 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.872 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' A' ' 79' ' ' TYR . 5.8 m-20 -114.93 87.42 2.65 Favored 'General case' 0 C--O 1.21 -1.023 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.502 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 7.4 pt-20 -55.04 -30.63 59.97 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.57 -37.7 68.38 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.4 m -107.76 -10.46 15.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.922 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.56 ' N ' ' O ' ' A' ' 75' ' ' ASP . 2.2 m-85 62.84 44.57 6.19 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.625 -0.672 . . . . 0.0 109.865 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.5 t -105.96 145.66 31.03 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.469 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -132.13 120.82 22.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.191 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.473 ' CB ' ' OE1' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -127.11 133.25 50.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.321 -179.675 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.607 ' CD1' ' CE1' ' A' ' 69' ' ' HIS . 24.6 p90 -144.11 170.75 15.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.827 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.1 m -145.94 125.69 13.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.018 0.437 . . . . 0.0 110.876 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.529 HD12 HD21 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -79.08 118.25 20.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.673 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -85.75 -41.81 15.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -175.486 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.673 ' N ' HD13 ' A' ' 86' ' ' ILE . 10.0 tp10 -162.59 174.75 12.2 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 118.948 0.795 . . . . 0.0 110.816 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 119.76 178.31 16.38 Favored Glycine 0 CA--C 1.505 -0.578 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.6 2.75 0.16 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.758 ' C ' HD23 ' A' ' 91' ' ' LEU . . . -72.07 -37.38 69.64 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 123.917 0.887 . . . . 0.0 111.22 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.867 HD23 ' N ' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -111.29 17.04 20.61 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 119.672 -0.204 . . . . 0.0 110.625 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.4 p 54.25 -133.4 1.74 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -177.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -131.81 -0.7 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.5 p -104.72 -7.71 19.35 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.702 HG21 HD13 ' A' ' 98' ' ' ILE . 6.9 mt -99.2 151.25 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.481 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -87.07 -50.5 6.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.351 176.165 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.455 ' N ' ' HG2' ' A' ' 96' ' ' GLU . 12.1 ptmt -172.61 149.56 2.09 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.702 HD13 HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -120.9 130.38 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.155 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.434 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -113.15 144.26 42.96 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.902 0.481 . . . . 0.0 111.015 -179.037 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.489 ' CE1' ' OG ' ' A' ' 117' ' ' SER . 0.3 OUTLIER -139.22 131.55 28.39 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.87 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.473 ' OE1' ' CB ' ' A' ' 82' ' ' SER . 8.9 tp10 -128.73 133.0 48.01 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.408 ' N ' ' CD ' ' A' ' 101' ' ' GLU . 0.5 OUTLIER -136.26 131.63 34.71 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 121.596 -0.69 . . . . 0.0 110.631 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.734 ' C ' HD23 ' A' ' 104' ' ' LEU . 38.3 tttm -124.33 134.17 53.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.863 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.858 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -100.6 126.17 47.05 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -178.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 112' ' ' THR . 0.7 OUTLIER -128.32 136.69 59.43 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.959 -178.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.68 133.42 44.61 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.117 -0.364 . . . . 0.0 110.596 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 24.7 t -121.7 173.35 7.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.547 0.339 . . . . 0.0 110.158 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.443 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -54.4 -36.61 58.3 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.901 -0.479 . . . . 0.0 111.901 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.9 m -93.98 15.94 15.66 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.25 1.42 . . . . 0.0 113.363 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 130.0 -83.99 0.32 Allowed Glycine 0 CA--C 1.534 1.235 0 C-N-CA 126.4 1.952 . . . . 0.0 113.095 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 84.1 p -161.62 132.13 5.04 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 126.99 2.116 . . . . 0.0 111.057 176.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 105' ' ' VAL . 45.0 m -99.83 118.12 35.61 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 60.5 mt -92.72 126.83 45.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.57 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.62 116.86 32.65 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.812 ' C ' HD13 ' A' ' 116' ' ' ILE . 1.9 p -111.62 124.3 52.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.335 0.588 . . . . 0.0 110.877 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.927 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -106.8 136.18 42.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 123.148 0.579 . . . . 0.0 109.922 -177.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.489 ' OG ' ' CE1' ' A' ' 100' ' ' TYR . 7.2 t -116.52 133.04 56.48 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.788 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.434 ' ND1' ' O ' ' A' ' 99' ' ' SER . 0.2 OUTLIER -136.47 109.35 7.61 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 120.766 0.317 . . . . 0.0 110.522 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.829 ' C ' HG23 ' A' ' 2' ' ' VAL . 7.3 m-85 -102.14 104.02 14.61 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.228 -0.295 . . . . 0.0 110.512 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -90.86 110.16 21.37 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.064 0.459 . . . . 0.0 109.823 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.4 p -94.1 171.3 8.93 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 122.021 0.915 . . . . 0.0 111.929 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.7 ptmm? -112.93 142.57 45.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.829 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 53.83 -109.68 1.19 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.615 ' H ' ' ND2' ' A' ' 124' ' ' ASN . 0.1 OUTLIER -117.48 2.26 12.4 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 122.299 -0.53 . . . . 0.0 111.264 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.484 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.4 mp -43.45 161.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.344 0.592 . . . . 0.0 110.812 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.484 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 9.9 pt-20 -148.31 150.28 33.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.238 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.551 HD12 HD11 ' A' ' 95' ' ' ILE . 1.6 mm -87.78 125.62 41.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -74.88 160.89 30.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.11 0.481 . . . . 0.0 111.002 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -70.1 -39.7 75.37 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.566 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.584 ' O ' HG22 ' A' ' 134' ' ' VAL . 8.8 mm-40 -66.47 -25.15 66.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.587 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -72.42 -51.17 21.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.387 0.613 . . . . 0.0 110.81 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 m -78.42 -30.6 15.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.07 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -66.83 -46.0 76.5 Favored 'General case' 0 C--O 1.222 -0.354 0 O-C-N 122.156 -0.34 . . . . 0.0 111.077 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 130' ' ' GLU . 25.4 m -70.5 -44.71 76.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.611 0.243 . . . . 0.0 110.771 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.522 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -69.06 -46.83 57.3 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -67.45 -50.49 58.99 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.504 -0.409 . . . . 0.0 110.866 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -55.27 -47.77 74.98 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -63.15 -53.64 50.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.539 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -48.49 -47.86 38.34 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.412 0.625 . . . . 0.0 110.837 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -54.26 -37.61 64.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.02 -32.4 84.05 Favored Glycine 0 C--O 1.228 -0.247 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.712 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -74.61 -41.06 61.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -59.33 -25.72 64.42 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -76.29 -33.76 59.09 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.85 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.861 ' HG ' ' HB2' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -66.26 -56.78 9.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.1 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.946 HG23 HD12 ' A' ' 29' ' ' LEU . 61.9 mt -65.02 -48.73 82.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.653 -178.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -47.0 -47.57 22.01 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.158 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.0 t -54.84 -42.95 72.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.469 0.652 . . . . 0.0 111.26 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.636 ' O ' ' N ' ' A' ' 153' ' ' HIS . 26.8 t80 -59.08 -44.67 91.92 Favored 'General case' 0 C--O 1.191 -1.997 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.871 HD11 ' HB2' ' A' ' 21' ' ' ALA . 1.9 mm? -66.21 -42.48 88.7 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 119.491 1.041 . . . . 0.0 111.794 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.458 ' H ' ' HG2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -62.57 -24.83 67.75 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 121.525 -0.734 . . . . 0.0 109.329 179.511 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.438 ' O ' ' ND1' ' A' ' 153' ' ' HIS . 28.6 t70 -106.22 -13.42 15.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.034 0.445 . . . . 0.0 110.774 178.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.636 ' N ' ' O ' ' A' ' 149' ' ' TYR . 54.4 m80 -155.82 66.8 4.63 Favored Pre-proline 0 C--N 1.309 -1.168 0 C-N-CA 125.425 1.49 . . . . 0.0 110.43 -178.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -74.18 -3.37 13.7 Favored 'Trans proline' 0 C--N 1.324 -0.739 0 C-N-CA 122.579 2.186 . . . . 0.0 111.522 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.612 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 4.0 p-10 -81.95 4.82 21.16 Favored 'General case' 0 C--O 1.21 -0.975 0 C-N-CA 123.953 0.901 . . . . 0.0 111.991 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.401 ' O ' ' CD ' ' A' ' 20' ' ' LYS . . . -49.35 129.79 18.96 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 119.325 -2.11 . . . . 0.0 111.395 -178.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.526 ' CD2' HD22 ' A' ' 24' ' ' LEU . 13.6 t80 55.0 6.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.612 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.197 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.653 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.823 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.4 p -134.66 148.96 29.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 122.547 -0.384 . . . . 0.0 111.032 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.76 111.82 23.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.345 177.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.3 m -96.09 134.82 38.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.002 0.43 . . . . 0.0 110.2 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.688 ' CE2' ' ND2' ' A' ' 7' ' ' ASN . 0.2 OUTLIER -131.54 122.19 25.72 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.688 ' C ' HD22 ' A' ' 7' ' ' ASN . 1.5 tt0 -117.04 127.8 54.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.695 -0.229 . . . . 0.0 111.149 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.688 HD22 ' C ' ' A' ' 6' ' ' GLU . 1.4 m-80 -138.26 175.74 9.31 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.591 0.234 . . . . 0.0 110.818 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -144.31 156.17 44.14 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -149.86 134.04 17.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.954 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -92.91 144.84 24.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.859 0.362 . . . . 0.0 111.803 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.45 154.02 50.0 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.114 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -96.38 28.18 3.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.044 0.45 . . . . 0.0 110.715 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.694 ' HB ' HD21 ' A' ' 18' ' ' LEU . 1.5 mt -119.04 126.03 27.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.73 -178.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -46.99 145.64 6.94 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 121.823 1.682 . . . . 0.0 111.758 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -55.78 -29.73 73.14 Favored 'Trans proline' 0 N--CA 1.482 0.805 0 C-N-CA 122.263 1.975 . . . . 0.0 112.808 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.9 m -63.86 -35.46 80.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -74.96 -59.2 2.84 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.694 HD21 ' HB ' ' A' ' 13' ' ' ILE . 2.3 mt -50.88 -42.41 59.05 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.967 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.732 ' O ' HG22 ' A' ' 23' ' ' VAL . 40.8 t80 -50.24 -57.44 7.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.675 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.836 ' CB ' HD21 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -69.89 -40.74 75.49 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 118.572 -1.251 . . . . 0.0 109.102 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.847 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -63.49 -2.74 1.7 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.648 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.488 ' HB2' ' O ' ' A' ' 18' ' ' LEU . 5.4 t80 -118.96 -9.35 10.08 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.886 HG23 HD13 ' A' ' 24' ' ' LEU . 3.6 m -132.54 -49.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.98 ' H ' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -99.09 -31.56 11.71 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.033 1.288 . . . . 0.0 112.03 -178.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.813 ' N ' HD22 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -107.68 -3.97 18.66 Favored 'General case' 0 C--O 1.211 -0.953 0 O-C-N 122.082 -0.386 . . . . 0.0 111.432 -178.511 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -67.05 -40.33 87.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.742 0.782 . . . . 0.0 111.728 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -84.02 13.89 4.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.837 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.436 ' H ' ' H ' ' A' ' 29' ' ' LEU . 65.3 m-20 -134.85 -9.34 2.37 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.898 HD12 HG23 ' A' ' 146' ' ' ILE . 0.2 OUTLIER -96.71 -48.13 5.61 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.949 -179.693 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.702 HG13 HD11 ' A' ' 146' ' ' ILE . 74.8 mt -54.45 -56.1 30.38 Favored Pre-proline 0 C--O 1.217 -0.624 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 34.9 Cg_endo -63.37 -26.32 71.11 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 C-N-CA 122.298 1.999 . . . . 0.0 113.886 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -71.69 -49.41 39.9 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.601 0.715 . . . . 0.0 111.896 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.755 HD12 ' HB3' ' A' ' 145' ' ' LEU . 0.7 OUTLIER -94.76 -34.81 5.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.674 -177.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.783 ' HB1' ' HB3' ' A' ' 37' ' ' ALA . . . -105.58 64.07 0.14 Allowed Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.5 ' HD3' ' C ' ' A' ' 33' ' ' ILE . 73.0 Cg_endo -76.59 -24.46 10.37 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 N-CA-C 107.909 -1.612 . . . . 0.0 107.909 174.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -73.79 -44.2 56.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.411 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.783 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . . . -71.11 -77.76 0.09 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.15 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 mt -100.32 146.22 9.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 121.085 0.469 . . . . 0.0 110.191 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -78.08 -53.18 7.68 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.22 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.715 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -173.14 165.86 4.92 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.157 0.503 . . . . 0.0 110.578 179.758 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.715 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -166.07 145.21 6.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.966 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -149.2 142.34 24.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.897 0.38 . . . . 0.0 110.412 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.625 HG23 ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -78.74 140.72 16.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.358 0.599 . . . . 0.0 111.201 -179.356 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.761 ' N ' HD12 ' A' ' 44' ' ' LEU . 3.7 mp -90.47 -39.86 12.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.494 178.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 52' ' ' THR . 13.9 mm-40 -143.23 134.87 26.47 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.306 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.95 -155.02 22.23 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.991 -0.443 . . . . 0.0 111.991 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.751 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -135.53 -11.72 2.1 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 123.416 0.686 . . . . 0.0 111.315 -177.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.604 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 135.2 12.23 1.28 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -178.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 52' ' ' THR . . . -110.63 -172.28 19.87 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -59.05 127.24 23.5 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 122.479 2.119 . . . . 0.0 113.283 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.84 4.8 55.54 Favored Glycine 0 N--CA 1.462 0.384 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 45' ' ' GLU . 19.3 m -94.18 142.06 27.84 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.626 -0.787 . . . . 0.0 111.883 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.634 HD12 ' C ' ' A' ' 52' ' ' THR . 1.8 mp -118.17 132.86 66.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 176.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.625 ' HG2' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -121.82 139.39 53.67 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.465 0.65 . . . . 0.0 111.148 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.692 ' HB3' HD11 ' A' ' 44' ' ' LEU . 26.2 ttpt -119.23 118.73 32.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.293 178.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.23 137.69 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.634 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.1 m -118.97 117.77 29.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.165 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -94.91 -175.14 3.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.434 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.59 144.39 30.08 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 7.3 mp0 -60.18 -59.48 5.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.924 0.392 . . . . 0.0 110.29 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.98 60.82 3.43 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.6 m -138.89 -178.13 5.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.129 0.49 . . . . 0.0 110.706 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.585 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 1.8 mp0 -68.4 -44.14 75.74 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.441 ' CD1' ' OD2' ' A' ' 89' ' ' ASP . 52.2 m-85 -91.58 145.12 24.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.97 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -128.3 -62.08 0.12 Allowed Glycine 0 CA--C 1.519 0.299 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -146.14 151.91 38.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.843 0.354 . . . . 0.0 110.494 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -157.21 150.29 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.946 0.403 . . . . 0.0 111.279 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.58 ' HB3' HD11 ' A' ' 86' ' ' ILE . 28.2 mmtt -105.57 106.79 17.45 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.175 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.476 ' CD2' ' C ' ' A' ' 69' ' ' HIS . 1.2 t-160 -105.24 111.02 23.61 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -105.2 128.83 53.6 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.816 0.341 . . . . 0.0 111.497 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.485 HD13 ' CG2' ' A' ' 52' ' ' THR . 2.9 mp -74.03 144.96 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -98.89 -55.51 2.69 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.792 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.9 m -165.94 141.22 4.8 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.5 mt -123.41 131.8 72.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 176.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 79' ' ' TYR . 2.8 m-20 -115.92 87.96 2.79 Favored 'General case' 0 C--O 1.208 -1.125 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -54.39 -29.89 50.26 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.73 75.66 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.023 177.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -107.11 -11.3 15.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.052 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.574 ' N ' ' O ' ' A' ' 75' ' ' ASP . 9.0 m-85 60.3 44.16 12.78 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 121.537 -0.727 . . . . 0.0 110.45 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 34.4 t -109.75 146.24 35.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.835 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -131.65 123.29 27.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.004 0.43 . . . . 0.0 111.111 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.35 134.65 48.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.056 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -143.93 166.03 26.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.903 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.0 m -145.9 135.3 23.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.17 0.509 . . . . 0.0 111.189 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.589 HD13 ' HB1' ' A' ' 90' ' ' ALA . 10.2 mt -80.75 117.09 21.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.58 HD11 ' HB3' ' A' ' 68' ' ' LYS . 4.1 pt -81.68 -44.58 20.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.798 0.332 . . . . 0.0 111.487 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.468 ' N ' ' CG1' ' A' ' 86' ' ' ILE . 19.9 tt0 -151.42 172.5 15.86 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 120.761 0.315 . . . . 0.0 110.451 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.74 177.23 18.44 Favored Glycine 0 CA--C 1.509 -0.287 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.441 ' OD2' ' CD1' ' A' ' 64' ' ' TYR . 6.4 p30 -61.27 1.12 0.21 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.589 ' HB1' HD13 ' A' ' 85' ' ' LEU . . . -62.92 -35.3 79.62 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.004 0.922 . . . . 0.0 109.931 177.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.878 ' N ' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -110.89 12.66 22.25 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 123.802 0.841 . . . . 0.0 109.575 -177.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.1 p 47.82 -126.3 1.78 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -130.44 -11.3 4.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.991 0.425 . . . . 0.0 111.07 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.4 -6.72 19.29 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.747 HG21 ' CD1' ' A' ' 98' ' ' ILE . 96.3 mt -98.16 152.01 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-O 122.251 1.024 . . . . 0.0 113.56 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.546 ' OE2' ' CE1' ' A' ' 120' ' ' HIS . 0.0 OUTLIER -91.08 -54.12 4.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.932 177.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.66 145.74 1.57 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.038 0.447 . . . . 0.0 111.943 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.747 ' CD1' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -121.41 132.64 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.222 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.472 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 0.3 OUTLIER -119.36 144.87 46.64 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.723 0.409 . . . . 0.0 111.51 -178.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.472 ' CD2' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -136.35 130.26 32.58 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.798 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.506 ' O ' HG12 ' A' ' 116' ' ' ILE . 30.3 tt0 -129.41 134.14 47.7 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.524 0.202 . . . . 0.0 110.511 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.7 OUTLIER -132.27 135.56 46.33 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.922 -0.486 . . . . 0.0 109.719 -179.037 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -119.53 133.82 55.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.58 126.07 40.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.466 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.27 135.25 47.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.422 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -73.33 138.72 45.56 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 121.936 -0.477 . . . . 0.0 110.304 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 52.4 t -121.34 170.39 9.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.889 0.376 . . . . 0.0 110.317 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.551 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.56 -34.75 50.13 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.9 m -85.41 -15.06 44.3 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.112 1.365 . . . . 0.0 114.321 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.18 -85.64 0.13 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.92 1.724 . . . . 0.0 111.396 -171.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.468 ' HA ' ' N ' ' A' ' 107' ' ' CYS . 41.2 t -161.32 132.73 5.48 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.654 1.582 . . . . 0.0 111.221 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 55.0 m -99.92 128.76 45.98 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.299 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 9.2 mt -101.51 127.79 54.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.548 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 102' ' ' THR . 3.3 mtpt -105.37 116.89 32.71 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.849 ' C ' HD13 ' A' ' 116' ' ' ILE . 0.9 OUTLIER -111.68 123.08 49.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.954 0.407 . . . . 0.0 110.548 -178.307 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.9 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -109.65 136.39 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.358 -177.496 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.3 t -118.05 133.24 56.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.544 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.472 ' ND1' ' O ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -136.79 103.81 5.31 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 120.913 0.387 . . . . 0.0 110.176 -179.407 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.823 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -97.33 108.41 21.13 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.029 -0.42 . . . . 0.0 110.524 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.546 ' CE1' ' OE2' ' A' ' 96' ' ' GLU . 0.4 OUTLIER -88.98 104.74 17.25 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.793 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.3 p -88.52 170.42 10.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.996 0.903 . . . . 0.0 111.731 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -113.02 156.26 23.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.882 179.424 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . 35.07 -109.24 0.06 OUTLIER Glycine 0 CA--C 1.529 0.936 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 124' ' ' ASN . 4.4 t30 -111.41 -2.79 15.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.939 0.399 . . . . 0.0 111.063 178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 126' ' ' GLU . 1.3 mp -43.21 160.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.274 0.559 . . . . 0.0 110.572 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.429 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 34.7 tt0 -152.54 148.7 27.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.284 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.2 mm -88.15 124.79 41.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -74.74 161.72 29.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.421 0.629 . . . . 0.0 111.698 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -69.72 -41.74 74.94 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.775 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 134' ' ' VAL . 53.6 mt-10 -62.25 -27.09 68.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.713 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -73.03 -49.99 25.6 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.417 0.627 . . . . 0.0 111.342 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.9 m -77.61 -29.86 16.57 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.192 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 46.1 mttm -67.15 -45.73 76.18 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 122.22 -0.3 . . . . 0.0 110.96 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 130' ' ' GLU . 34.1 m -67.99 -44.25 85.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.792 0.329 . . . . 0.0 110.287 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.485 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -67.37 -39.18 91.68 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -67.05 -47.22 71.99 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.711 -0.288 . . . . 0.0 110.661 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -55.2 -46.81 75.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.949 0.404 . . . . 0.0 110.201 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -64.71 -52.51 56.77 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.454 ' O ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.47 -42.66 43.86 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.55 0.691 . . . . 0.0 110.56 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.414 ' O ' ' ND1' ' A' ' 140' ' ' HIS . 1.3 t60 -60.97 -36.09 78.51 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.891 0.853 . . . . 0.0 109.51 178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.411 ' O ' HD22 ' A' ' 145' ' ' LEU . . . -61.23 -44.79 97.66 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -65.57 -40.54 92.89 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -59.79 -28.69 67.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -77.49 -35.9 53.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.286 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.761 HD23 ' HB2' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -68.26 -57.69 5.58 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.514 0.674 . . . . 0.0 110.23 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.898 HG23 HD12 ' A' ' 29' ' ' LEU . 45.1 mt -58.21 -50.04 79.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.661 -177.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -46.87 -55.21 8.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.622 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 41.8 t -52.91 -44.49 66.99 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.508 0.671 . . . . 0.0 110.971 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.658 ' HB2' HD13 ' A' ' 33' ' ' ILE . 24.8 t80 -58.58 -45.58 88.74 Favored 'General case' 0 C--O 1.194 -1.832 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.847 HD11 ' HB2' ' A' ' 21' ' ' ALA . 2.2 mm? -66.22 -43.18 87.42 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 120.257 1.389 . . . . 0.0 111.565 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -61.5 -24.09 66.36 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 121.489 -0.757 . . . . 0.0 109.159 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.469 ' OD2' ' CE1' ' A' ' 153' ' ' HIS . 10.6 t70 -105.73 -13.26 15.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.46 0.648 . . . . 0.0 110.595 178.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 149' ' ' TYR . 56.0 m80 -155.51 67.14 4.89 Favored Pre-proline 0 C--N 1.312 -1.05 0 C-N-CA 125.199 1.4 . . . . 0.0 110.101 -178.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.51 -3.62 14.02 Favored 'Trans proline' 0 N--CA 1.481 0.756 0 C-N-CA 122.566 2.177 . . . . 0.0 111.576 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.618 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 0.5 OUTLIER -83.9 5.16 26.37 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.953 -179.026 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -48.97 129.89 17.83 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 119.594 -1.941 . . . . 0.0 111.394 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.687 ' CG ' HD23 ' A' ' 24' ' ' LEU . 0.3 OUTLIER 56.11 6.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.987 0.515 . . . . 0.0 112.059 178.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.618 ' ND2' ' O ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.202 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.828 HG23 ' C ' ' A' ' 119' ' ' TYR . 7.3 p -134.46 148.49 29.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.829 0.347 . . . . 0.0 110.715 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.76 109.7 22.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.601 177.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.7 m -96.53 137.27 35.86 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.313 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -135.52 129.18 32.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.471 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.471 ' C ' HD22 ' A' ' 7' ' ' ASN . 1.5 tt0 -103.36 129.39 50.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.94 0.4 . . . . 0.0 110.749 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.56 ' ND2' ' N ' ' A' ' 7' ' ' ASN . 0.0 OUTLIER -142.89 164.75 29.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -178.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -155.51 159.53 39.82 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -144.56 140.78 29.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.341 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.03 147.68 24.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 111.521 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.3 t -145.36 164.2 32.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.688 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -102.88 23.98 11.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.891 0.376 . . . . 0.0 110.843 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.686 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.7 mt -112.57 126.61 28.05 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.627 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -47.35 144.21 10.05 Favored 'Trans proline' 0 C--N 1.326 -0.613 0 C-N-CA 122.019 1.813 . . . . 0.0 111.974 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.505 ' HA ' HD12 ' A' ' 18' ' ' LEU . 39.6 Cg_exo -55.45 -24.55 44.26 Favored 'Trans proline' 0 N--CA 1.484 0.931 0 C-N-CA 122.361 2.04 . . . . 0.0 112.7 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.444 ' O ' ' CG ' ' A' ' 20' ' ' LYS . 13.2 p -70.08 -37.04 75.36 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.425 HH21 ' HD2' ' A' ' 17' ' ' ARG . 4.5 mtt85 -75.22 -47.65 27.17 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.686 HD11 ' O ' ' A' ' 13' ' ' ILE . 5.2 mt -57.42 -48.29 79.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.554 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.741 ' O ' HG22 ' A' ' 23' ' ' VAL . 48.5 t80 -46.18 -57.51 4.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.081 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -69.72 -26.02 64.13 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.579 0.704 . . . . 0.0 109.953 -179.296 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.854 ' HB2' HD11 ' A' ' 150' ' ' LEU . . . -83.72 -2.57 56.53 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.293 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.484 ' CA ' ' HB2' ' A' ' 26' ' ' ALA . 1.6 t80 -117.55 -9.02 10.89 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.878 HG23 ' CD1' ' A' ' 24' ' ' LEU . 2.3 m -134.62 -36.76 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.878 ' CD1' HG23 ' A' ' 23' ' ' VAL . 2.5 mp -92.29 -53.06 4.38 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.185 0.902 . . . . 0.0 111.391 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.57 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.4 m-20 -114.37 13.8 17.83 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 116.846 -0.161 . . . . 0.0 111.358 -176.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -66.9 -42.17 85.93 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 121.244 0.545 . . . . 0.0 111.192 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -83.94 18.59 1.99 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.075 0.941 . . . . 0.0 110.259 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -135.95 -9.11 2.07 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.894 HD12 HG23 ' A' ' 146' ' ' ILE . 0.1 OUTLIER -90.65 -51.31 5.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 113.493 -1.685 . . . . 0.0 110.706 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.626 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -58.5 -52.16 76.63 Favored Pre-proline 0 C--O 1.215 -0.723 0 CA-C-O 120.777 0.323 . . . . 0.0 110.742 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 22.8 Cg_endo -60.5 -21.79 69.6 Favored 'Trans proline' 0 C--N 1.322 -0.866 0 C-N-CA 122.632 2.222 . . . . 0.0 112.763 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -75.22 -52.06 11.82 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.839 0.352 . . . . 0.0 111.07 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -95.2 -35.04 5.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.159 -177.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.827 ' HB2' ' CG ' ' A' ' 145' ' ' LEU . . . -106.77 81.54 0.91 Allowed Pre-proline 0 CA--C 1.507 -0.679 0 C-N-CA 122.78 0.432 . . . . 0.0 111.728 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.15 -10.71 27.84 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 N-CA-C 107.227 -1.874 . . . . 0.0 107.227 174.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -42.29 58.24 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.402 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.512 ' HB2' HD22 ' A' ' 142' ' ' LEU . . . -73.79 -82.03 0.06 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.874 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.1 mm -107.63 142.82 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.965 0.412 . . . . 0.0 110.974 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -79.73 -45.12 19.48 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.67 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.687 HE21 ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -178.6 166.28 1.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.814 179.024 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.687 ' N ' HE21 ' A' ' 40' ' ' GLN . . . -166.13 145.06 5.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.241 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -141.43 146.05 36.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.208 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.417 HG13 ' H ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -79.67 139.6 18.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.471 0.653 . . . . 0.0 110.703 -179.4 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.3 mp -88.52 -39.87 13.85 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.129 -0.942 . . . . 0.0 108.684 178.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.911 ' O ' HG23 ' A' ' 52' ' ' THR . 24.1 mt-10 -142.52 133.75 26.13 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.976 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.58 -156.15 24.57 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.734 ' H ' HD22 ' A' ' 47' ' ' ASN . 0.0 OUTLIER -139.76 -10.62 1.18 Allowed 'General case' 0 C--N 1.32 -0.698 0 O-C-N 122.529 -0.394 . . . . 0.0 110.975 -179.613 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.499 ' N ' HD22 ' A' ' 47' ' ' ASN . . . 143.6 13.09 0.32 Allowed Glycine 0 C--O 1.221 -0.718 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.26 -171.24 20.67 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 117.344 0.572 . . . . 0.0 112.089 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -62.53 126.15 17.73 Favored 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 123.024 2.483 . . . . 0.0 113.58 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.27 5.84 56.94 Favored Glycine 0 N--CA 1.463 0.479 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.911 HG23 ' O ' ' A' ' 45' ' ' GLU . 88.3 m -93.37 140.5 29.5 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.271 -0.964 . . . . 0.0 111.145 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -119.18 129.98 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.498 ' HB3' ' HZ3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -118.16 140.93 49.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.074 0.464 . . . . 0.0 111.047 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -118.96 128.64 54.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.173 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.681 ' N ' HD12 ' A' ' 56' ' ' ILE . 3.2 mp -105.21 125.36 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 120.715 -0.394 . . . . 0.0 109.956 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.1 m -102.54 118.61 37.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -92.62 -174.83 3.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.76 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.73 143.86 31.61 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 8.9 mp0 -60.72 -63.57 1.25 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.909 0.385 . . . . 0.0 110.653 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.77 62.2 3.36 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.8 t -136.7 178.52 7.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.908 0.385 . . . . 0.0 110.754 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -60.81 -49.66 76.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.745 0.307 . . . . 0.0 111.018 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -91.92 137.83 32.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.496 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.4 -58.72 0.52 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.439 ' CD2' ' N ' ' A' ' 66' ' ' TYR . 7.3 p90 -145.71 152.42 39.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.001 0.429 . . . . 0.0 110.652 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 87' ' ' GLU . 7.3 p -156.69 141.99 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.844 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.467 ' O ' ' CD1' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -108.2 118.6 37.18 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 122.705 1.24 . . . . 0.0 112.735 -178.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.602 ' CE1' ' CD2' ' A' ' 83' ' ' TYR . 1.7 t60 -100.43 119.23 38.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.977 178.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -102.39 126.65 49.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.046 0.451 . . . . 0.0 111.576 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.2 mt -84.69 137.2 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -99.44 -55.98 2.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.8 m -165.26 141.87 5.63 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.486 HD12 ' O ' ' A' ' 48' ' ' GLY . 59.7 mt -126.6 131.07 71.63 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.939 176.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 79' ' ' TYR . 43.1 m-20 -115.06 88.48 2.88 Favored 'General case' 0 C--O 1.207 -1.147 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.489 ' O ' ' CE1' ' A' ' 79' ' ' TYR . 6.7 mt-10 -54.45 -30.37 52.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.92 -39.02 76.97 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.561 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -107.95 -10.42 15.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.213 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 75' ' ' ASP . 4.5 m-85 63.17 47.15 4.25 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 121.537 -0.727 . . . . 0.0 109.886 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 p -105.86 142.72 35.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.749 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.406 ' CE2' ' CD1' ' A' ' 83' ' ' TYR . 17.3 t80 -132.67 120.73 22.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.814 0.34 . . . . 0.0 110.641 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 p -127.07 129.62 48.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.341 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.679 ' CE2' ' CD1' ' A' ' 100' ' ' TYR . 34.5 p90 -144.97 164.59 30.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.033 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.6 m -146.09 125.6 13.23 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.115 0.483 . . . . 0.0 111.069 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.546 HD22 ' HA ' ' A' ' 69' ' ' HIS . 0.2 OUTLIER -80.17 121.67 25.86 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.582 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.738 HD13 ' H ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -83.72 -43.51 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -175.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.738 ' H ' HD13 ' A' ' 86' ' ' ILE . 6.0 tt0 -162.69 178.62 8.34 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.28 -0.888 . . . . 0.0 110.481 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.604 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . 115.87 178.71 18.34 Favored Glycine 0 CA--C 1.504 -0.646 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.48 2.63 0.16 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.804 ' C ' HD23 ' A' ' 91' ' ' LEU . . . -71.96 -38.03 69.82 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 123.572 0.749 . . . . 0.0 110.94 178.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.858 HD23 ' N ' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -111.37 17.46 20.14 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 93' ' ' ASP . 6.9 p 57.11 -133.94 1.27 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.433 ' N ' ' OG1' ' A' ' 92' ' ' THR . 52.3 t0 -130.66 0.39 4.4 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.8 p -104.91 -8.41 18.66 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.382 -0.824 . . . . 0.0 113.124 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.688 HG21 HD13 ' A' ' 98' ' ' ILE . 4.6 mt -100.12 151.39 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.47 ' N ' ' CG2' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -86.56 -50.75 6.61 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.285 176.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HA ' ' CD1' ' A' ' 91' ' ' LEU . 13.0 ptpt -171.72 148.98 2.49 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.688 HD13 HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -122.97 129.02 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.465 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.584 ' C ' ' HD1' ' A' ' 118' ' ' HIS . 0.3 OUTLIER -119.69 145.3 46.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.847 -179.302 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.679 ' CD1' ' CE2' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -142.89 135.66 27.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.733 0.301 . . . . 0.0 110.497 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -130.62 132.46 45.49 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 0.2 OUTLIER -131.73 133.83 45.23 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.09 -0.381 . . . . 0.0 110.511 -178.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -119.9 133.17 55.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -97.98 132.33 43.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -178.201 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.36 137.18 52.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.105 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 111' ' ' SER . . . -72.94 134.68 44.84 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.411 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.541 ' SG ' ' N ' ' A' ' 108' ' ' GLY . 43.1 t -121.32 171.16 8.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.79 0.329 . . . . 0.0 110.253 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.541 ' N ' ' SG ' ' A' ' 107' ' ' CYS . . . -53.51 -34.68 49.74 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 112.08 -0.408 . . . . 0.0 112.08 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.5 p -89.83 -13.38 36.67 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 118.765 -2.609 . . . . 0.0 114.116 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.64 -80.76 0.12 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.411 1.481 . . . . 0.0 112.401 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 83.3 p -161.51 131.54 4.88 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 126.577 1.951 . . . . 0.0 111.178 176.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.1 m -99.9 118.74 36.97 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 36.5 mt -92.34 127.49 44.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.121 -178.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -105.26 116.33 31.77 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.551 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.769 ' C ' HD13 ' A' ' 116' ' ' ILE . 69.2 p -111.93 123.97 51.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.199 0.523 . . . . 0.0 111.302 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.949 ' N ' HD13 ' A' ' 116' ' ' ILE . 0.1 OUTLIER -105.44 136.05 41.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -178.32 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.7 m -114.49 135.19 54.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.05 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.584 ' HD1' ' C ' ' A' ' 99' ' ' SER . 0.4 OUTLIER -137.24 109.17 7.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 110.433 -179.315 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.828 ' C ' HG23 ' A' ' 2' ' ' VAL . 5.4 m-85 -102.46 104.1 14.53 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -90.39 109.62 20.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.017 0.436 . . . . 0.0 109.852 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.2 p -93.93 169.9 9.95 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.952 0.882 . . . . 0.0 111.657 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.1 ptmt -113.31 157.47 21.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.055 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 40.7 -109.73 0.16 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.546 HD22 ' N ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -116.19 7.51 14.13 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 122.703 -0.292 . . . . 0.0 111.396 179.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.546 ' N ' HD22 ' A' ' 124' ' ' ASN . 1.5 mp -48.35 161.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.311 0.577 . . . . 0.0 110.761 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.49 ' N ' ' CG2' ' A' ' 125' ' ' ILE . 9.2 pt-20 -148.67 149.59 31.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.228 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.594 HD12 HD11 ' A' ' 95' ' ' ILE . 2.7 mm -87.69 124.5 40.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -75.92 160.09 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.561 0.696 . . . . 0.0 111.665 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -70.47 -47.34 61.09 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.446 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.542 ' O ' HG22 ' A' ' 134' ' ' VAL . 49.5 mt-10 -59.96 -24.52 64.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.6 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.59 ' C ' ' HD1' ' A' ' 131' ' ' HIS . 2.1 t-80 -72.08 -53.91 11.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.365 0.602 . . . . 0.0 110.718 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 m -77.32 -28.11 16.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.167 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -67.03 -46.53 74.16 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.224 -0.298 . . . . 0.0 111.069 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 130' ' ' GLU . 28.0 m -70.55 -44.18 77.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.678 0.275 . . . . 0.0 110.491 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.507 ' N ' HG23 ' A' ' 134' ' ' VAL . . . -67.97 -41.49 87.53 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -67.13 -51.02 59.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.804 0.302 . . . . 0.0 111.02 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -56.63 -48.27 77.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 110.325 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -63.03 -51.38 66.97 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.61 ' HA ' ' HG ' ' A' ' 142' ' ' LEU . . . -49.71 -54.74 17.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.597 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -47.43 -38.67 13.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.342 0.591 . . . . 0.0 109.635 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.12 -31.5 80.93 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.667 HD23 ' N ' ' A' ' 142' ' ' LEU . 0.8 OUTLIER -74.99 -38.53 61.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.67 0.748 . . . . 0.0 109.993 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -58.07 -28.32 64.46 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -75.75 -34.46 60.29 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.733 -1.122 . . . . 0.0 109.972 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.827 ' CG ' ' HB2' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -57.39 -61.42 2.5 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 122.191 0.996 . . . . 0.0 112.043 -179.615 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.894 HG23 HD12 ' A' ' 29' ' ' LEU . 26.7 mt -69.11 -48.46 69.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.403 -177.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -47.16 -42.71 20.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.1 t -59.91 -43.14 95.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.218 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.654 ' O ' ' N ' ' A' ' 153' ' ' HIS . 19.5 t80 -58.39 -45.05 89.08 Favored 'General case' 0 C--O 1.185 -2.341 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.923 ' H ' HD22 ' A' ' 150' ' ' LEU . 1.4 mm? -68.06 -43.67 78.1 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 119.993 1.269 . . . . 0.0 111.653 -178.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.408 ' HG2' ' H ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -65.18 -24.45 67.38 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.881 179.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.429 ' O ' ' CD2' ' A' ' 153' ' ' HIS . 51.6 t0 -106.92 -13.08 15.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.039 0.923 . . . . 0.0 110.948 178.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.654 ' N ' ' O ' ' A' ' 149' ' ' TYR . 30.4 m80 -155.8 66.68 4.61 Favored Pre-proline 0 C--N 1.302 -1.49 0 C-N-CA 125.403 1.481 . . . . 0.0 110.193 -177.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.53 ' O ' ' ND2' ' A' ' 158' ' ' ASN . 36.3 Cg_endo -66.35 -2.8 7.73 Favored 'Trans proline' 0 N--CA 1.481 0.736 0 C-N-CA 122.571 2.181 . . . . 0.0 111.108 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.61 ' CA ' HD21 ' A' ' 158' ' ' ASN . 3.2 p30 -71.37 4.63 2.79 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.078 0.951 . . . . 0.0 113.077 -178.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.94 129.71 43.16 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.584 -1.322 . . . . 0.0 113.042 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.685 ' CG ' HD23 ' A' ' 24' ' ' LEU . 81.7 t80 53.23 4.51 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 177.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.61 HD21 ' CA ' ' A' ' 155' ' ' ASP . 2.5 p30 . . . . . 0 C--N 1.323 -0.559 0 O-C-N 120.506 -1.371 . . . . 0.0 110.381 179.663 . . . . . . . . 1 1 . 1 stop_ save_